PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Koivomagi, M; Valk, E; Venta, R; Iofik, A; Lepiku, M; Balog, ERM; Rubin, SM; Morgan, DO; Loog, M				Koivomaegi, Mardo; Valk, Ervin; Venta, Rainis; Iofik, Anna; Lepiku, Martin; Balog, Eva Rose M.; Rubin, Seth M.; Morgan, David O.; Loog, Mart			Cascades of multisite phosphorylation control Sic1 destruction at the onset of S phase	NATURE			English	Article							CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; PROTEIN CKS1; INHIBITOR; COMPLEX; CDK1; G(1); ULTRASENSITIVITY; REPLICATION	Multisite phosphorylation of proteins has been proposed to transform a graded protein kinase signal into an ultrasensitive switch-like response(1-4). Although many multiphosphorylated targets have been identified, the dynamics and sequence of individual phosphorylation events within the multisite phosphorylation process have never been thoroughly studied. In Saccharomyces cerevisiae, the initiation of S phase is thought to be governed by complexes of Cdk1 and Cln cyclins that phosphorylate six or more sites on the Clb5-Cdk1 inhibitor Sic1, directing it to SCF-mediated destruction(1,5-8). The resulting Sic1-free Clb5-Cdk1 complex triggers S phase(9). Here, we demonstrate that Sic1 destruction depends on a more complex process in which both Cln2-Cdk1 and Clb5-Cdk1 act in processive multiphosphorylation cascades leading to the phosphorylation of a small number of specific phosphodegrons. The routes of these phosphorylation cascades are shaped by precisely oriented docking interactions mediated by cyclin-specific docking motifs in Sic1 and by Cks1, the phospho-adaptor subunit of Cdk1. Our results indicate that Clb5-Cdk1-dependent phosphorylation generates positive feedback that is required for switch-like Sic1 destruction. Our evidence for a docking network within clusters of phosphorylation sites uncovers a new level of complexity in Cdk1-dependent regulation of cell cycle transitions, and has general implications for the regulation of cellular processes by multisite phosphorylation.	[Koivomaegi, Mardo; Valk, Ervin; Venta, Rainis; Iofik, Anna; Lepiku, Martin; Loog, Mart] Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia; [Balog, Eva Rose M.; Rubin, Seth M.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Morgan, David O.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of Tartu; University of California System; University of California Santa Cruz; University of California System; University of California San Francisco	Loog, M (corresponding author), Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia.	Mart.Loog@ut.ee	Balog, Eva Rose M/P-7661-2014	Balog, Eva Rose M/0000-0001-6792-6914; Rubin, Seth/0000-0002-1670-4147; Morgan, David/0000-0001-8753-4416; Venta, Rainis/0000-0001-6635-992X	Wellcome Trust [079014/Z/06/Z]; EMBO; HHMI [1253]; Estonian Science Foundation [6766]; Estonian Ministry of Education and Research [SF0180071s07]; Norwegian government [08071N]; National Institute of General Medical Sciences; National Cancer Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069901] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); EMBO(European Molecular Biology Organization (EMBO)); HHMI(Howard Hughes Medical Institute); Estonian Science Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Norwegian government; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Kellogg for strains and L. Peil for advice on mass spectrometry. This work was supported by International Senior Research Fellowship No. 079014/Z/06/Z from the Wellcome Trust (M.Lo.), an installation grant from EMBO and HHMI (M.Lo.), no. 1253, grants no. 6766 from the Estonian Science Foundation (M.Lo.) and SF0180071s07 from Estonian Ministry of Education and Research (M.Lo.), EMP grant no. 08071N from the Norwegian government, and grants from the National Institute of General Medical Sciences (D.O.M.) and National Cancer Institute (S.M.R.).	ARVAI AS, 1995, J MOL BIOL, V249, P835, DOI 10.1006/jmbi.1995.0341; Borg M, 2007, P NATL ACAD SCI USA, V104, P9650, DOI 10.1073/pnas.0702580104; Bourne Y, 2000, STRUCT FOLD DES, V8, P841, DOI 10.1016/S0969-2126(00)00175-1; Cross FR, 2007, GENETICS, V176, P1541, DOI 10.1534/genetics.107.073494; Deshaies RJ, 2001, CELL, V107, P819, DOI 10.1016/S0092-8674(01)00620-1; HADWIGER JA, 1989, MOL CELL BIOL, V9, P2034, DOI 10.1128/MCB.9.5.2034; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; Kinoshita E, 2005, J SEP SCI, V28, P155, DOI 10.1002/jssc.200401833; Koivomagi M, 2011, MOL CELL, V42, P610, DOI 10.1016/j.molcel.2011.05.016; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; McCusker D, 2007, NAT CELL BIOL, V9, P506, DOI 10.1038/ncb1568; Mittag T, 2010, STRUCTURE, V18, P494, DOI 10.1016/j.str.2010.01.020; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Patra D, 1999, J BIOL CHEM, V274, P36839, DOI 10.1074/jbc.274.52.36839; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Reynard GJ, 2000, MOL CELL BIOL, V20, P5858, DOI 10.1128/MCB.20.16.5858-5864.2000; Schneider BL, 1996, SCIENCE, V272, P560, DOI 10.1126/science.272.5261.560; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; TANG Y, 1993, GENE DEV, V7, P822, DOI 10.1101/gad.7.5.822; Thomson M, 2009, NATURE, V460, P274, DOI 10.1038/nature08102; Tyers M, 1996, P NATL ACAD SCI USA, V93, P7772, DOI 10.1073/pnas.93.15.7772; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455	25	155	156	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 1	2011	480	7375					128	U301		10.1038/nature10560	http://dx.doi.org/10.1038/nature10560			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	21993622	Green Submitted, Green Accepted			2022-12-28	WOS:000298031900048
J	van den Bogaart, G; Meyenberg, K; Risselada, HJ; Amin, H; Willig, KI; Hubrich, BE; Dier, M; Hell, SW; Grubmuller, H; Diederichsen, U; Jahn, R				van den Bogaart, Geert; Meyenberg, Karsten; Risselada, H. Jelger; Amin, Hayder; Willig, Katrin I.; Hubrich, Barbara E.; Dier, Markus; Hell, Stefan W.; Grubmueller, Helmut; Diederichsen, Ulf; Jahn, Reinhard			Membrane protein sequestering by ionic protein-lipid interactions	NATURE			English	Article							GIANT UNILAMELLAR VESICLES; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; SYNTAXIN CLUSTERS; PLASMA-MEMBRANE; FUSION; SNARES; MODEL; ORGANIZATION; CHOLESTEROL; DOMAINS	Neuronal exocytosis is catalysed by the SNAP receptor protein syntaxin-1A(1), which is clustered in the plasma membrane at sites where synaptic vesicles undergo exocytosis(2,3). However, how syntaxin-1A is sequestered is unknown. Here we show that syntaxin clustering is mediated by electrostatic interactions with the strongly anionic lipid phosphatidylinositol-4,5-bisphosphate (PIP2). Using super-resolution stimulated-emission depletion microscopy on the plasma membranes of PC12 cells, we found that PIP2 is the dominant inner-leaflet lipid in microdomains about 73 nanometres in size. This high accumulation of PIP2 was required for syntaxin-1A sequestering, as destruction of PIP2 by the phosphatase synaptojanin-1 reduced syntaxin-1A clustering. Furthermore, coreconstitution of PIP2 and the carboxy-terminal part of syntaxin-1A in artificial giant unilamellar vesicles resulted in segregation of PIP2 and syntaxin-1A into distinct domains even when cholesterol was absent. Our results demonstrate that electrostatic protein-lipid interactions can result in the formation of microdomains independently of cholesterol or lipid phases.	[van den Bogaart, Geert; Amin, Hayder; Dier, Markus; Jahn, Reinhard] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; [Meyenberg, Karsten; Hubrich, Barbara E.; Diederichsen, Ulf] Univ Gottingen, Inst Organ & Biomol Chem, D-37077 Gottingen, Germany; [Risselada, H. Jelger; Grubmueller, Helmut] Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, D-37077 Gottingen, Germany; [Willig, Katrin I.; Hell, Stefan W.] Max Planck Inst Biophys Chem, Dept Nanobiophoton, D-37077 Gottingen, Germany	Max Planck Society; University of Gottingen; Max Planck Society; Max Planck Society	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, Fassberg 11, D-37077 Gottingen, Germany.	r.jahn@gwdg.de	van den Bogaart, Geert/A-1089-2014; Willig, Katrin/AAH-5418-2020; van den Bogaart, Geert/GLV-3283-2022	van den Bogaart, Geert/0000-0003-2180-6735; Willig, Katrin/0000-0002-1860-334X; van den Bogaart, Geert/0000-0003-2180-6735; Jahn, Reinhard/0000-0003-1542-3498; Diederichsen, Ulf/0000-0002-2654-9160	Human Frontier Science Program; US National Institutes of Health [P01 GM072694]; Deutsche Forschungsgemeinschaft [SFB803]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM072694] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Holt, G. Bunt, F. S. Wouters and C. Eggeling for advice, and V. Haucke and S. Joo for the red-fluorescent-protein-tagged synaptojanin-1 construct. G.v.d.B. is financed by the Human Frontier Science Program. This work was supported by the US National Institutes of Health (P01 GM072694, to R.J.) and the Deutsche Forschungsgemeinschaft (SFB803, to K.M., H.J.R., U.D., H.G. and R.J.).	Aoyagi K, 2005, J BIOL CHEM, V280, P17346, DOI 10.1074/jbc.M413307200; Bacia K, 2004, J BIOL CHEM, V279, P37951, DOI 10.1074/jbc.M407020200; Carvalho K, 2008, BIOPHYS J, V95, P4348, DOI 10.1529/biophysj.107.126912; Christian DA, 2009, NAT MATER, V8, P843, DOI [10.1038/NMAT2512, 10.1038/nmat2512]; Denisov G, 1998, BIOPHYS J, V74, P731, DOI 10.1016/S0006-3495(98)73998-0; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; HAY JC, 1993, NATURE, V366, P572, DOI 10.1038/366572a0; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kweon DH, 2002, BIOCHEMISTRY-US, V41, P9264, DOI 10.1021/bi025934+; Laage R, 2000, J BIOL CHEM, V275, P17481, DOI 10.1074/jbc.M910092199; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Levental I, 2009, BIOCHEMISTRY-US, V48, P8241, DOI 10.1021/bi9007879; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Murray DH, 2009, BIOCHEMISTRY-US, V48, P4617, DOI 10.1021/bi9003217; Sieber JJ, 2006, BIOPHYS J, V90, P2843, DOI 10.1529/biophysj.105.079574; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; van den Bogaart G, 2011, J MOL CELL BIOL, V3, P204, DOI 10.1093/jmcb/mjr004; Wen PJ, 2011, PROG LIPID RES, V50, P52, DOI 10.1016/j.plipres.2010.08.001; Williams D, 2009, MOL BIOL CELL, V20, P4910, DOI 10.1091/mbc.E09-04-0284; Yesylevskyy SO, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000810	29	415	416	3	251	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 24	2011	479	7374					552	555		10.1038/nature10545	http://dx.doi.org/10.1038/nature10545			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	851QI	22020284	Green Accepted, Green Published			2022-12-28	WOS:000297285600056
J	Black, R; Bennett, SRG; Thomas, SM; Beddington, JR				Black, Richard; Bennett, Stephen R. G.; Thomas, Sandy M.; Beddington, John R.			Migration as adaptation	NATURE			English	Editorial Material									[Black, Richard] Univ Sussex, Sch Global Studies, Brighton BN1 9SJ, E Sussex, England; [Bennett, Stephen R. G.] Govt Off Sci, Foresight Programme, London SW1H 0ET, England	University of Sussex	Black, R (corresponding author), Univ Sussex, Sch Global Studies, Brighton BN1 9SJ, E Sussex, England.	foresightweb@bis.gsi.gov.uk		Black, Richard/0000-0003-4276-2057				Cutter S., 2011, KATRINA EXODUS INTER; FINDLEY SE, 1994, INT MIGR REV, V28, P539, DOI 10.2307/2546820; Foresight, 2011, MIGR GLOB ENV CHANG; Gray CL, 2011, GLOBAL ENVIRON CHANG, V21, P421, DOI 10.1016/j.gloenvcha.2011.02.004; Kolmannskog V., 2009, 180 UNHCR; McGregor J., 2011, CONFLICT MIGRATION E; Penning-Rowsell E., 2011, POPULATION MOVEMENT; Ratha D, 2011, LEVERAGING MIGRATION FOR AFRICA: REMITTANCES, SKILLS, AND INVESTMENTS, P1, DOI 10.1596/978-0-8213-8257-8; UNDP, 2009, OV BARR HUM MOB DEV; World Bank, 2010, WORLD DEV REP 2010 P	10	462	470	5	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 27	2011	478	7370					447	449		10.1038/478477a	http://dx.doi.org/10.1038/478477a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	837JI	22012304	Bronze			2022-12-28	WOS:000296194200014
J	Casanova, J; Jose, J; Garcia-Berro, E; Shore, SN; Calder, AC				Casanova, Jordi; Jose, Jordi; Garcia-Berro, Enrique; Shore, Steven N.; Calder, Alan C.			Kelvin-Helmholtz instabilities as the source of inhomogeneous mixing in nova explosions	NATURE			English	Article							NUCLEOSYNTHESIS; SIMULATIONS; CONVECTION; EVOLUTION; MODELS	Classical novae(1,2) are thermonuclear explosions in binary stellar systems containing a white dwarf accreting material from a close companion star. They repeatedly eject 10(-4)-10(-5) solar masses of nucleosynthetically enriched gas into the interstellar medium, recurring on intervals of decades to tens of millennia. They are probably the main sources(3,4) of Galactic N-15, O-17 and C-13. The origin of the large enhancements and inhomogeneous distribution of these species observed in high-resolution spectra(5) of ejected nova shells has, however, remained unexplained for almost half a century(6). Several mechanisms(7), including mixing by diffusion(8), shear(9) or resonant gravity waves(10), have been proposed in the framework of one-dimensional or two-dimensional simulations, but none has hitherto proven successful because convective mixing can only be modelled accurately in three dimensions. Here we report the results of a three-dimensional nuclear-hydrodynamic simulation of mixing at the core-envelope interface during nova outbursts. We show that buoyant fingering drives vortices from the Kelvin-Helmholtz instability, which inevitably enriches the accreted envelope with material from the outer white-dwarf core. Such mixing also naturally produces large-scale chemical inhomogeneities. Both the metallicity enhancement and the intrinsic dispersions in the abundances are consistent with the observed values.	[Casanova, Jordi; Jose, Jordi] Univ Politecn Cataluna, EUETIB, Dept Fis & Engn Nucl, E-08036 Barcelona, Spain; [Casanova, Jordi; Jose, Jordi; Garcia-Berro, Enrique] Inst Estudis Espacials Catalunya, E-08034 Barcelona, Spain; [Garcia-Berro, Enrique] Univ Politecn Cataluna, Dept Fis Aplicada, E-08860 Castelldefels, Barcelona, Spain; [Shore, Steven N.] Univ Pisa, Dipartimento Fis Enrico Fermi, I-56127 Pisa, Italy; [Shore, Steven N.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Calder, Alan C.] SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA	Universitat Politecnica de Catalunya; Institut d'Estudis Espacials de Catalunya (IEEC); Universitat Politecnica de Catalunya; University of Pisa; Istituto Nazionale di Fisica Nucleare (INFN); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Jose, J (corresponding author), Univ Politecn Cataluna, EUETIB, Dept Fis & Engn Nucl, C Comte Urgell 187, E-08036 Barcelona, Spain.	jordi.jose@upc.edu	Calder, Alan/E-5348-2011; Garcia-Berro, Enrique/C-8034-2014	Calder, Alan/0000-0001-5525-089X	Department of Energy; Spanish Ministerio de Educacion y Ciencia; Agencia de Gestio d'Ajuts Universitaris i de Recerca of the Generalitat de Catalunya; E.U. European Fund for Regional Development; European Science Foundation	Department of Energy(United States Department of Energy (DOE)); Spanish Ministerio de Educacion y Ciencia(Spanish Government); Agencia de Gestio d'Ajuts Universitaris i de Recerca of the Generalitat de Catalunya(Generalitat de Catalunya); E.U. European Fund for Regional Development; European Science Foundation(European Science Foundation (ESF)European Commission)	The software used in this work was developed in part by the Department of Energy-supported Alliances Center for Astrophysical Thermonuclear Flashes at the University of Chicago. This work was partly supported by Spanish Ministerio de Educacion y Ciencia grants, by the Agencia de Gestio d'Ajuts Universitaris i de Recerca of the Generalitat de Catalunya, by the E.U. European Fund for Regional Development, and by the European Science Foundation EUROCORES Program EuroGENESIS. We also acknowledge the Barcelona Supercomputing Center for allocation of time at the MareNostrum supercomputer.	Arnett D, 2009, ASTROPHYS J, V690, P1715, DOI 10.1088/0004-637X/690/2/1715; Bode M, 2008, CAM ASTROPH, pXII; Casanova J, 2011, ASTRON ASTROPHYS, V527, DOI 10.1051/0004-6361/201015895; Casanova J, 2010, ASTRON ASTROPHYS, V513, DOI 10.1051/0004-6361/201014178; Fryxell B, 2000, ASTROPHYS J SUPPL S, V131, P273, DOI 10.1086/317361; FRYXELL BA, 1982, ASTROPHYS J, V261, P332, DOI 10.1086/160344; Gehrz RD, 1998, PUBL ASTRON SOC PAC, V110, P3, DOI 10.1086/316107; Gehrz RD, 2008, CAM ASTROPH, P167; Glasner SA, 2007, ASTROPHYS J, V665, P1321, DOI 10.1086/519234; Glasner SA, 2005, ASTROPHYS J, V625, P347, DOI 10.1086/429482; Glasner SA, 1997, ASTROPHYS J, V475, P754, DOI 10.1086/303561; HERNANZ M, 2002, CLASSICAL NOVA EXPLO; Jose J, 2006, NUCL PHYS A, V777, P550, DOI 10.1016/j.nuclphysa.2005.02.121; Jose J, 2008, CAM ASTROPH, P121; Kercek A, 1998, ASTRON ASTROPHYS, V337, P379; Kercek A, 1999, ASTRON ASTROPHYS, V345, P831; KUTTER GS, 1987, ASTROPHYS J, V321, P386, DOI 10.1086/165637; McLaughlin D. B, 1964, ANN ASTROPHYS, V27, P450; Pope S. B, 2001, TURBULENT FLOWS; Porter JM, 1998, MON NOT R ASTRON SOC, V296, P943, DOI 10.1046/j.1365-8711.1998.01470.x; PRIALNIK D, 1984, ASTROPHYS J, V281, P367, DOI 10.1086/162107; Rosner R, 2001, ASTROPHYS J, V562, pL177, DOI 10.1086/338327; Shore S., 2007, ASTROPHYSICAL HYDROD; Shore S. N., 1994, INTERACTING BINARIES; Shore SN, 1997, ASTROPHYS J, V490, P393, DOI 10.1086/304850; STARRFIELD S, 1972, ASTROPHYS J, V176, P169, DOI 10.1086/151619; Starrfield S, 2008, CAM ASTROPH, P77; Vaytet NMH, 2007, MON NOT R ASTRON SOC, V380, P175, DOI 10.1111/j.1365-2966.2007.12057.x; Zingale M, 2002, ASTROPHYS J SUPPL S, V143, P539, DOI 10.1086/342754	30	70	71	0	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 27	2011	478	7370					490	492		10.1038/nature10520	http://dx.doi.org/10.1038/nature10520			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	22012262				2022-12-28	WOS:000296194200037
J	Maybury, C; Horsley, A; Lord, R; Bright-Thomas, R				Maybury, Catriona; Horsley, Alex; Lord, Robert; Bright-Thomas, Rowland			PICTURE QUIZ A very breathless woman	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CYSTIC-FIBROSIS; DIAGNOSIS; ADULTS		[Maybury, Catriona; Horsley, Alex; Lord, Robert; Bright-Thomas, Rowland] Univ S Manchester Hosp, Manchester Adult Cyst Fibrosis Centre, Manchester M23 9LT, Lancs, England	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Maybury, C (corresponding author), Univ S Manchester Hosp, Manchester Adult Cyst Fibrosis Centre, Manchester M23 9LT, Lancs, England.	catriona.maybury@gmail.com	Horsley, Alex/F-3286-2013; Horsley, Alex/A-2505-2012; Lord, Robert/AAA-3618-2021	Lord, Robert/0000-0001-9008-2502; Horsley, Alex/0000-0003-1828-0058				Balfour-Lynn IM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001915.pub4; Davies JC, 2007, BMJ-BRIT MED J, V335, P1255, DOI 10.1136/bmj.39391.713229.AD; Fischer R, 2007, PEDIATR PULM, V42, P1193, DOI 10.1002/ppul.20717; Flume PA, 2009, AM J RESP CRIT CARE, V180, P802, DOI 10.1164/rccm.200812-1845PP; Grainger RG, 2001, DIAGNOSTIC RADIOLOGY; HALFHIDE C, 2005, COCHRANE DB SYST REV, V4; Horsley A., 2010, CYSTIC FIBROSIS; Jones A. P., 2003, COCHRANE DB SYST REV, V3; Langton Hewer SC, 2009, COCHRANE DB SYST REV, V4, DOI [DOI 10.1002/14651858.CD004197.PUB2, 10.1002/14651858.CD004197.pub3]; Lau EMT, 2010, PAEDIATR RESPIR REV, V11, P90, DOI 10.1016/j.prrv.2010.01.008; Mahadeva R, 1998, BMJ-BRIT MED J, V316, P1771, DOI 10.1136/bmj.316.7147.1771; Mishra Avantika, 2005, Clin Biochem Rev, V26, P135; Nick JA, 2005, CURR OPIN PULM MED, V11, P513; PANTIN CFA, 1986, THORAX, V41, P34, DOI 10.1136/thx.41.1.34; Rodman DM, 2005, AM J RESP CRIT CARE, V171, P621, DOI 10.1164/rccm.200403-404OC; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Ryan G, 2003, COCHRANE DB SYST REV, V3; Schwartz M, 2009, UKGTN TESTING CRITER; Southern KW, 2004, COCHRANE DB SYST REV, V2; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; Wark P, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001506.pub3; Widerman E, 2000, CHEST, V118, P427, DOI 10.1378/chest.118.2.427	22	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	2011	343								d5935	10.1136/bmj.d5935	http://dx.doi.org/10.1136/bmj.d5935			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840DA	22034145				2022-12-28	WOS:000296417300001
J	Senthinathan, A; Kelly, V; Dzingina, M; Jones, D; Baker, M; Longson, D				Senthinathan, A.; Kelly, V.; Dzingina, M.; Jones, D.; Baker, M.; Longson, D.		Guideline Dev Grp	GUIDELINES Hyperglycaemia in acute coronary syndromes: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Longson, D.] Natl Inst Hlth & Clin Excellence, Guideline Dev Grp, Manchester M1 4BD, Lancs, England	National Institute for Health & Care Excellence	Longson, D (corresponding author), Manchester Mental Hlth & Social Care Trust, Dept Psychiat, Manchester M8 5RB, Lancs, England.	damien.longson@manchester.ac.uk	Dzingina, Mendwas/C-4957-2014					Bartnik M, 2004, EUR HEART J, V25, P1880, DOI 10.1016/j.ehj.2004.07.027; *NAT I HLTH CLIN E, 2007, MI SEC PREV CLIN GUI; *NAT I HLTH CLIN E, 2006, OB CLIN GUID 43; *NAT I HLTH CLIN E, 2010, UNST ANG NSTEMI CLIN; *NAT I HLTH CLIN E, 2008, SMOK CESS SERV PUBL; National Institute for Health and Clinical Excellence, 2011, HYP AC COR SYNDR MAN; National Institute for Health and Clinical Excellence, 2006, BRIEF INT REF SMOK C; National Institute for Health & Clinical Excellence, 2006, 4 COMM US METH INCR; Ryden L, 2007, EUR HEART J SUPPL, V9, pC3, DOI 10.1093/eurheartj/ehl261; Stranders I, 2004, ARCH INTERN MED, V164, P982, DOI 10.1001/archinte.164.9.982; Weston C, 2007, HEART, V93, P1542, DOI 10.1136/hrt.2006.108696	11	21	23	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 26	2011	343								d6646	10.1136/bmj.d6646	http://dx.doi.org/10.1136/bmj.d6646			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840CY	22031910				2022-12-28	WOS:000296417100001
J	Cheng, HG; Gomez, C; Khan, S; Wali, S				Cheng, Henry G.; Gomez, Caitlin; Khan, Sarah; Wali, Soma			A purple rash	LANCET			English	Editorial Material							HENOCH-SCHONLEIN PURPURA		[Cheng, Henry G.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Internal Med, UCLA Med Ctr UCLA Olive View, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cheng, HG (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Internal Med, UCLA Med Ctr UCLA Olive View, Box 951720,12-159 CHS, Los Angeles, CA 90095 USA.	hcheng@mednet.ucla.edu						Chen TC, 2004, CLIN NEPHROL, V61, P213; Donghi D, 2009, DERMATOLOGY, V219, P167, DOI 10.1159/000223237; Nikibakhsh AA, 2010, INT J RHEUMATOL, V2010, DOI 10.1155/2010/254316; Pillebout E, 2002, J AM SOC NEPHROL, V13, P1271, DOI 10.1097/01.ASN.0000013883.99976.22; Pillebout E, 2010, KIDNEY INT, V78, P495, DOI 10.1038/ki.2010.150	5	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 22	2011	378	9801					1526	1526		10.1016/S0140-6736(11)61181-1	http://dx.doi.org/10.1016/S0140-6736(11)61181-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	838VC	22018013				2022-12-28	WOS:000296319600027
J	Nauenberg, M				Nauenberg, Michael			Comment on "How Cats Lap: Water Uptake by Felis catus"	SCIENCE			English	Editorial Material									Univ Calif Santa Cruz, Dept Phys, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Nauenberg, M (corresponding author), Univ Calif Santa Cruz, Dept Phys, Santa Cruz, CA 95064 USA.	michael@physics.ucsc.edu						CROMPTON AW, BIOL LETT, DOI DOI 10.1098/RSBL.2011.0336; Plateau J.A.F., 1873, STATIQUE EXPT THEORI, V2; RAYLEIGH, 1878, P LONDON MATH SOC S, V1, P4, DOI DOI 10.1112/PLMS/S1-10.1.4; Reis PM, 2010, SCIENCE, V330, P1231, DOI 10.1126/science.1195421; Williams AM, 2005, INT J FOOD ENG, V1, DOI 10.2202/1556-3758.1002	5	2	2	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 21	2011	334	6054								10.1126/science.1202324	http://dx.doi.org/10.1126/science.1202324			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	22021840				2022-12-28	WOS:000296052500029
J	Rochefort, C; Arabo, A; Andre, M; Poucet, B; Save, E; Rondi-Reig, L				Rochefort, Christelle; Arabo, Arnaud; Andre, Marion; Poucet, Bruno; Save, Etienne; Rondi-Reig, Laure			Cerebellum Shapes Hippocampal Spatial Code	SCIENCE			English	Article							BILATERAL VESTIBULAR DEAFFERENTATION; ENTORHINAL CORTEX; PURKINJE-CELLS; PLACE CELLS; INTEGRATION; ADAPTATION; BEHAVIOR; INPUT; TASK; MICE	Spatial representation is an active process that requires complex multimodal integration from a large interacting network of cortical and subcortical structures. We sought to determine the role of cerebellar protein kinase C (PKC)-dependent plasticity in spatial navigation by recording the activity of hippocampal place cells in transgenic L7PKCI mice with selective disruption of PKC-dependent plasticity at parallel fiber-Purkinje cell synapses. Place cell properties were exclusively impaired when L7PKCI mice had to rely on self-motion cues. The behavioral consequence of such a deficit is evidenced here by selectively impaired navigation capabilities during a path integration task. Together, these results suggest that cerebellar PKC-dependent mechanisms are involved in processing self-motion signals essential to the shaping of hippocampal spatial representation.	[Rochefort, Christelle; Arabo, Arnaud; Rondi-Reig, Laure] Univ Paris 06, CNRS, Navigat Memory & Aging ENMVI Team, Neurobiol Proc Adaptatifs UMR 7102, F-75005 Paris, France; [Andre, Marion; Poucet, Bruno; Save, Etienne] Aix Marseille Univ, CNRS, Lab Neurobiol & Cognit, UMR 6155, F-13331 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Rondi-Reig, L (corresponding author), Univ Paris 06, CNRS, Navigat Memory & Aging ENMVI Team, Neurobiol Proc Adaptatifs UMR 7102, F-75005 Paris, France.	laure.rondi@snv.jussieu.fr	Rondi-Reig, Laure/M-6141-2016; Poucet, Bruno/B-4019-2010; Rondi-Reig, Laure/G-2816-2011	Poucet, Bruno/0000-0003-2704-804X; rochefort, christelle/0000-0001-8466-5218; Rondi-Reig, Laure/0000-0003-1006-0501	Agence Nationale de la Recherche (ANR) [07-JCJC-0108-01, ANR-09-EMER-005-02]; Action Concertee Incitative (ACI) [NIC0027]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Action Concertee Incitative (ACI)	We thank C. De Zeeuw for providing L7PKCI mice; S. Quet and F. Jarlier for technical supports; C. Lamouroux for animal care; G. Dallerac and K. Benchenane for helpful comments on the manuscript and programming; and C. Lena for scientific insights. Supported by grants from Agence Nationale de la Recherche (ANR Young Researcher 07-JCJC-0108-01 and ANR-09-EMER-005-02) (L.R.R.) and by Action Concertee Incitative (ACI) grant NIC0027 (B.P. and E.S.).	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Angelaki DE, 2010, CEREBELLUM, V9, P174, DOI 10.1007/s12311-009-0147-z; Bell CC, 2008, ANNU REV NEUROSCI, V31, P1, DOI 10.1146/annurev.neuro.30.051606.094225; Best PJ, 2001, ANNU REV NEUROSCI, V24, P459, DOI 10.1146/annurev.neuro.24.1.459; Brooks JX, 2009, J NEUROSCI, V29, P10499, DOI 10.1523/JNEUROSCI.1937-09.2009; Burguiere E, 2005, NAT NEUROSCI, V8, P1292, DOI 10.1038/nn1532; Burguiere E, 2010, J NEUROSCI, V30, P13265, DOI 10.1523/JNEUROSCI.2190-10.2010; Clower DM, 2001, J NEUROSCI, V21, P6283, DOI 10.1523/JNEUROSCI.21-16-06283.2001; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Dean P, 2010, NAT REV NEUROSCI, V11, P30, DOI 10.1038/nrn2756; Eichenbaum H, 2000, CURR BIOL, V10, pR785, DOI 10.1016/S0960-9822(00)00763-6; Giannetti S, 2002, BRAIN RES BULL, V58, P481, DOI 10.1016/S0361-9230(02)00815-8; Goddard M, 2008, BEHAV NEUROSCI, V122, P448, DOI 10.1037/0735-7044.122.2.448; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hoffmann LC, 2009, P NATL ACAD SCI USA, V106, P21371, DOI 10.1073/pnas.0908403106; ITO M, 1982, NEUROSCI LETT, V33, P253, DOI 10.1016/0304-3940(82)90380-9; Jeffery KJ, 2007, HIPPOCAMPUS, V17, P775, DOI 10.1002/hipo.20322; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Pasalar S, 2006, NAT NEUROSCI, V9, P1404, DOI 10.1038/nn1783; Rondi-Reig L, 2001, NEUROSCIENCE, V104, P207, DOI 10.1016/S0306-4522(01)00050-1; Rotenberg A, 1997, PHILOS T R SOC B, V352, P1505, DOI 10.1098/rstb.1997.0137; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Stackman RW, 2002, HIPPOCAMPUS, V12, P291, DOI 10.1002/hipo.1112; Wikgren J, 2010, NEUROSCIENCE, V165, P1538, DOI 10.1016/j.neuroscience.2009.11.044; Yakusheva TA, 2007, NEURON, V54, P973, DOI 10.1016/j.neuron.2007.06.003; Zheng YW, 2009, HIPPOCAMPUS, V19, P480, DOI 10.1002/hipo.20533	28	121	124	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 21	2011	334	6054					385	389		10.1126/science.1207403	http://dx.doi.org/10.1126/science.1207403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	22021859				2022-12-28	WOS:000296052500055
J	Frei, P; Poulsen, AH; Johansen, C; Olsen, JH; Steding-Jessen, M; Schuz, J				Frei, Patrizia; Poulsen, Aslak H.; Johansen, Christoffer; Olsen, Jorgen H.; Steding-Jessen, Marianne; Schuez, Joachim			Use of mobile phones and risk of brain tumours: update of Danish cohort study	BRITISH MEDICAL JOURNAL			English	Article							CELLULAR-TELEPHONE USE; NATIONWIDE COHORT; INCIDENCE TRENDS; TIME TRENDS; CANCER-RISK; DENMARK	Objective To investigate the risk of tumours in the central nervous system among Danish mobile phone subscribers. Design Nationwide cohort study. Setting Denmark. Participants All Danes aged >= 30 and born in Denmark after 1925, subdivided into subscribers and non-subscribers of mobile phones before 1995. Main outcome measures Risk of tumours of the central nervous system, identified from the complete Danish Cancer Register. Sex specific incidence rate ratios estimated with log linear Poisson regression models adjusted for age, calendar period, education, and disposable income. Results 358 403 subscription holders accrued 3.8 million person years. In the follow-up period 1990-2007, there were 10 729 cases of tumours of the central nervous system. The risk of such tumours was close to unity for both men and women. When restricted to individuals with the longest mobile phone use-that is, >= 13 years of subscription-the incidence rate ratio was 1.03 (95% confidence interval 0.83 to 1.27) in men and 0.91 (0.41 to 2.04) in women. Among those with subscriptions of >= 10 years, ratios were 1.04 (0.85 to 1.26) in men and 1.04 (0.56 to 1.95) in women for glioma and 0.90 (0.57 to 1.42) in men and 0.93 (0.46 to 1.87) in women for meningioma. There was no indication of dose-response relation either by years since first subscription for a mobile phone or by anatomical location of the tumour-that is, in regions of the brain closest to where the handset is usually held to the head. Conclusions In this update of a large nationwide cohort study of mobile phone use, there were no increased risks of tumours of the central nervous system, providing little evidence for a causal association.	[Frei, Patrizia; Poulsen, Aslak H.; Johansen, Christoffer; Olsen, Jorgen H.; Steding-Jessen, Marianne] Danish Canc Soc, Inst Canc Epidemiol, DK-2100 Copenhagen, Denmark; [Schuez, Joachim] Int Agcy Res Canc, Sect Environm & Radiat, F-69372 Lyon 08, France	Danish Cancer Society; World Health Organization; International Agency for Research on Cancer (IARC)	Frei, P (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Socinstr 57, CH-4002 Basel, Switzerland.	frei@cancer.dk	Johansen, Christoffer/AAG-7916-2020	Johansen, Christoffer/0000-0002-4384-206X; Olsen, Jorgen Helge/0000-0001-9633-5662	Danish Strategic Research Council [09-059984, 09-059045]; Swiss National Science Foundation; Danish Graduate School in Public Health Science	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Danish Graduate School in Public Health Science	This study was funded by the Danish Strategic Research Council (grant No 09-059984, 09-059045) to cover costs for data linkage. PF received a fellowship for prospective researchers by the Swiss National Science Foundation for this project. AHP was supported by a stipend for PhD students from the Danish Graduate School in Public Health Science. All other authors contributed to this work based on their respective core budget positions.	Ahlbom A, 2009, EPIDEMIOLOGY, V20, P639, DOI 10.1097/EDE.0b013e3181b0927d; Cardis E, 2008, PHYS MED BIOL, V53, P2771, DOI 10.1088/0031-9155/53/11/001; Cardis E, 2010, INT J EPIDEMIOL, V39, P675, DOI 10.1093/ije/dyq079; Dalton SO, 2008, EUR J CANCER, V44, P1938, DOI [10.1016/j.ejca.2008.06.010, 10.1016/j.ejca.2008.06.034]; Deltour I, 2009, J NATL CANCER I, V101, P1721, DOI 10.1093/jnci/djp415; Hardell L, 2010, NEUROEPIDEMIOLOGY, V35, P109, DOI 10.1159/000311044; Inskip PD, 2001, NEW ENGL J MED, V344, P79, DOI 10.1056/NEJM200101113440201; Inskip PD, 2010, NEURO-ONCOLOGY, V12, P1147, DOI 10.1093/neuonc/noq077; *ITU, 2010, KEY GLOB TEL IND WOR; Johansen C, 2001, JNCI-J NATL CANCER I, V93, P203, DOI 10.1093/jnci/93.3.203; Kuhn S, 2009, PHYS MED BIOL, V54, P5493, DOI 10.1088/0031-9155/54/18/010; Lonn S, 2004, INT J CANCER, V108, P450, DOI 10.1002/ijc.11578; *NAT BOARD HLTH, 2006, CANC INC DENM 2001 H; *NAT IT TEL AG, 2001, TEL YB; Neubauer G, 2010, BIOELECTROMAGNETICS, V31, P535, DOI 10.1002/bem.20587; Olsen JH, 2005, BRIT J CANCER, V92, P201, DOI 10.1038/sj.bjc.6602279; Roosli M, 2007, EUR J CANCER PREV, V16, P77, DOI 10.1097/01.cej.0000203618.61936.cd; Schuz J, 2011, AM J EPIDEMIOL, V174, P416, DOI 10.1093/aje/kwr112; Schuz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004389; Schuz J, 2006, JNCI-J NATL CANCER I, V98, P1707, DOI 10.1093/jnci/djj464; Schuz J, 2007, BIOELECTROMAGNETICS, V28, P130, DOI 10.1002/bem.20297; *SCI COMM EM NEWL, 2009, HLTH EFF EXP EMF; Storm HH, 1997, DAN MED BULL, V44, P535; Vrijheid M, 2006, J EXPO SCI ENV EPID, V16, P371, DOI 10.1038/sj.jes.7500509; Vrijheid M, 2009, J EXPO SCI ENV EPID, V19, P369, DOI 10.1038/jes.2008.27; World Health Organization, 1976, INT CLASS DIS ONC IC	26	95	99	2	40	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 20	2011	343								d6387	10.1136/bmj.d6387	http://dx.doi.org/10.1136/bmj.d6387			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HQ	22016439	hybrid, Green Published			2022-12-28	WOS:000296184000001
J	Chard, J; Kuczawski, M; Black, N; van der Meulen, J				Chard, J.; Kuczawski, M.; Black, N.; van der Meulen, J.		POiS Audit Steering Comm	Outcomes of elective surgery undertaken in independent sector treatment centres and NHS providers in England: audit of patient outcomes in surgery	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUESTIONNAIRE; PERCEPTIONS	Objective To compare characteristics of patients and outcomes after elective surgery in independent sector treatment centres (ISTCs) and NHS providers. Design Follow-up study with outcomes reported by patients three to six months after surgery. Setting 25 ISTCs and 72 NHS providers in England. Population Consecutive patients undergoing hip or knee replacement (5671 in ISTCs and 14 292 in NHS), inguinal hernia repair (640 and 2023, respectively), or surgery for varicose veins (248 and 1336, respectively). Main outcomes Symptoms and disability reported by patients (Oxford hip and knee scores on a 48 point scale; Aberdeen varicose vein questionnaire) and quality of life (EuroQol EQ-5D score). Results Patients in ISTCs were healthier than those in NHS providers, had less severe preoperative symptoms, and were more affluent, though the differences were small. With adjustment, patients undergoing joint replacements in NHS providers had poorer outcomes: difference of -1.7 (95% confidence interval -2.5 to -0.9) on the Oxford hip score and -0.9 (-1.6 to -0.2) on the Oxford knee score. They more often reported complications: odds ratio 1.3 (95% confidence interval 1.1 to 1.5) for hip and 1.4 (1.2 to 1.6) for knee. There were no significant differences in outcomes after surgery for hernia or varicose veins, except that NHS patients more often reported poor results after hernia repair (1.4, 1.0 to 1.9) and additional surgery after varicose vein surgery (2.8, 1.2 to 6.8). Conclusion Patients undergoing surgery in ISTCs were slightly healthier and had less severe conditions than those undergoing surgery in NHS providers. Some outcomes were better in ISTCs, but differences were small compared with the impact ISTCs could have on the provision of elective services.	[Black, N.; van der Meulen, J.] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1H 9SH, England; [Chard, J.; Kuczawski, M.; van der Meulen, J.] Royal Coll Surgeons England, Clin Effectiveness Unit, London WC2A 3PE, England	University of London; London School of Hygiene & Tropical Medicine; Royal College of Surgeons of England	van der Meulen, J (corresponding author), London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1H 9SH, England.	jan.vandermeulen@lshtm.ac.uk	Kuczawski, Maxine/GRY-4304-2022	van der Meulen, Jan/0000-0002-9451-2335; Kuczawski, Maxine/0000-0002-0774-8113	clinical effectiveness unit of the Royal College of Surgeons of England; Department of Health Commercial Directorate	clinical effectiveness unit of the Royal College of Surgeons of England; Department of Health Commercial Directorate	We thank the staff and patients at participating providers and other members of staff at the clinical effectiveness unit of the Royal College of Surgeons of England (John Browne, Lynn Copley, Jackie Horrocks, Andrew Hutchings, Jenny Neuberger) for their support.; The POiS audit was commissioned and sponsored by the Department of Health Commercial Directorate. Representatives of the department attended the meetings of the audit's steering committee as observers. The authors are responsible for the design of the audit, data analysis, the preparation of the manuscript, and the decision to publish.	Black N, 1993, Qual Health Care, V2, P157, DOI 10.1136/qshc.2.3.157; Black N, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2495; Browne J, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-78; Browne JP, 2010, J CLIN EPIDEMIOL, V63, P865, DOI 10.1016/j.jclinepi.2009.10.004; Dawson J, 1996, J BONE JOINT SURG BR, V78B, P185, DOI 10.1302/0301-620X.78B2.0780185; Dawson J, 1998, J BONE JOINT SURG BR, V80B, P63, DOI 10.1302/0301-620X.80B1.7859; Department of Health, 2006, ISTC MAN; Department of Health, 2009, GUID ROUT COLL PAT R; Department of Health, 2002, GROW CAP IND SECT DI; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Garratt A M, 1993, Qual Health Care, V2, P5, DOI 10.1136/qshc.2.1.5; Healthcare Commission, 2007, IND SECT TREATM CTR; House of Commons Health Committee, 2006, 9341 HC HLTH COMM, VI; Mason A, 2010, J ROY SOC MED, V103, P322, DOI 10.1258/jrsm.2010.100044; National Joint Registry for England and Wales, 2010, 7 NAT JOINT REG ENGL; Noble M, 2008, ENGLISH INDICES DEPR; O'Dowd A, 2006, BMJ-BRIT MED J, V332, P623, DOI 10.1136/bmj.332.7542.623; Royal College of Surgeons of England, 2006, RCS RESP HLTH SEL CO; SECHZER PH, 1963, ANESTHESIOLOGY, V24, P779, DOI 10.1097/00000542-196311000-00005; The Royal College of Surgeons of England, 2007, SEP EM EL SURG CAR R	20	60	60	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 19	2011	343								d6404	10.1136/bmj.d6404	http://dx.doi.org/10.1136/bmj.d6404			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HN	22012180	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000296183700004
J	Verghese, A; Brady, E; Kapur, CC; Horwitz, RI				Verghese, Abraham; Brady, Erika; Kapur, Cari Costanzo; Horwitz, Ralph I.			The Bedside Evaluation: Ritual and Reason	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PHYSICAL-EXAMINATION; TOUCH	The bedside evaluation, consisting of the history and physical examination, was once the primary means of diagnosis and clinical monitoring. The recent explosion of imaging and laboratory testing has inverted the diagnostic paradigm. Physicians often bypass the bedside evaluation for immediate testing and therefore encounter an image of the patient before seeing the patient in the flesh. In addition to risking delayed or missed diagnosis of readily recognizable disease, physicians who forgo or circumvent the bedside evaluation risk the loss of an important ritual that can enhance the physician-patient relationship. Patients expect that some form of bedside evaluation will take place when they visit a physician. When physicians complete this evaluation in an expert manner, it can have a salutary effect. If done poorly or not at all, in contrast, it can undermine the physician-patient relationship. Studies suggest that the context, locale, and quality of the bedside evaluation are associated with neurobiological changes in the patient. Recognizing the importance of the bedside evaluation as a healing ritual and a powerful diagnostic tool when paired with judicious use of technology could be a stimulus for the recovery of an ebbing skill set among physicians.	[Verghese, Abraham] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; Western Kentucky Univ, Bowling Green, KY 42101 USA; GlaxoSmithKline, King Of Prussia, PA USA	Stanford University; Western Kentucky University; GlaxoSmithKline	Verghese, A (corresponding author), Stanford Univ, Sch Med, Dept Med, 300 Pasteur Dr,S102, Stanford, CA 94305 USA.							BARNETT K, 1972, NURS RES, V21, P102; Barr Donald A, 2008, Acad Med, V83, P503, DOI 10.1097/ACM.0b013e31816bda16; Benedetti F, 2011, NEUROPSYCHOPHARMACOL, V36, P339, DOI 10.1038/npp.2010.81; EM Silverman, 2007, QUOTABLE OSLER, P99; EMERSON RM, 1962, AM SOCIOL REV, V27, P31, DOI 10.2307/2089716; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Han PKJ, 1997, ANN INTERN MED, V127, P910, DOI 10.7326/0003-4819-127-10-199711150-00010; KEREWSKYHALPERN B, 1985, SOC SCI MED, V21, P319, DOI 10.1016/0277-9536(85)90108-X; Kugler J, 2010, J GEN INTERN MED, V25, P756, DOI 10.1007/s11606-010-1400-3; MORALES E, 1994, CANCER NURS, V17, P464; OConnor Bonnie B., 2001, HEALING LOGICS CULTU, p13.35; Osler W, 1874, CAN MED SURG J, V3, P433; Phoon CKL, 2001, AM HEART J, V141, P500, DOI 10.1067/mhj.2001.113222; Phoon CKL, 2000, PERSPECT BIOL MED, V43, P548; Reilly BM, 2007, LANCET, V370, P705, DOI 10.1016/S0140-6736(07)61347-6; Tambiah SJ., 1973, MODES THOUGHT ESSAYS; Verghese A, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5448; Verghese A, 2009, HEALTH AFFAIR, V28, P1177, DOI 10.1377/hlthaff.28.4.1177; Verghese A, 2008, NEW ENGL J MED, V359, P2748, DOI 10.1056/NEJMp0807461; Youngtae Kim, 1997, Proceedings Eighth SIAM Conference on Parallel Processing for Scientific Computing	20	107	111	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2011	155	8					550	553		10.7326/0003-4819-155-8-201110180-00013	http://dx.doi.org/10.7326/0003-4819-155-8-201110180-00013			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	835WB	22007047				2022-12-28	WOS:000296066300022
J	Staver, AC; Archibald, S; Levin, SA				Staver, A. Carla; Archibald, Sally; Levin, Simon A.			The Global Extent and Determinants of Savanna and Forest as Alternative Biome States	SCIENCE			English	Article							AMAZON RAIN-FOREST; AFRICAN SAVANNAS; WOODY COVER; SOUTHERN AFRICA; C-4 GRASSLANDS; TREE COVER; FIRE; DYNAMICS; VEGETATION; WOODLAND	Theoretically, fire-tree cover feedbacks can maintain savanna and forest as alternative stable states. However, the global extent of fire-driven discontinuities in tree cover is unknown, especially accounting for seasonality and soils. We use tree cover, climate, fire, and soils data sets to show that tree cover is globally discontinuous. Climate influences tree cover globally but, at intermediate rainfall (1000 to 2500 millimeters) with mild seasonality (less than 7 months), tree cover is bimodal, and only fire differentiates between savanna and forest. These may be alternative states over large areas, including parts of Amazonia and the Congo. Changes in biome distributions, whether at the cost of savanna (due to fragmentation) or forest (due to climate), will be neither smooth nor easily reversible.	[Staver, A. Carla; Levin, Simon A.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Archibald, Sally] CSIR, ZA-0001 Pretoria, South Africa	Princeton University; Council for Scientific & Industrial Research (CSIR) - South Africa	Staver, AC (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	astaver@princeton.edu	Staver, Ann Carla/B-4990-2015; Archibald, Sally/O-1659-2015; Levin, Simon A/J-1218-2014	Archibald, Sally/0000-0003-2786-3976; Levin, Simon A/0000-0002-8216-5639	Andrew W. Mellon Foundation	Andrew W. Mellon Foundation	We thank A. Wolf, S. Batterman, and S. Rabin for manuscript feedback. Funding was provided by the Andrew W. Mellon Foundation. All data are freely available at http://modis.gsfc.nasa.gov/, http://trmm.gsfc.nasa.gov/, and www.fao.org/nr/land/soils/harmonized-world-soil-database/en/.	Archibald S, 2005, ECOL APPL, V15, P96, DOI 10.1890/03-5210; Archibald S, 2009, GLOBAL CHANGE BIOL, V15, P613, DOI 10.1111/j.1365-2486.2008.01754.x; Asner GP, 2010, NEW PHYTOL, V187, P569, DOI 10.1111/j.1469-8137.2010.03310.x; Balch JK, 2008, GLOBAL CHANGE BIOL, V14, P2276, DOI 10.1111/j.1365-2486.2008.01655.x; Bond WJ, 2008, ANNU REV ECOL EVOL S, V39, P641, DOI 10.1146/annurev.ecolsys.39.110707.173411; Bucini G, 2007, GLOBAL ECOL BIOGEOGR, V16, P593, DOI 10.1111/j.1466-8238.2007.00325.x; CAHOON DR, 1992, NATURE, V359, P812, DOI 10.1038/359812a0; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Desjardins T, 1996, OECOLOGIA, V108, P749, DOI 10.1007/BF00329051; Goetze D, 2006, J BIOGEOGR, V33, P653, DOI 10.1111/j.1365-2699.2005.01312.x; Good SP, 2011, P NATL ACAD SCI USA, V108, P4902, DOI 10.1073/pnas.1013100108; Keeley JE, 2005, ECOL LETT, V8, P683, DOI 10.1111/j.1461-0248.2005.00767.x; Kumar KK, 1999, SCIENCE, V284, P2156, DOI 10.1126/science.284.5423.2156; Lehmann CER, 2011, NEW PHYTOL, V191, P197, DOI 10.1111/j.1469-8137.2011.03689.x; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; Mayle FE, 2007, PHILOS T R SOC B, V362, P291, DOI 10.1098/rstb.2006.1987; Mitchard ETA, 2009, EARTH INTERACT, V13, DOI 10.1175/2009EI278.1; Moreira AG, 2000, J BIOGEOGR, V27, P1021, DOI 10.1046/j.1365-2699.2000.00422.x; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; PRINS HHT, 1993, J ECOL, V81, P305, DOI 10.2307/2261500; Pueyo S, 2010, ECOL LETT, V13, P793, DOI 10.1111/j.1461-0248.2010.01497.x; Ruggiero PGC, 2002, PLANT ECOL, V160, P1, DOI 10.1023/A:1015819219386; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Sankaran M, 2008, GLOBAL ECOL BIOGEOGR, V17, P236, DOI 10.1111/j.1466-8238.2007.00360.x; Staver AC, 2011, ECOLOGY, V92, P1063, DOI 10.1890/i0012-9658-92-5-1063; Staver AC, 2009, ECOL APPL, V19, P1909, DOI 10.1890/08-1907.1; SWAINE MD, 1992, BIOTROPICA, V24, P166, DOI 10.2307/2388670; Veenendaal EM, 2004, GLOBAL CHANGE BIOL, V10, P318, DOI 10.1111/j.1365-2486.2003.00699.x; Williams RJ, 1996, J BIOGEOGR, V23, P747, DOI 10.1111/j.1365-2699.1996.tb00036.x; Willis KJ, 2004, SCIENCE, V304, P402, DOI 10.1126/science.1093991	30	797	810	19	364	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					230	232		10.1126/science.1210465	http://dx.doi.org/10.1126/science.1210465			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998389				2022-12-28	WOS:000295833600047
J	Diller, L				Diller, Lisa			Adult Primary Care after Childhood Acute Lymphoblastic Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LONG-TERM SURVIVORS; CENTRAL-NERVOUS-SYSTEM; BONE-MINERAL DENSITY; GROWTH-HORMONE; 2ND NEOPLASMS; CANCER SURVIVOR; FOLLOW-UP; SECONDARY NEOPLASMS; 5-YEAR SURVIVORS; RISK-FACTORS	A 26-year-old woman presents to an internist to establish primary care. Her medical history includes a diagnosis of acute lymphoblastic leukemia (ALL) at 3 years of age. She does not know what therapies she received, but her parents told her that she was treated for 2 years and that her leukemia never recurred. She is a high-school graduate and works as a receptionist. What are the issues to consider in the care of this long-term survivor of childhood leukemia?	[Diller, Lisa] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol,Dept Med,Childrens Hosp, Boston, MA 02215 USA; [Diller, Lisa] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02215 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Diller, L (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol,Dept Med,Childrens Hosp, 450 Brookline Ave, Boston, MA 02215 USA.	lisa_diller@dfci.harvard.edu			Hyundai	Hyundai	Dr. Diller reports receiving fees for serving on the medical advisory committee for the Hope on Wheels Foundation, which is sponsored by Hyundai. No other potential conflict of interest relevant to this article was reported.	Banerjee J, 2009, NEURO-ONCOLOGY, V11, P543, DOI 10.1215/15228517-2008-122; Bar J, 2003, AM J OBSTET GYNECOL, V189, P853, DOI 10.1067/S0002-9378(03)00837-8; Bhatia S, 2002, BLOOD, V99, P4257, DOI 10.1182/blood.V99.12.4257; Bowers DC, 2006, J CLIN ONCOL, V24, P5277, DOI 10.1200/JCO.2006.07.2884; Brennan BMD, 1998, CLIN ENDOCRINOL, V48, P777; Brown RT, 1996, J DEV BEHAV PEDIATR, V17, P392, DOI 10.1097/00004703-199612000-00004; Children's Oncology Group, 2008, LONG TERM FOLL GUID; Chow EJ, 2009, PEDIATR BLOOD CANCER, V53, P432, DOI 10.1002/pbc.22082; de Vathaire F, 1999, BRIT J CANCER, V79, P1884, DOI 10.1038/sj.bjc.6690300; Diller L, 2009, J CLIN ONCOL, V27, P2339, DOI 10.1200/JCO.2008.21.1953; Ergun-Longmire B, 2006, J CLIN ENDOCR METAB, V91, P3494, DOI 10.1210/jc.2006-0656; Friedman DL, 2010, JNCI-J NATL CANCER I, V102, P1083, DOI 10.1093/jnci/djq238; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Gold DG, 2003, CANCER-AM CANCER SOC, V97, P2588, DOI 10.1002/cncr.11356; Goshen Y, 2007, PEDIATR BLOOD CANCER, V49, P294, DOI 10.1002/pbc.21153; Gurney JG, 2006, CANCER-AM CANCER SOC, V107, P1303, DOI 10.1002/cncr.22120; Hijiya N, 2007, JAMA-J AM MED ASSOC, V297, P1207, DOI 10.1001/jama.297.11.1207; HOOVER DL, 1988, OPHTHALMOLOGY, V95, P151; In Scottish Intercollegiate Guidelines Network, 2004, LONG TERM FOLL CAR S; Janiszewski PM, 2007, J CLIN ENDOCR METAB, V92, P3816, DOI 10.1210/jc.2006-2178; Kadan-Lottick NS, 2008, J CLIN ONCOL, V26, P3038, DOI 10.1200/JCO.2007.14.9088; Kadan-Lottick NS, 2010, JNCI-J NATL CANCER I, V102, P881, DOI 10.1093/jnci/djq156; Kadan-Lottick NS, 2002, JAMA-J AM MED ASSOC, V287, P1832, DOI 10.1001/jama.287.14.1832; Kaste SC, 2006, PEDIATR BLOOD CANCER, V46, P77, DOI 10.1002/pbc.20553; Kremer LCM, 2002, ANN ONCOL, V13, P819, DOI 10.1093/annonc/mdf167; Lipshultz SE, 2005, J CLIN ONCOL, V23, P2629, DOI 10.1200/JCO.2005.12.121; Loning L, 2000, BLOOD, V95, P2770, DOI 10.1182/blood.V95.9.2770.009k16_2770_2775; Mariotto AB, 2009, CANCER EPIDEM BIOMAR, V18, P1033, DOI 10.1158/1055-9965.EPI-08-0988; Meacham LR, 2010, CANCER EPIDEM BIOMAR, V19, P170, DOI 10.1158/1055-9965.EPI-09-0555; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; Mody R, 2008, BLOOD, V111, P5515, DOI 10.1182/blood-2007-10-117150; Mulhern RK, 2003, CURR PROB CANCER, V27, P177, DOI 10.1016/S0147-0272(03)00026-6; MULROONEY DA, 2009, BMJ-BRIT MED J, V339, DOI DOI 10.1136/BMJ.B4606; National Cancer Institute, SEER CANC STAT REV 1; Neglia JP, 2006, J NATL CANCER I, V98, P1528, DOI 10.1093/jnci/djj411; Nysom K, 1998, J CLIN ONCOL, V16, P3752, DOI 10.1200/JCO.1998.16.12.3752; Oeffinger KC, 2003, J CLIN ONCOL, V21, P1359, DOI 10.1200/JCO.2003.06.131; Oeffinger KC, 2008, PEDIATR BLOOD CANCER, V50, P462, DOI 10.1002/pbc.21410; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Rebholz CE, 2011, EUR J CANCER, V47, P221, DOI 10.1016/j.ejca.2010.09.017; Reulen RC, 2011, JAMA-J AM MED ASSOC, V305, P2311, DOI 10.1001/jama.2011.747; Reulen RC, 2010, JAMA-J AM MED ASSOC, V304, P172, DOI 10.1001/jama.2010.923; Robison LL, 2009, J CLIN ONCOL, V27, P2308, DOI 10.1200/JCO.2009.22.3339; Sklar CA, 2002, J CLIN ENDOCR METAB, V87, P3136, DOI 10.1210/jc.87.7.3136; SONIS AL, 1990, CANCER, V66, P2645, DOI 10.1002/1097-0142(19901215)66:12<2645::AID-CNCR2820661230>3.0.CO;2-S; Spiegler, 2006, J CLIN ONCOL, V24, P5181, DOI 10.1200/JCO.2006.09.002; Spiegler BJ, 2006, J CLIN ONCOL, V24, P3858, DOI 10.1200/JCO.2006.05.9055; Steffens M, 2008, CLIN ENDOCRINOL, V69, P819, DOI 10.1111/j.1365-2265.2008.03283.x; Thomas IH, 2008, CANCER-AM CANCER SOC, V113, P3248, DOI 10.1002/cncr.23912; United KingdomChildren's Cancer Study Group late effects group, 2005, THER BAS LONG TERM F; van Dalen EC, 2006, EUR J CANCER, V42, P3191, DOI 10.1016/j.ejca.2006.08.005; Whelan KF, 2010, PEDIATR BLOOD CANCER, V54, P103, DOI 10.1002/pbc.22277	52	32	34	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 13	2011	365	15					1417	1424		10.1056/NEJMcp1103645	http://dx.doi.org/10.1056/NEJMcp1103645			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832DQ	21995389				2022-12-28	WOS:000295782500009
J	Kuehn, BM				Kuehn, Bridget M.			New Model System Offers Clues to ALS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 12	2011	306	14					1534	1534		10.1001/jama.2011.1439	http://dx.doi.org/10.1001/jama.2011.1439			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831FS	21990293				2022-12-28	WOS:000295714700004
J	Raje, NS; Steele, DJR; Lawrimore, TM; Johri, AM; Sohani, AR				Raje, Noopur S.; Steele, David J. R.; Lawrimore, Tara M.; Johri, Amer M.; Sohani, Aliyah R.			Case 29-2011: A 66-Year-Old Woman with Cardiac and Renal Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DIAGNOSED MULTIPLE-MYELOMA; PLASMA-EXCHANGE; AL AMYLOIDOSIS; DEXAMETHASONE; BORTEZOMIB; THERAPY; CHEMOTHERAPY; NEPHROPATHY; IMPROVEMENT; CRITERIA		[Raje, Noopur S.] Dept Med, Div Hematol Oncol, Boston, MA 02101 USA; [Steele, David J. R.] Dept Med, Div Nephrol, Boston, MA USA; [Johri, Amer M.] Dept Med, Div Cardiol, Boston, MA USA; [Lawrimore, Tara M.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Sohani, Aliyah R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Raje, Noopur S.; Steele, David J. R.; Johri, Amer M.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Lawrimore, Tara M.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA USA; [Sohani, Aliyah R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Raje, NS (corresponding author), Dept Med, Div Hematol Oncol, Boston, MA 02101 USA.							Bradwell AR, 2005, CLIN CHEM, V51, P805, DOI 10.1373/clinchem.2005.048017; Burnette BL, 2011, NEW ENGL J MED, V364, P2365, DOI 10.1056/NEJMc1101834; Clark WF, 2005, ANN INTERN MED, V143, P777, DOI 10.7326/0003-4819-143-11-200512060-00005; Clark WF, 2007, ANN INTERN MED, V146, P471, DOI 10.7326/0003-4819-146-6-200703200-00024; Cserti C, 2007, TRANSFUSION, V47, P511, DOI 10.1111/j.1537-2995.2006.01143.x; Durie BGM, 2007, LEUKEMIA, V21, P1134, DOI 10.1038/sj.leu.2404582; Durie BGM, 2006, LEUKEMIA, V20, P2220, DOI 10.1038/sj.leu.2404428; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; FANG LST, 1985, KIDNEY INT, V27, P582, DOI 10.1038/ki.1985.50; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Hutchison CA, 2009, CLIN J AM SOC NEPHRO, V4, P745, DOI 10.2215/CJN.04590908; Jaccard A, 2007, NEW ENGL J MED, V357, P1083, DOI 10.1056/NEJMoa070484; Kastritis E, 2007, HAEMATOLOGICA, V92, P546, DOI 10.3324/haematol.10759; Kastritis E, 2010, J CLIN ONCOL, V28, P1031, DOI 10.1200/JCO.2009.23.8220; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; KYLE RA, 2009, J AM SOC NEPHROL, V20, P2055; Lacy MQ, 2008, J HEART LUNG TRANSPL, V27, P823, DOI 10.1016/j.healun.2008.05.016; Leung N, 2008, KIDNEY INT, V73, P1282, DOI 10.1038/ki.2008.108; Ludwig H, 2007, HAEMATOLOGICA, V92, P1411, DOI 10.3324/haematol.11463; McKenna RW, 2008, WHO CLASSIFICATION T, P200; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Mulkerin D, 2007, BLOOD, V110, p1018A, DOI 10.1182/blood.V110.11.3477.3477; Munshi NC, 2011, BLOOD, V117, P4696, DOI 10.1182/blood-2010-10-300970; PASQUALI S, 1987, CLIN NEPHROL, V27, P222; Richardson PG, 2010, BLOOD, V116, P679, DOI 10.1182/blood-2010-02-268862; Stewart AK, 2007, LEUKEMIA, V21, P529, DOI 10.1038/sj.leu.2404516; Tsakiris DJ, 2010, NEPHROL DIAL TRANSPL, V25, P1200, DOI 10.1093/ndt/gfp679; Wechalekar AD, 2008, BRIT J HAEMATOL, V140, P365, DOI 10.1111/j.1365-2141.2007.06936.x; ZUCCHELLI P, 1988, KIDNEY INT, V33, P1175, DOI 10.1038/ki.1988.127; 2003, BR J HAEMATOL, V121, P749	30	4	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2011	365	12					1129	1138		10.1056/NEJMcpc1100925	http://dx.doi.org/10.1056/NEJMcpc1100925			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822WR	21992126				2022-12-28	WOS:000295081600013
J	Marmot, M; Allen, J; Bell, R; Goldblatt, P				Marmot, Michael; Allen, Jessica; Bell, Ruth; Goldblatt, Peter			Building of the global movement for health equity: from Santiago to Rio and beyond	LANCET			English	Article							SELF-RATED HEALTH; SOCIOECONOMIC INEQUALITIES; EUROPEAN COUNTRIES; MORTALITY	Health inequalities are present throughout the world, both within and between countries. The Commission on Social Determinants of Health drew attention to dramatic social gradients in health within most countries and made proposals for action. These inequalities are not inevitable. The purpose of this article is to report on activity that has taken place worldwide after the report by the Commission on Social Determinants of Health. First, we summarise the global situation. Second, we summarise an interim report of the emerging findings from an independent review of social determinants and the health divide, which was commissioned by the WHO European region. The world conference on social determinants of health will be held in Rio de Janeiro, Brazil, in October, 2011. This summit provides an opportunity to galvanise support, prioritise action, and respond to the call by the Commission on Social Determinants of Health for social justice as a route to a fair distribution of health.	[Marmot, Michael; Allen, Jessica; Bell, Ruth; Goldblatt, Peter] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	University of London; University College London	Allen, J (corresponding author), UCL, Dept Epidemiol & Publ Hlth, 1-19 Torrington Pl, London WC1E 6BT, England.	jessica.allen@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419	WHO Regional Office for Europe; Medical Research Council; MRC [G0902037] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G8802774, G19/35, G0902037, G0100222] Funding Source: researchfish	WHO Regional Office for Europe; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank WHO Regional Office for Europe, which is funding the review of social determinants of health and the health divide in the WHO European region; colleagues at WHO, who provided comments on this report; and colleagues in the review team at UCL, Ellen Bloomer and Matilda Allen, who provided valuable support in preparing the paper for publication. MM is funded by the Medical Research Council.	[Anonymous], 2010, WORLD HLTH STAT 2010; [Anonymous], 1999, DEV FREEDOM; Billingsley S, 2009, THESIS U POMPEU FABR; Blas E, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P1; Bobak M, 1996, BRIT MED J, V312, P421; Burstrom B, 2001, J EPIDEMIOL COMMUN H, V55, P836, DOI 10.1136/jech.55.11.836; Buzeti T, 2011, HLTH INEQUALITIES SL; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Diderichsen F, 2011, ULIGHED SUNDHED ARSA; European Commission, 2009, SOL HLTH RED HLTH IN; Fogel RW, 2000, 4 GREAT AWAKENING FU; Healthy People 2020, 2010, FDN HLTH MEAS REP HE; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Kumar R, 2011, CORRUPTION CASES GOV; Kunst AE, 2007, REV EPIDEMIOL SANTE, V55, P3, DOI 10.1016/j.respe.2006.12.001; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mackenbach JP, 2008, FINAL EUROTHINE REPO; Malmo Stad, 2011, DIR CIT COUNC 2010; Marmot M., 2004, STATUS SYNDROME YOUR; Marmot Review, 2011, LOC EX ACT; Marmot Review Team, 2011, EURRC61INFDOC5 WHO R; Marmot Review Team, 1 WHO REG OFF EUR MA; Marmot Review Team, 2010, FAIR SOC HLTH LIV ST; Men T, 2003, BRIT MED J, V327, P964, DOI 10.1136/bmj.327.7421.964; Rose G., 2008, ROSES STRATEGY PREVE; Scottish Public Health Observatory, 2010, COMP HLTH PROF; Stiglitz J. E., 2010, FREEFALL AM FREE MAR; United Nations Children's Fund, 2001, 8 UNICEF INN RES CTR; Whitehead M, 1991, GEOL FORENINGAN STOC; WHO, 2005, COMM SOC DET HLTH OF; WHO, 2010, TRENDS MAT MORT 1990; WHO, 2010, EUR559346REV1 WHO; WHO Regional Office for Europe, 2010, PUTT OUR OWN HOUS OR; WHO Regional Office for Europe, 2010, EUR HLTH ALL DAT	34	63	66	1	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 14	2012	379	9811					181	188		10.1016/S0140-6736(11)61506-7	http://dx.doi.org/10.1016/S0140-6736(11)61506-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	879GM	22014678	hybrid, Green Submitted			2022-12-28	WOS:000299317700040
J	Zhao, W; Huang, F				Zhao, Wei; Huang, Feng			Abdominal calcifications	LANCET			English	Editorial Material									[Zhao, Wei; Huang, Feng] Chinese Peoples Liberat Army Gen Hosp, Dept Rheumatol, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital	Zhao, W (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Rheumatol, 28 Fuxing Rd, Beijing 100853, Peoples R China.	zhaowei-1@medmail.com.cn							0	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 17	2011	378	9809					E28	E28		10.1016/S0140-6736(11)61542-0	http://dx.doi.org/10.1016/S0140-6736(11)61542-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	865EL	22019025				2022-12-28	WOS:000298293600007
J	Hegarty, K; Glasziou, P				Hegarty, Kelsey; Glasziou, Paul			Tackling domestic violence: is increasing referral enough?	LANCET			English	Editorial Material							INTIMATE PARTNER VIOLENCE; HEALTH; WOMEN		[Hegarty, Kelsey] Univ Melbourne, Gen Practice & Primary Hlth Care Acad Ctr, Fac Med Dent & Hlth Sci, Carlton, Vic 3053, Australia; [Glasziou, Paul] Bond Univ, Ctr Res Evidence Based Practice, Fac Hlth Sci, Gold Coast, Qld, Australia	University of Melbourne; Bond University	Hegarty, K (corresponding author), Univ Melbourne, Gen Practice & Primary Hlth Care Acad Ctr, Fac Med Dent & Hlth Sci, Carlton, Vic 3053, Australia.	k.hegarty@unimelb.edu.au	Glasziou, Paul/A-7832-2008	Glasziou, Paul/0000-0001-7564-073X; Hegarty, Kelsey/0000-0002-7532-5147				Brown C.A., 2006, BMC MED RES METHODOL, V6, P54, DOI DOI 10.1186/1471-2288-6-54; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Feder G, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13160; Feder G, 2011, LANCET, DOI S0140-6736(11)61179-3; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; MacMillan HL, 2009, JAMA-J AM MED ASSOC, V302, P493, DOI 10.1001/jama.2009.1089; Nelson HD, 2004, ANN INTERN MED, V140, P387, DOI 10.7326/0003-4819-140-5-200403020-00015; Plsek PE, 2001, BRIT MED J, V323, P625, DOI 10.1136/bmj.323.7313.625; Ramsay J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005043.pub2; Sohal H, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-49; Taft AJ, 2010, JAMA-J AM MED ASSOC, V304, P577, DOI 10.1001/jama.2010.1093; Vos T, 2006, B WORLD HEALTH ORGAN, V84, P739, DOI 10.2471/BLT.06.030411	12	9	9	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2011	378	9805					1760	1762		10.1016/S0140-6736(11)61386-X	http://dx.doi.org/10.1016/S0140-6736(11)61386-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	851IS	22000682				2022-12-28	WOS:000297262300007
J	Kwok, S; Zhang, Y				Kwok, Sun; Zhang, Yong			Mixed aromatic-aliphatic organic nanoparticles as carriers of unidentified infrared emission features	NATURE			English	Article							INTERSTELLAR DUST; PROTOPLANETARY NEBULAE; REFLECTION NEBULAE; BANDS; HYDROCARBONS; SPECTRUM; CARBON; MODEL; CONDENSATION; EXCITATION	Unidentified infrared emission bands at wavelengths of 3-20 micrometres are widely observed in a range of environments in our Galaxy and in others(1). Some features have been identified as the stretching and bending modes of aromatic compounds(2,3), and are commonly attributed to polycyclic aromatic hydrocarbon molecules(4,5). The central argument supporting this attribution is that single-photon excitation of the molecule can account for the unidentified infrared emission features observed in 'cirrus' clouds in the diffuse interstellar medium(6). Of the more than 160 molecules identified in the circumstellar and interstellar environments, however, not one is a polycyclic aromatic hydrocarbon molecule. The detections of discrete and broad aliphatic spectral features suggest that the carrier of the unidentified infrared emission features cannot be a pure aromatic compound. Here we report an analysis of archival spectroscopic observations and demonstrate that the data are most consistent with the carriers being amorphous organic solids with a mixed aromatic-aliphatic structure. This structure is similar to that of the organic materials found in meteorites, as would be expected if the Solar System had inherited these organic materials from interstellar sources.	[Kwok, Sun; Zhang, Yong] Univ Hong Kong, Fac Sci, Dept Phys, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Kwok, S (corresponding author), Univ Hong Kong, Fac Sci, Dept Phys, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	sunkwok@hku.hk	Kwok, Sun/D-3080-2009; Zhang, Yong/D-3213-2009	Kwok, Sun/0000-0001-7708-081X; Zhang, Yong/0000-0002-1086-7922	Research Grants Council of the Hong Kong Special Administrative Region, China [HKU 7027/11P]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council)	We thank A. Tang for technical assistance in the preparation of this manuscript. This work was supported by a grant to S. K. from the Research Grants Council of the Hong Kong Special Administrative Region, China (project no. HKU 7027/11P).	ALLAMANDOLA LJ, 1989, ASTROPHYS J SUPPL S, V71, P733, DOI 10.1086/191396; Clayton GC, 2003, ASTROPHYS J, V592, P947, DOI 10.1086/375771; Cody G.D., 2011, P NATL ACAD SCI 0404; Derenne S, 2010, METEORIT PLANET SCI, V45, P1461, DOI 10.1111/j.1945-5100.2010.01122.x; Draine BT, 2007, ASTROPHYS J, V657, P810, DOI 10.1086/511055; Duley WW, 2011, ASTROPHYS J LETT, V737, DOI 10.1088/2041-8205/737/2/L44; Duley WW, 2009, ASTROPHYS J, V698, P808, DOI 10.1088/0004-637X/698/1/808; DULEY WW, 1981, MON NOT R ASTRON SOC, V196, P269, DOI 10.1093/mnras/196.2.269; Evans A, 2005, MON NOT R ASTRON SOC, V360, P1483, DOI 10.1111/j.1365-2966.2005.09146.x; Guillois O, 1996, ASTROPHYS J, V464, P810, DOI 10.1086/177366; Jager C, 2009, ASTROPHYS J, V696, P706, DOI 10.1088/0004-637X/696/1/706; Kahanpaa J, 2003, ASTRON ASTROPHYS, V405, P999, DOI 10.1051/0004-6361:20030440; KNACKE RF, 1977, NATURE, V269, P132, DOI 10.1038/269132a0; Kwok S, 1999, ASTRON ASTROPHYS, V350, pL35; Kwok S, 2004, NATURE, V430, P985, DOI 10.1038/nature02862; Kwok S, 2001, ASTROPHYS J, V554, pL87, DOI 10.1086/320913; Kwok S., 2011, ORGANIC MATTER UNIVE; NEY EP, 1978, ASTROPHYS J, V219, pL111, DOI 10.1086/182618; Onaka T, 2000, ADV SPACE RES, V25, P2167, DOI 10.1016/S0273-1177(99)01149-7; PAPOULAR R, 1989, ASTRON ASTROPHYS, V217, P204; Papoular R, 2001, ASTRON ASTROPHYS, V378, P597, DOI 10.1051/0004-6361:20011224; Peeters E, 2002, ASTRON ASTROPHYS, V390, P1089, DOI 10.1051/0004-6361:20020773; Pendleton YJ, 2002, ASTROPHYS J SUPPL S, V138, P75, DOI 10.1086/322999; Pilleri P, 2009, MON NOT R ASTRON SOC, V397, P1053, DOI 10.1111/j.1365-2966.2009.15067.x; PUGET JL, 1989, ANNU REV ASTRON ASTR, V27, P161; SAKATA A, 1987, ASTROPHYS J, V320, pL63, DOI 10.1086/184977; Sellgren K, 2007, ASTROPHYS J, V659, P1338, DOI 10.1086/511805; SELLGREN K, 1984, ASTROPHYS J, V277, P623, DOI 10.1086/161733; Tielens AGGM, 2008, ANNU REV ASTRON ASTR, V46, P289, DOI 10.1146/annurev.astro.46.060407.145211; Uchida KI, 2000, ASTROPHYS J, V530, P817, DOI 10.1086/308379	30	185	186	0	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2011	479	7371					80	83		10.1038/nature10542	http://dx.doi.org/10.1038/nature10542			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840FA	22031328				2022-12-28	WOS:000296422600035
J	Holmes, D				Holmes, David			Steve Wesselingh: the wizard of Oz	LANCET			English	Biographical-Item																			0	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 22	2011	378	9801					1455	1455		10.1016/S0140-6736(11)61636-X	http://dx.doi.org/10.1016/S0140-6736(11)61636-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	838VC	22018007	Bronze			2022-12-28	WOS:000296319600013
J	Hestrin, S				Hestrin, Shaul			The Strength of Electrical Synapses	SCIENCE			English	Editorial Material							MODULATION; NETWORKS		Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA	Stanford University	Hestrin, S (corresponding author), Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA.	shaul.hestrin@stanford.edu			NEI NIH HHS [R01 EY012114] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012114] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Brown SP, 2009, CURR OPIN NEUROBIOL, V19, P415, DOI 10.1016/j.conb.2009.07.011; Cowan WM, 2001, SYNAPSES, P1; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Haas JS, 2011, SCIENCE, V334, P389, DOI 10.1126/science.1207502; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Landisman CE, 2005, SCIENCE, V310, P1809, DOI 10.1126/science.1114655; Landisman CE, 2002, J NEUROSCI, V22, P1002, DOI 10.1523/JNEUROSCI.22-03-01002.2002; Pereda AE, 1998, P NATL ACAD SCI USA, V95, P13272, DOI 10.1073/pnas.95.22.13272; Sherman S.M., 2004, SYNAPTIC ORG BRAIN, P311; Zsiros V, 2008, J NEUROSCI, V28, P1804, DOI 10.1523/JNEUROSCI.4616-07.2008	11	14	15	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2011	334	6054					315	316		10.1126/science.1213894	http://dx.doi.org/10.1126/science.1213894			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	22021844	Green Accepted			2022-12-28	WOS:000296052500033
J	Muller, FJ; Schuppert, A				Mueller, Franz-Josef; Schuppert, Andreas			Few inputs can reprogram biological networks	NATURE			English	Letter							DIRECT CONVERSION; DEFINED FACTORS; FIBROBLASTS; PLURIPOTENCY; CELLS		[Mueller, Franz-Josef] Zentrum Integrat Psychiat, D-24105 Kiel, Germany; [Schuppert, Andreas] Rhein Westfal TH Aachen, Grad Sch Aachen Inst Adv Study Computat Engn Sci, D-52062 Aachen, Germany; [Schuppert, Andreas] Bayer Technol Serv GmbH, Proc Technol, D-51368 Leverkusen, Germany	RWTH Aachen University; Bayer AG	Muller, FJ (corresponding author), Zentrum Integrat Psychiat, Niemannsweg 147, D-24105 Kiel, Germany.	fj.mueller@zip-kiel.de	Müller, Franz-Josef/E-3336-2010	Müller, Franz-Josef/0000-0001-9478-8430; Schuppert, Andreas/0000-0003-3783-6605				Dudley JT, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.66; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Muller FJ, 2011, NAT METHODS, V8, P315, DOI 10.1038/NMETH.1580; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Whitney W. S., 2011, NATURE	10	69	69	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 20	2011	478	7369					E4	E4		10.1038/nature10543	http://dx.doi.org/10.1038/nature10543			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	22012402	Bronze			2022-12-28	WOS:000296021100001
J	Kelley, AS				Kelley, Amy S.			Treatment intensity at end of life-time to act on the evidence	LANCET			English	Editorial Material							PALLIATIVE CARE; MEDICAL EXPENDITURES; REGIONAL-VARIATIONS; OUTCOMES; CANCER; HEALTH		Mt Sinai Sch Med, Brookdale Dept Geriatr & Palliat Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Kelley, AS (corresponding author), Mt Sinai Sch Med, Brookdale Dept Geriatr & Palliat Med, New York, NY 10029 USA.	amy.kelley@mssm.edu			NATIONAL INSTITUTE ON AGING [K24AG022345] Funding Source: NIH RePORTER; NIA NIH HHS [K24 AG022345] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bach PB, 2010, NEW ENGL J MED, V362, P569, DOI 10.1056/NEJMp0909947; Bakitas M, 2009, JAMA-J AM MED ASSOC, V302, P741, DOI 10.1001/jama.2009.1198; Desbiens NA, 2000, J AM GERIATR SOC, V48, pS183, DOI 10.1111/j.1532-5415.2000.tb03130.x; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Hoover DR, 2002, HEALTH SERV RES, V37, P1625, DOI 10.1111/1475-6773.01113; Kelley AS, 2011, ANN INTERN MED, V154, P235, DOI 10.7326/0003-4819-154-4-201102150-00004; Kwok AC, 2011, LANCET, V378, P1408, DOI 10.1016/S0140-6736(11)61268-3; Morrison RS, 2008, ARCH INTERN MED, V168, P1783, DOI 10.1001/archinte.168.16.1783; Skinner J, 2010, NEW ENGL J MED, V362, P569, DOI 10.1056/NEJMp1000448; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Teno JM, 2002, J AM GERIATR SOC, V50, P496, DOI 10.1046/j.1532-5415.2002.50116.x; The Dartmouth Institute for Health Policy and Clinical Practice, DARTM ATL HLTH CAR E; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665	14	12	13	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 15	2011	378	9800					1364	1365		10.1016/S0140-6736(11)61420-7	http://dx.doi.org/10.1016/S0140-6736(11)61420-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	838EM	21982519				2022-12-28	WOS:000296269600008
J	Rambold, AS; Lippincott-Schwartz, J				Rambold, Angelika S.; Lippincott-Schwartz, Jennifer			SevERing Mitochondria	SCIENCE			English	Editorial Material							ENDOPLASMIC-RETICULUM; FISSION		[Rambold, Angelika S.; Lippincott-Schwartz, Jennifer] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Rambold, AS (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA.	lippincj@mail.nih.gov			Intramural NIH HHS [ZIA HD001609-16, Z01 HD001609-14] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Braschi E, 2010, BIOESSAYS, V32, P958, DOI 10.1002/bies.201000073; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; English AR, 2009, CURR OPIN CELL BIOL, V21, P596, DOI 10.1016/j.ceb.2009.04.004; Friedman J. R., 2011, SCIENCE         0901, DOI [10.1126/science.1207385, DOI 10.1126/SCIENCE.1207385]; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Kepp O, 2011, NAT IMMUNOL, V12, P199, DOI 10.1038/ni0311-199; Kornmann B, 2010, J CELL SCI, V123, P1389, DOI 10.1242/jcs.058636; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lackner LL, 2009, BBA-MOL BASIS DIS, V1792, P1138, DOI 10.1016/j.bbadis.2008.11.011; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Soubannier V, 2009, BBA-MOL CELL RES, V1793, P154, DOI 10.1016/j.bbamcr.2008.07.008; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	17	6	7	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2011	334	6053					186	187		10.1126/science.1214059	http://dx.doi.org/10.1126/science.1214059			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998377	Green Published, Green Accepted			2022-12-28	WOS:000295833600033
J	Kocher, R; Sahni, NR				Kocher, Robert; Sahni, Nikhil R.			Rethinking Health Care Labor	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kocher, Robert] Engelberg Ctr Hlth Care Reform, Brookings Inst, Washington, DC USA; [Sahni, Nikhil R.] Harvard Univ, Sch Business, Boston, MA 02163 USA; [Sahni, Nikhil R.] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Brookings Institution; Harvard University; Harvard University	Kocher, R (corresponding author), Engelberg Ctr Hlth Care Reform, Brookings Inst, Washington, DC USA.							American College of Radiology, 2007, ACR PRACT GUID US IN; McKinsey Global Institute, 2011, EC WORKS JOB CREAT A; MORE D, 2009, IODINE CONTRAST ALLE	3	40	41	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 13	2011	365	15					1370	1372		10.1056/NEJMp1109649	http://dx.doi.org/10.1056/NEJMp1109649			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	832DQ	21995383				2022-12-28	WOS:000295782500002
J	Turner, PJ; Kemp, AS; Campbell, DE				Turner, Paul J.; Kemp, Andrew S.; Campbell, Dianne E.			Advisory food labels: consumers with allergies need more than "traces" of information	BRITISH MEDICAL JOURNAL			English	Editorial Material							NUT ALLERGY; MANAGEMENT; ATTITUDES; INDUSTRY; CHILDREN; COOKIES; PEANUT		[Turner, Paul J.] Inst Child Hlth, Mol Immunol Unit, London WC1N 1EH, England; [Turner, Paul J.; Kemp, Andrew S.; Campbell, Dianne E.] Univ Sydney, Sydney, NSW 2006, Australia; [Kemp, Andrew S.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Campbell, Dianne E.] Childrens Hosp Westmead, Sydney, NSW, Australia	University of London; University College London; University of Sydney; Murdoch Children's Research Institute; University of Sydney	Turner, PJ (corresponding author), Inst Child Hlth, Mol Immunol Unit, 30 Guilford St, London WC1N 1EH, England.	paulyt@doctors.org.uk		Turner, Paul/0000-0001-9862-5161; Campbell, Dianne/0000-0002-0907-6963	National Institute for Health Research [CL-2009-18-009] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		*ALL BUR, WHAT IS VITAL; Awazuhara H, 1998, CLIN EXP ALLERGY, V28, P1559, DOI 10.1046/j.1365-2222.1998.00431.x; Barnett J, 2011, ALLERGY, V66, P969, DOI 10.1111/j.1398-9995.2011.02563.x; Boden M, 2005, P NUTR SOC, V64, P475, DOI 10.1079/PNS2005453; Crevel RWR, 2008, ALLERGY, V63, P597, DOI 10.1111/j.1398-9995.2008.01636.x; Crotty MP, 2010, J ALLERGY CLIN IMMUN, V125, P935, DOI 10.1016/j.jaci.2009.12.003; Cummings AJ, 2010, PEDIAT ALLERG IMM-UK, V21, P586, DOI 10.1111/j.1399-3038.2009.00975.x; *FOOD STAND AG, 2007, GUID ALL MAN CONS IN; Food Standards Agency, 2002, MAY CONT LAB CONS PE; Ford LS, 2010, J ALLERGY CLIN IMMUN, V126, P384, DOI 10.1016/j.jaci.2010.05.034; *GREEN BLACKS, FREQ ASK QUEST; Hefle SL, 2007, J ALLERGY CLIN IMMUN, V120, P171, DOI 10.1016/j.jaci.2007.04.013; Imamura T, 2008, PEDIAT ALLERG IMM-UK, V19, P270, DOI 10.1111/j.1399-3038.2007.00621.x; NG IE, 2011, PEDIAT ALLERGY  0713; Noimark L, 2009, PEDIATR ALLERGY IMMU, V20, P500, DOI 10.1111/j.1399-3038.2008.00796.x; Nowak-Wegrzyn A, 2009, CURR OPIN ALLERGY CL, V9, P234, DOI 10.1097/ACI.0b013e32832b88e7; Pele M, 2007, FOOD ADDIT CONTAM A, V24, P1334, DOI 10.1080/02652030701458113; Roder M, 2010, J FOOD PROTECT, V73, P1671; Sheth SS, 2010, ANN ALLERG ASTHMA IM, V104, P60, DOI 10.1016/j.anai.2009.11.008; Ward R, 2010, TRENDS FOOD SCI TECH, V21, P619, DOI 10.1016/j.tifs.2010.09.004	20	34	34	0	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 13	2011	343								d6180	10.1136/bmj.d6180	http://dx.doi.org/10.1136/bmj.d6180			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	835EQ	21998345				2022-12-28	WOS:000296018300002
J	D'Esposito, M; Gazzaley, A				D'Esposito, Mark; Gazzaley, Adam			Can Age-Associated Memory Decline Be Treated?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							WORKING-MEMORY		[D'Esposito, Mark] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [D'Esposito, Mark] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Gazzaley, Adam] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco	D'Esposito, M (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.							Berry AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011537; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; KOIVISTO K, 1995, NEUROLOGY, V45, P741, DOI 10.1212/WNL.45.4.741; Wang M, 2011, NATURE, V476, P210, DOI 10.1038/nature10243	5	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 6	2011	365	14					1346	1347		10.1056/NEJMcibr1108968	http://dx.doi.org/10.1056/NEJMcibr1108968			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829KL	21991958				2022-12-28	WOS:000295578700016
J	Nisa, L; Giger, R				Nisa, Lluis; Giger, Roland			Ectopic Tooth in the Maxillary Sinus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nisa, Lluis; Giger, Roland] Hop Sion, Sion, Switzerland		Nisa, L (corresponding author), Hop Sion, Sion, Switzerland.			Giger, Roland/0000-0002-5574-3210; Nisa, Lluis Ezra/0000-0003-0632-1676					0	4	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 29	2011	365	13					1232	1232		10.1056/NEJMicm1101021	http://dx.doi.org/10.1056/NEJMicm1101021			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825YO	21991896				2022-12-28	WOS:000295318400011
J	Sunkel, C				Sunkel, Charlene			Empowerment and partnership in mental health	LANCET			English	Editorial Material									Cent Gauteng Mental Hlth Soc, ZA-2000 Johannesburg, South Africa		Sunkel, C (corresponding author), Cent Gauteng Mental Hlth Soc, POB 10443, ZA-2000 Johannesburg, South Africa.	charlene@witsmhs.co.za		Sunkel, Charlene/0000-0001-5460-6305				[Anonymous], 2001, WORLD HLTH REP MENT; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4	2	12	12	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 21	2012	379	9812					201	202		10.1016/S0140-6736(11)61270-1	http://dx.doi.org/10.1016/S0140-6736(11)61270-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	879FW	22008424				2022-12-28	WOS:000299316100015
J	Jozwiak, M; Rengerink, KO; Benthem, M; van Beek, E; Dijksterhuis, MGK; de Graaf, IM; van Huizen, ME; Oudijk, MA; Papatsonis, DNM; Perquin, DAM; Porath, M; van der Post, JAM; Rijnders, RJP; Scheepers, HCJ; Spaanderman, MEA; van Pampus, MG; de Leeuw, JW; Mol, BWJ; Bloemenkamp, KWM				Jozwiak, Marta; Rengerink, Katrien Oude; Benthem, Marjan; van Beek, Erik; Dijksterhuis, Marja G. K.; de Graaf, Irene M.; van Huizen, Marloes E.; Oudijk, Martijn A.; Papatsonis, Dimitri N. M.; Perquin, Denise A. M.; Porath, Martina; van der Post, Joris A. M.; Rijnders, Robbert J. P.; Scheepers, Hubertina C. J.; Spaanderman, Marc E. A.; van Pampus, Maria G.; de Leeuw, Jan Willem; Mol, Ben W. J.; Bloemenkamp, Kitty W. M.		PROBAAT Study Grp	Foley catheter versus vaginal prostaglandin E2 gel for induction of labour at term (PROBAAT trial): an open-label, randomised controlled trial	LANCET			English	Article							E-2 GEL; PGE(2)	Background Induction of labour is a common obstetric procedure. Both mechanical (eg, Foley catheters) and pharmacological methods (eg, prostaglandins) are used for induction of labour in women with an unfavourable cervix. We aimed to compare the effectiveness and safety of induction of labour with a Foley catheter with induction with vaginal prostaglandin E2 gel. Methods We did an open-label, randomised controlled trial in 12 hospitals in the Netherlands between Feb 10, 2009, and May 17, 2010. We enrolled women with a term singleton pregnancy in cephalic presentation, intact membranes, an unfavourable cervix, an indication for induction of labour, and no prior caesarean section. Participants were randomly allocated by an online randomisation system to induction of labour with a 30 mL Foley catheter or vaginal prostaglandin E2 gel (1: 1 ratio). Because of the nature of the intervention this study was not blinded. The primary outcome was caesarean section rate. Secondary outcomes were maternal and neonatal morbidity and time from intervention to birth. All analyses were done on an intention-to-treat basis. We also did a meta-analysis that included our trial. The trial was registered with the Dutch trial registry, number NTR 1646. Findings 824 women were allocated to induction of labour with a Foley catheter (n=412) or vaginal prostaglandin E2 gel (n=412). Caesarean section rates were much the same between the two groups (23% vs 20%, risk ratio [RR] 1.13, 95% CI 0.87-1.47). A meta-analysis including our trial data confirmed that a Foley catheter did not reduce caesarean section rates. We recorded two serious maternal adverse events, both in the prostaglandin group: one uterine perforation and one uterine rupture. Interpretation In women with an unfavourable cervix at term, induction of labour with a Foley catheter is similar to induction of labour with prostaglandin E2 gel, with fewer maternal and neonatal side-effects.	[Bloemenkamp, Kitty W. M.] Leiden Univ, Med Ctr, Dept Obstet, NL-2300 RC Leiden, Netherlands; [Jozwiak, Marta] Groene Hart Hosp, Gouda, Netherlands; [Rengerink, Katrien Oude; van der Post, Joris A. M.; Mol, Ben W. J.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Benthem, Marjan; van Pampus, Maria G.] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [van Beek, Erik] St Antonius Hosp, Nieuwegein, Netherlands; [Dijksterhuis, Marja G. K.; de Leeuw, Jan Willem] Ikazia Hosp, Rotterdam, Netherlands; [de Graaf, Irene M.] Spaarne Hosp, Hoofddorp, Netherlands; [van Huizen, Marloes E.] Haga Hosp, The Hague, Netherlands; [Oudijk, Martijn A.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Papatsonis, Dimitri N. M.] Amphia Hosp, Breda, Netherlands; [Perquin, Denise A. M.] Med Ctr Leeuwarden, Leeuwarden, Netherlands; [Porath, Martina] Maxima Med Ctr, Veldhoven, Netherlands; [Rijnders, Robbert J. P.] Jeroen Bosch Hosp, Den Bosch, Netherlands; [Scheepers, Hubertina C. J.] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Spaanderman, Marc E. A.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; St. Antonius Hospital Utrecht; Ikazia Hospital; Spaarne Hospital; Haga Hospital; Utrecht University; Utrecht University Medical Center; Amphia Hospital; Medical Center Leeuwarden; Maxima Medical Center; Jeroen Bosch Ziekenhuis; Maastricht University; Radboud University Nijmegen	Bloemenkamp, KWM (corresponding author), Leiden Univ, Med Ctr, Dept Obstet, K6P-35,POB 9600, NL-2300 RC Leiden, Netherlands.	k.w.m.bloemenkamp@lumc.nl	Mol, Ben/I-4526-2012; van der Post, Joris A M/A-8991-2008; Oudijk, Martijn A/C-1520-2019	Oudijk, Martijn A/0000-0001-8672-4365; van der Post, Joris/0000-0003-3311-2116; van Pampus, Maria/0000-0002-3020-8908				Alfirevic Z, 2009, COCHRANE DB SYST REV, V4; [Anonymous], 1996, INT J GYNECOL OBSTET, V53, P65; [Anonymous], 2000, INT J GYNECOL OBSTET, V69, P283; [Anonymous], 2006, NVOGNET VOORLICHTING; APGAR V, 1953, Curr Res Anesth Analg, V32, P260; BISHOP EH, 1964, OBSTET GYNECOL, V24, P266; Blatteis CM, 2005, PROSTAG OTH LIPID M, V76, P1, DOI 10.1016/j.prostaglandins.2005.01.001; Boulvain M, 2001, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858; Centre THaSCI, 2010, NHS MAT STAT ENGL 20; Collaboration C, COCHR HDB SYST REV I; Cromi A, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.11.029; Dalui R, 2005, ACTA OBSTET GYN SCAN, V84, P362, DOI 10.1111/j.0001-6349.2005.00662.x; de Graaf JP, 2010, BJOG-INT J OBSTET GY, V117, P1098, DOI 10.1111/j.1471-0528.2010.02611.x; *EURO PERISTAT PRO, 2008, EUR PER HLTH REP; Fasbender G, 1906, GESCH GEBURTSHILFE; Guideline Development Group RCOG, NICE GUID IND LAB; Heinemann J, 2008, AM J OBSTET GYNECOL, V199, P177, DOI 10.1016/j.ajog.2008.05.005; Martin JA, 2009, BIRTHS FI NAL DATA 2; Nederland SPR, 2009, COCHRANE HDB SYSTEMA; Niromanesh S, 2003, INT J GYNECOL OBSTET, V81, P23, DOI 10.1016/S0020-7292(02)00392-2; Pennell CE, 2009, BJOG-INT J OBSTET GY, V116, P1443, DOI 10.1111/j.1471-0528.2009.02279.x; Prager M, 2008, BJOG-INT J OBSTET GY, V115, P1443, DOI 10.1111/j.1471-0528.2008.01843.x; Rayburn WF, 2002, OBSTET GYNECOL SURV, V57, P683, DOI 10.1097/00006254-200210000-00022; Saleem Samina, 2006, J Coll Physicians Surg Pak, V16, P276; Sciscione AC, 1999, AM J OBSTET GYNECOL, V180, P55, DOI 10.1016/S0002-9378(99)70149-3	25	138	145	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2011	378	9809					2095	2103		10.1016/S0140-6736(11)61484-0	http://dx.doi.org/10.1016/S0140-6736(11)61484-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	865EL	22030144	Green Submitted			2022-12-28	WOS:000298293600031
J	Wolfe, CDA; Rudd, AG				Wolfe, Charles D. A.; Rudd, Anthony G.			Improvement of care in acute stroke units	LANCET			English	Editorial Material							MANAGEMENT; TRIAL		[Wolfe, Charles D. A.; Rudd, Anthony G.] Kings Coll London, Div Hlth & Social Care, London SE1 3QD, England; [Wolfe, Charles D. A.; Rudd, Anthony G.] Guys & St Thomas NHS Trust, Natl Inst Hlth Res, Comprehens Biomed Res Ctr, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Wolfe, CDA (corresponding author), Kings Coll London, Div Hlth & Social Care, London SE1 3QD, England.	charles.wolfe@kcl.ac.uk		Wolfe, Charles/0000-0001-8264-0981				Bhalla A, 2003, EUR J NEUROL, V10, P25, DOI 10.1046/j.1468-1331.2003.00504.x; Gray CS, 2007, LANCET NEUROL, V6, P397, DOI 10.1016/S1474-4422(07)70080-7; Grieve R, 2001, STROKE, V32, P1684, DOI 10.1161/01.STR.32.7.1684; Hajat C, 2000, STROKE, V31, P410, DOI 10.1161/01.STR.31.2.410; Intercollegiate Stroke Working Party, 2011, NAT SENT AUD STROK; Kallmunzer B, 2011, CEREBROVASC DIS, V31, P532, DOI 10.1159/000324621; Langhorne P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub3; Lincoln NB, 2000, BMJ-BRIT MED J, V320, P549, DOI 10.1136/bmj.320.7234.549; Liu SD, 2011, CLIN MED, V11, P213, DOI 10.7861/clinmedicine.11-3-213; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Middleton S, 2011, LANCET, V378, P1699, DOI 10.1016/S0140-6736(11)61485-2; Rudd AG, 2011, J NEUROL NEUROSUR PS, V82, P14, DOI 10.1136/jnnp.2009.203174	12	10	10	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 12	2011	378	9804					1679	1680		10.1016/S0140-6736(11)61545-6	http://dx.doi.org/10.1016/S0140-6736(11)61545-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	846LB	21996469				2022-12-28	WOS:000296899800007
J	Tol, WA; Barbui, C; Galappatti, A; Silove, D; Betancourt, TS; Souza, R; Golaz, A; van Ommeren, M				Tol, Wietse A.; Barbui, Corrado; Galappatti, Ananda; Silove, Derrick; Betancourt, Theresa S.; Souza, Renato; Golaz, Anne; van Ommeren, Mark			Global Mental Health 3 Mental health and psychosocial support in humanitarian settings: linking practice and research	LANCET			English	Article							POSTTRAUMATIC-STRESS-DISORDER; NARRATIVE EXPOSURE THERAPY; SESSION BEHAVIORAL TREATMENT; ARMED CONFLICT; DEVELOPMENT ASSISTANCE; POLITICAL VIOLENCE; SOCIAL HEALTH; CHILDREN; WAR; INTERVENTION	This review links practice, funding, and evidence for interventions for mental health and psychosocial wellbeing in humanitarian settings. We studied practice by reviewing reports of mental health and psychosocial support activities (2007-10); funding by analysis of the financial tracking service and the creditor reporting system (2007-09); and interventions by systematic review and meta-analysis. In 160 reports, the five most commonly reported activities were basic counselling for individuals (39%); facilitation of community support of vulnerable individuals (23%); provision of child-friendly spaces (21%); support of community-initiated social support (21%); and basic counselling for groups and families (20%). Most interventions took place and were funded outside national mental health and protection systems. 32 controlled studies of interventions were identified, 13 of which were randomised controlled trials (RCTs) that met the criteria for meta-analysis. Two studies showed promising effects for strengthening community and family supports. Psychosocial wellbeing was not included as an outcome in the meta-analysis, because its definition varied across studies. In adults with symptoms of post-traumatic stress disorder (PTSD), meta-analysis of seven RCTs showed beneficial effects for several interventions (psychotherapy and psychosocial supports) compared with usual care or waiting list (standardised mean difference [SMD] -0.38, 95% CI -0.55 to -0.20). In children, meta-analysis of four RCTs failed to show an effect for symptoms of PTSD (-0.36, -0.83 to 0.10), but showed a beneficial effect of interventions (group psychotherapy, school-based support, and other psychosocial support) for internalising symptoms (six RCTs; SMD -0.24, -0.40 to -0.09). Overall, research and evidence focuses on interventions that are infrequently implemented, whereas the most commonly used interventions have had little rigorous scrutiny.	[Tol, Wietse A.] Yale Univ, MacMillan Ctr, Global Hlth Initiat, New Haven, CT 06520 USA; [Tol, Wietse A.] HealthNet TPO, Amsterdam, Netherlands; [Barbui, Corrado] Univ Verona, Sect Psychiat & Clin Psychol, I-37100 Verona, Italy; [Galappatti, Ananda] Univ Colombo, Colombo, Sri Lanka; [Silove, Derrick] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Betancourt, Theresa S.] Harvard Univ, FXB Ctr Hlth & Human Rights, Res Program Children & Global Advers, Boston, MA 02115 USA; [Souza, Renato] Int Comm Red Cross, Geneva, Switzerland; [Golaz, Anne] UNICEF, Geneva, Switzerland; [van Ommeren, Mark] WHO, Dept Mental Hlth & Subst Abuse, CH-1211 Geneva, Switzerland	Yale University; University of Verona; University of Colombo; University of New South Wales Sydney; Harvard University; World Health Organization	Tol, WA (corresponding author), Yale Univ, MacMillan Ctr, Global Hlth Initiat, New Haven, CT 06520 USA.	wietse.tol@yale.edu	Tol, Wietse A/G-8587-2013	Tol, Wietse A/0000-0003-2216-0526	NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH077246] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ager A, 2011, J CHILD PSYCHOL PSYC, V52, P1124, DOI 10.1111/j.1469-7610.2011.02407.x; [Anonymous], 2007, PSYCHIATRY, V70, P283, DOI 10.1521/psyc.2007.70.4.283; [Anonymous], 2010, WHO DOES WHAT UNT 4W; Barenbaum J, 2004, J CHILD PSYCHOL PSYC, V45, P41, DOI 10.1046/j.0021-9630.2003.00304.x; Basoglu M, 2005, J TRAUMA STRESS, V18, P1, DOI 10.1002/jts.20011; Basoglu M, 2007, PSYCHOL MED, V37, P203, DOI 10.1017/S0033291706009123; Bass J, 2012, SOC PSYCH PSYCH EPID, V47, P279, DOI 10.1007/s00127-011-0339-y; Batniji R, 2006, SOC SCI MED, V62, P1853, DOI 10.1016/j.socscimed.2005.08.050; Berger R, 2009, PSYCHOTHER PSYCHOSOM, V78, P364, DOI 10.1159/000235976; Betancourt TS, 2008, INTERVENTION, V6, P39, DOI 10.1097/WTF.0b013e3282f761ff; Betancourt TS, 2011, J AM ACAD CHILD PSY, V50, P323, DOI 10.1016/j.jaac.2011.01.008; Bichescu D, 2007, BEHAV RES THER, V45, P2212, DOI 10.1016/j.brat.2006.12.006; Bolton P, 2002, SOC PSYCH PSYCH EPID, V37, P537, DOI 10.1007/s00127-002-0580-5; Bolton P, 2007, JAMA-J AM MED ASSOC, V298, P519, DOI 10.1001/jama.298.5.519; Catani C, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-22; de Jong JTVM, 2003, LANCET, V361, P2128, DOI 10.1016/S0140-6736(03)13692-6; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Dybdahl R, 2001, CHILD DEV, V72, P1214, DOI 10.1111/1467-8624.00343; Ezard Nadine, 2011, Confl Health, V5, P1, DOI 10.1186/1752-1505-5-1; Goenjian AK, 1997, AM J PSYCHIAT, V154, P536; Harbom L, 2008, J PEACE RES, V45, P697, DOI 10.1177/0022343308094331; Harbom L, 2010, J PEACE RES, V47, P501, DOI 10.1177/0022343310376887; Harbom L, 2009, J PEACE RES, V46, P577, DOI 10.1177/0022343309339112; Hasanovic M, 2009, PSYCHIAT DANUB, V21, P463; Heidelberg Institute for International Conflict Research (HIIK), 2008, CONFL BAR 2008; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; HIIK, 2007, CONFL BAR 2007; HIIK, 2009, CONFL BAR 2009; Holder HD, 2000, JAMA-J AM MED ASSOC, V284, P2341, DOI 10.1001/jama.284.18.2341; IASC Reference Group for Mental Health and Psychosocial Support in Emergency Settings, 2010, MENT HLTH PSYCH SUPP; Igreja V, 2004, BRIT J PSYCHIAT, V184, P251, DOI 10.1192/bjp.184.3.251; Inter-Agency Standing Committee (IASC), 2007, IASC GUID MENT HLTH; Jordans MJD, 2010, J CHILD PSYCHOL PSYC, V51, P818, DOI 10.1111/j.1469-7610.2010.02209.x; Jordans MJD, 2009, CHILD ADOL MENT H-UK, V14, P2, DOI 10.1111/j.1475-3588.2008.00515.x; Kalksma-Van Lith B, 2007, INTERVENTION, V5, P3, DOI 10.1097/WTF.0b013e3280c264cd; Kar N, 2009, WORLD J PEDIATR, V5, P5, DOI 10.1007/s12519-009-0001-x; Karam EG, 2008, WORLD PSYCHIATRY, V7, P103; Kessler RC, 2008, INT J METH PSYCH RES, V17, pS1, DOI 10.1002/mpr.266; Khamis V., 2004, IMPACT CLASSROOM COM; Layne CM, 2008, J AM ACAD CHILD PSY, V47, P1048, DOI 10.1097/CHI.0b013e31817eecae; Lloyd E, 2010, CONTEMP ISS EARLY CH, V11, P278, DOI 10.2304/ciec.2010.11.3.278; Loughry M, 2006, J CHILD PSYCHOL PSYC, V47, P1211, DOI 10.1111/j.1469-7610.2006.01656.x; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; Miller KE, 2006, AM J ORTHOPSYCHIAT, V76, P409, DOI 10.1037/0002-9432.76.4.409; Miller KE, 2010, SOC SCI MED, V71, P1385, DOI 10.1016/j.socscimed.2010.07.020; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Mollica RF, 2002, BRIT J PSYCHIAT, V181, P339, DOI 10.1192/bjp.181.4.339; Mollica RF, 2004, LANCET, V365, P842; Neria Y, 2008, PSYCHOL MED, V38, P467, DOI 10.1017/S0033291707001353; Neuner F, 2004, J CONSULT CLIN PSYCH, V72, P579, DOI 10.1037/0022-006X.72.4.579; Neuner F, 2008, J CONSULT CLIN PSYCH, V76, P686, DOI 10.1037/0022-006X.76.4.686; Neuner F, 2010, SOC SCI MED, V71, P1381, DOI 10.1016/j.socscimed.2010.06.030; Nickerson A, 2011, CLIN PSYCHOL REV, V31, P399, DOI 10.1016/j.cpr.2010.10.004; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; North CS, 2011, ARCH GEN PSYCHIAT, V68, P173, DOI 10.1001/archgenpsychiatry.2010.131; Paardekoper B, 2002, THESIS VRIJE U AMSTE, P1; Patel P, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000090; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Peltonen K, 2010, AGGRESSIVE BEHAV, V36, P95, DOI 10.1002/ab.20334; Persson T J, 2009, Torture, V19, P88; Pitt C, 2010, LANCET, V376, P1485, DOI 10.1016/S0140-6736(10)61302-5; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Roberts NP, 2009, AM J PSYCHIAT, V166, P293, DOI 10.1176/appi.ajp.2008.08040590; Robjant K, 2010, CLIN PSYCHOL REV, V30, P1030, DOI 10.1016/j.cpr.2010.07.004; Salcioglu E, 2007, BEHAV RES THER, V45, P2268, DOI 10.1016/j.brat.2007.04.012; Schaal S, 2009, PSYCHOTHER PSYCHOSOM, V78, P298, DOI 10.1159/000229768; Schauer E, 2008, THESIS U KONSTANZ, P1; Shooshtary MH, 2008, J ADOLESCENT HEALTH, V42, P466, DOI 10.1016/j.jadohealth.2007.09.011; Silove D, 2008, ARCH GEN PSYCHIAT, V65, P1205, DOI 10.1001/archpsyc.65.10.1205; Staub E, 2005, J SOC CLIN PSYCHOL, V24, P297, DOI 10.1521/jscp.24.3.297.65617; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Thabet AA, 2005, EUR CHILD ADOLES PSY, V14, P262, DOI 10.1007/s00787-005-0466-7; The Sphere Project, 2011, HUM CHART MIN STAND; The World Bank, COUNTR LEND GROUPS; Tol WA, 2008, JAMA-J AM MED ASSOC, V300, P655, DOI 10.1001/jama.300.6.655; Tol WA, 2011, INT J QUAL HEALTH C, V23, P375, DOI 10.1093/intqhc/mzr032; Tol WA, 2010, J CONSULT CLIN PSYCH, V78, P818, DOI 10.1037/a0021348; Tol WA, 2010, SOC SCI MED, V70, P35, DOI 10.1016/j.socscimed.2009.09.037; Tol WA, 2009, INT J SOC PSYCHIATR, V55, P39, DOI 10.1177/0020764008091525; UN Office for the Coordination of Humanitarian Aff airs, CONS APP PROC; UN Office for the Coordination of Humanitarian Affairs, CENTR EM REL FUND; van Ommeren M, 2005, B WORLD HEALTH ORGAN, V83, P71; van Ommeren M, 2008, AM J PREV MED, V35, P284, DOI 10.1016/j.amepre.2008.06.021; Vijayakumar L, 2008, INT J SOC PSYCHIATR, V54, P293, DOI 10.1177/0020764008090283; Weiss MG, 2003, J NERV MENT DIS, V191, P611, DOI 10.1097/01.nmd.0000087188.96516.a3; Yabiku S, 2007, SUBST USE MISUSE, V42, P65, DOI 10.1080/10826080601094264; Yeomans PD, 2010, J TRAUMA STRESS, V23, P305, DOI 10.1002/jts.20531	87	291	296	2	92	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 29	2011	378	9802					1581	1591		10.1016/S0140-6736(11)61094-5	http://dx.doi.org/10.1016/S0140-6736(11)61094-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	844SL	22008428	Green Accepted, Green Submitted			2022-12-28	WOS:000296767500024
J	Kappe, SHI; Mikolajczak, SA				Kappe, Stefan H. I.; Mikolajczak, Sebastian A.			Another Shot at a Malaria Vaccine	SCIENCE			English	Editorial Material							CD8(+) T-CELLS; PROTECTION		[Kappe, Stefan H. I.; Mikolajczak, Sebastian A.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Kappe, Stefan H. I.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle	Kappe, SHI (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	stefan.kappe@seattlebiomed.org		Mikolajczak, Sebastian/0000-0003-1996-9703				Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Butler NS, 2011, CELL HOST MICROBE, V9, P451, DOI 10.1016/j.chom.2011.05.008; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Overstreet MG, 2008, IMMUNOL REV, V225, P272, DOI 10.1111/j.1600-065X.2008.00671.x; Roestenberg M, 2009, NEW ENGL J MED, V361, P468, DOI 10.1056/NEJMoa0805832; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010	7	7	7	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2011	334	6055					460	461		10.1126/science.1213934	http://dx.doi.org/10.1126/science.1213934			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837UR	22034421				2022-12-28	WOS:000296230500029
J	Hawkes, N				Hawkes, Nigel			DRUG MISUSE Highs and lows of drug decriminalisation	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						CAMPBELL D, 2011, GUARDIAN        0127; COELHO MFP, 2010, BMJ; NHS Information Centre, 2010, SMOK DRINK DRUG US Y; Pacula RL, 2011, INT J DRUG POLICY, V22, P326, DOI 10.1016/j.drugpo.2011.07.008	4	5	5	1	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 26	2011	343								d6881	10.1136/bmj.d6881	http://dx.doi.org/10.1136/bmj.d6881			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	840CY	22031913				2022-12-28	WOS:000296417100015
J	Wager, E				Wager, Elizabeth			Coping with scientific misconduct	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EDITORS		Comm Publicat Eth, Princes Risborough, England		Wager, E (corresponding author), Comm Publicat Eth, Princes Risborough, England.	liz@sideview.demon.co.uk		Wager, Elizabeth/0000-0002-4202-7813				Catano VM, 2007, MED LAW, V26, P465; Committee on Publication Ethics, COPE COD COND; Daroff RB, 2007, MED LAW, V26, P527; Hey E, 2010, J ROY SOC MED, V103, P133, DOI 10.1258/jrsm.2010.09k045; Smith R, 2006, J ROY SOC MED, V99, P232, DOI 10.1258/jrsm.99.5.232; Sox HC, 2006, ANN INTERN MED, V144, P609, DOI 10.7326/0003-4819-144-8-200604180-00123; Spece RG, 2007, MED LAW, V26, P477; Wager E, RETRACTIONS GUIDANCE; Wager E, 2007, MED LAW, V26, P535; White C, 2004, BRIT MED J, V328, P67, DOI 10.1136/bmj.328.7431.67	10	22	22	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 20	2011	343								d6586	10.1136/bmj.d6586	http://dx.doi.org/10.1136/bmj.d6586			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	837HQ	22016451				2022-12-28	WOS:000296184000002
J	Guo, CY; Gerasimova, T; Hao, HP; Ivanova, I; Chakraborty, T; Selimyan, R; Oltz, EM; Sen, RJ				Guo, Changying; Gerasimova, Tatiana; Hao, Haiping; Ivanova, Irina; Chakraborty, Tirtha; Selimyan, Roza; Oltz, Eugene M.; Sen, Ranjan			Two Forms of Loops Generate the Chromatin Conformation of the Immunoglobulin Heavy-Chain Gene Locus	CELL			English	Article							B-CELL DEVELOPMENT; INTRONIC ENHANCER; IGH LOCUS; LYMPHOCYTE DEVELOPMENT; SWITCH RECOMBINATION; REGULATORY ELEMENTS; V(D)J RECOMBINATION; VARIABLE REGION; CTCF SITES; INSULATORS	The immunoglobulin heavy-chain (IgH) gene locus undergoes radial repositioning within the nucleus and locus contraction in preparation for gene recombination. We demonstrate that IgH locus conformation involves two levels of chromosomal compaction. At the first level, the locus folds into several multi-looped domains. One such domain at the 30 end of the locus requires an enhancer, Em; two other domains at the 50 end are Em independent. At the second level, these domains are brought into spatial proximity by Em-dependent interactions with specific sites within the V-H region. Em is also required for radial repositioning of IgH alleles, indicating its essential role in large-scale chromosomal movements in developing lymphocytes. Our observations provide a comprehensive view of the conformation of IgH alleles in pro-B cells and the mechanisms by which it is established.	[Guo, Changying; Gerasimova, Tatiana; Ivanova, Irina; Chakraborty, Tirtha; Selimyan, Roza; Sen, Ranjan] NIA, Gene Regulat Sect, Lab Mol Biol & Immunol, Baltimore, MD 21224 USA; [Hao, Haiping] Johns Hopkins Univ, Sch Med, JHMI Deep Sequencing & Microarray Core, Baltimore, MD 21231 USA; [Oltz, Eugene M.] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Washington University (WUSTL)	Sen, RJ (corresponding author), NIA, Gene Regulat Sect, Lab Mol Biol & Immunol, 251 Bayview Blvd, Baltimore, MD 21224 USA.	rs465z@nih.gov	chang-ying, guo/F-2770-2018	Hao, Haiping/0000-0002-8826-1568	National Institute on Aging (Baltimore, MD); NIH [P01 HL68744, CA100905]; NATIONAL CANCER INSTITUTE [R01CA100905, R01CA156690] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000373] Funding Source: NIH RePORTER	National Institute on Aging (Baltimore, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are indebted to Cornelis Murre and Suchit Jhunjhunwala for sharing and troubleshooting the procedures for small probe FISH. We thank Drs. Dinah Singer, Amy Kenter, Cornelis Murre, Fred Alt, and Sebastian Fugmann for discussions throughout the work and critical appraisal of the manuscript. This work was supported by the Intramural Research Program of the National Institute on Aging (Baltimore, MD) and by NIH grant (P01 HL68744 and CA100905) to E.M.O.	Afshar R, 2006, J IMMUNOL, V176, P2439, DOI 10.4049/jimmunol.176.4.2439; Chakraborty T, 2007, MOL CELL, V27, P842, DOI 10.1016/j.molcel.2007.07.010; Chakraborty T, 2009, J EXP MED, V206, P1019, DOI 10.1084/jem.20081621; COOK PR, 1976, J CELL SCI, V22, P303; Degner SC, 2009, J IMMUNOL, V182, P44, DOI 10.4049/jimmunol.182.1.44; Ebert A, 2011, IMMUNITY, V34, P175, DOI 10.1016/j.immuni.2011.02.005; Featherstone K, 2010, J BIOL CHEM, V285, P9327, DOI 10.1074/jbc.M109.098251; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Garrett FE, 2005, MOL CELL BIOL, V25, P1511, DOI 10.1128/MCB.25.4.1511-1525.2005; GASSER SM, 1987, TRENDS GENET, V3, P16, DOI 10.1016/0168-9525(87)90156-9; Gerasimova TI, 2007, MOL CELL, V28, P761, DOI 10.1016/j.molcel.2007.09.024; Gondor A, 2008, NAT PROTOC, V3, P303, DOI 10.1038/nprot.2007.540; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; Johnston CM, 2006, J IMMUNOL, V176, P4221, DOI 10.4049/jimmunol.176.7.4221; Ju ZL, 2007, J BIOL CHEM, V282, P35169, DOI 10.1074/jbc.M705719200; Kadauke S, 2009, BBA-GENE REGUL MECH, V1789, P17, DOI 10.1016/j.bbagrm.2008.07.002; KLEIN S, 1984, EMBO J, V3, P2473, DOI 10.1002/j.1460-2075.1984.tb02158.x; Knoch T. A., 2000, 3 DIMENSIONAL CHROMO; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Krangel MS, 2009, CURR OPIN IMMUNOL, V21, P133, DOI 10.1016/j.coi.2009.03.009; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Maes J, 2001, J IMMUNOL, V167, P866, DOI 10.4049/jimmunol.167.2.866; MARSDEN MPF, 1979, CELL, V17, P849, DOI 10.1016/0092-8674(79)90325-8; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; PARK K, 1991, P NATL ACAD SCI USA, V88, P9804, DOI 10.1073/pnas.88.21.9804; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; Perlot T, 2005, P NATL ACAD SCI USA, V102, P14362, DOI 10.1073/pnas.0507090102; Perlot T, 2008, ADV IMMUNOL, V99, P1, DOI 10.1016/S0065-2776(08)00601-9; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Retter I, 2007, J IMMUNOL, V179, P2419, DOI 10.4049/jimmunol.179.4.2419; SACHS RK, 1995, P NATL ACAD SCI USA, V92, P2710, DOI 10.1073/pnas.92.7.2710; Sakai E, 1999, P NATL ACAD SCI USA, V96, P1526, DOI 10.1073/pnas.96.4.1526; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Subrahmanyam R, 2010, SEMIN IMMUNOL, V22, P337, DOI 10.1016/j.smim.2010.08.003; Takizawa T, 2008, CELL, V135, P9, DOI 10.1016/j.cell.2008.09.026; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wuerffe R, 2007, IMMUNITY, V27, P711, DOI 10.1016/j.immuni.2007.09.007	44	111	115	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 14	2011	147	2					332	343		10.1016/j.cell.2011.08.049	http://dx.doi.org/10.1016/j.cell.2011.08.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	21982154	Bronze, Green Accepted			2022-12-28	WOS:000296199300012
J	Macfarlane, RJ; Lee, B; Jones, MR; Harris, N; Schatz, GC; Mirkin, CA				Macfarlane, Robert J.; Lee, Byeongdu; Jones, Matthew R.; Harris, Nadine; Schatz, George C.; Mirkin, Chad A.			Nanoparticle Superlattice Engineering with DNA	SCIENCE			English	Article								A current limitation in nanoparticle superlattice engineering is that the identities of the particles being assembled often determine the structures that can be synthesized. Therefore, specific crystallographic symmetries or lattice parameters can only be achieved using specific nanoparticles as building blocks (and vice versa). We present six design rules that can be used to deliberately prepare nine distinct colloidal crystal structures, with control over lattice parameters on the 25- to 150-nanometer length scale. These design rules outline a strategy to independently adjust each of the relevant crystallographic parameters, including particle size (5 to 60 nanometers), periodicity, and interparticle distance. As such, this work represents an advance in synthesizing tailorable macroscale architectures comprising nanoscale materials in a predictable fashion.	[Macfarlane, Robert J.; Harris, Nadine; Schatz, George C.; Mirkin, Chad A.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Macfarlane, Robert J.; Jones, Matthew R.; Harris, Nadine; Schatz, George C.; Mirkin, Chad A.] Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA; [Lee, Byeongdu; Mirkin, Chad A.] Argonne Natl Lab, Adv Photon Source, Xray Sci Div, Argonne, IL 60439 USA; [Jones, Matthew R.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA	Northwestern University; Northwestern University; United States Department of Energy (DOE); Argonne National Laboratory; Northwestern University	Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	chadnano@northwestern.edu	Schatz, George C./ABF-1341-2020; Mirkin, Chad A/E-3911-2010	Jones, Matthew/0000-0002-9289-291X; Mirkin, Chad/0000-0002-6634-7627	Defense Research & Engineering Multidisciplinary University Research Initiative of the Air Force Office of Scientific Research; U.S. Department of Energy Office of Basic Energy Sciences [DE-SC0000989]; U.S. Department of Defense; NU; NSF; E. I. DuPont de Nemours Co.; Dow Chemical Company; state of Illinois; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NSF-NSEC; NSF-MRSEC; Keck Foundation; NU Office for Research	Defense Research & Engineering Multidisciplinary University Research Initiative of the Air Force Office of Scientific Research; U.S. Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); U.S. Department of Defense(United States Department of Defense); NU; NSF(National Science Foundation (NSF)); E. I. DuPont de Nemours Co.; Dow Chemical Company; state of Illinois; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF-NSEC(National Science Foundation (NSF)); NSF-MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Keck Foundation(W.M. Keck Foundation); NU Office for Research	Supported by the Defense Research & Engineering Multidisciplinary University Research Initiative of the Air Force Office of Scientific Research and by the U.S. Department of Energy Office of Basic Energy Sciences [award DE-SC0000989; Northwestern University (NU) Non-equilibrium Energy Research Center] (C.A.M. and G.C.S.); a National Security Science and Engineering Faculty Fellowship from the U.S. Department of Defense (C.A.M.); a NU Ryan Fellowship (R.J.M.); and a NU Ryan Fellowship and a NSF Graduate Research Fellowship (M.R.J.). Portions of this work were carried out at the DuPont-Northwestern-Dow Collaborative Access Team (DND-CAT) beamline located at Sector 5 of the Advanced Photon Source (APS). DND-CAT is supported by E. I. DuPont de Nemours & Co., Dow Chemical Company, and the state of Illinois. Use of the APS was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. The transmission electron microscope work was carried out in the EPIC facility of the NU Atomic and Nanoscale Characterization Experimental Center, which is supported by NSF-NSEC, NSF-MRSEC, Keck Foundation, the state of Illinois, and NU. Ultrathin sectioning was carried out at the NU Biological Imaging Facility, supported by the NU Office for Research.	Bell AT, 2003, SCIENCE, V299, P1688, DOI 10.1126/science.1083671; Bloomfield V.A., 2000, NUCL ACIDS STRUCTURE, V1st ed.; Bodnarchuk MI, 2010, J AM CHEM SOC, V132, P11967, DOI 10.1021/ja103083q; Chen CL, 2010, ANGEW CHEM INT EDIT, V49, P1924, DOI 10.1002/anie.200903572; Fan JA, 2010, SCIENCE, V328, P1135, DOI 10.1126/science.1187949; Grunes J, 2002, J PHYS CHEM B, V106, P11463, DOI 10.1021/jp021641e; Jones MR, 2011, CHEM REV, V111, P3736, DOI 10.1021/cr1004452; Jones MR, 2010, NAT MATER, V9, P913, DOI [10.1038/NMAT2870, 10.1038/nmat2870]; Kalsin AM, 2006, SCIENCE, V312, P420, DOI 10.1126/science.1125124; Kelly KL, 2003, J PHYS CHEM B, V107, P668, DOI 10.1021/jp026731y; Kiely CJ, 1998, NATURE, V396, P444, DOI 10.1038/24808; Macfarlane RJ, 2010, ANGEW CHEM INT EDIT, V49, P4589, DOI 10.1002/anie.201000633; Macfarlane RJ, 2009, P NATL ACAD SCI USA, V106, P10493, DOI 10.1073/pnas.0900630106; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Nie ZH, 2010, NAT NANOTECHNOL, V5, P15, DOI [10.1038/NNANO.2009.453, 10.1038/nnano.2009.453]; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; Park SJ, 2004, J PHYS CHEM B, V108, P12375, DOI 10.1021/jp040242b; Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508; Pauling L., 1960, NATURE CHEM BOND; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; Srivastava S, 2010, SCIENCE, V327, P1355, DOI 10.1126/science.1177218; Stebe KJ, 2009, SCIENCE, V325, P159, DOI 10.1126/science.1174401; Tkachenko AV, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.148303; Wong S, 2003, J AM CHEM SOC, V125, P15589, DOI 10.1021/ja0379969; Woodcock LV, 1997, NATURE, V385, P141, DOI 10.1038/385141a0; Xiong HM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.015504; Zhao Y, 2009, NAT MATER, V8, P979, DOI [10.1038/NMAT2565, 10.1038/nmat2565]; ZHOU O, 1991, NATURE, V351, P462, DOI 10.1038/351462a0	28	859	871	13	615	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2011	334	6053					204	208		10.1126/science.1210493	http://dx.doi.org/10.1126/science.1210493			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998382				2022-12-28	WOS:000295833600040
J	Hvid-Jensen, F; Pedersen, L; Drewes, AM; Sorensen, HT; Funch-Jensen, P				Hvid-Jensen, Frederik; Pedersen, Lars; Drewes, Asbjorn Mohr; Sorensen, Henrik Toft; Funch-Jensen, Peter			Incidence of Adenocarcinoma among Patients with Barrett's Esophagus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-GRADE DYSPLASIA; INTESTINAL METAPLASIA; CANCER-RISK; ESOPHAGOGASTRIC JUNCTION; GASTROESOPHAGEAL-REFLUX; MALIGNANT PROGRESSION; FOLLOW-UP; SURVEILLANCE; COHORT; DIAGNOSIS	BACKGROUND Accurate population-based data are needed on the incidence of esophageal adenocarcinoma and high-grade dysplasia among patients with Barrett's esophagus. METHODS We conducted a nationwide, population-based, cohort study involving all patients with Barrett's esophagus in Denmark during the period from 1992 through 2009, using data from the Danish Pathology Registry and the Danish Cancer Registry. We determined the incidence rates (numbers of cases per 1000 person-years) of adenocarcinoma and high-grade dysplasia. As a measure of relative risk, standardized incidence ratios were calculated with the use of national cancer rates in Denmark during the study period. RESULTS We identified 11,028 patients with Barrett's esophagus and analyzed their data for a median of 5.2 years. Within the first year after the index endoscopy, 131 new cases of adenocarcinoma were diagnosed. During subsequent years, 66 new adenocarcinomas were detected, yielding an incidence rate for adenocarcinoma of 1.2 cases per 1000 person-years (95% confidence interval [CI], 0.9 to 1.5). As compared with the risk in the general population, the relative risk of adenocarcinoma among patients with Barrett's esophagus was 11.3 (95% CI, 8.8 to 14.4). The annual risk of esophageal adenocarcinoma was 0.12% (95% CI, 0.09 to 0.15). Detection of low-grade dysplasia on the index endoscopy was associated with an incidence rate for adenocarcinoma of 5.1 cases per 1000 person-years. In contrast, the incidence rate among patients without dysplasia was 1.0 case per 1000 person-years. Risk estimates for patients with high-grade dysplasia were slightly higher. CONCLUSIONS Barrett's esophagus is a strong risk factor for esophageal adenocarcinoma, but the absolute annual risk, 0.12%, is much lower than the assumed risk of 0.5%, which is the basis for current surveillance guidelines. Data from the current study call into question the rationale for ongoing surveillance in patients who have Barrett's esophagus without dysplasia. (Funded by the Clinical Institute, University of Aarhus, Aarhus, Denmark.)	[Funch-Jensen, Peter] Univ Aarhus, Hamlet Hosp, DK-8200 Aarhus N, Denmark; [Funch-Jensen, Peter] Univ Aarhus, Inst Clin, DK-8200 Aarhus N, Denmark; [Hvid-Jensen, Frederik] Aarhus Univ Hosp, Dept Surg Gastroenterol L, DK-8000 Aarhus, Denmark; [Pedersen, Lars; Sorensen, Henrik Toft] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Drewes, Asbjorn Mohr] Aarhus Univ Hosp, Mech Sense Dept Gastroenterol, Aalborg, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Funch-Jensen, P (corresponding author), Univ Aarhus, Hamlet Hosp, Brendstrupgardsvej 21, DK-8200 Aarhus N, Denmark.	funchjensen@gmail.com	Sorensen, Henrik Toft/Z-6181-2019; Drewes, Asbjørn/AAR-7479-2021	Sorensen, Henrik Toft/0000-0003-4299-7040; Drewes, Asbjørn/0000-0001-7465-964X	Clinical Institute, University of Aarhus, Aarhus, Denmark	Clinical Institute, University of Aarhus, Aarhus, Denmark	Supported by the Clinical Institute, University of Aarhus, Aarhus, Denmark.	Bhat S, 2011, J NATL CANCER I, V103, P1049, DOI 10.1093/jnci/djr203; Bytzer P, 1999, AM J GASTROENTEROL, V94, P86; CAMERON AJ, 1995, GASTROENTEROLOGY, V109, P1541, DOI 10.1016/0016-5085(95)90642-8; Cameron AJ, 2002, AM J GASTROENTEROL, V97, P1375, DOI 10.1016/S0002-9270(02)04025-X; CAMERON AJ, 1990, GASTROENTEROLOGY, V99, P918, DOI 10.1016/0016-5085(90)90607-3; Chang EY, 2007, ANN SURG, V246, P11, DOI 10.1097/01.sla.0000261459.10565.e9; Conio M, 2003, AM J GASTROENTEROL, V98, P1931, DOI 10.1016/S0002-9270(03)00629-4; Corley DA, 2002, GASTROENTEROLOGY, V122, P633, DOI 10.1053/gast.2002.31879; de Jonge PJF, 2010, GUT, V59, P1030, DOI 10.1136/gut.2009.176701; DeMeester SR, 2000, ANN SURG, V231, P303, DOI 10.1097/00000658-200003000-00003; Dulai GS, 2005, AM J GASTROENTEROL, V100, P775, DOI 10.1111/j.1572-0241.2005.41300.x; Dulai GS, 2002, GASTROENTEROLOGY, V122, P26, DOI 10.1053/gast.2002.30297; Erichsen Rune, 2010, Clin Epidemiol, V2, P51; Garside R, 2006, HEALTH TECHNOL ASSES, V10, P1; Gatenby PAC, 2008, SCAND J GASTROENTERO, V43, P524, DOI 10.1080/00365520701879831; Hage M, 2004, SCAND J GASTROENTERO, V39, P1175, DOI 10.1080/00365520410003524; Inadomi JM, 2003, ANN INTERN MED, V138, P176, DOI 10.7326/0003-4819-138-3-200302040-00009; Montgomery E, 2001, HUM PATHOL, V32, P379, DOI 10.1053/hupa.2001.23511; Montgomery E, 2001, HUM PATHOL, V32, P368, DOI 10.1053/hupa.2001.23510; Murray L, 2003, BRIT MED J, V327, P534, DOI 10.1136/bmj.327.7414.534; O'Connor JB, 1999, AM J GASTROENTEROL, V94, P2037; Pedersen CB, 2006, DAN MED BULL, V53, P441; Playford RJ, 2006, GUT, V55, P442, DOI 10.1136/gut.2005.083600; Provenzale D, 1999, AM J GASTROENTEROL, V94, P2043; Rubenstein JH, 2011, AM J GASTROENTEROL, V106, P254, DOI 10.1038/ajg.2010.470; Shaheen NJ, 2000, GASTROENTEROLOGY, V119, P333, DOI 10.1053/gast.2000.9302; Sharma P, 2006, CLIN GASTROENTEROL H, V4, P566, DOI 10.1016/j.cgh.2006.03.001; Sikkema M, 2010, CLIN GASTROENTEROL H, V8, P235, DOI 10.1016/j.cgh.2009.10.010; Solaymani-Dodaran M, 2004, GUT, V53, P1070, DOI 10.1136/gut.2003.028076; Spechler SJ, 2004, AM J GASTROENTEROL, V99, P2295, DOI 10.1111/j.1572-0241.2004.41295_3.x; Spechler SJ, 2003, BRIT MED J, V326, P892, DOI 10.1136/bmj.326.7395.892; Spechler Stuart Jon, 2002, Rev Gastroenterol Disord, V2 Suppl 2, pS25; Stein Hubert J., 1993, Dysphagia, V8, P276, DOI 10.1007/BF01354551; Thomas T, 2007, ALIMENT PHARM THER, V26, P1465, DOI 10.1111/j.1365-2036.2007.03528.x; Vakil N, 2009, CLIN GASTROENTEROL H, V7, P756, DOI 10.1016/j.cgh.2009.03.031; van Blankenstein M, 2005, AM J GASTROENTEROL, V100, P766, DOI 10.1111/j.1572-0241.2005.40790.x; vanderBurgh A, 1996, GUT, V39, P5, DOI 10.1136/gut.39.1.5; Wang KK, 2008, AM J GASTROENTEROL, V103, P788, DOI 10.1111/j.1572-0241.2008.01835.x; Weston AP, 1999, AM J GASTROENTEROL, V94, P3413, DOI 10.1111/j.1572-0241.1999.01602.x; Ye WM, 2001, GASTROENTEROLOGY, V121, P1286, DOI 10.1053/gast.2001.29569; Yousef F, 2008, AM J EPIDEMIOL, V168, P237, DOI 10.1093/aje/kwn121	41	914	934	1	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 13	2011	365	15					1375	1383		10.1056/NEJMoa1103042	http://dx.doi.org/10.1056/NEJMoa1103042			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832DQ	21995385				2022-12-28	WOS:000295782500005
J	Lanuti, M; Sequist, LV; Sharma, A; Mino-Kenudson, M				Lanuti, Michael; Sequist, Lecia V.; Sharma, Amita; Mino-Kenudson, Mari			Case 31-2011: A 55-Year-Old Man with Oligometastatic Lung Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHEMOTHERAPY-NAIVE PATIENTS; DIAGNOSED BRAIN METASTASES; FACTOR RECEPTOR MUTATIONS; SURGICAL-TREATMENT; PHASE-II; GEFITINIB; MANAGEMENT; CARBOPLATIN; PACLITAXEL; CARCINOMA		[Lanuti, Michael] Massachusetts Gen Hosp, Dept Thorac Surg, Boston, MA 02114 USA; [Sharma, Amita] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Mino-Kenudson, Mari] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Sequist, Lecia V.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Lanuti, Michael] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Sequist, Lecia V.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Sharma, Amita] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Mino-Kenudson, Mari] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Lanuti, M (corresponding author), Massachusetts Gen Hosp, Dept Thorac Surg, Boston, MA 02114 USA.				Department of Continuing Education, Harvard Medical School, Boston; Boston Scientific; GlaxoSmithKline; Telik	Department of Continuing Education, Harvard Medical School, Boston; Boston Scientific(Boston Scientific); GlaxoSmithKline(GlaxoSmithKline); Telik	This case was discussed at the postgraduate course General Thoracic Surgery, directed by Douglas J. Mathisen, M.D., and Cameron Wright, M.D., of the Division of Thoracic Surgery, Massachusetts General Hospital, sponsored by the Department of Continuing Education, Harvard Medical School, Boston, and moderated by Eugene Mark, M.D.; Dr. Lanuti reports receiving consulting fees from Boston Scientific, and Dr. Sequist receiving consulting fees from GlaxoSmithKline, Telik, and Clovis Oncology and performing gratis consulting for Daiichi Sankyo and Merrimack Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.	Asahina H, 2006, BRIT J CANCER, V95, P998, DOI 10.1038/sj.bjc.6603393; Azzoli CG, 2009, J CLIN ONCOL, V27, P6251, DOI 10.1200/JCO.2009.23.5622; Billing PS, 2001, J THORAC CARDIOV SUR, V122, P548, DOI 10.1067/mtc.2001.116201; Bonnette P, 2001, CHEST, V119, P1469, DOI 10.1378/chest.119.5.1469; BURT M, 1992, J THORAC CARDIOV SUR, V103, P399; Detterbeck FC, 2001, DIAGNOSIS AND TREATMENT OF LUNG CANCER: AN EVIDENCE-BASED GUIDE FOR THE PRACTICING CLINICIAN, P94; Detterbeck FC, 2003, CHEST, V123, p244S, DOI 10.1378/chest.123.1_suppl.244S; Gaspar LE, 2010, J NEURO-ONCOL, V96, P17, DOI 10.1007/s11060-009-0060-9; Getman V, 2004, EUR J CARDIO-THORAC, V25, P1107, DOI 10.1016/j.ejcts.2004.02.021; Inoue A, 2006, J CLIN ONCOL, V24, P3340, DOI 10.1200/JCO.2005.05.4692; KNIGHTS EM, 1954, CANCER, V7, P259, DOI 10.1002/1097-0142(195403)7:2<259::AID-CNCR2820070208>3.0.CO;2-C; Linskey ME, 2010, J NEURO-ONCOL, V96, P45, DOI 10.1007/s11060-009-0073-4; Linskey ME, 2010, J NEUROONCOL, V96, P69; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; MAGILLIGAN DJ, 1986, ANN THORAC SURG, V42, P360, DOI 10.1016/S0003-4975(10)60536-X; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Mussi A, 1996, J THORAC CARDIOV SUR, V112, P146, DOI 10.1016/S0022-5223(96)70190-3; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; ROSSI NP, 1987, RESPIRATION, V51, P170, DOI 10.1159/000195199; Sandler A, 2007, NEW ENGL J MED, V356, P318; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Sequist, 2008, J CLIN ONCOL, V26, P3472, DOI 10.1200/JCO.2008.18.4747; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Sequist LV, 2007, ONCOLOGIST, V12, P90, DOI 10.1634/theoncologist.12-1-90; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; WRONSKI M, 1995, J NEUROSURG, V83, P605, DOI 10.3171/jns.1995.83.4.0605; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X	35	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 13	2011	365	15					1426	1435		10.1056/NEJMcpc1013930	http://dx.doi.org/10.1056/NEJMcpc1013930			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832DQ	21995391				2022-12-28	WOS:000295782500012
J	Roos, N; Kieler, H; Sahlin, L; Ekman-Ordeberg, G; Falconer, H; Stephansson, O				Roos, Nathalie; Kieler, Helle; Sahlin, Lena; Ekman-Ordeberg, Gunvor; Falconer, Henrik; Stephansson, Olof			Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IN-VITRO FERTILIZATION; GLUCOSE-TOLERANCE; COMMUNITY SAMPLE; BIRTH-WEIGHT; PREVALENCE; PCOS; COMPLICATIONS; METAANALYSIS; AGE	Objective To study the risk of adverse pregnancy outcomes in women with polycystic ovary syndrome, taking into account maternal characteristics and assisted reproductive technology. Design Population based cohort study. Setting Singleton births registered in the Swedish medical birth register between 1995 and 2007. Participants By linkage with the Swedish patient register, 3787 births among women with a diagnosis of polycystic ovary syndrome and 1 191 336 births among women without such a diagnosis. Main outcome measures Risk of adverse pregnancy outcomes (gestational diabetes, pre-eclampsia, preterm birth, stillbirth, neonatal death, low Apgar score (<7 at five minutes), meconium aspiration, large for gestational age, macrosomia, small for gestational age), adjusted for maternal characteristics (body mass index, age), socioeconomic factors (educational level, and cohabitating with infant's father), and assisted reproductive technology. Results Women with polycystic ovary syndrome were more often obese and more commonly used assisted reproductive technology than women without such a diagnosis (60.6% v 34.8% and 13.7% v 1.5%). Polycystic ovary syndrome was strongly associated with pre-eclampsia (adjusted odds ratio 1.45, 95% confidence interval 1.24 to 1.69) and very preterm birth (2.21, 1.69 to 2.90) and the risk of gestational diabetes was more than doubled (2.32, 1.88 to 2.88). Infants born to mothers with polycystic ovary syndrome were more prone to be large for gestational age (1.39, 1.19 to 1.62) and were at increased risk of meconium aspiration (2.02, 1.13 to 3.61) and having a low Apgar score (<7) at five minutes (1.41, 1.09 to 1.83). Conclusions Women with polycystic ovary syndrome are at increased risk of adverse pregnancy and birth outcomes that cannot be explained by assisted reproductive technology. These women may need increased surveillance during pregnancy and parturition.	[Roos, Nathalie; Ekman-Ordeberg, Gunvor; Falconer, Henrik] Karolinska Univ Hosp, Karolinska Inst, Div Obstet & Gynaecol, Dept Womens & Childrens Hlth, SE-17176 Stockholm, Sweden; [Roos, Nathalie; Kieler, Helle; Stephansson, Olof] Karolinska Inst, Clin Epidemiol Unit, Dept Med, Stockholm, Sweden; [Sahlin, Lena] Karolinska Inst, Div Reprod Endocrinol, Dept Womens & Childrens Hlth, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Roos, N (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Div Obstet & Gynaecol, Dept Womens & Childrens Hlth, H2 01, SE-17176 Stockholm, Sweden.	nathalie.roos@karolinska.se		Kieler, Helle/0000-0001-9338-7133; Falconer, Henrik/0000-0003-4427-9421; Sahlin, Lena/0000-0001-5609-4382; Roos, Nathalie/0000-0001-9752-2355; Stephansson, Olof/0000-0003-1528-4563	Swedish Research Council [73X-20137, 73X-14612]; board of postgraduate education at Karolinska Institutet, Stockholm, Sweden (Karolinska Institutet); Stockholm County Council; Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); board of postgraduate education at Karolinska Institutet, Stockholm, Sweden (Karolinska Institutet)(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: that this study received financial support from the Swedish Research Council (projects 73X-20137 (LS) 73X-14612 (GEO)) and the board of postgraduate education at Karolinska Institutet, Stockholm, Sweden (Karolinska Institutet Doctoral Student Financing Funds (KID)) (NR) for the submitted work, and that financial support was also provided through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet (LS); no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work. Ethical approval: This study was approved by the Karolinska Institute's local ethics committee.	Archer JS, 2004, BEST PRACT RES CL OB, V18, P737, DOI 10.1016/j.bpobgyn.2004.05.007; Asuncion M, 2000, J CLIN ENDOCR METAB, V85, P2434, DOI 10.1210/jc.85.7.2434; Baeten JM, 2001, AM J PUBLIC HEALTH, V91, P436, DOI 10.2105/AJPH.91.3.436; Boomsma CM, 2006, HUM REPROD UPDATE, V12, P673, DOI 10.1093/humupd/dml036; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Cok T, 2011, J MATERN-FETAL NEO M, V24, P1039, DOI 10.3109/14767058.2010.545910; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Fridstrom M, 1999, HYPERTENS PREGNANCY, V18, P73, DOI 10.3109/10641959909009612; Haakova L, 2003, HUM REPROD, V18, P1438, DOI 10.1093/humrep/deg289; Heijnen EMEW, 2006, HUM REPROD UPDATE, V12, P13, DOI 10.1093/humupd/dmi036; Hudecova M, 2009, HUM REPROD, V24, P1176, DOI 10.1093/humrep/den482; Jackson RA, 2004, OBSTET GYNECOL, V103, P551, DOI 10.1097/01.AOG.0000114989.84822.51; Kallen B, 2005, BJOG-INT J OBSTET GY, V112, P1529, DOI 10.1111/j.1471-0528.2005.00745.x; Knochenhauer ES, 1998, J CLIN ENDOCR METAB, V83, P3078, DOI 10.1210/jc.83.9.3078; Legro RS, 1998, P NATL ACAD SCI USA, V95, P14956, DOI 10.1073/pnas.95.25.14956; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Mikola M, 2001, HUM REPROD, V16, P226, DOI 10.1093/humrep/16.2.226; Moran LJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007506.pub3; Radon PA, 1999, OBSTET GYNECOL, V94, P194, DOI 10.1016/S0029-7844(99)00252-5; Rajashekar Lavanya, 2008, J Hum Reprod Sci, V1, P65; Romundstad LB, 2008, LANCET, V372, P737, DOI 10.1016/S0140-6736(08)61041-7; Salvesen KA, 2007, ULTRASOUND OBST GYN, V29, P433, DOI 10.1002/uog.3965; Schieve LA, 2002, NEW ENGL J MED, V346, P731, DOI 10.1056/NEJMoa010806; Sheiner E, 2004, PAEDIATR PERINAT EP, V18, P196, DOI 10.1111/j.1365-3016.2004.00557.x; Sir-Petermann T, 2005, HUM REPROD, V20, P2122, DOI 10.1093/humrep/dei009; Surkan PJ, 2004, OBSTET GYNECOL, V104, P720, DOI 10.1097/01.AOG.0000141442.59573.cd; Tehrani FR, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-39; Troisi R, 2003, CANCER EPIDEM BIOMAR, V12, P1268; Usta IM, 2008, AM J PERINAT, V25, P521, DOI 10.1055/s-0028-1085620; Vanky E, 2004, HUM REPROD, V19, P1734, DOI 10.1093/humrep/deh347; Vollenhoven B, 2000, AUST NZ J OBSTET GYN, V40, P54, DOI 10.1111/j.1479-828X.2000.tb03167.x	33	178	187	1	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2011	343								d6309	10.1136/bmj.d6309	http://dx.doi.org/10.1136/bmj.d6309			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835EQ	21998337	hybrid, Green Published			2022-12-28	WOS:000296018300004
J	White, C				White, Caroline			PATIENT LED CARE Do personal health budgets lead to better care choices?	BRITISH MEDICAL JOURNAL			English	Editorial Material												cwhite@bmjgroup.com							0	1	1	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 11	2011	343								d6532	10.1136/bmj.d6532	http://dx.doi.org/10.1136/bmj.d6532			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	835EJ	21990285				2022-12-28	WOS:000296017500012
J	Johnson, O; Bailey, SL; Willott, C; Crocker-Buque, T; Jessop, V; Birch, M; Ward, H; Yudkin, JS				Johnson, Oliver; Bailey, Sarah Lou; Willott, Chris; Crocker-Buque, Tim; Jessop, Vanessa; Birch, Marion; Ward, Helen; Yudkin, John S.		Global Hlth Learning Outcomes Work	Global health learning outcomes for medical students in the UK	LANCET			English	Editorial Material									[Johnson, Oliver] Kings Coll London, Kings Ctr Global Hlth, Weston Educ Ctr, London SE5 9RJ, England; [Bailey, Sarah Lou] Univ Sussex, Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Willott, Chris] UCL, Ctr Int Hlth & Dev, Inst Child Hlth, London, England; [Yudkin, John S.] UCL, Div Med, London, England; [Crocker-Buque, Tim; Jessop, Vanessa] Whipps Cross Univ Hosp NHS Trust, London, England; [Birch, Marion] Medact, London, England; [Ward, Helen] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England	University of London; King's College London; University of Brighton; University of Sussex; University of London; University College London; University of London; University College London; Imperial College London	Johnson, O (corresponding author), Kings Coll London, Kings Ctr Global Hlth, Weston Educ Ctr, London SE5 9RJ, England.	oliver.johnson@kcl.ac.uk	Ward, Helen/A-1836-2009; Yudkin, John S/C-1988-2008	Ward, Helen/0000-0001-8238-5036; Willott, Chris/0000-0003-0940-4215; Johnson, Oliver/0000-0001-8698-0553	National Institute for Health Research [ACF-2007-27-003] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Bateman C, 2001, LANCET, V358, P1539, DOI 10.1016/S0140-6736(01)06586-2; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Department of Health, 2010, FAIR SOC HLTH LIV MA; Frenk J, 2011, LANCET, V377, P1238, DOI 10.1016/S0140-6736(11)60500-X; General Medical Council, 2009, TOM DOCT OUTC STAND; Haq C, 2000, FAM MED, V32, P566; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Institute of Medicine, 2002, FUT PUBL HLTH 21 CEN; Koplan JP, 2009, LANCET, V373, P1993, DOI 10.1016/S0140-6736(09)60332-9; Kovats RS, 2006, EUR J PUBLIC HEALTH, V16, P592, DOI 10.1093/eurpub/ckl049; World Health Organization, 2010, WHO GLOB COD PRACT I; World Health Organization, 2005, WHO FRAM CONV TOB CO	13	57	57	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	2012	379	9831					2033	2035		10.1016/S0140-6736(11)61582-1	http://dx.doi.org/10.1016/S0140-6736(11)61582-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	951ZI	22019145				2022-12-28	WOS:000304759100012
J	Licausi, F; Kosmacz, M; Weits, DA; Giuntoli, B; Giorgi, FM; Voesenek, LACJ; Perata, P; van Dongen, JT				Licausi, Francesco; Kosmacz, Monika; Weits, Daan A.; Giuntoli, Beatrice; Giorgi, Federico M.; Voesenek, Laurentius A. C. J.; Perata, Pierdomenico; van Dongen, Joost T.			Oxygen sensing in plants is mediated by an N-end rule pathway for protein destabilization	NATURE			English	Article							ETHYLENE RESPONSE FACTORS; EVOLUTIONARY CONSERVATION; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; BINDING PROTEIN; HYPOXIA; STRESS; LOCALIZATION; SYSTEM; CELLS	The majority of eukaryotic organisms rely on molecular oxygen for respiratory energy production(1). When the supply of oxygen is compromised, a variety of acclimation responses are activated to reduce the detrimental effects of energy depletion(2-4). Various oxygen-sensing mechanisms have been described that are thought to trigger these responses(5-9), but they each seem to be kingdom specific and no sensing mechanism has been identified in plants until now. Here we show that one branch of the ubiquitin-dependent N-end rule pathway for protein degradation, which is active in both mammals and plants(10,11), functions as an oxygen-sensing mechanism in Arabidopsis thaliana. We identified a conserved amino-terminal amino acid sequence of the ethylene response factor (ERF)-transcription factor RAP2.12 to be dedicated to an oxygen-dependent sequence of post-translational modifications, which ultimately lead to degradation of RAP2.12 under aerobic conditions. When the oxygen concentration is low-as during flooding-RAP2.12 is released from the plasma membrane and accumulates in the nucleus to activate gene expression for hypoxia acclimation. Our discovery of an oxygen-sensing mechanism opens up new possibilities for improving flooding tolerance in crops.	[Licausi, Francesco; Kosmacz, Monika; Weits, Daan A.; Giorgi, Federico M.; van Dongen, Joost T.] Max Planck Inst Mol Plant Physiol, D-14476 Potsdam, Germany; [Licausi, Francesco; Giuntoli, Beatrice; Perata, Pierdomenico] Scuola Super Sant Anna, Inst Life Sci, PlantLab, I-56127 Pisa, Italy; [Voesenek, Laurentius A. C. J.] Univ Utrecht, Inst Environm Biol, NL-3584 CH Utrecht, Netherlands; [Voesenek, Laurentius A. C. J.] Ctr Biosyst Genom, NL-6708 PB Wageningen, Netherlands	Max Planck Society; Scuola Superiore Sant'Anna; Utrecht University; Centre for BioSystems Genomics	Licausi, F (corresponding author), Max Planck Inst Mol Plant Physiol, Muehlenberg 1, D-14476 Potsdam, Germany.	f.licausi@sssup.it; dongen@mpimp-golm.mpg.de	Giorgi, Federico M./AAD-5797-2020; Voesenek, Laurentius A.C.J./B-9661-2011; Perata, Pierdomenico/A-5658-2008; van Dongen, Joost T/F-5372-2016; Licausi, Francesco/F-7985-2011; GIUNTOLI, BEATRICE/HCH-7605-2022	Giorgi, Federico M./0000-0002-7325-9908; Perata, Pierdomenico/0000-0001-9444-0610; van Dongen, Joost T/0000-0001-7944-9289; GIUNTOLI, BEATRICE/0000-0003-4968-4071; Licausi, Francesco/0000-0003-4769-441X; Voesenek, Laurentius/0000-0002-3361-3837; Weits, Daniel/0000-0003-4423-5568	Max Planck Institute of Molecular Plant Physiology; Scuola Superiore Sant'Anna; Deutsche Forschungsgemeinschaft (DFG) [DO 1298/2-1]	Max Planck Institute of Molecular Plant Physiology; Scuola Superiore Sant'Anna; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We would like to thank H. van Veen and R. Sasidharan (for providing Rumex data), E. Maximova, F. Kragler (microscopy), W. Schulze and R. Bock (support and discussion), A. Fernie and R. Pierik (commenting on the manuscript) and S. Parlanti, L. Bartezko and K. Seehaus (plant cultivation). This work was financially supported by the Max Planck Institute of Molecular Plant Physiology, Scuola Superiore Sant'Anna, and the Deutsche Forschungsgemeinschaft (DFG) (DO 1298/2-1).	Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; Garzon M, 2007, FEBS LETT, V581, P3189, DOI 10.1016/j.febslet.2007.06.005; Gehl C, 2009, MOL PLANT, V2, P1051, DOI 10.1093/mp/ssp040; Graciet E, 2010, TRENDS PLANT SCI, V15, P447, DOI 10.1016/j.tplants.2010.04.011; Graciet E, 2010, PLANT J, V61, P741, DOI 10.1111/j.1365-313X.2009.04099.x; Green J, 2009, CURR OPIN MICROBIOL, V12, P145, DOI 10.1016/j.mib.2009.01.008; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; Hinz M, 2010, PLANT PHYSIOL, V153, P757, DOI 10.1104/pp.110.155077; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Kelly DP, 2008, NAT GENET, V40, P132, DOI 10.1038/ng0208-132; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Lee Min Woo, 2006, V323, P225; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Li HY, 2004, PLANT MOL BIOL, V54, P233, DOI 10.1023/B:PLAN.0000028790.75090.ab; Li HY, 2003, PLANT MOL BIOL, V51, P483, DOI 10.1023/A:1022330304402; Licausi F, 2011, NEW PHYTOL, V190, P442, DOI 10.1111/j.1469-8137.2010.03451.x; Licausi F, 2010, PLANT J, V62, P302, DOI 10.1111/j.1365-313X.2010.04149.x; Lohse M, 2010, PLANT PHYSIOL, V153, P642, DOI 10.1104/pp.109.152553; Mustroph A, 2010, PLANT PHYSIOL, V152, P1484, DOI 10.1104/pp.109.151845; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Papdi C, 2008, PLANT PHYSIOL, V147, P528, DOI 10.1104/pp.108.116897; Pierik R, 2011, NEW PHYTOL, V189, P122, DOI 10.1111/j.1469-8137.2010.03458.x; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; VALLON U, 1994, PROTOPLASMA, V182, P15, DOI 10.1007/BF01403684; van der Wel H, 2011, BIOCHEMISTRY-US, V50, P1700, DOI 10.1021/bi101977w; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Webb JD, 2009, CELL MOL LIFE SCI, V66, P3539, DOI 10.1007/s00018-009-0147-7; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97	35	473	497	8	253	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 17	2011	479	7373					419	U177		10.1038/nature10536	http://dx.doi.org/10.1038/nature10536			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	848OA	22020282	Green Published			2022-12-28	WOS:000297059700050
J	Whitlock, EP; Vesco, KK; Eder, M; Lin, JS; Senger, CA; Burda, BU				Whitlock, Evelyn P.; Vesco, Kimberly K.; Eder, Michelle; Lin, Jennifer S.; Senger, Caitlyn A.; Burda, Brittany U.			Liquid-Based Cytology and Human Papillomavirus Testing to Screen for Cervical Cancer: A Systematic Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; CONVENTIONAL CYTOLOGY; INTRAEPITHELIAL NEOPLASIA; PSYCHOSOCIAL IMPACT; NATURAL-HISTORY; FOLLOW-UP; WOMEN; RISK; DNA; COHORT	Background: Screening programs using conventional cytology have successfully reduced cervical cancer, but newer tests might enhance screening. Purpose: To systematically review the evidence on liquid-based cytology (LBC) and high-risk human papillomavirus (HPV) screening for U.S. Preventive Services Task Force use in updating its 2003 recommendation. Data Sources: MEDLINE, Cochrane Central Register of Controlled Trials, and PsycINFO from January 2000 through September 2010. Study Selection: Two independent reviewers selected fair-to good-quality English-language studies that compared LBC or HPV-enhanced primary screening with conventional cytology in countries with developed population-based screening for cervical cancer. Data Extraction: At least 2 independent reviewers critically appraised and rated the quality of studies and used standardized abstraction forms to extract data about test performance for detecting cervical intraepithelial neoplasia (CIN) and cancer and screening-related harms. Data Synthesis: On the basis of 4 fair-to good-quality studies (141 566 participants), LBC had equivalent sensitivity and specificity to conventional cytology. Six fair- to good-quality diagnostic accuracy studies showed that 1-time HPV screening was more sensitive than cytology for detecting CIN3+/CIN2+ but was less specific. On the basis of 2 fair- to good-quality randomized, controlled trials (RCTs) (120 533 participants), primary HPV screening detected more cases of CIN3 or cancer in women older than 30 years. Four fair- to good-quality diagnostic accuracy studies and 4 fair- to good-quality RCTs showed mixed results of cotesting (HPV plus cytology) in women aged 30 years or older compared with cytology alone, with no clear advantage over primary HPV screening. Incomplete reporting of results for all screening rounds, including detection of disease and colposcopies, limits our ability to determine the net benefit of HPV-enhanced testing strategies. Limitation: Resources were insufficient to gather unpublished data, short-term trial data showed possible ascertainment bias, and most RCTs used protocols that differed from current U. S. practice. Conclusion: Evidence supports the use of LBC or conventional cytology for cervical cancer screening, but more complete evidence is needed before HPV-enhanced primary screening is widely adopted for women aged 30 years or older.	[Whitlock, Evelyn P.; Vesco, Kimberly K.; Eder, Michelle; Lin, Jennifer S.; Senger, Caitlyn A.; Burda, Brittany U.] Kaiser Permanente NW, Ctr Hlth Res, Oregon Evidence Based Practice Ctr, Portland, OR 97227 USA	Kaiser Permanente	Whitlock, EP (corresponding author), Kaiser Permanente NW, Ctr Hlth Res, Oregon Evidence Based Practice Ctr, 3800 N Interstate Ave, Portland, OR 97227 USA.				Agency for Healthcare Research and Quality [HHS-290-2007-10057-I, task order 3]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This review was conducted by the Oregon Evidence-based Practice Center under contract to the Agency for Healthcare Research and Quality (contract HHS-290-2007-10057-I, task order 3).	[Anonymous], 2009, Obstet Gynecol, V114, P1409, DOI 10.1097/AOG.0b013e3181c6f8a4; [Anonymous], 2008, Obstet Gynecol, V112, P1419, DOI 10.1097/AOG.0b013e318192497c; Anttila A, 2011, INT J CANCER, V128, P1204, DOI 10.1002/ijc.25677; Anttila A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1804; Arbyn M, 2008, EUROPEAN GUIDELINES; ARBYN M, 2011, ANN ONCOL; Arbyn M, 2009, EUR J CANCER, V45, P2671, DOI 10.1016/j.ejca.2009.07.016; Arney A, 2010, LABMEDICINE, V41, P523, DOI 10.1309/LM75WGJSVMI7VVEF; Bigras G, 2005, BRIT J CANCER, V93, P575, DOI 10.1038/sj.bjc.6602728; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Cardenas-Turanzas M, 2008, CANCER EPIDEM BIOMAR, V17, P2865, DOI 10.1158/1055-9965.EPI-08-0137; Castle PE, 2011, J CLIN MICROBIOL, V49, P3029, DOI 10.1128/JCM.00422-11; Castle PE, 2011, OBSTET GYNECOL, V117, P650, DOI 10.1097/AOG.0b013e318209da59; Center for Devices and Radiological Health, 2002, SUMM SAF EFF DAT; Center for Devices and Radiological Health, 2003, APPR LETT DIG HYBR C; Coste J, 2003, BMJ-BRIT MED J, V326, P733, DOI 10.1136/bmj.326.7392.733; Datta SD, 2008, ANN INTERN MED, V148, P493, DOI 10.7326/0003-4819-148-7-200804010-00004; Dillner J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1754; Franceschi S, 2011, INT J CANCER, V128, P2765, DOI 10.1002/ijc.25915; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hartmann KE, 2002, SYSTEMATIC REV AGENC; Hologic, 2004, THINPREP PAP TEST QU; International Agency for Research on Cancer, 2005, IARC HDB CANC PREV, V10; Katki HA, 2011, LANCET ONCOL, V12, P663, DOI 10.1016/S1470-2045(11)70145-0; Kinney W, 2010, AM J CLIN PATHOL, V134, P193, DOI 10.1309/AJCPRI8XPQUEAA3K; Kitchener HC, 2008, INT J GYNECOL CANCER, V18, P743, DOI 10.1111/j.1525-1438.2007.01113.x; Kitchener HC, 2011, EUR J CANCER, V47, P864, DOI 10.1016/j.ejca.2011.01.008; Kitchener HC, 2009, LANCET ONCOL, V10, P672, DOI 10.1016/S1470-2045(09)70156-1; Kjaer S, 2006, CANCER RES, V66, P10630, DOI 10.1158/0008-5472.CAN-06-1057; Kotaniemi-Talonen L, 2011, ACTA ONCOL, V50, P106, DOI 10.3109/0284186X.2010.496793; Kulasingam SL, 2002, JAMA-J AM MED ASSOC, V288, P1749, DOI 10.1001/jama.288.14.1749; Kulasingam SL, 2011, AHRQ PUBLICATION; Leinonen M, 2009, JNCI-J NATL CANCER I, V101, P1612, DOI 10.1093/jnci/djp367; Littell RD, 2011, J LOW GENIT TRACT DI, V15, P54, DOI 10.1097/LGT.0b013e3181f2d659; Lord SJ, 2006, ANN INTERN MED, V144, P850, DOI 10.7326/0003-4819-144-11-200606060-00011; Maissi E, 2004, BMJ-BRIT MED J, V328, P1293, DOI 10.1136/bmj.328.7451.1293; Mayrand M, 2007, NEW ENGL J MED, V357, P1579, DOI 10.1056/NEJMoa071430; McCaffery K, 2004, BJOG-INT J OBSTET GY, V111, P1437, DOI 10.1111/j.1471-0528.2004.00279.x; McCaffery KJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4491; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; Medical Services Advisory Committee, 2002, LIQ BAS CYT CERV SCR; National Institute for Health and Clinical Excellence, 2006, GUID MAN; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Naucler P, 2009, JNCI-J NATL CANCER I, V101, P88, DOI 10.1093/jnci/djn444; NOORANI H, 2003, 40 CAN COORD OFF HLT; Ogilvie GS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-111; OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186; Petry KU, 2003, BRIT J CANCER, V88, P1570, DOI 10.1038/sj.bjc.6600918; Richart R M, 1973, Pathol Annu, V8, P301; Ronco G, 2007, BRIT MED J, V335, P28, DOI 10.1136/bmj.39196.740995.BE; Ronco G, 2006, JNCI-J NATL CANCER I, V98, P765, DOI 10.1093/jnci/djj209; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Saraiya M, 2010, ARCH INTERN MED, V170, P977, DOI 10.1001/archinternmed.2010.134; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Schiffman M, 2011, CANCER EPIDEM BIOMAR, V20, P1398, DOI 10.1158/1055-9965.EPI-11-0206; Schiffman M, 2011, JNCI-J NATL CANCER I, V103, P368, DOI 10.1093/jnci/djq562; Sherman ME, 2003, JNCI-J NATL CANCER I, V95, P46, DOI 10.1093/jnci/95.1.46; Siebers AG, 2009, JAMA-J AM MED ASSOC, V302, P1757, DOI 10.1001/jama.2009.1569; Stoler MH, 2011, INT J CANCER, V128, P1354, DOI 10.1002/ijc.25470; Taylor S, 2006, INT J CANCER, V118, P957, DOI 10.1002/ijc.21434; TriPath Imaging, 2004, SUREPATH TECHN IS CH; Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054; Vesco K, 2011, AHRQ PUBLICATION; Vesco KK, 2011, ANN INTERN MED, V155, P698, DOI 10.7326/0003-4819-155-10-201111150-00377; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P346, DOI 10.1016/j.ajog.2007.07.047; Wright Thomas C Jr, 2007, J Low Genit Tract Dis, V11, P223	67	122	132	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	2011	155	10					687	+		10.7326/0003-4819-155-10-201111150-00376	http://dx.doi.org/10.7326/0003-4819-155-10-201111150-00376			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849EI	22006930				2022-12-28	WOS:000297108000005
J	Kim, JJ				Kim, Jane J.			The Role of Cost-Effectiveness in US Vaccination Policy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES		Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth Decis Sci, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Kim, JJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth Decis Sci, Boston, MA 02115 USA.							Centers for Disease Control and prevention, CDC VACC PRIC LIST; Chesson HW, 2011, VACCINE, V29, P8443, DOI 10.1016/j.vaccine.2011.07.096; Kim JJ, 2008, VACCINE, V26, pK76, DOI 10.1016/j.vaccine.2008.06.009; Shepard CW, 2005, PEDIATRICS, V115, P1220, DOI 10.1542/peds.2004-2514; Smith PJ, 2011, PUBLIC HEALTH REP, V126, P109, DOI 10.1177/00333549111260S213	5	30	30	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 10	2011	365	19					1760	1761		10.1056/NEJMp1110539	http://dx.doi.org/10.1056/NEJMp1110539			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	844QQ	22010866				2022-12-28	WOS:000296762800004
J	Rosenfeld, DE; Gengeliczki, Z; Smith, BJ; Stack, TDP; Fayer, MD				Rosenfeld, Daniel E.; Gengeliczki, Zsolt; Smith, Brian J.; Stack, T. D. P.; Fayer, M. D.			Structural Dynamics of a Catalytic Monolayer Probed by Ultrafast 2D IR Vibrational Echoes	SCIENCE			English	Article							LANGMUIR-BLODGETT-FILMS; INFRARED-SPECTROSCOPY; RELAXATION; WATER; MOLECULES; EQUILIBRIUM; ORIENTATION; ABSORPTION; SURFACES; BOND	Ultrafast two-dimensional infrared (2D IR) vibrational echo spectroscopy has proven broadly useful for studying molecular dynamics in solutions. Here, we extend the technique to probing the interfacial dynamics and structure of a silica surface-tethered transition metal carbonyl complex-tricarbonyl (1,10-phenanthroline) rhenium chloride-of interest as a photoreduction catalyst. We interpret the data using a theoretical framework devised to separate the roles of structural evolution and excitation transfer in inducing spectral diffusion. The structural dynamics, as reported on by a carbonyl stretch vibration of the surface-bound complex, have a characteristic time of similar to 150 picoseconds in the absence of solvent, decrease in duration by a factor of three upon addition of chloroform, and decrease another order of magnitude for the bulk solution. Conversely, solvent-complex interactions increase the lifetime of the probed vibration by 160% when solvent is applied to the monolayer.	[Rosenfeld, Daniel E.; Gengeliczki, Zsolt; Smith, Brian J.; Stack, T. D. P.; Fayer, M. D.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University	Fayer, MD (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	fayer@stanford.edu		Smith, Brian/0000-0002-2329-190X	Fannie and John Hertz Foundation; National Science Foundation; Stanford Graduate Fellowship; Air Force Office of Scientific Research [F49620-01-1-0018]; Department of Energy [DE-FG03-84ER13251]; National Institutes of Health [GM50730]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050730, R29GM050730] Funding Source: NIH RePORTER	Fannie and John Hertz Foundation; National Science Foundation(National Science Foundation (NSF)); Stanford Graduate Fellowship(Stanford University); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank C. Xie and B. Cui for preparation of the SiO<INF>2</INF>-coated CaF<INF>2</INF> substrates and D. B. Wong for making the bulk solution orientational relaxation measurements. D.E.R. acknowledges the support of the Fannie and John Hertz Foundation, a National Science Foundation Graduate Research Fellowship, and a Stanford Graduate Fellowship. This material is based on work supported by the Air Force Office of Scientific Research under AFOSR grant F49620-01-1-0018 and the Department of Energy under grant DE-FG03-84ER13251. In addition, B.J.S. and T.D.P.S. thank the National Institutes of Health (GM50730).	Adams DM, 2003, J PHYS CHEM B, V107, P6668, DOI 10.1021/jp0268462; Backus EHG, 2005, SCIENCE, V310, P1790, DOI 10.1126/science.1120693; BAILEY DC, 1981, CHEM REV, V81, P109, DOI 10.1021/cr00042a001; Bent SF, 2011, P NATL ACAD SCI USA, V108, P956, DOI 10.1073/pnas.1006656107; Bredenbeck J, 2009, ACCOUNTS CHEM RES, V42, P1332, DOI 10.1021/ar900016c; Carter JA, 2009, ACCOUNTS CHEM RES, V42, P1343, DOI 10.1021/ar9000197; Cervetto V, 2004, J CHEM PHYS, V121, P5935, DOI 10.1063/1.1778163; CHABAL YJ, 1991, SURF SCI, V242, P524, DOI 10.1016/0039-6028(91)90321-I; Chung JK, 2011, J AM CHEM SOC, V133, P6681, DOI 10.1021/ja111009s; Collman JP, 2006, LANGMUIR, V22, P2457, DOI 10.1021/la052947q; De Vos DE, 2002, CHEM REV, V102, P3615, DOI 10.1021/cr010368u; Devaraj NK, 2007, QSAR COMB SCI, V26, P1253, DOI 10.1002/qsar.200740121; Dlott DD, 1996, J AM CHEM SOC, V118, P7853, DOI 10.1021/ja961494w; Eftekhari-Bafrooei A, 2011, J PHYS CHEM LETT, V2, P1353, DOI 10.1021/jz200194e; F?rster T., 1960, RADIATION RES      S, V2, P326, DOI DOI 10.2307/3583604; Fecko CJ, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1839179; Gengeliczki Z, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3442446; Gooding JJ, 2011, CHEM SOC REV, V40, P2704, DOI 10.1039/c0cs00139b; Gooding JJ, 2003, ELECTROANAL, V15, P81, DOI 10.1002/elan.200390017; Hill JR, 1996, J PHYS CHEM-US, V100, P18023, DOI 10.1021/jp961418f; Hocking RK, 2007, ORGANOMETALLICS, V26, P2815, DOI 10.1021/om061072n; HUBER DL, 1977, PHYS REV B, V16, P4642, DOI 10.1103/PhysRevB.16.4642; KENKRE VM, 1994, J CHEM PHYS, V101, P10618, DOI 10.1063/1.467876; Kim YS, 2005, P NATL ACAD SCI USA, V102, P11185, DOI 10.1073/pnas.0504865102; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Kwak K, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2927906; Kwak K, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2772269; Lane IM, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408413; Lindsey JS, 2011, ACCOUNTS CHEM RES, V44, P638, DOI 10.1021/ar200107x; McGuire JA, 2006, SCIENCE, V313, P1945, DOI 10.1126/science.1131536; Morris AJ, 2009, ACCOUNTS CHEM RES, V42, P1983, DOI 10.1021/ar9001679; Park S, 2007, LASER PHYS LETT, V4, P704, DOI 10.1002/lapl.200710046; Rao Y, 2006, J PHYS CHEM B, V110, P1727, DOI 10.1021/jp055340r; Rosenfeld DE, 2009, J PHYS CHEM B, V113, P13300, DOI 10.1021/jp907616x; Somorjai GA, 2011, P NATL ACAD SCI USA, V108, P917, DOI 10.1073/pnas.1006669107; Somorjai GA, 2009, SURF SCI, V603, P1293, DOI 10.1016/j.susc.2008.08.030; Stiopkin IV, 2011, NATURE, V474, P192, DOI 10.1038/nature10173; UMEMURA J, 1990, J PHYS CHEM-US, V94, P62, DOI 10.1021/j100364a009; Williams RB, 2001, J PHYS CHEM B, V105, P4068, DOI 10.1021/jp010798o; Xiong W, 2009, J AM CHEM SOC, V131, P18040, DOI 10.1021/ja908479r; Yamamoto S, 2010, PHYS CHEM CHEM PHYS, V12, P12909, DOI 10.1039/c0cp00538j; Zhang Y, 1996, J PHYS CHEM-US, V100, P13804, DOI 10.1021/jp961128z; Zheng JR, 2005, SCIENCE, V309, P1338, DOI 10.1126/science.1116213; ZHU XD, 1990, APPL PHYS B-PHOTO, V50, P535, DOI 10.1007/BF00408780	44	100	100	2	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2011	334	6056					634	639		10.1126/science.1211350	http://dx.doi.org/10.1126/science.1211350			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841EG	22021674				2022-12-28	WOS:000296494700045
J	Lund, C; De Silva, M; Plagerson, S; Cooper, S; Chisholm, D; Das, J; Knapp, M; Patel, V				Lund, Crick; De Silva, Mary; Plagerson, Sophie; Cooper, Sara; Chisholm, Dan; Das, Jishnu; Knapp, Martin; Patel, Vikram			Global Mental Health 1 Poverty and mental disorders: breaking the cycle in low-income and middle-income countries	LANCET			English	Article							SCHIZOPHRENIA; BEHAVIOR; INTERVENTION; DEPRESSION; PROGRAM; ILLNESS; TRIALS; CREDIT; CASH	Growing international evidence shows that mental ill health and poverty interact in a negative cycle in low-income and middle-income countries. However, little is known about the interventions that are needed to break this cycle. We undertook two systematic reviews to assess the effect of financial poverty alleviation interventions on mental, neurological, and substance misuse disorders and the effect of mental health interventions on individual and family or carer economic status in countries with low and middle incomes. We found that the mental health effect of poverty alleviation interventions was inconclusive, although some conditional cash transfer and asset promotion programmes had mental health benefits. By contrast, mental health interventions were associated with improved economic outcomes in all studies, although the difference was not statistically significant in every study. We recommend several areas for future research, including undertaking of high-quality intervention studies in low-income and middle-income countries, assessment of the macroeconomic consequences of scaling up of mental health care, and assessment of the effect of redistribution and market failures in mental health. This study supports the call to scale up mental health care, not only as a public health and human rights priority, but also as a development priority.	[Lund, Crick; Cooper, Sara] Univ Cape Town, Dept Psychiat & Mental Hlth, Ctr Publ Mental Hlth, ZA-7700 Cape Town, South Africa; [De Silva, Mary; Patel, Vikram] Univ London London Sch Hyg & Trop Med, Ctr Global Mental Hlth, London WC1E 7HT, England; [Plagerson, Sophie] MRC, Environm & Hlth Res Unit, Johannesburg, South Africa; [Chisholm, Dan] World Hlth Org, Dept Mental Hlth & Subst Abuse, Geneva, Switzerland; [Das, Jishnu] World Bank, Dev Res Grp, Washington, DC 20433 USA; [Knapp, Martin] Kings Coll London, London Sch Econ & Polit Sci, London WC2R 2LS, England; [Knapp, Martin] Kings Coll London, Inst Psychiat, London WC2R 2LS, England	University of Cape Town; University of London; London School of Hygiene & Tropical Medicine; World Health Organization; The World Bank; University of London; King's College London; London School Economics & Political Science; University of London; King's College London	Lund, C (corresponding author), Univ Cape Town, Dept Psychiat & Mental Hlth, Ctr Publ Mental Hlth, ZA-7700 Cape Town, South Africa.	crick.lund@uct.ac.za	Knapp, Martin RJ/G-3011-2011	Lund, Crick/0000-0002-5159-8220; Cooper, Sara/0000-0001-9894-236X; Knapp, Martin/0000-0003-1427-0215; Patel, Vikram/0000-0003-1066-8584	UK Department for International Development; Wellcome Trust; Department for International Development (DFID) [201446] Funding Source: researchfish	UK Department for International Development; Wellcome Trust(Wellcome TrustEuropean Commission); Department for International Development (DFID)	We thank Lishi Li for translation of the Chinese papers, Karen Blackhall and Hugh McGuire for developing the search strategy and help undertaking the database searches, and Florence Baingana, Alex Cohen, and Shekhar Saxena for comments on drafts of the report. This paper was produced as part of the Programme for Improving Mental health carE (PRIME), funded by the UK Department for International Development for the benefit of low-income and middle-income countries. Vikram Patel is supported by a Wellcome Trust Senior Research Fellowship in Tropical Medicine. The views expressed are not necessarily those of the funders.	Abdollahnejad M. R., 2008, THERAPEUTIC COMMUNIT, V29, P57; Ahmed SM, 2002, J HEALTH POPUL NUTR, V20, P334; Ahmed SM, 2001, WORLD DEV, V29, P1957, DOI 10.1016/S0305-750X(01)00069-9; [Anonymous], 1999, DEV FREEDOM; Baird S, 2011, WPS5644 WORLD BANK; Bolton P, 2003, JAMA-J AM MED ASSOC, V289, P3117, DOI 10.1001/jama.289.23.3117; Bond GR, 2008, PSYCHIATR REHABIL J, V31, P280, DOI 10.2975/31.4.2008.280.290; Burns T, 2007, LANCET, V370, P1146, DOI 10.1016/S0140-6736(07)61516-5; Case A., 2004, PERSPECTIVES EC AGIN, P287; Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2; Chisholm D, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c924; Cohen A, 2008, SCHIZOPHRENIA BULL, V34, P229, DOI 10.1093/schbul/sbm105; Costello EJ, 2003, JAMA-J AM MED ASSOC, V290, P2023, DOI 10.1001/jama.290.15.2023; Das J, 2009, WORLD BANK ECON REV, V23, P31, DOI 10.1093/wber/lhn010; De Silva MJ, 2007, SOC SCI MED, V64, P5, DOI 10.1016/j.socscimed.2006.08.044; Fernald LCH, 2008, LANCET, V371, P828, DOI 10.1016/S0140-6736(08)60382-7; Fernald LCH, 2009, LANCET, V374, P1997, DOI 10.1016/S0140-6736(09)61676-7; Fernald LCH, 2009, SOC SCI MED, V68, P2180, DOI 10.1016/j.socscimed.2009.03.032; Fernald LCH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-409; Flisher AJ, 2007, J HEALTH PSYCHOL, V12, P505, DOI 10.1177/1359105307076237; Frank RG, 2000, HANDB ECON, V17, P893; Gertler P, 2002, AM ECON REV, V92, P51, DOI 10.1257/000282802760015603; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hong JH, 2011, WORLD PSYCHIATRY, V10, P40; [胡雄 Hu X], 2007, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V11, P7787; Isaac M, 2007, BRIT J PSYCHIAT, V191, pS71, DOI 10.1192/bjp.191.50.s71; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Lawal RA, 1998, E AFR MED J, V75, P107; Locharernkul Chaichon, 2005, J Med Assoc Thai, V88 Suppl 4, pS207; Lopez-Casasnovas G, 2005, HEALTH AND ECONOMIC GROWTH: FINDINGS AND POLICY IMPLICATIONS, P1; Lund C, 2010, SOC SCI MED, V71, P517, DOI 10.1016/j.socscimed.2010.04.027; Mangalore R, 2007, PSYCHOL MED, V37, P1037, DOI 10.1017/S003329170600969X; Miranda JJ, 2005, PLOS MED, V2, P962, DOI 10.1371/journal.pmed.0020291; Ozer EJ, 2009, PEDIATRICS, V123, pE630, DOI 10.1542/peds.2008-2882; Patel V, 2003, LANCET, V361, P33, DOI 10.1016/S0140-6736(03)12119-8; Patel V, 2003, B WORLD HEALTH ORGAN, V81, P609; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Patel V, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P115; Paxson C, 2007, POLICY RES WORKING P; Ran MS, 2003, SOC PSYCH PSYCH EPID, V38, P69, DOI 10.1007/s00127-003-0601-z; Saraceno B, 1997, CAN J PSYCHIAT, V42, P285, DOI 10.1177/070674379704200306; Saraceno Benedetto, 2005, World Psychiatry, V4, P181; Sheriff RJS, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-69; Skeen S, 2010, INT REV PSYCHIATR, V22, P624, DOI 10.3109/09540261.2010.535509; Srinivasan TN, 1997, SCHIZOPHR RES, V25, P149, DOI 10.1016/S0920-9964(97)00016-9; Ssewamala FM, 2009, SOC SCI MED, V69, P191, DOI 10.1016/j.socscimed.2009.05.019; Stewart R., 2010, WHAT IS IMPACT MICRO; Thirthalli J, 2009, ACTA PSYCHIAT SCAND, V119, P209, DOI 10.1111/j.1600-0447.2008.01299.x; Trzesniewski KH, 2006, DEV PSYCHOL, V42, P381, DOI 10.1037/0012-1649.42.2.381; Wong K.K., 2001, HONG KONG J PSYCHIAT, V11, P13; World Health Organization, 2016, MHGAP INT GUID MENT; World Health Organization (WHO), 2010, MENT HLTH DEV TARG P; XIONG W, 1994, BRIT J PSYCHIAT, V165, P239, DOI 10.1192/bjp.165.2.239; Young S, 2010, ANTIPODE, V42, P201, DOI 10.1111/j.1467-8330.2009.00737.x	54	435	444	7	117	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2011	378	9801					1502	1514		10.1016/S0140-6736(11)60754-X	http://dx.doi.org/10.1016/S0140-6736(11)60754-X			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	838VC	22008425				2022-12-28	WOS:000296319600025
J	Baird, G; Douglas, HR; Murphy, MS				Baird, Gillian; Douglas, Hannah Rose; Murphy, M. Stephen			GUIDELINES Recognising and diagnosing autism in children and young people: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material							PREVALENCE; SPECTRUM		[Baird, Gillian] Guys Hosp, Newcomen Ctr, London SE1 9RT, England; [Douglas, Hannah Rose; Murphy, M. Stephen] Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England	Guy's & St Thomas' NHS Foundation Trust	Baird, G (corresponding author), Guys Hosp, Newcomen Ctr, London SE1 9RT, England.	gillian.baird@gstt.nhs.uk						American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Baron-Cohen S, 2009, BRIT J PSYCHIAT, V194, P500, DOI 10.1192/bjp.bp.108.059345; National Institute for Health and Clinical Excellence,, 2011, AUT REC REF DIAGN CH; World Health Organization, INT STAT CLASS DIS R, V10th; 2009, MMWR, V58, P1	6	28	28	0	18	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 21	2011	343								d6360	10.1136/bmj.d6360	http://dx.doi.org/10.1136/bmj.d6360			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	837HR	22021468				2022-12-28	WOS:000296184100002
J	Grebien, F; Hantschel, O; Wojcik, J; Kaupe, I; Kovacic, B; Wyrzucki, AM; Gish, GD; Cerny-Reiterer, S; Koide, A; Beug, H; Pawson, T; Valent, P; Koide, S; Superti-Furga, G				Grebien, Florian; Hantschel, Oliver; Wojcik, John; Kaupe, Ines; Kovacic, Boris; Wyrzucki, Arkadiusz M.; Gish, Gerald D.; Cerny-Reiterer, Sabine; Koide, Akiko; Beug, Hartmut; Pawson, Tony; Valent, Peter; Koide, Shohei; Superti-Furga, Giulio			Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis	CELL			English	Article							CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; PROTEIN-TYROSINE KINASES; C-ABL; SH2 DOMAINS; BINDING-SITE; ACTIVATION; BCR/ABL; TRANSFORMATION; INDUCTION	Chronic myelogenous leukemia (CML) is caused by the constitutively active tyrosine kinase Bcr-Abl and treated with the tyrosine kinase inhibitor (TKI) imatinib. However, emerging TKI resistance prevents complete cure. Therefore, alternative strategies targeting regulatory modules of Bcr-Abl in addition to the kinase active site are strongly desirable. Here, we show that an intramolecular interaction between the SH2 and kinase domains in Bcr-Abl is both necessary and sufficient for high catalytic activity of the enzyme. Disruption of this interface led to inhibition of downstream events critical for CML signaling and, importantly, completely abolished leukemia formation in mice. Furthermore, disruption of the SH2-kinase interface increased sensitivity of imatinib-resistant Bcr-Abl mutants to TKI inhibition. An engineered Abl SH2-binding fibronectin type III monobody inhibited Bcr-Abl kinase activity both in vitro and in primary CML cells, where it induced apoptosis. This work validates the SH2-kinase interface as an allosteric target for therapeutic intervention.	[Wojcik, John; Wyrzucki, Arkadiusz M.; Koide, Akiko; Koide, Shohei] Univ Chicago, Chicago, IL 60637 USA; [Kovacic, Boris; Beug, Hartmut] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Wyrzucki, Arkadiusz M.] Med Univ Gdansk, Intercoll Fac Biotechnol, Univ Gdansk, PL-80210 Gdansk, Poland; [Gish, Gerald D.; Pawson, Tony] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Pawson, Tony] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Cerny-Reiterer, Sabine; Valent, Peter] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol & Ludwig Boltzmann Clus, A-1090 Vienna, Austria; [Grebien, Florian; Hantschel, Oliver; Kaupe, Ines; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria	University of Chicago; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Fahrenheit Universities; Medical University Gdansk; University of Gdansk; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Ludwig Boltzmann Institute; Medical University of Vienna; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences	Hantschel, O (corresponding author), Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland.	oliver.hantschel@epfl.ch; gsuperti@cemm.oeaw.ac.at	Test, Test/Y-7921-2019; Hantschel, Oliver D/H-4705-2013; Gamperl, Susi/V-2715-2019; Valent, Peter/B-8533-2016; Test, PV/U-9451-2019; Superti-Furga, Giulio/F-4755-2015; Grebien, Florian/H-9234-2019; Kovacic, Boris/J-1871-2016; Hantschel, Oliver/M-7016-2019; Pawson, Tony J/E-4578-2013; Superti-Furga, Giulio/AAE-5681-2019; Gish, Gerald D/C-7228-2017	Hantschel, Oliver D/0000-0001-8569-8169; Gamperl, Susi/0000-0003-0456-5095; Valent, Peter/0000-0003-0456-5095; Superti-Furga, Giulio/0000-0002-0570-1768; Grebien, Florian/0000-0003-4289-2281; Kovacic, Boris/0000-0002-1148-4149; Hantschel, Oliver/0000-0001-8569-8169; Koide, Shohei/0000-0001-5473-4358	Austrian Academy of Sciences; Austrian Science Fund (FWF) [P18737, P22282]; Canadian Cancer Society; CIHR [MOP-6849]; EMBO [ASTF 293.00-2009]; National Institutes of Health [R01-GM72688, R21-CA132700, T32GM07281]; University of Chicago Cancer Research Center; National Center for Research Resources at NIH [RR-15301]; U.S. Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Novartis; BMS; Austrian Science Fund (FWF) [P 22282] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R21CA132700] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072688, T32GM007281] Funding Source: NIH RePORTER	Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Canadian Cancer Society(Canadian Cancer Society (CCS)); CIHR(Canadian Institutes of Health Research (CIHR)); EMBO(European Molecular Biology Organization (EMBO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Cancer Research Center; National Center for Research Resources at NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Novartis(Novartis); BMS(Bristol-Myers Squibb); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Austrian Academy of Sciences, in part by grants from the Austrian Science Fund (FWF) (#P18737 to O.H., I.K., and G.S.-F. and #P22282 to F.G.), a Terry Fox Programme Project grant from the Canadian Cancer Society and CIHR (#MOP-6849 to T.P.), an EMBO short-term fellowship (#ASTF 293.00-2009 to J.W.), the National Institutes of Health (R01-GM72688 and R21-CA132700 to S.K. and T32GM07281 to J.W.), and the University of Chicago Cancer Research Center (to S.K.). Part of the work was conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by award RR-15301 from the National Center for Research Resources at NIH. Use of the Advanced Photon Source is supported by the U.S. Department of Energy, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. We wish to thank all members of the participating laboratories for continuous support and discussions, D. Printz (CCRI Vienna) for expert FACS sorting, V. Komnenovic (IMBA Vienna) for help with histology, H. Pickersgill for help with manuscript preparation, and K. De Keersmaecker and T. Buerckstuemmer for critical reading of the manuscript. P.V. received a research grant and honorarium from Novartis and a research grant and honorarium from BMS. This work is dedicated to the memories of Maggie Pawson and Hartmut Beug.	Belshaw PJ, 1996, P NATL ACAD SCI USA, V93, P4604, DOI 10.1073/pnas.93.10.4604; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; De Keersmaecker K, 2008, LEUKEMIA, V22, P2208, DOI 10.1038/leu.2008.242; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; Filippakopoulos P, 2009, CURR OPIN STRUC BIOL, V19, P643, DOI 10.1016/j.sbi.2009.10.001; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Hantschel O, 2008, MOL ONCOL, V2, P272, DOI 10.1016/j.molonc.2008.07.003; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Hoelbl A, 2010, EMBO MOL MED, V2, P98, DOI 10.1002/emmm.201000062; ILARIA RL, 1995, BLOOD, V86, P3897, DOI 10.1182/blood.V86.10.3897.bloodjournal86103897; Jabbour E, 2010, LEUKEMIA, V24, P6, DOI 10.1038/leu.2009.193; Joseph RE, 2007, BIOCHEMISTRY-US, V46, P5595, DOI 10.1021/bi700127c; Koide A, 2007, METH MOL B, V352, P95; MAYER BJ, 1995, CURR BIOL, V5, P296, DOI 10.1016/S0960-9822(95)00060-1; MCWHIRTER JR, 1993, MOL CELL BIOL, V13, P7587, DOI 10.1128/MCB.13.12.7587; Mikkola ET, 2010, J MOL BIOL, V399, P618, DOI 10.1016/j.jmb.2010.04.045; Million RP, 2000, BLOOD, V96, P664; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nieborowska-Skorska M, 1999, J EXP MED, V189, P1229, DOI 10.1084/jem.189.8.1229; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Perrotti D, 2010, J CLIN INVEST, V120, P2254, DOI 10.1172/JCI41246; Quintas-Cardama A, 2007, NAT REV DRUG DISCOV, V6, P834, DOI 10.1038/nrd2324; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Roumiantsev S, 2001, BLOOD, V97, P4, DOI 10.1182/blood.V97.1.4; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Shah NP, 2008, CANCER CELL, V14, P485, DOI 10.1016/j.ccr.2008.11.001; Sherbenou DW, 2010, BLOOD, V116, P3278, DOI 10.1182/blood-2008-10-183665; Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200; Wojcik J, 2010, NAT STRUCT MOL BIOL, V17, P519, DOI 10.1038/nsmb.1793; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675	36	99	108	0	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 14	2011	147	2					306	319		10.1016/j.cell.2011.08.046	http://dx.doi.org/10.1016/j.cell.2011.08.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000011	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000296199300010
J	Miyamoto, T; Patapoutian, A				Miyamoto, Takashi; Patapoutian, Ardem			Why Does Morphine Make You Itch?	CELL			English	Editorial Material							OPIOID-RECEPTOR GENE; INDUCED ANALGESIA; SENSATION; MICE	Opioids such as morphine numb pain but often concomitantly induce itch. Liu et al. (2011) now separate the sensation of itch from opioid-induced analgesia, showing that in a subset of spinal neurons, morphine directly induces itch by signaling through a heteromer of opioid- and itch-mediating G protein-coupled receptors.	[Miyamoto, Takashi; Patapoutian, Ardem] Scripps Res Inst, Dept Cell Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Patapoutian, Ardem] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Scripps Research Institute; Novartis	Patapoutian, A (corresponding author), Scripps Res Inst, Dept Cell Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA.	apatapou@gnf.org						Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Liu XY, 2011, CELL, V147, P447, DOI 10.1016/j.cell.2011.08.043; Loh HH, 1998, MOL BRAIN RES, V54, P321, DOI 10.1016/S0169-328X(97)00353-7; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Pan YX, 2005, DNA CELL BIOL, V24, P736, DOI 10.1089/dna.2005.24.736; Patel KN, 2010, NEURON, V68, P334, DOI 10.1016/j.neuron.2010.10.018; Reich A, 2009, ACTA DERM-VENEREOL, V89, P236, DOI 10.2340/00015555-0650; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868	10	18	19	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 14	2011	147	2					261	262		10.1016/j.cell.2011.09.026	http://dx.doi.org/10.1016/j.cell.2011.09.026			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000005	Bronze			2022-12-28	WOS:000296199300004
J	Wang, T; Sha, RJ; Dreyfus, R; Leunissen, ME; Maass, C; Pine, DJ; Chaikin, PM; Seeman, NC				Wang, Tong; Sha, Ruojie; Dreyfus, Remi; Leunissen, Mirjam E.; Maass, Corinna; Pine, David J.; Chaikin, Paul M.; Seeman, Nadrian C.			Self-replication of information-bearing nanoscale patterns	NATURE			English	Article							DNA; CRYSTALLIZATION; COLLOIDS; ENZYME; DESIGN; ACID	DNA molecules provide what is probably the most iconic example of self-replication-the ability of a system to replicate, or make copies of, itself. In living cells the process is mediated by enzymes and occurs autonomously, with the number of replicas increasing exponentially over time without the need for external manipulation. Self-replication has also been implemented with synthetic systems, including RNA enzymes designed to undergo self-sustained exponential amplification(1-5). An exciting next step would be to use self-replication in materials fabrication, which requires robust and general systems capable of copying and amplifying functional materials or structures. Here we report a first development in this direction, using DNA tile motifs that can recognize and bind complementary tiles in a pre-programmed fashion. We first design tile motifs so they form a seven-tile seed sequence; then use the seeds to instruct the formation of a first generation of complementary seven-tile daughter sequences; and finally use the daughters to instruct the formation of seven-tile granddaughter sequences that are identical to the initial seed sequences. Considering that DNA is a functional material that can organize itself and other molecules into useful structures(6-13), our findings raise the tantalizing prospect that we may one day be able to realize self-replicating materials with various patterns or useful functions.	[Dreyfus, Remi; Leunissen, Mirjam E.; Maass, Corinna; Pine, David J.; Chaikin, Paul M.] NYU, Ctr Soft Matter Res, New York, NY 10003 USA; [Wang, Tong; Sha, Ruojie; Seeman, Nadrian C.] NYU, Dept Chem, New York, NY 10003 USA	New York University; New York University	Chaikin, PM (corresponding author), NYU, Ctr Soft Matter Res, 550 1St Ave, New York, NY 10003 USA.	chaikin@nyu.edu; ned.seeman@nyu.edu	Maass, Corinna/AAM-2328-2020; Pine, David J/B-7740-2016; Dreyfus, Remi/H-7028-2013	Maass, Corinna/0000-0001-6287-4107; Pine, David J/0000-0002-3304-6684; Dreyfus, Remi/0000-0002-4498-2582	W.M. Keck Foundation; National Science Foundation [DMR-0820341, CTS-0608889, CCF-0726378]; NASA [NNX08AK04G]; National Institute of General Medical Sciences [GM-29554]; Army Research Office [48681-EL, W911NF-07-1-0439]; Office of Naval Research [N000140910181, N000140911118]; Netherlands Organization for Scientific Research; DAAD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029554, R37GM029554] Funding Source: NIH RePORTER	W.M. Keck Foundation(W.M. Keck Foundation); National Science Foundation(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Army Research Office; Office of Naval Research(Office of Naval Research); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by the W.M. Keck Foundation (P. M. C., D.J.P., N.C.S.), the National Science Foundation (MRSEC Program award DMR-0820341, P. M. C., D.J.P. and grants CTS-0608889 and CCF-0726378, to N.C.S.), NASA (NNX08AK04G, to P. M. C.), the National Institute of General Medical Sciences (grant GM-29554, to N.C.S.), the Army Research Office (grants 48681-EL and W911NF-07-1-0439, to N.C.S.), the Office of Naval Research (grants N000140910181 and N000140911118, to N.C.S.), the Netherlands Organization for Scientific Research (Rubicon grant, to M. E. L.) and DAAD (post-doctoral grant, to C.M.).	Birac JJ, 2006, J MOL GRAPH MODEL, V25, P470, DOI 10.1016/j.jmgm.2006.03.005; Kim AJ, 2006, LANGMUIR, V22, P1991, DOI 10.1021/la0528955; Kuzuya A, 2007, NANO LETT, V7, P1757, DOI 10.1021/nl070828k; Lee DH, 1997, NATURE, V390, P591, DOI 10.1038/37569; LEHMAN IR, 1958, J BIOL CHEM, V233, P163; Leunissen ME, 2009, SOFT MATTER, V5, P2422, DOI 10.1039/b817679e; Leunissen ME, 2009, NAT MATER, V8, P590, DOI [10.1038/nmat2471, 10.1038/NMAT2471]; Lin CX, 2008, P NATL ACAD SCI USA, V105, P17626, DOI 10.1073/pnas.0805416105; Lincoln TA, 2009, SCIENCE, V323, P1229, DOI 10.1126/science.1167856; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508; Sacanna S, 2010, NATURE, V464, P575, DOI 10.1038/nature08906; Schulman R, 2007, P NATL ACAD SCI USA, V104, P15236, DOI 10.1073/pnas.0701467104; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; SEEMAN NC, 1990, J BIOMOL STRUCT DYN, V8, P573, DOI 10.1080/07391102.1990.10507829; Valignat MP, 2005, P NATL ACAD SCI USA, V102, P4225, DOI 10.1073/pnas.0500507102; Wang RS, 2010, CHEM COMMUN, V46, P4905, DOI 10.1039/c0cc01167c; WATSON JD, 1953, NATURE, V171, P964, DOI 10.1038/171964b0; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; WINTNER EA, 1994, ACCOUNTS CHEM RES, V27, P198, DOI 10.1021/ar00043a003; Zhang ZL, 2004, NANO LETT, V4, P1407, DOI 10.1021/nl0493500; Zheng JW, 2006, NANO LETT, V6, P1502, DOI 10.1021/nl060994c; Zhong H, 2006, NANO LETT, V6, P2899, DOI 10.1021/nl062183e; Zhu L, 2003, J AM CHEM SOC, V125, P10178, DOI 10.1021/ja035186r	24	83	83	1	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 13	2011	478	7368					225	U107		10.1038/nature10500	http://dx.doi.org/10.1038/nature10500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21993758	Green Accepted			2022-12-28	WOS:000295782800046
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING Quality rankings for US hospitals are released	BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				[Anonymous], US NEWS WORLD REPORT; CHASSIN MR, N ENGL J MED, V7, P683; MURPHY J, METHODOLOGY US NEWS, P2003; Sack K, 2011, NY TIMES, pA20; SUN LH, 2011, WASHINGTON POST 0927, pE1; ZHANI EE, 2011, JOINT COMMISSION ANN, P2003	6	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 12	2011	343								d6539	10.1136/bmj.d6539	http://dx.doi.org/10.1136/bmj.d6539			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	835EO	21994309				2022-12-28	WOS:000296018100004
J	Seton, M				Seton, Margaret			Providing for Those Who Have Too Little	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Seton, M (corresponding author), Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 29	2011	365	13					1169	1171		10.1056/NEJMp1107836	http://dx.doi.org/10.1056/NEJMp1107836			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	825YO	21991890				2022-12-28	WOS:000295318400003
J	Norman, JE; Stock, S				Norman, Jane E.; Stock, Sarah			Intracervical Foley catheter for induction of labour	LANCET			English	Editorial Material							ISOSORBIDE MONONITRATE		[Norman, Jane E.; Stock, Sarah] Univ Edinburgh, MRC Ctr Reprod Heath, Queens Med Res Ctr, Edinburgh EH16 4TY, Midlothian, Scotland	University of Edinburgh	Norman, JE (corresponding author), Univ Edinburgh, MRC Ctr Reprod Heath, Queens Med Res Ctr, Edinburgh EH16 4TY, Midlothian, Scotland.	jane.norman@ed.ac.uk		Norman, Jane/0000-0001-6031-6953	MRC [G1002033] Funding Source: UKRI; Medical Research Council [G1002033] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ACOG Committee on Practice Bulletins-Obstetrics, 2009, OBSTET GYNECOL, V114, P386, DOI DOI 10.1097/AOG.0B013E3181B48EF5; Bollapragada SS, 2009, BJOG-INT J OBSTET GY, V116, P1185, DOI 10.1111/j.1471-0528.2009.02216.x; Gulmezoglu AM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004945; Hofmeyr GJ, 2009, COCHRANE DB SYST REV, V3; Jozwiak M, 2011, LANCET, V378, P2095, DOI 10.1016/S0140-6736(11)61484-0; Kelly AJ, 2011, COCHRANE DB SYST REV, V6; Kelly AJ, 2009, COCHRANE DB SYST REV, V4; Koopmans CM, 2009, LANCET, V374, P979, DOI 10.1016/S0140-6736(09)60736-4; Ledingham MA, 2001, BRIT J OBSTET GYNAEC, V108, P276, DOI 10.1016/S0306-5456(00)00041-3; National Collaborating Centre for Women's and Children's Health, 2008, IND LAB CLIN GUID 20; NHS Information Centre for Health and Social Care, 2009, NHS MAT STAT 2009 10; Norman JE, 1998, HUM REPROD, V13, P251, DOI 10.1093/humrep/13.2.251; Romero R, 1998, HUM REPROD, V13, P248, DOI 10.1093/humrep/13.2.248; Smith GCS, 2004, BRIT MED J, V329, P375, DOI 10.1136/bmj.38160.634352.55; US Census Bureau, 2011, STAT ABSTR US BIRTHS	15	10	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2011	378	9809					2054	2055		10.1016/S0140-6736(11)61581-X	http://dx.doi.org/10.1016/S0140-6736(11)61581-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	865EL	22030142				2022-12-28	WOS:000298293600013
J	Goehring, NW; Trong, PK; Bois, JS; Chowdhury, D; Nicola, EM; Hyman, AA; Grill, SW				Goehring, Nathan W.; Trong, Philipp Khuc; Bois, Justin S.; Chowdhury, Debanjan; Nicola, Ernesto M.; Hyman, Anthony A.; Grill, Stephan W.			Polarization of PAR Proteins by Advective Triggering of a Pattern-Forming System	SCIENCE			English	Article							C-ELEGANS EMBRYOS; ANTERIOR-POSTERIOR POLARITY; CELL POLARITY; CAENORHABDITIS-ELEGANS; CORTICAL FLOWS; ESTABLISHMENT; MAINTENANCE; ASYMMETRY; ZYGOTE	In the Caenorhabditis elegans zygote, a conserved network of partitioning-defective (PAR) polarity proteins segregates into an anterior and a posterior domain, facilitated by flows of the cortical actomyosin meshwork. The physical mechanisms by which stable asymmetric PAR distributions arise from transient cortical flows remain unclear. We present evidence that PAR polarity arises from coupling of advective transport by the flowing cell cortex to a multistable PAR reaction-diffusion system. By inducing transient PAR segregation, advection serves as a mechanical trigger for the formation of a PAR pattern within an otherwise stably unpolarized system. We suggest that passive advective transport in an active and flowing material may be a general mechanism for mechanochemical pattern formation in developmental systems.	[Trong, Philipp Khuc; Bois, Justin S.; Chowdhury, Debanjan; Nicola, Ernesto M.; Grill, Stephan W.] Max Planck Inst Phys Complex Syst MPI PKS, D-01187 Dresden, Germany; [Goehring, Nathan W.; Trong, Philipp Khuc; Bois, Justin S.; Hyman, Anthony A.; Grill, Stephan W.] Max Planck Inst Mol Cell Biol & Genet MPI CBG, D-01307 Dresden, Germany	Max Planck Society; Max Planck Society	Grill, SW (corresponding author), Max Planck Inst Phys Complex Syst MPI PKS, D-01187 Dresden, Germany.	grill@mpi-cbg.de	Grill, Stephan/D-9427-2012; Hyman, Tony/F-1923-2011; Hyman, Anthony A/B-3917-2017; Chowdhury, Debanjan/G-3830-2012; Nicola, Ernesto/G-2290-2010; Goehring, Nathan/AAC-7310-2020	Hyman, Anthony A/0000-0003-3664-154X; Goehring, Nathan/0000-0001-8710-4467; Chowdhury, Debanjan/0000-0003-0758-0282; Bois, Justin/0000-0001-7137-8746	ARCHES Minerva Foundation; European Molecular Biology Organization; Alexander von Humboldt Foundation; European Commission [219286]; Human Frontier Science Program; MPI-PKS	ARCHES Minerva Foundation; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); Human Frontier Science Program(Human Frontier Science Program); MPI-PKS	We thank C. Hoege, A. Pozniakovsky, and S. Ernst for help in generating CAI-optimized transgenes and S. Jaensch for embryo size measurements. This work was supported by the ARCHES Minerva Foundation and the European Molecular Biology Organization Young Investigator Programme (S. W. G.), the Alexander von Humboldt Foundation and a Marie Curie Grant (219286) from the European Commission (N.W.G.), the Human Frontier Science Program (J.S.B.), and the MPI-PKS Visitors Program (D.C. and E.M.N.).	Arai Y, 2010, P NATL ACAD SCI USA, V107, P12399, DOI 10.1073/pnas.0908278107; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bois JS, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028103; Boyd L, 1996, DEVELOPMENT, V122, P3075; Chalmers AD, 2005, DEVELOPMENT, V132, P977, DOI 10.1242/dev.01645; Cowan CR, 2004, NATURE, V431, P92, DOI 10.1038/nature02825; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Gamba A, 2005, P NATL ACAD SCI USA, V102, P16927, DOI 10.1073/pnas.0503974102; Goehring NW, 2011, J CELL BIOL, V193, P583, DOI 10.1083/jcb.201011094; Hao YS, 2006, DEV CELL, V10, P199, DOI 10.1016/j.devcel.2005.12.015; HILL DP, 1988, DEV BIOL, V125, P75, DOI 10.1016/0012-1606(88)90060-7; HIRD SN, 1993, J CELL BIOL, V121, P1343, DOI 10.1083/jcb.121.6.1343; Hoege C, 2010, CURR BIOL, V20, P1296, DOI 10.1016/j.cub.2010.05.061; Howard J, 2011, NAT REV MOL CELL BIO, V12, P392, DOI 10.1038/nrm3120; Jilkine A, 2007, B MATH BIOL, V69, P1943, DOI 10.1007/s11538-007-9200-6; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001121; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; Mori Y, 2008, BIOPHYS J, V94, P3684, DOI [10.1529/biophysj.107.120824, 10.1529/biophysj.107.120827]; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Redemann S, 2011, NAT METHODS, V8, P250, DOI 10.1038/NMETH.1565; Shelton CA, 1999, J CELL BIOL, V146, P439, DOI 10.1083/jcb.146.2.439; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; Tostevin F, 2008, BIOPHYS J, V95, P4512, DOI 10.1529/biophysj.108.136416; Tsai MC, 2007, J CELL BIOL, V179, P397, DOI 10.1083/jcb.200708101; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Watts JL, 1996, DEVELOPMENT, V122, P3133; Zonies S, 2010, DEVELOPMENT, V137, P1669, DOI 10.1242/dev.045823	29	200	201	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 25	2011	334	6059					1137	1141		10.1126/science.1208619	http://dx.doi.org/10.1126/science.1208619			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22021673				2022-12-28	WOS:000297313900052
J	Schroder, FH				Schroeder, Fritz H.			Stratifying Risk - The US Preventive Services Task Force and Prostate-Cancer Screening	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Erasmus Univ, Med Ctr, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Schroder, FH (corresponding author), Erasmus Univ, Med Ctr, Rotterdam, Netherlands.							CHOU R, 2011, ANN INTERN MED  1007; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Klotz L, 2010, J CLIN ONCOL, V28, P126, DOI 10.1200/JCO.2009.24.2180; Roobol MJ, 2010, EUR UROL, V57, P79, DOI 10.1016/j.eururo.2009.08.025; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084	5	39	44	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2011	365	21					1953	1955		10.1056/NEJMp1112140	http://dx.doi.org/10.1056/NEJMp1112140			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	851PF	22029756				2022-12-28	WOS:000297282600004
J	Feder, G; Davies, RA; Baird, K; Dunne, D; Eldridge, S; Griffiths, C; Gregory, A; Howell, A; Johnson, M; Ramsay, J; Rutterford, C; Sharp, D				Feder, Gene; Davies, Roxane Agnew; Baird, Kathleen; Dunne, Danielle; Eldridge, Sandra; Griffiths, Chris; Gregory, Alison; Howell, Annie; Johnson, Medina; Ramsay, Jean; Rutterford, Clare; Sharp, Debbie			Identification and Referral to Improve Safety (IRIS) of women experiencing domestic violence with a primary care training and support programme: a cluster randomised controlled trial	LANCET			English	Article							INTIMATE PARTNER VIOLENCE; MENTAL-HEALTH; LOW-INCOME; PARTICIPATION; MULTICOUNTRY; SETTINGS	Background Most clinicians have no training about domestic violence, fail to identify patients experiencing abuse, and are uncertain about management after disclosure. We tested the effectiveness of a programme of training and support in primary health-care practices to increase identification of women experiencing domestic violence and their referral to specialist advocacy services. Methods In this cluster randomised controlled trial, we selected general practices in two urban primary care trusts, Hackney (London) and Bristol, UK. Practices in which investigators from this trial were employed or those who did not use electronic records were excluded. Practices were stratified by proportion of female doctors, postgraduate training status, number of patients registered, and percentage of practice population on low incomes. Within every primary care trust area, we randomised practices with a computer-minimisation programme with a random component to intervention or control groups. The intervention programme included practice-based training sessions, a prompt within the medical record to ask about abuse, and a referral pathway to a named domestic violence advocate, who also delivered the training and further consultancy. The primary outcome was recorded referral of patients to domestic violence advocacy services. The prespecified secondary outcome was recorded identification of domestic violence in the electronic medical records of the general practice. Poisson regression analyses accounting for clustering were done for all practices receiving the intervention. Practice staff and research associates were not masked and patients were not aware they were part of a study. This study is registered at Current Controlled Trials, ISRCTN74012786. Findings We randomised 51 (61%) of 84 eligible general practices in Hackney and Bristol. Of these, 24 received a training and support programme, 24 did not receive the programme, and three dropped out before the trial started. 1 year after the second training session, the 24 intervention practices recorded 223 referrals of patients to advocacy and the 24 control practices recorded 12 referrals (adjusted intervention rate ratio 22.1 [95% CI 11.5-42.4]). Intervention practices recorded 641 disclosures of domestic violence and control practices recorded 236 (adjusted intervention rate ratio 3.1 [95% CI 2.2-4.3). No adverse events were recorded. Interpretation A training and support programme targeted at primary care clinicians and administrative staff improved referral to specialist domestic violence agencies and recorded identification of women experiencing domestic violence. Our findings reduce the uncertainty about the benefit of training and support interventions in primary care settings for domestic violence and show that screening of women patients for domestic violence is not a necessary condition for improved identification and referral to advocacy services.	[Feder, Gene] Univ Bristol, Sch Social & Community Med, Acad Unit Primary Hlth Care, Bristol, Avon, England; [Davies, Roxane Agnew] Domest Violence Training Ltd, London, England; [Baird, Kathleen] Univ W England, Bristol BS16 1QY, Avon, England; [Dunne, Danielle; Eldridge, Sandra; Griffiths, Chris; Ramsay, Jean; Rutterford, Clare] Queen Mary Univ London, Ctr Primary Care & Publ Hlth, Barts & London Sch Med & Dent, London, England; [Howell, Annie] Nia Project, London, England; [Johnson, Medina] Next Link, Bristol, Avon, England	University of Bristol; University of West England; University of London; Queen Mary University London	Feder, G (corresponding author), Univ Bristol, Sch Social & Community Med, Acad Unit Primary Hlth Care, Bristol, Avon, England.	gene.feder@bristol.ac.uk	Baird, Kathleen/AAP-1894-2021	Baird, Kathleen/0000-0003-0142-6962; sharp, deborah/0000-0003-3071-9860; Feder, Gene/0000-0002-7890-3926; Gregory, Alison/0000-0002-4768-1574; Robinson, Clare/0000-0002-2673-2205	Health Foundation; National Institute of Health Research	Health Foundation; National Institute of Health Research(National Institute for Health Research (NIHR))	This study was funded by the Health Foundation, with service support costs covered by the UK National Health Service and is part of a programme of research funded by the National Institute of Health Research. We thank the general practice teams that participated in the trial (webappendix p 9) and, particularly, the clinicians who took on the mantle of IRIS champion within the intervention practices. We thank the work of our collaborating specialist domestic violence agencies, Next Link and the nia project, in the provision of training and support to practices, and in their advocacy work with the women referred during the trial. Particularly, we are grateful for the unstinting consultancy and managerial support of Carol Metters (director of Next Link) and Jan Buss (advocacy manager of the nia project). We thank Anna James who did the independent extraction of outcome data, the outcome panel (Sylvie Lo Fo Wong, Sandra Hollinghurst, and Liz Lee), and Richard Smith for commenting on an early draft of the manuscript. We also thank Egton Medical Information Systems Ltd (EMIS) for developing and supporting the electronic medical record template	Ahmad F, 2009, ANN INTERN MED, V151, P93, DOI 10.7326/0003-4819-151-2-200907210-00124; Allen NE, 2008, VIOLENCE AGAINST WOM, V10, P1015; Ansara DL, 2010, SOC SCI MED, V70, P1011, DOI 10.1016/j.socscimed.2009.12.009; Bonomi AE, 2009, ARCH INTERN MED, V169, P1692, DOI 10.1001/archinternmed.2009.292; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Casteel C, 2010, CLIN EVID, Vpii, P1013; Coid J, 2003, BRIT J PSYCHIAT, V183, P332, DOI 10.1192/bjp.183.4.332; Coker AL, 2002, AM J PREV MED, V23, P260, DOI 10.1016/S0749-3797(02)00514-7; Colombini M, 2008, B WORLD HEALTH ORGAN, V86, P635, DOI 10.2471/BLT.07.045906; Eldridge SM, 2005, CLIN TRIALS, V2, P91, DOI 10.1191/1740774505cn070oa; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Feder G, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13160; Feder GS, 2006, ARCH INTERN MED, V166, P22, DOI 10.1001/archinte.166.1.22; Finney A., 2006, DOMESTIC VIOLENCE SE; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Golding JM, 1999, J FAM VIOLENCE, V14, P99, DOI 10.1023/A:1022079418229; Gregory A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-54; Hathaway JE, 2008, J MIDWIFERY WOM HEAL, V53, P547, DOI 10.1016/j.jmwh.2008.07.008; Hegarty K., 2006, INTIMATE PARTNER ABU, P19; LLOYD DCEF, 1995, BRIT MED J, V310, P165, DOI 10.1136/bmj.310.6973.165; MacMillan HL, 2009, JAMA-J AM MED ASSOC, V302, P493, DOI 10.1001/jama.2009.1089; Morse B J, 1995, Violence Vict, V10, P251; Ramsay J, 2006, INTERVENTIONS REDUCE; Ramsay J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005043.pub2; Rhodes KV, 2006, ARCH INTERN MED, V166, P1107, DOI 10.1001/archinte.166.10.1107; Richardson J, 2001, BRIT J GEN PRACT, V51, P468; Richardson J, 2002, BRIT MED J, V324, P274, DOI 10.1136/bmj.324.7332.274; Schraiber LB, 2002, INT J GYNECOL OBSTET, V78, pS21, DOI 10.1016/S0020-7292(02)00040-1; Thompson RS, 2000, AM J PREV MED, V19, P253, DOI 10.1016/S0749-3797(00)00231-2; Tjaden P, 2000, EXTENT NATURE CONSEQ; Trautman DE, 2007, ANN EMERG MED, V49, P526, DOI 10.1016/j.annemergmed.2006.11.022	31	206	212	3	49	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2011	378	9805					1788	1795		10.1016/S0140-6736(11)61179-3	http://dx.doi.org/10.1016/S0140-6736(11)61179-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851IS	22000683				2022-12-28	WOS:000297262300023
J	Agnandji, ST; Lell, B; Soulanoudjingar, SS; Fernandes, JF; Abossolo, BP; Conzelmann, C; Methogo, BGNO; Doucka, Y; Flamen, A; Mordmuller, B; Issifou, S; Kremsner, PG; Sacarlal, J; Aide, P; Lanaspa, M; Aponte, JJ; Nhamuave, A; Quelhas, D; Bassat, Q; Mandjate, S; Macete, E; Alonso, P; Abdulla, S; Salim, N; Juma, O; Shomari, M; Shubis, K; Machera, F; Hamad, AS; Minja, R; Mpina, M; Mtoro, A; Sykes, A; Ahmed, S; Urassa, AM; Ali, AM; Mwangoka, G; Tanner, M; Tinto, H; D'Alessandro, U; Sorgho, H; Valea, I; Tahita, MC; Kabore, W; Ouedraogo, S; Sandrine, Y; Guiguemde, RT; Ouedraogo, JB; Hamel, MJ; Kariuki, S; Odero, C; Oneko, M; Otieno, K; Awino, N; Omoto, J; Williamson, J; Muturi-Kioi, V; Laserson, KF; Slutsker, L; Otieno, W; Otieno, L; Nekoye, O; Gondi, S; Otieno, A; Ogutu, B; Wasuna, R; Owira, V; Jones, D; Onyango, AA; Njuguna, P; Chilengi, R; Akoo, P; Kerubo, C; Gitaka, J; Maingi, C; Lang, T; Olotu, A; Tsofa, B; Bejon, P; Peshu, N; Marsh, K; Owusu-Agyei, S; Asante, KP; Osei-Kwakye, K; Boahen, O; Ayamba, S; Kayan, K; Owusu-Ofori, R; Dosoo, D; Asante, I; Adjei, G; Kwara, E; Chandramohan, D; Greenwood, B; Lusingu, J; Gesase, S; Malabeja, A; Abdul, O; Kilavo, H; Mahende, C; Liheluka, E; Lemnge, M; Theander, T; Drakeley, C; Ansong, D; Agbenyega, T; Adjei, S; Boateng, HO; Rettig, T; Bawa, J; Sylverken, J; Sambian, D; Agyekum, A; Owusu, L; Martinson, F; Hoffman, I; Mvalo, T; Kamthunzi, P; Nkomo, R; Msika, A; Jumbe, A; Chome, N; Nyakuipa, D; Chintedza, J; Ballou, WR; Bruls, M; Cohen, J; Guerra, Y; Jongert, E; Lapierre, D; Leach, A; Lievens, M; Ofori-Anyinam, O; Vekemans, J; Carter, T; Leboulleux, D; Loucq, C; Radford, A; Savarese, B; Schellenberg, D; Sillman, M; Vansadia, P				Agnandji, Selidji Todagbe; Lell, Bertrand; Soulanoudjingar, Solange Solmeheim; Fernandes, Jose Francisco; Abossolo, Beatrice Peggy; Conzelmann, Cornelia; Methogo, Barbara Gaelle Nfono Ondo; Doucka, Yannick; Flamen, Arnaud; Mordmueller, Benjamin; Issifou, Saadou; Kremsner, Peter Gottfried; Sacarlal, Jahit; Aide, Pedro; Lanaspa, Miguel; Aponte, John J.; Nhamuave, Arlindo; Quelhas, Diana; Bassat, Quique; Mandjate, Sofia; Macete, Eusebio; Alonso, Pedro; Abdulla, Salim; Salim, Nahya; Juma, Omar; Shomari, Mwanajaa; Shubis, Kafuruki; Machera, Francisca; Hamad, Ali Said; Minja, Rose; Mpina, Maxmillian; Mtoro, Ali; Sykes, Alma; Ahmed, Saumu; Urassa, Alwisa Martin; Ali, Ali Mohammed; Mwangoka, Grace; Tanner, Marcel; Tinto, Halidou; D'Alessandro, Umberto; Sorgho, Hermann; Valea, Innocent; Tahita, Marc Christian; Kabore, William; Ouedraogo, Sayouba; Sandrine, Yara; Guiguemde, Robert Tinga; Ouedraogo, Jean Bosco; Hamel, Mary J.; Kariuki, Simon; Odero, Chris; Oneko, Martina; Otieno, Kephas; Awino, Norbert; Omoto, Jackton; Williamson, John; Muturi-Kioi, Vincent; Laserson, Kayla F.; Slutsker, Laurence; Otieno, Walter; Otieno, Lucas; Nekoye, Otsyula; Gondi, Stacey; Otieno, Allan; Ogutu, Bernhards; Wasuna, Ruth; Owira, Victorine; Jones, David; Onyango, Agnes Akoth; Njuguna, Patricia; Chilengi, Roma; Akoo, Pauline; Kerubo, Christine; Gitaka, Jesse; Maingi, Charity; Lang, Trudie; Olotu, Ally; Tsofa, Benjamin; Bejon, Philip; Peshu, Norbert; Marsh, Kevin; Owusu-Agyei, Seth; Asante, Kwaku Poku; Osei-Kwakye, Kingsley; Boahen, Owusu; Ayamba, Samuel; Kayan, Kingsley; Owusu-Ofori, Ruth; Dosoo, David; Asante, Isaac; Adjei, George; Kwara, Evans; Chandramohan, Daniel; Greenwood, Brian; Lusingu, John; Gesase, Samwel; Malabeja, Anangisye; Abdul, Omari; Kilavo, Hassan; Mahende, Coline; Liheluka, Edwin; Lemnge, Martha; Theander, Thor; Drakeley, Chris; Ansong, Daniel; Agbenyega, Tsiri; Adjei, Samuel; Boateng, Harry Owusu; Rettig, Theresa; Bawa, John; Sylverken, Justice; Sambian, David; Agyekum, Alex; Owusu, Larko; Martinson, Francis; Hoffman, Irving; Mvalo, Tisungane; Kamthunzi, Portia; Nkomo, Ruthendo; Msika, Albans; Jumbe, Allan; Chome, Nelecy; Nyakuipa, Dalitso; Chintedza, Joseph; Ballou, W. Ripley; Bruls, Myriam; Cohen, Joe; Guerra, Yolanda; Jongert, Erik; Lapierre, Didier; Leach, Amanda; Lievens, Marc; Ofori-Anyinam, Opokua; Vekemans, Johan; Carter, Terrell; Leboulleux, Didier; Loucq, Christian; Radford, Afiya; Savarese, Barbara; Schellenberg, David; Sillman, Marla; Vansadia, Preeti		S Clinical Trials Partnership	First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; III MULTICENTER TRIAL; MOZAMBICAN CHILDREN; CANDIDATE VACCINE; EXPANDED-PROGRAM; EFFICACY; SAFETY; IMMUNIZATION; IMMUNOGENICITY; INFANTS	BACKGROUND An ongoing phase 3 study of the efficacy, safety, and immunogenicity of candidate malaria vaccine RTS,S/AS01 is being conducted in seven African countries. METHODS From March 2009 through January 2011, we enrolled 15,460 children in two age categories - 6 to 12 weeks of age and 5 to 17 months of age - for vaccination with either RTS,S/AS01 or a non-malaria comparator vaccine. The primary end point of the analysis was vaccine efficacy against clinical malaria during the 12 months after vaccination in the first 6000 children 5 to 17 months of age at enrollment who received all three doses of vaccine according to protocol. After 250 children had an episode of severe malaria, we evaluated vaccine efficacy against severe malaria in both age categories. RESULTS In the 14 months after the first dose of vaccine, the incidence of first episodes of clinical malaria in the first 6000 children in the older age category was 0.32 episodes per person-year in the RTS, S/AS01 group and 0.55 episodes per person-year in the control group, for an efficacy of 50.4% (95% confidence interval [CI], 45.8 to 54.6) in the intention-to-treat population and 55.8% (97.5% CI, 50.6 to 60.4) in the per-protocol population. Vaccine efficacy against severe malaria was 45.1% (95% CI, 23.8 to 60.5) in the intention-to-treat population and 47.3% (95% CI, 22.4 to 64.2) in the per-protocol population. Vaccine efficacy against severe malaria in the combined age categories was 34.8% (95% CI, 16.2 to 49.2) in the per-protocol population during an average follow-up of 11 months. Serious adverse events occurred with a similar frequency in the two study groups. Among children in the older age category, the rate of generalized convulsive seizures after RTS,S/AS01 vaccination was 1.04 per 1000 doses (95% CI, 0.62 to 1.64). CONCLUSIONS The RTS,S/AS01 vaccine provided protection against both clinical and severe malaria in African children. (Funded by GlaxoSmithKline Biologicals and the PATH Malaria Vaccine Initiative; RTS, S	[Agnandji, Selidji Todagbe; Lell, Bertrand; Soulanoudjingar, Solange Solmeheim; Fernandes, Jose Francisco; Abossolo, Beatrice Peggy; Conzelmann, Cornelia; Methogo, Barbara Gaelle Nfono Ondo; Doucka, Yannick; Flamen, Arnaud; Mordmueller, Benjamin; Issifou, Saadou; Kremsner, Peter Gottfried] Albert Schweitzer Hosp, Lambarene, Gabon; [Agnandji, Selidji Todagbe; Lell, Bertrand; Soulanoudjingar, Solange Solmeheim; Fernandes, Jose Francisco; Abossolo, Beatrice Peggy; Conzelmann, Cornelia; Methogo, Barbara Gaelle Nfono Ondo; Doucka, Yannick; Flamen, Arnaud; Mordmueller, Benjamin; Issifou, Saadou; Kremsner, Peter Gottfried] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Sacarlal, Jahit; Aide, Pedro; Lanaspa, Miguel; Aponte, John J.; Nhamuave, Arlindo; Quelhas, Diana; Bassat, Quique; Mandjate, Sofia; Macete, Eusebio; Alonso, Pedro] Ctr Invest Saude Manhica, Manhica, Mozambique; [Abdulla, Salim; Salim, Nahya; Juma, Omar; Shomari, Mwanajaa; Shubis, Kafuruki; Machera, Francisca; Hamad, Ali Said; Minja, Rose; Mpina, Maxmillian; Mtoro, Ali; Sykes, Alma; Ahmed, Saumu; Urassa, Alwisa Martin; Ali, Ali Mohammed; Mwangoka, Grace; Tanner, Marcel] Ifakara Hlth Inst, Bagamoyo, Tanzania; [Tinto, Halidou; D'Alessandro, Umberto; Sorgho, Hermann; Valea, Innocent; Tahita, Marc Christian; Kabore, William; Ouedraogo, Sayouba; Sandrine, Yara; Guiguemde, Robert Tinga; Ouedraogo, Jean Bosco] Inst Rech Sci Sante, Nanoro, Burkina Faso; [Hamel, Mary J.; Kariuki, Simon; Odero, Chris; Oneko, Martina; Otieno, Kephas; Awino, Norbert; Omoto, Jackton; Williamson, John; Muturi-Kioi, Vincent; Laserson, Kayla F.; Slutsker, Laurence] KEMRI CDC Res & Publ Hlth Collaborat, Kisumu, Kenya; [Otieno, Walter; Otieno, Lucas; Nekoye, Otsyula; Gondi, Stacey; Ogutu, Bernhards; Wasuna, Ruth; Owira, Victorine; Jones, David; Onyango, Agnes Akoth; Jumbe, Allan] KEMRI Walter Reed Project, Kombewa, Kenya; [Njuguna, Patricia; Chilengi, Roma; Akoo, Pauline; Kerubo, Christine; Gitaka, Jesse; Maingi, Charity; Lang, Trudie; Olotu, Ally; Tsofa, Benjamin; Bejon, Philip; Peshu, Norbert; Marsh, Kevin] KEMRI Wellcome Trust Res Program, Kilifi, Kenya; [Owusu-Agyei, Seth; Asante, Kwaku Poku; Osei-Kwakye, Kingsley; Boahen, Owusu; Ayamba, Samuel; Kayan, Kingsley; Owusu-Ofori, Ruth; Dosoo, David; Asante, Isaac; Adjei, George; Kwara, Evans; Chandramohan, Daniel; Greenwood, Brian] Kintampo Hlth Res Ctr, Kintampo, Ghana; [Lusingu, John; Gesase, Samwel; Malabeja, Anangisye; Abdul, Omari; Kilavo, Hassan; Mahende, Coline; Liheluka, Edwin; Lemnge, Martha; Theander, Thor; Drakeley, Chris] Natl Inst Med Res, Korogwe, Tanzania; [Ansong, Daniel; Agbenyega, Tsiri; Adjei, Samuel; Boateng, Harry Owusu; Rettig, Theresa; Bawa, John; Sylverken, Justice; Sambian, David; Agyekum, Alex; Owusu, Larko] Sch Med Sci, Kumasi, Ghana; [Martinson, Francis; Hoffman, Irving; Mvalo, Tisungane; Kamthunzi, Portia; Nkomo, Ruthendo; Msika, Albans; Jumbe, Allan; Chome, Nelecy; Nyakuipa, Dalitso; Chintedza, Joseph] Univ N Carolina Project, Lilongwe, Malawi; [Ballou, W. Ripley; Bruls, Myriam; Cohen, Joe; Guerra, Yolanda; Jongert, Erik; Lapierre, Didier; Leach, Amanda; Lievens, Marc; Ofori-Anyinam, Opokua; Vekemans, Johan] GlaxoSmithKline Inc, Wavre, Belgium; [Carter, Terrell; Leboulleux, Didier; Loucq, Christian; Radford, Afiya; Savarese, Barbara; Schellenberg, David; Sillman, Marla; Vansadia, Preeti] PATH Malaria Vaccine Initiat, Washington, DC USA	Eberhard Karls University of Tubingen; Centro de Investigacao em Saude de Manhica; Ifakara Health Institute; Kintampo Health Research Centre; GlaxoSmithKline	Agnandji, ST (corresponding author), Care of Mertes K, PATH Malaria Vaccine Initiat, Commun & Advocacy Unit, 455 Massachusetts Ave NW,Suite 1000, Washington, DC 20001 USA.		Kariuki, Simon/AFT-6596-2022; Tahita, Marc/AAG-6549-2019; Sacarlal, Jahit/R-3172-2016; Aide, Pedro/D-8771-2018; Leach, Amanda/AAS-1120-2020; Odero, Christopher/AAW-2752-2020; Theander, Thor/F-6714-2015; Mordmüller, Benjamin/A-5749-2010; Lanaspa, Miguel/AAO-4971-2020; D'Alessandro, Umberto/D-3457-2015; Lusingu, John P. A./GSJ-3228-2022; Bassat, Quique/P-2341-2016; Alonso, Pedro L/AAZ-3645-2020; Valea, Innocent/ABE-6694-2020	Tahita, Marc/0000-0003-2158-0182; Sacarlal, Jahit/0000-0003-1059-217X; Leach, Amanda/0000-0002-7114-9967; Odero, Christopher/0000-0003-2317-9405; Theander, Thor/0000-0002-3509-7514; Mordmüller, Benjamin/0000-0001-9101-2768; D'Alessandro, Umberto/0000-0001-6341-5009; Bassat, Quique/0000-0003-0875-7596; Alonso, Pedro L/0000-0003-3292-3443; Lanaspa, Miguel/0000-0002-9310-177X; Schellenberg, David/0000-0001-8222-0186; Muturi-Kioi, Vincent/0000-0003-1620-3999; ANSONG, Daniel/0000-0003-1328-9117; Owusu-Agyei, Seth/0000-0002-0807-1781; masoud, nahya salim/0000-0002-3784-6478; Ouedraogo, Jean Bosco/0000-0003-0412-8733; Lusingu, John P. A./0000-0002-9407-0602; Gitaka, Jesse/0000-0001-7516-522X; Valea, Innocent/0000-0002-3085-0490; Tinto, Halidou/0000-0002-0472-3586; Liheluka, Edwin/0000-0001-9043-7529	GlaxoSmithKline Biologicals (GSK); PATH Malaria Vaccine Initiative; Bill and Melinda Gates Foundation	GlaxoSmithKline Biologicals (GSK)(GlaxoSmithKline); PATH Malaria Vaccine Initiative; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Supported by GlaxoSmithKline Biologicals (GSK) and the PATH Malaria Vaccine Initiative, which received a grant from the Bill and Melinda Gates Foundation.	Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Agnandji ST, 2010, J INFECT DIS, V202, P1076, DOI 10.1086/656190; Aide P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013838; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Asante KP, 2011, LANCET INFECT DIS, V11, P741, DOI 10.1016/S1473-3099(11)70100-1; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Bonhoeffer J, 2004, VACCINE, V22, P557, DOI 10.1016/j.vaccine.2003.09.008; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Guinovart C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005165; *ICH TECHN REQ REG, 1996, GUID IND E6 GOOD CLI, P38; Leach A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-224; Lievens M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-222; Macete EV, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-11; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/S1473-3099(10)70262-0; Sacarlal J, 2009, J INFECT DIS, V200, P329, DOI 10.1086/600119; Steketee RW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-299; Swysen C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-223; Vekemans J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-221; Vekemans J, 2009, VACCINE, V27, pG67, DOI 10.1016/j.vaccine.2009.10.013; White MT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-82; WHO, 2010, WORLD MALARIA REPORT 2010, P1; World Health Organization, 2007, VERB AUT STAND ASC A; 2011, MEDDRA TERM SELECTIO, P49	27	580	599	1	121	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 17	2011	365	20					1863	1875		10.1056/NEJMoa1102287	http://dx.doi.org/10.1056/NEJMoa1102287			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	848HG	22007715	Green Accepted			2022-12-28	WOS:000297041900005
J	Yang, XJ; Ren, Z; Kuk, J; Moffat, K				Yang, Xiaojing; Ren, Zhong; Kuk, Jane; Moffat, Keith			Temperature-scan cryocrystallography reveals reaction intermediates in bacteriophytochrome	NATURE			English	Article							PSEUDOMONAS-AERUGINOSA BACTERIOPHYTOCHROME; CHROMOPHORE-BINDING DOMAIN; GROUND-STATE; MIDINFRARED SPECTROSCOPY; CRYSTAL-STRUCTURE; GAF DOMAIN; PHYTOCHROME; LIGHT; PHOTOCONVERSION; PFR	Light is a fundamental signal that regulates important physiological processes such as development and circadian rhythm in living organisms. Phytochromes form a major family of photoreceptors responsible for red light perception in plants, fungi and bacteria(1). They undergo reversible photoconversion between red-absorbing (Pr) and far-red-absorbing (Pfr) states, thereby ultimately converting a light signal into a distinct biological signal that mediates subsequent cellular responses(2). Several structures of microbial phytochromes have been determined in their dark-adapted Pr or Pfr states(3-7). However, the structural nature of initial photochemical events has not been characterized by crystallography. Here we report the crystal structures of three intermediates in the photoreaction of Pseudomonas aeruginosa bacteriophytochrome (PaBphP). We used cryotrapping crystallography to capture intermediates, and followed structural changes by scanning the temperature at which the photoreaction proceeded. Light-induced conformational changes in PaBphP originate in ring D of the biliverdin (BV) chromophore, and E-to-Z isomerization about the C-15 = C-16 double bond between rings C and D is the initial photochemical event. As the chromophore relaxes, the twist of the C-15 methine bridge about its two dihedral angles is reversed. Structural changes extend further to rings B and A, and to the surrounding protein regions. These data indicate that absorption of a photon by the Pfr state of PaBphP converts a light signal into a structural signal via twisting and untwisting of the methine bridges in the linear tetrapyrrole within the confined protein cavity.	[Yang, Xiaojing; Kuk, Jane; Moffat, Keith] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Ren, Zhong; Moffat, Keith] Univ Chicago, Ctr Adv Radiat Sources, Chicago, IL 60637 USA; [Moffat, Keith] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Yang, XJ (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 929 E 57th St, Chicago, IL 60637 USA.	xiaojingyang@uchicago.edu; moffat@cars.uchicago.edu		Kuk, Jane/0000-0002-8886-4078	National Institutes of Health [GM036452, RR07707]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR007707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036452, R37GM036452] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Moglich for comments and reading of the manuscript, and V. Srajer of BioCARS for assistance in microspectrometer experiments on crystals. We also thank the staff of LSCAT and BioCARS at the Advanced Photon Source, Argonne National Laboratory for beamline access. Supported by National Institutes of Health grant GM036452 to K.M. BioCARS is supported by National Institutes of Health grant RR07707 to K.M.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anderson S, 2004, PHOTOCHEM PHOTOBIOL, V80, P7, DOI 10.1562/2004-03-15-RA-115.1; Cornilescu G, 2008, J MOL BIOL, V383, P403, DOI 10.1016/j.jmb.2008.08.034; Dasgupta J, 2009, P NATL ACAD SCI USA, V106, P1784, DOI 10.1073/pnas.0812056106; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Foerstendorf H, 1996, BIOCHEMISTRY-US, V35, P10793, DOI 10.1021/bi960960r; Giraud E, 2005, J BIOL CHEM, V280, P32389, DOI 10.1074/jbc.M506890200; Giraud E, 2010, METHOD ENZYMOL, V471, P135, DOI 10.1016/S0076-6879(10)71009-0; Li H, 2010, P NATL ACAD SCI USA, V107, P10872, DOI 10.1073/pnas.1001908107; MOFFAT K, 1995, CURR OPIN STRUC BIOL, V5, P656, DOI 10.1016/0959-440X(95)80059-X; Montgomery BL, 2002, TRENDS PLANT SCI, V7, P357, DOI 10.1016/S1360-1385(02)02304-X; Muller MG, 2008, BIOPHYS J, V94, P4370, DOI 10.1529/biophysj.106.091652; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rajagopala S, 2004, ACTA CRYSTALLOGR D, V60, P860, DOI 10.1107/S0907444904004160; Rockwell NC, 2008, BIOCHEMISTRY-US, V47, P7304, DOI 10.1021/bi800088t; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rockwell NC, 2009, P NATL ACAD SCI USA, V106, P6123, DOI 10.1073/pnas.0902370106; Rohmer T, 2010, J AM CHEM SOC, V132, P4431, DOI 10.1021/ja9108616; Schmidt M, 2004, P NATL ACAD SCI USA, V101, P4799, DOI 10.1073/pnas.0305983101; Schumann C, 2008, BIOPHYS J, V94, P3189, DOI 10.1529/biophysj.107.119297; Schwinte P, 2009, PHOTOCHEM PHOTOBIOL, V85, P239, DOI 10.1111/j.1751-1097.2008.00426.x; Seibeck S, 2007, FEBS LETT, V581, P5425, DOI 10.1016/j.febslet.2007.10.043; Song C, 2011, P NATL ACAD SCI USA, V108, P3842, DOI 10.1073/pnas.1013377108; Tasler R, 2005, FEBS J, V272, P1927, DOI 10.1111/j.1742-4658.2005.04623.x; Ulijasz AT, 2010, NATURE, V463, P250, DOI 10.1038/nature08671; van Thor JJ, 2007, J AM CHEM SOC, V129, P126, DOI 10.1021/ja0660709; van Wilderen LJGW, 2009, J PHYS CHEM B, V113, P16354, DOI 10.1021/jp9038539; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104; Yang XJ, 2009, P NATL ACAD SCI USA, V106, P15639, DOI 10.1073/pnas.0902178106; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	35	125	128	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 17	2011	479	7373					428	U190		10.1038/nature10506	http://dx.doi.org/10.1038/nature10506			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	848OA	22002602	Green Accepted			2022-12-28	WOS:000297059700052
J	Frank, RG				Frank, Richard G.			Medicare Drug Prices and the Deficit	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Frank, RG (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.							[Anonymous], 2002, ISS DES PRESCR DRUG; [Anonymous], 2011, DAT BOOK HLTH CAR SP; Bagchi AD, 2007, HEALTH CARE FINANC R, V28, P43; Frank RG, 2008, HEALTH AFFAIR, V27, P33, DOI 10.1377/hlthaff.27.1.33; Office of the Inspector General, 2011, OEI031000320	5	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 3	2011	365	18					1657	1659		10.1056/NEJMp1109926	http://dx.doi.org/10.1056/NEJMp1109926			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	840FL	21995337				2022-12-28	WOS:000296424200003
J	Bergwitz, C; Collins, MT; Kamath, RS; Rosenberg, AE				Bergwitz, Clemens; Collins, Michael T.; Kamath, Ravi S.; Rosenberg, Andrew E.			Case 33-2011: A 56-Year-Old Man with Hypophosphatemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TUMOR-INDUCED OSTEOMALACIA; OF-THE-LITERATURE; ONCOGENIC OSTEOMALACIA; MESENCHYMAL TUMORS; AMELOBLASTIC FIBROSARCOMA; PHOSPHATE HOMEOSTASIS; CALCIUM-METABOLISM; VITAMIN-D; FIBROBLAST-GROWTH-FACTOR-23; LOCALIZATION		[Bergwitz, Clemens] Massachusetts Gen Hosp, Div Endocrinol, Boston, MA 02114 USA; [Kamath, Ravi S.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Rosenberg, Andrew E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Bergwitz, Clemens] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Kamath, Ravi S.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Rosenberg, Andrew E.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Collins, Michael T.] Natl Inst Dent & Craniofacial Res, Clin Studies Unit, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Bergwitz, C (corresponding author), Massachusetts Gen Hosp, Div Endocrinol, Boston, MA 02114 USA.				Genzyme; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK078361, R03DK089127] Funding Source: NIH RePORTER	Genzyme(Sanofi-AventisGenzyme Corporation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Rosenberg reports receiving consulting fees from Genzyme. No other potential conflict of interest relevant to this article was reported.	Andreopoulou P, 2011, J BONE MINER RES, V26, P1295, DOI 10.1002/jbmr.316; Aono Y, 2009, J BONE MINER RES, V24, P1879, DOI [10.1359/JBMR.090509, 10.1359/jbmr.090509]; Bergwitz C, 2010, ANNU REV MED, V61, P91, DOI 10.1146/annurev.med.051308.111339; Bringhurst FR, 2006, ENDOCRINOLOGY, V5, P805; DAFFNER RH, 1992, AM J ROENTGENOL, V159, P245, DOI 10.2214/ajr.159.2.1632335; DALLERA P, 1994, J CRANIO MAXILL SURG, V22, P349, DOI 10.1016/S1010-5182(05)80116-7; de Beur SMJ, 2002, LANCET, V359, P761, DOI 10.1016/S0140-6736(02)07846-7; Econs MJ, 1997, J CLIN ENDOCR METAB, V82, P674, DOI 10.1210/jc.82.2.674; Folpe AL, 2004, AM J SURG PATHOL, V28, P1, DOI 10.1097/00000478-200401000-00001; Geller JL, 2007, J BONE MINER RES, V22, P931, DOI 10.1359/JBMR.070304; Gupta A, 2004, J CLIN ENDOCR METAB, V89, P4489, DOI 10.1210/jc.2004-0724; HARVEY JN, 1992, CLIN ENDOCRINOL, V37, P379, DOI 10.1111/j.1365-2265.1992.tb02342.x; Hesse E, 2007, NEW ENGL J MED, V357, P422, DOI 10.1056/NEJMc070347; Hesse E, 2007, J BONE MINER RES, V22, P158, DOI 10.1359/JBMR.060909; JEFFERIS AF, 1985, J LARYNGOL OTOL, V99, P1011, DOI 10.1017/S0022215100098091; Jonsson KB, 2003, NEW ENGL J MED, V348, P1656, DOI 10.1056/NEJMoa020881; Kuro-o M, 2006, CURR OPIN NEPHROL HY, V15, P437, DOI 10.1097/01.mnh.0000232885.81142.83; MULLER S, 1995, ORAL SURG ORAL MED O, V79, P469, DOI 10.1016/S1079-2104(05)80130-1; Perwad F, 2007, AM J PHYSIOL-RENAL, V293, pF1577, DOI 10.1152/ajprenal.00463.2006; Razzaque MS, 2008, NEPHROL DIAL TRANSPL, V23, P459, DOI 10.1093/ndt/gfm702; Roarke MC, 2007, CLIN NUCL MED, V32, P300, DOI 10.1097/01.rlu.0000257180.03964.51; Segawa H, 2009, J AM SOC NEPHROL, V20, P104, DOI 10.1681/ASN.2008020177; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Stubbs J, 2007, SEMIN DIALYSIS, V20, P302, DOI 10.1111/j.1525-139X.2007.00308.x; Takeuchi Y, 2004, J CLIN ENDOCR METAB, V89, P3979, DOI 10.1210/jc.2004-0406; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Yan XM, 2005, GENES CELLS, V10, P489, DOI 10.1111/j.1365-2443.2005.00853.x	27	19	22	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2011	365	17					1625	1635		10.1056/NEJMcpc1104567	http://dx.doi.org/10.1056/NEJMcpc1104567			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HI	22029985	Green Accepted			2022-12-28	WOS:000296181800009
J	Akeson, R				Akeson, Rachel			Watery Disks	SCIENCE			English	Editorial Material							PLANET FORMATION		CALTECH, NASA Exoplanet Sci Inst, Pasadena, CA 91125 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA)	Akeson, R (corresponding author), CALTECH, NASA Exoplanet Sci Inst, Pasadena, CA 91125 USA.	rla@ipac.caltech.edu		Akeson, Rachel/0000-0001-9674-1564				Ceccarelli C, 2005, ASTROPHYS J, V631, pL81, DOI 10.1086/497028; HAYASHI C, 2005, PROTOSTARS PLANETS, V2, P1100; Hogerheijde MR, 2011, SCIENCE, V334, P338, DOI 10.1126/science.1208931; Honda M, 2009, ASTROPHYS J LETT, V690, pL110, DOI 10.1088/0004-637X/690/2/L110; Kennedy GM, 2008, ASTROPHYS J, V673, P502, DOI 10.1086/524130; Nakamura T, 2008, SCIENCE, V321, P1664, DOI 10.1126/science.1160995	8	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2011	334	6054					316	317		10.1126/science.1213752	http://dx.doi.org/10.1126/science.1213752			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	22021845				2022-12-28	WOS:000296052500034
J	Thomas, PJ				Thomas, Peter J.			Every Bit Counts	SCIENCE			English	Editorial Material							CAPACITY		[Thomas, Peter J.] Case Western Reserve Univ, Dept Math, Cleveland, OH 44106 USA; [Thomas, Peter J.] Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA; [Thomas, Peter J.] Case Western Reserve Univ, Dept Cognit Sci, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Thomas, PJ (corresponding author), Case Western Reserve Univ, Dept Math, Cleveland, OH 44106 USA.	pjthomas@case.edu		Thomas, Peter/0000-0001-7533-6770				Andrews BW, 2007, PLOS COMPUT BIOL, V3, P1489, DOI 10.1371/journal.pcbi.0030153; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BERGER T, 2003, IEEE INF THEORY  MAR, P53; Cheong R, 2011, SCIENCE, V334, P354, DOI 10.1126/science.1204553; Fuller D, 2010, P NATL ACAD SCI USA, V107, P9656, DOI 10.1073/pnas.0911178107; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; KABANOV YM, 1978, THEOR PROBAB APPL+, V23, P143, DOI 10.1137/1123013; Kimmel J.M., 2007, ADV NEURAL INFORM PR, V19, P705; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Rieke F., 1999, SPIKES EXPLORING NEU; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; Thomas MC, 2006, ELEMENTS INFORM THEO	16	13	14	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2011	334	6054					321	322		10.1126/science.1213834	http://dx.doi.org/10.1126/science.1213834			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	22021849				2022-12-28	WOS:000296052500038
J	Ito, K				Ito, Kouta			Proton-pump inhibitors were associated with reduced effectiveness of alendronate for preventing hip fractures	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RISK		Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Ito, K (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.			Abrahamsen, Bo/0000-0002-2730-6080				de Vries F, 2009, OSTEOPOROSIS INT, V20, P1989, DOI 10.1007/s00198-009-0891-4; Jacobson BC, 2003, AM J GASTROENTEROL, V98, P51, DOI 10.1111/j.1572-0241.2003.07186.x; Yu EW, 2011, AM J MED, V124, P519, DOI 10.1016/j.amjmed.2011.01.007	3	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2011	155	8							JC4-13	10.7326/0003-4819-155-8-201110180-02013	http://dx.doi.org/10.7326/0003-4819-155-8-201110180-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835WB	22007072				2022-12-28	WOS:000296066300012
J	Stephenson, NL; Das, AJ				Stephenson, Nathan L.; Das, Adrian J.			Comment on "Changes in Climatic Water Balance Drive Downhill Shifts in Plant Species' Optimum Elevations"	SCIENCE			English	Editorial Material							VEGETATION DISTRIBUTION		[Stephenson, Nathan L.; Das, Adrian J.] US Geol Survey, Western Ecol Res Ctr, Three Rivers, CA 93271 USA	United States Department of the Interior; United States Geological Survey	Stephenson, NL (corresponding author), US Geol Survey, Western Ecol Res Ctr, Three Rivers, CA 93271 USA.	nstephenson@usgs.gov						[Anonymous], CALVEG VEGETATION DA; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; Fites-Kaufman JA, 2007, TERRESTRIAL VEGETATION OF CALIFORNIA, 3RD EDITION, P456; Jump AS, 2009, TRENDS ECOL EVOL, V24, P694, DOI 10.1016/j.tree.2009.06.007; Lenoir J, 2010, ECOGRAPHY, V33, P295, DOI 10.1111/j.1600-0587.2010.06279.x; Major J., 1977, TERRESTRIAL VEGETATI; Shreve F., 1915, CARNEGIE I WASHINGTO, V217; Stephenson NL, 1998, J BIOGEOGR, V25, P855, DOI 10.1046/j.1365-2699.1998.00233.x; STEPHENSON NL, 1990, AM NAT, V135, P649, DOI 10.1086/285067; Thorne James H., 2008, Madrono, V55, P223, DOI 10.3120/0024-9637-55.3.223; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; WILLMOTT CJ, 1985, J CLIMATOL, V5, P589, DOI 10.1002/joc.3370050602	12	22	22	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2011	334	6053								10.1126/science.1205740	http://dx.doi.org/10.1126/science.1205740			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998371				2022-12-28	WOS:000295833600026
J	Tefferi, A; Litzow, MR; Pardanani, A				Tefferi, Ayalew; Litzow, Mark R.; Pardanani, Animesh			Long-Term Outcome of Treatment with Ruxolitinib in Myelofibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Tefferi, Ayalew; Litzow, Mark R.; Pardanani, Animesh] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Tefferi, A (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	tefferi.ayalew@mayo.edu						Gangat N, 2011, J CLIN ONCOL, V29, P392, DOI 10.1200/JCO.2010.32.2446; Tefferi A, 2006, BLOOD, V108, P1497, DOI 10.1182/blood-2006-03-009746; Tefferi A, 2011, J CLIN ONCOL, V29, P1356, DOI 10.1200/JCO.2010.32.9490; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028	4	117	123	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 13	2011	365	15					1455	1457		10.1056/NEJMc1109555	http://dx.doi.org/10.1056/NEJMc1109555			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832DQ	21995409				2022-12-28	WOS:000295782500032
J	Trakhtenberg, EF; Goldberg, JL				Trakhtenberg, Ephraim F.; Goldberg, Jeffrey L.			Neuroimmune Communication	SCIENCE			English	Editorial Material							ISCHEMIC-STROKE		[Trakhtenberg, Ephraim F.; Goldberg, Jeffrey L.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Interdisciplinary Stem Cell Inst,Neurosci Program, Miami, FL 33136 USA	Bascom Palmer Eye Institute; University of Miami	Trakhtenberg, EF (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Interdisciplinary Stem Cell Inst,Neurosci Program, Miami, FL 33136 USA.	jgoldberg@med.miami.edu		Goldberg, Jeffrey/0000-0002-1390-7360	NATIONAL EYE INSTITUTE [RC1EY020297, R01EY020913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS074490, R01NS061348] Funding Source: NIH RePORTER; NEI NIH HHS [EY020913, EY020297, P30-EY014081] Funding Source: Medline; NINDS NIH HHS [NS074490, NS061348] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Kimura K, 2005, CEREBROVASC DIS, V19, P171, DOI 10.1159/000083252; London A, 2011, J EXP MED, V208, P23, DOI 10.1084/jem.20101202; Madrigal JLM, 2009, J NEUROSCI, V29, P263, DOI 10.1523/JNEUROSCI.4926-08.2009; O Besedovsky H, 2006, NAT IMMUNOL, V7, P537, DOI 10.1038/ni0606-537; Probert L, 1997, J NEUROIMMUNOL, V72, P137, DOI 10.1016/S0165-5728(96)00184-1; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Trakhtenberg EC, 2008, INT J NEUROSCI, V118, P839, DOI 10.1080/00207450701792705; Wilson DR, 2008, PERSPECT PSYCHIATR C, V44, P285, DOI 10.1111/j.1744-6163.2008.00188.x; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301	13	36	37	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 7	2011	334	6052					47	48		10.1126/science.1213099	http://dx.doi.org/10.1126/science.1213099			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21980100				2022-12-28	WOS:000295580300032
J	Bayer, R; Oppenheimer, GM				Bayer, Ronald; Oppenheimer, Gerald M.			Routine HIV Screening - What Counts in Evidence-Based Policy?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bayer, Ronald; Oppenheimer, Gerald M.] Columbia Univ, Ctr Hist & Eth Publ Hlth, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY 10027 USA	Columbia University	Bayer, R (corresponding author), Columbia Univ, Ctr Hist & Eth Publ Hlth, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY 10027 USA.							AHRQ, 2007, AHRQ PUB; Beckwith CG, 2005, ANN INTERN MED, V143, P916, DOI 10.7326/0003-4819-143-12-200512200-00012; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Qaseem A, 2009, ANN INTERN MED, V150, P125, DOI 10.7326/0003-4819-150-2-200901200-00300; US Preventive Serv Task Force, 2005, ANN INTERN MED, V143, P32, DOI 10.7326/0003-4819-143-1-200507050-00008	5	14	14	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 6	2011	365	14					1265	1268		10.1056/NEJMp1108657	http://dx.doi.org/10.1056/NEJMp1108657			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829KL	21991946				2022-12-28	WOS:000295578700001
J	Foley, RN; Gilbertson, DT; Murray, T; Collins, AJ				Foley, Robert N.; Gilbertson, David T.; Murray, Thomas; Collins, Allan J.			Long Interdialytic Interval and Mortality among Patients Receiving Hemodialysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUDDEN-DEATH; SURVIVAL; TIME	Background Patients with end-stage renal disease requiring dialysis have limited tolerance of metabolic and volume-related deviations from normal ranges; in addition, the prevalence of cardiovascular disease is high among such patients. Given these problems, we hypothesized that a long interdialytic interval is associated with adverse events in patients receiving hemodialysis. Methods We studied 32,065 participants in the End-Stage Renal Disease Clinical Performance Measures Project, a nationally representative sample of U.S. patients receiving hemodialysis three times weekly, at the end of calendar years 2004 through 2007. We compared rates of death and cardiovascular-related hospital admissions on the day after the long (2-day) interdialytic interval with rates on other days. Results The mean age of the cohort was 62.2 years; 24.2% of the patients had been receiving dialysis treatment for 1 year or less. Over a mean follow-up interval of 2.2 years, the following event rates were higher on the day after the long interval than on other days: all-cause mortality (22.1 vs. 18.0 deaths per 100 person-years, P<0.001), mortality from cardiac causes (10.2 vs. 7.5, P<0.001), infection-related mortality (2.5 vs. 2.1, P=0.007), mortality from cardiac arrest (1.3 vs. 1.0, P=0.004), mortality from myocardial infarction (6.3 vs. 4.4, P<0.001), and admissions for myocardial infarction (6.3 vs. 3.9, P<0.001), congestive heart failure (29.9 vs. 16.9, P<0.001), stroke (4.7 vs. 3.1, P<0.001), dysrhythmia (20.9 vs. 11.0, P<0.001), and any cardiovascular event (44.2 vs. 19.7, P<0.001). Conclusions The long (2-day) interdialytic interval is a time of heightened risk among patients receiving hemodialysis. (Funded by the National Institutes of Health.)	[Foley, Robert N.; Gilbertson, David T.; Murray, Thomas; Collins, Allan J.] US Renal Data Syst, Minneapolis, MN 55404 USA; [Foley, Robert N.; Murray, Thomas; Collins, Allan J.] Univ Minnesota, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Foley, RN (corresponding author), US Renal Data Syst, 914 S 8th St,Suite S-406, Minneapolis, MN 55404 USA.	rfoley@usrds.org			National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases [HHSN267200715002C]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institutes of Health.; Supported by a contract (HHSN267200715002C) from the National Institute of Diabetes and Digestive and Kidney Diseases.	Abbott KC, 2003, AM J KIDNEY DIS, V41, P796, DOI 10.1016/S0272-6386(03)00027-1; Bleyer AJ, 2006, KIDNEY INT, V69, P2268, DOI 10.1038/sj.ki.5000446; Bleyer AJ, 1999, JAMA-J AM MED ASSOC, V281, P1211, DOI 10.1001/jama.281.13.1211; Bleyer AJ, 1999, KIDNEY INT, V55, P1553, DOI 10.1046/j.1523-1755.1999.00391.x; Bliwise DL, 2001, JAMA-J AM MED ASSOC, V286, P2690, DOI 10.1001/jama.286.21.2690; BLIWISE DL, 2002, JAMA-J AM MED ASSOC, V287, P192; Centers for Medicare and Medicaid Services, 2008, REL REP 2000 ESRD CP; Chertow GM, 2011, NEW ENGL J MED, V364, P93; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; *CTR MED MED SERV, ESRD DEATH NOT END S; Culleton BF, 2007, JAMA-J AM MED ASSOC, V298, P1291, DOI 10.1001/jama.298.11.1291; Genovesi S, 2009, NEPHROL DIAL TRANSPL, V24, P2529, DOI 10.1093/ndt/gfp104; Karnik JA, 2001, KIDNEY INT, V60, P350, DOI 10.1046/j.1523-1755.2001.00806.x; Kjellstrand C M, 1975, Kidney Int Suppl, P30; Kjellstrand CM, 1978, KIDNEY INT S, V8, pS120; Lafrance JP, 2006, NEPHROL DIAL TRANSPL, V21, P1006, DOI 10.1093/ndt/gfk007; Office of Clinical Standards and Quality, 2000, 2000 ANN REP ESRD CL; Owen WF, 1999, AM J KIDNEY DIS, V34, pS5, DOI 10.1053/ajkd.1999.v34.aajkd0344b0005; Saran R, 2003, KIDNEY INT, V64, P254, DOI 10.1046/j.1523-1755.2003.00064.x; United States Renal Data System, 2010, 2010 USRDS ANN DAT R	20	301	320	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2011	365	12					1099	1107		10.1056/NEJMoa1103313	http://dx.doi.org/10.1056/NEJMoa1103313			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822WR	21992122				2022-12-28	WOS:000295081600009
J	Kiss, EA; Vonarbourg, C; Kopfmann, S; Hobeika, E; Finke, D; Esser, C; Diefenbach, A				Kiss, Elina A.; Vonarbourg, Cedric; Kopfmann, Stefanie; Hobeika, Elias; Finke, Daniela; Esser, Charlotte; Diefenbach, Andreas			Natural Aryl Hydrocarbon Receptor Ligands Control Organogenesis of Intestinal Lymphoid Follicles	SCIENCE			English	Article							ROR-GAMMA-T; INFLAMMATORY-BOWEL-DISEASE; NODE DEVELOPMENT; NKP46(+) CELLS; HOMEOSTASIS; GUT; TISSUES; DIFFERENTIATION; LYMPHOCYTES; GENERATION	Innate lymphoid cells (ILC) expressing the transcription factor ROR gamma t induce the postnatal formation of intestinal lymphoid follicles and regulate intestinal homeostasis. ROR gamma t(+) ILC express the aryl hydrocarbon receptor (AhR), a highly conserved, ligand-inducible transcription factor believed to control adaptation of multicellular organisms to environmental challenges. We show that AhR is required for the postnatal expansion of intestinal ROR gamma t(+) ILC and the formation of intestinal lymphoid follicles. AhR activity within ROR gamma t(+) ILC could be induced by dietary ligands such as those contained in vegetables of the family Brassicaceae. AhR-deficient mice were highly susceptible to infection with Citrobacter rodentium, a mouse model for attaching and effacing infections. Our results establish a molecular link between nutrients and the formation of immune system components required to maintain intestinal homeostasis and resistance to infections.	[Kiss, Elina A.; Vonarbourg, Cedric; Kopfmann, Stefanie; Diefenbach, Andreas] Univ Freiburg, Med Ctr, IMMH, D-79104 Freiburg, Germany; [Kiss, Elina A.; Diefenbach, Andreas] Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany; [Kiss, Elina A.; Diefenbach, Andreas] Res Training Grp Organogenesis GRK1104, D-79104 Freiburg, Germany; [Hobeika, Elias] Univ Freiburg, Max Planck Inst Immunobiol & Epigenet, Fac Biol 3, D-79108 Freiburg, Germany; [Hobeika, Elias] Univ Freiburg, Fac Biol 3, Dept Mol Immunol, D-79108 Freiburg, Germany; [Finke, Daniela] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland; [Esser, Charlotte] Univ Dusseldorf, Leibniz Res Inst Environm Med, D-40225 Dusseldorf, Germany	University of Freiburg; Max Planck Society; University of Freiburg; University of Freiburg; University of Basel; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF)	Diefenbach, A (corresponding author), Univ Freiburg, Med Ctr, IMMH, Hermann Herder Str 11, D-79104 Freiburg, Germany.	andreas.diefenbach@uniklinik-freiburg.de	hobeika, elias/AAV-6663-2021; Diefenbach, Andreas/T-2589-2018	Diefenbach, Andreas/0000-0002-9176-9530	Deutsche Forschungsgemeinschaft [GRK1104, SGBM, SFB620/A14]; Bundesministerium fur Bildung und Forschung; Centrum fur Chronische Immundefizienz; Swiss National Science Foundation [SNF 310030_130674/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Centrum fur Chronische Immundefizienz; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank G. Hacker for support and for critically reading the manuscript; the members of the Diefenbach laboratory for valuable discussions; H. Pircher, Y. Tanriver, W. Schachterle, and S. Ganal for comments on the manuscript; J. Brandel for help with the figures; and N. Goppert and K. Oberle for technical assistance. We are grateful to T. Haarmann-Stemmann, C. Johner, D. Littman, R. Nechanitzky, G. Niedermann, M. Rosenbaum, F. Santori, and A. Schuhmacher for experimental support and to J. Wersing for cell sorting. The data reported in this paper are tabulated in the main paper and in the supporting online material. The work was supported by the Deutsche Forschungsgemeinschaft (GRK1104, SGBM, and SFB620/A14 to A. D. and E. A. K.), the Bundesministerium fur Bildung und Forschung, Centrum fur Chronische Immundefizienz (to A. D.), and the Swiss National Science Foundation (grant SNF 310030_130674/1 to D.F.).	Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; BJELDANES LF, 1991, P NATL ACAD SCI USA, V88, P9543, DOI 10.1073/pnas.88.21.9543; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Burow M, 2010, CURR OPIN PLANT BIOL, V13, P348, DOI 10.1016/j.pbi.2010.02.002; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chappaz S, 2010, J IMMUNOL, V185, P3514, DOI 10.4049/jimmunol.1000665; Dixon RA, 2004, ANNU REV PLANT BIOL, V55, P225, DOI 10.1146/annurev.arplant.55.031903.141729; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eckmann L, 2006, ANN NY ACAD SCI, V1072, P28, DOI 10.1196/annals.1326.008; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; Lochner M, 2011, J EXP MED, V208, P125, DOI 10.1084/jem.20100052; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Luther SA, 2003, J EXP MED, V197, P1191, DOI 10.1084/jem.20021294; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Pabst O, 2005, EUR J IMMUNOL, V35, P98, DOI 10.1002/eji.200425432; PUDDINGTON L, 1994, IMMUNITY, V1, P733, DOI 10.1016/S1074-7613(94)80015-4; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Sanos SL, 2011, IMMUNOLOGY, V132, P453, DOI 10.1111/j.1365-2567.2011.03410.x; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	32	562	586	2	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2011	334	6062					1561	1565		10.1126/science.1214914	http://dx.doi.org/10.1126/science.1214914			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22033518				2022-12-28	WOS:000298091400055
J	Buchholz, TA				Buchholz, Thomas A.			Radiotherapy and survival in breast cancer	LANCET			English	Editorial Material							POSTMASTECTOMY RADIOTHERAPY; ADJUVANT CHEMOTHERAPY; PROGESTERONE-RECEPTOR; ESTROGEN-RECEPTOR; RECURRENCE; RISK; TRASTUZUMAB; HER-2		Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Buchholz, TA (corresponding author), Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.	tbuchhol@mdanderson.org		Buchholz, Thomas/0000-0002-7859-5572				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abe O, 2005, LANCET, V366, P2087; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Kyndi M, 2008, J CLIN ONCOL, V26, P1419, DOI 10.1200/JCO.2007.14.5565; Kyndi M, 2009, RADIOTHER ONCOL, V90, P74, DOI 10.1016/j.radonc.2008.04.014; Nguyen PL, 2008, J CLIN ONCOL, V26, P2373, DOI 10.1200/JCO.2007.14.4287; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Woodward WA, 2003, INT J RADIAT ONCOL, V57, P336, DOI 10.1016/S0360-3016(03)00593-5	10	13	17	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 12	2011	378	9804					1680	1682		10.1016/S0140-6736(11)61296-8	http://dx.doi.org/10.1016/S0140-6736(11)61296-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846LB	22019143				2022-12-28	WOS:000296899800008
J							Early Breast Canc Trialists Collab	Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials	LANCET			English	Article							LUMPECTOMY PLUS TAMOXIFEN; TUMOR RECURRENCE; POSTOPERATIVE RADIOTHERAPY; CLINICAL-TRIAL; IRRADIATION; THERAPY; OLDER; POPULATION; MORTALITY; BOOST	Background After breast-conserving surgery, radiotherapy reduces recurrence and breast cancer death, but it may do so more for some groups of women than for others. We describe the absolute magnitude of these reductions according to various prognostic and other patient characteristics, and relate the absolute reduction in 15-year risk of breast cancer death to the absolute reduction in 10-year recurrence risk. Methods We undertook a meta-analysis of individual patient data for 10 801 women in 17 randomised trials of radiotherapy versus no radiotherapy after breast-conserving surgery, 8337 of whom had pathologically confirmed node-negative (pN0) or node-positive (pN+) disease. Findings Overall, radiotherapy reduced the 10-year risk of any (ie, locoregional or distant) first recurrence from 35.0% to 19.3% (absolute reduction 15.7%, 95% CI 13.7-17.7, 2p<0.00001) and reduced the 15-year risk of breast cancer death from 25.2% to 21.4% (absolute reduction 3.8%, 1.6-6.0, 2p=0.00005). In women with pN0 disease (n=7287), radiotherapy reduced these risks from 31.0% to 15.6% (absolute recurrence reduction 15.4%, 13.2-17.6, 2p<0.00001) and from 20.5% to 17.2% (absolute mortality reduction 3.3%, 0.8-5.8, 2p=0.005), respectively. In these women with pN0 disease, the absolute recurrence reduction varied according to age, grade, oestrogen-receptor status, tamoxifen use, and extent of surgery, and these characteristics were used to predict large (>= 20%), intermediate (10-19%), or lower (<10%) absolute reductions in the 10-year recurrence risk. Absolute reductions in 15-year risk of breast cancer death in these three prediction categories were 7.8% (95% CI 3.1-12.5), 1.1% (-2.0 to 4.2), and 0.1% (-7.5 to 7.7) respectively (trend in absolute mortality reduction 2p=0.03). In the few women with pN+ disease (n=1050), radiotherapy reduced the 10-year recurrence risk from 63.7% to 42.5% (absolute reduction 21.2%, 95% CI 14.5-27.9, 2p<0.00001) and the 15-year risk of breast cancer death from 51.3% to 42.8% (absolute reduction 8.5%, 1.8-15.2, 2p=0.01). Overall, about one breast cancer death was avoided by year 15 for every four recurrences avoided by year 10, and the mortality reduction did not differ significantly from this overall relationship in any of the three prediction categories for pN0 disease or for pN+ disease. Interpretation After breast-conserving surgery, radiotherapy to the conserved breast halves the rate at which the disease recurs and reduces the breast cancer death rate by about a sixth. These proportional benefits vary little between different groups of women. By contrast, the absolute benefits from radiotherapy vary substantially according to the characteristics of the patient and they can be predicted at the time when treatment decisions need to be made.					Cutter, David/AAU-6599-2021; Greil, Richard F/C-7673-2017; Gkiokas, Georgios/AAE-6312-2020; Falkson, Conrad/N-2681-2018; Rutgers, Emiel J T/C-5934-2015; Gnant, Michael/AAN-7054-2020; Pruneri, Giancarlo/AAC-7767-2022	Cutter, David/0000-0001-7307-7488; Greil, Richard F/0000-0002-4462-3694; Falkson, Conrad/0000-0001-8959-3807; Gnant, Michael/0000-0003-1002-2118; Fredriksson, Irma/0000-0001-7811-9317; Wang, Xiang/0000-0002-1522-9532; Ewertz, Marianne/0000-0002-5965-969X; Adolfsson, Jan/0000-0003-2992-1869; /0000-0003-4167-8910; Cardoso, Fatima/0000-0002-6692-2249; Delmestri, Antonella/0000-0003-0388-3403; Bowden, Sarah/0000-0001-7506-1340; Anderson, Stewart/0000-0001-8948-0650; Swain, Sandra/0000-0002-1320-3830; Valentini, Miriam/0000-0002-1421-6975; Garmo, Hans/0000-0001-7181-7083; Bergh, Jonas/0000-0001-5526-1847; Pruneri, Giancarlo/0000-0002-7963-7172; SEGUI PALMER, MIQUEL ANGEL/0000-0002-5103-6746; Bliss, Judith/0000-0001-7957-7424; van Tinteren, Harm/0000-0002-4626-8702; Hans, Trampisch/0000-0001-9136-1079; Markopoulos, Christos/0000-0002-5072-6390; Di Leo, Angelo/0000-0002-3665-9056; Warnberg, Fredrik/0000-0002-0130-7296; de Vries, Elisabeth/0000-0002-8949-7425; Valagussa, Pinuccia/0000-0003-3590-7916	Cancer Research UK; British Heart Foundation; UK Medical Research Council; British Heart Foundation Centre for Research Excellence [RE/08/04]; MRC [MC_U137686850] Funding Source: UKRI; Cancer Research UK [10588] Funding Source: researchfish; Medical Research Council [MC_U137686858, MC_U137686850] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation Centre for Research Excellence; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Cancer Research UK, British Heart Foundation, and UK Medical Research Council.; The main acknowledgments are to the thousands of women who took part in the trials, to the staff who treated and cared for them and who undertook the trials and shared their data with the Secretariat, and to the CTSU which hosts this collaboration. DC was supported by the British Heart Foundation Centre for Research Excellence (RE/08/04).	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abe O, 2005, LANCET, V366, P2087; ABE O, 1995, NEW ENGL J MED, V333, P1444; Bartelink H, 2007, J CLIN ONCOL, V25, P3259, DOI 10.1200/JCO.2007.11.4991; Blamey RW, 2007, EJC SUPPL, V5, P4, DOI 10.1016/S1359-6349(07)71701-9; CUZICK J, 1987, CANCER TREAT REP, V71, P15; CUZICK J, 1994, J CLIN ONCOL, V12, P447, DOI 10.1200/JCO.1994.12.3.447; Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; Early Breast Cancer Trialists' Collaborative Group (EBCTCG), LANCET IN PRESS; FISHER B, 1991, LANCET, V338, P327, DOI 10.1016/0140-6736(91)90475-5; Fisher B, 2002, J CLIN ONCOL, V20, P4141, DOI 10.1200/JCO.2002.11.101; Ford HT, 2006, ANN ONCOL, V17, P401, DOI 10.1093/annonc/mdj080; Forrest AP, 1996, LANCET, V348, P708, DOI 10.1016/S0140-6736(96)02133-2; Fyles AW, 2004, NEW ENGL J MED, V351, P963, DOI 10.1056/NEJMoa040595; GELMAN R, 1990, J CLIN ONCOL, V8, P548, DOI 10.1200/JCO.1990.8.3.548; Holli K, 2009, J CLIN ONCOL, V27, P927, DOI 10.1200/JCO.2008.19.7129; Houghton J, 2001, P ASCO, V20, p31a; Houghton J, 2001, P AN M AM SOC CLIN, V20, pA122; Hughes KS, 2004, NEW ENGL J MED, V351, P971, DOI 10.1056/NEJMoa040587; Inoue, 1996, Breast Cancer, V3, P39, DOI 10.1007/BF02966961; LILJEGREN G, 1994, JNCI-J NATL CANCER I, V86, P717, DOI 10.1093/jnci/86.9.717; Malmstrom P, 2003, EUR J CANCER, V39, P1690, DOI 10.1016/S0959-8049(03)00324-1; National Cancer Institute, 1997, PHAS 3 RAND STUD BRE; Potter R, 2007, INT J RADIAT ONCOL, V68, P334, DOI 10.1016/j.ijrobp.2006.12.045; Prescott RJ, 2007, HEALTH TECHNOL ASSES, V11, P1; Romestaing P, 1997, J CLIN ONCOL, V15, P963, DOI 10.1200/JCO.1997.15.3.963; Spooner D, 2009, CANC RES S, V69, pA5125; TSIATIS A, 1975, P NATL ACAD SCI USA, V72, P20, DOI 10.1073/pnas.72.1.20; VERONESI U, 1993, NEW ENGL J MED, V328, P1587, DOI 10.1056/NEJM199306033282202; VERONESI U, 1990, EUR J CANCER, V26, P671, DOI 10.1016/0277-5379(90)90114-9; WHELAN T, 1994, INT J RADIAT ONCOL, V30, P11, DOI 10.1016/0360-3016(94)90513-4; Winzer KJ, 2010, EUR J CANCER, V46, P95, DOI 10.1016/j.ejca.2009.10.007	32	2157	2211	11	72	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 12	2011	378	9804					1707	1716		10.1016/S0140-6736(11)61629-2	http://dx.doi.org/10.1016/S0140-6736(11)61629-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846LB	22019144	Green Accepted, Green Published			2022-12-28	WOS:000296899800028
J	Drew, N; Funk, M; Tang, S; Lamichhane, J; Chavez, E; Katontoka, S; Pathare, S; Lewis, O; Gostin, L; Saraceno, B				Drew, Natalie; Funk, Michelle; Tang, Stephen; Lamichhane, Jagannath; Chavez, Elena; Katontoka, Sylvester; Pathare, Soumitra; Lewis, Oliver; Gostin, Lawrence; Saraceno, Benedetto			Global Mental Health 6 Human rights violations of people with mental and psychosocial disabilities: an unresolved global crisis	LANCET			English	Article							MIDDLE-INCOME COUNTRIES; SOUTH-AFRICA; VOCATIONAL-REHABILITATION; USER INVOLVEMENT; ILLNESS; STIGMA; SERVICES; DISORDERS; ATTITUDES; CARE	This report reviews the evidence for the types of human rights violations experienced by people with mental and psychosocial disabilities in low-income and middle-income countries as well as strategies to prevent these violations and promote human rights in line with the UN Convention on the Rights of Persons with Disabilities (CRPD). The article draws on the views, expertise, and experience of 51 people with mental and psychosocial disabilities from 18 low-income and middle-income countries as well as a review of English language literature including from UN publications, non-governmental organisation reports, press reports, and the academic literature.	[Drew, Natalie; Funk, Michelle] WHO, CH-1211 Geneva, Switzerland; [Tang, Stephen] Australian Natl Univ, Dept Psychol, Canberra, ACT 0200, Australia; [Tang, Stephen] Australian Natl Univ, Coll Law, Canberra, ACT 0200, Australia; [Lamichhane, Jagannath] Nepal Mental Hlth Fdn, Kathmandu, Nepal; [Katontoka, Sylvester] Mental Hlth Users Network Zambia, Lusaka, Zambia; [Pathare, Soumitra] Indian Law Soc, Ctr Mental Hlth Law & Policy, Pune, Maharashtra, India; [Pathare, Soumitra] Ruby Hall Clin, Pune, Maharashtra, India; [Lewis, Oliver] MDAC, Budapest, Hungary; [Gostin, Lawrence] Georgetown Univ, Ctr Law, ONeil Inst Natl & Global Hlth Law, Washington, DC USA; [Saraceno, Benedetto] Univ Geneva, Dept Psychiat, Geneva, Switzerland; [Saraceno, Benedetto] Global Initiat Psychiat, Hilversum, Netherlands	World Health Organization; Australian National University; Australian National University; Georgetown University; University of Geneva	Drew, N (corresponding author), Ave Appia 20, CH-1211 Geneva 27, Switzerland.	drewn@who.int	Tang, Stephen/V-4290-2018	Tang, Stephen/0000-0001-9998-4692; Saraceno, Benedetto/0000-0001-7119-5712; Pathare, Soumitra/0000-0001-9311-9024; Gostin, Lawrence/0000-0001-5286-4044				Adewuya AO, 2008, AUST NZ J PSYCHIAT, V42, P389, DOI 10.1080/00048670801961115; Ae-Ngibise K, 2010, INT REV PSYCHIATR, V22, P558, DOI 10.3109/09540261.2010.536149; Ahern L, 2005, CLOSED DOORS HUMAN R; AHERN L, 2009, HIDDEN SUFFERING ROM; Ahern LR, 2007, TORMENT NOT TREATMEN; *AMN INT, 2002, BULG ARB DET ILL TRE; ANAS AA, 2009, MYJOYONLINE; Angermeyer MC, 2006, ACTA PSYCHIAT SCAND, V113, P163, DOI 10.1111/j.1600-0447.2005.00699.x; [Anonymous], 2009, MENT HLTH SYST SEL L; Bartlett P., 2006, MENTAL DISABILITY EU; BasicNeeds, 2008, MENT HLTH DEV MOD PR; Commission on Social Determinants of Health, 2007, ACH HLTH EQ ROOT CAU; Crawford MJ, 2003, ACTA PSYCHIAT SCAND, V107, P410, DOI 10.1034/j.1600-0447.2003.00049.x; Davidson L, 2009, HDB SERVICE USER INV; DHANDA A, 2007, SYRACUSE J INT LAW C, V34, P429; Dhanda A, 2007, LANCET, V370, P1197, DOI 10.1016/S0140-6736(07)61247-1; *DIS RIGHTS INT CO, 2010, AB DIS MEX SEGR AB C; DOKU V, 2008, PHASE 1 COUNTRY REPO; Eaton J, 2008, SOC PSYCH PSYCH EPID, V43, P552, DOI 10.1007/s00127-008-0321-5; *EUR COMM PREV TOR, 2006, REP TURK GOV VIS TUR, P30; *EUR COMM PREV TOR, 2010, CPT BRIEF; European Court of Human Rights, 2011, FACTSH MENT HLTH; European Union Agency for Fundamental Rights, 2010, RIGHT POL PART PERS; Faydi E, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-17; Fitzsimons S., 2002, J MENTAL HLTH, V11, P481, DOI [10.1080/09638230020023, DOI 10.1080/09638230020023]; Funk M., 2008, INT MENT HLTH PRIM C; Funk M., 2010, MENTAL HLTH DEV TARG; Funk M, 2005, HARVARD HLTH POLICY, V6, P57; FUNK M, 2007, GLOBAL PERSPECTIVE M; FUNK M, 2005, PROMOTING MENTAL HLT; Gabriel P., MENTAL HLTH WORK IMP; Gostin LO, 2008, PUBLIC HEALTH, V122, P906, DOI 10.1016/j.puhe.2007.11.003; Heywood M, 2009, J HUM RIGHTS PRACT, V1, P14, DOI 10.1093/jhuman/hun006; Hugo CJ, 2003, SOC PSYCH PSYCH EPID, V38, P715, DOI 10.1007/s00127-003-0695-3; *IDA CRPD FOR, PRINC IMPL ART 12; ISRAEL BA, 1994, HEALTH EDUC QUART, V21, P149, DOI 10.1177/109019819402100203; Kakuma R, 2010, AFR J PSYCHIATRY, V13, P116; Kapungwe A, 2010, AFR J PSYCHIATRY, V13, P192; Kermode M, 2009, SOC PSYCH PSYCH EPID, V44, P1087, DOI 10.1007/s00127-009-0031-7; Kigozi F, 2010, INT J MENT HEALTH SY, V4, DOI 10.1186/1752-4458-4-1; Knapp M, 2006, HEALTH POLICY PLANN, V21, P157, DOI 10.1093/heapol/czl003; LAMICHHANE J, 2010, GUARDIAN; MENON DK, 2002, ASIA PACIFIC DISABIL; *MENT DIS ADV CTR, WE WORK RUSS; *MENT DIS RIGHTS I, 2004, HUM RIGHTS MENT HLTH; Mental Disability Advocacy Center, 2007, GUARD HUM RIGHTS RUS, P15; Mitchell D, 2001, PRIM HEALTH CARE RES, V2, P107; *NAT I MENT HLTH N, 2008, MENT HLTH CAR HUM RI; Nordt C, 2006, SCHIZOPHRENIA BULL, V32, P709, DOI 10.1093/schbul/sbj065; Open Society Mental Health Initiative, 2006, ACC ED EMPL PEOPL IN; Patel V, 1999, SOC SCI MED, V49, P1461, DOI 10.1016/S0277-9536(99)00208-7; Patel V, 2008, J CHILD PSYCHOL PSYC, V49, P313, DOI 10.1111/j.1469-7610.2007.01824.x; Pinfold V, 2005, INT REV PSYCHIATR, V17, P123, DOI 10.1080/09540260500073638; PRIMANITA A, 2009, JAKARTA GLOBE; Raja S, 2010, INT J MENT HEALTH SY, V4, DOI 10.1186/1752-4458-4-11; Raye K., 1999, VIOLENCE WOMEN MENTA; Read UM, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-13; Roberts H, 2001, LANCET, V357, P1859, DOI 10.1016/S0140-6736(00)05020-0; ROSENTHAL E, 2004, ROLE INT HUMAN RIGHT; SANTEGOEDS J, 2007, ANOTHER WORLD IS POS; Saraceno B, 2007, LANCET, V370, P1164, DOI 10.1016/S0140-6736(07)61263-X; Sartorius N, 2010, NATURE, V468, P163, DOI 10.1038/468163a; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; Saxena Shekhar, 2003, J Ment Health Policy Econ, V6, P135; Sharma S, 2003, CURR OPIN PSYCHIATR, V16, P547, DOI 10.1097/00001504-200309000-00010; Simpson EL, 2002, BRIT MED J, V325, P1265, DOI 10.1136/bmj.325.7375.1265; Skeen S, 2010, INT REV PSYCHIATR, V22, P611, DOI 10.3109/09540261.2010.535510; Stuart H, 2008, WORLD PSYCHIATRY, V7, P185; Sweeney A, 2010, QUALITY ASSURANCE MO; Taylor TL, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-55; Thornicroft G, 2005, EPIDEMIOL PSICHIAT S, V14, P1; Thornicroft G, 2007, BRIT J PSYCHIAT, V190, P192, DOI 10.1192/bjp.bp.106.025791; Trivedi JK, 2007, MENT HEALTH REV J, V12, P22, DOI 10.1108/13619322200700027; Twamley EW, 2003, J NERV MENT DIS, V191, P515, DOI 10.1097/01.nmd.0000082213.42509.69; UN, 2007, HDB PARL CONV RIGHTS; UN General Assembly, 2008, A63175 UN GEN ASS; *UNICEF INN RES CT, 2005, CHILDR DIS TRANS CEE; *WHO, 2009, MENT HLTH POV PROJ P; *WHO, 2005, WHO RES BOOK MENT HL; WHO Regional Office for Europe, 2010, US EMP MENT HLTH STA; World Health Organisation, 2009, MENT HLTH POV DEV; World Health Organization, 2005, MENT HLTH ATL; Yip KS, 2007, ADM POLICY MENT HLTH, V34, P80, DOI 10.1007/s10488-005-0007-1	83	195	197	2	40	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	NOV 5	2011	378	9803					1664	1675		10.1016/S0140-6736(11)61458-X	http://dx.doi.org/10.1016/S0140-6736(11)61458-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	844ST	22008426				2022-12-28	WOS:000296768300032
J	Mintzes, JJ; Canas, A; Coffey, J; Gorman, J; Gurley, L; Hoffman, R; McGuire, SY; Miller, N; Moon, B; Trifone, J; Wandersee, JH				Mintzes, Joel J.; Canas, Alberto; Coffey, John; Gorman, James; Gurley, Laine; Hoffman, Robert; McGuire, Saundra Y.; Miller, Norma; Moon, Brian; Trifone, James; Wandersee, James H.			Comment on "Retrieval Practice Produces More Learning than Elaborative Studying with Concept Mapping"	SCIENCE			English	Editorial Material								Karpicke and Blunt (Reports, 11 February 2011, p. 772) reported that retrieval practice produces greater gains in learning than elaborative studying with concept mapping and concluded that this strategy is a powerful way to promote meaningful learning of complex concepts commonly found in science education. We question their findings on methodological and epistemological grounds.	[Mintzes, Joel J.] Calif State Univ Chico, Dept Biol Sci, Coll Nat Sci, Chico, CA 95929 USA; [Mintzes, Joel J.] Calif State Univ Chico, Dept Sci Educ, Coll Nat Sci, Chico, CA 95929 USA; [Canas, Alberto; Coffey, John; Hoffman, Robert] Univ Florida, Inst Human & Machine Cognit, Pensacola, FL 32502 USA; [Gorman, James] Northbridge High Sch, Whitinsville, MA 01588 USA; [Gurley, Laine] Harper Coll, Palatine, IL 60067 USA; [McGuire, Saundra Y.] Louisiana State Univ, Dept Chem, Baton Rouge, LA 70803 USA; [McGuire, Saundra Y.] Louisiana State Univ, Ctr Acad Success, Baton Rouge, LA 70803 USA; [Miller, Norma] Univ Tecnol Panama, Panama City 2011, Panama; [Moon, Brian] Perigean Technol LLC, Fredericksburg, VA 22401 USA; [Trifone, James] Cheshire High Sch, Cheshire, CT 06410 USA; [Wandersee, James H.] Louisiana State Univ, Coll Educ, Baton Rouge, LA 70803 USA	California State University System; California State University Chico; California State University System; California State University Chico; Florida Institute for Human & Machine Cognition (IHMC); State University System of Florida; University of Florida; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Universidad Tecnologica de Panama; Louisiana State University System; Louisiana State University	Mintzes, JJ (corresponding author), Calif State Univ Chico, Dept Biol Sci, Coll Nat Sci, Chico, CA 95929 USA.	jmintzes@csuchico.edu						Atkinson RC., 1968, PSYCHOL LEARNING MOT, V2, P89, DOI [10.1016/S0079-7421(08)60422-3, DOI 10.1016/S0079-7421(08)60422-3]; AUSUBEL D. P., 1978, ED PSYCHOL COGNITIVE, V2; Gagne R.M., 2004, PRINCIPLES INSTRUCTI, V5th Edn, DOI [10.1002/pfi.4140440211, DOI 10.1002/PFI.4140440211]; Karpicke JD, 2011, SCIENCE, V331, P772, DOI 10.1126/science.1199327; Martin BL, 2000, INT J SCI EDUC, V22, P303, DOI 10.1080/095006900289895; MILLER NL, 2008, CONCEPT MAPPING CONN, V2, P674; Mintzes J.J., 2005, ASSESSING SCI UNDERS; Mintzes JJ, 2005, TEACHING SCI UNDERST; MINTZES JJ, 2008, HDB COLL SCI TEACHIN; Novak J. D, 1984, LEARNING LEARN; Novak J. D., 2010, LEARNING CREATING US; Quinn H.J., 2003, J COLL SCI TEACH, V33, P12; Terry W.S., 2005, LEARNING MEMORY BASI; Vanides J., 2005, SCI SCOPE, V28, P27	14	16	17	3	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 28	2011	334	6055								10.1126/science.1203698	http://dx.doi.org/10.1126/science.1203698			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	837UR	22034416				2022-12-28	WOS:000296230500023
J	Fushinobu, S; Nishimasu, H; Hattori, D; Song, HJ; Wakagi, T				Fushinobu, Shinya; Nishimasu, Hiroshi; Hattori, Daiki; Song, Hyun-Jin; Wakagi, Takayoshi			Structural basis for the bifunctionality of fructose-1,6-bisphosphate aldolase/phosphatase	NATURE			English	Article							ALDOLASE; CATALYSIS; ARCHAEA	Enzymes catalyse specific reactions and are essential for maintaining life. Although some are referred to as being bifunctional, they consist of either two distinct catalytic domains or a single domain that displays promiscuous substrate specificity(1). Thus, one enzyme active site is generally responsible for one biochemical reaction. In contrast to this conventional concept, archaeal fructose-1,6-bisphosphate (FBP) aldolase/phosphatase (FBPA/P) consists of a single catalytic domain, but catalyses two chemically distinct reactions of gluconeogenesis: (1) the reversible aldol condensation of dihydroxyacetone phosphate (DHAP) and glyceraldehyde-3-phosphate (GA3P) to FBP; (2) the dephosphorylation of FBP to fructose-6-phosphate (F6P)(2). Thus, FBPA/P is fundamentally different from ordinary enzymes whose active sites are responsible for a specific reaction. However, the molecular mechanism by which FBPA/P achieves its unusual bifunctionality remains unknown. Here we report the crystal structure of FBPA/P at 1.5-angstrom resolution in the aldolase form, where a critical lysine residue forms a Schiff base with DHAP. A structural comparison of the aldolase form with a previously determined phosphatase form(3) revealed a dramatic conformational change in the active site, demonstrating that FBPA/P metamorphoses its active-site architecture to exhibit dual activities. Thus, our findings expand the conventional concept that one enzyme catalyses one biochemical reaction.	[Fushinobu, Shinya; Hattori, Daiki; Song, Hyun-Jin; Wakagi, Takayoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Nishimasu, Hiroshi] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan	University of Tokyo; University of Tokyo	Wakagi, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	atwakag@mail.ecc.u-tokyo.ac.jp	Fushinobu, Shinya/E-4987-2011; Wakagi, Takayoshi/AAJ-4145-2021	Fushinobu, Shinya/0000-0003-1346-6435; 				Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Choi KH, 2001, BIOCHEMISTRY-US, V40, P13868, DOI 10.1021/bi0114877; Due AV, 2011, P NATL ACAD SCI USA, V108, P3554, DOI 10.1073/pnas.1015996108; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; HUBER R, 1983, BIOPOLYMERS, V22, P261, DOI 10.1002/bip.360220136; Moore BD, 2004, TRENDS PLANT SCI, V9, P221, DOI 10.1016/j.tplants.2004.03.005; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishimasu H, 2004, STRUCTURE, V12, P949, DOI 10.1016/j.str.2004.03.026; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rashid N, 2002, J BIOL CHEM, V277, P30649, DOI 10.1074/jbc.M202868200; Sato T, 2004, J BACTERIOL, V186, P5799, DOI 10.1128/JB.186.17.5799-5807.2004; Say RF, 2010, NATURE, V464, P1077, DOI 10.1038/nature08884; St-Jean M, 2005, J BIOL CHEM, V280, P27262, DOI 10.1074/jbc.M502413200; St-Jean M, 2007, J BIOL CHEM, V282, P31028, DOI 10.1074/jbc.M704968200; Tousignant A, 2004, CHEM BIOL, V11, P1037, DOI 10.1016/j.chembiol.2004.06.007	15	44	52	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 27	2011	478	7370					538	U139		10.1038/nature10457	http://dx.doi.org/10.1038/nature10457			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	21983966				2022-12-28	WOS:000296194200048
J	Lindblad-Toh, K; Garber, M; Zuk, O; Lin, MF; Parker, BJ; Washietl, S; Kheradpour, P; Ernst, J; Jordan, G; Mauceli, E; Ward, LD; Lowe, CB; Holloway, AK; Clamp, M; Gnerre, S; Alfoldi, J; Beal, K; Chang, J; Clawson, H; Cuff, J; Di Palma, F; Fitzgerald, S; Flicek, P; Guttman, M; Hubisz, MJ; Jaffe, DB; Jungreis, I; Kent, WJ; Kostka, D; Lara, M; Martins, AL; Massingham, T; Moltke, I; Raney, BJ; Rasmussen, MD; Robinson, J; Stark, A; Vilella, AJ; Wen, JY; Xie, XH; Zody, MC; Worley, KC; Kovar, CL; Muzny, DM; Gibbs, RA; Warren, WC; Mardis, ER; Weinstock, GM; Wilson, RK; Birney, E; Margulies, EH; Herrero, J; Green, ED; Haussler, D; Siepel, A; Goldman, N; Pollard, KS; Pedersen, JS; Lander, ES; Kellis, M				Lindblad-Toh, Kerstin; Garber, Manuel; Zuk, Or; Lin, Michael F.; Parker, Brian J.; Washietl, Stefan; Kheradpour, Pouya; Ernst, Jason; Jordan, Gregory; Mauceli, Evan; Ward, Lucas D.; Lowe, Craig B.; Holloway, Alisha K.; Clamp, Michele; Gnerre, Sante; Alfoeldi, Jessica; Beal, Kathryn; Chang, Jean; Clawson, Hiram; Cuff, James; Di Palma, Federica; Fitzgerald, Stephen; Flicek, Paul; Guttman, Mitchell; Hubisz, Melissa J.; Jaffe, David B.; Jungreis, Irwin; Kent, W. James; Kostka, Dennis; Lara, Marcia; Martins, Andre L.; Massingham, Tim; Moltke, Ida; Raney, Brian J.; Rasmussen, Matthew D.; Robinson, Jim; Stark, Alexander; Vilella, Albert J.; Wen, Jiayu; Xie, Xiaohui; Zody, Michael C.; Worley, Kim C.; Kovar, Christie L.; Muzny, Donna M.; Gibbs, Richard A.; Warren, Wesley C.; Mardis, Elaine R.; Weinstock, George M.; Wilson, Richard K.; Birney, Ewan; Margulies, Elliott H.; Herrero, Javier; Green, Eric D.; Haussler, David; Siepel, Adam; Goldman, Nick; Pollard, Katherine S.; Pedersen, Jakob S.; Lander, Eric S.; Kellis, Manolis		Broad Inst; Baylor Coll Med; Washington Univ	A high-resolution map of human evolutionary constraint using 29 mammals	NATURE			English	Article							RELIABLE PREDICTION; GENOME SEQUENCE; CODING SEQUENCE; DISCOVERY; ELEMENTS; REVEALS; GENE; EXPRESSION; SELECTION; DYNAMICS	The comparison of related genomes has emerged as a powerful lens for genome interpretation. Here we report the sequencing and comparative analysis of 29 eutherian genomes. We confirm that at least 5.5% of the human genome has undergone purifying selection, and locate constrained elements covering similar to 4.2% of the genome. We use evolutionary signatures and comparisons with experimental data sets to suggest candidate functions for similar to 60% of constrained bases. These elements reveal a small number of new coding exons, candidate stop codon readthrough events and over 10,000 regions of overlapping synonymous constraint within protein-coding exons. We find 220 candidate RNA structural families, and nearly a million elements overlapping potential promoter, enhancer and insulator regions. We report specific amino acid residues that have undergone positive selection, 280,000 non-coding elements exapted from mobile elements and more than 1,000 primate-and human-accelerated elements. Overlap with disease-associated variants indicates that our findings will be relevant for studies of human biology, health and disease.	[Lindblad-Toh, Kerstin; Garber, Manuel; Zuk, Or; Lin, Michael F.; Kheradpour, Pouya; Ernst, Jason; Mauceli, Evan; Ward, Lucas D.; Clamp, Michele; Gnerre, Sante; Alfoeldi, Jessica; Chang, Jean; Di Palma, Federica; Guttman, Mitchell; Jaffe, David B.; Lara, Marcia; Robinson, Jim; Xie, Xiaohui; Zody, Michael C.; Lander, Eric S.; Kellis, Manolis] Broad Inst Harvard & Massachusetts Inst Technol M, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, SE-75123 Uppsala, Sweden; [Lin, Michael F.; Washietl, Stefan; Kheradpour, Pouya; Ernst, Jason; Ward, Lucas D.; Jungreis, Irwin; Rasmussen, Matthew D.; Kellis, Manolis] MIT Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Parker, Brian J.; Moltke, Ida; Wen, Jiayu; Pedersen, Jakob S.] Univ Copenhagen, Dept Biol, Bioinformat Ctr, DK-2200 Copenhagen, Denmark; [Jordan, Gregory; Beal, Kathryn; Fitzgerald, Stephen; Flicek, Paul; Massingham, Tim; Vilella, Albert J.; Birney, Ewan; Herrero, Javier; Goldman, Nick] EMBL EBI, Hinxton CB10 1SD, England; [Lowe, Craig B.; Clawson, Hiram; Raney, Brian J.; Haussler, David] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Lowe, Craig B.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Lowe, Craig B.; Haussler, David] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Holloway, Alisha K.; Kent, W. James; Kostka, Dennis; Pollard, Katherine S.] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94158 USA; [Clamp, Michele] BioTeam Inc, Middleton, MA 01949 USA; [Cuff, James] Harvard Univ, Fac Arts & Sci, Div Sci, Cambridge, MA 02138 USA; [Hubisz, Melissa J.; Martins, Andre L.; Siepel, Adam] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Stark, Alexander] Res Inst Mol Pathol IMP, A-1030 Vienna, Austria; [Worley, Kim C.; Kovar, Christie L.; Muzny, Donna M.; Gibbs, Richard A.; Weinstock, George M.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Warren, Wesley C.; Mardis, Elaine R.; Weinstock, George M.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63108 USA; [Margulies, Elliott H.] NHGRI, Genome Informat Sect, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Green, Eric D.] NHGRI, NISC Comparat Sequencing Program, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Green, Eric D.] NHGRI, NIH Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94158 USA; [Pollard, Katherine S.] Univ Calif San Francisco, Div Biostat, San Francisco, CA 94158 USA; [Pedersen, Jakob S.] Aarhus Univ Hosp, Dept Mol Med MOMA, DK-8200 Aarhus N, Denmark	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Uppsala University; Massachusetts Institute of Technology (MIT); University of Copenhagen; European Molecular Biology Laboratory (EMBL); University of California System; University of California Santa Cruz; Stanford University; Howard Hughes Medical Institute; University of California System; University of California San Francisco; The J David Gladstone Institutes; Harvard University; Cornell University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Baylor College of Medicine; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of California System; University of California San Francisco; University of California System; University of California San Francisco; Aarhus University	Lindblad-Toh, K (corresponding author), Broad Inst Harvard & Massachusetts Inst Technol M, Cambridge Ctr 7, Cambridge, MA 02142 USA.	kersli@broadinstitute.org; lander@broadinstitute.org; manoli@mit.edu	Kellis, Manolis/ABE-7385-2020; Wen, Jiayu/R-1673-2017; Moltke, Ida/C-6158-2011; Wilson, Richard K./AAF-4139-2019; Herrero, Javier/H-6971-2019; Stark, Alexander/D-1473-2012; Pedersen, Jakob/G-3382-2012; Mardis, Elaine/W-2202-2019; Raney, Brian/ABE-6267-2020; Holloway, Alisha/H-9574-2013; Clawson, Hiram/ABE-6101-2020; Weinstock, George M/C-6314-2013	Kellis, Manolis/0000-0001-7113-9630; Wen, Jiayu/0000-0003-1249-6456; Moltke, Ida/0000-0001-7052-8554; Wilson, Richard K./0000-0002-1992-1358; Herrero, Javier/0000-0001-7313-717X; Stark, Alexander/0000-0003-2611-0841; Pedersen, Jakob/0000-0002-7236-4001; Holloway, Alisha/0000-0001-9810-389X; Weinstock, George M/0000-0002-2997-4592; Jordan, Gregory/0000-0002-7655-6000; Xie, Xiaohui/0000-0002-5479-6345; Birney, Ewan/0000-0001-8314-8497; Siepel, Adam/0000-0002-3557-7219; Cuff, James/0000-0003-0570-4106; Goldman, Nick/0000-0001-8486-2211; Flicek, Paul/0000-0002-3897-7955; Vilella, Albert/0000-0002-2005-2516; Hubisz, Melissa/0000-0002-9561-6830; Di-Palma, Federica/0000-0002-4394-0102; Clawson, Hiram/0000-0002-0480-0545; Worley, Kim/0000-0002-0282-1000; Nicol, Robert/0000-0003-1932-1392; Ward, Lucas/0000-0002-8017-809X; Heiman, David/0000-0001-7895-4259; Parker, Brian/0000-0002-5193-6867	National Human Genome Research Institute (NHGRI) [U54 HG003273]; National Institute for General Medicine (NIGMS) [GM82901]; European Science Foundation; NSF National Science Foundation (NSF) [0905968, 0644282]; NIH [R01 HG004037]; Sloan Foundation; Austrian Fonds zur Forderung der Wissenschaftlichen Forschung; Gates Cambridge Trust; Novo Nordisk Foundation; Department of Mathematical Sciences, University of Copenhagen; David and Lucile Packard Foundation; Danish Council for Independent Research Medical Sciences; Lundbeck Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003474, U54HG003273, U54HG003067, R01HG004037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082901] Funding Source: NIH RePORTER; Lundbeck Foundation [R5-2006-123] Funding Source: researchfish	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute for General Medicine (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); European Science Foundation(European Science Foundation (ESF)European Commission); NSF National Science Foundation (NSF)(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Foundation(Alfred P. Sloan Foundation); Austrian Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Gates Cambridge Trust; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Department of Mathematical Sciences, University of Copenhagen; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Danish Council for Independent Research Medical Sciences(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Lundbeck Foundation(Lundbeckfonden)	We thank O. Ryder, E. Fuchs, D. Haring, A. Walsh, D. Duffield, S. Wong, T. Alvarado, J. Boylan, S. Combes, P. deJong, J. Allman, J. Patton, D. McMullen, D. Hafner, D. Miller, T. Kunz, G. Hewitt, J. Searle, H. Kunzle and D. Williams for providing organismal material. We thank L. Gaffney for help with figures. This work was supported by the National Human Genome Research Institute (NHGRI), including grant U54 HG003273 (R. A. G.), National Institute for General Medicine (NIGMS) grant no. GM82901 (Pollard laboratory) and the European Science Foundation (EURYI award to K.L.-T.), NSF National Science Foundation (NSF) postdoctoral fellowship award 0905968 (J.E.), National Science Foundation CAREER 0644282 and NIH R01 HG004037 and the Sloan Foundation (M. K.), and an Erwin Schrodinger Fellowship of the Austrian Fonds zur Forderung der Wissenschaftlichen Forschung (S. W.), the Gates Cambridge Trust (G.J.), Novo Nordisk Foundation (B.J.P. and J.W.); a Statistics Network Fellowship, Department of Mathematical Sciences, University of Copenhagen (B.J.P.); the David and Lucile Packard Foundation (A. S.); the Danish Council for Independent Research Medical Sciences (J.S.P.); The Lundbeck Foundation (J.S.P.).	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baek D, 2007, GENOME RES, V17, P145, DOI 10.1101/gr.5872707; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Chiaromonte F, 2003, COLD SPRING HARB SYM, V68, P245, DOI 10.1101/sqb.2003.68.245; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Cooper GM, 2003, GENOME RES, V13, P813, DOI 10.1101/gr.1064503; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gnerre S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r88; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Hubisz MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017034; Jungreis I, 2011, GENOME RES, V21, P2096, DOI 10.1101/gr.119974.110; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kheradpour P, 2007, GENOME RES, V17, P1919, DOI 10.1101/gr.7090407; Lampe X, 2008, NUCLEIC ACIDS RES, V36, P3214, DOI 10.1093/nar/gkn148; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Lin MF, 2007, GENOME RES, V17, P1823, DOI 10.1101/gr.6679507; Lin MF, 2011, GENOME RES, V21, P1916, DOI 10.1101/gr.108753.110; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Maenner S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000276; Martinez-Chantar ML, 2003, J BIOL CHEM, V278, P19885, DOI 10.1074/jbc.M211554200; Meader S, 2010, GENOME RES, V20, P1335, DOI 10.1101/gr.108795.110; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Parker BJ, 2011, GENOME RES, V21, P1929, DOI 10.1101/gr.112516.110; Pedersen JS, 2006, PLOS COMPUT BIOL, V2, P251, DOI 10.1371/journal.pcbi.0020033; Pillas D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000856; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Prabhakar S, 2008, SCIENCE, V321, P1346, DOI 10.1126/science.1159974; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Siepel A, 2007, GENOME RES, V17, P1763, DOI 10.1101/gr.7128207; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Tumpel S, 2008, P NATL ACAD SCI USA, V105, P20077, DOI 10.1073/pnas.0806360105; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	50	727	769	2	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2011	478	7370					476	482		10.1038/nature10530	http://dx.doi.org/10.1038/nature10530			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	21993624	Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000296194200035
J	Nussenzweig, MC; Mellman, I				Nussenzweig, Michel C.; Mellman, Ira			Ralph Steinman (1943-2011) OBITUARY	NATURE			English	Biographical-Item									[Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY USA; [Mellman, Ira] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Mellman, Ira] Genentech Inc, San Francisco, CA 94080 USA	Howard Hughes Medical Institute; Rockefeller University; University of California System; University of California San Francisco; Roche Holding; Genentech	Nussenzweig, MC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY USA.	nussen@mail.rockefeller.edu; mellman.ira@gene.com	Nussenzweig, Michel/AAE-7292-2019; Mellman, Ira/ABG-5896-2020						0	7	7	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 27	2011	478	7370					460	460		10.1038/478460a	http://dx.doi.org/10.1038/478460a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	22031432	Bronze			2022-12-28	WOS:000296194200026
J	Kocher, RP; Adashi, EY				Kocher, Robert P.; Adashi, Eli Y.			Hospital Readmissions and the Affordable Care Act Paying for Coordinated Quality Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02905 USA; [Kocher, Robert P.] Brookings Inst, Washington, DC 20036 USA	Brown University; Brookings Institution	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, 101 Dudley St, Providence, RI 02905 USA.	Eli_Adashi@brown.edu						Centers for Medicare and Medicaid Services, 2011, MED DEM DET COMM BAS; Centers for Medicare & Medicaid Services, FY 2012 IPPS PROP RU; Centers for Medicare & Medicaid Services, 2011, MED DEM IND HOM DEM; Centers for Medicare & Medicaid Services, 2011, CMS LAUNCH TOOLS IN; HealthCare, 2011, REP C NAT STRAT QUAL; Jencks SF, 2010, ANN INTERN MED, V153, P757, DOI 10.7326/0003-4819-153-11-201012070-00010; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Medicare Payment Advisory Commission, 2011, REP C ENH MED TECHN; US Department of Health and Human Services, STRAT PLA 2010 2015; USAID, 2011, WOM WAT WAT ALL CAMP	10	362	363	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 26	2011	306	16					1794	1795		10.1001/jama.2011.1561	http://dx.doi.org/10.1001/jama.2011.1561			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HH	22028355				2022-12-28	WOS:000296181600024
J	Mets, OM; Buckens, CFM; Zanen, P; Isgum, I; van Ginneken, B; Prokop, M; Gietema, HA; Lammers, JWJ; Vliegenthart, R; Oudkerk, M; van Klaveren, RJ; de Koning, HJ; Mali, WPTM; de Jong, PA				Mets, Onno M.; Buckens, Constantinus F. M.; Zanen, Pieter; Isgum, Ivana; van Ginneken, Bram; Prokop, Mathias; Gietema, Hester A.; Lammers, Jan-Willem J.; Vliegenthart, Rozemarijn; Oudkerk, Matthijs; van Klaveren, Rob J.; de Koning, Harry J.; Mali, Willem P. Th M.; de Jong, Pim A.			Identification of Chronic Obstructive Pulmonary Disease in Lung Cancer Screening Computed Tomographic Scans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COPD; DIAGNOSIS; MORTALITY	Context Smoking is a major risk factor for both cancer and chronic obstructive pulmonary disease (COPD). Computed tomography (CT)-based lung cancer screening may provide an opportunity to detect additional individuals with COPD at an early stage. Objective To determine whether low-dose lung cancer screening CT scans can be used to identify participants with COPD. Design, Setting, and Patients Single-center prospective cross-sectional study within an ongoing lung cancer screening trial. Prebronchodilator pulmonary function testing with inspiratory and expiratory CT on the same day was obtained from 1140 male participants between July 2007 and September 2008. Computed tomographic emphysema was defined as percentage of voxels less than -950 Hounsfield units (HU), and CT air trapping was defined as the expiratory: inspiratory ratio of mean lung density. Chronic obstructive pulmonary disease was defined as the ratio of forced expiratory volume in the first second to forced vital capacity (FEV1/FVC) of less than 70%. Logistic regression was used to develop a diagnostic prediction model for airflow limitation. Main Outcome Measures Diagnostic accuracy of COPD diagnosis using pulmonary function tests as the reference standard. Results Four hundred thirty-seven participants (38%) had COPD according to lung function testing. A diagnostic model with CT emphysema, CT air trapping, body mass index, pack-years, and smoking status corrected for overoptimism (internal validation) yielded an area under the receiver operating characteristic curve of 0.83 (95% CI, 0.81-0.86). Using the point of optimal accuracy, the model identified 274 participants with COPD with 85 false-positives, a sensitivity of 63% (95% CI, 58%-67%), specificity of 88% (95% CI, 85%-90%), positive predictive value of 76% (95% CI, 72%-81%); and negative predictive value of 79% (95% CI, 76%-82%). The diagnostic model showed an area under the receiver operating characteristic curve of 0.87 (95% CI, 0.86-0.88) for participants with symptoms and 0.78 (95% CI, 0.76-0.80) for those without symptoms. Conclusion Among men who are current and former heavy smokers, low-dose inspiratory and expiratory CT scans obtained for lung cancer screening can identify participants with COPD, with a sensitivity of 63% and a specificity of 88%. JAMA. 2011;306(16):1775-1781	[Mets, Onno M.; Prokop, Mathias; Gietema, Hester A.; Mali, Willem P. Th M.; de Jong, Pim A.] Univ Med Ctr Utrecht, Dept Radiol, NL-3508 GA Utrecht, Netherlands; [Buckens, Constantinus F. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Zanen, Pieter; Lammers, Jan-Willem J.] Univ Med Ctr Utrecht, Dept Pulmonol, NL-3508 GA Utrecht, Netherlands; [Isgum, Ivana; van Ginneken, Bram] Univ Med Ctr Utrecht, Image Sci Inst, NL-3508 GA Utrecht, Netherlands; [van Ginneken, Bram] Radboud Univ Nijmegen, Med Ctr, Diagnost Image Anal Grp, NL-6525 ED Nijmegen, Netherlands; [Prokop, Mathias] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6525 ED Nijmegen, Netherlands; [Vliegenthart, Rozemarijn; Oudkerk, Matthijs] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, NL-9713 AV Groningen, Netherlands; [van Klaveren, Rob J.] Lievensberg Ziekenhuis, Dept Pulmonol, Bergen Op Zoom, Netherlands; [de Koning, Harry J.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen; Erasmus University Rotterdam; Erasmus MC	Mets, OM (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Heidelberglaan 100,Postbus 85500, NL-3508 GA Utrecht, Netherlands.	o.m.mets@umcutrecht.nl	de+Koning, Harry/AAF-9062-2019; van Ginneken, Bram/A-3728-2012; Prokop, W.M./H-8081-2014; Mali, Willem PThM/I-1123-2014; Isgum, Ivana/H-8659-2014; de Jong, Pim A/G-7220-2014	de+Koning, Harry/0000-0003-4682-3646; van Ginneken, Bram/0000-0003-2028-8972; Mali, Willem PThM/0000-0003-4391-0904; Isgum, Ivana/0000-0003-1869-5034; de Jong, Pim A/0000-0003-4840-6854; Prokop, Mathias/0000-0001-8157-8055; zanen, pieter/0000-0002-5318-8276; Oudkerk, Matthijs/0000-0003-2800-4110	Netherlands Organisation for Health Research and Development; Dutch Cancer Society Koningin Wilhelmina Fonds; Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen; Siemens Germany; Rotterdam Oncologic Thoracic Steering Committee; G.Ph. Verhagen Trust; Flemish League Against Cancer; Foundation Against Cancer; Erasmus Trust	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Dutch Cancer Society Koningin Wilhelmina Fonds(KWF Kankerbestrijding); Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen; Siemens Germany(Siemens AG); Rotterdam Oncologic Thoracic Steering Committee; G.Ph. Verhagen Trust; Flemish League Against Cancer; Foundation Against Cancer; Erasmus Trust	The NELSON-trial was supported by the Netherlands Organisation for Health Research and Development; Dutch Cancer Society Koningin Wilhelmina Fonds; Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen; Siemens Germany; Rotterdam Oncologic Thoracic Steering Committee; and the G.Ph. Verhagen Trust, Flemish League Against Cancer, Foundation Against Cancer, and Erasmus Trust Fund.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Bednarek M, 2008, THORAX, V63, P402, DOI 10.1136/thx.2007.085456; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Cohen J., 2002, APPL MULTIPLE REGRES, V3rd, DOI 10.4324/9780203774441; Decramer M, 2011, EUR RESPIR J, V37, P738, DOI 10.1183/09031936.00020211; Decramer M, 2010, THORAX, V65, P837, DOI 10.1136/thx.2009.133355; Efron B., 1994, MONOGRAPHS STAT APPL; Gevenois PA, 1996, AM J RESP CRIT CARE, V154, P187, DOI 10.1164/ajrccm.154.1.8680679; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Henschke CI, 2011, J THORAC IMAG, V26, P5, DOI 10.1097/RTI.0b013e31820bada2; Kubo K, 1999, EUR RESPIR J, V13, P252, DOI 10.1034/j.1399-3003.1999.13b06.x; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Matsuoka S, 2008, AM J ROENTGENOL, V190, P762, DOI 10.2214/AJR.07.2820; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Newell J D Jr, 2004, Eur Respir J, V23, P769, DOI 10.1183/09031936.04.00026504; O'Donnell RA, 2004, THORAX, V59, P837, DOI 10.1136/thx.2003.019349; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Scanlon PD, 2000, AM J RESP CRIT CARE, V161, P381, DOI 10.1164/ajrccm.161.2.9901044; Schilham AMR, 2006, IEEE T MED IMAGING, V25, P451, DOI 10.1109/TMI.2006.871545; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Soriano JB, 2009, LANCET, V374, P721, DOI 10.1016/S0140-6736(09)61290-3; Steyerberg E., 2009, CLIN PREDICTION MODE; van Iersel CA, 2007, INT J CANCER, V120, P868, DOI 10.1002/ijc.22134; van Klaveren RJ, 2011, J THORAC IMAG, V26, P4, DOI 10.1097/RTI.0b013e31820badb3; van Rikxoort EM, 2009, MED PHYS, V36, P2934, DOI 10.1118/1.3147146	30	109	114	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 26	2011	306	16					1775	1781		10.1001/jama.2011.1531	http://dx.doi.org/10.1001/jama.2011.1531			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HH	22028353	Green Published, Bronze			2022-12-28	WOS:000296181600022
J	Richards, M				Richards, Mike			BREAST CANCER SCREENING An independent review is under way	BRITISH MEDICAL JOURNAL			English	Editorial Material									Dept Hlth, London SE1 6TE, England		Richards, M (corresponding author), Dept Hlth, London SE1 6TE, England.	Mike.Richards@ncat.nhs.uk						Advisory Committee on Breast Cancer Screening, 2006, J MED SCREEN, V13, P59; Duffy SW, 2010, J MED SCREEN, V17, P25, DOI 10.1258/jms.2009.009094; *INT AG RES CANC, 2002, EFF SCREEN BREAST CA, P119	3	38	39	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 25	2011	343								d6843	10.1136/bmj.d6843	http://dx.doi.org/10.1136/bmj.d6843			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	840CW	22028483				2022-12-28	WOS:000296416900009
J	Akhaddar, A; Boucetta, M				Akhaddar, Ali; Boucetta, Mohamed			Multiple Intracranial Tuberculomas	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Akhaddar, Ali; Boucetta, Mohamed] Mohammed V Mil Teaching Hosp, Rabat, Morocco	Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat	Akhaddar, A (corresponding author), Mohammed V Mil Teaching Hosp, Rabat, Morocco.		Akhaddar, Ali/B-1107-2011; Akhaddar, Ali/Q-9152-2019	Akhaddar, Ali/0000-0001-5743-2777; 					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2011	365	16					1527	1527		10.1056/NEJMicm1103165	http://dx.doi.org/10.1056/NEJMicm1103165			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835BW	22010919				2022-12-28	WOS:000296009500007
J	Chung, WJ; Oh, JW; Kwak, K; Lee, BY; Meyer, J; Wang, E; Hexemer, A; Lee, SW				Chung, Woo-Jae; Oh, Jin-Woo; Kwak, Kyungwon; Lee, Byung Yang; Meyer, Joel; Wang, Eddie; Hexemer, Alexander; Lee, Seung-Wuk			Biomimetic self-templating supramolecular structures	NATURE			English	Article							DERMAL COLLAGEN ARRAYS; CONVERGENT EVOLUTION; LIQUID-CRYSTALS; PHASE; BIOMATERIALS; COLORATION; PROTEIN; SKIN	In nature, helical macromolecules such as collagen, chitin and cellulose are critical to the morphogenesis and functionality of various hierarchically structured materials(1-3). During tissue formation, these chiral macromolecules are secreted and undergo self-templating assembly, a process whereby multiple kinetic factors influence the assembly of the incoming building blocks to produce non-equilibrium structures(1,4). A single macromolecule can form diverse functional structures when self-templated under different conditions. Collagen type I, for instance, forms transparent corneal tissues from orthogonally aligned nematic fibres(5), distinctively coloured skin tissues from cholesteric phase fibre bundles(6,7), and mineralized tissues from hierarchically organized fibres(8). Nature's self-templated materials surpass the functional and structural complexity achievable by current top-down and bottom-up fabrication methods(9-12). However, self-templating has not been thoroughly explored for engineering synthetic materials. Here we demonstrate the biomimetic, self-templating assembly of chiral colloidal particles (M13 phage) into functional materials. A single-step process produces long-range-ordered, supramolecular films showing multiple levels of hierarchical organization and helical twist. Three distinct supramolecular structures are created by this approach: nematic orthogonal twists, cholesteric helical ribbons and smectic helicolidal nanofilaments. Both chiral liquid crystalline phase transitions and competing interfacial forces at the interface are found to be critical factors in determining the morphology of the templated structures during assembly. The resulting materials show distinctive optical and photonic properties, functioning as chiral reflector/filters and structural colour matrices. In addition, M13 phages with genetically incorporated bioactive peptide ligands direct both soft and hard tissue growth in a hierarchically organized manner. Our assembly approach provides insight into the complexities of hierarchical assembly in nature and could be expanded to other chiral molecules to engineer sophisticated functional helical-twisted structures.	[Chung, Woo-Jae; Oh, Jin-Woo; Kwak, Kyungwon; Lee, Byung Yang; Meyer, Joel; Wang, Eddie; Lee, Seung-Wuk] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Chung, Woo-Jae; Oh, Jin-Woo; Kwak, Kyungwon; Lee, Byung Yang; Meyer, Joel; Wang, Eddie; Lee, Seung-Wuk] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Hexemer, Alexander] Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Lee, SW (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	leesw@berkeley.edu	Lee, Seung-Wuk/AAS-3031-2020; Kwak, Kyungwon/D-8046-2015	Lee, Byung Yang/0000-0003-0125-2501; Wang, Eddie/0000-0002-9814-0102; Hexemer, Alexander/0000-0002-5269-0125	National Science Foundation [DMR-0747713]; Center of Integrated Nanomechanical Systems (COINS) of the National Science Foundation [EEC-0832819]; National Institute of Dental and Craniofacial Research [R21DE018360]; Defense Advanced Research Projects Agency (DARPA); Nanoscience and Nanotechnology Institute at the University of California, Berkeley; Lawrence Berkeley National Laboratory; Korea Research Foundation; Korean government (MOEHRD) [KRF-2006-352-D00048]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE018360] Funding Source: NIH RePORTER; Division Of Materials Research [0747713] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Center of Integrated Nanomechanical Systems (COINS) of the National Science Foundation; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Nanoscience and Nanotechnology Institute at the University of California, Berkeley; Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Korea Research Foundation(National Research Foundation of Korea); Korean government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the National Science Foundation Early Career Development Award (DMR-0747713), the Center of Integrated Nanomechanical Systems (COINS) of the National Science Foundation (grant no. EEC-0832819), the National Institute of Dental and Craniofacial Research (R21DE018360), the Defense Advanced Research Projects Agency (DARPA) program on Tip-Based Nanofabrication (TBN), start-up funds from the Nanoscience and Nanotechnology Institute at the University of California, Berkeley, the Laboratory Directed Research and Development fund from the Lawrence Berkeley National Laboratory, and the Korea Research Foundation Grant (to W.J.C.) funded by the Korean government (MOEHRD) (KRF-2006-352-D00048).	Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; Bawden FC, 1936, NATURE, V138, P1051, DOI 10.1038/1381051a0; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Capito RM, 2008, SCIENCE, V319, P1812, DOI 10.1126/science.1154586; De Gennes, 1995, PHYS LIQUID CRYSTALS; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; Dogic Z, 2000, LANGMUIR, V16, P7820, DOI 10.1021/la000446t; Dogic Z, 1997, PHYS REV LETT, V78, P2417, DOI 10.1103/PhysRevLett.78.2417; Douglas T, 1998, NATURE, V393, P152, DOI 10.1038/30211; GIRAUD MM, 1978, TISSUE CELL, V10, P671, DOI 10.1016/0040-8166(78)90054-X; He T, 2010, SMALL, V6, P2230, DOI 10.1002/smll.201001108; Holmes DF, 2001, P NATL ACAD SCI USA, V98, P7307, DOI 10.1073/pnas.111150598; Lanfer B, 2009, BIOMATERIALS, V30, P5950, DOI 10.1016/j.biomaterials.2009.07.039; Lee SW, 2003, LANGMUIR, V19, P1592, DOI 10.1021/la026387w; Lee SW, 2002, SCIENCE, V296, P892, DOI 10.1126/science.1068054; LEFORESTIER A, 1991, BIOL CELL, V71, P115, DOI 10.1016/0248-4900(91)90058-U; Merzlyak A, 2009, NANO LETT, V9, P846, DOI 10.1021/nl8036728; Nam KT, 2006, SCIENCE, V312, P885, DOI 10.1126/science.1122716; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Neville A. C., 1993, BIOL FIBROUS COMPOSI; Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]; Prum RO, 2004, J EXP BIOL, V207, P2157, DOI 10.1242/jeb.00989; Prum RO, 2003, J EXP BIOL, V206, P2409, DOI 10.1242/jeb.00431; RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X; Sharma V, 2009, SCIENCE, V325, P449, DOI 10.1126/science.1172051; Smalyukh II, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.177801; Smalyukh II, 2010, NAT MATER, V9, P139, DOI [10.1038/NMAT2592, 10.1038/nmat2592]; Stewart GT, 2003, LIQ CRYST, V30, P541, DOI 10.1080/0267829031000097457; Tamaoki N, 2001, ADV MATER, V13, P1135, DOI 10.1002/1521-4095(200108)13:15<1135::AID-ADMA1135>3.0.CO;2-S; Weiner S, 1999, J STRUCT BIOL, V126, P241, DOI 10.1006/jsbi.1999.4107; Wu LY, 2011, J MATER CHEM, V21, P8550, DOI 10.1039/c1jm00078k; Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874	33	329	342	12	680	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 20	2011	478	7369					364	368		10.1038/nature10513	http://dx.doi.org/10.1038/nature10513			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	22012394				2022-12-28	WOS:000296021100041
J	Sheikh, A; Cornford, T; Barber, N; Avery, A; Takian, A; Lichtner, V; Petrakaki, D; Crowe, S; Marsden, K; Robertson, A; Morrison, Z; Klecun, E; Prescott, R; Quinn, C; Jani, Y; Ficociello, M; Voutsina, K; Paton, J; Fernando, B; Jacklin, A; Cresswell, K				Sheikh, Aziz; Cornford, Tony; Barber, Nicholas; Avery, Anthony; Takian, Amirhossein; Lichtner, Valentina; Petrakaki, Dimitra; Crowe, Sarah; Marsden, Kate; Robertson, Ann; Morrison, Zoe; Klecun, Ela; Prescott, Robin; Quinn, Casey; Jani, Yogini; Ficociello, Maryam; Voutsina, Katerina; Paton, James; Fernando, Bernard; Jacklin, Ann; Cresswell, Kathrin			Implementation and adoption of nationwide electronic health records in secondary care in England: final qualitative results from prospective national evaluation in "early adopter" hospitals	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFORMATION-TECHNOLOGY; MEDICAL-RECORD; MEANINGFUL USE; SYSTEM; EXPERIENCE; FRAMEWORK; LESSONS; ORGANIZATIONS; MASSACHUSETTS; CHALLENGES	Objectives To evaluate the implementation and adoption of the NHS detailed care records service in "early adopter" hospitals in England. Design Theoretically informed, longitudinal qualitative evaluation based on case studies. Setting 12 "early adopter" NHS acute hospitals and specialist care settings studied over two and a half years. Data sources Data were collected through in depth interviews, observations, and relevant documents relating directly to case study sites and to wider national developments that were perceived to impact on the implementation strategy. Data were thematically analysed, initially within and then across cases. The dataset consisted of 431 semistructured interviews with key stakeholders, including hospital staff, developers, and governmental stakeholders; 590 hours of observations of strategic meetings and use of the software in context; 334 sets of notes from observations, researchers' field notes, and notes from national conferences; 809 NHS documents; and 58 regional and national documents. Results Implementation has proceeded more slowly, with a narrower scope and substantially less clinical functionality than was originally planned. The national strategy had considerable local consequences (summarised under five key themes), and wider national developments impacted heavily on implementation and adoption. More specifically, delays related to unrealistic expectations about the capabilities of systems; the time needed to build, configure, and customise the software; the work needed to ensure that systems were supporting provision of care; and the needs of end users for training and support. Other factors hampering progress included the changing milieu of NHS policy and priorities; repeatedly renegotiated national contracts; different stages of development of diverse NHS care records service systems; and a complex communication process between different stakeholders, along with contractual arrangements that largely excluded NHS providers. There was early evidence that deploying systems resulted in important learning within and between organisations and the development of relevant competencies within NHS hospitals. Conclusions Implementation of the NHS Care Records Service in "early adopter" sites proved time consuming and challenging, with as yet limited discernible benefits for clinicians and no clear advantages for patients. Although our results might not be directly transferable to later adopting sites because the functionalities we evaluated were new and untried in the English context, they shed light on the processes involved in implementing major new systems. The move to increased local decision making that we advocated based on our interim analysis has been pursued and welcomed by the NHS, but it is important that policymakers do not lose sight of the overall goal of an integrated interoperable solution.	[Sheikh, Aziz; Robertson, Ann; Morrison, Zoe; Prescott, Robin; Fernando, Bernard; Cresswell, Kathrin] Univ Edinburgh, Ctr Populat Hlth Sci, Ehlth Res Grp, Edinburgh EH8 9DX, Midlothian, Scotland; [Cornford, Tony; Lichtner, Valentina; Klecun, Ela; Voutsina, Katerina] Univ London London Sch Econ & Polit Sci, Dept Management, London WC2A 2AE, England; [Barber, Nicholas; Takian, Amirhossein; Jani, Yogini] Univ London, Sch Pharm, Dept Practice & Policy, London WC1N 1AX, England; [Avery, Anthony; Crowe, Sarah; Marsden, Kate; Quinn, Casey] Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England; [Petrakaki, Dimitra] Univ Sussex, Dept Business & Management, Brighton BN1 9QF, E Sussex, England; [Ficociello, Maryam] Simon Fraser Univ, Beedie Sch Business, Burnaby, BC V5A 1S6, Canada; [Paton, James] Burton Hosp NHS Fdn Trust, Burton Upon Trent DE13 0RB, England; [Jacklin, Ann] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp NHS Trust, London SW7 2AZ, England	University of Edinburgh; University of London; London School Economics & Political Science; University of London; University College London; University of London School of Pharmacy; University of Nottingham; University of Sussex; Simon Fraser University; Imperial College London	Sheikh, A (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Ehlth Res Grp, Edinburgh EH8 9DX, Midlothian, Scotland.	aziz.sheikh@ed.ac.uk	Jani, Yogini/GRF-6258-2022; Sheikh, Aziz/D-2818-2009; Jani, Yogini/AAM-4436-2020	Sheikh, Aziz/0000-0001-7022-3056; Jani, Yogini/0000-0001-5927-5429; Petrakaki, Dimitra/0000-0003-2136-3858; Klecun, Ela/0000-0002-0329-1566; Avery, Anthony/0000-0001-7591-4438	National Institute for Health Research, through the Comprehensive Clinical Research Network; NHS	National Institute for Health Research, through the Comprehensive Clinical Research Network(National Institute for Health Research (NIHR)); NHS	We are grateful to the participating hospitals for supporting this work and to all interviewees who kindly gave their time. Throughout the process of undertaking this work we have had helpful support from colleagues at the NHS Connecting for Health Evaluation Programme led by Richard Lilford and supported by Lee Priest, Nathalie Maillard, and Jo Foster. Lee Priest also represented the funders on our independent project steering committee, which was chaired by David Bates. Other members of this committee included Martin Buxton, Antony Chuter, Ian Cowles, and Kathy Mason. We also acknowledge the support of the National Institute for Health Research, through the Comprehensive Clinical Research Network.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: all authors have support in the form of a grant from the NHS Connecting for Health Evaluation Programme for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	2020 Health, 2010, FIX NHSIT; Aarts J, 2004, J AM MED INFORM ASSN, V11, P207, DOI 10.1197/jamia.M1372; Adler Kenneth G, 2007, Fam Pract Manag, V14, P33; Ammenwerth E., 2006, BMC MED INFORM DECIS, V6, P13; Anderson R, 2009, DATABASE STATE REPOR; [Anonymous], 2008, BMA EV HOUS COMM HOM; [Anonymous], 2010, GUARDIAN; Ash J, 2003, INT J MED INFORM, V69, P305, DOI 10.1016/S1386-5056(02)00180-6; Audit Commission, 1999, SETT REC STRAIGHT RE; Austin CJ, 2000, J HEALTHC MANAG, V45, P229, DOI 10.1097/00115514-200007000-00006; Australian Government, 2010, NAT HLTH HOSP NETW A; Bali Rajeev K., 2008, International Journal of Healthcare Technology and Management, V9, P97, DOI 10.1504/IJHTM.2008.016850; Bates DW, 2003, J AM MED INFORM ASSN, V10, P1, DOI 10.1197/jamia.M1097; Bates DW, 2003, J AM MED INFORM ASSN, V10, P523, DOI 10.1197/jamia.M1370; Becker HS, 1971, SOCIOLOGICAL WORK; Beuscart-Zephir MC, 2001, INT J MED INFORM, V64, P157, DOI 10.1016/S1386-5056(01)00210-6; Black AD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000387; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Boonstra A, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-231; Bossen C, 2007, INT J MED INFORM, V76, P13, DOI 10.1016/j.ijmedinf.2006.01.001; Brennan S, 2007, J INF TECHNOL, V22, P202, DOI 10.1057/palgrave.jit.2000104; British Computer Society, 2006, WAY FORW NHS HLTH IN; Cabinet Office, 2011, GOV ICT STRAT; Callen JL, 2008, J AM MED INFORM ASSN, V15, P255, DOI 10.1197/jamia.M2468; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Clemmer TP, 2004, J CRIT CARE, V19, P201, DOI 10.1016/j.jcrc.2004.08.005; Coiera E, 2009, J AM MED INFORM ASSN, V16, P271, DOI 10.1197/jamia.M3183; Coiera EW, 2007, MED J AUSTRALIA, V186, P3, DOI 10.5694/j.1326-5377.2007.tb00774.x; CORNFORD T, 1994, OMEGA-INT J MANAGE S, V22, P491, DOI 10.1016/0305-0483(94)90030-2; Cresswell K, LONG WINDING ROAD IN; Cresswell Kathrin, 2009, Inform Prim Care, V17, P153; Crosson JC, 2005, ANN FAM MED, V3, P307, DOI 10.1370/afm.326; Dagroso Deborah, 2007, J Healthc Inf Manag, V21, P87; Davidson E, 2005, EUR J INFORM SYST, V14, P6, DOI 10.1057/palgrave.ejis.3000518; de Mul M, 2004, J CRIT CARE, V19, P208, DOI 10.1016/j.jcrc.2004.09.002; Department of Health, 2001, BUILD INF COR IMPL N; Department of Health, 2000, NHS PLAN PLAN INV PL; Department of Health, 2002, DEL NHS PLAN NEXT ST; Department of Health, 2002, DEL 21 CENT IT SUPP; Department of Health, 1998, INF HLTH INF STRAT M; Department of Health, 2010, EQ EXC LIB NHS; Department of Health, 2008, HLTH INF REV REP DAR; DesRoches CM, 2010, NEW ENGL J MED, V362, P1153, DOI 10.1056/NEJMc1000273; Dobrev, 2010, EUROPEAN COMMISSION; Duggan Christina, 2006, J AHIMA, V77, P52; eHealth Insider, 2008, IND SECT PERSP HEALT; Fenton SH, 2006, J AHIMA, V77, P60; Ferneley EH, 2006, EUR J INFORM SYST, V15, P345, DOI 10.1057/palgrave.ejis.3000629; Flyvbjerg B, 2006, QUAL INQ, V12, P219, DOI 10.1177/1077800405284363; George A. L., 2005, CASE STUDIES THEORY; Giuse DA, 2003, INT J MED INFORM, V69, P105, DOI 10.1016/S1386-5056(02)00182-X; Goroll AH, 2009, J AM MED INFORM ASSN, V16, P132, DOI 10.1197/jamia.M2899; Granlien MF, 2008, STUD HEALTH TECHNOL, V136, P419; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Greenhalgh T, 2010, DEVILS DETAIL FINAL; Greenhalgh T, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3111; Greenhalgh T, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1786; Halamka J, 2006, J AM MED INFORM ASSN, V13, P239, DOI 10.1197/jamia.M2028; Hayes G, 2009, INDEPENDENT REV NHS; Hendy J, 2005, BMJ-BRIT MED J, V331, P331, DOI 10.1136/bmj.331.7512.331; Hendy J, 2007, BRIT MED J, V334, P1360, DOI 10.1136/bmj.39195.598461.551; House of Commons Public Accounts Committee, 2009, NAT PROGR IT NHS PRO; James Donna, 2007, J Healthc Inf Manag, V21, P54; Jha AK, 2009, NEW ENGL J MED, V360, P1628, DOI 10.1056/NEJMsa0900592; Jones M., 2004, HLTH INFORM J, V10, P253; Karsten Helena, 2007, Int J Med Inform, V76 Suppl 1, pS136, DOI 10.1016/j.ijmedinf.2006.05.013; Keddie Zoe, 2005, Inform Prim Care, V13, P113; Keshavjee K, 2006, AMIA Annu Symp Proc, P982; King's Fund, 2008, TECHN NHS TRANSF PAT; Lilford RJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000186; Liu JLY, 2011, J AM MED INFORM ASSN, V18, P173, DOI 10.1136/jamia.2010.010306; Lium JT, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-2; Lorenzi NM, 2004, ST HEAL T, V107, P1077; Lu YC, 2005, INT J MED INFORM, V74, P409, DOI 10.1016/j.ijmedinf.2005.03.001; Ludwick DA, 2009, INT J MED INFORM, V78, P22, DOI 10.1016/j.ijmedinf.2008.06.005; Mays N., 1999, QUALITATIVE RES HLTH; Mehta NB, 2007, CLEV CLIN J MED, V74, P826, DOI 10.3949/ccjm.74.11.826; Miles MB., 2018, QUALITATIVE DATA ANA, DOI DOI 10.1016/0149-7189(96)88232-2; Miranda D, 2001, Comput Nurs, V19, P147; Moen A, 2003, J BIOMED INFORM, V36, P375, DOI 10.1016/j.jbi.2003.09.019; Morrison Z, 2011, J HEALTHC ENG, V2, P25, DOI 10.1260/2040-2295.2.1.25; Murray SA, 2006, LANCET, V368, P901, DOI 10.1016/S0140-6736(06)69350-1; National Audit Office, NAT PROGR IT NHS UPD; Nikula RE, 2001, STUD HEALTH TECHNOL, V84, P666; Ovretveit J, 2007, INT J QUAL HEALTH C, V19, P259, DOI 10.1093/intqhc/mzm031; Pagliari Claudia, 2005, Inform Prim Care, V13, P105; Pare G, 2008, METHOD INFORM MED, V47, P251, DOI 10.3414/ME0512; Pare Guy, 2002, Health Serv Manage Res, V15, P71, DOI 10.1258/0951484021912851; Patton M., 2002, QUALITATIVE RES EVAL; Pendergast Debra K, 2003, Nurs Adm Q, V27, P330; Peters T., 1982, SEARCH EXCELLENCE LE; Public Accounts Committee, PUBL ACC MIN EV; Public Accounts Committee, 2011, NAT PROGR IT NHS UPD; Puffer Matthew J, 2007, J Healthc Inf Manag, V21, P24; Quinzio L, 2003, EUR J ANAESTH, V20, P967, DOI 10.1097/00003643-200312000-00006; Raisanen C, 2004, ORGANIZATION, V11, P101, DOI 10.1177/1350508404039660; Reeves BC, 2008, SDO442003; Robertson A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4564; Rose J., 2005, Scandinavian Journal of Information Systems, V17, P133; Royal College of General Practitioners, 2009, INF SHAR CLIN CAR FI; Scott JT, 2005, BRIT MED J, V331, P1313, DOI 10.1136/bmj.38638.497477.68; Sheikh A., 2011, IMPACT EHEALTH QUALI; Silverman D., 2017, DOING QUALITATIVE RE, V5th; Stake R.E., 1995, ART CASE STUDY RES; Treasury HM, SPEND REV 2010; Warner N, 2011, SUITABLE CASE TREATM; Yin R.K., 2014, CASE STUDY RES DESIG	107	125	125	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 17	2011	343								d6054	10.1136/bmj.d6054	http://dx.doi.org/10.1136/bmj.d6054			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	851CH	22006942	Green Submitted, Green Published, hybrid, Green Accepted			2022-12-28	WOS:000297245400002
J	Cornet, AD; Vogel, JJ; Karagozoglu, KH; Thijs, A				Cornet, Alexander D.; Vogel, Justine J.; Karagozoglu, K. Hakki; Thijs, Abel			Cervical lump? The clue is in the hotspot	LANCET			English	Editorial Material							NASOPHARYNGEAL; EPIDEMIOLOGY		[Cornet, Alexander D.; Thijs, Abel] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, NL-1007 MB Amsterdam, Netherlands; [Vogel, Justine J.] Vrije Univ Amsterdam Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, NL-1007 MB Amsterdam, Netherlands; [Karagozoglu, K. Hakki] Vrije Univ Amsterdam Med Ctr, Dept Oral & Maxillofacial Surg Pathol, NL-1007 MB Amsterdam, Netherlands; [Karagozoglu, K. Hakki] Acad Ctr Dent Amsterdam, NL-1066 EA Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam	Cornet, AD (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Internal Med, POB 7075, NL-1007 MB Amsterdam, Netherlands.	cornet@vumc.nl		Cornet, Alexander/0000-0002-9917-5251				Caponigro F, 2010, ANTI-CANCER DRUG, V21, P471, DOI 10.1097/CAD.0b013e328337160e; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Lee A. W. M., 1997, Hong Kong Medical Journal, V3, P355; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858	5	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 15	2011	378	9800					1438	1438		10.1016/S0140-6736(11)61173-2	http://dx.doi.org/10.1016/S0140-6736(11)61173-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	838EM	22000140				2022-12-28	WOS:000296269600031
J	Schlich, T				Schlich, Thomas			The art of medicine The origins of organ transplantation	LANCET			English	Editorial Material									McGill Univ, Dept Social Studies Med, Montreal, PQ H3A 1X1, Canada	McGill University	Schlich, T (corresponding author), McGill Univ, Dept Social Studies Med, Montreal, PQ H3A 1X1, Canada.	thomas.schlich@mcgill.ca						Brent Leslie, 1997, HIST TRANSPLANTATION; Fox R., 1974, COURAGE FAIL SOCIAL; Hakim NS, 2003, HIST ORGAN CELL TRAN; Lederer Susan E., 2008, FLESH BLOOD ORGAN TR; Schlich Thomas, 2010, ORIGINS ORGAN TRANSP; Silverstein AM, 2009, HISTORY OF IMMUNOLOGY, 2ND EDITION, P1	6	8	8	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 15	2011	378	9800					1372	1373		10.1016/S0140-6736(11)61601-2	http://dx.doi.org/10.1016/S0140-6736(11)61601-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	838EM	22010264				2022-12-28	WOS:000296269600014
J	Chen, HH; Sun, H; You, FP; Sun, WX; Zhou, X; Chen, L; Yang, J; Wang, YT; Tang, H; Guan, YK; Xia, WW; Gu, J; Ishikawa, H; Gutman, D; Barber, G; Qin, ZH; Jiang, ZF				Chen, Huihui; Sun, Hui; You, Fuping; Sun, Wenxiang; Zhou, Xiang; Chen, Lu; Yang, Jing; Wang, Yutao; Tang, Hong; Guan, Yukun; Xia, Weiwei; Gu, Jun; Ishikawa, Hiroki; Gutman, Delia; Barber, Glen; Qin, Zhihai; Jiang, Zhengfan			Activation of STAT6 by STING Is Critical for Antiviral Innate Immunity	CELL			English	Article							NF-KAPPA-B; RIG-I; ADAPTER PROTEIN; CYTOSOLIC DNA; EXPRESSION; ALPHA; CELLS; INTERLEUKIN-4; RECOGNITION; RESPONSES	STAT6 plays a prominent role in adaptive immunity by transducing signals from extracellular cytokines. We now show that STAT6 is required for innate immune signaling in response to virus infection. Viruses or cytoplasmic nucleic acids trigger STING (also named MITA/ERIS) to recruit STAT6 to the endoplasmic reticulum, leading to STAT6 phosphorylation on Ser(407) by TBK1 and Tyr(641), independent of JAKs. Phosphorylated STAT6 then dimerizes and translocates to the nucleus to induce specific target genes responsible for immune cell homing. Virus-induced STAT6 activation is detected in all cell-types tested, in contrast to the cell-type specific role of STAT6 in cytokine signaling, and Stat6(-/-) mice are susceptible to virus infection. Thus, STAT6 mediates immune signaling in response to both cytokines at the plasma membrane, and virus infection at the endoplasmic reticulum.	[Chen, Huihui; Sun, Hui; You, Fuping; Sun, Wenxiang; Zhou, Xiang; Chen, Lu; Yang, Jing; Wang, Yutao; Tang, Hong; Guan, Yukun; Xia, Weiwei; Gu, Jun; Jiang, Zhengfan] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Chen, Huihui; Sun, Hui; You, Fuping; Sun, Wenxiang; Zhou, Xiang; Chen, Lu; Yang, Jing; Wang, Yutao; Tang, Hong; Guan, Yukun; Jiang, Zhengfan] Peking Univ, Sch Life Sci, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100871, Peoples R China; [Jiang, Zhengfan] Tsinghua Univ, Peking Univ, Joint Ctr Life Sci, Beijing 100084, Peoples R China; [Ishikawa, Hiroki; Gutman, Delia; Barber, Glen] Univ Miami, Sch Med, Dept Med, Miami, FL 33136 USA; [Ishikawa, Hiroki; Gutman, Delia; Barber, Glen] Univ Miami, Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Qin, Zhihai] Inst Biophys, State Key Lab Biomacromol, Beijing, Peoples R China	Peking University; Peking University; Peking University; Tsinghua University; University of Miami; University of Miami; Chinese Academy of Sciences; Institute of Biophysics, CAS	Jiang, ZF (corresponding author), Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	jiangzf@pku.edu.cn	Yang, Jing/GLU-3905-2022; SUN, Wenxiang/Q-3481-2017	Guan, Yukun/0000-0001-9312-0164; Yang, Jing/0000-0001-5414-2141; Qin, Zhihai/0000-0001-9793-7964; Sun, Hui/0000-0002-1152-5932	China Natural Science Foundation [30772024, 31025010]; Chinese Ministry of Science and Technology [2007CB914502]; Chinese Ministry of Education [108002]	China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Ministry of Education(Ministry of Education, China)	We thank Drs. Junlin Teng for histological processing; Zhijian J. Chen for Mavs<SUP>-/-</SUP> mice; George Stark for 2fTGH, U1A-U6A, and gamma 2A cells; Wen-Chen Yeh for Tbk1<SUP>-/-</SUP> MEFs and Tadatsugu Taniguchi for Irf3<SUP>-/-</SUP> MEFs; and Drs. M. Tian and Y. Rao for critical reading of the manuscript. This work was supported by grants from the China Natural Science Foundation (30772024 and 31025010), the Chinese Ministry of Science and Technology (2007CB914502) and the Chinese Ministry of Education (108002). Z.J. designed research; H.C., H.S., F.Y., W.S., X.Z., L.C., J.Y., Y.W., H.T., and Y.G. performed research; W.X., J.G., H.I., D.G., G.B., and Z.Q. contributed new reagents/ analytical tools; H.C., H.S., F.Y., W.S., X.Z., L.C., J.Y., Y.W., H.T., Y.G., and Z.J. analyzed data; and X.Z. and Z.J. wrote the paper.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Ahn HJ, 2009, KOREAN J PARASITOL, V47, P117, DOI 10.3347/kjp.2009.47.2.117; Akimoto T, 1998, J EXP MED, V187, P1537, DOI 10.1084/jem.187.9.1537; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; Bulanova E, 2003, J IMMUNOL, V170, P5045, DOI 10.4049/jimmunol.170.10.5045; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Elo LL, 2010, IMMUNITY, V32, P852, DOI 10.1016/j.immuni.2010.06.011; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Gupta S, 1999, J IMMUNOL, V163, P3834; Harper EG, 2009, J INVEST DERMATOL, V129, P2175, DOI 10.1038/jid.2009.65; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; Hedrick MN, 2009, J CLIN INVEST, V119, P2317, DOI 10.1172/JCI37378; Hokeness KL, 2005, J IMMUNOL, V174, P1549, DOI 10.4049/jimmunol.174.3.1549; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li ZG, 2008, CANCER RES, V68, P8687, DOI 10.1158/0008-5472.CAN-08-0449; Masuda A, 2000, J BIOL CHEM, V275, P29331, DOI 10.1074/jbc.M910290199; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mikita T, 1998, J BIOL CHEM, V273, P17634, DOI 10.1074/jbc.273.28.17634; Mikita T, 1996, MOL CELL BIOL, V16, P5811; Nakayama T, 2010, J IMMUNOL, V185, P6472, DOI 10.4049/jimmunol.0904126; QUELLE FW, 1995, MOL CELL BIOL, V15, P3336; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Weckmann M, 2007, NAT MED, V13, P1308, DOI 10.1038/nm1660; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yadav A, 2010, CLIN CHIM ACTA, V411, P1570, DOI 10.1016/j.cca.2010.07.006; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Yuan Q, 2006, EUR J IMMUNOL, V36, P2700, DOI 10.1002/eji.200636112; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	48	233	252	2	110	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 14	2011	147	2					436	446		10.1016/j.cell.2011.09.022	http://dx.doi.org/10.1016/j.cell.2011.09.022			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000020	Bronze			2022-12-28	WOS:000296199300020
J	Wolf, A; Anderegg, WRL				Wolf, Adam; Anderegg, William R. L.			Comment on "Changes in Climatic Water Balance Drive Downhill Shifts in Plant Species' Optimum Elevations"	SCIENCE			English	Editorial Material									[Wolf, Adam] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Anderegg, William R. L.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Princeton University; Stanford University	Wolf, A (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	adamwolf@princeton.edu						[Anonymous], CALFL DAT; Barbour M.G., 1999, N AM TERRESTRIAL VEG; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; Keeley Jon E., 2004, Madrono, V51, P372; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Wieslander A.E., 1935, MADRONO, V3, P140; Wieslander A. E, 1935, J FOREST, V33, P877, DOI DOI 10.1093/JOF/33.10.877	7	7	7	2	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2011	334	6053								10.1126/science.1204607	http://dx.doi.org/10.1126/science.1204607			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998369				2022-12-28	WOS:000295833600024
J	Eisenstein, M				Eisenstein, Michael			TELOMERES All's well that ends well	NATURE			English	Editorial Material							MICE											Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Parry EM, 2011, BLOOD, V117, P5607, DOI 10.1182/blood-2010-11-322149; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Tomas-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034; Wolkowitz OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017837	5	9	9	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 13	2011	478	7368					S13	S15		10.1038/478S13a	http://dx.doi.org/10.1038/478S13a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21993820	Bronze			2022-12-28	WOS:000295782800010
J	Martin, C; zur Hausen, H				Martin, Chris; zur Hausen, Harald			Science addict	NATURE			English	Editorial Material									[zur Hausen, Harald] German Canc Res Ctr, Heidelberg, Germany; [Martin, Chris] Univ Oxford, Dept Oncol, Oxford OX1 2JD, England	Helmholtz Association; German Cancer Research Center (DKFZ); University of Oxford	Martin, C (corresponding author), Univ Oxford, Dept Oncol, Oxford OX1 2JD, England.								0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2011	478	7368					S12	S12		10.1038/478S12a	http://dx.doi.org/10.1038/478S12a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21993819	Bronze			2022-12-28	WOS:000295782800009
J	Beaglehole, R; Bonita, R; Alleyne, G; Horton, R				Beaglehole, Robert; Bonita, Ruth; Alleyne, George; Horton, Richard			NCDs: celebrating success, moving forward	LANCET			English	Editorial Material							COSTS		[Beaglehole, Robert; Bonita, Ruth] Univ Auckland, Auckland 1, New Zealand; [Alleyne, George] Pan Amer Hlth Org, Washington, DC USA; [Horton, Richard] The Lancet, London NW1 7BY, England	University of Auckland; Pan American Health Organization	Beaglehole, R (corresponding author), Univ Auckland, Auckland 1, New Zealand.	r.beaglehole@auckland.ac.nz						Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Joffres MR, 2007, CAN J CARDIOL, V23, P437, DOI 10.1016/S0828-282X(07)70780-8; Organization WH, 2016, GLOBAL STATUS REPORT; *STOP TB, STOP TB PARTN; United Nations Conference on Sustainable Development, RIO 20; WHO, ACC COMM HLTH WOM CH; World Health Organization, 2007, PREV CARD DIS GUID A; World Health Organization, TARG MON PROGR RED B; PARTNERSHIP MATERNAL	10	21	23	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 8	2011	378	9799					1283	1284		10.1016/S0140-6736(11)61559-6	http://dx.doi.org/10.1016/S0140-6736(11)61559-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	831IU	21982085				2022-12-28	WOS:000295724300008
J	Richeldi, L; Costabel, U; Selman, M; Kim, DS; Hansell, DM; Nicholson, AG; Brown, KK; Flaherty, KR; Noble, PW; Raghu, G; Brun, M; Gupta, A; Juhel, N; Kluglich, M; du Bois, RM				Richeldi, Luca; Costabel, Ulrich; Selman, Moises; Kim, Dong Soon; Hansell, David M.; Nicholson, Andrew G.; Brown, Kevin K.; Flaherty, Kevin R.; Noble, Paul W.; Raghu, Ganesh; Brun, Michele; Gupta, Abhya; Juhel, Nolwenn; Klueglich, Matthias; du Bois, Roland M.			Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; CLINICAL-COURSE; THERAPY; INJURY; LUNG	Background Idiopathic pulmonary fibrosis is a progressive lung disease with a high mortality rate. Because the signaling pathways activated by several tyrosine kinase receptors have been shown to be involved in lung fibrosis, it has been suggested that the inhibition of these receptors may slow the progression of idiopathic pulmonary fibrosis. Methods In a 12-month, phase 2 trial, we assessed the efficacy and safety of four different oral doses of the tyrosine kinase inhibitor BIBF 1120 as compared with placebo in patients with idiopathic pulmonary fibrosis. The primary end point was the annual rate of decline in forced vital capacity (FVC). Secondary end points included acute exacerbations, quality of life (measured with the St. George's Respiratory Questionnaire [SGRQ]), and total lung capacity. Results A total of 432 patients underwent randomization to receive one of four doses of BIBF 1120 (50 mg once a day, 50 mg twice a day, 100 mg twice a day, or 150 mg twice a day) or placebo. In the group receiving 150 mg of BIBF 1120 twice a day, FVC declined by 0.06 liters per year, as compared with 0.19 liters per year in the placebo group, a 68.4% reduction in the rate of loss with BIBF 1120 (P=0.06 with the closed testing procedure for multiplicity correction; P=0.01 with the hierarchical testing procedure). This dose also resulted in a lower incidence of acute exacerbations, as compared with placebo (2.4 vs. 15.7 per 100 patient-years, P=0.02) and a small decrease in the SGRQ score (assessed on a scale of 0 to 100, with lower scores indicating better quality of life) as compared with an increase with placebo (-0.66 vs. 5.46, P=0.007). Gastrointestinal symptoms (which led to more discontinuations in the group receiving 150 mg twice a day than in the placebo group) and increases in levels of liver aminotransferases were more frequent in the group receiving 150 mg of BIBF 1120 twice daily than in the placebo group. Conclusions In patients with idiopathic pulmonary fibrosis, BIBF 1120 at a dose of 150 mg twice daily, as compared with placebo, was associated with a trend toward a reduction in the decline in lung function, with fewer acute exacerbations and preserved quality of life. (Funded by Boehringer Ingelheim; ClinicalTrials. gov number, NCT00514683.)	[Richeldi, Luca] Univ Modena & Reggio Emilia, Policlin Hosp, Ctr Rare Lung Dis, I-41100 Modena, Italy; [Costabel, Ulrich] Univ Duisburg Essen, Ruhrlandklin, Essen, Germany; [Costabel, Ulrich] Univ Duisburg Essen, Fac Med, Essen, Germany; [Selman, Moises] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico; [Kim, Dong Soon] Univ Ulsan, Div Pulm & Crit Care Med, Asan Med Ctr, Seoul, South Korea; [Hansell, David M.] Royal Brompton Hosp, Dept Radiol, London SW3 6LY, England; [Nicholson, Andrew G.] Royal Brompton Hosp, Dept Histopathol, London SW3 6LY, England; [Hansell, David M.; Nicholson, Andrew G.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Brown, Kevin K.] Natl Jewish Hlth, Denver, CO USA; [Flaherty, Kevin R.] Univ Michigan Hlth Syst, Div Pulm & Crit Care Med, Ann Arbor, MI USA; [Noble, Paul W.] Duke Univ, Med Ctr, Durham, NC USA; [Raghu, Ganesh] Univ Washington, Seattle, WA 98195 USA; [Brun, Michele; Juhel, Nolwenn] Boehringer Ingelheim GmbH & Co KG, Reims, France	Universita di Modena e Reggio Emilia; University of Duisburg Essen; University of Duisburg Essen; University of Ulsan; Royal Brompton Hospital; Royal Brompton Hospital; Imperial College London; National Jewish Health; University of Michigan System; University of Michigan; Duke University; University of Washington; University of Washington Seattle; Boehringer Ingelheim	Richeldi, L (corresponding author), Univ Modena & Reggio Emilia, Policlin Hosp, Ctr Rare Lung Dis, Via Pozzo 71, I-41100 Modena, Italy.	luca.richeldi@unimore.it	Richeldi, Luca/ABF-2486-2020; Brown, Kevin/ABF-2544-2020; Richeldi, Luca/B-6243-2019	Richeldi, Luca/0000-0001-8594-1448; Ohkouchi, Shinya/0000-0002-4658-6487	Boehringer Ingelheim.	Boehringer Ingelheim.(Boehringer Ingelheim)	Supported by Boehringer Ingelheim.	Abdollahi A, 2005, J EXP MED, V201, P925, DOI 10.1084/jem.20041393; Allen JT, 2001, RESP RES, V3, DOI 10.1186/rr162; Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Chaudhary NI, 2007, EUR RESPIR J, V29, P976, DOI 10.1183/09031936.00152106; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; De Vries J, 2001, EUR RESPIR J, V17, P954, DOI 10.1183/09031936.01.17509540; du Bois RM, 2011, AM J RESP CRIT CARE, V183, P1231, DOI [10.1164/rccm.201007.1179OC, 10.1164/rccm.201007-1179OC]; Grimminger F, 2010, NAT REV DRUG DISCOV, V9, P956, DOI 10.1038/nrd3297; Hamada N, 2005, J IMMUNOL, V175, P1224, DOI 10.4049/jimmunol.175.2.1224; Hilberg F, 2008, CANCER RES, V68, P4774, DOI 10.1158/0008-5472.CAN-07-6307; Hyzy R, 2007, CHEST, V132, P1652, DOI 10.1378/chest.07-0299; Jones Paul W, 2005, COPD, V2, P75; JONES PW, 1991, RESP MED, V85, P25, DOI 10.1016/S0954-6111(06)80166-6; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Swigris JJ, 2010, RESP MED, V104, P296, DOI 10.1016/j.rmed.2009.09.006; Swigris JJ, 2005, CHEST, V127, P284, DOI 10.1378/chest.127.1.284; Wells AU, 2008, RHEUMATOLOGY, V47, pV48, DOI 10.1093/rheumatology/ken311; Yu CD, 2003, AM J PATHOL, V163, P1653, DOI 10.1016/S0002-9440(10)63522-5	22	727	782	2	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2011	365	12					1079	1087		10.1056/NEJMoa1103690	http://dx.doi.org/10.1056/NEJMoa1103690			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822WR	21992121				2022-12-28	WOS:000295081600007
J	Kreuter, A; Wieland, U				Kreuter, Alexander; Wieland, Ulrike			Giant Condyloma Acuminatum of Buschke and Lowenstein	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kreuter, Alexander] Ruhr Univ Bochum, Bochum, Germany; [Wieland, Ulrike] Univ Cologne, Cologne, Germany	Ruhr University Bochum; University of Cologne	Kreuter, A (corresponding author), Ruhr Univ Bochum, Bochum, Germany.	a.kreuter@derma.de		Kreuter, Alexander/0000-0003-2275-499X					0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2011	365	17					1624	1624		10.1056/NEJMicm1006915	http://dx.doi.org/10.1056/NEJMicm1006915			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HI	22029984				2022-12-28	WOS:000296181800007
J	Fitzharris, P; Jordan, A				Fitzharris, Penny; Jordan, Anthony			RATIONAL TESTING Investigating recurrent angio-oedema	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Fitzharris, Penny; Jordan, Anthony] Auckland City Hosp, Dept Immunol, Auckland 1023, New Zealand	Auckland City Hospital	Fitzharris, P (corresponding author), Auckland City Hosp, Dept Immunol, Auckland 1023, New Zealand.	pennyf@adhb.govt.nz						[Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Cicardi M, 2004, ARCH INTERN MED, V164, P910, DOI 10.1001/archinte.164.8.910; Grigoriadou S, 2009, CLIN EXP IMMUNOL, V155, P367, DOI 10.1111/j.1365-2249.2008.03845.x; Haymore BR, 2009, ANN ALLERG ASTHMA IM, V103, P83, DOI 10.1016/S1081-1206(10)60151-2; Kaplan AP, 2010, ANN ALLERG ASTHMA IM, V104, P193, DOI 10.1016/j.anai.2010.01.007; Sabroe RA, 1997, BRIT J DERMATOL, V136, P153; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Wagenaar-Bos IGA, 2008, J IMMUNOL METHODS, V338, P14, DOI 10.1016/j.jim.2008.06.004; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317; Zuberbier T, 2009, ALLERGY, V64, P1417, DOI 10.1111/j.1398-9995.2009.02179.x	10	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2011	343								d6607	10.1136/bmj.d6607	http://dx.doi.org/10.1136/bmj.d6607			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840CU	22025533				2022-12-28	WOS:000296416700001
J	Bridson, J				Bridson, John			CHILD PROTECTION The GMC should be investigated over its Southall and Meadow hearings	BRITISH MEDICAL JOURNAL			English	Editorial Material							GENERAL MEDICAL COUNCIL; UNITED-KINGDOM					john.bridson@doctors.org.uk						Chadwick DL, 2006, PEDIATRICS, V117, P2247, DOI 10.1542/peds.2006-0429; DAVID TJ, 1994, LANCET, V344, P133; Dyer C, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6314; Dyer C, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6562; Jenny C, 2007, PEDIATRICS, V119, P797, DOI 10.1542/peds.2006-2472; Williams C, 2007, PEDIATRICS, V119, P800, DOI 10.1542/peds.2006-1980	6	3	3	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 19	2011	343								d6708	10.1136/bmj.d6708	http://dx.doi.org/10.1136/bmj.d6708			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HN	22012648				2022-12-28	WOS:000296183700008
J	Lipworth, BJ				Lipworth, Brian J.			Review: Tiotropium mist inhaler increases mortality in chronic obstructive pulmonary disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Dundee, Ninewells Hosp, Dundee, Scotland	University of Dundee	Lipworth, BJ (corresponding author), Univ Dundee, Ninewells Hosp, Dundee, Scotland.		Singh, Sonal/A-4614-2008	Singh, Sonal/0000-0003-0912-941X				Short PM, 2011, CHEST           0728	1	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2011	155	8							JC4-6	10.7326/0003-4819-155-8-201110180-02006	http://dx.doi.org/10.7326/0003-4819-155-8-201110180-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835WB	22007065				2022-12-28	WOS:000296066300005
J	Jamieson, S				Jamieson, Stuart			Bypass, circulatory arrest, and pulmonary endarterectomy	LANCET			English	Editorial Material							EXPERIENCE		Univ Calif San Diego, Div Cardiothorac Surg, San Diego, CA 92103 USA	University of California System; University of California San Diego	Jamieson, S (corresponding author), Univ Calif San Diego, Div Cardiothorac Surg, San Diego, CA 92103 USA.	sjamieson@ucsd.edu						Jamieson SW, 2003, ANN THORAC SURG, V76, P1457, DOI 10.1016/S0003-4975(03)00828-2; Jamieson SW, 2000, CURR PROB SURG, V37, P170; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Thomson B, 2008, EUR J CARDIO-THORAC, V33, P157, DOI 10.1016/j.ejcts.2007.11.009; Vuylsteke A, 2011, LANCET, V378, P1379, DOI 10.1016/S0140-6736(11)61144-6	6	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 15	2011	378	9800					1359	1360		10.1016/S0140-6736(11)61384-6	http://dx.doi.org/10.1016/S0140-6736(11)61384-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	838EM	22000123				2022-12-28	WOS:000296269600005
J	Cesana, M; Cacchiarelli, D; Legnini, I; Santini, T; Sthandier, O; Chinappi, M; Tramontano, A; Bozzoni, I				Cesana, Marcella; Cacchiarelli, Davide; Legnini, Ivano; Santini, Tiziana; Sthandier, Olga; Chinappi, Mauro; Tramontano, Anna; Bozzoni, Irene			A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA	CELL			English	Article							TRANSCRIPTION; EXPRESSION; MICRORNA-206; GENE; REGENERATION; PTEN	Recently, a new regulatory circuitry has been identified in which RNAs can crosstalk with each other by competing for shared microRNAs. Such competing endogenous RNAs (ceRNAs) regulate the distribution of miRNA molecules on their targets and thereby impose an additional level of post-transcriptional regulation. Here we identify a muscle-specific long noncoding RNA, linc-MD1, which governs the time of muscle differentiation by acting as a ceRNA in mouse and human myoblasts. Downregulation or overexpression of linc-MD1 correlate with retardation or anticipation of the muscle differentiation program, respectively. We show that linc-MD1 "sponges" miR-133 and miR-135 to regulate the expression of MAML1 and MEF2C, transcription factors that activate muscle-specific gene expression. Finally, we demonstrate that linc-MD1 exerts the same control over differentiation timing in human myoblasts, and that its levels are strongly reduced in Duchenne muscle cells. We conclude that the ceRNA network plays an important role in muscle differentiation.	[Cesana, Marcella; Cacchiarelli, Davide; Legnini, Ivano; Santini, Tiziana; Sthandier, Olga; Bozzoni, Irene] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, I-00185 Rome, Italy; [Chinappi, Mauro; Tramontano, Anna] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy; [Tramontano, Anna; Bozzoni, Irene] Univ Roma La Sapienza, Inst Pasteur Fondaz Cenci Bolognetti, I-00185 Rome, Italy; [Tramontano, Anna; Bozzoni, Irene] Univ Roma La Sapienza, Ctr Life Nano Sci Sapienza, Ist Italiano Tecnol, I-00185 Rome, Italy; [Bozzoni, Irene] Univ Roma La Sapienza, IBPM Consiglio Nazl Ric CNR, I-00185 Rome, Italy	Sapienza University Rome; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; Istituto Italiano di Tecnologia - IIT; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	Bozzoni, I (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Ple A Moro 5, I-00185 Rome, Italy.	irene.bozzoni@uniroma1.it	Cacchiarelli, Davide/AAC-2693-2022; Tramontano, anna/D-5378-2009; Cesana, Marcella/AAC-2697-2022	Cacchiarelli, Davide/0000-0002-9621-6716; Tramontano, anna/0000-0002-5610-3338; Cesana, Marcella/0000-0002-9099-8681; Chinappi, Mauro/0000-0002-4509-1247; Santini, Tiziana/0000-0002-7181-7267; Legnini, Ivano/0000-0002-8984-5215; bozzoni, irene/0000-0002-3485-8537	Telethon [GGP07049]; Parent Project Italia; EU [LSHG-CT-2006-037900]; KAUST [KUK-I1-012-43]; AIRC; IIT "SEED"; FIRB; PRIN; BEMM	Telethon(Fondazione Telethon); Parent Project Italia; EU(European Commission); KAUST(King Abdullah University of Science & Technology); AIRC(Fondazione AIRC per la ricerca sul cancro); IIT "SEED"(Istituto Italiano di Tecnologia - IIT); FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); BEMM	We thank N. Proudfoot and K. Perkins for introducing M. C. to the 3C analysis; M. Mora and the Telethon Neuromuscular Biobank for providing material; J. Martone, V. Cazzella for useful discussion; and M. Marchioni for technical support. D.C. is a recipient of a Microsoft research PhD fellowship. This work was partially supported by grants from: Telethon (GGP07049), Parent Project Italia, EU project SIROCCO (LSHG-CT-2006-037900), KAUST KUK-I1-012-43, AIRC, IIT "SEED," FIRB, PRIN, and BEMM.	Amaral P. P., 2008, GENOME RES, V17, P556; Amaral PP, 2008, MAMM GENOME, V19, P454, DOI 10.1007/s00335-008-9136-7; Ballarino M, 2009, MOL CELL BIOL, V29, P5632, DOI 10.1128/MCB.00664-09; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Buckingham M, 2009, CURR OPIN GENET DEV, V19, P444, DOI 10.1016/j.gde.2009.08.001; Cacchiarelli D, 2011, EMBO REP, V12, P136, DOI 10.1038/embor.2010.208; Cacchiarelli D, 2010, CELL METAB, V12, P341, DOI 10.1016/j.cmet.2010.07.008; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; El Hassan MA, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp028; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Ginger MR, 2006, P NATL ACAD SCI USA, V103, P5781, DOI 10.1073/pnas.0600745103; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Incitti T, 2010, MOL THER, V18, P1675, DOI 10.1038/mt.2010.123; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Khaitan D, 2011, CANCER RES, V71, P3852, DOI 10.1158/0008-5472.CAN-10-4460; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Mattick JS, 2011, FEBS LETT, V585, P1600, DOI 10.1016/j.febslet.2011.05.001; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Okitsu CY, 2010, MOL CELL BIOL, V30, P2933, DOI 10.1128/MCB.01478-09; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Potthoff MJ, 2007, MOL CELL BIOL, V27, P8143, DOI 10.1128/MCB.01187-07; Qureshi IA, 2010, BRAIN RES, V1338, P20, DOI 10.1016/j.brainres.2010.03.110; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shen HX, 2006, GENE DEV, V20, P675, DOI 10.1101/gad.1383706; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tan-Wong SM, 2008, P NATL ACAD SCI USA, V105, P5160, DOI 10.1073/pnas.0801048105; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Wilson-Rawls J, 1999, MOL CELL BIOL, V19, P2853; Yuasa K, 2008, CELL STRUCT FUNCT, V33, P163, DOI 10.1247/csf.08022; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	43	1995	2146	4	321	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 14	2011	147	2					358	369		10.1016/j.cell.2011.09.028	http://dx.doi.org/10.1016/j.cell.2011.09.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000014	Green Published, Bronze			2022-12-28	WOS:000296199300014
J	Young, OR				Young, Oran R.			A peaceful Arctic	NATURE			English	Editorial Material									Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Young, OR (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.	oran.young@gmail.com							0	2	2	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 13	2011	478	7368					180	181		10.1038/478180a	http://dx.doi.org/10.1038/478180a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21993742	Bronze			2022-12-28	WOS:000295782800027
J	Krumholz, HM; Ross, JS				Krumholz, Harlan M.; Ross, Joseph S.			A Model for Dissemination and Independent Analysis of Industry Data	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PLACEBO		[Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT USA; [Ross, Joseph S.] Yale Univ, Sch Med, Dept Internal Med, Sect Gen Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	Yale University; Yale University; Yale University; Yale University; Yale University	Krumholz, HM (corresponding author), 1 Church St,Ste 200, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020	Ross, Joseph/0000-0002-9218-3320	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01 HL105270, U01-HL105270-02] Funding Source: Medline; NIA NIH HHS [K08 AG032886] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Eyding D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4737; Kesselheim AS, 2007, JAMA-J AM MED ASSOC, V297, P308, DOI 10.1001/jama.297.3.308; Lyman Gary H, 2005, BMC Med Res Methodol, V5, P14, DOI 10.1186/1471-2288-5-14; Marciniak TA, 2010, MEMORANDUM CARDIOVAS; Ross JS, 2010, ARCH INTERN MED, V170, P2035, DOI 10.1001/archinternmed.2010.461; Ross JS, 2009, ARCH INTERN MED, V169, P1976, DOI 10.1001/archinternmed.2009.394; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Winslow R, 2011, WALL STREET J   0802	8	40	41	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 12	2011	306	14					1593	1594		10.1001/jama.2011.1459	http://dx.doi.org/10.1001/jama.2011.1459			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831FS	21990302	Green Accepted			2022-12-28	WOS:000295714700025
J	Yang, D; Khan, S; Sun, Y; Hess, K; Shmulevich, I; Sood, AK; Zhang, W				Yang, Da; Khan, Sofia; Sun, Yan; Hess, Kenneth; Shmulevich, Ilya; Sood, Anil K.; Zhang, Wei			Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GERM-LINE MUTATIONS; CLINICAL-FEATURES; BINDING; BREAST; WOMEN; RECOMBINATION; CCDC98; REPAIR; RISKS	Context Attempts to determine the clinical significance of BRCA1/2 mutations in ovarian cancer have produced conflicting results. Objective To determine the relationships between BRCA1/2 deficiency (ie, mutation and promoter hypermethylation) and overall survival (OS), progression-free survival (PFS), chemotherapy response, and whole-exome mutation rate in ovarian cancer. Design, Setting, and Patients Observational study of multidimensional genomics and clinical data on 316 high-grade serous ovarian cancer cases that were made public between 2009 and 2010 via The Cancer Genome Atlas project. Main Outcome Measures OS and PFS rates (primary outcomes) and chemotherapy response (secondary outcome). Results BRCA2 mutations (29 cases) were associated with significantly better OS (adjusted hazard ratio [HR], 0.33; 95% CI, 0.16-0.69; P=.003 and 5-year OS, 61% for BRCA2-mutated vs 25% for BRCA wild-type cases) and PFS (adjusted HR, 0.40; 95% CI, 0.22-0.74; P=.004 and 3-year PFS, 44% for BRCA2-mutated vs 16% for BRCA wild-type cases), whereas neither BRCA1 mutations (37 cases) nor BRCA1 methylation (33 cases) was associated with prognosis. Moreover, BRCA2 mutations were associated with a significantly higher primary chemotherapy sensitivity rate (100% for BRCA2-mutated vs 82% [P=.02] and 80% [P=.05] for BRCA wild-type and BRCA1-mutated cases, respectively) and longer platinum-free duration (median platinum-free duration, 18.0 months for BRCA2-mutated vs 11.7 [P=.02] and 12.5 [P=.04] months for BRCA wild-type and BRCA1-mutated cases, respectively). BRCA2-mutated, but not BRCA1-mutated cases, exhibited a "mutator phenotype" by containing significantly more mutations than BRCA wild-type cases across the whole exome (median mutation number per sample, 84 for BRCA2-mutated vs 52 for BRCA wildtype cases, false discovery rate <0.1). Conclusion Among women with high-grade serous ovarian cancer, BRCA2 mutation, but not BRCA1 deficiency, was associated with improved survival, improved chemotherapy response, and genome instability compared with BRCA wild-type. JAMA. 2011;306(14):1557-1565	[Zhang, Wei] Univ Texas MD Anderson Canc Ctr, Unit 85, Dept Pathol, Houston, TX 77030 USA; [Hess, Kenneth] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Dept Canc Biol, Houston, TX 77030 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Ctr RNAi & Non Coding RNA, Houston, TX 77030 USA; [Sun, Yan] Tianjin Med Univ Canc Inst & Hosp, Dept Pathol, Tianjin, Peoples R China; [Shmulevich, Ilya] Inst Syst Biol, Seattle, WA USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Tianjin Medical University; Institute for Systems Biology (ISB)	Zhang, W (corresponding author), Univ Texas MD Anderson Canc Ctr, Unit 85, Dept Pathol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	wzhang@mdanderson.org	wang, edwin/G-5372-2010; Hess, Kenneth/K-6546-2019; Yang, Da/I-9054-2012	Hess, Kenneth/0000-0003-1377-6070; Khan, Sofia/0000-0003-4185-8882; Yang, Da/0000-0002-8336-9457	National Institutes of Health (NIH) [U24CA143835]; Blanton-Davis Ovarian Cancer Research Program; Ovarian Cancer SPORE grant [P50 CA083639]; ASLA-Fulbright Research Grant; NATIONAL CANCER INSTITUTE [P50CA083639, P30CA016672, U24CA143835] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Blanton-Davis Ovarian Cancer Research Program; Ovarian Cancer SPORE grant; ASLA-Fulbright Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Hess, Shmulevich, Sood, and Zhang are funded by the National Institutes of Health (NIH) and various foundations and institutional funds. Dr Sun reports no disclosures.; This study was supported by grants from the NIH (U24CA143835) to Drs Shmulevich and Zhang, from the Blanton-Davis Ovarian Cancer Research Program to Dr Zhang, and the Ovarian Cancer SPORE grant (P50 CA083639) to Dr Sood. Dr Yang reports being an Odyssey Fellow at MD Anderson Cancer Center. Dr Khan reports being partially supported by an ASLA-Fulbright Research Grant for a junior scholar.	Aida H, 1998, CLIN CANCER RES, V4, P235; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Ben David Y, 2002, J CLIN ONCOL, V20, P463, DOI 10.1200/JCO.20.2.463; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berchuck A, 1998, CLIN CANCER RES, V4, P2433; Boyd J, 2000, JAMA-J AM MED ASSOC, V283, P2260, DOI 10.1001/jama.283.17.2260; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Brose MS, 2002, J NATL CANCER I, V94, P1365, DOI 10.1093/jnci/94.18.1365; Cass I, 2003, CANCER, V97, P2187, DOI 10.1002/cncr.11310; Chetrit A, 2008, J CLIN ONCOL, V26, P20, DOI 10.1200/JCO.2007.11.6905; Chi DS, 2006, GYNECOL ONCOL, V103, P559, DOI 10.1016/j.ygyno.2006.03.051; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Foster KA, 1996, CANCER RES, V56, P3622; Johannsson OT, 1998, J CLIN ONCOL, V16, P397, DOI 10.1200/JCO.1998.16.2.397; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; Lou ZK, 2005, NAT STRUCT MOL BIOL, V12, P589, DOI 10.1038/nsmb953; Majdak EJ, 2005, CANCER, V104, P1004, DOI 10.1002/cncr.21276; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; National Cancer Institute, CANC GEN ATL DAT POR; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Pharoah PDP, 1999, CANCER RES, V59, P868; Rubin SC, 1996, NEW ENGL J MED, V335, P1413, DOI 10.1056/NEJM199611073351901; Sankaran S, 2007, CANCER BIOL THER, V6, P1853, DOI 10.4161/cbt.6.12.5164; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; Tan DSP, 2008, J CLIN ONCOL, V26, P5530, DOI 10.1200/JCO.2008.16.1703; Thompson D, 2002, JNCI-J NATL CANCER I, V94, P1358, DOI 10.1093/jnci/94.18.1358; Tutt A, 2002, TRENDS MOL MED, V8, P571, DOI 10.1016/S1471-4914(02)02434-6; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Xia F, 2001, P NATL ACAD SCI USA, V98, P8644, DOI 10.1073/pnas.151253498; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837	37	405	416	0	41	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 12	2011	306	14					1557	1565		10.1001/jama.2011.1456	http://dx.doi.org/10.1001/jama.2011.1456			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831FS	21990299	Bronze, Green Accepted			2022-12-28	WOS:000295714700021
J	Cookson, B				Cookson, Barry			The art of medicine Five decades of MRSA: controversy and uncertainty continues	LANCET			English	Editorial Material									Hlth Protect Agcy, Lab Healthcare Associated Infect, London NW9 5HT, England	Health Protection Agency	Cookson, B (corresponding author), Hlth Protect Agcy, Lab Healthcare Associated Infect, London NW9 5HT, England.	barry.cookson@hpa.org.uk						Cookson B, 2011, J HOSP INFECT, V79, P260, DOI 10.1016/j.jhin.2011.07.008; Cookson B, 2008, EURO SURVEILL, V13; COOPER BS, 2003, HEALTH TECHNOL ASSES, V7, P39; JEVONS MP, 1961, BRIT MED J, V1, P124, DOI 10.1136/bmj.1.5219.124-a; Kock R, 2010, EURO SURVEILL, V15; MacKenzie FM, 2007, CLIN MICROBIOL INFEC, V13, P269, DOI 10.1111/j.1469-0691.2006.01592.x; Reynolds L, 2008, SUPERBUGS SUPERDRUGS	7	13	14	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 8	2011	378	9799					1291	1292		10.1016/S0140-6736(11)61566-3	http://dx.doi.org/10.1016/S0140-6736(11)61566-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	831IU	21991590	Bronze			2022-12-28	WOS:000295724300013
J	Deckelbaum, DL; Ntakiyiruta, G; Liberman, AS; Razek, T; Kyamanywa, P				Deckelbaum, Dan L.; Ntakiyiruta, Georges; Liberman, Alexander S.; Razek, Tarek; Kyamanywa, Patrick			Augmenting surgical capacity in resource-limited settings	LANCET			English	Editorial Material							SURGERY		[Deckelbaum, Dan L.; Liberman, Alexander S.; Razek, Tarek] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Montreal, PQ H3G 1A4, Canada; [Ntakiyiruta, Georges] Kigali Univ, Teaching Hosp, Natl Univ Rwanda, Kigali, Rwanda; [Kyamanywa, Patrick] Natl Univ Rwanda, Butare, Rwanda	McGill University; University of Rwanda; University of Rwanda	Deckelbaum, DL (corresponding author), McGill Univ, Montreal Gen Hosp, Ctr Hlth, Montreal, PQ H3G 1A4, Canada.	dan.deckelbaum@mail.mcgill.ca						Arah OA, 2008, AM J PUBLIC HEALTH, V98, P148, DOI 10.2105/AJPH.2006.095844; Bergman S, 2008, J TRAUMA, V65, P879, DOI 10.1097/TA.0b013e318184a9fe; Central Intelligence Agency, 2011, WORLD FACTB 2011; Kushner AL, 2010, J SURG EDUC, V67, P270, DOI 10.1016/j.jsurg.2010.05.004; Ministry of Health of Rwanda Human Resources for Health, 2011, STRAT PLAN 2011 2016; Mullan F, 2011, LANCET, V377, P1113, DOI 10.1016/S0140-6736(10)61961-7; Scheffler RM, 2008, B WORLD HEALTH ORGAN, V86, P516, DOI 10.2471/BLT.07.046474; Thompson MJ, 2005, ARCH SURG-CHICAGO, V140, P74, DOI 10.1001/archsurg.140.1.74; UN Millennium Project, INV DEV PRACT PLAN A; WHO, 2011, GLOB HLTH ATL 2011; World Health Organization (WHO), 2004, GLOB BURD DIS 2004	11	12	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 25	2012	380	9843					713	714		10.1016/S0140-6736(11)61090-8	http://dx.doi.org/10.1016/S0140-6736(11)61090-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	995IK	22030143				2022-12-28	WOS:000308001300009
J	Pollock, A; Macfarlane, A; Kirkwood, G; Majeed, FA; Greener, I; Morelli, C; Boyle, S; Mellett, H; Godden, S; Price, D; Brhlikova, P				Pollock, Allyson; Macfarlane, Alison; Kirkwood, Graham; Majeed, F. Azeem; Greener, Ian; Morelli, Carlo; Boyle, Sean; Mellett, Howard; Godden, Sylvia; Price, David; Brhlikova, Petra			No evidence that patient choice in the NHS saves lives	LANCET			English	Editorial Material							MORTALITY; ENGLAND; DISEASE		[Pollock, Allyson; Godden, Sylvia; Price, David] Univ London, Ctr Primary Care & Publ Hlth, London E1 4NS, England; [Macfarlane, Alison] City Univ London, Sch Hlth Sci, London EC1V 0HB, England; [Kirkwood, Graham; Brhlikova, Petra] Univ Edinburgh, Sch Social & Polit Sci, Edinburgh, Midlothian, Scotland; [Majeed, F. Azeem] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Greener, Ian] Univ Durham, NE Doctoral Training Ctr, Durham, England; [Morelli, Carlo] Univ Dundee, Dundee, Scotland; [Boyle, Sean] London Sch Econ & Polit Sci, LSE Hlth & Social Care, London, England; [Mellett, Howard] Cardiff Univ, Cardiff Business Sch, Cardiff, S Glam, Wales	University of London; City University London; University of Edinburgh; Imperial College London; Durham University; University of Dundee; University of London; London School Economics & Political Science; Cardiff University	Pollock, A (corresponding author), Univ London, Ctr Primary Care & Publ Hlth, London E1 4NS, England.	a.pollock@qmul.ac.uk		Greener, Ian/0000-0003-4918-8019; Majeed, Azeem/0000-0002-2357-9858; pollock, allyson/0000-0002-7388-3110; Brhlikova, Petra/0000-0003-2085-0304				Allison JJ, 2000, JAMA-J AM MED ASSOC, V284, P1256, DOI 10.1001/jama.284.10.1256; Bloom N, 2010, IMPACT COMPETITION M; Chen J, 1999, NEW ENGL J MED, V340, P286, DOI 10.1056/NEJM199901283400407; Cooper Z, 2010, 162010 LSE HLTH LOND; Cooper Z, 2011, ECON J, V121, pF228, DOI 10.1111/j.1468-0297.2011.02449.x; Dixon A., 2010, PATIENT CHOICE PATIE; Dixon S, 2009, REPORT NATL PATIENT; Dixon S, 2006, REPORT NATL PATIENT; Gaynor M, 2010, 10242 U BRIST CTR MA; Goldacre MJ, 2004, EUR J PUBLIC HEALTH, V14, P338, DOI 10.1093/eurpub/14.4.338; Healthcare Commission, 2008, IND SECT TREATM CTR; Healthcare Commission, 2007, IND SECT TREATM CTR; Healthcare Commission and Audit Commission, 2008, IS TREATM WORK PROGR; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; King's Fund, 2008, IND SECT DAT QUAL WO; McClellan M., 1999, 7327 NAT BUR EC RES; National Centre for Health Outcomes Development, 2001, MYOC INF IN IN PRESS; The London School of Economics and Political Science, 2011, LSE RES HOSP COMP IS; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Volpp KGM, 2003, HEALTH SERV RES, V38, P515, DOI 10.1111/1475-6773.00131; West RM, 2011, EUR HEART J, V32, P706, DOI 10.1093/eurheartj/ehq476	21	39	39	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2011	378	9809					2057	2060		10.1016/S0140-6736(11)61553-5	http://dx.doi.org/10.1016/S0140-6736(11)61553-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	865EL	21988764				2022-12-28	WOS:000298293600015
J	Musset, B; Smith, SME; Rajan, S; Morgan, D; Cherny, VV; DeCoursey, TE				Musset, Boris; Smith, Susan M. E.; Rajan, Sindhu; Morgan, Deri; Cherny, Vladimir V.; DeCoursey, Thomas E.			Aspartate 112 is the selectivity filter of the human voltage-gated proton channel	NATURE			English	Article							INFLUENZA-A VIRUS; ALVEOLAR EPITHELIAL-CELLS; HUMAN-NEUTROPHILS; NADPH OXIDASE; ION-CHANNEL; H+ CURRENTS; TRANSPORT; PERMEATION; SENSOR; PORE	The ion selectivity of pumps and channels is central to their ability to perform a multitude of functions. Here we investigate the mechanism of the extraordinary selectivity of the human voltage-gated proton channel(1), H(V)1 (also known as HVCN1). This selectivity is essential to its ability to regulate reactive oxygen species production by leukocytes(2-4), histamine secretion by basophils(5), sperm capacitation(6), and airway pH(7). The most selective ion channel known, H(V)1 shows no detectable permeability to other ions(1). Opposing classes of selectivity mechanisms postulate that (1) a titratable amino acid residue in the permeation pathway imparts proton selectivity(1,8-11), or (2) water molecules 'frozen' in a narrow pore conduct protons while excluding other ions(12). Here we identify aspartate 112 as a crucial component of the selectivity filter of H(V)1. When a neutral amino acid replaced Asp 112, the mutant channel lost proton specificity and became anion-selective or did not conduct. Only the glutamate mutant remained proton-specific. Mutation of the nearby Asp 185 did not impair proton selectivity, indicating that Asp 112 has a unique role. Although histidine shuttles protons in other proteins, when histidine or lysine replaced Asp 112, the mutant channel was still anion-permeable. Evidently, the proton specificity of H(V)1 requires an acidic group at the selectivity filter.	[Musset, Boris; Morgan, Deri; Cherny, Vladimir V.; DeCoursey, Thomas E.] Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA; [Smith, Susan M. E.] Emory Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Rajan, Sindhu] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Rush University; Emory University; University of Chicago	DeCoursey, TE (corresponding author), Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA.	tdecours@rush.edu	Musset, Boris/J-2520-2013; DeCoursey, Thomas/A-6820-2009; Musset, Boris/AAD-4158-2022	Musset, Boris/0000-0001-8242-8817; DeCoursey, Thomas/0000-0002-4263-180X; Musset, Boris/0000-0001-8242-8817	NSF [MCB-0943362]; NIH [GM087507]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087507] Funding Source: NIH RePORTER; Direct For Biological Sciences [0943362] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank P. H. Barry, D. Gillespie, V. S. Markin, J. F. Nagle, R. Pomes, D. Silverman and V. Sokolov for discussions or comments on the manuscript. Supported by NSF grant MCB-0943362 (S. M. E. S. and T. E. D.) and NIH grant GM087507 (T. E. D.). The content is solely the responsibility of the authors and does not necessarily represent the views of the National Institute of General Medical Sciences or the National Institutes of Health.	Acharya R, 2010, P NATL ACAD SCI USA, V107, P15075, DOI 10.1073/pnas.1007071107; Barry PH, 2006, CELL BIOCHEM BIOPHYS, V46, P143, DOI 10.1385/CBB:46:2:143; Capasso M, 2010, NAT IMMUNOL, V11, P265, DOI 10.1038/ni.1843; Cherny VV, 1999, J GEN PHYSIOL, V114, P819, DOI 10.1085/jgp.114.6.819; CHERNY VV, 1995, J GEN PHYSIOL, V105, P861, DOI 10.1085/jgp.105.6.861; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; DeCoursey TE, 2003, NATURE, V422, P531, DOI 10.1038/nature01523; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DeCoursey TE, 1997, J GEN PHYSIOL, V109, P415, DOI 10.1085/jgp.109.4.415; DECOURSEY TE, 1994, J MEMBRANE BIOL, V141, P203; DeCoursey TE, 1998, J GEN PHYSIOL, V112, P503, DOI 10.1085/jgp.112.4.503; FELSENSTEIN J, 1993, PROTPARS PROTEIN SEQ; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HENDERSON LM, 1987, BIOCHEM J, V246, P325, DOI 10.1042/bj2460325; Hu FH, 2010, SCIENCE, V330, P505, DOI 10.1126/science.1191714; Iovannisci D, 2010, J GEN PHYSIOL, V136, P35, DOI 10.1085/jgp.200910379; Leiding T, 2010, P NATL ACAD SCI USA, V107, P15409, DOI 10.1073/pnas.1009997107; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; LEVITT DG, 1978, BIOCHIM BIOPHYS ACTA, V512, P436, DOI 10.1016/0005-2736(78)90266-3; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Musset B, 2008, J PHYSIOL-LONDON, V586, P2477, DOI 10.1113/jphysiol.2007.149427; Musset B, 2008, P NATL ACAD SCI USA, V105, P11020, DOI 10.1073/pnas.0800886105; Musset B, 2010, J PHYSIOL-LONDON, V588, P1435, DOI 10.1113/jphysiol.2010.188318; NAGLE JF, 1978, P NATL ACAD SCI USA, V75, P298, DOI 10.1073/pnas.75.1.298; Nelson R D, 1999, J Mol Microbiol Biotechnol, V1, P281; Neron B, 2009, BIOINFORMATICS, V25, P3005, DOI 10.1093/bioinformatics/btp493; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Ramsey IS, 2010, NAT STRUCT MOL BIOL, V17, P869, DOI 10.1038/nsmb.1826; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Sansom MSP, 1997, VIROLOGY, V233, P163, DOI 10.1006/viro.1997.8578; Sokolov S, 2010, J GEN PHYSIOL, V136, P225, DOI 10.1085/jgp.201010414; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; TU CK, 1989, BIOCHEMISTRY-US, V28, P7913, DOI 10.1021/bi00445a054; Venkataraman P, 2005, J BIOL CHEM, V280, P21463, DOI 10.1074/jbc.M412406200	37	123	125	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2011	480	7376					273	U167		10.1038/nature10557	http://dx.doi.org/10.1038/nature10557			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857TR	22020278	Green Accepted			2022-12-28	WOS:000297744200058
J	Treusch, S; Hamamichi, S; Goodman, JL; Matlack, KES; Chung, CY; Baru, V; Shulman, JM; Parrado, A; Bevis, BJ; Valastyan, JS; Han, H; Lindhagen-Persson, M; Reiman, EM; Evans, DA; Bennett, DA; Olofsson, A; DeJager, PL; Tanzi, RE; Caldwell, KA; Caldwell, GA; Lindquist, S				Treusch, Sebastian; Hamamichi, Shusei; Goodman, Jessica L.; Matlack, Kent E. S.; Chung, Chee Yeun; Baru, Valeriya; Shulman, Joshua M.; Parrado, Antonio; Bevis, Brooke J.; Valastyan, Julie S.; Han, Haesun; Lindhagen-Persson, Malin; Reiman, Eric M.; Evans, Denis A.; Bennett, David A.; Olofsson, Anders; DeJager, Philip L.; Tanzi, Rudolph E.; Caldwell, Kim A.; Caldwell, Guy A.; Lindquist, Susan			Functional Links Between A beta Toxicity, Endocytic Trafficking, and Alzheimer's Disease Risk Factors in Yeast	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; ALPHA-SYNUCLEIN; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; IDENTIFIES VARIANTS; COMMON VARIANTS; PEPTIDE; OLIGOMERS; MEMBRANE; CELLS	A beta (beta-amyloid peptide) is an important contributor to Alzheimer's disease (AD). We modeled A beta toxicity in yeast by directing the peptide to the secretory pathway. A genome-wide screen for toxicity modifiers identified the yeast homolog of phosphatidylinositol binding clathrin assembly protein (PICALM) and other endocytic factors connected to AD whose relationship to A beta was previously unknown. The factors identified in yeast modified A beta toxicity in glutamatergic neurons of Caenorhabditis elegans and in primary rat cortical neurons. In yeast, A beta impaired the endocytic trafficking of a plasma membrane receptor, which was ameliorated by endocytic pathway factors identified in the yeast screen. Thus, links between A beta, endocytosis, and human AD risk factors can be ascertained with yeast as a model system.	[Treusch, Sebastian; Hamamichi, Shusei; Goodman, Jessica L.; Matlack, Kent E. S.; Chung, Chee Yeun; Baru, Valeriya; Bevis, Brooke J.; Valastyan, Julie S.; Han, Haesun; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Treusch, Sebastian; Matlack, Kent E. S.; Baru, Valeriya; Valastyan, Julie S.; Lindquist, Susan] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Hamamichi, Shusei; Caldwell, Kim A.; Caldwell, Guy A.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Shulman, Joshua M.; DeJager, Philip L.] Brigham & Womens Hosp, Inst Neurosci, Program Translat NeuroPsychiat Genom, Dept Neurol, Boston, MA 02115 USA; [Shulman, Joshua M.; DeJager, Philip L.] Brigham & Womens Hosp, Inst Neurosci, Program Translat NeuroPsychiat Genom, Dept Psychiat, Boston, MA 02115 USA; [Valastyan, Julie S.; DeJager, Philip L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Shulman, Joshua M.; DeJager, Philip L.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Parrado, Antonio; Tanzi, Rudolph E.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Genet & Aging Res Unit, Charlestown, MA 02129 USA; [Lindhagen-Persson, Malin; Olofsson, Anders] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Reiman, Eric M.] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA; [Reiman, Eric M.] Arizona Alzheimers Consortium, Phoenix, AZ 85004 USA; [Reiman, Eric M.] Univ Arizona, Banner Alzheimers Inst, Phoenix, AZ 85006 USA; [Reiman, Eric M.] Univ Arizona, Dept Psychiat, Phoenix, AZ 85006 USA; [Evans, Denis A.] Rush Univ, Med Ctr, Dept Internal Med, Rush Inst Hlth Aging, Chicago, IL 60612 USA; [Bennett, David A.] Rush Univ, Med Ctr, Dept Neurol Sci, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Alabama System; University of Alabama Tuscaloosa; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Umea University; Translational Genomics Research Institute; Banner Research; Banner Health; Banner Alzheimer's Institute; University of Arizona; University of Arizona; Rush University; Rush University	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu	Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454; Caldwell, Guy/0000-0002-8283-9090; Caldwell, Kim/0000-0003-1580-6122	Howard Hughes Medical Institute; National Research Service Award fellowship [F32 NS067782-02]; Cure Alzheimer's Fund; NIH [K08AG034290, P30AG10161, R01AG15819, R01AG17917]; Kempe foundation; Alzheimerfonden; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS067782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015819, P30AG019610, K08AG034290, P30AG010161, R01AG017917] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Research Service Award fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kempe foundation; Alzheimerfonden; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank L. Chibnik, B. Keenan, and D. Ng for helpful discussions; D. Wittrup, V. Lee, M. Vidal, and C. Link for materials; and J. Corneveaux, M. Huentelman, and other Translational Genomics investigators for assistance with the human study cohorts and participants in the Religious Orders Study and the Rush Memory and Aging Project. This work was supported by a Howard Hughes Medical Institute Collaborative Innovation Award; National Research Service Award fellowship F32 NS067782-02; the Cure Alzheimer's Fund; NIH grants K08AG034290, P30AG10161, R01AG15819, and R01AG17917; the Kempe foundation; and Alzheimerfonden. This paper is dedicated to Nell Matheney, Zhao Xindi, Rochelle Glatt, Matyas Topolszki, their families, and the countless other victims of Alzheimer's disease.	Bennett DA, 2009, NEUROLOGY, V72, P1495, DOI 10.1212/WNL.0b013e3181a2e87d; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Blacker D, 1997, NEUROLOGY, V48, P139, DOI 10.1212/WNL.48.1.139; Bozyczko-Coyne D, 2001, J NEUROCHEM, V77, P849, DOI 10.1046/j.1471-4159.2001.00294.x; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Gaidos G, 2007, J CELL SCI, V120, P2366, DOI 10.1242/jcs.004333; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jung N, 2007, TRAFFIC, V8, P1129, DOI 10.1111/j.1600-0854.2007.00595.x; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809; Knobloch M, 2007, NEUROBIOL AGING, V28, P1297, DOI 10.1016/j.neurobiolaging.2006.06.019; Kowalski JM, 1998, BIOCHEMISTRY-US, V37, P1264, DOI 10.1021/bi9722397; LaFerla FM, 2010, BIOCHEM SOC T, V38, P993, DOI 10.1042/BST0380993; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lee EB, 2006, J BIOL CHEM, V281, P4292, DOI 10.1074/jbc.M511018200; Lindhagen-Persson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013928; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Maldonado-Baez L, 2008, MOL BIOL CELL, V19, P2936, DOI 10.1091/mbc.E07-10-1019; Minano-Molina AJ, 2011, J BIOL CHEM, V286, P27311, DOI 10.1074/jbc.M111.227504; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; Ramjaun AR, 1997, J BIOL CHEM, V272, P16700, DOI 10.1074/jbc.272.26.16700; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shulman JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011244; Stamenova SD, 2004, J BIOL CHEM, V279, P16017, DOI 10.1074/jbc.M313479200; Su LHJ, 2010, DIS MODEL MECH, V3, P194, DOI 10.1242/dmm.004267; Sun YD, 2007, J CELL BIOL, V177, P355, DOI 10.1083/jcb.200611011; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Verdier Y, 2004, J PEPT SCI, V10, P229, DOI 10.1002/psc.573; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122	42	265	274	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2011	334	6060					1241	1245		10.1126/science.1213210	http://dx.doi.org/10.1126/science.1213210			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22033521	Green Submitted, Green Accepted			2022-12-28	WOS:000297553600041
J	McNaughton-Collins, MF; Barry, MJ				McNaughton-Collins, Mary F.; Barry, Michael J.			One Man at a Time - Resolving the PSA Controversy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[McNaughton-Collins, Mary F.] Harvard Univ, Sch Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	McNaughton-Collins, MF (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Hoffman RM, 2009, ARCH INTERN MED, V169, P1611, DOI 10.1001/archinternmed.2009.262; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; U.S. Preventive Services Task Force, 2011, DRAFT REC STAT; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066	5	55	58	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2011	365	21					1951	1953		10.1056/NEJMp1111894	http://dx.doi.org/10.1056/NEJMp1111894			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	851PF	22029758				2022-12-28	WOS:000297282600003
J	Ramsden, S; Richardson, FM; Josse, G; Thomas, MSC; Ellis, C; Shakeshaft, C; Seghier, ML; Price, CJ				Ramsden, Sue; Richardson, Fiona M.; Josse, Goulven; Thomas, Michael S. C.; Ellis, Caroline; Shakeshaft, Clare; Seghier, Mohamed L.; Price, Cathy J.			Verbal and non-verbal intelligence changes in the teenage brain	NATURE			English	Article							PREFRONTAL CORTEX; CEREBELLUM; CHILDREN; ACQUISITION; CHILDHOOD; ABILITY; FMRI	Intelligence quotient (IQ) is a standardized measure of human intellectual capacity that takes into account a wide range of cognitive skills(1). IQ is generally considered to be stable across the lifespan, with scores at one time point used to predict educational achievement and employment prospects in later years(1). Neuroimaging allows us to test whether unexpected longitudinal fluctuations in measured IQ are related to brain development. Here we show that verbal and non-verbal IQ can rise or fall in the teenage years, with these changes in performance validated by their close correlation with changes in local brain structure. A combination of structural and functional imaging showed that verbal IQ changed with grey matter in a region that was activated by speech, whereas non-verbal IQ changed with grey matter in a region that was activated by finger movements. By using longitudinal assessments of the same individuals, we obviated the many sources of variation in brain structure that confound cross-sectional studies. This allowed us to dissociate neural markers for the two types of IQ and to show that general verbal and non-verbal abilities are closely linked to the sensorimotor skills involved in learning. More generally, our results emphasize the possibility that an individual's intellectual capacity relative to their peers can decrease or increase in the teenage years. This would be encouraging to those whose intellectual potential may improve, and would be a warning that early achievers may not maintain their potential.	[Ramsden, Sue; Richardson, Fiona M.; Josse, Goulven; Ellis, Caroline; Shakeshaft, Clare; Seghier, Mohamed L.; Price, Cathy J.] UCL, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England; [Thomas, Michael S. C.] Univ London, Birkbeck Coll, Dept Psychol Sci, Dev Neurocognit Lab, London WC1E 7HX, England	University of London; University College London; University of London; Birkbeck University London	Price, CJ (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England.	c.price@fil.ion.ucl.ac.uk	Seghier, Mohamed L/C-6314-2009; Seghier, Mohamed/O-8634-2019	Seghier, Mohamed L/0000-0002-1146-8800; Seghier, Mohamed/0000-0002-1146-8800; Price, Catherine/0000-0001-7448-4835; Thomas, Michael/0000-0002-8231-6011	Wellcome Trust; Medical Research Council [G0300188] Funding Source: researchfish; MRC [G0300188] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Wellcome Trust. We thank J. Glensman, A. Brennan, A. Peters, L. Stewart, K. Pitcher and R. Rutherford for their help with data collection; and W. Penny for his advice on statistical analyses.	Camara WJ, 2000, PROF PSYCHOL-RES PR, V31, P141, DOI 10.1037/0735-7028.31.2.141; Colom Roberto, 2010, Dialogues Clin Neurosci, V12, P489; Davis AS, 2009, ARCH CLIN NEUROPSYCH, V24, P273, DOI 10.1093/arclin/acp032; Davis EE, 2010, CORTEX, V46, P919, DOI 10.1016/j.cortex.2009.10.001; Deary IJ, 2000, INTELLIGENCE, V28, P49, DOI 10.1016/S0160-2896(99)00031-8; Diamond A, 2000, CHILD DEV, V71, P44, DOI 10.1111/1467-8624.00117; Eckert MA, 2006, NEUROIMAGE, V32, P1001, DOI 10.1016/j.neuroimage.2006.05.014; Gong QY, 2005, NEUROIMAGE, V25, P1175, DOI 10.1016/j.neuroimage.2004.12.044; Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025; Huang J, 2002, HUM BRAIN MAPP, V15, P39, DOI 10.1002/hbm.1060; JONES OP, 2011, CEREB CORTEX    0624; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; KAUFMAN A, 2006, ASSESSING ADOLESCENT, P209; Lee H, 2007, J NEUROSCI, V27, P1184, DOI 10.1523/JNEUROSCI.4442-06.2007; MCCALL RB, 1977, SCIENCE, V197, P482, DOI 10.1126/science.197.4302.482; Nitschke MF, 1996, BRAIN, V119, P1023; Pangelinan MM, 2011, NEUROIMAGE, V54, P3093, DOI 10.1016/j.neuroimage.2010.11.021; Richardson FM, 2010, J COGNITIVE NEUROSCI, V22, P943, DOI 10.1162/jocn.2009.21238; Rosenbaum DA, 2001, ANNU REV PSYCHOL, V52, P453, DOI 10.1146/annurev.psych.52.1.453; Seghier ML, 2010, J NEUROSCI, V30, P16809, DOI 10.1523/JNEUROSCI.3377-10.2010; Seghier ML, 2009, NEUROIMAGE, V45, P349, DOI 10.1016/j.neuroimage.2008.12.017; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Stoodley CJ, 2010, BEHAV NEUROL, V23, P65, DOI [10.3233/BEN-2010-0268, 10.1155/2010/840942]; Wassenberg R, 2005, CHILD DEV, V76, P1092, DOI 10.1111/j.1467-8624.2005.00899.x; Wilke M, 2003, NEUROIMAGE, V20, P202, DOI 10.1016/S1053-8119(03)00199-X	25	125	125	4	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 3	2011	479	7371					113	116		10.1038/nature10514	http://dx.doi.org/10.1038/nature10514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	840FA	22012265	Green Accepted			2022-12-28	WOS:000296422600042
J	Hay, AD; Whiting, P; Butler, CC				Hay, Alastair D.; Whiting, Penny; Butler, Christopher C.			UNCERTAINTIES PAGE How best to diagnose urinary tract infection in preschool children in primary care?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FEBRILE YOUNG GIRLS; SCREENING-TEST; DECISION RULE; INFANTS; RISK; BACTERIURIA; PREVALENCE; CHILDHOOD; AGE		[Hay, Alastair D.] Univ Bristol, Sch Social & Community Med, NIHR Natl Sch Primary Care Res, Acad Unit Primary Hlth Care, Bristol BS8 2PS, Avon, England; [Butler, Christopher C.] Cardiff Univ, Sch Med, Dept Primary Care & Publ Hlth, Cardiff, S Glam, Wales	University of Bristol; Cardiff University	Hay, AD (corresponding author), Univ Bristol, Sch Social & Community Med, NIHR Natl Sch Primary Care Res, Acad Unit Primary Hlth Care, Bristol BS8 2PS, Avon, England.	alastair.hay@bristol.ac.uk	Hay, Alastair/L-1818-2019	Butler, Christopher/0000-0002-0102-3453; Whiting, Penny/0000-0003-1138-5682; Hay, Alastair/0000-0003-3012-375X	MRC [G0801405] Funding Source: UKRI; National Institute for Health Research [CDF-2009-02-10, 08/66/01] Funding Source: researchfish; Medical Research Council [G0801405] Funding Source: Medline; Department of Health [08/66/01, CDF-2009-02-10] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health		Armengol CE, 2001, PEDIATR INFECT DIS J, V20, P1176, DOI 10.1097/00006454-200112000-00018; Coulthard MG, 2003, BMJ-BRIT MED J, V327, P656, DOI 10.1136/bmj.327.7416.656; Craig JC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1594; Dayan PS, 2002, PEDIATR EMERG CARE, V18, P12, DOI 10.1097/00006565-200202000-00004; Etoubleau C, 2009, J PEDIATR-US, V154, P803, DOI 10.1016/j.jpeds.2009.01.008; Gorelick MH, 2003, PEDIATR EMERG CARE, V19, P162, DOI 10.1097/01.pec.0000081238.98249.40; Gorelick MH, 2000, ARCH PEDIAT ADOL MED, V154, P386, DOI 10.1001/archpedi.154.4.386; LEJEUNE B, 1991, J CLIN PATHOL, V44, P1029, DOI 10.1136/jcp.44.12.1029; National Institute for Health and Clinical Excellence (NICE), 2007, UR TRACT INF CHILDR; O'Brien K, 2011, SCAND J PRIM HEALTH, V29, P19, DOI 10.3109/02813432.2011.554268; SACKS SH, 1987, LANCET, V2, P991; Shaikh N, 2008, PEDIATR INFECT DIS J, V27, P302, DOI 10.1097/INF.0b013e31815e4122; Shaikh N, 2007, JAMA-J AM MED ASSOC, V298, P2895, DOI 10.1001/jama.298.24.2895; Shaikh N, 2010, PEDIATRICS, V126, P1084, DOI 10.1542/peds.2010-0685; SHAW KN, 1991, J PEDIATR-US, V118, P733, DOI 10.1016/S0022-3476(05)80035-6; Shaw KN, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.6.e1; Vernon SJ, 1997, BMJ-BRIT MED J, V315, P905; WETTERGREN B, 1985, ACTA PAEDIATR SCAND, V74, P925, DOI 10.1111/j.1651-2227.1985.tb10059.x; Whiting P, 2006, HEALTH TECHNOL ASSES, V10, P1	19	12	12	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2011	343								d6316	10.1136/bmj.d6316	http://dx.doi.org/10.1136/bmj.d6316			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	840CW	22028485	Green Submitted, Green Accepted			2022-12-28	WOS:000296416900003
J	Ludwig, J; Sanbonmatsu, L; Gennetian, L; Adam, E; Duncan, GJ; Katz, LF; Kessler, RC; Kling, JR; Lindau, ST; Whitaker, RC; McDade, TW				Ludwig, Jens; Sanbonmatsu, Lisa; Gennetian, Lisa; Adam, Emma; Duncan, Greg J.; Katz, Lawrence F.; Kessler, Ronald C.; Kling, Jeffrey R.; Lindau, Stacy Tessler; Whitaker, Robert C.; McDade, Thomas W.			Neighborhoods, Obesity, and Diabetes - A Randomized Social Experiment	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESIDENTIAL SEGREGATION	BACKGROUND The question of whether neighborhood environment contributes directly to the development of obesity and diabetes remains unresolved. The study reported on here uses data from a social experiment to assess the association of randomly assigned variation in neighborhood conditions with obesity and diabetes. METHODS From 1994 through 1998, the Department of Housing and Urban Development (HUD) randomly assigned 4498 women with children living in public housing in high-poverty urban census tracts (in which = 40% of residents had incomes below the federal poverty threshold) to one of three groups: 1788 were assigned to receive housing vouchers, which were redeemable only if they moved to a low-poverty census tract (where <10% of residents were poor), and counseling on moving; 1312 were assigned to receive unrestricted, traditional vouchers, with no special counseling on moving; and 1398 were assigned to a control group that was offered neither of these opportunities. From 2008 through 2010, as part of a long-term follow-up survey, we measured data indicating health outcomes, including height, weight, and level of glycated hemoglobin (HbA(1C)). RESULTS As part of our long-term survey, we obtained data on body-mass index (BMI, the weight in kilograms divided by the square of the height in meters) for 84.2% of participants and data on glycated hemoglobin level for 71.3% of participants. Response rates were similar across randomized groups. The prevalences of a BMI of 35 or more, a BMI of 40 or more, and a glycated hemoglobin level of 6.5% or more were lower in the group receiving the low-poverty vouchers than in the control group, with an absolute difference of 4.61 percentage points (95% confidence interval [CI], -8.54 to -0.69), 3.38 percentage points (95% CI, -6.39 to -0.36), and 4.31 percentage points (95% CI, -7.82 to -0.80), respectively. The differences between the group receiving traditional vouchers and the control group were not significant. CONCLUSIONS The opportunity to move from a neighborhood with a high level of poverty to one with a lower level of poverty was associated with modest but potentially important reductions in the prevalence of extreme obesity and diabetes. The mechanisms underlying these associations remain unclear but warrant further investigation, given their potential to guide the design of community-level interventions intended to improve health. (Funded by HUD and others.)	[Ludwig, Jens; Lindau, Stacy Tessler] Univ Chicago, Chicago, IL 60637 USA; [Ludwig, Jens; Sanbonmatsu, Lisa; Katz, Lawrence F.; Kling, Jeffrey R.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Katz, Lawrence F.] Harvard Univ, Cambridge, MA 02138 USA; [Gennetian, Lisa] Brookings Inst, Washington, DC 20036 USA; [Kling, Jeffrey R.] Congress Budget Off, Washington, DC USA; [Adam, Emma; McDade, Thomas W.] Northwestern Univ, Evanston, IL USA; [Duncan, Greg J.] Univ Calif Irvine, Irvine, CA USA; [Kessler, Ronald C.] Harvard Univ, Sch Med, Boston, MA USA; [Whitaker, Robert C.] Temple Univ, Philadelphia, PA 19122 USA	University of Chicago; National Bureau of Economic Research; Harvard University; Brookings Institution; Congressional Budget Office; Northwestern University; University of California System; University of California Irvine; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Ludwig, J (corresponding author), Univ Chicago, 1155 E 60th St, Chicago, IL 60637 USA.	jludwig@uchicago.edu	Schiaffino, Melody K/E-9629-2011		HUD [C-CHI-00808]; National Science Foundation [SES-0527615]; National Institute of Child Health and Human Development (NICHD) [R01-HD040404, R01-HD040444]; Centers for Disease Control and Prevention [R49-CE000906]; National Institute of Mental Health [R01-MH077026]; National Institute on Aging [R56-AG031259, P01-AG005842-22S1]; National Institutes of Health through NORC [5P30 AG012857]; University of Chicago Center on Demography and Economics of Aging Core on Biomeasures in Population Based Aging Research [1K23AG032870-01A1]; Institute of Education Sciences at the Department of Education [R305U070006]; Population Research Center at the National Opinion Research Center from NICHD [R24-HD051152-04]; Center for Health Administration Studies at the University of Chicago; John D. and Catherine T. MacArthur Foundation; Smith Richardson Foundation; Spencer Foundation; Annie E. Casey Foundation; Bill and Melinda Gates Foundation; Russell Sage Foundation; Eli Lilly; Mindsite; Wyeth-Ayerst; Wellness and Prevention; GlaxoSmithKline; Sanofi-Aventis; Kaiser Permanente; Merck; Ortho-McNeil Janssen Scientific Affairs; Pfizer; Shire US; SRA International; Takeda Global Research and Development; Transcept Pharmaceuticals; Plus One Health Management; Analysis Group; Bristol-Myers Squibb; EPI-Q; Walgreens; PepsiCo; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD051152] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040404, R01HD040444] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL [R49CE000906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031259, K23AG032870, P01AG005842, P30AG012857, R56AG031259] Funding Source: NIH RePORTER	HUD; National Science Foundation(National Science Foundation (NSF)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health through NORC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Center on Demography and Economics of Aging Core on Biomeasures in Population Based Aging Research; Institute of Education Sciences at the Department of Education; Population Research Center at the National Opinion Research Center from NICHD; Center for Health Administration Studies at the University of Chicago; John D. and Catherine T. MacArthur Foundation; Smith Richardson Foundation; Spencer Foundation; Annie E. Casey Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Russell Sage Foundation; Eli Lilly(Eli Lilly); Mindsite; Wyeth-Ayerst; Wellness and Prevention; GlaxoSmithKline(GlaxoSmithKline); Sanofi-Aventis(Sanofi-Aventis); Kaiser Permanente; Merck(Merck & Company); Ortho-McNeil Janssen Scientific Affairs(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Pfizer(Pfizer); Shire US; SRA International; Takeda Global Research and Development; Transcept Pharmaceuticals; Plus One Health Management; Analysis Group; Bristol-Myers Squibb(Bristol-Myers Squibb); EPI-Q; Walgreens; PepsiCo; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from HUD (C-CHI-00808), the National Science Foundation (SES-0527615), the National Institute of Child Health and Human Development (NICHD) (R01-HD040404 and R01-HD040444), the Centers for Disease Control and Prevention (R49-CE000906), the National Institute of Mental Health (R01-MH077026), the National Institute on Aging (R56-AG031259 and P01-AG005842-22S1), the National Institutes of Health (to Dr. Lindau) through NORC (5P30 AG012857) and the University of Chicago Center on Demography and Economics of Aging Core on Biomeasures in Population Based Aging Research (1K23AG032870-01A1), and the Institute of Education Sciences at the Department of Education (R305U070006) and by the Population Research Center at the National Opinion Research Center (through a grant [R24-HD051152-04] from the NICHD), the Center for Health Administration Studies at the University of Chicago, the John D. and Catherine T. MacArthur Foundation, the Smith Richardson Foundation, the Spencer Foundation, the Annie E. Casey Foundation, the Bill and Melinda Gates Foundation, and the Russell Sage Foundation.; Dr. Kessler reports receiving fees for board membership from Eli Lilly, Mindsite, and Wyeth-Ayerst; receiving consulting fees from Wellness and Prevention, GlaxoSmithKline, Sanofi-Aventis, Kaiser Permanente, Merck, Ortho-McNeil Janssen Scientific Affairs, Pfizer, Shire US, SRA International, Takeda Global Research and Development, Transcept Pharmaceuticals, Wyeth-Ayerst, and Plus One Health Management; and holding stock in DataStat. Dr. Kessler's institution, Harvard Medical School, has received grant support from Analysis Group, Bristol-Myers Squibb, Eli Lilly, EPI-Q, Ortho-McNeil Janssen Scientific Affairs, Pfizer, Sanofi-Aventis, Shire US, and Walgreens. Drs. Lindau and Ludwig's institution, the University of Chicago, has received grant support from PepsiCo. No other potential conflict of interest relevant to this article was reported.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; American Association for Public Opinion Research, STAND DEF; Black JL, 2010, AM J EPIDEMIOL, V171, P765, DOI 10.1093/aje/kwp458; BLOOM HS, 1984, EVALUATION REV, V8, P225, DOI 10.1177/0193841X8400800205; *BUR CENS, CENS TRACTS BLOCK NU; Chang VW, 2006, SOC SCI MED, V63, P1289, DOI 10.1016/j.socscimed.2006.03.049; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Cohen DA, 2006, SOC SCI MED, V62, P769, DOI 10.1016/j.socscimed.2005.06.033; Department of Housing and Urban Development, 1996, EXP HOUS CHOIC HUD A; Feins J, 1995, IMPLEMENTATION ASSIS; Feins J. D., 1996, MOVING OPPORTUNITY F; Finkelstein EA, 2008, OBESITY, V16, P1843, DOI 10.1038/oby.2008.290; Fowler-Brown AG, 2009, OBESITY, V17, P2106, DOI 10.1038/oby.2009.130; Franco M, 2008, AM J PREV MED, V35, P561, DOI 10.1016/j.amepre.2008.07.003; GOERING J, 2000, CHOOSING BETTER LIFE, P3; Groves RM., 2011, SURV METHODOL; Jacob Brian A, AM EC REV IN PRESS; Jargowsky P., 2003, STUNNING PROGR HIDDE; Kling JR, 2007, ECONOMETRICA, V75, P83, DOI 10.1111/j.1468-0262.2007.00733.x; Krishnan S, 2010, AM J EPIDEMIOL, V171, P564, DOI 10.1093/aje/kwp443; Lovasi GS, 2009, AM J PUBLIC HEALTH, V99, P279, DOI 10.2105/AJPH.2008.138230; Ludwig J, 2008, AM J SOCIOL, V114, P144, DOI 10.1086/588741; Morenoff JD, 2008, MAKING AM HLTH SOCIA, P309; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; National Institute of Health, 1998, NIH PUBLICATION, V98-4083; Office of the Surgeon General . 2010 . U.S. Department of Health and Human Services, 2010, SURG GEN VIS HLTH FI; Olsen EO, 2003, NBER CONF R, P365; Orr L., 2003, MOVING OPPORTUNITY I; Papas MA, 2007, EPIDEMIOL REV, V29, P129, DOI 10.1093/epirev/mxm009; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Saudek CD, 2008, J CLIN ENDOCR METAB, V93, P2447, DOI 10.1210/jc.2007-2174; *STAT, 2009, STAT 11 0; Trogdon JG, 2008, DIABETES CARE, V31, P2307, DOI 10.2337/dc08-1375; *U MI, 2008, HLTH RET STUD PHYS M; U.S. House Ways and Means Committee, 2008, GREEN BOOK; Watson T, 2009, REV INCOME WEALTH, V55, P820, DOI 10.1111/j.1475-4991.2009.00346.x; *WHATM, PROT SAV CARDS; HLTH METER PROFESSIO; MOVING OPPORTUNITY S	39	584	587	1	138	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2011	365	16					1509	1519		10.1056/NEJMsa1103216	http://dx.doi.org/10.1056/NEJMsa1103216			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	835BW	22010917	Green Accepted, Green Submitted			2022-12-28	WOS:000296009500005
J	Kansagara, D; Englander, H; Salanitro, A; Kagen, D; Theobald, C; Freeman, M; Kripalani, S				Kansagara, Devan; Englander, Honora; Salanitro, Amanda; Kagen, David; Theobald, Cecelia; Freeman, Michele; Kripalani, Sunil			Risk Prediction Models for Hospital Readmission A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							QUALITY-OF-CARE; GENERAL MEDICINE PATIENTS; HEART-FAILURE; STATISTICAL-MODELS; PATIENT PREDICTORS; 30-DAY READMISSION; FOLLOW-UP; TRANSITIONS; PERFORMANCE; VALIDATION	Context Predicting hospital readmission risk is of great interest to identify which patients would benefit most from care transition interventions, as well as to risk-adjust readmission rates for the purposes of hospital comparison. Objective To summarize validated readmission risk prediction models, describe their performance, and assess suitability for clinical or administrative use. Data Sources and Study Selection The databases of MEDLINE, CINAHL, and the Cochrane Library were searched from inception through March 2011, the EMBASE database was searched through August 2011, and hand searches were performed of the retrieved reference lists. Dual review was conducted to identify studies published in the English language of prediction models tested with medical patients in both derivation and validation cohorts. Data Extraction Data were extracted on the population, setting, sample size, follow-up interval, readmission rate, model discrimination and calibration, type of data used, and timing of data collection. Data Synthesis Of 7843 citations reviewed, 30 studies of 26 unique models met the inclusion criteria. The most common outcome used was 30-day readmission; only 1 model specifically addressed preventable readmissions. Fourteen models that relied on retrospective administrative data could be potentially used to risk-adjust readmission rates for hospital comparison; of these, 9 were tested in large US populations and had poor discriminative ability (c statistic range: 0.55-0.65). Seven models could potentially be used to identify high-risk patients for intervention early during a hospitalization (c statistic range: 0.56-0.72), and 5 could be used at hospital discharge (c statistic range: 0.68-0.83). Six studies compared different models in the same population and 2 of these found that functional and social variables improved model discrimination. Although most models incorporated variables for medical comorbidity and use of prior medical services, few examined variables associated with overall health and function, illness severity, or social determinants of health. Conclusions Most current readmission risk prediction models that were designed for either comparative or clinical purposes perform poorly. Although in certain settings such models may prove useful, efforts to improve their performance are needed as use becomes more widespread. JAMA. 2011;306(15):1688-1698	[Kansagara, Devan; Freeman, Michele] Portland VA Med Ctr, VA Evidence Based Synth Program, Portland, OR 97239 USA; [Kansagara, Devan; Kagen, David] Portland VA Med Ctr, Dept Gen Internal Med, Portland, OR 97239 USA; [Kansagara, Devan; Englander, Honora; Kagen, David] Oregon Hlth & Sci Univ, Dept Internal Med, Portland, OR 97201 USA; [Salanitro, Amanda] VA Tennessee Valley Healthcare Syst, Ctr Geriatr Res Educ & Clin, Nashville, TN USA; [Salanitro, Amanda; Theobald, Cecelia; Kripalani, Sunil] Vanderbilt Univ, Dept Med, Div Gen Internal Med & Publ Hlth, Sect Hosp Med, Nashville, TN USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University	Kansagara, D (corresponding author), Portland VA Med Ctr, VA Evidence Based Synth Program, Mailcode RD71,3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.	kansagar@ohsu.edu	Greiver, Michelle/N-8764-2015; Hug, Balthasar L./G-1568-2010	Greiver, Michelle/0000-0001-8957-0285; 	Department of Veterans Affairs; Veterans Health Administration, Office of Research and Development, Health Services Research and Development; National Center for Research Resources, National Institutes of Health [1 UL1 RR024976]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024977, TL1RR024978, UL1RR024975] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Health Administration, Office of Research and Development, Health Services Research and Development; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This report is based on research conducted by the Evidence-Based Synthesis Program Center located at the Portland VA Medical Center, and funded by the Department of Veterans Affairs and the Veterans Health Administration, Office of Research and Development, Health Services Research and Development. The research also was funded in part by Vanderbilt CTSA grant 1 UL1 RR024976 from the National Center for Research Resources, National Institutes of Health.	Allaudeen N, 2011, J GEN INTERN MED, V26, P771, DOI 10.1007/s11606-011-1663-3; Amarasingham R, 2010, MED CARE, V48, P981, DOI 10.1097/MLR.0b013e3181ef60d9; ANDERSON GF, 1985, INQUIRY-J HEALTH CAR, V22, P251; Ashton CM, 1996, SOC SCI MED, V43, P1533, DOI 10.1016/S0277-9536(96)00049-4; Axon RN, 2011, JAMA-J AM MED ASSOC, V305, P504, DOI 10.1001/jama.2011.72; Bahadori Katayoon, 2007, Int J Chron Obstruct Pulmon Dis, V2, P241; Billings J, 2007, HEALTH AFFAIR, V26, P1643, DOI 10.1377/hlthaff.26.6.1643; Billings J, 2006, BRIT MED J, V333, P327, DOI 10.1136/bmj.38870.657917.AE; Bottle A, 2006, J ROY SOC MED, V99, P406, DOI 10.1258/jrsm.99.8.406; BOULT C, 1993, J AM GERIATR SOC, V41, P811, DOI 10.1111/j.1532-5415.1993.tb06175.x; BURNS R, 1991, J GEN INTERN MED, V6, P389, DOI 10.1007/BF02598158; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Coleman EA, 2004, HEALTH SERV RES, V39, P1449, DOI 10.1111/j.1475-6773.2004.00298.x; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Desai MM, 2009, CIRC-CARDIOVASC QUAL, V2, P500, DOI 10.1161/CIRCOUTCOMES.108.832949; Eggli Y, 2005, PREVISION COUTS HOSP; EVANS RL, 1988, SOC SCI MED, V27, P947, DOI 10.1016/0277-9536(88)90286-9; Fisher E., 2009, HLTH CARE SPENDING Q; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Halfon P, 2002, J CLIN EPIDEMIOL, V55, P573, DOI 10.1016/S0895-4356(01)00521-2; Halfon P, 2006, MED CARE, V44, P972, DOI 10.1097/01.mlr.0000228002.43688.c2; Hammill BG, 2011, CIRC-CARDIOVASC QUAL, V4, P60, DOI 10.1161/CIRCOUTCOMES.110.954693; Hasan O, 2010, J GEN INTERN MED, V25, P211, DOI 10.1007/s11606-009-1196-1; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; HOLLOWAY JJ, 1990, HEALTH SERV RES, V25, P213; Holman CDJ, 2005, J CLIN EPIDEMIOL, V58, P1006, DOI 10.1016/j.jclinepi.2005.01.020; Howell S, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-96; Iezzoni LI, 2003, RISK ADJUSTMENT MEAS; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Joynt KE, 2011, CIRC-CARDIOVASC QUAL, V4, P53, DOI 10.1161/CIRCOUTCOMES.110.950964; Kripalani S, 2007, J HOSP MED, V2, P314, DOI 10.1002/jhm.228; Krumholz HM, 2006, CIRCULATION, V113, P456, DOI 10.1161/CIRCULATIONAHA.105.170769; Krumholz HM, 2000, AM HEART J, V139, P72, DOI 10.1016/S0002-8703(00)90311-9; Krumholz HM, 2008, HOSP 30 DAY ACUTE MY; Krumholz HM., 2008, HOSP 30 DAY PNEUMONI; Krumholz HNS, 2008, HOSP 30 DAY HEART FA; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; Morrissey EFR, 2003, CLIN DRUG INVEST, V23, P119, DOI 10.2165/00044011-200323020-00005; Mukamel DB, 1997, GERONTOLOGIST, V37, P777, DOI 10.1093/geront/37.6.777; NAESSENS JM, 1992, MAYO CLIN PROC, V67, P1140, DOI 10.1016/S0025-6196(12)61143-4; National Centre for HIV/ AIDS Vh STD and TB prevention Centers for Disease Control and Prevention, 2010, EST HOL FRAM RED IN; Naylor MD, 1999, JAMA-J AM MED ASSOC, V281, P613, DOI 10.1001/jama.281.7.613; Novotny NL, 2008, NURS RES, V57, P406, DOI 10.1097/NNR.0b013e31818c3e06; Oddone EZ, 1996, J GEN INTERN MED, V11, P597, DOI 10.1007/BF02599027; Ohman EM, 2000, JAMA-J AM MED ASSOC, V284, P876, DOI 10.1001/jama.284.7.876; Philbin EF, 1999, J AM COLL CARDIOL, V33, P1560, DOI 10.1016/S0735-1097(99)00059-5; QualityNet, READM MEAS OV PUBL R; Roper WL, 1988, HCFA PUBLICATION; Ross JS, 2008, ARCH INTERN MED, V168, P1371, DOI 10.1001/archinte.168.13.1371; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Silverstein Marc D, 2008, Proc (Bayl Univ Med Cent), V21, P363; Smith DM, 1996, J GEN INTERN MED, V11, P762, DOI 10.1007/BF02598996; SMITH DM, 1985, J CHRON DIS, V38, P213, DOI 10.1016/0021-9681(85)90064-5; SMITH DM, 1988, MED CARE, V26, P699, DOI 10.1097/00005650-198807000-00005; Society of Hospital Medicine Project BOOST, TOOL ADDR RISK GER E; Tabak YP, 2007, MED CARE, V45, P789, DOI 10.1097/MLR.0b013e31803d3b41; Thomas JW, 1996, INQUIRY-J HEALTH CAR, V33, P258; van Walraven C, 2011, CAN MED ASSOC J, V183, pE391, DOI 10.1503/cmaj.101860; van Walraven C, 2010, CAN MED ASSOC J, V182, P551, DOI 10.1503/cmaj.091117; Vest JR, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-88; Weissman JS, 1999, MED CARE, V37, P490, DOI 10.1097/00005650-199905000-00008	62	1197	1207	2	158	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 19	2011	306	15					1688	1698		10.1001/jama.2011.1515	http://dx.doi.org/10.1001/jama.2011.1515			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	834MA	22009101	Bronze, Green Accepted			2022-12-28	WOS:000295963200028
J	Brophy, JM				Brophy, James M.			Review: Varenicline increases risk for serious adverse cardiovascular events in tobacco users	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									McGill Univ, Montreal, ON, Canada	McGill University	Brophy, JM (corresponding author), McGill Univ, Montreal, ON, Canada.		brophy, james/H-6673-2019; Singh, Sonal/A-4614-2008	brophy, james/0000-0001-8049-6875; Singh, Sonal/0000-0003-0912-941X				Brophy J, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-8-201104190-02004; Cahill K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006103.pub5; Hays JT, 2011, CMAJ, V183, P1359	3	7	7	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2011	155	8							JC4-5	10.7326/0003-4819-155-8-201110180-02005	http://dx.doi.org/10.7326/0003-4819-155-8-201110180-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835WB	22007064				2022-12-28	WOS:000296066300004
J	de Zulueta, P				de Zulueta, Paquita			PERSONAL VIEW Asylum seekers and undocumented migrants must retain access to primary care	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England	Imperial College London	de Zulueta, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Publ Hlth, London, England.	p.dezulueta@imperial.ac.uk							0	4	4	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 18	2011	343								d6637	10.1136/bmj.d6637	http://dx.doi.org/10.1136/bmj.d6637			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HL	22010130				2022-12-28	WOS:000296183400012
J	van Onna, M; van Asbeck, BS; Jacobs, JWG				van Onna, Marieke; van Asbeck, B. Sweder; Jacobs, Johannes W. G.			PICTURE QUIZ Rusty joints	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEREDITARY HEMOCHROMATOSIS; DISEASE		[van Onna, Marieke; Jacobs, Johannes W. G.] Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, NL-3508 GA Utrecht, Netherlands; [van Asbeck, B. Sweder] Univ Med Ctr Utrecht, Dept Internal Med, NL-3508 GA Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	van Onna, M (corresponding author), Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, NL-3508 GA Utrecht, Netherlands.	mariekevanonna@hotmail.com						ADAMSON TC, 1983, RADIOLOGY, V147, P377, DOI 10.1148/radiology.147.2.6300958; Allen KJ, 2008, NEW ENGL J MED, V358, P221, DOI 10.1056/NEJMoa073286; Dallos T, 2010, ANN RHEUM DIS, V69, P2145, DOI 10.1136/ard.2009.122119; Heiland GR, 2010, ANN RHEUM DIS, V69, P1214, DOI 10.1136/ard.2009.120204; McLaren GD, 2008, CAN J GASTROENTEROL, V22, P923, DOI 10.1155/2008/907356; Milman N, 2001, ANN HEMATOL, V80, P737, DOI 10.1007/s002770100371; Pietrangelo A, 2010, J HEPATOL, V53, P3, DOI 10.1016/j.jhep.2010.03.001; SCHUMACHER HR, 1988, ANN NY ACAD SCI, V526, P224, DOI 10.1111/j.1749-6632.1988.tb55508.x	8	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 14	2011	343								d6197	10.1136/bmj.d6197	http://dx.doi.org/10.1136/bmj.d6197			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835ET	22001648				2022-12-28	WOS:000296018600001
J	Wang, ZJ; Huang, XS				Wang, Zhan Jun; Huang, Xu Sheng			Myotonia of the Tongue	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wang, Zhan Jun; Huang, Xu Sheng] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Wang, ZJ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China.	lewish63@yahoo.com.cn							0	3	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 13	2011	365	15					E32	E32		10.1056/NEJMicm1014605	http://dx.doi.org/10.1056/NEJMicm1014605			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832DQ	21995410				2022-12-28	WOS:000295782500011
J	Gophna, U				Gophna, Uri			The Guts of Dietary Habits	SCIENCE			English	Editorial Material							FECAL MICROBIOTA; CROHNS-DISEASE		Tel Aviv Univ, George S Wise Fac Life Sci, IL-69000 Tel Aviv, Israel	Tel Aviv University	Gophna, U (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, IL-69000 Tel Aviv, Israel.	urigo@tauex.tau.ac.il	Gophna, Uri/AAS-8376-2020	Gophna, Uri/0000-0001-5129-5652				Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005; Kovacs A, 2011, MICROB ECOL, V61, P423, DOI 10.1007/s00248-010-9787-2; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Scanlan PD, 2008, ENVIRON MICROBIOL, V10, P789, DOI 10.1111/j.1462-2920.2007.01503.x; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Spencer MD, 2011, GASTROENTEROLOGY, V140, P976, DOI 10.1053/j.gastro.2010.11.049; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344	14	21	35	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 7	2011	334	6052					45	46		10.1126/science.1213799	http://dx.doi.org/10.1126/science.1213799			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	829KW	21980098				2022-12-28	WOS:000295580300030
J	De Fazio, S; Bartonicek, N; Di Giacomo, M; Abreu-Goodger, C; Sankar, A; Funaya, C; Antony, C; Moreira, PN; Enright, AJ; O'Carroll, D				De Fazio, Serena; Bartonicek, Nenad; Di Giacomo, Monica; Abreu-Goodger, Cei; Sankar, Aditya; Funaya, Charlotta; Antony, Claude; Moreira, Pedro N.; Enright, Anton J.; O'Carroll, Donal			The endonuclease activity of Mili fuels piRNA amplification that silences LINE1 elements	NATURE			English	Article							DNA METHYLATION; PIWI PROTEINS; GENE; PATHWAY; RISC; RETROTRANSPOSON; TRANSPOSONS; ARGONAUTE2; EXPRESSION; RNAS	Piwi proteins and Piwi-interacting RNAs (piRNAs) have conserved functions in transposon silencing(1). The murine Piwi proteins Mili and Miwi2 (also called Piwil2 and Piwil4, respectively) direct epigenetic LINE1 and intracisternal A particle transposon silencing during genome reprogramming in the embryonic male germ line(2-4). Piwi proteins are proposed to be piRNA-guided endonucleases that initiate secondary piRNA biogenesis(5-7); however, the actual contribution of their endonuclease activities to piRNA biogenesis and transposon silencing remain unknown. To investigate the role of Piwi-catalysed endonucleolytic activity, we engineered point mutations in mice that substitute the second aspartic acid to an alanine in the DDH catalytic triad of Mili and Miwi2, generating the Mili(DAH) and Miwi2(DAH) alleles, respectively. Analysis of Mili-bound piRNAs from homozygous Mili(DAH) fetal gonadocytes revealed a failure of transposon piRNA amplification, resulting in the marked reduction of piRNA bound within Miwi2 ribonuclear particles. We find that Mili-mediated piRNA amplification is selectively required for LINE1, but not intracisternal A particle, silencing. The defective piRNA pathway in Mili(DAH) mice results in spermatogenic failure and sterility. Surprisingly, homozygous Miwi2(DAH) mice are fertile, transposon silencing is established normally and no defects in secondary piRNA biogenesis are observed. In addition, the hallmarks of piRNA amplification are observed in Miwi2-deficient gonadocytes. We conclude that cycles of intra-Mili secondary piRNA biogenesis fuel piRNA amplification that is absolutely required for LINE1 silencing.	[De Fazio, Serena; Di Giacomo, Monica; Sankar, Aditya; Moreira, Pedro N.; O'Carroll, Donal] European Mol Biol Lab, Mouse Biol Unit, I-00015 Monterotondo, Italy; [Bartonicek, Nenad; Abreu-Goodger, Cei; Enright, Anton J.] European Mol Biol Lab, European Bioinformat Inst, Cambridge CB10 1SD, England; [Funaya, Charlotta; Antony, Claude] European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	O'Carroll, D (corresponding author), European Mol Biol Lab, Mouse Biol Unit, Via Ramarini 32, I-00015 Monterotondo, Italy.	ocarroll@embl.it	Bartonicek, Nenad/B-6675-2016; Enright, Anton/F-3094-2011; antony, claude/K-5342-2013; Abreu-Goodger, Cei/A-1268-2010	Bartonicek, Nenad/0000-0003-2144-1887; Enright, Anton/0000-0002-6090-3100; Abreu-Goodger, Cei/0000-0001-8302-9893; Di Giacomo, Monica/0000-0002-4075-0725; O'Carroll, Donal/0000-0002-8626-2217; Fredriksson Funaya, Charlotta/0000-0003-1375-1287; Sankar, Aditya/0000-0002-1840-3356				Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Aravin AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000764; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Bestor TH, 2004, COLD SPRING HARB SYM, V69, P381, DOI 10.1101/sqb.2004.69.381; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chuma S, 2006, P NATL ACAD SCI USA, V103, P15894, DOI 10.1073/pnas.0601878103; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Kojima K, 2009, GENES CELLS, V14, P1155, DOI 10.1111/j.1365-2443.2009.01342.x; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Kuramochi-Miyagawa S, 2010, GENE DEV, V24, P887, DOI 10.1101/gad.1902110; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Mandal PK, 2008, CELL, V135, DOI 10.1016/j.cell.2008.09.028; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Patel DJ, 2006, COLD SPRING HARB SYM, V71, P81, DOI 10.1101/sqb.2006.71.053; Poueymirou WT, 2007, NAT BIOTECHNOL, V25, P91, DOI 10.1038/nbt1263; Reuter M, 2009, NAT STRUCT MOL BIOL, V16, P639, DOI 10.1038/nsmb.1615; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Vagin VV, 2009, GENE DEV, V23, P1749, DOI 10.1101/gad.1814809; Wang JQ, 2009, CURR BIOL, V19, P640, DOI 10.1016/j.cub.2009.02.061; Wen J, 2008, BIOCHEM SOC T, V36, P514, DOI 10.1042/BST0360514; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Zheng K, 2010, P NATL ACAD SCI USA, V107, P11841, DOI 10.1073/pnas.1003953107	40	227	232	2	28	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 8	2011	480	7376					259	U148		10.1038/nature10547	http://dx.doi.org/10.1038/nature10547			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857TR	22020280				2022-12-28	WOS:000297744200055
J	Jex, AR; Liu, SP; Li, B; Young, ND; Hall, RS; Li, YR; Yang, LF; Zeng, N; Xu, X; Xiong, ZJ; Chen, FY; Wu, X; Zhang, GJ; Fang, XD; Kang, Y; Anderson, GA; Harris, TW; Campbell, BE; Vlaminck, J; Wang, T; Cantacessi, C; Schwarz, EM; Ranganathan, S; Geldhof, P; Nejsum, P; Sternberg, PW; Yang, HM; Wang, J; Wang, J; Gasser, RB				Jex, Aaron R.; Liu, Shiping; Li, Bo; Young, Neil D.; Hall, Ross S.; Li, Yingrui; Yang, Linfeng; Zeng, Na; Xu, Xun; Xiong, Zijun; Chen, Fangyuan; Wu, Xuan; Zhang, Guojie; Fang, Xiaodong; Kang, Yi; Anderson, Garry A.; Harris, Todd W.; Campbell, Bronwyn E.; Vlaminck, Johnny; Wang, Tao; Cantacessi, Cinzia; Schwarz, Erich M.; Ranganathan, Shoba; Geldhof, Peter; Nejsum, Peter; Sternberg, Paul W.; Yang, Huanming; Wang, Jun; Wang, Jian; Gasser, Robin B.			Ascaris suum draft genome	NATURE			English	Article							BRUGIA-MALAYI; RNA-SEQ; SCHISTOSOMA-MANSONI; PARASITIC DISEASES; SWISS-PROT; GENE; DATABASE; TOOL; PREDICTION; NEMATODES	Parasitic diseases have a devastating, long-term impact on human health, welfare and food production worldwide. More than two billion people are infected with geohelminths, including the roundworms Ascaris (common roundworm), Necator and Ancylostoma (hookworms), and Trichuris (whipworm), mainly in developing or impoverished nations of Asia, Africa and Latin America(1). In humans, the diseases caused by these parasites result in about 135,000 deaths annually, with a global burden comparable with that of malaria or tuberculosis in disability-adjusted life years(1). Ascaris alone infects around 1.2 billion people and, in children, causes nutritional deficiency, impaired physical and cognitive development and, in severe cases, death(2). Ascaris also causes major production losses in pigs owing to reduced growth, failure to thrive and mortality(2). The Ascaris-swine model makes it possible to study the parasite, its relationship with the host, and ascariasis at the molecular level. To enable such molecular studies, we report the 273 mega-base draft genome of Ascaris suum and compare it with other nematode genomes. This genome has low repeat content (4.4%) and encodes about 18,500 protein-coding genes. Notably, the A. suum secretome (about 750 molecules) is rich in peptidases linked to the penetration and degradation of host tissues, and an assemblage of molecules likely to modulate or evade host immune responses. This genome provides a comprehensive resource to the scientific community and underpins the development of new and urgently needed interventions (drugs, vaccines and diagnostic tests) against ascariasis and other nematodiases.	[Jex, Aaron R.; Young, Neil D.; Hall, Ross S.; Anderson, Garry A.; Campbell, Bronwyn E.; Cantacessi, Cinzia; Gasser, Robin B.] Univ Melbourne, Fac Vet Sci, Parkville, Vic 3010, Australia; [Liu, Shiping; Li, Bo; Li, Yingrui; Yang, Linfeng; Zeng, Na; Xu, Xun; Xiong, Zijun; Chen, Fangyuan; Wu, Xuan; Zhang, Guojie; Fang, Xiaodong; Kang, Yi; Yang, Huanming; Wang, Jun; Wang, Jian] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Harris, Todd W.] MaRS Ctr, Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Vlaminck, Johnny; Wang, Tao; Geldhof, Peter] Univ Ghent, Lab Parasitol & Parasit Dis, B-9820 Merelbeke, Belgium; [Schwarz, Erich M.; Sternberg, Paul W.] CALTECH, Pasadena, CA 91125 USA; [Ranganathan, Shoba] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Nejsum, Peter] Univ Copenhagen, Fac Life Sci, DK-2200 Copenhagen, Denmark	University of Melbourne; Beijing Genomics Institute (BGI); Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Ghent University; California Institute of Technology; Macquarie University; University of Copenhagen	Jex, AR (corresponding author), Univ Melbourne, Fac Vet Sci, Parkville, Vic 3010, Australia.	ajex@unimelb.edu.au; wangjun@genomics.org.cn; wangjian@genomics.org.cn; robinbg@unimelb.edu.au	Zhang, Guojie/J-7273-2019; Li, Yingrui/K-1064-2015; Rivet, Catherine A/M-7978-2014; Cantacessi, Cinzia/B-7356-2014; Yang, Linfeng/AAZ-8792-2020; Gasser, Robin/ABH-6185-2020; Fang, Xiaodong/K-6743-2018; Xu, Xun/AAI-6763-2020; Young, Neil David/AAU-4572-2020; Wang, Jun/A-7261-2013; Zhang, Guojie/B-6188-2014; Jex, Aaron/AGZ-7897-2022; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Zhang, Guojie/0000-0001-6860-1521; Cantacessi, Cinzia/0000-0001-6863-2950; Gasser, Robin/0000-0002-4423-1690; Fang, Xiaodong/0000-0001-7061-3337; Xu, Xun/0000-0002-5338-5173; Young, Neil David/0000-0001-8756-229X; Zhang, Guojie/0000-0001-6860-1521; Jex, Aaron/0000-0002-1285-7947; Schwarz, Erich/0000-0003-3151-4381; LIU, Shiping/0000-0003-0019-619X; Wang, Jun/0000-0002-8540-8931; Vlaminck, Johnny/0000-0002-3601-9825; Ranganathan, Shoba/0000-0002-8290-813X; Harris, Todd/0000-0003-3406-163X; Wang, Tao/0000-0003-1359-8913; Sternberg, Paul/0000-0002-7699-0173; Xiong, Zijun/0000-0003-3923-0703; Campbell, Bronwyn/0000-0001-9090-764X; Wang, Jun/0000-0002-2113-5874; Nejsum, Peter/0000-0002-6673-8505	Australian Research Council; Victorian Life Sciences Computation Initiative on its Peak Computing Facility at the University of Melbourne [VR0007]	Australian Research Council(Australian Research Council); Victorian Life Sciences Computation Initiative on its Peak Computing Facility at the University of Melbourne	This project was funded by the Australian Research Council. This research was supported by a Victorian Life Sciences Computation Initiative (grant number VR0007) on its Peak Computing Facility at the University of Melbourne, an initiative of the Victorian Government. Other support from the Australian Academy of Science, the Australian-American Fulbright Commission, Melbourne Water Corporation, and the IBM Research Collaboratory for Life Sciences-Melbourne is gratefully acknowledged. P. W. S. is an investigator with the Howard Hughes Medical Institute. A.R.J. held a CDA1 (Industry) from the National Health and Medical Research Council of Australia. We are indebted to the faculty and staff of the BGI-Shenzhen, who contributed to this study. We also acknowledge the contributions of staff at WormBase (www.wormbase.org).	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BARGMANN CI, 2006, C ELEGANS WORMBOOK; Bellafiore S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000192; Bennuru S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000410; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; Campbell BE, 2011, BIOORG MED CHEM LETT, V21, P3277, DOI 10.1016/j.bmcl.2011.04.031; Campbell BE, 2011, BIOTECHNOL ADV, V29, P28, DOI 10.1016/j.biotechadv.2010.08.008; CAMPBELL WC, 1983, SCIENCE, V221, P823, DOI 10.1126/science.6308762; Cantacessi C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-266; Cass CL, 2007, MOL BIOCHEM PARASIT, V155, P84, DOI 10.1016/j.molbiopara.2007.06.002; Chen LQ, 2008, BIOORGAN MED CHEM, V16, P9340, DOI 10.1016/j.bmc.2008.08.062; Chen YJ, 2005, NUCLEIC ACIDS RES, V33, pD169; Crompton DWT, 2001, ADV PARASIT, V48, P285, DOI 10.1016/S0065-308X(01)48008-0; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Doyle MA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-222; Eddy Sean R, 2009, Genome Inform, V23, P205; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Ewen-Campen B, 2010, MOL REPROD DEV, V77, P3, DOI 10.1002/mrd.21091; Gasser RB, 2006, NAT PROTOC, V1, P3121, DOI 10.1038/nprot.2006.485; Geenen PL, 1999, J PARASITOL, V85, P616, DOI 10.2307/3285733; Geldhof P, 2007, PARASITOLOGY, V134, P609, DOI 10.1017/S0031182006002071; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Goldovsky Leon, 2005, Appl Bioinformatics, V4, P71, DOI 10.2165/00822942-200504010-00009; Harder A, 2003, INT J ANTIMICROB AG, V22, P318, DOI 10.1016/S0924-8579(03)00219-X; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; Hewitson JR, 2008, MOL BIOCHEM PARASIT, V160, P8, DOI 10.1016/j.molbiopara.2008.02.007; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kaminsky R, 2008, NATURE, V452, P176, DOI 10.1038/nature06722; Keiser J, 2010, ADV PARASIT, V73, P197, DOI 10.1016/S0065-308X(10)73008-6; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kuzniar A, 2008, TRENDS GENET, V24, P539, DOI 10.1016/j.tig.2008.08.009; LANDER E S, 1988, Genomics, V2, P231; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muller F, 2000, INT J PARASITOL, V30, P391, DOI 10.1016/S0020-7519(99)00199-X; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Renslo AR, 2006, NAT CHEM BIOL, V2, P701, DOI 10.1038/nchembio837; Saeed I, 2001, ACTA VET SCAND, V42, P279, DOI 10.1186/1751-0147-42-279; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Sambrook J., 2001, MOL CLONING LAB MANU, V3, pE3; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; She R, 2009, GENOME RES, V19, P143, DOI 10.1101/gr.082081.108; Tarailo-Graovac M., 2009, CURR PROTOCOLS BIOIN; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yeh W, 2004, GENOME RES, V14, P917, DOI 10.1101/gr.2050304; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhong WW, 2006, SCIENCE, V311, P1481, DOI 10.1126/science.1123287	73	203	207	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2011	479	7374					529	U257		10.1038/nature10553	http://dx.doi.org/10.1038/nature10553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	851QI	22031327	hybrid, Green Accepted			2022-12-28	WOS:000297285600051
J	Lucke, B; Scherer, M; Kruse, J; Pezze, L; Deuretzbacher, F; Hyllus, P; Topic, O; Peise, J; Ertmer, W; Arlt, J; Santos, L; Smerzi, A; Klempt, C				Luecke, B.; Scherer, M.; Kruse, J.; Pezze, L.; Deuretzbacher, F.; Hyllus, P.; Topic, O.; Peise, J.; Ertmer, W.; Arlt, J.; Santos, L.; Smerzi, A.; Klempt, C.			Twin Matter Waves for Interferometry Beyond the Classical Limit	SCIENCE			English	Article							STANDARD QUANTUM LIMIT; BEAM SPLITTER; ENTANGLEMENT; STATES; PHOTONS	Interferometers with atomic ensembles are an integral part of modern precision metrology. However, these interferometers are fundamentally restricted by the shot noise limit, which can only be overcome by creating quantum entanglement among the atoms. We used spin dynamics in Bose-Einstein condensates to create large ensembles of up to 10(4) pair-correlated atoms with an interferometric sensitivity -1.61(-1.1)(+0.98) decibels beyond the shot noise limit. Our proof-of-principle results point the way toward a new generation of atom interferometers.	[Luecke, B.; Scherer, M.; Kruse, J.; Topic, O.; Peise, J.; Ertmer, W.; Klempt, C.] Leibniz Univ Hannover, Inst Quantenopt, D-30167 Hannover, Germany; [Pezze, L.; Smerzi, A.] CNR, INO, I-50125 Florence, Italy; [Pezze, L.; Smerzi, A.] European Lab Nonlinear Spect LENS, I-50125 Florence, Italy; [Deuretzbacher, F.; Santos, L.] Leibniz Univ Hannover, Inst Theoret Phys, D-30167 Hannover, Germany; [Hyllus, P.] Univ Basque Country, Dept Theoret Phys, Bilbao 48080, Spain; [Arlt, J.] Aarhus Univ, Inst Fys & Astron, Ctr Quantum Opt QUANTOP, DK-8000 Aarhus C, Denmark	Leibniz University Hannover; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale di Ottica (INO-CNR); Leibniz University Hannover; University of Basque Country; Aarhus University	Klempt, C (corresponding author), Leibniz Univ Hannover, Inst Quantenopt, D-30167 Hannover, Germany.	klempt@iqo.uni-hannover.de	Klempt, Carsten/AAQ-9483-2021; Scherer, Manuel/D-3743-2012; PEZZE, LUCA/D-5967-2014; Arlt, Jan J/B-4943-2010; Klempt, Carsten/E-6906-2011	Klempt, Carsten/0000-0003-2402-3162; PEZZE, LUCA/0000-0003-0325-9555; Arlt, Jan J/0000-0002-5782-3927; Klempt, Carsten/0000-0003-2402-3162; Santos, Luis/0000-0001-7652-9574	Centre for Quantum Engineering and Space-Time Research (QUEST); European Science Foundation (EuroQUASAR); Danish National Research Foundation Center for Quantum Optics; European Research Council; Provincia Autonoma di Trento; Laboratoire Charles Fabry de L'Institut d' Optique	Centre for Quantum Engineering and Space-Time Research (QUEST); European Science Foundation (EuroQUASAR)(European Science Foundation (ESF)); Danish National Research Foundation Center for Quantum Optics; European Research Council(European Research Council (ERC)European Commission); Provincia Autonoma di Trento(Autonomous Province of Trento); Laboratoire Charles Fabry de L'Institut d' Optique	We thank E. Rasel for stimulating discussions and P. Zoller for helpful comments. We acknowledge support from the Centre for Quantum Engineering and Space-Time Research (QUEST), the European Science Foundation (EuroQUASAR), and the Danish National Research Foundation Center for Quantum Optics. P.H. acknowledges financial support of the European Research Council Starting Grant GEDENTQOPT. This work was supported in part by Provincia Autonoma di Trento within the activities of the BEC center. L.P. acknowledges support by the Laboratoire Charles Fabry de L'Institut d' Optique where part of this work was completed.	Afek I, 2010, SCIENCE, V328, P879, DOI 10.1126/science.1188172; Appel J, 2009, P NATL ACAD SCI USA, V106, P10960, DOI 10.1073/pnas.0901550106; BARNETT SM, 1990, PHYS REV A, V42, P6713, DOI 10.1103/PhysRevA.42.6713; Bollinger JJ, 1996, PHYS REV A, V54, pR4649, DOI 10.1103/PhysRevA.54.R4649; BORDE CJ, 1989, PHYS LETT A, V140, P10, DOI 10.1016/0375-9601(89)90537-9; Bucker R, 2011, NAT PHYS, V7, P608, DOI [10.1038/NPHYS1992, 10.1038/nphys1992]; CAMPOS RA, 1989, PHYS REV A, V40, P1371, DOI 10.1103/PhysRevA.40.1371; Chen ZL, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.133601; Duan LM, 2000, PHYS REV LETT, V85, P3991, DOI 10.1103/PhysRevLett.85.3991; ESSEN L, 1955, NATURE, V176, P281; Esteve J, 2008, NATURE, V455, P1216, DOI 10.1038/nature07332; Gross C, 2010, NATURE, V464, P1165, DOI 10.1038/nature08919; HOLLAND MJ, 1993, PHYS REV LETT, V71, P1355, DOI 10.1103/PhysRevLett.71.1355; Hyllus P, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.120501; Hyllus P, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.012337; Kim T, 1998, PHYS REV A, V57, P4004, DOI 10.1103/PhysRevA.57.4004; Klempt C, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.195303; Klempt C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.195302; Kuzmich A, 1998, QUANTUM SEMICL OPT, V10, P493, DOI 10.1088/1355-5111/10/3/008; Leibfried D, 2005, NATURE, V438, P639, DOI 10.1038/nature04251; Leroux ID, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.073602; Meyer V, 2001, PHYS REV LETT, V86, P5870, DOI 10.1103/PhysRevLett.86.5870; Mitchell MW, 2004, NATURE, V429, P161, DOI 10.1038/nature02493; Nagata T, 2007, SCIENCE, V316, P726, DOI 10.1126/science.1138007; Ou ZY, 1999, PHYS REV LETT, V83, P959, DOI 10.1103/PhysRevLett.83.959; Pezze L, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.100401; Pu H, 2000, PHYS REV LETT, V85, P3987, DOI 10.1103/PhysRevLett.85.3987; Riedel MF, 2010, NATURE, V464, P1170, DOI 10.1038/nature08988; Santarelli C, 1999, PHYS REV LETT, V82, P4619, DOI 10.1103/PhysRevLett.82.4619; Scherer M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.135302; Walther P, 2004, NATURE, V429, P158, DOI 10.1038/nature02552; Wynands R, 2005, METROLOGIA, V42, pS64, DOI 10.1088/0026-1394/42/3/S08	33	296	298	0	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 11	2011	334	6057					773	776		10.1126/science.1208798	http://dx.doi.org/10.1126/science.1208798			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845US	21998255	Green Submitted			2022-12-28	WOS:000296849600037
J	Ng, M; Gakidou, E; Levin-Rector, A; Khera, A; Murray, CJL; Dandona, L				Ng, Marie; Gakidou, Emmanuela; Levin-Rector, Alison; Khera, Ajay; Murray, Christopher J. L.; Dandona, Lalit			Assessment of population-level effect of Avahan, an HIV-prevention initiative in India	LANCET			English	Article							FEMALE SEX WORKERS; KARNATAKA STATE; SOUTH-INDIA; PREVALENCE; SURVEILLANCE; HIV/AIDS; DECLINES; PROGRAMS; IMPACT; INTERVENTION	Background The aim of Avahan, the India AIDS Initiative, was to reduce HIV transmission in the general population through large-scale prevention interventions focused on high-risk groups. It was launched in 2003 in six states with a total population of 300 million and a high HIV burden. We assessed the population-level effect of the first phase of Avahan (2003-08). Methods Population prevalence was estimated by use of adjustment factors from the national HIV sentinel surveillance data obtained annually from antenatal clinics. A mixed-effects multilevel regression model was developed to estimate the association between intervention intensity and population HIV prevalence trends, taking into account differences in the underlying epidemic trends in states and other potential confounders, and to estimate the number of HIV infections averted with Avahan. Findings 80 (61%) of 131 districts in the six Avahan states received funding from Avahan for HIV prevention, as the only or shared source. Greater intensity of Avahan, measured as amount of grant per HIV population (medians US$24-432 in the six states), was significantly associated with lower HIV prevalence in Andhra Pradesh (p=0.004), Karnataka (p=0.004), and Maharashtra (p=0.008) states; this association was not significant in TamilNadu (p=0.06), Manipur (p=0.62), and Nagaland (p=0.67). Overall, we estimated that 100 178 HIV infections (95% CI 25 897-207 713) were averted at the population level from 2003 up to 2008 as a result of Avahan. Interpretation The results of our analysis suggest that Avahan had a beneficial effect in reducing HIV prevalence at the population level over 5 years of programme implementation in some of the states. With stagnating funding for HIV prevention globally, our findings support investment in well planned and managed HIV prevention programmes in low-income and middle-income countries.	[Ng, Marie; Gakidou, Emmanuela; Levin-Rector, Alison; Murray, Christopher J. L.; Dandona, Lalit] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Ng, Marie] Univ Hong Kong, Fac Educ, Hong Kong, Hong Kong, Peoples R China; [Khera, Ajay] Govt India, Minist Hlth & Family Welf, New Delhi, India; [Dandona, Lalit] Publ Hlth Fdn India, New Delhi, India	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Hong Kong; Public Health Foundation of India	Gakidou, E (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.	gakidou@uw.edu	Levin-Rector, Alison/AAA-6756-2020		Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding Bill & Melinda Gates Foundation.	Alnwick D., 2007, BRINGING HIV PREVENT; [Anonymous], 2011, LANCET, V377, P1719, DOI 10.1016/S0140-6736(11)60713-7; [Anonymous], 2011, AV IND AIDS IN; [Anonymous], 2007, HLTH INSURANCE POOR; Bertozzi SM, 2008, LANCET, V372, P831, DOI 10.1016/S0140-6736(08)60889-2; Bertozzi SM, 2010, SEX TRANSM INFECT, V86, pI4, DOI 10.1136/sti.2009.039263; Bill & Melinda Gates Foundation, 2008, AV IND AIDS IN BUS H, P40; Boily MC, 2008, AIDS, V22, pS149, DOI 10.1097/01.aids.0000343773.59776.5b; Chandrasekaran P, 2008, AIDS, V22, pS1, DOI 10.1097/01.aids.0000343760.70078.89; Chandrasekaran P, 2006, LANCET INFECT DIS, V6, P508, DOI 10.1016/S1473-3099(06)70551-5; Claeson M, 2008, HEALTH AFFAIR, V27, P1091, DOI 10.1377/hlthaff.27.4.1091; Dandona L, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-31; Dandona Lalit, 2010, BMC Health Serv Res, V10, P117, DOI 10.1186/1472-6963-10-117; Gakidou E, 2006, LANCET, V368, P1920, DOI 10.1016/S0140-6736(06)69568-8; Galiani S, 2005, J POLIT ECON, V113, P83, DOI 10.1086/426041; Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X; Global HIV Prevention working Group, BEH CHANG HIV PREV R; Gouws E, 2008, SEX TRANSM INFECT, V84, pI17, DOI 10.1136/sti.2008.030452; Halperin DT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000414; IIPS, 2007, NAT HLTH FAM SURV NF; Jalan J, 2003, J ECONOMETRICS, V112, P153, DOI 10.1016/S0304-4076(02)00158-6; John TJ, 2011, LANCET, V377, P252, DOI 10.1016/S0140-6736(10)61265-2; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Lipovsek V, 2010, SEX TRANSM INFECT, V86, pI25, DOI 10.1136/sti.2009.038497; Marsh KA, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-27; Merson MH, 2008, LANCET, V372, P475, DOI 10.1016/S0140-6736(08)60884-3; Mogasale V, 2010, SEX TRANSM INFECT, V86, pI83, DOI 10.1136/sti.2009.038364; Montana LS, 2008, SEX TRANSM INFECT, V84, pI78, DOI 10.1136/sti.2008.030106; Moses S, 2008, AIDS, V22, pS101, DOI 10.1097/01.aids.0000343768.85325.92; Murray CJL, 2011, LANCET, V378, P8, DOI 10.1016/S0140-6736(10)62356-2; NACO, 2008, HIV SENT SURV HIV ES; NACO, 2010, ANN REP 2009 10 GOV; NACO, 2008, OP GUID HIV SENT SUR; *NAT AIDS CONTR OR, FUNDS EXP; National AIDS Control Organisation, 2007, HIV SENT SURV HIV ES; National AIDS Control Organization, 2006, NAT AIDS CONTR PROGR; National Commission on Population, 2006, POP PROJ IND STAT 20; National Intelligence Council, 2002, NEXT WAV HIV AIDS NI; Pandey A, 2009, INDIAN J MED RES, V129, P50; Phoolcharoen W, 1998, SCIENCE, V280, P1873, DOI 10.1126/science.280.5371.1873; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; Piot P, 2010, SEX TRANSM INFECT, V86, pI1, DOI 10.1136/sti.2009.040428; Potts M, 2003, BMJ-BRIT MED J, V326, P1389, DOI 10.1136/bmj.326.7403.1389; Ramakrishnan L, 2010, SEX TRANSM INFECT, V86, pI62, DOI 10.1136/sti.2009.038760; Ramesh BM, 2010, SEX TRANSM INFECT, V86, pI17, DOI 10.1136/sti.2009.038513; Reza-Paul S, 2008, AIDS, V22, pS91, DOI 10.1097/01.aids.0000343767.08197.18; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; Stover J, 2002, LANCET, V360, P73, DOI 10.1016/S0140-6736(02)09339-X; *UNAIDS, 2002, REP GLOB HIV AIDS EP; UNAIDS, 2010, UNAIDS REP GLOB AIDS; UNAIDS, 2006, REP GLOB AIDS EP; *UNAIDS, 2007, 2007 AIDS EP UPD	52	65	65	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 5	2011	378	9803					1643	1652		10.1016/S0140-6736(11)61390-1	http://dx.doi.org/10.1016/S0140-6736(11)61390-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	844ST	21993161				2022-12-28	WOS:000296768300029
J	Thompson, JF; Ollila, DW				Thompson, John F.; Ollila, David W.			Optimum excision margins for melanoma	LANCET			English	Editorial Material							CUTANEOUS MALIGNANT-MELANOMA; 2 CM; TRIALS; MM		[Thompson, John F.] Melanoma Inst Australia, Poche Ctr, Sydney, NSW 2060, Australia; [Ollila, David W.] Univ N Carolina, Div Surg Oncol & Endocrine Surg, Chapel Hill, NC USA	Melanoma Institute Australia; University of North Carolina; University of North Carolina Chapel Hill	Thompson, JF (corresponding author), Melanoma Inst Australia, Poche Ctr, Sydney, NSW 2060, Australia.	john.thompson@smu.org.au	Thompson, John/F-9075-2013	Thompson, John/0000-0002-2816-2496				Balch CM, 2001, ANN SURG ONCOL, V8, P101, DOI 10.1007/s10434-001-0101-x; Gillgren P, 2011, LANCET, V378, P1635, DOI 10.1016/S0140-6736(11)61546-8; Haigh PI, 2003, CAN J SURG, V46, P419; Khayat D, 2003, CANCER-AM CANCER SOC, V97, P1941, DOI 10.1002/cncr.11272; Lens MB, 2007, ARCH SURG-CHICAGO, V142, P885, DOI 10.1001/archsurg.142.9.885; North JP, 2008, J INVEST DERMATOL, V128, P2024, DOI 10.1038/jid.2008.41; Ringborg U, 1996, CANCER-AM CANCER SOC, V77, P1809, DOI 10.1002/(SICI)1097-0142(19960501)77:9<1809::AID-CNCR8>3.0.CO;2-6; Sladden MJ, 2009, COCHRANE DB SYST REV, V4; Snapinn Steven M, 2000, Curr Control Trials Cardiovasc Med, V1, P19, DOI 10.1186/CVM-1-1-019; Thomas JM, 2004, NEW ENGL J MED, V350, P757, DOI 10.1056/NEJMoa030681; VERONESI U, 1988, NEW ENGL J MED, V318, P1159, DOI 10.1056/NEJM198805053181804; Zee BCY, 2006, J CLIN ONCOL, V24, P1026, DOI 10.1200/JCO.2005.04.9684	12	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 5	2011	378	9803					1608	1610		10.1016/S0140-6736(11)61615-2	http://dx.doi.org/10.1016/S0140-6736(11)61615-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844ST	22027548				2022-12-28	WOS:000296768300009
J	Zaratiegui, M; Castel, SE; Irvine, DV; Kloc, A; Ren, J; Li, F; de Castro, E; Marin, L; Chang, AY; Goto, D; Cande, WZ; Antequera, F; Arcangioli, B; Martienssen, RA				Zaratiegui, Mikel; Castel, Stephane E.; Irvine, Danielle V.; Kloc, Anna; Ren, Jie; Li, Fei; de Castro, Elisa; Marin, Laura; Chang, An-Yun; Goto, Derek; Cande, W. Zacheus; Antequera, Francisco; Arcangioli, Benoit; Martienssen, Robert A.			RNAi promotes heterochromatic silencing through replication-coupled release of RNA Pol II	NATURE			English	Article							DNA-REPLICATION; FISSION YEAST; TRANSCRIPTION TERMINATION; HISTONE MODIFICATION; GENOME INTEGRITY; S-PHASE; RECOMBINATION; FORKS; MECHANISMS; REARRANGEMENTS	Heterochromatin comprises tightly compacted repetitive regions of eukaryotic chromosomes. The inheritance of heterochromatin through mitosis requires RNA interference (RNAi), which guides histone modification(1) during the DNA replication phase of the cell cycle(2). Here we show that the alternating arrangement of origins of replication and non-coding RNA in pericentromeric heterochromatin results in competition between transcription and replication in Schizosaccharomyces pombe. Co-transcriptional RNAi releases RNA polymerase II (Pol II), allowing completion of DNA replication by the leading strand DNA polymerase, and associated histone modifying enzymes(3) that spread heterochromatin with the replication fork. In the absence of RNAi, stalled forks are repaired by homologous recombination without histone modification.	[Castel, Stephane E.; Martienssen, Robert A.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Li, Fei; Cande, W. Zacheus] Univ Calif Berkeley, Berkeley, CA 94720 USA; [de Castro, Elisa; Marin, Laura; Antequera, Francisco] Univ Salamanca, CSIC, Inst Biol Func & Genom, Salamanca 37007, Spain; [Chang, An-Yun] SUNY Stony Brook, Mol & Cell Biol Program, Stony Brook, NY 11794 USA; [Arcangioli, Benoit] Inst Pasteur, Paris, France	Cold Spring Harbor Laboratory; University of California System; University of California Berkeley; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, POB 100, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu	Antequera, Francisco/B-1115-2017; Ren, Jie/L-6197-2013; Kloc, Anna/AAB-8853-2019; Marin Vinader, Laura/F-7878-2016	Antequera, Francisco/0000-0003-2623-4131; Li, Fei/0000-0002-1206-9684; Zaratiegui, Mikel/0000-0002-0342-0268; Marin Vinader, Laura/0000-0002-7707-0811; Kloc, Anna/0000-0003-2074-7884	NHMRC; Spanish Ministry of Science; Spanish Ministry of Science and Innovation [BFU2008-01919, CSD2007-00015]; NIH [R01 GM076396]; Division Of Integrative Organismal Systems [1025830] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076396] Funding Source: NIH RePORTER	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Roh and T. Volpe for isolating cDNA clones. D. V. I. was supported by a NHMRC CJ Martin Postdoctoral Research Fellowship. M.Z. was supported by a fellowship from the Spanish Ministry of Science. This work was supported by grants BFU2008-01919 and Consolider-Ingenio CSD2007-00015 from the Spanish Ministry of Science and Innovation to F. A., and NIH R01 GM076396 to W.Z.C. and R.A.M.	Bayne EH, 2010, CELL, V140, P666, DOI 10.1016/j.cell.2010.01.038; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Djupedal I, 2009, EMBO J, V28, P3832, DOI 10.1038/emboj.2009.351; Ghazal G, 2009, MOL CELL, V36, P99, DOI 10.1016/j.molcel.2009.07.029; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Hayashi MT, 2009, NAT CELL BIOL, V11, P357, DOI 10.1038/ncb1845; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Lambert S, 2005, CELL, V121, P689, DOI 10.1016/j.cell.2005.03.022; Lambert S, 2010, MOL CELL, V39, P346, DOI 10.1016/j.molcel.2010.07.015; Li F, 2011, NATURE, V475, P244, DOI 10.1038/nature10161; Minca EC, 2010, MOL CELL, V38, P649, DOI 10.1016/j.molcel.2010.03.020; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Motamedi MR, 2008, MOL CELL, V32, P778, DOI 10.1016/j.molcel.2008.10.026; Murakami H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000317; Pauler FM, 2007, TRENDS GENET, V23, P284, DOI 10.1016/j.tig.2007.03.018; Pirngruber J, 2009, CELL CYCLE, V8, P3636, DOI 10.4161/cc.8.22.9890; Rosonina E, 2006, GENE DEV, V20, P1050, DOI 10.1101/gad.1431606; Salles FJ, 1999, METHODS, V17, P38, DOI 10.1006/meth.1998.0705; Scott KC, 2006, CURR BIOL, V16, P119, DOI 10.1016/j.cub.2005.11.065; Segurado M, 2002, MOL CELL, V10, P907, DOI 10.1016/S1097-2765(02)00684-6; Shimmoto M, 2009, GENES CELLS, V14, P669, DOI 10.1111/j.1365-2443.2009.01300.x; SMITH JG, 1995, MOL CELL BIOL, V15, P5165; Svejstrup JQ, 2010, TRENDS BIOCHEM SCI, V35, P333, DOI 10.1016/j.tibs.2010.02.001; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Washburn RS, 2011, P NATL ACAD SCI USA, V108, P792, DOI 10.1073/pnas.1009564108; Zaratiegui M, 2011, NATURE, V469, P112, DOI 10.1038/nature09608; Zhang K, 2011, SCIENCE, V331, P1624, DOI 10.1126/science.1198712; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	34	120	121	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2011	479	7371					135	U175		10.1038/nature10501	http://dx.doi.org/10.1038/nature10501			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840FA	22002604	Green Accepted, Green Submitted			2022-12-28	WOS:000296422600047
J	Maj, M				Maj, Mario			The rights of people with mental disorders: WPA perspective	LANCET			English	Editorial Material							IMPLEMENTATION; MISTAKES		[Maj, Mario] Univ Naples Federico II, Dept Psychiat, I-80138 Naples, Italy; [Maj, Mario] World Psychiat Assoc, Geneva, Switzerland	University of Naples Federico II	Maj, M (corresponding author), Univ Naples Federico II, Dept Psychiat, I-80138 Naples, Italy.	majmario@tin.it						Baker Timothy B, 2008, Psychol Sci Public Interest, V9, P67, DOI 10.1111/j.1539-6053.2009.01036.x; Cepoiu M, 2008, J GEN INTERN MED, V23, P25, DOI 10.1007/s11606-007-0428-5; De Hert M, 2011, WORLD PSYCHIATRY, V10, P52, DOI 10.1002/j.2051-5545.2011.tb00014.x; Hanlon C, 2010, WORLD PSYCHIATRY, V9, P185; Herrman Helen, 2010, World Psychiatry, V9, P127; Maj M, 2010, WORLD PSYCHIATRY, V9, P65; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Patel V, 2010, WORLD PSYCHIATRY, V9, P169; Thornicroft G, 2010, WORLD PSYCHIATRY, V9, P67; WHO, 2008, CHAIN FREE IN	10	12	14	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 29	2011	378	9802					1534	1535		10.1016/S0140-6736(11)60745-9	http://dx.doi.org/10.1016/S0140-6736(11)60745-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	844SL	22008423				2022-12-28	WOS:000296767500010
J	Keshavjee, S; Harrington, M; Gonsalves, G; Chesire, L; Farmer, PE				Keshavjee, Salmaan; Harrington, Mark; Gonsalves, Gregg; Chesire, Lucy; Farmer, Paul E.			Time for zero deaths from tuberculosis	LANCET			English	Editorial Material									[Keshavjee, Salmaan; Gonsalves, Gregg; Farmer, Paul E.] Harvard Univ, Sch Med, Program Infect Dis & Social Change, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Harrington, Mark] Treatment Action Grp, New York, NY USA; [Chesire, Lucy] TB ACTION Grp, Nairobi, Kenya	Harvard University; Harvard Medical School	Keshavjee, S (corresponding author), Harvard Univ, Sch Med, Program Infect Dis & Social Change, Dept Global Hlth & Social Med, Boston, MA 02115 USA.	salmaan_keshavjee@hms.harvard.edu		Keshavjee, Salmaan/0000-0002-6967-3305; Gonsalves, Gregg/0000-0002-5789-9841				[Anonymous], 2011, LANCET, V378, P2, DOI 10.1016/S0140-6736(11)61000-3; [Anonymous], 2011, STOP TB PARTN SECR F, P6; Castro KG, 2011, EMERG INFECT DIS, V17, P337, DOI 10.3201/eid1703.110031; Dye C, 2008, J R SOC INTERFACE, V5, P653, DOI 10.1098/rsif.2007.1138; Keshavjee S, 2008, ANN NY ACAD SCI, V1136, P1, DOI 10.1196/annals.1425.009; Keshavjee S, 2010, NEW ENGL J MED, V363, P1781, DOI 10.1056/NEJMp1010023; KOCH ROBERT, 1932, AMER REV TUBERC, V25, P285; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Stop TB Partnership/World Health Organization, 2011, TIM ACT SAV MILL LIV; Treatment Action Group (TAG), 2011, STEPS BEING TAK COOR; UNAIDS, 2010, UNAIDS 2011 2015 STR; UNICEF, BEL ZER ACH ZER	12	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2011	378	9801					1449	1450		10.1016/S0140-6736(11)61521-3	http://dx.doi.org/10.1016/S0140-6736(11)61521-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	838VC	22018005				2022-12-28	WOS:000296319600009
J	Baker, S				Baker, Stephen			Genomic medicine has failed the poor	NATURE			English	Editorial Material									Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Oxford OX1 2JD, England	University of Oxford	Baker, S (corresponding author), Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Oxford OX1 2JD, England.	sbaker@oucru.org		Baker, Stephen/0000-0003-1308-5755				Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607	1	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 20	2011	478	7369					287	287		10.1038/478287a	http://dx.doi.org/10.1038/478287a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	22012349	Bronze			2022-12-28	WOS:000296021100006
J	Cassidy, J				Cassidy, Jane			LOBBY WATCH Save Our Pubs & Clubs	BRITISH MEDICAL JOURNAL			English	Editorial Material												janecassi2@googlemail.com						*SCOTT PARL HLTH S, 2009, TOB PRIM MED SERV SC	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 19	2011	343								d6707	10.1136/bmj.d6707	http://dx.doi.org/10.1136/bmj.d6707			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HN	22012647				2022-12-28	WOS:000296183700007
J	Gigerenzer, G				Gigerenzer, Gerd			THE ART OF RISK COMMUNICATION What are natural frequencies?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany	Max Planck Society	Gigerenzer, G (corresponding author), Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany.	gigerenzer@mpib-berlin.mpg.de	Gigerenzer, Gerd/A-6250-2012; Gigerenzer, Gerd/M-5595-2013	Gigerenzer, Gerd/0000-0002-6163-5419; 				Akl EA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006776.pub2; GIGERENZER G, 1995, PSYCHOL REV, V102, P684, DOI 10.1037/0033-295X.102.4.684; Gigerenzer G, 1999, PSYCHOL REV, V106, P425, DOI 10.1037/0033-295X.106.2.425; Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [10.1111/j.1539-6053.2008.00033.x, DOI 10.1111/J.1539-6053.2008.00033.X]; Hoffrage U, 1998, ACAD MED, V73, P538, DOI 10.1097/00001888-199805000-00024; Hoffrage U, 2000, SCIENCE, V290, P2261, DOI 10.1126/science.290.5500.2261; Woloshin S, 2011, ANN INTERN MED, V155, P87, DOI 10.7326/0003-4819-155-2-201107190-00004; Zhu LQ, 2006, COGNITION, V98, P287, DOI 10.1016/j.cognition.2004.12.003	8	45	45	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 17	2011	343								d6386	10.1136/bmj.d6386	http://dx.doi.org/10.1136/bmj.d6386			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	851CH	22006953	Green Submitted			2022-12-28	WOS:000297245400004
J	Vuylsteke, A; Sharples, L; Charman, G; Kneeshaw, J; Tsui, S; Dunning, J; Wheaton, E; Klein, A; Arrowsmith, J; Hall, R; Jenkins, D				Vuylsteke, Alain; Sharples, Linda; Charman, Gill; Kneeshaw, John; Tsui, Steven; Dunning, John; Wheaton, Ella; Klein, Andrew; Arrowsmith, Joseph; Hall, Roger; Jenkins, David			Circulatory arrest versus cerebral perfusion during pulmonary endarterectomy surgery (PEACOG): a randomised controlled trial	LANCET			English	Article							POSTOPERATIVE COGNITIVE DYSFUNCTION; DEEP HYPOTHERMIA; CARDIAC-SURGERY; HYPERTENSION; OUTCOMES; EXPERIENCE	Background For some surgical procedures to be done, a patient's blood circulation needs to be stopped. In such situations, the maintenance of blood flow to the brain is perceived beneficial even in the presence of deep hypothermia. We aimed to assess the benefits of the maintenance of antegrade cerebral perfusion (ACP) compared with deep hypothermic circulatory arrest (DHCA). Methods Patients aged 18-80 years undergoing pulmonary endarterectomy surgery in a UK centre (Papworth Hospital, Cambridge) were randomly assigned with a computer generated sequence to receive either DHCA for periods of up to 20 min at 20 degrees C or ACP (1:1 ratio). The primary endpoint was change in cognitive function at 12 weeks after surgery, as assessed by the trail-making A and B tests, the Rey auditory verbal learning test, and the grooved pegboard test. Patients and assessors were masked to treatment allocation. Primary analysis was by intention to treat. The trial is registered with Current Controlled Trials, number ISRCTN84972261. Findings We enrolled 74 of 196 screened patients (35 to receive DHCA and 39 to receive ACP). Nine patients crossed over from ACP to DHCA to allow complete endarterectomy. At 12 weeks, the mean difference between the two groups in Z scores (the change in cognitive function score from baseline divided by the baseline SD) for the three main cognitive tests was 0.14 (95% CI -0.14 to 0.42; p=0.33) for the trail-making A and B tests, -0.06 (-0.38 to 0.25; p=0.69) for the Rey auditory verbal learning test, and 0.01 (-0.26 to 0.29; p=0.92) for the grooved pegboard test. All patients showed improvement in cognitive function at 12 weeks. We recorded no significant difference in adverse events between the two groups. Three patients died (two in the DHCA group and one in the ACP group). Interpretation Cognitive function is not impaired by either ACP or DHCA. We recommend circulatory arrest as the optimum modality for patients undergoing pulmonary endarterectomy surgery.	[Vuylsteke, Alain; Charman, Gill; Kneeshaw, John; Dunning, John; Klein, Andrew; Arrowsmith, Joseph; Hall, Roger; Jenkins, David] Papworth Hosp NHS Fdn Trust, Cambridge, England; [Sharples, Linda; Wheaton, Ella] MRC, Biostat Unit, Cambridge CB2 2BW, England	Papworth Hospital; MRC Biostatistics Unit	Vuylsteke, A (corresponding author), Papworth Hosp, Dept Anaesthesia & Intens Care, Cambridge CB23 3RE, England.	a.vuylsteke@nhs.net	Vuylsteke, Alain/AAF-2108-2020	Sharples, Linda/0000-0003-0894-966X; Klein, Andrew/0000-0001-9913-6570	Medical Research Council Biostatistics Clinical Trials Methodology Hub; National Institute of Health Research; J P Moulton Charitable Foundation; Medical Research Council [MC_U105232027] Funding Source: researchfish; MRC [MC_U105232027] Funding Source: UKRI	Medical Research Council Biostatistics Clinical Trials Methodology Hub(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); J P Moulton Charitable Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Johanna Armstrong helped with writing the protocol and obtaining funding. Ella Wheaton did statistical analysis during a Clinical Trial Fellowship located within the Medical Research Council Biostatistics Clinical Trials Methodology Hub and funded by the National Institute of Health Research. Ray Latimer was involved in discussing the original protocol and supported the need for a study. We thank Stephanie Cadour for her contribution to the analysis of the CANTAB test results. We thank all staff at Papworth Hospital and the regional designated pulmonary hypertension referral hospitals for their care of the study patients.; Funding J P Moulton Charitable Foundation.	Bekker Alex Y, 2003, Best Pract Res Clin Anaesthesiol, V17, P259, DOI 10.1016/S1521-6896(03)00005-3; Bonser RS, 2005, EUR J CARDIO-THORAC, V28, P102, DOI 10.1016/j.ejcts.2005.03.002; Condliffe R, 2008, AM J RESP CRIT CARE, V177, P1122, DOI 10.1164/rccm.200712-1841OC; Criteria Committee of the New York Heart Association, 1994, NOMENCLATURE CRITERI, V9th, P253; Elefteriades JA, 2010, CARDIOL CLIN, V28, P381, DOI 10.1016/j.ccl.2010.02.004; Elefteriades JA, 2010, CARDIOL CLIN, V28, P403, DOI 10.1016/j.ccl.2010.02.013; Freed DH, 2011, J THORAC CARDIOV SUR, V141, P383, DOI 10.1016/j.jtcvs.2009.12.056; Funder KS, 2010, SEMIN CARDIOTHORAC V, V14, P119, DOI 10.1177/1089253210371520; Jamieson Stuart W, 2008, Ann Thorac Surg, V86, P1267, DOI 10.1016/j.athoracsur.2008.07.067; Jamieson SW, 2003, ANN THORAC SURG, V76, P1457, DOI 10.1016/S0003-4975(03)00828-2; Jamieson SW, 2000, CURR PROB SURG, V37, P170; Kirklin J.W., 1993, CARDIAC SURG, V2nd ed., P61; Macchiarini P, 2006, EUR J CARDIO-THORAC, V30, P237, DOI 10.1016/j.ejcts.2006.02.071; Mayer E, 2011, J THORAC CARDIOV SUR, V141, P702, DOI 10.1016/j.jtcvs.2010.11.024; McKenna S, 2006, QUAL LIFE RES, V15, P103, DOI 10.1007/s11136-005-3513-4; Mikus PM, 2008, EUR J CARDIO-THORAC, V34, P159, DOI 10.1016/j.ejcts.2008.04.048; Moller JT, 1998, LANCET, V351, P857, DOI 10.1016/S0140-6736(97)07382-0; MURKIN JM, 1995, ANN THORAC SURG, V59, P1289, DOI 10.1016/0003-4975(95)00106-U; Newman MF, 2001, NEW ENGL J MED, V344, P395, DOI 10.1056/NEJM200102083440601; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; PETCH CP, 1951, LANCET, V260, P1346; Piazza G, 2011, NEW ENGL J MED, V364, P351, DOI 10.1056/NEJMra0910203; Rudolph JL, 2010, ACTA ANAESTH SCAND, V54, P663, DOI 10.1111/j.1399-6576.2010.02236.x; SAHAKIAN BJ, 1992, J ROY SOC MED, V85, P399; Selwood A, 2004, BRIT MED J, V328, P120, DOI 10.1136/bmj.328.7432.120; Surie S, 2010, MOVEMENT DISORD, V25, P1101, DOI 10.1002/mds.23044; Thistlethwaite PA, 2008, ANN THORAC CARDIOVAS, V14, P274; Thomson B, 2008, EUR J CARDIO-THORAC, V33, P157, DOI 10.1016/j.ejcts.2007.11.009	28	103	112	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 15	2011	378	9800					1379	1387		10.1016/S0140-6736(11)61144-6	http://dx.doi.org/10.1016/S0140-6736(11)61144-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	838EM	22000135				2022-12-28	WOS:000296269600024
J	Henshilwood, CS; d'Errico, F; van Niekerk, KL; Coquinot, Y; Jacobs, Z; Lauritzen, SE; Menu, M; Garcia-Moreno, R				Henshilwood, Christopher S.; d'Errico, Francesco; van Niekerk, Karen L.; Coquinot, Yvan; Jacobs, Zenobia; Lauritzen, Stein-Erik; Menu, Michel; Garcia-Moreno, Renata			A 100,000-Year-Old Ochre-Processing Workshop at Blombos Cave, South Africa	SCIENCE			English	Article							MIDDLE STONE-AGE; CHRONOLOGY; GRAINS; CAPE	The conceptual ability to source, combine, and store substances that enhance technology or social practices represents a benchmark in the evolution of complex human cognition. Excavations in 2008 at Blombos Cave, South Africa, revealed a processing workshop where a liquefied ochre-rich mixture was produced and stored in two Haliotis midae (abalone) shells 100,000 years ago. Ochre, bone, charcoal, grindstones, and hammerstones form a composite part of this production toolkit. The application of the mixture is unknown, but possibilities include decoration and skin protection.	[Henshilwood, Christopher S.; d'Errico, Francesco; van Niekerk, Karen L.] Univ Bergen, Inst Archaeol Hist Culture & Relig, Oysteinsgate 3, N-5007 Bergen, Norway; [Henshilwood, Christopher S.] Univ Witwatersrand, Inst Human Evolut, Johannesburg, South Africa; [d'Errico, Francesco; Garcia-Moreno, Renata] Univ Bordeaux, CNRS, UMR 5199, F-33405 Talence, France; [Coquinot, Yvan; Menu, Michel] CNRS, UMR 171, Musees France, Ctr Rech & Restaurat, F-75001 Paris, France; [Jacobs, Zenobia] Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia; [Lauritzen, Stein-Erik] Univ Bergen, Dept Earth Sci, N-5007 Bergen, Norway	University of Bergen; University of Witwatersrand; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); University of Wollongong; University of Bergen	Henshilwood, CS (corresponding author), Univ Bergen, Inst Archaeol Hist Culture & Relig, Oysteinsgate 3, N-5007 Bergen, Norway.	christopher.henshilwood@ahkr.uib.no	van Niekerk, Karen/J-3511-2015; MENU, MICHEL/AAS-8325-2020; Jacobs, Zenobia/B-2721-2012; Henshilwood, Christopher S/K-3806-2014	van Niekerk, Karen/0000-0003-2261-6861; Jacobs, Zenobia/0000-0001-5424-5837; Henshilwood, Christopher S/0000-0002-2818-293X	European Research Council (ERC) under the European Union [249587]; CNRS; National Research Foundation/Department of Science and Technology at the University of the Witwatersrand, South Africa; Norwegian Research Council/South African National Research Foundation; Australian Research Council [DP1092843]	European Research Council (ERC) under the European Union(European Research Council (ERC)); CNRS(Centre National de la Recherche Scientifique (CNRS)); National Research Foundation/Department of Science and Technology at the University of the Witwatersrand, South Africa; Norwegian Research Council/South African National Research Foundation(Research Council of NorwayNational Research Foundation - South Africa); Australian Research Council(Australian Research Council)	C.S.H. and F.D. received funding from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 249587, the PROTEA French-South African research program, and the Groupe de Recherche International STAR of the CNRS. C.S.H. was also funded by a National Research Foundation/Department of Science and Technology-supported chair at the University of the Witwatersrand, South Africa, and by a joint Norwegian Research Council/South African National Research Foundation grant; and Z.J. was funded by Australian Research Council Discovery project grant DP1092843. The data described in the paper are presented in the supporting online material. C.S.H. and K.vN. excavated the toolkits; C.S.H., F.D., K.vN., and R.G.-M. wrote the text; Z.J. and S.-E.L. wrote the dating text; and all authors were involved in aspects of the data analysis. All the authors discussed the results and implications and commented on the manuscript at all stages. The authors declare no competing interests.	Atkinson QD, 2011, SCIENCE, V332, P346, DOI 10.1126/science.1199295; Compton JS, 2011, QUATERNARY SCI REV, V30, P506, DOI 10.1016/j.quascirev.2010.12.012; d'Errico F, 2010, J ARCHAEOL SCI, V37, P3099, DOI 10.1016/j.jas.2010.07.011; Haslam M, 2011, QUATERNARY RES, V75, P670, DOI 10.1016/j.yqres.2011.02.001; Henn BM, 2011, P NATL ACAD SCI USA, V108, P5154, DOI 10.1073/pnas.1017511108; Henshilwood CS, 2009, J HUM EVOL, V57, P27, DOI 10.1016/j.jhevol.2009.01.005; Henshilwood CS, 2001, J ARCHAEOL SCI, V28, P421, DOI 10.1006/jasc.2000.0638; Hovers E, 2003, CURR ANTHROPOL, V44, P491, DOI 10.1086/375869; Jacobs Z, 2007, EVOL ANTHROPOL, V16, P210, DOI 10.1002/evan.20150; Jacobs Z, 2006, J HUM EVOL, V51, P255, DOI 10.1016/j.jhevol.2006.03.007; Lian OB, 2006, QUATERNARY SCI REV, V25, P2449, DOI 10.1016/j.quascirev.2005.11.013; Richards DA, 2003, REV MINERAL GEOCHEM, V52, P407, DOI 10.2113/0520407; Sajnerova-Duskova A., 2009, NON FLINT RAW MATERI, P145; SCHWARCZ HP, 1980, ARCHAEOMETRY, V22, P3, DOI 10.1111/j.1475-4754.1980.tb00263.x; Tribolo C, 2006, ARCHAEOMETRY, V48, P341, DOI 10.1111/j.1475-4754.2006.00260.x; Van Peer P, 2003, J HUM EVOL, V45, P187, DOI 10.1016/S0047-2484(03)00103-9; Wadley L, 2010, J ARCHAEOL SCI, V37, P2397, DOI 10.1016/j.jas.2010.04.012; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Watts I, 2010, J HUM EVOL, V59, P392, DOI 10.1016/j.jhevol.2010.07.006	19	345	353	5	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2011	334	6053					219	222		10.1126/science.1211535	http://dx.doi.org/10.1126/science.1211535			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	832UI	21998386				2022-12-28	WOS:000295833600044
J	Hijmans, RJ				Hijmans, Robert J.			Comment on "Changes in Climatic Water Balance Drive Downhill Shifts in Plant Species' Optimum Elevations"	SCIENCE			English	Editorial Material									Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	University of California System; University of California Davis	Hijmans, RJ (corresponding author), Univ Calif Davis, Dept Environm Sci & Policy, 1 Shields Ave, Davis, CA 95616 USA.	rhijmans@ucdavis.edu	Hijmans, Robert/N-3299-2016	Hijmans, Robert/0000-0001-5872-2872				Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428	3	8	8	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053								10.1126/science.1203791	http://dx.doi.org/10.1126/science.1203791			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998370				2022-12-28	WOS:000295833600025
J	Jefferson, T				Jefferson, Tom			Should journals sell reprints? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Cochrane Acute Resp Infect Grp, Brisbane, Qld, Australia		Jefferson, T (corresponding author), Cochrane Acute Resp Infect Grp, Brisbane, Qld, Australia.	Jefferson.tom@gmail.com						Drazen JM, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4144; International Committee of Medical Journal Editors, BIOM J ETH CON UNPUB; Jefferson T, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b354; Lundh A, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000354; Massachusetts Medical Society, 2008, 2008 ANN REP MASS ME, P10	5	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 14	2011	343								d6448	10.1136/bmj.d6448	http://dx.doi.org/10.1136/bmj.d6448			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	835ET	22001651				2022-12-28	WOS:000296018600004
J	Zhong, DY; Franke, JH; Podiyanachari, SK; Blomker, T; Zhang, HM; Kehr, G; Erker, G; Fuchs, H; Chi, LF				Zhong, Dingyong; Franke, Joern-Holger; Podiyanachari, Santhosh Kumar; Bloemker, Tobias; Zhang, Haiming; Kehr, Gerald; Erker, Gerhard; Fuchs, Harald; Chi, Lifeng			Linear Alkane Polymerization on a Gold Surface	SCIENCE			English	Article							CARBON-HYDROGEN-BONDS; SELECTIVE OXIDATION; METHANE; ACTIVATION; CATALYSIS; HYDROCARBONS; POLYCONDENSATION; RECONSTRUCTION; ADSORPTION; REACTIVITY	In contrast to the many methods of selectively coupling olefins, few protocols catenate saturated hydrocarbons in a predictable manner. We report here the highly selective carbon-hydrogen (C-H) activation and subsequent dehydrogenative C-C coupling reaction of long-chain (>C(20)) linear alkanes on an anisotropic gold(110) surface, which undergoes an appropriate reconstruction by adsorption of the molecules and subsequent mild annealing, resulting in nanometer-sized channels (1.22 nanometers in width). Owing to the orientational constraint of the reactant molecules in these one-dimensional channels, the reaction takes place exclusively at specific sites (terminal CH(3) or penultimate CH(2) groups) in the chains at intermediate temperatures (420 to 470 kelvin) and selects for aliphatic over aromatic C-H activation.	[Podiyanachari, Santhosh Kumar; Bloemker, Tobias; Kehr, Gerald; Erker, Gerhard] Univ Munster, Inst Organ Chem, D-48149 Munster, Germany; [Zhong, Dingyong; Franke, Joern-Holger; Zhang, Haiming; Fuchs, Harald; Chi, Lifeng] Univ Munster, Inst Phys, D-48149 Munster, Germany; [Zhong, Dingyong; Franke, Joern-Holger; Zhang, Haiming; Fuchs, Harald; Chi, Lifeng] Ctr Nanotechnol, Munster, Germany	University of Munster; University of Munster	Erker, G (corresponding author), Univ Munster, Inst Organ Chem, Corrensstr 40, D-48149 Munster, Germany.	erker@uni-muenster.de; fuchsh@uni-muenster.de; chi@uni-muenster.de	Zhong, Dingyong/D-5617-2017; Chi, Lifeng/A-1419-2015; Fuchs, Harald/AAW-6196-2020	Zhong, Dingyong/0000-0001-5650-4767; Franke, Joern-Holger/0000-0002-3571-1633	Deutsche Forschungsgemeinschaft [SFB858, TRR61]; Institute of Nanotechnology of the Karlsruhe Institute of Technology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Institute of Nanotechnology of the Karlsruhe Institute of Technology	This work was financially supported by the Deutsche Forschungsgemeinschaft through grants SFB858 and TRR61. H.F. thanks the Institute of Nanotechnology of the Karlsruhe Institute of Technology for support. DFT computations were performed at the ZIVSMP and ZIVCLUSTER of the Univ. of Munster. A patent has been filed on the work presented herein.	Besenbacher F, 1998, SCIENCE, V279, P1913, DOI 10.1126/science.279.5358.1913; BLOMBERG MRA, 1983, J AM CHEM SOC, V105, P5557, DOI 10.1021/ja00355a005; Bromberg SE, 1997, SCIENCE, V278, P260, DOI 10.1126/science.278.5336.260; Cai JM, 2010, NATURE, V466, P470, DOI 10.1038/nature09211; Chen HY, 2000, SCIENCE, V287, P1995, DOI 10.1126/science.287.5460.1995; Chen MS, 2004, SCIENCE, V306, P252, DOI 10.1126/science.1102420; Chen X, 2009, ANGEW CHEM INT EDIT, V48, P5094, DOI 10.1002/anie.200806273; Crabtree RH, 2004, J ORGANOMET CHEM, V689, P4083, DOI 10.1016/j.jorganchem.2004.07.034; Goldman A. S, 2004, ACS S SERIES; Grill L, 2007, NAT NANOTECHNOL, V2, P687, DOI 10.1038/nnano.2007.346; HABERLE P, 1989, PHYS REV B, V39, P5810, DOI 10.1103/PhysRevB.39.5810; HALPERN J, 1985, INORG CHIM A-ART LET, V100, P41, DOI 10.1016/S0020-1693(00)88292-4; Haruta M, 1997, CATAL TODAY, V36, P153, DOI 10.1016/S0920-5861(96)00208-8; Hashmi ASK, 2006, ANGEW CHEM INT EDIT, V45, P7896, DOI 10.1002/anie.200602454; HERLEM M, 1977, PURE APPL CHEM, V49, P107, DOI 10.1351/pac197749010107; JONES WD, 1989, ACCOUNTS CHEM RES, V22, P91, DOI 10.1021/ar00159a002; Kratzer P, 1996, J CHEM PHYS, V105, P5595, DOI 10.1063/1.472399; Lafferentz L, 2009, SCIENCE, V323, P1193, DOI 10.1126/science.1168255; Lin ZY, 2007, COORDIN CHEM REV, V251, P2280, DOI 10.1016/j.ccr.2006.11.006; Lunsford JH, 2000, CATAL TODAY, V63, P165, DOI 10.1016/S0920-5861(00)00456-9; OLAH GA, 1968, J AM CHEM SOC, V90, P2726, DOI 10.1021/ja01012a066; OLAH GA, 1974, MAKROMOL CHEM, V175, P1039; ORO J, 1966, SCIENCE, V153, P1393, DOI 10.1126/science.153.3742.1393; Ritleng V, 2002, CHEM REV, V102, P1731, DOI 10.1021/cr0104330; SAULT AG, 1986, SURF SCI, V169, P347, DOI 10.1016/0039-6028(86)90616-3; Somorjai G.A., 2010, INTRO SURFACE CHEM C; Somorjai GA, 2005, PHILOS T ROY SOC A, V363, P879, DOI 10.1098/rsta.2004.1543; Turner M, 2008, NATURE, V454, P981, DOI 10.1038/nature07194; Wang LS, 1997, APPL CATAL A-GEN, V152, P173, DOI 10.1016/S0926-860X(96)00366-3; Wang LS, 1997, SCI CHINA SER B, V40, P161, DOI 10.1007/BF02876407; Xu YD, 1999, APPL CATAL A-GEN, V188, P53, DOI 10.1016/S0926-860X(99)00210-0; Zhao R, 2004, CHEM COMMUN, P904, DOI 10.1039/b315098d; Zhao XY, 2002, LANGMUIR, V18, P3910, DOI 10.1021/la011390l; Zope BN, 2010, SCIENCE, V330, P74, DOI 10.1126/science.1195055	34	272	278	24	379	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					213	216		10.1126/science.1211836	http://dx.doi.org/10.1126/science.1211836			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998384				2022-12-28	WOS:000295833600042
J	DiVincenzo, DP				DiVincenzo, David P.			Toward Control of Large-Scale Quantum Computing	SCIENCE			English	Editorial Material									Forschungszentrum Julich, Rhein Westfal TH Aachen, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich; RWTH Aachen University	DiVincenzo, DP (corresponding author), Forschungszentrum Julich, Rhein Westfal TH Aachen, D-52425 Julich, Germany.	d.divincenzo@fz-juelich.de	DiVincenzo, David P/H-5952-2013	DiVincenzo, David P/0000-0003-4332-645X				Blakestad R. B., 2011, ARXIV11065005; DiCarlo L, 2009, NATURE, V460, P240, DOI 10.1038/nature08121; Kielpinski D, 2002, NATURE, V417, P709, DOI 10.1038/nature00784; Lanyon BP, 2011, SCIENCE, V334, P57, DOI 10.1126/science.1208001; Mariantoni M, 2011, SCIENCE, V334, P61, DOI 10.1126/science.1208517; Mariantoni M, 2011, NAT PHYS, V7, P287, DOI [10.1038/nphys1885, 10.1038/NPHYS1885]	6	4	4	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 7	2011	334	6052					50	51		10.1126/science.1211284	http://dx.doi.org/10.1126/science.1211284			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21980102				2022-12-28	WOS:000295580300034
J	Kondov, SS; McGehee, WR; Zirbel, JJ; DeMarco, B				Kondov, S. S.; McGehee, W. R.; Zirbel, J. J.; DeMarco, B.			Three-Dimensional Anderson Localization of Ultracold Matter	SCIENCE			English	Article							DIFFUSION; ABSENCE; SPECKLE; ATOMS	Anderson localization (AL) is a ubiquitous interference phenomenon in which waves fail to propagate in a disordered medium. We observe three-dimensional AL of noninteracting ultracold matter by allowing a spin-polarized atomic Fermi gas to expand into a disordered potential. A two-component density distribution emerges consisting of an expanding mobile component and a nondiffusing localized component. We extract a mobility edge that increases with the disorder strength, whereas the thermally averaged localization length is shown to decrease with disorder strength and increase with particle energy. These measurements provide a benchmark for more sophisticated theories of AL.	[Kondov, S. S.; McGehee, W. R.; Zirbel, J. J.; DeMarco, B.] Univ Illinois, Dept Phys, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	DeMarco, B (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	bdemarco@illinois.edu		DeMarco, Brian/0000-0002-2791-0413	Defense Advanced Research Projects Agency; Office of Naval Research [N000140911023]; NSF [0855027]	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Office of Naval Research(Office of Naval Research); NSF(National Science Foundation (NSF))	We thank L. Sanchez-Palencia for stimulating discussions and M. White and P. Koehring for technical assistance. We acknowledge funding from the Defense Advanced Research Projects Agency Optical Lattice Emulator program, the Office of Naval Research (award N000140911023), and the NSF (award 0855027). The data presented in this paper are available for download at www.illinois.edu/similar to bdemarco.	ANDERSON PW, 1958, PHYS REV, V109, P1492, DOI 10.1103/PhysRev.109.1492; Billy J, 2008, NATURE, V453, P891, DOI 10.1038/nature07000; Clement D, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.170409; DeMarco B, 1999, PHYS REV LETT, V82, P4208, DOI 10.1103/PhysRevLett.82.4208; DeMarco B, 1999, SCIENCE, V285, P1703, DOI 10.1126/science.285.5434.1703; Dey P, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/48/485205; Esslinger T, 1998, PHYS REV A, V58, pR2664, DOI 10.1103/PhysRevA.58.R2664; Hu HF, 2008, NAT PHYS, V4, P945, DOI 10.1038/nphys1101; Kuhn RC, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/161; LEE PA, 1985, REV MOD PHYS, V57, P287, DOI 10.1103/RevModPhys.57.287; Lugan P, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.023605; Lye JE, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.070401; McKay D, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.063605; O'Holleran K, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.053902; Orso G, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.250402; Papp SB, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.135301; Pasienski M, 2008, OPT EXPRESS, V16, P2176, DOI 10.1364/OE.16.002176; Pilati S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/7/073003; Roati G, 2008, NATURE, V453, P895, DOI 10.1038/nature07071; Robert-de-Saint-Vincent M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.220602; Sanchez-Palencia L, 2010, NAT PHYS, V6, P87, DOI 10.1038/NPHYS1507; Storzer M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.063904; White M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.055301; Wiersma DS, 1997, NATURE, V390, P671, DOI 10.1038/37757; Yedjour A, 2010, EUR PHYS J D, V59, P249, DOI 10.1140/epjd/e2010-00141-5	26	280	285	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 7	2011	334	6052					66	68		10.1126/science.1209019	http://dx.doi.org/10.1126/science.1209019			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21980104	Green Submitted			2022-12-28	WOS:000295580300039
J	Al Rawi, S; Louvet-Vallee, S; Djeddi, A; Sachse, M; Culetto, E; Hajjar, C; Boyd, L; Legouis, R; Galy, V				Al Rawi, Sara; Louvet-Vallee, Sophie; Djeddi, Abderazak; Sachse, Martin; Culetto, Emmanuel; Hajjar, Connie; Boyd, Lynn; Legouis, Renaud; Galy, Vincent			Postfertilization Autophagy of Sperm Organelles Prevents Paternal Mitochondrial DNA Transmission	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; C. ELEGANS; INHERITANCE; GENES; UBIQUITIN; ROLES	In sexual reproduction of most animals, the spermatozoon provides DNA and centrioles, together with some cytoplasm and organelles, to the oocyte that is being fertilized. Paternal mitochondria and their genomes are generally eliminated in the embryo by an unknown degradation mechanism. We show that, upon fertilization, a Caenorhabditis elegans spermatozoon triggers the recruitment of autophagosomes within minutes and subsequent paternal mitochondria degradation. Whereas the nematode-specific sperm membranous organelles are ubiquitinated before autophagosome formation, the mitochondria are not. The degradation of both paternal structures and mitochondrial DNA requires an LC3-dependent autophagy. Analysis of fertilized mouse embryos shows the localization of autophagy markers, which suggests that this autophagy event is evolutionarily conserved to prevent both the transmission of paternal mitochondrial DNA to the offspring and the establishment of heteroplasmy.	[Al Rawi, Sara; Louvet-Vallee, Sophie; Djeddi, Abderazak; Galy, Vincent] Univ Paris 06, Biol Dev UMR7622, F-75005 Paris, France; [Al Rawi, Sara; Louvet-Vallee, Sophie; Djeddi, Abderazak; Galy, Vincent] CNRS, Biol Dev UMR7622, F-75005 Paris, France; [Sachse, Martin] Inst Pasteur, F-75015 Paris, France; [Culetto, Emmanuel; Legouis, Renaud] Univ Paris 11, CNRS, UPR3404, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; [Hajjar, Connie; Boyd, Lynn] Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Alabama System; University of Alabama Huntsville	Galy, V (corresponding author), Univ Paris 06, Biol Dev UMR7622, 9 Quai St Bernard, F-75005 Paris, France.	vgaly@snv.jussieu.fr	Culetto, Emmanuel/AFQ-8565-2022; Legouis, Renaud/G-9088-2014; Legouis, Renaud/S-1250-2017; Sachse, Martin/W-7403-2019	Legouis, Renaud/0000-0002-2699-2584; Sachse, Martin/0000-0001-5981-9166; Culetto, Emmanuel/0000-0003-4725-2654; Louvet, Sophie/0000-0001-7577-2329	NIH National Center for Research Resources; NIH [GM065444-03]; Centre National de la Recherche Scientifique; Univ. of Pierre and Marie Curie; Agence Nationale de la Recherche [ANR 07-BLAN-0063-21]; Association pour la Recherche contre le Cancer; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM065444] Funding Source: NIH RePORTER	NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Univ. of Pierre and Marie Curie; Agence Nationale de la Recherche(French National Research Agency (ANR)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Pappatico, T. Le, and C. Lefebvre for valuable technical assistance during all stages of this project; the staff of the IFR83 Imaging Platform for their efficient help with confocal imaging; K. Wassmann for providing access to research equipments; L. Kuras for advice for quantitative PCR; H. Zhang, S. Strome, and T. Ueno for sharing reagents; J. Plastino for generously providing unpublished reagents for MSP analysis; and A. Golden for assistance with the GFP::ubiquitin project. We also wish to thank P. Codogno and V.G.'s and R.L.'s lab members for careful reading of the manuscript. The LB138 strain was provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources. This research was supported by the NIH (grant GM065444-03 to L. B.), the Centre National de la Recherche Scientifique (R. L. and Action Thematique Incitative sur Programme grant to V. G.), the Univ. of Pierre and Marie Curie, the Agence Nationale de la Recherche (grant ANR 07-BLAN-0063-21 to V. G.), and the Association pour la Recherche contre le Cancer (R.L.).	Alberti A, 2010, AUTOPHAGY, V6, P622, DOI 10.4161/auto.6.5.12252; Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; Farina F, 2008, DEV DYNAM, V237, P1668, DOI 10.1002/dvdy.21578; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Kang C, 2007, GENE DEV, V21, P2161, DOI 10.1101/gad.1573107; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Nishimura Y, 2006, P NATL ACAD SCI USA, V103, P1382, DOI 10.1073/pnas.0506911103; Parry JM, 2009, CURR BIOL, V19, P1752, DOI 10.1016/j.cub.2009.09.015; Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Tsang WY, 2002, BIOCHEM CELL BIOL, V80, P645, DOI [10.1139/o02-135, 10.1139/O02-135]; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; WARD S, 1981, J CELL BIOL, V91, P26, DOI 10.1083/jcb.91.1.26; Washington NL, 2006, J CELL SCI, V119, P2552, DOI 10.1242/jcs.02980; Yoshimori T, 2008, CURR OPIN CELL BIOL, V20, P401, DOI 10.1016/j.ceb.2008.03.010	17	320	329	7	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2011	334	6059					1144	1147		10.1126/science.1211878	http://dx.doi.org/10.1126/science.1211878			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22033522				2022-12-28	WOS:000297313900054
J	Togan, E; Chu, Y; Imamoglu, A; Lukin, MD				Togan, E.; Chu, Y.; Imamoglu, A.; Lukin, M. D.			Laser cooling and real-time measurement of the nuclear spin environment of a solid-state qubit	NATURE			English	Article							DIAMOND SPINS; COHERENT; MAGNETOMETRY; PHOTON; MEDIA; FIELD	Control over quantum dynamics of open systems is one of the central challenges in quantum science and engineering. Coherent optical techniques, such as coherent population trapping involving dark resonances(1,2), are widely used to control quantum states of isolated atoms and ions. In conjunction with spontaneous emission, they allow for laser cooling of atomic motion(3), preparation and manipulation of atomic states(4), and rapid quantum optical measurements that are essential for applications in metrology(5-7). Here we show that these techniques can be applied to monitor and control individual atom-like impurities, and their local environment(8-11), in the solid state. Using all-optical manipulation of the electronic spin of an individual nitrogen-vacancy colour centre in diamond, we demonstrate optical cooling, real-time measurement and conditional preparation of its nuclear spin environment by post-selection. These methods offer potential applications ranging from all-optical nanomagnetometry to quantum feedback control of solid-state qubits, and may lead to new approaches for quantum information storage and processing	[Togan, E.; Chu, Y.; Lukin, M. D.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Imamoglu, A.] ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland	Harvard University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Lukin, MD (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	lukin@fas.harvard.edu			NSF; CUA; DARPA; ARO MURI; NDSEG Fellowship; Packard Foundation; ERC	NSF(National Science Foundation (NSF)); CUA; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); ARO MURI(MURI); NDSEG Fellowship; Packard Foundation(The David & Lucile Packard Foundation); ERC(European Research Council (ERC)European Commission)	We thank A. Aspect, J. I. Cirac, G. Giedke, M. Gullans, J. Hodges, M. Issler, V. Jacques, F. Jelezko, E. Kessler, A. Kubanek, J. McArthur, A. Pick, A. Sipahigil, J. Taylor, S. Yelin and A. S. Zibrov for discussions and experimental help. This work was supported by the NSF, NSF-funded CUA, DARPA (QUEST and QUASAR programmes), ARO MURI, the NDSEG Fellowship, the Packard Foundation and an ERC Advanced Investigator Grant. The content of this paper does not necessarily reflect the position or the policy of the US government, and no official endorsements should be inferred.	ASPECT A, 1988, PHYS REV LETT, V61, P826, DOI 10.1103/PhysRevLett.61.826; Balasubramanian G, 2008, NATURE, V455, P648, DOI 10.1038/nature07278; BARDOU F, 2002, LEVY STAT LASER COOL; Buckley BB, 2010, SCIENCE, V330, P1212, DOI 10.1126/science.1196436; Budker D, 2007, NAT PHYS, V3, P227, DOI 10.1038/nphys566; Chen G, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.045312; Childress L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.070504; Dolde F, 2011, NAT PHYS, V7, P459, DOI [10.1038/nphys1969, 10.1038/NPHYS1969]; Fleischhauer M, 2005, REV MOD PHYS, V77, P633, DOI 10.1103/RevModPhys.77.633; Fuchs GD, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.117601; Giedke G, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.032316; Dutt MVG, 2007, SCIENCE, V316, P1312, DOI 10.1126/science.1139831; Issler M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.267202; Klauser D, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.205302; Manson NB, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.104303; Maze JR, 2008, NATURE, V455, P644, DOI 10.1038/nature07279; Maze JR, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/025025; Neumann P, 2010, SCIENCE, V329, P542, DOI 10.1126/science.1189075; Ni KK, 2008, SCIENCE, V322, P231, DOI 10.1126/science.1163861; Robledo L, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.177403; Rudner M. S., 2011, GENERATING ENTANGLEM; Santori C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.247401; Scully M. O., 1997, QUANTUM OPT, P222; SCULLY MO, 1992, PHYS REV LETT, V69, P1360, DOI 10.1103/PhysRevLett.69.1360; Siyushev P, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3519849; Stepanenko D, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.136401; Togan E, 2010, NATURE, V466, P730, DOI 10.1038/nature09256; Vanier J, 2005, APPL PHYS B-LASERS O, V81, P421, DOI 10.1007/s00340-005-1905-3; Verstraete F, 2009, NAT PHYS, V5, P633, DOI 10.1038/NPHYS1342; Xu XD, 2009, NATURE, V459, P1105, DOI 10.1038/nature08120	30	77	81	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 27	2011	478	7370					497	501		10.1038/nature10528	http://dx.doi.org/10.1038/nature10528			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	22031442				2022-12-28	WOS:000296194200039
J	Carrero-Martinez, FA				Carrero-Martinez, Franklin A.			Rethink Summer Student Research	SCIENCE			English	Editorial Material							ACHIEVEMENT; EXPERIENCES; EDUCATION; SCIENCE; RACE		Univ Puerto Rico, Dept Biol, Mayaguez, PR 00681 USA	University of Puerto Rico; University of Puerto Rico Mayaguez	Carrero-Martinez, FA (corresponding author), Univ Puerto Rico, Dept Biol, Mayaguez, PR 00681 USA.	franklin.carrero@upr.edu						Anderson WA, 2011, SCIENCE, V331, P152, DOI 10.1126/science.1198280; August EM, 2012, J CANCER EDUC, V27, P105, DOI 10.1007/s13187-011-0265-4; Bensimon E.M., 2010, EP3 ED POLICY PRACTI; Cohen GL, 2008, CURR DIR PSYCHOL SCI, V17, P365, DOI 10.1111/j.1467-8721.2008.00607.x; EINAUDI P, 2011, NSF11319; Feldon DF, 2011, SCIENCE, V333, P1037, DOI 10.1126/science.1204109; Ginther DK, 2011, SCIENCE, V333, P1015, DOI 10.1126/science.1196783; Good JM, 2000, J NEGRO EDUC, V69, P375, DOI 10.2307/2696252; Gurin P, 2002, HARVARD EDUC REV, V72, P330, DOI 10.17763/haer.72.3.01151786u134n051; Li X., 2007, 2008156 NCES; Malcom L., 2010, TAPPING HSI STEM FUN; *NAT AC I MED, 2010, EXP UND MIN PART AM; National Science Foundation (NSF), 2011, WOM MIN PERS DIS SCI; *NSF, 2010, DOCT REC US U 2009; Russell SH, 2007, SCIENCE, V316, P548, DOI 10.1126/science.1140384; Tabak LA, 2011, SCIENCE, V333, P940, DOI 10.1126/science.1211704; Walton GM, 2007, J PERS SOC PSYCHOL, V92, P82, DOI 10.1037/0022-3514.92.1.82; Zydney A. L., 2002, J ENG EDUC, V91, P151, DOI 10.1002/j.2168-9830.2002.tb00687.x	18	6	6	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 21	2011	334	6054					313	313		10.1126/science.1209555	http://dx.doi.org/10.1126/science.1209555			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	835RC	22021843				2022-12-28	WOS:000296052500032
J	Whitelegge, J				Whitelegge, Julian			Up Close with Membrane Lipid-Protein Complexes	SCIENCE			English	Editorial Material							TRANSFORM MASS-SPECTROMETRY; CARDIOLIPIN; CRYSTALLIZATION; ATPASE		Univ Calif Los Angeles, NPI Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Whitelegge, J (corresponding author), Univ Calif Los Angeles, NPI Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA.	jpw@chem.ucla.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR023132] Funding Source: NIH RePORTER; NCRR NIH HHS [R21 RR023132] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Bernal RA, 2004, STRUCTURE, V12, P1789, DOI 10.1016/j.str.2004.07.017; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; EBLE KS, 1990, J BIOL CHEM, V265, P19434; Fearnley IM, 1996, BIOCHEM SOC T, V24, P912, DOI 10.1042/bst0240912; Fyfe PK, 2004, BBA-BIOENERGETICS, V1608, P11, DOI 10.1016/j.bbabio.2003.09.014; Hasan SS, 2011, J MOL BIOL, V414, P145, DOI 10.1016/j.jmb.2011.09.023; Ilag LL, 2004, J AM CHEM SOC, V126, P14362, DOI 10.1021/ja0450307; McAuley KE, 1999, P NATL ACAD SCI USA, V96, P14706, DOI 10.1073/pnas.96.26.14706; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Ryan CM, 2010, MOL CELL PROTEOMICS, V9, P791, DOI 10.1074/mcp.M900516-MCP200; SANTIAGO E, 1973, BIOCHEM BIOPH RES CO, V53, P439, DOI 10.1016/0006-291X(73)90681-5; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Thangaraj B, 2010, PROTEOMICS, V10, P3644, DOI 10.1002/pmic.201000190; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Whitelegge JP, 2002, MOL CELL PROTEOMICS, V1, P816, DOI 10.1074/mcp.M200045-MCP200; Zhang HM, 2003, P NATL ACAD SCI USA, V100, P5160, DOI 10.1073/pnas.0931431100; Zhou M, 2011, SCIENCE, V334, P380, DOI 10.1126/science.1210148	18	6	6	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2011	334	6054					320	321		10.1126/science.1214084	http://dx.doi.org/10.1126/science.1214084			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	22021848				2022-12-28	WOS:000296052500037
J	Shah, U; Shenoy-Bhangle, AS				Shah, Uzma; Shenoy-Bhangle, Anuradha S.			Case 32-2011: A 19-Year-Old Man with Recurrent Pancreatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IDIOPATHIC CHRONIC-PANCREATITIS; HEREDITARY PANCREATITIS; CHILDREN; CHOLANGIOPANCREATOGRAPHY; GALLSTONES; INHIBITOR; RISK; GENE		[Shah, Uzma] Massachusetts Gen Hosp, Dept Pediat Gastroenterol, Boston, MA 02114 USA; [Shah, Uzma] Massachusetts Gen Hosp, Dept Hepatol, Boston, MA 02114 USA; [Shah, Uzma] Massachusetts Gen Hosp, Dept Nutr, Boston, MA 02114 USA; [Shenoy-Bhangle, Anuradha S.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Shah, Uzma] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Shenoy-Bhangle, Anuradha S.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Shah, U (corresponding author), Massachusetts Gen Hosp, Dept Pediat Gastroenterol, Boston, MA 02114 USA.							Audrezet MP, 2002, EUR J HUM GENET, V10, P100, DOI 10.1038/sj.ejhg.5200786; Bogue CO, 2010, J PEDIATR GASTR NUTR, V50, P303, DOI 10.1097/MPG.0b013e3181b99c72; Chang YT, 2008, CLIN CHEM, V54, P131, DOI 10.1373/clinchem.2007.093492; Chavhan GB, 2008, RADIOGRAPHICS, V28, P1951, DOI 10.1148/rg.287085031; Chen JM, 2009, ANNU REV GENOM HUM G, V10, P63, DOI 10.1146/annurev-genom-082908-150009; Choi BH, 2003, J GASTROEN HEPATOL, V18, P915, DOI 10.1046/j.1440-1746.2003.03080.x; Clifton MS, 2007, J PEDIATR SURG, V42, P1203, DOI 10.1016/j.jpedsurg.2007.02.009; Cohn JA, 2005, HUM MUTAT, V26, P303, DOI 10.1002/humu.20232; Darge Kassa, 2009, Pediatr Radiol, V39 Suppl 2, pS153, DOI 10.1007/s00247-009-1145-5; Fitoz S, 2007, CLIN IMAG, V31, P93, DOI 10.1016/j.clinimag.2006.11.002; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Hellerhoff KJ, 2002, AM J ROENTGENOL, V179, P121, DOI 10.2214/ajr.179.1.1790121; Joergensen MT, 2010, AM J GASTROENTEROL, V105, P1876, DOI 10.1038/ajg.2010.193; Johnson C, 2010, PANCREATOLOGY, V10, P27, DOI 10.1159/000224147; Lopez MJ, 2002, J PEDIATR-US, V140, P622, DOI 10.1067/mpd.2002.123880; Park AJ, 2010, J PEDIATR GASTR NUTR, V51, P167, DOI 10.1097/MPG.0b013e3181cea545; Rebours V, 2009, GUT, V58, P97, DOI 10.1136/gut.2008.149179; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Ulrich CD, 2001, PANCREATOLOGY, V1, P416, DOI 10.1159/000055841; Urushihara N, 2010, J PEDIATR SURG, V45, P741, DOI 10.1016/j.jpedsurg.2009.05.027; Werlin SL, 2003, J PEDIATR GASTR NUTR, V37, P591, DOI 10.1097/00005176-200311000-00017; Whitcomb DC, 2010, ANNU REV MED, V61, P413, DOI 10.1146/annurev.med.041608.121416; Whitcomb DC, 1999, ANN NY ACAD SCI, V880, P201, DOI 10.1111/j.1749-6632.1999.tb09524.x; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088	24	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2011	365	16					1528	1536		10.1056/NEJMcpc1100920	http://dx.doi.org/10.1056/NEJMcpc1100920			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835BW	22010920				2022-12-28	WOS:000296009500009
J	Phua, J				Phua, Jason			Do You Still Feel It?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Natl Univ Singapore Hosp, Dept Med, Div Resp & Crit Care Med, Singapore 117548, Singapore	National University of Singapore	Phua, J (corresponding author), Natl Univ Singapore Hosp, Dept Med, Div Resp & Crit Care Med, Singapore 117548, Singapore.	jason_phua@nuhs.edu.sg							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 19	2011	306	15					1632	1633		10.1001/jama.2011.1472	http://dx.doi.org/10.1001/jama.2011.1472			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834MA	22009086				2022-12-28	WOS:000295963200001
J	Steele, RJC; Brewster, DH				Steele, Robert J. C.; Brewster, David H.			Should we use total mortality rather than cancer specific mortality to judge cancer screening programmes? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BREAST-CANCER; COLORECTAL-CANCER; TRIAL		[Steele, Robert J. C.] Scottish Bowel Screening Programme, Edinburgh, Midlothian, Scotland; [Brewster, David H.] Scottish Canc Registry, Edinburgh, Midlothian, Scotland		Steele, RJC (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland.	r.j.c.steele@dundee.ac.uk		Brewster, David/0000-0002-5346-5608; Steele, Robert JC/0000-0003-4248-6785				ANDERSSON I, 1988, BRIT MED J, V297, P943, DOI 10.1136/bmj.297.6654.943; Bjurstam N, 1997, CANCER, V80, P2091, DOI 10.1002/(SICI)1097-0142(19971201)80:11<2091::AID-CNCR8>3.0.CO;2-#; Black WC, 2002, JNCI-J NATL CANCER I, V94, P167, DOI 10.1093/jnci/94.3.167; Black WC, 2002, J NATL CANCER I, V94, P865, DOI 10.1093/jnci/94.11.865; Health Scotland, 2011, BOW SCREEN KNOW FACT; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Lindholm E, 2008, BRIT J SURG, V95, P1029, DOI 10.1002/bjs.6136; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Miller AB, 2000, JNCI-J NATL CANCER I, V92, P1490, DOI 10.1093/jnci/92.18.1490; NHS Scotland, 2010, SCOTT BOW SCREEN PRO; Raffle AE, 2007, SCREENING EVIDENCE P; ROBERTS MM, 1990, LANCET, V335, P241; Shapiro S, 1988, PERIODIC SCREENING B; TABAR L, 1989, J EPIDEMIOL COMMUN H, V43, P107, DOI 10.1136/jech.43.2.107	15	14	15	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2011	343								d6397	10.1136/bmj.d6397	http://dx.doi.org/10.1136/bmj.d6397			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	835EQ	21998348				2022-12-28	WOS:000296018300006
J	Neuman, J; Korenstein, D; Ross, JS; Keyhani, S				Neuman, Jennifer; Korenstein, Deborah; Ross, Joseph S.; Keyhani, Salomeh			Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article							PHARMACEUTICAL-INDUSTRY; DISCLOSURE; AUTHORS	Objective To determine the prevalence of financial conflicts of interest among members of panels producing clinical practice guidelines on screening, treatment, or both for hyperlipidaemia or diabetes. Design Cross sectional study. Setting Relevant guidelines published by national organisations in the United States and Canada between 2000 and 2010. Participants Members of guideline panels. Main outcome measures Prevalence of financial conflicts of interest among members of guideline panels and chairs of panels. Results Fourteen guidelines met our search criteria, of which five had no accompanying declaration of conflicts of interest by panel members. 288 panel members had participated in the guideline development process. Among the 288 panel members, 138 (48%) reported conflicts of interest at the time of the publication of the guideline and 150 (52%) either stated that they had no such conflicts or did not have an opportunity to declare any. Among 73 panellists who formally declared no conflicts, 8 (11%) were found to have one or more. Twelve of the 14 guideline panels evaluated identified chairs, among whom six had financial conflicts of interest. Overall, 150 (52%) panel members had conflicts, of which 138 were declared and 12 were undeclared. Panel members from government sponsored guidelines were less likely to have conflicts of interest compared with guidelines sponsored by non-government sources (15/92 (16%) v 135/196 (69%); P<0.001). Conclusions The prevalence of financial conflicts of interest and their under-reporting by members of panels producing clinical practice guidelines on hyperlipidaemia or diabetes was high, and a relatively high proportion of guidelines did not have public disclosure of conflicts of interest. Organisations that produce guidelines should minimise conflicts of interest among panel members to ensure the credibility and evidence based nature of the guidelines' content.	[Neuman, Jennifer] Mt Sinai Sch Med, Dept Prevent Med, New York, NY 10029 USA; [Korenstein, Deborah] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Ross, Joseph S.] Yale Univ, Dept Med, Sect Gen Internal Med, Sch Med, New Haven, CT 06520 USA; [Ross, Joseph S.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06520 USA; [Keyhani, Salomeh] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA; [Keyhani, Salomeh] VA Med Ctr, HSR&D Res Enhancement Award Program, San Francisco, CA 94121 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Yale University; Yale University; University of California System; University of California San Francisco	Neuman, J (corresponding author), Mt Sinai Sch Med, Dept Prevent Med, 1 Gustave Levy Pl,Box 1057, New York, NY 10029 USA.	neuman.jennifer@gmail.com		Ross, Joseph/0000-0002-9218-3320	Veterans' Administration; National Institute on Aging [K08 AG032886]; American Federation of Aging Research; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	Veterans' Administration(US Department of Veterans Affairs); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation of Aging Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was not directly supported by any research funds. SK is funded by a Veterans' Administration HSR&D career development award. JSR is supported by the National Institute on Aging (K08 AG032886) and by the American Federation of Aging Research through the Paul B Beeson Career Development Award Program.	*AG HEALTHC RES QU, 2007, HOUS PHARM COMP MED; Chimonas S, 2011, ARCH INTERN MED, V171, P81, DOI 10.1001/archinternmed.2010.341; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; Cosgrove L, 2009, PSYCHOTHER PSYCHOSOM, V78, P228, DOI 10.1159/000214444; Drazen Jeffrey M, 2010, BMJ, V340, pc3239, DOI 10.1136/bmj.c3239; Grilli R, 2000, LANCET, V355, P103, DOI 10.1016/S0140-6736(99)02171-6; Guyatt G, 2010, ANN INTERN MED, V152, P738, DOI 10.7326/0003-4819-152-11-201006010-00254; Holloway RG, 2008, NEUROLOGY, V71, P57, DOI 10.1212/01.wnl.0000316319.19159.c3; *I MED, 2011, GLOB US MED OUTL 201; *I MED US COMM CON, 2009, CONFL INT MED RES ED; Keyhani S, 2011, HEALTH AFFAIR, V30, P256, DOI 10.1377/hlthaff.2009.0447; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Lundh A, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000354; Mendelson TB, 2011, ARCH INTERN MED, V171, P577, DOI 10.1001/archinternmed.2011.96; Moynihan R, 2008, BRIT MED J, V336, P1402, DOI 10.1136/bmj.39575.675787.651; *NAT I HLTH CLIN E, 2008, COD PRACT DECL DEAL; *NAT I HLTH CLIN E, 2007, AR YOU TAK PART NICE; Okike K, 2009, NEW ENGL J MED, V361, P1466, DOI 10.1056/NEJMsa0807160; Roseman M, 2011, JAMA-J AM MED ASSOC, V305, P1008, DOI 10.1001/jama.2011.257; Ross JS, 2008, JAMA-J AM MED ASSOC, V299, P1800, DOI 10.1001/jama.299.15.1800; Steinbrook R, 2007, NEW ENGL J MED, V356, P331, DOI 10.1056/NEJMp068282; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; US Preventive Services Task Force, 2011, US PREV SERV TASK FO; Wang AT, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1344; *WHO, 2010, DECL INT WHO EXP; World Health Organisation (WHO), 2008, WHO HDB GUID DEV	27	165	167	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 11	2011	343								d5621	10.1136/bmj.d5621	http://dx.doi.org/10.1136/bmj.d5621			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835EJ	21990257	hybrid, Green Published			2022-12-28	WOS:000296017500001
J	Irvine, AD; McLean, WHI; Leung, DYM				Irvine, Alan D.; McLean, W. H. Irwin; Leung, Donald Y. M.			MECHANISMS OF DISEASE Filaggrin Mutations Associated with Skin and Allergic Diseases	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							OF-FUNCTION MUTATIONS; ATOPIC-DERMATITIS; STRATUM-CORNEUM; BARRIER FUNCTION; ICHTHYOSIS VULGARIS; CORNIFIED ENVELOPE; RISK-FACTOR; AUTOSOMAL-DOMINANT; FUNCTION VARIANTS; RARE MUTATIONS		[Irvine, Alan D.] Our Ladys Hosp Sick Children, Natl Childrens Res Ctr, Dublin, Ireland; [Irvine, Alan D.] Our Ladys Hosp Sick Children, Dept Paediat Dermatol, Dublin, Ireland; [Irvine, Alan D.] Trinity Coll Dublin, Dept Clin Med, Dublin, Ireland; [McLean, W. H. Irwin] Univ Dundee, Div Mol Med, Colleges Life Sci & Med Dent & Nursing, Dundee, Scotland; [Leung, Donald Y. M.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Leung, Donald Y. M.] Univ Colorado, Dept Pediat, Denver, CO 80202 USA	National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin; Our Ladys Children Hospital Crumlin; Trinity College Dublin; University of Dundee; National Jewish Health; University of Colorado System; University of Colorado Denver	Leung, DYM (corresponding author), Natl Jewish Hlth, Dept Pediat, 1400 Jackson St K926i, Denver, CO 80206 USA.	leungd@njhealth.org	Irvine, Alan D/A-3982-2008	Irvine, Alan D/0000-0002-9048-2044; McLean, William Henry Irwin/0000-0001-5539-5757	Medical Research Council [G0700314] Funding Source: Medline; NIAMS NIH HHS [R01 AR041256] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041256] Funding Source: NIH RePORTER; MRC [G0700314] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barker JNWN, 2007, J INVEST DERMATOL, V127, P564, DOI 10.1038/sj.jid.5700587; Barresi C, 2011, J INVEST DERMATOL, V131, P188, DOI 10.1038/jid.2010.231; Baurecht H, 2007, J ALLERGY CLIN IMMUN, V120, P1406, DOI 10.1016/j.jaci.2007.08.067; Betz RC, 2007, J INVEST DERMATOL, V127, P2539, DOI 10.1038/sj.jid.5700915; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Bisgaard H, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050131; Boguniewicz M, 2010, J ALLERGY CLIN IMMUN, V125, P4, DOI 10.1016/j.jaci.2009.11.027; Bonnart C, 2010, J CLIN INVEST, V120, P871, DOI 10.1172/JCI41440; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Brown SJ, 2011, J ALLERGY CLIN IMMUN, V127, P661, DOI 10.1016/j.jaci.2011.01.031; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Chen H, 2011, BR J DERMATOL   0324; Cramer C, 2010, J ALLERGY CLIN IMMUN, V125, P1254, DOI 10.1016/j.jaci.2010.03.036; DALE BA, 1985, J CELL BIOL, V101, P1257, DOI 10.1083/jcb.101.4.1257; DALE BA, 1977, BIOCHIM BIOPHYS ACTA, V491, P193, DOI 10.1016/0005-2795(77)90055-1; De Benedetto A, 2011, J ALLERGY CLIN IMMUN, V127, P773, DOI 10.1016/j.jaci.2010.10.018; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; De Jongh CM, 2008, CONTACT DERMATITIS, V58, P269, DOI 10.1111/j.1600-0536.2008.01317.x; de Juanes S, 2009, J INVEST DERMATOL, V129, P1429, DOI 10.1038/jid.2008.410; DELAPP NW, 1988, J INVEST DERMATOL, V90, P490, DOI 10.1111/1523-1747.ep12460964; Demerjian M, 2008, AM J PATHOL, V172, P86, DOI 10.2353/ajpath.2008.070161; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; Deraison C, 2007, J INVEST DERMATOL, V127, pS54; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Elias PM, 2001, ARCH DERMATOL, V137, P1079; Elias PM, 2010, CLIN REV ALLERG 1221; FARTASCH M, 1992, ACTA DERM-VENEREOL, P26; FLECKMAN P, 1985, J INVEST DERMATOL, V85, P507, DOI 10.1111/1523-1747.ep12277306; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; GAN SQ, 1991, BIOCHEMISTRY-US, V30, P5814; GAN SQ, 1990, BIOCHEMISTRY-US, V29, P9432, DOI 10.1021/bi00492a018; Gao PS, 2009, J ALLERGY CLIN IMMUN, V124, P507, DOI 10.1016/j.jaci.2009.07.034; Gruber R, 2009, BRIT J DERMATOL, V161, P1391, DOI 10.1111/j.1365-2133.2009.09471.x; Gruber R, 2011, AM J PATHOL, V178, P2252, DOI 10.1016/j.ajpath.2011.01.053; Hachem JP, 2005, J INVEST DERMATOL, V125, P510, DOI 10.1111/j.0022-202X.2005.23838.x; Hatano Y, 2009, J INVEST DERMATOL, V129, P1824, DOI 10.1038/jid.2008.444; Henderson J, 2008, J ALLERGY CLIN IMMUN, V121; Howell MD, 2008, J INVEST DERMATOL, V128, P2248, DOI 10.1038/jid.2008.74; Howell MD, 2007, J ALLERGY CLIN IMMUN, V120, P150, DOI 10.1016/j.jaci.2007.04.031; Illi S, 2004, J ALLERGY CLIN IMMUN, V113, P925, DOI 10.1016/j.jaci.2004.01.778; Irvine AD, 2007, J INVEST DERMATOL, V127, P504, DOI 10.1038/sj.jid.5700695; Irvine AD, 2006, J INVEST DERMATOL, V126, P1200, DOI 10.1038/sj.jid.5700365; Jensen JM, 2009, J ALLERGY CLIN IMMUN, V124, pR19, DOI 10.1016/j.jaci.2009.07.015; Jungersted JM, 2010, ALLERGY, V65, P911, DOI 10.1111/j.1398-9995.2010.02326.x; Kamata Y, 2009, J BIOL CHEM, V284, P12829, DOI 10.1074/jbc.M807908200; KAY J, 1994, J AM ACAD DERMATOL, V30, P35, DOI 10.1016/S0190-9622(94)70004-4; Kezic S, 2011, ALLERGY, V66, P934, DOI 10.1111/j.1398-9995.2010.02540.x; Krien PM, 2000, J INVEST DERMATOL, V115, P414, DOI 10.1046/j.1523-1747.2000.00083.x; LANE EB, 2008, DRUG DISCOV TODAY, V5, pE93; Lewis-Jones S, 2006, INT J CLIN PRACT, V60, P984, DOI 10.1111/j.1742-1241.2006.01047.x; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Liao HH, 2007, J INVEST DERMATOL, V127, P2795, DOI 10.1038/sj.jid.5700971; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; Maestrini E, 1996, NAT GENET, V13, P70, DOI 10.1038/ng0596-70; Mancini AJ, 2008, PEDIATR DERMATOL, V25, P1, DOI 10.1111/j.1525-1470.2007.00572.x; Marenholz I, 2006, J ALLERGY CLIN IMMUN, V118, P866, DOI 10.1016/j.jaci.2006.07.026; Matsui T, 2011, EMBO MOL MED, V3, P320, DOI 10.1002/emmm.201100140; McLean WHI, 2008, J ALLERGY CLIN IMMUN, V121, P1294, DOI 10.1016/j.jaci.2008.02.039; MEVORAH B, 1985, BRIT J DERMATOL, V112, P679, DOI 10.1111/j.1365-2133.1985.tb02336.x; Miajlovic H, 2011, J ALLERGY CLIN IMMUN, V126; Mildner M, 2010, J INVEST DERMATOL, V130, P2286, DOI 10.1038/jid.2010.115; Moniaga CS, 2010, AM J PATHOL, V176, P2385, DOI 10.2353/ajpath.2010.090957; Nachat R, 2005, J INVEST DERMATOL, V124, P384, DOI 10.1111/j.0022-202X.2004.23568.x; Nemes Z, 1999, EXP MOL MED, V31, P5, DOI 10.1038/emm.1999.2; Novak N, 2008, J INVEST DERMATOL, V128, P1430, DOI 10.1038/sj.jid.5701190; O'Regan GM, 2010, J ALLERGY CLIN IMMUN, V126, P574, DOI 10.1016/j.jaci.2010.04.038; O'Regan GM, 2009, J ALLERGY CLIN IMMUN, V124, pR2, DOI 10.1016/j.jaci.2009.07.013; Oyoshi MK, 2009, J ALLERGY CLIN IMMUN, V124, P485, DOI 10.1016/j.jaci.2009.05.042; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Palmer CNA, 2007, J ALLERGY CLIN IMMUN, V120, P64, DOI 10.1016/j.jaci.2007.04.001; PRESLAND RB, 1992, J BIOL CHEM, V267, P23772; Presland RB, 2000, J INVEST DERMATOL, V115, P1072, DOI 10.1046/j.1523-1747.2000.00178.x; Rodriguez E, 2008, PHARMACOGENOMICS, V9, P399, DOI 10.2217/14622416.9.4.399; Rowe SM, 2009, BIODRUGS, V23, P165, DOI 10.2165/00063030-200923030-00003; Ruether A, 2006, BRIT J DERMATOL, V155, P1093, DOI 10.1111/j.1365-2133.2006.07500.x; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Sandilands A, 2006, J INVEST DERMATOL, V126, P1770, DOI 10.1038/sj.jid.5700459; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Scharschmidt TC, 2009, J ALLERGY CLIN IMMUN, V124, P496, DOI 10.1016/j.jaci.2009.06.046; SCOTT IR, 1986, DEV BIOL, V115, P84, DOI 10.1016/0012-1606(86)90230-7; Sehra S, 2010, J IMMUNOL, V184, P3186, DOI 10.4049/jimmunol.0901860; Shamssain M, 2007, PEDIAT ALLERG IMM-UK, V18, P149, DOI 10.1111/j.1399-3038.2006.00498.x; Shaw TE, 2011, J INVEST DERMATOL, V131, P67, DOI 10.1038/jid.2010.251; Sicherer SH, 2000, J ALLERGY CLIN IMMUN, V106, P53, DOI [10.1067/mai.2000.108105, 10.1067/mai.2000.110158]; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; STEINERT PM, 1981, P NATL ACAD SCI-BIOL, V78, P4097, DOI 10.1073/pnas.78.7.4097; Strong CD, 2010, HUM MOL GENET, V19, P1453, DOI 10.1093/hmg/ddq019; Takahashi M, 1996, ARCH BIOCHEM BIOPHYS, V329, P123, DOI 10.1006/abbi.1996.0199; van den Oord RAHM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2433; Walterscheid JP, 2006, P NATL ACAD SCI USA, V103, P17420, DOI 10.1073/pnas.0603119103; Weidinger S, 2008, J ALLERGY CLIN IMMUN, V122, P976; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P724; WEIDINGER S, 2008, J ALLERGY CLIN IMMUN, V122; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P214, DOI 10.1016/j.jaci.2006.05.004; Weidinger S, 2008, J ALLERGY CLIN IMMUN, V121, P1203, DOI 10.1016/j.jaci.2008.02.014; WELLS RS, 1966, BRIT MED J, V1, P947, DOI 10.1136/bmj.1.5493.947; WERNER Y, 1985, ACTA DERM-VENEREOL, V65, P102; Williams HC, 2005, NEW ENGL J MED, V352, P2314, DOI 10.1056/NEJMcp042803; Yanagi T, 2010, AM J PATHOL, V177, P106, DOI 10.2353/ajpath.2010.091120; Ying S, 2006, J ALLERGY CLIN IMMUN, V118, P1386, DOI 10.1016/j.jaci.2006.08.030; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	102	740	768	4	95	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 6	2011	365	14					1315	1327		10.1056/NEJMra1011040	http://dx.doi.org/10.1056/NEJMra1011040			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829KL	21991953				2022-12-28	WOS:000295578700009
J	Tsai, MS; Yeh, ML				Tsai, Ming-Shian; Yeh, Ming-Lun			Patent Urachus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Tsai, Ming-Shian; Yeh, Ming-Lun] E Da Hosp, Kaohsiung, Taiwan	E-Da Hospital	Tsai, MS (corresponding author), E Da Hosp, Kaohsiung, Taiwan.	dtsurgq6@gmail.com							0	5	5	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 6	2011	365	14					1328	1328		10.1056/NEJMicm1101177	http://dx.doi.org/10.1056/NEJMicm1101177			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829KL	21991954				2022-12-28	WOS:000295578700010
J	Fiore, MC; Baker, TB				Fiore, Michael C.; Baker, Timothy B.			Treating Smokers in the Health Care Setting	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NICOTINE REPLACEMENT THERAPY; SMOKING-CESSATION PHARMACOTHERAPIES; PLACEBO-CONTROLLED TRIAL; STOP SMOKING; DOUBLE-BLIND; REDUCTION; INTERVENTION; VARENICLINE; DEPENDENCE; ADDICTION	A 45-year-old overweight woman with a history of depression sees her physician with a recurrence of acute bronchitis. She began smoking at 15 years of age and now smokes 10 to 15 cigarettes per day. She smokes her first cigarette immediately on awakening. She has made multiple attempts to quit, once briefly using a nicotine patch, but she had a relapse because of strong urges to smoke and weight gain. She is bothered by the cost of cigarettes and is worried about the effects of smoking on her health and that of her children. However, she is reluctant to attempt to quit now, in part because she fears she will not succeed. What would you advise?	[Fiore, Michael C.; Baker, Timothy B.] Univ Wisconsin, Ctr Tobacco Res & Intervent, Sch Med, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Fiore, MC (corresponding author), Univ Wisconsin, Ctr Tobacco Res & Intervent, Sch Med, 1930 Monroe St,Suite 200, Madison, WI 53705 USA.	mcf@ctri.wisc.edu			Nabi Biopharmaceuticals; GlaxoWellcome; NATIONAL CANCER INSTITUTE [K05CA139871, P50CA143188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA019706] Funding Source: NIH RePORTER	Nabi Biopharmaceuticals; GlaxoWellcome; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Dr. Fiore reports receiving research funding from Nabi Biopharmaceuticals and holding the position of chair for the study of tobacco dependence (sponsored by GlaxoWellcome) at the University of Wisconsin from 1997 through 2010. No other potential conflict of interest relevant to this article was reported.	Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; Baker TB, 2004, PSYCHOL REV, V111, P33, DOI 10.1037/0033-295X.111.1.33; Benowitz NL, 2010, NEW ENGL J MED, V362, P2295, DOI 10.1056/NEJMra0809890; Cahill K., 2007, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CDC006103.PUB2; *CAMP TOB FREE KID, 2010, TOLL TOB US; Carpenter MJ, 2004, J CONSULT CLIN PSYCH, V72, P371, DOI 10.1037/0022-006X.72.3.371; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention (CDC), 1993, MMWR Morb Mortal Wkly Rep, V42, P854; Chan SSC, 2011, ADDICTION, V106, P1155, DOI 10.1111/j.1360-0443.2011.03363.x; Curry SJ, 1998, NEW ENGL J MED, V339, P673, DOI 10.1056/NEJM199809033391006; *DEP HLTH HUM SERV, 2009, HLTH; Fiel SB, 1996, DRUGS, V52, P55, DOI 10.2165/00003495-199600522-00012; Fiore MC, 2004, PREV MED, V38, P412, DOI 10.1016/j.ypmed.2003.11.002; FIORE MC, 1995, MAYO CLIN PROC, V70, P209, DOI 10.4065/70.3.209; Fiore MC, 2008, TREATING TOBACCO USE; Godtfredsen NS, 2002, THORAX, V57, P967, DOI 10.1136/thorax.57.11.967; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Hettema J, 2005, ANNU REV CLIN PSYCHO, V1, P91, DOI 10.1146/annurev.clinpsy.1.102803.143833; Hjalmarson A, 2007, PREV MED, V45, P202, DOI 10.1016/j.ypmed.2007.06.014; Hughes JR, 2009, ADDICTION, V104, P1637, DOI 10.1111/j.1360-0443.2009.02645.x; Hughes JR, 2005, ADDICTION, V100, P1074, DOI 10.1111/j.1360-0443.2005.01174.x; Japuntich SJ, 2011, J CONSULT CLIN PSYCH, V79, P34, DOI 10.1037/a0022154; Kinnunen T, 2008, INT J PSYCHIAT MED, V38, P373, DOI 10.2190/PM.38.3.k; Kobinsky Kathleen H, 2010, WMJ, V109, P79; Lai DT, 2010, COCHRANE DB SYST REV, V1; Lancaster T, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001292.pub2, 10.1002/14651858.CD001292.pub3]; Lessov-Schlaggar CN, 2008, BIOCHEM PHARMACOL, V75, P178, DOI 10.1016/j.bcp.2007.08.018; LICHTENSTEIN E, 1992, J FAM PRACTICE, V34, P739; Lindholm Christopher, 2010, WMJ, V109, P335; Lindson N, 2011, PSYCHOPHARMACOLOGY, V214, P579, DOI 10.1007/s00213-010-2069-3; LOH WY, NICOTINE TO IN PRESS; *MED, SMOK CESS; Mills Edward J, 2010, Tob Induc Dis, V8, P8, DOI 10.1186/1617-9625-8-8; Moore D, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1024; *NCI, 20092010 NCI; Novotny T.E., 2000, TOBACCO CONTROL DEV, P287; PETERS EN, 2010, NICOTINE TOB RES, V12, P77; Peters EN, 2009, NICOTINE TOB RES, V11, P1083, DOI 10.1093/ntr/ntp105; Piper ME, 2010, ARCH GEN PSYCHIAT, V67, P77; Rigotti NA, 2010, CIRCULATION, V121, P221, DOI 10.1161/CIRCULATIONAHA.109.869008; Rose JE, 2009, NEBR SYM MOTIV, V55, P131, DOI 10.1007/978-0-387-78748-0_8; RUSSELL MAH, 1976, BRIT MED J, V1, P1043, DOI 10.1136/bmj.1.6017.1043; Shiffman S, 2008, CLIN THER, V30, P1852, DOI 10.1016/j.clinthera.2008.09.016; Shiffman S, 2008, AM J PREV MED, V34, P102, DOI 10.1016/j.amepre.2007.09.033; Smith SS, 2009, ARCH INTERN MED, V169, P2148, DOI 10.1001/archinternmed.2009.426; Stead L. F., 2008, COCHRANE DATABASE SY, V1; Transdisciplinary Tobacco Use Research Center (TTURC) Tobacco Dependence, 2007, Nicotine Tob Res, V9 Suppl 4, pS555, DOI 10.1080/14622200701673480; Vogt F, 2008, NICOTINE TOB RES, V10, P1405, DOI 10.1080/14622200802239280; Wennike P, 2003, ADDICTION, V98, P1395, DOI 10.1046/j.1360-0443.2003.00489.x; West R, 2011, NEW ENGL J MED, V365, P1193, DOI 10.1056/NEJMoa1102035; 2002, MMWR MORB MORTAL WKL, V51, P300	51	115	120	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 29	2011	365	13					1222	1231		10.1056/NEJMcp1101512	http://dx.doi.org/10.1056/NEJMcp1101512			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	825YO	21991895	Green Accepted			2022-12-28	WOS:000295318400010
J	Sato, M; Sato, K				Sato, Miyuki; Sato, Ken			Degradation of Paternal Mitochondria by Fertilization-Triggered Autophagy in C. elegans Embryos	SCIENCE			English	Article							DNA; INHERITANCE; COMPONENTS; MECHANISMS; OOCYTE; GENE	The mitochondrial genome is believed to be maternally inherited in many eukaryotes. Sperm-derived paternal mitochondria enter the oocyte cytoplasm upon fertilization and then normally disappear during early embryogenesis. However, the mechanism responsible for this clearance has been unknown. Here, we show that autophagy, which delivers cytosolic components to lysosomes for degradation, is required for the elimination of paternal mitochondria in Caenorhabditis elegans. Immediately after fertilization, sperm-derived components trigger the localized induction of autophagy around sperm mitochondria. Autophagosomes engulf paternal mitochondria, resulting in their lysosomal degradation during early embryogenesis. In autophagy-defective zygotes, paternal mitochondria and their genome remain even in the first larval stage. Thus, fertilization-triggered autophagy is required for selective degradation of paternal mitochondria and thereby maternal inheritance of mitochondrial DNA.	[Sato, Miyuki; Sato, Ken] Gunma Univ, Inst Mol & Cellular Regulat, Lab Mol Traff, Maebashi, Gunma 3718512, Japan	Gunma University	Sato, K (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Lab Mol Traff, Maebashi, Gunma 3718512, Japan.	sato-ken@gunma-u.ac.jp	Sato, Miyuki/S-5112-2018	Sato, Miyuki/0000-0002-1944-4918	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Uehara Memorial Foundation; Naito Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation)	We thank K. Sato and other members of Sato's laboratory for technical assistance and discussions; Y. Ohsumi for discussions; S. Mitani, Y. Kohara, and the Caenorhabditis Genetic Center for supplying strains and an antibody. This research was supported by a Grant-in-Aid for Young Scientists (A), Japan Society for the Promotion of Science; a Grant-in-Aid for Scientific Research on Priority Areas "Protein Community" and Scientific Research on Innovative Areas "Intracellular Logistics," Ministry of Education, Culture, Sports, Science, and Technology (MEXT); the GCOE Program, MEXT. This research was also supported by the Uehara Memorial Foundation (to K. S.) and the Naito Foundation (to M.S.).	Aitken RJ, 1995, REPROD FERT DEVELOP, V7, P659, DOI 10.1071/RD9950659; AnkelSimons F, 1996, P NATL ACAD SCI USA, V93, P13859, DOI 10.1073/pnas.93.24.13859; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cummins JM, 1997, ZYGOTE, V5, P301, DOI 10.1017/S0967199400003889; Greenstein David, 2005, WormBook, P1, DOI 10.1895/wormbook.1.53.1; GYLLENSTEN U, 1991, NATURE, V352, P255, DOI 10.1038/352255a0; HILL DP, 1989, DEV BIOL, V136, P154, DOI 10.1016/0012-1606(89)90138-3; Johnston WL, 2010, CURR BIOL, V20, P1932, DOI 10.1016/j.cub.2010.09.059; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; L'Hernault Steven W, 2006, WormBook, P1; LINDAHL KF, 1985, TRENDS GENET, V1, P135, DOI 10.1016/0168-9525(85)90055-1; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; Melendez Alicia, 2009, WormBook, P1, DOI 10.1895/wormbook.1.147.1; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nishimura Y, 2006, P NATL ACAD SCI USA, V103, P1382, DOI 10.1073/pnas.0506911103; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Singson A, 1998, CELL, V93, P71, DOI 10.1016/S0092-8674(00)81147-2; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Tsang WY, 2002, BIOCHEM CELL BIOL, V80, P645, DOI [10.1139/o02-135, 10.1139/O02-135]; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; WARD S, 1981, J CELL BIOL, V91, P26, DOI 10.1083/jcb.91.1.26; WARD S, 1979, DEV BIOL, V73, P304, DOI 10.1016/0012-1606(79)90069-1; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022	28	305	320	7	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2011	334	6059					1141	1144		10.1126/science.1210333	http://dx.doi.org/10.1126/science.1210333			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	21998252				2022-12-28	WOS:000297313900053
J	Gibbs, DJ; Lee, SC; Isa, NM; Gramuglia, S; Fukao, T; Bassel, GW; Correia, CS; Corbineau, F; Theodoulou, FL; Bailey-Serres, J; Holdsworth, MJ				Gibbs, Daniel J.; Lee, Seung Cho; Isa, Nurulhikma Md; Gramuglia, Silvia; Fukao, Takeshi; Bassel, George W.; Correia, Cristina Sousa; Corbineau, Francoise; Theodoulou, Frederica L.; Bailey-Serres, Julia; Holdsworth, Michael J.			Homeostatic response to hypoxia is regulated by the N-end rule pathway in plants	NATURE			English	Article							SUBMERGENCE TOLERANCE; ARABIDOPSIS-THALIANA; PROTEIN; OXYGEN; RICE; SENSITIVITY; STRESS; DEGRADATION; ADJUSTMENTS; SENSOR	Plants and animals are obligate aerobes, requiring oxygen for mitochondrial respiration and energy production. In plants, an unanticipated decline in oxygen availability (hypoxia), as caused by roots becoming waterlogged or foliage submergence, triggers changes in gene transcription and messenger RNA translation that promote anaerobic metabolism and thus sustain substrate-level ATP production(1). In contrast to animals(2), oxygen sensing has not been ascribed to a mechanism of gene regulation in response to oxygen deprivation in plants. Here we show that the N-end rule pathway of targeted proteolysis acts as a homeostatic sensor of severe low oxygen levels in Arabidopsis, through its regulation of key hypoxia-response transcription factors. We found that plants lacking components of the N-end rule pathway constitutively express core hypoxia-response genes and are more tolerant of hypoxic stress. We identify the hypoxia-associated ethylene response factor group VII transcription factors of Arabidopsis as substrates of this pathway. Regulation of these proteins by the N-end rule pathway occurs through a characteristic conserved motif at the amino terminus initiating with Met-Cys. Enhanced stability of one of these proteins, HRE2, under low oxygen conditions improves hypoxia survival and reveals a molecular mechanism for oxygen sensing in plants via the evolutionarily conserved N-end rule pathway. SUB1A-1, a major determinant of submergence tolerance in rice(3), was shown not to be a substrate for the N-end rule pathway despite containing the N-terminal motif, indicating that it is uncoupled from N-end rule pathway regulation, and that enhanced stability may relate to the superior tolerance of Sub1 rice varieties to multiple abiotic stresses(4).	[Gibbs, Daniel J.; Isa, Nurulhikma Md; Gramuglia, Silvia; Bassel, George W.; Correia, Cristina Sousa; Holdsworth, Michael J.] Univ Nottingham, Sch Biosci, Div Plant & Crop Sci, Loughborough LE12 5RD, Leics, England; [Gibbs, Daniel J.; Isa, Nurulhikma Md; Gramuglia, Silvia; Bassel, George W.; Correia, Cristina Sousa; Holdsworth, Michael J.] Univ Nottingham, Ctr Plant Integrat Biol, Loughborough LE12 5RD, Leics, England; [Lee, Seung Cho; Fukao, Takeshi; Bailey-Serres, Julia] Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA; [Lee, Seung Cho; Fukao, Takeshi; Bailey-Serres, Julia] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Corbineau, Francoise] Univ Paris 06, CNRS, UPMC, EAC 7180 UR5, F-75005 Paris, France; [Theodoulou, Frederica L.] Rothamsted Res, Dept Biol Chem, Harpenden AL5 2JQ, Herts, England	University of Nottingham; University of Nottingham; University of California System; University of California Riverside; University of California System; University of California Riverside; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Holdsworth, MJ (corresponding author), Univ Nottingham, Sch Biosci, Div Plant & Crop Sci, Loughborough LE12 5RD, Leics, England.	serres@ucr.edu; michael.holdsworth@nottingham.ac.uk	Gibbs, Daniel/ACT-4903-2022; Fukao, Takeshi/H-6548-2016; Holdsworth, Michael/ABA-8153-2020; Bailey-Serres, Julia/A-2470-2010	Gibbs, Daniel/0000-0002-4100-6682; Fukao, Takeshi/0000-0002-9930-1318; Holdsworth, Michael/0000-0002-3954-9215; Bailey-Serres, Julia/0000-0002-8568-7125; Bassel, George/0000-0002-3434-4499; Lee, Seung Cho/0000-0002-3626-8573; Theodoulou, Frederica/0000-0002-8306-0716	BBSRC [BB/G010595/1]; Marie Curie International Incoming Fellowship; Malaysian government;  [NSF IOS-0750811];  [NIFA 2008-35100-04528]; Biotechnology and Biological Sciences Research Council [BB/G010595/1, BBS/E/C/00004948] Funding Source: researchfish; BBSRC [BBS/E/C/00004948] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marie Curie International Incoming Fellowship(European Commission); Malaysian government; ; ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	M.J.H., D.J.G., S. G. and C. S. C. were supported by BBSRC grant BB/G010595/1; G. W. B. by a Marie Curie International Incoming Fellowship; N.M.I. by a MARA PhD fellowship from the Malaysian government; S. C. L., T. F. and J.B.-S. by grants NSF IOS-0750811 and NIFA 2008-35100-04528. We thank S. Liddell. Rothamsted Research receives grant-aided support from the BBSRC.	BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Branco-Price C, 2008, PLANT J, V56, P743, DOI 10.1111/j.1365-313X.2008.03642.x; Chung HJ, 1999, PLANT PHYSIOL, V121, P429, DOI 10.1104/pp.121.2.429; COME D, 1968, CR ACAD SCI D NAT, V266, P477; Dubin MJ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-3; Felle HH, 2005, ANN BOT-LONDON, V96, P519, DOI 10.1093/aob/mci207; Fukao T, 2011, PLANT CELL, V23, P412, DOI 10.1105/tpc.110.080325; Garzon M, 2007, FEBS LETT, V581, P3189, DOI 10.1016/j.febslet.2007.06.005; Graciet E, 2010, TRENDS PLANT SCI, V15, P447, DOI 10.1016/j.tplants.2010.04.011; Graciet E, 2010, PLANT J, V61, P741, DOI 10.1111/j.1365-313X.2009.04099.x; Graciet E, 2009, P NATL ACAD SCI USA, V106, P13618, DOI 10.1073/pnas.0906404106; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; Hinz M, 2010, PLANT PHYSIOL, V153, P757, DOI 10.1104/pp.110.155077; Holman TJ, 2009, P NATL ACAD SCI USA, V106, P4549, DOI 10.1073/pnas.0810280106; Horan K, 2008, PLANT PHYSIOL, V147, P41, DOI 10.1104/pp.108.117366; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Leonard SE, 2011, CURR OPIN CHEM BIOL, V15, P88, DOI 10.1016/j.cbpa.2010.11.012; Licausi F, 2010, PLANT J, V62, P302, DOI 10.1111/j.1365-313X.2010.04149.x; Lucas M, 2011, PLANT PHYSIOL, V155, P384, DOI 10.1104/pp.110.165126; Martinez-Garcia JF, 1999, PLANT J, V20, P251, DOI 10.1046/j.1365-313x.1999.00579.x; Mustroph A, 2010, PLANT PHYSIOL, V152, P1484, DOI 10.1104/pp.109.151845; Mustroph A, 2009, P NATL ACAD SCI USA, V106, P18843, DOI 10.1073/pnas.0906131106; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Papdi C, 2008, PLANT PHYSIOL, V147, P528, DOI 10.1104/pp.108.116897; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Takahashi H, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-39; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Williams AJ, 2003, PLANT PHYSIOL, V132, P2086, DOI 10.1104/pp.103.022749; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Yoshida S, 2002, PLANT J, V32, P129, DOI 10.1046/j.1365-313X.2002.01407.x	38	442	455	5	239	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 17	2011	479	7373					415	U172		10.1038/nature10534	http://dx.doi.org/10.1038/nature10534			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	848OA	22020279	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000297059700049
J	Venditti, C; Meade, A; Pagel, M				Venditti, Chris; Meade, Andrew; Pagel, Mark			Multiple routes to mammalian diversity	NATURE			English	Article							BODY-SIZE; EVOLUTIONARY PATTERNS; CLIMATE-CHANGE; FOSSIL RECORD; PHYLOGENIES; DISPARITY; RATES; MASS	The radiation of the mammals provides a 165-million-year test case for evolutionary theories of how species occupy and then fill ecological niches. It is widely assumed that species often diverge rapidly early in their evolution, and that this is followed by a longer, drawn-out period of slower evolutionary fine-tuning as natural selection fits organisms into an increasingly occupied niche space(1,2). But recent studies have hinted that the process may not be so simple(3-5). Here we apply statistical methods that automatically detect temporal shifts in the rate of evolution through time to a comprehensive mammalian phylogeny(6) and data set(7) of body sizes of 3,185 extant species. Unexpectedly, the majority of mammal species, including two of the most speciose orders (Rodentia and Chiroptera), have no history of substantial and sustained increases in the rates of evolution. Instead, a subset of the mammals has experienced an explosive increase (between 10- and 52-fold) in the rate of evolution along the single branch leading to the common ancestor of their monophyletic group (for example Chiroptera), followed by a quick return to lower or background levels. The remaining species are a taxonomically diverse assemblage showing a significant, sustained increase or decrease in their rates of evolution. These results necessarily decouple morphological diversification from speciation and suggest that the processes that give rise to the morphological diversity of a class of animals are far more free to vary than previously considered. Niches do not seem to fill up, and diversity seems to arise whenever, wherever and at whatever rate it is advantageous.	[Venditti, Chris] Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Meade, Andrew; Pagel, Mark] Univ Reading, Sch Biol Sci, Reading RG6 6BX, Berks, England; [Pagel, Mark] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Hull; University of Reading; The Santa Fe Institute	Venditti, C (corresponding author), Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England.	c.venditti@hull.ac.uk; m.pagel@reading.ac.uk			Leverhulme Trust [ECF/2009/0029]; Natural Environment Research Council, UK; European Research Council; Natural Environment Research Council [NE/C51992X/1] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); Natural Environment Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by a Leverhulme Trust Early Career Fellowship (ECF/2009/0029) to C. V., and by grants to M. P. from the Natural Environment Research Council, UK, the Leverhulme Trust and the European Research Council. We thank R. Freckleton for discussion regarding the implementation of our variable-rates model.	Alroy J, 1998, SCIENCE, V280, P731, DOI 10.1126/science.280.5364.731; Bininda-Emonds ORP, 2008, NATURE, V456, P274, DOI 10.1038/nature07347; Clauset A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.038103; Clauset A, 2008, SCIENCE, V321, P399, DOI 10.1126/science.1157534; Cooper N, 2010, AM NAT, V175, P727, DOI 10.1086/652466; Foote M, 1996, EVOLUTION, V50, P1, DOI 10.1111/j.1558-5646.1996.tb04467.x; FOOTE M, 1994, PALEOBIOLOGY, V20, P320, DOI 10.1017/S009483730001280X; GINGERICH PD, 1987, CAN J ZOOL, V65, P1053, DOI 10.1139/z87-169; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.1093/biomet/82.4.711; Harmon LJ, 2010, EVOLUTION, V64, P2385, DOI 10.1111/j.1558-5646.2010.01025.x; Hunt G, 2006, PALEOBIOLOGY, V32, P578, DOI 10.1666/05070.1; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Polly PD, 2001, AM NAT, V157, P596, DOI 10.1086/320622; RAFTERY AE, 1996, MARKOV CHAIN MONTE C, P163; READ AF, 1989, J ZOOL, V219, P329, DOI 10.1111/j.1469-7998.1989.tb02584.x; Ruta M, 2006, P ROY SOC B-BIOL SCI, V273, P2107, DOI 10.1098/rspb.2006.3577; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Simpson G.G., 1944, TEMPO MODE EVOLUTION, DOI DOI 10.1073/pnas.1821292116; Slater GJ, 2010, P ROY SOC B-BIOL SCI, V277, P3097, DOI 10.1098/rspb.2010.0408; SMITH FA, 1995, SCIENCE, V270, P2012, DOI 10.1126/science.270.5244.2012; Smith FA, 1998, ECOGRAPHY, V21, P140, DOI 10.1111/j.1600-0587.1998.tb00668.x; Venditti C, 2010, NATURE, V463, P349, DOI 10.1038/nature08630	25	202	202	0	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 17	2011	479	7373					393	396		10.1038/nature10516	http://dx.doi.org/10.1038/nature10516			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	848OA	22012260				2022-12-28	WOS:000297059700044
J	Bos, KI; Schuenemann, VJ; Golding, GB; Burbano, HA; Waglechner, N; Coombes, BK; McPhee, JB; DeWitte, SN; Meyer, M; Schmedes, S; Wood, J; Earn, DJD; Herring, DA; Bauer, P; Poinar, HN; Krause, J				Bos, Kirsten I.; Schuenemann, Verena J.; Golding, G. Brian; Burbano, Hernan A.; Waglechner, Nicholas; Coombes, Brian K.; McPhee, Joseph B.; DeWitte, Sharon N.; Meyer, Matthias; Schmedes, Sarah; Wood, James; Earn, David J. D.; Herring, D. Ann; Bauer, Peter; Poinar, Hendrik N.; Krause, Johannes			A draft genome of Yersinia pestis from victims of the Black Death	NATURE			English	Article							EVOLUTION; SEQUENCE; DYNAMICS; PATTERNS; LOST	Technological advances in DNA recovery and sequencing have drastically expanded the scope of genetic analyses of ancient specimens to the extent that full genomic investigations are now feasible and are quickly becoming standard(1). This trend has important implications for infectious disease research because genomic data from ancient microbes may help to elucidate mechanisms of pathogen evolution and adaptation for emerging and re-emerging infections. Here we report a reconstructed ancient genome of Yersinia pestis at 30-fold average coverage from Black Death victims securely dated to episodes of pestilence-associated mortality in London, England, 1348-1350. Genetic architecture and phylogenetic analysis indicate that the ancient organismis ancestral to most extant strains and sits very close to the ancestral node of all Y. pestis commonly associated with human infection. Temporal estimates suggest that the Black Death of 1347-1351 was the main historical event responsible for the introduction and widespread dissemination of the ancestor to all currently circulating Y. pestis strains pathogenic to humans, and further indicates that contemporary Y. pestis epidemics have their origins in the medieval era. Comparisons against modern genomes reveal no unique derived positions in the medieval organism, indicating that the perceived increased virulence of the disease during the Black Death may not have been due to bacterial phenotype. These findings support the notion that factors other than microbial genetics, such as environment, vector dynamics and host susceptibility, should be at the forefront of epidemiological discussions regarding emerging Y. pestis infections.	[Schuenemann, Verena J.; Krause, Johannes] Univ Tubingen, Inst Archaeol Sci, D-72070 Tubingen, Germany; [Bos, Kirsten I.; Poinar, Hendrik N.] McMaster Univ, Dept Anthropol, McMaster Ancient DNA Ctr, Hamilton, ON L8S 4L8, Canada; [Golding, G. Brian; Poinar, Hendrik N.] McMaster Univ, Dept Biol, Hamilton, ON L8S 4L8, Canada; [Burbano, Hernan A.; Meyer, Matthias] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Waglechner, Nicholas; Coombes, Brian K.; McPhee, Joseph B.; Earn, David J. D.; Poinar, Hendrik N.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8S 4L8, Canada; [DeWitte, Sharon N.] Univ S Carolina, Dept Anthropol, Columbia, SC 29208 USA; [DeWitte, Sharon N.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Schmedes, Sarah] Univ N Texas, Hlth Sci Ctr, Inst Appl Genet, Ft Worth, TX 76107 USA; [Wood, James] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Wood, James] Penn State Univ, Populat Res Inst, University Pk, PA 16802 USA; [Earn, David J. D.] McMaster Univ, Dept Math & Stat, Hamilton, ON L8S 4K1, Canada; [Bauer, Peter; Krause, Johannes] Univ Tubingen, Fac Med, Dept Human Genet, D-72070 Tubingen, Germany	Eberhard Karls University of Tubingen; McMaster University; McMaster University; Max Planck Society; McMaster University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of North Texas System; University of North Texas Health Science Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; McMaster University; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Krause, J (corresponding author), Univ Tubingen, Inst Archaeol Sci, Rumelinstr 23, D-72070 Tubingen, Germany.	poinarh@mcmaster.ca; johannes.krause@uni-tuebingen.de	Krause, Johannes/AFP-2642-2022; Krause, Johannes/E-6640-2015; McPhee, Joseph/AAG-5382-2019	Krause, Johannes/0000-0001-9144-3920; Krause, Johannes/0000-0001-5475-4690; Earn, David/0000-0002-7562-1341; Coombes, Brian/0000-0001-9883-1010; McPhee, Joseph/0000-0002-6844-755X; Bos, Kirsten/0000-0003-2937-3006; Burbano, Hernan A./0000-0003-3433-719X; DeWitte, Sharon/0000-0003-0754-8485	McMaster Ancient DNA Centre; Carl Zeiss Foundation; Human Genetics department of the Medical faculty in Tubingen; Canada Research Chairs program; Canadian Institute for Health Research; Social Science and Humanities Research Council of Canada; Michael G. DeGroote Institute for Infectious Disease Research; Ontario Ministry of Research and Education; Natural Sciences and Engineering Research Council of Canada; James S. McDonnell Foundation; University at Albany Research Foundation and Center for Social and Demographic Analysis; Wenner-Gren Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD044943] Funding Source: NIH RePORTER	McMaster Ancient DNA Centre; Carl Zeiss Foundation; Human Genetics department of the Medical faculty in Tubingen; Canada Research Chairs program(Canada Research Chairs); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Social Science and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Michael G. DeGroote Institute for Infectious Disease Research; Ontario Ministry of Research and Education; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); James S. McDonnell Foundation; University at Albany Research Foundation and Center for Social and Demographic Analysis; Wenner-Gren Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank W. White (deceased), J. Bekvalac and R. Redfern from the Museum of London Centre for Human Bioarchaeology for access to samples, M. Kircher and S. Forrest for assistance with computational analysis, G. Wright for support throughout the project, past and present members of the McMaster Ancient DNA Centre for support throughout the project, and D. Poinar for constructive comments on earlier versions of the manuscript. We also thank S. Paabo and the Max Planck Institute of Evolutionary Anthropology for use of their clean room facilities and molecular biology lab. Funding was provided by the Carl Zeiss Foundation (J. K.), the Human Genetics department of the Medical faculty in Tubingen (J. K.), the Canada Research Chairs program (H.N.P., G. B. G.), the Canadian Institute for Health Research (H.N.P.), the Social Science and Humanities Research Council of Canada (H.N.P.), the Michael G. DeGroote Institute for Infectious Disease Research (H.N.P., B. K. C., D. J. D. E.), an Early Research award from the Ontario Ministry of Research and Education (H.N.P.), the Natural Sciences and Engineering Research Council of Canada (D. J. D. E.), the James S. McDonnell Foundation (D. J. D. E.), and the University at Albany Research Foundation and Center for Social and Demographic Analysis and the Wenner-Gren Foundation (S.N.D.).	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Achtman M, 2004, P NATL ACAD SCI USA, V101, P17837, DOI 10.1073/pnas.0408026101; [Anonymous], 2011, P NATL ACAD SCI US; Barrett R, 1998, ANNU REV ANTHROPOL, V27, P247, DOI 10.1146/annurev.anthro.27.1.247; Baum J, 2002, EMERGING PATHOGENS, P67; Benedictow O.J., 2004, BLACK DEATH 1346 135; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Brown Nat F., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020042; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Cohn Samuel, 2003, BLACK DEATH TRANSFOR; Cowal L., 2008, BLACK DEATH CEMETERY; Eppinger M, 2009, J BACTERIOL, V191, P7628, DOI 10.1128/JB.01227-09; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Haensch S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001134; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Hodges E, 2009, NAT PROTOC, V4, P960, DOI 10.1038/nprot.2009.68; JOOSTEN MHAJ, 1994, NATURE, V367, P384, DOI 10.1038/367384a0; Keeling MJ, 2000, NATURE, V407, P903, DOI 10.1038/35038073; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Pouillot F, 2008, INFECT IMMUN, V76, P4592, DOI 10.1128/IAI.00568-08; Schuenemann VJ, 2011, P NATL ACAD SCI USA, V108, pE746, DOI 10.1073/pnas.1105107108; Scott S., 2001, BIOL PLAGUES; Singer M, 2003, MED ANTHROPOL Q, V17, P423, DOI 10.1525/maq.2003.17.4.423; Song YJ, 2004, DNA RES, V11, P179, DOI 10.1093/dnares/11.3.179; Stenseth NC, 2008, PLOS MED, V5, P9, DOI 10.1371/journal.pmed.0050003; Stoneking M, 2011, NAT REV GENET, V12, P603, DOI 10.1038/nrg3029; WHO, 2008, INT M PREV CONTR PLA; Wood JW, 2003, HUM BIOL, V75, P427, DOI 10.1353/hub.2003.0067	28	430	437	7	187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2011	478	7370					506	510		10.1038/nature10549	http://dx.doi.org/10.1038/nature10549			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	21993626	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000296194200041
J	Kangovi, S; Grande, D				Kangovi, Shreya; Grande, David			Hospital Readmissions-Not Just a Measure of Quality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INSURANCE STATUS; FOLLOW-UP; CARE; ACCESS; IMPACT		[Kangovi, Shreya] Univ Penn, Robert Wood Johnson Clin Scholars Program, Philadelphia, PA 19104 USA; [Grande, David] Univ Penn, Perelman Sch Med, Div Gen Internal Med, Philadelphia, PA 19104 USA; [Kangovi, Shreya; Grande, David] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Kangovi, Shreya] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Kangovi, S (corresponding author), Univ Penn, Robert Wood Johnson Clin Scholars Program, 423 Guardian Dr,13th Floor,Blockley Hall, Philadelphia, PA 19104 USA.	kangovi@mail.med.upenn.edu	Grande, David/AAJ-8191-2021	Grande, David/0000-0002-6717-6735				ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; Ashton CM, 1996, SOC SCI MED, V43, P1533, DOI 10.1016/S0277-9536(96)00049-4; Asplin BR, 2005, JAMA-J AM MED ASSOC, V294, P1248, DOI 10.1001/jama.294.10.1248; KELLERMANN AL, 1994, NEW ENGL J MED, V330, P1426; McWilliams JM, 2003, JAMA-J AM MED ASSOC, V290, P757, DOI 10.1001/jama.290.6.757; Misky GJ, 2010, J HOSP MED, V5, P392, DOI 10.1002/jhm.666; Sox CM, 1998, AM J MED, V105, P506, DOI 10.1016/S0002-9343(98)00324-6; Strunin L, 2007, J HOSP MED, V2, P297, DOI 10.1002/jhm.206; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206; WEISSMAN JS, 1994, INQUIRY-J HEALTH CAR, V31, P163	10	115	115	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 26	2011	306	16					1796	1797		10.1001/jama.2011.1562	http://dx.doi.org/10.1001/jama.2011.1562			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HH	22028356				2022-12-28	WOS:000296181600025
J	Denman, M				Denman, Michael			Corticosteroid injections improved short-term, but not long-term, recovery and pain in the greater trochanteric pain syndrome	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Northwick Pk Hosp & Clin Res Ctr, Harrow HA1 3UJ, Middx, England	Imperial College London	Denman, M (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Harrow HA1 3UJ, Middx, England.							Cohen SP, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1088; Segal NA, 2007, ARCH PHYS MED REHAB, V88, P988, DOI 10.1016/j.apmr.2007.04.014	2	3	3	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2011	155	8							JC4-9	10.7326/0003-4819-155-8-201110180-02009	http://dx.doi.org/10.7326/0003-4819-155-8-201110180-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835WB	22007068				2022-12-28	WOS:000296066300008
J	Richards, M; Hatch, SL				Richards, Marcus; Hatch, Stephani L.			ESSAY Good news about the ageing brain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OLDER; HEALTH		[Richards, Marcus] MRC Unit Lifelong Hlth & Ageing, London WC1B 5JU, England; [Hatch, Stephani L.] Kings Coll London, Inst Psychiat, London, England	University of London; King's College London	Richards, M (corresponding author), MRC Unit Lifelong Hlth & Ageing, London WC1B 5JU, England.	m.richards@nshd.mrc.ac.uk	Hatch, Stephani L/B-4235-2010	Richards, Marcus/0000-0001-9191-2192; Hatch, Stephani/0000-0001-9103-2427	MRC [MC_U123092722] Funding Source: UKRI; Medical Research Council [MC_U123092722] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Abrams L, 2011, HANDBOOK OF PSYCHOLINGUISTIC AND COGNITIVE PROCESSES: PERSPECTIVES IN COMMUNICATION DISORDERS, P49; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Baltes P. B., 1993, CURRENT DIRECTIONS P, V2, P75, DOI [10.1111/1467-8721.ep10770914, DOI 10.1111/1467-8721.EP10770914]; Coleman PG, 2004, AGEING DEV, P64; Greengross S, 1997, BRIT MED J, V315, P1029, DOI 10.1136/bmj.315.7115.1029; Harper S, LIVING LONGER PROSPE; Larrivierre D, 2009, NEUROLOGY, V73, P1; Lupton MK, 2010, INT J GERIATR PSYCH, V25, P30, DOI 10.1002/gps.2294; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; National Audit Office, 2007, IMPR SERV SUPP PEOPL; Nielsen L, 2011, SOC COGN AFFECT NEUR, V6, P149, DOI 10.1093/scan/nsr019; Park D.C., 2000, COGNITIVE AGING PRIM, P217; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Pearlin LI, 2007, J HEALTH SOC BEHAV, V48, P164, DOI 10.1177/002214650704800205; Potter GG, 2007, NEUROLOGIST, V13, P105, DOI 10.1097/01.nrl.0000252947.15389.a9; RABBITT P, 1993, Q J EXP PSYCHOL-A, V46, P385, DOI 10.1080/14640749308401055; Richards M, 2011, J GERONTOL B-PSYCHOL, V66, P26, DOI 10.1093/geronb/gbr013; Rowe JW, 1998, SUCCESSFUL AGING; Schunk D. H., 2000, HDB SELF REGULATION, P631, DOI [10.1016/B978-012109890-2/50048-2, DOI 10.1016/B978-012109890-2/50048-2]; Weierich MR, 2011, SOC COGN AFFECT NEUR, V6, P195, DOI 10.1093/scan/nsq056; Westerman SJ, 2000, OCCUP MED-OXFORD, V50, P478, DOI 10.1093/occmed/50.7.478	21	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 17	2011	343								d6288	10.1136/bmj.d6288	http://dx.doi.org/10.1136/bmj.d6288			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	851CH	22006943				2022-12-28	WOS:000297245400003
J	Liu, XY; Liu, ZC; Sun, YG; Ross, M; Kim, S; Tsai, FF; Li, QF; Jeffry, J; Kim, JY; Loh, HH; Chen, ZF				Liu, Xian-Yu; Liu, Zhong-Chun; Sun, Yan-Gang; Ross, Michael; Kim, Seungil; Tsai, Feng-Fang; Li, Qi-Fang; Jeffry, Joseph; Kim, Ji-Young; Loh, Horace H.; Chen, Zhou-Feng			Unidirectional Cross-Activation of GRPR by MOR1D Uncouples Itch and Analgesia Induced by Opioids	CELL			English	Article							DORSAL-HORN NEURONS; MAMMALIAN BOMBESIN RECEPTORS; MORPHINE-INDUCED ANALGESIA; GASTROINTESTINAL TRANSIT; MOLECULAR-MECHANISMS; SPLICE VARIANTS; KNOCKOUT MICE; SPINAL-CORD; MU; PRURITUS	Spinal opioid-induced itch, a prevalent side effect of pain management, has been proposed to result from pain inhibition. We now report that the m-opioid receptor (MOR) isoform MOR1D is essential for morphine-induced scratching (MIS), whereas the isoform MOR1 is required only for morphine-induced analgesia (MIA). MOR1D heterodimerizes with gastrin-releasing peptide receptor (GRPR) in the spinal cord, relaying itch information. We show that morphine triggers internalization of both GRPR and MOR1D, whereas GRP specifically triggers GRPR internalization and morphine-independent scratching. Providing potential insight into opioid-induced itch prevention, we demonstrate that molecular and pharmacologic inhibition of PLC beta 3 and IP3R3, downstream effectors of GRPR, specifically block MIS but not MIA. In addition, blocking MOR1D-GRPR association attenuates MIS but not MIA. Together, these data suggest that opioid-induced itch is an active process concomitant with but independent of opioid analgesia, occurring via the unidirectional cross-activation of GRPR signaling by MOR1D heterodimerization.	[Liu, Xian-Yu; Liu, Zhong-Chun; Sun, Yan-Gang; Ross, Michael; Kim, Seungil; Tsai, Feng-Fang; Li, Qi-Fang; Jeffry, Joseph; Chen, Zhou-Feng] Washington Univ, Sch Med, Pain Ctr, Ctr Study Itch, St Louis, MO 63110 USA; [Liu, Xian-Yu; Liu, Zhong-Chun; Kim, Seungil; Li, Qi-Fang; Jeffry, Joseph; Kim, Ji-Young; Chen, Zhou-Feng] Washington Univ, Sch Med, Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA; [Liu, Xian-Yu; Liu, Zhong-Chun; Kim, Seungil; Li, Qi-Fang; Jeffry, Joseph; Kim, Ji-Young; Chen, Zhou-Feng] Washington Univ, Sch Med, Pain Ctr, Dept Psychiat, St Louis, MO 63110 USA; [Liu, Xian-Yu; Liu, Zhong-Chun; Kim, Seungil; Li, Qi-Fang; Jeffry, Joseph; Kim, Ji-Young; Chen, Zhou-Feng] Washington Univ, Sch Med, Pain Ctr, Dept Dev Biol, St Louis, MO 63110 USA; [Loh, Horace H.] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Minnesota System; University of Minnesota Twin Cities	Chen, ZF (corresponding author), Washington Univ, Sch Med, Pain Ctr, Ctr Study Itch, St Louis, MO 63110 USA.	chenz@wustl.edu	LIU, XIANYU/B-8111-2014	Ross, Michael/0000-0002-5136-650X; Tsai, Feng-Fang/0000-0003-2390-3248; , qifang/0000-0002-5593-720X; Liu, Xianyu/0000-0001-6089-8826	NIDA; NIAMS; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056318] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Yin, S. Weng, Y.C. Pan, and Z.Q. Zhao for technical help and comments, C.J. Coscia, Y.X. Pan, and G.W. Pasternak for MOR1 and MOR1D plasmids, E. Wada and J. Battey for GRPR antibodies, P. Sternweis for PLC beta 3 antibody, E. Liman for IP3R3 antibody, D. Coy for a GRPR antagonist, B.W. Li for qRT-PCR help, and W. Huh for LCM. We also thank M. Bruchas for comments. J.J. has been supported by a NIDA training grant. The work was supported by a NIAMS grant to Z.-F.C.	Abbadie C, 2000, NEUROSCIENCE, V100, P141, DOI 10.1016/S0306-4522(00)00248-7; Agnati LF, 2003, PHARMACOL REV, V55, P509, DOI 10.1124/pr.55.3.2; Alvarez VA, 2002, J NEUROSCI, V22, P5769; Andoh T, 2008, J PHARMACOL SCI, V106, P667, DOI 10.1254/jphs.08004SC; BALLANTYNE JC, 1988, PAIN, V33, P149, DOI 10.1016/0304-3959(88)90085-1; Bergasa NV, 2005, J HEPATOL, V43, P1078, DOI 10.1016/j.jhep.2005.09.004; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Carstens E, 1997, J NEUROPHYSIOL, V77, P2499, DOI 10.1152/jn.1997.77.5.2499; Carstens EE, 2010, NEUROREPORT, V21, P303, DOI 10.1097/WNR.0b013e328337310a; CHANEY MA, 1995, CAN J ANAESTH, V42, P891, DOI 10.1007/BF03011037; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; Davidson S, 2007, J NEUROSCI, V27, P10007, DOI 10.1523/JNEUROSCI.2862-07.2007; Davidson S, 2010, TRENDS NEUROSCI, V33, P550, DOI 10.1016/j.tins.2010.09.002; Fairbanks CA, 1999, J PHARMACOL EXP THER, V288, P1107; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; HALES P, 1980, LANCET, V2, P204; Hampton LL, 1998, P NATL ACAD SCI USA, V95, P3188, DOI 10.1073/pnas.95.6.3188; Han SK, 2006, NEURON, V52, P691, DOI 10.1016/j.neuron.2006.09.036; Hipser C, 2010, MT SINAI J MED, V77, P374, DOI 10.1002/msj.20199; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Jensen RT, 2008, PHARMACOL REV, V60, P1, DOI 10.1124/pr.107.07108; JONES EA, 1990, HEPATOLOGY, V11, P884, DOI 10.1002/hep.1840110526; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Kieffer BL, 1999, TRENDS PHARMACOL SCI, V20, P19, DOI 10.1016/S0165-6147(98)01279-6; Ko MCH, 2000, ANESTHESIOLOGY, V92, P795, DOI 10.1097/00000542-200003000-00023; Ko MCH, 2004, J PHARMACOL EXP THER, V310, P169, DOI 10.1124/jpet.103.061101; Koch T, 2001, J BIOL CHEM, V276, P31408, DOI 10.1074/jbc.M100305200; KROOG GS, 1995, MED RES REV, V15, P389, DOI 10.1002/med.2610150502; Kuraishi Y, 2000, J BIOMED SCI, V7, P248, DOI 10.1159/000025455; Lagerstrom MC, 2010, NEURON, V68, P529, DOI 10.1016/j.neuron.2010.09.016; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; LING GSF, 1989, LIFE SCI, V45, P1627, DOI 10.1016/0024-3205(89)90272-5; Liu Y, 2010, NEURON, V68, P543, DOI 10.1016/j.neuron.2010.09.008; Loh HH, 1998, MOL BRAIN RES, V54, P321, DOI 10.1016/S0169-328X(97)00353-7; Lopez A, 2009, CELL MOL LIFE SCI, V66, P2093, DOI 10.1007/s00018-009-0008-4; MANARA L, 1986, J PHARMACOL EXP THER, V237, P945; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; MCMAHON SB, 1992, TRENDS NEUROSCI, V15, P497, DOI 10.1016/0166-2236(92)90102-E; Metze D, 1999, J AM ACAD DERMATOL, V41, P533, DOI 10.1016/S0190-9622(99)80048-6; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Nichols ML, 1999, SCIENCE, V286, P1558, DOI 10.1126/science.286.5444.1558; Pan YX, 2005, DNA CELL BIOL, V24, P736, DOI 10.1089/dna.2005.24.736; Pasternak GW, 2010, CLIN J PAIN, V26, pS3, DOI 10.1097/AJP.0b013e3181c49d2e; Pasternak GW, 2004, NEUROPHARMACOLOGY, V47, P312, DOI 10.1016/j.neuropharm.2004.07.004; Patel KN, 2010, NEURON, V68, P334, DOI 10.1016/j.neuron.2010.10.018; Paus R, 2006, J CLIN INVEST, V116, P1174, DOI 10.1172/JCI28553; Pfeiffer M, 2002, J BIOL CHEM, V277, P19762, DOI 10.1074/jbc.M110373200; Ravindranathan A, 2009, P NATL ACAD SCI USA, V106, P10811, DOI 10.1073/pnas.0904509106; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Samways DSK, 2006, CELL SIGNAL, V18, P151, DOI 10.1016/j.cellsig.2005.08.005; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Sora I, 1997, P NATL ACAD SCI USA, V94, P1544, DOI 10.1073/pnas.94.4.1544; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Szarvas S, 2003, J CLIN ANESTH, V15, P234, DOI 10.1016/S0952-8180(02)00501-9; Trafton JA, 2000, J NEUROSCI, V20, P8578; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; Waldhoer M, 2005, P NATL ACAD SCI USA, V102, P9050, DOI 10.1073/pnas.0501112102; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Xie W, 1999, P NATL ACAD SCI USA, V96, P10385, DOI 10.1073/pnas.96.18.10385; Zhao ZQ, 2007, P NATL ACAD SCI USA, V104, P14519, DOI 10.1073/pnas.0705740104	62	199	211	3	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 14	2011	147	2					447	458		10.1016/j.cell.2011.08.043	http://dx.doi.org/10.1016/j.cell.2011.08.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000021	Bronze, Green Accepted			2022-12-28	WOS:000296199300021
J	Manel, N; Littman, DR				Manel, Nicolas; Littman, Dan R.			Hiding in Plain Sight: How HIV Evades Innate Immune Responses	CELL			English	Review							IMMUNODEFICIENCY-VIRUS TYPE-1; DENDRITIC CELLS; MACROPHAGES; INFECTION; VPX; TRANSDUCTION; RESTRICTION; SAMHD1	Two groups have identified SAMHD1, a protein encoded by an Aicardi-Goutie` res Syndrome susceptibility gene, as the factor that restricts infection of macrophages and dendritic cells with HIV-1. Here we discuss implications of this discovery for induction of antiviral protective immunity.	[Manel, Nicolas] INSERM, U932, Inst Curie, F-75005 Paris, France; [Littman, Dan R.] NYU, Sch Med, Mol Pathogenesis Program, Kimmel Ctr Biol & Med,Skirball Inst Biomol Med, New York, NY 10016 USA; [Littman, Dan R.] NYU, Sch Med, Howard Hughes Med Inst, Kimmel Ctr Biol & Med,Skirball Inst Biomol Med, New York, NY 10016 USA	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; New York University; Howard Hughes Medical Institute; New York University	Manel, N (corresponding author), INSERM, U932, Inst Curie, 26 Rue Ulm, F-75005 Paris, France.	nicolas.manel@curie.fr; dan.littman@med.nyu.edu	Manel, Nicolas/E-2128-2011	Manel, Nicolas/0000-0002-1481-4430	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R21 AI084633-02, R21 AI084633] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI084633] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Izquierdo-Useros N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000740; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Mangeot PE, 2002, MOL THER, V5, P283, DOI 10.1006/mthe.2002.0541; Nish S, 2011, IMMUNITY, V34, P629, DOI 10.1016/j.immuni.2011.05.009; Ocwieja KE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001313; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Saez-Cirion A, 2011, BLOOD, V118, P955, DOI 10.1182/blood-2010-12-327106; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Sunseri N, 2011, J VIROL, V85, P6263, DOI 10.1128/JVI.00346-11; Yan N, 2011, CURR OPIN IMMUNOL, V23, P21, DOI 10.1016/j.coi.2010.11.004; Yan N, 2010, NAT IMMUNOL, V11, P1005, DOI 10.1038/ni.1941	20	53	55	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 14	2011	147	2					271	274		10.1016/j.cell.2011.09.010	http://dx.doi.org/10.1016/j.cell.2011.09.010			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000008	Bronze, Green Accepted			2022-12-28	WOS:000296199300007
J	Sadeh, R; Allis, CD				Sadeh, Ronen; Allis, C. David			Genome-wide "Re"-Modeling of Nucleosome Positions	CELL			English	Review							EUKARYOTIC GENOME; CHROMATIN; ORGANIZATION; DNA; TRANSCRIPTION; SEQUENCE; DETERMINANTS; PROMOTERS; BINDING; YEAST	Two recent studies mapped nucleosomes across the yeast and human genomes, teasing apart the relative contributions of DNA sequence and chromatin remodelers to nucleosome organization. These data suggest two emerging models: chromatin remodelers position nucleosomes around transcriptional start sites in yeast, and a few "locked" nucleosomes may serve as barriers from which nucleosome arrays emanate in human genomes.	[Sadeh, Ronen; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA	Rockefeller University	Sadeh, R (corresponding author), Rockefeller Univ, Lab Chromatin Biol & Epigenet, 1230 York Ave, New York, NY 10065 USA.	rsadeh@rockefeller.edu; alliscd@mail.rockefeller.edu		Sadeh, Ronen/0000-0003-1920-3898	NIGMS NIH HHS [R01 GM040922-27, R01 GM040922] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040922] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; FEDOR MJ, 1988, J MOL BIOL, V204, P109, DOI 10.1016/0022-2836(88)90603-1; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; IYER V, 1995, EMBO J, V14, P2570, DOI 10.1002/j.1460-2075.1995.tb07255.x; Kaplan N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-140; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kornblihtt AR, 2009, NAT STRUCT MOL BIOL, V16, P902, DOI 10.1038/nsmb0909-902; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; van Holde K.E., 1988, CHROMATIN; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508	24	58	58	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 14	2011	147	2					263	266		10.1016/j.cell.2011.09.042	http://dx.doi.org/10.1016/j.cell.2011.09.042			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000006	Green Accepted, Bronze			2022-12-28	WOS:000296199300005
J	Seimetz, M; Parajuli, N; Pichl, A; Veit, F; Kwapiszewska, G; Weisel, FC; Milger, K; Egemnazarov, B; Turowska, A; Fuchs, B; Nikam, S; Roth, M; Sydykov, A; Medebach, T; Klepetko, W; Jaksch, P; Dumitrascu, R; Garn, H; Voswinckel, R; Kostin, S; Seeger, W; Schermuly, RT; Grimminger, F; Ghofrani, HA; Weissmann, N				Seimetz, Michael; Parajuli, Nirmal; Pichl, Alexandra; Veit, Florian; Kwapiszewska, Grazyna; Weisel, Friederike C.; Milger, Katrin; Egemnazarov, Bakytbek; Turowska, Agnieszka; Fuchs, Beate; Nikam, Sandeep; Roth, Markus; Sydykov, Akylbek; Medebach, Thomas; Klepetko, Walter; Jaksch, Peter; Dumitrascu, Rio; Garn, Holger; Voswinckel, Robert; Kostin, Sawa; Seeger, Werner; Schermuly, Ralph T.; Grimminger, Friedrich; Ghofrani, Hossein A.; Weissmann, Norbert			Inducible NOS Inhibition Reverses Tobacco-Smoke-Induced Emphysema and Pulmonary Hypertension in Mice	CELL			English	Article							NITRIC-OXIDE SYNTHASE; ABDOMINAL AORTIC-ANEURYSMS; BB-94 LIMITS EXPANSION; CIGARETTE-SMOKE; GUINEA-PIG; ARTERIAL-HYPERTENSION; PROGENITOR CELLS; IN-VITRO; T-CELLS; DISEASE	Chronic obstructive pulmonary disease (COPD) is one of the most common causes of death worldwide. We report in an emphysema model of mice chronically exposed to tobacco smoke that pulmonary vascular dysfunction, vascular remodeling, and pulmonary hypertension (PH) precede development of alveolar destruction. We provide evidence for a causative role of inducible nitric oxide synthase (iNOS) and peroxynitrite in this context. Mice lacking iNOS were protected against emphysema and PH. Treatment of wild-type mice with the iNOS inhibitor N-6-(1-iminoethyl)-L-lysine (L-NIL) prevented structural and functional alterations of both the lung vasculature and alveoli and also reversed established disease. In chimeric mice lacking iNOS in bone marrow (BM)-derived cells, PH was dependent on iNOS from BM-derived cells, whereas emphysema development was dependent on iNOS from non-BM-derived cells. Similar regulatory and structural alterations as seen in mouse lungs were found in lung tissue from humans with end-stage COPD.	[Seimetz, Michael; Parajuli, Nirmal; Pichl, Alexandra; Veit, Florian; Kwapiszewska, Grazyna; Weisel, Friederike C.; Milger, Katrin; Egemnazarov, Bakytbek; Fuchs, Beate; Roth, Markus; Sydykov, Akylbek; Medebach, Thomas; Dumitrascu, Rio; Seeger, Werner; Grimminger, Friedrich; Ghofrani, Hossein A.; Weissmann, Norbert] UGLC, Excellence Cluster Cardiopulm Syst ECCPS, D-35392 Giessen, Germany; [Nikam, Sandeep; Voswinckel, Robert; Kostin, Sawa; Schermuly, Ralph T.] Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany; [Klepetko, Walter; Jaksch, Peter] Univ Hosp Vienna, Dept Cardiothorac Surg, A-1090 Vienna, Austria; [Turowska, Agnieszka; Garn, Holger] Biomed Res Ctr BMFZ, D-35043 Marburg, Germany	Max Planck Society; University Hospital Vienna	Weissmann, N (corresponding author), UGLC, Excellence Cluster Cardiopulm Syst ECCPS, D-35392 Giessen, Germany.	norbert.weissmann@innere.med.uni-giessen.de	Sydykov, Akylbek/K-8463-2019; Ghofrani, Ardeschir/AAD-5293-2020; Sydykov, Akylbek/O-1049-2017; Ghofrani, Hossein Ardeschir/AAD-2856-2022; Milger, Katrin/AFI-3881-2022; Parajuli, Nirmal/E-2536-2016	Sydykov, Akylbek/0000-0002-8122-7033; Ghofrani, Ardeschir/0000-0002-2029-4419; Sydykov, Akylbek/0000-0002-8122-7033; Egemnazarov, Bakytbek/0000-0002-1570-8322; Seeger, Werner/0000-0003-1946-0894; Schermuly, Ralph/0000-0002-5167-6970; Garn, Holger/0000-0002-5178-4023; Weissmann, Norbert/0000-0003-2675-3871; Milger, Katrin/0000-0003-2914-8773; Parajuli, Nirmal/0000-0002-0799-6301; Kwapiszewska, grazyna/0000-0003-0518-9079; jaksch, peter/0000-0003-4635-3242	German Research Foundation; Excellence Cluster Cardiopulmonary System (ECCPS); BMBF [ASCONET SP10]; State of Hessen (LOEWE)	German Research Foundation(German Research Foundation (DFG)); Excellence Cluster Cardiopulmonary System (ECCPS)(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); State of Hessen (LOEWE)	The authors thank Nadja Baumgartl, Ingrid Breitenborn-Muller, Uta Eule, Lisa Frohlich, Sabine Graf-Hochst, Carmen Homberger, Miriam Schmidt, and Karin Quanz for technical assistance. This work was in part funded by the German Research Foundation, Excellence Cluster Cardiopulmonary System (ECCPS), the BMBF (ASCONET SP10), and the State of Hessen (LOEWE).	Agusti AGN, 2003, EUR RESPIR J, V21, P347, DOI 10.1183/09031936.03.00405703; Asosingh K, 2008, AM J PATHOL, V172, P615, DOI 10.2353/ajpath.2008.070705; Austin ED, 2010, RESP MED, V104, P454, DOI 10.1016/j.rmed.2009.10.004; Baxter BT, 1999, J VASC SURG, V29, P138; Bigatel DA, 1999, J VASC SURG, V29, P130, DOI 10.1016/S0741-5214(99)70354-X; Black PN, 2008, EUR RESPIR J, V31, P998, DOI 10.1183/09031936.00017207; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Brindicci C, 2009, CHEST, V135, P353, DOI 10.1378/chest.08-0964; Chung KF, 2008, EUR RESPIR J, V31, P1334, DOI 10.1183/09031936.00018908; Churg A, 2008, AM J PHYSIOL-LUNG C, V294, pL612, DOI 10.1152/ajplung.00390.2007; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Cuttica MJ, 2011, AM J RESP CELL MOL, V45, P62, DOI 10.1165/rcmb.2009-0365OC; Ellisen LW, 2010, NAT MED, V16, P754, DOI 10.1038/nm0710-754; Feghali-Bostwick CA, 2008, AM J RESP CRIT CARE, V177, P156, DOI 10.1164/rccm.200701-014OC; Ferrer E, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-76; Huertas A, 2011, EUR RESPIR J, V37, P426, DOI 10.1183/09031936.00034810; Lawrence DM, 2004, J VASC SURG, V40, P334, DOI 10.1016/j.jvs.2004.05.020; Leco KJ, 2001, J CLIN INVEST, V108, P817, DOI 10.1172/JCI12067; Minai OA, 2010, CHEST, V137, p39S, DOI 10.1378/chest.10-0087; Mittal M, 2007, CIRC RES, V101, P258, DOI 10.1161/CIRCRESAHA.107.148015; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; MOORE WM, 1994, J MED CHEM, V37, P3886, DOI 10.1021/jm00049a007; Motz GT, 2010, AM J RESP CRIT CARE, V181, P1223, DOI 10.1164/rccm.200910-1485OC; MURRAY CJ, 1990, LANCET, V349, P1498, DOI DOI 10.1016/S0140-6736(96)07492-2; Niedbala W, 2007, P NATL ACAD SCI USA, V104, P15478, DOI 10.1073/pnas.0703725104; Ochs M, 2004, AM J RESP CRIT CARE, V169, P120, DOI 10.1164/rccm.200308-1107OC; Peinado VI, 2008, CHEST, V134, P808, DOI 10.1378/chest.08-0820; Ponnuswamy P, 2009, AM J PATHOL, V174, P2400, DOI 10.2353/ajpath.2009.080730; Potoka DA, 2003, AM J PHYSIOL-GASTR L, V285, pG861, DOI 10.1152/ajpgi.00412.2002; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Ricciardolo FLM, 2004, PHYSIOL REV, V84, P731, DOI 10.1152/physrev.00034.2003; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Singh D, 2007, AM J RESP CRIT CARE, V176, P988, DOI 10.1164/rccm.200704-588OC; Stenger S, 1995, EUR J PHARMACOL, V294, P703, DOI 10.1016/0014-2999(95)00618-4; Stockley Robert A, 2009, Proc Am Thorac Soc, V6, P524, DOI 10.1513/pats.200904-016DS; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Taraseviciene-Stewart L, 2008, J CLIN INVEST, V118, P394, DOI 10.1172/JCI31811; Tsoumakidou M, 2005, CHEST, V127, P1911, DOI 10.1378/chest.127.6.1911; Voelkel NF, 2006, AM J PHYSIOL-LUNG C, V290, pL209, DOI 10.1152/ajplung.00185.2005; Voswinckel R, 2003, CIRC RES, V93, P372, DOI 10.1161/01.RES.0000087643.60150.C2; Weissmann N, 2006, P NATL ACAD SCI USA, V103, P19093, DOI 10.1073/pnas.0606728103; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6; Wright JL, 2006, J APPL PHYSIOL, V100, P672, DOI 10.1152/japplphysiol.00274.2005; WRIGHT JL, 1991, EXP LUNG RES, V17, P997, DOI 10.3109/01902149109064331; WRIGHT JL, 1990, AM REV RESPIR DIS, V142, P1422, DOI 10.1164/ajrccm/142.6_Pt_1.1422; Wright JL, 2011, AM J RESP CRIT CARE, V183, P50, DOI 10.1164/rccm.201003-0399OC; Yoshida T, 2007, PHYSIOL REV, V87, P1047, DOI 10.1152/physrev.00048.2006; Yoshida T, 2010, NAT MED, V16, P767, DOI 10.1038/nm.2157; Zuckerbraun BS, 2006, J EXP MED, V203, P2109, DOI 10.1084/jem.20052267	49	224	235	2	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 14	2011	147	2					293	305		10.1016/j.cell.2011.08.035	http://dx.doi.org/10.1016/j.cell.2011.08.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000010	Bronze			2022-12-28	WOS:000296199300009
J	Yeeles, JTP; Marians, KJ				Yeeles, Joseph T. P.; Marians, Kenneth J.			The Escherichia coli Replisome Is Inherently DNA Damage Tolerant	SCIENCE			English	Article							STALLED REPLICATION FORKS; LEADING-STRAND; IN-VITRO; RECOMBINATIONAL REPAIR; RESTART; PROTEIN; STOICHIOMETRY; LESION	The Escherichia coli DNA replication machinery must frequently overcome template lesions under normal growth conditions. Yet, the outcome of a collision between the replisome and a leading-strand template lesion remains poorly understood. Here, we demonstrate that a single, site-specific, cyclobutane pyrimidine dimer leading-strand template lesion provides only a transient block to fork progression in vitro. The replisome remains stably associated with the fork after collision with the lesion. Leading-strand synthesis is then reinitiated downstream of the damage in a reaction that is dependent on the primase, DnaG, but independent of any of the known replication-restart proteins. These observations reveal that the replisome can tolerate leading-strand template lesions without dissociating by synthesizing the leading strand discontinuously.	[Yeeles, Joseph T. P.; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Marians, KJ (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA.	kmarians@sloankettering.edu		Yeeles, Joseph/0000-0002-2255-2119	NIH [GM34557]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034557, R37GM034557] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Bahng for establishing the protocol for replicating M13 DNA primed with the CPD oligonucleotide and C. Gabbai, S. Gupta, and S. Shuman for advice on the manuscript. These studies were supported by NIH grant GM34557.	Berdichevsky A, 2002, MOL CELL, V10, P917, DOI 10.1016/S1097-2765(02)00679-2; Carr KM, 2001, J BIOL CHEM, V276, P44919, DOI 10.1074/jbc.M107463200; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Guy CP, 2009, MOL CELL, V36, P654, DOI 10.1016/j.molcel.2009.11.009; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; HIASA H, 1994, J BIOL CHEM, V269, P16371; Higuchi K, 2003, GENES CELLS, V8, P437, DOI 10.1046/j.1365-2443.2003.00646.x; HILL TM, 1990, P NATL ACAD SCI USA, V87, P2481, DOI 10.1073/pnas.87.7.2481; IYER VN, 1971, BIOCHIM BIOPHYS ACTA, V228, P117, DOI 10.1016/0005-2787(71)90551-X; Marians KJ, 1998, J BIOL CHEM, V273, P2452, DOI 10.1074/jbc.273.4.2452; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; McInerney P, 2004, J BIOL CHEM, V279, P21543, DOI 10.1074/jbc.M401649200; Merrikh H, 2011, NATURE, V470, P554, DOI 10.1038/nature09758; Pages V, 2003, SCIENCE, V300, P1300, DOI 10.1126/science.1083964; Reyes-Lamothe R, 2010, SCIENCE, V328, P498, DOI 10.1126/science.1185757; RUPP WD, 1968, J MOL BIOL, V31, P291, DOI 10.1016/0022-2836(68)90445-2; WU CA, 1992, J BIOL CHEM, V267, P4030	18	100	102	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					235	238		10.1126/science.1209111	http://dx.doi.org/10.1126/science.1209111			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998391	Green Accepted			2022-12-28	WOS:000295833600049
J	Leffler, D				Leffler, Daniel			Celiac Disease Diagnosis and Management A 46-Year-Old Woman With Anemia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLUTEN-FREE DIET; IRRITABLE-BOWEL-SYNDROME; POPULATION-BASED COHORT; COST-EFFECTIVENESS ANALYSIS; ANTITISSUE TRANSGLUTAMINASE ANTIBODIES; PLACEBO-CONTROLLED TRIAL; QUALITY-OF-LIFE; UNITED-STATES; PEDIATRIC-GASTROENTEROLOGY; GASTROINTESTINAL SYMPTOMS	Celiac disease is one of the most prevalent autoimmune gastrointestinal disorders, but as the case of Ms J illustrates, diagnosis is often delayed or missed. Based on serologic studies, the prevalence of celiac disease in many populations is estimated to be approximately 1% and has been increasing steadily over the last 50 years. Evaluation for celiac disease is generally straightforward and uses commonly available serologic tests; however, the signs and symptoms of celiac disease are nonspecific and highly heterogeneous, making diagnosis difficult. Although celiac disease is often considered a mild disorder treatable with simple dietary changes, in reality celiac disease imparts considerable risks, including reduced bone mineral density, impaired quality of life, and increased overall mortality. In addition, a gluten-free diet is highly burdensome and can profoundly affect patients and their families. For these reasons, care of individuals with celiac disease requires prompt diagnosis and ongoing multidisciplinary management. JAMA. 2011;306(14):1582-1592	[Leffler, Daniel] Beth Israel Deaconess Med Ctr, Dept Gastroenterol, Boston, MA 02215 USA; [Leffler, Daniel] Harvard Univ, Sch Med, Dept Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Leffler, D (corresponding author), Beth Israel Deaconess Med Ctr, Dept Gastroenterol, Dana 501,330 Brookline Ave, Boston, MA 02215 USA.	dleffler@caregroup.harvard.edu			National Institutes of Health [DK082619]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK095937, K23DK082619] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Leffler reports that he receives support from National Institutes of Health K23 Career Development Award DK082619 and has served as a consultant for Alba Pharmaceuticals, Alvine Pharmaceuticals, Prometheus Laboratories, and Shire Pharmaceuticals.	Abdulkarim AS, 2002, AM J GASTROENTEROL, V97, P2016; Abenavoli L, 2009, EXPERT REV CLIN IMMU, V5, P789, DOI 10.1586/ECI.09.46; Accomando S, 2004, DIGEST LIVER DIS, V36, P492, DOI 10.1016/j.dld.2004.01.026; Akobeng AK, 2008, ALIMENT PHARM THER, V27, P1044, DOI 10.1111/j.1365-2036.2008.03669.x; American Dietetic Association, CEL DIS EV BAS NUTR; [Anonymous], 2004, NIH Consens State Sci Statements, V21, P1; Bernstein CN, 2003, GASTROENTEROLOGY, V124, P795, DOI 10.1053/gast.2003.50106; Biesiekierski JR, 2011, AM J GASTROENTEROL, V106, P508, DOI 10.1038/ajg.2010.487; Brandt LJ, 2009, AM J GASTROENTEROL, V104, pS1, DOI 10.1038/ajg.2008.122; Cataldo F, 1998, GUT, V42, P362, DOI 10.1136/gut.42.3.362; Catassi C, 2004, CURR OPIN PEDIATR, V16, P445, DOI 10.1097/01.mop.0000133637.64414.20; Catassi C, 2007, AM J CLIN NUTR, V85, P160, DOI 10.1093/ajcn/85.1.160; Catassi C, 2007, AM J GASTROENTEROL, V102, P1454, DOI 10.1111/j.1572-0241.2007.01173.x; Catassi C, 2010, AM J MED, V123, P691, DOI 10.1016/j.amjmed.2010.02.019; Cheng JF, 2010, J CLIN GASTROENTEROL, V44, P191, DOI 10.1097/MCG.0b013e3181ac9942; Collin P, 2003, AM J CLIN DERMATOL, V4, P13, DOI 10.2165/00128071-200304010-00002; Corazza GR, 1999, AM J GASTROENTEROL, V94, P391; Cosnes J, 2008, CLIN GASTROENTEROL H, V6, P753, DOI 10.1016/j.cgh.2007.12.022; Cranney A, 2007, DIGEST DIS SCI, V52, P1087, DOI 10.1007/s10620-006-9258-2; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Dipper CR, 2009, ALIMENT PHARM THER, V30, P236, DOI 10.1111/j.1365-2036.2009.04039.x; DISANTAGNESE PA, 1953, PEDIATRICS, V11, P224; Dube C, 2005, GASTROENTEROLOGY, V128, pS57, DOI 10.1053/j.gastro.2005.02.014; Evans KE, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3674; Fasano A, 2008, J PEDIATR GASTR NUTR, V47, P214, DOI 10.1097/MPG.0b013e318181afed; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Fasano A, 2009, BRIT MED J, V339, pb3592; Ferrara F, 2010, CLIN EXP IMMUNOL, V159, P217, DOI 10.1111/j.1365-2249.2009.04054.x; Ford AC, 2009, ARCH INTERN MED, V169, P651, DOI 10.1001/archinternmed.2009.22; Garud S, 2009, ALIMENT PHARM THER, V29, P898, DOI 10.1111/j.1365-2036.2009.03942.x; Giordano L, 2009, PEDIATR NEUROL, V41, P34, DOI 10.1016/j.pediatrneurol.2009.02.009; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Green PHR, 2009, CLIN GASTROENTEROL H, V7, P1210, DOI 10.1016/j.cgh.2009.07.011; Green PHR, 2001, AM J GASTROENTEROL, V96, P126, DOI 10.1111/j.1572-0241.2001.03462.x; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hadjivassiliou M, 2003, BRAIN, V126, P685, DOI 10.1093/brain/awg050; Hadjivassiliou M, 2006, J NEUROL NEUROSUR PS, V77, P1262, DOI 10.1136/jnnp.2006.093534; Hadjivassiliou M, 2010, LANCET NEUROL, V9, P318, DOI 10.1016/S1474-4422(09)70290-X; Hall NJ, 2009, ALIMENT PHARM THER, V30, P315, DOI 10.1111/j.1365-2036.2009.04053.x; Hernandez Lincoln, 2006, Curr Gastroenterol Rep, V8, P383, DOI 10.1007/s11894-006-0023-7; Hill ID, 2005, J PEDIATR GASTR NUTR, V40, P1, DOI 10.1097/00005176-200501000-00001; Howard MR, 2002, J CLIN PATHOL, V55, P754, DOI 10.1136/jcp.55.10.754; Hu WT, 2006, ARCH NEUROL-CHICAGO, V63, P1440, DOI 10.1001/archneur.63.10.1440; Johnston SD, 2004, EUR J GASTROEN HEPAT, V16, P1281, DOI 10.1097/00042737-200412000-00008; Kinsey L, 2008, EUR J CLIN NUTR, V62, P1333, DOI 10.1038/sj.ejcn.1602856; Lanzini A, 2009, ALIMENT PHARM THER, V29, P1299, DOI 10.1111/j.1365-2036.2009.03992.x; Lee AR, 2007, J HUM NUTR DIET, V20, P423, DOI 10.1111/j.1365-277X.2007.00763.x; Leffler DA, 2007, ALIMENT PHARM THER, V26, P1227, DOI 10.1111/j.1365-2036.2007.03501.x; Leffler DA, 2009, CLIN GASTROENTEROL H, V7, pe1; Leffler DA, 2007, CLIN GASTROENTEROL H, V5, P445, DOI 10.1016/j.cgh.2006.12.006; Leffler DA, 2010, AM J GASTROENTEROL, V105, P2520, DOI 10.1038/ajg.2010.276; Leffler DA, 2009, CLIN GASTROENTEROL H, V7, P530, DOI 10.1016/j.cgh.2008.12.032; Lionetti E, 2010, DEV MED CHILD NEUROL, V52, P700, DOI 10.1111/j.1469-8749.2010.03647.x; Lohi S, 2009, GUT, V58, P643, DOI 10.1136/gut.2007.140970; Ludvigsson JF, 2008, GUT, V57, P1074, DOI 10.1136/gut.2007.133868; Ludvigsson JF, 2005, GASTROENTEROLOGY, V129, P454, DOI 10.1053/j.gastro.2005.05.065; Ludvigsson JF, 2007, CLIN GASTROENTEROL H, V5, P1347, DOI 10.1016/j.cgh.2007.06.002; Ludvigsson JF, 2007, J AFFECT DISORDERS, V99, P117, DOI 10.1016/j.jad.2006.08.032; Ludvigsson JF, 2009, JAMA-J AM MED ASSOC, V302, P1171, DOI 10.1001/jama.2009.1320; Maglio M, 2010, J PEDIATR GASTR NUTR, V50, P43, DOI 10.1097/MPG.0b013e3181b99c8f; Mein SM, 2004, ALIMENT PHARM THER, V19, P1199, DOI 10.1111/j.1365-2036.2004.01958.x; Moccia M, 2010, MOVEMENT DISORD, V25, P877, DOI 10.1002/mds.22903; Murray JA, 2004, AM J CLIN NUTR, V79, P669; Mustalahti Kirsi, 2002, Eff Clin Pract, V5, P105; Nachman F, 2011, CLIN GASTROENTEROL H, V9, P214, DOI 10.1016/j.cgh.2010.06.017; National Institute for Health and Clinical Excellence, COEL DIS REC ASS COE; Neuhausen SL, 2008, J AUTOIMMUN, V31, P160, DOI 10.1016/j.jaut.2008.06.001; Olsson C, 2008, J HUM NUTR DIET, V21, P359, DOI 10.1111/j.1365-277X.2008.00867.x; Peracchi M, 2002, AM J GASTROENTEROL, V97, P2850; Primary Care Society for Gastroenterology, 2006, MAN AD COEL DIS PRIM; Ransford RAJ, 2002, J CLIN GASTROENTEROL, V35, P228, DOI 10.1097/00004836-200209000-00006; Robert ME, 2005, SEMIN DIAGN PATHOL, V22, P284, DOI 10.1053/j.semdp.2006.04.004; Rostami K, 2000, EUR J GASTROEN HEPAT, V12, P51, DOI 10.1097/00042737-200012010-00010; Rostom A, 2006, GASTROENTEROLOGY, V131, P1981, DOI 10.1053/j.gastro.2006.10.004; Rubio-Tapia A, 2007, HEPATOLOGY, V46, P1650, DOI 10.1002/hep.21949; Rubio-Tapia A, 2010, AM J GASTROENTEROL, V105, P1412, DOI 10.1038/ajg.2010.10; Rubio-Tapia A, 2010, GUT, V59, P547, DOI 10.1136/gut.2009.195131; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V137, P88, DOI 10.1053/j.gastro.2009.03.059; Sabel'nikova E A, 2004, Eksp Klin Gastroenterol, P31; Sanders DS, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5161; Sanders DS, 2005, DIGEST DIS SCI, V50, P587, DOI 10.1007/s10620-005-2479-y; Schuppan Detlef, 2005, Nutr Clin Care, V8, P54; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Shah S, 2010, WOMENS HEALTH, V6, P753, DOI 10.2217/WHE.10.57; Shamir R, 2006, MED DECIS MAKING, V26, P282, DOI 10.1177/0272989X06289012; Siniscalchi M, 2005, ALIMENT PHARM THER, V22, P489, DOI 10.1111/j.1365-2036.2005.02619.x; Sivash ES, 2004, EKSP KLIN GASTROENTE, V31, P102; Solaymani-Dodaran M, 2007, AM J GASTROENTEROL, V102, P864, DOI 10.1111/j.1572-0241.2007.01111.x; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885; Soni S, 2010, J REPROD MED, V55, P3; Spiegel BMR, 2004, GASTROENTEROLOGY, V126, P1721, DOI 10.1053/j.gastro.2004.03.012; Strong K, 2005, J MED SCREEN, V12, P12, DOI 10.1258/0969141053279086; Tata LJ, 2005, GASTROENTEROLOGY, V128, P849, DOI 10.1053/j.gastro.2005.02.017; Thompson T, 2005, J HUM NUTR DIET, V18, P163, DOI 10.1111/j.1365-277X.2005.00607.x; Thompson T, 2010, J AM DIET ASSOC, V110, P937, DOI 10.1016/j.jada.2010.03.014; Tursi A, 2008, DIGEST DIS SCI, V53, P2925, DOI 10.1007/s10620-008-0242-x; van der Windt DAWM, 2010, JAMA-J AM MED ASSOC, V303, P1738, DOI 10.1001/jama.2010.549; van Koppen EJ, 2009, PEDIATRICS, V123, pE582, DOI 10.1542/peds.2008-2221; Verdu EF, 2011, AM J GASTROENTEROL, V106, P516, DOI 10.1038/ajg.2010.490; Villalta D, 2005, CLIN CHIM ACTA, V356, P102, DOI 10.1016/j.cccn.2005.01.015; Virta LJ, 2009, SCAND J GASTROENTERO, V44, P933, DOI 10.1080/00365520903030795; Volta U, 2010, EXPERT REV GASTROENT, V4, P31, DOI 10.1586/EGH.09.66; Wahnschaffe U, 2007, CLIN GASTROENTEROL H, V5, P844, DOI 10.1016/j.cgh.2007.03.021; West J, 2004, BRIT MED J, V329, P716, DOI 10.1136/bmj.38169.486701.7C; Whitaker JKH, 2009, ALIMENT PHARM THER, V29, P1131, DOI 10.1111/j.1365-2036.2009.03983.x; World Gastroenterology Organisation, WORLD GASTR ORG PRAC; Zarkadas M, 2006, J HUM NUTR DIET, V19, P41, DOI 10.1111/j.1365-277X.2006.00659.x; Zelnik N, 2004, PEDIATRICS, V113, P1672, DOI 10.1542/peds.113.6.1672; Zipser RD, 2003, DIGEST DIS SCI, V48, P761, DOI 10.1023/A:1022897028030; Zone JJ, 2005, GASTROENTEROLOGY, V128, pS87, DOI 10.1053/j.gastro.2005.02.026	110	18	18	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 12	2011	306	14					1582	1592		10.1001/jama.2011.1312	http://dx.doi.org/10.1001/jama.2011.1312			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831FS	21990301	Green Accepted			2022-12-28	WOS:000295714700024
J	Towns, K; Szmitko, PE; Smith, C; Detsky, AS; Mourad, O				Towns, Kathryn; Szmitko, Paul E.; Smith, Chris; Detsky, Allan S.; Mourad, Ophyr			It's Not All in Your Head	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GIANT-CELL ARTERITIS; POLYMYALGIA-RHEUMATICA; TEMPORAL ARTERITIS; INVOLVEMENT; BIOPSY; LIVER		[Towns, Kathryn; Szmitko, Paul E.; Mourad, Ophyr] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Towns, Kathryn; Szmitko, Paul E.; Detsky, Allan S.; Mourad, Ophyr] Univ Toronto, Dept Med, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada; [Smith, Chris] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Queens University - Canada	Mourad, O (corresponding author), St Michaels Hosp, Dept Med, 30 Bond St, Toronto, ON M5B 1W8, Canada.	mourado@smh.on.ca						Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Gonzalez-Gay MA, 2004, ARTHRIT RHEUM-ARTHR, V51, P652, DOI 10.1002/art.20523; HUNT CM, 1994, GASTROENTEROLOGY, V107, P1844, DOI 10.1016/0016-5085(94)90830-3; Jafri Hasan S, 2006, J Gen Intern Med, V21, pC4, DOI 10.1111/j.1525-1497.2006.00414.x; KYLE V, 1991, BAILLIERE CLIN RHEUM, V5, P475, DOI 10.1016/S0950-3579(05)80066-4; McGonagle D, 2001, J RHEUMATOL, V28, P1837; Mukhtyar C, 2009, ANN RHEUM DIS, V68, P318, DOI 10.1136/ard.2008.088351; OGILVIE AL, 1981, J CLIN PATHOL, V34, P769, DOI 10.1136/jcp.34.7.769; Pavlica P, 2000, CLIN EXP RHEUMATOL, V18, pS38; PEDROBOTET J, 1994, AM J GASTROENTEROL, V89, P1898; Pineles Stacy L, 2007, Int Ophthalmol Clin, V47, P105, DOI 10.1097/IIO.0b013e318157fb08; ROUSSELET MC, 1989, PATHOL RES PRACT, V185, P329, DOI 10.1016/S0344-0338(89)80007-X; Salvarani C, 2008, LANCET, V372, P234, DOI 10.1016/S0140-6736(08)61077-6; Smetana GW, 2002, JAMA-J AM MED ASSOC, V287, P92, DOI 10.1001/jama.287.1.92; SONNENBLICK M, 1989, SEMIN ARTHRITIS RHEU, V19, P183, DOI 10.1016/0049-0172(89)90031-0	15	4	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 6	2011	365	14					1329	1334		10.1056/NEJMcps0900533	http://dx.doi.org/10.1056/NEJMcps0900533			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829KL	21991955				2022-12-28	WOS:000295578700012
J	Dheda, K; Migliori, GB				Dheda, Keertan; Migliori, Giovanni B.			The global rise of extensively drug-resistant tuberculosis: is the time to bring back sanatoria now overdue?	LANCET			English	Editorial Material							HEALTH-CARE WORKERS; XDR-TB; PULMONARY TUBERCULOSIS; MULTIDRUG-RESISTANT; SOUTH-AFRICA; EPIDEMIOLOGY; MANAGEMENT		[Dheda, Keertan] Univ Cape Town, Div Pulmonol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Dept Med, UCT Lung Inst, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Migliori, Giovanni B.] Fdn S Maugeri, Care & Res Inst, WHO Collaborating Ctr TB & Lung Dis, Tradate, Italy	University of Cape Town; University of Cape Town; University of Cape Town; Istituti Clinici Scientifici Maugeri IRCCS; World Health Organization	Dheda, K (corresponding author), Groote Schuur Hosp, Dept Med, H Floor,Old Main Bldg, ZA-7925 Cape Town, South Africa.	keertan.dheda@uct.ac.za	Migliori, Giovanni Battista/AAB-8589-2020	Migliori, Giovanni Battista/0000-0002-2597-574X				American S, 1914, TUBERCULOSIS BERLIN, V13, P129; Broekmans JF, 2002, EUR RESPIR J, V19, P765, DOI 10.1183/09031936.02.00261402; DAWSON JJY, 1966, B WORLD HEALTH ORGAN, V34, P533; Dheda K, 2010, INFECT DIS CLIN N AM, V24, P705, DOI 10.1016/j.idc.2010.05.001; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Dietrich-Daum E., 2011, TUBERCULOSIS; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Jarand J, 2010, TROP MED INT HEALTH, V15, P1179, DOI 10.1111/j.1365-3156.2010.02590.x; Keshavjee S, 2008, LANCET, V372, P1403, DOI 10.1016/S0140-6736(08)61204-0; Migliori GB, 2007, EUROSURVEILLANCE, V12; Migliori GB, 2007, EMERG INFECT DIS, V13, P780, DOI 10.3201/eid1305.070200; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; News 24, 2011, NEWS 24         0324; O'Donnell MR, 2010, ANN INTERN MED, V153, P516, DOI 10.7326/0003-4819-153-8-201010190-00008; Raviglione M, 2006, INT J TUBERC LUNG D, V10, P1185; Rutledge J. A., 1919, AM REV TUBERC, V2, P755; Shah NS, 2011, EMERG INFECT DIS, V17, P510, DOI 10.3201/eid1703.101363; Shean KP, 2008, INT J TUBERC LUNG D, V12, P1182; Sotgiu G, 2009, EUR RESPIR J, V33, P871, DOI 10.1183/09031936.00168008; Sotgiu G, EUR RESP J IN PRESS; Styblo K, 1969, Bull Int Union Tuberc, V42, P1; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; World Health Organization, 2009, WHO POL TB INF CONTR; World Health Organization, 2011, WHO PROGRESS REPORT	25	75	77	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 25	2012	379	9817					773	775		10.1016/S0140-6736(11)61062-3	http://dx.doi.org/10.1016/S0140-6736(11)61062-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	899CU	22033020				2022-12-28	WOS:000300792600033
J	Middleton, S; McElduff, P; Ward, J; Grimshaw, JM; Dale, S; D'Este, C; Drury, P; Griffiths, R; Cheung, NW; Quinn, C; Evans, M; Cadilhac, D; Levi, C				Middleton, Sandy; McElduff, Patrick; Ward, Jeanette; Grimshaw, Jeremy M.; Dale, Simeon; D'Este, Catherine; Drury, Peta; Griffiths, Rhonda; Cheung, N. Wah; Quinn, Clare; Evans, Malcolm; Cadilhac, Dominique; Levi, Christopher		QASC Trialists Grp	Implementation of evidence-based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): a cluster randomised controlled trial	LANCET			English	Article							GUIDELINES; TELEPHONE; SUBTYPES; UNIT; CARE	Background We assessed patient outcomes 90 days after hospital admission for stroke following a multidisciplinary intervention targeting evidence-based management of fever, hyperglycaemia, and swallowing dysfunction in acute stroke units (ASUs). Methods In the Quality in Acute Stroke Care (QASC) study, a single-blind cluster randomised controlled trial, we randomised ASUs (clusters) in New South Wales, Australia, with immediate access to CT and on-site high dependency units, to intervention or control group. Patients were eligible if they spoke English, were aged 18 years or older, had had an ischaemic stroke or intracerebral haemorrhage, and presented within 48 h of onset of symptoms. Intervention ASUs received treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction with multidisciplinary team building workshops to address implementation barriers. Control ASUs received only an abridged version of existing guidelines. We recruited pre-intervention and post-intervention patient cohorts to compare 90-day death or dependency (modified Rankin scale [mRS] >= 2), functional dependency (Barthel index), and SF-36 physical and mental component summary scores. Research assistants, the statistician, and patients were masked to trial groups. All analyses were done by intention to treat. This trial is registered at the Australia New Zealand Clinical Trial Registry (ANZCTR), number ACTRN12608000563369. Findings 19 ASUs were randomly assigned to intervention (n=10) or control (n=9). Of 6564 assessed for eligibility, 1696 patients' data were obtained (687 pre-intervention; 1009 post-intervention). Results showed that, irrespective of stroke severity, intervention ASU patients were significantly less likely to be dead or dependent (mRS >= 2) at 90 days than control ASU patients (236 [42%] of 558 patients in the intervention group vs 259 [58%] of 449 in the control group, p=0.002; number needed to treat 6.4; adjusted absolute difference 15.7% [95% CI 5.8-25.4]). They also had a better SF-36 mean physical component summary score (45.6 [SD 10.2] in the intervention group vs 42.5 [10.5] in the control group, p=0.002; adjusted absolute difference 3.4 [95% CI 1.2-5.5]) but no improvement was recorded in mortality (21 [4%] of 558 in intervention group and 24 [5%] of 451 in the control group, p=0.36), SF-36 mean mental component summary score (49.5 [10.9] in the intervention group vs 49.4 [10.6] in the control group, p=0.69) or functional dependency (Barthel Index >= 60: 487 [92%] of 532 patients vs 380 [90%] of 423 patients; p=0.44). Interpretation Implementation of multidisciplinary supported evidence-based protocols initiated by nurses for the management of fever, hyperglycaemia, and swallowing dysfunction delivers better patient outcomes after discharge from stroke units. Our findings show the possibility to augment stroke unit care.	[Middleton, Sandy; Dale, Simeon; Drury, Peta] Australian Catholic Univ, Sch Nursing, Sydney, NSW 2059, Australia; [Middleton, Sandy; Dale, Simeon; Drury, Peta] Australian Catholic Univ, St Vincents Hosp, Ctr Clin Outcomes Res NaCCOR, Darlinghurst, NSW, Australia; [McElduff, Patrick; Levi, Christopher] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2300, Australia; [D'Este, Catherine] Univ Newcastle, Sch Med & Publ Hlth, Fac Hlth, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2300, Australia; [Evans, Malcolm; Levi, Christopher] Univ Newcastle, Prior Ctr Brain & Mental Hlth Res, Newcastle, NSW 2300, Australia; [Ward, Jeanette] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Grimshaw, Jeremy M.] Univ Ottawa, Ottawa Hlth Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Grimshaw, Jeremy M.] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Griffiths, Rhonda] Univ Western Sydney, Sch Nursing & Midwifery, Penrith, NSW, Australia; [Cheung, N. Wah] Univ Sydney, Westmead, NSW 2145, Australia; [Cheung, N. Wah] Westmead Hosp, Ctr Diabet & Endocrinol Res, Westmead, NSW 2145, Australia; [Quinn, Clare] Prince Wales Hosp, Dept Pathol, Randwick, NSW 2031, Australia; [Cadilhac, Dominique] Monash Univ, So Clin Sch, Monash Med Ctr, Translat Publ Hlth Stroke & Ageing Res Ctr, Clayton, Vic, Australia; [Cadilhac, Dominique] Melbourne Brain Ctr, Florey Neurosci Inst, Natl Stroke Res Inst, Melbourne, Vic, Australia; [Cadilhac, Dominique] Univ Melbourne, Dept Med, Melbourne, Vic, Australia	Australian Catholic University; Australian Catholic University; St Vincents Hospital Sydney; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of Newcastle; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Western Sydney University; University of Sydney; University of Sydney; Monash University; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Middleton, S (corresponding author), St Vincents Hosp, Nursing Res Inst, Darlinghurst, NSW 2010, Australia.	sandy.middleton@acu.edu.au	Cadilhac, D A/I-1912-2014; Middleton, Sandy/J-5526-2015; Drury, Peta/P-8343-2016; Grimshaw, Jeremy/D-8726-2013; D'ESTE, CATHERINE ANNE/G-7392-2013	Cadilhac, D A/0000-0001-8162-682X; Middleton, Sandy/0000-0002-7201-4394; Drury, Peta/0000-0002-5340-7379; Dale, Simeon/0000-0003-3611-8740; Grimshaw, Jeremy/0000-0001-8015-8243; Cheung, Ngai Wah/0000-0001-6323-8006; Levi, Christopher/0000-0002-9474-796X	National Health & Medical Research Council [353803]; St Vincent's Clinic Foundation; Curran Foundation; Australian Diabetes Society-Servier; College of Nursing; Australian Catholic University	National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); St Vincent's Clinic Foundation; Curran Foundation; Australian Diabetes Society-Servier; College of Nursing; Australian Catholic University	This study was funded by the National Health & Medical Research Council (Project Grant ID 353803), St Vincent's Clinic Foundation, the Curran Foundation, Australian Diabetes Society-Servier, the College of Nursing, and Australian Catholic University. We would like to acknowledge the valuable contribution to the study governance of the QASC Trialists Group, the QASC steering committee, and the QASC expert advisory committee. We also would like to acknowledge the valuable contribution of the Stroke Unit Directors, Stroke Clinical Nurse Consultants, Clinical Nurse Educators, Stroke Liaison Nurses, Stroke Unit Coordinators, Clinical Research Assistants, and others from participating stroke units who assisted our trial; without their contribution, this trial would not have been possible.	BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Bernhardt J, 2006, INT J STROKE, V1, P169, DOI 10.1111/j.1747-4949.2006.00044.x; Cadilhac DA, 2006, INTERN MED J, V36, P700, DOI 10.1111/j.1445-5994.2006.01168.x; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Castillo J, 1998, STROKE, V29, P2455, DOI 10.1161/01.STR.29.12.2455; DEHAAN R, 1995, STROKE, V26, P2027, DOI 10.1161/01.STR.26.11.2027; Della Pietra GL, 2011, STROKE, V42, P2077, DOI 10.1161/STROKEAHA.111.613521; den Hertog HM, 2009, LANCET NEUROL, V8, P434, DOI 10.1016/S1474-4422(09)70051-1; Flodgren G, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000125.pub4, 10.1002/14651858.CD000125]; Forsetlund L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003030.pub2; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Grol R, 1999, Jt Comm J Qual Improv, V25, P503; Grol R, 2005, IMPROVING PATIENT CA, P6; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hamilton S, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-21; Hill K, 2009, AUST J ADV NURS, V26, P53; Hirst GHL, 2000, MED J AUSTRALIA, V172, P287, DOI 10.5694/j.1326-5377.2000.tb123949.x; Janssen PM, 2010, CEREBROVASC DIS, V29, P137, DOI 10.1159/000262309; Langhorne P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub3; Llanes Jennifer N, 2004, Prehosp Emerg Care, V8, P46; MAHONEY F I, 1965, Md State Med J, V14, P61; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; Middleton S, 2011, INTERN MED J, V41, P736, DOI 10.1111/j.1445-5994.2010.02330.x; Middleton S, 2008, STROKE, V39, pE5, DOI 10.1161/STROKEAHA.107.501890; Middleton S, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-16; National Institute for Health and Clinical Excellence, 2008, DIAGN IN MAN AC STRO; National Stroke Foundation, 2010, CLIN GUID STROK MAN; O'Brien Mary A, 2007, COCHRANE DB SYST REV, V4; Perkins JJ, 1998, J CLIN EPIDEMIOL, V51, P969, DOI 10.1016/S0895-4356(98)00088-2; Rudd AG, 2005, STROKE, V36, P103, DOI 10.1161/01.STR.0000149618.14922.8a; Sandercock PAG, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000029.pub2; Scott JF, 1999, LANCET, V353, P376, DOI 10.1016/S0140-6736(05)74948-5; Ware J.E., 1993, SF 36 HLTH SURV MAN; Zwarentein M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000072.pub2	35	238	242	0	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 12	2011	378	9804					1699	1706		10.1016/S0140-6736(11)61485-2	http://dx.doi.org/10.1016/S0140-6736(11)61485-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846LB	21996470	Green Submitted			2022-12-28	WOS:000296899800027
J	Aaron, HJ				Aaron, Henry J.			The Central Question for Health Policy in Deficit Reduction	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brookings Inst, Washington, DC 20036 USA	Brookings Institution	Aaron, HJ (corresponding author), Brookings Inst, Washington, DC 20036 USA.							Kogan Richard, 2011, POTENTIAL ACROSS THE	1	8	8	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 3	2011	365	18					1655	1657		10.1056/NEJMp1109940	http://dx.doi.org/10.1056/NEJMp1109940			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	840FL	21995336				2022-12-28	WOS:000296424200002
J	Ginsburg, PB; White, C				Ginsburg, Paul B.; White, Chapin			Health Care's Role in Deficit Reduction - Guiding Principles	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ginsburg, Paul B.; White, Chapin] Ctr Studying Hlth Syst Change, Washington, DC USA		Ginsburg, PB (corresponding author), Ctr Studying Hlth Syst Change, Washington, DC USA.							Americans I of M (US) C on the FHCW for O, 2008, HLTH STATUS HLTH CAR; Emanuel EJ, 2011, NY TIMES        0822	2	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2011	365	17					1559	1561		10.1056/NEJMp1109863	http://dx.doi.org/10.1056/NEJMp1109863			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	837HI	22029975				2022-12-28	WOS:000296181800012
J	Joyce, T				Joyce, Theodore			The Supply-Side Economics of Abortion	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TEXAS		[Joyce, Theodore] CUNY, Baruch Coll, New York, NY 10021 USA; [Joyce, Theodore] CUNY, Grad Ctr, New York, NY 10021 USA; [Joyce, Theodore] Natl Bur Econ Res, New York, NY 10003 USA	City University of New York (CUNY) System; Baruch College (CUNY); City University of New York (CUNY) System; National Bureau of Economic Research	Joyce, T (corresponding author), CUNY, Baruch Coll, New York, NY 10021 USA.		Joyce, Theodore/P-5231-2019					Colman S, 2011, J POLICY ANAL MANAG, V30, P775, DOI 10.1002/pam.20603; Jones RK, 2011, PERSPECT SEX REPRO H, V43, P41, DOI 10.1363/4304111; Joyce T, 2006, NEW ENGL J MED, V354, P1031, DOI 10.1056/NEJMsa054047	3	42	43	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2011	365	16					1466	1469		10.1056/NEJMp1109889	http://dx.doi.org/10.1056/NEJMp1109889			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	835BW	22010912				2022-12-28	WOS:000296009500014
J	Saul, K; Thistlethwaite, JE				Saul, Krysia; Thistlethwaite, Jill E.			A PATIENT'S JOURNEY Facial disfigurement	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Saul, Krysia] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Thistlethwaite, Jill E.] Univ Queensland, Sch Med, Herston, Qld, Australia	University of Warwick; University of Queensland	Saul, K (corresponding author), Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	Krysia.saul@gmail.com		Thistlethwaite, Jill/0000-0001-8122-4679					0	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 19	2011	343								d5203	10.1136/bmj.d5203	http://dx.doi.org/10.1136/bmj.d5203			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HN	22012808	Green Submitted, Bronze			2022-12-28	WOS:000296183700001
J	Poses, RM				Poses, Roy M.			NSAIDs were associated with increased risk for mortality or recurrent MI in patients who had previous MI	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ROFECOXIB; NAPROXEN		Brown Univ, Alpert Med Sch, Providence, RI 02912 USA	Brown University	Poses, RM (corresponding author), Brown Univ, Alpert Med Sch, Providence, RI 02912 USA.							Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; Lisse JR, 2003, ANN INTERN MED, V139, P539, DOI 10.7326/0003-4819-139-7-200310070-00005; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286	4	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2011	155	8							JC4-11	10.7326/0003-4819-155-8-201110180-02011	http://dx.doi.org/10.7326/0003-4819-155-8-201110180-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835WB	22007070				2022-12-28	WOS:000296066300010
J	Bevan, G; Skellern, M				Bevan, Gwyn; Skellern, Matthew			Does competition between hospitals improve clinical quality? A review of evidence from two eras of competition in the English NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE		[Bevan, Gwyn] Univ London London Sch Econ & Polit Sci, Dept Management, London WC2A 2AE, England; [Skellern, Matthew] Univ London London Sch Econ & Polit Sci, Dept Econ, London WC2A 2AE, England	University of London; London School Economics & Political Science; University of London; London School Economics & Political Science	Bevan, G (corresponding author), Univ London London Sch Econ & Polit Sci, Dept Management, Houghton St, London WC2A 2AE, England.	R.G.Bevan@lse.ac.uk						*AUD COMM HEALTHC, 2008, IS TREATM WORK; Bevan G, 2005, J HEALTH POLIT POLIC, V30, P53, DOI 10.1215/03616878-30-1-2-53; Bloom Nicholas, 2011, IMPACT COMPETI UNPUB; Brereton L, 2010, REFUSING TREATMENT N; Brereton L, 2010, IMPACT NHS MARKET; Chassin MR, 2002, HEALTH AFFAIR, V21, P40, DOI 10.1377/hlthaff.21.4.40; Cooper Z, 2011, ECON J, V121, pF228, DOI 10.1111/j.1468-0297.2011.02449.x; Department of Health, 2011, GOV CHANG RESP NHS F; Dixon A., 2010, PATIENT CHOICE PATIE; Dixon A, 2011, UNDERSTANDING NEW LA; GAYNOR MS, 2011, DEATH MARKET P UNPUB; Grand JL, 2007, OTHER INVISIBLE HAND: DELIVERING PUBLIC SERVICES THROUGH CHOICE AND COMPETITION, P1; Kessler DP, 2000, Q J ECON, V115, P577, DOI 10.1162/003355300554863; Klein Rudolf., 2010, NEW POLITICS NHS, V6th ed; Le Grand J, 1998, LEARNING NHS INTERNA; Propper C, 2004, J PUBLIC ECON, V88, P1247, DOI 10.1016/S0047-2727(02)00216-5; PROPPER C, HLTH EC IN PRESS; Propper C, 2008, ECON J, V118, P138, DOI 10.1111/j.1468-0297.2007.02107.x; Secretary of State for Health, 2010, CM7881; Vallance-Owen A, 2004, J PUBLIC HEALTH-UK, V26, P187, DOI 10.1093/pubmed/fdh127	20	35	36	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2011	343								d6470	10.1136/bmj.d6470	http://dx.doi.org/10.1136/bmj.d6470			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	832CV	21984819	Green Published			2022-12-28	WOS:000295779900001
J	West, R; Zatonski, W; Cedzynska, M; Lewandowska, D; Pazik, J; Aveyard, P; Stapleton, J				West, Robert; Zatonski, Witold; Cedzynska, Magdalena; Lewandowska, Dorota; Pazik, Joanna; Aveyard, Paul; Stapleton, John			Placebo-Controlled Trial of Cytisine for Smoking Cessation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECEPTOR PARTIAL AGONISTS; NICOTINE DEPENDENCE; FAGERSTROM TEST; DOUBLE-BLIND; VARENICLINE	BACKGROUND Cytisine, a partial agonist that binds with high affinity to the alpha(4)beta(2) nicotinic acetylcholine receptor, is a low-cost treatment that may be effective in aiding smoking cessation. This study assessed the efficacy and safety of cytisine as compared with placebo. METHODS We conducted a single-center, randomized, double-blind, placebo-controlled trial. Participants were randomly assigned to receive cytisine or matching placebo for 25 days; participants in both groups received a minimal amount of counseling during the study. The primary outcome measure was sustained, biochemically verified smoking abstinence for 12 months after the end of treatment. Of 1542 adult smokers screened, 740 were enrolled and 370 were randomly assigned to each study group. RESULTS The rate of sustained 12-month abstinence was 8.4% (31 participants) in the cytisine group as compared with 2.4% (9 participants) in the placebo group (difference, 6.0 percentage points; 95% confidence interval [CI], 2.7 to 9.2; P = 0.001). The 7-day point prevalence for abstinence at the 12-month follow-up was 13.2% in the cytisine group versus 7.3% in the placebo group (P= 0.01). Gastrointestinal adverse events were reported more frequently in the cytisine group (difference, 5.7 percentage points; 95% CI, 1.2 to 10.2). CONCLUSIONS In this single-center study, cytisine was more effective than placebo for smoking cessation. The lower price of cytisine as compared with that of other pharmacotherapies for smoking cessation may make it an affordable treatment to advance smoking cessation globally. (Funded by the National Prevention Research Initiative and others; Current Controlled Trials number, ISRCTN37568749.)	[West, Robert; Stapleton, John] UCL, Dept Epidemiol & Publ Hlth, Canc Res UK Hlth Behav Res Ctr, 2-16 Torrington Pl, London WC1E 6BT, England; [Zatonski, Witold; Cedzynska, Magdalena; Lewandowska, Dorota; Pazik, Joanna] Ctr Canc, PL-02781 Warsaw, Poland; [Zatonski, Witold; Cedzynska, Magdalena; Lewandowska, Dorota; Pazik, Joanna] Inst Oncol, Canc Epidemiol & Prevent Dept, PL-02781 Warsaw, Poland; [Aveyard, Paul] Univ Birmingham, UK Ctr Tobacco Control Studies, Birmingham, W Midlands, England	Cancer Research UK; University of London; University College London; Maria Sklodowska-Curie National Research Institute of Oncology; University of Birmingham	West, R (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Canc Res UK Hlth Behav Res Ctr, 2-16 Torrington Pl, London WC1E 6BT, England.	robert.west@ucl.ac.uk	Stapleton, John A/I-6550-2012; West, Robert/B-5414-2009; West, Robert/B-5414-2009	West, Robert/0000-0002-0291-5760; West, Robert/0000-0001-6398-0921; CEDZYNSKA, MAGDALENA/0000-0001-8090-1674; Aveyard, Paul/0000-0002-1802-4217	National Prevention Research Initiative; United Kingdom National Prevention Research Initiative; Cancer Research UK; National Institute for Health Research; British Heart Foundation; Chief Scientist Office of the Scottish Government Health Directorates; Department of Health; Diabetes UK; Economic and Social Research Council; Research and Development Office of Health and Social Care in Northern Ireland; Medical Research Council; Welsh Assembly	National Prevention Research Initiative(Diabetes UK); United Kingdom National Prevention Research Initiative; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); Chief Scientist Office of the Scottish Government Health Directorates; Department of Health; Diabetes UK(Diabetes UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Research and Development Office of Health and Social Care in Northern Ireland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Welsh Assembly	Funded by the National Prevention Research Initiativer Supported by a grant from the United Kingdom National Prevention Research Initiative (to Dr. West), which included contributions from the British Heart Foundation, Cancer Research UK, Chief Scientist Office of the Scottish Government Health Directorates, Department of Health, Diabetes UK, Economic and Social Research Council, Research and Development Office of Health and Social Care in Northern Ireland, Medical Research Council, and Welsh Assembly; and by grants from Cancer Research UK (to Dr. West and Mr. Stapleton) and the National Institute for Health Research (to Dr. Aveyard). Disclosure forms provided by the authors are available with the full text of this article at NEJM.org. We thank the members of the Trial Steering Committee (Michael Ussher, Lindsay Stead, Elspeth Lee, Robert Hewings, Martin Edwards, and Dorota Olszak); the members of the Data Monitoring and Ethics Committee (Peter Hajek, Ann McNeill, and Lesley Owen); the doctors (Ewelina Bobek-Pstrucha, Joanna Jonska, Elz-bieta Karpinska, Marzena Piasecka, Joanna Surowinska, Ewelina Sliwka, Olga Tronina, and Ewa Wazna), nurses (Teresa Kankiewicz, Miroslawa Kleszcz, Katarzyna Marczyk, Elzbieta Milkowska, Malgorzata Pokorska, Dorota Sadowska, and Magdalena Starosciak), psychologists and therapists (Anna Blogosz, Anna Debska, Justyna Koziorowska, Marta Porebiak, Irena Przepiorka, and Agnieszka Smolinska), and secretarial staff (Halina Gaj, Joanna Szwechowicz, and Ewa Tarnowska) who assisted with the conduct of the trial; Ognyan Donev of Sopharma for performing the randomization and providing study medication; and Prof. Piotr Tutka for his help and advice before and during the study.	Beck A T, 1974, Mod Probl Pharmacopsychiatry, V7, P151; Cahill K, 2010, COCHRANE DB SYST REV, V12; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Etter JF, 2008, DRUG ALCOHOL DEPEN, V92, P3, DOI 10.1016/j.drugalcdep.2007.06.017; Fagerstrom K, 2008, ADDICTION, V103, P841, DOI 10.1111/j.1360-0443.2008.02190.x; Gotti C, 2010, J NEUROSCI, V30, P5311, DOI 10.1523/JNEUROSCI.5095-09.2010; Gunnell D, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3805; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; Hughes JR, 2007, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD000031.PUB3; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Mottillo S, 2009, EUR HEART J, V30, P718, DOI 10.1093/eurheartj/ehn552; *NAT I CLIN EXC TE, 2002, NAT I CLIN EXC TECHN; *PUBL HLTH SERV, 2008, TREAT TOB US DEP 200; Rollema H, 2010, BRIT J PHARMACOL, V160, P334, DOI 10.1111/j.1476-5381.2010.00682.x; Shafey O, 2009, TOBACCO ATLAS, V3, P37; Stead L. F., 2008, COCHRANE DATABASE SY, V1; Stoyanov S, 1965, CHIMPHARM SOFIA, V2, P13; Tonstad S, 2010, DRUG SAFETY, V33, P289, DOI 10.2165/11319180-000000000-00000; Tutka P, 2008, EXPERT OPIN INV DRUG, V17, P1473, DOI 10.1517/13543784.17.10.1473 ; Tutka P, 2006, PHARMACOL REP, V58, P777; Vinnikov D, 2008, J SMOK CESS, V3, P57, DOI 10.1375/jsc.3.1.57; West R, 2005, ADDICTION, V100, P299, DOI 10.1111/j.1360-0443.2004.00995.x; West R, 2008, PSYCHOPHARMACOLOGY, V197, P371, DOI 10.1007/s00213-007-1041-3; World Health Organization, 2008, WHO REP GLOB TOB EP; Zatonski W, 2006, TOB CONTROL, V15, P481, DOI 10.1136/tc.2006.016097	27	138	142	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 29	2011	365	13					1193	1200		10.1056/NEJMoa1102035	http://dx.doi.org/10.1056/NEJMoa1102035			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825YO	21991893				2022-12-28	WOS:000295318400007
J	Campbell, JL; Roberts, M; Wright, C; Hill, J; Greco, M; Taylor, M; Richards, S				Campbell, John L.; Roberts, Martin; Wright, Christine; Hill, Jacqueline; Greco, Michael; Taylor, Matthew; Richards, Suzanne			Factors associated with variability in the assessment of UK doctors' professionalism: analysis of survey results	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MULTISOURCE FEEDBACK; PEER RATINGS; PRIMARY-CARE; PATIENT; PHYSICIAN; SATISFACTION; PERFORMANCE; COLLEAGUE	Objectives To investigate potential sources of systematic bias arising in the assessment of doctors' professionalism. Design Linear regression modelling of cross sectional questionnaire survey data. Setting 11 clinical practices in England and Wales. Participants 1065 non-training grade doctors from various clinical specialties and settings, 17 031 of their colleagues, and 30 333 of their patients. Main outcome measures Two measures of a doctor's professional performance using patient and colleague questionnaires from the United Kingdom's General Medical Council (GMC). We selected potential predictor variables from the characteristics of the doctors and of their patient and colleague assessors. Results After we adjusted for characteristics of the doctor as well as characteristics of the patient sample, less favourable scores from patient feedback were independently predicted by doctors having obtained their primary medical degree from any non-European country; doctors practising as a psychiatrist; lower proportions of white patients providing feedback; lower proportions of patients rating their consultation as being very important; and lower proportions of patients reporting that they were seeing their usual doctor. Lower scores from colleague feedback were independently predicted by doctors having obtained their primary medical degree from countries outside the UK and South Asia; currently employed in a locum capacity; working as a general practitioner or psychiatrist; being employed in a staff grade, associate specialist, or other equivalent role; and with a lower proportion of colleagues reporting they had daily or weekly professional contact with the doctor. In fully adjusted models, the doctor's age, sex, and ethnic group were not independent predictors of patient or colleague feedback. Neither the age or sex profiles of the patient or colleague samples were independent predictors of doctors' feedback scores, and nor was the ethnic group of colleague samples. Conclusions Caution is necessary when considering patient and colleague feedback regarding doctors' professionalism. Multisource feedback undertaken for revalidation using the GMC patient and colleague questionnaires should, at least initially, be principally formative in nature.	[Campbell, John L.; Roberts, Martin; Wright, Christine; Hill, Jacqueline; Richards, Suzanne] Peninsula Coll Med & Dent, Exeter EX1 2LU, Devon, England; [Greco, Michael; Taylor, Matthew] Client Focused Evaluat Programme UK, Exeter, Devon, England	University of Exeter; University of Plymouth	Campbell, JL (corresponding author), Peninsula Coll Med & Dent, Exeter EX1 2LU, Devon, England.	john.campbell@pms.ac.uk	Campbell, John/A-5792-2011; Roberts, Martin John/C-3305-2013	Campbell, John/0000-0002-6752-3493; Roberts, Martin John/0000-0002-8010-1068; Richards, Suzanne/0000-0003-1416-0569	Client Focused Evaluation Programme UK (CFEP-UK); UK GMC	Client Focused Evaluation Programme UK (CFEP-UK); UK GMC	We thank the doctors who contributed to this study, along with their patients, colleagues, and supporting administrative staff, for their cooperation and support; Tina Bealing and Louise Coleman (both of the Client Focused Evaluation Programme UK (CFEP-UK)) for their support of the project; Professor Martin Roland and Dr Obi Ukoumunne for their comments on earlier drafts of the research; and Helen Forster for proofreading the manuscript.; The study was funded by the UK GMC as an unrestricted research award. JC is an adviser to the GMC and has received only direct costs associated with presentation of this work. MG is a director of CFEP-UK and provided survey administration in respect of this research; MT was an employee of CFEP-UK at the time the research was undertaken. The study sponsor did not have any role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Bridgewater B, 2011, MAINTAINING PATIENTS; Campbell JL, 2008, QUAL SAF HEALTH CARE, V17, P187, DOI 10.1136/qshc.2007.024679; Campbell SM, 2010, ANN FAM MED, V8, P499, DOI 10.1370/afm.1145; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Crossley J, 2008, MED EDUC, V42, P359, DOI 10.1111/j.1365-2923.2007.02977.x; Department of Health, 2011, RESP OFF; Department of Health-Workforce Directorate, 2008, MED REV PRINC NEXT S; Elliott MN, 2009, HEALTH SERV RES, V44, P501, DOI 10.1111/j.1475-6773.2008.00914.x; Franciosi M, 2004, DIABETES RES CLIN PR, V66, P277, DOI 10.1016/j.diabres.2004.03.009; General Medical Council, 2010, REV WAY AH; General Medical Council, 2011, SUPP INF APPR REV; General Medical Council, 2006, GOOD MED PRACT; Gerard K, 2008, J HEALTH SERV RES PO, V13, P3, DOI 10.1258/jhsrp.2007.007087; Hall W, 1999, CAN MED ASSOC J, V161, P52; Lipner RS, 2002, ACAD MED, V77, pS64, DOI 10.1097/00001888-200210001-00021; Lockyer J, 2008, PRACTICAL GUIDE EVAL, P74; Mackillop LH, 2011, MED TEACH, V33, pe75, DOI 10.3109/0142159X.2010.535870; Maylett T, 2009, COMPENSATION BENEFIT, V41, P52, DOI DOI 10.1177/0886368709337922; MILLER GE, 1990, ACAD MED, V65, pS63, DOI 10.1097/00001888-199009000-00045; Rademakers J, 2011, BMJ QUAL SAF, V20, P326, DOI 10.1136/bmjqs.2010.042358; RAMSEY PG, 1993, JAMA-J AM MED ASSOC, V269, P1655, DOI 10.1001/jama.269.13.1655; Royal College of General Practitioners, 2010, RCGP GUID REV GEN PR; Royal College of Physicians, 2011, REV PRACT; Salisbury C, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5004; Sargeant JM, 2003, ACAD MED, V78, pS42, DOI 10.1097/00001888-200310001-00014; Stern, 2006, MEASURING MED PROFES; Violato C, 2003, BMJ-BRIT MED J, V326, P546, DOI 10.1136/bmj.326.7388.546; Weech-Maldonado R, 2003, HEALTH SERV RES, V38, P789, DOI 10.1111/1475-6773.00147; WENRICH MD, 1993, ACAD MED, V68, P680, DOI 10.1097/00001888-199309000-00014; Wright C, 2011, ASSESSING PROF UNPUB	30	25	25	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	2011	343								d6212	10.1136/bmj.d6212	http://dx.doi.org/10.1136/bmj.d6212			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840DA	22034193	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000296417300002
J	Wislar, JS; Flanagin, A; Fontanarosa, PB; DeAngelis, CD				Wislar, Joseph S.; Flanagin, Annette; Fontanarosa, Phil B.; DeAngelis, Catherine D.			Honorary and ghost authorship in high impact biomedical journals: a cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article							PREVALENCE; INTEGRITY	Objectives To assess the prevalence of honorary and ghost authors in six leading general medical journals in 2008 and compare this with the prevalence reported by authors of articles published in 1996. Design Cross sectional survey using a web based questionnaire. Setting International survey of journal authors. Participants Sample of corresponding authors of 896 research articles, review articles, and editorial/opinion articles published in six general medical journals with high impact factors in 2008: Annals of Internal Medicine, JAMA, Lancet, Nature Medicine, New England Journal of Medicine, and PLoS Medicine. Main outcome measures Self reported compliance with International Committee of Medical Journal Editors (ICMJE) criteria for authorship for all authors on the selected articles. Results A total of 630/896 (70.3%) corresponding authors responded to the survey. The prevalence of articles with honorary authorship or ghost authorship, or both, was 21.0% (95% CI 18.0% to 24.3%), a decrease from 29.2% reported in 1996 (P=0.004). Based on 545 responses on honorary authorship, 96 articles (17.6% (95% CI 14.6% to 21.0%)) had honorary authors (range by journal 12.2% to 29.3%), a non-significant change from 1996 (19.3%; P=0.439). Based on 622 responses on ghost authorship, 49 articles (7.9% (6.0% to 10.3%)) had ghost authors (range by journal 2.1% to 11.0%), a significant decline from 1996 (11.5%; P=0.023). The prevalence of honorary authorship was 25.0% in original research reports, 15.0% in reviews, and 11.2% in editorials, whereas the prevalence of ghost authorship was 11.9% in research articles, 6.0% in reviews, and 5.3% in editorials. Conclusions Evidence of honorary and ghost authorship in 21% of articles published in major medical journals in 2008 suggests that increased efforts by scientific journals, individual authors, and academic institutions are essential to promote responsibility, accountability, and transparency in authorship, and to maintain integrity in scientific publication.	[Wislar, Joseph S.; Flanagin, Annette; Fontanarosa, Phil B.; DeAngelis, Catherine D.] Amer Med Assoc, Chicago, IL 60654 USA	American Medical Association	Wislar, JS (corresponding author), Amer Med Assoc, 515 N State St, Chicago, IL 60654 USA.	joseph.wislar@jama-archives.org						DeAngelis CD, 2008, JAMA-J AM MED ASSOC, V299, P1833, DOI 10.1001/jama.299.15.1833; DEBAKEY L, 1974, SURGERY, V75, P38; DYER C, 2008, BRIT MED J, V337, P1711; Flanagin A, 1998, JAMA-J AM MED ASSOC, V280, P222, DOI 10.1001/jama.280.3.222; GOODMAN NW, 1994, BRIT MED J, V309, P1482, DOI 10.1136/bmj.309.6967.1482; *I SCI INF, 2008, JOURN CIT REP 2008; International Committee of Medical Journal Editors, 2009, UN REQ MAN SUBM BIOM; Iverson C, 2007, AM MED ASS MANUAL ST; Mowatt G, 2002, JAMA-J AM MED ASSOC, V287, P2769, DOI 10.1001/jama.287.21.2769; Place F, 1934, Bull Med Libr Assoc, V22, P209; PRICE DD, 1981, SCIENCE, V212, P986, DOI 10.1126/science.212.4498.986-a; RENNIE D, 1994, JAMA-J AM MED ASSOC, V271, P469, DOI 10.1001/jama.271.6.469; Rennie D, 1997, JAMA-J AM MED ASSOC, V278, P579, DOI 10.1001/jama.278.7.579; Ross JS, 2008, JAMA-J AM MED ASSOC, V299, P1800, DOI 10.1001/jama.299.15.1800; SHAPIRO DW, 1994, JAMA-J AM MED ASSOC, V271, P438, DOI 10.1001/jama.271.6.438; Singer N., 2009, NEW YORK TIMES, pB1; Smith J, 2005, BMJ-BRIT MED J, V331, P245, DOI 10.1136/bmj.331.7511.245; SMITH J, 1994, BRIT MED J, V309, P1456, DOI 10.1136/bmj.309.6967.1456; SPSS, 2005, SPSS WIND VERS 14 0; The American Association for Public Opinion Research, 2009, STAND DEF FIN DISP C; Titus SL, 2008, NATURE, V453, P980, DOI 10.1038/453980a; *US SEN FIN, 2010, GHOSTWR MED LIT MIN; 2011, NEUROLOGY; 2010, BMJ	24	251	259	1	23	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 25	2011	343								d6128	10.1136/bmj.d6128	http://dx.doi.org/10.1136/bmj.d6128			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840CW	22028479	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000296416900001
J	Blenner, S; Reddy, A; Augustyn, M				Blenner, Stephanie; Reddy, Arathi; Augustyn, Marilyn			Diagnosis and management of autism in childhood	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SPECTRUM DISORDERS; MODIFIED CHECKLIST; SPECIAL NEEDS; CHILDREN; AGE; IDENTIFICATION; INDIVIDUALS; PREVALENCE; SYMPTOMS; TODDLERS		[Blenner, Stephanie; Augustyn, Marilyn] Boston Univ, Sch Med, Div Dev Behav Pediat, Boston, MA 02118 USA; [Reddy, Arathi] Boston Med Ctr, Boston, MA USA	Boston University; Boston Medical Center	Blenner, S (corresponding author), Boston Univ, Sch Med, Div Dev Behav Pediat, Boston, MA 02118 USA.	stephanie.blenner@bmc.org		Blenner, Stephanie/0000-0002-3904-2705; Reddy, Arathi/0000-0002-4353-2571; Augustyn, Marilyn/0000-0001-9975-6067	Boston University School of Medicine; Boston Medical Center	Boston University School of Medicine; Boston Medical Center	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: SB, AR, and MA had support from Boston University School of Medicine and Boston Medical Center for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	*AM AC PED COUNC C, 2006, PEDIATRICS, V118, P1808; ANGKUSTSIRI K, 2011, AUTISM; BAGHDADLI A, 2011, J AUTISM DEV DISORD; Baird G, 2008, J AUTISM DEV DISORD, V38, P1827, DOI 10.1007/s10803-008-0571-9; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Barbaro J, 2009, J DEV BEHAV PEDIATR, V30, P447, DOI 10.1097/DBP.0b013e3181ba0f9f; Barnard-Brak L, 2011, PEDIATR NEUROL, V44, P97, DOI 10.1016/j.pediatrneurol.2010.09.011; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Billstedt E, 2005, J AUTISM DEV DISORD, V35, P351, DOI 10.1007/s10803-005-3302-5; CHANDLER S, 2007, J AM ACAD CHILD ADOL, V46, P10; Charman T, 2011, PSYCHOL MED, V41, P619, DOI 10.1017/S0033291710000991; Duby JC, 2006, PEDIATRICS, V118, P405, DOI 10.1542/peds.2006-1231; Dumont-Mathieu T, 2005, MENT RETARD DEV D R, V11, P253, DOI 10.1002/mrdd.20072; Freitag CM, 2010, EUR CHILD ADOLES PSY, V19, P169, DOI 10.1007/s00787-009-0076-x; Gardener H, 2011, PEDIATRICS, V128, P344, DOI 10.1542/peds.2010-1036; Giannotti F, 2006, J AUTISM DEV DISORD, V36, P741, DOI 10.1007/s10803-006-0116-z; Hertz-Picciotto I, 2009, EPIDEMIOLOGY, V20, P84, DOI 10.1097/EDE.0b013e3181902d15; Huffman LC, 2011, J DEV BEHAV PEDIATR, V32, P56, DOI 10.1097/DBP.0b013e3182040acf; Ibrahim SH, 2009, PEDIATRICS, V124, P680, DOI 10.1542/peds.2008-2933; Immunization Safety Review Committee, 2004, IMM SAF REV VACC AUT; Johnson CP, 2007, PEDIATRICS, V120, P1183, DOI 10.1542/peds.2007-2361; Johnson S, 2011, ARCH DIS CHILD, V96, P73, DOI 10.1136/adc.2010.194795; Kleinman JM, 2008, J AUTISM DEV DISORD, V38, P606, DOI 10.1007/s10803-007-0427-8; Lainhart JE, 1997, J AM ACAD CHILD PSY, V36, P282, DOI 10.1097/00004583-199702000-00019; Mandell DS, 2005, J AUTISM DEV DISORD, V35, P313, DOI 10.1007/s10803-005-3296-z; Mandell DS, 2005, PEDIATRICS, V116, P1480, DOI 10.1542/peds.2005-0185; MARJALEENA M, 2011, J AM ACAD CHILD ADOL, V50; McPheeters ML, 2011, PEDIATRICS, V127, pE1312, DOI 10.1542/peds.2011-0427; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; MILLWARD C, 2008, COCHRANE DB SYST REV, V2; Myers SM, 2007, PEDIATRICS, V120, P1162, DOI 10.1542/peds.2007-2362; National Research Council, 2001, ED CHILDR AUT; OZONOFF SJ, 2010, AM ACAD CHILD ADOLES, V49; PARR JR, 2011, J AUTISM DEV DISORD, V30, P157; PIERCE K, 2011, J PEDIAT, V159; Ronald A, 2011, AM J MED GENET B, V156B, P255, DOI 10.1002/ajmg.b.31159; Sandler AD, 2001, PEDIATRICS, V107, P598; Schaefer GB, 2008, GENET MED, V10, P301, DOI 10.1097/GIM.0b013e31816b5cc9; Simonoff E, 2008, J AM ACAD CHILD PSY, V47, P921, DOI 10.1097/CHI.0b013e318179964f; Taylor JL, 2011, J AUTISM DEV DISORD, V41, P566, DOI 10.1007/s10803-010-1070-3; Warren Z, 2011, PEDIATRICS, V127, pE1303, DOI 10.1542/peds.2011-0426; Wass S, 2011, BRAIN COGNITION, V75, P18, DOI 10.1016/j.bandc.2010.10.005; Weissman JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003815; Werner E, 2000, J AUTISM DEV DISORD, V30, P157, DOI 10.1023/A:1005463707029; YOUNG R, 2003, AUTISM, V41, P332	45	27	30	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2011	343								d6238	10.1136/bmj.d6238	http://dx.doi.org/10.1136/bmj.d6238			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	837HR	22021467				2022-12-28	WOS:000296184100001
J	Zhang, W; Jin, WS; Fukushima, T; Saeki, A; Seki, S; Aida, T				Zhang, Wei; Jin, Wusong; Fukushima, Takanori; Saeki, Akinori; Seki, Shu; Aida, Takuzo			Supramolecular Linear Heterojunction Composed of Graphite-Like Semiconducting Nanotubular Segments	SCIENCE			English	Article							POLYMER PHOTOVOLTAIC CELLS; SOLAR-CELLS; CYLINDRICAL MICELLES; COAXIAL NANOTUBES; SELF-ORGANIZATION; CONTROLLED LENGTH; ARCHITECTURES; NANOWIRES; DONOR; FILMS	One-dimensionally connected organic nanostructures with dissimilar semiconducting properties are expected to provide a reliable platform in understanding the behaviors of photocarriers, which are important for the development of efficient photon-to-electrical energy conversion systems. Although bottom-up supramolecular approaches are considered promising for the realization of such nanoscale heterojunctions, the dynamic nature of molecular assembly is problematic. We report a semiconducting nanoscale organic heterojunction, demonstrated by stepwise nanotubular coassembly of two strategically designed molecular graphenes. The dissimilar nanotubular segments, thus connected noncovalently, were electronically communicable with one another over the heterojunction interface and displayed characteristic excitation energy transfer and charge transport properties not present in a mixture of the corresponding homotropically assembled nanotubes.	[Zhang, Wei; Fukushima, Takanori; Aida, Takuzo] RIKEN Adv Sci Inst, Funct Soft Matter Res Grp, Wako, Saitama 3510198, Japan; [Zhang, Wei; Aida, Takuzo] Univ Tokyo, Dept Chem & Biotechnol, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Jin, Wusong] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai 201620, Peoples R China; [Fukushima, Takanori] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Saeki, Akinori; Seki, Shu] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan	RIKEN; University of Tokyo; Donghua University; Tokyo Institute of Technology; Osaka University	Fukushima, T (corresponding author), RIKEN Adv Sci Inst, Funct Soft Matter Res Grp, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	fukushima@riken.jp; aida@macro.t.u-tokyo.ac.jp	修平, 関/E-5346-2010; Aida, Takuzo/I-9117-2012; Saeki, Akinori/B-7756-2011; Fukushima, Takanori/D-2474-2015	修平, 関/0000-0001-7851-4405; Saeki, Akinori/0000-0001-7429-2200; Fukushima, Takanori/0000-0001-5586-9238	Japan Society for the Promotion of Science [21.9925]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [21350108]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank E. Ohta (RIKEN) for DFT calculation of HBC 2. W.Z. thanks the Japan Society for the Promotion of Science Young Scientist Fellowship (21.9925). T.F. thanks Ministry of Education, Culture, Sports, Science, and Technology, Japan, for financial support (21350108).	Banerjee S, 2002, NANO LETT, V2, P195, DOI 10.1021/nl015651n; Bjork MT, 2002, NANO LETT, V2, P87, DOI 10.1021/nl010099n; De Greef TFA, 2009, CHEM REV, V109, P5687, DOI 10.1021/cr900181u; Gadt T, 2009, NAT MATER, V8, P144, DOI [10.1038/NMAT2356, 10.1038/nmat2356]; Gilroy JB, 2010, NAT CHEM, V2, P566, DOI [10.1038/NCHEM.664, 10.1038/nchem.664]; Gunes S, 2007, CHEM REV, V107, P1324, DOI 10.1021/cr050149z; Harnack O, 2003, NANO LETT, V3, P1097, DOI 10.1021/nl034240z; Hill JP, 2004, SCIENCE, V304, P1481, DOI 10.1126/science.1097789; Hochbaum AI, 2010, CHEM REV, V110, P527, DOI 10.1021/cr900075v; Hoeben FJM, 2005, CHEM REV, V105, P1491, DOI 10.1021/cr030070z; Jin W, 2008, J AM CHEM SOC, V130, P9434, DOI 10.1021/ja801179e; Kim JY, 2007, SCIENCE, V317, P222, DOI 10.1126/science.1141711; Li G, 2005, NAT MATER, V4, P864, DOI 10.1038/nmat1500; Patra SK, 2011, J AM CHEM SOC, V133, P8842, DOI 10.1021/ja202408w; Peumans P, 2003, NATURE, V425, P158, DOI 10.1038/nature01949; Saeki A, 2011, MACROMOLECULES, V44, P3416, DOI 10.1021/ma2004844; Sakai N, 2010, J AM CHEM SOC, V132, P6923, DOI 10.1021/ja101944r; Sisson AL, 2008, ANGEW CHEM INT EDIT, V47, P3727, DOI 10.1002/anie.200800203; Thompson BC, 2008, ANGEW CHEM INT EDIT, V47, P58, DOI 10.1002/anie.200702506; Tian BZ, 2007, NATURE, V449, P885, DOI 10.1038/nature06181; Tsai FS, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.025002; Wang XS, 2007, SCIENCE, V317, P644, DOI 10.1126/science.1141382; Wurthner F, 2004, J AM CHEM SOC, V126, P10611, DOI 10.1021/ja0475353; Yamamoto Y, 2006, SCIENCE, V314, P1761, DOI 10.1126/science.1134441; Yamamoto Y, 2009, P NATL ACAD SCI USA, V106, P21051, DOI 10.1073/pnas.0905655106; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; Zhang G, 2007, J AM CHEM SOC, V129, P719, DOI 10.1021/ja0671518; Zhang W, 2009, ANGEW CHEM INT EDIT, V48, P4747, DOI 10.1002/anie.200900756	28	334	334	4	362	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 21	2011	334	6054					340	343		10.1126/science.1210369	http://dx.doi.org/10.1126/science.1210369			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	22021852				2022-12-28	WOS:000296052500043
J	Chen, J; Normand, SLT; Wang, Y; Krumholz, HM				Chen, Jersey; Normand, Sharon-Lise T.; Wang, Yun; Krumholz, Harlan M.			National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; LONG-TERM TRENDS; RISK-FACTORS; 1ST HOSPITALIZATION; ELDERLY-PATIENTS; OLDER-ADULTS; OUTCOMES; POPULATION; SURVIVAL; EPIDEMIOLOGY	Context It is not known whether recent declines in ischemic heart disease and its risk factors have been accompanied by declines in heart failure (HF) hospitalization and mortality. Objective To examine changes in HF hospitalization rate and 1-year mortality rate in the United States, nationally and by state or territory. Design, Setting, and Participants From acute care hospitals in the United States and Puerto Rico, 55 097 390 fee-for-service Medicare beneficiaries hospitalized between 1998 and 2008 with a principal discharge diagnosis code for HF. Main Outcome Measures Changes in patient demographics and comorbidities, HF hospitalization rates, and 1-year mortality rates. Results The HF hospitalization rate adjusted for age, sex, and race declined from 2845 per 100 000 person-years in 1998 to 2007 per 100 000 person-years in 2008 (P < .001), a relative decline of 29.5%. Age-adjusted HF hospitalization rates declined over the study period for all race-sex categories. Black men had the lowest rate of decline (4142 to 3201 per 100 000 person-years) among all race-sex categories, which persisted after adjusting for age (incidence rate ratio, 0.81; 95% CI, 0.79-0.84). Heart failure hospitalization rates declined significantly faster than the national mean in 16 states and significantly slower in 3 states. Risk-adjusted 1-year mortality decreased from 31.7% in 1999 to 29.6% in 2008 (P < .001), a relative decline of 6.6%. One-year mortality rates declined significantly in 4 states but increased in 5 states. Conclusions The overall HF hospitalization rate declined substantially from 1998 to 2008 but at a lower rate for black men. The overall 1-year mortality rate declined slightly over the past decade but remains high. Changes in HF hospitalization and 1-year mortality rates were uneven across states. JAMA. 2011;306(15):1669-1678	[Chen, Jersey; Wang, Yun; Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sch Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06520 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06520 USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Normand, Sharon-Lise T.; Wang, Yun] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Wang, Yun; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	Yale University; Yale University; Yale University; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Yale University	Chen, J (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, 333 Cedar St, New Haven, CT 06520 USA.	jersey.chen@yale.edu	, Harlan/AAI-2875-2020	Normand, Sharon-Lise/0000-0001-7027-4769	Centers for Medicare & Medicaid Services; Yale University; Medtronic Inc through Yale University; Agency for Healthcare Research and Quality (AHRQ) [1K08HS018781-01]; National Heart, Lung, Blood Institute (NHLBI) [U01HL105270-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018781] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	Centers for Medicare & Medicaid Services; Yale University; Medtronic Inc through Yale University(Medtronic); Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Heart, Lung, Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Chen, Normand, Wang, and Krumholz reported that they develop and maintain performance measures under contract with the Centers for Medicare & Medicaid Services. Dr Normand reported receiving consulting fees from Yale University. Dr Krumholz reported that he chairs a cardiac scientific advisory board for United Healthcare and is the recipient of a research grant from Medtronic Inc through Yale University.; This work was supported by an Agency for Healthcare Research and Quality (AHRQ) Career Development Award (1K08HS018781-01) for Dr Chen and a National Heart, Lung, Blood Institute (NHLBI) Cardiovascular Outcomes Center Award (U01HL105270-01) for Drs Chen, Normand, Wang, and Krumholz.	Bernheim SM, 2010, 2010 MEASURES MAINTE; Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; Bueno H, 2010, JAMA-J AM MED ASSOC, V303, P2141, DOI 10.1001/jama.2010.748; Chen J, 2010, CIRCULATION, V121, P1322, DOI 10.1161/CIRCULATIONAHA.109.862094; Curtis LH, 2008, ARCH INTERN MED, V168, P418, DOI 10.1001/archinternmed.2007.80; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Dunlay SM, 2009, AM J MED, V122, P1023, DOI 10.1016/j.amjmed.2009.04.022; Eicheldinger C, 2008, HEALTH CARE FINANC R, V29, P27; Ezekowitz JA, 2011, EUR J HEART FAIL, V13, P142, DOI 10.1093/eurjhf/hfq185; Ezekowitz JA, 2010, HEART FAIL REV, V15, P407, DOI 10.1007/s10741-010-9162-x; Fang J, 2008, J AM COLL CARDIOL, V52, P428, DOI 10.1016/j.jacc.2008.03.061; Fonarow GC, 2007, AM HEART J, V153, P1021, DOI [10.1016/j.ahj.2007.03.012, 10.1016/j.ahj.2007.07.043]; Fonarow GC, 2010, CIRCULATION, V122, P585, DOI 10.1161/CIRCULATIONAHA.109.934471; Grosso LM, 2009 MEASURES MAINTE; Hajjar I, 2006, ANNU REV PUBL HEALTH, V27, P465, DOI 10.1146/annurev.publhealth.27.021405.102132; He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996; Hellermann JP, 2003, AM J EPIDEMIOL, V157, P1101, DOI 10.1093/aje/kwg078; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jhund PS, 2009, CIRCULATION, V119, P515, DOI 10.1161/CIRCULATIONAHA.108.812172; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Lee DS, 2004, AM J MED, V116, P581, DOI 10.1016/j.amjmed.2003.11.025; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; McAlister FA, 2007, JAMA-J AM MED ASSOC, V297, P2502, DOI 10.1001/jama.297.22.2502; Medicare Payment Advisory Commission, 2008, REP C MED PAYM POL M; Mehta PA, 2009, HEART, V95, P1851, DOI 10.1136/hrt.2008.156034; Morgan RO, 1997, NEW ENGL J MED, V337, P169, DOI 10.1056/NEJM199707173370306; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Schaufelberger M, 2004, EUR HEART J, V25, P300, DOI 10.1016/j.ehj.2003.12.012; Shafazand M, 2011, EUR J HEART FAIL, V13, P135, DOI 10.1093/eurjhf/hfq205; Shah RU, 2011, CIRC-HEART FAIL, V4, P301, DOI 10.1161/CIRCHEARTFAILURE.110.959114; Smith NL, 2004, AM HEART J, V148, P710, DOI 10.1016/j.ahj.2004.04.002; Teng THK, 2010, CIRC-HEART FAIL, V3, P236, DOI 10.1161/CIRCHEARTFAILURE.109.879239; Titler MG, 2008, HEALTH SERV RES, V43, P635, DOI 10.1111/j.1475-6773.2007.00789.x; Wang TJ, 2005, CIRCULATION, V112, P1651, DOI 10.1161/CIRCULATIONAHA.104.490599; Wasywich CA, 2010, EUR J HEART FAIL, V12, P462, DOI 10.1093/eurjhf/hfq027; Wier LM, HCUP FACTS FIGURES S; Wong CY, 2011, AM J MED, V124, P136, DOI 10.1016/j.amjmed.2010.08.017; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	43	514	570	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 19	2011	306	15					1669	1678		10.1001/jama.2011.1474	http://dx.doi.org/10.1001/jama.2011.1474			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834MA	22009099	Bronze, Green Accepted			2022-12-28	WOS:000295963200026
J	Kiaii, M; Djurdjev, O; Farah, M; Levin, A; Jung, B; MacRae, J				Kiaii, Mercedeh; Djurdjev, Ognjenka; Farah, Myriam; Levin, Adeera; Jung, Beverly; MacRae, Jennifer			Use of Electron-Beam Sterilized Hemodialysis Membranes and Risk of Thrombocytopenia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIALYSIS MEMBRANES; THROMBUS FORMATION; PLATELET; ACTIVATION	Context Thrombocytopenia is not widely recognized as a potential dialyzer-related complication. Following the observation of significant thrombocytopenia among 20 patients undergoing hemodialysis in a single dialysis unit after the introduction of dialyzers sterilized by electron beam (e-beam), a larger investigation was undertaken. Objective To determine the prevalence and etiology of thrombocytopenia in hemodialysis populations of 2 Canadian provinces (British Columbia and Alberta). Design, Setting, and Participants A cohort study of patients undergoing hemodialysis in British Columbia (n = 1706) and southern Alberta (n = 425) between April 1, 2009, and November 30, 2010. Retrospective analyses of historical patient, laboratory, and dialyzer data predating conversion to e-beam dialyzers were undertaken, with prospective collection of predialysis and postdialysis platelet counts before and after the change from e-beam to non-e-beam sterilized dialyzers in September 2009. Main Outcome Measure Significant thrombocytopenia, defined a priori as postdialysis treatment platelet count of less than 100 x 10(3)/mu L and a postdialysis decrease in platelet count of more than 15%. Results Among 1706 patients undergoing hemodialysis in British Columbia, 1411 (83%) were undergoing hemodialysis with e-beam sterilized dialyzers. Of 1706 patients, 194 (11.4%; 95% CI, 9.9%-12.9%) had postdialysis platelet counts of less than 100 x 10(3)/mu L; 400 (23.4%; 95% CI, 21.5%-25.5%) had postdialysis decreases in platelet counts of more than 15%; and 123 (7.2%; 95% CI, 6.0%-8.6%) met both criteria. Among 425 patients in Alberta undergoing dialysis with polysulfone, e-beam sterilized dialyzers made by a different manufacturer, 46 (10.8%; 95% CI, 8.1%-14.3%) had platelet counts of less than 100 x 10(3)/mu L; 156 (32.0%; 95% CI, 27.6%-36.7%) had decreases in platelet counts of more than 15%; and 31 (7.3%; 95% CI, 5.1%-10.3%) met both criteria. In multivariable analysis adjusting for patient and dialysis history characteristics, a significant association was observed between using an e-beam sterilized dialyzer and risk of significant thrombocytopenia (odds ratio [OR], 2.52; 95% CI, 1.20-5.29; P =. 02). Compared with use of e-beam sterilized dialyzers, following the change to use of non-e-beam sterilized dialyzers, among 1784 patients, significant reductions were observed in postdialysis thrombocytopenia (120 patients [6.7%; 95% CI, 5.6%-8.0%; P < .001] had platelet counts of <100 x 10(3)/mu L; 167 patients [9.4%; 95% CI, 8.1%-10.8%; P < .001] had decreases in platelet counts of >15%; and 38 patients [2.1%; 95% CI, 1.5%-2.9%; P < .001] met both criteria). Using generalized estimating equation modeling for repeated data with binary outcome, after adjusting for patient characteristics, the odds of significant thrombocytopenia were higher during the use of e-beam sterilized dialyzers than with use of non-e-beam sterilized dialyzers (OR, 3.57; 95% CI, 2.54-5.04; P < .001). Conclusion In this cohort of patients undergoing hemodialysis in 2 Canadian provinces in 2009-2010, the use of e-beam sterilized dialyzers was associated with significant thrombocytopenia following dialysis. JAMA. 2011;306(15):1679-1687	[Kiaii, Mercedeh; Farah, Myriam; Levin, Adeera; Jung, Beverly] Univ British Columbia, Div Nephrol, Vancouver, BC V6Z 2E8, Canada; [Djurdjev, Ognjenka; Levin, Adeera] British Columbia Prov Renal Agcy, Vancouver, BC, Canada; [MacRae, Jennifer] Univ Calgary, Div Nephrol, Calgary, AB, Canada	University of British Columbia; University of Calgary	Kiaii, M (corresponding author), Univ British Columbia, Div Nephrol, 602-1160 Burrard St, Vancouver, BC V6Z 2E8, Canada.	mkiaii@providencehealth.bc.ca	MacRae, Jennifer/AAV-9827-2020	MacRae, Jennifer/0000-0002-4711-1440				Clark WR, 2002, SEMIN DIALYSIS, V15, P191, DOI 10.1046/j.1525-139X.2002.00019.x; Daugirdas J T, 1988, Kidney Int Suppl, V24, pS37; Gavioli G, 2002, HEMODIALYSIS TECHNOL, P80; GAWAZ MP, 1994, KIDNEY INT, V46, P489, DOI 10.1038/ki.1994.299; Gritters-van den Oever Mareille, 2009, Blood Purif, V28, P253, DOI 10.1159/000232933; HAKIM RM, 1993, CARDIOVASC PATHOL, V2, pS187; HAKIM RM, 1985, AM J MED, V78, P575, DOI 10.1016/0002-9343(85)90398-5; LINDSAY RM, 1973, BRIT J HAEMATOL, V24, P377, DOI 10.1111/j.1365-2141.1973.tb01661.x; LINDSAY RM, 1972, BRIT MED J, V4, P454, DOI 10.1136/bmj.4.5838.454; LINDSAY RM, 1973, T AM SOC ART INT ORG, V19, P487; LOTNER GZ, 1980, J IMMUNOL, V124, P676; Milburn JA, 2011, INT J ARTIF ORGANS, V34, P280, DOI 10.5301/IJAO.2011.6469; Olafiranye F, 2011, CASE REP MED, V2011, DOI 10.1155/2011/134295; Posadas MA, 2011, HEMODIAL INT, V15, P416, DOI 10.1111/j.1542-4758.2011.00561.x; Post JB, 2010, AM J KIDNEY DIS, V55, pE25, DOI 10.1053/j.ajkd.2009.10.059; SHINTANI H, 1991, J BIOMED MATER RES, V25, P1275, DOI 10.1002/jbm.820251008; Uhlenbusch-Korwer I., 2004, UNDERSTANDING MEMBRA, P265	17	39	40	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 19	2011	306	15					1679	1687		10.1001/jama.2011.1499	http://dx.doi.org/10.1001/jama.2011.1499			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834MA	22009100	Bronze			2022-12-28	WOS:000295963200027
J	Hubbard, RA; Kerlikowske, K; Flowers, CI; Yankaskas, BC; Zhu, WW; Miglioretti, DL				Hubbard, Rebecca A.; Kerlikowske, Karla; Flowers, Chris I.; Yankaskas, Bonnie C.; Zhu, Weiwei; Miglioretti, Diana L.			Cumulative Probability of False-Positive Recall or Biopsy Recommendation After 10 Years of Screening Mammography A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							SERVICES TASK-FORCE; CANCER SURVEILLANCE CONSORTIUM; BREAST-CANCER; INTERPRETIVE PERFORMANCE; RANDOMIZED-TRIALS; FILM MAMMOGRAPHY; RISK; ACCURACY; RADIOLOGISTS; VARIABILITY	Background: False-positive mammography results are common. Biennial screening may decrease the cumulative probability of false-positive results across many years of repeated screening but could also delay cancer diagnosis. Objective: To compare the cumulative probability of false-positive results and the stage distribution of incident breast cancer after 10 years of annual or biennial screening mammography. Design: Prospective cohort study. Setting: 7 mammography registries in the National Cancer Institute-funded Breast Cancer Surveillance Consortium. Participants: 169 456 women who underwent first screening mammography at age 40 to 59 years between 1994 and 2006 and 4492 women with incident invasive breast cancer diagnosed between 1996 and 2006. Measurements: False-positive recalls and biopsy recommendations stage distribution of incident breast cancer. Results: False-positive recall probability was 16.3% at first and 9.6% at subsequent mammography. Probability of false-positive biopsy recommendation was 2.5% at first and 1.0% at subsequent examinations. Availability of comparison mammograms halved the odds of a false-positive recall (adjusted odds ratio, 0.50 [95% CI, 0.45 to 0.56]). When screening began at age 40 years, the cumulative probability of a woman receiving at least 1 false-positive recall after 10 years was 61.3% (CI, 59.4% to 63.1%) with annual and 41.6% (CI, 40.6% to 42.5%) with biennial screening. Cumulative probability of false-positive biopsy recommendation was 7.0% (CI, 6.1% to 7.8%) with annual and 4.8% (CI, 4.4% to 5.2%) with biennial screening. Estimates were similar when screening began at age 50 years. A non-statistically significant increase in the proportion of late-stage cancers was observed with biennial compared with annual screening (absolute increases, 3.3 percentage points [CI, -1.1 to 7.8 percentage points] for women age 40 to 49 years and 2.3 percentage points [CI, -1.0 to 5.7 percentage points] for women age 50 to 59 years) among women with incident breast cancer. Limitations: Few women underwent screening over the entire 10-year period. Radiologist characteristics influence recall rates and were unavailable. Most mammograms were film rather than digital. Incident cancer was analyzed in a small sample of women who developed cancer. Conclusion: After 10 years of annual screening, more than half of women will receive at least 1 false-positive recall, and 7% to 9% will receive a false-positive biopsy recommendation. Biennial screening appears to reduce the cumulative probability of false-positive results after 10 years but may be associated with a small absolute increase in the probability of late-stage cancer diagnosis.	Univ Washington, Grp Hlth Cooperat, Seattle, WA 98195 USA; Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; Univ N Carolina, Chapel Hill, NC USA	Group Health Cooperative; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of North Carolina; University of North Carolina Chapel Hill	Hubbard, RA (corresponding author), Grp Hlth Res Inst, Suite 1600,1730 Minor Ave, Seattle, WA 98101 USA.	hubbard.r@ghc.org	Flowers, Chris/AAC-9097-2019; Hubbard, Rebecca/Y-6500-2019	Hubbard, Rebecca/0000-0003-0879-0994	National Cancer Institute [U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040, R03CA150007, RC2CA148577]; NCI/NIH; NATIONAL CANCER INSTITUTE [U01CA063740, U01CA086082, U01CA063731, U01CA063736, U01CA070040, R03CA150007, RC2CA148577, U01CA069976, U01CA086076, U01CA070013] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the National Cancer Institute-funded Breast Cancer Surveillance Consortium cooperative agreement (grants U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, and U01CA70040) and the National Cancer Institute-funded grants R03CA150007 and RC2CA148577. The collection of cancer data used in this study was supported in part by several state public health departments and cancer registries throughout the United States. For a full description of these sources, please see http://breastscreening.cancer.gov/work/acknowledgement.html.; Dr. Hubbard: Grant (money to institution): NCI; Grants/grants pending (money to institution): NCI. Dr. Kerlikowske: Grant (money to institution): NCI. Dr. Flowers: Payment for development of educational presentations: Oakstone Publishing. Dr. Yankaskas: Grant (money to institution): NCI/NIH; Support for travel to meetings for study or other purposes (money to institution): NCI/NIH. Dr. Zhu: Grant: NCI. Dr. Miglioretti: Grant (money to institution): NCI; Grants/grants pending (money to institution): NCI. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M10- 2026.	American College of Radiology, 2003, BREAST IM REP DAT SY; American Joint Committee on Cancer, 2002, MAN STAG CANC; Baker Stuart G, 2003, BMC Med Res Methodol, V3, P11, DOI 10.1186/1471-2288-3-11; BallardBarbash R, 1997, AM J ROENTGENOL, V169, P1001, DOI 10.2214/ajr.169.4.9308451; Barlow WE, 2004, JNCI-J NATL CANCER I, V96, P1840, DOI 10.1093/jnci/djh333; Beam CA, 1996, ARCH INTERN MED, V156, P209, DOI 10.1001/archinte.156.2.209; Blanchard K, 2006, RADIOLOGY, V240, P335, DOI 10.1148/radiol.2402050107; Breas Cancer Surveillance Consortium, 2010, BCSC GLOSS TERMS; Brewer NT, 2007, ANN INTERN MED, V146, P502, DOI 10.7326/0003-4819-146-7-200704030-00006; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Christiansen CL, 2000, JNCI-J NATL CANCER I, V92, P1657, DOI 10.1093/jnci/92.20.1657; Cook AJ, 2010, J CLIN EPIDEMIOL, V63, P441, DOI 10.1016/j.jclinepi.2009.06.008; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Elmore JG, 2002, JNCI-J NATL CANCER I, V94, P1373; Elmore JG, 2009, RADIOLOGY, V253, P641, DOI 10.1148/radiol.2533082308; Food and Drug Administration, MAMM QUAL STAND ACT; Gelfand AE, 2000, STAT MED, V19, P1865, DOI 10.1002/1097-0258(20000730)19:14<1865::AID-SIM512>3.0.CO;2-M; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Hubbard RA, 2010, STAT METHODS MED RES, V19, P429, DOI 10.1177/0962280209359842; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Ichikawa LE, 2010, RADIOLOGY, V256, P74, DOI 10.1148/radiol.10091881; Kerlikowske K, 2000, ANN INTERN MED, V133, P855, DOI 10.7326/0003-4819-133-11-200012050-00009; LANE PW, 1982, BIOMETRICS, V38, P613, DOI 10.2307/2530043; Montgomery M, 2010, ONCOL NURS FORUM, V37, P77, DOI 10.1188/10.ONF.77-83; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Pisano ED, 2008, RADIOLOGY, V246, P376, DOI 10.1148/radiol.2461070200; Smith RA, 2004, RADIOL CLIN N AM, V42, P793, DOI 10.1016/j.rcl.2004.06.014; Smith-Bindman R, 2005, JNCI-J NATL CANCER I, V97, P358, DOI 10.1093/jnci/dji060; Tabar L, 2000, RADIOL CLIN N AM, V38, P625, DOI 10.1016/S0033-8389(05)70191-3; Taplin SH, 2010, J NATL CANCER I, V102, P1040, DOI 10.1093/jnci/djq233; White E, 2004, JNCI-J NATL CANCER I, V96, P1832, DOI 10.1093/jnci/djh337; Xu JL, 2004, BIOMETRICS, V60, P651, DOI 10.1111/j.0006-341X.2004.00214.x; Yankaskas BC, 2005, RADIOLOGY, V234, P363, DOI 10.1148/radiol.2342040048; Yazici B, 2006, CLIN RADIOL, V61, P619, DOI 10.1016/j.crad.2006.03.008; Zagouri F, 2008, BREAST, V17, P71, DOI 10.1016/j.breast.2007.07.039	38	309	315	0	29	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2011	155	8					481	U46		10.7326/0003-4819-155-8-201110180-00004	http://dx.doi.org/10.7326/0003-4819-155-8-201110180-00004			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835WB	22007042	Green Accepted			2022-12-28	WOS:000296066300013
J	Vesikari, T; Knuf, M; Wutzler, P; Karvonen, A; Kieninger-Baum, D; Schmitt, HJ; Baehner, F; Borkowski, A; Tsai, TF; Clemens, R				Vesikari, Timo; Knuf, Markus; Wutzler, Peter; Karvonen, Aino; Kieninger-Baum, Dorothee; Schmitt, Heinz-Josef; Baehner, Frank; Borkowski, Astrid; Tsai, Theodore F.; Clemens, Ralf			Oil-in-Water Emulsion Adjuvant with Influenza Vaccine in Young Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIBODY-RESPONSES; HEALTHY-CHILDREN; B VIRUSES; EFFICACY; SAFETY; IMMUNOGENICITY; INFECTION; BURDEN; MF59	BACKGROUND The efficacy of inactivated influenza vaccines is known to be poor in infants and young children. METHODS We studied the effect of the adjuvant MF59, an oil-in-water emulsion, on the efficacy of trivalent inactivated influenza vaccine (TIV) in 4707 healthy children 6 to less than 72 months of age who had not previously been vaccinated against influenza. The children were randomly assigned to three study groups, each of which received the assigned vaccines in two doses, 28 days apart, during two consecutive influenza seasons. Two of the groups were given age-appropriate doses of TIV either with or without the MF59 adjuvant, and the third group was given control (noninfluenza) vaccines to assess their absolute and relative efficacy against influenza-like illness, as confirmed by means of polymerase-chain-reaction (PCR) assay. RESULTS Attack rates of influenza-like illness across both influenza seasons were 0.7%, 2.8%, and 4.7% in the adjuvant, nonadjuvant, and control vaccine groups, respectively. The absolute vaccine efficacy rates against all influenza strains (94 of 110 cases were due to vaccine-matched H3N2 viruses) were 86% (95% confidence interval [CI], 74 to 93) for the MF59-adjuvant vaccine (ATIV) and 43% (95% CI, 15 to 61) for the vaccine without the adjuvant (TIV); the relative vaccine efficacy rate for ATIV versus TIV was 75% (95% CI, 55 to 87). The efficacy rates for ATIV were 79% (95% CI, 55 to 90) in children 6 to less than 36 months of age and 92% (95% CI, 77 to 97) in those 36 to less than 72 months of age, as compared with 40% (95% CI, -6 to 66) and 45% (95% CI, 6 to 68), respectively, for TIV. Antibody responses were higher with ATIV and remained so through day 181. The rates of systemic and local reactions to the influenza vaccines with and without the adjuvant were similar in the younger age group (relative risk, 1.04; 95% CI, 0.98 to 1.09), but systemic events in the older age group were more frequent after administration of ATIV (63%) than after administration of TIV (44%) or the control vaccine (50%). Serious adverse events were distributed evenly across the three vaccine groups. CONCLUSIONS Influenza vaccine with the MF59 adjuvant is efficacious against PCR-confirmed influenza in infants and young children. (Funded by Novartis Vaccines and Diagnostics; ClinicalTrials.gov number, NCT00644059.)	[Vesikari, Timo; Karvonen, Aino] Univ Tampere, Sch Med, Tampere 33520, Finland; [Knuf, Markus; Kieninger-Baum, Dorothee; Schmitt, Heinz-Josef] Univ Med, Zentrum Kinder & Jugendmed, Mainz, Germany; [Wutzler, Peter] Univ Jena, Inst Virol & Antiviral Therapy, Jena Univ Hosp, Jena, Germany; [Baehner, Frank; Borkowski, Astrid; Tsai, Theodore F.; Clemens, Ralf] Novartis Vaccines & Diagnost, Marburg, Germany	Tampere University; Friedrich Schiller University of Jena; Novartis	Vesikari, T (corresponding author), Univ Tampere, Sch Med, Biokatu 10, Tampere 33520, Finland.	timo.vesikari@uta.fi		Clemens, Ralf/0000-0003-4685-4207	Novartis Vaccines and Diagnostics	Novartis Vaccines and Diagnostics	Supported by Novartis Vaccines and Diagnostics.	Allison MA, 2006, J PEDIATR-US, V149, P755, DOI 10.1016/j.jpeds.2006.06.036; Ambrose CS, 2010, PEDIATR INFECT DIS J, V29, P806, DOI 10.1097/INF.0b013e3181e2872f; Ansaldi F, 2010, VACCINE, V28, P4123, DOI 10.1016/j.vaccine.2010.04.030; Arguedas A, 2010, NEW ENGL J MED, V362, P370, DOI 10.1056/NEJMc0909988; Atmar RL, 2006, CLIN INFECT DIS, V43, P1135, DOI 10.1086/508174; Banzhoff A, 2011, HUM VACCINES, V7, P539, DOI 10.4161/hv.7.5.14821; Banzhoff A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004384; BARKER WH, 1986, AM J PUBLIC HEALTH, V76, P761, DOI 10.2105/AJPH.76.7.761; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Belshe RB, 2010, VACCINE, V28, P2149, DOI 10.1016/j.vaccine.2009.11.068; Black S, 2010, VACCINE, V28, P7331, DOI 10.1016/j.vaccine.2010.08.075; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Fiore Anthony E., 2010, Morbidity and Mortality Weekly Report, V59, P993; GLEZEN WP, 1978, NEW ENGL J MED, V298, P587, DOI 10.1056/NEJM197803162981103; Heikkinen T, 2006, EUR J PEDIATR, V165, P223, DOI 10.1007/s00431-005-0040-9; Heinonen S, 2011, LANCET INFECT DIS, V11, P23, DOI 10.1016/S1473-3099(10)70255-3; Hoberman A, 2003, JAMA-J AM MED ASSOC, V290, P1608, DOI 10.1001/jama.290.12.1608; Jefferson T, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004879.pub3; Jefferson T, 2005, LANCET, V365, P773, DOI 10.1016/S0140-6736(05)17984-7; KENDAL AP, 1982, CONCEPTS PROCEDURES, pB17; LEVANDOWSKI RA, 1991, PEDIATRICS, V88, P1031; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Mannino S, 2010, AM J EPIDEMIOL, V171, pS157; MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Neuzil KM, 2001, PEDIATR INFECT DIS J, V20, P733, DOI 10.1097/00006454-200108000-00004; O'Hagan DT, 2007, EXPERT REV VACCINES, V6, P699, DOI 10.1586/14760584.6.5.699; Paget WJ, 2010, EUR J PEDIATR, V169, P997, DOI 10.1007/s00431-010-1164-0; Pellegrini M, 2009, VACCINE, V27, P6959, DOI 10.1016/j.vaccine.2009.08.101; Podda A, 2001, VACCINE, V19, P2673, DOI 10.1016/S0264-410X(00)00499-0; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Puppe W, 2004, J CLIN VIROL, V30, P165, DOI 10.1016/j.jcv.2003.10.003; Reyes F, 2007, Can Commun Dis Rep, V33, P21; Rhorer J, 2009, VACCINE, V27, P1101, DOI 10.1016/j.vaccine.2008.11.093; Ritzwoller DP, 2005, PEDIATRICS, V116, P153, DOI 10.1542/peds.2005-0049; Schultze V, 2008, VACCINE, V26, P3209, DOI 10.1016/j.vaccine.2008.03.093; SUGAYA N, 1994, JAMA-J AM MED ASSOC, V272, P1122, DOI 10.1001/jama.272.14.1122; Vesikari T, 2009, VACCINE, V27, P6291, DOI [10.1016/j.vaccine.2009.02.004, 10.1016/j.vaccine.2009.09.115]; Vesikari T, 2010, PEDIATRICS, V126, pE762, DOI 10.1542/peds.2009-2628; Vesikari T, 2009, PEDIATR INFECT DIS J, V28, P563, DOI 10.1097/INF.0b013e31819d6394; *WHO, INFL SEAS 2010 2011	42	225	236	1	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 13	2011	365	15					1406	1416		10.1056/NEJMoa1010331	http://dx.doi.org/10.1056/NEJMoa1010331			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832DQ	21995388	Bronze			2022-12-28	WOS:000295782500008
J	Harte, B				Harte, Ben			Diamond Window into the Lower Mantle	SCIENCE			English	Editorial Material							DEEP MANTLE; INCLUSIONS; BREAKUP; CRUST		Univ Edinburgh, Ctr Sci Extreme Condit, Sch Geosci, Edinburgh EH9 3JW, Midlothian, Scotland	University of Edinburgh	Harte, B (corresponding author), Univ Edinburgh, Ctr Sci Extreme Condit, Sch Geosci, Edinburgh EH9 3JW, Midlothian, Scotland.	ben.harte@ed.ac.uk						Cawood PA, 2005, EARTH-SCI REV, V69, P249, DOI 10.1016/j.earscirev.2004.09.001; Fukao Y, 2009, ANNU REV EARTH PL SC, V37, P19, DOI 10.1146/annurev.earth.36.031207.124224; Harte B, 2010, MINERAL MAG, V74, P189, DOI 10.1180/minmag.2010.074.2.189; Harte B, 2012, GONDWANA RES, V21, P236, DOI 10.1016/j.gr.2011.07.001; Hirose K, 2005, EARTH PLANET SC LETT, V237, P239, DOI 10.1016/j.epsl.2005.06.035; IRIFUNE T, 1993, EARTH PLANET SC LETT, V117, P101, DOI 10.1016/0012-821X(93)90120-X; Keppler H., 2006, WATER NOMINALLY ANHY; Komabayashi T, 2006, PHYS EARTH PLANET IN, V156, P89, DOI 10.1016/j.pepi.2006.02.002; Litasov KD, 2006, GEOPHYS MONOGR SER, V168, P95, DOI 10.1029/168GM08; Ricolleau A, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006709; Stachel T, 2005, ELEMENTS, V1, P73, DOI 10.2113/gselements.1.2.73; STOREY BC, 1995, NATURE, V377, P301, DOI 10.1038/377301a0; Walter MJ, 2011, SCIENCE, V334, P54, DOI 10.1126/science.1209300; Zhao DP, 2011, J ASIAN EARTH SCI, V40, P689, DOI 10.1016/j.jseaes.2010.11.013	14	11	11	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 7	2011	334	6052					51	52		10.1126/science.1213012	http://dx.doi.org/10.1126/science.1213012			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21980103				2022-12-28	WOS:000295580300035
J	O'Connor, P; Wolinsky, JS; Confavreux, C; Comi, G; Kappos, L; Olsson, TP; Benzerdjeb, H; Truffinet, P; Wang, L; Miller, A; Freedman, MS				O'Connor, Paul; Wolinsky, Jerry S.; Confavreux, Christian; Comi, Giancarlo; Kappos, Ludwig; Olsson, Tomas P.; Benzerdjeb, Hadj; Truffinet, Philippe; Wang, Lin; Miller, Aaron; Freedman, Mark S.		TEMSO Trial Grp	Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLACEBO-CONTROLLED TRIAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; AGOUTI RAT MODEL; DOUBLE-BLIND; RHEUMATIC-DISEASES; INTERFERON BETA-1B; LEFLUNOMIDE; ENCEPHALOMYELITIS; SEGMENTATION; MULTICENTER	BACKGROUND Teriflunomide is a new oral disease-modifying therapy for relapsing forms of multiple sclerosis. METHODS We concluded a randomized trial involving 1088 patients with multiple sclerosis, 18 to 55 years of age, with a score of 0 to 5.5 on the Expanded Disability Status Scale and at least one relapse in the previous year or at least two relapses in the previous 2 years. Patients were randomly assigned (in a 1:1:1 ratio) to placebo, 7 mg of teriflunomide, or 14 mg of teriflunomide once daily for 108 weeks. The primary end point was the annualized relapse rate, and the key secondary end point was confirmed progression of disability for at least 12 weeks. RESULTS Teriflunomide reduced the annualized relapse rate (0.54 for placebo vs. 0.37 for teriflunomide at either 7 or 14 mg), with relative risk reductions of 31.2% and 31.5%, respectively (P<0.001 for both comparisons with placebo). The proportion of patients with confirmed disability progression was 27.3% with placebo, 21.7% with teriflunomide at 7 mg (P = 0.08), and 20.2% with teriflunomide at 14 mg (P = 0.03). Both teriflunomide doses were superior to placebo on a range of end points measured by magnetic resonance imaging (MRI). Diarrhea, nausea, and hair thinning were more common with teriflunomide than with placebo. The incidence of elevated alanine aminotransferase levels (= 1 times the upper limit of the normal range) was higher with teriflunomide at 7 mg and 14 mg (54.0% and 57.3%, respectively) than with placebo (35.9%); the incidence of levels that were at least 3 times the upper limit of the normal range was similar in the lower-and higher-dose teriflunomide groups and the placebo group (6.3%, 6.7%, and 6.7%, respectively). Serious infections were reported in 1.6%, 2.5%, and 2.2% of patients in the three groups, respectively. No deaths occurred. CONCLUSIONS Teriflunomide significantly reduced relapse rates, disability progression (at the higher dose), and MRI evidence of disease activity, as compared with placebo.(Funded by Sanofi-Aventis; TEMSO ClinicalTrials. gov number, NCT00134563.)	[O'Connor, Paul] Univ Toronto, Toronto, ON, Canada; [Wolinsky, Jerry S.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Confavreux, Christian] Univ Lyon 1, Hop Neurol, F-69365 Lyon, France; [Benzerdjeb, Hadj; Truffinet, Philippe] Sanofi Aventis, Chilly Mazarin, France; [Comi, Giancarlo] Univ Vita Salute San Raffaele, Milan, Italy; [Kappos, Ludwig] Univ Basel, Basel, Switzerland; [Olsson, Tomas P.] Karolinska Inst, Stockholm, Sweden; [Wang, Lin] Sanofi Aventis, Bridgewater, NJ USA; [Miller, Aaron] Mt Sinai Sch Med, New York, NY USA; [Freedman, Mark S.] Univ Ottawa, Ottawa, ON, Canada	University of Toronto; University of Texas System; UTMD Anderson Cancer Center; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Sanofi-Aventis; Vita-Salute San Raffaele University; University of Basel; Karolinska Institutet; Sanofi-Aventis; Icahn School of Medicine at Mount Sinai; University of Ottawa	O'Connor, P (corresponding author), St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada.	oconnorp@smh.ca	amato, Maria Pia/AAL-5998-2020; Kremenchutzky, Marcelo/B-6413-2015	amato, Maria Pia/0000-0003-3325-3760; Pozzilli, Carlo/0000-0002-6360-4798; Brundin, Lou/0000-0003-4408-7817; Reingold, Stephen/0000-0003-4485-8634; frederiksen, jette/0000-0003-1661-7438; antel, jack/0000-0002-5148-0636; Cutter, Gary/0000-0002-8455-980X; Magy, Laurent/0000-0003-1784-2901; Moskovko, Sergii/0000-0003-3910-2672; lebrun-frenay, christine/0000-0002-3713-2416; Smolanka, Volodymyr/0000-0001-7296-8297; Chan, Andrew/0000-0003-3434-7283	Sanofi-Aventis	Sanofi-Aventis(Sanofi-Aventis)	Supported by Sanofi-Aventis.	Cannon GW, 2004, J RHEUMATOL, V31, P1906; Confavreux C, 2010, MULT SCLER, V16, pS291; Datta S, 2006, NEUROIMAGE, V29, P467, DOI 10.1016/j.neuroimage.2005.07.042; DUQUETTE P, 1993, NEUROLOGY, V43, P655, DOI 10.1212/wnl.43.4.655; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Fox RI, 1999, CLIN IMMUNOL, V93, P198, DOI 10.1006/clim.1999.4777; Giovannoni G, 2010, NEW ENGL J MED, V362, P416, DOI 10.1056/NEJMoa0902533; GOLD R, 2010, ACTA NEUROL SCA 0929; Inusah S, 2010, MULT SCLER J, V16, P1414, DOI 10.1177/1352458510379246; Jacobs LD, 1996, ANN NEUROL, V40, P480; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Johnson K P, 1996, Mult Scler, V1, P325; Jones PBB, 2010, OPEN ACCESS RHEUMATO, V2, P53, DOI 10.2147/OARRR.S9448; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Li DK, 2010, MULT SCLER, V16, pS142; LIMSAKUN T, 2010, MULT SCLER, V16, P1004; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Merrill JE, 2009, J NEUROL, V256, P89, DOI 10.1007/s00415-009-0075-3; Molloy ES, 2008, AUTOIMMUN REV, V8, P144, DOI 10.1016/j.autrev.2008.07.006; O'Connor PW, 2006, NEUROLOGY, V66, P894, DOI 10.1212/01.wnl.0000203121.04509.31; PATY DW, 1993, NEUROLOGY, V43, P662, DOI 10.1212/WNL.43.4.662; Petty M, 2010, NEUROLOGY, V74, pA415; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Rahmlow M, 2008, ARCH NEUROL-CHICAGO, V65, P1538, DOI 10.1001/archneur.65.11.1538; Ruckemann K, 1998, J BIOL CHEM, V273, P21682, DOI 10.1074/jbc.273.34.21682; Sajja BR, 2006, ANN BIOMED ENG, V34, P142, DOI 10.1007/s10439-005-9009-0; Tao G, 2009, COMPUT METH PROG BIO, V95, P105, DOI 10.1016/j.cmpb.2009.01.011; Warnatz K, 2003, ANN RHEUM DIS, V62, P50, DOI 10.1136/ard.62.1.50; Warnke C, 2009, NEUROPSYCH DIS TREAT, V5, P333	29	640	653	2	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 6	2011	365	14					1293	1303		10.1056/NEJMoa1014656	http://dx.doi.org/10.1056/NEJMoa1014656			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829KL	21991951	Bronze			2022-12-28	WOS:000295578700007
J	Tantisira, KG; Lasky-Su, J; Harada, M; Murphy, A; Litonjua, AA; Himes, BE; Lange, C; Lazarus, R; Sylvia, J; Klanderman, B; Duan, QL; Qiu, WL; Hirota, T; Martinez, FD; Mauger, D; Sorkness, C; Szefler, S; Lazarus, SC; Lemanske, RF; Peters, SP; Lima, JJ; Nakamura, Y; Tamari, M; Weiss, ST				Tantisira, Kelan G.; Lasky-Su, Jessica; Harada, Michishige; Murphy, Amy; Litonjua, Augusto A.; Himes, Blanca E.; Lange, Christoph; Lazarus, Ross; Sylvia, Jody; Klanderman, Barbara; Duan, Qing Ling; Qiu, Weiliang; Hirota, Tomomitsu; Martinez, Fernando D.; Mauger, David; Sorkness, Christine; Szefler, Stanley; Lazarus, Stephen C.; Lemanske, Robert F., Jr.; Peters, Stephen P.; Lima, John J.; Nakamura, Yusuke; Tamari, Mayumi; Weiss, Scott T.			Genomewide Association between GLCCI1 and Response to Glucocorticoid Therapy in Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INHALED CORTICOSTEROIDS; PERSISTENT ASTHMA; REPLICATION; APOPTOSIS; GENOTYPE; VARIANT; ADULT; LOCI; GENE	BACKGROUND The response to treatment for asthma is characterized by wide interindividual variability, with a significant number of patients who have no response. We hypothesized that a genomewide association study would reveal novel pharmacogenetic determinants of the response to inhaled glucocorticoids. METHODS We analyzed a small number of statistically powerful variants selected on the basis of a family-based screening algorithm from among 534,290 single-nucleotide polymorphisms (SNPs) to determine changes in lung function in response to inhaled glucocorticoids. A significant, replicated association was found, and we characterized its functional effects. RESULTS We identified a significant pharmacogenetic association at SNP rs37972, replicated in four independent populations totaling 935 persons (P = 0.0007), which maps to the glucocorticoid-induced transcript 1 gene (GLCCI1) and is in complete linkage disequilibrium (i.e., perfectly correlated) with rs37973. Both rs37972 and rs37973 are associated with decrements in GLCCI1 expression. In isolated cell systems, the rs37973 variant is associated with significantly decreased luciferase reporter activity. Pooled data from treatment trials indicate reduced lung function in response to inhaled glucocorticoids in subjects with the variant allele (P = 0.0007 for pooled data). Overall, the mean (+/- SE) increase in forced expiratory volume in 1 second in the treated subjects who were homozygous for the mutant rs37973 allele was only about one third of that seen in similarly treated subjects who were homozygous for the wild-type allele (3.2 +/- 1.6% vs. 9.4 +/- 1.1%), and their risk of a poor response was significantly higher (odds ratio, 2.36; 95% confidence interval, 1.27 to 4.41), with genotype accounting for about 6.6% of overall inhaled glucocorticoid response variability. CONCLUSIONS A functional GLCCI1 variant is associated with substantial decrements in the response to inhaled glucocorticoids in patients with asthma. (Funded by the National Institutes of Health and others; ClinicalTrials.gov number, NCT00000575.)	[Tantisira, Kelan G.; Lasky-Su, Jessica; Murphy, Amy; Litonjua, Augusto A.; Himes, Blanca E.; Lazarus, Ross; Sylvia, Jody; Klanderman, Barbara; Duan, Qing Ling; Qiu, Weiliang; Weiss, Scott T.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Tantisira, Kelan G.; Litonjua, Augusto A.] Brigham & Womens Hosp, Div Pulm, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; [Lange, Christoph] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Harada, Michishige; Hirota, Tomomitsu; Nakamura, Yusuke; Tamari, Mayumi] Inst Phys & Chem Res RIKEN, Ctr Genom Med, Kanagawa, Japan; [Lazarus, Stephen C.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Lemanske, Robert F., Jr.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Peters, Stephen P.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Gen, Sect Pulm Crit Care Allergy & Immunol Dis, Winston Salem, NC USA; [Martinez, Fernando D.] Univ Arizona, Arizona Resp Ctr, Tucson, AZ USA; [Martinez, Fernando D.] Univ Arizona, Dept Pediat, Tucson, AZ 85721 USA; [Mauger, David] Penn State Hershey Coll Med, Hershey, PA USA; [Szefler, Stanley] Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80262 USA; [Lima, John J.] Nemours Clin, Jacksonville, FL USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; RIKEN; University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Madison; Wake Forest University; Wake Forest Baptist Medical Center; University of Arizona; University of Arizona; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Tantisira, KG (corresponding author), Brigham & Womens Hosp, Channing Lab, 181 Longwood Ave, Boston, MA 02115 USA.	rekgt@channing.harvard.edu	Tamari, Mayumi/N-5378-2015	Litonjua, Augusto/0000-0003-0422-5875; Lasky-Su, Jessica/0000-0001-6236-4705; Qiu, Weiliang/0000-0002-9155-6957; lazarus, ross/0000-0003-3939-1961; Szefler, Stanley/0000-0002-6911-3199	National Institutes of Health (NIH) [U01 HL65899, P01 HL083069, R01 HG003646, R01 HL092197, K23 HG3983]; NIH Pharmacogenomics Research Network; Ministry of Education, Culture, Sports, Science, and Technology in Japan; National Heart, Lung, and Blood Institute (NHLBI) [U01 HL65899, P01 HL083069, U01 HL075419, R01 HL086601, T32 HL07427]; NHLBI [U01 HL51510, U01 HL51834, U01 HL51831, U01 HL51845, U01 HL51843, M01 RR00079, M01 RR03186, N02-HL-6-4278]; GlaxoSmithKline; Grants-in-Aid for Scientific Research [23791204] Funding Source: KAKEN; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR003186, M01RR000079] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL105663, R00HL096840, R01HL086601, U10HL051843, U10HL051834, U01HL075419, U10HL051845, P01HL083069, R01HL092197, U01HL065899, U10HL051831, T32HL007427] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K23HG003983, R01HG003646] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Pharmacogenomics Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); GlaxoSmithKline(GlaxoSmithKline); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Supported by grants from the National Institutes of Health (NIH U01 HL65899, P01 HL083069, R01 HG003646, R01 HL092197, and K23 HG3983), the NIH Pharmacogenomics Research Network, and the Ministry of Education, Culture, Sports, Science, and Technology in Japan. The Childhood Asthma Management Program (CAMP) Genetics Ancillary Study is supported by grants from the National Heart, Lung, and Blood Institute (NHLBI) (U01 HL075419, U01 HL65899, P01 HL083069, R01 HL086601, and T32 HL07427); the Single-Nucleotide Polymorphism Health Association Asthma Resource Project (SHARP) was funded by the NHLBI and was carried out by researchers from the Asthma Clinical Research Network, the CAMP, and the Childhood Asthma Research and Education (CARE) Network; the Asthma Clinical Research Network (ACRN) investigators and research teams were supported by grants from the NHLBI (U01 HL51510, U01 HL51834, U01 HL51831, U01 HL51845, U01 HL51843, M01 RR00079, and M01 RR03186); and the Leukotriene Modifier or Corticosteroid or Corticosteroid-Salmeterol (LOCCS) trial was supported by an unrestricted grant to the American Lung Association from GlaxoSmithKline. SHARP genotyping services were provided by Affymetrix under a contract (N02-HL-6-4278) from the NHLBI.	Abney M, 2002, AM J HUM GENET, V70, P920, DOI 10.1086/339705; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; ARMALY MF, 1966, ARCH OPHTHALMOL-CHIC, V75, P32; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Bielory L, 2000, CLIN DRUG INVEST, V19, P93, DOI 10.2165/00044011-200019020-00002; CHAPMAN MS, 1995, MOL CELL ENDOCRINOL, V108, pR1, DOI 10.1016/0303-7207(95)03481-L; Chapman MS, 1996, MOL ENDOCRINOL, V10, P967, DOI 10.1210/me.10.8.967; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; *CHILDH ASTHM MAN, 2000, NEW ENGLAND J MED, V0343; Drazen JM, 1999, NAT GENET, V22, P168, DOI 10.1038/9680; Drazen JM, 2000, BRIT MED BULL, V56, P1054, DOI 10.1258/0007142001903535; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Ho CY, 2002, CHEST, V122, P1751, DOI 10.1378/chest.122.5.1751; Inglis GC, 1999, J CLIN ENDOCR METAB, V84, P4132, DOI 10.1210/jc.84.11.4132; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Lange C, 2003, AM J HUM GENET, V73, P801, DOI 10.1086/378591; Lange C., 2004, STAT APPL GENET MOL, V3, P17, DOI [DOI 10.2202/1544-6115.1067, 10.2202/1544-6115.1067]; Lasky-Su J, 2008, AM J HUM GENET, V82, P849, DOI 10.1016/j.ajhg.2008.01.018; Lazarus SC, 2001, JAMA-J AM MED ASSOC, V285, P2583, DOI 10.1001/jama.285.20.2583; Lemanske RF, 2001, JAMA-J AM MED ASSOC, V285, P2594, DOI 10.1001/jama.285.20.2594; Liptak T., 1958, MAGYAR TUD AKAD MAT, V3, P171; Litonjua AA, 2008, AM J RESP CRIT CARE, V178, P688, DOI 10.1164/rccm.200709-1363OC; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Ober C, 2001, AM J HUM GENET, V69, P1068, DOI 10.1086/324025; Peters SP, 2007, NEW ENGL J MED, V357, P728; SCHWARTZ JT, 1972, J MED GENET, V9, P137, DOI 10.1136/jmg.9.2.137; Sorkness CA, 2007, J ALLERGY CLIN IMMUN, V120, P285; Steptoe A, 2009, PSYCHONEUROENDOCRINO, V34, P273, DOI 10.1016/j.psyneuen.2008.09.006; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Szefler SJ, 2002, J ALLERGY CLIN IMMUN, V109, P410, DOI 10.1067/mai.2002.122635; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P233, DOI 10.1016/j.jaci.2004.11.014; Tantisira KG, 2007, J ALLERGY CLIN IMMUN, V120, P1285, DOI 10.1016/j.jaci.2007.09.005; Tantisira KG, 2004, HUM MOL GENET, V13, P1353, DOI 10.1093/hmg/ddh149; Tantisira KG, 2004, P NATL ACAD SCI USA, V101, P18099, DOI 10.1073/pnas.0408532102; Van Steen K, 2005, NAT GENET, V37, P683, DOI 10.1038/ng1582; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Won SH, 2009, STAT MED, V28, P1537, DOI 10.1002/sim.3569	39	262	275	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 29	2011	365	13					1173	1183		10.1056/NEJMoa0911353	http://dx.doi.org/10.1056/NEJMoa0911353			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825YO	21991891	Green Accepted, Green Published			2022-12-28	WOS:000295318400005
J	Balague, F; Mannion, AF; Pellise, F; Cedraschi, C				Balague, Federico; Mannion, Anne F.; Pellise, Ferran; Cedraschi, Christine			Non-specific low back pain	LANCET			English	Article							INTERVERTEBRAL DISC DEGENERATION; NERVE GROWTH-FACTOR; 2-YEAR FOLLOW-UP; PRIMARY-CARE; EUROPEAN GUIDELINES; CAUSAL ASSESSMENT; LUMBAR SPINE; GENERAL-PRACTICE; OLDER-ADULTS; HEALTH-CARE	Non-specific low back pain has become a major public health problem worldwide. The lifetime prevalence of low back pain is reported to be as high as 84%, and the prevalence of chronic low back pain is about 23%, with 11-12% of the population being disabled by low back pain. Mechanical factors, such as lifting and carrying, probably do not have a major pathogenic role, but genetic constitution is important. History taking and clinical examination are included in most diagnostic guidelines, but the use of clinical imaging for diagnosis should be restricted. The mechanism of action of many treatments is unclear, and effect sizes of most treatments are low. Both patient preferences and clinical evidence should be taken into account for pain management, but generally self-management, with appropriate support, is recommended and surgery and overtreatment should be avoided.	[Balague, Federico] Hop Cantonal Fribourg, Hop Fribourgeois, Dept Rheumatol Phys Med & Rehabil, CH-1708 Fribourg, Switzerland; [Balague, Federico] Univ Geneva, Geneva, Switzerland; [Mannion, Anne F.] Schulthess Klin, Spine Ctr, Dept Res & Dev, Zurich, Switzerland; [Pellise, Ferran] Univ Vall dHebron, Spine Unit Hosp, Barcelona, Spain; [Cedraschi, Christine] Univ Geneva, Univ Hosp, Div Clin Pharmacol & Toxicol, Div Gen Med Rehabil, Geneva, Switzerland; [Cedraschi, Christine] Univ Geneva, Univ Hosp, Div Clin Pharmacol & Toxicol, Ctr Multidisciplinary Pain, Geneva, Switzerland	University of Geneva; Schulthess Clinic; University of Geneva; University of Geneva	Balague, F (corresponding author), Hop Cantonal Fribourg, Hop Fribourgeois, Dept Rheumatol Phys Med & Rehabil, CH-1708 Fribourg, Switzerland.	balaguef@h-fr.ch	Mannion, Anne F./C-6615-2009; Mannion, Anne F./AAN-5908-2020; Pellise, Ferran/D-4488-2016	Mannion, Anne F./0000-0002-1203-1096; Mannion, Anne F./0000-0002-1203-1096; Pellise, Ferran/0000-0002-0644-7757				Adamson J, 2011, FAM PRACT, V28, P163, DOI 10.1093/fampra/cmq085; Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Albert HB, 2008, MED HYPOTHESES, V70, P361, DOI 10.1016/j.mehy.2007.05.014; Artus M, 2010, RHEUMATOLOGY, V49, P2346, DOI 10.1093/rheumatology/keq245; Auvinen JP, 2009, SPINE, V34, P1192, DOI 10.1097/BRS.0b013e3181a401df; Barrett B, 2005, MED DECIS MAKING, V25, P250, DOI 10.1177/0272989X05276863; Battie MC, 2007, PAIN, V131, P272, DOI 10.1016/j.pain.2007.01.010; Bigos SJ, 2009, SPINE J, V9, P147, DOI 10.1016/j.spinee.2008.11.001; Blumenthal S, 2005, SPINE, V30, P1565, DOI 10.1097/01.brs.0000170587.32676.0e; Boom Merel, 2010, J Pain Res, V3, P183, DOI 10.2147/JPR.S13616; Brox JI, 2010, ANN RHEUM DIS, V69, P1643, DOI 10.1136/ard.2009.108902; Buchbinder R, 2007, SPINE, V32, pE156, DOI 10.1097/01.brs.0000256885.00681.00; Buckalew N, 2010, PAIN MED, V11, P1183, DOI 10.1111/j.1526-4637.2010.00899.x; Burton AK, 2006, EUR SPINE J, V15, pS136, DOI 10.1007/s00586-006-1070-3; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; Choi BK, 2010, COCHRANE DB SYST REV, V1; Chou R, 2011, ANN INTERN MED, V154, P181, DOI 10.7326/0003-4819-154-3-201102010-00008; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; Chou R, 2010, DRUGS, V70, P387, DOI 10.2165/11318690-000000000-00000; Chou R, 2009, LANCET, V373, P463, DOI 10.1016/S0140-6736(09)60172-0; Cook C, 2010, PHYSIOTHER RES INT, DOI [10.1002/pri500, DOI 10.1002/PRI500]; Costa LDM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3829; Cote P, 2001, MED CARE, V39, P956, DOI 10.1097/00005650-200109000-00006; Coudeyre E, 2006, PAIN, V124, P330, DOI 10.1016/j.pain.2006.05.003; Dagenais S, 2010, SPINE J, V10, P514, DOI 10.1016/j.spinee.2010.03.032; Dai F, 2010, SPINE J, V10, P949, DOI 10.1016/j.spinee.2010.07.387; de Schepper EIT, 2010, SPINE, V35, P531, DOI 10.1097/BRS.0b013e3181aa5b33; Deyo RA, 2004, NEW ENGL J MED, V350, P722, DOI 10.1056/NEJMsb031771; Deyo RA, 1998, SPINE, V23, P2003, DOI 10.1097/00007632-199809150-00018; DEYO RA, 1988, J GEN INTERN MED, V3, P230, DOI 10.1007/BF02596337; Deyo RA, 2006, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000198726.62514.75; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; Deyo RA, 2010, JAMA-J AM MED ASSOC, V303, P1259, DOI 10.1001/jama.2010.338; Deyo RA, 2009, J AM BOARD FAM MED, V22, P62, DOI 10.3122/jabfm.2009.01.080102; Dionne CE, 2008, SPINE, V33, P95, DOI 10.1097/BRS.0b013e31815e7f94; Doehring A, 2011, EUR J PAIN, V15, P11, DOI 10.1016/j.ejpain.2010.06.004; Dunn KM, 2011, PAIN, V152, P66, DOI 10.1016/j.pain.2010.09.006; El-Sayed AM, 2010, SPINE, V35, P684, DOI 10.1097/BRS.0b013e3181b4926e; Endean A, 2011, SPINE, V36, P160, DOI 10.1097/BRS.0b013e3181cd9adb; Fairbank J, 2005, BMJ-BRIT MED J, V330, P1233, DOI 10.1136/bmj.38441.620417.8F; Ferreira ML, 2010, EUR J PAIN, V14, DOI 10.1016/j.ejpain.2009.11.005; Ferreira ML, 2008, AUST J PHYSIOTHER, V54, P229, DOI 10.1016/S0004-9514(08)70001-1; Ferrer M, 2006, SPINE, V31, P1372, DOI 10.1097/01.brs.0000218477.53318.bc; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Foster NE, 2011, MANUAL THER, V16, P3, DOI 10.1016/j.math.2010.05.013; Fullen BM, 2009, EUR J PAIN, V13, P908, DOI 10.1016/j.ejpain.2008.11.013; George SZ, 2010, J PAIN, V11, P1074, DOI 10.1016/j.jpain.2010.02.016; Gibbs-Strauss SL, 2010, MOL IMAGING, V9, P128, DOI 10.2310/7290.2010.00009; Government Accountability Office, 2008, MED B; Greenhalgh S, 2009, PHYSIOTHERAPY, V95, P223, DOI 10.1016/j.physio.2009.04.006; Gross DP, 2010, SPINE, V35, P906, DOI 10.1097/BRS.0b013e3181c91140; Hellum C, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2786; Heneweer H, 2009, PAIN, V143, P21, DOI 10.1016/j.pain.2008.12.033; Henschke N, 2009, ARTHRITIS RHEUM-US, V60, P3072, DOI 10.1002/art.24853; Henschke N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a171; Hicks GE, 2008, ARTHRIT RHEUM-ARTHR, V59, P1306, DOI 10.1002/art.24006; Huntoon MA, 2008, PAIN PHYSICIAN, V11, P713; Iles RA, 2009, J OCCUP REHABIL, V19, P25, DOI 10.1007/s10926-008-9161-0; Jarvik JG, 2003, JAMA-J AM MED ASSOC, V289, P2810, DOI 10.1001/jama.289.21.2810; Jeffries LJ, 2007, SPINE, V32, P2630, DOI 10.1097/BRS.0b013e318158d70b; Jordan KP, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-144; Kalichman L, 2008, JOINT BONE SPINE, V75, P388, DOI 10.1016/j.jbspin.2007.11.002; Kalichman L, 2008, JOINT BONE SPINE, V75, P383, DOI 10.1016/j.jbspin.2007.11.003; Kamper SJ, 2010, BEST PRACT RES CL RH, V24, P181, DOI 10.1016/j.berh.2009.11.003; Kapellen PJ, 2010, SEMIN ROENTGENOL, V45, P218, DOI 10.1053/j.ro.2009.12.001; Karppinen J, 2009, EUR SPINE J, V18, P1963, DOI 10.1007/s00586-009-1139-x; Keller A, 2007, EUR SPINE J, V16, P1776, DOI 10.1007/s00586-007-0379-x; Kendall NAS, 1997, GUIDE ASSESSING PSYC; Kent P, 2004, SPINE, V29, P1022, DOI 10.1097/00007632-200405010-00015; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Kong MH, 2009, J NEUROSURG-SPINE, V10, P357, DOI 10.3171/2008.12.SPINE08321; Krismer M, 2007, BEST PRACT RES CL RH, V21, P77, DOI 10.1016/j.berh.2006.08.004; Kuijpers T, 2011, EUR SPINE J, V20, P40, DOI 10.1007/s00586-010-1541-4; Lalkadamyali H, 2008, AM J ROENTGENOL, V191, P973, DOI 10.2214/AJR.07.2829; Lamb SE, 2010, LANCET, V375, P916, DOI 10.1016/S0140-6736(09)62164-4; Lane NE, 2010, NEW ENGL J MED, V363, P1521, DOI 10.1056/NEJMoa0901510; Lang LJ, 2010, ANN NY ACAD SCI, V1193, P111, DOI 10.1111/j.1749-6632.2009.05343.x; Lauridsen HH, 2009, EUR SPINE J, V18, P1858, DOI 10.1007/s00586-009-1070-1; Linton SJ, 2002, J OCCUP REHABIL, V12, P223, DOI 10.1023/A:1020218422974; Lotsch J, 2010, TRENDS PHARMACOL SCI, V31, P312, DOI 10.1016/j.tips.2010.04.002; Lotsch J, 2009, PHARMACOL THERAPEUT, V124, P168, DOI 10.1016/j.pharmthera.2009.06.010; Louw QA, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-105; Machado LAC, 2009, RHEUMATOLOGY, V48, P520, DOI 10.1093/rheumatology/ken470; Mannion AF, 2005, EUR SPINE J, V14, P1014, DOI 10.1007/s00586-005-0911-9; Mannion AF, 1996, SPINE, V21, P2603, DOI 10.1097/00007632-199611150-00010; Mannion AF, 2009, J OCCUP ENVIRON MED, V51, P1256, DOI 10.1097/JOM.0b013e3181beac69; Martimo KP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005958; Maus T, 2010, PHYS MED REH CLIN N, V21, P725, DOI 10.1016/j.pmr.2010.07.004; May S, 2010, NAT REV RHEUMATOL, V6, P199, DOI 10.1038/nrrheum.2010.26; McCarberg BH, 2010, CURR MED RES OPIN, V26, P179, DOI 10.1185/03007990903451348; Meyer T, 2007, SPINE, V32, P2380, DOI 10.1097/BRS.0b013e3181557955; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Ozguler A, 2000, J EPIDEMIOL COMMUN H, V54, P215, DOI 10.1136/jech.54.3.215; Papageorgiou AC, 1996, PAIN, V66, P181, DOI 10.1016/0304-3959(96)03022-9; Pellise F, 2009, ARCH PEDIAT ADOL MED, V163, P65, DOI 10.1001/archpediatrics.2008.512; Petersen S, 2009, PEDIATRICS, V124, pE759, DOI 10.1542/peds.2008-1546; Picavet HSJ, 2008, SPINE, V33, P436, DOI 10.1097/BRS.0b013e318163e054; Pincus T, 2010, CLIN J PAIN, V26, P739, DOI 10.1097/AJP.0b013e3181f15d45; Plenet A., 2010, Annals of Physical and Rehabilitation Medicine, V53, P224, DOI 10.1016/j.rehab.2010.03.006; Pransky G, 2010, BEST PRACT RES CL RH, V24, P291, DOI 10.1016/j.berh.2010.01.001; Puts MTE, 2008, AGE AGEING, V37, P187, DOI 10.1093/ageing/afm185; Reimann F, 2010, P NATL ACAD SCI USA, V107, P5148, DOI 10.1073/pnas.0913181107; Roffey DM, 2010, SPINE J, V10, P639, DOI 10.1016/j.spinee.2010.04.028; Roffey DM, 2010, SPINE J, V10, P544, DOI 10.1016/j.spinee.2010.03.025; Roffey DM, 2010, SPINE J, V10, P262, DOI 10.1016/j.spinee.2009.12.023; Roffey DM, 2010, SPINE J, V10, P89, DOI 10.1016/j.spinee.2009.09.003; Roffey DM, 2010, SPINE J, V10, P252, DOI 10.1016/j.spinee.2009.12.005; Rubinstein SM, 2008, BEST PRACT RES CL RH, V22, P471, DOI 10.1016/j.berh.2007.12.003; Savigny P., 2009, LOND NATL COLLAB CEN; Schers H, 2000, BRIT J GEN PRACT, V50, P640; Sheehan NJ, 2010, ANN RHEUM DIS, V69, P7, DOI 10.1136/ard.2009.110973; Shiri R, 2010, AM J MED, V123, p87e7; Shiri R, 2010, AM J EPIDEMIOL, V171, P135, DOI 10.1093/aje/kwp356; Shye D, 1998, INT J QUAL HEALTH C, V10, P83, DOI 10.1093/intqhc/10.2.83; Stanton TR, 2010, EUR SPINE J, V19, P533, DOI 10.1007/s00586-009-1214-3; Stanton TR, 2008, SPINE, V33, P2923, DOI 10.1097/BRS.0b013e31818a3167; Stovall BA, 2010, PM&R, V2, P48, DOI 10.1016/j.pmrj.2009.11.001; Tegeder I, 2009, J CELL MOL MED, V13, P1605, DOI 10.1111/j.1582-4934.2009.00703.x; Tousignant M, 2005, DISABIL REHABIL, V27, P553, DOI 10.1080/09638280400018411; Urquhart DM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001703.pub3; Urquhart DM, 2009, CLIMACTERIC, V12, P266, DOI 10.1080/13697130802635645; van der Windt DAWM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007431.pub2; van Tulder M, 2006, EUR SPINE J, V15, pS169, DOI 10.1007/s00586-006-1071-2; Verbunt JA, 2010, PAIN, V149, P428, DOI 10.1016/j.pain.2010.01.020; Vingard E, 2002, SPINE, V27, P2159, DOI 10.1097/00007632-200210010-00016; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; Waddell G, 2007, SPINE, V32, P2139, DOI 10.1097/BRS.0b013e31814541bc; Wai EK, 2010, SPINE J, V10, P628, DOI 10.1016/j.spinee.2010.03.027; Wai EK, 2010, SPINE J, V10, P554, DOI 10.1016/j.spinee.2010.03.033; Wai EK, 2010, SPINE J, V10, P76, DOI 10.1016/j.spinee.2009.06.005; Wai EK, 2009, SPINE J, V9, P447, DOI 10.1016/j.spinee.2008.11.009; Wand BM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-11; Wand BM, 2011, MANUAL THER, V16, P15, DOI 10.1016/j.math.2010.06.008; Wang H, 2008, CLIN J PAIN, V24, P273, DOI 10.1097/AJP.0b013e31816111d3; Weinstein JN, 2006, SPINE, V31, P2707, DOI 10.1097/01.brs.0000248132.15231.fe; Werner EL, 2008, PATIENT EDUC COUNS, V71, P198, DOI 10.1016/j.pec.2007.12.009; Wieser S, 2011, EUR J HEALTH ECON, V12, P455, DOI 10.1007/s10198-010-0258-y; Williams CM, 2010, ARCH INTERN MED, V170, P271, DOI 10.1001/archinternmed.2009.507; Wood JN, 2010, NEW ENGL J MED, V363, P1572, DOI 10.1056/NEJMe1004416; Yamauchi K, 2009, SPINE, V34, P2263, DOI 10.1097/BRS.0b013e3181a5521d	140	966	1022	9	204	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2012	379	9814					482	491		10.1016/S0140-6736(11)60610-7	http://dx.doi.org/10.1016/S0140-6736(11)60610-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	891AF	21982256				2022-12-28	WOS:000300187800038
J	Lorch, JM; Meteyer, CU; Behr, MJ; Boyles, JG; Cryan, PM; Hicks, AC; Ballmann, AE; Coleman, JTH; Redell, DN; Reeder, DM; Blehert, DS				Lorch, Jeffrey M.; Meteyer, Carol U.; Behr, Melissa J.; Boyles, Justin G.; Cryan, Paul M.; Hicks, Alan C.; Ballmann, Anne E.; Coleman, Jeremy T. H.; Redell, David N.; Reeder, DeeAnn M.; Blehert, David S.			Experimental infection of bats with Geomyces destructans causes white-nose syndrome	NATURE			English	Article							MYOTIS-LUCIFUGUS; EXTINCTION; DISEASE; SPREAD; UPDATE	White-nose syndrome(WNS) has caused recent catastrophic declines among multiple species of bats in eastern North America(1,2). The disease's name derives from a visually apparent white growth of the newly discovered fungus Geomyces destructans on the skin (including the muzzle) of hibernating bats(1,3). Colonization of skin by this fungus is associated with characteristic cutaneous lesions that are the only consistent pathological finding related to WNS4. However, the role of G. destructans in WNS remains controversial because evidence to implicate the fungus as the primary cause of this disease is lacking. The debate is fuelled, in part, by the assumption that fungal infections in mammals are most commonly associated with immune system dysfunction(5-7). Additionally, the recent discovery that G. destructans commonly colonizes the skin of bats of Europe, where no unusual bat mortality events have been reported(8-10), has generated further speculation that the fungus is an opportunistic pathogen and that other unidentified factors are the primary cause of WNS11,12. Here we demonstrate that exposure of healthy little brown bats (Myotis lucifugus) to pure cultures of G. destructans causes WNS. Live G. destructans was subsequently cultured from diseased bats, successfully fulfilling established criteria for the determination of G. destructans as a primary pathogen(13). We also confirmed that WNS can be transmitted from infected bats to healthy bats through direct contact. Our results provide the first direct evidence that G. destructans is the causal agent of WNS and that the recent emergence of WNS in North America may represent translocation of the fungus to a region with a naive population of animals(8). Demonstration of causality is an instrumental step in elucidating the pathogenesis(14) and epidemiology(15) of WNS and in guiding management actions to preserve bat populations against the novel threat posed by this devastating infectious disease.	[Lorch, Jeffrey M.; Meteyer, Carol U.; Ballmann, Anne E.; Blehert, David S.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI 53711 USA; [Lorch, Jeffrey M.] Univ Wisconsin, Mol & Environm Toxicol Ctr, Madison, WI 53706 USA; [Behr, Melissa J.] Wisconsin Vet Diagnost Lab, Madison, WI 53706 USA; [Boyles, Justin G.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Cryan, Paul M.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA; [Hicks, Alan C.] New York Dept Environm Conservat, Albany, NY 12233 USA; [Coleman, Jeremy T. H.] US Fish & Wildlife Serv, Hadley, MA 01035 USA; [Redell, David N.] Wisconsin Dept Nat Resources, Madison, WI 53707 USA; [Reeder, DeeAnn M.] Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA	United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Wisconsin Madison; University of Tennessee System; University of Tennessee Knoxville; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service; Bucknell University	Blehert, DS (corresponding author), US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI 53711 USA.	dblehert@usgs.gov	Boyles, Justin G/A-5152-2010	Blehert, David/0000-0002-1065-9760; Cryan, Paul/0000-0002-2915-8894; Lorch, Jeffrey/0000-0003-2239-1252; Reeder, DeeAnn/0000-0001-8651-2012; Coleman, Jeremy/0000-0002-2762-947X	US Geological Survey; US Fish and Wildlife Service; Bat Conservation International; Indiana State University Center for North American Bat Research and Conservation	US Geological Survey(United States Geological Survey); US Fish and Wildlife Service(US Fish & Wildlife Service); Bat Conservation International; Indiana State University Center for North American Bat Research and Conservation	Financial support for this project was provided by the US Geological Survey, the US Fish and Wildlife Service, Bat Conservation International, and the Indiana State University Center for North American Bat Research and Conservation. Use of trade, product, or firm names is for descriptive purposes only and does not imply endorsement by the US Government. We acknowledge E. Buckles, S. Darling and T. Tomasi for discussions during the development of this project. We thank N. Keller for comments during the preparation of this manuscript. We also thank J. P. White, R. Dusek, A. Klein, L. Leppert, K. Schuler, C. L. White and NWHC Animal Care Staff for their help with set-up and maintenance of animals, and D. Berndt, L. Muller, A. Pike and M. Verant for their assistance during necropsies. We thank X. Yu for help with statistical analyses.	Blanco JL, 2008, VET IMMUNOL IMMUNOP, V125, P47, DOI 10.1016/j.vetimm.2008.04.020; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Casadevall A, 2005, FUNGAL GENET BIOL, V42, P98, DOI 10.1016/j.fgb.2004.11.008; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; Desprez-Loustau ML, 2007, TRENDS ECOL EVOL, V22, P472, DOI 10.1016/j.tree.2007.04.005; FENTON MB, 1969, CAN J ZOOLOG, V47, P597, DOI 10.1139/z69-103; Foley J, 2011, CONSERV BIOL, V25, P223, DOI 10.1111/j.1523-1739.2010.01638.x; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; KOCH R, 1884, MITT KAISER GESUNDH, V2, P1, DOI DOI 10.1016/S0174-3031(82)80099-1; Lorch JM, 2010, J VET DIAGN INVEST, V22, P224, DOI 10.1177/104063871002200208; Martinkova N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013853; Maschmeyer G, 2009, MED MYCOL, V47, P571, DOI 10.1080/13693780902946559; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Puechmaille SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019167; Puechmaille SJ, 2010, EMERG INFECT DIS, V16, P290, DOI 10.3201/eid1602.091391; Rajkumar SS, 2011, EMERG INFECT DIS, V17, P1273, DOI 10.3201/eid1707.102056; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; THOMAS DW, 1979, BEHAV ECOL SOCIOBIOL, V6, P129, DOI 10.1007/BF00292559; Turner Gregory G., 2011, Bat Research News, V52, P13; Turner Gregory G., 2009, Bat Research News, V50, P47; White T.J., 1990, PCR PROTOCOLS GUIDE, P315; Wibbelt G, 2010, EMERG INFECT DIS, V16, P1237, DOI 10.3201/eid1608.100002	23	324	331	1	282	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					376	U129		10.1038/nature10590	http://dx.doi.org/10.1038/nature10590			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22031324				2022-12-28	WOS:000298033000053
J	Pejchal, R; Doores, KJ; Walker, LM; Khayat, R; Huang, PS; Wang, SK; Stanfield, RL; Julien, JP; Ramos, A; Crispin, M; Depetris, R; Katpally, U; Marozsan, A; Cupo, A; Maloveste, S; Liu, Y; McBride, R; Ito, Y; Sanders, RW; Ogohara, C; Paulson, JC; Feizi, T; Scanlan, CN; Wong, CH; Moore, JP; Olson, WC; Ward, AB; Poignard, P; Schief, WR; Burton, DR; Wilson, IA				Pejchal, Robert; Doores, Katie J.; Walker, Laura M.; Khayat, Reza; Huang, Po-Ssu; Wang, Sheng-Kai; Stanfield, Robyn L.; Julien, Jean-Philippe; Ramos, Alejandra; Crispin, Max; Depetris, Rafael; Katpally, Umesh; Marozsan, Andre; Cupo, Albert; Maloveste, Sebastien; Liu, Yan; McBride, Ryan; Ito, Yukishige; Sanders, Rogier W.; Ogohara, Cassandra; Paulson, James C.; Feizi, Ten; Scanlan, Christopher N.; Wong, Chi-Huey; Moore, John P.; Olson, William C.; Ward, Andrew B.; Poignard, Pascal; Schief, William R.; Burton, Dennis R.; Wilson, Ian A.			A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN COMPLEX; GP120; PANEL	The HIV envelope (Env) protein gp120 is protected from antibody recognition by a dense glycan shield. However, several of the recently identified PGT broadly neutralizing antibodies appear to interact directly with the HIV glycan coat. Crystal structures of antigen-binding fragments (Fabs) PGT 127 and 128 with Man(9) at 1.65 and 1.29 angstrom resolution, respectively, and glycan binding data delineate a specific high mannose-binding site. Fab PGT 128 complexed with a fully glycosylated gp120 outer domain at 3.25 angstroms reveals that the antibody penetrates the glycan shield and recognizes two conserved glycans as well as a short beta-strand segment of the gp120 V3 loop, accounting for its high binding affinity and broad specificify. Furthermore, our data suggest that the high neutralization potency of PGT 127 and 128 immunoglobulin Gs may be mediated by cross-linking Env trimers on the viral surface.	[Doores, Katie J.; Walker, Laura M.; Ramos, Alejandra; Poignard, Pascal; Schief, William R.; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Pejchal, Robert; Doores, Katie J.; Walker, Laura M.; Khayat, Reza; Stanfield, Robyn L.; Julien, Jean-Philippe; Ramos, Alejandra; Ward, Andrew B.; Poignard, Pascal; Schief, William R.; Burton, Dennis R.; Wilson, Ian A.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Pejchal, Robert; Khayat, Reza; Stanfield, Robyn L.; Julien, Jean-Philippe; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Doores, Katie J.; Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02129 USA; [Huang, Po-Ssu; Ogohara, Cassandra; Schief, William R.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Wang, Sheng-Kai; Wong, Chi-Huey] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Crispin, Max; Scanlan, Christopher N.] Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, Oxford OX1 3QU, England; [Depetris, Rafael; Sanders, Rogier W.; Moore, John P.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Katpally, Umesh; Marozsan, Andre; Cupo, Albert; Olson, William C.] Progen Pharmaceut, Tarrytown, NY 10591 USA; [Maloveste, Sebastien] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Liu, Yan; Feizi, Ten] Univ London Imperial Coll Sci Technol & Med, Dept Med, Glycosci Lab, London W12 0NN, England; [McBride, Ryan; Paulson, James C.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Ito, Yukishige] RIKEN Adv Sci Inst, Wako, Saitama 3510198, Japan; [Ito, Yukishige] Japan Sci & Technol Agcy, Exploratory Res Adv Technol, Wako, Saitama 3510198, Japan; [Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Poignard, Pascal] Int AIDS Vaccine Initiat, New York, NY 10038 USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Washington; University of Washington Seattle; Scripps Research Institute; University of Oxford; Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Imperial College London; Scripps Research Institute; RIKEN; Japan Science & Technology Agency (JST); University of Amsterdam; Academic Medical Center Amsterdam; International AIDS Vaccine Initiative	Burton, DR (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	burton@scripps.edu; wilson@scripps.edu	McBride, Ryan/E-6812-2011; Stanfield, Robyn/AAH-3190-2019; Liu, Yan/D-9117-2013; poignard, pascal/N-6678-2013; Crispin, Max/AAG-4098-2020; Paulson, James/AAG-3565-2019; Ward, Andrew B/F-9203-2014; Schief, William/ABF-3645-2020; poignard, pascal/AAB-4613-2020; Ward, Andrew/ABD-7728-2021; Ito, Yukishige/M-5119-2014; Ito, Yukishige/ACL-6203-2022	Crispin, Max/0000-0002-1072-2694; Ward, Andrew B/0000-0001-7153-3769; Schief, William/0000-0002-1120-0150; Ward, Andrew/0000-0001-7153-3769; Ito, Yukishige/0000-0001-6251-7249; Ito, Yukishige/0000-0001-6251-7249; Julien, Jean-Philippe/0000-0001-7602-3995; Poignard, Pascal/0000-0002-0021-7192; Huang, Possu/0000-0002-7948-2895; Wang, Sheng-Kai/0000-0002-3827-7983; Liu, Yan/0000-0002-2566-6867; Doores, Katie/0000-0002-5507-1725; Feizi, Ten/0000-0001-6495-0329	International AIDS Vaccine Initiative Neutralizing Antibody Center; NIH [AI84817, AI74372]; National Institute of Allergy and Infectious Diseases [AI33292]; Canadian Institutes of Health Research [FRN HFE-224662]; HIV Vaccine Research and Design grant [AI082362]; UK Research Councils' Basic Technology Initiative [GRS/79268]; Engineering and Physical Sciences Research Council [EP/G037604/1]; National Cancer Institute (NCI) [U01 CA128416, Y1-CO-1020]; Ragon Institute; NIH through the National Center for Research Resources' [RR017573]; DOE Office of Biological and Environmental Research; NIH's National Center for Research Resources [P41RR001209]; National Institute of General Medical Sciences (NIGMS) [Y1-GM-1104]; DOE, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; EPSRC [EP/G037604/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [GR/S79268/02] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U01CA128416] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573, P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI082362, R01AI084817, R56AI084817, R37AI033292, F32AI074372, R01AI033292] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative Neutralizing Antibody Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); HIV Vaccine Research and Design grant; UK Research Councils' Basic Technology Initiative; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ragon Institute; NIH through the National Center for Research Resources'(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH's National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Y. Hua, K. Le, and V. Thaney for technical assistance; D. Ekiert for help with initial cloning of PGTs 125 and 126; X. Dai and X. Zhu for help with x-ray data collection and analysis; C. Corbaci and C. Williams for help with figure preparation; B. Walker for helpful comments on the manuscript; and members of The Glycosciences Laboratory for their collaboration in the establishment of the neoglycolipid-based microarray system. This work was supported by the International AIDS Vaccine Initiative Neutralizing Antibody Center, NIH grant AI84817 (I. A. W.), National Institute of Allergy and Infectious Diseases grant AI33292 (D. R. B.), NIH/National Research Service Award fellowship AI74372 (R. P.), Canadian Institutes of Health Research fellowship FRN HFE-224662 (J.-P.J.), HIV Vaccine Research and Design grant AI082362 (W.C.O., J.P.M., and I. A. W.), UK Research Councils' Basic Technology Initiative "Glycoarrays" grant GRS/79268, Engineering and Physical Sciences Research Council Translational Grant EP/G037604/1, National Cancer Institute (NCI) Alliance of Glycobiologists for Detection of Cancer and Cancer Risk grant U01 CA128416, and the Ragon Institute. The three-dimensional reconstructions were conducted at the National Resource for Automated Molecular Microscopy, which is supported by NIH through the National Center for Research Resources' P41 program (RR017573). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), a Directorate of the SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U. S. Department of Energy (DOE) Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research; NIH's National Center for Research Resources, Biomedical Technology Program (P41RR001209); and the National Institute of General Medical Sciences (NIGMS). Use of the Advanced Photon Source was supported by the DOE, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. GM/CA CAT has been funded in whole or in part with federal funds from NCI (grant Y1-CO-1020) and NIGMS (grant Y1-GM-1104). Coordinates and structure factors for the Fab PGT 128/Man<INF>9</INF>, Fab PGT 127/Man<INF>9</INF>, and Fab PGT 128/eODmV3 structures have been deposited with the Protein Data Bank under accession codes 3TV3, 3TWC, and 3TYG. The Fab PGT 128/d664G trimer EM reconstruction density has been deposited with the Electron Microscopy Data Bank under accession code EMD-1970. Progenics Pharmaceuticals and the Cornell Research Foundation, on behalf of Cornell University, are the joint owners of U. S. Patent 7,939,083 and have additional patent applications on the stabilized Env trimer used in this manuscript. The IAVI and Theraclone hold U. S. patent 61/515,528 on the PGT antibodies. The Scripps Research Institute and IAVI have applied for a patent relating to the eODmV3 construct. Materials will be made available for noncommercial use under material transfer agreements with Progenics or Cornell (stabilized Env 664G trimer), IAVI (PGT antibodies), and TSRI (eODmV3). This is manuscript 21407-MB from The Scripps Research Institute.	Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021; Beddows S, 2006, AIDS RES HUM RETROV, V22, P569, DOI 10.1089/aid.2006.22.569; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2002, J VIROL, V76, P2606, DOI 10.1128/JVI.76.6.2606-2616.2002; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Dowd KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002111; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; Harris A, 2011, P NATL ACAD SCI USA, V108, P11440, DOI 10.1073/pnas.1101414108; Klasse PJ, 2007, VIROLOGY, V369, P245, DOI 10.1016/j.virol.2007.06.044; Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908; Klein JS, 2009, P NATL ACAD SCI USA, V106, P7385, DOI 10.1073/pnas.0811427106; Krause JC, 2011, MBIO, V2, DOI 10.1128/mBio.00345-10; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LAYNE SP, 1992, VIROLOGY, V189, P695, DOI 10.1016/0042-6822(92)90593-E; Le Doux JM, 1999, BIOTECHNOL BIOENG, V63, P654, DOI 10.1002/(SICI)1097-0290(19990620)63:6<654::AID-BIT3>3.0.CO;2-1; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Nandi A, 2010, VIROLOGY, V396, P339, DOI 10.1016/j.virol.2009.10.044; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Parren PWHI, 1998, J VIROL, V72, P3512, DOI 10.1128/JVI.72.5.3512-3519.1998; Parren PWHI, 2001, ADV IMMUNOL, V77, P195, DOI 10.1016/S0065-2776(01)77018-6; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; SATTENTAU QJ, 1995, J EXP MED, V182, P185, DOI 10.1084/jem.182.1.185; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; Tang HL, 2011, J VIROL, V85, P9286, DOI 10.1128/JVI.02286-10; TOONE EJ, 1994, CURR OPIN STRUC BIOL, V4, P719, DOI 10.1016/S0959-440X(94)90170-8; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; WILSON IA, 1995, NAT STRUCT BIOL, V2, P433, DOI 10.1038/nsb0695-433; Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	38	555	609	0	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2011	334	6059					1097	1103		10.1126/science.1213256	http://dx.doi.org/10.1126/science.1213256			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	21998254	Green Accepted			2022-12-28	WOS:000297313900041
J	Shomura, Y; Yoon, KS; Nishihara, H; Higuchi, Y				Shomura, Yasuhito; Yoon, Ki-Seok; Nishihara, Hirofumi; Higuchi, Yoshiki			Structural basis for a [4Fe-3S] cluster in the oxygen-tolerant membrane-bound [NiFe]-hydrogenase	NATURE			English	Article							RALSTONIA-EUTROPHA H16; NIFE HYDROGENASE; CRYSTAL-STRUCTURE; CATALYTIC CYCLE; ACTIVE-SITE; GAS ACCESS; REFINEMENT; ACTIVATION; ANGSTROM; CENTERS	Membrane-bound respiratory [NiFe]-hydrogenase (MBH), a H-2-uptake enzyme found in the periplasmic space of bacteria, catalyses the oxidation of dihydrogen: H-2 -> 2H(+) + 2e(-) (ref. 1). In contrast to the well-studied O-2-sensitive [NiFe]-hydrogenases (referred to as the standard enzymes), MBH has an O-2-tolerant H-2 oxidation activity(2-4); however, the mechanism of O-2 tolerance is unclear(5). Here we report the crystal structures of Hydrogenovibrio marinus MBH in three different redox conditions at resolutions between 1.18 and 1.32 angstrom. We find that the proximal iron-sulphur (Fe-S) cluster of MBH has a [4Fe-3S] structure coordinated by six cysteine residues-in contrast to the [4Fe-4S] cubane structure coordinated by four cysteine residues found in the proximal Fe-S cluster of the standard enzymes-and that an amide nitrogen of the polypeptide backbone is deprotonated and additionally coordinates the cluster when chemically oxidized, thus stabilizing the superoxidized state of the cluster. The structure of MBH is very similar to that of the O-2-sensitive standard enzymes except for the proximal Fe-S cluster. Our results give a reasonable explanation why the O-2 tolerance of MBH is attributable to the unique proximal Fe-S cluster; we propose that the cluster is not only a component of the electron transfer for the catalytic cycle, but that it also donates two electrons and one proton crucial for the appropriate reduction of O-2 in preventing the formation of an unready, inactive state of the enzyme.	[Shomura, Yasuhito; Higuchi, Yoshiki] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Kamigori, Hyogo 6781297, Japan; [Shomura, Yasuhito; Higuchi, Yoshiki] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan; [Yoon, Ki-Seok; Nishihara, Hirofumi] Ibaraki Univ, Coll Agr, Dept Bioresource Sci, Ami, Ibaraki 3000393, Japan; [Higuchi, Yoshiki] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan	University of Hyogo; RIKEN; Ibaraki University; Japan Science & Technology Agency (JST)	Higuchi, Y (corresponding author), Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, 3-2-1 Koto, Kamigori, Hyogo 6781297, Japan.	hig@sci.u-hyogo.ac.jp		Higuchi, Yoshiki/0000-0001-8284-5709	Academia Sinica; National Synchrotron Radiation Research Center (Taiwan); MEXT [20051022, 22770111, 18GS0207]; JSPS [20580094, 22370061, 22657031]; University of Hyogo; Hyogo Science and Technology Association; GCOE Program; Japanese Aerospace Exploration Agency Project; JST, Japan	Academia Sinica(Academia Sinica - Taiwan); National Synchrotron Radiation Research Center (Taiwan); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); University of Hyogo; Hyogo Science and Technology Association; GCOE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Aerospace Exploration Agency Project; JST, Japan(Japan Science & Technology Agency (JST))	We thank K. Hagiya for technical assistance at Ibaraki University. The synchrotron radiation experiments were performed at the BL41XU (proposal no. 2010A1223) and BL44XU (proposal no. 2010A/B6520) with the approval of JASRI. The CCD detector MX225-HE (Rayonix) at BL44XU was financially supported by Academia Sinica and National Synchrotron Radiation Research Center (Taiwan). This work was supported by a grant-in-aid for Scientific Research from MEXT (20051022 (Y.S.), 22770111 (Y.S.), 18GS0207 (Y.H.)), grant-in-aid for Scientific Research from JSPS (20580094 (H.N.), 22370061 (Y.H.) and 22657031 (Y.H.)), grant-in-aid for research and education from University of Hyogo (Y.S.), and grant-in-aid for young scientists from Hyogo Science and Technology Association (Y.S.). This work was also partially supported by the GCOE Program (Y.H.), the Japanese Aerospace Exploration Agency Project (Y.H.), and the basic research programs CREST type, 'Development of the Foundation for Nano-Interface Technology' from JST, Japan (Y.H.).	Aragao D, 2008, ACTA CRYSTALLOGR D, V64, P665, DOI 10.1107/S0907444908009165; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Brugna-Guiral M, 2003, EXTREMOPHILES, V7, P145, DOI 10.1007/s00792-002-0306-3; Buhrke T, 2005, J BIOL CHEM, V280, P23791, DOI 10.1074/jbc.M503260200; Burgdorf T, 2005, J MOL MICROB BIOTECH, V10, P181, DOI 10.1159/000091564; Cracknell JA, 2009, P NATL ACAD SCI USA, V106, P20681, DOI 10.1073/pnas.0905959106; De Lacey AL, 2007, CHEM REV, V107, P4304, DOI 10.1021/cr0501947; Dementin S, 2004, J BIOL CHEM, V279, P10508, DOI 10.1074/jbc.M312716200; Duche O, 2005, FEBS J, V272, P3899, DOI 10.1111/j.1742-4658.2005.04806.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERNANDEZ VM, 1986, BIOCHIM BIOPHYS ACTA, V883, P145, DOI 10.1016/0304-4165(86)90145-5; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Goris T, 2011, NAT CHEM BIOL, V7, P310, DOI 10.1038/nchembio.555; Higuchi Y, 1997, STRUCTURE, V5, P1671, DOI 10.1016/S0969-2126(97)00313-4; Huang WJ, 1997, STRUCTURE, V5, P691, DOI 10.1016/S0969-2126(97)00223-2; KNUTTEL K, 1994, B POL ACAD SCI-CHEM, V42, P495; Lubitz W, 2007, CHEM REV, V107, P4331, DOI 10.1021/cr050186q; Lukey MJ, 2010, J BIOL CHEM, V285, P3928, DOI 10.1074/jbc.M109.067751; Luo XJ, 2009, J BIOL INORG CHEM, V14, P1275, DOI 10.1007/s00775-009-0572-y; Marques MC, 2010, J MOL BIOL, V396, P893, DOI 10.1016/j.jmb.2009.12.013; Matias PM, 2001, J BIOL INORG CHEM, V6, P63, DOI 10.1007/s007750000167; Montet Y, 1997, NAT STRUCT BIOL, V4, P523, DOI 10.1038/nsb0797-523; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandelia ME, 2011, P NATL ACAD SCI USA, V108, P6097, DOI 10.1073/pnas.1100610108; Peters JW, 1997, BIOCHEMISTRY-US, V36, P1181, DOI 10.1021/bi9626665; Saggu M, 2009, J BIOL CHEM, V284, P16264, DOI 10.1074/jbc.M805690200; SCHNEIDER K, 1983, BIOCHIM BIOPHYS ACTA, V748, P353, DOI 10.1016/0167-4838(83)90179-6; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shomura Y, 2011, ACTA CRYSTALLOGR F, V67, P827, DOI 10.1107/S1744309111019804; Teixeira VH, 2008, PROTEINS, V70, P1010, DOI 10.1002/prot.21588; Ueno G, 2005, J SYNCHROTRON RADIAT, V12, P380, DOI 10.1107/S0909049505004735; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vincent KA, 2005, P NATL ACAD SCI USA, V102, P16951, DOI 10.1073/pnas.0504499102; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Yoon KS, 2011, INT J HYDROGEN ENERG, V36, P7081, DOI 10.1016/j.ijhydene.2011.03.049	37	217	217	2	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2011	479	7372					253	U143		10.1038/nature10504	http://dx.doi.org/10.1038/nature10504			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PD	22002607				2022-12-28	WOS:000298030800048
J	Colantuoni, C; Lipska, BK; Ye, TZ; Hyde, TM; Tao, R; Leek, JT; Colantuoni, EA; Elkahloun, AG; Herman, MM; Weinberger, DR; Kleinman, JE				Colantuoni, Carlo; Lipska, Barbara K.; Ye, Tianzhang; Hyde, Thomas M.; Tao, Ran; Leek, Jeffrey T.; Colantuoni, Elizabeth A.; Elkahloun, Abdel G.; Herman, Mary M.; Weinberger, Daniel R.; Kleinman, Joel E.			Temporal dynamics and genetic control of transcription in the human prefrontal cortex	NATURE			English	Article							HUMAN BRAIN; EXPRESSION; DISEASE; MOUSE; MICRORNA; RNA	Previous investigations have combined transcriptional and genetic analyses in human cell lines(1-3), but few have applied these techniques to human neural tissue(4-8). To gain a global molecular perspective on the role of the human genome in cortical development, function and ageing, we explore the temporal dynamics and genetic control of transcription in human prefrontal cortex in an extensive series of post-mortem brains from fetal development through ageing. We discover a wave of gene expression changes occurring during fetal development which are reversed in early postnatal life. One half-century later in life, this pattern of reversals is mirrored in ageing and in neurodegeneration. Although we identify thousands of robust associations of individual genetic polymorphisms with gene expression, we also demonstrate that there is no association between the total extent of genetic differences between subjects and the global similarity of their transcriptional profiles. Hence, the human genome produces a consistent molecular architecture in the prefrontal cortex, despite millions of genetic differences across individuals and races. To enable further discovery, this entire data set is freely available (from Gene Expression Omnibus: accession GSE30272; and dbGaP: accession phs000417.v1.p1) and can also be interrogated via a biologist-friendly stand-alone application (http://www.libd.org/braincloud).	[Colantuoni, Carlo; Lipska, Barbara K.; Ye, Tianzhang; Hyde, Thomas M.; Tao, Ran; Herman, Mary M.; Weinberger, Daniel R.; Kleinman, Joel E.] NIMH, Sect Neuropathol, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program,IRP,NIH, Bethesda, MD 20892 USA; [Colantuoni, Carlo; Leek, Jeffrey T.; Colantuoni, Elizabeth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Colantuoni, Carlo] Illuminato Biotechnol Inc, Baltimore, MD 21211 USA; [Colantuoni, Carlo; Hyde, Thomas M.; Weinberger, Daniel R.] Johns Hopkins Univ, Med Ctr, Lieber Inst Brain Dev, Baltimore, MD 21205 USA; [Elkahloun, Abdel G.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Kleinman, JE (corresponding author), NIMH, Sect Neuropathol, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program,IRP,NIH, Bethesda, MD 20892 USA.	kleinmaj@mail.nih.gov	Lipska, Barbara K/E-4569-2017; Tao, Ran/C-2662-2013; Tao, Ran/L-3460-2014	Colantuoni, Carlo/0000-0001-6818-6380; Leek, Jeffrey/0000-0002-2873-2671	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002399, ZICMH002903] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIC HG200365-03, ZIC HG200365-02, ZIC HG200365-01] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Colantuoni C, 2002, BIOINFORMATICS, V18, P1540, DOI 10.1093/bioinformatics/18.11.1540; Coolen M, 2009, CURR OPIN NEUROBIOL, V19, P461, DOI 10.1016/j.conb.2009.09.006; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; De S, 2010, PHYSIOL GENOMICS, V42A, P162, DOI 10.1152/physiolgenomics.00008.2010; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Gao FB, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-25; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Lipska BK, 2006, BIOL PSYCHIAT, V60, P650, DOI 10.1016/j.biopsych.2006.06.019; Liu C, 2010, MOL PSYCHIATR, V15, P779, DOI 10.1038/mp.2009.128; Loerch PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003329; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schaeffer EM, 2008, ONCOGENE, V27, P7180, DOI 10.1038/onc.2008.327; Somel M, 2010, GENOME RES, V20, P1207, DOI 10.1101/gr.106849.110; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Torkamani A, 2010, GENOME RES, V20, P403, DOI 10.1101/gr.101956.109; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Zhang YQ, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-1	27	509	516	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2011	478	7370					519	U117		10.1038/nature10524	http://dx.doi.org/10.1038/nature10524			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	22031444	Green Accepted			2022-12-28	WOS:000296194200044
J	Stewart, DE				Stewart, Donna E.			Depression during Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEROTONIN-REUPTAKE INHIBITORS; MATERNAL DEPRESSION; PRENATAL EXPOSURE; CONGENITAL-MALFORMATIONS; NEONATAL OUTCOMES; MAJOR DEPRESSION; RISK; BIRTH; ANTIDEPRESSANTS; METAANALYSIS	A 24-year-old married woman presents with a 1-month history of diminished concentration and interest, insomnia, fatigue, tearfulness, and depressed mood. She is 10 weeks pregnant, stopped working 3 weeks ago, and mostly stays in bed. Two years ago, she was successfully treated briefly with sertraline at a daily dose of 50 mg for depression after a suicide attempt. She reports that she wants to continue the pregnancy and says that she does not feel suicidal. What would you advise?	[Stewart, Donna E.] Univ Toronto, Womens Hlth Program, Univ Hlth Network, Toronto, ON, Canada; [Stewart, Donna E.] Univ Toronto, Toronto Gen Res Inst, Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Stewart, DE (corresponding author), Toronto Gen Hosp, 200 Elizabeth St,EN-7-229, Toronto, ON M5G 2C4, Canada.	donna.stewart@uhn.ca	Stewart, Donna Eileen/J-2844-2016	Stewart, Donna Eileen/0000-0002-8157-7746	Eli Lilly; INC Research	Eli Lilly(Eli Lilly); INC Research	Dr. Stewart reports receiving fees for board membership from Eli Lilly and consulting fees from INC Research (a contract research organization) for Eli Lilly. No other potential conflict of interest relevant to this article was reported.	Alwan S, 2007, NEW ENGL J MED, V356, P2684, DOI 10.1056/NEJMoa066584; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Anderson EL, 2009, PSYCHOSOM MED, V71, P235, DOI 10.1097/PSY.0b013e318190d7ca; [Anonymous], 2010, Obstet Gynecol, V115, P394, DOI 10.1097/AOG.0b013e3181d035aa; [Anonymous], 2010, PRACT GUID TREATM PA, P66; Bar-Oz B, 2007, CLIN THER, V29, P918, DOI 10.1016/j.clinthera.2007.05.003; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Bennett HA, 2004, OBSTET GYNECOL, V103, P1344; Chambers CD, 2006, NEW ENGL J MED, V354, P579, DOI 10.1056/NEJMoa052744; Chambers CD, 1996, NEW ENGL J MED, V335, P1010, DOI 10.1056/NEJM199610033351402; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; Cooper WO, 2007, AM J OBSTET GYNECOL, V196, P544, DOI 10.1016/j.ajog.2007.01.033; Costei AM, 2002, ARCH PEDIAT ADOL MED, V156, P1129, DOI 10.1001/archpedi.156.11.1129; Cox J. L., 1994, PERINATAL PSYCHIAT U; Croen LA, 2011, ARCH GEN PSYCHI 0704; Davis EP, 2007, J AM ACAD CHILD PSY, V46, P737, DOI 10.1097/chi.0b013e318047b775; Deave T, 2008, BJOG-INT J OBSTET GY, V115, P1043, DOI 10.1111/j.1471-0528.2008.01752.x; Dennis CL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006309; Dennis CL, 2008, COCHRANE DB SYST REV, V4; Diav-Citrin O, 2008, BRIT J CLIN PHARMACO, V66, P695, DOI 10.1111/j.1365-2125.2008.03261.x; Dietz PM, 2007, AM J PSYCHIAT, V164, P1515, DOI 10.1176/appi.ajp.2007.06111893; Dimidjian S, 2009, CLIN OBSTET GYNECOL, V52, P498, DOI 10.1097/GRF.0b013e3181b52da6; Field T, 2006, INFANT BEHAV DEV, V29, P445, DOI 10.1016/j.infbeh.2006.03.003; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Headley J, 2004, EUR J CLIN PHARMACOL, V60, P355, DOI 10.1007/s00228-004-0775-7; Hemels MEH, 2005, ANN PHARMACOTHER, V39, P803, DOI 10.1345/aph.1E547; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Lattimore Keri A, 2005, J Perinatol, V25, P595; Leech SL, 2006, J AM ACAD CHILD PSY, V45, P223, DOI 10.1097/01.chi.0000184930.18552.4d; Linde K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000448.pub3; Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407; Malm H, 2011, OBSTET GYNECOL, V118, P111, DOI 10.1097/AOG.0b013e318220edcc; National Institute for Health and Clinical Excellence, 2007, ANT POSTN MENT HLTH; Oberlander TF, 2008, MOL PSYCHIATR, V13, P65, DOI 10.1038/sj.mp.4002007; Oberlander TF, 2008, BRIT J PSYCHIAT, V192, P338, DOI 10.1192/bjp.bp.107.037101; Oberlander TF, 2008, BIRTH DEFECTS RES B, V83, P68, DOI 10.1002/bdrb.20144; Oberlander TF, 2006, ARCH GEN PSYCHIAT, V63, P898, DOI 10.1001/archpsyc.63.8.898; Patten Scott B, 2006, Clin Pract Epidemiol Ment Health, V2, P13, DOI 10.1186/1745-0179-2-13; Pedersen LH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3569; Rahimi R, 2006, REPROD TOXICOL, V22, P571, DOI 10.1016/j.reprotox.2006.03.019; Reis M, 2010, PSYCHOL MED, V40, P1723, DOI 10.1017/S0033291709992194; Robertson E, 2004, GEN HOSP PSYCHIAT, V26, P289, DOI 10.1016/j.genhosppsych.2004.02.006; Simon GE, 2002, AM J PSYCHIAT, V159, P2055, DOI 10.1176/appi.ajp.159.12.2055; Spitzer RL, 2000, AM J OBSTET GYNECOL, V183, P759, DOI 10.1067/mob.2000.106580; Suri R, 2007, AM J PSYCHIAT, V164, P1206, DOI 10.1176/appi.ajp.2007.06071172; Udechuku A, 2010, AUST NZ J PSYCHIAT, V44, P978, DOI 10.3109/00048674.2010.507543; Vos T, 2004, ARCH GEN PSYCHIAT, V61, P1097, DOI 10.1001/archpsyc.61.11.1097; Wurst KE, 2010, BIRTH DEFECTS RES A, V88, P159, DOI 10.1002/bdra.20627; Yonkers KA, 2009, GEN HOSP PSYCHIAT, V31, P403, DOI [10.1097/AOG.0b013e3181ba0632, 10.1016/j.genhosppsych.2009.04.003]	51	114	118	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2011	365	17					1605	1611		10.1056/NEJMcp1102730	http://dx.doi.org/10.1056/NEJMcp1102730			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	837HI	22029982				2022-12-28	WOS:000296181800005
J	Das, P				Das, Pamela			Kenneth Castro: a public health hero	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 22	2011	378	9801					1456	1456		10.1016/S0140-6736(11)61637-1	http://dx.doi.org/10.1016/S0140-6736(11)61637-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	838VC	22018008				2022-12-28	WOS:000296319600014
J	Czako, G; Bowman, JM				Czako, Gabor; Bowman, Joel M.			Dynamics of the Reaction of Methane with Chlorine Atom on an Accurate Potential Energy Surface	SCIENCE			English	Article							DIFFERENTIAL CROSS-SECTIONS; PRODUCT; CHD3; DIMENSIONALITY	The reaction of the chlorine atom with methane has been the focus of numerous studies that aim to test, extend, and/or modify our understanding of mode-selective reactivity in polyatomic systems. To this point, theory has largely been unable to provide accurate results in comparison with experiments. Here, we report an accurate global potential energy surface for this reaction. Quasi-classical trajectory calculations using this surface achieve excellent agreement with experiment on the rotational distributions of the hydrogen chloride (HCl) product. For the Cl + CHD(3) -> HCl + CD(3) reaction at low collision energies, we confirm the unexpected experimental finding that CH-stretch excitation is no more effective in activating this late-barrier reaction than is the translational energy, which is in contradiction to expectations based on results for many atom-diatom reactions.	[Czako, Gabor] Emory Univ, Cherry L Emerson Ctr Sci Computat, Atlanta, GA 30322 USA; Emory Univ, Dept Chem, Atlanta, GA 30322 USA	Emory University; Emory University	Czako, G (corresponding author), Emory Univ, Cherry L Emerson Ctr Sci Computat, Atlanta, GA 30322 USA.	czako@chem.elte.hu	Czako, Gabor/U-1091-2017	Czako, Gabor/0000-0001-5136-4777	National Science Foundation [CHE-0625237]; U.S. Department of Energy [DE-FG02-97ER14782]	National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE))	G.C. thanks the National Science Foundation (grant CHE-0625237), and J.M.B. thanks the U.S. Department of Energy (grant DE-FG02-97ER14782) for financial support.	Banks ST, 2007, PHYS CHEM CHEM PHYS, V9, P933, DOI 10.1039/b615460c; Bowman JM, 2011, PHYS CHEM CHEM PHYS, V13, P8094, DOI 10.1039/c0cp02722g; Braams BJ, 2009, INT REV PHYS CHEM, V28, P577, DOI 10.1080/01442350903234923; Castillo JF, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2357741; Che L, 2007, SCIENCE, V317, P1061, DOI 10.1126/science.1144984; Corchado JC, 2000, J CHEM PHYS, V112, P9375, DOI 10.1063/1.481602; Csaszar AG, 1998, J CHEM PHYS, V108, P9751, DOI 10.1063/1.476449; Czako G, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3490795; Czako G, 2009, J AM CHEM SOC, V131, P17534, DOI 10.1021/ja906886z; Czako G, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3068528; Greaves SJ, 2011, PHYS CHEM CHEM PHYS, V13, P11438, DOI 10.1039/c0cp02694h; Lin JJ, 2003, SCIENCE, V300, P966, DOI 10.1126/science.1083672; Murray C, 2004, CHEM PHYS, V301, P239, DOI 10.1016/j.chemphys.2003.11.025; Peterson KA, 2002, J CHEM PHYS, V117, P10548, DOI 10.1063/1.1520138; POLANYI JC, 1987, SCIENCE, V236, P680, DOI 10.1126/science.236.4802.680; RAGHAVACHARI K, 1989, CHEM PHYS LETT, V157, P479, DOI 10.1016/S0009-2614(89)87395-6; Rangel C, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2179067; Simpson WR, 1996, J PHYS CHEM-US, V100, P7938, DOI 10.1021/jp952627n; SIMPSON WR, 1995, J CHEM PHYS, V103, P7313, DOI 10.1063/1.470305; Skouteris D, 1999, SCIENCE, V286, P1713, DOI 10.1126/science.286.5445.1713; VARLEY DF, 1995, J PHYS CHEM-US, V99, P9843, DOI 10.1021/j100024a028; Wang FY, 2011, SCIENCE, V331, P900, DOI 10.1126/science.1199771; Yan S, 2007, SCIENCE, V316, P1723, DOI 10.1126/science.1142313; Yu HG, 1999, J CHEM PHYS, V111, P6693, DOI 10.1063/1.480039; Zhang WQ, 2009, SCIENCE, V325, P303, DOI 10.1126/science.1175018	25	156	157	5	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 21	2011	334	6054					343	346		10.1126/science.1208514	http://dx.doi.org/10.1126/science.1208514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	22021853				2022-12-28	WOS:000296052500044
J	Waters, MR; Stafford, TW; McDonald, HG; Gustafson, C; Rasmussen, M; Cappellini, E; Olsen, JV; Szklarczyk, D; Jensen, LJ; Gilbert, MTP; Willerslev, E				Waters, Michael R.; Stafford, Thomas W., Jr.; McDonald, H. Gregory; Gustafson, Carl; Rasmussen, Morten; Cappellini, Enrico; Olsen, Jesper V.; Szklarczyk, Damian; Jensen, Lars Juhl; Gilbert, M. Thomas P.; Willerslev, Eske			Pre-Clovis Mastodon Hunting 13,800 Years Ago at the Manis Site, Washington	SCIENCE			English	Article							PLEISTOCENE; DNA	The tip of a projectile point made of mastodon bone is embedded in a rib of a single disarticulated mastodon at the Manis site in the state of Washington. Radiocarbon dating and DNA analysis show that the rib is associated with the other remains and dates to 13,800 years ago. Thus, osseous projectile points, common to the Beringian Upper Paleolithic and Clovis, were made and used during pre-Clovis times in North America. The Manis site, combined with evidence of mammoth hunting at sites in Wisconsin, provides evidence that people were hunting proboscideans at least two millennia before Clovis.	[Waters, Michael R.] Texas A&M Univ, Ctr Study Amer 1, Dept Anthropol, College Stn, TX 77843 USA; [Waters, Michael R.] Texas A&M Univ, Ctr Study Amer 1, Dept Geog, College Stn, TX 77843 USA; [Stafford, Thomas W., Jr.] Stafford Res, Lafayette, CO 80026 USA; [McDonald, H. Gregory] Natl Pk Serv, Pk Museum Management Program, Ft Collins, CO 80525 USA; [Stafford, Thomas W., Jr.; Rasmussen, Morten; Cappellini, Enrico; Gilbert, M. Thomas P.; Willerslev, Eske] Univ Copenhagen, Ctr GeoGenet, DK-1350 Copenhagen, Denmark; [Olsen, Jesper V.; Szklarczyk, Damian; Jensen, Lars Juhl] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Fac Hlth Sci, DK-2200 Copenhagen, Denmark	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; United States Department of the Interior; University of Copenhagen; University of Copenhagen	Waters, MR (corresponding author), Texas A&M Univ, Ctr Study Amer 1, Dept Anthropol, College Stn, TX 77843 USA.	mwaters@tamu.edu	Gilbert, Marcus TP/A-8936-2013; Waters, Michael/ABI-2377-2020; Cappellini, Enrico/F-9346-2013; Olsen, Jesper/ABH-4638-2020; Jensen, Lars Juhl/C-6492-2008; Waters, Michael R/A-9430-2009; Willerslev, Eske/AAA-5686-2019; Willerslev, Eske/A-9619-2011	Gilbert, Marcus TP/0000-0002-5805-7195; Waters, Michael/0000-0003-2660-3355; Cappellini, Enrico/0000-0001-7885-7811; Olsen, Jesper/0000-0002-4747-4938; Jensen, Lars Juhl/0000-0001-7885-715X; Willerslev, Eske/0000-0002-7081-6748	Danish National Research Foundation; European Union [237227]; Novo Nordisk Foundation Center for Protein Research; Chair in First Americans Studies; Lundbeck Foundation [R24-2008-2527, R70-2010-6286] Funding Source: researchfish; Novo Nordisk Foundation Center for Protein Research [PI Lars Juhl Jensen] Funding Source: researchfish	Danish National Research Foundation(Danmarks Grundforskningsfond); European Union(European Commission); Novo Nordisk Foundation Center for Protein Research; Chair in First Americans Studies; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation Center for Protein Research	We thank the North Star Archaeological Research Program established by J. Cramer and R. Cramer and the Chair in First Americans Studies for funding. We thank J. Southon for providing the ultrafiltration <SUP>14</SUP>C measurements. Work conducted at the Center for GeoGenetics was supported by the Danish National Research Foundation. E.C. is supported by the European Union with a Marie Curie Intra European Fellowship (grant number 237227). J.O., D.S., and L.J. are supported by the Novo Nordisk Foundation Center for Protein Research. CT scanning was performed at the High Resolution X-ray CT Facility at the University of Texas, Austin. J. Halligan prepared the illustrations. T. Jennings, J. Halligan, T. Goebel, S. Fiedel, and two anonymous individuals reviewed the manuscript.	[Anonymous], 2010, INT MONOGRAPHS PREHI; Dillehay TD, 2008, SCIENCE, V320, P784, DOI 10.1126/science.1156533; Gilbert MTP, 2008, SCIENCE, V320, P786, DOI 10.1126/science.1154116; Gill JL, 2009, SCIENCE, V326, P1100, DOI 10.1126/science.1179504; Goebel T, 1999, EVOL ANTHROPOL, V8, P208; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Grayson DK, 2003, J ARCHAEOL SCI, V30, P585, DOI 10.1016/S0305-4403(02)00205-4; Gustafson C.E., 1979, CANADIAN J ARCHAEOLO, V3, P157; Guthrie RD, 1983, BAR INT SERIES, P273; Haynes G., 2002, EARLY SETTLEMENT N A; Holmes CE, 2001, ARCTIC ANTHROPOL, V38, P154; Joyce DJ, 2006, QUATERN INT, V142, P44, DOI 10.1016/j.quaint.2005.03.004; Kenady SM, 2011, QUATERN INT, V233, P130, DOI 10.1016/j.quaint.2010.04.013; Knecht H, 1997, INTERD CONT, P191; Martin P.S., 1984, P354; MORGAN VE, 1985, THESIS WASHINGTON ST; Overstreet David F., 2005, PALEOAMERICAN ORIGIN, P183; PETERSEN KL, 1983, QUATERNARY RES, V20, P215, DOI 10.1016/0033-5894(83)90078-9; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; RUNNINGS AL, 1984, THESIS WASHINGTON ST; Ryan TM, 2006, J ARCHAEOL SCI, V33, P871, DOI 10.1016/j.jas.2005.10.020; Taylor PG, 1996, MOL BIOL EVOL, V13, P283, DOI 10.1093/oxfordjournals.molbev.a025566; Waters MR, 2007, SCIENCE, V315, P1122, DOI 10.1126/science.1137166; Waters MR, 2011, SCIENCE, V331, P1599, DOI 10.1126/science.1201855; [No title captured]	25	121	124	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2011	334	6054					351	353		10.1126/science.1207663	http://dx.doi.org/10.1126/science.1207663			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	22021854				2022-12-28	WOS:000296052500046
J	Geller, AM; Mathieu, RD				Geller, Aaron M.; Mathieu, Robert D.			A mass transfer origin for blue stragglers in NGC 188 as revealed by half-solar-mass companions	NATURE			English	Article							WIYN OPEN CLUSTER; GIANT BRANCH STARS; SPECTROSCOPIC BINARIES; GLOBULAR-CLUSTERS; MAIN-SEQUENCE; EVOLUTION; POPULATION; SYSTEMS; ORBITS; M67	In open star clusters, where all members formed at about the same time, blue straggler stars are typically observed to be brighter and bluer than hydrogen-burning main-sequence stars, and therefore should already have evolved into giant stars and stellar remnants. Correlations between blue straggler frequency and cluster binary star fraction(1), core mass(2) and radial position(3) suggest that mass transfer or mergers in binary stars dominates the production of blue stragglers in open clusters. Analytic models(4,5), detailed observations(6) and sophisticated N-body simulations(7), however, argue in favour of stellar collisions. Here we report that the blue stragglers in long-period binaries in the old(8) (7x10(9)-year) open cluster NGC 188 have companions with masses of about half a solar mass, with a surprisingly narrow mass distribution. This conclusively rules out a collisional origin, as the collision hypothesis predicts a companion mass distribution with significantly higher masses. Mergers in hierarchical triple stars(9) are marginally permitted by the data, but the observations do not favour this hypothesis. The data are highly consistent with a mass transfer origin for the long-period blue straggler binaries in NGC 188, in which the companions would be white dwarfs of about half a solar mass.	[Geller, Aaron M.; Mathieu, Robert D.] Univ Wisconsin, Dept Astron, Madison, WI 53706 USA; [Geller, Aaron M.] Northwestern Univ, CIERA, Evanston, IL 60208 USA; [Geller, Aaron M.] Northwestern Univ, Dept Phys & Astron, Evanston, IL 60208 USA	University of Wisconsin System; University of Wisconsin Madison; Northwestern University; Northwestern University	Geller, AM (corresponding author), Univ Wisconsin, Dept Astron, Madison, WI 53706 USA.	a-geller@northwestern.edu			National Science Foundation; US National Science Foundation [AST-0908082]; Wisconsin Space Grant Consortium; Northwestern University	National Science Foundation(National Science Foundation (NSF)); US National Science Foundation(National Science Foundation (NSF)); Wisconsin Space Grant Consortium; Northwestern University	We thank the staff of the WIYN Observatory and the many graduate and undergraduate students who have assisted in observing NGC 188. Thanks to J. Hurley, A. Sills, N. Leigh, R. Taam and H. Perets for their comments and suggestions. Both A.M.G. and R.D.M. were visiting astronomers at Kitt Peak National Observatory, National Optical Astronomy Observatory, which is operated by the Association of Universities for Research in Astronomy under cooperative agreement with the National Science Foundation. The WIYN Observatory is a joint facility of the University of Wisconsin-Madison, Indiana University, Yale University and the US National Optical Astronomy Observatories. This work was funded by the US National Science Foundation grant AST-0908082 to the University of Wisconsin-Madison, the Wisconsin Space Grant Consortium and the Lindheimer Fellowship at Northwestern University.	Belczynski K, 2008, ASTROPHYS J SUPPL S, V174, P223, DOI 10.1086/521026; CARNEY BW, 1989, ASTRON J, V97, P423, DOI 10.1086/114992; Carney BW, 2005, ASTRON J, V129, P466, DOI 10.1086/426566; Chen XF, 2008, MON NOT R ASTRON SOC, V387, P1416, DOI 10.1111/j.1365-2966.2008.13334.x; Ferraro FR, 1997, ASTRON ASTROPHYS, V324, P915; Geller AM, 2009, ASTRON J, V137, P3743, DOI 10.1088/0004-6256/137/4/3743; Hurley JR, 2005, MON NOT R ASTRON SOC, V363, P293, DOI 10.1111/j.1365-2966.2005.09448.x; Hurley JR, 2002, MON NOT R ASTRON SOC, V329, P897, DOI 10.1046/j.1365-8711.2002.05038.x; Hurley JR, 2000, MON NOT R ASTRON SOC, V315, P543, DOI 10.1046/j.1365-8711.2000.03426.x; Hurley JR, 2002, ASTROPHYS J, V570, P184, DOI 10.1086/339495; Ivanova N, 2008, ESO ASTROPHY SYMP, P101, DOI 10.1007/978-3-540-74745-1_14; Knigge C, 2009, NATURE, V457, P288, DOI 10.1038/nature07635; Kroupa P, 2001, MON NOT R ASTRON SOC, V322, P231, DOI 10.1046/j.1365-8711.2001.04022.x; Leigh N, 2011, MON NOT R ASTRON SOC, V410, P2370, DOI 10.1111/j.1365-2966.2010.17609.x; Leonard PJT, 1996, ASTROPHYS J, V470, P521, DOI 10.1086/177884; Marigo P, 2008, ASTRON ASTROPHYS, V482, P883, DOI 10.1051/0004-6361:20078467; Marinovic AAB, 2008, ASTRON ASTROPHYS, V480, P797, DOI 10.1051/0004-6361:20078297; Mathieu RD, 2000, ASTR SOC P, V198, P517; Mathieu RD, 2009, NATURE, V462, P1032, DOI 10.1038/nature08568; MAZEH T, 1992, ASTROPHYS J, V394, P592, DOI 10.1086/171611; MCCREA WH, 1964, MON NOT R ASTRON SOC, V128, P147, DOI 10.1093/mnras/128.2.147; Perets HB, 2009, ASTROPHYS J, V697, P1048, DOI 10.1088/0004-637X/697/2/1048; Robin AC, 2003, ASTRON ASTROPHYS, V409, P523, DOI 10.1051/0004-6361:20031117; Sandquist EL, 2005, ASTROPHYS J, V635, pL73, DOI 10.1086/499124; Sarajedini A, 1999, ASTRON J, V118, P2894, DOI 10.1086/301149; Soker N, 2000, ASTRON ASTROPHYS, V357, P557; Sollima A, 2008, MON NOT R ASTRON SOC, V388, P307, DOI 10.1111/j.1365-2966.2008.13387.x; Tokovinin A, 2006, ASTRON ASTROPHYS, V450, P681, DOI 10.1051/0004-6361:20054427; Tokovinin AA, 1997, ASTRON ASTROPHYS SUP, V124, P75, DOI 10.1051/aas:1997181	30	73	73	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 20	2011	478	7369					356	359		10.1038/nature10512	http://dx.doi.org/10.1038/nature10512			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	22012393	Green Submitted			2022-12-28	WOS:000296021100039
J	Russell, CJ				Russell, Charles J.			Stalking Influenza Diversity with a Universal Antibody	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Russell, CJ (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.		Russell, Charles/AAU-6006-2020; Russell, Charles/K-4824-2013	Russell, Charles/0000-0001-5683-3990; Russell, Charles/0000-0001-5683-3990				Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566	5	9	10	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2011	365	16					1541	1542		10.1056/NEJMcibr1109447	http://dx.doi.org/10.1056/NEJMcibr1109447			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835BW	22010922				2022-12-28	WOS:000296009500011
J	Smeulders, MJ; Barends, TRM; Pol, A; Scherer, A; Zandvoort, MH; Udvarhelyi, A; Khadem, AF; Menzel, A; Hermans, J; Shoeman, RL; Wessels, HJCT; van den Heuvel, LP; Russ, L; Schlichting, I; Jetten, MSM; den Camp, HJMO				Smeulders, Marjan J.; Barends, Thomas R. M.; Pol, Arjan; Scherer, Anna; Zandvoort, Marcel H.; Udvarhelyi, Aniko; Khadem, Ahmad F.; Menzel, Andreas; Hermans, John; Shoeman, Robert L.; Wessels, Hans J. C. T.; van den Heuvel, Lambert P.; Russ, Lina; Schlichting, Ilme; Jetten, Mike S. M.; den Camp, Huub J. M. Op			Evolution of a new enzyme for carbon disulphide conversion by an acidothermophilic archaeon	NATURE			English	Article							SULFUR-COMPOUNDS; SULFIDE COS; ANHYDRASE; SUBSTRATE; MODEL; CS2; MACROMOLECULES; CONSUMPTION; METABOLISM; SCATTERING	Extremophilic organisms require specialized enzymes for their exotic metabolisms. Acid-loving thermophilic Archaea that live in the mudpots of volcanic solfataras obtain their energy from reduced sulphur compounds such as hydrogen sulphide (H2S) and carbon disulphide (CS2)(1,2). The oxidation of these compounds into sulphuric acid creates the extremely acidic environment that characterizes solfataras. The hyperthermophilic Acidianus strain A1-3, which was isolated from the fumarolic, ancient sauna building at the Solfatara volcano (Naples, Italy), was shown to rapidly convert CS2 into H2S and carbon dioxide (CO2), but nothing has been known about the modes of action and the evolution of the enzyme(s) involved. Here we describe the structure, the proposed mechanism and evolution of a CS2 hydrolase from Acidianus A1-3. The enzyme monomer displays a typical beta-carbonic anhydrase fold and active site, yet CO2 is not one of its substrates. Owing to large carboxy-and amino-terminal arms, an unusual hexadecameric catenane oligomer has evolved. This structure results in the blocking of the entrance to the active site that is found in canonical beta-carbonic anhydrases and the formation of a single 15-angstrom-long, highly hydrophobic tunnel that functions as a specificity filter. The tunnel determines the enzyme's substrate specificity for CS2, which is hydrophobic. The transposon sequences that surround the gene encoding this CS2 hydrolase point to horizontal gene transfer as a mechanism for its acquisition during evolution. Our results show how the ancient beta-carbonic anhydrase, which is central to global carbon metabolism, was transformed by divergent evolution into a crucial enzyme in CS2 metabolism.	[Smeulders, Marjan J.; Pol, Arjan; Zandvoort, Marcel H.; Khadem, Ahmad F.; Hermans, John; Russ, Lina; Jetten, Mike S. M.; den Camp, Huub J. M. Op] Radboud Univ Nijmegen, Dept Microbiol, NL-6525 AJ Nijmegen, Netherlands; [Barends, Thomas R. M.; Scherer, Anna; Udvarhelyi, Aniko; Shoeman, Robert L.; Schlichting, Ilme] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany; [Menzel, Andreas] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Wessels, Hans J. C. T.; van den Heuvel, Lambert P.] Radboud Univ Nijmegen, Nijmegen Ctr Mitochondrial Disorders, Nijmegen Prote Facil, Dept Lab Med,Med Ctr, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Max Planck Society; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Radboud University Nijmegen	Jetten, MSM (corresponding author), Radboud Univ Nijmegen, Dept Microbiol, Heyendaalseweg 135, NL-6525 AJ Nijmegen, Netherlands.	m.jetten@science.ru.nl	Menzel, Andreas/C-4388-2012; Jetten, Mike/B-8834-2011; Schlichting, Ilme/I-1339-2013; Camp, Huub J.M. Op den/F-5114-2011; van den Heuvel, L.P.W.J./H-8044-2014; van den Heuvel, Lambertus/AAM-1772-2021; Wessels, Hans J/P-6248-2015	Menzel, Andreas/0000-0002-0489-609X; Jetten, Mike/0000-0002-4691-7039; Camp, Huub J.M. Op den/0000-0003-1990-9030; van den Heuvel, L.P.W.J./0000-0003-3917-6727; van den Heuvel, Lambertus/0000-0003-3917-6727; Wessels, Hans J/0000-0001-5957-3127; Udvarhelyi, Aniko/0000-0002-6962-4722	STW [STW_6353]; Max-Planck Society	STW(Technologiestichting STW); Max-Planck Society(Max Planck SocietyFoundation CELLEX)	J. Eygensteyn is acknowledged for ICP-MS analysis. We thank H. Harhangi for advice on cloning, S. Zimmermann for assistance with cloning, A. Meinhart for discussions and support for cloning and crystallography, and D. Ringe and J. Reinstein for discussions. We thank the Dortmund-Heidelberg data collection team, especially W. Blankenfeldt, and the staff of beam lines X10SA and X12SA at the Swiss Light Source of the PSI in Villigen for their help and facilities. We also thank A. Rufer for help with the analytical ultracentrifuge and I. Vetter for support with the crystallographic software. The work was funded by an STW grant (STW_6353) to M.J.S. and M.H.Z. and by the Max-Planck Society.	Alber BE, 1999, BIOCHEMISTRY-US, V38, P13119, DOI 10.1021/bi9828876; ALLARD P, 1991, J VOLCANOL GEOTH RES, V48, P139, DOI 10.1016/0377-0273(91)90039-3; ALLEN MB, 1959, ARCH MIKROBIOL, V32, P270, DOI 10.1007/BF00409348; Blezinger S, 2000, BIOGEOCHEMISTRY, V48, P185, DOI 10.1023/A:1006134213995; Bornberg-Bauer E, 2010, CURR OPIN STRUC BIOL, V20, P390, DOI 10.1016/j.sbi.2010.02.005; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao ZB, 2005, STRUCTURE, V13, P1661, DOI 10.1016/j.str.2005.07.021; CHIN M, 1993, GLOBAL BIOGEOCHEM CY, V7, P321, DOI 10.1029/93GB00568; Covarrubias AS, 2005, J BIOL CHEM, V280, P18782, DOI 10.1074/jbc.M414348200; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DERIKX PJL, 1990, APPL ENVIRON MICROB, V56, P176, DOI 10.1128/AEM.56.1.176-180.1990; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fuchs T, 1996, SYST APPL MICROBIOL, V19, P56, DOI 10.1016/S0723-2020(96)80009-9; Haritos VS, 2005, COMP BIOCHEM PHYS C, V140, P139, DOI 10.1016/j.cca.2005.01.012; He ZG, 2000, FEMS MICROBIOL LETT, V193, P217, DOI 10.1111/j.1574-6968.2000.tb09427.x; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jordan SL, 1997, ARCH MICROBIOL, V168, P225, DOI 10.1007/s002030050492; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KHALIFAH RG, 1971, J BIOL CHEM, V246, P2561; Kimber MS, 2000, EMBO J, V19, P1407, DOI 10.1093/emboj/19.7.1407; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kowalchuk G. A., 2004, MOL MICROBIAL ECOLOG, V1; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lane TW, 2005, NATURE, V435, P42, DOI 10.1038/435042a; MacAuley SR, 2009, BIOCHEMISTRY-US, V48, P817, DOI 10.1021/bi802246s; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Notni J, 2007, CHEMBIOCHEM, V8, P530, DOI 10.1002/cbic.200600436; Pol A, 2007, APPL MICROBIOL BIOT, V74, P439, DOI 10.1007/s00253-006-0663-4; ProtoschillKrebs G, 1996, ATMOS ENVIRON, V30, P3151, DOI 10.1016/1352-2310(96)00026-X; Reno ML, 2009, P NATL ACAD SCI USA, V106, P8605, DOI 10.1073/pnas.0808945106; Rowlett RS, 2010, BBA-PROTEINS PROTEOM, V1804, P362, DOI 10.1016/j.bbapap.2009.08.002; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schenk S, 2004, CHEM-EUR J, V10, P3091, DOI 10.1002/chem.200305754; Schlicker C, 2009, J MOL BIOL, V385, P1207, DOI 10.1016/j.jmb.2008.11.037; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sinnecker S, 2001, INORG CHEM, V40, P1006, DOI 10.1021/ic001149e; Smith KS, 1999, J BACTERIOL, V181, P6247, DOI 10.1128/JB.181.20.6247-6253.1999; Smith KS, 1999, P NATL ACAD SCI USA, V96, P15184, DOI 10.1073/pnas.96.26.15184; Strop P, 2001, J BIOL CHEM, V276, P10299, DOI 10.1074/jbc.M009182200; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teng YB, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-67; Vasilakos C, 2005, J ATMOS CHEM, V52, P101, DOI 10.1007/s10874-005-8853-5; VISHNIAC W, 1957, BACTERIOL REV, V21, P195, DOI 10.1128/MMBR.21.3.195-213.1957; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wessels HJCT, 2011, METHOD ENZYMOL, V486, P465, DOI [10.1016/S0076-6879(11)86021-0, 10.1016/B978-0-12-381294-0.00021-3]; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4	51	69	73	1	67	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 20	2011	478	7369					412	+		10.1038/nature10464	http://dx.doi.org/10.1038/nature10464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	22012399				2022-12-28	WOS:000296021100052
J	Spence, D				Spence, Des			FROM THE FRONTLINE Primary care: an investment opportunity you can't refuse?	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 19	2011	343								d6746	10.1136/bmj.d6746	http://dx.doi.org/10.1136/bmj.d6746			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	837HN	22012811				2022-12-28	WOS:000296183700010
J	Willett, LR				Willett, Laura Rees			Exemestane prevented invasive breast cancer in postmenopausal women at moderately increased risk	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Willett, LR (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ 08901 USA.							Bondy ML, 2006, JNCI-J NATL CANCER I, V98, P1172, DOI 10.1093/jnci/djj365; Cuppone F, 2008, CANCER-AM CANCER SOC, V112, P260, DOI 10.1002/cncr.23171; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Nelson HD, 2009, ANN INTERN MED, V151, P703, DOI [10.7326/0000605-200911170-00147, 10.7326/0003-4819-151-10-200911170-00147]	4	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2011	155	8							JC4-3	10.7326/0003-4819-155-8-201110180-02003	http://dx.doi.org/10.7326/0003-4819-155-8-201110180-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835WB	22007062				2022-12-28	WOS:000296066300002
J	Goldsby, DL; Tullis, TE				Goldsby, David L.; Tullis, Terry E.			Flash Heating Leads to Low Frictional Strength of Crustal Rocks at Earthquake Slip Rates	SCIENCE			English	Article							SAN-ANDREAS FAULT; DEPENDENT FRICTION; FLUID PRESSURE; STRESS; LUBRICATION; QUARTZ; TIME; PSEUDOTACHYLYTE; RESISTANCE; CONTACT	The sliding resistance of faults during earthquakes is a critical unknown in earthquake physics. The friction coefficient of rocks at slow slip rates in the laboratory ranges from 0.6 to 0.85, consistent with measurements of high stresses in Earth's crust. Here, we demonstrate that at fast, seismic slip rates, an extraordinary reduction in the friction coefficient of crustal silicate rocks results from intense "flash" heating of microscopic asperity contacts and the resulting degradation of their shear strengths. Values of the friction coefficient due to flash heating could explain the lack of an observed heat flow anomaly along some active faults such as the San Andreas Fault. Nearly pure velocity-weakening friction due to flash heating could explain how earthquake ruptures propagate as self-healing slip pulses.	[Goldsby, David L.; Tullis, Terry E.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	Brown University	Goldsby, DL (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.	david_goldsby@brown.edu		Goldsby, David/0000-0002-9004-0086	U.S. Geological Survey-National Earthquake Hazards Reduction Program [G10AP00067, G09AP00053, 08-HQGR0067]; Southern California Earthquake Center from its National Science Foundation [EAR-0529922]	U.S. Geological Survey-National Earthquake Hazards Reduction Program(United States Geological Survey); Southern California Earthquake Center from its National Science Foundation	Funding from the U.S. Geological Survey-National Earthquake Hazards Reduction Program, Awards G10AP00067, G09AP00053, and 08-HQGR0067, and the Southern California Earthquake Center, from its National Science Foundation grant EAR-0529922, is gratefully acknowledged. The data in this paper are available as supporting material on Science Online and archived in the Rock Friction Database in the Rock Deformation Laboratory at Brown University, Department of Geological Sciences.	Beeler NM, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB004988; Beeler NM, 1997, J GEOPHYS RES-SOL EA, V102, P22595, DOI 10.1029/97JB01828; Blok H, 1937, I MECH ENG P GEN DIS, V2, P18; BRUNE JN, 1969, J GEOPHYS RES, V74, P3821, DOI 10.1029/JB074i015p03821; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; Di Toro G, 2006, SCIENCE, V311, P647, DOI 10.1126/science.1121012; Di Toro G, 2004, NATURE, V427, P436, DOI 10.1038/nature02249; Di Toro G, 2011, NATURE, V471, P494, DOI 10.1038/nature09838; DIETERICH JH, 1984, J GEOPHYS RES, V89, P4196, DOI 10.1029/JB089iB06p04196; DIETERICH JH, 1979, J GEOPHYS RES, V84, P2161, DOI 10.1029/JB084iB05p02161; DIETERICH JH, 1978, PURE APPL GEOPHYS, V116, P790, DOI 10.1007/BF00876539; Dieterich JH, 1996, TECTONOPHYSICS, V256, P219, DOI 10.1016/0040-1951(95)00165-4; Goldsby DL, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015240; GREENWOOD JA, 1966, PROC R SOC LON SER-A, V295, P300, DOI 10.1098/rspa.1966.0242; HEATON TH, 1990, PHYS EARTH PLANET IN, V64, P1, DOI 10.1016/0031-9201(90)90002-F; Jaeger JC, 1942, PROC R SOC NEW S WAL, V76, P203; LACHENBRUCH AH, 1980, J GEOPHYS RES, V85, P6097, DOI 10.1029/JB085iB11p06097; LACHENBRUCH AH, 1980, J GEOPHYS RES, V85, P6185, DOI 10.1029/JB085iB11p06185; MASE CW, 1985, PURE APPL GEOPHYS, V122, P583, DOI DOI 10.1007/BF00874618; MOUNT VS, 1987, GEOLOGY, V15, P1143, DOI 10.1130/0091-7613(1987)15<1143:SOSNTS>2.0.CO;2; Noda Hiroyuki, 2009, Journal of Geophysical Research - Part B - Solid Earth, V114, DOI 10.1029/2008JB006143; Reches Z, 2010, NATURE, V467, P452, DOI 10.1038/nature09348; Rice JR, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004006; Schubert G., 2007, EARTHQUAKE SEISMOLOG, V4, P131; SIBSON RH, 1973, NATURE-PHYS SCI, V243, P66, DOI 10.1038/physci243066a0; Sibson RH, 2006, GEOPHYS MONOGR SER, V170, P153; SPRAY JG, 1987, J STRUCT GEOL, V9, P49, DOI 10.1016/0191-8141(87)90043-5; Tsutsumi A, 1997, GEOPHYS RES LETT, V24, P699, DOI 10.1029/97GL00503; Yuan FP, 2008, INT J SOLIDS STRUCT, V45, P4247, DOI 10.1016/j.ijsolstr.2008.03.012; Zheng G, 1998, B SEISMOL SOC AM, V88, P1466; ZOBACK MD, 1987, SCIENCE, V238, P1105, DOI 10.1126/science.238.4830.1105	31	199	204	4	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					216	218		10.1126/science.1207902	http://dx.doi.org/10.1126/science.1207902			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998385				2022-12-28	WOS:000295833600043
J	O'Neill, LAJ; Bowie, AG				O'Neill, Luke A. J.; Bowie, Andrew G.			The Powerstroke and Camshaft of the RIG-I Antiviral RNA Detection Machine	CELL			English	Editorial Material							INNATE IMMUNITY; RECOGNITION	The innate immune sensor RIG-I responds to infection by binding to viral double-stranded RNA (dsRNA). In this issue of Cell, Kowalinski et al. (2011) and Luo et al. (2011) reveal the structure of RIG-I, and in combination with functional analyses, they show how RIG-I recognizes viral RNA to initiate signaling and a type I interferon response.	[O'Neill, Luke A. J.; Bowie, Andrew G.] Trinity Coll Dublin, Immunol Res Ctr, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland	Trinity College Dublin	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Immunol Res Ctr, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland.	laoneill@tcd.ie; agbowie@tcd.ie		O'Neill, Luke/0000-0002-4333-2748; Bowie, Andrew/0000-0001-5316-4373				Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Gee P, 2008, J BIOL CHEM, V283, P9488, DOI 10.1074/jbc.M706777200; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; O'Neill LAJ, 2010, CURR BIOL, V20, pR328, DOI 10.1016/j.cub.2010.01.044; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029	10	20	20	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 14	2011	147	2					259	261		10.1016/j.cell.2011.09.027	http://dx.doi.org/10.1016/j.cell.2011.09.027			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000004	Bronze			2022-12-28	WOS:000296199300003
J	Puder, JJ; Marques-Vidal, P; Schindler, C; Zahner, L; Niederer, I; Burgi, F; Ebenegger, V; Nydegger, A; Kriemler, S				Puder, J. J.; Marques-Vidal, P.; Schindler, C.; Zahner, L.; Niederer, I.; Buergi, F.; Ebenegger, V.; Nydegger, A.; Kriemler, S.			Effect of multidimensional lifestyle intervention on fitness and adiposity in predominantly migrant preschool children (Ballabeina): cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREVENT CHILDHOOD OBESITY; PHYSICAL-ACTIVITY; CARDIORESPIRATORY FITNESS; OVERWEIGHT PREVENTION; CARDIOVASCULAR RISK; EATING HABITS; FOLLOW-UP; ALL-CAUSE; HIP-HOP; HEALTH	Objective To test the effect of a multidimensional lifestyle intervention on aerobic fitness and adiposity in predominantly migrant preschool children. Design Cluster randomised controlled single blinded trial (Ballabeina study) over one school year; randomisation was performed after stratification for linguistic region. Setting 40 preschool classes in areas with a high migrant population in the German and French speaking regions of Switzerland. Participants 652 of the 727 preschool children had informed consent and were present for baseline measures (mean age 5.1 years (SD 0.7), 72% migrants of multicultural origins). No children withdrew, but 26 moved away. Intervention The multidimensional culturally tailored lifestyle intervention included a physical activity programme, lessons on nutrition, media use (use of television and computers), and sleep and adaptation of the built environment of the preschool class. It lasted from August 2008 to June 2009. Main outcome measures Primary outcomes were aerobic fitness (20 m shuttle run test) and body mass index (BMI). Secondary outcomes included motor agility, balance, percentage body fat, waist circumference, physical activity, eating habits, media use, sleep, psychological health, and cognitive abilities. Results Compared with controls, children in the intervention group had an increase in aerobic fitness at the end of the intervention (adjusted mean difference: 0.32 stages (95% confidence interval 0.07 to 0.57; P=0.01) but no difference in BMI (-0.07 kg/m(2), -0.19 to 0.06; P=0.31). Relative to controls, children in the intervention group had beneficial effects in motor agility (-0.54 s, -0.90 to -0.17; P=0.004), percentage body fat (-1.1%, -2.0 to -0.2; P=0.02), and waist circumference (-1.0 cm, -1.6 to -0.4; P=0.001). There were also significant benefits in the intervention group in reported physical activity, media use, and eating habits, but not in the remaining secondary outcomes. Conclusions A multidimensional intervention increased aerobic fitness and reduced body fat but not BMI in predominantly migrant preschool children.	[Puder, J. J.] Univ Lausanne, CHU Vaudois, Serv Endocrinol Diabet & Metab, CH-1011 Lausanne, Switzerland; [Marques-Vidal, P.] Univ Lausanne, CHU Vaudois, Inst Social & Prevent Med, CH-1011 Lausanne, Switzerland; [Schindler, C.; Kriemler, S.] Univ Basel, Swiss Trop & Publ Hlth Inst, CH-4002 Basel, Switzerland; [Zahner, L.; Niederer, I.; Buergi, F.] Univ Basel, Inst Exercise & Hlth Sci, CH-4052 Basel, Switzerland; [Ebenegger, V.] Univ Lausanne, Inst Sport Sci, CH-1015 Lausanne, Switzerland; [Nydegger, A.] Univ Lausanne, CHU Vaudois, Dept Paediat Gastroenterol & Nutr, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Puder, JJ (corresponding author), Univ Lausanne, CHU Vaudois, Serv Endocrinol Diabet & Metab, Rue Bugnon 46, CH-1011 Lausanne, Switzerland.	jardena.puder@chuv.ch	Marques-Vidal, Pedro M/C-9449-2009; Schindler, Christian/D-3472-2015	Marques-Vidal, Pedro M/0000-0002-4548-8500; Puder, Jardena/0000-0002-0460-7614	Swiss National Science Foundation [3200B0-116837]; Health Promotion Switzerland [2104]; University of Lausanne; Takeda; Wyeth Foundation for the Health of Children and Adolescents; Freie Akademische Gesellschaft; Nestle	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Health Promotion Switzerland; University of Lausanne; Takeda(Takeda Pharmaceutical Company Ltd); Wyeth Foundation for the Health of Children and Adolescents; Freie Akademische Gesellschaft; Nestle(Nestle SA)	The study was mainly supported by the Swiss National Science Foundation (grant No 3200B0-116837) and Health Promotion Switzerland (project No 2104). Additional funding was obtained from a research award for interdisciplinary research from the University of Lausanne, a Takeda research award, the Wyeth Foundation for the Health of Children and Adolescents, the Freie Akademische Gesellschaft, and an unrestricted educational grant from Nestle. The funding sources had no role in the study design, data collection, analysis, interpretation of data, in the writing of the report, and in the decision to submit the article for publication.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Andersen LB, 2008, INT J PEDIATR OBES, V3, P58, DOI 10.1080/17477160801896366; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; Baquet G, 2007, PREV MED, V44, P143, DOI 10.1016/j.ypmed.2006.10.004; Bayer O, 2009, CLIN NUTR, V28, P122, DOI 10.1016/j.clnu.2009.01.001; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; Brown T, 2009, OBES REV, V10, P110, DOI 10.1111/j.1467-789X.2008.00515.x; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Connelly JB, 2007, PUBLIC HEALTH, V121, P510, DOI 10.1016/j.puhe.2006.11.015; Dennison BA, 2004, ARCH PEDIAT ADOL MED, V158, P170, DOI 10.1001/archpedi.158.2.170; Dobbins M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007651; Ebenegger V, 2011, EUR J CLIN NUTR, V65, P210, DOI 10.1038/ejcn.2010.248; Ebenegger V, 2010, NUTR RES, V30, P104, DOI 10.1016/j.nutres.2010.01.006; Ekelund U, 2000, INT J SPORTS MED, V21, P586, DOI 10.1055/s-2000-8487; Eliakim A, 2007, J PEDIATR ENDOCR MET, V20, P711; Ettrich KU., 2006, TESTMANUAL ZUM KONZE; Fitzgibbon ML, 2006, OBESITY, V14, P1616, DOI 10.1038/oby.2006.186; Fitzgibbon ML, 2005, J PEDIATR-US, V146, P618, DOI 10.1016/j.jpeds.2004.12.019; Green DJ, 2006, BMJ-BRIT MED J, V333, P1171, DOI 10.1136/bmj.39045.484167.FA; Grob A., 2009, INTELLIGENCE DEV SCA; Health Promotion Switzerland, 2011, KIDZ BOX 25 SPIEL TI; Kalies H, 2002, INT J OBESITY, V26, P1211, DOI 10.1038/sj.ijo.0802013; Kapteyn T S, 1983, Agressologie, V24, P321; Kriemler S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c785; Kunz T., 1993, WENIGER UNFALLE DURC; Lasserre AM, 2007, OBESITY, V15, P2912, DOI 10.1038/oby.2007.347; Lee CD, 1999, AM J CLIN NUTR, V69, P373; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Lopes VP, 2011, SCAND J MED SCI SPOR, V21, P663, DOI 10.1111/j.1600-0838.2009.01027.x; Malina Robert, 2004, GROWTH MATURATION PH, DOI DOI 10.1016/j.jsams.2011.04.003; Mattocks C, 2007, MED SCI SPORT EXER, V39, P622, DOI 10.1249/mss.0b013e318030631b; Mo-suwan L, 1998, AM J CLIN NUTR, V68, P1006, DOI 10.1093/ajcn/68.5.1006; Muckelbauer R, 2010, OBESITY, V18, P528, DOI 10.1038/oby.2009.270; Muller MJ, 2005, P NUTR SOC, V64, P249, DOI 10.1079/PNS2005424; Nemet D, 2011, J PEDIATR-US, V158, P796, DOI 10.1016/j.jpeds.2010.10.040; Niederer I, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-94; Okely AD, 2010, J SPORT SCI, V28, P851, DOI 10.1080/02640411003716959; Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0; Reilly JJ, 2006, BMJ-BRIT MED J, V333, P1041, DOI 10.1136/bmj.38979.623773.55; Rolland-Cachera MF, 2006, INT J OBESITY, V30, pS11, DOI 10.1038/sj.ijo.0803514; SCHAEFER F, 1994, PEDIATR RES, V35, P617, DOI 10.1203/00006450-199405000-00016; Speiser PW, 2005, J CLIN ENDOCR METAB, V90, P1871, DOI 10.1210/jc.2004-1389; Swiss Society for Nutrition, 2011, NUTR DISK REC HLTH T; Taylor AW, 2011, MATERN CHILD HL 0420; Tomkinson Grant R, 2007, Med Sport Sci, V50, P46, DOI 10.1159/000101075; Tremblay Mark S, 2010, Health Rep, V21, P7; Trost SG, 2000, MED SCI SPORT EXER, V32, P426, DOI 10.1097/00005768-200002000-00025; Urquia ML, 2010, J EPIDEMIOL COMMUN H, V64, P243, DOI 10.1136/jech.2008.083535; van Sluijs EMF, 2007, BMJ-BRIT MED J, V335, P703, DOI 10.1136/bmj.39320.843947.BE; VANSAASE JLC, 1990, BRIT MED J, V301, P1409, DOI 10.1136/bmj.301.6766.1409; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-1; Vogt U., 1978, MOTORIK 3 BIS 6JAHRI; Werner H, 2008, ARCH PEDIAT ADOL MED, V162, P350, DOI 10.1001/archpedi.162.4.350	56	145	146	11	60	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2011	343								d6195	10.1136/bmj.d6195	http://dx.doi.org/10.1136/bmj.d6195			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835EQ	21998346	Green Published, hybrid			2022-12-28	WOS:000296018300003
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA The government's criticisms of PFI don't add up	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				2004, BRIT MED J, V329, P1349, DOI DOI 10.1136/BMJ.329.7478.1349; 1999, BRIT MED J, V319, P2003	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 12	2011	343								d6566	10.1136/bmj.d6566	http://dx.doi.org/10.1136/bmj.d6566			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	835EO	21994310				2022-12-28	WOS:000296018100006
J	Hancock, AM; Brachi, B; Faure, N; Horton, MW; Jarymowycz, LB; Sperone, FG; Toomajian, C; Roux, F; Bergelson, J				Hancock, Angela M.; Brachi, Benjamin; Faure, Nathalie; Horton, Matthew W.; Jarymowycz, Lucien B.; Sperone, F. Gianluca; Toomajian, Chris; Roux, Fabrice; Bergelson, Joy			Adaptation to Climate Across the Arabidopsis thaliana Genome	SCIENCE			English	Article							COMPLEXITY; EVOLUTION; PATTERNS; PLANTS; SHIFT; LINES; COST	Understanding the genetic bases and modes of adaptation to current climatic conditions is essential to accurately predict responses to future environmental change. We conducted a genome-wide scan to identify climate-adaptive genetic loci and pathways in the plant Arabidopsis thaliana. Amino acid-changing variants were significantly enriched among the loci strongly correlated with climate, suggesting that our scan effectively detects adaptive alleles. Moreover, from our results, we successfully predicted relative fitness among a set of geographically diverse A. thaliana accessions when grown together in a common environment. Our results provide a set of candidates for dissecting the molecular bases of climate adaptations, as well as insights about the prevalence of selective sweeps, which has implications for predicting the rate of adaptation.	[Hancock, Angela M.; Horton, Matthew W.; Jarymowycz, Lucien B.; Sperone, F. Gianluca; Bergelson, Joy] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Brachi, Benjamin; Faure, Nathalie; Roux, Fabrice] Univ Sci & Technol Lille 1, FRE CNRS 3268, Lab Genet & Evolut Populat Vegetales, Villeneuve Dascq, France; [Toomajian, Chris] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66502 USA	University of Chicago; Universite de Lille - ISITE; Universite de Lille; Kansas State University	Bergelson, J (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.	jbergels@uchicago.edu	Toomajian, Christopher/ABA-2615-2021	Toomajian, Christopher/0000-0002-6763-0678; Bergelson, Joy/0000-0001-7893-7387; Brachi, Benjamin/0000-0001-5988-7150; Horton, Matthew/0000-0002-7537-0730; Fabrice, Roux/0000-0001-8059-5638; Hancock, Angela/0000-0002-4768-3377	NIH [GM083068]; NSF [DEB0519961]; V. Dropkin Postdoctoral Fellowship; Graduate Assistance in Areas of National Need (GAANN) training grant; University of Lille; French Research Ministry; College Doctoral Europeen; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083068] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); V. Dropkin Postdoctoral Fellowship; Graduate Assistance in Areas of National Need (GAANN) training grant(US Department of Education); University of Lille; French Research Ministry(Ministry of Research, France); College Doctoral Europeen; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by NIH GM083068 and NSF DEB0519961 to J.B. A. M. H. was supported by a V. Dropkin Postdoctoral Fellowship, and M. W. H. was supported by an NSF Predoctoral Fellowship and a Graduate Assistance in Areas of National Need (GAANN) training grant. F. R. was supported by a Bonus Qualite Reserche (BQR) grant from the University of Lille, and B. B. received funding from a Ph.D. fellowship from the French Research Ministry and a mobility grant from the College Doctoral Europeen. This is contribution 11-389-J from the Kansas Agricultural Experiment Station. We thank J. Borevitz, A. Fournier-Level, M. Nordborg, A. Platt, J. Schmitt, members of the Bergelson laboratory, and two anonymous reviewers for helpful input. Climate data for the 948 accessions used in these analyses, result files for the correlation analyses, and a browser that allows for viewing the results in their genomic context are available at http://bergelson.uchicago.edu/regmap-data/climate-genome-scan/. The genotype data used for these analyses resulted from the RegMap project (http://regmap.uchicago.edu).	ATHAR H, 2005, HDB PHOTOSYNTHESIS, P928; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bergelson J, 2010, NAT REV GENET, V11, P867, DOI 10.1038/nrg2896; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Bradshaw WE, 2001, P NATL ACAD SCI USA, V98, P14509, DOI 10.1073/pnas.241391498; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Franks SJ, 2007, P NATL ACAD SCI USA, V104, P1278, DOI 10.1073/pnas.0608379104; Gillespie JH, 2000, GENETICS, V155, P909; Hancock AM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001375; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; LYNCH M, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P234; Orr HA, 2000, EVOLUTION, V54, P13, DOI 10.1111/j.0014-3820.2000.tb00002.x; RATHCKE B, 1985, ANNU REV ECOL SYST, V16, P179, DOI 10.1146/annurev.es.16.110185.001143; Roux F, 2004, GENETICS, V166, P449, DOI 10.1534/genetics.166.1.449; Toomajian C, 2006, PLOS BIOL, V4, P732, DOI 10.1371/journal.pbio.0040137; Umina PA, 2005, SCIENCE, V308, P691, DOI 10.1126/science.1109523; Wagner GP, 2011, NAT REV GENET, V12, P204, DOI 10.1038/nrg2949; Wang Z, 2010, P NATL ACAD SCI USA, V107, P18034, DOI 10.1073/pnas.1004666107; Weinig C, 2002, GENETICS, V162, P1875	21	447	452	3	269	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 7	2011	334	6052					83	86		10.1126/science.1209244	http://dx.doi.org/10.1126/science.1209244			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21980108				2022-12-28	WOS:000295580300044
J	Chan, CC; Lin, SJ				Chan, Chih-Chieh; Lin, Sung-Jan			Porphyria Cutanea Tarda	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chan, Chih-Chieh; Lin, Sung-Jan] Natl Taiwan Univ Hosp, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital	Chan, CC (corresponding author), Natl Taiwan Univ Hosp, Taipei, Taiwan.	009015@ntuh.gov.tw		Lin, Sung-Jan/0000-0003-1325-3464					0	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2011	365	12					1128	1128		10.1056/NEJMicm1100668	http://dx.doi.org/10.1056/NEJMicm1100668			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822WR	21992125	Green Submitted			2022-12-28	WOS:000295081600012
J	Brett, AS; Ablin, RJ				Brett, Allan S.; Ablin, Richard J.			Prostate-Cancer Screening - What the US Preventive Services Task Force Left Out	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Brett, Allan S.] Univ S Carolina, Sch Med, Dept Med, Columbia, SC 29208 USA; [Ablin, Richard J.] Univ Arizona, Coll Med, Arizona Canc Ctr, Dept Pathol, Tucson, AZ 85724 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Arizona Center Cancer Care; University of Arizona	Brett, AS (corresponding author), Univ S Carolina, Sch Med, Dept Med, Columbia, SC 29208 USA.							American Urological Association, 2009, PROST SPEC ANT BEST; [Anonymous], 2011, SCREEN PROST CANC DR; Department of Health and Human Services, 2011, ASPE ISS BRIEF OV UN; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Thompson IM, 2004, NEW ENGL J MED, V351, P1470; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066	6	53	53	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2011	365	21					1949	1951		10.1056/NEJMp1112191	http://dx.doi.org/10.1056/NEJMp1112191			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	851PF	22029759				2022-12-28	WOS:000297282600002
J	Kayagaki, N; Warming, S; Lamkanfi, M; Vande Walle, L; Louie, S; Dong, J; Newton, K; Qu, Y; Liu, JF; Heldens, S; Zhang, J; Lee, WP; Roose-Girma, M; Dixit, VM				Kayagaki, Nobuhiko; Warming, Soren; Lamkanfi, Mohamed; Vande Walle, Lieselotte; Louie, Salina; Dong, Jennifer; Newton, Kim; Qu, Yan; Liu, Jinfeng; Heldens, Sherry; Zhang, Juan; Lee, Wyne P.; Roose-Girma, Merone; Dixit, Vishva M.			Non-canonical inflammasome activation targets caspase-11	NATURE			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; GAMMA-INDUCING FACTOR; ANTHRAX LETHAL TOXIN; NLRP3 INFLAMMASOME; MICE DEFICIENT; RECOGNITION; IL-1-BETA; RECEPTORS; APOPTOSIS; RESPONSES	Caspase-1 activation by inflammasome scaffolds comprised of intracellular nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) and the adaptor ASC is believed to be essential for production of the pro-inflammatory cytokines interleukin (IL)-1 beta and IL-18 during the innate immune response(1-5). Here we show, with C57BL/6 Casp11 gene-targeted mice, that caspase-11 (also known as caspase-4)(6-8) is critical for caspase-1 activation and IL-1 beta production in macrophages infected with Escherichia coli, Citrobacter rodentium or Vibrio cholerae. Strain 129 mice, like Casp11(-/-) mice, exhibited defects in IL-1 beta production and harboured a mutation in the Casp11 locus that attenuated caspase-11 expression. This finding is important because published targeting of the Casp1 gene was done using strain 129 embryonic stem cells(9,10). Casp1 and Casp11 are too close in the genome to be segregated by recombination; consequently, the published Casp1(-/-) mice lack both caspase-11 and caspase-1. Interestingly, Casp11(-/-) macrophages secreted IL-1 beta normally in response to ATP and monosodium urate, indicating that caspase-11 is engaged by a non-canonical inflammasome. Casp1(-/-)Casp11(129mt/129mt) macrophages expressing caspase-11 from a C57BL/6 bacterial artificial chromosome transgene failed to secrete IL-1 beta regardless of stimulus, confirming an essential role for caspase-1 in IL-1 beta production. Caspase-11 rather than caspase-1, however, was required for non-canonical inflammasome-triggered macrophage cell death, indicating that caspase-11 orchestrates both caspase-1-dependent and -independent outputs. Caspase-1 activation by non-canonical stimuli required NLRP3 and ASC, but caspase-11 processing and cell death did not, implying that there is a distinct activator of caspase-11. Lastly, loss of caspase-11 rather than caspase-1 protected mice from a lethal dose of lipopolysaccharide. These data highlight a unique pro-inflammatory role for caspase-11 in the innate immune response to clinically significant bacterial infections.	[Kayagaki, Nobuhiko; Louie, Salina; Dong, Jennifer; Newton, Kim; Qu, Yan; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Warming, Soren; Heldens, Sherry; Roose-Girma, Merone] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Lamkanfi, Mohamed; Vande Walle, Lieselotte] VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Lamkanfi, Mohamed; Vande Walle, Lieselotte] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Liu, Jinfeng] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Zhang, Juan; Lee, Wyne P.] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Flanders Institute for Biotechnology (VIB); Ghent University; Roche Holding; Genentech; Roche Holding; Genentech	Kayagaki, N (corresponding author), Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA.	kayagaki@gene.com; dixit@gene.com	dixit, vishva m/A-4496-2012; Warming, Soren/ABD-5729-2021	dixit, vishva m/0000-0001-6983-0326; Liu, Jinfeng/0000-0002-0343-8222; Warming, Soren/0000-0002-5721-0741				Beddoe T, 2010, TRENDS BIOCHEM SCI, V35, P411, DOI 10.1016/j.tibs.2010.02.003; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dunne A, 2010, J IMMUNOL, V185, P1711, DOI 10.4049/jimmunol.1000105; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Freche B, 2007, SEMIN IMMUNOPATHOL, V29, P249, DOI 10.1007/s00281-007-0085-0; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Meixenberger K, 2010, J IMMUNOL, V184, P922, DOI 10.4049/jimmunol.0901346; Ng J, 2010, GASTROENTEROLOGY, V139, P542, DOI 10.1053/j.gastro.2010.04.005; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Toma C, 2010, J IMMUNOL, V184, P5287, DOI 10.4049/jimmunol.0903536; Van Keuren ML, 2009, TRANSGENIC RES, V18, P769, DOI 10.1007/s11248-009-9271-2; Walsh JG, 2011, J BIOL CHEM, V286, P32513, DOI 10.1074/jbc.M111.225862; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wickliffe KE, 2008, CELL MICROBIOL, V10, P332, DOI 10.1111/j.1462-5822.2007.01044.x	35	1556	1613	13	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2011	479	7371					117	U146		10.1038/nature10558	http://dx.doi.org/10.1038/nature10558			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840FA	22002608				2022-12-28	WOS:000296422600043
J	Vasiliauskas, D; Mazzoni, EO; Sprecher, SG; Brodetskiy, K; Johnston, RJ; Lidder, P; Vogt, N; Celik, A; Desplan, C				Vasiliauskas, Daniel; Mazzoni, Esteban O.; Sprecher, Simon G.; Brodetskiy, Konstantin; Johnston, Robert J., Jr.; Lidder, Preetmoninder; Vogt, Nina; Celik, Arzu; Desplan, Claude			Feedback from rhodopsin controls rhodopsin exclusion in Drosophila photoreceptors	NATURE			English	Article							TUMOR-SUPPRESSOR GENE; EXPRESSION; R7; IDENTIFICATION; TRANSGENESIS; SPECIFICITY; DISSECTION; ENCODES; SYSTEM; CELLS	Sensory systems with high discriminatory power use neurons that express only one of several alternative sensory receptor proteins. This exclusive receptor gene expression restricts the sensitivity spectrum of neurons and is coordinated with the choice of their synaptic targets(1-3). However, little is known about how it is maintained throughout the life of a neuron. Here we show that the green-light sensing receptor rhodopsin 6 (Rh6) acts to exclude an alternative blue-sensitive rhodopsin 5 (Rh5) from a subset of Drosophila R8 photoreceptor neurons(4). Loss of Rh6 leads to a gradual expansion of Rh5 expression into all R8 photoreceptors of the ageing adult retina. The Rh6 feedback signal results in repression of the rh5 promoter and can be mimicked by other Drosophila rhodopsins; it is partly dependent on activation of rhodopsin by light, and relies on G(alpha q) activity, but not on the subsequent steps of the phototransduction cascade(5). Our observations reveal a thus far unappreciated spectral plasticity of R8 photoreceptors, and identify rhodopsin feedback as an exclusion mechanism.	[Vasiliauskas, Daniel; Mazzoni, Esteban O.; Sprecher, Simon G.; Brodetskiy, Konstantin; Johnston, Robert J., Jr.; Lidder, Preetmoninder; Vogt, Nina; Celik, Arzu; Desplan, Claude] NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA	New York University	Desplan, C (corresponding author), NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA.	cd38@nyu.edu	Vasiliauskas, Daniel/AAV-1981-2020; Fuss, ARZU Celik/AAD-2870-2020; Sprecher, Simon/B-5188-2012; Sprecher, Simon/K-4249-2015	Vasiliauskas, Daniel/0000-0002-0570-2322; Fuss, ARZU Celik/0000-0001-9889-6957; Vogt, Nina/0000-0002-2658-9138; Sprecher, Simon/0000-0001-9060-3750; mazzoni, esteban/0000-0001-8994-681X; Desplan, Claude/0000-0002-6914-1413	National Institutes of Health [R01EY13012, F32EY016309]; NATIONAL EYE INSTITUTE [F32EY016309, R01EY013012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J. Blau, B. Collins, M. Cols, T. Erclik, S. H. Fuss, D. Jukam, J. P. Kumar, E. Laufer, H.-S. Li, B. Minke, C. Montell, F. Pichaud, J. Rister and A. Tomlinson for suggestions and comments on the manuscript, V. Douard for help with qRT-PCR, J. Goodness for help identifying rh6<SUP>fs</SUP> allele, S. G. Britt, P. J. Dolph, P. R. Hiesinger, F. Pichaud, N. Pinal, D. F. Ready, C. S. Zuker, and the Bloomington Drosophila Stock Center for flies or antibodies. This work was funded by the National Institutes of Health R01EY13012 to C. D. and F32EY016309 to D.V.	Arikawa K, 2003, J NEUROSCI, V23, P4527; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Chou WH, 1996, NEURON, V17, P1101, DOI 10.1016/S0896-6273(00)80243-3; Chou WH, 1999, DEVELOPMENT, V126, P607; Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Earl JB, 2006, GENE EXPR PATTERNS, V6, P687, DOI 10.1016/j.modgep.2006.01.003; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; FRANCESCHINI N, 1981, SCIENCE, V213, P1264, DOI 10.1126/science.7268434; Fuss SH, 2009, MOL CELL NEUROSCI, V41, P101, DOI 10.1016/j.mcn.2009.02.014; GERRESHEIM F, 1988, BEHAV GENET, V18, P227, DOI 10.1007/BF01067844; GREEN P, 1993, CELL TISSUE RES, V273, P583, DOI 10.1007/BF00333712; HARRIS WA, 1976, J PHYSIOL-LONDON, V256, P415; HOFBAUER A, 1989, NATURWISSENSCHAFTEN, V76, P335, DOI 10.1007/BF00368438; Huang JH, 2010, CURR BIOL, V20, P189, DOI 10.1016/j.cub.2009.12.019; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Mazzoni EO, 2008, PLOS BIOL, V6, P825, DOI 10.1371/journal.pbio.0060097; Mikeladze-Dvali T, 2005, CELL, V122, P775, DOI 10.1016/j.cell.2005.07.026; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; Morey M, 2008, NATURE, V456, P795, DOI 10.1038/nature07419; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; O'Keefe LV, 2011, HUM MOL GENET, V20, P497, DOI 10.1093/hmg/ddq495; Oberstein A, 2005, NAT METHODS, V2, P583, DOI 10.1038/NMETH775; OTOUSA JE, 1989, J NEUROGENET, V6, P41, DOI 10.3109/01677068909107099; Papatsenko D, 1997, DEVELOPMENT, V124, P1665; Papatsenko D, 2001, MECH DEVELOP, V101, P143, DOI 10.1016/S0925-4773(00)00581-5; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Rister J, 2011, DEV NEUROBIOL, V71, P1212, DOI 10.1002/dneu.20905; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shen WL, 2011, SCIENCE, V331, P1333, DOI 10.1126/science.1198904; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Sprecher SG, 2008, NATURE, V454, P533, DOI 10.1038/nature07062; Sprecher SG, 2007, GENE DEV, V21, P2182, DOI 10.1101/gad.1565407; Stapleton M, 2002, GENOME RES, V12, P1294, DOI 10.1101/gr.269102; Tahayato A, 2003, DEV CELL, V5, P391, DOI 10.1016/S1534-5807(03)00239-9; Till BJ, 2003, METH MOL B, V236, P205; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; XU TA, 1995, DEVELOPMENT, V121, P1053; Yamaguchi S, 2008, P NATL ACAD SCI USA, V105, P4910, DOI 10.1073/pnas.0711484105; Yasuyama K, 1999, J COMP NEUROL, V412, P193, DOI 10.1002/(SICI)1096-9861(19990920)412:2<193::AID-CNE1>3.0.CO;2-0	48	33	33	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2011	479	7371					108	+		10.1038/nature10451	http://dx.doi.org/10.1038/nature10451			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840FA	21983964	Green Accepted, Green Submitted			2022-12-28	WOS:000296422600041
J	Goshen, I; Brodsky, M; Prakash, R; Wallace, J; Gradinaru, V; Ramakrishnan, C; Deisseroth, K				Goshen, Inbal; Brodsky, Matthew; Prakash, Rohit; Wallace, Jenelle; Gradinaru, Viviana; Ramakrishnan, Charu; Deisseroth, Karl			Dynamics of Retrieval Strategies for Remote Memories	CELL			English	Article							RETROGRADE-AMNESIA; CONTEXTUAL FEAR; HIPPOCAMPAL-LESIONS; DORSAL HIPPOCAMPUS; SPATIAL MEMORY; PLACE CELLS; CONSOLIDATION; RECONSOLIDATION; REORGANIZATION; TRANSFORMATION	Prevailing theory suggests that long-term memories are encoded via a two-phase process requiring early involvement of the hippocampus followed by the neocortex. Contextual fear memories in rodents rely on the hippocampus immediately following training but are unaffected by hippocampal lesions or pharmacological inhibition weeks later. With fast optogenetic methods, we examine the real-time contribution of hippocampal CA1 excitatory neurons to remote memory and find that contextual fear memory recall, even weeks after training, can be reversibly abolished by temporally precise optogenetic inhibition of CA1. When this inhibition is extended to match the typical time course of pharmacological inhibition, remote hippocampus dependence converts to hippocampus independence, suggesting that long-term memory retrieval normally depends on the hippocampus but can adaptively shift to alternate structures. Further revealing the plasticity of mechanisms required for memory recall, we confirm the remote-timescale importance of the anterior cingulate cortex (ACC) and implicate CA1 in ACC recruitment for remote recall.	[Goshen, Inbal; Brodsky, Matthew; Prakash, Rohit; Wallace, Jenelle; Gradinaru, Viviana; Ramakrishnan, Charu; Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, CNC Program, Dept Bioengn,Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Howard Hughes Med Inst, CNC Program, Dept Bioengn,Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	deissero@stanford.edu	Goshen, Inbal/GQI-2230-2022	Goshen, Inbal/0000-0001-7578-2615; Ramakrishnan, Charu/0000-0002-3474-6332; Wallace, Jenelle/0000-0002-9565-2751	Gatsby Charitable Foundation; Keck Foundation; Snyder Foundation; Woo Foundation; Yu Foundation; McKnight Foundation; CIRM; NIMH; NINDS; NIDA; DARPA; Machiah Foundation; Weizmann Institute of Science; NIH; BioX undergraduate summer research program; Stanford Graduate Fellowship program	Gatsby Charitable Foundation; Keck Foundation(W.M. Keck Foundation); Snyder Foundation; Woo Foundation; Yu Foundation; McKnight Foundation; CIRM(California Institute for Regenerative Medicine); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Machiah Foundation; Weizmann Institute of Science; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BioX undergraduate summer research program; Stanford Graduate Fellowship program	We thank the entire Deisseroth laboratory for their support. K. D. is supported by the Gatsby Charitable Foundation and the Keck, Snyder, Woo, Yu, and McKnight Foundations, as well as by CIRM, NIMH, NINDS, NIDA, and the DARPA REPAIR program. I. G. is supported by the Machiah Foundation and the Weizmann Institute of Science National Postdoctoral Award Program for Advancing Women in Science, R.P. is supported by the NIH, J.W. is supported by the BioX undergraduate summer research program, and V.G. by the Stanford Graduate Fellowship program.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Broadbent NJ, 2006, LEARN MEMORY, V13, P187, DOI 10.1101/lm.134706; Cipolotti L, 2006, CURR OPIN NEUROL, V19, P593, DOI 10.1097/01.wco.0000247608.42320.f9; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Dudai Y, 2006, CURR OPIN NEUROBIOL, V16, P174, DOI 10.1016/j.conb.2006.03.010; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Martin SJ, 2005, NEUROPSYCHOLOGIA, V43, P609, DOI 10.1016/j.neuropsychologia.2004.07.007; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; McHugh TJ, 2007, BEHAV NEUROSCI, V121, P335, DOI 10.1037/0735-7044.121.2.335; Moita MAP, 2004, J NEUROSCI, V24, P7015, DOI 10.1523/JNEUROSCI.5492-03.2004; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Squire LR, 2007, CURR OPIN NEUROBIOL, V17, P185, DOI 10.1016/j.conb.2007.02.006; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Sutherland RJ, 2008, HIPPOCAMPUS, V18, P710, DOI 10.1002/hipo.20431; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; Wang H, 2003, P NATL ACAD SCI USA, V100, P4287, DOI 10.1073/pnas.0636870100; Wang SH, 2010, ANNU REV PSYCHOL, V61, P49, DOI 10.1146/annurev.psych.093008.100523; Wang SH, 2009, NAT NEUROSCI, V12, P253, DOI 10.1038/nn.2263; Wiltgen BJ, 2010, CURR BIOL, V20, P1336, DOI 10.1016/j.cub.2010.06.068; Winocur G, 2007, NAT NEUROSCI, V10, P555, DOI 10.1038/nn1880; Winocur G, 2010, NEUROPSYCHOLOGIA, V48, P2339, DOI 10.1016/j.neuropsychologia.2010.04.016; Winocur G, 2009, LEARN MEMORY, V16, P722, DOI 10.1101/lm.1447209; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	48	364	405	0	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 28	2011	147	3					678	689		10.1016/j.cell.2011.09.033	http://dx.doi.org/10.1016/j.cell.2011.09.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	842EH	22019004	Bronze			2022-12-28	WOS:000296573700021
J	Willett, WC; Ludwig, DS				Willett, Walter C.; Ludwig, David S.			The 2010 Dietary Guidelines - The Best Recipe for Health?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							METAANALYSIS; RISK		[Willett, Walter C.; Ludwig, David S.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Ludwig, David S.] Childrens Hosp, Dept Med, Optimal Weight Life Program, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital	Willett, WC (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.			Ludwig, David/0000-0003-3307-8544				Barclay AW, 2008, AM J CLIN NUTR, V87, P627, DOI 10.1093/ajcn/87.3.627; Bischoff-Ferrari HA, 2011, J BONE MINER RES, V26, P833, DOI 10.1002/jbmr.279; Institute of Medicine, 2011, DIETARY REFERENCE IN; Mozaffarian D, 2010, JAMA-J AM MED ASSOC, V304, P681, DOI 10.1001/jama.2010.1116; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	5	19	22	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2011	365	17					1563	1565		10.1056/NEJMp1107075	http://dx.doi.org/10.1056/NEJMp1107075			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	837HI	22029977				2022-12-28	WOS:000296181800014
J	Dueber, EC; Schoeffler, AJ; Lingel, A; Elliott, JM; Fedorova, AV; Giannetti, AM; Zobel, K; Maurer, B; Varfolomeev, E; Wu, P; Wallweber, HJA; Hymowitz, SG; Deshayes, K; Vucic, D; Fairbrother, WJ				Dueber, Erin C.; Schoeffler, Allyn J.; Lingel, Andreas; Elliott, J. Michael; Fedorova, Anna V.; Giannetti, Anthony M.; Zobel, Kerry; Maurer, Brigitte; Varfolomeev, Eugene; Wu, Ping; Wallweber, Heidi J. A.; Hymowitz, Sarah G.; Deshayes, Kurt; Vucic, Domagoj; Fairbrother, Wayne J.			Antagonists Induce a Conformational Change in cIAP1 That Promotes Autoubiquitination	SCIENCE			English	Article							ALPHA-DEPENDENT APOPTOSIS; KAPPA-B ACTIVATION; IAP ANTAGONISTS; CASPASE ACTIVATION; STRUCTURAL BASIS; BIR3 DOMAIN; PROTEINS; CANCER; BINDING; SMAC	Inhibitor of apoptosis (IAP) proteins are negative regulators of cell death. IAP family members contain RING domains that impart E3 ubiquitin ligase activity. Binding of endogenous or small-molecule antagonists to select baculovirus IAP repeat (BIR) domains within cellular IAP (cIAP) proteins promotes autoubiquitination and proteasomal degradation and so releases inhibition of apoptosis mediated by cIAP. Although the molecular details of antagonist-BIR domain interactions are well understood, it is not clear how this binding event influences the activity of the RING domain. Here biochemical and structural studies reveal that the unliganded, multidomain cIAP1 sequesters the RING domain within a compact, monomeric structure that prevents RING dimerization. Antagonist binding induces conformational rearrangements that enable RING dimerization and formation of the active E3 ligase.	[Dueber, Erin C.; Schoeffler, Allyn J.; Lingel, Andreas; Fedorova, Anna V.; Zobel, Kerry; Varfolomeev, Eugene; Deshayes, Kurt; Vucic, Domagoj; Fairbrother, Wayne J.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Elliott, J. Michael] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Giannetti, Anthony M.] Genentech Inc, Dept Biochem Pharmacol, San Francisco, CA 94080 USA; [Maurer, Brigitte; Wu, Ping; Wallweber, Heidi J. A.; Hymowitz, Sarah G.] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Vucic, D (corresponding author), Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA.	domagoj@gene.com; fairbro@gene.com	Schoeffler, Allyn/GOE-3900-2022; Lingel, Andreas/AAP-5078-2021	Schoeffler, Allyn/0000-0002-7112-409X; 	Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy (DOE) [DE-AC02-05CH11231]; DOE Office of Biological and Environmental Research; National Center for Research Resources, NIH [P41RR001209]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank C. Yu, P. Lupardus, Shamrock Structures LLC, and staff at the Advanced Light Source, the Stanford Synchrotron Radiation Lightsource (SSRL) and the Advanced Photon Source at Argonne National Laboratory for their assistance with sample handling and data collection. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy (DOE) under contract no. DE-AC02-05CH11231. SSRL is a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the DOE Office of Science by Stanford University. The Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the Biomedical Technology Program, National Center for Research Resources, NIH (P41RR001209). Use of the Advanced Photon Source, a facility operated for DOE Office of Science by Argonne National Laboratory, was supported under contract no. DE-AC02-06CH11357. We also thank the Microchemistry and Proteomics Laboratory and the Oligo Synthesis and DNA Sequencing facilities at Genentech for their technical support. Atomic coordinates and structure factors have been deposited in the Protein DataBank with accession code 3T6P. Reagents are available from Genentech subject to a material transfer agreement.	Blankenship JW, 2009, BIOCHEM J, V417, P149, DOI 10.1042/BJ20081885; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dynek J.N., 2010, CANC LETT; Feltham R, 2011, J BIOL CHEM, V286, P17015, DOI 10.1074/jbc.M111.222919; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Flygare JA, 2010, EXPERT OPIN THER PAT, V20, P251, DOI 10.1517/13543770903567077; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Kulathila R, 2009, ACTA CRYSTALLOGR D, V65, P58, DOI 10.1107/S0907444908039243; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Mace PD, 2010, CELL DEATH DIFFER, V17, P46, DOI 10.1038/cdd.2009.45; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; Ndubaku C, 2009, ACS CHEM BIOL, V4, P557, DOI 10.1021/cb900083m; Oost TK, 2004, J MED CHEM, V47, P4417, DOI 10.1021/jm040037k; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Salvesen GS, 2004, ONCOGENE, V23, P2774, DOI 10.1038/sj.onc.1207522; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Varfolomeev E, 2006, J BIOL CHEM, V281, P29022, DOI 10.1074/jbc.M605116200; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vucic D, 2007, CLIN CANCER RES, V13, P5995, DOI 10.1158/1078-0432.CCR-07-0729; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Zobel K, 2006, ACS CHEM BIOL, V1, P525, DOI 10.1021/cb600276q	25	156	161	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 21	2011	334	6054					376	380		10.1126/science.1207862	http://dx.doi.org/10.1126/science.1207862			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	22021857				2022-12-28	WOS:000296052500053
J	Brawand, D; Soumillon, M; Necsulea, A; Julien, P; Csardi, G; Harrigan, P; Weier, M; Liechti, A; Aximu-Petri, A; Kircher, M; Albert, FW; Zeller, U; Khaitovich, P; Grutzner, F; Bergmann, S; Nielsen, R; Paabo, S; Kaessmann, H				Brawand, David; Soumillon, Magali; Necsulea, Anamaria; Julien, Philippe; Csardi, Gabor; Harrigan, Patrick; Weier, Manuela; Liechti, Angelica; Aximu-Petri, Ayinuer; Kircher, Martin; Albert, Frank W.; Zeller, Ulrich; Khaitovich, Philipp; Gruetzner, Frank; Bergmann, Sven; Nielsen, Rasmus; Paeaebo, Svante; Kaessmann, Henrik			The evolution of gene expression levels in mammalian organs	NATURE			English	Article							SEX-CHROMOSOMES; X-CHROMOSOME; RNA-SEQ; DOSAGE COMPENSATION; HUMAN GENOME; PRIMATES; HUMANS; CONSERVATION; CHIMPANZEES; SEQUENCE	Changes in gene expression are thought to underlie many of the phenotypic differences between species. However, large-scale analyses of gene expression evolution were until recently prevented by technological limitations. Here we report the sequencing of polyadenylated RNA from six organs across ten species that represent all major mammalian lineages (placentals, marsupials and monotremes) and birds (the evolutionary outgroup), with the goal of understanding the dynamics of mammalian transcriptome evolution. We show that the rate of gene expression evolution varies among organs, lineages and chromosomes, owing to differences in selective pressures: transcriptome change was slow in nervous tissues and rapid in testes, slower in rodents than in apes and monotremes, and rapid for the X chromosome right after its formation. Although gene expression evolution in mammals was strongly shaped by purifying selection, we identify numerous potentially selectively driven expression switches, which occurred at different rates across lineages and tissues and which probably contributed to the specific organ biology of various mammals.	[Brawand, David; Soumillon, Magali; Necsulea, Anamaria; Julien, Philippe; Weier, Manuela; Liechti, Angelica; Kaessmann, Henrik] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Brawand, David; Soumillon, Magali; Necsulea, Anamaria; Julien, Philippe; Csardi, Gabor; Bergmann, Sven; Kaessmann, Henrik] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Csardi, Gabor; Bergmann, Sven] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Harrigan, Patrick; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Aximu-Petri, Ayinuer; Kircher, Martin; Albert, Frank W.; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; [Zeller, Ulrich] Humboldt Univ, Chair Systemat Zool, D-10099 Berlin, Germany; [Khaitovich, Philipp] CAS MPG Partner Inst Computat Biol, Shanghai 200031, Peoples R China; [Gruetzner, Frank] Univ Adelaide, Robinson Inst, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Nielsen, Rasmus] Univ Copenhagen, Bioinformat Ctr, DK-2200 Copenhagen, Denmark	University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; University of California System; University of California Berkeley; Max Planck Society; Humboldt University of Berlin; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Robinson Research Institute; University of Adelaide; University of Copenhagen	Kaessmann, H (corresponding author), Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland.	henrik.kaessmann@unil.ch	Kaessmann, Henrik/B-4989-2013; Kircher, Martin/H-6909-2019; Grutzner, Frank/ABB-2820-2021; Khaitovich, Philipp/HGC-8520-2022; Julien, Philippe/C-1295-2011; Grutzner, Frank/AAD-5834-2020; Kircher, Martin/HDL-9392-2022; Nielsen, Rasmus/D-4405-2009	Kaessmann, Henrik/0000-0001-7563-839X; Kircher, Martin/0000-0001-9278-5471; Grutzner, Frank/0000-0002-3088-7314; Nielsen, Rasmus/0000-0003-0513-6591; Csardi, Gabor/0000-0001-7098-9676; Bergmann, Sven/0000-0002-6785-9034; Albert, Frank/0000-0002-1380-8063	European Research Council [242597]; Swiss National Science Foundation [31003A_130287, 31003A_130691/1]; Swiss Institute of Bioinformatics; Max Planck Society; FEBS postdoctoral fellowship	European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Institute of Bioinformatics; Max Planck Society(Max Planck SocietyFoundation CELLEX); FEBS postdoctoral fellowship	We thank K. Harshman and the LGTF for high-throughput sequencing support; I. Xenarios and the Vital-IT computational facility (Swiss Institute of Bioinformatics) for computational support; P. Jensen and L. Andersson for the red jungle fowl samples; E. Ait Yahya Graison and A. Reymond for C57BL/6J mouse RNA-seq data from male brain; C. Henrichsen and A. Reymond for wild-mouse samples; T. Daish, A. Casey, S. Lim, R. Jones and Glenrock station for platypus tissue collection and sample preparation; all other people and institutions that provided samples (Supplementary Table 1); W. Enard for ape sample organization; the members of the Kaessmann group for discussions; J. Meunier for statistical support; D. Cortez and M. Warnefors for comments on the manuscript; and R. Durbin and the Gorilla Genome Analysis Consortium for making the gorilla genome data available and for granting permission to use them for RNA-seq read mapping before publication. This research was supported by grants from the European Research Council (Starting Independent Researcher Grant: 242597, SexGenTransEvolution) and the Swiss National Science Foundation (grant 31003A_130287), to H.K. S.B. was supported by the Swiss National Science Foundation (grant 31003A_130691/1), the Swiss Institute of Bioinformatics and the European Framework Project 6 (AnEuploidy and EuroDia projects). S.P. was supported by the European Research Council (ERC-2008-AdG, TWOPAN) and by the Max Planck Society. A.N. was supported by a long-term FEBS postdoctoral fellowship. F.G. is an ARC Australian Research Fellow.	Babbitt CC, 2010, GENOME BIOL EVOL, V2, P67, DOI 10.1093/gbe/evq002; Bachtrog D, 2009, PLOS BIOL, V7, P712, DOI 10.1371/journal.pbio.1000082; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; Caswell JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000057; Chan Esther T., 2009, Journal of Biology (London), V8, P33, DOI 10.1186/jbiol130; CHARLESWORTH B, 1978, P NATL ACAD SCI USA, V75, P5618, DOI 10.1073/pnas.75.11.5618; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72; Clark MB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000625; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Fyfe JC, 2006, GENOME RES, V16, P1084, DOI 10.1101/gr.5268806; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; Goodman M, 1999, AM J HUM GENET, V64, P31, DOI 10.1086/302218; Grutzner F, 2004, NATURE, V432, P913, DOI 10.1038/nature03021; HARCOURT AH, 1981, NATURE, V293, P55, DOI 10.1038/293055a0; Haygood R, 2010, P NATL ACAD SCI USA, V107, P7853, DOI 10.1073/pnas.0911249107; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Ihmels J, 2004, BIOINFORMATICS, V20, P1993, DOI 10.1093/bioinformatics/bth166; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Keightley PD, 2005, PLOS BIOL, V3, P282, DOI 10.1371/journal.pbio.0030042; Kemkemer C, 2009, CHROMOSOME RES, V17, P811, DOI 10.1007/s10577-009-9072-8; KEMP TS, 2005, ORIGIN EVOLUTION MAM; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Khaitovich P, 2006, NAT REV GENET, V7, P693, DOI 10.1038/nrg1940; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li WH, 1996, MOL PHYLOGENET EVOL, V5, P182, DOI 10.1006/mpev.1996.0012; Liao BY, 2006, MOL BIOL EVOL, V23, P530, DOI 10.1093/molbev/msj054; Marcus G., 2004, BIRTH MIND; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Picard F, 2007, BIOMETRICS, V63, P758, DOI 10.1111/j.1541-0420.2006.00729.x; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Ponting CP, 2008, NAT REV GENET, V9, P689, DOI 10.1038/nrg2413; Potrzebowski L, 2008, PLOS BIOL, V6, P709, DOI 10.1371/journal.pbio.0060080; Potrzebowski L, 2010, TRENDS GENET, V26, P1, DOI 10.1016/j.tig.2009.11.001; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Schoenemann PT, 2005, NAT NEUROSCI, V8, P242, DOI 10.1038/nn1394; Tong Y, 2010, NEUROGENETICS, V11, P41, DOI 10.1007/s10048-009-0201-5; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uddin M, 2004, P NATL ACAD SCI USA, V101, P2957, DOI 10.1073/pnas.0308725100; Vauti F, 2007, GENE, V389, P174, DOI 10.1016/j.gene.2006.11.004; Veyrunes F, 2008, GENOME RES, V18, P965, DOI 10.1101/gr.7101908; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Wilson MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000568; Xiong YY, 2010, NAT GENET, V42, P1043, DOI 10.1038/ng.711; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]	59	740	748	9	279	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2011	478	7369					343	+		10.1038/nature10532	http://dx.doi.org/10.1038/nature10532			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	22012392				2022-12-28	WOS:000296021100037
J	Rayner, KJ; Esau, CC; Hussain, FN; McDaniel, AL; Marshall, SM; van Gils, JM; Ray, TD; Sheedy, FJ; Goedeke, L; Liu, XQ; Khatsenko, OG; Kaimal, V; Lees, CJ; Fernandez-Hernando, C; Fisher, EA; Temel, RE; Moore, KJ				Rayner, Katey J.; Esau, Christine C.; Hussain, Farah N.; McDaniel, Allison L.; Marshall, Stephanie M.; van Gils, Janine M.; Ray, Tathagat D.; Sheedy, Frederick J.; Goedeke, Leigh; Liu, Xueqing; Khatsenko, Oleg G.; Kaimal, Vivek; Lees, Cynthia J.; Fernandez-Hernando, Carlos; Fisher, Edward A.; Temel, Ryan E.; Moore, Kathryn J.			Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides	NATURE			English	Article							CHOLESTEROL; MICRORNA-33; INTRON	Cardiovascular disease remains the leading cause of mortality in westernized countries, despite optimum medical therapy to reduce the levels of low-density lipoprotein (LDL)-associated cholesterol. The pursuit of novel therapies to target the residual risk has focused on raising the levels of high-density lipoprotein (HDL)-associated cholesterol in order to exploit its atheroprotective effects(1). MicroRNAs (miRNAs) have emerged as important posttranscriptional regulators of lipid metabolism and are thus a new class of target for therapeutic intervention(2). MicroRNA-33a and microRNA-33b (miR-33a/b) are intronic miRNAs whose encoding regions are embedded in the sterol-response-element-binding protein genes SREBF2 and SREBF1 (refs 3-5), respectively. These miRNAs repress expression of the cholesterol transporter ABCA1, which is a key regulator of HDL biogenesis. Recent studies in mice suggest that antagonizing miR-33a may be an effective strategy for raising plasma HDL levels(3-5) and providing protection against atherosclerosis(6); however, extrapolating these findings to humans is complicated by the fact that mice lack miR-33b, which is present only in the SREBF1 gene of medium and large mammals. Here we show in African green monkeys that systemic delivery of an anti-miRNA oligonucleotide that targets both miR-33a and miR-33b increased hepatic expression of ABCA1 and induced a sustained increase in plasma HDL levels over 12 weeks. Notably, miR-33 antagonism in this non-human primate model also increased the expression of miR-33 target genes involved in fatty acid oxidation (CROT, CPT1A, HADHB and PRKAA1) and reduced the expression of genes involved in fatty acid synthesis (SREBF1, FASN, ACLY and ACACA), resulting in a marked suppression of the plasma levels of very-low-density lipoprotein (VLDL)-associated triglycerides, a finding that has not previously been observed in mice. These data establish, in a model that is highly relevant to humans, that pharmacological inhibition of miR-33a and miR33b is a promising therapeutic strategy to raise plasma HDL and lower VLDL triglyceride levels for the treatment of dyslipidaemias that increase cardiovascular disease risk.	[Rayner, Katey J.; Hussain, Farah N.; van Gils, Janine M.; Ray, Tathagat D.; Sheedy, Frederick J.; Goedeke, Leigh; Fernandez-Hernando, Carlos; Fisher, Edward A.; Moore, Kathryn J.] NYU, Sch Med, Marc & Ruti Bell Vasc Biol & Dis Program, Leon H Charney Div Cardiol,Dept Med, New York, NY 10016 USA; [Esau, Christine C.; Liu, Xueqing; Khatsenko, Oleg G.; Kaimal, Vivek] Regulus Therapeut, San Diego, CA 92121 USA; [McDaniel, Allison L.; Marshall, Stephanie M.; Temel, Ryan E.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Sect Lipid Sci, Winston Salem, NC 27157 USA; [Lees, Cynthia J.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Comparat Med Sect, Winston Salem, NC 27157 USA	New York University; Isis Pharmaceuticals Inc; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Moore, KJ (corresponding author), NYU, Sch Med, Marc & Ruti Bell Vasc Biol & Dis Program, Leon H Charney Div Cardiol,Dept Med, New York, NY 10016 USA.	rtemel@wfubmc.edu; kathryn.moore@nyumc.org	Rayner, Katey/K-8914-2012; Fisher, Edward/ABE-7469-2020; 应, 宁宁/G-9472-2011; Moore, Kathryn/ABE-6416-2020	Moore, Kathryn/0000-0003-2505-2547; Rayner, Katey/0000-0001-6230-426X; Goedeke, Leigh/0000-0002-7690-1572; Sheedy, Frederick/0000-0002-4722-3135; Kaimal, Vivek/0000-0003-4807-4394; Sheedy, Frederick/0000-0003-2645-8493; van Gils, Janine/0000-0003-2429-7462; Fisher, Edward/0000-0001-9802-143X	National Institutes of Health [R01AG02055, R01HL108182, P01HL098055, R01HL084312, R01HL58541, 1P30HL101270, R01HL107953, R00HL088528]; Canadian Institutes of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108182, P01HL098055, R00HL088528, R01HL107953, P30HL101270, R01HL058541, R01HL084312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health to K.J.M. (R01AG02055 and R01HL108182), E.A.F. (P01HL098055, R01HL084312 and R01HL58541), C.F.-H. (1P30HL101270 and R01HL107953), R.E.T. (R00HL088528), as well as by the Canadian Institutes of Health Research (K.J.R.)	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Chyu KY, 2011, CURR ATHEROSCLER REP, V13, P405, DOI 10.1007/s11883-011-0189-9; Davalos A, 2011, P NATL ACAD SCI USA, V108, P9232, DOI 10.1073/pnas.1102281108; Degoma EM, 2011, NAT REV CARDIOL, V8, P266, DOI 10.1038/nrcardio.2010.200; Fitzgerald ML, 2001, J BIOL CHEM, V276, P15137, DOI 10.1074/jbc.M100474200; Garber DW, 2000, J LIPID RES, V41, P1020; Geary RS, 2009, EXPERT OPIN DRUG MET, V5, P381, DOI [10.1517/17425250902877680 , 10.1517/17425250902877680]; Gerin I, 2010, J BIOL CHEM, V285, P33652, DOI 10.1074/jbc.M110.152090; Horie T, 2010, P NATL ACAD SCI USA, V107, P17321, DOI 10.1073/pnas.1008499107; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; KIEFT KA, 1991, J LIPID RES, V32, P859; KORITNIK DL, 1983, J LIPID RES, V24, P1639; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Moore KJ, 2010, TRENDS ENDOCRIN MET, V21, P699, DOI 10.1016/j.tem.2010.08.008; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Rayner KJ, 2011, J CLIN INVEST, V121, P2921, DOI 10.1172/JCI57275; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Wagner JD, 2006, ILAR J, V47, P259, DOI 10.1093/ilar.47.3.259; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731	20	556	594	4	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2011	478	7369					404	+		10.1038/nature10486	http://dx.doi.org/10.1038/nature10486			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	22012398	Green Accepted			2022-12-28	WOS:000296021100050
J	Wicks, C; de la Llera, JC; Lara, LE; Lowenstern, J				Wicks, Charles; Carlos de la Llera, Juan; Lara, Luis E.; Lowenstern, Jacob			The role of dyking and fault control in the rapid onset of eruption at Chaiten volcano, Chile	NATURE			English	Article							SATELLITE RADAR INTERFEROMETRY; 7.1 HECTOR MINE; SURFACE DEFORMATION; SLIP DISTRIBUTION; EARTHQUAKE; MAGMA; GPS; CALIFORNIA; INSAR; ANDES	Rhyolite is the most viscous of liquid magmas, so it was surprising that on 2 May 2008 at Chaiten Volcano, located in Chile's southern Andean volcanic zone, rhyolitic magma migrated from more than 5 km depth in less than 4 hours (ref. 1) and erupted explosively with only two days of detected precursory seismic activity(2). The last major rhyolite eruption before that at Chaiten was the largest volcanic eruption in the twentieth century, at Novarupta volcano, Alaska, in 1912. Because of the historically rare and explosive nature of rhyolite eruptions and because of the surprisingly short warning before the eruption of the Chaiten volcano, any information about the workings of the magmatic system at Chaiten, and rhyolitic systems in general, is important from both the scientific and hazard perspectives. Here we present surface deformation data related to the Chaiten eruption based on radar interferometry observations from the Japan Aerospace Exploration Agency (JAXA) DAICHI (ALOS) satellite. The data on this explosive rhyolite eruption indicate that the rapid ascent of rhyolite occurred through dyking and that melt segregation and magma storage were controlled by existing faults.	[Wicks, Charles; Lowenstern, Jacob] US Geol Survey, Menlo Pk, CA 94025 USA; [Carlos de la Llera, Juan] Pontificia Univ Catolica Chile, Escuela Ingn, Santiago 7820436, Chile; [Lara, Luis E.] Volcano Hazards Program, Serv Nacl Geol & Mineria, Santiago 8320119, Chile	United States Department of the Interior; United States Geological Survey; Pontificia Universidad Catolica de Chile	Wicks, C (corresponding author), US Geol Survey, 345 Middlefield Rd, Menlo Pk, CA 94025 USA.	cwicks@usgs.gov	Lara, Luis E. E./J-2604-2014	Lara, Luis E. E./0000-0002-7028-1464; de la Llera, Juan Carlos/0000-0002-9064-0938; Lowenstern, Jacob/0000-0003-0464-7779	NASA; National Science Foundation; US Geological Survey; US Government	NASA(National Aeronautics & Space Administration (NASA)); National Science Foundation(National Science Foundation (NSF)); US Geological Survey(United States Geological Survey); US Government	We thank D. Dzurisin, Z. Lu and W. Thatcher for providing helpful comments on the manuscript. All ALOS/PALSAR data are copyright JAXA and the Japanese Ministry of Economy, Trade and Industry (2008, 2009, 2010) and were provided by the Alaska Satellite Facility. The data were made available through JAXA project PI059 and the US Government Sponsored Research Consortium data pool supported by NASA, the National Science Foundation and the US Geological Survey.	Alfano F, 2011, B VOLCANOL, V73, P613, DOI 10.1007/s00445-010-0428-x; BARRIENTOS SE, 1990, GEOPHYS J INT, V103, P589, DOI 10.1111/j.1365-246X.1990.tb05673.x; Bird P, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2001GC000252; Brodtkorb P. A., 2000, P 10 INT OFFSH POL E, VIII, P343; Carn S.A., 2009, EOS, V90, P205, DOI [10.1029/2009EO240001, DOI 10.1029/2009E0240001]; Castro JM, 2009, NATURE, V461, P780, DOI 10.1038/nature08458; Cembrano J, 2002, TECTONOPHYSICS, V354, P289, DOI 10.1016/S0040-1951(02)00388-8; Cembrano J, 1996, TECTONOPHYSICS, V259, P55, DOI 10.1016/0040-1951(95)00066-6; Cembrano J, 2009, TECTONOPHYSICS, V471, P96, DOI 10.1016/j.tecto.2009.02.038; Cisternas M, 2005, NATURE, V437, P404, DOI 10.1038/nature03943; Fournier TJ, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002558; HILDRETH W, 1981, J GEOPHYS RES, V86, P153, DOI 10.1029/JB086iB11p10153; Jonsson S, 2002, B SEISMOL SOC AM, V92, P1377, DOI 10.1785/0120000922; Jonsson S., 2002, THESIS STANFORD U; KANAMORI H, 1993, J GEOPHYS RES-SOL EA, V98, P6511, DOI 10.1029/92JB02867; KILIAN R, 1992, ZENTRALBLATT GEOLOGI, V1991, P1693; Lange D, 2008, TECTONOPHYSICS, V455, P14, DOI 10.1016/j.tecto.2008.04.014; LARA L, 2008, EOS S, V89; Legrand D, 2011, CONT SHELF RES, V31, P154, DOI 10.1016/j.csr.2010.05.008; Lohman RB, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC00849; Lohman RB, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000841; Lohman RB, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000627; Mastin L.G., 2008, US GEOLOGICAL SURVEY, P461; Myrhaug D, 1998, J SHIP RES, V42, P199; OKADA Y, 1985, B SEISMOL SOC AM, V75, P1135; Parsons B, 2006, GEOPHYS J INT, V164, P202, DOI [10.1111/j.1365-246X.2005.02655.X, 10.1111/J.1365-246X.2005.02655.x]; RUBIN AM, 1995, ANNU REV EARTH PL SC, V23, P287, DOI 10.1146/annurev.ea.23.050195.001443; Ruegg JC, 2009, PHYS EARTH PLANET IN, V175, P78, DOI 10.1016/j.pepi.2008.02.015; Thomson SN, 2002, GEOL SOC AM BULL, V114, P1159; Watt SFL, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006219; WEERTMAN J, 1971, J GEOPHYS RES, V76, P1171, DOI 10.1029/JB076i005p01171; Wessel P, 1991, EOS T AM GEOPHYS UN, V72, P445, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]	33	60	60	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2011	478	7369					374	+		10.1038/nature10541	http://dx.doi.org/10.1038/nature10541			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	22012396				2022-12-28	WOS:000296021100043
J	Adams, BD				Adams, Bruce D.			Longer perishock pauses were associated with decreased survival to hospital discharge after out-of-hospital shockable cardiac arrest	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									William Beaumont Army Med Ctr, El Paso, TX 79920 USA	William Beaumont Army Medical Center	Adams, BD (corresponding author), William Beaumont Army Med Ctr, El Paso, TX 79920 USA.		Cheskes, Sheldon/I-4456-2015	Cheskes, Sheldon/0000-0001-7835-3074				Link MS, 2010, CIRCULATION, V122, pS706, DOI 10.1161/CIRCULATIONAHA.110.970954	1	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2011	155	8							JC4-12	10.7326/0003-4819-155-8-201110180-02012	http://dx.doi.org/10.7326/0003-4819-155-8-201110180-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835WB	22007071				2022-12-28	WOS:000296066300011
J	de Tisi, J; Bell, GS; Peacock, JL; McEvoy, AW; Harkness, WFJ; Sander, JW; Duncan, JS				de Tisi, Jane; Bell, Gail S.; Peacock, Janet L.; McEvoy, Andrew W.; Harkness, William F. J.; Sander, Josemir W.; Duncan, John S.			The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study	LANCET			English	Article							TEMPORAL-LOBE EPILEPSY; VISUAL-FIELD DEFICITS; FOLLOW-UP; LOBECTOMY; SCLEROSIS; RESECTION; RECURRENCE	Background Surgery is increasingly used as treatment for refractory focal epilepsy; however, few rigorous reports of long-term outcome exist. We did this study to identify long-term outcome of epilepsy surgery in adults by establishing patterns of seizure remission and relapse after surgery. Methods We report long-term outcome of surgery for epilepsy in 615 adults (497 anterior temporal resections, 40 temporal lesionectomies, 40 extratemporal lesionectomies, 20 extratemporal resections, 11 hemispherectomies, and seven palliative procedures [corpus callosotomy, subpial transection]), with prospective annual follow-up fora median of 8 years (range 1-19). We used Kaplan-Meier survival analysis to estimate time to first seizure, and investigated patterns of seizure outcome. Findings We used survival methods to estimate that 52% (95% CI 48-56) of patients remained seizure free (apart from simple partial seizures [SPS]) at 5 years after surgery, and 47% (42-51) at 10 years. Patients who had extratemporal resections were more likely to have seizure recurrence than were those who had anterior temporal resections (hazard ratio [HR] 2.0, 1.1-3.6; p=0.02); whereas for those having lesionectomies, no difference from anterior lobe resection was recorded. Those with SPS in the first 2 years after temporal lobe surgery had a greater chance of subsequent seizures with impaired awareness than did those with no SPS (2.4, 1.5-3.9). Relapse was less likely the longer a person was seizure free and, conversely, remission was less likely the longer seizures continued. In 18 (19%) of 93 people, late remission was associated with introduction of a previously untried antiepileptic drug. 104 of 365 (28%) seizure-free individuals had discontinued drugs at latest follow-up. Interpretation Neurosurgical treatment is appealing for selected people with refractory focal epilepsy. Our data provide realistic expectations and indicate the scope for further improvements in presurgical assessment and surgical treatment of people with chronic epilepsy.	[de Tisi, Jane; Bell, Gail S.; McEvoy, Andrew W.; Harkness, William F. J.; Sander, Josemir W.; Duncan, John S.] UCL, Dept Clin & Expt Epilepsy, Inst Neurol, Natl Hosp Neurol & Neurosurg, London, England; [Bell, Gail S.; Sander, Josemir W.; Duncan, John S.] Epilepsy Soc, Gerrards Cross, Bucks, England; [Peacock, Janet L.] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England; [Sander, Josemir W.] Netherlands Fdn, SEIN Epilepsy Inst, Heemstede, Netherlands	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; King's College London	Duncan, JS (corresponding author), Natl Hosp Neurol & Neurosurg, Dept Clin & Expt Epilepsy, UCL Inst Neurol, Queen Sq, London WC1N 3BG, England.	j.duncan@ucl.ac.uk	Sander, Josemir W/C-1576-2008	Sander, Josemir W/0000-0001-6041-9661; Peacock, Janet/0000-0002-0310-2518; Duncan, John S/0000-0002-1373-0681; de Tisi, Jane/0000-0002-7666-2268	Forth Medical; Eisai; GlaxoSmithKline; MedTronic; Pfizer; UCB; Cyberonics; VSM MedTech; UK Department of Health National Institute for Health Research (NIHR); Epilepsy Society; National Institute for Health Research [NF-SI-0509-10161] Funding Source: researchfish	Forth Medical; Eisai(Eisai Co Ltd); GlaxoSmithKline(GlaxoSmithKline); MedTronic(Medtronic); Pfizer(Pfizer); UCB(UCB Pharma SA); Cyberonics; VSM MedTech; UK Department of Health National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Epilepsy Society; National Institute for Health Research(National Institute for Health Research (NIHR))	JDT, JLP, and AWMcE declare that they have no conflicts of interest. GSB's husband works for, and has shares in, GlaxoSmithlKline. WFH has been consulted by and received research grants and fees for lectures from Forth Medical. JWS has been consulted by and received fees for lectures and research grants from Eisai, GlaxoSmithKline, MedTronic, Pfizer, and UCB. JSD has been consulted by and received fees to his institution for lectures from Eisai, GE Healthcare, Pfizer, GlaxoSmithKline, Sanofi- Aventis, and UCB; he has had departmental and grant support from MedTronic, Cyberonics, and VSM MedTech.; Funding UK Department of Health National Institute for Health Research (NIHR) Biomedical Research Centres funding scheme, Epilepsy Society, Dr Marvin Weil Epilepsy Research Fund.	Altman D.G., 2000, STAT CONFIDENCE, Vsecond; Bell GS, 2010, J NEUROL NEUROSUR PS, V81, P716, DOI 10.1136/jnnp.2008.170837; BERKOVIC SF, 1995, NEUROLOGY, V45, P1358, DOI 10.1212/WNL.45.7.1358; Buckingham SE, 2010, EPILEPSIA, V51, P1987, DOI 10.1111/j.1528-1167.2010.02721.x; Burneo JG, 2008, SEIZURE-EUR J EPILEP, V17, P314, DOI 10.1016/j.seizure.2007.10.002; Chan CH, 2006, J NEUROSURG, V104, P62, DOI 10.3171/jns.2006.104.1.62; Chandrasekar T, 2008, EPILEPSY RES, V78, P195, DOI 10.1016/j.eplepsyres.2007.12.004; Clusmann H, 2004, NEUROSURGERY, V54, P847, DOI 10.1227/01.NEU.0000114141.37640.37; Clusmann H, 2002, J NEUROSURG, V97, P1131, DOI 10.3171/jns.2002.97.5.1131; Cohen-Gadol AA, 2006, J NEUROSURG, V104, P513, DOI 10.3171/jns.2006.104.4.513; Duncan JS, 2011, EPILEPSY BEHAV, V20, P230, DOI 10.1016/j.yebeh.2010.06.040; Dunlea O, 2010, SEIZURE-EUR J EPILEP, V19, P247, DOI 10.1016/j.seizure.2010.03.001; Dupont S, 2006, EPILEPSIA, V47, P2115, DOI 10.1111/j.1528-1167.2006.00852.x; ELWES RDC, 1991, J NEUROL NEUROSUR PS, V54, P949, DOI 10.1136/jnnp.54.11.949; Engel J, 1996, NEW ENGL J MED, V334, P647, DOI 10.1056/NEJM199603073341008; Janszky J, 2005, EPILEPSY RES, V64, P35, DOI 10.1016/j.eplepsyres.2005.02.004; Jeelani NUO, 2010, J NEUROL NEUROSUR PS, V81, P985, DOI 10.1136/jnnp.2009.182378; Jehi L, 2010, EPILEPSIA, V51, P994, DOI 10.1111/j.1528-1167.2010.02556.x; Lee SA, 2006, SEIZURE-EUR J EPILEP, V15, P397, DOI 10.1016/j.seizure.2006.05.003; McIntosh AM, 2004, BRAIN, V127, P2018, DOI 10.1093/brain/awh221; Paglioli E, 2004, EPILEPSIA, V45, P1383, DOI 10.1111/j.0013-9580.2004.22204.x; Salanova V, 1999, EPILEPSIA, V40, P1417, DOI 10.1111/j.1528-1157.1999.tb02014.x; Schwartz TH, 2006, EPILEPSIA, V47, P567, DOI 10.1111/j.1528-1167.2006.00469.x; Tellez-Zenteno JF, 2005, BRAIN, V128, P1188, DOI 10.1093/brain/awh449; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Wieser HG, 2001, EPILEPSIA, V42, P282, DOI 10.1046/j.1528-1157.2001.4220282.x; Yogarajah M, 2009, BRAIN, V132, P1656, DOI 10.1093/brain/awp114	27	518	525	5	48	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 15	2011	378	9800					1388	1395		10.1016/S0140-6736(11)60890-8	http://dx.doi.org/10.1016/S0140-6736(11)60890-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	838EM	22000136	Green Submitted, Bronze			2022-12-28	WOS:000296269600025
J	Pincock, S				Pincock, Stephen			Profile Anthony Atala: at the cutting edge of regenerative surgery	LANCET			English	Biographical-Item														Pincock, Stephen/0000-0003-1655-2902				ATALA A, PUBLICATION LIST	1	1	3	1	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 15	2011	378	9800					1371	1371		10.1016/S0140-6736(11)61600-0	http://dx.doi.org/10.1016/S0140-6736(11)61600-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	838EM	22000126				2022-12-28	WOS:000296269600013
J	Endres, M; Cheneau, M; Fukuhara, T; Weitenberg, C; Schauss, P; Gross, C; Mazza, L; Banuls, MC; Pollet, L; Bloch, I; Kuhr, S				Endres, M.; Cheneau, M.; Fukuhara, T.; Weitenberg, C.; Schauss, P.; Gross, C.; Mazza, L.; Banuls, M. C.; Pollet, L.; Bloch, I.; Kuhr, S.			Observation of Correlated Particle-Hole Pairs and String Order in Low-Dimensional Mott Insulators	SCIENCE			English	Article							BOSE-HUBBARD MODEL; OPTICAL LATTICES; ULTRACOLD ATOMS; TRANSITION; SUPERFLUID; PHASES; PHYSICS; GASES	Quantum phases of matter are characterized by the underlying correlations of the many-body system. Although this is typically captured by a local order parameter, it has been shown that a broad class of many-body systems possesses a hidden nonlocal order. In the case of bosonic Mott insulators, the ground state properties are governed by quantum fluctuations in the form of correlated particle-hole pairs that lead to the emergence of a nonlocal string order in one dimension. By using high-resolution imaging of low-dimensional quantum gases in an optical lattice, we directly detect these pairs with single-site and single-particle sensitivity and observe string order in the one-dimensional case.	[Endres, M.; Cheneau, M.; Fukuhara, T.; Weitenberg, C.; Schauss, P.; Gross, C.; Mazza, L.; Banuls, M. C.; Bloch, I.; Kuhr, S.] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Pollet, L.] ETH, CH-8093 Zurich, Switzerland; [Bloch, I.] Univ Munich, D-80799 Munich, Germany; [Kuhr, S.] Univ Strathclyde, Scottish Univ Phys Alliance, Glasgow G4 0NG, Lanark, Scotland	Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Munich; University of Strathclyde	Endres, M (corresponding author), Max Planck Inst Quantum Opt, D-85748 Garching, Germany.	manuel.endres@mpq.mpg.de	Kuhr, Stefan/ABC-8654-2020; Cheneau, Marc/O-9312-2014; Bañuls, Maria Carmen/D-9155-2017; Bloch, Immanuel/N-9169-2019; Pollet, Lode C/F-6845-2010; Gross, Christian/P-5475-2014; Kuhr, Stefan/F-7296-2011; Bloch, Immanuel/G-3174-2010; Fukuhara, Takeshi/A-6254-2014; Schauss, Peter/AAV-1298-2020; Mazza, Leonardo/M-3547-2013	Kuhr, Stefan/0000-0001-8386-5357; Cheneau, Marc/0000-0001-7261-566X; Bañuls, Maria Carmen/0000-0001-6419-6610; Pollet, Lode C/0000-0002-7274-2842; Gross, Christian/0000-0003-2292-5234; Kuhr, Stefan/0000-0001-8386-5357; Bloch, Immanuel/0000-0002-0679-4759; Fukuhara, Takeshi/0000-0002-6702-9882; Schauss, Peter/0000-0002-8505-5195; Mazza, Leonardo/0000-0002-6754-127X	Max-Planck-Gesellschaft; Deutsche Forschungsgemeinschaft; European Union; Japan Society for Promotion of Science; Swiss National Science Foundation [PZ00P2-131892/1]	Max-Planck-Gesellschaft(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We acknowledge helpful discussions with E. Altman, E. Dalla Torre, M. Rizzi, and I. Cirac. This work was supported by Max-Planck-Gesellschaft, Deutsche Forschungsgemeinschaft, European Union (NAMEQUAM, AQUTE, and Marie Curie Fellowship to M.C.), and Japan Society for Promotion of Science (Postdoctoral Fellowship for Research Abroad to T.F.). L.P. is supported by the Swiss National Science Foundation under grant PZ00P2-131892/1. DMRG simulations were performed with use of code released within the PwP project (www.qti.sns.it). QMC calculations were performed on the Brutus cluster at ETH Zurich.	Anfuso F, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.144420; Bakr WS, 2010, SCIENCE, V329, P547, DOI 10.1126/science.1192368; Berg E, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.245119; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Capogrosso-Sansone B, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.015602; Chen X, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.035107; Dalla Torre EG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.260401; DENNIJS M, 1989, PHYS REV B, V40, P4709, DOI 10.1103/PhysRevB.40.4709; Duan LM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.090402; FISHER MPA, 1989, PHYS REV B, V40, P546, DOI 10.1063/1.38820; Gerbier F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.050404; Jaksch D, 2005, ANN PHYS-NEW YORK, V315, P52, DOI 10.1016/j.aop.2004.09.010; Kapit E, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.013644; Kashurnikov VA, 1996, JETP LETT+, V64, P99, DOI 10.1134/1.567139; Kim EH, 2000, PHYS REV B, V62, P14965, DOI 10.1103/PhysRevB.62.14965; Kuhner TD, 2000, PHYS REV B, V61, P12474, DOI 10.1103/PhysRevB.61.12474; Kuklov AB, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.100401; Lewenstein M, 2007, ADV PHYS, V56, P243, DOI 10.1080/00018730701223200; Perez-Garcia D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.167202; Saffman M, 2010, REV MOD PHYS, V82, P2313, DOI 10.1103/RevModPhys.82.2313; Sherson JF, 2010, NATURE, V467, P68, DOI 10.1038/nature09378; Spielman IB, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.080404; Stoferle T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.130403; Trotzky S, 2008, SCIENCE, V319, P295, DOI 10.1126/science.1150841; Verstraete F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.207204; Zwolak M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.207205	29	217	218	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					200	203		10.1126/science.1209284	http://dx.doi.org/10.1126/science.1209284			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998381	Green Submitted			2022-12-28	WOS:000295833600039
J	Mayer, AL; Khalyani, AH				Mayer, Audrey L.; Khalyani, Azad Henareh			Grass Trumps Trees with Fire	SCIENCE			English	Editorial Material							CLIMATE; EVOLUTION; SHIFTS; SAHARA; ORIGIN; BIOME		[Mayer, Audrey L.; Khalyani, Azad Henareh] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA	Michigan Technological University	Mayer, AL (corresponding author), Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA.	almayer@mtu.edu	Mayer, AL/AAO-3225-2020	Mayer, AL/0000-0003-3278-1182				Anderson RC, 2006, J TORREY BOT SOC, V133, P626, DOI 10.3159/1095-5674(2006)133[626:EAOOTC]2.0.CO;2; Beerling DJ, 2006, GLOBAL CHANGE BIOL, V12, P2023, DOI 10.1111/j.1365-2486.2006.01239.x; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; Foley JA, 2003, ECOSYSTEMS, V6, P524, DOI 10.1007/s10021-002-0227-0; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Janis CM, 2002, PALAEOGEOGR PALAEOCL, V177, P183, DOI 10.1016/S0031-0182(01)00359-5; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; Ratnam J, 2011, GLOBAL ECOL BIOGEOGR, V20, P653, DOI 10.1111/j.1466-8238.2010.00634.x; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Rietkerk M, 2011, ECOL COMPLEX, V8, P223, DOI 10.1016/j.ecocom.2011.03.001; SCHEFFER M, 2009, CRITICAL TRANSITIONS, P86; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Suding KN, 2009, TRENDS ECOL EVOL, V24, P271, DOI 10.1016/j.tree.2008.11.012; Willis KJ, 2006, SCIENCE, V314, P1261, DOI 10.1126/science.1122667	14	49	53	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					188	189		10.1126/science.1213908	http://dx.doi.org/10.1126/science.1213908			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998379				2022-12-28	WOS:000295833600035
J	Nathan, C				Nathan, Carl			Is iNOS Beginning to Smoke?	CELL			English	Editorial Material							NITRIC-OXIDE SYNTHASE	Inducible nitric oxide synthase (iNOS) helps drive numerous inflammatory disorders, but its inhibition has not had therapeutic success. Now Seimetz et al. (2011) make a case for inhibiting iNOS in an effort to treat one of the world's leading causes of death-chronic obstructive pulmonary disease.	Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA	Cornell University	Nathan, C (corresponding author), Weill Cornell Med Coll, Dept Microbiol & Immunol, 1300 York Ave, New York, NY 10065 USA.	cnathan@med.cornell.edu						BARNES PJ, 2001, NAT IMMUNOL, V2, P907; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Eyler CE, 2011, CELL, V146, P53, DOI 10.1016/j.cell.2011.06.006; HIBBS JB, 1987, SCIENCE, V235, P473, DOI 10.1126/science.2432665; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Molon B, 2011, J EXP MED, V208, P1949, DOI 10.1084/jem.20101956; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Seimetz M, 2011, CELL, V147, P293, DOI 10.1016/j.cell.2011.08.035; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522	9	11	11	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 14	2011	147	2					257	258		10.1016/j.cell.2011.09.031	http://dx.doi.org/10.1016/j.cell.2011.09.031			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000003	Bronze			2022-12-28	WOS:000296199300002
J	Parenteau, J; Durand, M; Morin, G; Gagnon, J; Lucier, JF; Wellinger, RJ; Chabot, B; Abou Elela, S				Parenteau, Julie; Durand, Mathieu; Morin, Genevieve; Gagnon, Jules; Lucier, Jean-Francois; Wellinger, Raymund J.; Chabot, Benoit; Abou Elela, Sherif			Introns within Ribosomal Protein Genes Regulate the Production and Function of Yeast Ribosomes	CELL			English	Article							MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; CARCINOMA CELLS; EVOLUTION; REVEALS; STAUROSPORINE; REDUNDANCY; EUKARYOTES; DIVERSITY; APOPTOSIS	In budding yeast, the most abundantly spliced pre-mRNAs encode ribosomal proteins (RPs). To investigate the contribution of splicing to ribosome production and function, we systematically eliminated introns from all RP genes to evaluate their impact on RNA expression, pre-rRNA processing, cell growth, and response to stress. The majority of introns were required for optimal cell fitness or growth under stress. Most introns are found in duplicated RP genes, and surprisingly, in the majority of cases, deleting the intron from one gene copy affected the expression of the other in a nonreciprocal manner. Consistently, 70% of all duplicated genes were asymmetrically expressed, and both introns and gene deletions displayed copy-specific phenotypic effects. Together, our results indicate that splicing in yeast RP genes mediates intergene regulation and implicate the expression ratio of duplicated RP genes in modulating ribosome function.	[Parenteau, Julie; Durand, Mathieu; Morin, Genevieve; Gagnon, Jules; Lucier, Jean-Francois; Wellinger, Raymund J.; Chabot, Benoit; Abou Elela, Sherif] Univ Sherbrooke, Lab Genom Fonct, Dept Microbiol & Infectiol, Fac Med & Sci Sante, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Abou Elela, S (corresponding author), Univ Sherbrooke, Lab Genom Fonct, Dept Microbiol & Infectiol, Fac Med & Sci Sante, 3001 12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	sherif.abou.elela@usherbrooke.ca	Wellinger, Raymund/K-3207-2019	Wellinger, Raymund/0000-0001-6670-2759; Abou Elela, Sherif/0000-0002-0630-3294; Chabot, Benoit/0000-0003-0994-0042	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research [MOP-97874]; Fonds de la Recherche en Sante du Quebec (FRSQ)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	We thank members of the S.A.E. lab for discussions and Jean-Philippe Brosseau and Philippe Thibault for help with the analysis of the qPCR data. This work was supported by grants from Natural Sciences and Engineering Research Council of Canada to S.A.E. and Canadian Institutes of Health Research to R.J.W. (grant MOP-97874). B.C. is the Canada Research Chair in Functional Genomics. R.J.W. is the Canada Research Chair in Telomere Biology. S.A.E. is a Chercheur National of the Fonds de la Recherche en Sante du Quebec (FRSQ). J.G. is supported by Fonds de la Recherche en Sante du Quebec (FRSQ).	Allmang C, 1996, RNA, V2, P63; Allmang C, 1998, J MOL BIOL, V278, P67, DOI 10.1006/jmbi.1998.1693; Ares M, 1999, RNA, V5, P1138, DOI 10.1017/S1355838299991379; Arvas M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-325; Babenko VN, 2004, NUCLEIC ACIDS RES, V32, P5029, DOI 10.1093/nar/gkh833; Benz E J Jr, 1997, Trans Am Clin Climatol Assoc, V108, P78; Brosseau JP, 2010, RNA, V16, P442, DOI 10.1261/rna.1877010; Bulman S, 2007, PROTIST, V158, P423, DOI 10.1016/j.protis.2007.04.005; Catala M, 2008, MOL CELL BIOL, V28, P619, DOI 10.1128/MCB.01805-07; Davidovich C, 2009, RES MICROBIOL, V160, P487, DOI 10.1016/j.resmic.2009.07.004; Davis CA, 2000, NUCLEIC ACIDS RES, V28, P1700, DOI 10.1093/nar/28.8.1700; de Mayolo PA, 2003, J MOL BIOL, V333, P697, DOI 10.1016/j.jmb.2003.09.006; FINK GR, 1987, CELL, V49, P5, DOI 10.1016/0092-8674(87)90746-X; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Granneman S, 2005, MOL CELL BIOL, V25, P10352, DOI 10.1128/MCB.25.23.10352-10364.2005; Grate L, 2002, METHOD ENZYMOL, V350, P380, DOI 10.1016/S0076-6879(02)50975-7; Heerdt BG, 2000, CANCER RES, V60, P6704; Ihmels J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100127; Juneau K, 2007, P NATL ACAD SCI USA, V104, P1522, DOI 10.1073/pnas.0610354104; Juneau K, 2009, GENETICS, V183, P185, DOI 10.1534/genetics.109.105155; Kafri R, 2006, P NATL ACAD SCI USA, V103, P11653, DOI 10.1073/pnas.0604883103; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Kriventseva EV, 2003, TRENDS GENET, V19, P124, DOI 10.1016/S0168-9525(03)00023-4; Lee C, 2010, RNA, V16, P91, DOI 10.1261/rna.1812710; Li JJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001187; Meskauskas A, 2008, NUCLEIC ACIDS RES, V36, P1826, DOI 10.1093/nar/gkn034; Nadano D, 2001, BIOCHEMISTRY-US, V40, P15184, DOI 10.1021/bi0108397; OHTA T, 1988, GENETICS, V120, P841; Parenteau J, 2008, MOL BIOL CELL, V19, P1932, DOI 10.1091/mbc.E07-12-1254; Preker PJ, 2006, RNA, V12, P994, DOI 10.1261/rna.6706; Rose MD., 1990, METHODS YEAST GENETI; Roy SW, 2006, GENOME RES, V16, P1270, DOI 10.1101/gr.5410606; Russell AG, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-45; Sakurai A, 2002, GENE, V300, P89, DOI 10.1016/S0378-1119(02)01035-1; Solis AS, 2008, FRONT BIOSCI-LANDMRK, V13, P1926, DOI 10.2741/2812; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; Stetefeld J, 2005, TRENDS BIOCHEM SCI, V30, P515, DOI 10.1016/j.tibs.2005.07.001; Sugino RP, 2006, TRENDS GENET, V22, P642, DOI 10.1016/j.tig.2006.09.014; Toussaint M, 2006, MUTAT RES-GEN TOX EN, V606, P92, DOI 10.1016/j.mrgentox.2006.03.006; TUHACKOVA Z, 1994, BIOCHEM MOL BIOL INT, V32, P545; VILARDELL J, 1994, GENE DEV, V8, P211, DOI 10.1101/gad.8.2.211; Vilardell J, 1997, MOL CELL BIOL, V17, P1959, DOI 10.1128/MCB.17.4.1959; Wang HF, 2007, BIOCHEM BIOPH RES CO, V354, P203, DOI 10.1016/j.bbrc.2006.12.184; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Weng S, 2003, NUCLEIC ACIDS RES, V31, P216, DOI 10.1093/nar/gkg054; Williamson JR, 2003, RNA, V9, P165, DOI 10.1261/rna.2164903; ZAKIAN VA, 1982, MOL CELL BIOL, V2, P221, DOI 10.1128/MCB.2.3.221; Zhuo DG, 2007, P NATL ACAD SCI USA, V104, P882, DOI 10.1073/pnas.0604777104	48	86	88	2	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 14	2011	147	2					320	331		10.1016/j.cell.2011.08.044	http://dx.doi.org/10.1016/j.cell.2011.08.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000012	Bronze			2022-12-28	WOS:000296199300011
J	Whitaker, BJ				Whitaker, Benjamin J.			Shining Light on Diabolic Points	SCIENCE			English	Editorial Material							SPECTROSCOPY; MOLECULES; DYNAMICS		Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Whitaker, BJ (corresponding author), Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England.	b.j.whitaker@leeds.ac.uk						Marangos JP, 2008, PHYS CHEM CHEM PHYS, V10, P35, DOI 10.1039/b714126m; Schwarz WHE, 2006, ANGEW CHEM INT EDIT, V45, P1508, DOI 10.1002/anie.200501333; Shiner AD, 2011, NAT PHYS, V7, P464, DOI [10.1038/NPHYS1940, 10.1038/nphys1940]; Stolow A, 2008, ADV CHEM PHYS, V139, P497, DOI 10.1002/9780470259498.ch6; Suzuki T, 2006, ANNU REV PHYS CHEM, V57, P555, DOI 10.1146/annurev.physchem.57.032905.104601; Worner HJ, 2011, SCIENCE, V334, P208, DOI 10.1126/science.1208664; Yarkony DR, 1996, REV MOD PHYS, V68, P985, DOI 10.1103/RevModPhys.68.985	7	2	2	3	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					187	188		10.1126/science.1212327	http://dx.doi.org/10.1126/science.1212327			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998378				2022-12-28	WOS:000295833600034
J	Brigham, L				Brigham, Lawson			Marine protection in the Arctic cannot wait	NATURE			English	Editorial Material									[Brigham, Lawson] Univ Alaska Fairbanks, Fairbanks, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks	Brigham, L (corresponding author), Univ Alaska Fairbanks, Fairbanks, AK 99775 USA.	lwbrigham@alaska.edu							0	22	22	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 13	2011	478	7368					157	157		10.1038/478157a	http://dx.doi.org/10.1038/478157a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21993720	Bronze			2022-12-28	WOS:000295782800016
J	Buckley, LM				Buckley, Lenore M.			Critical Moments - Doctors and Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Virginia Commonwealth Univ, Sch Med, Richmond, VA 23284 USA	Virginia Commonwealth University	Buckley, LM (corresponding author), Virginia Commonwealth Univ, Sch Med, Richmond, VA 23284 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 6	2011	365	14					1270	1271		10.1056/NEJMp1106647	http://dx.doi.org/10.1056/NEJMp1106647			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829KL	21991948				2022-12-28	WOS:000295578700003
J	Lencer, WI; von Andrian, UH				Lencer, Wayne I.; von Andrian, Ulrich H.			Eliciting Mucosal Immunity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DENDRITIC CELLS		[Lencer, Wayne I.] Harvard Univ, Sch Med, Childrens Hosp, Dept Med, Boston, MA 02115 USA; [von Andrian, Ulrich H.] Harvard Univ, Sch Med, Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Lencer, WI (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Dept Med, Boston, MA 02115 USA.		von Andrian, Ulrich H/A-5775-2008	Lencer, Wayne/0000-0001-7346-2730	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048106, P30DK034854, R37DK048106] Funding Source: NIH RePORTER; NIDDK NIH HHS [R37 DK048106, R01 DK048106, P30 DK034854] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Fairfield KM, 2002, JAMA-J AM MED ASSOC, V287, P3116, DOI 10.1001/jama.287.23.3116; Fairfield KM, 2002, JAMA-J AM MED ASSOC, V288, P1720; HAMMERSCHMIDT SI, 2011, J CLIN INVEST   0701; Moore SR, 2011, NAT REV GASTRO HEPAT, V8, P363, DOI 10.1038/nrgastro.2011.103; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Tan XF, 2011, J VIROL, V85, P8316, DOI 10.1128/JVI.00781-11	7	6	8	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2011	365	12					1151	1153		10.1056/NEJMcibr1107816	http://dx.doi.org/10.1056/NEJMcibr1107816			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822WR	21992128	Green Accepted			2022-12-28	WOS:000295081600017
J	Remuzzi, G				Remuzzi, Giuseppe			Ethical disputes still beset Italian medicine 150 years after Count Cavour's death	LANCET			English	Editorial Material							ASSISTED REPRODUCTION; LAW		Mario Negri Inst Pharmacol Res, Negri Bergamo Labs, I-24126 Bergamo, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Remuzzi, G (corresponding author), Mario Negri Inst Pharmacol Res, Negri Bergamo Labs, I-24126 Bergamo, Italy.	giuseppe.remuzzi@marionegri.it	Remuzzi, Giuseppe/V-9766-2017	Remuzzi, Giuseppe/0000-0002-6194-3446				Abbott A, 2009, NATURE, V460, P19, DOI 10.1038/460019a; [Anonymous], 1861, BOSTON MED SURG J, V64, P495; [Anonymous], 1861, LANCET, V77, P593; [Anonymous], 2010, TIMES HIGHER ED; Bianchi N, 1874, CARLO MATTEUCCI ITAL; Boggio A, 2005, HUM REPROD, V20, P1153, DOI 10.1093/humrep/deh871; Brown J., 1784, ELEMENTA MED EDITIO; Cattaneo E, 2010, NATURE, V463, P729, DOI 10.1038/463729c; Cazzaniga A., 1951, GRANDE CRISI MED ITA; Cosmacini G., 1987, STORIA MED SANITA IT; De Feo I, 2011, CAVOUR UOMO OPERA; European Commission CORDIS, 2006, IT WITHDR ETH DECL E; Fineschi V, 2005, J MED ETHICS, V31, P536, DOI 10.1136/jme.2004.010231; Levi-Montalcini R, 2010, ELOGIO IMPERFEZIONE; Luchetti M, 2010, J MED ETHICS, V36, P333, DOI 10.1136/jme.2009.034835; Nature Cell Biology, 2008, NATURE CELL BIOL, V10, P1373; Paterlini M, 2011, EMBO REP, V12, P23, DOI 10.1038/embor.2010.194; Paterlini M, 2009, LANCET, V373, P1413, DOI 10.1016/S0140-6736(09)60803-5; Poggi R., 2009, MORTE CAVOUR; Pontificia Accdemia per la Vita, 2000, DICH PROD SULL SCI T; Rasori G., 1795, COMPENDIO NUOVA DOTT; Robertson JA, 2004, HUM REPROD, V19, P1693, DOI 10.1093/humrep/deh326; Romeo Rosario, 2004, VITA CAVOUR; Ruini C., 2005, PROL CARD CAM RUIN 5; Times Higher Education, 2008, TIMES HIGHER ED 0417; Wollaston R., 1861, BRIT MED J, V2, P48; World Health Organization, 2000, WORLD HLTH REP 2000	28	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 17	2012	379	9820					1068	1073		10.1016/S0140-6736(11)61382-2	http://dx.doi.org/10.1016/S0140-6736(11)61382-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	911JE	22000154				2022-12-28	WOS:000301712300035
J	Nagalingum, NS; Marshall, CR; Quental, TB; Rai, HS; Little, DP; Mathews, S				Nagalingum, N. S.; Marshall, C. R.; Quental, T. B.; Rai, H. S.; Little, D. P.; Mathews, S.			Recent Synchronous Radiation of a Living Fossil	SCIENCE			English	Article							CERATOZAMIA ZAMIACEAE; EVOLUTION; CYCADS; POLLINATION; DIVERGENCE; PHYLOGENY; NUCLEAR; DNA	Modern survivors of previously more diverse lineages are regarded as living fossils, particularly when characterized by morphological stasis. Cycads are often cited as a classic example, reaching their greatest diversity during the Jurassic-Cretaceous (199.6 to 65.5 million years ago) then dwindling to their present diversity of similar to 300 species as flowering plants rose to dominance. Using fossil-calibrated molecular phylogenies, we show that cycads underwent a near synchronous global rediversification beginning in the late Miocene, followed by a slowdown toward the Recent. Although the cycad lineage is ancient, our timetrees indicate that living cycad species are not much older than similar to 12 million years. These data reject the hypothesized role of dinosaurs in generating extant diversity and the designation of today's cycad species as living fossils.	[Nagalingum, N. S.; Rai, H. S.; Mathews, S.] Arnold Arboretum Harvard Univ, Cambridge, MA 02138 USA; [Nagalingum, N. S.; Marshall, C. R.; Quental, T. B.] Univ Calif Berkeley, Univ Calif Museum Paleontol, Berkeley, CA 94720 USA; [Nagalingum, N. S.] Royal Bot Garden Sydney, Natl Herbarium New S Wales, Sydney, NSW 2000, Australia; [Quental, T. B.] Univ Sao Paulo, Dept Ecol, Sao Paulo, Brazil; [Rai, H. S.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Little, D. P.] New York Bot Garden, Cullman Program Mol Systemat, Bronx, NY 10458 USA	Harvard University; University of California System; University of California Berkeley; Universidade de Sao Paulo; Utah System of Higher Education; Utah State University; New York Botanical Garden	Nagalingum, NS (corresponding author), Arnold Arboretum Harvard Univ, 22 Divin Ave, Cambridge, MA 02138 USA.	nathalie.nagalingum@rbgsyd.nsw.gov.au; smathews@oeb.harvard.edu	Quental, Tiago B/C-7077-2013; Mathews, Sarah/A-6513-2015	Mathews, Sarah/0000-0002-5518-7541	NSF [EF-0629890]	NSF(National Science Foundation (NSF))	This work was supported by NSF's Assembling the Tree of Life program (grant EF-0629890 to S. M.). The data reported in this paper are tabulated in the supporting online material and archived in GenBank (JN655891 to JN656096) and TreeBase (11891). We thank M. Beilstein, M. Clements, and K. Schellenberg for discussions and technical assistance; A. Vo for help with cloning and sequencing; J. Hilton for information regarding fossil ages; S. Ho and M. Sanderson for advice on divergence time analyses; D. Stevenson for cycad tissue; and the reviewers for suggestions and comments.	Arakaki M, 2011, P NATL ACAD SCI USA, V108, P8379, DOI 10.1073/pnas.1100628108; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Butler RJ, 2009, BIOL REV, V84, P73, DOI 10.1111/j.1469-185X.2008.00065.x; Calix M., 2018, EUROPEAN RED LIST SA; Chaw SM, 2005, MOL PHYLOGENET EVOL, V37, P214, DOI 10.1016/j.ympev.2005.01.006; Cibrian-Jaramillo A, 2010, MOL ECOL, V19, P2364, DOI 10.1111/j.1365-294X.2010.04638.x; Cooper A, 1998, TRENDS ECOL EVOL, V13, P151, DOI 10.1016/S0169-5347(97)01277-9; Crane P. R., 1987, ORIGIN ANGIOSPERMS T, P207; Crisp MD, 2011, NEW PHYTOL, V192, P997, DOI 10.1111/j.1469-8137.2011.03862.x; Crisp MD, 2009, EVOLUTION, V63, P2257, DOI 10.1111/j.1558-5646.2009.00728.x; Downie DA, 2008, MOL PHYLOGENET EVOL, V47, P102, DOI 10.1016/j.ympev.2008.01.023; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Gernandt DS, 2008, INT J PLANT SCI, V169, P1086, DOI 10.1086/590472; Gonzalez D, 2002, SYST BOT, V27, P654; Hill KD, 2003, INT J PLANT SCI, V164, P933, DOI 10.1086/378538; HILL KD, 2007, MEMOIRS NEW YORK BOT, V97, P454; Ickert-Bond SM, 2009, J SYST EVOL, V47, P444, DOI 10.1111/j.1759-6831.2009.00053.x; Jones, 2002, CYCADS WORLD ANCIENT; Lohne C, 2008, TAXON, V57, P1123, DOI 10.1002/tax.574008; Mustoe G, 2007, CYCAD NEWSLETTER, V65, P6; Nicolalde-Morejon F, 2009, BRITTONIA, V61, P301, DOI 10.1007/s12228-009-9077-9; NORSTOG K, 1997, BIOL CYCADS; NORSTOG KJ, 1986, BIOTROPICA, V18, P300, DOI 10.2307/2388573; Potter PE, 2009, EARTH-SCI REV, V96, P279, DOI 10.1016/j.earscirev.2009.07.003; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Quental TB, 2010, TRENDS ECOL EVOL, V25, P434, DOI 10.1016/j.tree.2010.05.002; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Schneider D, 2002, NATURWISSENSCHAFTEN, V89, P281, DOI 10.1007/s00114-002-0330-2; Taylor TN, 2009, PALEOBOTANY: THE BIOLOGY AND EVOLUTION OF FOSSIL PLANTS, 2ND EDITION, P1; Terry I, 2008, AUST J BOT, V56, P321, DOI 10.1071/BT06202; Terry I, 2007, SCIENCE, V318, P70, DOI 10.1126/science.1145147; Treutlein J, 2002, NATURWISSENSCHAFTEN, V89, P221, DOI 10.1007/s00114-002-0308-0; van der Bank H, 2001, BIOCHEM SYST ECOL, V29, P241, DOI 10.1016/S0305-1978(00)00064-8; Vovides A., 2003, CURR TOPICS PLANT BI, V4, P159; Vovides AP, 2008, BOT J LINN SOC, V157, P169, DOI 10.1111/j.1095-8339.2008.00793.x; Watson J., 2005, MONOGR PALAEONTOGR S, V622, P189; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zgurski JM, 2008, MOL PHYLOGENET EVOL, V47, P1232, DOI 10.1016/j.ympev.2008.03.002; Zhang Q, 2011, J SYST EVOL, V49, P315, DOI 10.1111/j.1759-6831.2011.00129.x	40	247	259	4	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 11	2011	334	6057					796	799		10.1126/science.1209926	http://dx.doi.org/10.1126/science.1209926			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845US	22021670				2022-12-28	WOS:000296849600044
J	Berwick, DM				Berwick, Donald M.			Making Good on ACOs' Promise - The Final Rule for the Medicare Shared Savings Program	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Berwick, Donald M.] Ctr Medicare Serv, Baltimore, MD USA; [Berwick, Donald M.] Ctr Medicaid Serv, Baltimore, MD USA	Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services	Berwick, DM (corresponding author), Ctr Medicare Serv, Baltimore, MD USA.								0	116	116	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 10	2011	365	19					1753	1756		10.1056/NEJMp1111671	http://dx.doi.org/10.1056/NEJMp1111671			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	844QQ	22013899				2022-12-28	WOS:000296762800001
J	Engheta, N				Engheta, Nader			Antenna-Guided Light	SCIENCE			English	Editorial Material							ELECTROMAGNETIC-FIELDS		Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA	University of Pennsylvania	Engheta, N (corresponding author), Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA.	engheta@ee.upenn.edu						Bliznyuk N, 2004, MICROW OPT TECHN LET, V40, P361, DOI 10.1002/mop.11382; Born M., 1980, PRINCIPLES OPTICS; Caiazzo M, 2004, IEEE ANTENN WIREL PR, V3, P261, DOI 10.1109/LAWP.2004.836576; Holloway CL, 2008, IET MICROW ANTENNA P, V2, P120, DOI 10.1049/iet-map:20060309; Kuester EF, 2003, IEEE T ANTENN PROPAG, V51, P2641, DOI 10.1109/TAP.2003.817560; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Padgett M, 2004, PHYS TODAY, V57, P35, DOI 10.1063/1.1768672; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pozar DM, 1997, IEEE T ANTENN PROPAG, V45, P287, DOI 10.1109/8.560348; Ryan CGM, 2010, IEEE T ANTENN PROPAG, V58, P1486, DOI 10.1109/TAP.2010.2044356; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713	11	36	38	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 21	2011	334	6054					317	318		10.1126/science.1213278	http://dx.doi.org/10.1126/science.1213278			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	22021846				2022-12-28	WOS:000296052500035
J	Salvesen, GS; Ashkenazi, A				Salvesen, Guy S.; Ashkenazi, Avi			SnapShot: Caspases	CELL			English	Editorial Material							ACTIVATION; APOPTOSIS; PLATFORM; DEATH		[Salvesen, Guy S.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Ashkenazi, Avi] Genentech Inc, San Francisco, CA 94080 USA	Sanford Burnham Prebys Medical Discovery Institute; Roche Holding; Genentech	Salvesen, GS (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.		Ashkenazi, Avi/ABG-2712-2020	Ashkenazi, Avi/0000-0002-6890-4589				Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kuranaga E, 2007, TRENDS CELL BIOL, V17, P135, DOI 10.1016/j.tcb.2007.01.001; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Manzl C, 2009, J CELL BIOL, V185, P291, DOI 10.1083/jcb.200811105; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714	10	41	43	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 14	2011	147	2							476.e1	10.1016/j.cell.2011.09.030	http://dx.doi.org/10.1016/j.cell.2011.09.030			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000022	Bronze			2022-12-28	WOS:000296199300023
J	Lee, FJ; Raleigh, J				Lee, Frederick J.; Raleigh, James			Tropical Calcific Pancreatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lee, Frederick J.] St Vincents Hosp, Sydney, NSW 2010, Australia; [Raleigh, James] Royal Prince Alfred Hosp, Sydney, NSW, Australia	St Vincents Hospital Sydney; University of Sydney	Lee, FJ (corresponding author), St Vincents Hosp, Sydney, NSW 2010, Australia.	flee3@stvincents.com.au							0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 13	2011	365	15					1425	1425		10.1056/NEJMicm1101168	http://dx.doi.org/10.1056/NEJMicm1101168			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832DQ	21995390				2022-12-28	WOS:000295782500010
J	Roth, C; Magnus, P; Schjolberg, S; Stoltenberg, C; Suren, P; McKeague, IW; Smith, GD; Reichborn-Kjennerud, T; Susser, E				Roth, Christine; Magnus, Per; Schjolberg, Synnve; Stoltenberg, Camilla; Suren, Pal; McKeague, Ian W.; Smith, George Davey; Reichborn-Kjennerud, Ted; Susser, Ezra			Folic Acid Supplements in Pregnancy and Severe Language Delay in Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEURAL-TUBE DEFECTS; PERICONCEPTIONAL VITAMIN SUPPLEMENTATION; NORWEGIAN MOTHER; DIETARY-SUPPLEMENTS; BIRTH COHORT; GENE; PREVENTION; FOLATE; OUTCOMES; WOMEN	Context Prenatal folic acid supplements reduce the risk of neural tube defects and may have beneficial effects on other aspects of neurodevelopment. Objective To examine associations between mothers' use of prenatal folic acid supplements and risk of severe language delay in their children at age 3 years. Design, Setting, and Patients The prospective observational Norwegian Mother and Child Cohort Study recruited pregnant women between 1999 and December 2008. Data on children born before 2008 whose mothers returned the 3-year follow-up questionnaire by June 16, 2010, were used. Maternal use of folic acid supplements within the interval from 4 weeks before to 8 weeks after conception was the exposure. Relative risks were approximated by estimating odds ratios (ORs) with 95% CIs in a logistic regression analysis. Main Outcome Measure Children's language competency at age 3 years measured by maternal report on a 6-point ordinal language grammar scale. Children with minimal expressive language (only 1-word or unintelligible utterances) were rated as having severe language delay. Results Among 38 954 children, 204 (0.5%) had severe language delay. Children whose mothers took no dietary supplements in the specified exposure interval were the reference group (n=9052 [24.0%], with severe language delay in 81 children [0.9%]). Adjusted ORs for 3 patterns of exposure to maternal dietary supplements were (1) other supplements, but no folic acid (n=2480 [6.6%], with severe language delay in 22 children [0.9%]; OR, 1.04; 95% CI, 0.62-1.74); (2) folic acid only (n=7127 [18.9%], with severe language delay in 28 children [0.4%]; OR, 0.55; 95% CI, 0.35-0.86); and (3) folic acid in combination with other supplements (n=19 005 [50.5%], with severe language delay in 73 children [0.4%]; OR, 0.55; 95% CI, 0.39-0.78). Conclusion Among this Norwegian cohort of mothers and children, maternal use of folic acid supplements in early pregnancy was associated with a reduced risk of severe language delay in children at age 3 years. JAMA. 2011;306(14):1566-1573	[Roth, Christine; Schjolberg, Synnve; Reichborn-Kjennerud, Ted] Norwegian Inst Publ Hlth, Div Mental Hlth, N-0403 Oslo, Norway; [Magnus, Per; Stoltenberg, Camilla; Suren, Pal] Norwegian Inst Publ Hlth, Div Epidemiol, N-0403 Oslo, Norway; [McKeague, Ian W.] Columbia Univ, Dept Biostat, New York, NY USA; [Susser, Ezra] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Roth, Christine; Susser, Ezra] Columbia Univ, Imprints Ctr Genet & Environm Life Course Studies, New York, NY USA; [Smith, George Davey] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Sch Social & Community Med, Bristol, Avon, England; [Reichborn-Kjennerud, Ted] Univ Oslo, Inst Psychiat, Oslo, Norway; [Susser, Ezra] New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Norwegian Institute of Public Health (NIPH); Norwegian Institute of Public Health (NIPH); Columbia University; Columbia University; Columbia University; University of Bristol; University of Oslo; New York State Psychiatry Institute	Roth, C (corresponding author), Norwegian Inst Publ Hlth, Div Mental Hlth, POB 4404, N-0403 Oslo, Norway.	christine.roth@fhi.no	Stoltenberg, Camilla/G-5090-2017; Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768	Norwegian Ministry of Health; Ministry of Education and Research; National Institutes of Health/National Institute of Environmental Health Sciences [N01-ES-85433]; National Institutes of Health/National Institute of Neurological Disorders and Stroke [1 UO1 NS 047537-01]; Norwegian Research Council/FUGE (Funksjonell genomforskning) [151918/S10]; National Alliance for Research on Schizophrenia and Depression; Norwegian Research Council [181847/V50]; American Women's Club of Oslo; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [N01ES085433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047537] Funding Source: NIH RePORTER; Medical Research Council [G0600705] Funding Source: researchfish; MRC [G0600705] Funding Source: UKRI	Norwegian Ministry of Health; Ministry of Education and Research; National Institutes of Health/National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Norwegian Research Council/FUGE (Funksjonell genomforskning)(Research Council of Norway); National Alliance for Research on Schizophrenia and Depression(NARSAD); Norwegian Research Council(Research Council of NorwayEuropean Commission); American Women's Club of Oslo; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Norwegian Ministry of Health and the Ministry of Education and Research, and grants N01-ES-85433 from the National Institutes of Health/National Institute of Environmental Health Sciences, 1 UO1 NS 047537-01 from the National Institutes of Health/National Institute of Neurological Disorders and Stroke, and 151918/S10 from the Norwegian Research Council/FUGE (Funksjonell genomforskning). Dr Susser was supported in part by a National Alliance for Research on Schizophrenia and Depression distinguished investigator award. Dr Roth was supported by grant 181847/V50 from the Norwegian Research Council and by a travel grant from the American Women's Club of Oslo.	Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Brantsaeter AL, 2007, ANN NUTR METAB, V51, P146, DOI 10.1159/000103275; Clegg J, 2005, J CHILD PSYCHOL PSYC, V46, P128, DOI 10.1111/j.1469-7610.2004.00342.x; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; Dale PS, 2003, J SPEECH LANG HEAR R, V46, P544, DOI 10.1044/1092-4388(2003/044); Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Feldman HM, 2005, CHILD DEV, V76, P856, DOI 10.1111/j.1467-8624.2005.00882.x; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Haberg SE, 2009, ARCH DIS CHILD, V94, P180, DOI 10.1136/adc.2008.142448; Haberg SE, 2011, J ALLERGY CLIN IMMUN, V127, P262, DOI 10.1016/j.jaci.2010.10.004; Haugen M, 2008, ANN NUTR METAB, V52, P272, DOI 10.1159/000146274; Iskandar BJ, 2010, J CLIN INVEST, V120, P1603, DOI 10.1172/JCI40000; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Johansson M, 2010, JAMA-J AM MED ASSOC, V303, P2377, DOI 10.1001/jama.2010.808; Julvez J, 2009, PAEDIATR PERINAT EP, V23, P199, DOI 10.1111/j.1365-3016.2009.01032.x; Lawlor DA, 2004, LANCET, V363, P1724, DOI 10.1016/S0140-6736(04)16260-0; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; McClellan JM, 2006, JAMA-J AM MED ASSOC, V296, P582, DOI 10.1001/jama.296.5.582; MILUNSKY A, 1989, JAMA-J AM MED ASSOC, V262, P2847, DOI 10.1001/jama.262.20.2847; Miniscalco C, 2006, DEV MED CHILD NEUROL, V48, P361, DOI 10.1017/S0012162206000788; Nilsen RM, 2006, AM J CLIN NUTR, V84, P1134, DOI 10.1093/ajcn/84.5.1134; Nilsen RM, 2010, J NUTR, V140, P572, DOI 10.3945/jn.109.118158; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; Relton CL, 2004, J MED GENET, V41, P256, DOI 10.1136/jmg.2003.010694; Rice ML, 2008, J SPEECH LANG HEAR R, V51, P394, DOI 10.1044/1092-4388(2008/029); Ronningen KS, 2006, EUR J EPIDEMIOL, V21, P619, DOI 10.1007/s10654-006-9041-x; Roza SJ, 2010, BRIT J NUTR, V103, P445, DOI 10.1017/S0007114509991954; Schlotz W, 2010, J CHILD PSYCHOL PSYC, V51, P594, DOI 10.1111/j.1469-7610.2009.02182.x; Schmidt RJ, 2011, EPIDEMIOLOGY, V22, P476, DOI 10.1097/EDE.0b013e31821d0e30; SMITHELLS RW, 1980, LANCET, V1, P339; Sparrow SS., 2005, VINELAND ADAPTIVE BE, V2nd ed, DOI [10.1037/t15164-000, DOI 10.1037/T15164-000]; Squires J, 1997, J PEDIATR PSYCHOL, V22, P313, DOI 10.1093/jpepsy/22.3.313; Steegers-Theunissen RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007845; Stoltenberg C, 2010, MOL PSYCHIATR, V15, P676, DOI 10.1038/mp.2009.143; WALD N, 1991, LANCET, V338, P131; Wehby GL, 2008, MATERN CHILD HLTH J, V12, P180, DOI 10.1007/s10995-007-0230-3; Zeisel SH, 2009, AM J CLIN NUTR, V89, p673S, DOI 10.3945/ajcn.2008.26811D	37	170	177	1	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 12	2011	306	14					1566	1573		10.1001/jama.2011.1433	http://dx.doi.org/10.1001/jama.2011.1433			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831FS	21990300	Green Accepted, Bronze			2022-12-28	WOS:000295714700022
J	Jack, A				Jack, Andrew			DRUG REGULATION Letting the sunshine in on doctor-pharma relationships	BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Jack, A (corresponding author), Financial Times, London, England.	Andrew.Jack@FT.Com		Jack, Andrew/0000-0001-9679-2898				Arie S, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4979; *DAN MED AG, 2010, GUID NOT INF DOCT DE; *GEN MED COUNC, GOOD MED PRACT CONFL; JACK A, 2011, FINANCIAL TIMES 0829; *PROPUBLICA, 2011, DOLL DOCS	5	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 11	2011	343								d6459	10.1136/bmj.d6459	http://dx.doi.org/10.1136/bmj.d6459			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835EJ	21990283				2022-12-28	WOS:000296017500008
J	Spence, D				Spence, Des			FROM THE FRONTLINE Doctor speak	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 11	2011	343								d6537	10.1136/bmj.d6537	http://dx.doi.org/10.1136/bmj.d6537			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	835EJ	21990155				2022-12-28	WOS:000296017500015
J	Ginsburg, PB				Ginsburg, Paul B.			Reforming Provider Payment - The Price Side of the Equation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ginsburg, Paul B.] Ctr Studying Hlth Syst Change, Washington, DC USA; [Ginsburg, Paul B.] Natl Inst Hlth Care Reform, Washington, DC USA	National Institutes of Health (NIH) - USA	Ginsburg, PB (corresponding author), Ctr Studying Hlth Syst Change, Washington, DC USA.							*AM HOSP AS, 2011, TRENDW CHARTB 2011 T; FELLAND LE, 2011, KEY FINDINGS HSCS 20; *OFF MA ATT GEN M, 2011, EX HLTH CAR COST TRE	3	4	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 6	2011	365	14					1268	1270		10.1056/NEJMp1107019	http://dx.doi.org/10.1056/NEJMp1107019			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829KL	21991947				2022-12-28	WOS:000295578700002
J	McDonough, JE; Yuan, R; Suzuki, M; Seyednejad, N; Elliott, WM; Sanchez, PG; Wright, AC; Gefter, WB; Litzky, L; Coxson, HO; Pare, PD; Sin, DD; Pierce, RA; Woods, JC; McWilliams, AM; Mayo, JR; Lam, SC; Cooper, JD; Hogg, JC				McDonough, John E.; Yuan, Ren; Suzuki, Masaru; Seyednejad, Nazgol; Elliott, W. Mark; Sanchez, Pablo G.; Wright, Alexander C.; Gefter, Warren B.; Litzky, Leslie; Coxson, Harvey O.; Pare, Peter D.; Sin, Don D.; Pierce, Richard A.; Woods, Jason C.; McWilliams, Annette M.; Mayo, John R.; Lam, Stephen C.; Cooper, Joel D.; Hogg, James C.			Small-Airway Obstruction and Emphysema in Chronic Obstructive Pulmonary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE IIB TRIAL; LUNGS; DYSPLASIA; PRESSURE; SMOKERS; NUMBER; SITE	BACKGROUND The major sites of obstruction in chronic obstructive pulmonary disease (COPD) are small airways (<2 mm in diameter). We wanted to determine whether there was a relationship between small-airway obstruction and emphysematous destruction in COPD. METHODS We used multidetector computed tomography (CT) to compare the number of airways measuring 2.0 to 2.5 mm in 78 patients who had various stages of COPD, as judged by scoring on the Global Initiative for Chronic Obstructive Lung Disease (GOLD) scale, in isolated lungs removed from patients with COPD who underwent lung transplantation, and in donor (control) lungs. MicroCT was used to measure the extent of emphysema (mean linear intercept), the number of terminal bronchioles per milliliter of lung volume, and the minimum diameters and cross-sectional areas of terminal bronchioles. RESULTS On multidetector CT, in samples from patients with COPD, as compared with control samples, the number of airways measuring 2.0 to 2.5 mm in diameter was reduced in patients with GOLD stage 1 disease (P = 0.001), GOLD stage 2 disease (P = 0.02), and GOLD stage 3 or 4 disease (P<0.001). MicroCT of isolated samples of lungs removed from patients with GOLD stage 4 disease showed a reduction of 81 to 99.7% in the total cross-sectional area of terminal bronchioles and a reduction of 72 to 89% in the number of terminal bronchioles (P<0.001). A comparison of the number of terminal bronchioles and dimensions at different levels of emphysematous destruction (i.e., an increasing value for the mean linear intercept) showed that the narrowing and loss of terminal bronchioles preceded emphysematous destruction in COPD (P<0.001). CONCLUSIONS These results show that narrowing and disappearance of small conducting airways before the onset of emphysematous destruction can explain the increased peripheral airway resistance reported in COPD. (Funded by the National Heart, Lung, and Blood Institute and others.)	[McDonough, John E.; Yuan, Ren; Suzuki, Masaru; Seyednejad, Nazgol; Elliott, W. Mark; Coxson, Harvey O.; Pare, Peter D.; Sin, Don D.; Hogg, James C.] Univ British Columbia, James Hogg Res Ctr, St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; [Pare, Peter D.; Sin, Don D.] Univ British Columbia, Div Resp, Dept Med, Vancouver, BC V6Z 1Y6, Canada; [McWilliams, Annette M.; Lam, Stephen C.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Coxson, Harvey O.; Mayo, John R.] Vancouver Gen Hosp, Dept Radiol, Vancouver, BC V5Z 1M9, Canada; [Sanchez, Pablo G.; Cooper, Joel D.] Univ Penn, Div Thorac Surg, Philadelphia, PA 19104 USA; [Wright, Alexander C.; Gefter, Warren B.] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [Litzky, Leslie] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA; [Pierce, Richard A.] Washington Univ, Dept Internal Med, St Louis, MO 63130 USA; [Woods, Jason C.] Washington Univ, Dept Radiol, St Louis, MO 63130 USA	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Washington University (WUSTL); Washington University (WUSTL)	Hogg, JC (corresponding author), Univ British Columbia, James Hogg Res Ctr, St Pauls Hosp, 166-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	jim.hogg@hli.ubc.ca	Sin, Don/AAC-2219-2021; Pare, Peter D/C-7425-2011; Coxson, Harvey O/A-9861-2017; Suzuki, Masaru/H-2087-2012	Coxson, Harvey O/0000-0001-5750-9711; Suzuki, Masaru/0000-0002-2124-6793; McDonough, John/0000-0003-2497-0258	National Heart, Lung, and Blood Institute [HL084922, HL084948, HL062194, HL090806]; Canadian Institute of Health Research-Thoracic Imaging Network of Canada; Canadian Collaborative Innovative Research Fund; GlaxoSmithKline; Lavin Family Supporting Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090806, P50HL084922, P50HL084948, R01HL062194] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Canadian Institute of Health Research-Thoracic Imaging Network of Canada(Canadian Institutes of Health Research (CIHR)); Canadian Collaborative Innovative Research Fund; GlaxoSmithKline(GlaxoSmithKline); Lavin Family Supporting Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the National Heart, Lung, and Blood Institute and others.; Supported by grants (HL084922, HL084948, HL062194, and HL090806) from the National Heart, Lung, and Blood Institute, by the Canadian Institute of Health Research-Thoracic Imaging Network of Canada, by the Canadian Collaborative Innovative Research Fund, by GlaxoSmithKline, and by the Lavin Family Supporting Foundation.	BIGNON J, 1969, AM REV RESPIR DIS, V99, P669; Choong CK, 2005, J THORAC CARDIOV SUR, V130, P922, DOI 10.1016/j.jtcvs.2005.03.046; Diaz AA, 2010, CHEST, V138, P880, DOI 10.1378/chest.10-0542; DUNNILL M. S., 1962, THORAX, V17, P320, DOI 10.1136/thx.17.4.320; HOGG JC, 1968, NEW ENGL J MED, V278, P1355, DOI 10.1056/NEJM196806202782501; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Howard C, 1998, UNBIASED STEREOLOGY; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Lam S, 2004, CLIN CANCER RES, V10, P6502, DOI 10.1158/1078-0432.CCR-04-0686; Lam S, 2002, JNCI-J NATL CANCER I, V94, P1001; LEOPOLD J. G., 1957, THORAX, V12, P219, DOI 10.1136/thx.12.3.219; MATSUBA K, 1972, AM J PATHOL, V67, P265; McWilliams AM, 2006, J THORAC ONCOL, V1, P61, DOI 10.1097/01243894-200601000-00012; PEDLEY TJ, 1970, RESP PHYSIOL, V9, P387, DOI 10.1016/0034-5687(70)90094-0; Robbesom AA, 2003, MODERN PATHOL, V16, P1, DOI 10.1097/01.MP.0000043519.29370.C2; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; VANBRABANDT H, 1983, J APPL PHYSIOL, V55, P1733, DOI 10.1152/jappl.1983.55.6.1733; Weibel E.R., 1963, MORPHOMETRY HUMAN LU, DOI DOI 10.1007/978-3-642-87553-3; YANAI M, 1992, J APPL PHYSIOL, V72, P1016, DOI 10.1152/jappl.1992.72.3.1016	19	730	752	1	69	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2011	365	17					1567	1575		10.1056/NEJMoa1106955	http://dx.doi.org/10.1056/NEJMoa1106955			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HI	22029978	Green Accepted			2022-12-28	WOS:000296181800001
J	Sicardy, B; Ortiz, JL; Assafin, M; Jehin, E; Maury, A; Lellouch, E; Hutton, RG; Braga-Ribas, F; Colas, F; Hestroffer, D; Lecacheux, J; Roques, F; Santos-Sanz, P; Widemann, T; Morales, N; Duffard, R; Thirouin, A; Castro-Tirado, AJ; Jelinek, M; Kubanek, P; Sota, A; Sanchez-Ramirez, R; Andrei, AH; Camargo, JIB; Neto, DND; Gomes, AR; Martins, RV; Gillon, M; Manfroid, J; Tozzi, GP; Harlingten, C; Saravia, S; Behrend, R; Mottola, S; Melendo, EG; Peris, V; Fabregat, J; Madiedo, JM; Cuesta, L; Eibe, MT; Ullan, A; Organero, F; Pastor, S; de los Reyes, JA; Pedraz, S; Castro, A; de la Cueva, I; Muler, G; Steele, IA; Cebrian, M; Montanes-Rodriguez, P; Oscoz, A; Weaver, D; Jacques, C; Corradi, WJB; Santos, FP; Reis, W; Milone, A; Emilio, M; Gutierrez, L; Vazquez, R; Hernandez-Toledo, H				Sicardy, B.; Ortiz, J. L.; Assafin, M.; Jehin, E.; Maury, A.; Lellouch, E.; Gil Hutton, R.; Braga-Ribas, F.; Colas, F.; Hestroffer, D.; Lecacheux, J.; Roques, F.; Santos-Sanz, P.; Widemann, T.; Morales, N.; Duffard, R.; Thirouin, A.; Castro-Tirado, A. J.; Jelinek, M.; Kubanek, P.; Sota, A.; Sanchez-Ramirez, R.; Andrei, A. H.; Camargo, J. I. B.; da Silva Neto, D. N.; Ramos Gomes, A., Jr.; Vieira Martins, R.; Gillon, M.; Manfroid, J.; Tozzi, G. P.; Harlingten, C.; Saravia, S.; Behrend, R.; Mottola, S.; Garcia Melendo, E.; Peris, V.; Fabregat, J.; Madiedo, J. M.; Cuesta, L.; Eibe, M. T.; Ullan, A.; Organero, F.; Pastor, S.; de los Reyes, J. A.; Pedraz, S.; Castro, A.; de la Cueva, I.; Muler, G.; Steele, I. A.; Cebrian, M.; Montanes-Rodriguez, P.; Oscoz, A.; Weaver, D.; Jacques, C.; Corradi, W. J. B.; Santos, F. P.; Reis, W.; Milone, A.; Emilio, M.; Gutierrez, L.; Vazquez, R.; Hernandez-Toledo, H.			A Pluto-like radius and a high albedo for the dwarf planet Eris from an occultation	NATURE			English	Article							OBJECT; ATMOSPHERE; METHANE; UB313; SIZE; TNOS; COOL; NIX	The dwarf planet Eris is a trans-Neptunian object with an orbital eccentricity of 0.44, an inclination of 44 degrees and a surface composition very similar to that of Pluto(1). It resides at present at 95.7 astronomical units (1 AU is the Earth-Sun distance) from Earth, near its aphelion and more than three times farther than Pluto. Owing to this great distance, measuring its size or detecting a putative atmosphere is difficult. Here we report the observation of a multi-chord stellar occultation by Eris on 6 November 2010 UT. The event is consistent with a spherical shape for Eris, with radius 1,163 +/- 6 kilometres, density 2.52 +/- 0.05 grams per cm(3) and a high visible geometric albedo, p(V) = 0.96(-0.04)(+0.09). No nitrogen, argon or methane atmospheres are detected with surface pressure larger than similar to 1 nanobar, about 10,000 times more tenuous than Pluto's present atmosphere(2-5). As Pluto's radius is estimated(3-8) to be between 1,150 and 1,200 kilometres, Eris appears as a Pluto twin, with a bright surface possibly caused by a collapsed atmosphere, owing to its cold environment. We anticipate that this atmosphere may periodically sublimate as Eris approaches its perihelion, at 37.8 astronomical units from the Sun.	[Sicardy, B.; Lellouch, E.; Braga-Ribas, F.; Lecacheux, J.; Roques, F.; Santos-Sanz, P.; Widemann, T.] Univ Paris Diderot, Univ Paris 06, CNRS, LESIA Observ Paris, F-92195 Meudon, France; [Sicardy, B.] Univ Paris 06, F-75252 Paris 5, France; [Sicardy, B.] Inst Univ France, F-75005 Paris, France; [Ortiz, J. L.; Morales, N.; Duffard, R.; Thirouin, A.; Castro-Tirado, A. J.; Jelinek, M.; Kubanek, P.; Sota, A.; Sanchez-Ramirez, R.] CSIC, Inst Astrofis Andalucia, E-18080 Granada, Spain; [Assafin, M.; Andrei, A. H.; Camargo, J. I. B.; Ramos Gomes, A., Jr.; Vieira Martins, R.] Observ Valongo UFRJ, BR-20080090 Rio De Janeiro, Brazil; [Jehin, E.; Gillon, M.; Manfroid, J.] Univ Liege, Inst Astrophys, B-4000 Liege, Belgium; [Maury, A.; Saravia, S.] San Pedro de Atacama Celestial Explorat, San Pedro De Atacama, Chile; [Gil Hutton, R.] Complejo Astron El Leoncito CASLEO, San Juan, Argentina; [Gil Hutton, R.] San Juan Natl Univ, San Juan, Argentina; [Braga-Ribas, F.; Andrei, A. H.; Camargo, J. I. B.; da Silva Neto, D. N.; Vieira Martins, R.] Observ Nacl MCT, BR-20921400 Rio De Janeiro, Brazil; [Colas, F.; Hestroffer, D.; Vieira Martins, R.] Univ Lille 1, Univ Paris 06, CNRS, IMCCE Observ Paris, F-75014 Paris, France; [da Silva Neto, D. N.] Ctr Univ Estadual Zona Oeste, BR-23070200 Rio De Janeiro, Brazil; [Tozzi, G. P.] Osserv Astrofis Arcetri, INAF, I-50125 Florence, Italy; [Harlingten, C.] Caisey Harlingten Observ, Erpingham NR11 7QX, Norfolk, England; [Behrend, R.] Observ Geneva, CH-1290 Sauverny, Switzerland; [Mottola, S.] DLR German Aerosp Ctr, D-12489 Berlin, Germany; [Garcia Melendo, E.] Fundacio Privada Observ Esteve Duran, Seva 08553, Spain; [Garcia Melendo, E.] Fac Ciencies, Inst Ciencies Espai CSIC IEEC, Bellaterra 08193, Spain; [Peris, V.; Fabregat, J.] Univ Valencia, Astron Observ, Paterna 46980, Spain; [Madiedo, J. M.] Univ Huelva, Fac Ciencias Expt, Huelva 21071, Spain; [Cuesta, L.; Eibe, M. T.; Ullan, A.] Ctr Astrobiol CSIC INTA, Madrid 28850, Spain; [Organero, F.] Observ Astron La Hita, La Puebla De Almoradiel 45840, Toledo, Spain; [Pastor, S.; de los Reyes, J. A.] Observ Murta, Murcia 30153, Spain; [Pedraz, S.] Ctr Astron Hispano Aleman, Calar Alto Observ, Almeria 04004, Spain; [Castro, A.] Ctr Cultural Jose Maria Gutierrez Romero, Soc Malaguena Astron, Malaga 29016, Spain; [de la Cueva, I.] Astroimagen, Ibiza 07800, Spain; [Muler, G.] Observ Nazaret, Nazaret 35539, Lanzarote, Spain; [Steele, I. A.] Liverpool JMU, Birkenhead CH41 1LD, Merseyside, England; [Cebrian, M.; Montanes-Rodriguez, P.; Oscoz, A.] Inst Astrofis Canarias, Tenerife 38205, Spain; [Weaver, D.] Colegio Christus, Observ Astron Christus, BR-60140140 Fortaleza, Ceara, Brazil; [Jacques, C.] Observ CEAMIG REA, BR-31545120 Belo Horizonte, MG, Brazil; [Corradi, W. J. B.; Santos, F. P.; Reis, W.] Univ Fed Minas Gerais, Inst Ciencias Exatas, Dept Fis, BR-31270901 Belo Horizonte, MG, Brazil; [Milone, A.] Inst Nacl Pesquisas Espaciais INPE MCT, Div Astrofis, BR-12227010 Sao Jose Dos Campos, Brazil; [Emilio, M.] Univ Estadual Ponta Grossa, OA DEGEO, BR-84030900 Ponta Grossa, PR, Brazil; [Gutierrez, L.; Vazquez, R.] Univ Nacl Autonoma Mexico, Inst Astron, Ensenada 22860, Baja California, Mexico; [Hernandez-Toledo, H.] Univ Nacl Autonoma Mexico, Inst Astron, Mexico City 04510, DF, Mexico	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Institut Universitaire de France; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); Universidade Federal do Rio de Janeiro; University of Liege; Universidad Nacional de San Juan; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite de Lille - ISITE; Universite de Lille; Centro Universitario Estadual da Zona Oeste; Istituto Nazionale Astrofisica (INAF); University of Geneva; Helmholtz Association; German Aerospace Centre (DLR); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); University of Barcelona; University of Valencia; Universidad de Huelva; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Liverpool John Moores University; Instituto de Astrofisica de Canarias; Universidade Federal de Minas Gerais; Instituto Nacional de Pesquisas Espaciais (INPE); Universidade Estadual de Ponta Grossa; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Sicardy, B (corresponding author), Univ Paris Diderot, Univ Paris 06, CNRS, LESIA Observ Paris, 11 Rue Marcelin Berthelot, F-92195 Meudon, France.	bruno.sicardy@obspm.fr	Vázquez, Roberto/L-3613-2016; Madiedo, Jose/AAD-8811-2022; Bueno de Camargo, Julio Ignacio/C-3145-2013; Kubánek, Petr/G-7209-2014; Reyes, José Antonio Reyes/GXZ-6957-2022; Andrei, Alexandre H/M-4597-2017; Ortiz, Jose L./L-3192-2014; Sota, Alfredo/ABE-3298-2020; Duffard, Rene/A-2233-2009; Fabregat, Juan/F-9066-2016; Santos-Sanz, Pablo/O-1308-2019; Corradi, Wagner J.B./C-1896-2015; de Castro Milone, Andre/B-8489-2012; Júnior, Altair Ramos Gomes/AAB-6776-2021; Emilio, Marcelo/C-4118-2011; Jelínek, Martin/E-5290-2016; Ribas, Felipe Braga/H-4727-2012; Pedraz, Santos/M-5207-2015; Assafin, Marcelo/C-3188-2013	Vázquez, Roberto/0000-0002-3279-9764; Bueno de Camargo, Julio Ignacio/0000-0002-1642-4065; Kubánek, Petr/0000-0002-1877-1386; Andrei, Alexandre H/0000-0001-8154-7646; Ortiz, Jose L./0000-0002-8690-2413; Sota, Alfredo/0000-0002-9404-6952; Duffard, Rene/0000-0001-5963-5850; Fabregat, Juan/0000-0002-5986-9347; Santos-Sanz, Pablo/0000-0002-1123-983X; Corradi, Wagner J.B./0000-0002-5150-5282; de Castro Milone, Andre/0000-0002-6725-1109; Júnior, Altair Ramos Gomes/0000-0002-3362-2127; Emilio, Marcelo/0000-0001-5589-9015; Jelínek, Martin/0000-0003-3922-7416; Ribas, Felipe Braga/0000-0003-2311-2438; Pedraz, Santos/0000-0003-1346-208X; Madiedo, Jose Maria/0000-0003-0806-5194; Castro-Tirado, A. J./0000-0003-2999-3563; Gillon, Michael/0000-0003-1462-7739; Montanes Rodriguez, Pilar/0000-0002-6855-9682; Morales Palomino, Nicolas F./0000-0003-0419-1599; Sanchez-Ramirez, Ruben/0000-0002-7158-5099; Tozzi, Gian Paolo/0000-0003-4775-5788; Assafin, Marcelo/0000-0002-8211-0777; HESTROFFER, Daniel/0000-0003-0472-9459; Thirouin, Audrey/0000-0002-1506-4248	French grant 'Beyond Neptune'; Institut Universitaire de France; Spanish AYA grants; FEDER; Belgian Fund for Scientific Research (FRS-FNRS); CNPq; FAPERJ; CDFB/CAPES, Brazil; STFC [PP/E001149/1, ST/H002391/1, ST/G009465/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/H002391/1, PP/E001149/1, ST/G009465/1] Funding Source: researchfish	French grant 'Beyond Neptune'; Institut Universitaire de France; Spanish AYA grants; FEDER(European Commission); Belgian Fund for Scientific Research (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CDFB/CAPES, Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank W. M. Owen and S. Preston for providing astrometric updates on the occulted star just before the observations, and I. Belskaya and M. E. Brown for discussions when writing the paper. We acknowledge support from the French grant 'Beyond Neptune' and from the Institut Universitaire de France. J.L.O., A.J.C.-T., L. C. and M. T. E. acknowledge funding from Spanish AYA grants and FEDER funds. TRAPPIST is a project funded by the Belgian Fund for Scientific Research (FRS-FNRS) with the participation of the Swiss National Science Foundation (SNF). J.I.B.C. acknowledges CNPq and FAPERJ grants. F.B.-R. acknowledges the support of CDFB/CAPES, Brazil. W.J.B.C., W. R. and F. P. S. thank the Brazilian Agency FAPEMIG.	Assafin M, 2010, ASTRON ASTROPHYS, V515, DOI 10.1051/0004-6361/200913690; Bertoldi F, 2006, NATURE, V439, P563, DOI 10.1038/nature04494; Brown ME, 2006, ASTROPHYS J, V643, pL61, DOI 10.1086/504843; Brown ME, 2005, ASTROPHYS J, V635, pL97, DOI 10.1086/499336; Brown ME, 2007, SCIENCE, V316, P1585, DOI 10.1126/science.1139415; Brucker MJ, 2009, ICARUS, V201, P284, DOI 10.1016/j.icarus.2008.12.040; Duffard R, 2008, ASTRON ASTROPHYS, V479, P877, DOI 10.1051/0004-6361:20078619; Elliot JL, 2007, ASTRON J, V134, P1, DOI 10.1086/517998; Elliot JL, 2010, NATURE, V465, P897, DOI 10.1038/nature09109; Howett CJA, 2010, ICARUS, V206, P573, DOI 10.1016/j.icarus.2009.07.016; Lacerda P, 2007, ASTRON J, V133, P1393, DOI 10.1086/511772; Lellouch E, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014648; Lellouch E, 2009, ASTRON ASTROPHYS, V495, pL17, DOI 10.1051/0004-6361/200911633; McKinnon W. B., 2008, SOLAR SYSTEM NEPTUNE, P213; Muller TG, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014683; Rabinowitz DL, 2006, ASTROPHYS J, V639, P1238, DOI 10.1086/499575; Sheppard SS, 2007, ASTRON J, V134, P787, DOI 10.1086/519072; Stansberry J., 2008, SOLAR SYSTEM NEPTUNE, V161; Tegler SC, 2010, ASTROPHYS J, V725, P1296, DOI 10.1088/0004-637X/725/1/1296; Tholen DJ, 2008, ASTRON J, V135, P777, DOI 10.1088/0004-6256/135/3/777; THOLEN DJ, 1997, PLUTO CHARON, P193; THOLEN DJ, 1990, B AM ASTRON SOC, V22, P1129; Verbiscer A, 2007, SCIENCE, V315, P815, DOI 10.1126/science.1134681; Yelle R.V., 1997, PLUTO CHARON PART 4, P347; Young E. F., 1994, ICARUS, V108, P186; Zalucha AM, 2011, ICARUS, V211, P804, DOI 10.1016/j.icarus.2010.08.018	26	120	120	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2011	478	7370					493	496		10.1038/nature10550	http://dx.doi.org/10.1038/nature10550			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	22031441	Green Submitted			2022-12-28	WOS:000296194200038
J	Jardine, AG; Gaston, RS; Fellstrom, BC; Holdaas, H				Jardine, Alan G.; Gaston, Robert S.; Fellstrom, Bengt C.; Holdaas, Hallvard			Organ Transplantation 2 Prevention of cardiovascular disease in adult recipients of kidney transplants	LANCET			English	Article							EARLY CYCLOSPORINE WITHDRAWAL; LEFT-VENTRICULAR MASS; RENAL-TRANSPLANTATION; NEW-ONSET; DIABETES-MELLITUS; LONG-TERM; GRAFT-SURVIVAL; BLOOD-PRESSURE; GLUCOSE-METABOLISM; CARDIAC OUTCOMES	Although advances in immunosuppression, tissue typing, surgery, and medical management have made transplantation a routine and preferred treatment for patients with irreversible renal failure, successful transplant recipients have a greatly increased risk of premature mortality because of cardiovascular disease and malignancy compared with the general population. Conventional cardiovascular risk factors such as hyperlipidaemia, hypertension, and diabetes are common in transplant recipients, partly because of the effects of immunosuppressive drugs, and are associated with adverse outcomes. However, the natural history of cardiovascular disease in such recipients differs from that in the general population, and only statin therapy has been studied in a large-scale interventional trial. Thus, the management of this disease and the balance between management of conventional risk factors and modification of immunosuppression is complex.	[Jardine, Alan G.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow G12 8TA, Lanark, Scotland; [Gaston, Robert S.] Univ Alabama Birmingham, Birmingham, AL USA; [Fellstrom, Bengt C.] Uppsala Univ, Uppsala, Sweden; [Holdaas, Hallvard] Univ Oslo, Rikshosp, N-0027 Oslo, Norway	University of Glasgow; University of Alabama System; University of Alabama Birmingham; Uppsala University; University of Oslo; National Hospital Norway	Jardine, AG (corresponding author), Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow G12 8TA, Lanark, Scotland.	alan.jardine@glasgow.ac.uk	Jardine, Alan/L-5770-2019; Gaston, Robert/AAR-2932-2020	Jardine, Alan/0000-0001-5815-9370	Novartis; Astellas; Pfizer; Bristol-Myers Squibb; AstraZeneca; Merck Sharp Dohme	Novartis(Novartis); Astellas(Astellas Pharmaceuticals); Pfizer(Pfizer); Bristol-Myers Squibb(Bristol-Myers Squibb); AstraZeneca(AstraZeneca); Merck Sharp Dohme(Merck & Company)	AGJ, HH, and BCF have received honoraria and consultancy fees from Novartis, Astellas, Pfizer, Bristol-Myers Squibb, AstraZeneca, and Merck Sharp & Dohme in the specialties of cardiovascular disease and transplantation. RSG has received honoraria and consultancy fees from Novartis and Astellas.	Abedini S, 2010, KIDNEY INT, V77, P44, DOI 10.1038/ki.2009.382; Abedini S, 2009, CLIN J AM SOC NEPHRO, V4, P1246, DOI 10.2215/CJN.00930209; Baigent C, 2000, LANCET, V356, P147, DOI 10.1016/S0140-6736(00)02456-9; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Ballantyne CM, 2003, ARCH INTERN MED, V163, P553, DOI 10.1001/archinte.163.5.553; Baron C, 2010, CURR OPIN ORGAN TRAN, V15, P492, DOI 10.1097/MOT.0b013e32833bd3b5; Bostom AG, 2011, CIRCULATION, V123, P1763, DOI 10.1161/CIRCULATIONAHA.110.000588; Cole EH, 2008, CLIN J AM SOC NEPHRO, V3, P814, DOI 10.2215/CJN.04681107; Cosio FG, 2002, AM J KIDNEY DIS, V40, P638, DOI 10.1053/ajkd.2002.34927; Eckardt KU, 2009, AM J TRANSPLANT, V9, pS1, DOI 10.1111/j.1600-6143.2009.02834.x; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Gaston RS, 2009, AM J TRANSPLANT, V9, P1811, DOI 10.1111/j.1600-6143.2009.02696.x; Ghisdal L, 2009, J AM SOC NEPHROL, V20, P2459, DOI 10.1681/ASN.2008121314; Heinze G, 2006, J AM SOC NEPHROL, V17, P889, DOI 10.1681/ASN.2005090955; Heinze G, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4018; Hillebrand U, 2009, TRANSPL INT, V22, P1073, DOI 10.1111/j.1432-2277.2009.00922.x; Hjelmesaeth J, 2006, KIDNEY INT, V69, P588, DOI 10.1038/sj.ki.5000116; Holdaas H, 2005, AM J TRANSPLANT, V5, P2929, DOI 10.1111/j.1600-6143.2005.01105.x; Holdaas H, 2003, LANCET, V361, P2024, DOI 10.1016/S0140-6736(03)13638-0; Holdaas H, 2001, KIDNEY INT, V60, P1990, DOI 10.1046/j.1523-1755.2001.00010.x; Holdaas H., 2009, CLIN LIPIDOL, P486; Israni AK, 2010, AM J TRANSPLANT, V10, P338, DOI 10.1111/j.1600-6143.2009.02949.x; Jardine AG, 2005, AM J KIDNEY DIS, V46, P529, DOI 10.1053/j.ajkd.2005.05.014; Johnson RWG, 2001, TRANSPLANTATION, V72, P777, DOI 10.1097/00007890-200109150-00007; Johnston O, 2008, J AM SOC NEPHROL, V19, P1411, DOI 10.1681/ASN.2007111202; Joss N, 2007, CLIN TRANSPLANT, V21, P136, DOI 10.1111/j.1399-0012.2006.00580.x; Kasiske BL, 2000, J AM SOC NEPHROL, V11, P753, DOI 10.1681/ASN.V114753; Kasiske BL, 2003, AM J TRANSPLANT, V3, P178, DOI 10.1034/j.1600-6143.2003.00010.x; Kasiske BL, 1996, J AM SOC NEPHROL, V7, P158; Kasiske BL, 2000, J AM SOC NEPHROL, V11, P1735, DOI 10.1681/ASN.V1191735; Knight SR, 2010, TRANSPLANTATION, V89, P1, DOI 10.1097/TP.0b013e3181c518cc; KOBASHIGAWA JA, 1995, NEW ENGL J MED, V333, P621, DOI 10.1056/NEJM199509073331003; Kotton CN, 2010, NAT REV NEPHROL, V6, P711, DOI 10.1038/nrneph.2010.141; Larsen CP, 2010, TRANSPLANTATION, V90, P1528, DOI 10.1097/TP.0b013e3181ff87cd; Lentine KL, 2011, TRANSPLANTATION, V91, P1120, DOI 10.1097/TP.0b013e31821570c8; Luan FL, 2010, TRANSPLANTATION, V89, P1034, DOI 10.1097/TP.0b013e3181d05a90; Mark PB, 2006, KIDNEY INT, V69, P1839, DOI 10.1038/sj.ki.5000249; Midtvedt K, 2004, J AM SOC NEPHROL, V15, P3233, DOI 10.1097/01.ASN.0000145435.80005.1E; Midtvedt K, 2001, TRANSPLANTATION, V72, P107, DOI 10.1097/00007890-200107150-00021; Miller LW, 2002, AM J TRANSPLANT, V2, P807, DOI 10.1034/j.1600-6143.2002.20902.x; Oberbauer R, 2005, TRANSPLANT INT, V18, P22, DOI 10.1111/j.1432-2277.2004.00052.x; Opelz G, 2005, AM J TRANSPLANT, V5, P2725, DOI 10.1111/j.1600-6143.2005.01093.x; Opelz G, 1998, KIDNEY INT, V53, P217, DOI 10.1046/j.1523-1755.1998.00744.x; Opelz G, 2006, J AM SOC NEPHROL, V17, P3257, DOI 10.1681/ASN.2006050543; Patel RK, 2009, CLIN J AM SOC NEPHRO, V4, P1477, DOI 10.2215/CJN.03350509; Philipp T, 2010, NEPHROL DIAL TRANSPL, V25, P967, DOI 10.1093/ndt/gfp581; Pilmore H, 2010, TRANSPLANTATION, V89, P851, DOI 10.1097/TP.0b013e3181caeead; Pilmore HL, 2011, TRANSPLANTATION, V91, P542, DOI 10.1097/TP.0b013e31820437bd; Ponticelli C, 2011, TRANSPL INT, V24, P523, DOI 10.1111/j.1432-2277.2011.01242.x; Revanur VK, 2001, CLIN TRANSPLANT, V15, P89, DOI 10.1034/j.1399-0012.2001.150202.x; Rigatto C, 2006, SEMIN NEPHROL, V26, P307, DOI 10.1016/j.semnephrol.2006.05.007; Roodnat JI, 2006, TRANSPLANTATION, V82, P362, DOI 10.1097/01.tp.0000228923.75739.88; Schaeffner ES, 2007, TRANSPLANT INT, V20, P247, DOI 10.1111/j.1432-2277.2006.00436.x; Shamseddin MK, 2011, CLIN J AM SOC NEPHRO, V6, P1786, DOI 10.2215/CJN.01310211; Silver SA, 2011, TRANSPLANTATION, V92, P183, DOI 10.1097/TP.0b013e31821f303f; Soveri I, 2006, NEPHROL DIAL TRANSPL, V21, P2282, DOI 10.1093/ndt/gfl095; Srinivas TR, 2008, CLIN J AM SOC NEPHRO, V3, pS101, DOI 10.2215/CJN.03510807; van Hooff JP, 2005, TRANSPLANTATION, V79, P1465, DOI 10.1097/01.TP.0000157870.21957.E5; Vanrenterghem Y, 2011, TRANSPLANTATION, V91, P976, DOI 10.1097/TP.0b013e31820c10eb; Vincenti F, 2007, AM J TRANSPLANT, V7, P1506, DOI 10.1111/j.1600-6143.2007.01749.x; Wilkinson A, 2005, CLIN TRANSPLANT, V19, P291, DOI 10.1111/j.1399-0012.2005.00359.x; Winkelmayer WC, 2005, KIDNEY INT, V68, P2857, DOI 10.1111/j.1523-1755.2005.00759.x; Wissing KM, 2006, TRANSPLANTATION, V82, P771, DOI 10.1097/01.tp.0000235446.50715.ef; Woodle ES, 2008, ANN SURG, V248, P564, DOI 10.1097/SLA.0b013e318187d1da; Woodward RS, 2003, AM J TRANSPLANT, V3, P590, DOI 10.1034/j.1600-6143.2003.00082.x; Zelle DM, 2011, TRANSPLANTATION, V92, P203, DOI 10.1097/TP.0b013e318222ca10; Zuber J, 2009, NAT REV NEPHROL, V5, P480, DOI 10.1038/nrneph.2009.98	68	195	198	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 15	2011	378	9800					1419	1427		10.1016/S0140-6736(11)61334-2	http://dx.doi.org/10.1016/S0140-6736(11)61334-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	838EM	22000138				2022-12-28	WOS:000296269600029
J	Lane, N				Lane, Nick			The Costs of Breathing	SCIENCE			English	Editorial Material							MITOCHONDRIAL; MUTATIONS		UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England	University of London; University College London	Lane, N (corresponding author), UCL, Dept Genet Evolut & Environm, Gower St, London WC1E 6BT, England.	nick.lane@ucl.ac.uk		Lane, Nick/0000-0002-5433-3973				Barja G, 2007, REJUV RES, V10, P215, DOI 10.1089/rej.2006.0516; Blackstone NW, 1999, BIOESSAYS, V21, P84, DOI 10.1002/(SICI)1521-1878(199901)21:1<84::AID-BIES11>3.0.CO;2-0; Ellison CK, 2008, EVOLUTION, V62, P631, DOI 10.1111/j.1558-5646.2007.00305.x; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Rand DM, 2004, TRENDS ECOL EVOL, V19, P645, DOI 10.1016/j.tree.2004.10.003; Wallace DC, 2010, P NATL ACAD SCI USA, V107, P8947, DOI 10.1073/pnas.0914635107; Wolf JBW, 2010, PHILOS T R SOC B, V365, P1717, DOI 10.1098/rstb.2010.0023	9	32	34	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					184	185		10.1126/science.1214012	http://dx.doi.org/10.1126/science.1214012			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998376				2022-12-28	WOS:000295833600032
J	Minlebaev, M; Colonnese, M; Tsintsadze, T; Sirota, A; Khazipov, R				Minlebaev, Marat; Colonnese, Matthew; Tsintsadze, Timur; Sirota, Anton; Khazipov, Roustem			Early Gamma Oscillations Synchronize Developing Thalamus and Cortex	SCIENCE			English	Article							SOMATIC SENSORY CORTEX; RAT BARREL CORTEX; SOMATOSENSORY CORTEX; IN-VIVO; SYNAPTIC PLASTICITY; CORTICAL NETWORKS; INHIBITION; POTENTIALS; MECHANISMS; EXPERIENCE	During development, formation of topographic maps in sensory cortex requires precise temporal binding in thalamocortical networks. However, the physiological substrate for such synchronization is unknown. We report that early gamma oscillations (EGOs) enable precise spatiotemporal thalamocortical synchronization in the neonatal rat whisker sensory system. Driven by a thalamic gamma oscillator and initially independent of cortical inhibition, EGOs synchronize neurons in a single thalamic barreloid and corresponding cortical barrel and support plasticity at developing thalamocortical synapses. We propose that the multiple replay of sensory input in thalamocortical circuits during EGOs allows thalamic and cortical neurons to be organized into vertical topographic functional units before the development of horizontal binding in adult brain.	[Minlebaev, Marat; Colonnese, Matthew; Tsintsadze, Timur; Khazipov, Roustem] INSERM, U901, F-13273 Marseille, France; [Minlebaev, Marat; Colonnese, Matthew; Tsintsadze, Timur; Khazipov, Roustem] Univ Aix Marseille, F-13273 Marseille, France; [Sirota, Anton] Univ Tubingen, Ctr Integrat Neurosci, D-76072 Tubingen, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Eberhard Karls University of Tubingen	Khazipov, R (corresponding author), INSERM, U901, 163 Ave Luminy,BP 13, F-13273 Marseille, France.	khazipov@inmed.univ-mrs.fr	MINLEBAEV, Marat/B-4927-2015; Khazipov, Roustem/M-1834-2016; MINLEBAEV, Marat/R-4794-2019	MINLEBAEV, Marat/0000-0002-0722-7027; Khazipov, Roustem/0000-0002-6763-2841; MINLEBAEV, Marat/0000-0002-0722-7027; Colonnese, Matthew/0000-0002-2480-1270	Agence Nationale de la Recherche [ANR_09MNPS006]; Fondation pour la Recherche Medicale [FRM_DEq.20110421301]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We thank S. Beguin and D. Zaynutdinova for slice staining and morphology and G. Buzsaki, A. Destexhe, R. Cossart, Y. Ben-Ari, C. Hammond, D. Debanne, R. Miles, S. Feldt, and N. Burnashev for comments. Financial support was provided by the Agence Nationale de la Recherche (ANR_09MNPS006) and the Fondation pour la Recherche Medicale (FRM_DEq.20110421301).	AGMON A, 1992, J NEUROPHYSIOL, V68, P345, DOI 10.1152/jn.1992.68.1.345; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Borgdorff AJ, 2007, J NEUROPHYSIOL, V97, P2992, DOI 10.1152/jn.00013.2007; Bureau I, 2004, NEURON, V42, P789, DOI 10.1016/j.neuron.2004.05.002; Buzsaki G., 2006, RHYTHMS BRAIN; Castelo-Branco M, 1998, J NEUROSCI, V18, P6395; Colonnese MT, 2010, NEURON, V67, P480, DOI 10.1016/j.neuron.2010.07.015; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Daw MI, 2007, NAT NEUROSCI, V10, P453, DOI 10.1038/nn1866; Feldman DE, 1999, J NEUROBIOL, V41, P92, DOI 10.1002/(SICI)1097-4695(199910)41:1<92::AID-NEU12>3.0.CO;2-U; FOX K, 1992, J NEUROSCI, V12, P1826; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Golshani P, 2009, J NEUROSCI, V29, P10890, DOI 10.1523/JNEUROSCI.2012-09.2009; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Landers M, 2006, SOMATOSENS MOT RES, V23, P1, DOI 10.1080/08990220600700768; Minlebaev M, 2007, J NEUROPHYSIOL, V97, P692, DOI 10.1152/jn.00759.2006; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; PINAULT D, 1992, NEUROSCIENCE, V51, P245, DOI 10.1016/0306-4522(92)90312-P; Rochefort NL, 2009, P NATL ACAD SCI USA, V106, P15049, DOI 10.1073/pnas.0907660106; SIMONS DJ, 1987, NATURE, V326, P694, DOI 10.1038/326694a0; Timofeev I, 1997, J PHYSIOL-LONDON, V504, P153, DOI 10.1111/j.1469-7793.1997.153bf.x; Uhlhaas PJ, 2010, TRENDS COGN SCI, V14, P72, DOI 10.1016/j.tics.2009.12.002; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Whittington MA, 2011, DEV NEUROBIOL, V71, P92, DOI 10.1002/dneu.20814; Yang JW, 2009, J NEUROSCI, V29, P9011, DOI 10.1523/JNEUROSCI.5646-08.2009	29	189	193	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					226	229		10.1126/science.1210574	http://dx.doi.org/10.1126/science.1210574			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998388				2022-12-28	WOS:000295833600046
J	Noordermeer, D; Leleu, M; Splinter, E; Rougemont, J; De Laat, W; Duboule, D				Noordermeer, Daan; Leleu, Marion; Splinter, Erik; Rougemont, Jacques; De Laat, Wouter; Duboule, Denis			The Dynamic Architecture of Hox Gene Clusters	SCIENCE			English	Article							NUCLEAR REORGANIZATION; CHROMATIN; DIFFERENTIATION; EXPRESSION	The spatial and temporal control of Hox gene transcription is essential for patterning the vertebrate body axis. Although this process involves changes in histone posttranslational modifications, the existence of particular three-dimensional (3D) architectures remained to be assessed in vivo. Using high-resolution chromatin conformation capture methodology, we examined the spatial configuration of Hox clusters in embryonic mouse tissues where different Hox genes are active. When the cluster is transcriptionally inactive, Hox genes associate into a single 3D structure delimited from flanking regions. Once transcription starts, Hox clusters switch to a bimodal 3D organization where newly activated genes progressively cluster into a transcriptionally active compartment. This transition in spatial configurations coincides with the dynamics of chromatin marks, which label the progression of the gene clusters from a negative to a positive transcription status. This spatial compartmentalization may be key to process the colinear activation of these compact gene clusters.	[Noordermeer, Daan; Leleu, Marion; Rougemont, Jacques; Duboule, Denis] Ecole Polytech Fed EPFL, Sch Life Sci, Natl Res Ctr Frontiers Genet, CH-1015 Lausanne, Switzerland; [Splinter, Erik; De Laat, Wouter] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Splinter, Erik; De Laat, Wouter] Univ Med Ctr, NL-3584 CT Utrecht, Netherlands; [Rougemont, Jacques] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Duboule, Denis] Univ Geneva, Dept Genet & Evolut, CH-1211 Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Swiss Institute of Bioinformatics; University of Geneva	Duboule, D (corresponding author), Ecole Polytech Fed EPFL, Sch Life Sci, Natl Res Ctr Frontiers Genet, CH-1015 Lausanne, Switzerland.	denis.duboule@unige.ch	Noordermeer, Daan/F-3306-2011	Noordermeer, Daan/0000-0002-9296-7002; duboule, denis/0000-0001-9961-2960; de Laat, Wouter/0000-0002-6393-595X	Ecole Polytechnique Federale (Lausanne); University of Geneva; Swiss National Research Fund; National Research Centre "Frontiers in Genetics"; European Research Council	Ecole Polytechnique Federale (Lausanne); University of Geneva; Swiss National Research Fund(Swiss National Science Foundation (SNSF)); National Research Centre "Frontiers in Genetics"; European Research Council(European Research Council (ERC)European Commission)	We thank B. Mascrez for assistance with mouse handling and genotyping, P. Descombes and members of the National Research Centre genomics platform for high-throughput sequencing, and members of the Duboule laboratories for discussion. Computations were performed at the Vital-IT Center for high-performance computing (www.vital-it.ch) at the Swiss Institute of Bioinformatics. This work was supported by funds from the Ecole Polytechnique Federale (Lausanne), the University of Geneva, the Swiss National Research Fund, the National Research Centre "Frontiers in Genetics," and the European Research Council grant SystemsHox.ch (to D.D.). Data are all based on ENSEMBL Mouse assembly NCBIM37. 4C-seq patterns can be obtained from www.sciencemag.org/nnnnn or http://duboule-lab.epfl.ch/page-66605-en.html. Microarray and ChIP-seq data have been submitted to the Gene Expression Omnibus (GEO) repository (www.ncbi.nlm.nih.gov/geo/) under accession no. GSE31570.	Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Ferraiuolo MA, 2010, NUCLEIC ACIDS RES, V38, P7472, DOI 10.1093/nar/gkq644; Fraser J, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r37; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Lee AP, 2006, P NATL ACAD SCI USA, V103, P6994, DOI 10.1073/pnas.0601492103; Morey C, 2008, J CELL SCI, V121, P571, DOI 10.1242/jcs.023234; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Tschopp P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000398; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wellik DM, 2007, DEV DYNAM, V236, P2454, DOI 10.1002/dvdy.21286; Young T, 2009, DEV CELL, V17, P516, DOI 10.1016/j.devcel.2009.08.010; Zeltser L, 1996, DEVELOPMENT, V122, P2475	16	287	298	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					222	225		10.1126/science.1207194	http://dx.doi.org/10.1126/science.1207194			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998387				2022-12-28	WOS:000295833600045
J	Pyeritz, RE				Pyeritz, Reed E.			The Coming Explosion in Genetic Testing - Is There a Duty to Recontact?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Pyeritz, Reed E.] Univ Penn, Leonard Davis Inst Hlth Econ, Ctr Bioeth, Ctr Integrat Genet Healthcare Technol, Philadelphia, PA 19104 USA; [Pyeritz, Reed E.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Pyeritz, Reed E.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Pyeritz, RE (corresponding author), Univ Penn, Leonard Davis Inst Hlth Econ, Ctr Bioeth, Ctr Integrat Genet Healthcare Technol, Philadelphia, PA 19104 USA.							Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Hirschhorn K, 1999, Genet Med, V1, P171; HIRSCHHORN K, 1999, GENET MED, V1, P186; Hunter AGW, 2001, AM J MED GENET, V103, P265, DOI 10.1002/ajmg.1568.abs; Jackson L, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002064; Kohane IS, 2006, JAMA-J AM MED ASSOC, V296, P212, DOI 10.1001/jama.296.2.212	6	60	61	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 13	2011	365	15					1367	1369		10.1056/NEJMp1107564	http://dx.doi.org/10.1056/NEJMp1107564			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	832DQ	21995382				2022-12-28	WOS:000295782500001
J	Cassidy, J				Cassidy, Jane			LOBBY WATCH Keep Our NHS Public	BRITISH MEDICAL JOURNAL			English	Editorial Material												janecassi2@googlemail.com						2011, BRIT MED J, V343, pD6391, DOI DOI 10.1136/BMJ.D6391	1	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 11	2011	343								d6528	10.1136/bmj.d6528	http://dx.doi.org/10.1136/bmj.d6528			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	835EJ	21990153				2022-12-28	WOS:000296017500011
J	Aliu, E; Arlen, T; Aune, T; Beilicke, M; Benbow, W; Bouvier, A; Bradbury, SM; Buckley, JH; Bugaev, V; Byrum, K; Cannon, A; Cesarini, A; Christiansen, JL; Ciupik, L; Collins-Hughes, E; Connolly, MP; Cui, W; Dickherber, R; Duke, C; Errando, M; Falcone, A; Finley, JP; Finnegan, G; Fortson, L; Furniss, A; Galante, N; Gall, D; Gibbs, K; Gillanders, GH; Godambe, S; Griffin, S; Grube, J; Guenette, R; Gyuk, G; Hanna, D; Holder, J; Huan, H; Hughes, G; Hui, CM; Humensky, TB; Imran, A; Kaaret, P; Karlsson, N; Kertzman, M; Kieda, D; Krawczynski, H; Krennrich, F; Lang, MJ; Lyutikov, M; Madhavan, AS; Maier, G; Majumdar, P; McArthur, S; McCann, A; McCutcheon, M; Moriarty, P; Mukherjee, R; Nunez, P; Ong, RA; Orr, M; Otte, AN; Park, N; Perkins, JS; Pizlo, F; Pohl, M; Prokoph, H; Quinn, J; Ragan, K; Reyes, LC; Reynolds, PT; Roache, E; Rose, HJ; Ruppel, J; Saxon, DB; Schroedter, M; Sembroski, GH; Senturk, GD; Smith, AW; Staszak, D; Tesic, G; Theiling, M; Thibadeau, S; Tsurusaki, K; Tyler, J; Varlotta, A; Vassiliev, VV; Vincent, S; Vivier, M; Wakely, SP; Ward, JE; Weekes, TC; Weinstein, A; Weisgarber, T; Williams, DA; Zitzer, B				Aliu, E.; Arlen, T.; Aune, T.; Beilicke, M.; Benbow, W.; Bouvier, A.; Bradbury, S. M.; Buckley, J. H.; Bugaev, V.; Byrum, K.; Cannon, A.; Cesarini, A.; Christiansen, J. L.; Ciupik, L.; Collins-Hughes, E.; Connolly, M. P.; Cui, W.; Dickherber, R.; Duke, C.; Errando, M.; Falcone, A.; Finley, J. P.; Finnegan, G.; Fortson, L.; Furniss, A.; Galante, N.; Gall, D.; Gibbs, K.; Gillanders, G. H.; Godambe, S.; Griffin, S.; Grube, J.; Guenette, R.; Gyuk, G.; Hanna, D.; Holder, J.; Huan, H.; Hughes, G.; Hui, C. M.; Humensky, T. B.; Imran, A.; Kaaret, P.; Karlsson, N.; Kertzman, M.; Kieda, D.; Krawczynski, H.; Krennrich, F.; Lang, M. J.; Lyutikov, M.; Madhavan, A. S.; Maier, G.; Majumdar, P.; McArthur, S.; McCann, A.; McCutcheon, M.; Moriarty, P.; Mukherjee, R.; Nunez, P.; Ong, R. A.; Orr, M.; Otte, A. N.; Park, N.; Perkins, J. S.; Pizlo, F.; Pohl, M.; Prokoph, H.; Quinn, J.; Ragan, K.; Reyes, L. C.; Reynolds, P. T.; Roache, E.; Rose, H. J.; Ruppel, J.; Saxon, D. B.; Schroedter, M.; Sembroski, G. H.; Sentuerk, G. D.; Smith, A. W.; Staszak, D.; Tesic, G.; Theiling, M.; Thibadeau, S.; Tsurusaki, K.; Tyler, J.; Varlotta, A.; Vassiliev, V. V.; Vincent, S.; Vivier, M.; Wakely, S. P.; Ward, J. E.; Weekes, T. C.; Weinstein, A.; Weisgarber, T.; Williams, D. A.; Zitzer, B.		VERITAS Collaboration	Detection of Pulsed Gamma Rays Above 100 GeV from the Crab Pulsar	SCIENCE			English	Article							HIGH-ENERGY EMISSION; AREA TELESCOPE; OUTER MAGNETOSPHERE; MILLISECOND PULSARS; LIGHT CURVES; SLOT GAPS; NEBULA; RADIATION; TEV; CATALOG	We report the detection of pulsed gamma rays from the Crab pulsar at energies above 100 giga-electron volts (GeV) with the Very Energetic Radiation Imaging Telescope Array System (VERITAS) array of atmospheric Cherenkov telescopes. The detection cannot be explained on the basis of current pulsar models. The photon spectrum of pulsed emission between 100 mega-electron volts and 400 GeV is described by a broken power law that is statistically preferred over a power law with an exponential cutoff. It is unlikely that the observation can be explained by invoking curvature radiation as the origin of the observed gamma rays above 100 GeV. Our findings require that these gamma rays be produced more than 10 stellar radii from the neutron star.	[Griffin, S.; Guenette, R.; Hanna, D.; McCann, A.; McCutcheon, M.; Ragan, K.; Staszak, D.; Tesic, G.; Tyler, J.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; [Aliu, E.; Errando, M.; Mukherjee, R.] Columbia Univ Barnard Coll, Dept Phys & Astron, New York, NY 10027 USA; [Arlen, T.; Majumdar, P.; Ong, R. A.; Vassiliev, V. V.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Aune, T.; Bouvier, A.; Furniss, A.; Otte, A. N.; Williams, D. A.] Univ Calif Santa Cruz, Dept Phys, Santa Cruz, CA 95064 USA; [Aune, T.; Bouvier, A.; Furniss, A.; Otte, A. N.; Williams, D. A.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Beilicke, M.; Buckley, J. H.; Bugaev, V.; Dickherber, R.; Krawczynski, H.; McArthur, S.; Thibadeau, S.] Washington Univ, Dept Phys, St Louis, MO 63130 USA; [Benbow, W.; Galante, N.; Gibbs, K.; Perkins, J. S.; Roache, E.; Schroedter, M.; Weekes, T. C.] Harvard Smithsonian Ctr Astrophys, Fred Lawrence Whipple Observ, Amado, AZ 85645 USA; [Bradbury, S. M.; Rose, H. J.] Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England; [Byrum, K.; Smith, A. W.; Zitzer, B.] Argonne Natl Lab, Argonne, IL 60439 USA; [Cannon, A.; Collins-Hughes, E.; Quinn, J.; Ward, J. E.] Univ Coll Dublin, Sch Phys, Dublin 4, Ireland; [Cesarini, A.; Connolly, M. P.; Gillanders, G. H.; Lang, M. J.] Natl Univ Ireland Galway, Sch Phys, Galway, Ireland; [Christiansen, J. L.] Calif Polytech State Univ San Luis Obispo, Dept Phys, San Luis Obispo, CA 94307 USA; [Ciupik, L.; Grube, J.; Gyuk, G.] Adler Planetarium & Astron Museum, Dept Astron, Chicago, IL 60605 USA; [Cui, W.; Finley, J. P.; Lyutikov, M.; Pizlo, F.; Sembroski, G. H.; Theiling, M.; Varlotta, A.] Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA; [Duke, C.] Grinnell Coll, Dept Phys, Grinnell, IA 50112 USA; [Falcone, A.] Penn State Univ, Dept Astron & Astrophys, Davey Lab 525, University Pk, PA 16802 USA; [Finnegan, G.; Godambe, S.; Hui, C. M.; Kieda, D.; Nunez, P.; Vincent, S.] Univ Utah, Dept Phys & Astron, Salt Lake City, UT 84112 USA; [Fortson, L.; Karlsson, N.] Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA; [Holder, J.; Saxon, D. B.; Vivier, M.] Univ Delaware, Dept Phys & Astron, Newark, DE 19716 USA; [Holder, J.; Saxon, D. B.; Vivier, M.] Univ Delaware, Bartol Res Inst, Newark, DE 19716 USA; [Huan, H.; Humensky, T. B.; Park, N.; Reyes, L. C.; Wakely, S. P.; Weisgarber, T.] Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; [Hughes, G.; Maier, G.; Pohl, M.; Prokoph, H.] DESY, D-15738 Zeuthen, Germany; [Imran, A.; Krennrich, F.; Madhavan, A. S.; Orr, M.; Weinstein, A.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Gall, D.; Kaaret, P.; Tsurusaki, K.] Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; [Kertzman, M.] Depauw Univ, Dept Phys & Astron, Greencastle, IN 46135 USA; [Moriarty, P.] Galway Mayo Inst Technol, Dept Life & Phys Sci, Galway, Ireland; [Pohl, M.; Ruppel, J.] Univ Potsdam, Inst Phys & Astron, D-14476 Potsdam, Germany; [Reynolds, P. T.] Cork Inst Technol, Dept Appl Phys & Instrumentat, Cork, Ireland; [Sentuerk, G. D.] Columbia Univ, Dept Phys, New York, NY 10027 USA	McGill University; Columbia University; University of California System; University of California Los Angeles; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Washington University (WUSTL); Harvard University; Smithsonian Institution; University of Leeds; United States Department of Energy (DOE); Argonne National Laboratory; University College Dublin; Ollscoil na Gaillimhe-University of Galway; California State University System; California Polytechnic State University San Luis Obispo; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Utah System of Higher Education; University of Utah; University of Minnesota System; University of Minnesota Twin Cities; University of Delaware; University of Delaware; University of Chicago; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Iowa State University; University of Iowa; DePauw University; Galway Mayo Institute of Technology; University of Potsdam; Cork Institute of Technology; Columbia University	McCann, A (corresponding author), McGill Univ, Dept Phys, 3600 Univ St, Montreal, PQ H3A 2T8, Canada.	mccann@hep.physics.mcgill.ca; nepomuk.otte@gmail.com; schroedter@veritas.sao.arizona.edu	Lyutikov, Maxim/AAX-1992-2020; Pohl, Martin/P-4920-2017; Otte, Adam Nepomuk/L-4638-2019; Weinstein, Amanda/D-1445-2019; Cesarini, Andrea/AAS-9877-2020; Cui, Wei/Y-3279-2019	Pohl, Martin/0000-0001-7861-1707; Otte, Adam Nepomuk/0000-0002-5955-6383; Weinstein, Amanda/0000-0002-2126-2419; Cesarini, Andrea/0000-0002-8611-8610; Cui, Wei/0000-0002-6324-5772; Fortson, Lucy/0000-0002-1067-8558; Lang, Mark/0000-0003-4641-4201; Ward, John E/0000-0003-1973-0794; Quinn, John/0000-0002-4855-2694; Benbow, Wystan/0000-0003-2098-170X; Errando, Manel/0000-0002-1853-863X; Kieda, David/0000-0003-4785-0101; Krawczynski, Henric/0000-0002-1084-6507; Hui, Chiumun/0000-0002-0468-6025; McCann, Andrew/0000-0002-5221-6669; Ong, Rene/0000-0002-4837-5253; Maier, Gernot/0000-0001-9868-4700	U.S. Department of Energy; NSF; Smithsonian Institution; Natural Sciences and Engineering Research Council of Canada; Science Foundation Ireland (SFI) [10/RFP/AST2748]; Science and Technology Facilities Council in the United Kingdom; Alexander von Humboldt Foundation; Division Of Physics [0854911] Funding Source: National Science Foundation	U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Smithsonian Institution(Smithsonian Institution); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Science Foundation Ireland (SFI)(Science Foundation Ireland); Science and Technology Facilities Council in the United Kingdom; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This research is supported by grants from the U.S. Department of Energy, NSF, and the Smithsonian Institution; by Natural Sciences and Engineering Research Council of Canada; by Science Foundation Ireland (SFI 10/RFP/AST2748); and by the Science and Technology Facilities Council in the United Kingdom. We acknowledge the excellent work of the technical support staff at the Fred Lawrence Whipple Observatory and at the collaborating institutions in the construction and operation of the instrument. A.N.O. was supported in part by a Feodor-Lynen fellowship of the Alexander von Humboldt Foundation. We are grateful to M. Roberts and A. Lyne for providing us with Crab-pulsar ephemerides before the public ones became available.	Abdo AA, 2010, ASTROPHYS J SUPPL S, V187, P460, DOI 10.1088/0067-0049/187/2/460; Abdo AA, 2010, ASTROPHYS J, V708, P1254, DOI 10.1088/0004-637X/708/2/1254; Aharonian F, 2004, ASTROPHYS J, V614, P897, DOI 10.1086/423931; Albert J, 2008, ASTROPHYS J, V674, P1037, DOI 10.1086/525270; Aliu E, 2008, SCIENCE, V322, P1221, DOI 10.1126/science.1164718; [Anonymous], JODR BANK CRAB PULS; ARONS J, 1983, ASTROPHYS J, V266, P215, DOI 10.1086/160771; ATNF, ATNF PULS CAT; Bai XN, 2010, ASTROPHYS J, V715, P1282, DOI 10.1088/0004-637X/715/2/1282; Baring MG, 2004, ADV SPACE RES-SERIES, V33, P552, DOI 10.1016/j.asr.2003.08.020; CHENG KS, 1986, ASTROPHYS J, V300, P500, DOI 10.1086/163829; Cogan P, 2008, P ICRC MERIDA, P1385; de Naurois M, 2002, ASTROPHYS J, V566, P343, DOI 10.1086/337991; DEJAGER OC, 1994, ASTROPHYS J, V436, P239, DOI 10.1086/174896; Fierro JM, 1998, ASTROPHYS J, V494, P734, DOI 10.1086/305219; Frackowiak M, 2005, ADV SPACE RES-SERIES, V35, P1152, DOI 10.1016/j.asr.2005.02.031; Harding AK, 2005, ASTROPHYS J, V622, P531, DOI 10.1086/427840; HEWISH A, 1968, NATURE, V217, P709, DOI 10.1038/217709a0; hillas A.M., 1985, P 19 INT COSM RAY C, V3, P445; Hirotani K, 2006, ASTROPHYS J, V652, P1475, DOI 10.1086/508317; Holder J, 2006, ASTROPART PHYS, V25, P391, DOI 10.1016/j.astropartphys.2006.04.002; Lee KJ, 2010, MON NOT R ASTRON SOC, V405, P2103, DOI 10.1111/j.1365-2966.2010.16600.x; Lessard RW, 2000, ASTROPHYS J, V531, P942, DOI 10.1086/308495; LYNE AG, 1993, MON NOT R ASTRON SOC, V265, P1003, DOI 10.1093/mnras/265.4.1003; Lyutikov M., 2011, ARXIV11083824; Manchester RN, 2005, ASTRON J, V129, P1993, DOI 10.1086/428488; Muslimov AG, 2003, ASTROPHYS J, V588, P430, DOI 10.1086/368162; Oser S, 2001, ASTROPHYS J, V547, P949, DOI 10.1086/318415; Romani RW, 1996, ASTROPHYS J, V470, P469, DOI 10.1086/177878; Tang APS, 2008, ASTROPHYS J, V676, P562, DOI 10.1086/527029; Venter C, 2009, ASTROPHYS J, V707, P800, DOI 10.1088/0004-637X/707/1/800; WEEKES TC, 1989, ASTROPHYS J, V342, P379, DOI 10.1086/167599	32	132	134	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 7	2011	334	6052					69	72		10.1126/science.1208192	http://dx.doi.org/10.1126/science.1208192			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21980105	Green Submitted			2022-12-28	WOS:000295580300040
J	Kimberlin, DW; Whitley, RJ; Wan, W; Powell, DA; Storch, G; Ahmed, A; Palmer, A; Sanchez, PJ; Jacobs, RF; Bradley, JS; Robinson, JL; Shelton, M; Dennehy, PH; Leach, C; Rathore, M; Abughali, N; Wright, P; Frenkel, LM; Brady, RC; Van Dyke, R; Weiner, LB; Guzman-Cottrill, J; McCarthy, CA; Griffin, J; Jester, P; Parker, M; Lakeman, FD; Kuo, HC; Lee, CH; Cloud, GA				Kimberlin, David W.; Whitley, Richard J.; Wan, Wen; Powell, Dwight A.; Storch, Gregory; Ahmed, Amina; Palmer, April; Sanchez, Pablo J.; Jacobs, Richard F.; Bradley, John S.; Robinson, Joan L.; Shelton, Mark; Dennehy, Penelope H.; Leach, Charles; Rathore, Mobeen; Abughali, Nazha; Wright, Peter; Frenkel, Lisa M.; Brady, Rebecca C.; Van Dyke, Russell; Weiner, Leonard B.; Guzman-Cottrill, Judith; McCarthy, Carol A.; Griffin, Jill; Jester, Penelope; Parker, Misty; Lakeman, Fred D.; Kuo, Huichien; Lee, Choo Hyung; Cloud, Gretchen A.		Natl Inst Allergy & Infect Dis; Collaborative Antiviral Study Grp	Oral Acyclovir Suppression and Neurodevelopment after Neonatal Herpes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SIMPLEX-VIRUS-INFECTION; HIGH-DOSE ACYCLOVIR; GENITAL HERPES; VIDARABINE THERAPY; CONTROLLED TRIAL; DOUBLE-BLIND; VALACICLOVIR; ENCEPHALITIS; NEUTROPENIA; PNEUMONIA	BACKGROUND Poor neurodevelopmental outcomes and recurrences of cutaneous lesions remain unacceptably frequent among survivors of neonatal herpes simplex virus (HSV) disease. METHODS We enrolled neonates with HSV disease in two parallel, identical, double-blind, placebo-controlled studies. Neonates with central nervous system (CNS) involvement were enrolled in one study, and neonates with skin, eye, and mouth involvement only were enrolled in the other. After completing a regimen of 14 to 21 days of parenteral acyclovir, the infants were randomly assigned to immediate acyclovir suppression (300 mg per square meter of body-surface area per dose orally, three times daily for 6 months) or placebo. Cutaneous recurrences were treated with open-label episodic therapy. RESULTS A total of 74 neonates were enrolled -45 with CNS involvement and 29 with skin, eye, and mouth disease. The Mental Development Index of the Bayley Scales of Infant Development (in which scores range from 50 to 150, with a mean of 100 and with higher scores indicating better neurodevelopmental outcomes) was assessed in 28 of the 45 infants with CNS involvement (62%) at 12 months of age. After adjustment for covariates, infants with CNS involvement who had been randomly assigned to acyclovir suppression had significantly higher mean Bayley mental-development scores at 12 months than did infants randomly assigned to placebo (88.24 vs. 68.12, P = 0.046). Overall, there was a trend toward more neutropenia in the acyclovir group than in the placebo group (P = 0.09). CONCLUSIONS Infants surviving neonatal HSV disease with CNS involvement had improved neurodevelopmental outcomes when they received suppressive therapy with oral acyclovir for 6 months.(Funded by the National Institute of Allergy and Infectious Diseases; CASG 103 and CASG 104 ClinicalTrials. gov numbers, NCT00031460 and NCT00031447, respectively.)	[Kimberlin, David W.; Whitley, Richard J.; Griffin, Jill; Jester, Penelope; Parker, Misty; Lakeman, Fred D.] Univ Alabama, Div Pediat Infect Dis, Dept Pediat, Birmingham, AL 35233 USA; [Wan, Wen; Kuo, Huichien; Lee, Choo Hyung; Cloud, Gretchen A.] Univ Alabama, Dept Med, Birmingham, AL 35294 USA; [Powell, Dwight A.] Nationwide Childrens Hosp, Columbus, OH USA; [Storch, Gregory] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Ahmed, Amina] Carolinas Med Ctr, Charlotte, NC 28203 USA; [Palmer, April] Univ Mississippi, Jackson, MS USA; [Sanchez, Pablo J.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Jacobs, Richard F.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Bradley, John S.] Rady Childrens Hosp, San Diego, CA USA; [Robinson, Joan L.] Univ Alberta, Edmonton, AB, Canada; [Shelton, Mark] Cook Childrens Med Ctr, Ft Worth, TX USA; [Dennehy, Penelope H.] Hasbro Childrens Hosp, Providence, RI USA; [Leach, Charles] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Rathore, Mobeen] Univ Florida, Hlth Sci Ctr, Jacksonville, FL USA; [Abughali, Nazha] Metro Hlth Med Ctr, Cleveland, OH USA; [Wright, Peter] Vanderbilt Univ, Nashville, TN USA; [Frenkel, Lisa M.] Univ Washington, Seattle, WA 98195 USA; [Brady, Rebecca C.] Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH USA; [Van Dyke, Russell] Tulane Univ, New Orleans, LA 70118 USA; [Guzman-Cottrill, Judith] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [McCarthy, Carol A.] Maine Med Ctr, Portland, OR USA; [Weiner, Leonard B.] SUNY, Dept Med, Syracuse, NY USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Washington University (WUSTL); Carolinas Medical Center; University of Mississippi; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Arkansas System; University of Arkansas Medical Sciences; Rady Childrens Hospital San Diego; University of Alberta; Cook Children's Medical Center; Hasbro Children's Hospital; University of Texas System; University of Texas Health San Antonio; State University System of Florida; University of Florida; MetroHealth System; Vanderbilt University; University of Washington; University of Washington Seattle; Cincinnati Children's Hospital Medical Center; Tulane University; Oregon Health & Science University; State University of New York (SUNY) System; SUNY Maritime College	Kimberlin, DW (corresponding author), Univ Alabama, Div Pediat Infect Dis, Dept Pediat, 1600 7th Ave S,CHB 303, Birmingham, AL 35233 USA.	dkimberlin@peds.uab.edu	de Lima, Antonio Marcos Oliveira/AAT-2148-2021; ROBINSON, JOAN/J-3349-2019; Dennehy, Penelope/CAF-1123-2022	ROBINSON, JOAN/0000-0001-9831-5681; Dennehy, Penelope/0000-0002-2259-5370; Frenkel, Lisa M/0000-0001-9566-8959	Division of Microbiology and Infectious Diseases of the National Institute of Allergy and Infectious Diseases (NIAID) [N01-AI-30025, N01-AI-65306, N01-AI-15113, N01-AI-62554]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI065306, N01AI062554, N01AI015113, N01AI030025] Funding Source: NIH RePORTER	Division of Microbiology and Infectious Diseases of the National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by contracts (N01-AI-30025, N01-AI-65306, N01-AI-15113, and N01-AI-62554) with the Division of Microbiology and Infectious Diseases of the National Institute of Allergy and Infectious Diseases (NIAID). Oral acyclovir and matching placebo were supplied by GlaxoSmithKline, Alpharma USPD, and Pharm Ops.	[Anonymous], 2009 RED BOOK REPORT; BEAN B, 1985, 25 INT C ANT AG CHEM, P786; DOUGLAS JM, 1984, NEW ENGL J MED, V310, P1551, DOI 10.1056/NEJM198406143102402; FEDER HM, 1995, CLIN INFECT DIS, V20, P1557, DOI 10.1093/clinids/20.6.1557; GOLD D, 1987, ANTIMICROB AGENTS CH, V31, P361, DOI 10.1128/AAC.31.3.361; GUTMAN LT, 1986, J INFECT DIS, V154, P415, DOI 10.1093/infdis/154.3.415; Kimberlin D, 1996, PEDIATR INFECT DIS J, V15, P247, DOI 10.1097/00006454-199603000-00014; Kimberlin DW, 2010, CLIN INFECT DIS, V50, P221, DOI 10.1086/649212; Kimberlin DW, 2004, NEW ENGL J MED, V350, P1970, DOI 10.1056/NEJMcp023065; Kimberlin DW, 2001, PEDIATRICS, V108, P230, DOI 10.1542/peds.108.2.230; Kimberlin DW, 2001, PEDIATRICS, V108, P223, DOI 10.1542/peds.108.2.223; MCPHERSON ML, 1988, CLIN PHARMACY, V7, P398; Mertz GJ, 1997, ARCH INTERN MED, V157, P343, DOI 10.1001/archinte.157.3.343; Patel R, 1997, GENITOURIN MED, V73, P105; Reitano M, 1998, J INFECT DIS, V178, P603, DOI 10.1086/515385; RUDD C, 1994, ACTA PAEDIATR, V83, P1237, DOI 10.1111/j.1651-2227.1994.tb13004.x; SPRUANCE SL, 1988, JAMA-J AM MED ASSOC, V260, P1597, DOI 10.1001/jama.260.11.1597; Tiffany K F, 2005, J Perinatol, V25, P156, DOI 10.1038/sj.jp.7211247; WADE JC, 1983, J INFECT DIS, V148, P557, DOI 10.1093/infdis/148.3.557; WADE JC, 1982, AM J MED, V73, P249, DOI 10.1016/0002-9343(82)90100-0; WHITLEY R, 1991, NEW ENGL J MED, V324, P444, DOI 10.1056/NEJM199102143240703; Whitley RJ, 1998, CLIN INFECT DIS, V26, P541, DOI 10.1086/514600; WHITLEY RJ, 1983, PEDIATRICS, V72, P778; WHITLEY RJ, 1980, PEDIATRICS, V66, P495; *WHO, 2003, WHO TOX GRAD SCAL	25	145	150	2	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 6	2011	365	14					1284	1292		10.1056/NEJMoa1003509	http://dx.doi.org/10.1056/NEJMoa1003509			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829KL	21991950	Green Accepted, Bronze			2022-12-28	WOS:000295578700006
J	Teo, EY; Wee, TC				Teo, Eng Yee; Wee, Tze Chao			Renal Tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Teo, Eng Yee; Wee, Tze Chao] Changi Gen Hosp, Singapore, Singapore	Changi General Hospital	Teo, EY (corresponding author), Changi Gen Hosp, Singapore, Singapore.	calebey@gmail.com	Chao, Wee/AAV-1271-2020						0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2011	365	12					E26	E26		10.1056/NEJMicm1100769	http://dx.doi.org/10.1056/NEJMicm1100769			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822WR	21992143				2022-12-28	WOS:000295081600003
J	Bertolotto, C; Lesueur, F; Giuliano, S; Strub, T; de Lichy, M; Bille, K; Dessen, P; d'Hayer, B; Mohamdi, H; Remenieras, A; Maubec, E; de la Fouchardiere, A; Molinie, V; Vabres, P; Dalle, S; Poulalhon, N; Martin-Denavit, T; Thomas, L; Andry-Benzaquen, P; Dupin, N; Boitier, F; Rossi, A; Perrot, JL; Labeille, B; Robert, C; Escudier, B; Caron, O; Brugieres, L; Saule, S; Gardie, B; Gad, S; Richard, S; Couturier, J; Teh, BT; Ghiorzo, P; Pastorino, L; Puig, S; Badenas, C; Olsson, H; Ingvar, C; Rouleau, E; Lidereau, R; Bahadoran, P; Vielh, P; Corda, E; Blanche, H; Zelenika, D; Galan, P; Chaudru, V; Lenoir, GM; Lathrop, M; Davidson, I; Avril, MF; Demenais, F; Ballotti, R; Bressac-de Paillerets, B				Bertolotto, Corine; Lesueur, Fabienne; Giuliano, Sandy; Strub, Thomas; de Lichy, Mahaut; Bille, Karine; Dessen, Philippe; d'Hayer, Benoit; Mohamdi, Hamida; Remenieras, Audrey; Maubec, Eve; de la Fouchardiere, Arnaud; Molinie, Vincent; Vabres, Pierre; Dalle, Stephane; Poulalhon, Nicolas; Martin-Denavit, Tanguy; Thomas, Luc; Andry-Benzaquen, Pascale; Dupin, Nicolas; Boitier, Francoise; Rossi, Annick; Perrot, Jean-Luc; Labeille, Bruno; Robert, Caroline; Escudier, Bernard; Caron, Olivier; Brugieres, Laurence; Saule, Simon; Gardie, Betty; Gad, Sophie; Richard, Stephane; Couturier, Jerome; Teh, Bin Tean; Ghiorzo, Paola; Pastorino, Lorenza; Puig, Susana; Badenas, Celia; Olsson, Hakan; Ingvar, Christian; Rouleau, Etienne; Lidereau, Rosette; Bahadoran, Philippe; Vielh, Philippe; Corda, Eve; Blanche, Helene; Zelenika, Diana; Galan, Pilar; Chaudru, Valerie; Lenoir, Gilbert M.; Lathrop, Mark; Davidson, Irwin; Avril, Marie-Francoise; Demenais, Florence; Ballotti, Robert; Bressac-de Paillerets, Brigitte		French Familial Melanoma Study Grp	A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma	NATURE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; CANCER; CELLS; HYPOXIA; SURVIVAL; SUMO; IDENTIFICATION; RECEPTOR	So far, no common environmental and/or phenotypic factor has been associated with melanoma and renal cell carcinoma (RCC). The known risk factors for melanoma include sun exposure, pigmentation and nevus phenotypes(1); risk factors associated with RCC include smoking, obesity and hypertension(2). A recent study of coexisting melanoma and RCC in the same patients supports a genetic predisposition underlying the association between these two cancers(3). The microphthalmia-associated transcription factor (MITF) has been proposed to act as a melanoma oncogene(4); it also stimulates the transcription of hypoxia inducible factor(5) (HIF1A), the pathway of which is targeted by kidney cancer susceptibility genes(6). We therefore proposed that MITF might have a role in conferring a genetic predisposition to co-occurring melanoma and RCC. Here we identify a germline missense substitution in MITF (Mi-E318K) that occurred at a significantly higher frequency in genetically enriched patients affected with melanoma, RCC or both cancers, when compared with controls. Overall, Mi-E318K carriers had a higher than fivefold increased risk of developing melanoma, RCC or both cancers. Codon 318 is located in a small-ubiquitin-like modifier (SUMO) consensus site (Psi KXE) and Mi-E318K severely impaired SUMOylation of MITF. Mi-E318K enhanced MITF protein binding to the HIF1A promoter and increased its transcriptional activity compared to wild-type MITF. Further, we observed a global increase in Mi-E318K occupied loci. In an RCC cell line, gene expression profiling identified a Mi-E318K signature related to cell growth, proliferation and inflammation. Lastly, the mutant protein enhanced melanocytic and renal cell clonogenicity, migration and invasion, consistent with a gain-of-function role in tumorigenesis. Our data provide insights into the link between SUMOylation, transcription and cancer.	[Bertolotto, Corine; Giuliano, Sandy; Bille, Karine; Ballotti, Robert] C3M, Equipe Labelisee Ligue Canc, INSERM, U895,Equipe 1, F-06204 Nice, France; [Bertolotto, Corine; Giuliano, Sandy; Ballotti, Robert] Univ Nice Sophia Antipolis, UFR Med, F-06204 Nice, France; [Bertolotto, Corine; Bahadoran, Philippe; Ballotti, Robert] Ctr Hosp Univ Nice, Serv Dermatol, F-06204 Nice, France; [Strub, Thomas; Davidson, Irwin] Univ Strasbourg, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Dessen, Philippe] Inst Cancerol Gustave Roussy, INSERM, UMR985, F-94805 Villejuif, France; [Mohamdi, Hamida; Maubec, Eve; Corda, Eve; Chaudru, Valerie; Demenais, Florence; Bressac-de Paillerets, Brigitte] INSERM, U946, Genet Variat & Human Dis Unit, F-75010 Paris, France; [Mohamdi, Hamida; Demenais, Florence] Univ Paris Diderot, Inst Univ Hematol, F-75010 Paris, France; [Mohamdi, Hamida; Corda, Eve; Blanche, Helene; Chaudru, Valerie; Lathrop, Mark; Demenais, Florence] Fdn Jean Dausset, CEPH, F-75010 Paris, France; [Maubec, Eve] Hop Bichat Claude Bernard, AP HP, Serv Dermatol, Fac Paris Diderot, F-75018 Paris, France; [de la Fouchardiere, Arnaud] Ctr Leon Berard, Dept Pathol, F-69008 Lyon, France; [Molinie, Vincent] Hop St Joseph, Dept Pathol, F-75014 Paris, France; [Vabres, Pierre] Ctr Hosp Univ, Dept Dermatol, F-21079 Dijon, France; [Dalle, Stephane; Poulalhon, Nicolas; Martin-Denavit, Tanguy; Thomas, Luc] Univ Lyon 1, F-69495 Pierre Benite, France; [Dalle, Stephane; Poulalhon, Nicolas; Martin-Denavit, Tanguy; Thomas, Luc] Ctr Hosp Lyon Sud, Dept Dermatol, F-69495 Pierre Benite, France; [Andry-Benzaquen, Pascale; Dupin, Nicolas; Boitier, Francoise; Avril, Marie-Francoise] Hop Cochin Tarnier, AP HP, Serv Dermatol, F-75006 Paris, France; [Andry-Benzaquen, Pascale; Dupin, Nicolas; Boitier, Francoise; Avril, Marie-Francoise] Univ Paris 05, F-75006 Paris, France; [Rossi, Annick] CHU Rouen, Hop Charles Nicolle, Unite Genet Clin, F-76038 Rouen, France; [Perrot, Jean-Luc; Labeille, Bruno] CHU Hop Nord, Dept Dermatol, F-42055 St Etienne, France; [Robert, Caroline; Escudier, Bernard; Caron, Olivier] Inst Cancerol Gustave Roussy, Dept Med, F-94805 Villejuif, France; [Brugieres, Laurence] Inst Cancerol Gustave Roussy, Dept Pediatry, F-94805 Villejuif, France; [Saule, Simon] Univ Paris 11, INSERM, U1021, F-91405 Orsay, France; [Saule, Simon] Univ Paris 11, Inst Curie, CNRS, UMR33, F-91405 Orsay, France; [Gardie, Betty; Gad, Sophie; Richard, Stephane] Univ Paris 11, Genet Oncol EPHE INSERM U753, Fac Med, F-94805 Villejuif, France; [Richard, Stephane] Hop Bicetre, Ctr Expert Natl Canc Rares PREDIR, INCa AP HP, Serv Urol, F-94275 Le Kremlin Bicetre, France; [Couturier, Jerome] Inst Curie, Serv Genet, F-75005 Paris, France; [Teh, Bin Tean] Van Andel Res Inst, Canc Genet Lab, Grand Rapids, MI 49503 USA; [Teh, Bin Tean] Natl Canc Ctr Singapore, NCCS VARI Translat Res Lab, Singapore 16910, Singapore; [Ghiorzo, Paola; Pastorino, Lorenza] Univ Genoa, Dept Internal Med, I-16132 Genoa, Italy; [Puig, Susana; Badenas, Celia] Hosp Clin Barcelona, Dept Dermatol, IDIBAPS, E-08036 Barcelona, Spain; [Puig, Susana; Badenas, Celia] Hosp Clin Barcelona, Melanoma Unit, IDIBAPS, E-08036 Barcelona, Spain; [Puig, Susana; Badenas, Celia] Inst Salud Carlos III, CIBER Enfermedades Raras, Barcelona 08036, Spain; [Olsson, Hakan] Lund Univ & Hosp, Dept Oncol, S-22185 Lund, Sweden; [Ingvar, Christian] Lund Univ & Hosp, Dept Surg, S-22185 Lund, Sweden; [Rouleau, Etienne; Lidereau, Rosette] Hop Rene Huguenin, Serv Oncogenet, F-92210 St Cloud, France; [Vielh, Philippe] Inst Cancerol Gustave Roussy, Dept Pathol, Translat Res Lab & Biobank, F-94805 Villejuif, France; [Galan, Pilar] CRNH Idf, INSERM, UMR557, INRA U1125,CNAM, F-93000 Bobigny, France; [Chaudru, Valerie] Univ Evry Val Essonne, F-91025 Evry, France; [Zelenika, Diana; Lathrop, Mark] CEA, Ctr Natl Genotypage, F-91057 Evry, France; [Lenoir, Gilbert M.] Univ Paris 11, Fac Med, F-94275 Le Kremlin Bicetre, France; [Lesueur, Fabienne; de Lichy, Mahaut; d'Hayer, Benoit; Remenieras, Audrey; Lenoir, Gilbert M.; Bressac-de Paillerets, Brigitte] Inst Cancerol Gustave Roussy, Serv Genet, F-94805 Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Foundation Jean Dausset-CEPH; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Centre Leon Berard; Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; CHU Dijon Bourgogne; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU de Rouen; CHU de St Etienne; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National du Cancer (INCA) France; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Van Andel Institute; National Cancer Centre Singapore (NCCS); University of Genoa; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Rene Huguenin Hospital; UNICANCER; Gustave Roussy; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Bressac-de Paillerets, B (corresponding author), Int Agcy Res Canc, Genet Canc Susceptibil Grp, 150 Cours Albert Thomas, F-69372 Lyon, France.	brigitte.bressac@igr.fr	Lesueur, Fabienne/R-2178-2017; Giuliano, Sandy/U-2498-2019; Maubec, Eve/V-4296-2017; Puig, Susana/AAB-2091-2020; BALLOTTI, Robert/F-8825-2013; Pilar, Galan/F-2908-2017; Vabres, Pierre/D-3906-2011; Ingvar, Christian/AAE-9841-2019; Dalle, Stephane/E-4552-2018; RICHARD, Stéphane/O-1005-2017; Bertolotto-Ballotti, Corine/O-2155-2016; Pastorino, Lorenza/E-6084-2018; Ghiorzo, Paola/CAG-0673-2022; Bertolotto, Corine/AAF-6634-2021; Badenas, Celia/ABH-5480-2020; de la Fouchardiere, Arnaud/I-2807-2019; Demenais, Florence/G-3298-2013; Paillerets, Brigitte Bressac-de/D-8954-2018; Gardie, Betty/K-9243-2015; Strub, Thomas/AAH-3573-2019; Vabres, Pierre/V-3850-2019; Robert, Caroline/G-6157-2018	Lesueur, Fabienne/0000-0001-7404-4549; Maubec, Eve/0000-0003-1658-6686; Puig, Susana/0000-0003-1337-9745; Pilar, Galan/0000-0003-1706-3107; Vabres, Pierre/0000-0001-8693-3183; Dalle, Stephane/0000-0002-3423-4548; RICHARD, Stéphane/0000-0002-9859-9773; Pastorino, Lorenza/0000-0002-2575-8331; Ghiorzo, Paola/0000-0002-3651-8173; Bertolotto, Corine/0000-0001-6971-7753; Badenas, Celia/0000-0002-0621-0477; de la Fouchardiere, Arnaud/0000-0003-2251-8241; Demenais, Florence/0000-0001-8361-0936; Paillerets, Brigitte Bressac-de/0000-0003-0245-8608; Vabres, Pierre/0000-0001-8693-3183; Robert, Caroline/0000-0002-9493-0238; Aubin, Francois/0000-0002-1421-4996; Davidson, Irwin/0000-0001-5533-1171; Bulai Livideanu, Cristina/0000-0002-5275-6868; Faivre, Laurence/0000-0001-9770-444X; Bahadoran, Philippe/0000-0002-2481-0556; Strub, Thomas/0000-0001-6252-0181; Teh, Bin Tean/0000-0003-1514-1124; VENAT-BOUVET, Laurence/0000-0002-0716-2550; GAD (LAPITEAU), Sophie/0000-0002-3158-6791; Grob, Jean-Jacques/0000-0002-0667-153X; Dupin, Nicolas/0000-0002-6237-4951; Olsson, Hakan/0000-0002-8794-9635; BALLOTTI, Robert/0000-0002-7322-4908	INSERM; Ligue Nationale Contre Le Cancer [PRE05/FD, PRE 09/FD]; Programme Hospitalier de Recherche Clinique (PHRC) [2007/AOM-07-195]; ARC [A09/5/5003, 4985]; Institut National du Cancer (INCa)-Canceropole Ile de France [13]; INCa-PNES rein; INCa [R08009AP]; Fondation de France; Fond de maturation IGR; Fondation Gustave Roussy; Societe Francaise de Dermatologie [SDF2004, SFD2009]; AGAUR [2009 SGR 1337]; Generalitat de Catalunya; Fondo de Investigaciones Sanitarias [FIS PS09/01393]; Instituto de Salud Carlos III, Spain	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue Nationale Contre Le Cancer(Ligue nationale contre le cancer); Programme Hospitalier de Recherche Clinique (PHRC); ARC(Australian Research Council); Institut National du Cancer (INCa)-Canceropole Ile de France(Institut National du Cancer (INCA) France); INCa-PNES rein; INCa(Institut National du Cancer (INCA) France); Fondation de France(Fondation de France); Fond de maturation IGR; Fondation Gustave Roussy; Societe Francaise de Dermatologie; AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Generalitat de Catalunya(Generalitat de Catalunya); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	We thank the patients and family members who participated in this study and the clinicians who identified these families, the French Familial Melanoma Study Group and the Inherited Predisposition to Kidney Cancer network. We acknowledge the contribution of the IGR Biobank for providing MELARISK samples and the CEPH Biobank for processing DNA samples. We thank L. Larue, J, Feunteun, A. Sarasin and E. Solary for critical reviews of the manuscript. We thank V. Lazar and S. Forget for coordination of the IGR's genomics and genetic platforms, N. Pata-Merci, V. Marty, S. Le Gras and A. Chabrier for their technical expertise, and M. Barrois for technical counselling. We also thank A. Boland for DNA extraction and quality control for genome-wide genotyping. This work was supported by grants from INSERM, Ligue Nationale Contre Le Cancer (PRE05/FD and PRE 09/FD) to F. D.; Programme Hospitalier de Recherche Clinique (PHRC 2007/AOM-07-195) to M.-F.A. and F. D.; ARC N<SUP>o</SUP>A09/5/5003 to B.B.-d.P.; ARC 4985 to C. B.; Institut National du Cancer (INCa)-Canceropole Ile de France (melanoma network RS#13) to B.B.-deP.; INCa-PNES rein to B. G., S.Ga. and S. R., INCa grant R08009AP to C. B.; Fondation de France 2010 to R. B.; INCa and Ligue National Contre le Cancer to I. D., Fond de maturation IGR and Fondation Gustave Roussy to B.B.-d.P.; Societe Francaise de Dermatologie SDF2004 to R. B. and P. B., SFD2009 to B.B.-d.P.; 2009 SGR 1337 from AGAUR, Generalitat de Catalunya, and FIS PS09/01393 from the Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain to S. P. and C. B.; and personal donations from C. and N. de Paillerets and M.-H.Wagner. to B.B.-d.P. B.B-d.P. holds an INSERM Research Fellowship for hospital-based scientists. Work at the Centre National de Genotypage (CNG) and Centre d'Etude du Polymorphisme Humain (CEPH) was supported in part by INCa.	Bedogni B, 2006, CELL CYCLE, V5, P1258, DOI 10.4161/cc.5.12.2810; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bertolotto C, 1996, J CELL BIOL, V134, P747, DOI 10.1083/jcb.134.3.747; Bischof O, 2006, MOL CELL, V22, P783, DOI 10.1016/j.molcel.2006.05.016; Camparo P, 2008, AM J SURG PATHOL, V32, P656, DOI 10.1097/PAS.0b013e3181609914; Cheli Y, 2010, PIGM CELL MELANOMA R, V23, P27, DOI 10.1111/j.1755-148X.2009.00653.x; Datta D, 2010, J BIOL CHEM, V285, P36842, DOI 10.1074/jbc.M110.170324; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Goldstein AM, 2006, CANCER RES, V66, P9818, DOI 10.1158/0008-5472.CAN-06-0494; Granter SR, 2002, APPL IMMUNOHISTO M M, V10, P47, DOI 10.1097/00022744-200203000-00008; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Hershey CL, 2005, GENE, V347, P73, DOI 10.1016/j.gene.2004.12.002; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Li Y, 2009, CANCER BIOL THER, V8, P322, DOI 10.4161/cbt.8.4.7332; Li ZZ, 2010, CURR TOP MICROBIOL, V345, P21, DOI 10.1007/82_2010_75; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Liu FY, 2011, ONCOL REP, V25, P383, DOI 10.3892/or.2010.1090; Manie S, 2001, TRENDS GENET, V17, P580, DOI 10.1016/S0168-9525(01)02420-9; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Martianov I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-530; Maubec E, 2010, CANCER-AM CANCER SOC, V116, P5716, DOI 10.1002/cncr.25562; Mullenders J, 2010, MOL CANCER RES, V8, P592, DOI 10.1158/1541-7786.MCR-09-0386; Murakami H, 2005, PIGM CELL RES, V18, P265, DOI 10.1111/j.1600-0749.2005.00234.x; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Tempe D, 2008, BIOCHEM SOC T, V36, P874, DOI 10.1042/BST0360874; Tucker MA, 2009, HEMATOL ONCOL CLIN N, V23, P383, DOI 10.1016/j.hoc.2009.03.010; Wang MJ, 2009, J BIOL CHEM, V284, P36500, DOI 10.1074/jbc.M109.008904; Was H, 2006, AM J PATHOL, V169, P2181, DOI 10.2353/ajpath.2006.051365; Wysocki PJ, 2010, CANCER GENE THER, V17, P465, DOI 10.1038/cgt.2010.2; Yang Z, 2009, CURR CANCER DRUG TAR, V9, P915, DOI 10.2174/156800909790192383; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Yu JX, 2009, EMBO J, V28, P21, DOI 10.1038/emboj.2008.238; Zou AP, 2003, ACTA PHYSIOL SCAND, V179, P233, DOI 10.1046/j.0001-6772.2003.01206.x	37	346	351	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2011	480	7375					94	U259		10.1038/nature10539	http://dx.doi.org/10.1038/nature10539			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22012259				2022-12-28	WOS:000298031900041
J	Uhl, L				Uhl, Lynne			Patient Blood Management A 68-Year-Old Woman Contemplating Autologous Blood Donation Before Elective Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; PREOPERATIVE HEMOGLOBIN LEVELS; ACUTE LUNG INJURY; TOTAL HIP; COST-EFFECTIVENESS; TRANSFUSION REQUIREMENTS; CARDIAC-SURGERY; EPOETIN-ALPHA; SURGICAL-PROCEDURES; KNEE SURGERY	Globally, more than 81 million units of red blood cells are transfused annually. Of the 15 million red blood cell components transfused annually in the United States, approximately 40% are transfused to patients undergoing elective surgical procedures. Because of concerns about limited blood availability as well as risks of transfusion-related adverse events, blood products should be used judiciously. Using the case of Ms C, a 68-year-old woman considering autologous blood donation prior to knee replacement surgery, the concept of patient blood management is discussed. This approach entails a complete evaluation of the patient in the preoperative period to assess for bleeding risks and anemia, with a goal to optimize a patient's condition prior to surgery; use of various strategies in the operative period to mitigate the need for allogeneic blood transfusion; and meticulous postoperative care to again avoid the need for blood transfusion. JAMA. 2011; 306(17): 1902-1910	[Uhl, Lynne] Beth Israel Deaconess Med Ctr, Div Lab & Transfus Med, Boston, MA 02215 USA; [Uhl, Lynne] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Uhl, L (corresponding author), Beth Israel Deaconess Med Ctr, Div Lab & Transfus Med, Yamins 309,330 Brookline Ave, Boston, MA 02215 USA.	luhl@bidmc.harvard.edu						AABB, 2020, STANDARDS BLOOD BANK; Aledort LM, 2005, TRANSFUS MED REV, V19, P66, DOI 10.1016/j.tmrv.2004.09.05; Alghamdi AA, 2006, TRANSFUSION, V46, P1120, DOI 10.1111/j.1537-2995.2006.00860.x; Ashworth A, 2010, BRIT J ANAESTH, V105, P401, DOI 10.1093/bja/aeq244; Barr PJ, 2010, VOX SANG, V99, P239, DOI 10.1111/j.1423-0410.2010.01349.x; Bern MM, 2006, TRANSFUSION MED, V16, P313, DOI 10.1111/j.1365-3148.2006.00701.x; Bierbaum BE, 1999, J BONE JOINT SURG AM, V81A, P2, DOI 10.2106/00004623-199901000-00002; Billote DB, 2002, J BONE JOINT SURG AM, V84A, P1299, DOI 10.2106/00004623-200208000-00003; BIRKMEYER JD, 1993, TRANSFUSION, V33, P544, DOI 10.1046/j.1537-2995.1993.33793325048.x; BIRKMEYER JD, 1994, ANN THORAC SURG, V57, P161, DOI 10.1016/0003-4975(94)90386-7; Blajchman MA, 2006, NEW ENGL J MED, V355, P1303, DOI 10.1056/NEJMp068178; Brecher ME, 2001, TRANSFUSION, V41, P1459, DOI 10.1046/j.1537-2995.2001.41121459.x; Carless PA, 2010, COCHRANE DB SYST REV, V4; Centers for Medicare and Medicaid Services, 2011, MED BEN POL MAN COV; Centers forMedicare and Medicaid Services, 2011, MED NAT COV DET MA 2; Chambers L A, 1990, Transfus Med Rev, V4, P35, DOI 10.1016/S0887-7963(90)70246-5; D'Ambra MN, 1997, ANN THORAC SURG, V64, P1686, DOI 10.1016/S0003-4975(97)00839-4; Davis M, 2003, BJU INT, V91, P474, DOI 10.1046/j.1464-410X.2003.04129.x; Davis RE, 2011, TRANSFUS MED REV, V25, P12, DOI 10.1016/j.tmrv.2010.08.003; de Andrade J R, 1996, Am J Orthop (Belle Mead NJ), V25, P533; Department of Health and Human Services, 2009, BIOV US EFF BRIDG CR; Domen RE, 1998, TRANSFUSION, V38, P296, DOI 10.1046/j.1537-2995.1998.38398222875.x; Eder AF, 2008, TECHNICAL MANUAL, P137; Eder AF, 2007, ARCH PATHOL LAB MED, V131, P708; Eder AF, 2010, TRANSFUSION, V50, P1732, DOI 10.1111/j.1537-2995.2010.02652.x; Elmistekawy EM, 2009, J CARDIOTHORAC SURG, V4, DOI 10.1186/1749-8090-4-20; Epstein JS, 2010, TRANSFUSION, V50, P1408, DOI 10.1111/j.1537-2995.2010.02728.x; ETCHASON J, 1995, NEW ENGL J MED, V332, P719, DOI 10.1056/NEJM199503163321106; Faris PM, 1996, J BONE JOINT SURG AM, V78A, P62, DOI 10.2106/00004623-199601000-00009; Faris PM, 1998, CLIN ORTHOP RELAT R, P60; Fergusson DA, 2005, CAN J ANAESTH, V52, P347; Ferraris VA, 2007, ANN THORAC SURG, V83, P27, DOI 10.1016/j.athoracsur.2007.02.099; Freischlag JA, 2004, CRIT CARE, V8, pS53, DOI 10.1186/cc2409; Glynn SA, 2010, TRANSFUSION, V50, P1164, DOI 10.1111/j.1537-2995.2010.02674.x; Goldberg M A, 1996, Am J Orthop (Belle Mead NJ), V25, P544; Gombotz H, 2007, TRANSFUSION, V47, P1468, DOI 10.1111/j.1537-2995.2007.01286.x; Gonzalez-Porras JR, 2009, TRANSFUSION MED, V19, P35, DOI 10.1111/j.1365-3148.2009.00908.x; Goodnough LT, 2011, BRIT J ANAESTH, V106, P13, DOI 10.1093/bja/aeq361; Goodnough LT, 2007, ARCH PATHOL LAB MED, V131, P695; Goodnough LT, 2005, TRANSFUSION-FREE MEDICINE AND SURGERY, P60, DOI 10.1002/9780470994788.ch3; Goodnough LT, 2004, CRIT CARE, V8, pS49, DOI 10.1186/cc2408; GOODNOUGH LT, 1994, UROLOGY, V44, P226; GOODNOUGH LT, 1992, VOX SANG, V63, P96, DOI 10.1111/j.1423-0410.1992.tb02493.x; Goodnough LT, 2000, BLOOD, V96, P823, DOI 10.1182/blood.V96.3.823.015k49_823_833; Goodnough LT, 2011, TRANSFUSION THERAPY, P699; Hajjar LA, 2010, JAMA-J AM MED ASSOC, V304, P1559, DOI 10.1001/jama.2010.1446; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Henry DA, 2010, PREOPERATIVE AUTOLOG; Holland PV, 1997, TRANSFUS MED REV, V11, P274, DOI 10.1016/S0887-7963(97)80093-4; Karkouti K, 2005, CAN J ANAESTH, V52, P362; Keating EM, 2007, J ARTHROPLASTY, V22, P325, DOI 10.1016/j.arth.2006.11.002; Killion DF, 2007, TRANSFUSION, V47, P557, DOI 10.1111/j.1537-2995.2007.01185.x; LAUPACIS A, 1993, LANCET, V342, P378, DOI 10.1016/0140-6736(93)91527-S; Liang TB, 2008, TRANSPLANTATION, V85, P863, DOI 10.1097/TP.0b013e3181671f2e; Mahadevan D, 2010, J ORTHOP TRAUMATOL, V11, P159, DOI 10.1007/s10195-010-0105-z; Marchetti M, 2000, TRANSFUSION, V40, P673, DOI 10.1046/j.1537-2995.2000.40060673.x; Martinez V, 2007, BRIT J ANAESTH, V99, P794, DOI 10.1093/bja/aem266; MCVAY PA, 1990, TRANSFUSION, V30, P249, DOI 10.1046/j.1537-2995.1990.30390194347.x; Monk TG, 1999, ANESTHESIOLOGY, V91, P24, DOI 10.1097/00000542-199907000-00008; Moonen AFCM, 2008, J BONE JOINT SURG BR, V90B, P1079, DOI 10.1302/0301-620X.90B8.20595; Moskowitz DM, 2004, ANN THORAC SURG, V77, P626, DOI 10.1016/S0003-4975(03)01345-6; Myers E, 2004, ARCH ORTHOP TRAUM SU, V124, P699, DOI 10.1007/s00402-004-0754-6; Newman BH, 2003, TRANSFUSION, V43, P598, DOI 10.1046/j.1537-2995.2003.00368.x; Newman B, 2007, TRANSFUSION, V47, P1524, DOI 10.1111/j.1537-2995.2007.01293.x; Olijhoek G, 2001, TRANSFUSION, V41, P957, DOI 10.1046/j.1537-2995.2001.41070957.x; Patel MS, 2009, MED CLIN N AM, V93, P1095, DOI 10.1016/j.mcna.2009.05.007; Rhamy JF, 2010, TRANSFUSION, V50, P2793, DOI 10.1111/j.1537-2995.2010.02946.x; Salido JA, 2002, J BONE JOINT SURG AM, V84A, P216, DOI 10.2106/00004623-200202000-00008; Segal JB, 2004, TRANSFUSION, V44, P632, DOI 10.1111/j.1537-2995.2004.03353.x; Seifried E, 2011, Vox Sang, V100, P10, DOI 10.1111/j.1423-0410.2010.01446.x; Shander A, 2010, TRANSFUSION, V50, P753, DOI 10.1111/j.1537-2995.2009.02518.x; Shander AS, 2010, JAMA-J AM MED ASSOC, V304, P1610, DOI 10.1001/jama.2010.1483; Shaz BH, 2011, BLOOD, V117, P1463, DOI 10.1182/blood-2010-04-278135; Sowade O, 1997, BLOOD, V89, P411, DOI 10.1182/blood.V89.2.411; Spahn DR, 2010, ANESTHESIOLOGY, V113, P482, DOI 10.1097/ALN.0b013e3181e08e97; Stainsby D, 2006, TRANSFUS MED REV, V20, P273, DOI 10.1016/j.tmrv.2006.05.002; Stehling L, 1991, GUIDELINES ESTABLISH; Stowell CP, 1999, ORTHOPEDICS, V22, pS105; Stramer SL, 2007, ARCH PATHOL LAB MED, V131, P702; The Joint Commission, 2011, PAT BLOOD MAN PERF M; Theusinger OM, 2007, ANESTHESIOLOGY, V107, P923, DOI 10.1097/01.anes.0000291441.10704.82; TOY P, 1988, Transfusion (Bethesda), V28, p17S; Vitale MG, 2007, SPINE J, V7, P292, DOI 10.1016/j.spinee.2006.04.004; Waters JH, 2004, TRANSFUSION, V44, p40S, DOI 10.1111/j.0041-1132.2004.04176.x; Whitaker B, 2011, REPORT US DEP HLTH H; *WHO, 2009, 10 FACTS BLOOD TRANS; Wong CJ, 2007, TRANSFUSION, V47, P832, DOI 10.1111/j.1537-2995.2007.01197.x; Yazer M, 2007, TRANSFUSION, V47, P366, DOI 10.1111/j.1537-2995.2007.01151.x	88	11	11	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 2	2011	306	17					1902	1910		10.1001/jama.2011.1526	http://dx.doi.org/10.1001/jama.2011.1526			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839OD	21990097				2022-12-28	WOS:000296376200024
J	Innocentin, YLS; Withers, DR; Roberts, NA; Gallagher, AR; Grigorieva, EF; Wilhelm, C; Veldhoen, M				Innocentin, Ying Li Silvia; Withers, David R.; Roberts, Natalie A.; Gallagher, Alec R.; Grigorieva, Elena F.; Wilhelm, Christoph; Veldhoen, Marc			Exogenous Stimuli Maintain Intraepithelial Lymphocytes via Aryl Hydrocarbon Receptor Activation	CELL			English	Article							INFLAMMATORY-BOWEL-DISEASE; DELTA-T-CELLS; CROHNS-DISEASE; INTESTINAL EPITHELIUM; GENE-EXPRESSION; ALPHA-DEFENSINS; DEFICIENT MICE; CULTURE-MEDIUM; IMMUNE-SYSTEM; AH RECEPTOR	The body's surfaces form the interface with the external environment, protecting the host. These epithelial barriers are also colonized by a controlled diversity of microorganisms, disturbances of which can give rise to disease. Specialized intraepithelial lymphocytes (IELs), which reside at these sites, are important as a first line of defense as well as in epithelial barrier organization and wound repair. We show here that the aryl hydrocarbon receptor (AhR) is a crucial regulator in maintaining IEL numbers in both the skin and the intestine. In the intestine, AhR deficiency or the lack of AhR ligands compromises the maintenance of IELs and the control of the microbial load and composition, resulting in heightened immune activation and increased vulnerability to epithelial damage. AhR activity can be regulated by dietary components, such as those present in cruciferous vegetables, providing a mechanistic link between dietary compounds, the intestinal immune system, and the microbiota.	[Innocentin, Ying Li Silvia; Wilhelm, Christoph; Veldhoen, Marc] MRC Natl Inst Med Res, Div Mol Immunol, London NW7 1AA, England; [Gallagher, Alec R.] MRC Natl Inst Med Res, Div Biol Serv, London NW7 1AA, England; [Grigorieva, Elena F.] MRC Natl Inst Med Res, Div Dev Neurobiol, London NW7 1AA, England; [Withers, David R.; Veldhoen, Marc] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England; [Roberts, Natalie A.; Gallagher, Alec R.] Univ Birmingham, Sch Med, Inst Biomed Res, MRC Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research; MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Birmingham	Veldhoen, M (corresponding author), MRC Natl Inst Med Res, Div Mol Immunol, Mill Hill, London NW7 1AA, England.	marc.veldhoen@babraham.ac.uk	Wilhelm, Christoph/ABE-7176-2020; Veldhoen, Marc/AAJ-2759-2020; Withers, David/C-7055-2015; Veldhoen, Marc/AAM-5357-2021	Wilhelm, Christoph/0000-0002-9839-0291; Veldhoen, Marc/0000-0002-1478-9562; Withers, David/0000-0003-3757-7594; /0000-0001-9113-6306	Medical Research Council UK [U117512792]; Biotechnology and Biological Sciences Research Council; BBSRC [BBS/E/B/0000S042] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000S042] Funding Source: researchfish; Medical Research Council [G9818340B] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Rae and G. Preece for assistance with cell sorting; H. Boyes, J. Holland, and T. Norton for assistance with maintenance of mouse strains; and Drs. B. Stockinger, E. Simpson, G. Butcher, and M. Turner for helpful discussions and advice. The work was supported by the Medical Research Council UK (Ref. U117512792) and the Biotechnology and Biological Sciences Research Council.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Amre DK, 2007, AM J GASTROENTEROL, V102, P2016, DOI 10.1111/j.1572-0241.2007.01411.x; Andoh A, 2011, J GASTROENTEROL, V46, P479, DOI 10.1007/s00535-010-0368-4; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; BERGSTRESSER PR, 1984, METHOD ENZYMOL, V108, P683; Bernstein CN, 2005, GASTROENTEROLOGY, V129, P827, DOI 10.1053/j.gastro.2005.06.021; BJELDANES LF, 1991, P NATL ACAD SCI USA, V88, P9543, DOI 10.1073/pnas.88.21.9543; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; CARDING SR, 1990, GENE DEV, V4, P1304, DOI 10.1101/gad.4.8.1304; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Cong YZ, 1998, J EXP MED, V187, P855, DOI 10.1084/jem.187.6.855; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; D'Souza S, 2008, INFLAMM BOWEL DIS, V14, P367, DOI 10.1002/ibd.20333; Davenport CM, 2002, INT IMMUNOPHARMACOL, V2, P653, DOI 10.1016/S1567-5769(01)00201-6; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Einarsdottir E, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-8; Fahrer AM, 2001, P NATL ACAD SCI USA, V98, P10261, DOI 10.1073/pnas.171320798; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; FernandezSalguero PM, 1997, VET PATHOL, V34, P605, DOI 10.1177/030098589703400609; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fuss IJ, 1996, J IMMUNOL, V157, P1261; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; Girardi M, 2003, J EXP MED, V198, P747, DOI 10.1084/jem.20021282; Guerreiro CS, 2007, AM J GASTROENTEROL, V102, P2551, DOI 10.1111/j.1572-0241.2007.01439.x; HARPER PH, 1985, GUT, V26, P279, DOI 10.1136/gut.26.3.279; Hoffmann RM, 2004, INFLAMM BOWEL DIS, V10, P140, DOI 10.1097/00054725-200403000-00013; Ismail AS, 2009, J IMMUNOL, V182, P3047, DOI 10.4049/jimmunol.0802705; Ito SJ, 2007, J CLIN INVEST, V117, P1940, DOI 10.1172/JCI31647; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; King DP, 1999, J IMMUNOL, V162, P5033; Kliewer SA, 1999, SCIENCE, V284, P757, DOI 10.1126/science.284.5415.757; KNUTSON JC, 1982, CELL, V30, P225, DOI 10.1016/0092-8674(82)90028-9; KOMANO H, 1995, P NATL ACAD SCI USA, V92, P6147, DOI 10.1073/pnas.92.13.6147; Lahvis GP, 1998, BIOCHEM PHARMACOL, V56, P781, DOI 10.1016/S0006-2952(98)00134-8; Leon F, 2006, J IMMUNOL, V177, P6974, DOI 10.4049/jimmunol.177.10.6974; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Marlowe JL, 2005, J CELL BIOCHEM, V96, P1174, DOI 10.1002/jcb.20656; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; MOMBAERTS P, 1993, NATURE, V365, P53, DOI 10.1038/365053a0; Moore TA, 2000, J IMMUNOL, V165, P2643, DOI 10.4049/jimmunol.165.5.2643; Najarian DJ, 2003, J AM ACAD DERMATOL, V48, P805, DOI 10.1067/mjd.2003.540; Oberg M, 2005, TOXICOL SCI, V85, P935, DOI 10.1093/toxsci/kfi154; Pellequer JL, 1998, P NATL ACAD SCI USA, V95, P5884, DOI 10.1073/pnas.95.11.5884; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Roberts SJ, 1996, P NATL ACAD SCI USA, V93, P11774, DOI 10.1073/pnas.93.21.11774; ROCHA B, 1994, J EXP MED, V180, P681, DOI 10.1084/jem.180.2.681; SADEK CM, 1994, J BIOL CHEM, V269, P16067; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Selin LK, 2001, J IMMUNOL, V166, P6784, DOI 10.4049/jimmunol.166.11.6784; Shanahan F, 2000, SCIENCE, V289, P1311, DOI 10.1126/science.289.5483.1311; Sokol H, 2006, INFLAMM BOWEL DIS, V12, P106, DOI 10.1097/01.MIB.0000200323.38139.c6; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Walisser JA, 2005, P NATL ACAD SCI USA, V102, P17858, DOI 10.1073/pnas.0504757102; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Xiong N, 2002, IMMUNITY, V16, P453, DOI 10.1016/S1074-7613(02)00285-6	66	538	565	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 28	2011	147	3					629	640		10.1016/j.cell.2011.09.025	http://dx.doi.org/10.1016/j.cell.2011.09.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	842EH	21999944	Bronze			2022-12-28	WOS:000296573700017
J	Turnbull, JE				Turnbull, Jeremy E.			Getting the Farm Out of Pharma for Heparin Production	SCIENCE			English	Editorial Material							ADVERSE CLINICAL EVENTS; SULFATE; DRUG		[Turnbull, Jeremy E.] Univ Liverpool, Ctr Glycobiol, Liverpool L69 7ZB, Merseyside, England; [Turnbull, Jeremy E.] Univ Liverpool, Inst Integrat Biol, Dept Biochem & Cell Biol, Liverpool L69 7ZB, Merseyside, England	University of Liverpool; University of Liverpool	Turnbull, JE (corresponding author), Univ Liverpool, Ctr Glycobiol, Liverpool L69 7ZB, Merseyside, England.	j.turnbull@liverpool.ac.uk			BBSRC [BB/D006325/1, BB/I004343/1] Funding Source: UKRI; MRC [G117/423] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I004343/1, BB/D006325/1] Funding Source: Medline; Medical Research Council [G117/423] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arungundram S, 2009, J AM CHEM SOC, V131, P17394, DOI 10.1021/ja907358k; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Cole CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011644; de Paz JL, 2006, J AM CHEM SOC, V128, P2766, DOI 10.1021/ja057584v; Guerrini M, 2008, NAT BIOTECHNOL, V26, P669, DOI 10.1038/nbt1407; Guerrini M, 2009, P NATL ACAD SCI USA, V106, P16956, DOI 10.1073/pnas.0906861106; Hu YP, 2011, NAT CHEM, V3, P557, DOI 10.1038/nchem.1073; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724; Liu HY, 2009, NAT PROD REP, V26, P313, DOI 10.1039/b819896a; Patey SJ, 2006, J MED CHEM, V49, P6129, DOI 10.1021/jm051221o; Petitou M, 2004, ANGEW CHEM INT EDIT, V43, P3118, DOI 10.1002/anie.200300640; Stevenson JL, 2005, CLIN CANCER RES, V11, P7003, DOI 10.1158/1078-0432.CCR-05-1131; *US FDA, INF ADV EV REP HEP; WANG Z, 2010, CHEMISTRY, V26, P8365; Xu YM, 2011, SCIENCE, V334, P498, DOI 10.1126/science.1207478	16	11	11	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 28	2011	334	6055					462	463		10.1126/science.1211605	http://dx.doi.org/10.1126/science.1211605			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837UR	22034422				2022-12-28	WOS:000296230500030
J	Fleming, TR; Emerson, SS				Fleming, Thomas R.; Emerson, Scott S.			Evaluating Rivaroxaban for Nonvalvular Atrial Fibrillation - Regulatory Considerations	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fleming, Thomas R.; Emerson, Scott S.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Fleming, TR (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98195 USA.				NIAID NIH HHS [R37 AI029168] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Fleming TR, 2011, CLIN TRIALS, V8, P432, DOI 10.1177/1740774511410994; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; US Government Printing Office, 1995, FED REGISTER, V60, P39180	4	32	33	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2011	365	17					1557	1559		10.1056/NEJMp1110639	http://dx.doi.org/10.1056/NEJMp1110639			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HI	21992495				2022-12-28	WOS:000296181800011
J	Romm, J				Romm, Joseph			The next dust bowl	NATURE			English	Editorial Material							CLIMATE		Ctr Amer Progress Act Fund, Washington, DC USA		Romm, J (corresponding author), Ctr Amer Progress Act Fund, Washington, DC USA.	jromm@americanprogress.org						[Anonymous], 2009, GLOBAL CLIMATE CHANG; Barnett TP, 2008, SCIENCE, V319, P1080, DOI 10.1126/science.1152538; Dai AG, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015541; Dai AG, 2011, WIRES CLIM CHANGE, V2, P45, DOI 10.1002/wcc.81; RIND D, 1990, J GEOPHYS RES-ATMOS, V95, P9983, DOI 10.1029/JD095iD07p09983; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Seidel DJ, 2008, NAT GEOSCI, V1, P21, DOI 10.1038/ngeo.2007.38; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; Woodhouse CA, 2010, P NATL ACAD SCI USA, V107, P21283, DOI 10.1073/pnas.0911197107	10	106	110	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2011	478	7370					450	451		10.1038/478450a	http://dx.doi.org/10.1038/478450a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	22031419	Bronze			2022-12-28	WOS:000296194200015
J	Probstfield, JL; Frye, RL				Probstfield, Jeffrey L.; Frye, Robert L.			Strategies for Recruitment and Retention of Participants in Clinical Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Probstfield, Jeffrey L.] Univ Washington, Clin Trials Serv Unit, Div Cardiol, Dept Med, Seattle, WA 98102 USA; [Frye, Robert L.] Mayo Clin, Sch Med, Div Cardiol, Dept Med, Rochester, MN USA	University of Washington; University of Washington Seattle; Mayo Clinic	Probstfield, JL (corresponding author), Univ Washington, Clin Trials Serv Unit, Div Cardiol, Dept Med, 2815 Eastlake Ave E,Ste 200, Seattle, WA 98102 USA.	jeffprob@u.washington.edu						Djulbegovic B, 2011, JAMA-J AM MED ASSOC, V305, P2005, DOI 10.1001/jama.2011.650; IOM (Institute of Medicine), 2010, TRANSF CLIN RES US C; Katz Jay, 1996, YALE LAW SCH OCCASIO; Miller FG, 2011, NEW ENGL J MED, V364, P476, DOI 10.1056/NEJMsb1011301; Mills EJ, 2006, LANCET ONCOL, V7, P141, DOI 10.1016/S1470-2045(06)70576-9	5	59	59	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 26	2011	306	16					1798	1799		10.1001/jama.2011.1544	http://dx.doi.org/10.1001/jama.2011.1544			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HH	22028357				2022-12-28	WOS:000296181600026
J	Adli, M; Kleinert, S; Bonk, M; Wesselingh, S; Ganten, D				Adli, Mazda; Kleinert, Sabine; Bonk, Mathias; Wesselingh, Steve; Ganten, Detlev			Science to policy: M8 Alliance invites policy makers to step in	LANCET			English	Editorial Material							HEALTH-CARE		[Adli, Mazda; Bonk, Mathias; Ganten, Detlev] Charite, D-10117 Berlin, Germany; [Kleinert, Sabine] Lancet, London, England; [Wesselingh, Steve] Monash Univ, Fac Med Nursing & Hlth Sci, Clayton, Vic 3800, Australia	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Monash University	Adli, M (corresponding author), Charite, D-10117 Berlin, Germany.	mazda.adli@charite.de	Adli, Mazda/GYV-2083-2022					Adli M, 2010, LANCET, V376, P1197, DOI 10.1016/S0140-6736(10)61549-8; Beaglehole R, 2011, LANCET, V378, P1283, DOI 10.1016/S0140-6736(11)61559-6; Bloom DE, 2011, GLOBAL EC BURDEN NON; Crisp Nigel., 2010, TURNING WORLD UPSIDE; Dye C, 2008, SCIENCE, V319, P766, DOI 10.1126/science.1150198; Ganten D, 2010, LANCET, V376, P1802, DOI 10.1016/S0140-6736(10)62139-3; Levitt NS, 2008, HEART, V94, P1376, DOI 10.1136/hrt.2008.147306; Lim MK, 2005, ANN ACAD MED SINGAP, V34, P461; Peen J, 2010, ACTA PSYCHIAT SCAND, V121, P84, DOI 10.1111/j.1600-0447.2009.01438.x; Victora CG, 2011, LANCET, V377, P2042, DOI 10.1016/S0140-6736(11)60055-X	10	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2011	378	9801					1447	1449		10.1016/S0140-6736(11)61618-8	http://dx.doi.org/10.1016/S0140-6736(11)61618-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	838VC	22018004				2022-12-28	WOS:000296319600008
J	Mize, DLE; Gandhi, GY				Mize, Dara L. Eckerle; Gandhi, Gunjan Y.			Review: Evidence for the effectiveness of interventions to prevent foot ulcers in patients with diabetes is limited	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Mize, Dara L. Eckerle; Gandhi, Gunjan Y.] Mayo Clin, Jacksonville, FL 32224 USA	Mayo Clinic	Mize, DLE (corresponding author), Mayo Clin, Jacksonville, FL 32224 USA.							Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI 10.2337/dc11-S011; Roback K, 2010, EXPERT REV MED DEVIC, V7, P711, DOI 10.1586/ERD.10.35; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217	3	0	0	1	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2011	155	8							JC4-8	10.7326/0003-4819-155-8-201110180-02008	http://dx.doi.org/10.7326/0003-4819-155-8-201110180-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835WB	22007067				2022-12-28	WOS:000296066300007
J	Ziso, B; Quantrill, SJ				Ziso, B.; Quantrill, S. J.			PICTURE QUIZ Abnormal chest radiograph in pregnancy	BRITISH MEDICAL JOURNAL			English	Editorial Material							PULMONARY ASPERGILLOSIS		[Quantrill, S. J.] Whipps Cross Univ Hosp, Chest Clin, London E11 1NR, England; [Ziso, B.] Barts & London NHS Trust, Royal London Hosp, London, England	University of London; Queen Mary University London; Barts Health NHS Trust; Royal London Hospital	Quantrill, SJ (corresponding author), Whipps Cross Univ Hosp, Chest Clin, London E11 1NR, England.	simon.quantrill@whippsx.nhs.uk						Daly P, 2001, BRIT J BIOMED SCI, V58, P197; Denning DW, 2003, CLIN INFECT DIS, V37, pS265, DOI 10.1086/376526; Eskandar OS, 2010, OBSTET GYNAECOL, V12, P71, DOI 10.1576/toag.12.2.71.27571; Health Protection Agency The Royal College of Radiologists and the Royal College of Radiographers, 2009, PROT PREGN PAT DIAGN; Morice AH, 2006, THORAX, V61, pI1, DOI 10.1136/thx.2006.065144; Soubani AO, 2002, CHEST, V121, P1988, DOI 10.1378/chest.121.6.1988	6	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 17	2011	343								d6035	10.1136/bmj.d6035	http://dx.doi.org/10.1136/bmj.d6035			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851CH	22006941				2022-12-28	WOS:000297245400001
J	Penston, J				Penston, James			Should we use total mortality rather than cancer specific mortality to judge cancer screening programmes? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							ALL-CAUSE MORTALITY; COLORECTAL-CANCER; BREAST; TRIAL		Scunthorpe Gen Hosp, Scunthorpe DN15 7BH, England		Penston, J (corresponding author), Scunthorpe Gen Hosp, Scunthorpe DN15 7BH, England.	james.penston@nhs.net						Black WC, 2002, JNCI-J NATL CANCER I, V94, P167, DOI 10.1093/jnci/94.3.167; Gotzsche PC, 2011, J ROY SOC MED, V104, P361, DOI 10.1258/jrsm.2011.110078; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; Moayyedi P, 2006, AM J GASTROENTEROL, V101, P380, DOI 10.1111/j.1572-0241.2006.00537.x; Newman DH, 2010, JNCI-J NATL CANCER I, V102, P1008, DOI 10.1093/jnci/djq190; Scholefield JH, 2002, GUT, V50, P840, DOI 10.1136/gut.50.6.840; Tabar L, 2002, J MED SCREEN, V9, P159, DOI 10.1136/jms.9.4.159	7	39	39	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 13	2011	343								d6395	10.1136/bmj.d6395	http://dx.doi.org/10.1136/bmj.d6395			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	835EQ	21998347				2022-12-28	WOS:000296018300005
J	Bardage, C; Persson, I; Ortqvist, A; Bergman, U; Ludvigsson, JF; Granath, F				Bardage, Carola; Persson, Ingemar; Ortqvist, Ake; Bergman, Ulf; Ludvigsson, Jonas F.; Granath, Fredrik			Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GUILLAIN-BARRE-SYNDROME; BELLS-PALSY; ASSOCIATION; CHILDREN; SAFETY	Objective To examine the risk of neurological and autoimmune disorders of special interest in people vaccinated against pandemic influenza A (H1N1) with Pandemrix (GlaxoSmithKline, Middlesex, UK) compared with unvaccinated people over 8-10 months. Design Retrospective cohort study linking individualised data on pandemic vaccinations to an inpatient and specialist database on healthcare utilisation in Stockholm county for follow-up during and after the pandemic period. Setting Stockholm county, Sweden. Population All people registered in Stockholm county on 1 October 2009 and who had lived in this region since 1 January 1998; 1 024 019 were vaccinated against H1N1 and 921 005 remained unvaccinated. Main outcome measures Neurological and autoimmune diagnoses according to the European Medicines Agency strategy for monitoring of adverse events of special interest defined using ICD-10 codes for Guillain-Barre syndrome, Bell's palsy, multiple sclerosis, polyneuropathy, anaesthesia or hypoaesthesia, paraesthesia, narcolepsy (added), and autoimmune conditions such as rheumatoid arthritis, inflammatory bowel disease, and type 1 diabetes; and short term mortality according to vaccination status. Results Excess risks among vaccinated compared with unvaccinated people were of low magnitude for Bell's palsy (hazard ratio 1.25, 95% confidence interval 1.06 to 1.48) and paraesthesia (1.11, 1.00 to 1.23) after adjustment for age, sex, socioeconomic status, and healthcare utilisation. Risks for Guillain-Barre syndrome, multiple sclerosis, type 1 diabetes, and rheumatoid arthritis remained unchanged. The risks of paraesthesia and inflammatory bowel disease among those vaccinated in the early phase (within 45 days from 1 October 2009) of the vaccination campaign were significantly increased; the risk being increased within the first six weeks after vaccination. Those vaccinated in the early phase were at a slightly reduced risk of death than those who were unvaccinated (0.94, 0.91 to 0.98), whereas those vaccinated in the late phase had an overall reduced mortality (0.68, 0.64 to 0.71). These associations could be real or explained, partly or entirely, by residual confounding. Conclusions Results for the safety of Pandemrix over 8-10 months of follow-up were reassuring -notably, no change in the risk for Guillain-Barre syndrome, multiple sclerosis, type 1 diabetes, or rheumatoid arthritis. Relative risks were significantly increased for Bell's palsy, paraesthesia, and inflammatory bowel disease after vaccination, predominantly in the early phase of the vaccination campaign. Small numbers of children and adolescents with narcolepsy precluded any meaningful conclusions.	[Bardage, Carola; Persson, Ingemar] Med Prod Agcy, SE-75103 Uppsala, Sweden; [Persson, Ingemar; Bergman, Ulf; Ludvigsson, Jonas F.; Granath, Fredrik] Karolinska Inst, Ctr Pharmacoepidemiol, Stockholm, Sweden; [Ortqvist, Ake] Stockholm Cty Council, Dept Communicable Dis Control & Prevent, Stockholm, Sweden; [Ortqvist, Ake] Karolinska Inst, Karolinska Univ Hosp, Infect Dis Unit, Dept Med, Stockholm, Sweden; [Bergman, Ulf] Karolinska Inst, Div Clin Pharmacol, Reg Drug Safety Unit, Stockholm, Sweden; [Ludvigsson, Jonas F.] Orebro Univ Hosp, Dept Paediat, Orebro, Sweden	Medical Products Agency; Karolinska Institutet; Stockholm County Council; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Orebro University	Bardage, C (corresponding author), Med Prod Agcy, POB 26, SE-75103 Uppsala, Sweden.	Carola.Bardage@mpa.se	Ludvigsson, Jonas F/A-8560-2012	Ludvigsson, Jonas F/0000-0003-1024-5602; Bergman, Ulf/0000-0003-4654-2211	Stockholm County Council; Medical Products Agency	Stockholm County Council(Stockholm County Council); Medical Products Agency	Stockholm County Council and the Medical Products Agency.	[Anonymous], 2000, Diabetologia, V43, P47; [Anonymous], 2011, NAT NARC TASK FORC I; [Anonymous], 2009, EMEA3593812009 EMA; [Anonymous], 2011, OCC NARC CAT CHILDR; DeStefano F, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.6.e112; Diez-Domingo J, 2010, PEDIATR INFECT DIS J, V29, pE35, DOI 10.1097/INF.0b013e3181daf921; Haber P, 2004, JAMA-J AM MED ASSOC, V292, P2478, DOI 10.1001/jama.292.20.2478; HURWITZ ES, 1981, NEW ENGL J MED, V304, P1557, DOI 10.1056/NEJM198106253042601; Hviid A, 2004, NEW ENGL J MED, V350, P1398, DOI 10.1056/NEJMoa032665; Johansen K, 2009, EUROSURVEILLANCE, V14, P12; Karvonen M, 1999, BRIT MED J, V318, P1169, DOI 10.1136/bmj.318.7192.1169; Kuroda Y, 2004, BIOMED PHARMACOTHER, V58, P325, DOI 10.1016/j.biopha.2004.04.009; Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501; Liang XF, 2011, NEW ENGL J MED, V364, P638, DOI 10.1056/NEJMoa1008553; Lofgren S, 2010, SCAND J PUBLIC HEALT, V38, P418, DOI 10.1177/1403494810370232; Lu CC, 2011, VACCINE, V29, P444, DOI 10.1016/j.vaccine.2010.10.081; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Medical Products Agency, 2011, REG BAS COMP COH STU; Ortqvist A, 2011, CLIN INFECT DIS, V52, P1203, DOI 10.1093/cid/cir182; Park SW, 2011, AM J INFECT CONTROL, V39, P69, DOI 10.1016/j.ajic.2010.08.007; ROSCELLI JD, 1991, AM J EPIDEMIOL, V133, P952, DOI 10.1093/oxfordjournals.aje.a115974; SAFRANEK TJ, 1991, AM J EPIDEMIOL, V133, P940, DOI 10.1093/oxfordjournals.aje.a115973; Satoh M, 2003, J AUTOIMMUN, V21, P1, DOI 10.1016/S0896-8411(03)00083-0; Schwarz TF, 2009, VACCINE, V27, P6284, DOI 10.1016/j.vaccine.2009.01.040; Silfverdal SA, 2010, ACTA PAEDIATR, V99, P1287, DOI [10.1111/j.1651-2227.2010.01839.x, 10.1111/j.1651-2227.2010.01901.x]; Stowe J, 2006, HUM VACCINES, V2, P110, DOI 10.4161/hv.2790; Stowe J, 2009, AM J EPIDEMIOL, V169, P382, DOI 10.1093/aje/kwn310; Szego J.Bebyggelsensmosaik, 2009, 7 REG; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P249; World Health Organization, 2005, INFL PAND PREP RESP; Wu JA, 2010, NEW ENGL J MED, V363, P2416, DOI 10.1056/NEJMoa1006736; Zhou WG, 2004, PHARMACOEPIDEM DR S, V13, P505, DOI 10.1002/pds.998	32	130	132	1	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 12	2011	343								d5956	10.1136/bmj.d5956	http://dx.doi.org/10.1136/bmj.d5956			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835EO	21994316	Green Published, hybrid			2022-12-28	WOS:000296018100002
J	McKee, M; Pollock, AM; Clarke, A; McCoy, D; Middleton, J; Raine, R; Scott-Samuel, A				McKee, Martin; Pollock, Allyson M.; Clarke, Aileen; McCoy, David; Middleton, John; Raine, Rosalind; Scott-Samuel, Alex			HEALTH AND SOCIAL CARE BILL In defence of the NHS: why writing to the House of Lords was necessary	BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK ADJUSTMENT		[McKee, Martin] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Pollock, Allyson M.] Univ London, London WC1E 7HU, England; [Clarke, Aileen] Univ Warwick, Coventry CV4 7AL, W Midlands, England; [McCoy, David; Middleton, John; Raine, Rosalind] UCL, London WC1E 6BT, England; [Scott-Samuel, Alex] Univ Liverpool, Liverpool L69 3BX, Merseyside, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University of Warwick; University of London; University College London; University of Liverpool	McKee, M (corresponding author), Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England.	martin.mckee@lshtm.ac.uk; a.pollock@qmul.ac.uk; aileen.clarke@warwick.ac.uk; d.mccoy@ucl.ac.uk; john.middleton11@btinternet.com; r.raine@ucl.ac.uk; A.Scott-Samuel@liverpool.ac.uk	Clarke, Aileen/I-5679-2012; McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	Clarke, Aileen/0000-0001-8299-3146; McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Raine, Rosalind/0000-0003-0904-749X; pollock, allyson/0000-0002-7388-3110				Himmelstein DU, 1999, JAMA-J AM MED ASSOC, V282, P159, DOI 10.1001/jama.282.2.159; Himmelstein DU, 2001, BLEEDING PATIENT CON; Kmietowicz Z, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6391; Liu YL, 1999, SOC SCI MED, V49, P1349, DOI 10.1016/S0277-9536(99)00207-5; Pollock AM, 2011, BRIT MED J, V342, P1695; Reynolds L, LANCET, DOI 101016/S0140- 6736(11)61264-6; Schoen C, 2011, HEALTH AFFAIR, V30, P1762, DOI 10.1377/hlthaff.2011.0335; Stocker K, 1999, NEW ENGL J MED, V340, P1131, DOI 10.1056/NEJM199904083401425; van de Ven WPMM, 2003, HEALTH POLICY, V65, P75, DOI 10.1016/S0168-8510(02)00118-5; Van de Ven WPMM, 2011, HEALTH ECON POLICY L, V6, P147, DOI 10.1017/S1744133110000319	10	4	4	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 11	2011	343								d6535	10.1136/bmj.d6535	http://dx.doi.org/10.1136/bmj.d6535			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	835EJ	21990261	Green Published, Green Submitted			2022-12-28	WOS:000296017500014
J	Berthet, N; Nakoune, E; Whist, E; Selekon, B; Burguiere, AM; Manuguerra, JC; Gessain, A; Kazanji, M				Berthet, Nicolas; Nakoune, Emmanuel; Whist, Eline; Selekon, Benjamin; Burguiere, Ana-Maria; Manuguerra, Jean-Claude; Gessain, Antoine; Kazanji, Mirdad			Maculopapular lesions in the Central African Republic	LANCET			English	Editorial Material							MICROARRAYS; MONKEYPOX		[Nakoune, Emmanuel; Selekon, Benjamin; Kazanji, Mirdad] Inst Pasteur, Dept Virol, Bangui, Cent Afr Republ; [Berthet, Nicolas; Gessain, Antoine] CNRS URA 3015, Epidemiol & Physiopathol Oncogen Viruses Unit, Inst Pasteur, Paris, France; [Burguiere, Ana-Maria; Manuguerra, Jean-Claude] Inst Pasteur, Lab Urgent Responses Biol Threats, Paris, France; [Whist, Eline] Med Sans Frontieres, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Doctors Without Borders	Kazanji, M (corresponding author), Inst Pasteur, Dept Virol, BP 923, Bangui, Cent Afr Republ.	mirdad.kazanji@pasteur.fr	Berthet, Nicolas/J-9373-2012; Nakoune, Emmanuel/W-2710-2019					Berthet N, 2008, MICROB BIOTECHNOL, V1, P79, DOI 10.1111/j.1751-7915.2007.00012.x; Berthet N, 2010, NAT BIOTECHNOL, V28, P25, DOI 10.1038/nbt0110-25; Di Giulio DB, 2004, LANCET INFECT DIS, V4, P15, DOI 10.1016/S1473-3099(03)00856-9; Panning M, 2004, CLIN CHEM, V50, P702, DOI 10.1373/clinchem.2003.026781; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299	5	39	39	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 8	2011	378	9799					1354	1354		10.1016/S0140-6736(11)61142-2	http://dx.doi.org/10.1016/S0140-6736(11)61142-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831IU	21982097				2022-12-28	WOS:000295724300030
J	Picetti, E; Mergoni, M				Picetti, Edoardo; Mergoni, Mario			Traumatic Diaphragmatic Hernia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Picetti, Edoardo; Mergoni, Mario] Serv Anestesia & Rianimaz, Parma, Italy		Picetti, E (corresponding author), Serv Anestesia & Rianimaz, Parma, Italy.								0	2	2	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 6	2011	365	14					E30	E30		10.1056/NEJMicm1101087	http://dx.doi.org/10.1056/NEJMicm1101087			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829KL	21991980				2022-12-28	WOS:000295578700011
J	Vestbo, J; Edwards, LD; Scanlon, PD; Yates, JC; Agusti, A; Bakke, P; Calverley, PMA; Celli, B; Coxson, HO; Crim, C; Lomas, DA; MacNee, W; Miller, BE; Silverman, EK; Tal-Singer, R; Wouters, E; Rennard, SI				Vestbo, Jorgen; Edwards, Lisa D.; Scanlon, Paul D.; Yates, Julie C.; Agusti, Alvar; Bakke, Per; Calverley, Peter M. A.; Celli, Bartolome; Coxson, Harvey O.; Crim, Courtney; Lomas, David A.; MacNee, William; Miller, Bruce E.; Silverman, Edwin K.; Tal-Singer, Ruth; Wouters, Emiel; Rennard, Stephen I.		ECLIPSE Investigators	Changes in Forced Expiratory Volume in 1 Second over Time in COPD	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIR-FLOW OBSTRUCTION; LUNG-FUNCTION; NATURAL-HISTORY; ECLIPSE COHORT; DECLINE; EXACERBATION; EPIDEMIOLOGY; PROPIONATE; HEALTH	BACKGROUND A key feature of chronic obstructive pulmonary disease (COPD) is an accelerated rate of decline in forced expiratory volume in 1 second (FEV(1)), but data on the variability and determinants of this change in patients who have established disease are scarce. METHODS We analyzed the changes in FEV1 after administration of a bronchodilator over a 3-year period in 2163 patients. A random-coefficient model was used to evaluate possible predictors of both FEV1 levels and their changes over time. RESULTS The mean (+/- SE) rate of change in FEV1 was a decline of 33 +/- 2 ml per year, with significant variation among the patients studied. The between-patient standard deviation for the rate of decline was 59 ml per year. Over the 3-year study period, 38% of patients had an estimated decline in FEV1 of more than 40 ml per year, 31% had a decline of 21 to 40 ml per year, 23% had a change in FEV1 that ranged from a decrease of 20 ml per year to an increase of 20 ml per year, and 8% had an increase of more than 20 ml per year. The mean rate of decline in FEV1 was 21 +/- 4 ml per year greater in current smokers than in current nonsmokers, 13 +/- 4 ml per year greater in patients with emphysema than in those without emphysema, and 17 +/- 4 ml per year greater in patients with bronchodilator reversibility than in those without reversibility. CONCLUSIONS The rate of change in FEV1 among patients with COPD is highly variable, with increased rates of decline among current smokers, patients with bronchodilator reversibility, and patients with emphysema. (Funded by GlaxoSmithKline; ECLIPSE-ClinicalTrials.gov number, NCT00292552.)	[Vestbo, Jorgen] Univ Copenhagen, Hvidovre Hosp, Resp Sect, DK-2650 Hvidovre, Denmark; [Vestbo, Jorgen] Univ Copenhagen, Copenhagen, Denmark; [Vestbo, Jorgen] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Calverley, Peter M. A.] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Lomas, David A.] Univ Cambridge, Cambridge, England; [MacNee, William] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Edwards, Lisa D.; Yates, Julie C.; Crim, Courtney] GlaxoSmithKline Inc, Res Triangle Pk, NC USA; [Miller, Bruce E.; Tal-Singer, Ruth] GlaxoSmithKline Inc, King Of Prussia, PA USA; [Scanlon, Paul D.] Mayo Clin, Rochester, MN USA; [Agusti, Alvar] Univ Barcelona, Thorax Inst, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Agusti, Alvar] CIBER Enfermedades Resp, Palma De Mallorca, Mallorca, Spain; [Bakke, Per] Univ Bergen, Inst Internal Med, Bergen, Norway; [Celli, Bartolome; Silverman, Edwin K.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Celli, Bartolome; Silverman, Edwin K.] Harvard Univ, Sch Med, Boston, MA USA; [Coxson, Harvey O.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Wouters, Emiel] Univ Maastricht, Maastricht, Netherlands; [Rennard, Stephen I.] Univ Nebraska Med Ctr, Omaha, NE USA	University of Copenhagen; University of Copenhagen; University of Manchester; University of Liverpool; University of Cambridge; University of Edinburgh; GlaxoSmithKline; GlaxoSmithKline; Mayo Clinic; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Bergen; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of British Columbia; Maastricht University; University of Nebraska System; University of Nebraska Medical Center	Vestbo, J (corresponding author), Univ Copenhagen, Hvidovre Hosp, Resp Sect 253, Kettegaard 30, DK-2650 Hvidovre, Denmark.	jvestbo@dadlnet.dk	Wouters, Emiel/ABD-6200-2021; Coxson, Harvey O/A-9861-2017; Garcia-Navarro, Alvar Agusti/F-4474-2015; Vestbo, Jorgen/Y-2912-2019; Tal-Singer, Ruth/AAQ-2925-2021	Coxson, Harvey O/0000-0001-5750-9711; Garcia-Navarro, Alvar Agusti/0000-0003-3271-3788; Tal-Singer, Ruth/0000-0002-5275-8062; MacNee, William/0000-0002-3692-1448; Edwards, Lisa/0000-0002-4867-2151; Vestbo, Jorgen/0000-0001-6355-6362	GlaxoSmithKline; AstraZeneca; Boehringer Ingelheim; Chiesi; Novartis; Nycomed; Pfizer; Forest Laboratories; Almirall; Esteve; Roche; Merck and Novartis; Aeris; Rox Medical; GlaxoSmithKline and Spiration; Able Associates; Adelphi Research; APT Pharma/Britnall; Aradigm; CommonHealth; Consult Complete; COPDforum; Datamonitor; Decision Resources; Defined Health; Dey; Dunn Group; Easton Associates; Equinox; Forest; Gerson; InfoMed; KOL Connection; M. Pankove; MedaCorp; MDRx Financial; Mpex; Oriel Therapeutics; Otsuka; Pennside; Parma Ventures; Pearl; Pharmaxis; Price Waterhouse; Propagate; Pulmatrix; Reckner Associates; Recruiting Resources; Sankyo; Schlesinger Medical; Scimed; Sudler and Hennessey; TargeGen; Theravance; United BioSource; Uptake Medical; VantagePoint Management; Convergent Health Solutions for Reviews and Trends in COPD; COPD Foundation; Creative Educational Concepts; France Foundation; Information TV; Network for Continuing Education (CHARM); Novartis (Horsham); Biomarck; Centocor; Nabi; MRC [G0901786, G0901697] Funding Source: UKRI; Medical Research Council [G0901697, G0901786] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Chiesi(Chiesi Pharmaceuticals Inc); Novartis(Novartis); Nycomed; Pfizer(Pfizer); Forest Laboratories; Almirall(Almirall); Esteve; Roche(Roche Holding); Merck and Novartis; Aeris; Rox Medical; GlaxoSmithKline and Spiration; Able Associates; Adelphi Research; APT Pharma/Britnall; Aradigm; CommonHealth; Consult Complete; COPDforum; Datamonitor; Decision Resources; Defined Health; Dey; Dunn Group; Easton Associates; Equinox; Forest; Gerson; InfoMed; KOL Connection; M. Pankove; MedaCorp; MDRx Financial; Mpex; Oriel Therapeutics; Otsuka(Otsuka Pharmaceutical); Pennside; Parma Ventures; Pearl(Luxembourg National Research Fund); Pharmaxis; Price Waterhouse; Propagate; Pulmatrix; Reckner Associates; Recruiting Resources; Sankyo; Schlesinger Medical; Scimed; Sudler and Hennessey; TargeGen; Theravance; United BioSource; Uptake Medical; VantagePoint Management; Convergent Health Solutions for Reviews and Trends in COPD; COPD Foundation; Creative Educational Concepts; France Foundation; Information TV; Network for Continuing Education (CHARM); Novartis (Horsham); Biomarck; Centocor; Nabi; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants from GlaxoSmithKline (to Drs. Vestbo, Scanlon, Agusti, Bakke, Calverley, Celli, Coxson, Lomas, MacNee, Silverman, Wouters, and Rennard).; Dr. Vestbo reports receiving consulting fees from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Novartis, Nycomed, and Pfizer, speaking fees from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis, and Nycomed, and grants on behalf of his institution from GlaxoSmithKline; Dr. Scanlon, receiving travel support from Boehringer Ingelheim and Novartis and receiving grants from Boehringer Ingelheim, Forest Laboratories, GlaxoSmithKline, Pfizer, and Novartis on behalf of his institution; Dr. Agusti, receiving fees for serving on the boards of Almirall, AstraZeneca, Boehringer Ingelheim, Esteve, GlaxoSmithKline, Novartis, Nycomed, and Roche, speaking fees from Almirall, AstraZeneca, Boehringer Ingelheim, Esteve, GlaxoSmithKline, and Nycomed, payment for the development of educational presentations from Nycomed, and receiving grants from Almirall, GlaxoSmithKline, and Nycomed on behalf of his institution; Dr. Bakke, receiving speaking fees from AstraZeneca, GlaxoSmithKline, and Pfizer; Dr. Calverley, receiving fees for serving on the boards of GlaxoSmithKline, Boehringer Ingelheim, and Nycomed, consulting fees from Merck and Novartis, payment for providing expert testimony for Forest, speaking fees from AstraZeneca and GlaxoSmithKline, travel support from Boehringer Ingelheim, and receiving speaking fees from Novartis and Pfizer on behalf of his institution; Dr. Celli, receiving consulting fees from Aeris, Almirall, AstraZeneca, Boehringer Ingelheim, Novartis, and Rox Medical; Dr. Coxson, receiving consulting fees from GlaxoSmithKline and Spiration, speaking fees from AstraZeneca, travel support from AstraZeneca and Spiration, and receiving grants from GlaxoSmithKline and Spiration on behalf of his institution; Dr. Lomas, receiving fees for serving on the board of GlaxoSmithKline, consulting fees from GlaxoSmithKline, speaking fees from GlaxoSmithKline, travel support from Boehringer Ingelheim and GlaxoSmithKline, and receiving grants from GlaxoSmithKline on behalf of his institution; Dr. MacNee, receiving travel support from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, and Pfizer, and he and his institution receiving consulting fees from Pfizer and fees for membership on the boards of Pfizer and GlaxoSmithKline; Dr. Rennard, receiving fees for membership on the boards of Almirall, Novartis, Nycomed, and Pfizer, consulting fees from Able Associates, Adelphi Research, APT Pharma/Britnall, Aradigm, AstraZeneca, Boehringer Ingelheim, Chiesi, CommonHealth, Consult Complete, COPDforum, Datamonitor, Decision Resources, Defined Health, Dey, Dunn Group, Easton Associates, Equinox, Forest, Gerson, GlaxoSmithKline, InfoMed, KOL Connection, M.; Pankove, MedaCorp, MDRx Financial, Mpex, Novartis, Nycomed, Oriel Therapeutics, Otsuka, Pennside, Parma Ventures, Pearl, Pharmaxis, Price Waterhouse, Propagate, Pulmatrix, Reckner Associates, Recruiting Resources, Roche, Sankyo, Schlesinger Medical, Scimed, Sudler and Hennessey, TargeGen, Theravance, United BioSource, Uptake Medical, and VantagePoint Management, speaking fees from AstraZeneca, Convergent Health Solutions for Reviews and Trends in COPD, COPD Foundation, Creative Educational Concepts, Dey, France Foundation, Information TV, Network for Continuing Education (CHARM), Novartis (Horsham), Nycomed, Otsuka, and Pfizer, travel support from Almirall, AstraZeneca, Boehringer Ingelheim, California Allergy Society, Creative Educational Concept, France Foundation, GlaxoSmithKline, Information TV, Network for Continuing Education, Novartis, Nycomed, and Pfizer, and receiving grantsfrom AstraZeneca, Biomarck, Boehringer Ingelheim, Centocor, Mpex, Nabi, Novartis, Nycomed, and Otsuka on behalf of his institution; Dr. Silverman, receiving consulting fees from AstraZeneca and GlaxoSmithKline, speaking fees from AstraZeneca and GlaxoSmithKline, and receiving grants from GlaxoSmithKline on behalf of his institution; and Dr. Wouters, receiving fees for membership on the board of Nycomed, speaking fees from AstraZeneca, GlaxoSmithKline, and Novartis, and grants from AstraZeneca and GlaxoSmithKline. Drs. Crim, Edwards, Miller, Tal- Singer, and Yates report being employees of and owning stock in GlaxoSmithKline. No other potential conflict of interest relevant to this article was reported.	Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Anthonisen NR, 2005, EUR RESPIR J, V26, P45, DOI 10.1183/09031936.05.00102604; Anto JM, 2001, EUR RESPIR J, V17, P982, DOI 10.1183/09031936.01.17509820; Bridevaux PO, 2008, THORAX, V63, P768, DOI 10.1136/thx.2007.093724; Brutsche MH, 2006, THORAX, V61, P671, DOI 10.1136/thx.2005.052241; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PMA, 2003, THORAX, V58, P659, DOI 10.1136/thorax.58.8.659; Celli BR, 2008, AM J RESP CRIT CARE, V178, P332, DOI 10.1164/rccm.200712-1869OC; Decramer M, 2009, LANCET, V374, P1171, DOI 10.1016/S0140-6736(09)61298-8; Donaldson GC, 2008, THORAX, V63, P753; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Fletcher CM, 1976, NATURAL HIST CHRONIC; Gietema HA, 2011, ACAD RADIOL, V18, P661, DOI 10.1016/j.acra.2011.01.011; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Hansen EF, 1999, AM J RESP CRIT CARE, V159, P1267, DOI 10.1164/ajrccm.159.4.9807121; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Jenkins CR, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-59; Kanner RE, 2001, AM J RESP CRIT CARE, V164, P358, DOI 10.1164/ajrccm.164.3.2010017; Raherison C, 2009, EUR RESPIR REV, V18, P213, DOI 10.1183/09059180.00003609; Sin Don D, 2009, Proc Am Thorac Soc, V6, P543, DOI 10.1513/pats.200904-019DS; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Viegi G, 2007, EUR RESPIR J, V30, P993, DOI 10.1183/09031936.00082507	24	664	683	1	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 29	2011	365	13					1184	1192		10.1056/NEJMoa1105482	http://dx.doi.org/10.1056/NEJMoa1105482			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825YO	21991892	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000295318400006
J	El-Serag, HB				El-Serag, Hashem B.			CURRENT CONCEPTS Hepatocellular Carcinoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HEPATITIS-C VIRUS; TO-TREAT ANALYSIS; RANDOMIZED CONTROLLED-TRIAL; LIVER-TRANSPLANTATION; UNITED-STATES; ALPHA-FETOPROTEIN; CANCER-RISK; CIRRHOSIS; SURVEILLANCE; METAANALYSIS	Each year, hepatocellular carcinoma is diagnosed in more than half a million people worldwide, including approximately 20,000 new cases in the United States.(1,2) Liver cancer is the fifth most common cancer in men and the seventh in women. Most of the burden of disease (85%) is borne in developing countries, with the highest incidence rates reported in regions where infection with hepatitis B virus (HBV) is endemic: Southeast Asia and sub-Saharan Africa (Fig. 1).(3) Hepatocellular carcinoma rarely occurs before the age of 40 years and reaches a peak at approximately 70 years of age. Rates of liver cancer among men are two to four times as high as the rates among women. Hepatocellular carcinoma related to infection with hepatitis C virus (HCV) has become the fastest-rising cause of cancer-related death in the United States, and during the past two decades, the incidence of hepatocellular carcinoma in the United States has tripled while the 5-year survival rate has remained below 12%(2) (Fig. 2). The greatest proportional increase in cases of hepatocellular carcinoma has been seen among Hispanics and whites between 45 and 60 years of age.(4)	[El-Serag, Hashem B.] Baylor Coll Med, Sect Gastroenterol & Hepatol, Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA; [El-Serag, Hashem B.] Houston Ctr Qual Care & Utilizat Studies, Houston, TX USA	Baylor College of Medicine	El-Serag, HB (corresponding author), Baylor Coll Med, Sect Gastroenterol & Hepatol, Michael E DeBakey VA Med Ctr, 2002 Holcombe Blvd,152, Houston, TX 77030 USA.	hasheme@bcm.edu	Ibrahim, Essam Hassan/G-1960-2018; ting, huang/V-6326-2017	Ibrahim, Essam Hassan/0000-0003-0130-2257; 	Vertex Pharmaceuticals; Bayer Pharmaceuticals	Vertex Pharmaceuticals(Vertex Pharmaceuticals); Bayer Pharmaceuticals(Bayer AG)	Dr. El-Serag reports receiving consulting fees from Vertex Pharmaceuticals and support from a grant from Bayer Pharmaceuticals to the Baylor College of Medicine. No other potential conflict of interest relevant to this article was reported.	Bruix J, 2004, GASTROENTEROLOGY, V127, pS179, DOI 10.1053/j.gastro.2004.09.032; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chen CJ, 2009, HEPATOLOGY, V49, pS72, DOI 10.1002/hep.22884; Chen JG, 2003, J MED SCREEN, V10, P204, DOI 10.1258/096914103771773320; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; Cho YK, 2009, HEPATOLOGY, V49, P453, DOI 10.1002/hep.22648; Davila JA, 2011, ANN INTERN MED, V154, P85, DOI 10.7326/0003-4819-154-2-201101180-00006; Davila JA, 2010, HEPATOLOGY, V52, P132, DOI 10.1002/hep.23615; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Di Bisceglie AM, 2008, NEW ENGL J MED, V359, P2429, DOI 10.1056/NEJMoa0707615; Donato F, 2002, AM J EPIDEMIOL, V155, P323, DOI 10.1093/aje/155.4.323; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; El-Serag HB, 2007, ARCH INTERN MED, V167, P1983, DOI 10.1001/archinte.167.18.1983; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007; El-Serag HB, 2006, J HEPATOL, V44, P158, DOI 10.1016/j.jhep.2005.10.002; El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Ferlay J, 2001, INT AGENCY RES CANC, V5; Forner A, 2010, SEMIN LIVER DIS, V30, P61, DOI 10.1055/s-0030-1247133; Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439; Lammer J, 2010, CARDIOVASC INTER RAD, V33, P41, DOI 10.1007/s00270-009-9711-7; Larsson SC, 2007, GASTROENTEROLOGY, V132, P1740, DOI 10.1053/j.gastro.2007.03.044; Lencioni R, 2010, HEPATOLOGY, V52, P762, DOI 10.1002/hep.23725; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933; Llovet JM, 2005, SEMIN LIVER DIS, V25, P181, DOI 10.1055/s-2005-871198; Llovet JM, 1999, HEPATOLOGY, V30, P1434, DOI 10.1002/hep.510300629; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2006, GASTROENTEROLOGY, V131, P1758, DOI 10.1053/j.gastro.2006.09.014; Lok AS, 2010, GASTROENTEROLOGY, V138, P493, DOI 10.1053/j.gastro.2009.10.031; Marrero JA, 2010, GASTROENTEROLOGY, V138, P400, DOI 10.1053/j.gastro.2009.08.076; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; MOLLER H, 1994, EUR J CANCER, V30A, P344, DOI 10.1016/0959-8049(94)90254-2; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; NEUSCHWANDERTET.BA, 2003, HEPATOLOGY, V38, P536; Pelletier SJ, 2009, LIVER TRANSPLANT, V15, P859, DOI 10.1002/lt.21778; Salem R, 2010, GASTROENTEROLOGY, V138, P52, DOI 10.1053/j.gastro.2009.09.006; Schoenleber SJ, 2009, BRIT J CANCER, V100, P1385, DOI 10.1038/sj.bjc.6605017; Sherman M, 2010, J HEPATOL, V52, P614, DOI 10.1016/j.jhep.2009.11.026; Sherman Morris, 2007, Clin Liver Dis, V11, P817, DOI 10.1016/j.cld.2007.08.011; Silva MA, 2008, GUT, V57, P1592, DOI 10.1136/gut.2008.149062; Singal A, 2009, ALIMENT PHARM THER, V30, P37, DOI 10.1111/j.1365-2036.2009.04014.x; Singal AG, 2010, CLIN GASTROENTEROL H, V8, P280, DOI 10.1016/j.cgh.2009.11.018; Singal AK, 2010, CLIN GASTROENTEROL H, V8, P192, DOI 10.1016/j.cgh.2009.10.026; Sung JJY, 2008, ALIMENT PHARM THER, V28, P1067, DOI 10.1111/j.1365-2036.2008.03816.x; Surveillance Epidemiology and End Results (SEER) Program, 2010, SEER STAT DAT INC SE; Tanaka Y, 2006, GASTROENTEROLOGY, V130, P703, DOI 10.1053/j.gastro.2006.01.032; Trevisani F, 2002, AM J GASTROENTEROL, V97, P734; Wolk A, 2001, CANCER CAUSE CONTROL, V12, P13, DOI 10.1023/A:1008995217664; World Health Organization International Agency for Research on Cancer, GLOBOCAN 2008; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243; Yao FY, 2008, HEPATOLOGY, V48, P819, DOI 10.1002/hep.22412; Yao FY, 2001, HEPATOLOGY, V33, P1394, DOI 10.1053/jhep.2001.24563; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0	57	3065	3219	18	538	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2011	365	12					1118	1127		10.1056/NEJMra1001683	http://dx.doi.org/10.1056/NEJMra1001683			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822WR	21992124				2022-12-28	WOS:000295081600011
J	Tripodi, M; Stepien, AE; Arber, S				Tripodi, Marco; Stepien, Anna E.; Arber, Silvia			Motor antagonism exposed by spatial segregation and timing of neurogenesis	NATURE			English	Article							FUNCTIONALLY COMPLEX MUSCLES; SPINAL-CORD; MODULAR ORGANIZATION; FLUORESCENT PROTEIN; LOCOMOTOR-ACTIVITY; GENE-EXPRESSION; CAT HINDLIMB; NEURONS; PATTERN; MOTONEURONS	Walking is a key motor behaviour of limbed animals, executed by contraction of functionally antagonistic muscle groups during swing and stance phases. Nevertheless, neuronal circuits regulating the activation of antagonistic extensor-flexor muscles remain poorly understood. Here we use monosynaptically restricted trans-synaptic viruses to elucidate premotor anatomical substrates for extensor-flexor control in mice. We observe a medio-lateral spatial segregation between extensor and flexor premotor interneurons in the dorsal spinal cord. These premotor interneuron populations are derived from common progenitor domains, but segregate by timing of neurogenesis. We find that proprioceptive sensory feedback from the periphery is targeted to medial extensor premotor populations and is required for extensor-specific connectivity profiles during development. Our findings provide evidence for a discriminating anatomical basis of antagonistic circuits at the level of premotor interneurons, and point to synaptic input and developmental ontogeny as key factors in the establishment of circuits regulating motor behavioural dichotomy.	[Tripodi, Marco; Stepien, Anna E.; Arber, Silvia] Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland; [Tripodi, Marco; Stepien, Anna E.; Arber, Silvia] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	University of Basel; Friedrich Miescher Institute for Biomedical Research	Arber, S (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.	silvia.arber@unibas.ch	Tripodi, Marco/AGN-5956-2022	Tripodi, Marco/0000-0002-6827-6690; Arber, Silvia/0000-0002-6261-250X	EMBO long-term fellowship; ERC Advanced Grant; Swiss National Science Foundation; Kanton Basel-Stadt; EU Framework Program 7; Novartis Research Foundation	EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); ERC Advanced Grant(European Research Council (ERC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton Basel-Stadt; EU Framework Program 7; Novartis Research Foundation	We are grateful to M. Sigrist for the generation of Tau<SUP>lox-stop-lox-SynGFP</SUP> mice, M. Mielich for help in the production of viruses, P. Schwarb, L. Gelman, A. Ponti and M. Stadler for help and advice with image acquisition and statistical analysis, and to P. Caroni, G. Courtine, T. Jessell, B. Roska and P. Scheiffele for discussions and comments on the manuscript. We thank E. Callaway and K. Conzelmann for advice on virus work, and C. Birchmeier for Lbx1<SUP>cre</SUP> mice and Tlx3 antibodies. M. T. was supported by an EMBO long-term fellowship, M. T., A. E. S. and S. A. by an ERC Advanced Grant, the Swiss National Science Foundation, the Kanton Basel-Stadt, EU Framework Program 7 and the Novartis Research Foundation.	Akay T, 2006, J NEUROPHYSIOL, V96, P642, DOI 10.1152/jn.00174.2006; Angel MJ, 2005, J PHYSIOL-LONDON, V563, P597, DOI 10.1113/jphysiol.2004.076034; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; BAEV K V, 1979, Neirofiziologiya, V11, P329; Bizzi E, 2008, BRAIN RES REV, V57, P125, DOI 10.1016/j.brainresrev.2007.08.004; Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077; Carrier L, 1997, J NEUROPHYSIOL, V77, P1979, DOI 10.1152/jn.1997.77.4.1979; CHANAUD CM, 1991, EXP BRAIN RES, V85, P271, DOI 10.1007/BF00229406; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; CONWAY BA, 1987, EXP BRAIN RES, V68, P643; de Leon RD, 1999, J NEUROPHYSIOL, V82, P359, DOI 10.1152/jn.1999.82.1.359; Deguchi Y, 2011, NAT NEUROSCI, V14, P495, DOI 10.1038/nn.2768; ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794; ECCLES RM, 1958, J PHYSIOL-LONDON, V144, P271, DOI 10.1113/jphysiol.1958.sp006101; Friese A, 2009, P NATL ACAD SCI USA, V106, P13588, DOI 10.1073/pnas.0906809106; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Greene E.C., 1935, T AM PHILOS SOC, V27, P1; GRILLNER S, 1985, ANNU REV NEUROSCI, V8, P233, DOI 10.1146/annurev.ne.08.030185.001313; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Hiebert GW, 1999, J NEUROPHYSIOL, V81, P758, DOI 10.1152/jn.1999.81.2.758; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; HULTBORN H, 1971, J PHYSIOL-LONDON, V215, P613, DOI 10.1113/jphysiol.1971.sp009488; Imamura F, 2011, NAT NEUROSCI, V14, P331, DOI 10.1038/nn.2754; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9; JONES CL, 1979, J MORPHOL, V162, P275, DOI 10.1002/jmor.1051620207; Kaneko K, 2008, NEUROSCIENCE, V157, P781, DOI 10.1016/j.neuroscience.2008.09.029; Kiehn O, 2011, CURR OPIN NEUROBIOL, V21, P100, DOI 10.1016/j.conb.2010.09.004; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; LLOYD DPC, 1946, J NEUROPHYSIOL, V9, P439, DOI 10.1152/jn.1946.9.6.439; Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; McCrea DA, 1998, ANN NY ACAD SCI, V860, P216, DOI 10.1111/j.1749-6632.1998.tb09051.x; McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588; Mears SC, 1997, J NEUROSCI, V17, P3128; Muller T, 2005, GENE DEV, V19, P733, DOI 10.1101/gad.326105; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; NORNES HO, 1978, BRAIN RES, V159, P1, DOI 10.1016/0006-8993(78)90105-1; Pearson KG, 1998, ANN NY ACAD SCI, V860, P203, DOI 10.1111/j.1749-6632.1998.tb09050.x; Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000; PRATT CA, 1991, EXP BRAIN RES, V85, P281, DOI 10.1007/BF00229407; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Schouenborg J, 2002, BRAIN RES REV, V40, P80, DOI 10.1016/S0165-0173(02)00191-1; Sherrington CS, 1910, J PHYSIOL-LONDON, V40, P28; Sieber MA, 2007, J NEUROSCI, V27, P4902, DOI 10.1523/JNEUROSCI.0717-07.2007; Stein PSG, 2008, BRAIN RES REV, V57, P118, DOI 10.1016/j.brainresrev.2007.07.008; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Stuart DG, 2008, BRAIN RES REV, V59, P74, DOI 10.1016/j.brainresrev.2008.06.001; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042; Wang Z, 2008, J NEUROPHYSIOL, V100, P185, DOI 10.1152/jn.90354.2008; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wilson JM, 2010, J NEUROSCI, V30, P1137, DOI 10.1523/JNEUROSCI.1401-09.2010; Windhorst U, 2007, BRAIN RES BULL, V73, P155, DOI 10.1016/j.brainresbull.2007.03.010; Yakovenko S, 2002, J NEUROPHYSIOL, V87, P1542, DOI 10.1152/jn.00479.2001; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Zeilhofer HU, 2005, J COMP NEUROL, V482, P123, DOI 10.1002/cne.20349; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	63	121	121	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2011	479	7371					61	U84		10.1038/nature10538	http://dx.doi.org/10.1038/nature10538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840FA	22012263				2022-12-28	WOS:000296422600032
J	Cho, JH; Gregersen, PK				Cho, Judy H.; Gregersen, Peter K.			Genomics and the Multifactorial Nature of Human Autoimmune Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PRIMARY BILIARY-CIRRHOSIS; SCLEROSIS SUSCEPTIBILITY LOCI; INFLAMMATORY-BOWEL-DISEASE; OF-FUNCTION VARIANT; WIDE ASSOCIATION; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS; RISK LOCI; TYROSINE-PHOSPHATASE		[Cho, Judy H.] Yale Univ, Dept Med, Sect Digest Dis, New Haven, CT 06520 USA; [Cho, Judy H.] Yale Univ, Dept Genet, Sect Digest Dis, New Haven, CT 06520 USA; [Gregersen, Peter K.] Feinstein Inst Med Res, Robert S Boas Ctr Genom & Human Genet, Manhasset, NY USA	Yale University; Yale University; Northwell Health	Cho, JH (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Digest Dis, 333 Cedar St,1080 LMP, New Haven, CT 06520 USA.	judy.cho@yale.edu						Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Arechiga AF, 2009, J IMMUNOL, V182, P3343, DOI 10.4049/jimmunol.0713370; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Begovich AB, 2005, AM J HUM GENET, V76, P184, DOI 10.1086/427244; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chapman SJ, 2006, NAT GENET, V38, P499, DOI 10.1038/ng0506-499; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Concannon P, 2009, NEW ENGL J MED, V360, P1646, DOI 10.1056/NEJMra0808284; Cooper GS, 2010, RHEUMATOLOGY, V49, P2172, DOI 10.1093/rheumatology/keq214; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Cui J, 2010, ARTHRITIS RHEUM-US, V62, P1849, DOI 10.1002/art.27457; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Ferreira RC, 2010, NAT GENET, V42, P777, DOI 10.1038/ng.644; Festen EAM, 2009, GUT, V58, P799, DOI 10.1136/gut.2008.166918; Flesher DLT, 2010, EXPERT REV CLIN IMMU, V6, P461, DOI [10.1586/ECI.10.8, 10.1586/eci.10.8]; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Gregersen PK, 2006, SEMIN IMMUNOL, V18, P214, DOI 10.1016/j.smim.2006.03.009; GREGERSEN PK, 2011, CECIL MED, P45; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Guarner F, 2006, NAT CLIN PRACT GASTR, V3, P275, DOI 10.1038/ncpgasthep0471; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hall JC, 2010, NAT REV RHEUMATOL, V6, P40, DOI 10.1038/nrrheum.2009.237; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; Hirschfield GM, 2010, NAT GENET, V42, P655, DOI 10.1038/ng.631; Huffmeier U, 2010, NAT GENET, V42, P996, DOI 10.1038/ng.688; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Hyoty H, 2002, DIABETOLOGIA, V45, P1353, DOI 10.1007/s00125-002-0852-3; Jin Y, 2010, NAT GENET, V42, P576, DOI 10.1038/ng.602; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Kochi Y, 2010, NAT GENET, V42, P515, DOI 10.1038/ng.583; Lamsyah H, 2009, TISSUE ANTIGENS, V74, P228, DOI 10.1111/j.1399-0039.2009.01304.x; Liston A, 2005, IMMUNOL REV, V204, P87, DOI 10.1111/j.0105-2896.2005.00253.x; Liu XD, 2010, NAT GENET, V42, P658, DOI 10.1038/ng.627; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Mahdi H, 2009, NAT GENET, V41, P1319, DOI 10.1038/ng.480; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Mells GF, 2011, NAT GENET, V43, P329, DOI 10.1038/ng.789; MENARD L, 2011, J CLIN INVEST   0801; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Oliver JE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2585; Opar A, 2010, NAT REV DRUG DISCOV, V9, P257, DOI 10.1038/nrd3155; Orru V, 2009, HUM MOL GENET, V18, P569, DOI 10.1093/hmg/ddn363; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Perl A, 2009, CURR OPIN RHEUMATOL, V21, P443, DOI 10.1097/BOR.0b013e32832efe6b; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Preidis GA, 2009, GASTROENTEROLOGY, V136, P2015, DOI 10.1053/j.gastro.2009.01.072; Quan C, 2010, NAT GENET, V42, P614, DOI 10.1038/ng.603; Radstake TRDJ, 2010, NAT GENET, V42, P426, DOI 10.1038/ng.565; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Shikama N, 2009, ENDOCRIN METAB CLIN, V38, P273, DOI 10.1016/j.ecl.2009.01.011; Silverstein AM, 2005, NAT IMMUNOL, V6, P639, DOI 10.1038/ni0705-639; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Sun LD, 2010, NAT GENET, V42, P1005, DOI 10.1038/ng.690; Surolia I, 2010, NATURE, V466, P243, DOI 10.1038/nature09115; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; von Boehmer H, 2010, NAT IMMUNOL, V11, P14, DOI 10.1038/ni.1794; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; ZHANG J, 2011, NAT GENET       0814; Zhernakova A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002004; Zikherman J, 2009, J IMMUNOL, V182, P4093, DOI 10.4049/jimmunol.0803317	83	220	245	1	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2011	365	17					1612	1623		10.1056/NEJMra1100030	http://dx.doi.org/10.1056/NEJMra1100030			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HI	22029983				2022-12-28	WOS:000296181800006
J	Havlir, DV; Kendall, MA; Ive, P; Kumwenda, J; Swindells, S; Qasba, SS; Luetkemeyer, AF; Hogg, E; Rooney, JF; Wu, XY; Hosseinipour, MC; Lalloo, U; Veloso, VG; Some, FF; Kumarasamy, N; Padayatchi, N; Santos, BR; Reid, S; Hakim, J; Mohapi, L; Mugyenyi, P; Sanchez, J; Lama, JR; Pape, JW; Sanchez, A; Asmelash, A; Moko, E; Sawe, F; Andersen, J; Sanne, I				Havlir, Diane V.; Kendall, Michelle A.; Ive, Prudence; Kumwenda, Johnstone; Swindells, Susan; Qasba, Sarojini S.; Luetkemeyer, Anne F.; Hogg, Evelyn; Rooney, James F.; Wu, Xingye; Hosseinipour, Mina C.; Lalloo, Umesh; Veloso, Valdilea G.; Some, Fatuma F.; Kumarasamy, N.; Padayatchi, Nesri; Santos, Breno R.; Reid, Stewart; Hakim, James; Mohapi, Lerato; Mugyenyi, Peter; Sanchez, Jorge; Lama, Javier R.; Pape, Jean W.; Sanchez, Alejandro; Asmelash, Aida; Moko, Evans; Sawe, Fred; Andersen, Janet; Sanne, Ian		AIDS Clinical Trials Grp Study	Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-TRIALS; CHALLENGES; INITIATION	Background Antiretroviral therapy (ART) is indicated during tuberculosis treatment in patients infected with human immunodeficiency virus type 1 (HIV-1), but the timing for the initiation of ART when tuberculosis is diagnosed in patients with various levels of immune compromise is not known. Methods We conducted an open-label, randomized study comparing earlier ART (within 2 weeks after the initiation of treatment for tuberculosis) with later ART (between 8 and 12 weeks after the initiation of treatment for tuberculosis) in HIV-1 infected patients with CD4+ T-cell counts of less than 250 per cubic millimeter and suspected tuberculosis. The primary end point was the proportion of patients who survived and did not have a new (previously undiagnosed) acquired immunodeficiency syndrome (AIDS)-defining illness at 48 weeks. Results A total of 809 patients with a median baseline CD4+ T-cell count of 77 per cubic millimeter and an HIV-1 RNA level of 5.43 log(10) copies per milliliter were enrolled. In the earlier-ART group, 12.9% of patients had a new AIDS-defining illness or died by 48 weeks, as compared with 16.1% in the later-ART group (95% confidence interval [CI], -1.8 to 8.1; P = 0.45). Among patients with screening CD4+ T-cell counts of less than 50 per cubic millimeter, 15.5% of patients in the earlier-ART group versus 26.6% in the later-ART group had a new AIDS-defining illness or died (95% CI, 1.5 to 20.5; P = 0.02). Tuberculosis-associated immune reconstitution inflammatory syndrome was more common with earlier ART than with later ART (11% vs. 5%, P = 0.002). The rate of viral suppression at 48 weeks was 74% and did not differ between the groups (P = 0.38). Conclusions Overall, earlier ART did not reduce the rate of new AIDS-defining illness and death, as compared with later ART. In persons with CD4+ T-cell counts of less than 50 per cubic millimeter, earlier ART was associated with a lower rate of new AIDS-defining illnesses and death. (Funded by the National Institutes of Health and others; ACTG A5221 ClinicalTrials.gov number, NCT00108862.)	[Havlir, Diane V.; Luetkemeyer, Anne F.] Univ Calif San Francisco, San Francisco, CA 94110 USA; [Kendall, Michelle A.; Wu, Xingye; Andersen, Janet] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Ive, Prudence; Sanne, Ian] Univ Witwatersrand, Johannesburg, South Africa; [Kumwenda, Johnstone] Johns Hopkins Project, Coll Med, Blantyre, Malawi; [Hosseinipour, Mina C.] Univ N Carolina Project, Kamuzu Cent Hosp, Lilongwe, Malawi; [Swindells, Susan] Univ Nebraska, Omaha, NE 68182 USA; [Qasba, Sarojini S.] Montgomery Cty Dept Hlth & Human Serv, Silver Spring, MD USA; [Hogg, Evelyn] Social & Sci Syst, Silver Spring, MD USA; [Rooney, James F.] Gilead Sci Inc, Foster City, CA 94404 USA; [Lalloo, Umesh] Univ KwaZulu Natal, Durban, South Africa; [Padayatchi, Nesri] Ctr AIDS Programme Res S Africa CAPRISA eThekwini, Durban, South Africa; [Mohapi, Lerato] Chris Hani Baragwanath Hosp, AIDS Clin Trials Grp CRS, Soweta, South Africa; [Veloso, Valdilea G.] Fundacao Oswaldo Cruz Misisterio Saude, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil; [Some, Fatuma F.] Moi Univ, Fac Hlth Sci, Eldoret, Kenya; [Sawe, Fred] Kenya Govt Med Res Ctr, Kericho, Kenya; [Sawe, Fred] Walter Reed Project, Kericho, Kenya; [Sawe, Fred] US Mil HIV Res Program, Kericho, Kenya; [Kumarasamy, N.] YR Gaitonde Ctr AIDS Res & Educ, Voluntary Hlth Serv, Madras, Tamil Nadu, India; [Santos, Breno R.] Hosp Nossa Senhora da Conceicao, Porto Alegre, RS, Brazil; [Reid, Stewart] Ctr Infect Dis Res Zambia, HIV & AIDS Clin Trials Unit, Lusaka, Zambia; [Hakim, James] Parirenyatwa CRS, Harare, Zimbabwe; [Mugyenyi, Peter] Joint Clin Res Ctr, Kampala, Uganda; [Sanchez, Jorge] Miraflores CRS, Asociac Civil Impacta Salud & Educ IMPACTA, Lima, Peru; [Lama, Javier R.] Lince CRS, Invest Med Salud INMENSA, Lima, Peru; [Pape, Jean W.] GHESKIO, Port Au Prince, Haiti; [Sanchez, Alejandro] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Asmelash, Aida; Moko, Evans] Botswana Harvard Aids Inst CRS, Gaborone, Botswana; [Asmelash, Aida; Moko, Evans] Botswana Harvard Aids Inst CRS, Molepolole, Botswana	University of California System; University of California San Francisco; Harvard University; Harvard T.H. Chan School of Public Health; University of Witwatersrand; University of Malawi; University of Nebraska System; Social & Scientific Systems; Gilead Sciences; University of Kwazulu Natal; Moi University; Kenya Medical Research Institute; Joint Clinic Research Center - United Arab Emirates; University of Southern California; Botswana-Harvard AIDS Institute Partnership; Botswana-Harvard AIDS Institute Partnership	Havlir, DV (corresponding author), Univ Calif San Francisco, 995 Potrero Ave,Bldg 80,Ward 84, San Francisco, CA 94110 USA.	dhavlir@php.ucsf.edu	Veloso, Valdilea Gonçalves/J-6189-2012; Kumarasasmy, Nagalingeswaran/AAB-7348-2021; Mitchell, Ellen/H-5475-2013; Kendall, Michelle A/B-7665-2016; Franzeck, Fabian C/B-5055-2011; Sanne, Ian/ABH-2231-2020; padayatchi, nesri/Q-2780-2019	Kendall, Michelle A/0000-0001-9160-4544; padayatchi, nesri/0000-0003-2543-9071; Hanekom, Willem/0000-0003-3070-6154; Reid, Stewart/0000-0001-7779-4820	National Institutes of Health; Division of AIDS at the National Institute of Allergy and Infectious Diseases; Gilead Sciences; Merck Pharmaceuticals; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI038855, U01AI068636, UM1AI069432, K24AI051982, U01AI068634, P30AI027763, U01AI038858, U01AI069432, UM1AI068634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of AIDS at the National Institute of Allergy and Infectious Diseases; Gilead Sciences(Gilead Sciences); Merck Pharmaceuticals(Merck & Company); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institutes of Health and others; ACTG A5221 ClinicalTrials.gov number, NCT00108862.; Supported by the Division of AIDS at the National Institute of Allergy and Infectious Diseases, Gilead Sciences, and Merck Pharmaceuticals.	Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Breen RAM, 2004, THORAX, V59, P704, DOI 10.1136/thx.2003.019224; Burman W, 2007, INT J TUBERC LUNG D, V11, P1282; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Havlir DV, 2008, JAMA-J AM MED ASSOC, V300, P423, DOI 10.1001/jama.300.4.423; Howard AA, 2010, CLIN INFECT DIS, V50, pS238, DOI 10.1086/651497; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Meintjes G, 2010, AIDS, V24, P2381, DOI 10.1097/QAD.0b013e32833dfc68; National Institute of Allergy and Infectious Diseases, 2004, DIV AIDS TABL GRAD S; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Pai M, 2009, CLIN CHEST MED, V30, P701, DOI 10.1016/j.ccm.2009.08.016; Sterling TR, 2010, CLIN INFECT DIS, V50, pS223, DOI 10.1086/651495; Torok ME, 2011, CLIN INFECT DIS, V52, P1374, DOI 10.1093/cid/cir230; *WHO, 2009, GLOB TUB CONTR SHORT; Zolopa AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005575	21	413	424	1	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2011	365	16					1482	1491		10.1056/NEJMoa1013607	http://dx.doi.org/10.1056/NEJMoa1013607			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835BW	22010914	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000296009500002
J	Kerlikowske, K; Hubbard, RA; Miglioretti, DL; Geller, BM; Yankaskas, BC; Lehman, CD; Taplin, SH; Sickles, EA				Kerlikowske, Karla; Hubbard, Rebecca A.; Miglioretti, Diana L.; Geller, Berta M.; Yankaskas, Bonnie C.; Lehman, Constance D.; Taplin, Stephen H.; Sickles, Edward A.		Breast Canc Surveillance Consortiu	Comparative Effectiveness of Digital Versus Film-Screen Mammography in Community Practice in the United States A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CANCER SURVEILLANCE CONSORTIUM; CARCINOMA IN-SITU; BREAST-CANCER; THERAPY USE; POPULATION; ACCURACY; DENSITY; PROGRAM; PERFORMANCE; WOMEN	Background: Few studies have examined the comparative effectiveness of digital versus film-screen mammography in U. S. community practice. Objective: To determine whether the interpretive performance of digital and film-screen mammography differs. Design: Prospective cohort study. Setting: Mammography facilities in the Breast Cancer Surveillance Consortium. Participants: 329 261 women aged 40 to 79 years underwent 869 286 mammograms (231 034 digital; 638 252 film-screen). Measurements: Invasive cancer or ductal carcinoma in situ diagnosed within 12 months of a digital or film-screen examination and calculation of mammography sensitivity, specificity, cancer detection rates, and tumor outcomes. Results: Overall, cancer detection rates and tumor characteristics were similar for digital and film-screen mammography, but the sensitivity and specificity of each modality varied by age, tumor characteristics, breast density, and menopausal status. Compared with film-screen mammography, the sensitivity of digital mammography was significantly higher for women aged 60 to 69 years (89.9% vs. 83.0%; P = 0.014) and those with estrogen receptor-negative cancer (78.5% vs. 65.8%; P = 0.016); borderline significantly higher for women aged 40 to 49 years (82.4% vs. 75.6%; P = 0.071), those with extremely dense breasts (83.6% vs. 68.1%; P = 0.051), and pre- or perimenopausal women (87.1% vs. 81.7%; P = 0.057); and borderline significantly lower for women aged 50 to 59 years (80.5% vs. 85.1%; P = 0.097). The specificity of digital and film-screen mammography was similar by decade of age, except for women aged 40 to 49 years (88.0% vs. 89.7%; P < 0.001). Limitation: Statistical power for subgroup analyses was limited. Conclusion: Overall, cancer detection with digital or film-screen mammography is similar in U. S. women aged 50 to 79 years undergoing screening mammography. Women aged 40 to 49 years are more likely to have extremely dense breasts and estrogen receptor-negative tumors; if they are offered mammography screening, they may choose to undergo digital mammography to optimize cancer detection.	[Kerlikowske, Karla] San Francisco VA Med Ctr, Gen Internal Med Sect, San Francisco, CA 94121 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Washington, Sch Publ Hlth & Community Med, Grp Hlth Res Inst, Grp Hlth Cooperat, Seattle, WA 98195 USA; Univ Washington, Sch Med, Seattle, WA USA; Univ Vermont, Coll Med, Burlington, VT USA; Univ N Carolina, Chapel Hill, NC USA; NCI, Appl Res Program, Rockville, MD USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; Group Health Cooperative; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Vermont; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kerlikowske, K (corresponding author), San Francisco VA Med Ctr, Gen Internal Med Sect, 111A1,4150 Clement St, San Francisco, CA 94121 USA.	Karla.Kerlikowske@ucsf.edu	Hubbard, Rebecca/Y-6500-2019	Hubbard, Rebecca/0000-0003-0879-0994	National Cancer Institute [U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040, R03CA150007, RC2CA148577]; NATIONAL CANCER INSTITUTE [U01CA070013, U01CA086076, U01CA069976, RC2CA148577, U01CA063736, R03CA150007, U01CA086082, U01CA063731, U01CA070040, U01CA063740] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the National Cancer Institute-funded BCSC cooperative agreement (grants U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, and U01CA70040) and National Cancer Institute grants R03CA150007 and RC2CA148577. The collection of cancer data used in this study was supported in part by several state public health departments and cancer registries throughout the United States; for a full description of these sources, see http://breastscreening.cancer.gov/work/acknowledgement.html.	American College of Radiology (ACR), 2003, ILL BREAST IM REP DA; American Joint Committee on Cancer, 2002, MAN STAG CANC; BallardBarbash R, 1997, AM J ROENTGENOL, V169, P1001, DOI 10.2214/ajr.169.4.9308451; Buist DSM, 2011, RADIOLOGY, V259, P72, DOI 10.1148/radiol.10101698; Buist DSM, 2004, JNCI-J NATL CANCER I, V96, P1432, DOI 10.1093/jnci/djh269; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Ciatto S, 2005, BREAST, V14, P269, DOI 10.1016/j.breast.2004.12.004; Ernster VL, 2002, J NATL CANCER I, V94, P1546; Farhat GN, 2010, J CLIN ONCOL, V28, P5140, DOI 10.1200/JCO.2010.29.5121; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Ichikawa LE, 2010, RADIOLOGY, V256, P74, DOI 10.1148/radiol.10091881; Jiang YL, 2010, RADIOLOGY, V256, P29, DOI 10.1148/radiol.10091394; Karssemeijer N, 2009, RADIOLOGY, V253, P353, DOI 10.1148/radiol.2532090225; Kerlikowske K, 1998, J NATL CANCER I, V90, P1801, DOI 10.1093/jnci/90.23.1801; Kerlikowske K, 2003, J CLIN ONCOL, V21, P4314, DOI 10.1200/JCO.2003.05.151; Kerlikowske K, 2007, J NATL CANCER I, V99, P386, DOI 10.1093/jnci/djk066; Kerlikowske K, 2007, NEW ENGL J MED, V356, P297, DOI 10.1056/NEJMe068244; LANE PW, 1982, BIOMETRICS, V38, P613, DOI 10.2307/2530043; Lewin JM, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.3.1790671; Neuhaus JM, 1998, BIOMETRICS, V54, P638, DOI 10.2307/3109770; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Pisano ED, 2008, RADIOLOGY, V246, P376, DOI 10.1148/radiol.2461070200; Roubidoux MA, 2004, RADIOLOGY, V230, P42, DOI 10.1148/radiol.2301020589; Sala M, 2009, RADIOLOGY, V252, P31, DOI 10.1148/radiol.2521080696; Skaane P, 2009, ACTA RADIOL, V50, P3, DOI 10.1080/02841850802563269; Skaane P, 2007, RADIOLOGY, V244, P708, DOI 10.1148/radiol.2443061478; Smith-Bindman R, 2005, JNCI-J NATL CANCER I, V97, P358, DOI 10.1093/jnci/dji060; U.S. Food and Drug Administration, 2011, MAMM QUAL STAND ACT; Vinnicombe S, 2009, RADIOLOGY, V251, P347, DOI 10.1148/radiol.2512081235; Yankaskas BC, 2005, RADIOLOGY, V234, P363, DOI 10.1148/radiol.2342040048	30	189	193	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2011	155	8					493	U64		10.7326/0003-4819-155-8-201110180-00005	http://dx.doi.org/10.7326/0003-4819-155-8-201110180-00005			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835WB	22007043	Green Accepted			2022-12-28	WOS:000296066300014
J	Worner, HJ; Bertrand, JB; Fabre, B; Higuet, J; Ruf, H; Dubrouil, A; Patchkovskii, S; Spanner, M; Mairesse, Y; Blanchet, V; Mevel, E; Constant, E; Corkum, PB; Villeneuve, DM				Woerner, H. J.; Bertrand, J. B.; Fabre, B.; Higuet, J.; Ruf, H.; Dubrouil, A.; Patchkovskii, S.; Spanner, M.; Mairesse, Y.; Blanchet, V.; Mevel, E.; Constant, E.; Corkum, P. B.; Villeneuve, D. M.			Conical Intersection Dynamics in NO2 Probed by Homodyne High-Harmonic Spectroscopy	SCIENCE			English	Article							WAVE-PACKET DYNAMICS; RATE CONSTANTS; TIME; STATE; MODEL	Conical intersections play a crucial role in the chemistry of most polyatomic molecules, ranging from the simplest bimolecular reactions to the photostability of DNA. The real-time study of the associated electronic dynamics poses a major challenge to the latest techniques of ultrafast measurement. We show that high-harmonic spectroscopy reveals oscillations in the electronic character that occur in nitrogen dioxide when a photoexcited wave packet crosses a conical intersection. At longer delays, we observe the onset of statistical dissociation dynamics. The present results demonstrate that high-harmonic spectroscopy could become a powerful tool to highlight electronic dynamics occurring along nonadiabatic chemical reaction pathways.	[Woerner, H. J.; Bertrand, J. B.; Patchkovskii, S.; Spanner, M.; Corkum, P. B.; Villeneuve, D. M.] Natl Res Council Canada, Joint Lab Attosecond Sci, Ottawa, ON K1A 0R6, Canada; [Woerner, H. J.; Bertrand, J. B.; Patchkovskii, S.; Spanner, M.; Corkum, P. B.; Villeneuve, D. M.] Univ Ottawa, Ottawa, ON K1A 0R6, Canada; [Woerner, H. J.] ETH, Phys Chem Lab, CH-8093 Zurich, Switzerland; [Fabre, B.; Higuet, J.; Ruf, H.; Dubrouil, A.; Mairesse, Y.; Mevel, E.; Constant, E.] Univ Bordeaux, CEA, CNRS, Ctr Lasers Intenses & Applicat,UMR5107, F-33405 Talence, France; [Blanchet, V.] Univ Toulouse, UPS, Lab Collis Agregats React IRSAMC, F-31062 Toulouse, France; [Blanchet, V.] CNRS, UMR 5589, F-31062 Toulouse, France	National Research Council Canada; University of Ottawa; Swiss Federal Institutes of Technology Domain; ETH Zurich; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite de Bordeaux; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Worner, HJ (corresponding author), Natl Res Council Canada, Joint Lab Attosecond Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	woerner@phys.chem.ethz.ch	Wörner, Hans Jakob/B-1802-2013; Villeneuve, David M/I-4140-2012; Mairesse, Yann/B-3049-2015; MEVEL, Eric/ABG-5051-2021; blanchet, valerie/L-3677-2014; FABRE, Baptiste/E-3815-2015	Villeneuve, David M/0000-0002-2810-3648; Mairesse, Yann/0000-0002-9098-7421; MEVEL, Eric/0000-0002-0449-3266; blanchet, valerie/0000-0002-6464-3879; FABRE, Baptiste/0000-0001-9843-8139; Corkum, Paul/0000-0003-3394-5572	Swiss National Science Foundation [PP00P2_128274]; Agence Nationale de la Recherche [ANR-08-JCJC-0029]; Centre National de la Recherche Scientifique; National Sciences and Engineering Research Council of Canada; Canadian Institute for Photonic Innovations; Air Force Office of Scientific Research	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute for Photonic Innovations; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	We thank A. Stolow for fruitful discussions and B. Whitaker and K. Takatsuka for permission to use information underlying Figs. 1 and 4C. We acknowledge financial support from the Swiss National Science Foundation (PP00P2_128274), Agence Nationale de la Recherche (ANR-08-JCJC-0029 HarmoDyn), Centre National de la Recherche Scientifique (PICS: Imagerie moleculaire par impulsions attosecondes), National Sciences and Engineering Research Council of Canada, Canadian Institute for Photonic Innovations, and Air Force Office of Scientific Research.	Abel B, 2001, J CHEM PHYS, V115, P6522, DOI 10.1063/1.1398305; Arasaki Y, 2007, CHEM PHYS, V338, P175, DOI 10.1016/j.chemphys.2007.04.025; Arasaki Y, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3369647; Bertrand JB, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.023001; Bisgaard CZ, 2009, SCIENCE, V323, P1464, DOI 10.1126/science.1169183; Bucksbaum PH, 2007, SCIENCE, V317, P766, DOI 10.1126/science.1142135; BUSCH GE, 1972, J CHEM PHYS, V56, P3626, DOI 10.1063/1.1677740; Domcke W., 2004, CONICAL INTERSECTION, V15; Form NT, 2006, PHYS CHEM CHEM PHYS, V8, P2925, DOI 10.1039/b602825j; Frolov MV, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.243901; Goulielmakis E, 2010, NATURE, V466, P739, DOI 10.1038/nature09212; Hamard JB, 2010, J PHYS CHEM A, V114, P3167, DOI 10.1021/jp909129g; IONOV SI, 1993, J CHEM PHYS, V99, P3420, DOI 10.1063/1.465152; Irimia D, 2010, J PHYS CHEM A, V114, P3157, DOI 10.1021/jp909031p; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183; Le AT, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.203001; Li W, 2008, SCIENCE, V322, P1207, DOI 10.1126/science.1163077; Mahapatra S, 2000, CHEM PHYS, V259, P211, DOI 10.1016/S0301-0104(00)00204-4; Mairesse Y, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.143903; Meckel M, 2008, SCIENCE, V320, P1478, DOI 10.1126/science.1157980; Morishita T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.013903; Nugent-Glandorf L, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.193002; Polli D, 2010, NATURE, V467, P440, DOI 10.1038/nature09346; QUACK M, 1974, BER BUNSEN PHYS CHEM, V78, P240, DOI 10.1002/bbpc.19740780306; Santoro F, 1999, J CHEM PHYS, V110, P4419, DOI 10.1063/1.478325; Schultz T, 2004, SCIENCE, V306, P1765, DOI 10.1126/science.1104038; Schultze M, 2010, SCIENCE, V328, P1658, DOI 10.1126/science.1189401; Swoboda M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.103003; Vredenborg A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2924134; Wilkinson I, 2010, ANNU REP PROG CHEM C, V106, P274, DOI DOI 10.1039/B924653N; Worner HJ, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.103002; Worner HJ, 2010, NATURE, V466, P604, DOI 10.1038/nature09185; Worner HJ, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.233904; Worner HJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.103901	34	201	203	3	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					208	212		10.1126/science.1208664	http://dx.doi.org/10.1126/science.1208664			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998383	Green Submitted			2022-12-28	WOS:000295833600041
J	Elmore, S				Elmore, Shekinah			The Good Doctor	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Elmore, S (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	shekinah@hms.harvard.edu		Elmore, Shekinah/0000-0002-7136-1597					0	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 12	2011	306	14					1525	1526		10.1001/jama.2011.1469	http://dx.doi.org/10.1001/jama.2011.1469			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831FS	21990290				2022-12-28	WOS:000295714700001
J	Cortes, JE; Curns, AT; Tate, JE; Cortese, MM; Patel, MM; Zhou, FJ; Parashar, UD				Cortes, Jennifer E.; Curns, Aaron T.; Tate, Jacqueline E.; Cortese, Margaret M.; Patel, Manish M.; Zhou, Fangjun; Parashar, Umesh D.			Rotavirus Vaccine and Health Care Utilization for Diarrhea in US Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; GASTROENTERITIS; HOSPITALIZATIONS; EFFICACY; SAFETY	Background Routine vaccination of U. S. infants with pentavalent rotavirus vaccine (RV5) began in 2006. Methods Using MarketScan databases, we assessed RV5 coverage and diarrhea-associated health care use from July 2007 through June 2009 versus July 2001 through June 2006 in children under 5 years of age. We compared the rates of diarrhea-associated health care use in unvaccinated children in the period from January through June (when rotavirus is most prevalent) in 2008 and 2009 with the prevaccine rates to estimate indirect benefits. We estimated national reductions in the number of hospitalizations for diarrhea, and associated costs, by extrapolation. Results By December 31, 2008, at least one dose of RV5 had been administered in 73% of children under 1 year of age, 64% of children 1 year of age, and 8% of children 2 to 4 years of age. Among children under 5 years of age, rates of hospitalization for diarrhea in 2001-2006, 2007-2008, and 2008-2009 were 52, 35, and 39 cases per 10,000 person-years, respectively, for relative reductions from 2001-2006 by 33% (95% confidence interval [CI], 31 to 35) in 2007-2008 and by 25% (95% CI, 23 to 27) in 2008-2009; rates of hospitalization specifically coded for rotavirus infection were 14, 4, and 6 cases per 10,000 person-years, respectively, for relative reductions in the rate from 2001-2006 by 75% (95% CI, 72 to 77) in 2007-2008 and by 60% (95% CI, 58 to 63) in 2008-2009. In the January-June periods of 2008 and 2009, the respective relative rate reductions among vaccinated children as compared with unvaccinated children were as follows: hospitalization for diarrhea, 44% (95% CI, 33 to 53) and 58% (95% CI, 52 to 64); rotavirus-coded hospitalization, 89% (95% CI, 79 to 94) and 89% (95% CI, 84 to 93); emergency department visits for diarrhea, 37% (95% CI, 31 to 43) and 48% (95% CI, 44 to 51); and outpatient visits for diarrhea, 9% (95% CI, 6 to 11) and 12% (95% CI, 10 to 15). Indirect benefits (in unvaccinated children) were seen in 2007-2008 but not in 2008-2009. Nationally, for the 2007-2009 period, there was an estimated reduction of 64,855 hospitalizations, saving approximately $278 million in treatment costs. Conclusions Since the introduction of rotavirus vaccine, diarrhea-associated health care utilization and medical expenditures for U. S. children have decreased substantially.	[Cortes, Jennifer E.; Curns, Aaron T.; Tate, Jacqueline E.; Cortese, Margaret M.; Patel, Manish M.; Parashar, Umesh D.] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA 30333 USA; [Cortes, Jennifer E.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Off Workforce & Career Dev, Atlanta, GA 30333 USA; [Zhou, Fangjun] Ctr Dis Control & Prevent, Immunizat Serv Div, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Parashar, UD (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, 1600 Clifton Rd,MS A-47, Atlanta, GA 30333 USA.	uparashar@cdc.gov			NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 2010, MMWR RECOMM REP, V59, P1074; Atlanta: Centers for Disease Control and Prevention, 2008, MARKETSCAN; Block SL, 2007, PEDIATRICS, V119, P11, DOI 10.1542/peds.2006-2058; Boom JA, 2010, PEDIATRICS, V125, pE199, DOI 10.1542/peds.2009-1021; Buttery JP, 2011, VACCINE, V29, P3061, DOI 10.1016/j.vaccine.2011.01.088; Clark HF, 2009, CLIN VACCINE IMMUNOL, V16, P382, DOI 10.1128/CVI.00382-08; Cortese M, 2010, ADV COMM IMM PRACT M; Cortese MM, 2010, PEDIATR INFECT DIS J, V29, P489, DOI 10.1097/INF.0b013e3181d95b53; Glass RI, 1996, J INFECT DIS, V174, pS5, DOI 10.1093/infdis/174.Supplement_1.S5; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Parashar Umesh D., 2006, Morbidity and Mortality Weekly Report, V55, P1; Patel MM, 2011, NEW ENGL J MED, V364, P2283, DOI 10.1056/NEJMoa1012952; Patel MM, 2011, VITALSTATS, V364, P2283; Payne DC, 2010, PEDIATR INFECT DIS J, V29, P287, DOI 10.1097/INF.0b013e3181d40e76; Payne DC, 2009, PEDIATR INFECT DIS J, V28, P948, DOI 10.1097/INF.0b013e3181a6ad6e; Pitzer VE, 2009, SCIENCE, V325, P290, DOI 10.1126/science.1172330; Rothman K., 1998, MODERN EPIDEMIOLOGY; Rothman KJ, 1998, NAT IMM SURV EST VAC; Tate JE, 2011, PEDIATR INFECT DIS J, V30, pS30, DOI 10.1097/INF.0b013e3181ffe3eb; Tate JE, 2009, PEDIATRICS, V123, P744, DOI 10.1542/peds.2008-1200; US Department of Labor Bureau of Labor Statistics, CONS PRIC IND; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Wang FT, 2010, PEDIATRICS, V125, pE208, DOI 10.1542/peds.2009-1246; Widdowson MA, 2007, PEDIATRICS, V119, P684, DOI 10.1542/peds.2006-2876; Yen C, 2011, PEDIATRICS, V127, pE9, DOI 10.1542/peds.2010-1393	25	124	127	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2011	365	12					1108	1117		10.1056/NEJMoa1000446	http://dx.doi.org/10.1056/NEJMoa1000446			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822WR	21992123				2022-12-28	WOS:000295081600010
J	Sosnick, TR; Hinshaw, JR				Sosnick, Tobin R.; Hinshaw, James R.			How Proteins Fold	SCIENCE			English	Editorial Material							TRANSITION-STATE; PREDICTION; PATHWAYS		[Sosnick, Tobin R.] Univ Chicago, Dept Biochem & Mol Biol, Computat Inst, Inst Biophys Dynam, Chicago, IL 60637 USA; [Hinshaw, James R.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Sosnick, TR (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, Computat Inst, Inst Biophys Dynam, 920 E 58th St, Chicago, IL 60637 USA.		Freed, Karl F/J-7764-2018	Freed, Karl F/0000-0001-6240-2599				BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; Baxa MC, 2008, J MOL BIOL, V381, P1362, DOI 10.1016/j.jmb.2008.06.067; Chung HS, 2009, P NATL ACAD SCI USA, V106, P11837, DOI 10.1073/pnas.0901178106; Klimov DK, 2005, J MOL BIOL, V353, P1171, DOI 10.1016/j.jmb.2005.09.029; Krantz BA, 2004, J MOL BIOL, V337, P463, DOI 10.1016/j.jmb.2004.01.018; Lindberg MO, 2007, CURR OPIN STRUC BIOL, V17, P21, DOI 10.1016/j.sbi.2007.01.008; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Maity H, 2005, P NATL ACAD SCI USA, V102, P4741, DOI 10.1073/pnas.0501043102; Moult J, 2009, PROTEINS, V77, P1, DOI 10.1002/prot.22589; Nauli S, 2001, NAT STRUCT BIOL, V8, P602, DOI 10.1038/89638; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Shen TY, 2005, BIOCHEMISTRY-US, V44, P6433, DOI 10.1021/bi0500170; Sosnick TR, 2011, CURR OPIN STRUC BIOL, V21, P12, DOI 10.1016/j.sbi.2010.11.002; Stigler J, 2011, SCIENCE, V334, P512, DOI 10.1126/science.1207598; Takada S, 1999, P NATL ACAD SCI USA, V96, P11698, DOI 10.1073/pnas.96.21.11698; Yang SC, 2004, P NATL ACAD SCI USA, V101, P13786, DOI 10.1073/pnas.0403724101	16	13	13	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 28	2011	334	6055					464	465		10.1126/science.1214018	http://dx.doi.org/10.1126/science.1214018			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837UR	22034424				2022-12-28	WOS:000296230500032
J	Reich, K; Langley, RG; Papp, KA; Ortonne, JP; Unnebrink, K; Kaul, M; Valdes, JM				Reich, Kristian; Langley, Richard G.; Papp, Kim A.; Ortonne, Jean-Paul; Unnebrink, Kristina; Kaul, Martin; Valdes, Joaquin M.			A 52-Week Trial Comparing Briakinumab with Methotrexate in Patients with Psoriasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY; QUALITY-OF-LIFE; DOUBLE-BLIND; EFFICACY; PLACEBO; SAFETY; USTEKINUMAB; EXPRESSION; MODERATE; INDEX	BACKGROUND Briakinumab is a monoclonal antibody against the p40 molecule shared by interleukin-12 and interleukin-23, which is overexpressed in psoriatic skin lesions. We assessed the efficacy and safety of briakinumab as compared with methotrexate in patients with psoriasis. METHODS In this 52-week trial, we randomly assigned 317 patients with moderate-to-severe psoriasis to briakinumab, at a dose of 200 mg at weeks 0 and 4 and 100 mg at week 8 and every 4 weeks thereafter (154 patients), or methotrexate, at a dose of 5 to 25 mg weekly (163 patients). The primary end points were the percentages of patients with at least 75% improvement in the score on the psoriasis area-and-severity index (PASI) at weeks 24 and 52 and a score on the physician's global assessment of 0 (clear; i.e., no apparent disease) or 1 (minimal disease) at weeks 24 and 52. A total of 248 patients were enrolled in an ongoing 160-week open-label continuation study. RESULTS At week 24, a total of 81.8% of the patients in the briakinumab group versus 39.9% in the methotrexate group had at least 75% improvement in the PASI score, and 80.5% versus 34.4% had a score of 0 or 1 on the physician's global assessment. The corresponding percentages at week 52 were 66.2% versus 23.9% with at least a 75% improvement in the PASI score and 63.0% versus 20.2% with a score of 0 or 1 on the physician's global assessment (P<0.001 for all comparisons). During the 52-week study, serious adverse events occurred in 9.1% of the patients in the briakinumab group (12.9 events per 100 patient-years) and in 6.1% in the methotrexate group (10.6 events per 100 patient-years). Serious infections occurred in 2.6% of the patients in the briakinumab group (4.1 events per 100 patient-years) and in 1.8% in the methotrexate group (2.7 events per 100 patient-years); cancers occurred in 1.9% (2.0 events per 100 patient-years) versus 0%. CONCLUSIONS Briakinumab showed higher efficacy than methotrexate in patients with moderate-to-severe psoriasis. Serious infections and cancers occurred more frequently with briakinumab, but the differences were not significant. (Funded by Abbott Laboratories; ClinicalTrials.gov number, NCT00679731.)	[Reich, Kristian] Dermatologikum Hamburg, D-20354 Hamburg, Germany; [Reich, Kristian] Univ Gottingen, Gottingen, Germany; [Unnebrink, Kristina; Kaul, Martin] Abbott, Ludwigshafen, Germany; [Langley, Richard G.] Dalhousie Univ, Halifax, NS, Canada; [Papp, Kim A.] Prob Med Res, Waterloo, ON, Canada; [Papp, Kim A.] Univ Western Ontario, London, ON, Canada; [Ortonne, Jean-Paul] Hop LArchet, Nice, France; [Valdes, Joaquin M.] Abbott Labs, Abbott Pk, IL 60064 USA	Dermatologikum Hamburg; University of Gottingen; Dalhousie University; Western University (University of Western Ontario); CHU Nice; Abbott Laboratories	Reich, K (corresponding author), Dermatologikum Hamburg, Stephans Pl 5, D-20354 Hamburg, Germany.	kreich@dermatologikum.de		Papp, Kim A./0000-0001-9557-3642	Abbott Laboratories	Abbott Laboratories(Abbott Laboratories)	Supported by Abbott Laboratories.	Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; FINLAY AY, 1995, BRIT J DERMATOL, V132, P236; Gordon K, 2010, 3 INT C PSOR PAR JUL; Gottlieb A, 2010, LANCET, V376, P1542; Gottlieb A, 2009, LANCET, V373, P633, DOI 10.1016/S0140-6736(09)60140-9; Heydendael VMR, 2003, NEW ENGL J MED, V349, P658, DOI 10.1056/NEJMoa021359; Hongbo Y, 2005, J INVEST DERMATOL, V125, P659, DOI 10.1111/j.0022-202X.2005.23621.x; Khilji F., 2002, BR J DERMATOL S62, V147, P50, DOI 10.1046/j.1365-2133.147.s62.16.x; Kimball AB, 2008, ARCH DERMATOL, V144, P200, DOI 10.1001/archdermatol.2007.63; Ko H-S, 1998, 49 M DERM OPHTH ADV; Krueger G, 2001, ARCH DERMATOL, V137, P280; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Krueger JG, 2005, ANN RHEUM DIS, V64, P30, DOI 10.1136/ard.2004.031120; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Leonardi CL, 2008, LANCET, V371, P1838; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Menter A, 2009, J AM ACAD DERMATOL, V61, P451, DOI 10.1016/j.jaad.2009.03.027; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Piskin G, 2006, J IMMUNOL, V176, P1908, DOI 10.4049/jimmunol.176.3.1908; Rich P, 2003, J AM ACAD DERMATOL, V49, P206, DOI 10.1067/S0190-9622(03)00910-1; Saurat JH, 2008, BRIT J DERMATOL, V158, P558, DOI 10.1111/j.1365-2133.2007.08315.x; Schmitt J, 2008, BRIT J DERMATOL, V159, P513, DOI 10.1111/j.1365-2133.2008.08732.x; Yawalkar N, 1998, J INVEST DERMATOL, V111, P1053, DOI 10.1046/j.1523-1747.1998.00446.x	27	146	154	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2011	365	17					1586	1596		10.1056/NEJMoa1010858	http://dx.doi.org/10.1056/NEJMoa1010858			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HI	22029980	Green Published, Green Submitted			2022-12-28	WOS:000296181800003
J	Lloyd, DM				Lloyd, David M.			PERSONAL VIEW Robots don't perform surgery, surgeons do	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Hosp Leicester, Leicester, Leics, England	University Hospitals of Leicester NHS Trust; University of Leicester	Lloyd, DM (corresponding author), Univ Hosp Leicester, Leicester, Leics, England.	dmlloyd1@aol.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 26	2011	343								d6830	10.1136/bmj.d6830	http://dx.doi.org/10.1136/bmj.d6830			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	840CY	22031911				2022-12-28	WOS:000296417100009
J	Thanabalasingham, G; Owen, KR				Thanabalasingham, Gaya; Owen, Katharine R.			Diagnosis and management of maturity onset diabetes of the young (MODY)	BRITISH MEDICAL JOURNAL			English	Review							INSULIN SENSITIVITY; CLINICAL CHARACTERISTICS; GLUCOKINASE MUTATIONS; GENETIC DIAGNOSIS; ADOLESCENTS; SECRETION; CHILDREN; HETEROGENEITY; HYPERGLYCEMIA; CRITERIA		[Thanabalasingham, Gaya; Owen, Katharine R.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Thanabalasingham, Gaya; Owen, Katharine R.] Churchill Hosp, Oxford NIHR Biomed Res Ctr, Oxford OX3 7LJ, England	University of Oxford; University of Oxford	Owen, KR (corresponding author), Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, S Parks Rd, Oxford OX3 7LJ, England.	katharine.owen@drl.ox.ac.uk			NIHR; Oxford NIHR Biomedical Research Centre; National Institute for Health Research [DHCS/07/07/008] Funding Source: researchfish	NIHR(National Institute for Health Research (NIHR)); Oxford NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	KRO is an NIHR funded clinician scientist. GT is an Oxford NIHR Biomedical Research Centre funded clinical research fellow.	Bellanne-Chantelot C, 2011, J CLIN ENDOCR METAB, V96, pE1346, DOI 10.1210/jc.2011-0268; Besser REJ, 2011, DIABETES CARE, V34, P286, DOI 10.2337/dc10-1293; Ellard S, 2008, DIABETOLOGIA, V51, P546, DOI 10.1007/s00125-008-0942-y; Feigerlova E, 2006, EUR J PEDIATR, V165, P446, DOI 10.1007/s00431-006-0106-3; GILLCAREY OJ, 2007, DIABETIC MED, V24, pA6; Hattersley A, 2009, PEDIATR DIABETES, V10, P33, DOI 10.1111/j.1399-5448.2009.00571.x; LEDERMANN HM, 1995, LANCET, V345, P648, DOI 10.1016/S0140-6736(95)90548-0; Lorini R, 2009, DIABETES CARE, V32, P1864, DOI 10.2337/dc08-2018; Martin D, 2008, DIABETES CARE, V31, P1321, DOI 10.2337/dc07-2017; McDonald TJ, 2011, DIABETIC MED, V28, P1028, DOI 10.1111/j.1464-5491.2011.03287.x; McDonald TJ, 2011, DIABETES CARE, V34, P1860, DOI 10.2337/dc11-0323; Owen KR, 2010, DIABETES CARE, V33, P1919, DOI 10.2337/dc10-0288; Owen KR, 2002, DIABETIC MED, V19, P758, DOI 10.1046/j.1464-5491.2002.00766.x; Pearson ER, 2005, DIABETOLOGIA, V48, P878, DOI 10.1007/s00125-005-1738-y; Pearson ER, 2003, LANCET, V362, P1275, DOI 10.1016/S0140-6736(03)14571-0; Schober E, 2009, DIABETIC MED, V26, P466, DOI 10.1111/j.1464-5491.2009.02720.x; Shepherd M, 2009, DIABETIC MED, V26, P437, DOI 10.1111/j.1464-5491.2009.02690.x; Shepherd M, 2001, PRACT DIAB INT, V18, P16, DOI [DOI 10.1002/PDI.108, 10.1002/pdi.108]; Shield JPH, 2007, HORM RES, V67, P77, DOI 10.1159/000096354; Shields BM, 2010, DIABETOLOGIA, V53, P2504, DOI 10.1007/s00125-010-1799-4; Steele AM, 2011, DIABETIC MED, V28, P28; Stride A, 2002, DIABETOLOGIA, V45, P427, DOI 10.1007/s00125-001-0770-9; TATTERSALL RB, 1974, Q J MED, V43, P339; THANABALASINGHA.G, 2011, DIABETOLOGIA; Thanabalasingham G, 2010, DIABETOLOGIA, V53, pS63; Tripathy D, 2000, DIABETOLOGIA, V43, P1476, DOI 10.1007/s001250051558; Tuomi T, 2006, DIABETES CARE, V29, P189, DOI 10.2337/diacare.29.02.06.dc05-1314; Vaxillaire M, 1999, EUR J ENDOCRINOL, V141, P609, DOI 10.1530/eje.0.1410609; Velho G, 1997, DIABETOLOGIA, V40, P217, DOI 10.1007/s001250050666	29	114	126	0	20	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 19	2011	343								d6044	10.1136/bmj.d6044	http://dx.doi.org/10.1136/bmj.d6044			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HN	22012810				2022-12-28	WOS:000296183700003
J	Attaran, A; Pang, T; Whitworth, J; Oxman, A; McKee, M				Attaran, Amir; Pang, Tikki; Whitworth, Judith; Oxman, Andrew; McKee, Martin			Healthy by law: the missed opportunity to use laws for public health	LANCET			English	Editorial Material							INSURANCE; RWANDA	Health is the result of biological and social determinants; both are important. Nature dictates the laws for biological determinants; people create the laws for social determinants. Nature's laws are hard to discover and are eternal whether or not they suit humanity; people's laws are easily written and can be changed at anytime to suit humanity better. So why is it that the public health community, which expends much effort and expense probing natural laws, places negligible emphasis on collection, analysis, and making greater use of the world's public health laws?	[Attaran, Amir] Univ Ottawa, Fac Law, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada; [Pang, Tikki] WHO, Res Policy & Cooperat, CH-1211 Geneva, Switzerland; [Whitworth, Judith] Australian Natl Univ, Canberra, ACT, Australia; [Oxman, Andrew] Norwegian Knowledge Ctr, Hlth Serv, Oslo, Norway; [McKee, Martin] London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1, England	University of Ottawa; World Health Organization; Australian National University; Norwegian Knowledge Centre for Health Services; University of London; London School of Hygiene & Tropical Medicine	Attaran, A (corresponding author), Univ Ottawa, Fac Law, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada.	aattaran@uottawa.ca	Oxman, Andrew/Y-3004-2019; Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011	Oxman, Andrew/0000-0002-5608-5061; Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X				[Anonymous], 1949, JAMA, V141, P494; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Daube M, 2008, TOB CONTROL, V17, P426, DOI 10.1136/tc.2008.027763; Goodman PG, 2009, INT J PUBLIC HEALTH, V54, P367, DOI 10.1007/s00038-009-0089-8; Greenleaf G, 2010, U NEW S WALES FACULT, P19; Hartsfield DeKeely, 2007, Am J Public Health, V97 Suppl 1, pS56, DOI 10.2105/AJPH.2005.082057; Hauser D J, 1974, Can Med Assoc J, V110, P1418; Kalk A, 2010, TROP MED INT HEALTH, V15, P94, DOI 10.1111/j.1365-3156.2009.02424.x; Knai C, 2011, EUR J PUBLIC HEALTH, V21, P295, DOI 10.1093/eurpub/ckq062; McBride LM, 1957, FOOD DRUG LAW J, V12, P142; Quentin W, 2007, INT J PUBLIC HEALTH, V52, P295, DOI 10.1007/s00038-007-5131-0; ROEMER R, 1965, AM J PUBLIC HEALTH N, V55, P1337, DOI 10.2105/AJPH.55.9.1337; Twahirwa A, 2008, B WORLD HEALTH ORGAN, V86, P823, DOI 10.2471/BLT.08.021108; Vieira FS, 2008, REV PANAM SALUD PUBL, V24, P91, DOI 10.1590/S1020-49892008000800003; WHO, 1946, CONST WHO	15	14	14	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 21	2012	379	9812					283	285		10.1016/S0140-6736(11)60069-X	http://dx.doi.org/10.1016/S0140-6736(11)60069-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	879FW	21982516				2022-12-28	WOS:000299316100042
J	Jakab, Z; Marmot, M				Jakab, Zsuzsanna; Marmot, Michael			Social determinants of health in Europe	LANCET			English	Editorial Material									[Marmot, Michael] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Jakab, Zsuzsanna] WHO European Reg, Copenhagen, Denmark	University of London; University College London	Marmot, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Mortimer St, London WC1E 6BT, England.	m.marmot@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419	British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G19/35, G0902037, G0100222, G8802774] Funding Source: Medline; MRC [G0902037] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Marmot M, 2012, LANCET, V379, P181, DOI 10.1016/S0140-6736(11)61506-7; *MIN HLTH CAR SERV, 2007, 20 MIN HLTH CAR SERV; WHO, 2011, GOV HLTH 21 CENT; World Health Organization, 2008, TALL CHART HLTH SYST	5	30	30	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 14	2012	379	9811					103	105		10.1016/S0140-6736(11)61511-0	http://dx.doi.org/10.1016/S0140-6736(11)61511-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	879GM	22014679				2022-12-28	WOS:000299317700015
J	Oken, MM; Hocking, WG; Kvale, PA; Andriole, GL; Buys, SS; Church, TR; Crawford, ED; Fouad, MN; Isaacs, C; Reding, DJ; Weissfeld, JL; Yokochi, LA; O'Brien, B; Ragard, LR; Rathmell, JM; Riley, TL; Wright, P; Caparaso, N; Hu, P; Izmirlian, G; Pinsky, PF; Prorok, PC; Kramer, BS; Miller, AB; Gohagan, JK; Berg, CD				Oken, Martin M.; Hocking, Willam G.; Kvale, Paul A.; Andriole, Gerald L.; Buys, Saundra S.; Church, Timothy R.; Crawford, E. David; Fouad, Mona N.; Isaacs, Claudine; Reding, Douglas J.; Weissfeld, Joel L.; Yokochi, Lance A.; O'Brien, Barbara; Ragard, Lawrence R.; Rathmell, Joshua M.; Riley, Thomas L.; Wright, Patrick; Caparaso, Neil; Hu, Ping; Izmirlian, Grant; Pinsky, Paul F.; Prorok, Philip C.; Kramer, Barnett S.; Miller, Anthony B.; Gohagan, John K.; Berg, Christine D.		PLCO Project Team	Screening by Chest Radiograph and Lung Cancer Mortality The Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context The effect on mortality of screening for lung cancer with modern chest radiographs is unknown. Objective To evaluate the effect on mortality of screening for lung cancer using radiographs in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Design, Setting, and Participants Randomized controlled trial that involved 154 901 participants aged 55 through 74 years, 77 445 of whom were assigned to annual screenings and 77 456 to usual care at 1 of 10 screening centers across the United States between November 1993 and July 2001. The data from a subset of eligible participants for the National Lung Screening Trial (NLST), which compared chest radiograph with spiral computed tomographic (CT) screening, were analyzed. Intervention Participants in the intervention group were offered annual postero-anterior view chest radiograph for 4 years. Diagnostic follow-up of positive screening results was determined by participants and their health care practitioners. Participants in the usual care group were offered no interventions and received their usual medical care. All diagnosed cancers, deaths, and causes of death were ascertained through the earlier of 13 years of follow-up or until December 31, 2009. Main Outcome Measures Mortality from lung cancer. Secondary outcomes included lung cancer incidence, complications associated with diagnostic procedures, and all-cause mortality. Results Screening adherence was 86.6% at baseline and 79% to 84% at years 1 through 3; the rate of screening use in the usual care group was 11%. Cumulative lung cancer incidence rates through 13 years of follow-up were 20.1 per 10 000 person-years in the intervention group and 19.2 per 10 000 person-years in the usual care group (rate ratio [RR]; 1.05, 95% CI, 0.98-1.12). A total of 1213 lung cancer deaths were observed in the intervention group compared with 1230 in usual care group through 13 years (mortality RR, 0.99; 95% CI, 0.87-1.22). Stage and histology were similar between the 2 groups. The RR of mortality for the subset of participants eligible for the NLST, over the same 6-year follow-up period, was 0.94 (95% CI, 0.81-1.10). Conclusion Annual screening with chest radiograph did not reduce lung cancer mortality compared with usual care.	[Hu, Ping; Izmirlian, Grant; Pinsky, Paul F.; Prorok, Philip C.; Berg, Christine D.] NCI, Biometry Res Grp, Canc Prevent Div, NIH, Bethesda, MD 20892 USA; [Hu, Ping; Izmirlian, Grant; Pinsky, Paul F.; Prorok, Philip C.; Berg, Christine D.] NCI, Early Detect Res Grp, Canc Prevent Div, NIH, Bethesda, MD 20892 USA; [Kramer, Barnett S.] NCI, Phys Data Query Screening & Prevent Editorial Boa, NIH, Bethesda, MD 20892 USA; [Oken, Martin M.; Church, Timothy R.] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; [Hocking, Willam G.; Reding, Douglas J.] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI 54449 USA; [Kvale, Paul A.] Henry Ford Hlth Syst, Detroit, MI USA; [Andriole, Gerald L.] Washington Univ, St Louis, MO USA; [Buys, Saundra S.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Crawford, E. David] Univ Colorado, Denver, CO 80202 USA; [Fouad, Mona N.] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Isaacs, Claudine] Georgetown Univ, Lombardi Canc Ctr, Washington, DC USA; [Weissfeld, Joel L.] Univ Pittsburgh, Med Ctr Canc Pavil, Pittsburgh, PA USA; [Yokochi, Lance A.] Pacific Hlth Res & Educ Inst, Honolulu, HI USA; [O'Brien, Barbara; Ragard, Lawrence R.] Westat Corp, Rockville, MD USA; [Rathmell, Joshua M.; Riley, Thomas L.; Wright, Patrick] Informat Management Serv Inc, Rockville, MD USA; [Caparaso, Neil] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Miller, Anthony B.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Gohagan, John K.] NIH, Off Dis Prevent, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Minnesota System; University of Minnesota Twin Cities; Marshfield Clinic; Henry Ford Health System; Henry Ford Hospital; Washington University (WUSTL); Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of Colorado System; University of Colorado Denver; University of Alabama System; University of Alabama Birmingham; Georgetown University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pacific Health Research & Education Institute; Westat; Information Management Services, Inc.; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Toronto; National Institutes of Health (NIH) - USA	Prorok, PC (corresponding author), NCI, Biometry Res Grp, Canc Prevent Div, NIH, 6130 Execut Blvd, Bethesda, MD 20892 USA.	prorokp@mail.nih.gov	Berg, Christine/K-1047-2014; Church, Timothy/AAH-7017-2020	Church, Timothy/0000-0003-3292-5035; Hocking, William/0000-0002-0690-3759	National Cancer Institute (NCI); National Institute of Diabetes and Digestive and Kidney Diseases; Division of Cancer Prevention of the NCI; Division of Cancer Epidemiology and Genetics NCI, National Institutes of Health, Department of Health and Human Services; NATIONAL CANCER INSTITUTE [N01CA075022] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Division of Cancer Prevention of the NCI; Division of Cancer Epidemiology and Genetics NCI, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Mr Hocking reported receiving grant support and travel support for himself and his institution from the National Cancer Institute (NCI). Dr Kvale reported receiving institutional support and travel expenses from the NCI. Dr Andriole reported receiving institutional grant support from the NCI; serving as a consultant for Amarex, Amgen, Augmenix, Bayer, Bristol-Myers Squib, Cambridge Endo, Caris, GlaxoSmithKline, Janssen Biotech Inc, Myriad Genetics Steba Biotech, Ortho-Clinical Diagnostics, and Viking Medical; having pending institutional grants from the NCI and National Institute of Diabetes and Digestive and Kidney Diseases; receiving royalties; receiving payment for developing educational presentations for Amgen; owning stocks or stock options from Augmenix, Cambridge Endo, Envisioning Medical, and Viking Medical; and receiving travel expenses from Amarex, Amgen, Augmenix, Bayer, Bristol-Myers Squibb, Cambridge Endo, Caris, Myriad Genetics, Ortho-Clinical Diagnostics, and Steba Biotech. Dr Buys reported receiving institutional support from the NCI. Dr Crawford reported receiving institutional grant and travel support and pending grants from the NCI. Dr Fouad reported receiving institutional grant support and travel support from the NCI. Dr Isaacs reported receiving institutional grant and travel support from the NCI. Dr Redding reported receiving institutional grant support from the NCI. Dr Weissfeld reported receiving institutional grant and travel support and compensation for participation for in review activites for the NCI. Dr Miller reported receiving travel support and compensation for participation in review activities for the NCI. No other disclosures were reported.; The NCI funded the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. This research also was supported by contracts from the Division of Cancer Prevention of the NCI and by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics NCI, National Institutes of Health, Department of Health and Human Services. Role of the Sponsor: The NCI was responsible for the design and conduct of the study; collection, management, analysis, and interpretation of the data; and in the preparation, review, or approval of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Ahlbom A, 1993, BIOSTATISTICS EPIDEM; *AM JOINT COMM CAN, 1997, AJCC CANC STAG MAN; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2010, SAS STAT COMP PROGR; Chien CR, 2008, INT J CANCER, V122, P2594, DOI 10.1002/ijc.23413; FONTANA RS, 1986, J OCCUP ENVIRON MED, V28, P746, DOI 10.1097/00043764-198608000-00038; Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Hocking WG, 2010, JNCI-J NATL CANCER I, V102, P722, DOI 10.1093/jnci/djq126; Izmirlian G, 2011, 11025088 ARXIV; KUBIK A, 1990, INT J CANCER, V45, P26, DOI 10.1002/ijc.2910450107; MELAMED MR, 1984, CHEST, V86, P44, DOI 10.1378/chest.86.1.44; Miller AB, 2000, CONTROL CLIN TRIALS, V21, p400S, DOI 10.1016/S0197-2456(00)00095-7; National Cancer Institute, 2010, LUNG CANC TRIAL RES; Pinsky PF, 2004, BIOMETRICS, V60, P191, DOI 10.1111/j.0006-341X.2004.00023.x; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Proschan MA, 2006, STAT BIOL HEALTH, P1; Tockman MS, 1985, LUNG CANCER, V3, P25; Wu DF, 2011, LUNG CANCER, V72, P322, DOI 10.1016/j.lungcan.2010.10.010	19	406	430	0	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 2	2011	306	17					1865	1873		10.1001/jama.2011.1591	http://dx.doi.org/10.1001/jama.2011.1591			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839OD	22031728				2022-12-28	WOS:000296376200020
J	Helgen, KM				Helgen, Kristofer M.			The Mammal Family Tree	SCIENCE			English	Editorial Material									Smithsonian Inst, Natl Museum Nat Hist, Div Mammals, Washington, DC 20013 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Helgen, KM (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Div Mammals, MRC 108,POB 37012, Washington, DC 20013 USA.	helgenk@si.edu	Helgen, Kristofer M./AAB-8348-2019	Helgen, Kristofer M./0000-0002-8776-4040				Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Flannery T., 2004, ASTONISHING ANIMALS; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gregory W. K., 1910, B AM MUS NAT HIST, V27, P1, DOI DOI 10.1007/S13364-013-0165-6; Luo ZX, 2011, NATURE, V476, P442, DOI 10.1038/nature10291; Mason VC, 2011, GENOME RES, V21, P1695, DOI 10.1101/gr.120196.111; Meredith RW, 2008, J MAMM EVOL, V15, P1, DOI 10.1007/s10914-007-9062-6; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Miller W, 2009, GENOME RES, V19, P213, DOI 10.1101/gr.082628.108; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1	11	10	11	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 28	2011	334	6055					458	459		10.1126/science.1214544	http://dx.doi.org/10.1126/science.1214544			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837UR	22034419				2022-12-28	WOS:000296230500027
J	Mellman, I; Nussenzweig, M				Mellman, Ira; Nussenzweig, Michel			Ralph M. Steinman (1943-2011)	SCIENCE			English	Biographical-Item									[Mellman, Ira] Genentech Inc, San Francisco, CA 94080 USA; [Nussenzweig, Michel] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Roche Holding; Genentech; Howard Hughes Medical Institute; Rockefeller University	Mellman, I (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	mellman.ira@gene.com; nussen@mail.rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019; Mellman, Ira/ABG-5896-2020		Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)			0	12	14	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 28	2011	334	6055					466	466		10.1126/science.1215136	http://dx.doi.org/10.1126/science.1215136			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837UR	22034425				2022-12-28	WOS:000296230500033
J	Malebranche, D				Malebranche, David			With His Hands	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Emory Univ, Sch Med, Div Gen Med, Atlanta, GA 30322 USA	Emory University	Malebranche, D (corresponding author), Emory Univ, Sch Med, Div Gen Med, Atlanta, GA 30322 USA.	dmalebr@emory.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 26	2011	306	16					1741	1742		10.1001/jama.2011.1543	http://dx.doi.org/10.1001/jama.2011.1543			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HH	22028343				2022-12-28	WOS:000296181600001
J	Chen, HN; Gu, XY; Liu, YH; Wang, J; Wirt, SE; Bottino, R; Schorle, H; Sage, J; Kim, SK				Chen, Hainan; Gu, Xueying; Liu, Yinghua; Wang, Jing; Wirt, Stacey E.; Bottino, Rita; Schorle, Hubert; Sage, Julien; Kim, Seung K.			PDGF signalling controls age-dependent proliferation in pancreatic beta-cells	NATURE			English	Article							GROWTH-FACTOR; TRANSGENIC MICE; DNA-SYNTHESIS; RAT ISLETS; MASS; RECEPTOR; EXPRESSION; REPLICATION; EXPANSION; EZH2	Determining the signalling pathways that direct tissue expansion is a principal goal of regenerative biology. Vigorous pancreatic beta-cell replication in juvenile mice and humans declines with age, and elucidating the basis for this decay may reveal strategies for inducing beta-cell expansion, a long-sought goal for diabetes therapy. Here we show that platelet-derived growth factor receptor (Pdgfr) signalling controls age-dependent beta-cell proliferation in mouse and human pancreatic islets. With age, declining beta-cell Pdgfr levels were accompanied by reductions in beta-cell enhancer of zeste homologue 2 (Ezh2) levels and beta-cell replication. Conditional inactivation of the Pdgfra gene in beta-cells accelerated these changes, preventing mouse neonatal beta-cell expansion and adult beta-cell regeneration. Targeted human PDGFR-a activation in mouse beta-cells stimulated Erk1/2 phosphorylation, leading to Ezh2-dependent expansion of adult beta-cells. Adult human islets lack PDGF signalling competence, but exposure of juvenile human islets to PDGF-AA stimulated beta-cell proliferation. The discovery of a conserved pathway controlling age-dependent beta-cell proliferation indicates new strategies for beta-cell expansion.	[Chen, Hainan; Gu, Xueying; Liu, Yinghua; Wang, Jing; Kim, Seung K.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Wirt, Stacey E.; Sage, Julien] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Wirt, Stacey E.; Sage, Julien] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Bottino, Rita] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Div Immunogenet,Dept Pediat, Pittsburgh, PA 15213 USA; [Schorle, Hubert] Univ Bonn, Sch Med, Inst Pathol, Dept Dev Biol, D-53127 Bonn, Germany; [Kim, Seung K.] Stanford Univ, Sch Med, Dept Med Oncol, Stanford, CA 94305 USA; [Kim, Seung K.] Howard Hughes Med Inst, Dept Dev Biol, Beckman Ctr B300, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Bonn; Stanford University; Howard Hughes Medical Institute	Kim, SK (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.	seungkim@stanford.edu	LIU, YING/GZL-7252-2022; Schorle, Hubert/M-5001-2016; liu, ying/GXF-4294-2022; Schorle, Hubert/S-1713-2019	Schorle, Hubert/0000-0001-8272-0076; Kim, Seung/0000-0001-6135-7810	NIH; NIH-NCI [RO1 CA114102]; Stem Cell Network NRW; Deutsche Krebshilfe; Dewey family fund; Juvenile Diabetes Research Foundation; Snyder Foundation; Stinehart Foundation; NIH Beta Cell Biology Consortium [UO1 DK89532, UO1 DK89572]; Howard Hughes Medical Institute (HHMI); NATIONAL CANCER INSTITUTE [T32CA009302, R01CA114102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075919, U01DK089532, U01DK089572, R01DK056709, R01DK072184] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stem Cell Network NRW; Deutsche Krebshilfe(Deutsche Krebshilfe); Dewey family fund; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Snyder Foundation; Stinehart Foundation; NIH Beta Cell Biology Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Bhushan, A. Stewart, A. Powers, P. Beachy, M. White, X. Chen and X. Li for helpful discussions and advice, A. Tarakhovsky, P. Herrera and M. Hara for mice, A. Powers, A. Thompson and S. Bryant for human islet sample procurement, and members of the S.K.K. laboratory for comments on the manuscript. H.C. was supported by the NIH Ruth L. Kirschstein NRSA/Stanford Regenerative Medicine Training Program. J.S. was supported by NIH-NCI RO1 CA114102. H.S. was supported by the Stem Cell Network NRW and Deutsche Krebshilfe. Work in the S.K.K. laboratory was supported by a gift from the Dewey family fund, and grants from the Juvenile Diabetes Research Foundation, Snyder Foundation, Stinehart Foundation, the NIH Beta Cell Biology Consortium (UO1 DK89532 to S.K.K. and UO1 DK89572 to A. Powers) and by the Howard Hughes Medical Institute (HHMI). S.K.K. is an Investigator of the HHMI.	Beattie GM, 2002, DIABETES, V51, P3435, DOI 10.2337/diabetes.51.12.3435; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; BRELJE TC, 1994, DIABETES, V43, P263, DOI 10.2337/diabetes.43.2.263; Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; EBERT M, 1995, INT J CANCER, V62, P529, DOI 10.1002/ijc.2910620507; FUJII S, 2011, ONCOGENE        0418, DOI DOI 10.1038/ONC.2011.118; Furstoss O, 2002, FEBS LETT, V526, P82, DOI 10.1016/S0014-5793(02)03120-4; Garcia-Ocana A, 2000, J BIOL CHEM, V275, P1226, DOI 10.1074/jbc.275.2.1226; Gupta RK, 2007, GENE DEV, V21, P756, DOI 10.1101/gad.1535507; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hilberg F, 2008, CANCER RES, V68, P4774, DOI 10.1158/0008-5472.CAN-07-6307; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; LeBras S, 1998, DIABETOLOGIA, V41, P1474, DOI 10.1007/s001250051094; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Miettinen PJ, 2006, DIABETES, V55, P3299, DOI 10.2337/db06-0413; Moberg K, 1996, MOL CELL BIOL, V16, P1436; Moenning A, 2009, MOL CELL BIOL, V29, P881, DOI 10.1128/MCB.00885-08; Nyblom HK, 2009, J PROTEOME RES, V8, P5650, DOI 10.1021/pr9006816; Pallante BA, 2007, CIRC RES, V100, pE1, DOI 10.1161/01.RES.0000253487.02398.85; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Rieck S, 2010, TRENDS ENDOCRIN MET, V21, P151, DOI 10.1016/j.tem.2009.11.001; Scherping SC, 1997, CONNECT TISSUE RES, V36, P1, DOI 10.3109/03008209709160209; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Sugiyama T, 2007, P NATL ACAD SCI USA, V104, P175, DOI 10.1073/pnas.0609490104; SWENNE I, 1988, ENDOCRINOLOGY, V122, P214, DOI 10.1210/endo-122-1-214; Tallquist MD, 2003, DEVELOPMENT, V130, P507, DOI 10.1242/dev.00241; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Uhrbom L, 2004, NAT MED, V10, P1257, DOI 10.1038/nm1120; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Vasavada RC, 2006, INT J BIOCHEM CELL B, V38, P931, DOI 10.1016/j.biocel.2005.08.003; Vasavada RC, 2000, J BIOL CHEM, V275, P15399, DOI 10.1074/jbc.275.20.15399; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; WELSH M, 1990, P NATL ACAD SCI USA, V87, P5807, DOI 10.1073/pnas.87.15.5807; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	43	206	214	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 20	2011	478	7369					349	+		10.1038/nature10502	http://dx.doi.org/10.1038/nature10502			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	21993628	Green Accepted			2022-12-28	WOS:000296021100038
J	Foley, JA; Ramankutty, N; Brauman, KA; Cassidy, ES; Gerber, JS; Johnston, M; Mueller, ND; O'Connell, C; Ray, DK; West, PC; Balzer, C; Bennett, EM; Carpenter, SR; Hill, J; Monfreda, C; Polasky, S; Rockstrom, J; Sheehan, J; Siebert, S; Tilman, D; Zaks, DPM				Foley, Jonathan A.; Ramankutty, Navin; Brauman, Kate A.; Cassidy, Emily S.; Gerber, James S.; Johnston, Matt; Mueller, Nathaniel D.; O'Connell, Christine; Ray, Deepak K.; West, Paul C.; Balzer, Christian; Bennett, Elena M.; Carpenter, Stephen R.; Hill, Jason; Monfreda, Chad; Polasky, Stephen; Rockstrom, Johan; Sheehan, John; Siebert, Stefan; Tilman, David; Zaks, David P. M.			Solutions for a cultivated planet	NATURE			English	Article							GREENHOUSE-GAS EMISSIONS; CROP YIELDS; LAND-USE; AGRICULTURAL INTENSIFICATION; WATER-RESOURCES; CLIMATE; PHOSPHORUS; MANAGEMENT; CROPLANDS; FUTURE	Increasing population and consumption are placing unprecedented demands on agriculture and natural resources. Today, approximately a billion people are chronically malnourished while our agricultural systems are concurrently degrading land, water, biodiversity and climate on a global scale. To meet the world's future food security and sustainability needs, food production must grow substantially while, at the same time, agriculture's environmental footprint must shrink dramatically. Here we analyse solutions to this dilemma, showing that tremendous progress could be made by halting agricultural expansion, closing 'yield gaps' on underperforming lands, increasing cropping efficiency, shifting diets and reducing waste. Together, these strategies could double food production while greatly reducing the environmental impacts of agriculture.	[Foley, Jonathan A.; Brauman, Kate A.; Cassidy, Emily S.; Gerber, James S.; Johnston, Matt; Mueller, Nathaniel D.; O'Connell, Christine; Ray, Deepak K.; West, Paul C.; Hill, Jason; Polasky, Stephen; Sheehan, John; Tilman, David] Univ Minnesota, Inst Environm IonE, St Paul, MN 55108 USA; [Ramankutty, Navin] McGill Univ, Dept Geog, Montreal, PQ H3A 2K6, Canada; [Ramankutty, Navin] McGill Univ, Global Environm & Climate Change Ctr, Montreal, PQ H3A 2K6, Canada; [O'Connell, Christine] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Bennett, Elena M.] McGill Univ, Sch Environm, Ste Anne De Bellevue, PQ H9X 3V9, Canada; [Bennett, Elena M.] McGill Univ, Dept Nat Resource Sci, Ste Anne De Bellevue, PQ H9X 3V9, Canada; [Carpenter, Stephen R.] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Hill, Jason] Univ Minnesota, Dept Bioprod & Biosyst Engn, St Paul, MN 55108 USA; [Monfreda, Chad] Arizona State Univ, CSPO, Tempe, AZ 85287 USA; [Polasky, Stephen] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA; [Rockstrom, Johan] Stockholm Univ, Stockholm Resilience Ctr, SE-10691 Stockholm, Sweden; [Siebert, Stefan] Univ Bonn, Inst Crop Sci & Resource Conservat, D-53115 Bonn, Germany; [Tilman, David] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Zaks, David P. M.] Univ Wisconsin, Ctr Sustainabil & Global Environm SAGE, Madison, WI 53726 USA	University of Minnesota System; University of Minnesota Twin Cities; McGill University; McGill University; University of California System; University of California Santa Barbara; McGill University; McGill University; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; Arizona State University; Arizona State University-Tempe; University of Minnesota System; University of Minnesota Twin Cities; Stockholm University; University of Bonn; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison	Foley, JA (corresponding author), Univ Minnesota, Inst Environm IonE, 1954 Buford Ave, St Paul, MN 55108 USA.	jfoley@umn.edu	Foley, Jonathan A/GRS-5522-2022; Bennett, Elena/A-9553-2008; Carpenter, Stephen/AAQ-6404-2020; Ray, Deepak K/F-7720-2012; Siebert, Stefan/B-8621-2009; Hill, Jason/A-8919-2008; Brauman, Kate A/ABD-5349-2021; Mueller, Nathan D/E-5864-2010; Tilman, David/ABD-5309-2021; West, Paul C./J-1665-2015; Polasky, Stephen/AAC-5341-2019; Ramankutty, Navin/AAM-6074-2020	Siebert, Stefan/0000-0002-9998-0672; Hill, Jason/0000-0001-7609-6713; Brauman, Kate A/0000-0002-8099-285X; Mueller, Nathan D/0000-0003-1857-5104; West, Paul C./0000-0001-9024-1657; Ramankutty, Navin/0000-0002-3737-5717; Cassidy, Emily/0000-0003-4405-0264; Rockstrom, Johan/0000-0001-8988-2983; Ray, Deepak/0000-0002-2856-9608; Bennett, Elena/0000-0003-3944-2925; Gerber, James/0000-0002-6890-0481	NASA; National Science Foundation; Stockholm Resilience Centre	NASA(National Aeronautics & Space Administration (NASA)); National Science Foundation(National Science Foundation (NSF)); Stockholm Resilience Centre	We are grateful for the support of NASA and the National Science Foundation. We also acknowledge the support of the Stockholm Resilience Centre, for convening a workshop on meeting global agricultural demands while staying within the 'planetary limits'. We thank C. Godfray and C. Prentice for comments on the manuscript. We also thank M. Hoff and S. Karnas for help with the manuscript and figures.	[Anonymous], 2009, REAP BEN SCI SUST IN, p[1, 47]; [Anonymous], GLOB BIOGEOCHEM CYCL; [Anonymous], 2005, EC HUM WELL BEING, V2, P9; Bennett EM, 2001, BIOSCIENCE, V51, P227, DOI 10.1641/0006-3568(2001)051[0227:HIOEPA]2.0.CO;2; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Chen XP, 2011, P NATL ACAD SCI USA, V108, P6399, DOI 10.1073/pnas.1101419108; Cirera X, 2010, PHILOS T R SOC B, V365, P2821, DOI 10.1098/rstb.2010.0164; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; DeFries R, 2010, P NATL ACAD SCI USA, V107, P19627, DOI 10.1073/pnas.1011163107; DeFries RS, 2004, FRONT ECOL ENVIRON, V2, P249, DOI 10.1890/1540-9295(2004)002[0249:LCBHNA]2.0.CO;2; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2007, FRONT ECOL ENVIRON, V5, P25, DOI 10.1890/1540-9295(2007)5[25:ARFDAL]2.0.CO;2; Food and Agriculture Organization of the United Nations (FAO), 2009, STAT FOOD INS WORLD, P8; Friedlingstein P, 2010, NAT GEOSCI, V3, P811, DOI 10.1038/ngeo1022; Galford GL, 2010, P NATL ACAD SCI USA, V107, P19649, DOI 10.1073/pnas.1000780107; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Gibbs HK, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/3/034001; Gleick P. H., 2009, WORLDS WATER 2008 20, P202; Gleick PH, 2003, SCIENCE, V302, P1524, DOI 10.1126/science.1089967; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Gordon LJ, 2005, P NATL ACAD SCI USA, V102, P7612, DOI 10.1073/pnas.0500208102; Gustavsson J., 2011, GLOBAL FOOD LOSSES F; International Assessment of Agricultural Knowledge ( IAASTD), 2009, AGR CROSSR GLOB REP, p[1, 4]; IPCC, 2007, CLIM CHANG 2007 IPCC; Jaggard KW, 2010, PHILOS T R SOC B, V365, P2835, DOI 10.1098/rstb.2010.0153; Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149; Kremen C, 2008, CONSERV BIOL, V22, P795, DOI 10.1111/j.1523-1739.2008.00940.x; Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108; Licker R, 2010, GLOBAL ECOL BIOGEOGR, V19, P769, DOI 10.1111/j.1466-8238.2010.00563.x; Liu JG, 2010, P NATL ACAD SCI USA, V107, P8035, DOI 10.1073/pnas.0913658107; Lundqvist J., 2008, SAVING WATER FIELD F, P20; MacDonald GK, 2011, P NATL ACAD SCI USA, V108, P3086, DOI 10.1073/pnas.1010808108; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; Mayaux P, 2005, PHILOS T R SOC B, V360, P373, DOI 10.1098/rstb.2004.1590; Naylor R, 2011, FOOD SECUR, V3, P233, DOI 10.1007/s12571-011-0123-6; Neumann K, 2010, AGR SYST, V103, P316, DOI 10.1016/j.agsy.2010.02.004; Parfitt J, 2010, PHILOS T R SOC B, V365, P3065, DOI 10.1098/rstb.2010.0126; Pelletier N, 2010, P NATL ACAD SCI USA, V107, P18371, DOI 10.1073/pnas.1004659107; Portmann FT, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003435; Postel SL, 1996, SCIENCE, V271, P785, DOI 10.1126/science.271.5250.785; Potter P, 2010, EARTH INTERACT, V14, DOI 10.1175/2009EI288.1; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; Ramankutty N, 1999, GLOBAL BIOGEOCHEM CY, V13, P997, DOI 10.1029/1999GB900046; Ramankutty N, 2002, GLOBAL ECOL BIOGEOGR, V11, P377, DOI 10.1046/j.1466-822x.2002.00294.x; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rosegrant M. W., 2002, WORLD WATER FOOD 202, P1; Rudel TK, 2009, P NATL ACAD SCI USA, V106, P20675, DOI 10.1073/pnas.0812540106; Sachs J, 2010, NATURE, V466, P558, DOI 10.1038/466558a; Sanchez PA, 2010, NAT GEOSCI, V3, P299, DOI 10.1038/ngeo853; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Siebert S, 2010, J HYDROL, V384, P198, DOI 10.1016/j.jhydrol.2009.07.031; Smil V, 2000, ANNU REV ENERG ENV, V25, P53, DOI 10.1146/annurev.energy.25.1.53; Steinfeld H., 2006, Renewable Resources Journal, V24, P15; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Thurow R., 2009, ENOUGH WHY WORLDS PO, p[2, 12, 4]; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; van der Werf GR, 2009, NAT GEOSCI, V2, P737, DOI 10.1038/ngeo671; Verge XPC, 2007, AGR FOREST METEOROL, V142, P255, DOI 10.1016/j.agrformet.2006.06.011; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; West PC, 2010, P NATL ACAD SCI USA, V107, P19645, DOI 10.1073/pnas.1011078107; Zaks DPM, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/1/014017; [No title captured]	72	4213	4374	169	4499	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2011	478	7369					337	342		10.1038/nature10452	http://dx.doi.org/10.1038/nature10452			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	21993620	Green Published			2022-12-28	WOS:000296021100036
J	Yusa, K; Rashid, ST; Strick-Marchand, H; Varela, I; Liu, PQ; Paschon, DE; Miranda, E; Ordonez, A; Hannan, NRF; Rouhani, FJ; Darche, S; Alexander, G; Marciniak, SJ; Fusaki, N; Hasegawa, M; Holmes, MC; Di Santo, JP; Lomas, DA; Bradley, A; Vallier, L				Yusa, Kosuke; Rashid, S. Tamir; Strick-Marchand, Helene; Varela, Ignacio; Liu, Pei-Qi; Paschon, David E.; Miranda, Elena; Ordonez, Adriana; Hannan, Nicholas R. F.; Rouhani, Foad J.; Darche, Sylvie; Alexander, Graeme; Marciniak, Stefan J.; Fusaki, Noemi; Hasegawa, Mamoru; Holmes, Michael C.; Di Santo, James P.; Lomas, David A.; Bradley, Allan; Vallier, Ludovic			Targeted gene correction of alpha(1)-antitrypsin deficiency in induced pluripotent stem cells	NATURE			English	Article							EFFICIENT; GENERATION; PIGGYBAC; GENOME; INDUCTION; COMPLEX	Human induced pluripotent stem cells (iPSCs) represent a unique opportunity for regenerative medicine because they offer the prospect of generating unlimited quantities of cells for autologous transplantation, with potential application in treatments for a broad range of disorders(1-4). However, the use of human iPSCs in the context of genetically inherited human disease will require the correction of disease-causing mutations in a manner that is fully compatible with clinical applications(3,5). The methods currently available, such as homologous recombination, lack the necessary efficiency and also leave residual sequences in the targeted genome(6). Therefore, the development of new approaches to edit the mammalian genome is a prerequisite to delivering the clinical promise of human iPSCs. Here we show that a combination of zinc finger nucleases (ZFNs)(7) and piggyBac(8,9) technology in human iPSCs can achieve biallelic correction of a point mutation (Glu342Lys) in the alpha(1)-antitrypsin (A1AT, also known as SERPINA1) gene that is responsible for alpha(1)-antitrypsin deficiency. Genetic correction of human iPSCs restored the structure and function of A1AT in subsequently derived liver cells in vitro and in vivo. This approach is significantly more efficient than any other gene-targeting technology that is currently available and crucially prevents contamination of the host genome with residual non-human sequences. Our results provide the first proof of principle, to our knowledge, for the potential of combining human iPSCs with genetic correction to generate clinically relevant cells for autologous cell-based therapies.	[Yusa, Kosuke; Rouhani, Foad J.; Bradley, Allan] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Rashid, S. Tamir; Hannan, Nicholas R. F.; Rouhani, Foad J.; Vallier, Ludovic] Univ Cambridge, Anne McLaren Lab Regenerat Med, Dept Surg, Cambridge CB2 0SZ, England; [Rashid, S. Tamir; Miranda, Elena; Ordonez, Adriana; Marciniak, Stefan J.; Lomas, David A.] Univ Cambridge, Dept Med, Cambridge Inst Med Res, Cambridge CB0 2XY, England; [Strick-Marchand, Helene; Darche, Sylvie; Di Santo, James P.] Inst Pasteur, Innate Immun Unit, F-75724 Paris, France; [Strick-Marchand, Helene; Darche, Sylvie; Di Santo, James P.] INSERM, U668, F-75724 Paris, France; [Varela, Ignacio] CSIC UC SODERCAN, Inst Biomed & Biotecnol Cantabria, Santander 39011, Spain; [Liu, Pei-Qi; Paschon, David E.; Holmes, Michael C.] Sangamo BioSci Inc, Richmond, CA 94804 USA; [Miranda, Elena] Univ Roma La Sapienza, Dept Biol Biotecnol Charles Darwin, I-00185 Rome, Italy; [Alexander, Graeme] Cambridge Univ Hosp NHS Trust, Dept Med, Div Gastroenterol & Hepatol, Cambridge CB2 2QQ, England; [Fusaki, Noemi; Hasegawa, Mamoru] DNAVEC Corp, Tsukuba, Ibaraki 3002611, Japan; [Fusaki, Noemi] JST, PRESTO, Saitama 3320012, Japan	Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Sangamo Therapeutics, Inc.; Sapienza University Rome; DNAVEC Corporation; Japan Science & Technology Agency (JST)	Bradley, A (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	abradley@sanger.ac.uk; lv225@cam.ac.uk	Marciniak, Stefan J/F-1855-2010; Hannan, Nicholas/ABG-6497-2020; Varela, Ignacio/G-1699-2016; vallier, ludovic/C-6368-2011; Varela, Ignacio/AAA-7680-2021; Miranda, Elena/J-4999-2012; Hannan, Nicholas/A-8731-2013; Di Santo, James P/M-4298-2014; Strick-Marchand, Helene/M-6525-2014; Wilson, Matthew H/K-3193-2013; Fusaki, Noemi/U-1628-2019	Varela, Ignacio/0000-0002-0969-506X; Varela, Ignacio/0000-0002-0969-506X; Miranda, Elena/0000-0002-0586-8795; Di Santo, James P/0000-0002-7146-1862; Strick-Marchand, Helene/0000-0002-0519-214X; Bradley, Allan/0000-0002-2349-8839; Vallier, Ludovic/0000-0002-3848-2602; Marciniak, Stefan/0000-0001-8472-7183; Hannan, Nicholas/0000-0002-9843-1559; Rashid, Sheikh Tamir/0000-0001-6779-2506	Wellcome Trust [WT077187]; MRC; Cambridge Hospitals National Institute for Health Research Biomedical Research Center; Papworth NHS Trust; Bill and Melinda Gates Foundation; Inserm; Institut Pasteur; Japan Science and Technology Agency; Japan Society for the Promotion of Science; International Human Frontiers Science Program Organization; MRC [G0901786, G0800784, G0601840, G0701448, G1000847] Funding Source: UKRI; Medical Research Council [G0901786, G0701448, G0800784B, G0601840, G1000847, G0800784] Funding Source: researchfish; National Institute for Health Research [CL-2011-14-005] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge Hospitals National Institute for Health Research Biomedical Research Center; Papworth NHS Trust; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Pasteur(European Commission); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); International Human Frontiers Science Program Organization(Human Frontier Science Program); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank A. Klug and M. Minczuk for their advice, M. A. Li for comments on the manuscript, P. Ellis, N. Hammond and C. McGee for CGH analysis, the Sanger Institute sequencing facility for exome sequencing, N. Conte and S. Rice for assistance with bioinformatic analysis, M. Alexander for her help with cell culture reagents. We also thank L. Zhang, S. Hinkley and the production group for ZFN assembly and validation, K. Tong and X. Meng for technical assistance, J. C. Miller and E. Leung for ZFN off-target site analysis and S. Abrahamson and P. D. Gregory for careful reading of the manuscript. This work was supported by the Wellcome Trust (WT077187; A.B.), the MRC Senior non-clinical fellowship and the Cambridge Hospitals National Institute for Health Research Biomedical Research Center (L.V.), the Medical Research Council and Papworth NHS Trust (D.A.L.), the Bill and Melinda Gates Foundation, Inserm and Institut Pasteur (H. S.-M.) and Japan Science and Technology Agency (N.F.). K.Y. is supported by a postdoctoral fellowship of Japan Society for the Promotion of Science. S.T.R. and F.J.R. are Wellcome Trust Clinical Training Fellows. I.V. is supported by a fellowship from the International Human Frontiers Science Program Organization.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Fairchild PJ, 2010, NAT REV IMMUNOL, V10, P868, DOI 10.1038/nri2878; Fraser MJ, 1996, INSECT MOL BIOL, V5, P141, DOI 10.1111/j.1365-2583.1996.tb00048.x; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Lacoste A, 2009, CELL STEM CELL, V5, P332, DOI 10.1016/j.stem.2009.07.011; Lefort N, 2008, NAT BIOTECHNOL, V26, P1364, DOI 10.1038/nbt.1509; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Meier ID, 2010, FASEB J, V24, P1714, DOI 10.1096/fj.09-140749; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Perlmutter DH, 2009, CELL DEATH DIFFER, V16, P39, DOI 10.1038/cdd.2008.103; Rashid ST, 2010, J CLIN INVEST, V120, P3127, DOI 10.1172/JCI43122; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Spits C, 2008, NAT BIOTECHNOL, V26, P1361, DOI 10.1038/nbt.1510; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tenzen T, 2010, J CELL PHYSIOL, V222, P278, DOI 10.1002/jcp.21948; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Van der Weyden L, 2002, PHYSIOL GENOMICS, V11, P133, DOI 10.1152/physiolgenomics.00074.2002; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	36	485	540	2	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2011	478	7369					391	+		10.1038/nature10424	http://dx.doi.org/10.1038/nature10424			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	21993621	Green Submitted, Green Accepted			2022-12-28	WOS:000296021100047
J	Dowswell, G; Ismail, T; Greenfield, S; Clifford, S; Hancock, B; Wilson, S				Dowswell, George; Ismail, Tariq; Greenfield, Sheila; Clifford, Sue; Hancock, Beverley; Wilson, Sue			Men's experience of erectile dysfunction after treatment for colorectal cancer: qualitative interview study	BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE CONSULTATIONS; CROSS-SECTIONAL SURVEY; PROSTATE-CANCER; INFORMATION NEEDS; OF-LIFE; SEEKING BEHAVIOR; HEALTH; SILDENAFIL; CONSTRUCTIONS; PREVALENCE	Objectives To examine the experiences of men after treatment for colorectal cancer, identify barriers to accessing services, and suggest improvements to providing information in primary and secondary care. Design Semistructured, qualitative interview study with purposive sampling and thematic analysis. Participants 28 patients treated for colorectal cancer. Setting West Midlands. Results Most men treated for colorectal cancer experience erectile dysfunction as a consequence. Not all, however, want the same response from health professionals. Although, erectile dysfunction is profoundly stressful for most men, affecting self image, behaviour, and relationships, some do not regard it as a health priority. Many of the men were uninformed about erectile dysfunction and were unprepared for it, and the majority neither helped themselves nor asked for help. Almost none were receiving adequate, effective, and affordable care. Evidence of ageism was strong. Conclusions Unlike patients with prostate cancer, men with colorectal cancer are not routinely offered information and treatment for erectile dysfunction. Greater coordination of care and consistent strategies are needed to tackle the unmet needs of this widely diverse patient group. Currently, clinicians are inadvertently neglecting, misleading, and offending such patients; better training could improve this situation, as might the reorganisation of services. Further research is needed to determine whether trained clinical nurse specialists in colorectal cancer units could coordinate ongoing care.	[Dowswell, George; Greenfield, Sheila; Clifford, Sue; Hancock, Beverley; Wilson, Sue] Univ Birmingham, Canc & Chron Dis Team, Birmingham B15 2TT, W Midlands, England; [Ismail, Tariq] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Greenfield, S (corresponding author), Univ Birmingham, Canc & Chron Dis Team, Birmingham B15 2TT, W Midlands, England.	s.m.greenfield@bham.ac.uk		Ismail, Tariq/0000-0002-8554-7974	National Institute for Health Research [PB-PG-0407-13245]	National Institute for Health Research(National Institute for Health Research (NIHR))	This paper presents independent research commissioned by the National Institute for Health Research under the research for patient benefit programme (PB-PG-0407-13245). The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research, or the Department of Health.	Barry CA, 2000, BRIT MED J, V320, P1246, DOI 10.1136/bmj.320.7244.1246; BRITTEN N, 1995, BRIT MED J, V311, P251, DOI 10.1136/bmj.311.6999.251; CAMPION PD, 1992, FAM PRACT, V9, P181, DOI 10.1093/fampra/9.2.181; *CANC RES UK, 2010, BOW CANC STAT KEY FA; Cancer Research UK, 2010, BOW COL CANC UK INC; Chapple A, 2004, BRIT J GEN PRACT, V54, P25; Charmaz K., 1995, MENS HLTH ILLNESS GE, P266; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Dahn JR, 2004, UROLOGY, V63, P273, DOI 10.1016/j.urology.2003.09.048; Davison BJ, 2007, BJU INT, V100, P780, DOI 10.1111/j.1464-410X.2007.07043.x; Denzin N.K., 2013, LANDSCAPE QUALITATIV; Ellis R, 2010, J SEX MED, V7, P1488, DOI 10.1111/j.1743-6109.2009.01461.x; Galbraith Michael E, 2008, Semin Oncol Nurs, V24, P102, DOI 10.1016/j.soncn.2008.02.010; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Goldstein I, 1998, NEW ENGL J MED, V338, P1397, DOI 10.1056/NEJM199805143382001; Graham J, 2008, BRIT MED J, V336, P610, DOI 10.1136/bmj.39498.525706.AD; Hall JA, 2002, PATIENT EDUC COUNS, V48, P217, DOI 10.1016/S0738-3991(02)00174-X; Hendren SK, 2005, ANN SURG, V242, P212, DOI 10.1097/01.sla.0000171299.43954.ce; Hordern A, 2008, CANCER NURS, V31, pE9, DOI 10.1097/01.NCC.0000305695.12873.d5; Hordern AJ, 2007, SOC SCI MED, V64, P1704, DOI 10.1016/j.socscimed.2006.12.012; Incrocci L, 2003, UROLOGY, V62, P116, DOI 10.1016/S0090-4295(03)00133-X; Johnson JD, 1997, CANC RELATED INFORM; Lee R.M., 1993, DOING RES SENSITIVE; Lewis, 2006, QUALITATIVE RES PRAC; Leydon GM, 2000, BMJ-BRIT MED J, V320, P909, DOI 10.1136/bmj.320.7239.909; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; Lindsey I, 2002, DIS COLON RECTUM, V45, P727, DOI 10.1007/s10350-004-6287-9; Mayer DK, 2007, PATIENT EDUC COUNS, V65, P342, DOI 10.1016/j.pec.2006.08.015; Meredith C, 1996, BMJ-BRIT MED J, V313, P724; Miles BJ, 1999, UROLOGY, V53, P169, DOI 10.1016/S0090-4295(98)00456-7; Milne JL, 2008, INT J NURS STUD, V45, P765, DOI 10.1016/j.ijnurstu.2007.01.006; National Health Service, 2010, NHS CHOIC; National Institute for Health and Clinical Excellence, 2008, NICE CLIN GUID; Oliffe J, 2009, MEN MASC, V11, P346, DOI 10.1177/1097184X06298777; Patton MQ., 2015, QUALITATIVE RES EVAL, V3; Payne S, 2007, J MENS HLTH GENDER, V4, P131, DOI DOI 10.1016/J.JMHG.2007.03.005; Phillips C, 2000, CANCER PRACT, V8, P165, DOI 10.1046/j.1523-5394.2000.84009.x; Pinder R., 1990, MANAGEMENT CHRONIC I; Potosky AL, 2004, J NATL CANCER I, V96, P1358, DOI 10.1093/jnci/djh259; Ralph D, 2000, BRIT MED J, V321, P499, DOI 10.1136/bmj.321.7259.499; Ramanadhan S, 2006, HEALTH COMMUN, V20, P131, DOI 10.1207/s15327027hc2002_4; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; Schover LR, 2002, CANCER, V95, P1773, DOI 10.1002/cncr.10848; Seale C., 1999, QUALITY QUALITATIVE; Selman L, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1326; Smith LK, 2005, LANCET, V366, P825, DOI 10.1016/S0140-6736(05)67030-4; SPRANGERS MAG, 1995, DIS COLON RECTUM, V38, P361, DOI 10.1007/BF02054222; Tomlinson JM, 2004, BMJ-BRIT MED J, V328, P1037, DOI 10.1136/bmj.38044.662176.EE; Wall David, 2005, Nurs Inq, V12, P87, DOI 10.1111/j.1440-1800.2005.00258.x	49	22	23	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 18	2011	343								d5824	10.1136/bmj.d5824	http://dx.doi.org/10.1136/bmj.d5824			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HL	22010127	Green Published, hybrid			2022-12-28	WOS:000296183400008
J	Li, DK; Yang, CM; Andrade, S; Tavares, V; Ferber, JR				Li, De-Kun; Yang, Chunmei; Andrade, Susan; Tavares, Venessa; Ferber, Jeannette R.			Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							ACE-INHIBITORS; PREGNANCY	Objective To examine a reported association between use of angiotensin converting enzyme (ACE) inhibitors during the first trimester and risk of malformations in offspring. Design A population based, retrospective cohort study linking automated clinical and pharmacy databases including comprehensive electronic medical records. Participants Pregnant women and their live born offspring (465 754 mother-infant pairs) in the Kaiser Permanente Northern California region from 1995 to 2008. Main outcome measure Congenital malformation in live births. Results The prevalence of ACE inhibitor use in the first trimester only was 0.9/1000, and the use of other antihypertensive medications was 2.4/1000. After adjustment for maternal age, ethnicity, parity, and obesity, use of ACE inhibitors during the first trimester only seemed to be associated with increased risk of congenital heart defects in offspring compared with normal controls (those with neither hypertension nor use of any antihypertensives during pregnancy) (15/381 (3.9%) v 6232/400 021 (1.6%) cases, odds ratio 1.54 (95% confidence interval 0.90 to 2.62)). A similar association was observed for use of other antihypertensives (28/1090 (2.6%) cases of congenital heart defects, odds ratio 1.52 (1.04 to 2.21)). However, compared with hypertension controls (those with a diagnosis of hypertension but without use of antihypertensives) (708/29 735 (2.4%) cases of congenital heart defects), neither use of ACE inhibitors or of other antihypertensives in the first trimester was associated with increased congenital heart defects risk (odds ratios 1.14 (0.65 to 1.98) and1.12 (0.76 to 1.64) respectively). Conclusions Maternal use of ACE inhibitors in the first trimester has a risk profile similar to the use of other antihypertensives regarding malformations in live born offspring. The apparent increased risk of malformations associated with use of ACE inhibitors (and other antihypertensives) in the first trimester is likely due to the underlying hypertension rather than the medications.	[Li, De-Kun; Yang, Chunmei; Tavares, Venessa; Ferber, Jeannette R.] Kaiser Permanente, Kaiser Fdn Res Inst, Div Res, Oakland, CA 94612 USA; [Andrade, Susan] Meyers Primary Care Inst, Worcester, MA 01605 USA	Kaiser Permanente	Li, DK (corresponding author), Kaiser Permanente, Kaiser Fdn Res Inst, Div Res, Oakland, CA 94612 USA.	de-kun.li@kp.org			Agency for Healthcare Research and Quality, US Department of Health and Human Services [290050033I]; Food and Drug Administration, Office of Women's Health	Agency for Healthcare Research and Quality, US Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Food and Drug Administration, Office of Women's Health	This project was funded under Contract No 290050033I from the Agency for Healthcare Research and Quality, US Department of Health and Human Services as part of the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) programme. The Food and Drug Administration, Office of Women's Health also contributed funds. The authors of this report are responsible for its content. Statements in the report should not be construed as endorsement by the Agency for Healthcare Research and Quality, the Food and Drug Administration, or the US Department of Health and Human Services.	Banhidy F, 2011, HYPERTENS RES, V34, P257, DOI 10.1038/hr.2010.227; BARR M, 1994, TERATOLOGY, V50, P399, DOI 10.1002/tera.1420500606; Caton AR, 2009, HYPERTENSION, V54, P63, DOI 10.1161/HYPERTENSIONAHA.109.129098; Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202; Ferrara A, 2003, CIRCULATION, V107, P43, DOI 10.1161/01.CIR.0000042701.17528.95; Friedman JM, 2006, NEW ENGL J MED, V354, P2498, DOI 10.1056/NEJMe068089; Kroner BA, 2008, J MANAGE CARE PHARM, V14, P155, DOI 10.18553/jmcp.2008.14.2.155; Lennestal R, 2009, EUR J CLIN PHARMACOL, V65, P615, DOI 10.1007/s00228-009-0620-0; Ratnapalan S, 2002, CAN FAM PHYSICIAN, V48, P1047; Selby JV, 2001, DIABETES CARE, V24, P1547, DOI 10.2337/diacare.24.9.1547; 1997, MMWR MORB MORTAL WKL, V46, P240	11	98	106	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 18	2011	343								d5931	10.1136/bmj.d5931	http://dx.doi.org/10.1136/bmj.d5931			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HL	22010128	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000296183400009
J	Gombotz, H				Gombotz, Hans			Patient blood management is key before elective surgery	LANCET			English	Editorial Material							PREOPERATIVE ANEMIA		Gen Hosp Linz, Dept Anaesthesiol & Intens Care, A-4020 Linz, Austria	Kepler University Hospital	Gombotz, H (corresponding author), Gen Hosp Linz, Dept Anaesthesiol & Intens Care, A-4020 Linz, Austria.	hans.gombotz@akh.linz.at						Aapro MS, 2008, ONCOLOGIST, V13, P33, DOI 10.1634/theoncologist.13-S3-33; Beattie WS, 2009, ANESTHESIOLOGY, V110, P574, DOI 10.1097/ALN.0b013e31819878d3; Bennett CL, 2008, JAMA-J AM MED ASSOC, V299, P914, DOI 10.1001/jama.299.8.914; Gombotz H, 2007, TRANSFUSION, V47, P1468, DOI 10.1111/j.1537-2995.2007.01286.x; Goodnough LT, 2011, BRIT J ANAESTH, V106, P13, DOI 10.1093/bja/aeq361; Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812; Moskowitz DM, 2010, ANN THORAC SURG, V90, P451, DOI 10.1016/j.athoracsur.2010.04.089; Musallam KM, 2011, LANCET, V378, P1396, DOI 10.1016/S0140-6736(11)61381-0; Shander A, 2010, TRANSFUSION, V50, P753, DOI 10.1111/j.1537-2995.2009.02518.x; Spahn DR, 2010, ANESTHESIOLOGY, V113, P482, DOI 10.1097/ALN.0b013e3181e08e97; Spahn DR, 2008, ANESTHESIOLOGY, V109, P951, DOI 10.1097/ALN.0b013e31818e3d75; Zarychanski R, 2008, CAN MED ASSOC J, V179, P333, DOI 10.1503/cmaj.071131	12	19	19	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 15	2011	378	9800					1362	1363		10.1016/S0140-6736(11)61552-3	http://dx.doi.org/10.1016/S0140-6736(11)61552-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	838EM	21982518				2022-12-28	WOS:000296269600007
J	Sumazin, P; Yang, XR; Chiu, HS; Chung, WJ; Iyer, A; Llobet-Navas, D; Rajbhandari, P; Bansal, M; Guarnieri, P; Silva, J; Califano, A				Sumazin, Pavel; Yang, Xuerui; Chiu, Hua-Sheng; Chung, Wei-Jen; Iyer, Archana; Llobet-Navas, David; Rajbhandari, Presha; Bansal, Mukesh; Guarnieri, Paolo; Silva, Jose; Califano, Andrea			An Extensive MicroRNA-Mediated Network of RNA-RNA Interactions Regulates Established Oncogenic Pathways in Glioblastoma	CELL			English	Article							INTEGRATED GENOMIC ANALYSIS; WIDE IDENTIFICATION; GENES; PTEN; PROLIFERATION; EXPRESSION; PROTEIN; MIRNAS; MODEL	By analyzing gene expression data in glioblastoma in combination with matched microRNA profiles, we have uncovered a posttranscriptional regulation layer of surprising magnitude, comprising more than 248,000 microRNA (miR)-mediated interactions. These include similar to 7,000 genes whose transcripts act as miR "sponges" and 148 genes that act through alternative, nonsponge interactions. Biochemical analyses in cell lines confirmed that this network regulates established drivers of tumor initiation and subtype implementation, including PTEN, PDGFRA, RB1, VEGFA, STAT3, and RUNX1, suggesting that these interactions mediate crosstalk between canonical oncogenic pathways. siRNA silencing of 13 miR-mediated PTEN regulators, whose locus deletions are predictive of PTEN expression variability, was sufficient to downregulate PTEN in a 30UTR-dependent manner and to increase tumor cell growth rates. Thus, miR-mediated interactions provide a mechanistic, experimentally validated rationale for the loss of PTEN expression in a large number of glioma samples with an intact PTEN locus.	[Sumazin, Pavel; Yang, Xuerui; Chiu, Hua-Sheng; Chung, Wei-Jen; Iyer, Archana; Rajbhandari, Presha; Bansal, Mukesh; Guarnieri, Paolo; Califano, Andrea] Columbia Univ, Columbia Initiat Syst Biol, New York, NY 10032 USA; [Sumazin, Pavel; Yang, Xuerui; Chiu, Hua-Sheng; Chung, Wei-Jen; Bansal, Mukesh; Guarnieri, Paolo; Califano, Andrea] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Chiu, Hua-Sheng; Chung, Wei-Jen; Califano, Andrea] Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA; [Silva, Jose] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Califano, Andrea] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Llobet-Navas, David; Silva, Jose; Califano, Andrea] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Llobet-Navas, David; Silva, Jose; Califano, Andrea] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Califano, A (corresponding author), Columbia Univ, Columbia Initiat Syst Biol, New York, NY 10032 USA.	califano@c2b2.columbia.edu	Llobet-Navas, David/B-5660-2009; Sumazin, Pavel/AAE-6607-2020; Llobet-Navas, David/AAT-4676-2021	Llobet-Navas, David/0000-0003-1443-7003; Sumazin, Pavel/0000-0002-1215-4977; Califano, Andrea/0000-0003-4742-3679; Yang, Xuerui/0000-0002-7731-2147	NIH [U54CA121852, R01CA109755, NCI-caBIG 29XS192]; NATIONAL CANCER INSTITUTE [U54CA121852, R01CA109755, RC2CA148308, R01CA190891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061776] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank James Chi-ping Chen and Mariano J. Alvarez for critical discussion and Katia Basso, Francesco Niola, Antonio Iavarone, and Anna Lasorella for support and suggestions. We would also like to acknowledge the generous funding provided by the NIH under the following grant awards: (1) Roadmap grant for a Center for the Multiscale Analysis of Genetic Networks (MAGNet) (U54CA121852), (2) Genetic Network Inference with Combinational Phenotypes (R01CA109755), and (3) In Silico Research Centre of Excellence NCI-caBIG 29XS192. P.S. and A.C. conceived and supervised the project and participated in its computational and experimental design. P.S., H.-S.C, W.-J.C., M.B., and P.G. designed and implemented the computational methods. P.S., X.Y., H.-S.C., and W.-J.C. analyzed data. P.S., X.Y., J.S., and A.C. designed the experimental assays. X.Y., A.I., D.L.-N., and P.R. performed the experiments. P.S., X.Y., H.-S.C., and A.C. wrote the paper.	Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chatterjee S, 2011, DEV CELL, V20, P388, DOI 10.1016/j.devcel.2011.02.008; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Eiring AM, 2010, CELL, V140, P652, DOI 10.1016/j.cell.2010.01.007; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Gabriely G, 2011, CANCER RES, V71, P3563, DOI 10.1158/0008-5472.CAN-10-3568; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Jeyapalan Z, 2011, NUCLEIC ACIDS RES, V39, P3026, DOI 10.1093/nar/gkq1003; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim H, 2010, P NATL ACAD SCI USA, V107, P2183, DOI 10.1073/pnas.0909896107; Kim MS, 2010, J PATHOL, V221, P139, DOI 10.1002/path.2683; Kim TM, 2011, CANCER RES, V71, P3387, DOI 10.1158/0008-5472.CAN-10-4117; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kwak HJ, 2011, ONCOGENE, V30, P2433, DOI 10.1038/onc.2010.620; Lee DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013599; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Marioni JC, 2006, BIOINFORMATICS, V22, P1144, DOI 10.1093/bioinformatics/btl089; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Su WL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.23; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009; Zhou YM, 2010, P NATL ACAD SCI USA, V107, P7904, DOI 10.1073/pnas.0908441107	37	567	587	1	103	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 14	2011	147	2					370	381		10.1016/j.cell.2011.09.041	http://dx.doi.org/10.1016/j.cell.2011.09.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000015	Bronze, Green Accepted			2022-12-28	WOS:000296199300015
J	Travesset, A				Travesset, Alex			Self-Assembly Enters the Design Era	SCIENCE			English	Editorial Material							NANOPARTICLE SUPERLATTICES; BUILDING-BLOCKS; DNA; CRYSTALLIZATION; ORGANIZATION		[Travesset, Alex] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Travesset, Alex] Iowa State Univ, Ames Lab, Ames, IA 50011 USA	Iowa State University; Iowa State University; United States Department of Energy (DOE); Ames National Laboratory	Travesset, A (corresponding author), Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA.	trvsst@ameslab.gov						Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; Jones MR, 2010, NAT MATER, V9, P913, DOI [10.1038/NMAT2870, 10.1038/nmat2870]; Knorowski C, 2011, CURR OPIN SOLID ST M, V15, P262, DOI 10.1016/j.cossms.2011.07.002; Knorowski C, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.215501; Kumar SK, 2010, ANNU REV CHEM BIOMOL, V1, P37, DOI 10.1146/annurev-chembioeng-073009-100856; Macfarlane RJ, 2011, SCIENCE, V334, P204, DOI 10.1126/science.1210493; Macfarlane RJ, 2009, P NATL ACAD SCI USA, V106, P10493, DOI 10.1073/pnas.0900630106; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; Sknepnek R, 2008, ACS NANO, V2, P1259, DOI 10.1021/nn8001449; Tkachenko AV, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.255501; Valignat MP, 2005, P NATL ACAD SCI USA, V102, P4225, DOI 10.1073/pnas.0500507102	16	28	28	1	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					183	184		10.1126/science.1213070	http://dx.doi.org/10.1126/science.1213070			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998375				2022-12-28	WOS:000295833600031
J	Ungar, PS; Sponheimer, M				Ungar, Peter S.; Sponheimer, Matt			The Diets of Early Hominins	SCIENCE			English	Review							DENTAL MICROWEAR; AUSTRALOPITHECUS-ANAMENSIS; PARANTHROPUS-BOISEI; ISOTOPIC EVIDENCE; EVOLUTION; ECOLOGY; HOMO; STERKFONTEIN; BIOMECHANICS; VARIABILITY	Diet changes are considered key events in human evolution. Most studies of early hominin diets focused on tooth size, shape, and craniomandibular morphology, as well as stone tools and butchered animal bones. However, in recent years, dental microwear and stable isotope analyses have hinted at unexpected diversity and complexity in early hominin diets. Some traditional ideas have held; others, such as an increasing reliance on hard-object feeding and a dichotomy between Australopithecus and Paranthropus, have been challenged. The first known evidence of C-4 plant (tropical grasses and sedges) and hard-object (e.g., seeds and nuts) consumption dates to millions of years after the appearance of the earliest probable hominins, and there are no consistent trends in diet change among these species through time.	[Ungar, Peter S.] Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA; [Sponheimer, Matt] Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Colorado System; University of Colorado Boulder	Ungar, PS (corresponding author), Univ Arkansas, Dept Anthropol, Fayetteville, AR 72701 USA.	pungar@uark.edu; msponheimer@gmail.com	Sponheimer, Matt/A-6075-2013	Sponheimer, Matt/0000-0002-8743-1123	NSF; Leakey Foundation; Wenner-Gren Foundation	NSF(National Science Foundation (NSF)); Leakey Foundation; Wenner-Gren Foundation	Supported by NSF, the Leakey Foundation, and the Wenner-Gren Foundation. We thank C. Campbell, J. Leichliter, O. Paine, Y. Rahman, C. Ross, and P. Sandberg for comments; T. Cerling, D. Codron, D. de Ruiter, F. Grine, J. Lee-Thorp, R. Scott, M. Teaford, and N. van der Merwe for discussions over the years; and D. de Ruiter for the image of SK 1. All raw data referred to in this paper are published in (21-24, 34-38, 49).	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; BEYNON AD, 1986, AM J PHYS ANTHROPOL, V70, P177, DOI 10.1002/ajpa.1330700205; Bobe R, 2006, J ARID ENVIRON, V66, P564, DOI 10.1016/j.jaridenv.2006.01.010; Cerling TE, 1999, OECOLOGIA, V120, P364, DOI 10.1007/s004420050869; Cerling TE, 2011, P NATL ACAD SCI USA, V108, P9337, DOI 10.1073/pnas.1104627108; DAEGLING DJ, 1991, AM J PHYS ANTHROPOL, V86, P321, DOI 10.1002/ajpa.1330860302; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Dominy NJ, 2008, EVOL BIOL, V35, P159, DOI 10.1007/s11692-008-9026-7; Fleagle JG, 1988, PRIMATE ADAPTATION E; GRINE FE, 1986, J HUM EVOL, V15, P783, DOI 10.1016/S0047-2484(86)80010-0; Grine FE, 2006, S AFR J SCI, V102, P301; Hylander W.L., 1988, P55; JOLLY CJ, 1970, MAN, V5, P5, DOI 10.2307/2798801; Koch PL, 1998, CHEM GEOL, V152, P119, DOI 10.1016/S0009-2541(98)00101-6; Larsen C. S., 1991, HUMAN ORIGINS FOSSIL; Lee-Thorp J, 2000, J HUM EVOL, V39, P565, DOI 10.1006/jhev.2000.0436; LEETHORP JA, 1989, J ARCHAEOL SCI, V16, P585, DOI 10.1016/0305-4403(89)90024-1; LEETHORP JA, 1991, J ARCHAEOL SCI, V18, P343, DOI 10.1016/0305-4403(91)90070-6; LEETHORP JA, 1994, J HUM EVOL, V27, P361, DOI 10.1006/jhev.1994.1050; Lucas P., 2004, DENT FUNCTIONAL MORP; MCGREW WC, 1981, J HUM EVOL, V10, P227, DOI 10.1016/S0047-2484(81)80061-9; McHenry HM, 2000, ANNU REV ANTHROPOL, V29, P125, DOI 10.1146/annurev.anthro.29.1.125; McPherron SP, 2010, NATURE, V466, P857, DOI 10.1038/nature09248; Milton K, 1999, EVOL ANTHROPOL, V8, P11, DOI 10.1002/(SICI)1520-6505(1999)8:1<11::AID-EVAN6>3.3.CO;2-D; RODMAN PS, 1980, AM J PHYS ANTHROPOL, V52, P103, DOI 10.1002/ajpa.1330520113; Schoeninger MJ, 1999, AM J PRIMATOL, V49, P297, DOI 10.1002/(SICI)1098-2345(199912)49:4<297::AID-AJP2>3.0.CO;2-N; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Semaw S, 2000, J ARCHAEOL SCI, V27, P1197, DOI 10.1006/jasc.1999.0592; SOLOUNIAS N, 1988, PALEOBIOLOGY, V14, P287, DOI 10.1017/S009483730001201X; Sponheimer M, 2006, J HUM EVOL, V51, P128, DOI 10.1016/j.jhevol.2006.02.002; Sponheimer M, 2005, J HUM EVOL, V48, P301, DOI 10.1016/j.jhevol.2004.11.008; Sponheimer M, 2006, SCIENCE, V314, P980, DOI 10.1126/science.1133827; Strait DS, 2009, P NATL ACAD SCI USA, V106, P2124, DOI 10.1073/pnas.0808730106; Suwa G, 2009, SCIENCE, V326, P94, DOI 10.1126/science.1175824; TEAFORD MF, 1992, AM J PHYS ANTHROPOL, V88, P347, DOI 10.1002/ajpa.1330880308; Teaford MF, 2000, P NATL ACAD SCI USA, V97, P13506, DOI 10.1073/pnas.260368897; TEAFORD MF, 1988, AM J PHYS ANTHROPOL, V75, P279; Ungar P, 2004, J HUM EVOL, V46, P605, DOI 10.1016/j.jhevol.2004.03.004; Ungar P.S., 2010, MAMMAL TEETH ORIGIN; Ungar PS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002044; Ungar PS, 2006, ANNU REV ANTHROPOL, V35, P209, DOI 10.1146/annurev.anthro.35.081705.123153; Ungar PS, 2012, J HUM EVOL, V63, P429, DOI 10.1016/j.jhevol.2011.04.006; Ungar PS, 2010, PHILOS T R SOC B, V365, P3345, DOI 10.1098/rstb.2010.0033; Ungar PS, 2009, FRONT ORAL BIOL, V13, P38, DOI 10.1159/000242388; van der Merwe NJ, 2008, S AFR J SCI, V104, P153; van der Merwe NJ, 2003, J HUM EVOL, V44, P581, DOI 10.1016/S0047-2484(03)00050-2; White TD, 2009, SCIENCE, V326, P87, DOI 10.1126/science.1175822; Wood B, 2007, YEARB PHYS ANTHROPOL, V50, P106, DOI 10.1002/ajpa.20732; Wood B, 2008, J ANAT, V212, P354, DOI 10.1111/j.1469-7580.2008.00871.x	50	164	171	2	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2011	334	6053					190	193		10.1126/science.1207701	http://dx.doi.org/10.1126/science.1207701			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	832UI	21998380				2022-12-28	WOS:000295833600036
J	Zhu, XB; Saito, S; Kemp, A; Kakuyanagi, K; Karimoto, S; Nakano, H; Munro, WJ; Tokura, Y; Everitt, MS; Nemoto, K; Kasu, M; Mizuochi, N; Semba, K				Zhu, Xiaobo; Saito, Shiro; Kemp, Alexander; Kakuyanagi, Kosuke; Karimoto, Shin-ichi; Nakano, Hayato; Munro, William J.; Tokura, Yasuhiro; Everitt, Mark S.; Nemoto, Kae; Kasu, Makoto; Mizuochi, Norikazu; Semba, Kouichi			Coherent coupling of a superconducting flux qubit to an electron spin ensemble in diamond	NATURE			English	Article							QUANTUM STATE; CAVITY; DYNAMICS	During the past decade, research into superconducting quantum bits (qubits) based on Josephson junctions has made rapid progress(1). Many foundational experiments have been performed(2-8), and superconducting qubits are now considered one of the most promising systems for quantum information processing. However, the experimentally reported coherence times are likely to be insufficient for future large-scale quantum computation. A natural solution to this problem is a dedicated engineered quantum memory based on atomic and molecular systems. The question of whether coherent quantum coupling is possible between such natural systems and a single macroscopic artificial atom has attracted considerable attention(9-12) since the first demonstration of macroscopic quantum coherence in Josephson junction circuits(2). Here we report evidence of coherent strong coupling between a single macroscopic superconducting artificial atom (a flux qubit) and an ensemble of electron spins in the form of nitrogen-vacancy colour centres in diamond. Furthermore, we have observed coherent exchange of a single quantum of energy between a flux qubit and a macroscopic ensemble consisting of about 3 x 10(7) such colour centres. This provides a foundation for future quantum memories and hybrid devices coupling microwave and optical systems.	[Zhu, Xiaobo; Saito, Shiro; Kemp, Alexander; Kakuyanagi, Kosuke; Karimoto, Shin-ichi; Nakano, Hayato; Munro, William J.; Tokura, Yasuhiro; Kasu, Makoto; Semba, Kouichi] NTT Corp, NTT Basic Res Labs, Kanagawa 2430198, Japan; [Everitt, Mark S.; Nemoto, Kae] Res Org Informat & Syst, Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan; [Mizuochi, Norikazu] Osaka Univ, Grad Sch Engn Sci, Osaka 5608531, Japan; [Mizuochi, Norikazu] PRESTO JST, Kawaguchi, Saitama 3320012, Japan	Nippon Telegraph & Telephone Corporation; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; Osaka University; Japan Science & Technology Agency (JST)	Semba, K (corresponding author), NTT Corp, NTT Basic Res Labs, 3-1 Morinosato Wakamiya, Kanagawa 2430198, Japan.	semba.kouichi@lab.ntt.co.jp	Nemoto, Kae/A-8833-2011; Munro, William/A-8453-2011; Tokura, Yasuhiro/A-5550-2011; MIZUOCHI, Norikazu/I-4199-2014; Kasu, Makoto/N-4118-2018; Saito, Shiro/C-1848-2018; Semba, Kouichi/B-3638-2016	Munro, William/0000-0003-1835-2250; Tokura, Yasuhiro/0000-0001-6656-4237; MIZUOCHI, Norikazu/0000-0003-3099-3210; Kasu, Makoto/0000-0002-0881-9454; Everitt, Mark Stanley/0000-0003-2142-4438	Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST); MEXT [18001002]; Japanese Society for the Promotion of Science (JSPS) [22102502, 22241025]; Grants-in-Aid for Scientific Research [21102002, 22241025] Funding Source: KAKEN	Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Tawara, H. Gotoh and T. Sogawa for optical measurements at an early stage of this work. We also thank H. Tanji, Y. Matsuzaki, S. J. Devitt, J. Schmiedmayer and J. E. Mooij for discussions. This work was supported in part by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST), Scientific Research of Specially Promoted Research (grant no. 18001002) by MEXT, a Grant-in-Aid for Scientific Research on Innovative Areas (grant no. 22102502), and Scientific Research (A) grant no. 22241025 from the Japanese Society for the Promotion of Science (JSPS). M. S. E. was supported by a JSPS fellowship.	Amsuss R, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.060502; Ansmann M, 2009, NATURE, V461, P504, DOI 10.1038/nature08363; Brune M, 1996, PHYS REV LETT, V76, P1800, DOI 10.1103/PhysRevLett.76.1800; Chiorescu I, 2003, SCIENCE, V299, P1869, DOI 10.1126/science.1081045; Chiorescu I, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.024413; Clarke J, 2008, NATURE, V453, P1031, DOI 10.1038/nature07128; DiCarlo L, 2009, NATURE, V460, P240, DOI 10.1038/nature08121; Fedorov A, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.060503; Gruber A, 1997, SCIENCE, V276, P2012, DOI 10.1126/science.276.5321.2012; Hanson R, 2008, SCIENCE, V320, P352, DOI 10.1126/science.1155400; Jelezko F, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.076401; Johansson J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.127006; Kubo Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.140502; Kurtsiefer C, 2000, PHYS REV LETT, V85, P290, DOI 10.1103/PhysRevLett.85.290; Majer J, 2007, NATURE, V449, P443, DOI 10.1038/nature06184; Marcos D, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.210501; Mizuochi N, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.041201; Mooij JE, 1999, SCIENCE, V285, P1036, DOI 10.1126/science.285.5430.1036; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; Naydenov B, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3409221; Neumann P, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/1/013017; RAIZEN MG, 1989, PHYS REV LETT, V63, P240, DOI 10.1103/PhysRevLett.63.240; Schuster DI, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.140501; Sillanpaa MA, 2007, NATURE, V449, P438, DOI 10.1038/nature06124; Sorensen AS, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.063601; Tian L, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.247902; Vion D, 2002, SCIENCE, V296, P886, DOI 10.1126/science.1069372; Wu H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.140503; Zhu XB, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3486472	30	336	339	0	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 13	2011	478	7368					221	224		10.1038/nature10462	http://dx.doi.org/10.1038/nature10462			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21993757	Green Submitted			2022-12-28	WOS:000295782800045
J	Iheanacho, I				Iheanacho, Ike			DRUG TALES AND OTHER STORIES Ink spots: are tattoos useful?	BRITISH MEDICAL JOURNAL			English	Editorial Material																		2011, BRIT MED J, V343, pD5528, DOI DOI 10.1136/BMJ.D5528	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 11	2011	343								d6455	10.1136/bmj.d6455	http://dx.doi.org/10.1136/bmj.d6455			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835EJ	21990151				2022-12-28	WOS:000296017500007
J	Chernew, M; Goldman, D; Axeen, S				Chernew, Michael; Goldman, Dana; Axeen, Sarah			How Much Savings Can We Wring from Medicare?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chernew, Michael] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Goldman, Dana; Axeen, Sarah] Univ So Calif, Leonard D Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA; [Goldman, Dana] RAND Corp, Santa Monica, CA 90406 USA	Harvard University; Harvard Medical School; University of Southern California; RAND Corporation	Chernew, M (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.		Goldman, Dana P/E-7667-2013	Goldman, Dana P/0000-0001-8498-6396	NATIONAL INSTITUTE ON AGING [P30AG024968] Funding Source: NIH RePORTER; NIA NIH HHS [P30 AG024968, P30 AG043073] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Liu C F, 2001, J Health Care Finance, V27, P39; Medicare Payment Advisory Commission, 2009, REP C IMPR INC MED P; MARCH 2011 MEDICARE	3	10	10	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 6	2011	365	14								10.1056/NEJMp1110593	http://dx.doi.org/10.1056/NEJMp1110593			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829KL	21991979	Green Accepted			2022-12-28	WOS:000295578700005
J	Orvedahl, A; Sumpter, R; Xiao, GH; Ng, A; Zou, ZJ; Tang, Y; Narimatsu, M; Gilpin, C; Sun, QH; Roth, M; Forst, CV; Wrana, JL; Zhang, YE; Luby-Phelps, K; Xavier, RJ; Xie, Y; Levine, B				Orvedahl, Anthony; Sumpter, Rhea, Jr.; Xiao, Guanghua; Ng, Aylwin; Zou, Zhongju; Tang, Yi; Narimatsu, Masahiro; Gilpin, Christopher; Sun, Qihua; Roth, Michael; Forst, Christian V.; Wrana, Jeffrey L.; Zhang, Ying E.; Luby-Phelps, Katherine; Xavier, Ramnik J.; Xie, Yang; Levine, Beth			Image-based genome-wide siRNA screen identifies selective autophagy factors	NATURE			English	Article							UBIQUITIN LIGASE; DEGRADATION; P62/SQSTM1; MITOPHAGY; PROTEIN; SYSTEM; PARKIN; VDAC1	Selective autophagy involves the recognition and targeting of specific cargo, such as damaged organelles, misfolded proteins, or invading pathogens for lysosomal destruction(1-4). Yeast genetic screens have identified proteins required for different forms of selective autophagy, including cytoplasm-to-vacuole targeting, pexophagy and mitophagy, and mammalian genetic screens have identified proteins required for autophagy regulation(5). However, there have been no systematic approaches to identify molecular determinants of selective autophagy in mammalian cells. Here, to identify mammalian genes required for selective autophagy, we performed a high-content, image-based, genome-wide small interfering RNA screen to detect genes required for the colocalization of Sindbis virus capsid protein with autophagolysosomes. We identified 141 candidate genes required for viral autophagy, which were enriched for cellular pathways related to messenger RNA processing, interferon signalling, vesicle trafficking, cytoskeletal motor function and metabolism. Ninety-six of these genes were also required for Parkin-mediated mitophagy, indicating that common molecular determinants may be involved in autophagic targeting of viral nucleocapsids and autophagic targeting of damaged mitochondria. Murine embryonic fibroblasts lacking one of these gene products, the C2-domain containing protein, SMURF1, are deficient in the autophagosomal targeting of Sindbis and herpes simplex viruses and in the clearance of damaged mitochondria. Moreover, SMURF1-deficient mice accumulate damaged mitochondria in the heart, brain and liver. Thus, our study identifies candidate determinants of selective autophagy, and defines SMURF1 as a newly recognized mediator of both viral autophagy and mitophagy.	[Orvedahl, Anthony; Sumpter, Rhea, Jr.; Zou, Zhongju; Sun, Qihua; Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Orvedahl, Anthony; Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Sumpter, Rhea, Jr.; Zou, Zhongju; Sun, Qihua; Levine, Beth] Univ Texas SW Med Ctr Dallas, Ctr Autophagy Res, Dallas, TX 75390 USA; [Xiao, Guanghua; Forst, Christian V.; Xie, Yang] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Ng, Aylwin; Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Ng, Aylwin; Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA; [Ng, Aylwin; Xavier, Ramnik J.] Broad Inst Harvard, Cambridge, MA 02142 USA; [Ng, Aylwin; Xavier, Ramnik J.] MIT, Cambridge, MA 02142 USA; [Zou, Zhongju; Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Tang, Yi; Zhang, Ying E.] NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Narimatsu, Masahiro; Wrana, Jeffrey L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Gilpin, Christopher; Luby-Phelps, Katherine] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Roth, Michael] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Roth, Michael; Xie, Yang; Levine, Beth] Univ Texas SW Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Wrana, Jeffrey L.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Toronto	Levine, B (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	beth.levine@utsouthwestern.edu	Wrana, Jeffrey/F-8857-2013; Ng, Aylwin/AAQ-6478-2020; Sumpter, Jr., Rhea/N-8152-2018; Zhang, Ying E/G-3657-2015	Zhang, Ying E/0000-0003-2753-7601; Luby-Phelps, Katherine/0000-0002-8378-1409; Roth, Michael/0000-0002-9056-332X; Forst, Christian/0000-0003-0229-9459	NIH [AI109617, CA84254, UL1 RR024982, AI062773, DK83756, DK086502, DK043351]; NSF [DMS-0907562]; Center for Cancer Research, National Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA084254, ZIABC011168] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062773, R01AI051367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, RC1DK086502, R01DK083756, P30DK043351] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Vishwanath, S. Wei and B. Posner for assistance with high-throughput siRNA screening; W. Sun for information technology support; K. Scudder for assistance with image analysis algorithms; A. Diehl for expert medical illustration; V. Stollar, M. McDonald, R. Kuhn and R. Youle for helpful discussions and providing reagents; A. Bugde for assistance in the UTSW Live Cell Imaging Facility; and L. Mueller and T. Januszewski for assistance with electron microscopy. This work was supported by NIH grants AI109617 (B. L.), CA84254 (B. L.), UL1 RR024982 (G. X., Y.X.), AI062773 (R.J.X.), DK83756 (R.J.X.), DK086502 (R.J.X.) and DK043351 (R.J.X. and A.N.); NSF grant DMS-0907562 (G. X.); and the Center for Cancer Research, National Cancer Institute Intramural Research Program (Y.E.Z.).	Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Komatsu M, 2010, GENES CELLS, V15, P923, DOI 10.1111/j.1365-2443.2010.01433.x; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; Longatti A, 2009, CELL DEATH DIFFER, V16, P956, DOI 10.1038/cdd.2009.39; Lu KF, 2011, J BIOL CHEM, V286, P16861, DOI 10.1074/jbc.M110.211979; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Monastyrska I, 2009, BIOL REV, V84, P431, DOI 10.1111/j.1469-185X.2009.00082.x; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Xing LP, 2010, J CELL BIOCHEM, V110, P554, DOI 10.1002/jcb.22586; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035	25	363	377	2	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 1	2011	480	7375					113	117		10.1038/nature10546	http://dx.doi.org/10.1038/nature10546			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22020285	Green Accepted			2022-12-28	WOS:000298031900045
J	Conway, PH; Berwick, DM				Conway, Patrick H.; Berwick, Donald M.			Improving the Rules for Hospital Participation in Medicare and Medicaid	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Conway, Patrick H.; Berwick, Donald M.] Ctr Medicare Serv, Baltimore, MD 21244 USA; [Conway, Patrick H.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Conway, Patrick H.; Berwick, Donald M.] Ctr Medicaid Serv, Baltimore, MD 21244 USA	Centers for Medicare & Medicaid Services; Cincinnati Children's Hospital Medical Center; Centers for Medicare & Medicaid Services	Conway, PH (corresponding author), Ctr Medicare Serv, Mailstop S3-02-01,7500 Secur Blvd, Baltimore, MD 21244 USA.	Patrick.Conway@cms.hhs.gov						US Centers for Medicare & Medicaid Services, PROP RUL; US Centers for Medicare & Medicaid Services, ACCR STAND	2	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 23	2011	306	20					2256	2257		10.1001/jama.2011.1611	http://dx.doi.org/10.1001/jama.2011.1611			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851GD	22008181				2022-12-28	WOS:000297255500025
J	Greer, EL; Maures, TJ; Ucar, D; Hauswirth, AG; Mancini, E; Lim, JP; Benayoun, BA; Shi, Y; Brunet, A				Greer, Eric L.; Maures, Travis J.; Ucar, Duygu; Hauswirth, Anna G.; Mancini, Elena; Lim, Jana P.; Benayoun, Berenice A.; Shi, Yang; Brunet, Anne			Transgenerational epigenetic inheritance of longevity in Caenorhabditis elegans	NATURE			English	Article							SYSTEMATIC RNAI SCREEN; LIFE-SPAN; C. ELEGANS; H3K4 TRIMETHYLATION; STRESS RESISTANCE; GENES; COMPLEX; METHYLATION; DEMETHYLATION; CHROMATIN	Chromatin modifiers regulate lifespan in several organisms, raising the question of whether changes in chromatin states in the parental generation could be incompletely reprogrammed in the next generation and thereby affect the lifespan of descendants. The histone H3 lysine 4 trimethylation (H3K4me3) complex, composed of ASH-2, WDR-5 and the histone methyltransferase SET-2, regulates Caenorhabditis elegans lifespan. Here we show that deficiencies in the H3K4me3 chromatin modifiers ASH-2, WDR-5 or SET-2 in the parental generation extend the lifespan of descendants up until the third generation. The transgenerational inheritance of lifespan extension by members of the ASH-2 complex is dependent on the H3K4me3 demethylase RBR-2, and requires the presence of a functioning germline in the descendants. Transgenerational inheritance of lifespan is specific for the H3K4me3 methylation complex and is associated with epigenetic changes in gene expression. Thus, manipulation of specific chromatin modifiers only in parents can induce an epigenetic memory of longevity in descendants.	[Greer, Eric L.; Maures, Travis J.; Ucar, Duygu; Hauswirth, Anna G.; Mancini, Elena; Lim, Jana P.; Benayoun, Berenice A.; Brunet, Anne] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Greer, Eric L.; Shi, Yang] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Greer, Eric L.; Shi, Yang] Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA	Stanford University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Brunet, A (corresponding author), Stanford Univ, Dept Genet, 300 Pasteur Dr, Stanford, CA 94305 USA.	anne.brunet@stanford.edu	Benayoun, Bérénice A./K-7048-2012	Benayoun, Bérénice A./0000-0002-7401-4777; Ucar, Duygu/0000-0002-9772-3066; Greer, Eric/0000-0002-7501-7371	NIH [R01-AG31198, ARRA-AG31198, R01-GM058012, F32-AG037254, T32-MH020016]; NSF; Helen Hay Whitney Post-Doctoral fellowship;  [T32-CA009361]; NATIONAL CANCER INSTITUTE [T32CA009361, T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG031198, R01AG031198, F32AG037254] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Helen Hay Whitney Post-Doctoral fellowship; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to J. Lieb, A. Rechtsteiner and S. Strome for sharing their ModENCODE data pre-publication and for helpful discussion. We thank K. Shen, M. W. Tan and T. Stiernagle and the Caenorhabditis Genetics Center for gifts of strains and reagents. We thank B. Meyer for her gift of the ASH-2 antibody. We thank A. Fire, S. Kim, J. Sage, S. Iwase, J. Lipsick, E. Pollina, A. Villeneuve and members of the Brunet lab for discussions and critical reading of the manuscript. We thank S. Han for screening different H3K4me3 antibodies for western blots in worm extracts. We thank R. Liefke and H. Tang for help with microarray analysis. This work was supported by NIH R01-AG31198 grant and by a generous gift from the Glenn Foundation for Medical Research to A. B.; E. L. G. was supported by an NSF graduate fellowship, by NIH ARRA-AG31198, by T32-CA009361, by a Helen Hay Whitney Post-Doctoral fellowship, and by a NIH R01-GM058012 (to Y.S.). T. J. M. was supported by NIH F32-AG037254. J. P. L. was supported by NIH T32-MH020016.	Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; BRINK RA, 1956, GENETICS, V41, P872; Buck MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r97; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; Chen S, 2009, P NATL ACAD SCI USA, V106, P1496, DOI 10.1073/pnas.0802674106; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Fisher K, 2010, DEV BIOL, V341, P142, DOI 10.1016/j.ydbio.2010.02.023; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195; Haag ES, 2002, CURR BIOL, V12, P2035, DOI 10.1016/S0960-9822(02)01333-7; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Jin CY, 2011, CELL METAB, V14, P161, DOI 10.1016/j.cmet.2011.07.001; Katz DJ, 2009, CELL, V137, P308, DOI 10.1016/j.cell.2009.02.015; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim Y, 2007, AGING CELL, V6, P489, DOI 10.1111/j.1474-9726.2007.00302.x; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Li TG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001349; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Martin C, 2007, CURR OPIN CELL BIOL, V19, P266, DOI 10.1016/j.ceb.2007.04.002; Maures TJ, 2011, AGING CELL, V10, P980, DOI 10.1111/j.1474-9726.2011.00738.x; McColl G, 2008, J BIOL CHEM, V283, P350, DOI 10.1074/jbc.M705028200; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Muramoto T, 2010, CURR BIOL, V20, P397, DOI 10.1016/j.cub.2010.01.017; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pferdehirt RR, 2011, GENE DEV, V25, P499, DOI 10.1101/gad.2016011; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Seong KH, 2011, CELL, V145, P1049, DOI 10.1016/j.cell.2011.05.029; Siebold AP, 2010, P NATL ACAD SCI USA, V107, P169, DOI 10.1073/pnas.0907739107; Simonet T, 2007, DEV BIOL, V312, P367, DOI 10.1016/j.ydbio.2007.09.035; Spencer WC, 2011, GENOME RES, V21, P325, DOI 10.1101/gr.114595.110; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Takahashi Y, 2011, CELL METAB, V13, P505, DOI 10.1016/j.cmet.2011.03.017; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Woodhouse MR, 2006, PLOS BIOL, V4, P1678, DOI 10.1371/journal.pbio.0040339; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xiao Y, 2011, P NATL ACAD SCI USA, V108, P8305, DOI 10.1073/pnas.1019290108	45	418	441	7	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 17	2011	479	7373					365	U204		10.1038/nature10572	http://dx.doi.org/10.1038/nature10572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	848OA	22012258	Green Accepted			2022-12-28	WOS:000297059700038
J	Lange, J; Pan, J; Cole, F; Thelen, MP; Jasin, M; Keeney, S				Lange, Julian; Pan, Jing; Cole, Francesca; Thelen, Michael P.; Jasin, Maria; Keeney, Scott			ATM controls meiotic double-strand-break formation	NATURE			English	Article							MOUSE SPERMATOCYTES; CHROMOSOME SYNAPSIS; PROPHASE ARREST; RECOMBINATION; MICE; SURVEILLANCE; DEFECTS; SPO11; GENE; PHOSPHORYLATION	In many organisms, developmentally programmed double-strand breaks (DSBs) formed by the SPO11 transesterase initiate meiotic recombination, which promotes pairing and segregation of homologous chromosomes(1). Because every chromosome must receive a minimum number of DSBs, attention has focused on factors that support DSB formation(2). However, improperly repaired DSBs can cause meiotic arrest or mutation(3,4); thus, having too many DSBs is probably as deleterious as having too few. Only a small fraction of SPO11 protein ever makes a DSB in yeast or mouse(5) and SPO11 and its accessory factors remain abundant long after most DSB formation ceases(1), implying the existence of mechanisms that restrain SPO11 activity to limit DSB numbers. Here we report that the number of meiotic DSBs in mouse is controlled by ATM, a kinase activated by DNA damage to trigger checkpoint signalling and promote DSB repair. Levels of SPO11-oligonucleotide complexes, by-products of meiotic DSB formation, are elevated at least tenfold in spermatocytes lacking ATM. Moreover, Atm mutation renders SPO11-oligonucleotide levels sensitive to genetic manipulations that modulate SPO11 protein levels. We propose that ATM restrains SPO11 via a negative feedback loop in which kinase activation by DSBs suppresses further DSB formation. Our findings explain previously puzzling phenotypes of Atm-null mice and provide a molecular basis for the gonadal dysgenesis observed in ataxia telangiectasia, the human syndrome caused by ATM deficiency.	[Lange, Julian; Pan, Jing; Keeney, Scott] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Cole, Francesca; Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Thelen, Michael P.] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA; [Keeney, Scott] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Keeney, S (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA.	m-jasin@ski.mskcc.org; s-keeney@ski.mskcc.org	Keeney, Scott/GVR-8515-2022; Thelen, Michael/C-6834-2008; Thelen, Michael P/G-2032-2014	Thelen, Michael/0000-0002-2479-5480; Thelen, Michael P/0000-0002-2479-5480; Cole, Francesca/0000-0001-6391-2363; Keeney, Scott/0000-0002-1283-6417	NIH [HD040916, HD053855, GM058673]; Leukemia and Lymphoma Society; Ruth L. Kirschstein NRSA [F32HD51392]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD053855] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058673] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Ruth L. Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Neale for discussions, R. Cha and K. McKim for sharing data before publication, and M. Hwang for assistance in monoclonal antibody development. This work was supported by NIH grants HD040916 and HD053855 (to M.J. and S. K.) and GM058673 (to S. K.). J.P. was supported in part by a Leukemia and Lymphoma Society Fellowship and F. C. by a Ruth L. Kirschstein NRSA (F32HD51392). S. K. is an Investigator of the Howard Hughes Medical Institute.	Barchi M, 2005, MOL CELL BIOL, V25, P7203, DOI 10.1128/MCB.25.16.7203-7215.2005; Barchi M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000076; Barlow C, 1998, DEVELOPMENT, V125, P4007; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Bellani MA, 2005, J CELL SCI, V118, P3233, DOI 10.1242/jcs.02466; Bellani MA, 2010, MOL CELL BIOL, V30, P4391, DOI 10.1128/MCB.00002-10; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Cole F, 2010, GENE DEV, V24, P1201, DOI 10.1101/gad.1944710; Daniel K, 2011, NAT CELL BIOL, V13, P599, DOI 10.1038/ncb2213; Di Giacomo M, 2005, P NATL ACAD SCI USA, V102, P737, DOI 10.1073/pnas.0406212102; Eaker S, 2002, DEV BIOL, V249, P85, DOI 10.1006/dbio.2002.0708; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Hochwagen A, 2006, CURR BIOL, V16, pR217, DOI 10.1016/j.cub.2006.03.009; Kauppi L, 2011, SCIENCE, V331, P916, DOI 10.1126/science.1195774; Keeney S, 1999, GENOMICS, V61, P170, DOI 10.1006/geno.1999.5956; Keeney Scott, 2008, V2, P81, DOI 10.1007/7050_2007_026; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Romanienko PJ, 1999, GENOMICS, V61, P156, DOI 10.1006/geno.1999.5955; Sasaki M, 2010, NAT REV MOL CELL BIO, V11, P182, DOI 10.1038/nrm2849; Sasanuma H, 2008, GENE DEV, V22, P398, DOI 10.1101/gad.1626608; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Sedgwick R, 1991, HDB CLIN NEUROLOGY, P347; Shannon M, 1999, FEBS LETT, V462, P329, DOI 10.1016/S0014-5793(99)01546-X; Terasawa M, 2008, GENES GENET SYST, V83, P209, DOI 10.1266/ggs.83.209; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411	30	172	173	3	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2011	479	7372					237	U117		10.1038/nature10508	http://dx.doi.org/10.1038/nature10508			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PD	22002603	Green Accepted			2022-12-28	WOS:000298030800044
J	Kakuma, R; Minas, H; van Ginneken, N; Dal Poz, MR; Desiraju, K; Morris, JE; Saxena, S; Scheffler, RM				Kakuma, Ritsuko; Minas, Harry; van Ginneken, Nadja; Dal Poz, Mario R.; Desiraju, Keshav; Morris, Jodi E.; Saxena, Shekhar; Scheffler, Richard M.			Global Mental Health 5 Human resources for mental health care: current situation and strategies for action	LANCET			English	Article							RANDOMIZED-CONTROLLED-TRIAL; MIDDLE-INCOME COUNTRIES; PSYCHOEDUCATIONAL INTERVENTION; RURAL INDIA; COMMUNITY; SCHIZOPHRENIA; DEPRESSION; PSYCHIATRY; CAREGIVERS; DISORDERS	A challenge faced by many countries is to provide adequate human resources for delivery of essential mental health interventions. The overwhelming worldwide shortage of human resources for mental health, particularly in low-income and middle-income countries, is well established. Here, we review the current state of human resources for mental health, needs, and strategies for action. At present, human resources for mental health in countries of low and middle income show a serious shortfall that is likely to grow unless effective steps are taken. Evidence suggests that mental health care can be delivered effectively in primary health-care settings, through community-based programmes and task-shifting approaches. Non-specialist health professionals, lay workers, affected individuals, and caregivers with brief training and appropriate supervision by mental health specialists are able to detect, diagnose, treat, and monitor individuals with mental disorders and reduce caregiver burden. We also discuss scale-up costs, human resources management, and leadership for mental health, particularly within the context of low-income and middle-income countries.	[Kakuma, Ritsuko; Minas, Harry] Univ Melbourne, Melbourne Sch Populat Hlth, Ctr Int Mental Hlth, Melbourne, Vic, Australia; [Kakuma, Ritsuko] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Kakuma, Ritsuko] Univ Toronto, Toronto, ON, Canada; [van Ginneken, Nadja] London Sch Hyg & Trop Med, London WC1, England; [Dal Poz, Mario R.] WHO, Dept Human Resources Hlth, CH-1211 Geneva, Switzerland; [Morris, Jodi E.; Saxena, Shekhar] WHO, Dept Mental Hlth & Subst Abuse, CH-1211 Geneva, Switzerland; [Desiraju, Keshav] Govt India, Minist Hlth & Family Welf, New Delhi, India; [Scheffler, Richard M.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of Melbourne; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of London; London School of Hygiene & Tropical Medicine; World Health Organization; World Health Organization; University of California System; University of California Berkeley	Kakuma, R (corresponding author), Level 5,207 Bouverie St, Carlton, Vic 3053, Australia.	ritz.kakuma@gmail.com	, Dal Poz/D-3564-2009; Minas, Harry/O-8276-2019; Minas, Harry/F-7718-2010	, Dal Poz/0000-0002-3005-3280; Minas, Harry/0000-0003-1719-7367; Kakuma, Ritsuko/0000-0002-0196-2100; van Ginneken, Nadja/0000-0002-4843-2617				Adewuya AO, 2007, SOC PSYCH PSYCH EPID, V42, P931, DOI 10.1007/s00127-007-0246-4; AGARWAL SP, 2004, MENTAL HLTH INDIAN P, P119; Alem A, 2010, ACAD PSYCHIATR, V34, P424, DOI 10.1176/appi.ap.34.6.424; [Anonymous], 2005, MENT HLTH POL SERV G; Araya R, 2003, LANCET, V361, P995, DOI 10.1016/S0140-6736(03)12825-5; Assadollahi G A, 2000, East Mediterr Health J, V6, P118; Ball DE, 2000, EPILEPSIA, V41, P1044, DOI 10.1111/j.1528-1157.2000.tb00292.x; Ballester Dinarte Alexandre, 2005, Sao Paulo Med. J., V123, P72, DOI 10.1590/S1516-31802005000200008; Beinecke RH, 2010, INT J LEADERSHIP P S, V6, P63, DOI DOI 10.5042/IJLPS.2010.0575; Bolton P, 2003, JAMA-J AM MED ASSOC, V289, P3117, DOI 10.1001/jama.289.23.3117; Budosan B, 2009, J HUMANITARIAN  0501; Chatterjee S, 2003, BRIT J PSYCHIAT, V182, P57, DOI 10.1192/bjp.182.1.57; Chatterjee S, 2009, BRIT J PSYCHIAT, V195, P433, DOI 10.1192/bjp.bp.108.057596; Chisholm D, 2007, EPIDEMIOL PSICHIAT S, V16, P282, DOI 10.1017/S1121189X0000244X; Chisholm D, 2007, BRIT J PSYCHIAT, V191, P528, DOI 10.1192/bjp.bp.107.038463; Dal Poz Mario R, 2006, Hum Resour Health, V4, P21, DOI 10.1186/1478-4491-4-21; Das M, 2002, PSYCHIATR BULL, V26, P70, DOI DOI 10.1192/PB.26.2.70; Dharmono S, 2005, MENTAL HLTH CONTEXT; Dias A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002333; DOKU V, 2008, PHASE 1 COUNTRY REPO; Fulton BD, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-1; Funk M., 2008, INT MENT HLTH PRIM C; Ganatra HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004620; Gao X, 2010, HEALTH POLICY, V95, P74, DOI 10.1016/j.healthpol.2009.11.004; Gavrilova SI, 2009, INT J GERIATR PSYCH, V24, P347, DOI 10.1002/gps.2126; Ghanizadeh A, 2005, J CHILD ADOLESC MENT, V17, P31, DOI 10.2989/17280580509486590; Government of India Ministry of Health and Family Welfare, 1982, NAT MENT HLTH PROGR; Gureje O, 2009, WORLD PSYCHIATRY, V8, P115; Gutierrez-Maldonado J, 2007, QUAL LIFE RES, V16, P739, DOI 10.1007/s11136-007-9173-9; Gutierrez-Maldonado J, 2009, SOC PSYCH PSYCH EPID, V44, P343, DOI 10.1007/s00127-008-0451-9; Hauff E., 1996, AUSTRALAS PSYCHIATRY, V4, P187, DOI DOI 10.3109/10398569609080486; Irmansyah I, 2010, INT J MENT HEALTH SY, V4, DOI 10.1186/1752-4458-4-8; Jacob KS, 2007, ACTA PSYCHIAT SCAND, V116, P125, DOI 10.1111/j.1600-0447.2006.00923.x; Javadpour A, 2009, INT J GERIATR PSYCH, V24, P469, DOI 10.1002/gps.2138; Jenkins R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009049; Keliat BA, 2005, COMMUNITY MENTAL HLT; KIGOZI FN, 2008, PHASE 1 COUNTRY REPO; Kulhara P, 2009, ACTA PSYCHIAT SCAND, V119, P472, DOI 10.1111/j.1600-0447.2008.01304.x; LMIC filters, 2010, LMIC FILT; Lund C, 2008, MENTAL HLTH POLICY D; Minas Harry, 2005, Australas Psychiatry, V13, P33, DOI 10.1111/j.1440-1665.2004.02147.x; Minas H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-317; Mohit A, 1999, East Mediterr Health J, V5, P373; Murthy RS, 2005, PSYCHOL MED, V35, P341, DOI 10.1017/S0033291704003551; Mwanza J, 2008, PHASE 1 COUNTRY REPO; Ndetei DM, 2008, ACAD PSYCHIATR, V32, P154, DOI 10.1176/appi.ap.32.2.154; Patel V, 2009, PSYCHOL MED, V39, P1759, DOI 10.1017/S0033291709005224; Patel V, 2010, LANCET, V376, P2086, DOI 10.1016/S0140-6736(10)61508-5; Patel VH, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-4; Prasetiyawan, 2006, INT REV PSYCHIATR, V18, P559, DOI 10.1080/09540260601039959; Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2; Ran MS, 2003, SOC PSYCH PSYCH EPID, V38, P69, DOI 10.1007/s00127-003-0601-z; Ranson MK, 2010, B WORLD HEALTH ORGAN, V88, P435, DOI 10.2471/BLT.09.066290; Rojas G, 2007, LANCET, V370, P1629, DOI 10.1016/S0140-6736(07)61685-7; Saraceno B, 2005, WHO RECOMMENDATIONS; Saraceno B, 2007, LANCET, V370, P1164, DOI 10.1016/S0140-6736(07)61263-X; Savin D, 2000, PSYCHIATR SERV, V51, P935, DOI 10.1176/appi.ps.51.7.935; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; Saxena Shekhar, 2003, J Ment Health Policy Econ, V6, P135; Scheffler RM, 2011, HUMAN RESOURCES MENT; Schiffbauer J, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-23; Setiawan GP, 2005, MENTAL HLTH SERVICE; Sherk KE, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-1; Singh B, 2008, INT REV PSYCHIATR, V20, P413, DOI 10.1080/09540260802397362; Skeen S, 2010, INT REV PSYCHIATR, V22, P611, DOI 10.3109/09540261.2010.535510; Tripathy P, 2010, LANCET, V375, P1182, DOI 10.1016/S0140-6736(09)62042-0; WHO, 2001, ATL MENT HLTH RES WO; WHO, 2005, ATL PSYCH ED TRAIN W; Wilczynski Nancy L, 2006, Ann Gen Psychiatry, V5, P4, DOI 10.1186/1744-859X-5-4; Wilczynski NL, 2004, CAN MED ASSOC J, V171, P1179, DOI 10.1503/cmaj.1040512; World Health Organization, 2011, MENT HLTH ATL 2011; World Health Organization, 2005, ATL CHILD AD MENT HL; World Health Organization, 2005, MENT HLTH ATL; World Health Organization, 2016, MHGAP INT GUID MENT; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; XIANG MG, 1994, BRIT J PSYCHIAT, V165, P544, DOI 10.1192/bjp.165.4.544	76	497	501	2	87	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 5	2011	378	9803					1654	1663		10.1016/S0140-6736(11)61093-3	http://dx.doi.org/10.1016/S0140-6736(11)61093-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	844ST	22008420				2022-12-28	WOS:000296768300031
J	Foroughi, J; Spinks, GM; Wallace, GG; Oh, J; Kozlov, ME; Fang, SL; Mirfakhrai, T; Madden, JDW; Shin, MK; Kim, SJ; Baughman, RH				Foroughi, Javad; Spinks, Geoffrey M.; Wallace, Gordon G.; Oh, Jiyoung; Kozlov, Mikhail E.; Fang, Shaoli; Mirfakhrai, Tissaphern; Madden, John D. W.; Shin, Min Kyoon; Kim, Seon Jeong; Baughman, Ray H.			Torsional Carbon Nanotube Artificial Muscles	SCIENCE			English	Article							YARNS; ACTUATORS; ELECTROLYTE; ARRAYS; MOTOR; TUBE	Rotary motors of conventional design can be rather complex and are therefore difficult to miniaturize; previous carbon nanotube artificial muscles provide contraction and bending, but not rotation. We show that an electrolyte-filled twist-spun carbon nanotube yarn, much thinner than a human hair, functions as a torsional artificial muscle in a simple three-electrode electrochemical system, providing a reversible 15,000 degrees rotation and 590 revolutions per minute. A hydrostatic actuation mechanism, as seen in muscular hydrostats in nature, explains the simultaneous occurrence of lengthwise contraction and torsional rotation during the yarn volume increase caused by electrochemical double-layer charge injection. The use of a torsional yarn muscle as a mixer for a fluidic chip is demonstrated.	[Foroughi, Javad; Spinks, Geoffrey M.; Wallace, Gordon G.] Univ Wollongong, Intelligent Polymer Res Inst, ARC Ctr Excellence Electromat Sci, Wollongong, NSW 2522, Australia; [Oh, Jiyoung; Kozlov, Mikhail E.; Fang, Shaoli; Baughman, Ray H.] Univ Texas Dallas, Alan G MacDiarmid Nanotech Inst, Richardson, TX 75083 USA; [Mirfakhrai, Tissaphern; Madden, John D. W.] Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC V6T 1Z4, Canada; [Shin, Min Kyoon; Kim, Seon Jeong] Hanyang Univ, Ctr Bioartificial Muscle, Seoul 133791, South Korea; [Shin, Min Kyoon; Kim, Seon Jeong] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea	University of Wollongong; University of Texas System; University of Texas Dallas; University of British Columbia; Hanyang University; Hanyang University	Spinks, GM (corresponding author), Univ Wollongong, Intelligent Polymer Res Inst, ARC Ctr Excellence Electromat Sci, Wollongong, NSW 2522, Australia.	gspinks@uow.edu.au; ray.baughman@utdallas.edu	Wallace, Gordon G/H-1123-2011; Kim, Seon Jeong/AAR-8127-2021; Spinks, Geoffrey/E-5612-2011; Baughman, Ray/A-8628-2018; Foroughi, Javad/A-1439-2012; Spinks, Geoffrey/T-6363-2019; Madden, John DW/B-8948-2009	Wallace, Gordon G/0000-0002-0381-7273; Kim, Seon Jeong/0000-0002-2867-6737; Spinks, Geoffrey/0000-0003-4656-9473; Baughman, Ray/0000-0001-5845-5137; Foroughi, Javad/0000-0003-1979-5213; Spinks, Geoffrey/0000-0003-4656-9473; Madden, John DW/0000-0002-0014-4712	Air Force Office of Scientific Research [FA9550-09-1-0537]; Air Force [AOARD-10-4067]; Office of Naval Research [N00014-08-1-0654]; Robert A. Welch Foundation [AT-0029]; Creative Research Initiative Center for Bio-Artificial Muscle (Korea); Natural Sciences and Engineering Research Council of Canada; Australian Research Council	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Air Force; Office of Naval Research(Office of Naval Research); Robert A. Welch Foundation(The Welch Foundation); Creative Research Initiative Center for Bio-Artificial Muscle (Korea); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Australian Research Council(Australian Research Council)	Supported by Air Force Office of Scientific Research grant FA9550-09-1-0537, Air Force grant AOARD-10-4067, Office of Naval Research MURI grant N00014-08-1-0654, and Robert A. Welch Foundation grant AT-0029; the Creative Research Initiative Center for Bio-Artificial Muscle (Korea); the Natural Sciences and Engineering Research Council of Canada through a Discovery Grant and Graduate Scholarship (T.M.); and Centre of Excellence funding from the Australian Research Council. We thank K. E. Smith, G. L. Vanderford, and D. Hastie for technical assistance.	Barisci JN, 2003, J ELECTROCHEM SOC, V150, pE409, DOI 10.1149/1.1593045; Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340; Baughman RH, 1998, SCIENCE, V279, P1522, DOI 10.1126/science.279.5356.1522; Chou CP, 1996, IEEE T ROBOTIC AUTOM, V12, P90, DOI 10.1109/70.481753; Conway BE, 2013, ELECTROCHEMICAL SUPE; Demirkoparan H, 2008, J ELASTICITY, V92, P61, DOI 10.1007/s10659-007-9149-6; Fang Y, 2011, IEEE-ASME T MECH, V16, P656, DOI 10.1109/TMECH.2010.2049366; Fennimore AM, 2003, NATURE, V424, P408, DOI 10.1038/nature01823; Hollerbach J., 1991, ROBOTICS REV, P301; Hughes M, 2005, ADV MATER, V17, P443, DOI 10.1002/adma.200401076; Keefe AC, 2000, SMART MATER STRUCT, V9, P665, DOI 10.1088/0964-1726/9/5/311; Kim J, 2001, SMART MATER STRUCT, V10, P750, DOI 10.1088/0964-1726/10/4/320; Li DB, 2009, MRS BULL, V34, P671, DOI 10.1557/mrs2009.179; Li QW, 2006, ADV MATER, V18, P3160, DOI 10.1002/adma.200601344; Lima MD, 2011, SCIENCE, V331, P51, DOI 10.1126/science.1195912; Madden JD, 2007, SCIENCE, V318, P1094, DOI 10.1126/science.1146351; Miao MH, 2010, CARBON, V48, P2802, DOI 10.1016/j.carbon.2010.04.009; Mirfakhrai T, 2007, SMART MATER STRUCT, V16, pS243, DOI 10.1088/0964-1726/16/2/S07; Nakayama Y, 2008, JPN J APPL PHYS, V47, P8149, DOI 10.1143/JJAP.47.8149; Ruch PW, 2009, ELECTROCHIM ACTA, V54, P4451, DOI 10.1016/j.electacta.2009.03.022; Smith K.K., 1989, American Scientist, V77, P28; Sowa Y, 2008, Q REV BIOPHYS, V41, P103, DOI 10.1017/S0033583508004691; Trivedi Deepak, 2008, Applied Bionics and Biomechanics, V5, P99, DOI 10.1080/11762320802557865; Ue M, 2002, J ELECTROCHEM SOC, V149, pA1385, DOI 10.1149/1.1507593; Xiao L, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2909593; Yun Y, 2006, NANO LETT, V6, P689, DOI 10.1021/nl052435w; Zhang M, 2004, SCIENCE, V306, P1358, DOI 10.1126/science.1104276; Zhang S, 2008, J MATER SCI, V43, P4356, DOI 10.1007/s10853-008-2558-5; Zhang XB, 2006, ADV MATER, V18, P1505, DOI 10.1002/adma.200502528	29	409	424	43	688	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 28	2011	334	6055					494	497		10.1126/science.1211220	http://dx.doi.org/10.1126/science.1211220			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837UR	21998253				2022-12-28	WOS:000296230500042
J	Jacob, Z; Shalaev, VM				Jacob, Zubin; Shalaev, Vladimir M.			Plasmonics Goes Quantum	SCIENCE			English	Editorial Material							METAMATERIALS		[Jacob, Zubin] Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB T5K2M3, Canada; [Shalaev, Vladimir M.] Purdue Univ, Dept Elect & Comp Engn, Birck Nanotechnol Ctr, W Lafayette, IN 47906 USA	University of Alberta; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Jacob, Z (corresponding author), Univ Alberta, Dept Elect & Comp Engn, Edmonton, AB T5K2M3, Canada.	zjacob@ualberta.ca; shalaev@purdue.edu	Shalaev, Vladimir M./B-9331-2019; jacob, zubin/ABF-2665-2020	Shalaev, Vladimir M./0000-0001-8976-1102; 				Aharonovich I, 2011, NAT PHOTONICS, V5, P397, DOI [10.1038/NPHOTON.2011.54, 10.1038/nphoton.2011.54]; Akimov AV, 2007, NATURE, V450, P402, DOI 10.1038/nature06230; Altewischer E, 2002, NATURE, V418, P304, DOI 10.1038/nature00869; Bergman DJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.027402; Boltasseva A, 2011, SCIENCE, V331, P290, DOI 10.1126/science.1198258; Brongersma ML, 2010, SCIENCE, V328, P440, DOI 10.1126/science.1186905; Chang DE, 2007, NAT PHYS, V3, P807, DOI 10.1038/nphys708; Fasel S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.110501; Huck A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.096801; Huck A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.246802; Jacob Z, 2010, APPL PHYS B-LASERS O, V100, P215, DOI 10.1007/s00340-010-4096-5; Kolesov R, 2009, NAT PHYS, V5, P470, DOI 10.1038/NPHYS1278; Noginov MA, 2010, OPT LETT, V35, P1863, DOI 10.1364/OL.35.001863; Zuloaga J, 2009, NANO LETT, V9, P887, DOI 10.1021/nl803811g	14	149	152	2	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 28	2011	334	6055					463	464		10.1126/science.1211736	http://dx.doi.org/10.1126/science.1211736			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837UR	22034423				2022-12-28	WOS:000296230500031
J	Cho, J; Jeon, S; Wilson, SA; Liu, LV; Kang, EA; Braymer, JJ; Lim, MH; Hedman, B; Hodgson, KO; Valentine, JS; Solomon, EI; Nam, W				Cho, Jaeheung; Jeon, Sujin; Wilson, Samuel A.; Liu, Lei V.; Kang, Eun A.; Braymer, Joseph J.; Lim, Mi Hee; Hedman, Britt; Hodgson, Keith O.; Valentine, Joan Selverstone; Solomon, Edward I.; Nam, Wonwoo			Structure and reactivity of a mononuclear non-haem iron(III)-peroxo complex	NATURE			English	Article							ELECTRONIC-STRUCTURE; SPECTROSCOPIC CHARACTERIZATION; CRYSTAL-STRUCTURE; PEROXO COMPLEX; IRON; BOND; DEFORMYLATION; BIOSYNTHESIS; INTERMEDIATE; DIOXYGENASE	Oxygen-containing mononuclear iron species-iron(III)-peroxo, iron(III)-hydroperoxo and iron(IV)-oxo-are key intermediates in the catalytic activation of dioxygen by iron-containing metalloenzymes(1-7). It has been difficult to generate synthetic analogues of these three active iron-oxygen species in identical host complexes, which is necessary to elucidate changes to the structure of the iron centre during catalysis and the factors that control their chemical reactivities with substrates. Here we report the high-resolution crystal structure of a mononuclear non-haem side-on iron(III)-peroxo complex, [Fe(III)(TMC)(OO)](+). We also report a series of chemical reactions in which this iron(III)-peroxo complex is cleanly converted to the iron(III)-hydroperoxo complex, [Fe(III)(TMC)(OOH)](2+), via a short-lived intermediate on protonation. This iron(III)-hydroperoxo complex then cleanly converts to the ferryl complex, [Fe(IV)(TMC)(O)](2+), via homolytic O-O bond cleavage of the iron(III)-hydroperoxo species. All three of these iron species-the three most biologically relevant iron-oxygen intermediates-have been spectroscopically characterized; we note that they have been obtained using a simple macrocyclic ligand. We have performed relative reactivity studies on these three iron species which reveal that the iron(III)-hydroperoxo complex is the most reactive of the three in the deformylation of aldehydes and that it has a similar reactivity to the iron(IV)-oxo complex in C-H bond activation of alkylaromatics. These reactivity results demonstrate that iron(III)-hydroperoxo species are viable oxidants in both nucleophilic and electrophilic reactions by iron-containing enzymes.	[Cho, Jaeheung; Jeon, Sujin; Kang, Eun A.; Valentine, Joan Selverstone; Nam, Wonwoo] Ewha Womans Univ, Dept Chem & Nano Sci, Ctr Biomimet Syst, Dept Bioinspired Sci, Seoul 120750, South Korea; [Wilson, Samuel A.; Liu, Lei V.; Hodgson, Keith O.; Solomon, Edward I.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Braymer, Joseph J.; Lim, Mi Hee] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Braymer, Joseph J.; Lim, Mi Hee] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Hedman, Britt; Hodgson, Keith O.; Solomon, Edward I.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Valentine, Joan Selverstone] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	Ewha Womans University; Stanford University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of California System; University of California Los Angeles	Valentine, JS (corresponding author), Ewha Womans Univ, Dept Chem & Nano Sci, Ctr Biomimet Syst, Dept Bioinspired Sci, Seoul 120750, South Korea.	jsv@chem.ucla.edu; edward.solomon@stanford.edu; wwnam@ewha.ac.kr	Lim, Mi Hee/D-1913-2018; Valentine, Joan S/B-6665-2008; Liu, Lei/H-4942-2011	Valentine, Joan S/0000-0002-7174-925X; Solomon, Edward/0000-0003-0291-3199; Cho, Jaeheung/0000-0002-2712-4295; Nam, Wonwoo/0000-0001-8592-4867	NRF/MEST of Korea through the CRI; NRF/MEST of Korea through the GRL [2010-00353]; NRF/MEST of Korea through the WCU [R31-2008-000-10010-0]; NIH [GM 40392, RR-001209]; NSF [MCB 0919027]; NSF EAPSI [OISE-1014685]; University of Michigan; Department of Energy (DOE) Office of Science; DOE, Office of Biological and Environmental Research; NIH, National Center for Research Resources [5P41RR001209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040392] Funding Source: NIH RePORTER	NRF/MEST of Korea through the CRI; NRF/MEST of Korea through the GRL; NRF/MEST of Korea through the WCU; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NSF EAPSI(National Science Foundation (NSF)); University of Michigan(University of Michigan System); Department of Energy (DOE) Office of Science(United States Department of Energy (DOE)); DOE, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by NRF/MEST of Korea through the CRI (W.N.), the GRL (2010-00353; W.N.), the WCU (R31-2008-000-10010-0; W.N. and J.S.V.) and the 2011 KRICT OASIS Project (W.N.), by NIH grants GM 40392 (E. I. S.) and RR-001209 (K.O.H.), and by NSF grant MCB 0919027 (E. I. S.). J.J.B. acknowledges a Fellowship from NSF EAPSI (OISE-1014685) and the Warner Linfield Award from the University of Michigan. SSRL operations are funded by the Department of Energy (DOE) Office of Science and operated by Stanford University. The SSRL Structural Molecular Biology programme is supported by the DOE, Office of Biological and Environmental Research, and by the NIH, National Center for Research Resources (grant 5P41RR001209), Biomedical Technology Program.	AKHTAR M, 1994, BIOCHEMISTRY-US, V33, P4410, DOI 10.1021/bi00180a039; Annaraj J, 2005, CHEM COMMUN, P4529, DOI 10.1039/b505562h; Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Cho J, 2010, J AM CHEM SOC, V132, P16977, DOI 10.1021/ja107177m; Cho J, 2009, NAT CHEM, V1, P568, DOI [10.1038/NCHEM.366, 10.1038/nchem.366]; Cicchillo RM, 2009, NATURE, V459, P871, DOI 10.1038/nature07972; Cramer CJ, 2003, P NATL ACAD SCI USA, V100, P3635, DOI 10.1073/pnas.0535926100; Fukuzumi S, 2010, NAT CHEM, V2, P756, DOI [10.1038/NCHEM.731, 10.1038/nchem.731]; Jensen KB, 1999, CHEM COMMUN, P1313, DOI 10.1039/a902985k; Karlsson A, 2003, SCIENCE, V299, P1039, DOI 10.1126/science.1078020; Kovaleva EG, 2008, NAT CHEM BIOL, V4, P186, DOI 10.1038/nchembio.71; Kovaleva EG, 2007, SCIENCE, V316, P453, DOI 10.1126/science.1134697; Lehnert N, 2002, J AM CHEM SOC, V124, P10810, DOI 10.1021/ja012621d; Li FF, 2011, J AM CHEM SOC, V133, P7256, DOI 10.1021/ja111742z; Liu JG, 2009, ANGEW CHEM INT EDIT, V48, P9262, DOI 10.1002/anie.200904572; Mayer JM, 2011, ACCOUNTS CHEM RES, V44, P36, DOI 10.1021/ar100093z; Neese F, 1998, J AM CHEM SOC, V120, P12829, DOI 10.1021/ja981561h; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Rohde JU, 2003, SCIENCE, V299, P1037, DOI 10.1126/science.299.5609.1037; Sastri CV, 2007, P NATL ACAD SCI USA, V104, P19181, DOI 10.1073/pnas.0709471104; Selke M, 1998, J AM CHEM SOC, V120, P2652, DOI 10.1021/ja9733301; Seo MS, 2007, ANGEW CHEM INT EDIT, V46, P377, DOI 10.1002/anie.200603414; Shan X, 2007, INORG CHEM, V46, P8410, DOI 10.1021/ic700649w; Simaan AJ, 2001, INORG CHEM, V40, P6538, DOI 10.1021/ic010635e; Solomon EI, 2009, CURR OPIN CHEM BIOL, V13, P99, DOI 10.1016/j.cbpa.2009.02.011; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; VAZ ADN, 1991, J AM CHEM SOC, V113, P5886, DOI 10.1021/ja00015a066; Wada A, 2002, INORG CHEM, V41, P616, DOI 10.1021/ic001058h; Wertz DL, 2000, STRUCT BOND, V97, P37; Westre TE, 1997, J AM CHEM SOC, V119, P6297, DOI 10.1021/ja964352a	30	230	230	4	229	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 27	2011	478	7370					502	505		10.1038/nature10535	http://dx.doi.org/10.1038/nature10535			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	22031443	Green Submitted, Green Accepted			2022-12-28	WOS:000296194200040
J	Delamothe, T				Delamothe, Tony			ON THE CONTRARY What should we do with child sex offenders?	BRITISH MEDICAL JOURNAL			English	Editorial Material												tdelamothe@bmj.com							0	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 26	2011	343								d6908	10.1136/bmj.d6908	http://dx.doi.org/10.1136/bmj.d6908			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	840CY	22031916				2022-12-28	WOS:000296417100018
J	Hogerheijde, MR; Bergin, EA; Brinch, C; Cleeves, LI; Fogel, JKJ; Blake, GA; Dominik, C; Lis, DC; Melnick, G; Neufeld, D; Panic, O; Pearson, JC; Kristensen, L; Yildiz, UA; van Dishoeck, EF				Hogerheijde, Michiel R.; Bergin, Edwin A.; Brinch, Christian; Cleeves, L. Ilsedore; Fogel, Jeffrey K. J.; Blake, Geoffrey A.; Dominik, Carsten; Lis, Dariusz C.; Melnick, Gary; Neufeld, David; Panic, Olja; Pearson, John C.; Kristensen, Lars; Yildiz, Umut A.; van Dishoeck, Ewine F.			Detection of the Water Reservoir in a Forming Planetary System	SCIENCE			English	Article							T TAURI STARS; PROTOPLANETARY DISKS; HERSCHEL; LINES; ICE; INTERSTELLAR; EMISSION; SURFACE; REGION; GRAINS	Icy bodies may have delivered the oceans to the early Earth, yet little is known about water in the ice-dominated regions of extrasolar planet-forming disks. The Heterodyne Instrument for the Far-Infrared on board the Herschel Space Observatory has detected emission lines from both spin isomers of cold water vapor from the disk around the young star TW Hydrae. This water vapor likely originates from ice-coated solids near the disk surface, hinting at a water ice reservoir equivalent to several thousand Earth oceans in mass. The water's ortho-to-para ratio falls well below that of solar system comets, suggesting that comets contain heterogeneous ice mixtures collected across the entire solar nebula during the early stages of planetary birth.	[Hogerheijde, Michiel R.; Brinch, Christian; Kristensen, Lars; Yildiz, Umut A.; van Dishoeck, Ewine F.] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [Bergin, Edwin A.; Cleeves, L. Ilsedore; Fogel, Jeffrey K. J.] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; [Blake, Geoffrey A.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Dominik, Carsten] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 XH Amsterdam, Netherlands; [Lis, Dariusz C.] CALTECH, Div Phys Math & Astron, Pasadena, CA 91125 USA; [Melnick, Gary] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Neufeld, David] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Panic, Olja] European So Observ, D-85748 Garching, Germany; [Pearson, John C.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [van Dishoeck, Ewine F.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany	Leiden University; Leiden University - Excl LUMC; University of Michigan System; University of Michigan; California Institute of Technology; University of Amsterdam; California Institute of Technology; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Johns Hopkins University; European Southern Observatory; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Max Planck Society	Hogerheijde, MR (corresponding author), Leiden Univ, Leiden Observ, POB 9513, NL-2300 RA Leiden, Netherlands.	michiel@strw.leidenuniv.nl	Kristensen, Lars/F-4774-2011; Brinch, Christian/D-9622-2014; Yildiz, Umut/C-5257-2011; Brinch, Christian/G-5157-2015	Kristensen, Lars/0000-0003-1159-3721; Brinch, Christian/0000-0002-5074-7183; Yildiz, Umut/0000-0001-6197-2864; Brinch, Christian/0000-0002-5074-7183; Lis, Dariusz/0000-0002-0500-4700; Dominik, Carsten/0000-0002-3393-2459; Cleeves, L. Ilsedore/0000-0003-2076-8001	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [639.042.404]; NSF [0707777]; NASA	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	Herschel is a European Space Agency space observatory with science instruments provided by European-led principal investigator consortia and with important participation from NASA. This work was partially supported by Nederlandse Organisatie voor Wetenschappelijk Onderzoek grant 639.042.404, NSF grant 0707777, and, as part of the NASA Herschel HIFI guaranteed time program, NASA. The data presented here are archived at the Herschel Science Archive, http://archives.esac.esa.int/hda/ui, under OBSID 1342198337 and 1342201585.	Andersson S, 2008, ASTRON ASTROPHYS, V491, P907, DOI 10.1051/0004-6361:200810374; Bonev BP, 2007, ASTROPHYS J, V661, pL97, DOI 10.1086/518419; Calvet N, 2002, ASTROPHYS J, V568, P1008, DOI 10.1086/339061; Carr JS, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/2/102; De Graauw T, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014698; Dominik C, 2005, ASTROPHYS J, V635, pL85, DOI 10.1086/498942; Gorti U, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/2/90; Hayashi C., 1981, Progress of Theoretical Physics Supplement, P35, DOI 10.1143/PTPS.70.35; Honda M, 2009, ASTROPHYS J LETT, V690, pL110, DOI 10.1088/0004-637X/690/2/L110; Hughes AM, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/2/85; Kastner JH, 1997, SCIENCE, V277, P67, DOI 10.1126/science.277.5322.67; Limbach HH, 2006, CHEMPHYSCHEM, V7, P551, DOI 10.1002/cphc.200500559; MATSUI T, 1986, NATURE, V322, P526, DOI 10.1038/322526a0; Pilbratt GL, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014759; Pontoppidan KM, 2010, ASTROPHYS J LETT, V722, pL173, DOI 10.1088/2041-8205/722/2/L173; Sandford SA, 2006, SCIENCE, V314, P1720, DOI 10.1126/science.1135841; Shinnaka Y, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/81; Thi WF, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014578; Webb RA, 1999, ASTROPHYS J, V512, pL63, DOI 10.1086/311856; Woitke P, 2009, ASTRON ASTROPHYS, V501, pL5, DOI 10.1051/0004-6361/200912249; Wooden DH, 2008, SPACE SCI REV, V138, P75, DOI 10.1007/s11214-008-9424-2	24	196	198	7	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 21	2011	334	6054					338	340		10.1126/science.1208931	http://dx.doi.org/10.1126/science.1208931			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	22021851	Green Submitted			2022-12-28	WOS:000296052500042
J	Kilpatrick, AM				Kilpatrick, A. Marm			Globalization, Land Use, and the Invasion of West Nile Virus	SCIENCE			English	Review							EMERGING INFECTIOUS-DISEASES; DIPTERA-CULICIDAE; HOST; EMERGENCE; VECTORS; EPIDEMIOLOGY; ENCEPHALITIS; AMERICA	Many invasive species that have been spread through the globalization of trade and travel are pathogens. A paradigmatic case is the introduction of West Nile virus (WNV) into North America in 1999. A decade of research on the ecology and evolution of WNV includes three findings that provide insight into the outcome of future pathogen introductions. First, WNV transmission in North America is highest in urbanized and agricultural habitats, in part because the hosts and vectors of WNV are abundant in human-modified areas. Second, after its introduction, the virus quickly adapted to infect local mosquito vectors more efficiently than the originally introduced strain. Third, highly focused feeding patterns of the mosquito vectors of WNV result in unexpected host species being important for transmission. This research provides a framework for predicting and preventing the emergence of foreign vector-borne pathogens.	Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Kilpatrick, AM (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	akilpatr@ucsc.edu			NSF [EF-0914866, BCS-0826779]; NIH [1R01AI090159-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090159] Funding Source: NIH RePORTER; Division Of Behavioral and Cognitive Sci [0826779] Funding Source: National Science Foundation; Division Of Environmental Biology [0914866] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	I thank T. Bogich, K. Koelle, I. Parker, N. Komar, and the Kilpatrick lab for input. NSF grants EF-0914866 and BCS-0826779 and NIH grant 1R01AI090159-01 provided funding.	Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Beasley DWC, 2011, IMMUNOTHERAPY-UK, V3, P269, DOI 10.2217/IMT.10.93; Bowden SE, 2011, AM J TROP MED HYG, V84, P234, DOI 10.4269/ajtmh.2011.10-0134; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davis CT, 2005, VIROLOGY, V342, P252, DOI 10.1016/j.virol.2005.07.022; Fyodorova MV, 2006, J MED ENTOMOL, V43, P552, DOI 10.1603/0022-2585(2006)43[552:EOPWNV]2.0.CO;2; Hall RA, 2001, ANN NY ACAD SCI, V951, P153; Hamer GL, 2008, VECTOR-BORNE ZOONOT, V8, P57, DOI 10.1089/vbz.2007.0123; Hamer GL, 2009, AM J TROP MED HYG, V80, P268, DOI 10.4269/ajtmh.2009.80.268; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; Kent R, 2009, J MED ENTOMOL, V46, P380, DOI 10.1603/033.046.0226; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kilpatrick AM, 2006, CONSERV BIOL, V20, P1224, DOI 10.1111/j.1523-1739.2006.00423.x; Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; Kilpatrick AM, 2005, EMERG INFECT DIS, V11, P425, DOI 10.3201/eid1103.040364; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Komar N, 2006, REV PANAM SALUD PUBL, V19, P112, DOI 10.1590/S1020-49892006000200006; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Lembo T, 2008, J APPL ECOL, V45, P1246, DOI 10.1111/j.1365-2664.2008.01468.x; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Lundstrom JO, 2001, J MED ENTOMOL, V38, P289, DOI 10.1603/0022-2585-38.2.289; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; McINTOSH B. M., 1967, S AFR J MED SCI, V32, P1; Molaei G, 2010, AM J TROP MED HYG, V83, P1269, DOI 10.4269/ajtmh.2010.10-0392; Moudy RM, 2007, AM J TROP MED HYG, V77, P365, DOI 10.4269/ajtmh.2007.77.365; Petersen LR, 2008, MED CLIN N AM, V92, P1307, DOI 10.1016/j.mcna.2008.07.004; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Reisen WK, 2005, J MED ENTOMOL, V42, P367, DOI 10.1603/0022-2585(2005)042[0367:AHAMDC]2.0.CO;2; Russell CA, 2005, PLOS BIOL, V3, P382, DOI 10.1371/journal.pbio.0030088; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; SOUTHAM CM, 1954, AM J TROP MED HYG, V3, P19, DOI 10.4269/ajtmh.1954.3.19; TAYLOR RM, 1956, AM J TROP MED HYG, V5, P579, DOI 10.4269/ajtmh.1956.5.579; Thompson JN, 1999, AM NAT, V153, pS1, DOI 10.1086/303208; Turell MJ, 2002, CURR TOP MICROBIOL, V267, P241; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008	40	295	310	3	276	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2011	334	6054					323	327		10.1126/science.1201010	http://dx.doi.org/10.1126/science.1201010			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	22021850	Green Accepted			2022-12-28	WOS:000296052500039
J	Whiting, PF; Rutjes, AWS; Westwood, ME; Mallett, S; Deeks, JJ; Reitsma, JB; Leeflang, MMG; Sterne, JAC; Bossuyt, PMM				Whiting, Penny F.; Rutjes, Anne W. S.; Westwood, Marie E.; Mallett, Susan; Deeks, Jonathan J.; Reitsma, Johannes B.; Leeflang, Mariska M. G.; Sterne, Jonathan A. C.; Bossuyt, Patrick M. M.		QUADAS-2 Grp	QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies	ANNALS OF INTERNAL MEDICINE			English	Article							METAANALYSIS; BIAS; TESTS	In 2003, the QUADAS tool for systematic reviews of diagnostic accuracy studies was developed. Experience, anecdotal reports, and feedback suggested areas for improvement; therefore, QUADAS-2 was developed. This tool comprises 4 domains: patient selection, index test, reference standard, and flow and timing. Each domain is assessed in terms of risk of bias, and the first 3 domains are also assessed in terms of concerns regarding applicability. Signalling questions are included to help judge risk of bias. The QUADAS-2 tool is applied in 4 phases: summarize the review question, tailor the tool and produce review-specific guidance, construct a flow diagram for the primary study, and judge bias and applicability. This tool will allow for more transparent rating of bias and applicability of primary diagnostic accuracy studies.	Univ Bristol, Bristol, Avon, England; Kleijnen Systemat Reviews, York, N Yorkshire, England; Univ Oxford, Oxford, England; Univ Birmingham, Birmingham, W Midlands, England; Univ Med Ctr Utrecht, Utrecht, Netherlands; Univ Amsterdam, Amsterdam, Netherlands; Univ Bern, Bern, Switzerland	University of Bristol; Kleijnen Systematic Reviews; University of Oxford; University of Birmingham; Utrecht University; Utrecht University Medical Center; University of Amsterdam; University of Bern	Whiting, PF (corresponding author), Sch Social & Community Med, Canynge Hall,39 Whatley Rd, Bristol BS8 2PS, Avon, England.	penny.whiting@bristol.ac.uk	Sterne, Jonathan/Z-3106-2019; Rutjes, Anne/L-8750-2017; Bossuyt, Patrick M./B-4557-2016; Bossuyt, Patrick M/AAR-1183-2021; Leeflang, Mariska/AAF-8199-2019; Mallett, Sue/GPS-9933-2022; Deeks, Jon/AAV-5745-2020	Sterne, Jonathan/0000-0001-8496-6053; Rutjes, Anne/0000-0001-9782-779X; Bossuyt, Patrick M./0000-0003-4427-0128; Bossuyt, Patrick M/0000-0003-4427-0128; Leeflang, Mariska/0000-0001-5960-0471; Deeks, Jon/0000-0002-8850-1971; Mallett, Sue/0000-0002-0596-8200; Reitsma, Johannes/0000-0003-4026-4345; Whiting, Penny/0000-0003-1138-5682	Medical Research Council as part of the Medical Research Council-National Institute for Health Research; National Institute for Health Research; Cancer Research UK; Netherlands Organization for Scientific Research [916.10.034]; MRC [G0801405, G0800808] Funding Source: UKRI; Medical Research Council [G0800808, G0801405] Funding Source: researchfish	Medical Research Council as part of the Medical Research Council-National Institute for Health Research; National Institute for Health Research(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council as part of the Medical Research Council-National Institute for Health Research Methodology Research Programme and the National Institute for Health Research. Dr. Mallett is supported by Cancer Research UK. Dr Leeflang is supported by the Netherlands Organization for Scientific Research (project 916.10.034).	Biesheuvel C, 2007, CLIN CHEM, V53, P1725, DOI 10.1373/clinchem.2007.087403; BOSSUYT PM, 2009, COCHRANE HDB SYSTEMA, pCH6; HIGGINS JP, BMJ IN PRESS; Leeflang MMG, 2008, CLIN CHEM, V54, P729, DOI 10.1373/clinchem.2007.096032; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Macaskill P, 2010, COCHRANE HDB SYSTEMA; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Reitsma JB., 2009, COCHRANE HDB SYSTEMA; RUTJES A, 2003, 11 COCHR C EV HLTH C; Stengel D, 2005, RADIOLOGY, V236, P102, DOI 10.1148/radiol.2361040791; VANRIJKOM HM, 1995, CARIES RES, V29, P364, DOI 10.1159/000262094; Whiting P, 2006, BMJ-BRIT MED J, V332, P875, DOI 10.1136/bmj.38771.583796.7C; Whiting P, 2006, HEALTH TECHNOL ASSES, V10, P1; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010; Whiting P., 2010, UPDATING QUADAS EVID; WHITING P, 2006, HEALTH TECHNOL ASSES, V10, pR11; WHITING P, 2006, HEALTH TECHNOL ASSES, V10, pR3; Whiting Penny, 2005, BMC Med Res Methodol, V5, P19, DOI 10.1186/1471-2288-5-19; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting Penny F, 2006, BMC Med Res Methodol, V6, P9, DOI 10.1186/1471-2288-6-9; Whiting PF, 2010, ANN INTERN MED, V152, P456, DOI 10.7326/0003-4819-152-7-201004060-00010; Willis BH, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-27; 1999, JAMA, V282, P1054	24	6953	7126	12	161	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2011	155	8					529	U104		10.7326/0003-4819-155-8-201110180-00009	http://dx.doi.org/10.7326/0003-4819-155-8-201110180-00009			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835WB	22007046				2022-12-28	WOS:000296066300018
J	Hirota, M; Holmgren, M; Van Nes, EH; Scheffer, M				Hirota, Marina; Holmgren, Milena; Van Nes, Egbert H.; Scheffer, Marten			Global Resilience of Tropical Forest and Savanna to Critical Transitions	SCIENCE			English	Article							ALTERNATIVE STABLE STATES; AFRICAN SAVANNAS; TREE COVER; AMAZON; DEFORESTATION; CLIMATE; FIRE; RAINFALL; SIMULATION; AUSTRALIA	It has been suggested that tropical forest and savanna could represent alternative stable states, implying critical transitions at tipping points in response to altered climate or other drivers. So far, evidence for this idea has remained elusive, and integrated climate models assume smooth vegetation responses. We analyzed data on the distribution of tree cover in Africa, Australia, and South America to reveal strong evidence for the existence of three distinct attractors: forest, savanna, and a treeless state. Empirical reconstruction of the basins of attraction indicates that the resilience of the states varies in a universal way with precipitation. These results allow the identification of regions where forest or savanna may most easily tip into an alternative state, and they pave the way to a new generation of coupled climate models.	[Holmgren, Milena] Wageningen Univ, Resource Ecol Grp, NL-6700 AA Wageningen, Netherlands; [Hirota, Marina; Van Nes, Egbert H.; Scheffer, Marten] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, NL-6700 AA Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Holmgren, M (corresponding author), Wageningen Univ, Resource Ecol Grp, POB 47, NL-6700 AA Wageningen, Netherlands.	milena.holmgren@wur.nl	Scheffer, Marten/C-1852-2012; van Nes, Egbert H/F-2681-2011; Hirota, Marina/E-6058-2012	van Nes, Egbert/0000-0002-6345-104X; Hirota, Marina/0000-0002-1958-3651	European Research Council; Spinoza award	European Research Council(European Research Council (ERC)European Commission); Spinoza award	This research was partly funded by the European Research Council-Early Warning grant and Spinoza award received by M.S. The data reported in this paper are extracted as described in the supporting online material from the publicly available sites of MODIS (www.glcf.umd.edu/data/vcf/) and the Climatic Research Unit (www.cru.uea.ac.uk/cru/data/hrg/).	Avissar R, 2005, J HYDROMETEOROL, V6, P134, DOI 10.1175/JHM406.1; Bond WJ, 2008, ANNU REV ECOL EVOL S, V39, P641, DOI 10.1146/annurev.ecolsys.39.110707.173411; Bowman DMJS, 2010, LANDSCAPE ECOL, V25, P1247, DOI 10.1007/s10980-010-9496-8; Brovkin V, 1998, J GEOPHYS RES-ATMOS, V103, P31613, DOI 10.1029/1998JD200006; Bucini G, 2007, GLOBAL ECOL BIOGEOGR, V16, P593, DOI 10.1111/j.1466-8238.2007.00325.x; DUBLIN HT, 1990, J ANIM ECOL, V59, P1147, DOI 10.2307/5037; ELTAHIR EAB, 1994, ADV WATER RESOUR, V17, P101, DOI 10.1016/0309-1708(94)90027-2; Higgins SI, 2007, ECOLOGY, V88, P1119, DOI 10.1890/06-1664; Hill MJ., 2011, ECOSYSTEM FUNCTION S; Holmgren M, 2001, ECOSYSTEMS, V4, P151, DOI 10.1007/s100210000065; Holmgren Milena, 1997, Ecology (Washington D C), V78, P1966, DOI 10.1890/0012-9658(1997)078[1966:TIOFAC]2.0.CO;2; House JI, 2003, J BIOGEOGR, V30, P1763, DOI 10.1046/j.1365-2699.2003.00873.x; Laurance WF, 2002, J BIOGEOGR, V29, P737, DOI 10.1046/j.1365-2699.2002.00721.x; Liedloff AC, 2007, ECOL MODEL, V201, P269, DOI 10.1016/j.ecolmodel.2006.09.013; Livina VN, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028672; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Mayle FE, 2007, PHILOS T R SOC B, V362, P291, DOI 10.1098/rstb.2006.1987; Nepstad DC, 2008, PHILOS T R SOC B, V363, P1737, DOI 10.1098/rstb.2007.0036; Nobre CA, 2009, CURR OPIN ENV SUST, V1, P28, DOI 10.1016/j.cosust.2009.07.003; Oyama MD, 2004, J CLIMATE, V17, P3203, DOI [10.1175/1520-0442(2004)017<3203:CCOALD>2.0.CO;2, 10.1175/1520-0442(2004)017&lt;3203:CCOALD&gt;2.0.CO;2]; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Scheffer M., 2020, CRITICAL TRANSITIONS, V16, DOI 10.2307/j.ctv173f1g1; Scheffer M, 2008, ECOSYSTEMS, V11, P226, DOI 10.1007/s10021-007-9118-8; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Staver AC, 2011, ECOLOGY, V92, P1063, DOI 10.1890/i0012-9658-92-5-1063; Sternberg LDL, 2001, GLOBAL ECOL BIOGEOGR, V10, P369, DOI 10.1046/j.1466-822X.2001.00243.x; Warman L, 2009, LANDSCAPE ECOL, V24, P1, DOI 10.1007/s10980-008-9285-9; Williams RJ, 1996, J BIOGEOGR, V23, P747, DOI 10.1111/j.1365-2699.1996.tb00036.x; Woodward FI, 2004, PHILOS T ROY SOC B, V359, P1465, DOI 10.1098/rstb.2004.1525	29	721	732	24	497	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					232	235		10.1126/science.1210657	http://dx.doi.org/10.1126/science.1210657			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998390				2022-12-28	WOS:000295833600048
J	Lichten, M; de Massy, B				Lichten, Michael; de Massy, Bernard			The Impressionistic Landscape of Meiotic Recombination	CELL			English	Review							INITIATION; HOTSPOTS; MEIOSIS; YEAST; PRDM9; CONSERVATION; FEATURES; SITES; MOUSE	Two high-resolution maps of meiotic recombination initiation sites across the genomes of budding yeast and mice illuminate broad similarities in the control of meiotic recombination in these diverse species but also highlight key differences. These studies offer new insights into the relationships between recombination, chromosome structure, and genome evolution.	[de Massy, Bernard] CNRS, Inst Human Genet, UPR1142, F-34396 Montpellier, France; [Lichten, Michael] NCI, Lab Biochem & Mol Biol, Ctr Canc Res, Bethesda, MD 20892 USA	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	de Massy, B (corresponding author), CNRS, Inst Human Genet, UPR1142, F-34396 Montpellier, France.	bernard.de-massy@igh.cnrs.fr	Lichten, Michael/C-5795-2013	Lichten, Michael/0000-0001-9707-2956	Center for Cancer Research, National Cancer Institute, NIH; Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [09-BLAN-0269-01]; Association pour la Recherche contre le Cancer; Fondation pour la Recherche Medicale; NATIONAL CANCER INSTITUTE [ZIABC005268] Funding Source: NIH RePORTER	Center for Cancer Research, National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dan Camerini-Otero, Galina Pethukova, Scott Keeney, and members of their groups for data used in Figure 1. We apologize to many colleagues whose work was not cited here due to space limits. M.L. is supported by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, NIH; B.d.M. is supported by the Centre National de la Recherche Scientifique, the Agence Nationale de la Recherche (09-BLAN-0269-01), the Association pour la Recherche contre le Cancer, and the Fondation pour la Recherche Medicale.	Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Buard J, 2009, EMBO J, V28, P2616, DOI 10.1038/emboj.2009.207; Gerton JL, 2005, NAT REV GENET, V6, P477, DOI 10.1038/nrg1614; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hunter N., 2007, CURR TOPICS GENET, V17, P381; Kauppi L, 2011, SCIENCE, V331, P916, DOI 10.1126/science.1195774; Keeney Scott, 2008, V2, P81, DOI 10.1007/7050_2007_026; Lichten Michael, 2008, V3, P165, DOI 10.1007/7050_2008_040; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Mets DG, 2009, CELL, V139, P73, DOI 10.1016/j.cell.2009.07.035; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Paigen K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000119; Pan J, 2007, PLOS BIOL, V5, P2774, DOI 10.1371/journal.pbio.0050333; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Panizza S, 2011, CELL, V146, P372, DOI 10.1016/j.cell.2011.07.003; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Ponting CP, 2011, TRENDS GENET, V27, P165, DOI 10.1016/j.tig.2011.02.001; Sasaki M, 2010, NAT REV MOL CELL BIO, V11, P182, DOI 10.1038/nrm2849; Smagulova F, 2011, NATURE, V472, P375, DOI 10.1038/nature09869; Storlazzi A, 2010, CELL, V141, P94, DOI 10.1016/j.cell.2010.02.041; Tsai IJ, 2010, P NATL ACAD SCI USA, V107, P7847, DOI 10.1073/pnas.0908774107	23	57	57	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 14	2011	147	2					267	270		10.1016/j.cell.2011.09.038	http://dx.doi.org/10.1016/j.cell.2011.09.038			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000007	Bronze, Green Accepted			2022-12-28	WOS:000296199300006
J	Kullerud, L				Kullerud, Lars			A green Arctic	NATURE			English	Editorial Material									Univ Arctic, UNEP GRID Arendal, N-4836 Arendal, Norway		Kullerud, L (corresponding author), Univ Arctic, UNEP GRID Arendal, N-4836 Arendal, Norway.	lars.kullerud@uarctic.org	Kullerud, Lars/F-2531-2013	Kullerud, Lars/0000-0002-8978-3886					0	6	6	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 13	2011	478	7368					179	180		10.1038/478179a	http://dx.doi.org/10.1038/478179a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21993741				2022-12-28	WOS:000295782800026
J	Papaemmanuil, E; Cazzola, M; Boultwood, J; Malcovati, L; Vyas, P; Bowen, D; Pellagatti, A; Wainscoat, JS; Hellstrom-Lindberg, E; Gambacorti-Passerini, C; Godfrey, AL; Rapado, I; Cvejic, A; Rance, R; McGee, C; Ellis, P; Mudie, LJ; Stephens, PJ; McLaren, S; Massie, CE; Tarpey, PS; Varela, I; Nik-Zainal, S; Davies, HR; Shlien, A; Jones, D; Raine, K; Hinton, J; Butler, AP; Teague, JW; Baxter, EJ; Score, J; Galli, A; Della Porta, MG; Travaglino, E; Groves, M; Tauro, S; Munshi, NC; Anderson, KC; El-Naggar, A; Fischer, A; Mustonen, V; Warren, AJ; Cross, NCP; Green, AR; Futreal, PA; Stratton, MR; Campbell, PJ				Papaemmanuil, E.; Cazzola, M.; Boultwood, J.; Malcovati, L.; Vyas, P.; Bowen, D.; Pellagatti, A.; Wainscoat, J. S.; Hellstrom-Lindberg, E.; Gambacorti-Passerini, C.; Godfrey, A. L.; Rapado, I.; Cvejic, A.; Rance, R.; McGee, C.; Ellis, P.; Mudie, L. J.; Stephens, P. J.; McLaren, S.; Massie, C. E.; Tarpey, P. S.; Varela, I.; Nik-Zainal, S.; Davies, H. R.; Shlien, A.; Jones, D.; Raine, K.; Hinton, J.; Butler, A. P.; Teague, J. W.; Baxter, E. J.; Score, J.; Galli, A.; Della Porta, M. G.; Travaglino, E.; Groves, M.; Tauro, S.; Munshi, N. C.; Anderson, K. C.; El-Naggar, A.; Fischer, A.; Mustonen, V.; Warren, A. J.; Cross, N. C. P.; Green, A. R.; Futreal, P. A.; Stratton, M. R.; Campbell, P. J.		Int Canc Genome Consortium	Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DNMT3A MUTATIONS; FREQUENT MUTATION; GENE ASXL1; CLASSIFICATION; MECHANISMS; PATHWAYS; PATTERNS; TET2	BACKGROUND Myelodysplastic syndromes are a diverse and common group of chronic hematologic cancers. The identification of new genetic lesions could facilitate new diagnostic and therapeutic strategies. METHODS We used massively parallel sequencing technology to identify somatically acquired point mutations across all protein-coding exons in the genome in 9 patients with low-grade myelodysplasia. Targeted resequencing of the gene encoding RNA splicing factor 3B, subunit 1 (SF3B1), was also performed in a cohort of 2087 patients with myeloid or other cancers. RESULTS We identified 64 point mutations in the 9 patients. Recurrent somatically acquired mutations were identified in SF3B1. Follow-up revealed SF3B1 mutations in 72 of 354 patients (20%) with myelodysplastic syndromes, with particularly high frequency among patients whose disease was characterized by ring sideroblasts (53 of 82 [65%]). The gene was also mutated in 1 to 5% of patients with a variety of other tumor types. The observed mutations were less deleterious than was expected on the basis of chance, suggesting that the mutated protein retains structural integrity with altered function. SF3B1 mutations were associated with down-regulation of key gene networks, including core mitochondrial pathways. Clinically, patients with SF3B1 mutations had fewer cytopenias and longer event-free survival than patients without SF3B1 mutations. CONCLUSIONS Mutations in SF3B1 implicate abnormalities of messenger RNA splicing in the pathogenesis of myelodysplastic syndromes. (Funded by the Wellcome Trust and others.)	[Papaemmanuil, E.; Rapado, I.; Cvejic, A.; Rance, R.; McGee, C.; Ellis, P.; Mudie, L. J.; Stephens, P. J.; McLaren, S.; Tarpey, P. S.; Varela, I.; Nik-Zainal, S.; Davies, H. R.; Shlien, A.; Jones, D.; Raine, K.; Hinton, J.; Butler, A. P.; Teague, J. W.; Fischer, A.; Mustonen, V.; Futreal, P. A.; Stratton, M. R.; Campbell, P. J.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Boultwood, J.; Pellagatti, A.] Univ Oxford, Nuffield Dept Clin Lab Sci, Oxford, England; [Vyas, P.] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Bowen, D.] St James Hosp, St James Inst Oncol, Leeds LS9 7TF, W Yorkshire, England; [Godfrey, A. L.; Cvejic, A.; Massie, C. E.; Baxter, E. J.; Warren, A. J.; Green, A. R.; Campbell, P. J.] Univ Cambridge, Dept Haematol, Cambridge, England; [Warren, A. J.] Univ Cambridge, MRC, Mol Biol Lab, Cambridge, England; [Warren, A. J.; Green, A. R.; Campbell, P. J.] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 2QQ, England; [Score, J.; Cross, N. C. P.] Univ Southampton, Sch Med, Southampton, Hants, England; [Groves, M.; Tauro, S.] Univ Dundee, Div Med Sci, Dundee, Scotland; [Cazzola, M.; Malcovati, L.; Galli, A.; Della Porta, M. G.; Travaglino, E.] Univ Pavia, Policlin San Matteo, Fdn Ist Ricovero & Cura Carattere Sci, I-27100 Pavia, Italy; [Hellstrom-Lindberg, E.] Karolinska Inst, Dept Hematol, Stockholm, Sweden; [Gambacorti-Passerini, C.] S Gerardo Hosp, Dept Hematol, Monza, Italy; [Gambacorti-Passerini, C.] Univ Milano Bicocca, Milan, Italy; [Munshi, N. C.; Anderson, K. C.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Munshi, N. C.] VA Boston Healthcare Syst, Boston, MA USA; [El-Naggar, A.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Fischer, A.] Univ Cologne, Inst Theoret Phys, D-5000 Cologne, Germany	Wellcome Trust Sanger Institute; University of Oxford; University of Oxford; Saint James's University Hospital; University of Cambridge; MRC Laboratory Molecular Biology; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Southampton; University of Dundee; IRCCS Fondazione San Matteo; University of Pavia; Karolinska Institutet; University of Milano-Bicocca; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; University of Texas System; UTMD Anderson Cancer Center; University of Cologne	Campbell, PJ (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England.	pc8@sanger.ac.uk	Malcovati, Luca/CAJ-1695-2022; Munshi, Nikhil/ABE-2338-2021; Vyas, Paresh/B-5708-2009; Mustonen, Ville/J-1155-2018; Mustonen, Ville/X-1599-2019; Gallì, Anna/N-8109-2019; Varela, Ignacio/G-1699-2016; Cross, Nicholas/B-4817-2009; Varela, Ignacio/AAA-7680-2021; Nik-Zainal, Serena/ABD-4437-2020; Cazzola, Mario/AAQ-8854-2021	Malcovati, Luca/0000-0002-1460-1611; Vyas, Paresh/0000-0003-3931-0914; Mustonen, Ville/0000-0002-7270-1792; Mustonen, Ville/0000-0002-7270-1792; Gallì, Anna/0000-0002-4039-3756; Varela, Ignacio/0000-0002-0969-506X; Cross, Nicholas/0000-0001-5481-2555; Varela, Ignacio/0000-0002-0969-506X; Cazzola, Mario/0000-0001-6984-8817; Massie, Charlie/0000-0003-2314-4843; GAMBACORTI PASSERINI, CARLO/0000-0001-6058-515X; Baxter, Elizabeth Joanna/0000-0002-5946-5238; Cvejic, Ana/0000-0003-3204-9311; Boultwood, Jacqueline/0000-0002-4330-2928; Della Porta, Matteo Giovanni/0000-0002-6915-5970; Pellagatti, Andrea/0000-0002-6122-0221; Green, Anthony/0000-0002-9795-0218; Nik-Zainal, Serena/0000-0001-5054-1727; Raine, Keiran/0000-0002-5634-1539	Wellcome Trust [077012/Z/05/Z, WT088340MA]; Kay Kendall Leukaemia Fund; Leukemia Lymphoma Research; Adenoid Cystic Carcinoma Research Foundation; Medical Research Council (MRC); Oxford National Institutes for Health Research Biomedical Research Centre; International Human Frontier Science Program Organization; Department of Veterans Affairs; National Institutes of Health [R01-124929, P01-155249, P50-100007, P01-78378]; Association for International Cancer Research; Leukemia Lymphoma Society; Associazione Italiana per la Ricerca sul Cancro; Fondazione Cariplo; MRC [G1000729, G0800784, MC_U105161083] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA124929, P01CA078378] Funding Source: NIH RePORTER; Medical Research Council [G0800784, G0800784B, MC_U105161083, G1000729, G1000801c] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Kay Kendall Leukaemia Fund; Leukemia Lymphoma Research; Adenoid Cystic Carcinoma Research Foundation; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford National Institutes for Health Research Biomedical Research Centre; International Human Frontier Science Program Organization(Human Frontier Science Program); Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association for International Cancer Research; Leukemia Lymphoma Society(Leukemia and Lymphoma Society); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariplo(Fondazione Cariplo); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants from the Wellcome Trust (077012/Z/05/Z, for the overall study, as well as WT088340MA, to Dr. Campbell), the Kay Kendall Leukaemia Fund, Leukemia Lymphoma Research (for the overall study and to Drs. Boultwood, Green, Vyas, and Wainscoat), the Adenoid Cystic Carcinoma Research Foundation, the Medical Research Council (MRC) (to Dr. Warren), the Oxford National Institutes for Health Research Biomedical Research Centre (to Drs. Boultwood, Vyas, and Wainscoat), the Swedish Cancer Society (to Dr. Hellstrom-Lindburg), the International Human Frontier Science Program Organization (to Dr. Varela), the Department of Veterans Affairs and the National Institutes of Health (R01-124929, P01-155249, P50-100007, and P01-78378, to Drs. Munshi and Anderson), the Association for International Cancer Research and the Leukemia Lymphoma Society (to Drs. Warren and Green), Associazione Italiana per la Ricerca sul Cancro (to the University of Pavia, the University of Milan Bicocca, and Dr. Cazzola), and Fondazione Cariplo (to the University of Pavia and the University of Milan Bicocca).	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Boultwood J, 2010, LEUKEMIA, V24, P1062, DOI 10.1038/leu.2010.20; Boultwood J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001970; Camaschella C, 2009, SEMIN HEMATOL, V46, P371, DOI 10.1053/j.seminhematol.2009.07.001; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Ewalt M, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.7; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fischer A, 2011, GENETICS, V188, P383, DOI 10.1534/genetics.111.127480; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Golas MM, 2005, MOL CELL, V17, P869, DOI 10.1016/j.molcel.2005.02.016; Golas MM, 2003, SCIENCE, V300, P980, DOI 10.1126/science.1084155; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Malcovati L, 2005, J CLIN ONCOL, V23, P7594, DOI 10.1200/JCO.2005.01.7038; Navarro I, 2006, LEUKEMIA RES, V30, P971, DOI 10.1016/j.leukres.2005.11.015; Notta F, 2010, NATURE, V471, P254; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Pellagatti, 2006, BLOOD, V108, P1128; Pellagatti A, 2010, LEUKEMIA, V24, P756, DOI 10.1038/leu.2010.31; Pellagatti A, 2007, P NATL ACAD SCI USA, V104, P11406, DOI 10.1073/pnas.0610477104; Pellagatti A, 2006, BLOOD, V108, P337, DOI 10.1182/blood-2005-12-4769; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tefferi A, 2009, NEW ENGL J MED, V361, P1872, DOI 10.1056/NEJMra0902908; Tehranchi R, 2005, BLOOD, V106, P247, DOI 10.1182/blood-2004-12-4649; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Wang CY, 1998, GENE DEV, V12, P1409, DOI 10.1101/gad.12.10.1409	40	847	891	4	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 13	2011	365	15					1384	1395		10.1056/NEJMoa1103283	http://dx.doi.org/10.1056/NEJMoa1103283			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832DQ	21995386	Green Published, Green Accepted			2022-12-28	WOS:000295782500006
J	Ouslander, JG; Berenson, RA				Ouslander, Joseph G.; Berenson, Robert A.			Reducing Unnecessary Hospitalizations of Nursing Home Residents	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ouslander, Joseph G.] Florida Atlantic Univ, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA; [Berenson, Robert A.] Urban Inst, Washington, DC 20037 USA	State University System of Florida; Florida Atlantic University; Urban Institute	Ouslander, JG (corresponding author), Florida Atlantic Univ, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA.							Grabowski DC, 2007, MILBANK Q, V85, P579, DOI 10.1111/j.1468-0009.2007.00502.x; Mor V, 2010, HEALTH AFFAIR, V29, P57, DOI 10.1377/hlthaff.2009.0629; Ouslander JG, 2011, J AM GERIATR SOC, V59, P745, DOI 10.1111/j.1532-5415.2011.03333.x; Ouslander JG, 2010, J AM GERIATR SOC, V58, P627, DOI 10.1111/j.1532-5415.2010.02768.x; Saliba D, 2000, J AM GERIATR SOC, V48, P154, DOI 10.1111/j.1532-5415.2000.tb03906.x	5	120	120	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 29	2011	365	13					1165	1167		10.1056/NEJMp1105449	http://dx.doi.org/10.1056/NEJMp1105449			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	825YO	21991889				2022-12-28	WOS:000295318400001
J	Chonghaile, TN; Sarosiek, KA; Vo, TT; Ryan, JA; Tammareddi, A; Moore, VD; Deng, J; Anderson, KC; Richardson, P; Tai, YT; Mitsiades, CS; Matulonis, UA; Drapkin, R; Stone, R; DeAngelo, DJ; McConkey, DJ; Sallan, SE; Silverman, L; Hirsch, MS; Carrasco, DR; Letai, A				Chonghaile, Triona Ni; Sarosiek, Kristopher A.; Thanh-Trang Vo; Ryan, Jeremy A.; Tammareddi, Anupama; Moore, Victoria Del Gaizo; Deng, Jing; Anderson, Kenneth C.; Richardson, Paul; Tai, Yu-Tzu; Mitsiades, Constantine S.; Matulonis, Ursula A.; Drapkin, Ronny; Stone, Richard; DeAngelo, Daniel J.; McConkey, David J.; Sallan, Stephen E.; Silverman, Lewis; Hirsch, Michelle S.; Carrasco, Daniel Ruben; Letai, Anthony			Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy	SCIENCE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; MULTIPLE-MYELOMA CELLS; IN-VIVO; APOPTOSIS; PROLIFERATION; INHIBITOR; PROTEINS; THERAPY; DEATH; LENALIDOMIDE	Cytotoxic chemotherapy targets elements common to all nucleated human cells, such as DNA and microtubules, yet it selectively kills tumor cells. Here we show that clinical response to these drugs correlates with, and may be partially governed by, the pretreatment proximity of tumor cell mitochondria to the apoptotic threshold, a property called mitochondrial priming. We used BH3 profiling to measure priming in tumor cells from patients with multiple myeloma, acute myelogenous and lymphoblastic leukemia, and ovarian cancer. This assay measures mitochondrial response to peptides derived from proapoptotic BH3 domains of proteins critical for death signaling to mitochondria. Patients with highly primed cancers exhibited superior clinical response to chemotherapy. In contrast, chemoresistant cancers and normal tissues were poorly primed. Manipulation of mitochondrial priming might enhance the efficacy of cytotoxic agents.	[Chonghaile, Triona Ni; Sarosiek, Kristopher A.; Thanh-Trang Vo; Ryan, Jeremy A.; Tammareddi, Anupama; Deng, Jing; Anderson, Kenneth C.; Richardson, Paul; Tai, Yu-Tzu; Mitsiades, Constantine S.; Matulonis, Ursula A.; Drapkin, Ronny; Stone, Richard; DeAngelo, Daniel J.; Carrasco, Daniel Ruben; Letai, Anthony] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Moore, Victoria Del Gaizo] Elon Univ, Dept Chem, Elon, NC 27244 USA; [McConkey, David J.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Thanh-Trang Vo] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Drapkin, Ronny; Hirsch, Michelle S.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Sallan, Stephen E.; Silverman, Lewis] Childrens Hosp Boston, Dana Farber Canc Inst, Dept Pediat Hematol Oncol, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Elon University; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute	Letai, A (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02215 USA.	anthony_letai@dfci.harvard.edu	Chonghaile, Triona Ni/L-9418-2015; Drapkin, Ronny/E-9944-2016	Chonghaile, Triona Ni/0000-0002-3041-4031; Drapkin, Ronny/0000-0002-6912-6977; Del Gaizo Moore, Victoria/0000-0002-6317-7693; Ryan, Jeremy/0000-0002-3327-1283; Sarosiek, Kristopher/0000-0002-4618-5085	Multiple Myeloma Research Foundation; American Cancer Society [121360-PF-11-256-01-TBG]; Dana-Farber Cancer Institute; Gabrielle's Angel Foundation for Cancer Research; FLAMES Fund of the Pan-Mass Challenge; NIH [RO1CA129974, P01CA068484, P01CA139980]; NATIONAL CANCER INSTITUTE [P01CA139980, R01CA129974, P01CA068484] Funding Source: NIH RePORTER	Multiple Myeloma Research Foundation; American Cancer Society(American Cancer Society); Dana-Farber Cancer Institute; Gabrielle's Angel Foundation for Cancer Research; FLAMES Fund of the Pan-Mass Challenge; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank I. Galinsky, J. Feather, R. Berkowitz, N. Horowitz, C. Feltmate, M. Muto, E. Kantoff, K. Daniels, and C. Doyle for assistance with human tumor sample procurement; K.-K. Wong and T. Mitchison for critical review; and K. Stevenson for help with biostatistical analysis. We thank Abbott Laboratories for providing ABT-737. We gratefully acknowledge funding from the Multiple Myeloma Research Foundation (T. N. C.), American Cancer Society Postdoctoral Fellowship 121360-PF-11-256-01-TBG (K. A. S.), Women's Cancers Program at the Dana-Farber Cancer Institute (K. A. S.), Gabrielle's Angel Foundation for Cancer Research (T.-T.V.), FLAMES Fund of the Pan-Mass Challenge, and NIH grants RO1CA129974, P01CA068484, and P01CA139980. A. L. is a Leukemia and Lymphoma Society Scholar. A. L. is a cofounder of and a paid advisor to Eutropics Pharmaceuticals, which has purchased a license for BH3 profiling from Dana-Farber Cancer Institute. P. R. is a paid advisor to Millennium Pharmaceuticals, Celgene Corporation, Novartis Pharmaceuticals, Johnson & Johnson, and Bristol Myers Squibb. T. N. C. and J. A. R. are paid consultants to Eutropics Pharmaceuticals. R. D. is a paid consultant for Novartis Pharmaceuticals and Forma Therapeutics. C. S. M. is a paid consultant for Millennium, Celgene, Novartis, Bristol-Myers Squibb, Merck & Co., Kosan Pharmaceuticals, Pharmion, Centocor, and Amnis Therapeutics. The authors (A. L.) and Dana-Farber Cancer Institute have applied for a patent relating to the use of BH3 profiling in predicting chemosensitivity.	Anderson KC, 2005, SEMIN HEMATOL, V42, pS3, DOI 10.1053/j.seminhematol.2005.10.001; Bosch F, 2008, CLIN CANCER RES, V14, P155, DOI 10.1158/1078-0432.CCR-07-1371; Brunelle JK, 2009, J CELL BIOL, V187, P429, DOI 10.1083/jcb.200904049; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chauhan D, 1997, ONCOGENE, V15, P837, DOI 10.1038/sj.onc.1201253; Chauhan D, 2010, BLOOD, V115, P834, DOI 10.1182/blood-2009-03-213009; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Hideshima T, 2001, CANCER RES, V61, P3071; Hurwitz JL, 2009, ONCOLOGIST, V14, P986, DOI 10.1634/theoncologist.2009-0026; KUBBEN FJGM, 1994, GUT, V35, P530, DOI 10.1136/gut.35.4.530; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Marcus R, 2005, BLOOD, V105, P1417, DOI 10.1182/blood-2004-08-3175; Moore VD, 2007, J CLIN INVEST, V117, P112, DOI 10.1172/JCI28281; Noguchi S, 2006, CANCER SCI, V97, P813, DOI 10.1111/j.1349-7006.2006.00265.x; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pasieka JL, 2003, CURR OPIN ONCOL, V15, P78, DOI 10.1097/00001622-200301000-00012; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Ringshausen I, 2006, CANCER CELL, V10, P501, DOI 10.1016/j.ccr.2006.10.010; Ryan JA, 2010, P NATL ACAD SCI USA, V107, P12895, DOI 10.1073/pnas.0914878107; SKIPPER HE, 1971, CANCER-AM CANCER SOC, V28, P1479, DOI 10.1002/1097-0142(197112)28:6<1479::AID-CNCR2820280622>3.0.CO;2-M; van Delft MF, 2010, CELL DEATH DIFFER, V17, P821, DOI 10.1038/cdd.2009.166; van Gent R, 2008, CANCER RES, V68, P10137, DOI 10.1158/0008-5472.CAN-08-2325; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; WEINSTEIN GD, 1984, J INVEST DERMATOL, V82, P623, DOI 10.1111/1523-1747.ep12261462	31	406	428	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 25	2011	334	6059					1129	1133		10.1126/science.1206727	http://dx.doi.org/10.1126/science.1206727			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22033517	Green Accepted			2022-12-28	WOS:000297313900050
J	Bertrand, R; Lenoir, J; Piedallu, C; Riofrio-Dillon, G; de Ruffray, P; Vidal, C; Pierrat, JC; Gegout, JC				Bertrand, Romain; Lenoir, Jonathan; Piedallu, Christian; Riofrio-Dillon, Gabriela; de Ruffray, Patrice; Vidal, Claude; Pierrat, Jean-Claude; Gegout, Jean-Claude			Changes in plant community composition lag behind climate warming in lowland forests	NATURE			English	Article							RANGE SHIFTS; TEMPERATURE; DIVERSITY; IMPACTS	Climate change is driving latitudinal and altitudinal shifts in species distribution worldwide(1,2), leading to novel species assemblages(3,4). Lags between these biotic responses and contemporary climate changes have been reported for plants and animals(5). Theoretically, the magnitude of these lags should be greatest in lowland areas, where the velocity of climate change is expected to be much greater than that in highland areas(6). We compared temperature trends to temperatures reconstructed from plant assemblages (observed in 76,634 surveys) over a 44-year period in France (1965-2008). Here we report that forest plant communities had responded to 0.54 degrees C of the effective increase of 1.07 degrees C in highland areas (500-2,600 m above sea level), while they had responded to only 0.02 degrees C of the 1.11 degrees C warming trend in lowland areas. There was a larger temperature lag (by 3.1 times) between the climate and plant community composition in lowland forests than in highland forests. The explanation of such disparity lies in the following properties of lowland, as compared to highland, forests: the higher proportion of species with greater ability for local persistence as the climate warms(7), the reduced opportunity for short-distance escapes(8,9), and the greater habitat fragmentation. Although mountains are currently considered to be among the ecosystems most threatened by climate change (owing to mountaintop extinction), the current inertia of plant communities in lowland forests should also be noted, as it could lead to lowland biotic attrition(10).	[Bertrand, Romain; Piedallu, Christian; Riofrio-Dillon, Gabriela; Pierrat, Jean-Claude; Gegout, Jean-Claude] AgroParisTech, ENGREF, UMR1092, Lab Etud Ressources Foret Bois LERFoB, F-54000 Nancy, France; [Bertrand, Romain; Piedallu, Christian; Riofrio-Dillon, Gabriela; Pierrat, Jean-Claude; Gegout, Jean-Claude] INRA, Ctr Nancy, UMR1092, Lab Etud Ressources Foret Bois LERFoB, F-54280 Champenoux, France; [Lenoir, Jonathan] Aarhus Univ, Dept Biosci, Ecoinformat & Biodivers Grp, DK-8000 Aarhus C, Denmark; [de Ruffray, Patrice] Univ Strasbourg UDS, Inst Biol Mol Plantes IBMP, CNRS, F-67084 Strasbourg, France; [Vidal, Claude] Inventaire Forestier Natl, F-45290 Nogent Sur Marne, France	AgroParisTech; INRAE; Aarhus University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Bertrand, R (corresponding author), AgroParisTech, ENGREF, UMR1092, Lab Etud Ressources Foret Bois LERFoB, 14 Rue Girardet, F-54000 Nancy, France.	romain.bertrand@engref.agroparistech.fr	Lenoir, Jonathan/AAE-8441-2019	Lenoir, Jonathan/0000-0003-0638-9582; Bertrand, Romain/0000-0003-2386-9174; Gegout, Jean-Claude/0000-0002-5760-9920	French Institute of Agricultural, Forest and Environmental Engineering (ENGREF, AgroParisTech); National Forest Department (ONF); French Agency for Environment and Energy Management (ADEME); Danish Council for Independent Research - Natural Sciences [272-07-0242]; ADEME; Regional Council of Lorraine	French Institute of Agricultural, Forest and Environmental Engineering (ENGREF, AgroParisTech); National Forest Department (ONF); French Agency for Environment and Energy Management (ADEME)(French National Research Agency (ANR)); Danish Council for Independent Research - Natural Sciences(Det Frie Forskningsrad (DFF)); ADEME; Regional Council of Lorraine(Region Grand-Est)	We thank J.-D. Bontemps and P. Merian for comments; V. Perez, F. Lebourgeois and E. K. Cavalheri for help in the compilation of the meteorological database; V. Perez for technical support in GIS; I. Seynave for management of the EcoPlant database; H. Brisse, J. Drapier and F. Morneau for contributions to the Sophy and NFI databases; and all who have participated in the conception of the EcoPlant, Sophy and NFI databases. The phytoecological database (EcoPlant) was funded by the French Institute of Agricultural, Forest and Environmental Engineering (ENGREF, AgroParisTech), the National Forest Department (ONF), and the French Agency for Environment and Energy Management (ADEME). J. L. acknowledges a grant from the Danish Council for Independent Research - Natural Sciences (272-07-0242 to J.-C. Svenning). This study was funded through a PhD grant to R. B. by ADEME and the Regional Council of Lorraine.	Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Cannone N, 2007, FRONT ECOL ENVIRON, V5, P360, DOI 10.1890/1540-9295(2007)5[360:UIOCCO]2.0.CO;2; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; Davis M.B., 1986, COMMUNITY ECOL, P269; Doak DF, 2010, NATURE, V467, P959, DOI 10.1038/nature09439; Heikkila M, 2003, QUATERNARY SCI REV, V22, P541, DOI 10.1016/S0277-3791(02)00189-0; Hillebrand H, 2010, GLOBAL CHANGE BIOL, V16, P1181, DOI 10.1111/j.1365-2486.2009.02045.x; Huntley B, 2007, HEREDITY, V98, P247, DOI 10.1038/sj.hdy.6800972; Jackson ST, 2010, TRENDS ECOL EVOL, V25, P153, DOI 10.1016/j.tree.2009.10.001; Jump AS, 2009, TRENDS ECOL EVOL, V24, P694, DOI 10.1016/j.tree.2009.06.007; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; le Roux PC, 2008, GLOBAL CHANGE BIOL, V14, P2950, DOI 10.1111/j.1365-2486.2008.01687.x; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lenoir J, 2010, J VEG SCI, V21, P949, DOI 10.1111/j.1654-1103.2010.01201.x; Lenoir J, 2010, ECOGRAPHY, V33, P295, DOI 10.1111/j.1600-0587.2010.06279.x; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Ninyerola M, 2000, INT J CLIMATOL, V20, P1823, DOI 10.1002/1097-0088(20001130)20:14<1823::AID-JOC566>3.0.CO;2-B; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PRIMACK RB, 1992, CONSERV BIOL, V6, P513, DOI 10.1046/j.1523-1739.1992.06040513.x; Rosenzweig C, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P79; Scherrer D, 2011, J BIOGEOGR, V38, P406, DOI 10.1111/j.1365-2699.2010.02407.x; TERBRAAK CJF, 1989, HYDROBIOLOGIA, V178, P209, DOI 10.1007/BF00006028; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Vennetier M, 2009, FOREST ECOL MANAG, V258, pS56, DOI 10.1016/j.foreco.2009.09.015; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Wing SL, 2005, SCIENCE, V310, P993, DOI 10.1126/science.1116913	30	506	531	13	409	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 24	2011	479	7374					517	520		10.1038/nature10548	http://dx.doi.org/10.1038/nature10548			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	851QI	22012261				2022-12-28	WOS:000297285600048
J	Smear, M; Shusterman, R; O'Connor, R; Bozza, T; Rinberg, D				Smear, Matthew; Shusterman, Roman; O'Connor, Rodney; Bozza, Thomas; Rinberg, Dmitry			Perception of sniff phase in mouse olfaction	NATURE			English	Article							NEURONS; BULB; REPRESENTATIONS; COMPUTATION; RESPONSES; DYNAMICS; PATTERNS; UNITS	Olfactory systems encode odours by which neurons respond and by when they respond(1-3). In mammals, every sniff evokes a precise, odour-specific sequence of activity across olfactory neurons(4-6). Likewise, in a variety of neural systems, ranging from sensory periphery(7,8) to cognitive centres(9), neuronal activity is timed relative to sampling behaviour and/or internally generated oscillations. As in these neural systems, relative timing of activity may represent information in the olfactory system(10,11). However, there is no evidence that mammalian olfactory systems read such cues(12,13). To test whether mice perceive the timing of olfactory activation relative to the sniff cycle ('sniff phase'), we used optogenetics in gene-targeted mice to generate spatially constant, temporally controllable olfactory input. Here we show that mice can behaviourally report the sniff phase of optogenetically driven activation of olfactory sensory neurons. Furthermore, mice can discriminate between light-evoked inputs that are shifted in the sniff cycle by as little as 10 milliseconds, which is similar to the temporal precision of olfactory bulb odour responses(14,15). Electrophysiological recordings in the olfactory bulb of awake mice show that individual cells encode the timing of photoactivation in relation to the sniff in both the timing and the amplitude of their responses. Our work provides evidence that the mammalian olfactory system can read temporal patterns, and suggests that timing of activity relative to sampling behaviour is a potent cue that may enable accurate olfactory percepts to form quickly(11,16).	[Smear, Matthew; Shusterman, Roman; O'Connor, Rodney; Bozza, Thomas; Rinberg, Dmitry] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Smear, Matthew; Bozza, Thomas] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA	Howard Hughes Medical Institute; Northwestern University	Rinberg, D (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	bozza@northwestern.edu; rinbergd@janelia.hhmi.org	Shusterman, Roman/B-9514-2008	Shusterman, Roman/0000-0002-1081-2884; O'Connor, Rodney/0000-0002-3916-3101	JFRC; NIDCD [R01DC009640, R21DC010911]; Whitehall Foundation; Brain Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009640, R21DC010911] Funding Source: NIH RePORTER	JFRC; NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Whitehall Foundation; Brain Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank L. Doglio and the Transgenic and Targeted Mutagenesis Laboratory at Northwestern University for generation of chimaeric mice, B. Weiland for technical help with cloning and gene targeting, D. Huber, D. O'Connor and T. Komiyama for advice on mouse behaviour, D. Wesson and M. Wachowiak for instruction on sniff measurement, J. Nunez-Iglesias for assistance with statistics, G. Shtengel for advice on laser set-up, and T. Tabachnik and H. Davidowitz for help designing the behavioural rig. J. Osborne fabricated the microdrive. G. Lott provided digital acquisition software. A. Koulakov contributed to spike-sorting and classification algorithms. We thank W. Denk, K. Svoboda, R. Gutig, R. Egnor, M. Orger and A. Resulaj for comments on the manuscript. This work was supported by the Visiting Scientist Program at JFRC. T. B. was supported by NIDCD (R01DC009640, R21DC010911), the Whitehall Foundation and the Brain Research Foundation.	Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Brody CD, 2003, NEURON, V37, P843, DOI 10.1016/S0896-6273(03)00120-X; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Cang JH, 2003, J NEUROSCI, V23, P4108; CHAPUT M, 1980, J PHYSIOL-PARIS, V76, P551; Curtis JC, 2009, NAT NEUROSCI, V12, P492, DOI 10.1038/nn.2283; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; Di Lorenzo PM, 2009, BEHAV NEUROSCI, V123, P14, DOI 10.1037/a0014176; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Garthwaite P., 2002, STAT INFERENCE; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; Grosmaitre X, 2007, NAT NEUROSCI, V10, P348, DOI 10.1038/nn1856; HALL C, 1995, J COMP PHYSIOL A, V177, P29; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Jacobs AL, 2009, P NATL ACAD SCI USA, V106, P5936, DOI 10.1073/pnas.0900573106; Junek S, 2010, NEURON, V67, P872, DOI 10.1016/j.neuron.2010.08.005; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Leon M, 2009, CELL MOL LIFE SCI, V66, P2135, DOI 10.1007/s00018-009-0011-9; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; MONOD B, 1989, BEHAV BRAIN RES, V33, P51, DOI 10.1016/S0166-4328(89)80018-X; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; Nagel KI, 2011, NAT NEUROSCI, V14, P208, DOI 10.1038/nn.2725; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Perkel D. H., 1968, NEUROSCI RES PROGRAM, V6, P219; Raman B, 2010, J NEUROSCI, V30, P1994, DOI 10.1523/JNEUROSCI.5639-09.2010; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Schaefer AT, 2007, TRENDS NEUROSCI, V30, P92, DOI 10.1016/j.tins.2007.01.001; Shusterman R, 2011, NAT NEUROSCI, V14, P1039, DOI 10.1038/nn.2877; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; SZABO T, 1967, PHYSIOL BEHAV, V2, P331, DOI 10.1016/0031-9384(67)90047-9; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010	33	154	157	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2011	479	7373					397	U149		10.1038/nature10521	http://dx.doi.org/10.1038/nature10521			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	848OA	21993623				2022-12-28	WOS:000297059700045
J	Covinsky, KE; Pierluissi, E; Johnston, CB				Covinsky, Kenneth E.; Pierluissi, Edgar; Johnston, C. Bree			Hospitalization-Associated Disability "She Was Probably Able to Ambulate, but I'm Not Sure"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONG-TERM-CARE; FUNCTIONAL DECLINE; OLDER PATIENTS; RANDOMIZED-TRIAL; LOW MOBILITY; MULTICOMPONENT INTERVENTION; GERIATRIC ASSESSMENT; RESTRICTED ACTIVITY; MEDICAL UNIT; ELDERS ACE	In older patients, acute medical illness that requires hospitalization is a sentinel event that often precipitates disability. This results in the subsequent inability to live independently and complete basic activities of daily living (ADLs). This hospitalization-associated disability occurs in approximately one-third of patients older than 70 years of age and may be triggered even when the illness that necessitated the hospitalization is successfully treated. In this article, we describe risk factors and risk stratification tools that identify older adults at highest risk of hospitalization-associated disability. We describe hospital processes that may promote hospitalization-associated disability and models of care that have been developed to prevent it. Since recognition of functional status problems is an essential prerequisite to preventing and managing disability, we also describe a pragmatic approach toward functional status assessment in the hospital focused on evaluation of ADLs, mobility, and cognition. Based on studies of acute geriatric units, we describe interventions hospitals and clinicians can consider to prevent hospitalization-associated disability in patients. Finally, we describe approaches clinicians can implement to improve the quality of life of older adults who develop hospitalization-associated disability and that of their caregivers. JAMA. 2011;306(16):1782-1793	[Covinsky, Kenneth E.; Pierluissi, Edgar; Johnston, C. Bree] Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94121 USA; [Covinsky, Kenneth E.; Pierluissi, Edgar; Johnston, C. Bree] Univ Calif San Francisco, Dept Med, San Francisco, CA 94121 USA; [Pierluissi, Edgar] San Francisco Gen Hosp, Dept Med, San Francisco, CA 94110 USA; [Pierluissi, Edgar] San Francisco Gen Hosp, Div Hosp Med, San Francisco, CA 94110 USA; [Covinsky, Kenneth E.; Johnston, C. Bree] San Francisco VA Med Ctr, Sect Geriatr & Palliat Care, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; San Francisco General Hospital Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Covinsky, KE (corresponding author), Univ Calif San Francisco, Div Geriatr, 4150 Clement St 181G, San Francisco, CA 94121 USA.	ken.covinsky@ucsf.edu			National Institute on Aging; SCAN Foundation	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); SCAN Foundation	This work was supported in part by a K24 midcareer investigator award from the National Institute on Aging (Covinsky). The Care of the Aging Patient series is made possible by funding from The SCAN Foundation.	Asplund K, 2000, J AM GERIATR SOC, V48, P1381, DOI 10.1111/j.1532-5415.2000.tb02626.x; Bachmann S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1718; Baztan JJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b50; Bogardus ST, 2001, J GEN INTERN MED, V16, P728, DOI 10.1046/j.1525-1497.2001.00625.x; Boltz M, 2008, GERIATR NURS, V29, P176, DOI 10.1016/j.gerinurse.2008.02.002; Boyd CM, 2008, J AM GERIATR SOC, V56, P2171, DOI 10.1111/j.1532-5415.2008.02023.x; Brown CJ, 2004, J AM GERIATR SOC, V52, P1263, DOI 10.1111/j.1532-5415.2004.52354.x; Brown CJ, 2009, J AM GERIATR SOC, V57, P1660, DOI 10.1111/j.1532-5415.2009.02393.x; Brown CJ, 2009, ANN INTERN MED, V150, P372, DOI 10.7326/0003-4819-150-6-200903170-00005; Collard A F, 1985, QRB Qual Rev Bull, V11, P180; Counsell SR, 2000, J AM GERIATR SOC, V48, P1572, DOI 10.1111/j.1532-5415.2000.tb03866.x; Covinsky KE, 1997, J AM GERIATR SOC, V45, P729, DOI 10.1111/j.1532-5415.1997.tb01478.x; Covinsky KE, 1999, J AM GERIATR SOC, V47, P532, DOI 10.1111/j.1532-5415.1999.tb02566.x; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; Covinsky KE, 1997, ANN INTERN MED, V126, P417, DOI 10.7326/0003-4819-126-6-199703150-00001; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; Emanuel EJ, 2000, ANN INTERN MED, V132, P451, DOI 10.7326/0003-4819-132-6-200003210-00005; Ferrucci L, 1997, JAMA-J AM MED ASSOC, V277, P728; Fortinsky RH, 1999, J GERONTOL A-BIOL, V54, pM521, DOI 10.1093/gerona/54.10.M521; Fried LP, 1997, J AM GERIATR SOC, V45, P92, DOI 10.1111/j.1532-5415.1997.tb00986.x; Gill TM, 2008, J AM GERIATR SOC, V56, P436, DOI 10.1111/j.1532-5415.2007.01603.x; Gill TM, 2010, JAMA-J AM MED ASSOC, V304, P1919, DOI 10.1001/jama.2010.1568; Gill TM, 2004, JAMA-J AM MED ASSOC, V292, P2115, DOI 10.1001/jama.292.17.2115; Gill TM, 1998, ANN INTERN MED, V128, P96, DOI 10.7326/0003-4819-128-2-199801150-00004; Goode PS, 2010, JAMA-J AM MED ASSOC, V303, P2172, DOI 10.1001/jama.2010.749; Gray LC, 2008, J AM GERIATR SOC, V56, P536, DOI 10.1111/j.1532-5415.2007.01590.x; Hardy SE, 2004, JAMA-J AM MED ASSOC, V291, P1596, DOI 10.1001/jama.291.13.1596; HARRIS RD, 1991, AUST NZ J MED, V21, P230, DOI 10.1111/j.1445-5994.1991.tb00448.x; HIRSCH CH, 1990, J AM GERIATR SOC, V38, P1296, DOI 10.1111/j.1532-5415.1990.tb03451.x; Inouye SK, 2009, NEW ENGL J MED, V360, P2390, DOI 10.1056/NEJMp0900963; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Inouye SK, 1996, JAMA-J AM MED ASSOC, V275, P852, DOI 10.1001/jama.275.11.852; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Inouye SK, 1998, J GEN INTERN MED, V13, P234, DOI 10.1046/j.1525-1497.1998.00073.x; INOUYE SK, 1993, J GEN INTERN MED, V8, P645, DOI 10.1007/BF02598279; Kane RL, 2011, JAMA-J AM MED ASSOC, V305, P284, DOI 10.1001/jama.2010.2015; Kaye HS, 2010, HEALTH AFFAIR, V29, P11, DOI 10.1377/hlthaff.2009.0535; Kelley AS, 2010, NEW ENGL J MED, V363, P781, DOI 10.1056/NEJMe1004139; Kiely DK, 2007, J GERONTOL A-BIOL, V62, P174, DOI 10.1093/gerona/62.2.174; Kortebein P, 2008, J GERONTOL A-BIOL, V63, P1076, DOI 10.1093/gerona/63.10.1076; LANDEFELD CS, 1995, NEW ENGL J MED, V332, P1338, DOI 10.1056/NEJM199505183322006; Leff B, 2005, ANN INTERN MED, V143, P798, DOI 10.7326/0003-4819-143-11-200512060-00008; Leff B, 2009, J AM GERIATR SOC, V57, P273, DOI 10.1111/j.1532-5415.2008.02103.x; Levine C, 1999, NEW ENGL J MED, V340, P1587, DOI 10.1056/NEJM199905203402013; Li AK, 2005, J GEN INTERN MED, V20, P168, DOI 10.1111/j.1525-1497.2005.30315.x; Lindenberger EC, 2003, J AM GERIATR SOC, V51, P621, DOI 10.1034/j.1600-0579.2003.00205.x; Magaziner J, 2000, J GERONTOL A-BIOL, V55, pM498, DOI 10.1093/gerona/55.9.M498; Mahoney JE, 1999, J GERONTOL A-BIOL, V54, pM83, DOI 10.1093/gerona/54.2.M83; Malone ML, 2010, J AM GERIATR SOC, V58, P161, DOI 10.1111/j.1532-5415.2009.02624.x; Marcantonio ER, 2010, J AM GERIATR SOC, V58, P1019, DOI 10.1111/j.1532-5415.2010.02871.x; Medicare, WHAT IS HOM HLTH CAR; Mehta KM, 2011, J AM GERIATR SOC, V59, P1206, DOI 10.1111/j.1532-5415.2011.03409.x; PALMER RM, 1994, J AM GERIATR SOC, V42, P545, DOI 10.1111/j.1532-5415.1994.tb04978.x; PFEIFFER E, 1975, J AM GERIATR SOC, V23, P433, DOI 10.1111/j.1532-5415.1975.tb00927.x; REUBEN DB, 1995, NEW ENGL J MED, V332, P1345, DOI 10.1056/NEJM199505183322007; Sager MA, 1996, J AM GERIATR SOC, V44, P251, DOI 10.1111/j.1532-5415.1996.tb00910.x; Saint S, 2002, ANN INTERN MED, V137, P125, DOI 10.7326/0003-4819-137-2-200207160-00012; Sands LP, 2003, J GERONTOL A-BIOL, V58, P37; Scanlan J, 2001, INT J GERIATR PSYCH, V16, P216, DOI 10.1002/1099-1166(200102)16:2<216::AID-GPS316>3.0.CO;2-B; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Smith AK, 2010, ANN INTERN MED, V153, P563, DOI 10.7326/0003-4819-153-9-201011020-00005; Steinman MA, 2010, JAMA-J AM MED ASSOC, V304, P1592, DOI 10.1001/jama.2010.1482; Tamura MK, 2009, NEW ENGL J MED, V361, P1539, DOI 10.1056/NEJMoa0904655; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024; TINETTI ME, 1995, JAMA-J AM MED ASSOC, V273, P1348, DOI 10.1001/jama.273.17.1348; Wachterman MW, 2011, JAMA-J AM MED ASSOC, V305, P472, DOI 10.1001/jama.2011.70; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2987, DOI 10.1001/jama.285.23.2987; Widera E, 2011, JAMA-J AM MED ASSOC, V305, P698, DOI 10.1001/jama.2011.164; Yaffe K, 2002, JAMA-J AM MED ASSOC, V287, P2090, DOI 10.1001/jama.287.16.2090; Zisberg A, 2011, J AM GERIATR SOC, V59, P266, DOI 10.1111/j.1532-5415.2010.03276.x	72	497	500	3	53	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 26	2011	306	16					1782	1793		10.1001/jama.2011.1556	http://dx.doi.org/10.1001/jama.2011.1556			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	837HH	22028354				2022-12-28	WOS:000296181600023
J	Nicholls, H				Nicholls, Henry			CLIMATE CHANGE AND HEALTH Unhealthier by degrees	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POPULATION					henry@henrynicholls.com						de Bruin KC, 2009, CLIMATIC CHANGE, V95, P63, DOI 10.1007/s10584-008-9535-5; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; Hsiang SM, 2011, NATURE, V476, P438, DOI 10.1038/nature10311; Stott R, 2006, BRIT MED J, V332, P1385, DOI 10.1136/bmj.332.7554.1385; Zhang DD, 2007, P NATL ACAD SCI USA, V104, P19214, DOI 10.1073/pnas.0703073104; Zhou XN, 2008, AM J TROP MED HYG, V78, P188, DOI 10.4269/ajtmh.2008.78.188	6	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 26	2011	343								d6893	10.1136/bmj.d6893	http://dx.doi.org/10.1136/bmj.d6893			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	840CY	22031914				2022-12-28	WOS:000296417100016
J	Azoitei, ML; Correia, BE; Ban, YEA; Carrico, C; Kalyuzhniy, O; Chen, L; Schroeter, A; Huang, PS; McLellan, JS; Kwong, PD; Baker, D; Strong, RK; Schief, WR				Azoitei, Mihai L.; Correia, Bruno E.; Ban, Yih-En Andrew; Carrico, Chris; Kalyuzhniy, Oleksandr; Chen, Lei; Schroeter, Alexandria; Huang, Po-Ssu; McLellan, Jason S.; Kwong, Peter D.; Baker, David; Strong, Roland K.; Schief, William R.			Computation-Guided Backbone Grafting of a Discontinuous Motif onto a Protein Scaffold	SCIENCE			English	Article							EPITOPE-SCAFFOLDS; HIV-1 GP120; DESIGN; ANTIBODIES; NEUTRALIZATION; SITE	The manipulation of protein backbone structure to control interaction and function is a challenge for protein engineering. We integrated computational design with experimental selection for grafting the backbone and side chains of a two-segment HIV gp120 epitope, targeted by the cross-neutralizing antibody b12, onto an unrelated scaffold protein. The final scaffolds bound b12 with high specificity and with affinity similar to that of gp120, and crystallographic analysis of a scaffold bound to b12 revealed high structural mimicry of the gp120-b12 complex structure. The method can be generalized to design other functional proteins through backbone grafting.	[Azoitei, Mihai L.; Correia, Bruno E.; Ban, Yih-En Andrew; Carrico, Chris; Kalyuzhniy, Oleksandr; Schroeter, Alexandria; Huang, Po-Ssu; Baker, David; Schief, William R.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Correia, Bruno E.] Inst Gulbenkian Ciencias, PhD Program Computat Biol, Oeiras, Portugal; [Carrico, Chris; Strong, Roland K.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Chen, Lei; McLellan, Jason S.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, Bethesda, MD 20892 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Schief, William R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Schief, William R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	University of Washington; University of Washington Seattle; Instituto Gulbenkian de Ciencia; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute	Schief, WR (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	schief@scripps.edu	Baker, David/K-8941-2012; Schief, William/ABF-3645-2020; McLellan, Jason/A-6874-2010	Baker, David/0000-0001-7896-6217; Schief, William/0000-0002-1120-0150; Huang, Possu/0000-0002-7948-2895; McLellan, Jason/0000-0003-3991-542X; Carrico, Chris/0000-0003-0939-9006; Kalyuzhniy, Oleksandr/0000-0002-5273-1951	International AIDS Vaccine Initiative Neutralizing Antibody Consortium; Bill and Melinda Gates Foundation Consortium for AIDS Vaccine Discovery; Portuguese Fundacao para a Ciencia e a Tecnologia [SFRH/774 BD/32958/2006]; PDB [3RPT, 3RU8]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005024] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative Neutralizing Antibody Consortium; Bill and Melinda Gates Foundation Consortium for AIDS Vaccine Discovery; Portuguese Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); PDB; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the International AIDS Vaccine Initiative Neutralizing Antibody Consortium and the Bill and Melinda Gates Foundation Consortium for AIDS Vaccine Discovery. B.E.C. was supported by a fellowship from the Portuguese Fundacao para a Ciencia e a Tecnologia (SFRH/774 BD/32958/2006). We thank I. Wilson for comments on the manuscript; D. Burton, A. Hessell, and the IAVI Neutralizing Antibody Consortium Reagent Repository for providing b6, b12, and b13; J. Mascola for VRC01 and VRC03; Progenics Inc. for CD4-IgG2; D. Dimitrov for m6, m14, and m18; J. Robinson for 15E; and R. Wyatt for F105 and HxB2 gp120. We thank G. Nabel, M. Kanekiyo, and Z.-Y. Yang for experiments on early generations of b12 scaffolds. Coordinates and structure factors were deposited in the PDB as entries 3RPT and 3RU8. The University of Washington has filed a patent application on the b12 scaffolds and the scaffolding method developed in this study. Materials and information will be provided to noncommercial users under the Uniform Biological Materials Transfer Agreement. The Multigraft software developed in this work is freely available to noncommercial users through the Rosetta Commons agreement (www.rosettacommons.org).	Baker D, 2010, PROTEIN SCI, V19, P1817, DOI 10.1002/pro.481; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010; Drakopoulou E, 1996, J BIOL CHEM, V271, P11979, DOI 10.1074/jbc.271.20.11979; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; JIN L, 1992, J MOL BIOL, V226, P851, DOI 10.1016/0022-2836(92)90636-X; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Lu SM, 2002, J BIOL CHEM, V277, P23515, DOI 10.1074/jbc.M201981200; Mandell DJ, 2009, NAT CHEM BIOL, V5, P797, DOI 10.1038/nchembio.251; Martin L, 2003, NAT BIOTECHNOL, V21, P71, DOI 10.1038/nbt768; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Rubinstein ND, 2008, MOL IMMUNOL, V45, P3477, DOI 10.1016/j.molimm.2007.10.016; Rutledge SE, 2003, J AM CHEM SOC, V125, P14336, DOI 10.1021/ja034508o; Sia SK, 2003, P NATL ACAD SCI USA, V100, P9756, DOI 10.1073/pnas.1733910100; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	23	162	165	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 21	2011	334	6054					373	376		10.1126/science.1209368	http://dx.doi.org/10.1126/science.1209368			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	22021856				2022-12-28	WOS:000296052500052
J	Iglehart, JK				Iglehart, John K.			Defining Essential Health Benefits - The View from the IOM Committee	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		CBO (Congressional Budget Office), 2009, COMMUNICATION   1130; Department of Labor, 2011, SEL MED BEN REP DEP; Eibner C., 2010, ESTABLISHING STATE H; Institute of Medicine Committee on defining and Revising Essential Health Benefits Package for Qualified Health Plans, 2011, REP ESS HLTH BEN BAL	4	9	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2011	365	16					1461	1463		10.1056/NEJMp1109982	http://dx.doi.org/10.1056/NEJMp1109982			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	835BW	21992514	Bronze			2022-12-28	WOS:000296009500012
J	Saha, K; Hurlbut, JB				Saha, Krishanu; Hurlbut, J. Benjamin			Treat donors as partners in biobank research	NATURE			English	Editorial Material									[Saha, Krishanu] Harvard Kennedy Sch, Program Sci Technol & Soc, Cambridge, MA 02138 USA; [Saha, Krishanu] Whitehead Inst, Cambridge, MA 02138 USA; [Hurlbut, J. Benjamin] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Harvard University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Arizona State University; Arizona State University-Tempe	Saha, K (corresponding author), Harvard Kennedy Sch, Program Sci Technol & Soc, Cambridge, MA 02138 USA.	saha@wi.mit.edu; bhurlbut@asu.edu	Saha, Krishanu/J-3980-2014	Saha, Krishanu/0000-0003-2837-0858				[Anonymous], 2008, NATURE; Do C. B., 2011, GENET MED, V7, DOI DOI 10.1097/GIM.0B013E3182310BA0; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Jasanoff S, 2011, BASIC BIOETH, P1; Ludman E. J., 2010, FED REG         0726, V5, P9; Ludman EJ, 2010, J EMPIR RES HUM RES, V5, P9, DOI 10.1525/jer.2010.5.3.9; Mathews DJH, 2011, SCIENCE, V331, P725, DOI 10.1126/science.1201382; Poste G, 2011, NATURE, V469, P156, DOI 10.1038/469156a; President's Council of Advisors on Science and Technology, 2008, PRIORITIES PERSONALI; Vaught J., 2009, RES POLICY INITIATIV	10	33	34	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 20	2011	478	7369					312	313		10.1038/478312a	http://dx.doi.org/10.1038/478312a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	22012372				2022-12-28	WOS:000296021100017
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA Off-label prescribing in macular degeneration	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				2011, BRIT MED J, V343, pD6169, DOI DOI 10.1136/BMJ.D6169; 2010, ARCH OPHTHALMOL-CHIC, V128, P1273, DOI DOI 10.1001/ARCHOPHTHALMOL.2010.223; 2011, NEW ENGL J MED, V364, P1897, DOI DOI 10.1056/NEJMOA1102673	3	3	3	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 19	2011	343								d6778	10.1136/bmj.d6778	http://dx.doi.org/10.1136/bmj.d6778			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HN	22012651				2022-12-28	WOS:000296183700012
J	Delmonico, FL; Dominguez-Gil, B; Matesanz, R; Noel, L				Delmonico, Francis L.; Dominguez-Gil, Beatriz; Matesanz, Rafael; Noel, Luc			Organ Transplantation 1 A call for government accountability to achieve national self-sufficiency in organ donation and transplantation	LANCET			English	Article							DONOR; CARE; DEATH; FORUM	Roughly 100 000 patients worldwide undergo organ transplantation annually, but many other patients remain on waiting lists. Transplantation rates vary substantially across countries. Affluent patients in nations with long waiting lists do not always wait for donations from within their own countries. Commercially driven transplantation, however, does not always ensure proper medical care of recipients or donors, and might lengthen waiting times for resident patients or increase the illegal and unethical purchase of organs from living donors. Governments should systematically address the needs of their countries according to a legal framework. Medical strategies to prevent end-stage organ failure must also be implemented. In view of the Madrid Resolution, the Declaration of Istanbul, and the 63rd World Health Assembly Resolution, a new paradigm of national self-sufficiency is needed. Each country or region should strive to provide a sufficient number of organs from within its own population, guided by WHO ethics principles.	[Delmonico, Francis L.] New England Organ Bank Inc, Waltham, MA 02451 USA; [Delmonico, Francis L.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Surg, Cambridge, MA 02138 USA; [Dominguez-Gil, Beatriz; Matesanz, Rafael] Org Nacl Trasplantes, Madrid, Spain; [Noel, Luc] WHO, CH-1211 Geneva, Switzerland	Harvard University; Massachusetts General Hospital; World Health Organization	Delmonico, FL (corresponding author), New England Organ Bank Inc, 60 1st Ave, Waltham, MA 02451 USA.	francis_delmonico@neob.org		Dominguez-Gil, Beatriz/0000-0002-5695-8993				Abbud M, 2008, LANCET, V372, P5, DOI 10.1016/S0140-6736(08)60967-8; Barber K, 2006, BMJ-BRIT MED J, V332, P1124, DOI 10.1136/bmj.38804.658183.55; Barr ML, 2006, TRANSPLANTATION, V81, P1373, DOI 10.1097/01.tp.0000216825.56841.cd; Bernat JL, 2010, CRIT CARE MED, V38, P963, DOI 10.1097/CCM.0b013e3181c58916; Bernat JL, 2006, AM J TRANSPLANT, V6, P281, DOI 10.1111/j.1600-6143.2005.01194.x; Budiani-Saberi DA, 2008, AM J TRANSPLANT, V8, P925, DOI 10.1111/j.1600-6143.2008.02200.x; Council of Europe, TRAFF ORG TISS CELLS; Delmonico FL, 2005, TRANSPLANTATION, V79, pS53; Dominguez-Gil B, 2011, TRANSPL INT, V24, P676, DOI 10.1111/j.1432-2277.2011.01257.x; Dominguez-Gil B, 2011, TRANSPL INT, V24, P373, DOI 10.1111/j.1432-2277.2011.01243.x; Matesanz R, 2011, TRANSPL INT, V24, P333, DOI 10.1111/j.1432-2277.2010.01204.x; Roels L, 2008, TRANSPLANTATION, V86, P1738, DOI 10.1097/TP.0b013e3181908e08; Segev DL, 2010, JAMA-J AM MED ASSOC, V303, P959, DOI 10.1001/jama.2010.237; Sheehy E, 2003, NEW ENGL J MED, V349, P667, DOI 10.1056/NEJMsa021271; United Nations Development Program, INT HUM DEV IND; Wesslau C, 2007, TRANSPL INT, V20, P147, DOI 10.1111/j.1432-2277.2006.00413.x; Wijdicks EFM, 2010, NEUROLOGY, V74, P1911, DOI 10.1212/WNL.0b013e3181e242a8; World Health Organization, WHO GUID PRINC HUM C; World Health Organization, GLOB OBS DON TRANSPL; World Health Organization Transplantation Society and Organization Nacional de Transplantes, 2011, TRANSPLANTATION, V91, pS29, DOI DOI 10.1097/01.TP.0000399131.74618.A5	20	106	111	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 15	2011	378	9800					1414	1418		10.1016/S0140-6736(11)61486-4	http://dx.doi.org/10.1016/S0140-6736(11)61486-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	838EM	22000137				2022-12-28	WOS:000296269600028
J	Kwok, AC; Semel, ME; Lipsitz, SR; Bader, AM; Barnato, AE; Gawande, AA; Jha, AK				Kwok, Alvin C.; Semel, Marcus E.; Lipsitz, Stuart R.; Bader, Angela M.; Barnato, Amber E.; Gawande, Atul A.; Jha, Ashish K.			The intensity and variation of surgical care at the end of life: a retrospective cohort study	LANCET			English	Article							MEDICARE EXPENDITURES; UNITED-STATES; CANCER; TRENDS; ICD-9-CM; OUTCOMES; QUALITY; AGE	Background Although the extent of hospital and intensive-care use at the end of life is well known, patterns of surgical care during this period are poorly understood. We examined national patterns of surgical care in the USA among elderly fee-for-service Medicare beneficiaries in their last year of life. Methods We did a retrospective cohort study of elderly beneficiaries of fee-for-service Medicare in the USA, aged 65 years or older, who died in 2008. We identified claims for inpatient surgical procedures in the year before death and examined the relation between receipt of an inpatient procedure and both age and geographical region. We calculated an end-of-life surgical intensity (EOLSI) score for each hospital referral region defined as proportion of decedents who underwent a surgical procedure during the year before their death, adjusted for age, sex, race, and income. We compared patient characteristics with Rao-Scott chi(2) tests, resource use with generalised estimating equations, regional differences with generalised estimating equations Wald tests, and end-of-life surgical intensity scores with Spearman's partial-rank-order correlation coefficients. Findings Of 1 802 029 elderly beneficiaries of fee-for-service Medicare who died in 2008, 31.9% (95% CI 31.9-32.0; 575596 of 1802 029) underwent an inpatient surgical procedure during the year before death, 18.3% (18.2-18.4; 329 771 of 1802 029) underwent a procedure in their last month of life, and 8.0% (8.0-8.1; 144 162 of 1 802 029) underwent a procedure during their last week of life. Between the ages of 80 and 90 years, the percentage of decedents undergoing a surgical procedure in the last year of life decreased by 33% (35.3% [95% CI 34.7-35.9; 8858 of 25 094] to 23.6% [22.9-24.3; 3340 of 14 152]). EOLSI score in the highest intensity region (Munster, IN) was 34.4(95% Cl 33.7-35.1) and in the lowest intensity region (Honolulu, HI) was 11.5 (11.3-11.7). Regions with a high number of hospital beds per head had high end-of-life surgical intensity (r=0.37, 95% CI 0.27-0.46; p<0.0001), as did regions with high total Medicare spending (r=0.50, 0.41-0.58; p<0.0001). Interpretation Many elderly people in the USA undergo surgery in the year before their death. The rate at which they undergo surgery varies substantially with age and region and might suggest discretion in health-care providers' decisions to intervene surgically at the end of life.	[Kwok, Alvin C.; Bader, Angela M.; Gawande, Atul A.; Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Kwok, Alvin C.; Semel, Marcus E.; Lipsitz, Stuart R.; Bader, Angela M.; Gawande, Atul A.] Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Boston, MA 02115 USA; [Jha, Ashish K.] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA; [Jha, Ashish K.] VA Boston Healthcare Syst, Boston, MA USA; [Barnato, Amber E.] Univ Pittsburgh, Med Ctr, Div Gen Med, Pittsburgh, PA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jha, AK (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	ajha@hsph.harvard.edu		Gawande, Atul/0000-0002-1824-9176; Kwok, Alvin/0000-0003-2215-3764				Angus DC, 2004, CRIT CARE MED, V32, P638, DOI 10.1097/01.CCM.0000114816.62331.08; [Anonymous], 1995, JAMA, V274, P1591; Bach PB, 2004, JAMA-J AM MED ASSOC, V292, P2765, DOI 10.1001/jama.292.22.2765; Bach PB, 2010, NEW ENGL J MED, V362, P569, DOI 10.1056/NEJMp0909947; Barnato AE, 2004, HEALTH SERV RES, V39, P363, DOI 10.1111/j.1475-6773.2004.00232.x; Centers for Disease Control and Prevention/National Center for Health Statistics, 1998, AMB INP PROC US 1996; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Debas HT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1245; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fisher LS, 2000, HEALTH SERV RES, V34, P1351; Gielen B, 2010, HEALTH POLICY, V97, P53, DOI 10.1016/j.healthpol.2010.03.002; Goodman DC, QUALITY END OF LIFE; Linstone H.A., 1975, DELPHI METHOD; LUBITZ JD, 1993, NEW ENGL J MED, V328, P1092, DOI 10.1056/NEJM199304153281506; Medicare Provider Analysis and Review (MedPAR), MEDICARE PROVIDER AN; Prendergast TJ, 1998, AM J RESP CRIT CARE, V158, P1163, DOI 10.1164/ajrccm.158.4.9801108; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; RAO JNK, 1987, ANN STAT, V15, P385, DOI 10.1214/aos/1176350273; Shugarman LR, 2008, WOMEN HEALTH ISS, V18, P199, DOI 10.1016/j.whi.2008.02.008; Shugarman LR, 2004, J GEN INTERN MED, V19, P127, DOI 10.1111/j.1525-1497.2004.30223.x; Teno JM, 2005, J AM GERIATR SOC, V53, P1905, DOI 10.1111/j.1532-5415.2005.53563.x; The Dartmouth Institute for Health Policy and Clinical Practice, DARTM ATL HLTH CAR 2; The Dartmouth Institute for Health Policy and Clinical Practice, DARTM ATL HLTH CAR E; The Dartmouth Institute for Health Policy and Clinical Practice, DARTM ATL HLTH CAR C; US Census Bureau: median income, US CENS BUR MED INC; Weiser TG, 2011, WORLD J SURG, V35, P1950, DOI 10.1007/s00268-011-1169-5; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	29	223	226	2	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 15	2011	378	9800					1408	1413		10.1016/S0140-6736(11)61268-3	http://dx.doi.org/10.1016/S0140-6736(11)61268-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	838EM	21982520	Green Submitted			2022-12-28	WOS:000296269600027
J	Vaishnava, S; Yamamoto, M; Severson, KM; Ruhn, KA; Yu, XF; Koren, O; Ley, R; Wakeland, EK; Hooper, LV				Vaishnava, Shipra; Yamamoto, Miwako; Severson, Kari M.; Ruhn, Kelly A.; Yu, Xiaofei; Koren, Omry; Ley, Ruth; Wakeland, Edward K.; Hooper, Lora V.			The Antibacterial Lectin RegIII gamma Promotes the Spatial Segregation of Microbiota and Host in the Intestine	SCIENCE			English	Article							GERM-FREE; EXPRESSION; MICE; COLONIZATION; HOMEOSTASIS; COMMENSAL; INNATE; CELLS	The mammalian intestine is home to similar to 100 trillion bacteria that perform important metabolic functions for their hosts. The proximity of vast numbers of bacteria to host intestinal tissues raises the question of how symbiotic host-bacterial relationships are maintained without eliciting potentially harmful immune responses. Here, we show that RegIII gamma, a secreted antibacterial lectin, is essential for maintaining a similar to 50-micrometer zone that physically separates the microbiota from the small intestinal epithelial surface. Loss of host-bacterial segregation in RegIII gamma(-/-) mice was coupled to increased bacterial colonization of the intestinal epithelial surface and enhanced activation of intestinal adaptive immune responses by the microbiota. Together, our findings reveal that RegIII gamma is a fundamental immune mechanism that promotes host-bacterial mutualism by regulating the spatial relationships between microbiota and host.	[Vaishnava, Shipra; Yamamoto, Miwako; Severson, Kari M.; Ruhn, Kelly A.; Yu, Xiaofei; Wakeland, Edward K.; Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Koren, Omry; Ley, Ruth] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cornell University	Hooper, LV (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.	lora.hooper@utsouthwestern.edu	Koren, Omry/A-5222-2016; Ley, Ruth E/M-8542-2014; Yu, Xiaofei/J-9245-2017; yu, Xiaofei/E-7100-2011	Koren, Omry/0000-0002-7738-1337; Ley, Ruth E/0000-0002-9087-1672; Yu, Xiaofei/0000-0002-1712-331X; 	NIH [R01 DK070855]; Crohn's and Colitis Foundation of America; Human Microbiome Project Data Analysis and Coordination Center; Packard Fellowship in Science and Engineering; Hartwell Foundation; Beckman Young Investigator award; Burroughs Wellcome Foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070855] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Human Microbiome Project Data Analysis and Coordination Center; Packard Fellowship in Science and Engineering; Hartwell Foundation; Beckman Young Investigator award; Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. DeFranco for the Myd88<SUP>fl/fl</SUP> mice, R. Medzhitov for the FLAG-MyD88 transgene, and A. Mobley for assistance with flow cytometry. This work was supported by NIH R01 DK070855 (L. V. H.), a Crohn's and Colitis Foundation of America Fellowship Award (S. V.), the Human Microbiome Project Data Analysis and Coordination Center (O.K.), a Packard Fellowship in Science and Engineering (R. L.), a Hartwell Foundation investigator award (R. L.), a Beckman Young Investigator award (R. L.), a Burroughs Wellcome Foundation New Investigators in the Pathogenesis of Infectious Diseases Award (L. V. H.), and the Howard Hughes Medical Institute (L. V. H.). The data reported in this paper are tabulated in the main text and the supporting online material, and the sequencing data have been deposited in RG-RAST (accession no. MGP135).	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Ismail AS, 2011, P NATL ACAD SCI USA, V108, P8743, DOI 10.1073/pnas.1019574108; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Ogawa H, 2003, INFLAMM BOWEL DIS, V9, P162, DOI 10.1097/00054725-200305000-00003; Putsep K, 2000, J BIOL CHEM, V275, P40478, DOI 10.1074/jbc.M007816200; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105	18	915	948	9	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2011	334	6053					255	258		10.1126/science.1209791	http://dx.doi.org/10.1126/science.1209791			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998396	Green Accepted			2022-12-28	WOS:000295833600055
J	Valastyan, S; Weinberg, RA				Valastyan, Scott; Weinberg, Robert A.			Tumor Metastasis: Molecular Insights and Evolving Paradigms	CELL			English	Review							BREAST-CANCER METASTASIS; EXPRESSION PROFILES; MOUSE MODEL; STEM-CELLS; PROGRESSION; SURVIVAL; KINASE; GROWTH; BONE; DIFFERENTIATION	Metastases represent the end products of a multistep cell-biological process termed the invasion-metastasis cascade, which involves dissemination of cancer cells to anatomically distant organ sites and their subsequent adaptation to foreign tissue microenvironments. Each of these events is driven by the acquisition of genetic and/or epigenetic alterations within tumor cells and the co-option of nonneoplastic stromal cells, which together endow incipient metastatic cells with traits needed to generate macroscopic metastases. Recent advances provide provocative insights into these cell-biological and molecular changes, which have implications regarding the steps of the invasion-metastasis cascade that appear amenable to therapeutic targeting.	[Valastyan, Scott; Weinberg, Robert A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Valastyan, Scott; Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Weinberg, Robert A.] MIT, Ludwig Ctr Mol Oncol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Valastyan, S (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	scott_valastyan@hms.harvard.edu; weinberg@wi.mit.edu			NIH; MIT Ludwig Center for Molecular Oncology; U.S. Department of Defense; Breast Cancer Research Foundation; Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE [P01CA080111, R01CA078461] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIT Ludwig Center for Molecular Oncology; U.S. Department of Defense(United States Department of Defense); Breast Cancer Research Foundation; Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We apologize to the many individuals whose valuable contributions to metastasis research were unable to be cited due to space restrictions. We thank Joan Brugge, Julie Valastyan, Wenjun Guo, and Sandra McAllister for critical review of this manuscript, as well as Eva Valastyan for helpful discussions. Research in the authors' laboratories is supported by the NIH, MIT Ludwig Center for Molecular Oncology, U.S. Department of Defense, and Breast Cancer Research Foundation. S.V. is a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation. R.A.W. is an American Cancer Society Research Professor and a Daniel K. Ludwig Foundation Cancer Research Professor.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Al-Mehdi AB, 2000, NAT MED, V6, P100, DOI 10.1038/71429; Auguste P, 2007, AM J PATHOL, V170, P1781, DOI 10.2353/ajpath.2007.060886; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Barkan D, 2010, CANCER RES, V70, P5706, DOI 10.1158/0008-5472.CAN-09-2356; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Desmedt C, 2008, CLIN CANCER RES, V14, P5158, DOI 10.1158/1078-0432.CCR-07-4756; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Gupta GP, 2007, P NATL ACAD SCI USA, V104, P19506, DOI 10.1073/pnas.0709185104; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; HART IR, 1980, CANCER RES, V40, P2281; Hiratsuka S, 2011, P NATL ACAD SCI USA, V108, P3725, DOI 10.1073/pnas.1100446108; Hiratsuka S, 2011, P NATL ACAD SCI USA, V108, P302, DOI 10.1073/pnas.1016917108; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Huang YJ, 2009, CANCER RES, V69, P7529, DOI 10.1158/0008-5472.CAN-08-4382; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Iwanicki MP, 2011, CANCER DISCOV, V1, P144, DOI 10.1158/2159-8274.CD-11-0010; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kang SY, 2009, P NATL ACAD SCI USA, V106, P12115, DOI 10.1073/pnas.0903120106; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liu WN, 2009, NAT MED, V15, P559, DOI 10.1038/nm.1944; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Ma L, 2010, NAT BIOTECHNOL, V28, P341, DOI 10.1038/nbt.1618; Mazzieri R, 2011, CANCER CELL, V19, P512, DOI 10.1016/j.ccr.2011.02.005; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Miles D, 2011, J CLIN ONCOL, V29, P83, DOI 10.1200/JCO.2010.30.2794; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Oskarsson T, 2010, J AM CHEM SOC, V132, P3224, DOI 10.1021/ja9101503; Padera TP, 2008, MOL CANCER THER, V7, P2272, DOI 10.1158/1535-7163.MCT-08-0182; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Palmieri D, 2005, JNCI-J NATL CANCER I, V97, P632, DOI 10.1093/jnci/dji111; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Podsypanina K, 2008, SCIENCE, V321, P1841, DOI 10.1126/science.1161621; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Sethi N, 2011, CANCER CELL, V19, P192, DOI 10.1016/j.ccr.2010.12.022; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Sonoshita M, 2011, CANCER CELL, V19, P125, DOI 10.1016/j.ccr.2010.11.008; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Tabaries S, 2011, ONCOGENE, V30, P1318, DOI 10.1038/onc.2010.518; TARIN D, 1984, CANCER RES, V44, P3584; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Valastyan S, 2011, GENE DEV, V25, P646, DOI 10.1101/gad.2004211; Valastyan S, 2009, CELL CYCLE, V8, P3506, DOI 10.4161/cc.8.21.9802; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wang WG, 2004, CANCER RES, V64, P8585, DOI 10.1158/0008-5472.CAN-04-1136; Weigelt B, 2003, P NATL ACAD SCI USA, V100, P15901, DOI 10.1073/pnas.2634067100; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	112	2492	2596	19	716	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 14	2011	147	2					275	292		10.1016/j.cell.2011.09.024	http://dx.doi.org/10.1016/j.cell.2011.09.024			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000009	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000296199300008
J	Hartzband, P; Groopman, J				Hartzband, Pamela; Groopman, Jerome			The New Language of Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hartzband, Pamela] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Hartzband, P (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.							Barry MJ, 2009, NEW ENGL J MED, V360, P1351, DOI 10.1056/NEJMe0901166; Broedl UC, 2003, J GEN INTERN MED, V18, P190, DOI 10.1046/j.1525-1497.2003.20207.x; Groopman J, 2011, YOUR MED MIND; Krugman P., 2011, NY TIMES, pA23; Swensen SJ, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp0911199	5	31	31	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 13	2011	365	15					1372	1373		10.1056/NEJMp1107278	http://dx.doi.org/10.1056/NEJMp1107278			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	832DQ	21995384				2022-12-28	WOS:000295782500003
J	Ingelfinger, JR				Ingelfinger, Julie R.			Bariatric Surgery in Adolescents	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	32	32	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 13	2011	365	15					1365	1367		10.1056/NEJMp1109981	http://dx.doi.org/10.1056/NEJMp1109981			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832DQ	21995381				2022-12-28	WOS:000295782500033
J	Maxmen, A				Maxmen, Amy			TRANSLATIONAL RESEARCH The American way	NATURE			English	Editorial Material																			0	7	9	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 13	2011	478	7368					S16	S18		10.1038/478S16a	http://dx.doi.org/10.1038/478S16a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21993821	Bronze			2022-12-28	WOS:000295782800011
J	Watts, G				Watts, Geoff			Profile Jacques Miller: immunologist who discovered role of the thymus	LANCET			English	Biographical-Item																			0	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 8	2011	378	9799					1290	1290		10.1016/S0140-6736(11)61565-1	http://dx.doi.org/10.1016/S0140-6736(11)61565-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831IU	21982088				2022-12-28	WOS:000295724300012
J	Chou, R; Croswell, JM; Dana, T; Bougatsos, C; Blazina, I; Fu, RW; Gleitsmann, K; Koenig, HC; Lam, C; Maltz, A; Rugge, JB; Lin, K				Chou, Roger; Croswell, Jennifer M.; Dana, Tracy; Bougatsos, Christina; Blazina, Ian; Fu, Rongwei; Gleitsmann, Ken; Koenig, Helen C.; Lam, Clarence; Maltz, Ashley; Rugge, J. Bruin; Lin, Kenneth			Screening for Prostate Cancer: A Review of the Evidence for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							QUALITY-OF-LIFE; ANDROGEN DEPRIVATION THERAPY; RANDOMIZED CONTROLLED-TRIAL; POPULATION-BASED COHORT; COMPARING RADICAL PROSTATECTOMY; EXTERNAL-BEAM RADIOTHERAPY; FOLLOW-UP; CARDIOVASCULAR-DISEASE; 30-DAY MORTALITY; SYMPTOM BURDEN	Background: Screening can detect prostate cancer at earlier, asymptomatic stages, when treatments might be more effective. Purpose: To update the 2002 and 2008 U.S. Preventive Services Task Force evidence reviews on screening and treatments for prostate cancer. Data Sources: MEDLINE (2002 to July 2011) and the Cochrane Library Database (through second quarter of 2011). Study Selection: Randomized trials of prostate-specific antigen-based screening, randomized trials and cohort studies of prostatectomy or radiation therapy versus watchful waiting, and large observational studies of perioperative harms. Data Extraction: Investigators abstracted and checked study details and quality using predefined criteria. Data Synthesis: Of 5 screening trials, the 2 largest and highest-quality studies reported conflicting results. One found that screening was associated with reduced prostate cancer-specific mortality compared with no screening in a subgroup of men aged 55 to 69 years after 9 years (relative risk, 0.80 [95% CI, 0.65 to 0.98]; absolute risk reduction, 0.07 percentage point). The other found no statistically significant effect after 10 years (relative risk, 1.1 [CI, 0.80 to 1.5]). After 3 or 4 screening rounds, 12% to 13% of screened men had false-positive results. Serious infections or urine retention occurred after 0.5% to 1.0% of prostate biopsies. There were 3 randomized trials and 23 cohort studies of treatments. One good-quality trial found that prostatectomy for localized prostate cancer decreased risk for prostate cancer-specific mortality compared with watchful waiting through 13 years of follow-up (relative risk, 0.62 [CI, 0.44 to 0.87]; absolute risk reduction, 6.1%). Benefits seemed to be limited to men younger than 65 years. Treating approximately 3 men with prostatectomy or 7 men with radiation therapy instead of watchful waiting would each result in 1 additional case of erectile dysfunction. Treating approximately 5 men with prostatectomy would result in 1 additional case of urinary incontinence. Prostatectomy was associated with perioperative death (about 0.5%) and cardiovascular events (0.6% to 3%), and radiation therapy was associated with bowel dysfunction. Limitations: Only English-language articles were included. Few studies evaluated newer therapies. Conclusion: Prostate-specific antigen-based screening results in small or no reduction in prostate cancer-specific mortality and is associated with harms related to subsequent evaluation and treatments, some of which may be unnecessary. Primary Funding Source: Agency for Healthcare Research and Quality.	[Chou, Roger] Oregon Hlth & Sci Univ, Mailcode BICC, Portland, OR 97239 USA; Agcy Healthcare Res & Qual, Rockville, MD 20850 USA; Hosp Univ Penn, Philadelphia, PA 19104 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; Stamford Hosp Ctr Integrat Med & Wellness, Stamford, CT USA; Georgetown Univ, Sch Med, Washington, DC 20017 USA	Oregon Health & Science University; Agency for Healthcare Research & Quality; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Stamford Hospital; Georgetown University	Chou, R (corresponding author), Oregon Hlth & Sci Univ, Mailcode BICC, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	chour@ohsu.edu		Chou, Roger/0000-0001-9889-8610; Blazina, Ian/0000-0003-0164-6674	Agency for Healthcare Research and Quality [HHSA-290-2007-10057-I-EPC3]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By the Agency for Healthcare Research and Quality (contract number HHSA-290-2007-10057-I-EPC3, Task Order 3).	Abdel-Wahab M, 2008, INT J RADIAT ONCOL, V72, P58, DOI 10.1016/j.ijrobp.2007.12.043; Albertsen PC, 2007, J UROLOGY, V177, P932, DOI 10.1016/j.juro.2006.10.051; Alibhai SMH, 2005, JNCI-J NATL CANCER I, V97, P1525, DOI 10.1093/jnci/dji313; American Cancer Society, 2010, CANC FACTS FIG 2010; American Urological Association, PROST SPEC ANT BEST; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; [Anonymous], SEER STAT FACT SHEET; Augustin H, 2003, EUR UROL, V43, P113, DOI 10.1016/S0302-2838(02)00495-5; Bacon CG, 2001, J UROLOGY, V166, P1804, DOI 10.1016/S0022-5347(05)65679-0; Begg CB, 2002, NEW ENGL J MED, V346, P1138, DOI 10.1056/NEJMsa011788; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; Bill-Axelson A, 2008, J NATL CANCER I, V100, P1144, DOI 10.1093/jnci/djn255; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; BYAR DP, 1981, UROLOGY, V17, P7; Choo R, 2010, SUPPORT CARE CANCER, V18, P715, DOI 10.1007/s00520-009-0675-6; Chou R, 2011, EVIDENCE SYNTHESIS, V91; Chou R, 2010, J CLIN EPIDEMIOL, V63, P502, DOI 10.1016/j.jclinepi.2008.06.007; Clark JA, 2001, MED CARE, V39, P1118, DOI 10.1097/00005650-200110000-00009; Cooperberg MR, 2010, J CLIN ONCOL, V28, P1117, DOI 10.1200/JCO.2009.26.0133; Croswell JM, 2009, ANN FAM MED, V7, P212, DOI 10.1370/afm.942; Djulbegovic M, 2011, BMJ-BRIT MED J, V341, pc4543, DOI DOI 10.1136/BMJ.C4543; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Draisma G, 2009, JNCI-J NATL CANCER I, V101, P374, DOI 10.1093/jnci/djp001; Fransson P, 2001, CANCER-AM CANCER SOC, V92, P3111, DOI 10.1002/1097-0142(20011215)92:12<3111::AID-CNCR10160>3.0.CO;2-E; Fransson P, 2009, SCAND J UROL NEPHROL, V43, P119, DOI 10.1080/00365590802519396; Galbraith M E, 2001, Oncol Nurs Forum, V28, P551; GRAVERSEN PH, 1990, UROLOGY, V36, P493, DOI 10.1016/0090-4295(90)80184-O; Harris R, 2002, ANN INTERN MED, V137, P917, DOI 10.7326/0003-4819-137-11-200212030-00014; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hoffman RM, 2003, CANCER, V97, P1653, DOI 10.1002/cncr.11233; Holmberg L, 2002, NEW ENGL J MED, V347, P781, DOI 10.1056/NEJMoa012794; Holmberg L, 2006, HEMATOL ONCOL CLIN N, V20, P845, DOI 10.1016/j.hoc.2006.03.007; Hu JC, 2008, J CLIN ONCOL, V26, P2278, DOI 10.1200/JCO.2007.13.4528; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Ilic D, 2011, BJU INT, V107, P882, DOI 10.1111/j.1464-410X.2010.10032.x; IVERSEN P, 1995, SCAND J UROL NEPHROL, P65; Johansson E, 2009, EUR UROL, V55, P422, DOI 10.1016/j.eururo.2008.08.054; Keating NL, 2006, J CLIN ONCOL, V24, P4448, DOI 10.1200/JCO.2006.06.2497; Keating NL, 2010, J NATL CANCER I, V102, P39, DOI 10.1093/jnci/djp404; Kiellman A, 2009, J UROLOGY, V181, P1615, DOI 10.1016/j.juro.2008.11.115; Kilpelainen TP, 2010, BRIT J CANCER, V102, P469, DOI 10.1038/sj.bjc.6605512; Labrie F, 2004, PROSTATE, V59, P311, DOI 10.1002/pros.20017; Labrie F, 1999, PROSTATE, V38, P83, DOI 10.1002/(SICI)1097-0045(19990201)38:2<83::AID-PROS1>3.0.CO;2-B; Ladjevardi S, 2010, EUR UROL, V57, P631, DOI 10.1016/j.eururo.2009.03.007; Lin K, 2011, EVIDENCE SYNTHESIS, V90; Lin K, 2008, ANN INTERN MED, V149, P192, DOI 10.7326/0003-4819-149-3-200808050-00009; Litwin MS, 2002, CANCER, V95, P54, DOI 10.1002/cncr.10651; LITWIN MS, 1995, JAMA-J AM MED ASSOC, V273, P129, DOI 10.1001/jama.273.2.129; LITWIN MS, 1995, CANCER, V75, P2000, DOI 10.1002/1097-0142(19950401)75:7+<2000::AID-CNCR2820751641>3.0.CO;2-4; Lu-Yao GL, 2008, JAMA-J AM MED ASSOC, V300, P173, DOI 10.1001/jama.300.2.173; Lubeck DP, 1999, UROLOGY, V53, P180, DOI 10.1016/S0090-4295(98)00408-7; Merglen A, 2007, ARCH INTERN MED, V167, P1944, DOI 10.1001/archinte.167.18.1944; NCCN, 2010, NCCN CLIN PRACT GUID; Nieder AM, 2008, J UROLOGY, V180, P2005; Potosky AL, 2002, J NATL CANCER I, V94, P430, DOI 10.1093/jnci/94.6.430; Raaijmakers R, 2002, UROLOGY, V60, P826, DOI 10.1016/S0090-4295(02)01958-1; Rabbani F, 2010, EUR UROL, V57, P371, DOI 10.1016/j.eururo.2009.11.034; Sandblom G, 2004, EUR UROL, V46, P717, DOI 10.1016/j.eururo.2004.08.011; Sandblom G, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1539; Schapira MM, 2001, MED CARE, V39, P243, DOI 10.1097/00005650-200103000-00005; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Schymura MJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-152; Shahinian VB, 2005, NEW ENGL J MED, V352, P154, DOI 10.1056/NEJMoa041943; Shao YH, 2010, ARCH INTERN MED, V170, P1256, DOI 10.1001/archinternmed.2010.221; Siegel T, 2001, J UROLOGY, V165, P430, DOI 10.1097/00005392-200102000-00019; Smith DP, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4817; Smith DS, 2000, CANCER, V88, P1454, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1454::AID-CNCR25>3.3.CO;2-J; Stattin P, 2010, JNCI-J NATL CANCER I, V102, P950, DOI 10.1093/jnci/djq154; Steineck G, 2002, NEW ENGL J MED, V347, P790, DOI 10.1056/NEJMoa021483; Talcott JA, 2003, J CLIN ONCOL, V21, P3979, DOI 10.1200/JCO.2003.01.199; Tewari A, 2007, J UROLOGY, V177, P911, DOI 10.1016/j.juro.2006.10.040; Thompson I, 2007, J UROLOGY, V177, P2106, DOI 10.1016/j.juro.2007.03.003; Thong MSY, 2010, BJU INT, V105, P652, DOI 10.1111/j.1464-410X.2009.08815.x; U. S. Cancer Statistics Working Group, 2010, US CANC STAT 1999 20; US Preventive Serv Task Force, 2008, ANN INTERN MED, V149, P185, DOI 10.7326/0003-4819-149-3-200808050-00008; Walz J, 2008, BJU INT, V101, P826, DOI 10.1111/j.1464-410X.2007.07373.x; Welch HG, 2009, J NATL CANCER I, V101, P1325, DOI 10.1093/jnci/djp278; Wilt TJ, 2009, CONTEMP CLIN TRIALS, V30, P81, DOI 10.1016/j.cct.2008.08.002; Wong YN, 2006, JAMA-J AM MED ASSOC, V296, P2683, DOI 10.1001/jama.296.22.2683; Yao SL, 1999, J NATL CANCER I, V91, P1950, DOI 10.1093/jnci/91.22.1950; Zhou EH, 2009, INT J RADIAT ONCOL, V73, P15, DOI 10.1016/j.ijrobp.2008.04.001	81	406	416	0	46	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2011	155	11					762	U94		10.7326/0003-4819-155-11-201112060-00375	http://dx.doi.org/10.7326/0003-4819-155-11-201112060-00375			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	860ZS	21984740				2022-12-28	WOS:000297988400005
J	de Nijs, RNJ				de Nijs, Ron N. J.			Spinal tuberculosis	LANCET			English	Editorial Material									Elkerliek Hosp, Dept Rheumatol, NL-5707 HA Helmond, Netherlands		de Nijs, RNJ (corresponding author), Elkerliek Hosp, Dept Rheumatol, Wesselmanlaan 25, NL-5707 HA Helmond, Netherlands.	rdenijs@elkerliek.nl	de Nijs, Ron/AAV-3045-2021						0	5	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 3	2011	378	9807					E18	E19		10.1016/S0140-6736(11)61482-7	http://dx.doi.org/10.1016/S0140-6736(11)61482-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	863AW	21982257				2022-12-28	WOS:000298136200007
J	Cayla, G; Hulot, JS; O'Connor, SA; Pathak, A; Scott, SA; Gruel, Y; Silvain, J; Vignalou, JB; Huerre, Y; de la Briolle, A; Allanic, F; Beygui, F; Barthelemy, O; Montalescot, G; Collet, JP				Cayla, Guillaume; Hulot, Jean-Sebastien; O'Connor, Stephen A.; Pathak, Atul; Scott, Stuart A.; Gruel, Yves; Silvain, Johanne; Vignalou, Jean-Baptiste; Huerre, Yves; de la Briolle, Axel; Allanic, Frederick; Beygui, Farzin; Barthelemy, Olivier; Montalescot, Gilles; Collet, Jean-Philippe			Clinical, Angiographic, and Genetic Factors Associated With Early Coronary Stent Thrombosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLOPIDOGREL-TREATED PATIENTS; PLATELET REACTIVITY; CYP2C19 GENOTYPE; HEART-DISEASE; LONG-TERM; POLYMORPHISM; PARAOXONASE-1; THERAPY; RISK; METAANALYSIS	Context Despite dual antiplatelet therapy, stent thrombosis remains a devastating and unpredictable complication of percutaneous coronary intervention (PCI). Objective To perform a sequential analysis of clinical and genetic factors associated with definite early stent thrombosis. Design, Setting, and Participants Case-control study conducted in 10 centers in France between January 2007 and May 2010 among 123 patients undergoing PCI who had definite early stent thrombosis and DNA samples available, matched on age and sex with 246 stent thrombosis-free controls. Main Outcome Measure Accuracy of early stent thrombosis prediction by 23 genetic variants. Results Among the 23 genetic variants investigated in 15 different genes, the significant determinants of early stent thrombosis were CYP2C19 metabolic status (adjusted odds ratio [OR], 1.99; 95% CI, 1.47-2.69), ABCB1 3435 TT genotype (adjusted OR, 2.16; 95% CI, 1.21-3.88), and ITGB3 PLA2 carriage (adjusted OR, 0.52; 95% CI, 0.28-0.95). Nongenetic independent correlates were acuteness of PCI (adjusted OR, 3.05; 95% CI, 1.54-6.07), complex lesions (American College of Cardiology/American Heart Association type C) (adjusted OR, 2.33; 95% CI, 1.40-3.89), left ventricular function less than 40% (adjusted OR, 2.25; 95% CI, 1.09-4.70), diabetes mellitus (adjusted OR, 1.82; 95% CI, 1.02-3.24), use of proton pump inhibitors (adjusted OR, 2.19; 95% CI, 1.29-3.75), and higher clopidogrel loading doses (adjusted OR, 0.73; 95% CI, 0.57-0.93). The discriminative accuracy of the clinical-only model was similar to that of a genetic-only model (area under the curve, 0.73 [95% CI, 0.67-0.78] vs 0.68 [95% CI, 0.62-0.74], respectively; P=.34). A combined clinical and genetic model led to a statistically significant increase in the discriminatory power of the model compared with the clinical-only model (area under the curve, 0.78 [95% CI, 0.73-0.83] vs 0.73 [95% CI, 0.67-0.78]; P=.004). Conclusions This case-control study identified 3 genes (CYP2C19, ABCB1, and ITGB3) and 2 clopidogrel-related factors (loading dose and proton pump inhibitors) that were independently associated with early stent thrombosis. Future studies are needed to validate the prognostic accuracy of these risk factors in prospective cohorts. JAMA. 2011;306(16):1765-1774	[Montalescot, Gilles] Hop La Pitie Salpetriere, Inst Cardiol, Bur 236, INSERM,Unite Mixte Rech UMR S 937, F-75013 Paris, France; [Hulot, Jean-Sebastien; Allanic, Frederick] Univ Paris 06, UMR S 956, Paris, France; [Cayla, Guillaume] Ctr Hosp Univ CHU Nimes, Dept Cardiol, Nimes, France; [Cayla, Guillaume; Huerre, Yves] Univ Montpellier I, Fac Med, Montpellier, France; [Huerre, Yves] CHU Montpellier, Dept Cardiol, Montpellier, France; [Hulot, Jean-Sebastien] Mt Sinai Sch Med, Cardiovasc Res Ctr, New York, NY USA; [Scott, Stuart A.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Pathak, Atul] Univ Toulouse, Fac Med, INSERM, U1048,Lab Pharmacol Med & Clin, Toulouse, France; [Pathak, Atul] CHU Rangueil, Serv Cardiol, F-31054 Toulouse, France; CNRS, UMR 6239, Dept Hematol Hemostasis, Tours, France; [de la Briolle, Axel] CHU Tours, Dept Cardiol, Tours, France; [Gruel, Yves; de la Briolle, Axel] Univ Tours, Fac Med, Tours, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; CHU de Toulouse; Centre National de la Recherche Scientifique (CNRS); CHU Tours; Universite de Tours	Montalescot, G (corresponding author), Hop La Pitie Salpetriere, Inst Cardiol, Bur 236, INSERM,Unite Mixte Rech UMR S 937, 47 Bd Hop, F-75013 Paris, France.	gilles.montalescot@psl.aphp.fr	Hulot, Jean-Sébastien/A-2278-2016; Pathak, Atul/ABC-5223-2020; SILVAIN, Johanne/C-7521-2016	Hulot, Jean-Sébastien/0000-0001-5463-6117; Pathak, Atul/0000-0001-6151-0096; Scott, Stuart/0000-0001-5720-1864; SILVAIN, Johanne/0000-0002-1901-2808; O'Connor, Stephen/0000-0002-6539-0375	la Federation Francaise de Cardiologie; Abbott Vascular; AstraZeneca; CLS Behring; Daiichi Sankyo; Eli Lilly; Biotronik; Iroko Cardio; Fondation de France; INSERM; Federation Francaise de Cardiologie; Medco Research Institute; Medco Health Solutions; sanofi-aventis; Brahms; Societe Francaise de Cardiologie; Servier; Boston Scientific; Cordis; Guerbet Medical; ITC Edison; Medtronic; Pfizer; Stago; Bayer; Cardiovascular Research Foundation; Cleveland Clinic Research Foundation; Duke Institute; Europa; Lead-up; GlaxoSmithKline; Institut de Cardiologie de Montreal; Menarini; Nanospheres; Novartis; Portola; Medicines Company; TIMI Study Group; Bristol-Myers Squibb; ACTION; SGAM Foundation	la Federation Francaise de Cardiologie; Abbott Vascular(Abbott Laboratories); AstraZeneca(AstraZeneca); CLS Behring; Daiichi Sankyo(Daiichi Sankyo Company Limited); Eli Lilly(Eli Lilly); Biotronik; Iroko Cardio; Fondation de France(Fondation de France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Federation Francaise de Cardiologie; Medco Research Institute; Medco Health Solutions; sanofi-aventis(Sanofi-Aventis); Brahms; Societe Francaise de Cardiologie; Servier(Servier); Boston Scientific(Boston Scientific); Cordis; Guerbet Medical; ITC Edison; Medtronic(Medtronic); Pfizer(Pfizer); Stago; Bayer(Bayer AG); Cardiovascular Research Foundation; Cleveland Clinic Research Foundation; Duke Institute; Europa; Lead-up; GlaxoSmithKline(GlaxoSmithKline); Institut de Cardiologie de Montreal; Menarini(Menarini Group); Nanospheres; Novartis(Novartis); Portola; Medicines Company; TIMI Study Group; Bristol-Myers Squibb(Bristol-Myers Squibb); ACTION; SGAM Foundation	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Cayla reports receiving a research grant from la Federation Francaise de Cardiologie; consultant fees from Abbott Vascular, AstraZeneca, CLS Behring, Daiichi Sankyo, and Eli Lilly; and lecture fees from Abbott Vascular, AstraZeneca, Biotronik, CLS Behring, Daiichi Sankyo, Eli Lilly, and Iroko Cardio. Dr Hulot reports receiving research grant support from Fondation de France, INSERM, Federation Francaise de Cardiologie, Biotronik, and Medco Research Institute; consulting fees from Biotronik and Medco Health Solutions; and lecture fees from sanofi-aventis, Daiichi Sankyo, and Eli Lilly. Dr Pathak reports receiving honoraria from BMS, AstraZeneca, and Daiichi. Dr Silvain reports that he has received research grants (to his institution) from sanofi-aventis, Daiichi Sankyo, Eli Lilly, Brahms, INSERM, Federation Francaise de Cardiologie, and Societe Francaise de Cardiologie; has served as a consultant to Daiichi Sankyo and Eli Lilly; and has received lecture fees from AstraZeneca, Daiichi Sankyo, Eli Lilly, Iroko Cardio, and Servier. Dr Montalescot reports receiving grant support from Abbott Vascular, Boston Scientific, Cordis, Eli Lilly, Federation Francaise de Cardiologie, Fondation de France, Guerbet Medical, INSERM, ITC Edison, Medtronic, Pfizer, sanofi-aventis, Societe Francaise de Cardiologie, and Stago and consulting or board fees and lecture fees from AstraZeneca, Bayer, Boehringer Ingelheim, Cardiovascular Research Foundation, Cleveland Clinic Research Foundation, Daiichi Sankyo, Duke Institute, Eli Lilly, Europa, Lead-up, GlaxoSmithKline, Institut de Cardiologie de Montreal, Menarini, Nanospheres, Novartis, Pfizer, Portola, sanofi-aventis, the Medicines Company, and the TIMI Study Group. Dr Collet reports receiving research grants from Bristol-Myers Squibb, sanofi-aventis, Eli Lilly, Guerbet Medical, Medtronic, Boston Scientific, Cordis, Stago, Fondation de France, INSERM, Federation Francaise de Cardiologie, and Societe Francaise de Cardiologie; consulting fees from sanofi-aventis, Eli Lilly, and Bristol-Myers Squibb; and lecture fees from Bristol-Myers Squibb, sanofi-aventis, Eli Lilly and AstraZeneca. No other disclosures were reported.; This study was funded by ACTION, the Societe Francaise de Cardiologie, the Federation Francaise de Cardiologie, and INSERM. The ONASSIST program was also partially supported by an unrestricted grant from Eli Lilly and by a grant from the SGAM Foundation.	Angiolillo DJ, 2011, CLIN PHARMACOL THER, V89, P65, DOI 10.1038/clpt.2010.219; Angiolillo DJ, 2004, BLOOD COAGUL FIBRIN, V15, P89, DOI 10.1097/00001721-200401000-00014; Bhatt DL., 2009, TRANSC CARD THER TCT; Bonello L, 2010, J AM COLL CARDIOL, V56, P1630, DOI 10.1016/j.jacc.2010.07.004; Bonello L, 2010, J AM COLL CARDIOL, V56, P919, DOI 10.1016/j.jacc.2010.04.047; Bouman HJ, 2011, NAT MED, V17, P110, DOI 10.1038/nm.2281; Campo G, 2011, J AM COLL CARDIOL, V57, P2474, DOI 10.1016/j.jacc.2010.12.047; Collet JP, 2009, LANCET, V373, P1172, DOI 10.1016/S0140-6736(09)60682-6; Collet JP, 2008, CIRCULATION, V118, P1225, DOI [10.1161/CIRCULATIONAHA.108.776757, 10.1161/CIRCULATIONAHA.108.191108]; Collet JP, 2011, JACC-CARDIOVASC INTE, V4, P392, DOI 10.1016/j.jcin.2011.03.002; Cooke GE, 2006, J AM COLL CARDIOL, V47, P541, DOI 10.1016/j.jacc.2005.09.034; Cuisset T, 2011, NAT MED, V17, P1039, DOI 10.1038/nm.2367; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Dangas GD, 2011, CIRCULATION, V123, P1745, DOI 10.1161/CIRCULATIONAHA.110.981688; Dansette PM, 2011, NAT MED, V17, P1040, DOI 10.1038/nm.2436; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Hulot JS, 2010, J AM COLL CARDIOL, V56, P134, DOI 10.1016/j.jacc.2009.12.071; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; Kazui M, 2010, DRUG METAB DISPOS, V38, P92, DOI 10.1124/dmd.109.029132; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Klerk M, 2002, JAMA-J AM MED ASSOC, V288, P2023, DOI 10.1001/jama.288.16.2023; L'Allier PL, 2008, J AM COLL CARDIOL, V51, P1066, DOI 10.1016/j.jacc.2007.12.013; Lev EI, 2007, THROMB RES, V119, P355, DOI 10.1016/j.thromres.2006.02.006; Marin F, 2009, J AM COLL CARDIOL, V54, P1041, DOI 10.1016/j.jacc.2009.04.084; Mega JL, 2010, LANCET, V376, P1312, DOI 10.1016/S0140-6736(10)61273-1; Mega JL, 2010, JAMA-J AM MED ASSOC, V304, P1821, DOI 10.1001/jama.2010.1543; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475; Pellitero S, 2010, THROMB HAEMOSTASIS, V103, P630, DOI 10.1160/TH09-07-0453; Pena A, 2009, CIRCULATION, V119, P2854, DOI 10.1161/CIRCULATIONAHA.108.857722; Satra M, 2011, PHARMACOGENOMICS, V12, P195, DOI [10.2217/pgs.10.180, 10.2217/PGS.10.180]; Scott SA, 2011, CLIN PHARMACOL THER, V90, P328, DOI 10.1038/clpt.2011.132; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Sibbing D, 2011, EUR HEART J, V32, P1605, DOI 10.1093/eurheartj/ehr155; Sibbing D, 2010, CIRCULATION, V121, P512, DOI 10.1161/CIRCULATIONAHA.109.885194; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; [Task Force on Myocardial Revascularization of the European Society of Cardiology European Association for Cardio-Thoracic Surgery], 2010, EUR HEART J, V31, P2051; Taubert D, 2006, CLIN PHARMACOL THER, V80, P486, DOI 10.1016/j.clpt.2006.07.007; Trenk D, 2011, CIRC-CARDIOVASC GENE, V4, P429, DOI 10.1161/CIRCGENETICS.111.960112; van Werkum JW, 2009, J AM COLL CARDIOL, V53, P1399, DOI 10.1016/j.jacc.2008.12.055; van Werkum JW, 2009, CIRCULATION, V119, P828, DOI 10.1161/CIRCULATIONAHA.108.799403; Wallentin L, 2010, LANCET, V376, P1320, DOI 10.1016/S0140-6736(10)61274-3; Wang YB, 2006, CIRCULATION, V113, P1615, DOI 10.1161/CIRCULATIONAHA.105.580167	44	166	178	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 26	2011	306	16					1765	1774		10.1001/jama.2011.1529	http://dx.doi.org/10.1001/jama.2011.1529			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HH	22028352	Bronze			2022-12-28	WOS:000296181600021
J	Zhou, M; Morgner, N; Barrera, NP; Politis, A; Isaacson, SC; Matak-Vinkovic, D; Murata, T; Bernal, RA; Stock, D; Robinson, CV				Zhou, Min; Morgner, Nina; Barrera, Nelson P.; Politis, Argyris; Isaacson, Shoshanna C.; Matak-Vinkovic, Dijana; Murata, Takeshi; Bernal, Ricardo A.; Stock, Daniela; Robinson, Carol V.			Mass Spectrometry of Intact V-Type ATPases Reveals Bound Lipids and the Effects of Nucleotide Binding	SCIENCE			English	Article							THERMOPHILUS H+-ATPASE/SYNTHASE; THERMUS-THERMOPHILUS; ENTEROCOCCUS-HIRAE; PERIPHERAL STALK; ATP SYNTHESIS; NA+-ATPASE; MACROMOLECULAR ASSEMBLIES; CRYSTAL-STRUCTURE; VACUOLAR ATPASE; ROTOR RING	The ability of electrospray to propel large viruses into a mass spectrometer is established and is rationalized by analogy to the atmospheric transmission of the common cold. Much less clear is the fate of membrane-embedded molecular machines in the gas phase. Here we show that rotary adenosine triphosphatases (ATPases)/synthases from Thermus thermophilus and Enterococcus hirae can be maintained intact with membrane and soluble subunit interactions preserved in vacuum. Mass spectra reveal subunit stoichiometries and the identity of tightly bound lipids within the membrane rotors. Moreover, subcomplexes formed in solution and gas phases reveal the regulatory effects of nucleotide binding on both ATP hydrolysis and proton translocation. Consequently, we can link specific lipid and nucleotide binding with distinct regulatory roles.	[Zhou, Min; Morgner, Nina; Politis, Argyris; Isaacson, Shoshanna C.; Robinson, Carol V.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England; [Barrera, Nelson P.; Matak-Vinkovic, Dijana] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Barrera, Nelson P.] Pontificia Univ Catolica Chile, Dept Physiol, Santiago, Chile; [Murata, Takeshi] Chiba Univ, Grad Sch Sci, Dept Chem, Chiba 2638522, Japan; [Bernal, Ricardo A.] Univ Texas El Paso, Dept Chem, El Paso, TX 79968 USA; [Stock, Daniela] Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia; [Stock, Daniela] Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia	University of Oxford; University of Cambridge; Pontificia Universidad Catolica de Chile; Chiba University; University of Texas System; University of Texas El Paso; Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Robinson, CV (corresponding author), Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England.	carol.robinson@chem.ox.ac.uk	Morgner, Nina/I-7975-2012; Bernal, Ricardo A/B-2124-2010; Morgner, Nina/O-7021-2018; Politis, Argyris/R-4333-2019; Murata, Takeshi/J-6181-2017	Morgner, Nina/0000-0002-1872-490X; Murata, Takeshi/0000-0002-5748-4670; Bernal, Ricardo A./0000-0001-5849-8647; Barrera, Nelson/0000-0001-7825-1406; robinson, carol/0000-0001-7829-5505	Wellcome Trust; European Union [HEALTHF4-2008-201648]; Royal Society; Australian National Health and Medical Research Council [573712]; FONDECYT [1100515]; Medical Research Council [G1000819] Funding Source: researchfish; MRC [G1000819] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); European Union(European Commission); Royal Society(Royal Society of London); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding from the Wellcome Trust and by the PROSPECTS (HEALTHF4-2008-201648) grant within the Research Framework of the European Union together with funding from the Royal Society (C.V.R.), the Australian National Health and Medical Research Council grant 573712 (D.S.), and the FONDECYT 1100515 (N.P.B.) is acknowledged.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Armbruster A, 2005, FEBS LETT, V579, P1961, DOI 10.1016/j.febslet.2005.02.042; Barrera NP, 2008, SCIENCE, V321, P243, DOI 10.1126/science.1159292; Barrera NP, 2009, NAT METHODS, V6, P585, DOI 10.1038/nmeth.1347; BELTRAN C, 1992, ACTA PHYSIOL SCAND, V146, P41; Benesch JL, 2006, CURR OPIN STRUC BIOL, V16, P245, DOI 10.1016/j.sbi.2006.03.009; Bernal RA, 2004, STRUCTURE, V12, P1789, DOI 10.1016/j.str.2004.07.017; CARSON D, 1979, BIOCHIM BIOPHYS ACTA, V575, P225, DOI 10.1016/0005-2760(79)90024-9; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Clare DK, 2006, STRUCTURE, V14, P1149, DOI 10.1016/j.str.2006.05.014; Dautant A, 2010, J BIOL CHEM, V285, P29502, DOI 10.1074/jbc.M110.124529; Esteban O, 2008, J BIOL CHEM, V283, P2595, DOI 10.1074/jbc.M704941200; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Hildenbrand ZL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012588; Hoffmann J, 2010, PHYS CHEM CHEM PHYS, V12, P13375, DOI 10.1039/c0cp00733a; Hunte C, 2008, CURR OPIN STRUC BIOL, V18, P406, DOI 10.1016/j.sbi.2008.03.008; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Jefferies KC, 2008, ARCH BIOCHEM BIOPHYS, V476, P33, DOI 10.1016/j.abb.2008.03.025; Kane PM, 2003, J BIOENERG BIOMEMBR, V35, P313, DOI 10.1023/A:1025724814656; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Lau WCY, 2010, P NATL ACAD SCI USA, V107, P1367, DOI 10.1073/pnas.0911085107; Lee LK, 2010, NAT STRUCT MOL BIOL, V17, P373, DOI 10.1038/nsmb.1761; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2007, MOL MICROBIOL, V65, P1181, DOI 10.1111/j.1365-2958.2007.05857.x; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Muller V, 2003, CELL MOL LIFE SCI, V60, P474, DOI 10.1007/s000180300040; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Murata T, 2003, J BIOL CHEM, V278, P21162, DOI 10.1074/jbc.M301620200; Murata T, 1999, J BIOCHEM, V125, P414, DOI 10.1093/oxfordjournals.jbchem.a022302; NUMOTO N, 2009, EMBO REP, V25, P25; Okazaki K, 2011, STRUCTURE, V19, P588, DOI 10.1016/j.str.2011.01.013; RAY PH, 1971, J BACTERIOL, V108, P227, DOI 10.1128/JB.108.1.227-235.1971; TAKASE K, 1994, J BIOL CHEM, V269, P11037; Toei M, 2007, P NATL ACAD SCI USA, V104, P20256, DOI 10.1073/pnas.0706914105; Uetrecht C, 2010, CHEM SOC REV, V39, P1633, DOI 10.1039/b914002f; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Yamamoto M, 2008, J BIOL CHEM, V283, P19422, DOI 10.1074/jbc.M801772200; Yokoyama K, 2003, J BIOL CHEM, V278, P42686, DOI 10.1074/jbc.M305853200; Yokoyama K, 2000, J BIOL CHEM, V275, P13955, DOI 10.1074/jbc.275.18.13955; ZHANG JM, 1992, J BIOL CHEM, V267, P9773	42	216	218	0	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2011	334	6054					380	385		10.1126/science.1210148	http://dx.doi.org/10.1126/science.1210148			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	22021858	Green Accepted			2022-12-28	WOS:000296052500054
J	[Anonymous]				[Anonymous]			GLOBAL WARMING Call for urgent action on climate change	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 18	2011	343								d6760	10.1136/bmj.d6760	http://dx.doi.org/10.1136/bmj.d6760			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HL	22008811				2022-12-28	WOS:000296183400016
J	Grayson, M				Grayson, Michelle			Medical research masterclass	NATURE			English	Editorial Material																			0	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 13	2011	478	7368					S1	S1		10.1038/478S1a	http://dx.doi.org/10.1038/478S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21993817	Bronze			2022-12-28	WOS:000295782800060
J	Burkle, FM; Redmond, AD; McArdle, DF				Burkle, Frederick M., Jr.; Redmond, Anthony D.; McArdle, Dudley F.			An authority for crisis coordination and accountability	LANCET			English	Editorial Material									[Burkle, Frederick M., Jr.] Harvard Univ, Sch Publ Hlth, Harvard Humanitarian Initiat, Cambridge, MA 02138 USA; [Burkle, Frederick M., Jr.] Woodrow Wilson Int Ctr Scholars, Washington, DC 20560 USA; [Redmond, Anthony D.] Univ Manchester, Manchester Med Sch, Manchester, Lancs, England; [Redmond, Anthony D.] Univ Manchester, Humanitarian & Conflict Response Inst, Manchester, Lancs, England; [McArdle, Dudley F.] Monash Univ, Melbourne, Vic 3004, Australia	Harvard University; Harvard T.H. Chan School of Public Health; University of Manchester; University of Manchester; Monash University	Burkle, FM (corresponding author), Harvard Univ, Sch Publ Hlth, Harvard Humanitarian Initiat, Cambridge, MA 02138 USA.	fburkle@hsph.harvard.edu	Burkle, Frederick/AAE-5423-2020					Hein K, 2010, PREHOSP DISASTER MED, V25, P396, DOI 10.1017/S1049023X0000844X; Institute of Medicine, 2010, CRISIS STANDARDS CAR, P69; Inter-Agency Standing Committee Global Health Cluster, 2011, CONC PAP FOR MED TEA; Office for the Coordination of Humanitarian Affairs, OCHA 2011 ANN PLAN B; Walker P., 2010, PROFESSIONALISING HU; Walker P, 2010, HEALTH AFFAIR, V29, P2223, DOI 10.1377/hlthaff.2010.1023; WHO Implementation of the International Health Regulations, 2011, IMPL INT HLTH REG 20	7	16	16	2	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 16	2012	379	9833					2223	2225		10.1016/S0140-6736(11)60979-3	http://dx.doi.org/10.1016/S0140-6736(11)60979-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	962AM	22014334	Green Published, Bronze			2022-12-28	WOS:000305511400010
J	Smith, SA; Wilson, NG; Goetz, FE; Feehery, C; Andrade, SCS; Rouse, GW; Giribet, G; Dunn, CW				Smith, Stephen A.; Wilson, Nerida G.; Goetz, Freya E.; Feehery, Caitlin; Andrade, Sonia C. S.; Rouse, Greg W.; Giribet, Gonzalo; Dunn, Casey W.			Resolving the evolutionary relationships of molluscs with phylogenomic tools	NATURE			English	Article							CEPHALOPODA; MONOPLACOPHORAN; RECONSTRUCTION; APLACOPHORA; ALGORITHMS; ALIGNMENT; GENOMES; CHITONS; RADULA; FOSSIL	Molluscs (snails, octopuses, clams and their relatives) have a great disparity of body plans and, among the animals, only arthropods surpass them in species number. This diversity has made Mollusca one of the best-studied groups of animals, yet their evolutionary relationships remain poorly resolved(1). Open questions have important implications for the origin of Mollusca and for morphological evolution within the group. These questions include whether the shell-less, vermiform aplacophoran molluscs diverged before the origin of the shelled molluscs (Conchifera)(2-4) or lost their shells secondarily. Monoplacophorans were not included in molecular studies until recently(5,6), when it was proposed that they constitute a clade named Serialia together with Polyplacophora (chitons), reflecting the serial repetition of body organs in both groups(5). Attempts to understand the early evolution of molluscs become even more complex when considering the large diversity of Cambrian fossils. These can have multiple dorsal shell plates and sclerites(7-10) or can be shell-less but with a typical molluscan radula and serially repeated gills(11). To better resolve the relationships among molluscs, we generated transcriptome data for 15 species that, in combination with existing data, represent for the first time all major molluscan groups. We analysed multiple data sets containing up to 216,402 sites and 1,185 gene regions using multiple models and methods. Our results support the clade Aculifera, containing the three molluscan groups with spicules but without true shells, and they support the monophyly of Conchifera. Monoplacophora is not the sister group to other Conchifera but to Cephalopoda. Strong support is found for a clade that comprises Scaphopoda (tusk shells), Gastropoda and Bivalvia, with most analyses placing Scaphopoda and Gastropoda as sister groups. This well-resolved tree will constitute a framework for further studies of mollusc evolution, development and anatomy.	[Wilson, Nerida G.] Australian Museum, Sydney, NSW 2010, Australia; [Smith, Stephen A.; Goetz, Freya E.; Feehery, Caitlin; Dunn, Casey W.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Smith, Stephen A.] Heidelberg Inst Theoret Studies, D-69118 Heidelberg, Germany; [Wilson, Nerida G.; Feehery, Caitlin; Rouse, Greg W.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Andrade, Sonia C. S.; Giribet, Gonzalo] Harvard Univ, Dept Organism & Evolutionary Biol, Museum Comparat Zool, Cambridge, MA 02138 USA	Australian Museum; Brown University; Heidelberg Institute for Theoretical Studies; University of California System; University of California San Diego; Scripps Institution of Oceanography; Harvard University	Wilson, NG (corresponding author), Australian Museum, Sydney, NSW 2010, Australia.	nerida.wilson@austmus.gov.au; ggiribet@oeb.harvard.edu; casey_dunn@brown.edu	Rouse, Gregory/AAW-1494-2021; Wilson, Nerida/G-8433-2011; Rouse, Greg W/F-2611-2010; Andrade, Sonia/I-9263-2012; Giribet, Gonzalo/P-1086-2015; Wilson, Nerida G./AAC-1456-2019; Smith, Stephen/AAE-8623-2019; Andrade, Sonia/F-8267-2014	Rouse, Gregory/0000-0001-9036-9263; Wilson, Nerida/0000-0002-0784-0200; Rouse, Greg W/0000-0001-9036-9263; Giribet, Gonzalo/0000-0002-5467-8429; Smith, Stephen/0000-0003-2035-9531; Dunn, Casey/0000-0003-0628-5150; Andrade, Sonia/0000-0002-1302-5261	US National Science Foundation [0844596, 0844881, 0844652]; AToL Program [EF-0531757]; EPSCoR (Infrastructure to Advance Life Sciences in the Ocean State) [1004057]; iPlant Collaborative [0735191]; Scripps Institution of Oceanography; University of California Ship Funds; Museum of Comparative Zoology; Carlsberg Foundation; Division Of Environmental Biology [0844596, 0844652] Funding Source: National Science Foundation; Office of Integrative Activities [1004057] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); AToL Program; EPSCoR (Infrastructure to Advance Life Sciences in the Ocean State); iPlant Collaborative(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Scripps Institution of Oceanography(University of California System); University of California Ship Funds(University of California System); Museum of Comparative Zoology; Carlsberg Foundation(Carlsberg Foundation); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This research was supported by the US National Science Foundation through the Systematics Program (awards 0844596, 0844881 and 0844652), the AToL Program (EF-0531757), EPSCoR (Infrastructure to Advance Life Sciences in the Ocean State, 1004057) and the iPlant Collaborative (0735191). Support was also provided by the Scripps Institution of Oceanography, the University of California Ship Funds and the Museum of Comparative Zoology. Collecting in Greenland was supported by the Carlsberg Foundation. A. Riesgo and J. Harasewych provided tissue samples of Octopus and Perotrochus, respectively. E. Rottinger assisted with Nautilus. C. Palacin allowed us to use an Octopus vulgaris photograph. At Brown University, Illumina sequencing was enabled by the Genomics Core Facility, and computational analyses were facilitated by L. Dong and the Center for Computing and Visualization. At Harvard University, Illumina sequencing was enabled by the Bauer Core in the Faculty of Arts and Sciences (FAS) Center for Systems Biology, and analyses were supported by the staff of the Research Computing cluster Odyssey facility in the FAS.	Aktipis SW, 2010, INVERTEBR BIOL, V129, P220, DOI 10.1111/j.1744-7410.2010.00198.x; Aktipis Stephanie W., 2008, P201; Apeltsin L, 2011, BIOINFORMATICS, V27, P326, DOI 10.1093/bioinformatics/btq655; Caron JB, 2006, NATURE, V442, P159, DOI 10.1038/nature04894; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Giribet G, 2003, SM S COMP E, P45; Giribet G, 2006, P NATL ACAD SCI USA, V103, P7723, DOI 10.1073/pnas.0602578103; Haszprunar G, 2000, AM MALACOL BULL, V15, P115; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; HUELSENBECK JP, 2005, MRBAYES BAYESIAN ANA; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lindgren AR, 2004, CLADISTICS, V20, P454, DOI 10.1111/j.1096-0031.2004.00032.x; Morris SC, 2007, SCIENCE, V315, P1255, DOI 10.1126/science.1137187; Nielsen C, 2007, ACTA ZOOL-STOCKHOLM, V88, P231, DOI 10.1111/j.1463-6395.2007.00270.x; Parkinson J, 2004, BIOINFORMATICS, V20, P1398, DOI 10.1093/bioinformatics/bth101; Passamaneck YJ, 2004, MOL PHYLOGENET EVOL, V32, P25, DOI 10.1016/j.ympev.2003.12.016; Ponder WF, 1997, ZOOL J LINN SOC-LOND, V119, P83, DOI 10.1111/j.1096-3642.1997.tb00137.x; Ponder WF., 2008, PHYLOGENY EVOLUTION; Prendini L, 2001, SYST BIOL, V50, P290, DOI 10.1080/10635150118650; Rokas A, 2005, SCIENCE, V310, P1933, DOI 10.1126/science.1116759; RUNNEGAR B, 1974, SCIENCE, V186, P311, DOI 10.1126/science.186.4161.311; Runnegar Bruce, 1996, P77; Salvini-Plawen Luitfried v., 1996, P29; Scheltema AH, 2003, J MORPHOL, V257, P219, DOI 10.1002/jmor.10121; Scheltema Amelie H., 1996, P53; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strugnell J, 2007, J MOLLUS STUD, V73, P399, DOI 10.1093/mollus/eym038; Sutton MD, 2004, PALAEONTOLOGY, V47, P293, DOI 10.1111/j.0031-0239.2004.00374.x; van Dongen Stijn, 2000, INFORM SYSTEMS INS R, V2000; Vendrasco MJ, 2004, NATURE, V429, P288, DOI 10.1038/nature02548; Vinther J, 2005, ZOOL SCR, V34, P81, DOI 10.1111/j.1463-6409.2005.00177.x; Waller Thomas R., 1998, P1; Wanninger Andreas, 2008, P427; Wasmuth JD, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-187; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wilson NG, 2010, MOL PHYLOGENET EVOL, V54, P187, DOI 10.1016/j.ympev.2009.07.028; Wilson NG, 2009, J MOLLUS STUD, V75, P195, DOI 10.1093/mollus/eyp013; YOCHELSON EL, 1978, MALACOLOGIA, V17, P165; YOCHELSON EL, 1973, LETHAIA, V6, P275, DOI 10.1111/j.1502-3931.1973.tb01199.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	45	311	320	4	205	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					364	U114		10.1038/nature10526	http://dx.doi.org/10.1038/nature10526			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22031330				2022-12-28	WOS:000298033000050
J	Xu, J; Peng, C; Sankaran, VG; Shao, Z; Esrick, EB; Chong, BG; Ippolito, GC; Fujiwara, Y; Ebert, BL; Tucker, PW; Orkin, SH				Xu, Jian; Peng, Cong; Sankaran, Vijay G.; Shao, Zhen; Esrick, Erica B.; Chong, Bryan G.; Ippolito, Gregory C.; Fujiwara, Yuko; Ebert, Benjamin L.; Tucker, Philip W.; Orkin, Stuart H.			Correction of Sickle Cell Disease in Adult Mice by Interference with Fetal Hemoglobin Silencing	SCIENCE			English	Article							MOUSE MODEL; GAMMA-GLOBIN; BCL11A; BETA; HAEMOGLOBIN; THALASSEMIA; FAMILIES; THERAPY	Persistence of human fetal hemoglobin (HbF, alpha(2)gamma(2)) in adults lessens the severity of sickle cell disease (SCD) and the beta-thalassemias. Here, we show that the repressor BCL11A is required in vivo for silencing of gamma-globin expression in adult animals, yet dispensable for red cell production. BCL11A serves as a barrier to HbF reactivation by known HbF inducing agents. In a proof-of-principle test of BCL11A as a potential therapeutic target, we demonstrate that inactivation of BCL11A in SCD transgenic mice corrects the hematologic and pathologic defects associated with SCD through high-level pancellular HbF induction. Thus, interference with HbF silencing by manipulation of a single target protein is sufficient to reverse SCD.	[Xu, Jian; Peng, Cong; Sankaran, Vijay G.; Shao, Zhen; Esrick, Erica B.; Chong, Bryan G.; Fujiwara, Yuko; Orkin, Stuart H.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Xu, Jian; Peng, Cong; Sankaran, Vijay G.; Shao, Zhen; Esrick, Erica B.; Chong, Bryan G.; Fujiwara, Yuko; Orkin, Stuart H.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Xu, Jian; Peng, Cong; Sankaran, Vijay G.; Shao, Zhen; Esrick, Erica B.; Chong, Bryan G.; Fujiwara, Yuko; Orkin, Stuart H.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Xu, Jian; Fujiwara, Yuko; Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Esrick, Erica B.; Ebert, Benjamin L.] Harvard Univ, Dana Farber Canc Inst, Brigham & Womens Hosp, Harvard Stem Cell Inst,Med Sch, Boston, MA 02115 USA; [Ippolito, Gregory C.; Tucker, Philip W.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Sankaran, Vijay G.] Broad Inst, Cambridge, MA 02142 USA; [Sankaran, Vijay G.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; University of Texas System; University of Texas Austin; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute	Orkin, SH (corresponding author), Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu	Peng, Cong/H-2286-2011; Ippolito, Gregory C./AAR-2930-2021	Ippolito, Gregory C./0000-0002-7565-7002; Shao, Zhen/0000-0002-4934-4360	NIH; National Cancer Institute (NCI); Marie Betzner Morrow Endowment; National Institute of Diabetes and Digestive and Kidney Diseases; National Research Service Award/NCI; NATIONAL CANCER INSTITUTE [T32CA009172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK093543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Marie Betzner Morrow Endowment; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Research Service Award/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank K. Peterson and H. Fedosyuk for beta-locus mice, K. Gaensler and M. Groudine for the A20 strain of beta-locus mice, T. M. Townes for the SCD mice, and M. Nguyen, R. Okabe, and J. Alves for technical assistance. We thank D. Higgs, D. A. Williams, L. I. Zon, D. E. Bauer, H. F. Xie, M. Kerenyi, T. Menne, J. Harriss, and J. Decker for advice and discussions. This work was supported by funding from NIH (S.H.O. and B. L. E.); the National Cancer Institute (NCI) and the Marie Betzner Morrow Endowment (P. W. T.); and a Center Award from the National Institute of Diabetes and Digestive and Kidney Diseases (S.H.O.). G. C. I. was supported by a National Research Service Award/NCI postdoctoral fellowship, and J. X. is a Howard Hughes Medical Institute-Helen Hay Whitney Foundation fellow. The authors declare no conflict of interest.	Bradner JE, 2010, P NATL ACAD SCI USA, V107, P12617, DOI 10.1073/pnas.1006774107; CONLEY CL, 1963, BLOOD, V21, P261, DOI 10.1182/blood.V21.3.261.261; DESIMONE J, 1982, P NATL ACAD SCI-BIOL, V79, P4428, DOI 10.1073/pnas.79.14.4428; Dykxhoorn DM, 2006, CELL, V126, P231, DOI 10.1016/j.cell.2006.07.007; Fabry ME, 2001, BLOOD, V97, P410, DOI 10.1182/blood.V97.2.410; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Heinrich AC, 2004, BLOOD, V104, P659, DOI 10.1182/blood-2003-05-1442; Herrick J.B., 1910, ARCH INTERN MED, V6, P517; INGRAM VM, 1956, NATURE, V178, P792, DOI 10.1038/178792a0; Koehler AN, 2010, CURR OPIN CHEM BIOL, V14, P331, DOI 10.1016/j.cbpa.2010.03.022; KRAUS AP, 1961, BRIT MED J, V1, P1434, DOI 10.1136/bmj.1.5237.1434; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; LEY TJ, 1982, NEW ENGL J MED, V307, P1469, DOI 10.1056/NEJM198212093072401; Li CW, 2011, P NATL ACAD SCI USA, V108, P14258, DOI 10.1073/pnas.1109522108; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Pawliuk R, 2001, SCIENCE, V294, P2368, DOI 10.1126/science.1065806; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Ryan TM, 1997, SCIENCE, V278, P873, DOI 10.1126/science.278.5339.873; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Shaw KL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002594; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Wilber A, 2011, BLOOD, V117, P3945, DOI 10.1182/blood-2010-11-316893; Wilber A, 2011, BLOOD, V117, P2817, DOI 10.1182/blood-2010-08-300723; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310	29	228	241	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 18	2011	334	6058					993	996		10.1126/science.1211053	http://dx.doi.org/10.1126/science.1211053			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CA	21998251	Green Accepted			2022-12-28	WOS:000297101800060
J	Vesco, KK; Whitlock, EP; Eder, M; Burda, BU; Senger, CA; Lutz, K				Vesco, Kimberly K.; Whitlock, Evelyn P.; Eder, Michelle; Burda, Brittany U.; Senger, Caitlyn A.; Lutz, Kevin			Risk Factors and Other Epidemiologic Considerations for Cervical Cancer Screening: A Narrative Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							HUMAN-PAPILLOMAVIRUS INFECTION; MULTICENTRIC CASE-CONTROL; INTRAEPITHELIAL NEOPLASIA; COLLABORATIVE REANALYSIS; NATURAL-HISTORY; INDIVIDUAL DATA; UNITED-STATES; RETROSPECTIVE COHORT; INVASIVE CANCER; HPV INFECTION	Despite the success of cervical cancer screening programs, questions remain about the appropriate time to begin and end screening. This review explores epidemiologic and contextual data on cervical cancer screening to inform decisions about when screening should begin and end. Cervical cancer is rare among women younger than 20 years. Screening for cervical cancer in this age group is complicated by lower rates of detection and higher rates of false-positive results than in older women. Methods used to diagnose and treat cervical intraepithelial neoplasia have important potential adverse effects. High-risk human papillomavirus infections and abnormalities on cytologic and histologic examination have relatively high rates of regression. Accordingly, cervical cancer screening in women younger than 20 years may be harmful. The incidence of, and mortality rates from, cervical cancer and the proportion of U.S. women aged 65 years or older who have had a Papanicolaou smear within 3 years have decreased since 2000. Available evidence supports discontinuation of cervical cancer screening among women aged 65 years or older who have had adequate screening and are not otherwise at high risk. Further reductions in the burden of cervical cancer in older women are probably best achieved by focusing on screening those who have not been adequately screened.	[Vesco, Kimberly K.; Whitlock, Evelyn P.; Eder, Michelle; Burda, Brittany U.; Senger, Caitlyn A.; Lutz, Kevin] Kaiser Permanente NW, Oregon Evidence Based Practice Ctr, Ctr Hlth Res, Portland, OR 97227 USA	Kaiser Permanente	Vesco, KK (corresponding author), Kaiser Permanente NW, Oregon Evidence Based Practice Ctr, Ctr Hlth Res, 3800 N Interstate Ave, Portland, OR 97227 USA.				Agency for Healthcare Research and Quality, Rockville, Maryland [HHS-290-2007-10057-I, task order 3]	Agency for Healthcare Research and Quality, Rockville, Maryland(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This review was conducted by the Oregon Evidence-based Practice Center under contract to the Agency for Healthcare Research and Quality, Rockville, Maryland (contract HHS-290-2007-10057-I, task order 3). Agency staff provided oversight for the project and assisted in external review of the companion draft evidence synthesis. The USPSTF liaisons helped to resolve issues around the scope of the evidence synthesis but were not involved in the conduct of the review.	American Academy of Family Physicians, 2008, CERV CANC; American Cancer Society, 2010, AM CANC SOC GUID EAR; American Cancer Society, 2006, CERV CANC; [Anonymous], 2009, Obstet Gynecol, V114, P1409, DOI 10.1097/AOG.0b013e3181c6f8a4; [Anonymous], 2011, CERV SCREEN WAL; Appleby P, 2006, INT J CANCER, V119, P1108, DOI 10.1002/ijc.21953; Arbyn M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1284; Arbyn M, 2008, EUROPEAN GUIDELINES; Armaroli P, 2008, BRIT J CANCER, V99, P239, DOI 10.1038/sj.bjc.6604455; Ault Kevin A, 2006, Infect Dis Obstet Gynecol, V2006 Suppl, P40470; Australia Department of Health and Aging, 2011, NAT CERV SCREEN PROG; Barnholtz-Sloan J, 2009, CANCER CAUSE CONTROL, V20, P1129, DOI 10.1007/s10552-009-9317-z; Bosch FX, 2007, DIS MARKERS, V23, P213, DOI 10.1155/2007/914823; Canadian Task Force on Preventive Health Care, 1994, SCREEN CERV CANC; Carreon JD, 2007, INT J GYNECOL PATHOL, V26, P441, DOI 10.1097/pgp.0b013e31805152ab; Castellsague X, 2006, JNCI-J NATL CANCER I, V98, P303, DOI 10.1093/jnci/djj067; Castle PE, 2009, OBSTET GYNECOL, V113, P18, DOI 10.1097/AOG.0b013e31818f5008; Centers for Disease Control and Prevention, 2011, CERV CANC SCREEN RAT; Clifford GM, 2003, BRIT J CANCER, V89, P101, DOI 10.1038/sj.bjc.6601024; Cotton SC, 2007, BRIT J CANCER, V97, P133, DOI 10.1038/sj.bjc.6603822; Cox JT, 2006, CURR OPIN OBSTET GYN, V18, pS5, DOI 10.1097/01.gco.0000216315.72572.fb; Cox JT, 2003, AM J OBSTET GYNECOL, V188, P1406, DOI 10.1067/mob.2003.461; Cruickshank M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2546; Datta SD, 2008, ANN INTERN MED, V148, P493, DOI 10.7326/0003-4819-148-7-200804010-00004; de Gonzalez AB, 2007, INT J CANCER, V120, P885, DOI 10.1002/ijc.22357; Dowling EC, 2010, J MED SCREEN, V17, P139, DOI 10.1258/jms.2010.010033; FAHS MC, 1992, ANN INTERN MED, V117, P520, DOI 10.7326/0003-4819-117-6-520; Finnish Cancer Registry, 2011, CERV CANC SCREE SCRE; Hartmann KE, 2002, SYSTEMATIC REV AGENC, Vii-74; Hawkes AP, 1996, AM J PREV MED, V12, P342; Henley S. Jane, 2010, Morbidity and Mortality Weekly Report, V59, P1; HSC Public Health Agency, 2011, NI CANC SCREEN PROGR; IARC, 2021, CERV CANC SCREEN IAR; Insinga RP, 2007, CANCER EPIDEM BIOMAR, V16, P709, DOI 10.1158/1055-9965.EPI-06-0846; Insinga RP, 2004, AM J OBSTET GYNECOL, V191, P105, DOI 10.1016/j.ajog.2004.01.043; JANERICH DT, 1995, AM J PUBLIC HEALTH, V85, P791, DOI 10.2105/AJPH.85.6.791; Kalliala I, 2005, BRIT MED J, V331, P1183, DOI 10.1136/bmj.38663.459039.7C; Kalliala I, 2010, INT J CANCER, V126, P224, DOI 10.1002/ijc.24713; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; Kinney W, 1998, GYNECOL ONCOL, V71, P428, DOI 10.1006/gyno.1998.5135; Kulasingam SL, SCREENING CERV UNPUB; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Lewis CL, 2010, J GEN INTERN MED, V25, P859, DOI 10.1007/s11606-010-1346-5; Leyden WA, 2005, JNCI-J NATL CANCER I, V97, P675, DOI 10.1093/jnci/dji115; Mandelblatt J, 2004, ARCH INTERN MED, V164, P245, DOI 10.1001/archinte.164.3.245; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; McDougall JA, 2007, CANCER CAUSE CONTROL, V18, P1175, DOI 10.1007/s10552-007-9056-y; Moreno V, 2002, LANCET, V359, P1085, DOI 10.1016/S0140-6736(02)08150-3; Munoz N, 2002, LANCET, V359, P1093, DOI 10.1016/S0140-6736(02)08151-5; National Cancer Institute, 2011, SEER CANC STAT REV 1; National Health Service Cervical Screening Programme, 2011, CERV CANC SCREEN; New Zealand National Cervical Screening Programme, 2008, GUID CERV SCREEN NZ; OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186; Palma PD, 2009, AM J CLIN PATHOL, V132, P125, DOI 10.1309/AJCPBRK7D1YIUWFP; Peto J, 2004, BRIT J CANCER, V91, P942, DOI 10.1038/sj.bjc.6602049; Plummer M, 2003, CANCER CAUSE CONTROL, V14, P805, DOI 10.1023/B:CACO.0000003811.98261.3e; Plummer M, 2007, J INFECT DIS, V195, P1582, DOI 10.1086/516784; Rajkumar T, 2006, INT J CANCER, V118, P1481; Rebolj M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1354; Sasieni P., 2006, CURR DIAGN PATHOL, V12, P114, DOI [10.1016/j.cdip.2005.12.006, DOI 10.1016/J.CDIP.2005.12.006]; Sasieni P, 2009, BRIT MED J, V339, pb2968, DOI DOI 10.1136/BMJ.B2968; Sawaya GF, 2009, AM J OBSTET GYNECOL, V200; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Schiffman M, 2011, JNCI-J NATL CANCER I, V103, P368, DOI 10.1093/jnci/djq562; Sharp L, 2009, BJOG-INT J OBSTET GY, V116, P1506, DOI 10.1111/j.1471-0528.2009.02263.x; Sigurdsson K, 2007, EUR J CANCER, V43, P769, DOI 10.1016/j.ejca.2006.11.017; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Strander B, 2007, BMJ-BRIT MED J, V335, P1077, DOI 10.1136/bmj.39363.471806.BE; Sung HY, 2000, CANCER, V88, P2283, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2283::AID-CNCR12>3.3.CO;2-4; Surveillance Epidemiology and End Results (SEER), 2011, SEER STAT DAT ALL CO; Surveillance Epidemiology and End Results (SEER) Program, 2010, SEER STAT FACT SHEET; Surveillance Epidemiology and End Results (SEER) Program, 2011, SEER STAT DAT INC SE; The Scottish Government, 2008, CERV CANC SCREEN PRO; Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054; US Preventive Services Task Force, 2008, AHRQ PUBL; US Preventive Services Task Force. Screening for Cervical Cancer: Recommendations and Rationale. Agency for Healthcare Research and Quality, 2003, SCREEN CERV CANC REC; Vesco K, 2011, AHRQ PUBLICATION; Whitlock EP, 2011, ANN INTERN MED, V155, P687, DOI 10.7326/0003-4819-155-10-201111150-00376; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4; Wright Thomas C Jr, 2007, J Low Genit Tract Dis, V11, P201, DOI 10.1097/LGT.0b013e3181585870; Xu J., 2010, NATL VITAL STAT REP, V58, P1	82	76	79	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	2011	155	10					698	+		10.7326/0003-4819-155-10-201111150-00377	http://dx.doi.org/10.7326/0003-4819-155-10-201111150-00377			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849EI	22006929				2022-12-28	WOS:000297108000006
J	Fritsch, J; Scheerer, P; Frielingsdorf, S; Kroschinsky, S; Friedrich, B; Lenz, O; Spahn, CMT				Fritsch, Johannes; Scheerer, Patrick; Frielingsdorf, Stefan; Kroschinsky, Sebastian; Friedrich, Baerbel; Lenz, Oliver; Spahn, Christian M. T.			The crystal structure of an oxygen-tolerant hydrogenase uncovers a novel iron-sulphur centre	NATURE			English	Article							MEMBRANE-BOUND HYDROGENASE; NIFE HYDROGENASE; ALCALIGENES-EUTROPHUS; PROTEIN; CRYSTALLOGRAPHY; POTENTIALS; CONVERSION; CLUSTER; O-2; H-2	Hydrogenases are abundant enzymes that catalyse the reversible interconversion of H-2 into protons and electrons at high rates(1). Those hydrogenases maintaining their activity in the presence of O-2 are considered to be central to H-2-based technologies, such as enzymatic fuel cells and for light-driven H-2 production(2). Despite comprehensive genetic, biochemical, electrochemical and spectroscopic investigations(3-8), the molecular background allowing a structural interpretation of how the catalytic centre is protected from irreversible inactivation by O-2 has remained unclear. Here we present the crystal structure of an O-2-tolerant [NiFe]-hydrogenase from the aerobic H-2 oxidizer Ralstonia eutropha H16 at 1.5 angstrom resolution. The heterodimeric enzyme consists of a large subunit harbouring the catalytic centre in the H-2-reduced state and a small subunit containing an electron relay consisting of three different iron-sulphur clusters. The cluster proximal to the active site displays an unprecedented [4Fe-3S] structure and is coordinated by six cysteines. According to the current model, this cofactor operates as an electronic switch depending on the nature of the gas molecule approaching the active site. It serves as an electron acceptor in the course of H-2 oxidation and as an electron-delivering device upon O-2 attack at the active site. This dual function is supported by the capability of the novel iron-sulphur cluster to adopt three redox states at physiological redox potentials(7-9). The second structural feature is a network of extended water cavities that may act as a channel facilitating the removal of water produced at the [NiFe] active site. These discoveries will have an impact on the design of biological and chemical H-2-converting catalysts that are capable of cycling H-2 in air.	[Scheerer, Patrick; Kroschinsky, Sebastian; Spahn, Christian M. T.] Charite, Inst Med Phys & Biophys CC2, D-10117 Berlin, Germany; [Fritsch, Johannes; Frielingsdorf, Stefan; Friedrich, Baerbel; Lenz, Oliver] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Spahn, Christian M. T.] Humboldt Univ, Zentrum Biophys & Bioinformat, D-10115 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Humboldt University of Berlin	Scheerer, P (corresponding author), Charite, Inst Med Phys & Biophys CC2, Charitepl 1, D-10117 Berlin, Germany.	patrick.scheerer@charite.de; oliver.lenz@cms.hu-berlin.de; christian.spahn@charite.de	Frielingsdorf, Stefan/AAD-8065-2019; vedha, angeline/F-7272-2012; Lenz, Oliver/N-5130-2019; Lenz, Oliver/C-1582-2019	Frielingsdorf, Stefan/0000-0002-4141-7836; Lenz, Oliver/0000-0003-4550-5128; Lenz, Oliver/0000-0003-4550-5128; Scheerer, Patrick/0000-0001-5028-2075	EU; DFG Cluster of Excellence 'Unifying Concepts in Catalysis'; ERC [ERC-2009/249910-TUDOR];  [Sfb740]	EU(European Commission); DFG Cluster of Excellence 'Unifying Concepts in Catalysis'(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); 	We are grateful to U. Muller, M. Weiss and the scientific staff of the BESSY-MX/Helmholtz Zentrum Berlin fur Materialien und Energie at beamlines BL 14.1 and BL 14.2, D. von Stetten and A. Royant of the ID29S-Cryobench (ESRF, Grenoble) and the European Synchrotron Radiation Facility (ESRF, Grenoble) at beamlines ID23-1, ID23-2, ID14-1 and ID 14-4, where the data were collected, for support. This work was supported by the EU/FP7 programme Solar-H2 (to J.F.), the DFG Cluster of Excellence 'Unifying Concepts in Catalysis' (to S. F., B. F., O.L.), and the Sfb740 (to C. M. T. S.). P. S. acknowledges K. P. Hofmann and his advanced investigator ERC grant (ERC-2009/249910-TUDOR) for support.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAMMACK R, 1973, BIOCHEM BIOPH RES CO, V54, P548, DOI 10.1016/0006-291X(73)91457-5; Cammack R., 2001, HYDROGEN FUEL LEARNI; Capozzi F, 1998, STRUCT BOND, V90, P127; CARTER CW, 1977, J BIOL CHEM, V252, P7802; Cracknell JA, 2009, P NATL ACAD SCI USA, V106, P20681, DOI 10.1073/pnas.0905959106; De Lacey AL, 2007, CHEM REV, V107, P4304, DOI 10.1021/cr0501947; DeLano W.L, PYMOL MOL GRAPHICS S; Dey A, 2007, SCIENCE, V318, P1464, DOI 10.1126/science.1147753; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Flot D, 2010, J SYNCHROTRON RADIAT, V17, P107, DOI 10.1107/S0909049509041168; Friedrich B, 2011, CURR OPIN BIOTECH, V22, P358, DOI 10.1016/j.copbio.2011.01.006; Goris T, 2011, NAT CHEM BIOL, V7, P310, DOI 10.1038/nchembio.555; HEERING HA, 1995, BIOCHEMISTRY-US, V34, P14675, DOI 10.1021/bi00045a008; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KNUTTEL K, 1994, B POL ACAD SCI-CHEM, V42, P495; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, APPL CRYST, V26, P283; Lenz O, 2010, CHEMPHYSCHEM, V11, P1107, DOI 10.1002/cphc.200901002; Ludwig M, 2009, J BIOL CHEM, V284, P465, DOI 10.1074/jbc.M803676200; Lukey MJ, 2010, J BIOL CHEM, V285, P3928, DOI 10.1074/jbc.M109.067751; Matias PM, 2001, J BIOL INORG CHEM, V6, P63, DOI 10.1007/s007750000167; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Montet Y, 1997, NAT STRUCT BIOL, V4, P523, DOI 10.1038/nsb0797-523; Ogata H, 2010, J MOL BIOL, V402, P428, DOI 10.1016/j.jmb.2010.07.041; Ogata H, 2009, DALTON T, P7577, DOI 10.1039/b903840j; Pandelia ME, 2011, P NATL ACAD SCI USA, V108, P6097, DOI 10.1073/pnas.1100610108; Peters JW, 1997, BIOCHEMISTRY-US, V36, P1181, DOI 10.1021/bi9626665; Saggu M, 2009, J BIOL CHEM, V284, P16264, DOI 10.1074/jbc.M805690200; SCHINK B, 1979, BIOCHIM BIOPHYS ACTA, V567, P315, DOI 10.1016/0005-2744(79)90117-7; SCHNEIDER K, 1983, BIOCHIM BIOPHYS ACTA, V748, P353, DOI 10.1016/0167-4838(83)90179-6; Schubert T, 2007, MOL MICROBIOL, V66, P453, DOI 10.1111/j.1365-2958.2007.05933.x; Schwartz E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P496, DOI 10.1007/0-387-30742-7_17; Seefeldt LC, 2009, ANNU REV BIOCHEM, V78, P701, DOI 10.1146/annurev.biochem.78.070907.103812; Stripp ST, 2009, P NATL ACAD SCI USA, V106, P17331, DOI 10.1073/pnas.0905343106; THOMSON AJ, 1981, BIOCHIM BIOPHYS ACTA, V637, P423, DOI 10.1016/0005-2728(81)90047-5; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; Volbeda A, 2005, J BIOL INORG CHEM, V10, P239, DOI 10.1007/s00775-005-0632-x; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127	48	272	272	2	213	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2011	479	7372					249	U134		10.1038/nature10505	http://dx.doi.org/10.1038/nature10505			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PD	22002606				2022-12-28	WOS:000298030800047
J	Raviola, G; Becker, AE; Farmer, P				Raviola, Giuseppe; Becker, Anne E.; Farmer, Paul			A global scope for global health-including mental health	LANCET			English	Editorial Material							HAITI; CARE		[Raviola, Giuseppe; Becker, Anne E.; Farmer, Paul] Harvard Univ, Sch Med, Program Global Mental Hlth & Social Change, Dept Global Hlth & Social Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Raviola, G (corresponding author), Harvard Univ, Sch Med, Program Global Mental Hlth & Social Change, Dept Global Hlth & Social Med, Boston, MA 02115 USA.	giuseppe_raviola@hms.harvard.edu	Raviola, Giuseppe/AAE-9002-2021	Raviola, Giuseppe/0000-0003-3379-0371; Becker, Anne/0000-0001-9129-6510				[Anonymous], 1995, WORLD MENTAL HLTH PR; Burns Jonathan Kenneth, 2009, Health Hum Rights, V11, P19; Chisholm D, 2007, BRIT J PSYCHIAT, V191, P528, DOI 10.1192/bjp.bp.107.038463; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Farmer Paul, 2008, Health Hum Rights, V10, P5; Grand Challenges in Global Mental Health, OV DEF; Ivers LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019276; Kleinman A, 2009, LANCET, V374, P603, DOI 10.1016/S0140-6736(09)61510-5; Koenig Serena, 2010, HIV Therapy, V4, P145, DOI [10.2217/hiv.10.6, 10.2217/HIV.10.6]; Lee PT, 2010, LANCET, V376, P516, DOI 10.1016/S0140-6736(10)61254-8; Meyer AC, 2010, B WORLD HEALTH ORGAN, V88, P260, DOI 10.2471/BLT.09.064147; Patel V, 2011, BRIT J PSYCHIAT, V198, P88, DOI 10.1192/bjp.bp.109.074518; Patel V, 2010, JAMA-J AM MED ASSOC, V303, P1976, DOI 10.1001/jama.2010.616; Patel V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000159; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Razzouk D, 2010, HEALTH POLICY, V94, P211, DOI 10.1016/j.healthpol.2009.09.009; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; Tomlinson M, 2009, B WORLD HEALTH ORGAN, V87, P438, DOI 10.2471/BLT.08.054353; Walton DA, 2004, J PUBLIC HEALTH POL, V25, P137, DOI 10.1057/palgrave.jphp.3190013; WHO, 2011, MOSC DECL COMM ACT W; World Health Organization, 2016, MHGAP INT GUID MENT	21	33	34	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 5	2011	378	9803					1613	1615		10.1016/S0140-6736(11)60941-0	http://dx.doi.org/10.1016/S0140-6736(11)60941-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	844ST	22008421				2022-12-28	WOS:000296768300012
J	Kieling, C; Baker-Henningham, H; Belfer, M; Conti, G; Ertem, I; Omigbodun, O; Rohde, LA; Srinath, S; Ulkuer, N; Rahman, A				Kieling, Christian; Baker-Henningham, Helen; Belfer, Myron; Conti, Gabriella; Ertem, Ilgi; Omigbodun, Olayinka; Rohde, Luis Augusto; Srinath, Shoba; Ulkuer, Nurper; Rahman, Atif			Global Mental Health 2 Child and adolescent mental health worldwide: evidence for action	LANCET			English	Article							MIDDLE-INCOME COUNTRIES; POSTTRAUMATIC-STRESS-DISORDER; TEACHER-TRAINING PROGRAM; RISK-FACTORS; PSYCHOSOCIAL INTERVENTION; GROUP-PSYCHOTHERAPY; BEHAVIOR PROBLEMS; URBAN CHILDREN; YOUNG-CHILDREN; PREVALENCE	Mental health problems affect 10-20% of children and adolescents worldwide. Despite their relevance as a leading cause of health-related disability in this age group and their longlasting effects throughout life, the mental health needs of children and adolescents are neglected, especially in low-income and middle-income countries. In this report we review the evidence and the gaps in the published work in terms of prevalence, risk and protective factors, and interventions to prevent and treat childhood and adolescent mental health problems. We also discuss barriers to, and approaches for, the implementation of such strategies in low-resource settings. Action is imperative to reduce the burden of mental health problems in future generations and to allow for the full development of vulnerable children and adolescents worldwide.	[Rahman, Atif] Univ Liverpool, Inst Psychol Hlth & Soc, Child Mental Hlth Unit, Alder Hey Childrens NHS Fdn Trust, Liverpool L12 2AP, Merseyside, England; [Kieling, Christian; Rohde, Luis Augusto] Univ Fed Rio Grande do Sul, Dept Psychiat, Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Baker-Henningham, Helen] Univ W Indies, Res Inst Trop Med, Kingston 7, Jamaica; [Belfer, Myron] Harvard Univ, Sch Med, Boston, MA USA; [Conti, Gabriella] Univ Chicago, Harris Sch Publ Policy, Chicago, IL 60637 USA; [Ertem, Ilgi] Ankara Univ, Sch Med, Dept Pediat, Dev Behav Pediat Unit, TR-06100 Ankara, Turkey; [Omigbodun, Olayinka] Univ Ibadan, Dept Psychiat, Coll Med, Ibadan, Nigeria; [Omigbodun, Olayinka] Univ Coll Hosp, Ibadan, Nigeria; [Srinath, Shoba] Natl Inst Mental Hlth & Neurosci, Dept Child & Adolescent Psychiat, Bangalore 560029, Karnataka, India; [Ulkuer, Nurper] UN Childrens Fund, Early Childhood Dev Unit, New York, NY USA	Alder Hey Children's NHS Foundation Trust; University of Liverpool; Universidade Federal do Rio Grande do Sul; University West Indies Mona Jamaica; Harvard University; Harvard Medical School; University of Chicago; Ankara University; University of Ibadan; University of Ibadan; University College Hospital, Ibadan; National Institute of Mental Health & Neurosciences - India	Rahman, A (corresponding author), Univ Liverpool, Inst Psychol Hlth & Soc, Child Mental Hlth Unit, Alder Hey Childrens NHS Fdn Trust, Mulberry House, Liverpool L12 2AP, Merseyside, England.	atif.rahman@liverpool.ac.uk	Psiquiatria, Inct/I-1060-2013; Rohde, Luis Augusto P/A-6426-2008; Kieling, Christian/U-3905-2019	Rohde, Luis Augusto P/0000-0002-4552-4188; Kieling, Christian/0000-0001-7691-4149; Baker-Henningham, Helen/0000-0001-5697-155X; Conti, Gabriella/0000-0003-4699-2490	Novartis; Shire; Deva; Janssen-Cilag; Abbott; Eli-Lilly; Brazilian Research Council (CNPq); Wellcome Trust [080534/Z/06/Z]	Novartis(Novartis); Shire; Deva; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Abbott(Abbott Laboratories); Eli-Lilly(Eli Lilly); Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Wellcome Trust(Wellcome TrustEuropean Commission)	CK took part in two meetings for attention-deficit hyperactivity disorder sponsored by Novartis and Shire. CK also took part in a meeting on the promotion of editorial capacity among editors from low-income and middle-income countries sponsored by Deva. LAR was on the speakers' bureau and acted as consultant for Eli-Lilly, Janssen-Cilag, Novartis, and Shire in the past 3 years (received less than US$10 000 per year, which is less than 5% of LAR's gross income per year). LAR also received travel awards (air tickets and hotel costs) from Novartis and Janssen-Cilag in 2010 for taking part of two child psychiatric meetings. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by LAR received unrestricted educational and research support from the following pharmaceutical companies in the past 3 years; Abbott, Eli-Lilly, Janssen-Cilag, Novartis, and Shire.; CK has received a scholarship from the Brazilian Research Council (CNPq). HB-H was supported by a Wellcome Trust Fellowship (#080534/Z/06/Z).	Abu-Rabia S, 2005, DYSLEXIA, V11, P1, DOI 10.1002/dys.271; Angelucci M, 2010, OFFICE STRATEGIC PLA; [Anonymous], 2010, LANCET, V376, P1274, DOI 10.1016/S0140-6736(10)61897-1; Anselmi L, 2004, J CHILD PSYCHOL PSYC, V45, P779, DOI 10.1111/j.1469-7610.2004.00271.x; Armecin G., 2006, EARLY CHILDHOOD DEV; Arun Priti, 2009, Indian J Med Sci, V63, P281, DOI 10.4103/0019-5359.55112; Asbahr FR, 2005, J AM ACAD CHILD PSY, V44, P1128, DOI 10.1097/01.chi.0000177324.40005.6f; Atkins MS, 2008, J CONSULT CLIN PSYCH, V76, P905, DOI 10.1037/a0013036; Baker-Henningham H, 2011, CHILD CARE HLTH DEV, V37, P649, DOI 10.1111/j.1365-2214.2011.01208.x; Baker-Henningham H, 2009, W INDIAN MED J, V58, P460; Baker-Henningham H, 2009, CHILD CARE HLTH DEV, V35, P632, DOI 10.1111/j.1365-2214.2009.00996.x; Baker-Henningham H, 2009, CHILD CARE HLTH DEV, V35, P624, DOI 10.1111/j.1365-2214.2009.00964.x; Bandeali Salman, 2008, J Pak Med Assoc, V58, P345; Belfer ML, 2006, LANCET, V367, P551, DOI 10.1016/S0140-6736(06)68199-3; Belfer ML, 2008, J CHILD PSYCHOL PSYC, V49, P226, DOI 10.1111/j.1469-7610.2007.01855.x; Bella H, 2005, J TROP PEDIATRICS, V51, P265, DOI 10.1093/tropej/fmi009; Benjet C, 2010, CURR OPIN PSYCHIATR, V23, P356, DOI 10.1097/YCO.0b013e32833ad79b; Bonhauser M, 2005, HEALTH PROMOT INT, V20, P113, DOI 10.1093/heapro/dah603; Bordin IA, 2009, B WORLD HEALTH ORGAN, V87, P336, DOI 10.2471/BLT.07.043125; Canino G, 2008, J CHILD PSYCHOL PSYC, V49, P237, DOI 10.1111/j.1469-7610.2007.01854.x; Carneiro P., 2003, INEQUALITY AM WHAT R; Chang SM, 2002, J CHILD PSYCHOL PSYC, V43, P775, DOI 10.1111/1469-7610.00088; Chaux E, 2009, AGGRESSIVE BEHAV, V35, P520, DOI 10.1002/ab.20320; Conti G, 2010, PERSPECT PSYCHOL SCI, V5, P585, DOI 10.1177/1745691610383502; Conti G, 2010, AM ECON REV, V100, P234, DOI 10.1257/aer.100.2.234; Cunningham Wendy, 2008, SUPPORTING YOUTH RIS; Curto BM, 2011, SOC PSYCH PSYCH EPID, V46, P1221, DOI 10.1007/s00127-010-0291-2; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Doyle O, 2009, ECON HUM BIOL, V7, P1, DOI 10.1016/j.ehb.2009.01.002; Durkin MS, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P933; Dybdahl R, 2001, CHILD DEV, V72, P1214, DOI 10.1111/1467-8624.00343; Earls F, 2008, J CHILD PSYCHOL PSYC, V49, P295, DOI 10.1111/j.1469-7610.2007.01864.x; Eisenberg L, 2009, J CHILD PSYCHOL PSYC, V50, P26, DOI 10.1111/j.1469-7610.2008.01984.x; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Erol N, 2010, EUR CHILD ADOLES PSY, V19, P113, DOI 10.1007/s00787-009-0047-2; Ertem IO, 2010, RUDOLPHS PEDIAT, P36; Fararouei M, 2010, BRIT J NUTR, V104, P1363, DOI 10.1017/S0007114510002175; Fernald LCH, 2009, LANCET, V374, P1997, DOI 10.1016/S0140-6736(09)61676-7; Flisher AJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000235; Freitas GVS, 2008, EUR CHILD ADOLES PSY, V17, P336, DOI 10.1007/s00787-007-0668-2; Funk M, 2006, HEALTH PROMOT INT, V21, P70, DOI 10.1093/heapro/dai031; Goodman R, 1997, BRIT MED J, V314, P813, DOI 10.1136/bmj.314.7083.813; Gordon JS, 2008, J CLIN PSYCHIAT, V69, P1469, DOI 10.4088/JCP.v69n0915; Graeff-Martins AS, 2008, J CHILD PSYCHOL PSYC, V49, P335, DOI 10.1111/j.1469-7610.2007.01827.x; Graeff-Martins AS, 2006, EUR CHILD ADOLES PSY, V15, P442, DOI 10.1007/s00787-006-0555-2; Grantham-McGregor S, 2007, LANCET, V369, P824, DOI 10.1016/S0140-6736(07)60404-8; Gruber J, 2009, PROBLEMS DISADVANTAG; Guindon GE, 2010, CAN MED ASSOC J, V182, pE362, DOI 10.1503/cmaj.081165; Harel-Fisch Y, 2010, CHILD ABUSE NEGLECT, V34, P623, DOI 10.1016/j.chiabu.2009.12.007; Harper G, 2008, INT REV PSYCHIATR, V20, P217, DOI 10.1080/09540260802030559; Harpham T, 2005, J EPIDEMIOL COMMUN H, V59, P1060, DOI 10.1136/jech.2005.039180; Heckman JJ, 2007, P NATL ACAD SCI USA, V104, P13250, DOI 10.1073/pnas.0701362104; Heymann J., 2006, FORGOTTEN FAMILIES E; Hoven CW, 2008, INT REV PSYCHIATR, V20, P261, DOI 10.1080/09540260801995950; Huey SJ, 2004, J AM ACAD CHILD PSY, V43, P183, DOI 10.1097/00004583-200402000-00014; Iranfar S., 2005, Eastern Mediterranean Health Journal, V11, P618; Ison MS, 2001, PSYCHOL REP, V88, P903, DOI 10.2466/PR0.88.3.903-911; Ivanova MY, 2007, J CLIN CHILD ADOLESC, V36, P405, DOI 10.1080/15374410701444363; Jensen PS, 2006, REV BRAS PSIQUIATR, V28, P1, DOI 10.1590/S1516-44462006000100001; Jia ZB, 2010, QUAL LIFE RES, V19, P1381, DOI 10.1007/s11136-010-9703-8; Jordans MJD, 2010, INT J MENT HEALTH SY, V4, DOI 10.1186/1752-4458-4-15; Jordans MJD, 2010, J CHILD PSYCHOL PSYC, V51, P818, DOI 10.1111/j.1469-7610.2010.02209.x; Jordans MJD, 2009, CHILD ADOL MENT H-UK, V14, P2, DOI 10.1111/j.1475-3588.2008.00515.x; Kagitcibasi C, 2009, J APPL DEV PSYCHOL, V30, P764, DOI 10.1016/j.appdev.2009.05.003; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; Kim-Cohen J, 2003, ARCH GEN PSYCHIAT, V60, P709, DOI 10.1001/archpsyc.60.7.709; Klein PS, 2004, INFANT YOUNG CHILD, V17, P340, DOI 10.1097/00001163-200410000-00007; Kohrt BA, 2010, TRANSCULT PSYCHIATRY, V47, P727, DOI 10.1177/1363461510381290; Kordas K, 2005, J PEDIATR-US, V147, P632, DOI 10.1016/j.jpeds.2005.06.037; Kuehn BM, 2005, JAMA-J AM MED ASSOC, V294, P293, DOI 10.1001/jama.294.3.293; Kumakech E, 2009, SOC SCI MED, V68, P1038, DOI 10.1016/j.socscimed.2008.10.033; Lam LT, 2010, ARCH PEDIAT ADOL MED, V164, P901, DOI 10.1001/archpediatrics.2010.159; Laxminarayan R, 2006, INTERVENTION COST EF; Layne CM, 2010, CHILD DEV, V81, P1053, DOI 10.1111/j.1467-8624.2010.01454.x; Layne CM, 2008, J AM ACAD CHILD PSY, V47, P1048, DOI 10.1097/CHI.0b013e31817eecae; Layne CM, 2001, GROUP DYN-THEOR RES, V5, P277, DOI 10.1037//1089-2699.5.4.277; Lee S, 2011, PSYCHOL MED, V41, P85, DOI 10.1017/S0033291710000450; Lee S, 2009, BRIT J PSYCHIAT, V194, P411, DOI 10.1192/bjp.bp.108.054841; Li XH, 2010, AUST NZ J PSYCHIAT, V44, P543, DOI 10.3109/00048671003601400; Lin Hong, 2007, Beijing Da Xue Xue Bao Yi Xue Ban, V39, P319; Lo WS, 2009, ACTA PAEDIATR, V98, P1959, DOI 10.1111/j.1651-2227.2009.01472.x; Lopez AD, 2006, DIS CONTROL PRIORITI; Loughry M, 2006, J CHILD PSYCHOL PSYC, V47, P1211, DOI 10.1111/j.1469-7610.2006.01656.x; Lozoff B, 2003, PEDIATRICS, V112, P846; Lozoff B, 2010, PEDIATRICS, V126, pE884, DOI 10.1542/peds.2009-3535; Lund C, 2010, SOC SCI MED, V71, P517, DOI 10.1016/j.socscimed.2010.04.027; Mangrulkar L., 2001, LIFE SKILLS APPROACH; Medhin G, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-32; Mels C, 2010, J CHILD PSYCHOL PSYC, V51, P1096, DOI 10.1111/j.1469-7610.2010.02241.x; Miller G, 2006, SCIENCE, V311, P458, DOI 10.1126/science.311.5760.458; Miller M, 2011, DRUG ALCOHOL DEPEN, V113, P110, DOI 10.1016/j.drugalcdep.2010.07.016; Mishara BL, 2006, EARLY CHILD RES Q, V21, P110, DOI 10.1016/j.ecresq.2006.01.002; Naudeau S, 2008, NEW DIR CHILD ADOLES, V122, P75, DOI 10.1002/cd.230; O'Shea TM, 2009, EARLY HUM DEV, V85, P719, DOI 10.1016/j.earlhumdev.2009.08.060; OConnell ME, 2009, PREVENTING MENTAL, EMOTIONAL, AND BEHAVIORAL DISORDERS AMONG YOUNG PEOPLE: PROGRESS AND POSSIBILITIES, P1; Oveisi S, 2010, CHILD ABUSE NEGLECT, V34, P206, DOI 10.1016/j.chiabu.2009.05.008; Owens JS, 2008, J CLIN CHILD ADOLESC, V37, P434, DOI 10.1080/15374410801955912; Page J, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-6; Panter-Brick C, 2009, LANCET, V374, P807, DOI 10.1016/S0140-6736(09)61080-1; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Qouta S, 2008, AGGRESSIVE BEHAV, V34, P231, DOI 10.1002/ab.20236; Rahman A, 2000, J CHILD PSYCHOL PSYC, V41, P539, DOI 10.1017/S0021963099005776; Raine A, 2003, AM J PSYCHIAT, V160, P1627, DOI 10.1176/appi.ajp.160.9.1627; Richmond J, 1983, PREVENTING READING D; Rivet-Duval E, 2011, CHILD ADOL MENT H-UK, V16, P86, DOI 10.1111/j.1475-3588.2010.00584.x; Rodriguez JDM, 2011, SOC PSYCH PSYCH EPID, V46, P381, DOI 10.1007/s00127-010-0202-6; Roy A, 2009, ENVIRON HEALTH PERSP, V117, P1607, DOI 10.1289/ehp.0900625; Rudatsikira E, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-67; Ruiz-Casares M, 2009, EUR CHILD ADOLES PSY, V18, P369, DOI 10.1007/s00787-009-0739-7; Rutter M, 2006, ANN NY ACAD SCI, V1094, P1, DOI 10.1196/annals.1376.002; S Goldstein, 2006, HDB RESILIANCE CHILD; Sachs JD, 2005, LANCET, V365, P347, DOI 10.1016/S0140-6736(05)70201-4; Shatkin Jess P, 2004, Child Adolesc Ment Health, V9, P104, DOI 10.1111/j.1475-3588.2004.00090.x; Shin JY, 2009, J INTELL DISABIL RES, V53, P339, DOI 10.1111/j.1365-2788.2008.01151.x; Shonkoff JP, 2009, JAMA-J AM MED ASSOC, V301, P2252, DOI 10.1001/jama.2009.754; St Petersburg USA Orphanage Res Team, 2008, MONOGR SOC RES CHILD, V73, P1, DOI 10.1111/j.1540-5834.2008.00483.x; Tol WA, 2008, JAMA-J AM MED ASSOC, V300, P655, DOI 10.1001/jama.300.6.655; Unicef, 2008, STAT MON; United Nations, CONV RIGHTS CHILD; United Nations, CONV RIGHTS PERS DIS; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Walker SP, 2006, BRIT MED J, V333, P472, DOI 10.1136/bmj.38897.555208.2F; Walker SP, 2010, DEV MED CHILD NEUROL, V52, pe148, DOI 10.1111/j.1469-8749.2010.03637.x; Wang Yi, 2007, Beijing Da Xue Xue Bao Yi Xue Ban, V39, P315; Wong ST, 2010, CAN J PUBLIC HEALTH, V101, P241, DOI 10.1007/BF03404382; World Health Organization, 2002, WORLD REPORT VIOLENC; Wu ZY, 2002, AM J PUBLIC HEALTH, V92, P1952, DOI 10.2105/AJPH.92.12.1952; Wyman PA, 1999, CHILD DEV, V70, P645, DOI 10.1111/1467-8624.00047; Yu D. L., 2002, PREVENTION TREATMENT, V5, P9; Zashikhina A, 2007, ACTA PAEDIATR, V96, P890, DOI 10.1111/j.1651-2227.2007.00277.x; Zechmeister I, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-20	132	1113	1134	14	228	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2011	378	9801					1515	1525		10.1016/S0140-6736(11)60827-1	http://dx.doi.org/10.1016/S0140-6736(11)60827-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	838VC	22008427				2022-12-28	WOS:000296319600026
J	Suter, LG; Paltiel, AD; Rome, BN; Solomon, DH; Golovaty, I; Gerlovin, H; Katz, JN; Losina, E				Suter, Lisa G.; Paltiel, A. David; Rome, Benjamin N.; Solomon, Daniel H.; Golovaty, Ilya; Gerlovin, Hanna; Katz, Jeffrey N.; Losina, Elena			Medical Device Innovation - Is "Better" Good Enough?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES		[Suter, Lisa G.] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Paltiel, A. David] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Suter, Lisa G.] Vet Affairs Connecticut Healthcare Syst, West Haven, CT USA; [Rome, Benjamin N.; Solomon, Daniel H.; Golovaty, Ilya; Gerlovin, Hanna; Katz, Jeffrey N.; Losina, Elena] Brigham & Womens Hosp, Boston, MA 02115 USA; [Solomon, Daniel H.; Losina, Elena] Harvard Univ, Sch Med, Boston, MA USA; [Katz, Jeffrey N.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Boston, MA USA	Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Boston University	Suter, LG (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.		Rome, Benjamin/I-4251-2012	Paltiel, A. David/0000-0002-4861-3290; Gerlovin, Hanna/0000-0002-6700-2129; Rome, Benjamin/0000-0001-5776-3293; Losina, ELENA/0000-0002-3424-0892	NIAMS NIH HHS [R01 AR053112, K24 AR057827] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053112, K24AR057827] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Institute of Medicine, 2011, MED DEV PUBL HLTH FD; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Losina E, 2011, ANN INTERN MED, V154, P217, DOI 10.7326/0003-4819-154-4-201102150-00001; OKEEFFE K, 2011, MED DEVICE DIAGNOSTI; Paxton EW, 2010, J BONE JOINT SURG AM, V92A, P117, DOI 10.2106/JBJS.J.00807	5	14	14	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2011	365	16					1464	1466		10.1056/NEJMp1109285	http://dx.doi.org/10.1056/NEJMp1109285			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835BW	22010911	Green Accepted			2022-12-28	WOS:000296009500013
J	Crescenti, A; Borghi, G; Bignami, E; Bertarelli, G; Landoni, G; Casiraghi, GM; Briganti, A; Montorsi, F; Rigatti, P; Zangrillo, A				Crescenti, Antonella; Borghi, Giovanni; Bignami, Elena; Bertarelli, Gaia; Landoni, Giovanni; Casiraghi, Giuseppina Maria; Briganti, Alberto; Montorsi, Francesco; Rigatti, Patrizio; Zangrillo, Alberto			Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostatectomy: double blind, randomised, placebo controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BLOOD-LOSS; HEMORRHAGE; OUTCOMES; SURGERY; SAFETY	Objectives To determine the efficacy of intraoperative treatment with low dose tranexamic acid in reducing the rate of perioperative transfusions in patients undergoing radical retropubic prostatectomy. Design Double blind, parallel group, randomised, placebo controlled trial. Setting One university hospital in Milan, Italy. Participants 200 patients older than 18 years and undergoing radical retropubic prostatectomy agreed to participate in the trial. Exclusion criteria were atrial fibrillation, coronary artery disease treated with drug eluting stent, severe chronic renal failure, congenital or acquired thrombophilia, and known or suspected allergy to tranexamic acid. Interventions Intravenous infusion of tranexamic acid or equivalent volume of placebo (saline) according to the following protocol: loading dose of 500 mg tranexamic acid 20 minutes before surgery followed by continuous infusion of tranexamic acid at 250 mg/h during surgery. Main outcome measures Primary outcome: number of patients receiving blood transfusions perioperatively. Secondary outcome: intraoperative blood loss. Six month follow-up to assess long term safety in terms of mortality and thromboembolic events. Results All patients completed treatment and none was lost to follow-up. Patients transfused were 34 (34%) in the tranexamic acid group and 55 (55%) in the control group (absolute reduction in transfusion rate 21% (95% CI 7% to 34%); relative risk of receiving transfusions for patients treated with tranexamic acid 0.62 (0.45 to 0.85); number needed to treat 5 (3 to 14); P=0.004). At follow-up, no patients died and the occurrence of thromboembolic events did not differ between the two groups. Conclusions Intraoperative treatment with low dose tranexamic acid is safe and effective in reducing the rate of perioperative blood transfusions in patients undergoing radical retropubic prostatectomy.	[Crescenti, Antonella; Borghi, Giovanni; Bignami, Elena; Bertarelli, Gaia; Landoni, Giovanni; Casiraghi, Giuseppina Maria; Zangrillo, Alberto] Univ Vita Salute San Raffaele, Dept Anaesthesia & Intens Care, I-20132 Milan, Italy; [Briganti, Alberto; Montorsi, Francesco; Rigatti, Patrizio] Univ Vita Salute San Raffaele, Dept Urol, I-20132 Milan, Italy	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University	Landoni, G (corresponding author), Univ Vita Salute San Raffaele, Dept Anaesthesia & Intens Care, I-20132 Milan, Italy.	landoni.giovanni@hsr.it	Zangrillo, Alberto/AAH-2037-2019; Giovanni, Landoni/AAH-1881-2019; Briganti, Alberto/AAN-1965-2020; Bertarelli, Gaia/AAA-3128-2020; Montorsi, Francesco/AAN-2473-2020	Zangrillo, Alberto/0000-0002-7687-7648; Giovanni, Landoni/0000-0002-8594-5980; Bertarelli, Gaia/0000-0002-1099-530X; 	Department of Anaesthesia and Intensive Care of San Raffaele Hospital	Department of Anaesthesia and Intensive Care of San Raffaele Hospital	Provided by the Department of Anaesthesia and Intensive Care of San Raffaele Hospital.	Altekruse SF, 2010, SEER CANC STAT REV 1; [Anonymous], 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3795; Bill-Axelson A, 2008, J NATL CANCER I, V100, P1144, DOI 10.1093/jnci/djn255; Cardone D, 2009, EUR J ANAESTH, V26, P722, DOI 10.1097/EJA.0b013e32832c5280; Dunn CJ, 1999, DRUGS, V57, P1005, DOI 10.2165/00003495-199957060-00017; Fergusson DA, 2008, NEW ENGL J MED, V358, P2319, DOI 10.1056/NEJMoa0802395; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Ferlay J, 2010, IARC CANCERBASE, V10; Ferraris VA, 2011, ANN THORAC SURG, V91, P944, DOI 10.1016/j.athoracsur.2010.11.078; Ficarra V, 2009, EUR UROL, V55, P1037, DOI 10.1016/j.eururo.2009.01.036; Finkelstein Julia, 2010, Rev Urol, V12, P35; Friederich PW, 2003, LANCET, V361, P201, DOI 10.1016/S0140-6736(03)12268-4; Hendrickson JE, 2009, ANESTH ANALG, V108, P759, DOI 10.1213/ane.0b013e3181930a6e; Henry David A, 2011, Cochrane Database Syst Rev, pCD001886, DOI 10.1002/14651858.CD001886.pub4; Kagoma YK, 2009, THROMB RES, V123, P687, DOI 10.1016/j.thromres.2008.09.015; Karkouti K, 2004, TRANSFUSION, V44, P1453, DOI 10.1111/j.1537-2995.2004.04144.x; Klein HG, 2007, LANCET, V370, P415, DOI 10.1016/S0140-6736(07)61197-0; Levi M, 2010, NEW ENGL J MED, V363, P1791, DOI 10.1056/NEJMoa1006221; MacIvor D, 2009, TRANSFUSION, V49, P1431, DOI 10.1111/j.1537-2995.2009.02131.x; Molenaar IQ, 2007, AM J TRANSPLANT, V7, P185, DOI 10.1111/j.1600-6143.2006.01591.x; Nielsen JD, 1997, BRIT J UROL, V80, P889, DOI 10.1046/j.1464-410X.1997.00483.x; O'Connor PJ, 2006, CAN J ANAESTH, V53, P873, DOI 10.1007/BF03022829; O'Hara JF, 1999, UROLOGY, V54, P130, DOI 10.1016/S0090-4295(99)00042-4; Perkins HA, 2010, TRANSFUSION, V50, P2080, DOI 10.1111/j.1537-2995.2010.02851.x; Ponschab M, 2011, J CARDIOTHORAC VASC; Rannikko A, 2004, UROLOGY, V64, P955, DOI 10.1016/j.urology.2004.07.008; Schulz KF, 2011, INT J SURG, V9, P672, DOI 10.1016/j.ijsu.2011.09.004; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Touijer K, 2008, J UROLOGY, V179, P1811, DOI 10.1016/j.juro.2008.01.026; Wang JK, 2010, VOX SANG, V98, P2, DOI 10.1111/j.1423-0410.2009.01223.x; Whitaker BI, 2010, 2007 NATL BLOOD COLL; World Medical Association, 2011, DECL HELS ETH PRINC; Ziegler S, 2008, EUR J ANAESTH, V25, P538, DOI 10.1017/S0265021508003852	33	84	86	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 19	2011	343								d5701	10.1136/bmj.d5701	http://dx.doi.org/10.1136/bmj.d5701			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HN	22012809	Green Published, hybrid			2022-12-28	WOS:000296183700002
J	Barrett-Connor, E				Barrett-Connor, Elizabeth			Review: Intensive-dose statin therapy increases incident diabetes compared with moderate-dose therapy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RANDOMIZED-TRIALS; METAANALYSIS; CHOLESTEROL; EFFICACY		Univ Calif, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Barrett-Connor, E (corresponding author), Univ Calif, La Jolla, CA 92093 USA.			Preiss, David/0000-0003-3139-1836				Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6	3	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2011	155	8							JC4-7	10.7326/0003-4819-155-8-201110180-02007	http://dx.doi.org/10.7326/0003-4819-155-8-201110180-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835WB	22007066				2022-12-28	WOS:000296066300006
J	Bates, SM; Guyatt, GH				Bates, Shannon M.; Guyatt, Gordon H.			Outpatient treatment was noninferior to inpatient treatment for preventing recurrent VTE in low-risk patients with acute PE	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PULMONARY-EMBOLISM		[Bates, Shannon M.; Guyatt, Gordon H.] McMaster Univ, Hamilton, ON, Canada	McMaster University	Bates, SM (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Otero R, 2010, THROMB RES, V126, pE1, DOI 10.1016/j.thromres.2009.09.026; Othieno R, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003076.pub2; Squizzato A, 2009, EUR RESPIR J, V33, P1148, DOI 10.1183/09031936.00133608	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2011	155	8							JC4-2	10.7326/0003-4819-155-8-201110180-02002	http://dx.doi.org/10.7326/0003-4819-155-8-201110180-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835WB	22007061				2022-12-28	WOS:000296066300001
J	Owens, C; Owen, G; Belam, J; Lloyd, K; Rapport, F; Donovan, J; Lambert, H				Owens, Christabel; Owen, Gareth; Belam, Judith; Lloyd, Keith; Rapport, Frances; Donovan, Jenny; Lambert, Helen			Recognising and responding to suicidal crisis within family and social networks: qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MENTAL-HEALTH; HELP-SEEKING; PREVENTION; EPIDEMIOLOGY; CONTACT	Objective To shed light on the difficulties faced by relatives, friends, and colleagues in interpreting signs of suicidality and deciding whether and how to intervene. Design Qualitative study of completed suicides, based on in-depth interviews with multiple informants. Setting London, southwest England, and south Wales. Participants 31 lay informants (one to five for each case), including parents, partners, siblings, friends, and colleagues of 14 cases of suicide in which the deceased was aged 18-34 and was not in contact with secondary mental health services. Results Informants described both intellectual and emotional barriers to awareness and intervention within the family and social network. They reported that signs and communications of distress were often oblique and difficult to interpret, that they may have disregarded warning signals and focused instead on positive signs, and that, even when they were aware that something was seriously wrong, taking any action at all involved considerable personal risks. Conclusions As the suicidal process unfolds, significant others are faced with a highly complex task. Their proximity to the suicidal person and their emotional investment in the relationship make it difficult for them to see what is happening, to say anything to the person or to other members of the network, or to seek help outside the network. Efforts to strengthen the capacity of lay people to play a role in preventing suicide are urgently needed and should be informed by a thorough understanding of these difficulties. They should highlight the ambiguous nature of warning signs and should focus on helping people to acknowledge and overcome their fears about intervening.	[Owens, Christabel] Devon Partnership NHS Trust, Exeter EX2 4SG, Devon, England; [Owens, Christabel; Owen, Gareth] Univ Exeter, Peninsula Med Sch, Exeter EX2 4SG, Devon, England; [Lloyd, Keith; Rapport, Frances] Swansea Univ, Coll Med, Swansea SA2 8PP, W Glam, Wales; [Donovan, Jenny; Lambert, Helen] Univ Bristol, Dept Social Med, Bristol BS8 2PS, Avon, England	University of Exeter; University of Exeter; Swansea University; University of Bristol	Owens, C (corresponding author), Devon Partnership NHS Trust, Salmon Pool Lane, Exeter EX2 4SG, Devon, England.	c.v.owens@exeter.ac.uk	Owen, Gareth/F-4879-2011; Lloyd, Keith/H-7458-2012	Lloyd, Keith/0000-0002-1440-4124; Rapport, Frances/0000-0002-4428-2826	UK Medical Research Council [G0600296]; NIHR CLAHRC for the Southwest Peninsula; MRC [G0600296] Funding Source: UKRI; Medical Research Council [G0600296] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR CLAHRC for the Southwest Peninsula; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the UK Medical Research Council, grant number G0600296. CO was partly supported during the writing of this paper by NIHR CLAHRC for the Southwest Peninsula. The views expressed are those of the authors and not necessarily those of the MRC, NHS, NIHR, or Department of Health. The sponsor for the study was Devon Partnership NHS Trust. The role of the sponsor was to ensure that the study was carried out in accordance with the Research Governance Framework issued by the Department of Health. Neither the funder nor the sponsor played any role in the study design; in the collection, analysis, and interpretation of data; or in the drafting of this paper.	Appleby L, 1999, BRIT MED J, V318, P1235; Associate Minister of Health, 2006, NZ SUIC PREV STRAT 2; Biddle L, 2008, BRIT MED J, V336, P539, DOI 10.1136/bmj.39475.603935.25; Biddle L, 2007, SOCIOL HEALTH ILL, V29, P983, DOI 10.1111/j.1467-9566.2007.01030.x; Britten N, 2000, QUALITATIVE RES HLTH; Britten N, 1995, QUALITATIVE RES METH; CANNON S, 1989, SOCIOL HEALTH ILL, V11, P62, DOI 10.1111/1467-9566.ep10844052; DAVISON C, 1991, SOCIOL HEALTH ILL, V13, P1, DOI 10.1111/1467-9566.ep11340301; Department of Health, 2002, NAT SUIC PREV STRAT; Government of Western Australia Department of Health, 2009, W AUSTR SUIC PREV ST; Gunnell D, 2005, INT J EPIDEMIOL, V34, P433, DOI 10.1093/ije/dyh398; Hale R, 2008, RELATING SELF HARM S; Hawton K, 1998, J AFFECT DISORDERS, V50, P269; Hendin H, 2001, SUICIDE LIFE-THREAT, V31, P115, DOI 10.1521/suli.31.2.115.21515; Holloway W, 2000, DOING QUALITATIVE RE; Holstein K, 1997, QUALITATIVE RES THEO; JEFFERSON G, 1981, J PRAGMATICS, V5, P399, DOI 10.1016/0378-2166(81)90026-6; Kelly CM, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-17; Kendall M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4122; Kitchener BA, 2002, BMC PSYCHIATRY, V2, DOI 10.1186/1471-244X-2-10; Lee R.M., 1993, DOING RES SENSITIVE; Lewis, 2006, QUALITATIVE RES PRAC; Luoma JB, 2002, AM J PSYCHIAT, V159, P909, DOI 10.1176/appi.ajp.159.6.909; MacNaughton J, 2004, OXFORD TXB PRIMARY M, V1; Maris R. W., 1981, PATHWAYS SUICIDE SUR; Maris R.W., 1969, SOCIAL FORCES URBAN; Mays N, 2000, QUALITATIVE RES HLTH; McCance TV, 2001, J ADV NURS, V33, P350, DOI 10.1046/j.1365-2648.2001.01671.x; Mellanby RJ, 2010, VET REC, V167, P730, DOI 10.1136/vr.c5427; Nigg J, 1995, NATURAL RISK CIVIL P; OMER H, 1994, AM J COMMUN PSYCHOL, V22, P273, DOI 10.1007/BF02506866; Owens C, 2005, BRIT J GEN PRACT, V55, P503; Owens C, 2004, BRIT J GEN PRACT, V54, P279; Owens C, 2008, SOCIOL HEALTH ILL, V30, P237, DOI 10.1111/j.1467-9566.2007.01034.x; Owens Christabel, 2003, Crisis, V24, P113, DOI 10.1027//0227-5910.24.3.113; Owens C, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-308; PESCOSOLIDO BA, 1992, AM J SOCIOL, V97, P1096, DOI 10.1086/229863; RUTZ W, 1989, ACTA PSYCHIAT SCAND, V80, P151, DOI 10.1111/j.1600-0447.1989.tb01318.x; Scottish Executive, 2002, CHOOS LIF NAT STRAT; SPEIGHT N, 1989, BRIT MED J, V298, P879, DOI 10.1136/bmj.298.6677.879; Wengraf Tom., 2001, QUALITATIVE RES INTE; WHOSUPRE World Health Organization (WHO), 2010, SUIC PREV SUPRE	42	50	51	3	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2011	343								d5801	10.1136/bmj.d5801	http://dx.doi.org/10.1136/bmj.d5801			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	837HL	22010126	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000296183400007
J	Kowalinski, E; Lunardi, T; McCarthy, AA; Louber, J; Brunel, J; Grigorov, B; Gerlier, D; Cusack, S				Kowalinski, Eva; Lunardi, Thomas; McCarthy, Andrew A.; Louber, Jade; Brunel, Joanna; Grigorov, Boyan; Gerlier, Denis; Cusack, Stephen			Structural Basis for the Activation of Innate Immune Pattern-Recognition Receptor RIG-I by Viral RNA	CELL			English	Article							ANTIVIRAL SIGNALING PROTEIN; DOUBLE-STRANDED-RNA; HEPATITIS-C-VIRUS; INDUCIBLE GENE-I; INTERFERON INDUCTION; 5'-TRIPHOSPHATE RNA; UBIQUITIN LIGASE; ADAPTER PROTEIN; IFN-BETA; HELICASE	RIG-I is a key innate immune pattern-recognition receptor that triggers interferon expression upon detection of intracellular 5'triphosphate double-stranded RNA (5'ppp-dsRNA) of viral origin. RIG-I comprises N-terminal caspase activation and recruitment domains (CARDs), a DECH helicase, and a C-terminal domain (CTD). We present crystal structures of the ligand-free, autorepressed, and RNA-bound, activated states of RIG-I. Inactive RIG-I has an open conformation with the CARDs sequestered by a helical domain inserted between the two helicase moieties. ATP and dsRNA binding induce a major rearrangement to a closed conformation in which the helicase and CTD bind the blunt end 5'ppp-dsRNA with perfect complementarity but incompatibly with continued CARD binding. We propose that after initial binding of 5'ppp-dsRNA to the flexibly linked CTD, co-operative tight binding of ATP and RNA to the helicase domain liberates the CARDs for downstream signaling. These findings significantly advance our molecular understanding of the activation of innate immune signaling helicases.	[Kowalinski, Eva; Lunardi, Thomas; McCarthy, Andrew A.; Cusack, Stephen] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France; [Kowalinski, Eva; Lunardi, Thomas; McCarthy, Andrew A.; Cusack, Stephen] UJF EMBL CNRS, UMI 3265, Unit Virus Host Cell Interact, F-38042 Grenoble 9, France; [Louber, Jade; Brunel, Joanna; Grigorov, Boyan; Gerlier, Denis] Univ Lyon 1, INSERM, U758, ENS Lyon, F-69007 Lyon, France	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Cusack, S (corresponding author), European Mol Biol Lab, Grenoble Outstn, 6 Rue Jules Horowitz,BP181, F-38042 Grenoble 9, France.	cusack@embl.fr	McCarthy, Andrew A/A-5926-2013; BRUNEL, JOANNA/C-6322-2015; Grigorov, Boyan/AFT-7687-2022; Gerlier, Denis/L-6094-2014	McCarthy, Andrew A/0000-0003-4478-0136; BRUNEL, JOANNA/0000-0002-3978-9833; Grigorov, Boyan/0000-0003-0376-7779; Gerlier, Denis/0000-0001-5539-456X; Kowalinski, Eva/0000-0002-9785-9027; Cusack, Stephen/0000-0002-9324-0796	EU; FINOVI Foundation	EU(European Commission); FINOVI Foundation	The authors thank the ESRF-EMBL Joint Structural Biology Group for access to ESRF beamlines and the EMBL-ESRF-ILL-IBS Partnership for Structural Biology for access to structural biology instrumentation, notably the high-throughput crystallization platform (J. Marquez and colleagues), the eukaryotic expression facility (I. Berger and colleagues), MALLS (M. Jamin), and mass-spectroscopy (L. Signor). We also used the flow cytometry (T. Andrieu, S. Dussurgey) and qPCR (B. Blanquier) facilities of the SFR Biosciences Gerland-Lyon Sud (UMS344/US8). We thank T. Fujita, J. Perrault, C. Rice, D. Trono, R. Iggo, and D. Garcin for reagents; D. Kolakofsky for insightful discussions; and C. Petosa for a critical reading of the manuscript. The project was partially supported by the EU FP7 SPINE2-Complexes Project and the FINOVI Foundation.	Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; Banroques J, 2010, J MOL BIOL, V396, P949, DOI 10.1016/j.jmb.2009.12.025; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001; Binder M, 2011, J BIOL CHEM, V286, P27278, DOI 10.1074/jbc.M111.256974; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Datta AB, 2009, J MOL BIOL, V392, P1117, DOI 10.1016/j.jmb.2009.07.090; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fan L, 2010, J VIROL, V84, P1785, DOI 10.1128/JVI.01362-09; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2010, J VIROL, V84, P3220, DOI 10.1128/JVI.02241-09; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Gee P, 2008, J BIOL CHEM, V283, P9488, DOI 10.1074/jbc.M706777200; Gerlier D, 2011, MICROBIOL MOL BIOL R, V75, P468, DOI 10.1128/MMBR.00007-11; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Karpala AJ, 2011, J IMMUNOL, V186, P5397, DOI 10.4049/jimmunol.1003712; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Kuo RL, 2010, VIROLOGY, V408, P146, DOI 10.1016/j.virol.2010.09.012; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Marq JB, 2010, J BIOL CHEM, V285, P18208, DOI 10.1074/jbc.M109.089425; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mosedale G, 2005, NAT STRUCT MOL BIOL, V12, P763, DOI 10.1038/nsmb981; Nishino T, 2005, STRUCTURE, V13, P143, DOI 10.1016/j.str.2004.11.008; Nistal-Villan E, 2010, J BIOL CHEM, V285, P20252, DOI 10.1074/jbc.M109.089912; Onoguchi K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001012; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Plumet S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000279; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shigemoto T, 2009, J BIOL CHEM, V284, P13348, DOI 10.1074/jbc.M809449200; Straehle L, 2007, J VIROL, V81, P12227, DOI 10.1128/JVI.01300-07; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029	57	453	470	4	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 14	2011	147	2					423	435		10.1016/j.cell.2011.09.039	http://dx.doi.org/10.1016/j.cell.2011.09.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000019	Bronze			2022-12-28	WOS:000296199300019
J	Smith, J				Smith, Jane			Should journals sell reprints? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Smith, J (corresponding author), BMJ, London WC1H 9JR, England.	jsmith@bmj.com						Angell M., 2004, TRUTH DRUG CO THEY D; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Garattini S, 2003, BMJ-BRIT MED J, V326, P1199, DOI 10.1136/bmj.326.7400.1199; Krumholz H, 2007, BMJ-BRIT MED J, V334, P120, DOI 10.1136/bmj.39024.487720.68; Smith R, 2003, BRIT MED J, V326, P1202, DOI 10.1136/bmj.326.7400.1202	5	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 14	2011	343								d6428	10.1136/bmj.d6428	http://dx.doi.org/10.1136/bmj.d6428			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	835ET	22001650				2022-12-28	WOS:000296018600003
J	Wong, VK; Turmezei, TD; Weston, VC				Wong, V. K.; Turmezei, T. D.; Weston, V. C.			Actinomycosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ABDOMINAL ACTINOMYCOSIS; THORACIC ACTINOMYCOSIS; INFECTIONS; FEATURES; DEVICE		[Wong, V. K.; Weston, V. C.] Queens Med Ctr, Nottingham NG7 2UH, England; [Turmezei, T. D.] Addenbrookes Hosp, Cambridge, England	University of Nottingham; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Wong, VK (corresponding author), Queens Med Ctr, Nottingham NG7 2UH, England.	vanessawong@doctors.org.uk						Acevedo F, 2008, INT J INFECT DIS, V12, P358, DOI 10.1016/j.ijid.2007.10.006; Agarwal Krishna, 2004, Indian J Med Sci, V58, P394; BENNHOFF DF, 1984, LARYNGOSCOPE, V94, P1198, DOI 10.1288/00005537-198409000-00013; Bonacho I, 2001, GYNECOL OBSTET INVES, V52, P119, DOI 10.1159/000052955; Brook I, 2008, SOUTH MED J, V101, P1019, DOI 10.1097/SMJ.0b013e3181864c1f; BROWN JR, 1973, HUM PATHOL, V4, P319, DOI 10.1016/S0046-8177(73)80097-8; Cayley J, 1998, BRIT J FAM PLAN, V23, P137; Choi MM, 2009, YONSEI MED J, V50, P555, DOI 10.3349/ymj.2009.50.4.555; FASS RJ, 1973, ANN INTERN MED, V78, P853, DOI 10.7326/0003-4819-78-6-853; Felz MW, 2003, SOUTH MED J, V96, P294, DOI 10.1097/01.SMJ.0000050775.22394.60; Fiorino AS, 1996, OBSTET GYNECOL, V87, P142, DOI 10.1016/0029-7844(95)00350-9; FOWLER RC, 1983, CLIN RADIOL, V34, P301, DOI 10.1016/S0009-9260(83)80341-9; HA HK, 1993, AM J ROENTGENOL, V161, P791, DOI 10.2214/ajr.161.4.8372760; Hansen J M, 2009, Open Microbiol J, V3, P113, DOI 10.2174/1874285800903010113; Kim TS, 2006, AM J ROENTGENOL, V186, P225, DOI 10.2214/AJR.04.1749; KINNEAR WJM, 1990, RESP MED, V84, P57, DOI 10.1016/S0954-6111(08)80095-9; Kolditz M, 2009, J ANTIMICROB CHEMOTH, V63, P839, DOI 10.1093/jac/dkp016; LEWIS RP, 1978, MEDICINE, V57, P279, DOI 10.1097/00005792-197807000-00001; Mabeza GF, 2003, EUR RESPIR J, V21, P545, DOI 10.1183/09031936.03.00089103; MARTIN MV, 1985, BRIT J ORAL MAX SURG, V23, P428, DOI 10.1016/0266-4356(85)90027-0; MILLER PH, 1995, J CLIN MICROBIOL, V33, P329, DOI 10.1128/JCM.33.2.329-330.1995; Oostman Olga, 2005, Curr Infect Dis Rep, V7, P170, DOI 10.1007/s11908-005-0030-0; Pickhardt PJ, 2005, RADIOGRAPHICS, V25, P719, DOI 10.1148/rg.253045145; Pulverer G, 2003, CLIN INFECT DIS, V37, P490, DOI 10.1086/376621; Russo TA., 2010, PRINCIPLES PRACTICE, V7th ed, P3209; SCHAAL KP, 1992, GENE, V115, P201, DOI 10.1016/0378-1119(92)90560-C; Schaal KP, 1983, BIOL ACTINOMYCETES, P383; Smego RA, 1998, CLIN INFECT DIS, V26, P1255, DOI 10.1086/516337; SMEGO RA, 1987, REV INFECT DIS, V9, P855; Smith AJ, 2005, J ANTIMICROB CHEMOTH, V56, P407, DOI 10.1093/jac/dki206; Song JU, 2010, ANN THORAC MED, V5, P80, DOI 10.4103/1817-1737.62470; Sudhakar SS, 2004, CLIN INFECT DIS, V38, P444, DOI 10.1086/381099; WEESE WC, 1975, ARCH INTERN MED, V135, P1562, DOI 10.1001/archinte.135.12.1562	33	215	225	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 11	2011	343								d6099	10.1136/bmj.d6099	http://dx.doi.org/10.1136/bmj.d6099			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835EJ	21990282				2022-12-28	WOS:000296017500005
J	Hoover, RN; Hyer, M; Pfeiffer, RM; Adam, E; Bond, B; Cheville, AL; Colton, T; Hartge, P; Hatch, EE; Herbst, AL; Karlan, BY; Kaufman, R; Noller, KL; Palmer, JR; Robboy, SJ; Saal, RC; Strohsnitter, W; Titus-Ernstoff, L; Troisi, R				Hoover, Robert N.; Hyer, Marianne; Pfeiffer, Ruth M.; Adam, Ervin; Bond, Brian; Cheville, Andrea L.; Colton, Theodore; Hartge, Patricia; Hatch, Elizabeth E.; Herbst, Arthur L.; Karlan, Beth Y.; Kaufman, Raymond; Noller, Kenneth L.; Palmer, Julie R.; Robboy, Stanley J.; Saal, Robert C.; Strohsnitter, William; Titus-Ernstoff, Linda; Troisi, Rebecca			Adverse Health Outcomes in Women Exposed In Utero to Diethylstilbestrol	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							YOUNG-WOMEN; MEDICAL RECORDS; BREAST-CANCER; FOLLOW-UP; PREGNANCY; STILBESTROL; RISK; VAGINA; NATIONAL-COOPERATIVE-DIETHYLSTILBESTROL-ADENOSIS-(DESAD)-PROJECT; ADENOCARCINOMA	BACKGROUND Before 1971, several million women were exposed in utero to diethylstilbestrol (DES) given to their mothers to prevent pregnancy complications. Several adverse outcomes have been linked to such exposure, but their cumulative effects are not well understood. METHODS We combined data from three studies initiated in the 1970s with continued long-term follow-up of 4653 women exposed in utero to DES and 1927 unexposed controls. We assessed the risks of 12 adverse outcomes linked to DES exposure, including cumulative risks to 45 years of age for reproductive outcomes and to 55 years of age for other outcomes, and their relationships to the baseline presence or absence of vaginal epithelial changes, which are correlated with a higher dose of, and earlier exposure to, DES in utero. RESULTS Cumulative risks in women exposed to DES, as compared with those not exposed, were as follows: for infertility, 33.3% vs. 15.5% (hazard ratio, 2.37; 95% confidence interval [CI], 2.05 to 2.75); spontaneous abortion, 50.3% vs. 38.6% (hazard ratio, 1.64; 95% CI, 1.42 to 1.88); preterm delivery, 53.3% vs. 17.8% (hazard ratio, 4.68; 95% CI, 3.74 to 5.86); loss of second-trimester pregnancy, 16.4% vs. 1.7% (hazard ratio, 3.77; 95% CI, 2.56 to 5.54); ectopic pregnancy, 14.6% vs. 2.9% (hazard ratio, 3.72; 95% CI, 2.58 to 5.38); preeclampsia, 26.4% vs. 13.7% (hazard ratio 1.42; 95% CI, 1.07 to 1.89); stillbirth, 8.9% vs. 2.6% (hazard ratio, 2.45; 95% CI, 1.33 to 4.54); early menopause, 5.1% vs. 1.7% (hazard ratio, 2.35; 95% CI, 1.67 to 3.31); grade 2 or higher cervical intraepithelial neoplasia, 6.9% vs. 3.4% (hazard ratio, 2.28; 95% CI, 1.59 to 3.27); and breast cancer at 40 years of age or older, 3.9% vs. 2.2% (hazard ratio, 1.82; 95% CI, 1.04 to 3.18). For most outcomes, the risks among exposed women were higher for those with vaginal epithelial changes than for those without such changes. CONCLUSIONS In utero exposure of women to DES is associated with a high lifetime risk of a broad spectrum of adverse health outcomes. (Funded by the National Cancer Institute.)	[Hoover, Robert N.; Pfeiffer, Ruth M.; Hartge, Patricia; Troisi, Rebecca] NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Hyer, Marianne] Informat Management Serv Inc, Rockville, MD USA; [Saal, Robert C.] Westat Corp, Rockville, MD USA; [Adam, Ervin] Baylor Coll Med, Dept Virol & Epidemiol, Houston, TX 77030 USA; [Kaufman, Raymond] Methodist Hosp, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Bond, Brian; Strohsnitter, William] Boston Univ, Sch Publ Hlth, Dept Obstet & Gynecol, Tufts Med Ctr, Boston, MA USA; [Colton, Theodore; Hatch, Elizabeth E.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Palmer, Julie R.] Boston Univ, Slone Epidemiol Ctr, Boston, MA USA; [Cheville, Andrea L.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA; [Herbst, Arthur L.] Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA; [Karlan, Beth Y.] Cedars Sinai Med Ctr, Div Gynecol Oncol, Los Angeles, CA 90048 USA; [Noller, Kenneth L.] Amer Board Obstet & Gynecol, Dallas, TX USA; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Titus-Ernstoff, Linda] Dartmouth Med Sch, Dept Community & Family Med, Lebanon, NH USA; [Titus-Ernstoff, Linda] Dartmouth Med Sch, Dept Pediat, Lebanon, NH USA; [Titus-Ernstoff, Linda] Norris Cotton Canc Ctr, Lebanon, NH USA; [Titus-Ernstoff, Linda] Hood Ctr Children & Families, Lebanon, NH USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.; Westat; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Boston University; Tufts Medical Center; Boston University; Boston University; Mayo Clinic; University of Chicago; Cedars Sinai Medical Center; Duke University; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Hoover, RN (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	hooverr@mail.nih.gov		Palmer, Julie/0000-0002-6534-335X; Hatch, Elizabeth/0000-0001-7901-3928; Colton, Theodore/0000-0001-6329-0955	Division of Cancer Epidemiology and Genetics of the National Cancer Institute; UCB, Belgium; IRIS International; NATIONAL CANCER INSTITUTE [ZIACP010168] Funding Source: NIH RePORTER	Division of Cancer Epidemiology and Genetics of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); UCB, Belgium(UCB Pharma SA); IRIS International; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics of the National Cancer Institute.; Dr. Robboy reports receiving consulting fees from UCB, Belgium. Dr. Karlan reports holding stock in and receiving board membership fees from IRIS International. No other potential conflict of interest relevant to this article was reported.	Baird DD, 2005, REPROD TOXICOL, V20, P81, DOI 10.1016/j.reprotox.2005.01.002; BARNES AB, 1980, NEW ENGL J MED, V302, P609, DOI 10.1056/NEJM198003133021105; BIBBO M, 1977, OBSTET GYNECOL, V49, P1; Breslow NE, 1972, J R STAT SOC B, V34, P216, DOI DOI 10.1111/J.2517-6161.1972.TB00900.X; Cox D. R., 1984, ANAL SURVIVAL DATA; D'Aloisio AA, 2010, ENVIRON HEALTH PERSP, V118, P375, DOI 10.1289/ehp.0901423; DALOISIO AA, 2010, ENV HLTH PERSPECT, V118, P380; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; DIECKMANN WJ, 1953, AM J OBSTET GYNECOL, V66, P1062; Dodds EC, 1938, NATURE, V141, P247, DOI 10.1038/141247b0; FERGUSON JH, 1953, AM J OBSTET GYNECOL, V65, P592, DOI 10.1016/0002-9378(83)90615-4; GREENBERG ER, 1984, NEW ENGL J MED, V311, P1393, DOI 10.1056/NEJM198411293112201; HARLOW SD, 1989, AM J EPIDEMIOL, V129, P233, DOI 10.1093/oxfordjournals.aje.a115129; Hatch EE, 2001, CANCER CAUSE CONTROL, V12, P837, DOI 10.1023/A:1012229112696; Hatch EE, 2006, AM J EPIDEMIOL, V164, P682, DOI 10.1093/aje/kwj257; HERBST AL, 1970, CANCER, V25, P745, DOI 10.1002/1097-0142(197004)25:4<745::AID-CNCR2820250402>3.0.CO;2-2; HERBST AL, 1975, NEW ENGL J MED, V292, P334, DOI 10.1056/NEJM197502132920704; HERBST AL, 1972, OBSTET GYNECOL, V40, P287; HERBST AL, 1971, NEW ENGL J MED, V284, P878, DOI 10.1056/NEJM197104222841604; Kaufman RH, 2000, OBSTET GYNECOL, V96, P483, DOI 10.1016/S0029-7844(00)00959-5; LABARTHE D, 1978, OBSTET GYNECOL, V51, P453, DOI 10.1097/00006250-197804000-00014; Missmer SA, 2004, FERTIL STERIL, V82, P1501, DOI 10.1016/j.fertnstert.2004.04.065; O'Reilly EJ, 2010, AM J EPIDEMIOL, V171, P876, DOI 10.1093/aje/kwq023; OBRIEN PC, 1979, OBSTET GYNECOL, V53, P300; Olson JE, 1997, AM J EPIDEMIOL, V145, P58; Palmer JR, 2001, AM J EPIDEMIOL, V154, P316, DOI 10.1093/aje/154.4.316; Palmer JR, 2006, CANCER EPIDEM BIOMAR, V15, P1509, DOI 10.1158/1055-9965.EPI-06-0109; ROBBOY SJ, 1979, OBSTET GYNECOL, V53, P309; SAS Institute, 2008, SAS STAT 9 2 US GUID; SMITH OW, 1948, AM J OBSTET GYNECOL, V56, P821; SWYER GIM, 1953, J ENDOCRINOL, V10, pR6; Tilghman SL, 2010, STEROIDS, V75, P520, DOI 10.1016/j.steroids.2010.05.004; TILLEY BC, 1985, AM J EPIDEMIOL, V121, P269, DOI 10.1093/oxfordjournals.aje.a113997; Titus-Ernstoff L, 2003, EPIDEMIOLOGY, V14, P155, DOI 10.1097/00001648-200303000-00008; Troisi R, 2007, OBSTET GYNECOL, V110, P113, DOI 10.1097/01.AOG.0000268796.75591.02; Troisi R, 2007, INT J CANCER, V121, P356, DOI 10.1002/ijc.22631; ULFELDER H, 1980, CANCER, V45, P3008, DOI 10.1002/1097-0142(19800615)45:12<3008::AID-CNCR2820451222>3.0.CO;2-A; Verloop J, 2010, CANCER CAUSE CONTROL, V21, P999, DOI 10.1007/s10552-010-9526-5; Wise LA, 2005, OBSTET GYNECOL, V105, P167, DOI 10.1097/01.AOG.0000147839.74848.7c; 1955, LANCET, V269, P833	41	260	271	0	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 6	2011	365	14					1304	1314		10.1056/NEJMoa1013961	http://dx.doi.org/10.1056/NEJMoa1013961			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829KL	21991952				2022-12-28	WOS:000295578700008
J	Ekser, B; Ezzelarab, M; Hara, H; van der Windt, DJ; Wijkstrom, M; Bottino, R; Trucco, M; Cooper, DKC				Ekser, Burcin; Ezzelarab, Mohamed; Hara, Hidetaka; van der Windt, Dirk J.; Wijkstrom, Martin; Bottino, Rita; Trucco, Massimo; Cooper, David K. C.			Clinical xenotransplantation: the next medical revolution?	LANCET			English	Review							PIG-LIVER XENOTRANSPLANTATION; ACUTE VASCULAR REJECTION; LONG-TERM SURVIVAL; TRANSGENIC PIGS; TISSUE FACTOR; ALPHA-1,3-GALACTOSYLTRANSFERASE GENE; PORCINE ISLETS; ENDOTHELIAL-CELLS; NONHUMAN-PRIMATES; IMMUNE-RESPONSE	The shortage of organs and cells from deceased individuals continues to restrict allotransplantation. Pigs could provide an alternative source of tissue and cells but the immunological challenges and other barriers associated with xenotransplantation need to be overcome. Transplantation of organs from genetically modified pigs into non-human primates is now not substantially limited by hyperacute, acute antibody-mediated, or cellular rejection, but other issues have become more prominent, such as development of thrombotic micro angiopathy in the graft or systemic consumptive coagulopathy in the recipient. To address these problems, pigs that express one or more human thromboregulatory or anti-inflammatory genes are being developed. The results of preclinical transplantation of pig cells-eg, islets, neuronal cells, hepatocytes, or corneas-are much more encouraging than they are for organ transplantation, with survival times greater than 1 year in all cases. Risk of transfer of an infectious microorganism to the recipient is small.	[Ekser, Burcin; Ezzelarab, Mohamed; Hara, Hidetaka; van der Windt, Dirk J.; Wijkstrom, Martin; Cooper, David K. C.] Univ Pittsburgh Med Ctr, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15261 USA; [Ekser, Burcin] Univ Hosp Catania, Vasc Surg & Organ Transplant Unit, Dept Surg Transplantat & Adv Technol, Catania, Italy; [van der Windt, Dirk J.; Bottino, Rita; Trucco, Massimo] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Div Immunogenet, Pittsburgh, PA USA; [van der Windt, Dirk J.] Erasmus Univ, Med Ctr Rotterdam, Dept Surg, Rotterdam, Netherlands	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Catania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Erasmus University Rotterdam; Erasmus MC	Cooper, DKC (corresponding author), Univ Pittsburgh Med Ctr, Thomas E Starzl Transplantat Inst, Pittsburgh, PA 15261 USA.	cooperdk@upmc.edu	Hara, Hidetaka/AEY-6794-2022; Ekser, Burcin/I-3288-2019; Ezzelarab, Mohamed/AGJ-9904-2022; Ezzelarab, Mohamed/CAA-4267-2022	Hara, Hidetaka/0000-0002-4179-7365; Ekser, Burcin/0000-0003-0741-8007; van der Windt, Dirk J/0000-0001-8839-577X; Ezzelarab, Mohamed/0000-0002-3919-5250	National Institutes of Health [U01 AI068642, R21 A1074844, U19 A1090959]; US Department of Defense [W81XWH-11-1-0417]; University of Pittsburgh; Revivicor Inc; American Society of Transplantation; European Society for Organ Transplantation; National Institutes of Health NIAID [T32 AI 074490]; Genentech; International Pancreas and Islet Transplant Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI074490, U01AI068642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); University of Pittsburgh(University of Pittsburgh); Revivicor Inc; American Society of Transplantation; European Society for Organ Transplantation; National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Genentech(Roche HoldingGenentech); International Pancreas and Islet Transplant Association; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank our collaborators at Revivicor Inc, Blacksburg, VA, USA (led by David Ayares); the University of Maryland (Robin Pierson); and the Beth Israel-Deaconess Medical Center and Harvard Medical School (Simon Robson). Work on xenotransplantation at the University of Pittsburgh has been supported in part by National Institutes of Health (grant numbers U01 AI068642, R21 A1074844, U19 A1090959), US Department of Defense (grant number W81XWH-11-1-0417), and by Sponsored Research Agreements between the University of Pittsburgh and Revivicor Inc. BE has been a recipient of an American Society of Transplantation and European Society for Organ Transplantation exchange grant and is a recipient of a National Institutes of Health NIAID T32 AI 074490 training grant. DJvdW is the recipient of the Derek Gray Award of the International Pancreas and Islet Transplant Association, and is a recipient of the American Society of Transplantation and Genentech Basic Science Fellowship grant.	Azimzadeh AM, 2010, AM J TRANSPLANT, V10, P186; BACH FH, 1994, IMMUNOL REV, V141, P5, DOI 10.1111/j.1600-065X.1994.tb00870.x; Badin R. A., 2010, TRANSPLANTATION S2, V90, P47; Baldan N, 2004, AM J TRANSPLANT, V4, P475, DOI 10.1111/j.1600-6143.2004.00407.x; Bauer A, 2010, XENOTRANSPLANTATION, V17, P243, DOI 10.1111/j.1399-3089.2010.00587.x; Berman DM, 2009, AM J TRANSPLANT, V9, P91, DOI 10.1111/j.1600-6143.2008.02489.x; Bonavita AG, 2010, XENOTRANSPLANTATION, V17, P181, DOI 10.1111/j.1399-3089.2010.00588.x; Buhler L, 2000, TRANSPLANTATION, V70, P1323; Burlak C, 2010, XENOTRANSPLANTATION, V17, P350, DOI 10.1111/j.1399-3089.2010.00605.x; Byrne GW, 2006, TRANSPLANTATION, V82, P1787, DOI 10.1097/01.tp.0000251387.40499.0f; Cantu E, 2007, AM J TRANSPLANT, V7, P66, DOI 10.1111/j.1600-6143.2006.01603.x; Cantu E, 2004, AM J TRANSPLANT, V4, P25, DOI 10.1111/j.1600-6135.2004.0342.x; Cardona K, 2006, NAT MED, V12, P304, DOI 10.1038/nm1375; Casu A, 2008, DIABETOLOGIA, V51, P120, DOI 10.1007/s00125-007-0844-4; Casu A, 2005, PEDIATR CLIN N AM, V52, P1779, DOI 10.1016/j.pcl.2005.07.002; Chen DX, 2004, AM J TRANSPLANT, V4, P1958, DOI 10.1111/j.1600-6143.2004.00625.x; Chu AJ, 2006, FRONT BIOSCI-LANDMRK, V11, P256, DOI 10.2741/1796; Cooper D K, 1993, Transpl Immunol, V1, P198, DOI 10.1016/0966-3274(93)90047-C; Cooper DKC, 2010, J HEART LUNG TRANSPL, V29, P838, DOI 10.1016/j.healun.2010.03.017; Cooper DKC, 2010, CLIN LAB MED, V30, P365, DOI 10.1016/j.cll.2010.02.001; Cooper DKC, 2009, J HEART VALVE DIS, V18, P671; Cooper DKC, 2009, XENOTRANSPLANTATION, V16, P58, DOI 10.1111/j.1399-3089.2009.00518.x; COOPER DKC, 1993, LANCET, V342, P682, DOI 10.1016/0140-6736(93)91791-J; Cooper DKC, 2003, LANCET, V362, P557, DOI 10.1016/S0140-6736(03)14118-9; COOPER DKC, 1988, J HEART TRANSPLANT, V7, P238; COOPER DKC, 2000, XENO PROMISE TRANSPL; Costa C, 1999, FASEB J, V13, P1762, DOI 10.1096/fasebj.13.13.1762; Cowan PJ, 2011, CURR OPIN ORGAN TRAN, V16, P214, DOI 10.1097/MOT.0b013e3283446c65; Cowan PJ, 2009, CURR OPIN ORGAN TRAN, V14, P161, DOI 10.1097/MOT.0b013e3283279591; Cowan PJ, 2000, TRANSPLANTATION, V69, P2504, DOI 10.1097/00007890-200006270-00008; Cozzi E, 2004, AM J TRANSPLANT, V4, P335, DOI 10.1046/j.1600-6143.2003.00349.x; COZZI E, 1995, NAT MED, V1, P964, DOI 10.1038/nm0995-964; Crikis S, 2010, AM J TRANSPLANT, V10, P2586, DOI 10.1111/j.1600-6143.2010.03257.x; Dai YF, 2002, NAT BIOTECHNOL, V20, P251, DOI 10.1038/nbt0302-251; Daly KA, 2009, TISSUE ENG PT A, V15, P3877, DOI [10.1089/ten.tea.2009.0089, 10.1089/ten.TEA.2009.0089]; Diamond LE, 2001, TRANSPLANTATION, V71, P132, DOI 10.1097/00007890-200101150-00021; Dieckhoff B, 2008, XENOTRANSPLANTATION, V15, P36, DOI 10.1111/j.1399-3089.2008.00442.x; Dufrane D, 2010, TRANSPLANTATION, V90, P1054, DOI 10.1097/TP.0b013e3181f6e267; Echeverria GJ, 2009, AM J TRANSPLANT, V9, P2485, DOI 10.1111/j.1600-6143.2009.02815.x; Ekser B, 2010, AM J TRANSPLANT, V10, P273, DOI 10.1111/j.1600-6143.2009.02945.x; Ekser B, 2011, XENOTRANSPLANTATION, V18, P158, DOI 10.1111/j.1399-3089.2011.00642.x; Ekser B, 2010, TRANSPLANTATION, V90, P483, DOI 10.1097/TP.0b013e3181e98d51; Ekser B, 2009, TRANSPLANTATION, V88, P1041, DOI 10.1097/TP.0b013e3181ba0555; Elliott RB, 2007, XENOTRANSPLANTATION, V14, P157, DOI 10.1111/j.1399-3089.2007.00384.x; Esch JSA, 1997, BLOOD, V90, P4425, DOI 10.1182/blood.V90.11.4425.4425_4425_4437; Ezzelarab M, 2008, TRANSPLANTATION, V86, P733, DOI 10.1097/TP.0b013e3181821cad; Ezzelarab M, 2010, XENOTRANSPLANTATION, V17, P3, DOI 10.1111/j.1399-3089.2009.00567.x; Ezzelarab M, 2009, XENOTRANSPLANTATION, V16, P370; Ezzelarab M, 2009, TRANSPLANTATION, V87, P805, DOI 10.1097/TP.0b013e318199c34f; FODOR WL, 1994, P NATL ACAD SCI USA, V91, P11153, DOI 10.1073/pnas.91.23.11153; Gollackner B, 2004, TRANSPLANTATION, V77, P1735, DOI 10.1097/01.TP.0000131167.21930.B8; GOOD AH, 1992, TRANSPL P, V24, P559; Goto M, 2008, XENOTRANSPLANTATION, V15, P225, DOI 10.1111/j.1399-3089.2008.00482.x; HARA H, 2010, AM J TRANSPLANT S, V10, P298; Hara H, 2011, INVEST OPHTH VIS SCI, V52, P5278, DOI 10.1167/iovs.10-6947; Hara H, 2011, CORNEA, V30, P371, DOI 10.1097/ICO.0b013e3181f237ef; Hara H, 2010, XENOTRANSPLANTATION, V17, P338, DOI 10.1111/j.1399-3089.2010.00608.x; Hara H, 2010, AM J TRANSPLANT, V10, P187; Hering BJ, 2009, XENOTRANSPLANTATION, V16, P196, DOI 10.1111/j.1399-3089.2009.00547.x; Hering BJ, 2006, NAT MED, V12, P301, DOI 10.1038/nm1369; Houser SL, 2004, XENOTRANSPLANTATION, V11, P416, DOI 10.1111/j.1399-3089.2004.00155.x; Ibrahim Z, 2006, XENOTRANSPLANTATION, V13, P488, DOI 10.1111/j.1399-3089.2006.00346.x; Ide K, 2007, P NATL ACAD SCI USA, V104, P5062, DOI 10.1073/pnas.0609661104; Ierino FL, 1998, TRANSPLANTATION, V66, P1439, DOI 10.1097/00007890-199812150-00006; KAWAI T, 2008, NEW ENGL J MED, V24, P358; Kim HI, 2010, J KOREAN MED SCI, V25, P203, DOI 10.3346/jkms.2010.25.2.203; Kim MK, 2011, CURR OPIN ORGAN TRAN, V16, P231, DOI 10.1097/MOT.0b013e328344870c; Klose R, 2005, TRANSPLANTATION, V80, P222, DOI 10.1097/01.TP.0000164817.59006.C2; Knosalla C, 2009, AM J TRANSPLANT, V9, P1006, DOI 10.1111/j.1600-6143.2009.02602.x; Korsgren O, 2008, DIABETOLOGIA, V51, P227, DOI 10.1007/s00125-007-0868-9; Kuwaki K, 2005, NAT MED, V11, P29, DOI 10.1038/nm1171; Lahpor JR, 2009, CURR OPIN ORGAN TRAN, V14, P554, DOI 10.1097/MOT.0b013e3283303750; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Laurencin CT, 2008, J AM ACAD ORTHOP SUR, V16, P4, DOI 10.5435/00124635-200801000-00002; Lee KFE, 2008, XENOTRANSPLANTATION, V15, P191, DOI 10.1111/j.1399-3089.2008.00476.x; Leveque X, 2011, CURR OPIN ORGAN TRAN, V16, P190, DOI 10.1097/MOT.0b013e32834494b5; Li Y, 2000, TRANSPLANT P, V32, P875, DOI 10.1016/S0041-1345(00)01020-4; Lila N, 2010, J HEART LUNG TRANSPL, V29, P538, DOI 10.1016/j.healun.2009.10.007; Lin CC, 2010, AM J TRANSPLANT, V10, P1556, DOI 10.1111/j.1600-6143.2010.03147.x; Lin CC, 2008, TRANSPLANTATION, V86, P702, DOI 10.1097/TP.0b013e31818410a3; Lin YJ, 2008, TRANSPLANTATION, V86, P1452, DOI 10.1097/TP.0b013e318188acb0; LoCascio SA, 2010, TRANSPLANTATION, V90, P1607, DOI 10.1097/TP.0b013e3181ffbaff; Londrigan SL, 2010, TRANSPLANTATION, V90, P951, DOI 10.1097/TP.0b013e3181f54728; Martin C, 2005, TRANSGENIC RES, V14, P373, DOI 10.1007/s11248-004-7268-4; McGregor C, 2010, XENOTRANSPLANTATION, V17, P114, DOI 10.1111/j.1399-3089.2010.00573_16.x; McGregor CGA, 2009, XENOTRANSPLANTATION, V16, P356; McKenzie IFC, 1998, J IMMUNOL, V161, P5116; Miwa Y, 2004, XENOTRANSPLANTATION, V11, P247, DOI 10.1111/j.1399-3089.2004.00126.x; Miyagawa S, 2001, J BIOL CHEM, V276, P39310, DOI 10.1074/jbc.M104359200; Miyagawa S, 2010, XENOTRANSPLANTATION, V17, P11, DOI 10.1111/j.1399-3089.2010.00569.x; Moberg L, 2002, LANCET, V360, P2039, DOI 10.1016/S0140-6736(02)12020-4; Mohiuddin MM, 2010, TRANSPLANTATION S, V90, P325; Morgan BP, 2005, XENOTRANSPLANTATION, V12, P258, DOI 10.1111/j.1399-3089.2005.00237.x; Muller YD, 2009, XENOTRANSPLANTATION, V16, P121, DOI 10.1111/j.1399-3089.2009.00531.x; Nagata H, 2007, GASTROENTEROLOGY, V132, P321, DOI 10.1053/j.gastro.2006.10.013; Nguyen BNH, 2007, J THORAC CARDIOV SUR, V133, P1354, DOI 10.1016/j.jtcvs.2006.11.043; Onions D, 2000, XENOTRANSPLANTATION, V7, P143, DOI 10.1034/j.1399-3089.2000.00047.x; Oropeza M, 2009, XENOTRANSPLANTATION, V16, P522, DOI 10.1111/j.1399-3089.2009.00556.x; Petersen B, 2010, XENOTRANSPLANTATION, V17, P102, DOI 10.1111/j.1399-3089.2010.00573_7.x; Petersen B, 2009, XENOTRANSPLANTATION, V16, P486, DOI 10.1111/j.1399-3089.2009.00537.x; Phelps C, 2009, XENOTRANSPLANTATION, V16, P374; Phelps CJ, 2009, XENOTRANSPLANTATION, V16, P477, DOI 10.1111/j.1399-3089.2009.00533.x; Phelps CJ, 2003, SCIENCE, V299, P411, DOI 10.1126/science.1078942; Pierson RN, 2009, XENOTRANSPLANTATION, V16, P263, DOI 10.1111/j.1399-3089.2009.00534.x; Platt JL, 1997, XENOTRANSPLANTATION, P8; Pless G, 2010, METHODS MOL BIOL, V640, P511, DOI 10.1007/978-1-60761-688-7_28; Ramirez P, 2000, TRANSPLANTATION, V70, P989, DOI 10.1097/00007890-200010150-00001; Ramsoondar J, 2009, XENOTRANSPLANTATION, V16, P164, DOI 10.1111/j.1399-3089.2009.00525.x; Rayat GR, 1999, ANN NY ACAD SCI, V875, P175, DOI 10.1111/j.1749-6632.1999.tb08502.x; Reutershan J, 2009, FASEB J, V23, P473, DOI 10.1096/fj.08-119701; Robson SC, 2000, XENOTRANSPLANTATION, V7, P166, DOI 10.1034/j.1399-3089.2000.00067.x; Roussel JC, 2008, AM J TRANSPLANT, V8, P1101, DOI 10.1111/j.1600-6143.2008.02210.x; Rustad KC, 2010, ORGANOGENESIS, V6, P151, DOI 10.4161/org.6.3.12139; Saethre M, 2008, J IMMUNOL, V180, P6346, DOI 10.4049/jimmunol.180.9.6346; Schmelzle M, 2010, CURR OPIN ORGAN TRAN, V15, P212, DOI 10.1097/MOT.0b013e3283373ccc; Schulte am Esch J 2nd, 2001, Ann Transplant, V6, P12; Schuurman HJ, 2008, XENOTRANSPLANTATION, V15, P116, DOI 10.1111/j.1399-3089.2008.00467.x; Seol JG, 2010, NATURE PRECEDINGS; Sgroi A, 2010, TRANSPLANTATION, V90, P597, DOI 10.1097/TP.0b013e3181eb2e8c; Soin B, 2001, KIDNEY INT, V60, P1592, DOI 10.1046/j.1523-1755.2001.00973.x; Sun YL, 1996, J CLIN INVEST, V98, P1417, DOI 10.1172/JCI118929; Sykes M, 2004, TRANSPLANTATION, V78, P1101, DOI 10.1097/01.TP.0000142886.27906.3E; Tahara H, 2010, J IMMUNOL, V184, P3269, DOI 10.4049/jimmunol.0902857; Takeuchi Y, 2010, XENOTRANSPLANTATION, V17, P429, DOI 10.1111/j.1399-3089.2010.00614.x; Tseng YL, 2005, TRANSPLANTATION, V79, P1, DOI 10.1097/01.TP.0000146504.73727.13; van der Windt DJ, 2009, AM J TRANSPLANT, V9, P2716, DOI 10.1111/j.1600-6143.2009.02850.x; van der Windt DJ, 2007, XENOTRANSPLANTATION, V14, P288, DOI 10.1111/j.1399-3089.2007.00419.x; van der Windt DJ, 2008, CELL TRANSPLANT, V17, P1005, DOI 10.3727/096368908786991515; van der Windt DJ, CELL TRANSP IN PRESS; Watanabe M, 2010, BIOCHEM BIOPH RES CO, V402, P14, DOI 10.1016/j.bbrc.2010.09.092; Weiss EH, 2009, TRANSPLANTATION, V87, P35, DOI 10.1097/TP.0b013e318191c784; Xu XC, 2002, AM J TRANSPLANT, V2, P314, DOI 10.1034/j.1600-6143.2002.20405.x; Yamada K, 2005, NAT MED, V11, P32, DOI 10.1038/nm1172; Yazaki S, 2009, XENOTRANSPLANTATION, V16, P511, DOI 10.1111/j.1399-3089.2009.00549.x	134	271	291	9	139	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 18	2012	379	9816					672	683		10.1016/S0140-6736(11)61091-X	http://dx.doi.org/10.1016/S0140-6736(11)61091-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	897ES	22019026				2022-12-28	WOS:000300629000038
J	Diskin, R; Scheid, JF; Marcovecchio, PM; West, AP; Klein, F; Gao, H; Gnanapragasam, PNP; Abadir, A; Seaman, MS; Nussenzweig, MC; Bjorkman, PJ				Diskin, Ron; Scheid, Johannes F.; Marcovecchio, Paola M.; West, Anthony P., Jr.; Klein, Florian; Gao, Han; Gnanapragasam, Priyanthi N. P.; Abadir, Alexander; Seaman, Michael S.; Nussenzweig, Michel C.; Bjorkman, Pamela J.			Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; BROAD; VACCINE; BINDING; GP120; RECEPTOR; INDIVIDUALS; PROTECTION	Antibodies against the CD4 binding site (CD4bs) on the HIV-1 spike protein gp120 can show exceptional potency and breadth. We determined structures of NIH45-46, a more potent clonal variant of VRC01, alone and bound to gp120. Comparisons with VRC01-gp120 revealed that a four-residue insertion in heavy chain complementarity-determining region 3 (CDRH3) contributed to increased interaction between NIH45-46 and the gp120 inner domain, which correlated with enhanced neutralization. We used structure-based design to create NIH45-46(G54W), a single substitution in CDRH2 that increases contact with the gp120 bridging sheet and improves breadth and potency, critical properties for potential clinical use, by an order of magnitude. Together with the NIH45-46-gp120 structure, these results indicate that gp120 inner domain and bridging sheet residues should be included in immunogens to elicit CD4bs antibodies.	[Diskin, Ron; Marcovecchio, Paola M.; West, Anthony P., Jr.; Gao, Han; Gnanapragasam, Priyanthi N. P.; Bjorkman, Pamela J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Scheid, Johannes F.; Klein, Florian; Abadir, Alexander; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Scheid, Johannes F.] Charite, D-10117 Berlin, Germany; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Bjorkman, Pamela J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; Rockefeller University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Beth Israel Deaconess Medical Center; Howard Hughes Medical Institute; Rockefeller University; California Institute of Technology; Howard Hughes Medical Institute	Bjorkman, PJ (corresponding author), CALTECH, Div Biol, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	bjorkman@caltech.edu	Nussenzweig, Michel/AAE-7292-2019; Cheng, Yushao/E-6256-2011		Collaboration for AIDS Vaccine Discovery (CAVD); Bill and Melinda Gates Foundation [38660, 38619, 38619s]; NIH [P01 AI081677-01, RR00862, RR022220]; Molecular Observatory at Caltech; Gordon and Betty Moore Foundation; Sanofi-Aventis; German Research Foundation (DFG) [KL 2389/1-1]; U.S. Department of Energy; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022220, P41RR000862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI081677] Funding Source: NIH RePORTER	Collaboration for AIDS Vaccine Discovery (CAVD); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Observatory at Caltech; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Sanofi-Aventis(Sanofi-Aventis); German Research Foundation (DFG)(German Research Foundation (DFG)); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Hahn, J. Baalwa, F. McCutchan, G. Shaw, D. Montefiori, M. Thomson, J. Overbaugh, R. Swanstrom, L. Morris, J. Kim, L. Zhang, D. Ellenberger, and C. Williamson for contributing the HIV-1 envelope plasmids used in our neutralization panel; the Caltech Protein Expression Center; T. Oliveira and A. Halper-Stromberg for calculations and helpful discussions; and members of the Bjorkman and Nussenzweig laboratories for critical reading of the manuscript. R. D., J.F.S., M.C.N., and P.J.B. have pending patent applications with the U. S. Patent and Trademark Office, patent numbers U. S. 61/486,960 and 61/523,244, titled "Human immunodeficiency virus neutralizing antibodies and methods of use thereof" and "Anti-HIV antibodies and related methods and compositions," respectively. The reagents are available with a Materials Transfer Agreement. This work was supported by Collaboration for AIDS Vaccine Discovery (CAVD) grants with support from the Bill and Melinda Gates Foundation [grant 38660 (P.J.B.), grant 38619 (M. S. S.) and grant 38619s (M.C.N.)]; NIH grants P01 AI081677-01 (M.C.N.), RR00862, and RR022220; and the Molecular Observatory at Caltech, supported by the Gordon and Betty Moore Foundation and the Sanofi-Aventis Bioengineering Research Program. F. K. was supported by the German Research Foundation (DFG, KL 2389/1-1). Operations at Stanford Synchrotron Radiation Lightsource are supported by the U.S. Department of Energy and NIH. The data reported in this paper are tabulated in the main text and the supporting online material, and coordinates and x-ray crystallographic data for the NIH45-46-gp120 complex and NIH45-46 Fab have been deposited in the PDB (accession codes 3U7Y and 3U7W, respectively).	Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Madani N, 2008, STRUCTURE, V16, P1689, DOI 10.1016/j.str.2008.09.005; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Nabel GJ, 2011, PHILOS T R SOC B, V366, P2759, DOI 10.1098/rstb.2011.0096; SATTENTAU QJ, 1988, CELL, V52, P631, DOI 10.1016/0092-8674(88)90397-2; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801	30	307	320	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2011	334	6060					1289	1293		10.1126/science.1213782	http://dx.doi.org/10.1126/science.1213782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22033520	Green Accepted			2022-12-28	WOS:000297553600054
J	Berer, K; Mues, M; Koutrolos, M; Al Rasbi, Z; Boziki, M; Johner, C; Wekerle, H; Krishnamoorthy, G				Berer, Kerstin; Mues, Marsilius; Koutrolos, Michail; Al Rasbi, Zakeya; Boziki, Marina; Johner, Caroline; Wekerle, Hartmut; Krishnamoorthy, Gurumoorthy			Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination	NATURE			English	Article							T-CELL RESPONSES; MULTIPLE-SCLEROSIS; B-CELLS; TRANSGENIC MICE; AUTOANTIBODIES; INDUCTION; BACTERIA; DISEASE; MOG	Active multiple sclerosis lesions show inflammatory changes suggestive of a combined attack by autoreactive T and B lymphocytes against brain white matter(1). These pathogenic immune cells derive from progenitors that are normal, innocuous components of the healthy immune repertoire but become autoaggressive upon pathological activation. The stimuli triggering this autoimmune conversion have been commonly attributed to environmental factors, in particular microbial infection(2). However, using the relapsing-remitting mouse model of spontaneously developing experimental autoimmune encephalomyelitis(3), here we show that the commensal gut flora-in the absence of pathogenic agents-is essential in triggering immune processes, leading to a relapsing-remitting autoimmune disease driven by myelin-specific CD4(+) T cells. We show further that recruitment and activation of autoantibody-producing B cells from the endogenous immune repertoire depends on availability of the target autoantigen, myelin oligodendrocyte glycoprotein (MOG), and commensal microbiota. Our observations identify a sequence of events triggering organ-specific autoimmune disease and these processes may offer novel therapeutic targets.	[Berer, Kerstin; Mues, Marsilius; Koutrolos, Michail; Al Rasbi, Zakeya; Boziki, Marina; Wekerle, Hartmut; Krishnamoorthy, Gurumoorthy] Max Planck Inst Neurobiol, Dept Neuroimmunol, D-82152 Martinsried, Germany; [Johner, Caroline] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany	Max Planck Society; Max Planck Society	Wekerle, H (corresponding author), Max Planck Inst Neurobiol, Dept Neuroimmunol, D-82152 Martinsried, Germany.	hwekerle@neuro.mpg.de; guru@neuro.mpg.de	Krishnamoorthy, Gurumoorthy/O-1650-2013; Boziki, Marina/AAV-2196-2021	Krishnamoorthy, Gurumoorthy/0000-0002-7798-6707; Boziki, Marina/0000-0002-6601-5163	German Competence Network on Multiple Sclerosis (KKNMS); ARSEP (France); Max Planck Society; Emirates Foundation; Hellenic Neurological Society;  [SFB 571]	German Competence Network on Multiple Sclerosis (KKNMS); ARSEP (France); Max Planck Society(Max Planck Society); Emirates Foundation; Hellenic Neurological Society; 	We thank I. Arnold-Ammer, N. Reisser and L. Penner for technical assistance, and M. Pfunder, U. Stauffer, C. Hornung and N. Joswig for maintaining our germ-free colony and technical support. We are much obliged to R. Kemler for his support. This work was funded by SFB 571 (Project B6), the German Competence Network on Multiple Sclerosis (KKNMS), ARSEP (France), and by the Max Planck Society. K. B. is supported by a fellowship from ARSEP. Z.A.R. is supported by a PhD fellowship from the Emirates Foundation. M. B. receives a fellowship from the Hellenic Neurological Society.	Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Barnett MH, 2006, MULT SCLER, V12, P121, DOI 10.1191/135248506ms1304rr; CSERR HF, 1992, BRAIN PATHOL, V2, P269, DOI 10.1111/j.1750-3639.1992.tb00703.x; Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946; Delarasse C, 2003, J CLIN INVEST, V112, P544, DOI 10.1172/JCI200315861; Ercolini AM, 2007, J IMMUNOL, V179, P6604, DOI 10.4049/jimmunol.179.10.6604; Feng T, 2010, J EXP MED, V207, P1321, DOI 10.1084/jem.20092253; Franciotta D, 2008, LANCET NEUROL, V7, P852, DOI 10.1016/S1474-4422(08)70192-3; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330; Hohfeld R, 2009, EUR J IMMUNOL, V39, P2036, DOI 10.1002/eji.200939545; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kira J, 1999, J NEUROL SCI, V166, P53, DOI 10.1016/S0022-510X(99)00115-X; Kirvan CA, 2007, J IMMUNOL, V178, P7412, DOI 10.4049/jimmunol.178.11.7412; Knip M, 2010, NEW ENGL J MED, V363, P1900, DOI 10.1056/NEJMoa1004809; Lampropoulou V, 2008, J IMMUNOL, V180, P4763, DOI 10.4049/jimmunol.180.7.4763; Lauer K, 1997, NEUROLOGY, V49, pS55, DOI 10.1212/WNL.49.2_Suppl_2.S55; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Litzenburger T, 1998, J EXP MED, V188, P169, DOI 10.1084/jem.188.1.169; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; Schwickert TA, 2009, J EXP MED, V206, P2907, DOI 10.1084/jem.20091225; Vaahtovuo J, 2008, J RHEUMATOL, V35, P1500	28	807	834	0	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2011	479	7374					538	U266		10.1038/nature10554	http://dx.doi.org/10.1038/nature10554			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	851QI	22031325				2022-12-28	WOS:000297285600053
J	Garcia, V; Phelps, SEL; Gray, S; Neale, MJ				Garcia, Valerie; Phelps, Sarah E. L.; Gray, Stephen; Neale, Matthew J.			Bidirectional resection of DNA double-strand breaks by Mre11 and Exo1	NATURE			English	Article							RAD32(MRE11) NUCLEASE; MEIOSIS; CTP1(CTIP); MUTATION; REMOVAL; REPAIR; ROLES; AXIS; SAE2	Repair of DNA double-strand breaks (DSBs) by homologous recombination requires resection of 5'-termini to generate 3'-single-strand DNA tails(1). Key components of this reaction are exonuclease 1 and the bifunctional endo/exonuclease, Mre11 (refs 2-4). Mre11 endonuclease activity is critical when DSB termini are blocked by bound protein-such as by the DNA end-joining complex(5), topoisomerases(6) or the meiotic transesterase Spo11 (refs 7-13)-but a specific function for the Mre11 3'-5' exonuclease activity has remained elusive. Here we use Saccharomyces cerevisiae to reveal a role for the Mre11 exonuclease during the resection of Spo11-linked 5'-DNA termini in vivo. We show that the residual resection observed in Exo1-mutant cells is dependent on Mre11, and that both exonuclease activities are required for efficient DSB repair. Previous work has indicated that resection traverses unidirectionally(1). Using a combination of physical assays for 5'-end processing, our results indicate an alternative mechanism involving bidirectional resection. First, Mre11 nicks the strand to be resected up to 300 nucleotides from the 5'-terminus of the DSB-much further away than previously assumed. Second, this nick enables resection in a bidirectional manner, using Exo1 in the 5'-3' direction away from the DSB, and Mre11 in the 3'-5' direction towards the DSB end. Mre11 exonuclease activity also confers resistance to DNA damage in cycling cells, suggesting that Mre11-catalysed resection may be a general feature of various DNA repair pathways.	[Garcia, Valerie; Phelps, Sarah E. L.; Gray, Stephen; Neale, Matthew J.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	University of Sussex	Neale, MJ (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	m.neale@sussex.ac.uk	Garcia, Valerie/R-4543-2016	Neale, Matthew/0000-0002-6453-1877; Gray, Stephen/0000-0003-1483-560X; Garcia, Valerie/0000-0002-4941-0989	MRC; Royal Society; Human Frontiers Science Program Organisation; Medical Research Council [G0800005] Funding Source: researchfish; MRC [G0800005] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Human Frontiers Science Program Organisation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank R. Cha, E. Hoffmann, N. Hunter, S. Keeney and J. Nitiss for yeast strains; L. Symington for plasmids; F. Klein and J. Petrini for antisera. V. G. is supported by an MRC New Investigator Grant to M. J. N. M. J. N. is supported by a University Research Fellowship from the Royal Society and a Career Development Award from the Human Frontiers Science Program Organisation.	Carballo JA, 2008, CELL, V132, P758, DOI 10.1016/j.cell.2008.01.035; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; Hartsuiker E, 2009, MOL CELL BIOL, V29, P1671, DOI 10.1128/MCB.01182-08; Hartsuiker E, 2009, MOL CELL, V33, P117, DOI 10.1016/j.molcel.2008.11.021; Hodgson A, 2011, DNA REPAIR, V10, P138, DOI 10.1016/j.dnarep.2010.11.008; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Jazayeri A, 2008, EMBO J, V27, P1953, DOI 10.1038/emboj.2008.128; Keelagher RE, 2011, DNA REPAIR, V10, P126, DOI 10.1016/j.dnarep.2010.09.024; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Kim KP, 2010, CELL, V143, P924, DOI 10.1016/j.cell.2010.11.015; Manfrini N, 2010, J BIOL CHEM, V285, P11628, DOI 10.1074/jbc.M110.104083; Milman N, 2009, MOL CELL BIOL, V29, P5998, DOI 10.1128/MCB.01127-09; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Moreau S, 1999, MOL CELL BIOL, V19, P556; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Panizza S, 2011, CELL, V146, P372, DOI 10.1016/j.cell.2011.07.003; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Rothenberg M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000722; SZANKASI P, 1992, J BIOL CHEM, V267, P3014; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Tsubouchi H, 2000, MOL BIOL CELL, V11, P2221, DOI 10.1091/mbc.11.7.2221; Usui T, 2001, MOL CELL, V7, P1255, DOI 10.1016/S1097-2765(01)00270-2; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Zakharyevich K, 2010, MOL CELL, V40, P1001, DOI 10.1016/j.molcel.2010.11.032; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	30	277	281	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2011	479	7372					241	U123		10.1038/nature10515	http://dx.doi.org/10.1038/nature10515			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PD	22002605	Green Accepted			2022-12-28	WOS:000298030800045
J	Kim, EB; Fang, XD; Fushan, AA; Huang, ZY; Lobanov, AV; Han, LJ; Marino, SM; Sun, XQ; Turanov, AA; Yang, PC; Yim, SH; Zhao, X; Kasaikina, MV; Stoletzki, N; Peng, CF; Polak, P; Xiong, ZQ; Kiezun, A; Zhu, YB; Chen, YX; Kryukov, GV; Zhang, Q; Peshkin, L; Yang, L; Bronson, RT; Buffenstein, R; Wang, B; Han, CL; Li, QY; Chen, L; Zhao, W; Sunyaev, SR; Park, TJ; Zhang, GJ; Wang, J; Gladyshev, VN				Kim, Eun Bae; Fang, Xiaodong; Fushan, Alexey A.; Huang, Zhiyong; Lobanov, Alexei V.; Han, Lijuan; Marino, Stefano M.; Sun, Xiaoqing; Turanov, Anton A.; Yang, Pengcheng; Yim, Sun Hee; Zhao, Xiang; Kasaikina, Marina V.; Stoletzki, Nina; Peng, Chunfang; Polak, Paz; Xiong, Zhiqiang; Kiezun, Adam; Zhu, Yabing; Chen, Yuanxin; Kryukov, Gregory V.; Zhang, Qiang; Peshkin, Leonid; Yang, Lan; Bronson, Roderick T.; Buffenstein, Rochelle; Wang, Bo; Han, Changlei; Li, Qiye; Chen, Li; Zhao, Wei; Sunyaev, Shamil R.; Park, Thomas J.; Zhang, Guojie; Wang, Jun; Gladyshev, Vadim N.			Genome sequencing reveals insights into physiology and longevity of the naked mole rat	NATURE			English	Article							LONGEST-LIVING RODENT; HETEROCEPHALUS-GLABER; RESISTANCE; FOSSORIAL; PROTEIN-1; CELLS	The naked mole rat (Heterocephalus glaber) is a strictly subterranean, extraordinarily long-lived eusocial mammal(1). Although it is the size of a mouse, its maximum lifespan exceeds 30 years, making this animal the longest-living rodent. Naked mole rats show negligible senescence, no age-related increase in mortality, and high fecundity until death(2). In addition to delayed ageing, they are resistant to both spontaneous cancer and experimentally induced tumorigenesis(3,4). Naked mole rats pose a challenge to the theories that link ageing, cancer and redox homeostasis. Although characterized by significant oxidative stress(5), the naked mole rat proteome does not show age-related susceptibility to oxidative damage or increased ubiquitination(6). Naked mole rats naturally reside in large colonies with a single breeding female, the 'queen', who suppresses the sexual maturity of her subordinates(7). They also live in full darkness, at low oxygen and high carbon dioxide concentrations(8), and are unable to sustain thermogenesis(9) nor feel certain types of pain(10,11). Here we report the sequencing and analysis of the naked mole rat genome, which reveals unique genome features and molecular adaptations consistent with cancer resistance, poikilothermy, hairlessness and insensitivity to low oxygen, and altered visual function, circadian rythms and taste sensing. This information provides insights into the naked mole rat's exceptional longevity and ability to live in hostile conditions, in the dark and at low oxygen. The extreme traits of the naked mole rat, together with the reported genome and transcriptome information, offer opportunities for understanding ageing and advancing other areas of biological and biomedical research.	[Fang, Xiaodong; Huang, Zhiyong; Han, Lijuan; Sun, Xiaoqing; Yang, Pengcheng; Zhao, Xiang; Peng, Chunfang; Xiong, Zhiqiang; Zhu, Yabing; Chen, Yuanxin; Zhang, Qiang; Yang, Lan; Wang, Bo; Han, Changlei; Li, Qiye; Chen, Li; Zhao, Wei; Zhang, Guojie; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Kim, Eun Bae; Fushan, Alexey A.; Gladyshev, Vadim N.] Ewha Womans Univ, Dept Bioinspired Sci, Seoul 120750, South Korea; [Lobanov, Alexei V.; Marino, Stefano M.; Turanov, Anton A.; Yim, Sun Hee; Kasaikina, Marina V.; Stoletzki, Nina; Polak, Paz; Kiezun, Adam; Kryukov, Gregory V.; Sunyaev, Shamil R.; Gladyshev, Vadim N.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Genet, Boston, MA 02115 USA; [Kryukov, Gregory V.; Sunyaev, Shamil R.; Gladyshev, Vadim N.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Peshkin, Leonid] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Bronson, Roderick T.] Harvard Univ, Sch Med, Rodent Histopathol Lab, Boston, MA 02115 USA; [Buffenstein, Rochelle] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78245 USA; [Buffenstein, Rochelle] Univ Texas Hlth Sci Ctr San Antonio, Sam & Ann Barshop Inst Longev & Aging Studies, San Antonio, TX 78245 USA; [Park, Thomas J.] Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen N, Denmark; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen N, Denmark	Beijing Genomics Institute (BGI); Ewha Womans University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen	Zhang, GJ (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	zhanggj@genomics.org.cn; wangj@genomics.org.cn; vgladyshev@rics.bwh.harvard.edu	Gladyshev, Vadim N/A-9894-2013; Polak, Paz/AAH-9380-2020; Wang, Jun/A-7261-2013; Fang, Xiaodong/K-6743-2018; Zhang, Guojie/J-7273-2019; Gladyshev, Vadim N/J-6187-2013; Zhang, Guojie/B-6188-2014; Yang, Pengcheng/N-1037-2014; 高, 雨莉/HGU-8187-2022; Li, Qiye/C-1348-2015; Kryukov, Gregory V/A-9592-2008; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Fang, Xiaodong/0000-0001-7061-3337; Zhang, Guojie/0000-0001-6860-1521; Zhang, Guojie/0000-0001-6860-1521; Yang, Pengcheng/0000-0001-5496-8357; Li, Qiye/0000-0002-5993-0312; Gladyshev, Vadim/0000-0002-0372-7016; Stoletzki, Nina/0000-0002-4648-3103; Peshkin, Leonid/0000-0002-6420-848X; Kryukov, Gregory/0000-0002-6131-9483; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874	WCU [R31-2008-000-10010-0]; NIH [AG038004, AG021518, CA080946]; Shenzhen Municipal Government [ZYC200903240077A]; National Natural Science Foundation of China [30725008]; National Science Foundation [0744979]; NATIONAL CANCER INSTITUTE [R01CA080946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038004, R01AG021518] Funding Source: NIH RePORTER; Direct For Biological Sciences [0744979] Funding Source: National Science Foundation	WCU; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shenzhen Municipal Government; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank P. C. LaVinka for help in preparing NMR tissues and N. Estologa for help in preparing the manuscript. We acknowledge financial support from the WCU Program (R31-2008-000-10010-0), the NIH (AG038004, AG021518 and CA080946), the Shenzhen Municipal Government (ZYC200903240077A), the National Natural Science Foundation of China (30725008) and the National Science Foundation (0744979).	Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x; Bennett N.C., 2000, AFRICAN MOLE RATS EC; Bhattacharyya S, 2009, J BIOL CHEM, V284, P14966, DOI 10.1074/jbc.M900195200; Bienengraeber M, 1998, BIOCHEMISTRY-US, V37, P3, DOI 10.1021/bi972463w; Buffenstein R, 2001, AM J PHYSIOL-REG I, V280, pR149, DOI 10.1152/ajpregu.2001.280.1.R149; Buffenstein R, 2008, J COMP PHYSIOL B, V178, P439, DOI 10.1007/s00360-007-0237-5; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Edrey YH, 2011, EXP GERONTOL, V46, P116, DOI 10.1016/j.exger.2010.09.005; Higgins ME, 2007, NUCLEIC ACIDS RES, V35, pD721, DOI 10.1093/nar/gkl811; Hong MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003024; JARVIS JUM, 1981, SCIENCE, V212, P571, DOI 10.1126/science.7209555; JOHANSEN K, 1976, RESP PHYSIOL, V28, P303, DOI 10.1016/0034-5687(76)90025-6; Larson J, 2009, NEUROREPORT, V20, P1634, DOI 10.1097/WNR.0b013e32833370cf; Liang ST, 2010, AGING CELL, V9, P626, DOI 10.1111/j.1474-9726.2010.00588.x; MCNAB BK, 1979, ECOLOGY, V60, P1010, DOI 10.2307/1936869; Nikitina NV, 2004, ANAT REC PART A, V277A, P317, DOI 10.1002/ar.a.20025; Park TJ, 2008, PLOS BIOL, V6, P156, DOI 10.1371/journal.pbio.0060013; Perez VI, 2009, P NATL ACAD SCI USA, V106, P3059, DOI 10.1073/pnas.0809620106; Porter RK, 2008, J BIOENERG BIOMEMBR, V40, P457, DOI 10.1007/s10863-008-9172-8; QUAY WB, 1981, J NEURAL TRANSM, V52, P107, DOI 10.1007/BF01253102; Riccio AP, 2000, PHYSIOL BEHAV, V71, P1, DOI 10.1016/S0031-9384(00)00281-X; Schneider A, 2009, GENOME BIOL EVOL, V1, P114, DOI 10.1093/gbe/evp012; Seluanov A, 2009, P NATL ACAD SCI USA, V106, P19352, DOI 10.1073/pnas.0905252106; Smith ES, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-29; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Woodley R, 2002, COMP BIOCHEM PHYS A, V133, P827, DOI 10.1016/S1095-6433(02)00199-X; Wuehlbauer E, 2009, EUR J PHARMACOL, V606, P61, DOI 10.1016/j.ejphar.2009.01.029	29	387	417	1	368	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2011	479	7372					223	227		10.1038/nature10533	http://dx.doi.org/10.1038/nature10533			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PD	21993625	Green Accepted, hybrid			2022-12-28	WOS:000298030800041
J	Gillgren, P; Drzewiecki, KT; Niin, M; Gullestad, HP; Hellborg, H; Mansson-Brahme, E; Ingvar, C; Ringborg, U				Gillgren, Peter; Drzewiecki, Krzysztof T.; Niin, Marianne; Gullestad, Hans P.; Hellborg, Henrik; Mansson-Brahme, Eva; Ingvar, Christian; Ringborg, Ulrik			2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial	LANCET			English	Article							REQUIRING PROLONGED OBSERVATION; MALIGNANT-MELANOMA; LOCAL RECURRENCE; THICKNESS; RESECTION; MANAGEMENT; PATIENT; DESIGN; TRENDS; RISK	Background Optimum surgical resection margins for patients with clinical stage IIA-C cutaneous melanoma thicker than 2 mm are controversial. The aim of the study was to test whether survival was different for a wide local excision margin of 2 cm compared with a 4-cm excision margin. Methods We undertook a randomised controlled trial in nine European centres. Patients with cutaneous melanoma thicker than 2 mm, at clinical stage IIA-C, were allocated to have either a 2-cm or a 4-cm surgical resection margin. Patients were randomised in a 1:1 allocation to one of the two groups and stratified by geographic region. Randomisation was done by sealed envelope or by computer generated lists with permuted blocks. Our primary endpoint was overall survival. The trial was not masked at any stage. Analyses were by intention to treat. Adverse events were not systematically recorded. The study is registered with ClinicalTrials.gov, number NCT01183936. Findings 936 patients were enrolled from Jan 22, 1992, to May 19, 2004; 465 were randomly allocated to treatment with a 2-cm resection margin, and 471 to receive treatment with a 4-cm resection margin. One patient in each group was lost to follow-up but included in the analysis. After a median follow-up of 6.7 years (IQR 4.3-9.5) 181 patients in the 2-cm margin group and 177 in the 4-cm group had died (hazard ratio 1.05, 95% CI 0.85-1.29; p=0.64). 5-year overall survival was 65% (95% CI 60-69) in the 2-cm group and 65% (60-70) in the 4-cm group (p=0.69). Interpretation Our findings suggest that a 2-cm resection margin is sufficient and safe for patients with cutaneous melanoma thicker than 2 mm.	[Gillgren, Peter] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Gillgren, Peter; Mansson-Brahme, Eva; Ringborg, Ulrik] Karolinska Inst, Dept Pathol & Oncol, Stockholm, Sweden; [Gillgren, Peter] Stockholm Soder Hosp, Dept Surg, Stockholm, Sweden; [Drzewiecki, Krzysztof T.] Rigshosp, Univ Hosp, Dept Plast Surg Breast Surg & Burns, DK-2100 Copenhagen, Denmark; [Niin, Marianne] N Estonian Reg Hosp, Dept Oncol & Gen Surg, Tallinn, Estonia; [Gullestad, Hans P.] Radiumhosp, Oslo Univ Hosp, Dept Surg, Oslo, Norway; [Hellborg, Henrik] Karolinska Univ Hosp, Ctr Oncol, Stockholm, Sweden; [Ingvar, Christian] Univ Lund Hosp, Dept Surg, S-22185 Lund, Sweden	Karolinska Institutet; Karolinska Institutet; Rigshospitalet; University of Copenhagen; University of Oslo; Karolinska Institutet; Karolinska University Hospital; Lund University; Skane University Hospital	Gillgren, P (corresponding author), Soder Sjukhuset, Dept Surg, SE-11883 Stockholm, Sweden.	peter.gillgren@sodersjukhuset.se	Gillgren, Peter/AAB-4724-2020; Ingvar, Christian/AAE-9841-2019	Gillgren, Peter/0000-0003-0538-3496; 	Swedish Cancer Society; Stockholm Cancer Society	Swedish Cancer Society(Swedish Cancer Society); Stockholm Cancer Society	Funding Swedish Cancer Society and Stockholm Cancer Society.	ALBERT LS, 1990, J AM ACAD DERMATOL, V22, P69, DOI 10.1016/0190-9622(90)70010-F; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Balch CM, 2001, ANN SURG ONCOL, V8, P101, DOI 10.1007/s10434-001-0101-x; BALCH CM, 1993, ANN SURG, V218, P262, DOI 10.1097/00000658-199309000-00005; Banzet P, 1993, P AN M AM SOC CLIN, V97, P1941; Berwick M, 2003, CUTANEOUS MELANOMA, P15; BRESLOW A, 1970, ANN SURG, V172, P902, DOI 10.1097/00000658-197011000-00017; BRESLOW A, 1977, SURG GYNECOL OBSTET, V145, P691; Cascinelli N, 1998, SEMIN SURG ONCOL, V14, P272, DOI 10.1002/(SICI)1098-2388(199806)14:4<272::AID-SSU2>3.0.CO;2-#; CLARK WH, 1986, HUM PATHOL, V17, P443, DOI 10.1016/S0046-8177(86)80032-6; CLARK WH, 1969, CANCER RES, V29, P705; Cohn-Cedermark G, 2000, CANCER-AM CANCER SOC, V89, P1495, DOI 10.1002/1097-0142(20001001)89:7<1495::AID-CNCR12>3.0.CO;2-D; CohnCedermark G, 1997, CANCER-AM CANCER SOC, V80, P1418, DOI 10.1002/(SICI)1097-0142(19971015)80:8<1418::AID-CNCR8>3.0.CO;2-A; COX DR, 1972, J R STAT SOC B, V34, P187; Handley WS, 1907, LANCET, V1, P996; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Karakousis CP, 1996, ANN SURG ONCOL, V3, P446, DOI 10.1007/BF02305762; KHAYAT D, 2003, CANCER, V97, P1941, DOI DOI 10.1002/CNCR.11272; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; PRITCHARD GA, 1988, EUR J SURG ONCOL, V14, P371; Ringborg U, 1996, CANCER-AM CANCER SOC, V77, P1809, DOI 10.1002/(SICI)1097-0142(19960501)77:9<1809::AID-CNCR8>3.0.CO;2-6; Roberts DLL, 2002, BRIT J DERMATOL, V146, P7, DOI 10.1046/j.1365-2133.2001.04614.x; Sladden MJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004835.pub2; Soong SJ, 2009, CUTANEOUS MELANOMA, P87; The National Board of Health and Welfare, 2009, CANC INC SWED 2008 S; The National Board of Health and Welfare, 2008, CANC INC SWED 2007 S; The National Board of Health and Welfare, 2011, CAUS DEATH REG 2011; The National Board of Health and Welfare, 2010, CANC INC SWED 2009 S; Thomas JM, 2004, NEW ENGL J MED, V350, P757, DOI 10.1056/NEJMoa030681; VERONESI U, 1991, ARCH SURG-CHICAGO, V126, P438; VERONESI U, 1988, NEW ENGL J MED, V318, P1159, DOI 10.1056/NEJM198805053181804; WILCOXON F, 1945, BIOMETRICS BULL, V1, P80, DOI 10.1093/jee/39.2.269	34	118	124	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 5	2011	378	9803					1635	1642		10.1016/S0140-6736(11)61546-8	http://dx.doi.org/10.1016/S0140-6736(11)61546-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844ST	22027547				2022-12-28	WOS:000296768300028
J	Greenberg, RA				Greenberg, Roger A.			BRCA1, Everything But the RING?	SCIENCE			English	Editorial Material							BINDING; REPEATS; DOMAIN; BREAKS		[Greenberg, Roger A.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; [Greenberg, Roger A.] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Pathol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Greenberg, RA (corresponding author), Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, 421 Curie Blvd, Philadelphia, PA 19104 USA.	rogergr@mail.med.upenn.edu			NCI NIH HHS [R01 CA138835] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA138835] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Brzovic PS, 2001, J BIOL CHEM, V276, P41399, DOI 10.1074/jbc.M106551200; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Nagy V, 2010, BIOL CHEM, V391, P163, DOI 10.1515/bc.2010.021; Reid LJ, 2008, P NATL ACAD SCI USA, V105, P20876, DOI 10.1073/pnas.0811203106; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Shakya R, 2011, SCIENCE, V334, P525, DOI 10.1126/science.1209909; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Turner JMA, 2004, CURR BIOL, V14, P2135, DOI 10.1016/j.cub.2004.11.032; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zhu Q, 2011, NATURE, V477, P179, DOI 10.1038/nature10371	16	6	6	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 28	2011	334	6055					459	460		10.1126/science.1214057	http://dx.doi.org/10.1126/science.1214057			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837UR	22034420	Green Accepted			2022-12-28	WOS:000296230500028
J	McGillicuddy, DJ				McGillicuddy, Dennis J., Jr.			Eddies Masquerade as Planetary Waves	SCIENCE			English	Editorial Material							OCEAN COLOR; PHYTOPLANKTON; PATCHINESS		Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	McGillicuddy, DJ (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	dmcgillicuddy@whoi.edu		McGillicuddy, Dennis/0000-0002-1437-2425				Abraham ER, 1998, NATURE, V391, P577, DOI 10.1038/35361; Charria G, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016390; Chelton DB, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030812; Chelton DB, 2011, SCIENCE, V334, P328, DOI 10.1126/science.1208897; Chelton DB, 2011, PROG OCEANOGR, V91, P167, DOI 10.1016/j.pocean.2011.01.002; Cipollini P, 2001, GEOPHYS RES LETT, V28, P323, DOI 10.1029/1999GL011231; Dandonneau Y, 2003, SCIENCE, V302, P1548, DOI 10.1126/science.1090729; GOWER JFR, 1980, NATURE, V288, P157, DOI 10.1038/288157a0; Killworth PD, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001768; Levy M, 2001, J MAR RES, V59, P535, DOI 10.1357/002224001762842181; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; MCWILLIAMS JC, 1976, DEEP-SEA RES, V23, P285, DOI 10.1016/0011-7471(76)90871-8; Pascual A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024633; Siegel DA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047660; Uz BM, 2001, NATURE, V409, P597, DOI 10.1038/35054527	15	14	15	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 21	2011	334	6054					318	319		10.1126/science.1208892	http://dx.doi.org/10.1126/science.1208892			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	22021847				2022-12-28	WOS:000296052500036
J	Pinker, S				Pinker, Steven			Taming the devil within us	NATURE			English	Editorial Material									Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Harvard University	Pinker, S (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	pinker@wjh.harvard.edu	Pinker, Steven/GPX-7942-2022						0	22	23	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 20	2011	478	7369					309	311		10.1038/478309a	http://dx.doi.org/10.1038/478309a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	22012371	Green Submitted, Bronze			2022-12-28	WOS:000296021100016
J	Kane, M; Case, LK; Kopaskie, K; Kozlova, A; MacDearmid, C; Chervonsky, AV; Golovkina, TV				Kane, Melissa; Case, Laure K.; Kopaskie, Karyl; Kozlova, Alena; MacDearmid, Cameron; Chervonsky, Alexander V.; Golovkina, Tatyana V.			Successful Transmission of a Retrovirus Depends on the Commensal Microbiota	SCIENCE			English	Article							MAMMARY-TUMOR VIRUS; TOLL-LIKE RECEPTORS; INNATE IMMUNITY; ORAL TOLERANCE; T-CELLS; RECOGNITION; MICROFLORA; INFECTION; FLORA; HIV	To establish chronic infections, viruses must develop strategies to evade the host's immune responses. Many retroviruses, including mouse mammary tumor virus (MMTV), are transmitted most efficiently through mucosal surfaces rich in microbiota. We found that MMTV, when ingested by newborn mice, stimulates a state of unresponsiveness toward viral antigens. This process required the intestinal microbiota, as antibiotic-treated mice or germ-free mice did not transmit infectious virus to their offspring. MMTV-bound bacterial lipopolysaccharide triggered Toll-like receptor 4 and subsequent interleukin-6 (IL-6)-dependent induction of the inhibitory cytokine IL-10. Thus, MMTV has evolved to rely on the interaction with the microbiota to induce an immune evasion pathway. Together, these findings reveal the fundamental importance of commensal microbiota in viral infections.	[Kane, Melissa; Case, Laure K.; Kopaskie, Karyl; Kozlova, Alena; MacDearmid, Cameron; Golovkina, Tatyana V.] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Chervonsky, Alexander V.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Golovkina, TV (corresponding author), Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.	tgolovki@bsd.uchicago.edu		Chervonsky, Alexander/0000-0001-7547-871X; Kane, Melissa/0000-0002-4580-1210	Juvenile Diabetes Research Foundation [2005-204, 2007-353]; National Institute of Allergy and Infectious Diseases (NIAID) NIH [AI082418]; National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Digestive Disease Research Core Center [DK42086]; National Cancer Institute, NIH [CA100383]; NIAID [AI090084];  [T32GM007183];  [T32 AI065382-01];  [P30 CA014599]; NATIONAL CANCER INSTITUTE [R01CA134667, P30CA014599, R01CA100383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090084, T32AI065382, R01AI082418, R56AI090084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institute of Allergy and Infectious Diseases (NIAID) NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Digestive Disease Research Core Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Theriault and A. Vest for their help in monitoring gnotobiotic animals. This work was supported by T32GM007183 to M. K., K. K., and C. M.; by T32 AI065382-01 to L. C.; by Juvenile Diabetes Research Foundation grants 2005-204 and 2007-353; by the National Institute of Allergy and Infectious Diseases (NIAID) NIH AI082418 and the National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Digestive Disease Research Core Center grant DK42086 to A. V. C.; by National Cancer Institute, NIH, grant CA100383 and NIAID grant AI090084 to T. V. G.; and by a grant (P30 CA014599) to The University of Chicago. A material transfer agreement is required for use of the SPF and GF C3H-based mutant strains of mice. The data reported in this paper are tabulated in the main paper and the supporting online material.	Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Browne EP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000298; Dewhirst FE, 1999, APPL ENVIRON MICROB, V65, P3287; Dittmer U, 2004, IMMUNITY, V20, P293, DOI 10.1016/S1074-7613(04)00054-8; Golovkina TV, 1998, J IMMUNOL, V161, P2375; Golovkina TV, 1999, SCIENCE, V286, P1965, DOI 10.1126/science.286.5446.1965; Hardy AW, 2007, P NATL ACAD SCI USA, V104, P17453, DOI 10.1073/pnas.0707244104; Hayes KS, 2010, SCIENCE, V328, P1391, DOI 10.1126/science.1187703; Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330; Humphrey JH, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6580; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Jude BA, 2003, NAT IMMUNOL, V4, P573, DOI 10.1038/ni926; Kane M, 2011, IMMUNITY, V35, P135, DOI 10.1016/j.immuni.2011.05.011; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; MARRACK P, 1991, NATURE, V349, P524, DOI 10.1038/349524a0; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; MOREAU MC, 1988, INFECT IMMUN, V56, P2766, DOI 10.1128/IAI.56.10.2766-2768.1988; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rakoff-Nahoum S, 2008, MUCOSAL IMMUNOL, V1, pS10, DOI 10.1038/mi.2008.49; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rassa JC, 2002, P NATL ACAD SCI USA, V99, P2281, DOI 10.1073/pnas.042355399; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Sudo N, 1997, J IMMUNOL, V159, P1739; Wargo MJ, 2006, CURR OPIN MICROBIOL, V9, P359, DOI 10.1016/j.mib.2006.06.001; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336	28	254	263	2	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					245	249		10.1126/science.1210718	http://dx.doi.org/10.1126/science.1210718			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998394	Green Accepted			2022-12-28	WOS:000295833600052
J	Liu, CL; Fu, XF; Liu, LL; Ren, XJ; Chau, CKL; Li, SH; Xiang, L; Zeng, HL; Chen, GH; Tang, LH; Lenz, P; Cui, XD; Huang, W; Hwa, T; Huang, JD				Liu, Chenli; Fu, Xiongfei; Liu, Lizhong; Ren, Xiaojing; Chau, Carlos K. L.; Li, Sihong; Xiang, Lu; Zeng, Hualing; Chen, Guanhua; Tang, Lei-Han; Lenz, Peter; Cui, Xiaodong; Huang, Wei; Hwa, Terence; Huang, Jian-Dong			Sequential Establishment of Stripe Patterns in an Expanding Cell Population	SCIENCE			English	Article							ESCHERICHIA-COLI; BACTERIA; MIGRATION; CHEMOTAXIS; MUTANTS; GROWTH; AGAR	Periodic stripe patterns are ubiquitous in living organisms, yet the underlying developmental processes are complex and difficult to disentangle. We describe a synthetic genetic circuit that couples cell density and motility. This system enabled programmed Escherichia coli cells to form periodic stripes of high and low cell densities sequentially and autonomously. Theoretical and experimental analyses reveal that the spatial structure arises from a recurrent aggregation process at the front of the continuously expanding cell population. The number of stripes formed could be tuned by modulating the basal expression of a single gene. The results establish motility control as a simple route to establishing recurrent structures without requiring an extrinsic pacemaker.	[Liu, Chenli; Liu, Lizhong; Chau, Carlos K. L.; Xiang, Lu; Huang, Wei; Huang, Jian-Dong] Univ Hong Kong, Dept Biochem, Pokfulam, Hong Kong, Peoples R China; [Fu, Xiongfei; Li, Sihong; Zeng, Hualing; Cui, Xiaodong; Huang, Wei] Univ Hong Kong, Dept Phys, Pokfulam, Hong Kong, Peoples R China; [Ren, Xiaojing; Chen, Guanhua] Univ Hong Kong, Dept Chem, Pokfulam, Hong Kong, Peoples R China; [Tang, Lei-Han] Hong Kong Baptist Univ, Dept Phys, Kowloon, Hong Kong, Peoples R China; [Lenz, Peter] Univ Marburg, Dept Phys, D-35032 Marburg, Germany; [Lenz, Peter] Univ Marburg, Ctr Synthet Microbiol, D-35032 Marburg, Germany; [Hwa, Terence] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA	University of Hong Kong; University of Hong Kong; University of Hong Kong; Hong Kong Baptist University; Philipps University Marburg; Philipps University Marburg; University of California System; University of California San Diego	Huang, W (corresponding author), Univ Hong Kong, Dept Biochem, Pokfulam, Hong Kong, Peoples R China.	huangwei@hku.hk; hwa@ucsd.edu; jdhuang@hku.hk	Hwa, Terence/J-4012-2013; Hwa, Terry/GOJ-9904-2022; Liu, Chenli/D-8004-2013; Cui, Xiaodong/C-2023-2009; Lenz, Peter/L-5980-2013; Huang, Wei/AAW-1423-2021; Chen, GuanHua/G-6630-2014; Zeng, Hualing/J-4411-2014; Tang, Lei-Han/ABB-3219-2020; Liu, Lizhong/GSD-9231-2022; /C-4277-2009	Hwa, Terence/0000-0003-1837-6842; Cui, Xiaodong/0000-0002-2013-8336; Tang, Lei-Han/0000-0002-2925-4691; Liu, Chenli/0000-0003-3029-7207; /0000-0001-7531-2816; Lenz, Peter/0000-0001-7705-3950; Fu, Xiongfei/0000-0003-3657-8296	Hong Kong University (HKU); HKU Committee; Research Grants Council (RGC) [HKU1/CRF/10]; HKU Faculty of Medicine; NSF through the Center for Theoretical Biological Physics [PHY-0822283]; State Hessen; RGC of the Hong Kong Special Administrative Region [201606]	Hong Kong University (HKU)(University of Hong Kong); HKU Committee; Research Grants Council (RGC)(Hong Kong Research Grants Council); HKU Faculty of Medicine; NSF through the Center for Theoretical Biological Physics(National Science Foundation (NSF)); State Hessen; RGC of the Hong Kong Special Administrative Region	We are grateful to members of the University of Hong Kong Team for The International Genetic Engineering Machine Competition (iGEM) 2008 for their contribution to the project. We thank H. Berg, A. Courey, A. Danchin, D. Smith, J. Tailleur, and C. Voigt for valuable comments. This project was supported by a Hong Kong University (HKU) University Development Fund, a Small Project Grant from the HKU Committee on Research and Conference Grants, and a Collaborative Research Fund from the Research Grants Council (RGC) (HKU1/CRF/10) to J.D.H., and a HKU Faculty of Medicine Development Fund to W.H. TH is supported by the NSF through the Center for Theoretical Biological Physics (grant PHY-0822283) and additionally acknowledges an HKU Distinguished Visiting Professorship. P.L. acknowledges support through the LOEWE program of the State Hessen. L.H.T. acknowledges support by the RGC of the Hong Kong Special Administrative Region under grant 201606. E. coli strains and plasmids are available under a material transfer agreement with the University of Hong Kong.	Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Aman A, 2010, DEV BIOL, V341, P20, DOI 10.1016/j.ydbio.2009.11.014; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Ben-Jacob E, 2000, ADV PHYS, V49, P395, DOI 10.1080/000187300405228; BERG HC, 1975, ANNU REV BIOPHYS BIO, V4, P119, DOI 10.1146/annurev.bb.04.060175.001003; BUDRENE EO, 1991, NATURE, V349, P630, DOI 10.1038/349630a0; Cates ME, 2010, P NATL ACAD SCI USA, V107, P11715, DOI 10.1073/pnas.1001994107; Chuong CM, 2009, INT J DEV BIOL, V53, P653, DOI 10.1387/ijdb.082594cc; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Elowitz M, 2010, NATURE, V468, P889, DOI 10.1038/468889a; FUJIKAWA H, 1992, PHYSICA A, V189, P15, DOI 10.1016/0378-4371(92)90123-8; HELD LI, 1992, MODELS EMBRYONIC PER; Isalan M, 2005, PLOS BIOL, V3, P488, DOI 10.1371/journal.pbio.0030064; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Matsuyama T, 2000, J BACTERIOL, V182, P385, DOI 10.1128/JB.182.2.385-393.2000; Montell DJ, 2006, CURR OPIN GENET DEV, V16, P374, DOI 10.1016/j.gde.2006.06.010; Mukherji S, 2009, NAT REV GENET, V10, P859, DOI 10.1038/nrg2697; Murray J.D., 2007, INTERDISCIPLINARY AP, V2, P1; Niswander L, 2003, NAT REV GENET, V4, P133, DOI 10.1038/nrg1001; PARKINSON JS, 1982, J BACTERIOL, V151, P106, DOI 10.1128/JB.151.1.106-113.1982; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Rorth P, 2007, TRENDS CELL BIOL, V17, P575, DOI 10.1016/j.tcb.2007.09.007; Sanna MG, 1996, J BACTERIOL, V178, P6275, DOI 10.1128/jb.178.21.6275-6280.1996; Tailleur J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.218103; Turing A. M., 1952, PHILOS T R SOC B, V237, P37; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Weiss LE, 2008, BIOTECHNOL BIOENG, V100, P1251, DOI 10.1002/bit.21862; WOLFE AJ, 1989, P NATL ACAD SCI USA, V86, P6973, DOI 10.1073/pnas.86.18.6973; WOODWARD DE, 1995, BIOPHYS J, V68, P2181	29	239	252	11	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					238	241		10.1126/science.1209042	http://dx.doi.org/10.1126/science.1209042			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998392	Green Submitted			2022-12-28	WOS:000295833600050
J	Bryson, D				Bryson, David			PERSONAL VIEW Care homes shouldn't profit from delays in assessing their residents for discharge from hospital	BRITISH MEDICAL JOURNAL			English	Editorial Material									Gen Hosp Kettering, Kettering, England		Bryson, D (corresponding author), Gen Hosp Kettering, Kettering, England.	davidjbryson@hotmail.com							0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 12	2011	343								d6570	10.1136/bmj.d6570	http://dx.doi.org/10.1136/bmj.d6570			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	835EO	21994319				2022-12-28	WOS:000296018100007
J	Savolainen, O				Savolainen, Outi			The Genomic Basis of Local Climatic Adaptation	SCIENCE			English	Editorial Material							ARABIDOPSIS-THALIANA; GENETIC-VARIATION; PATTERNS		Univ Oulu, Dept Biol, FIN-90014 Oulu, Finland	University of Oulu	Savolainen, O (corresponding author), Univ Oulu, Dept Biol, FIN-90014 Oulu, Finland.	outi.savolainen@oulu.fi						Anderson JT, 2011, TRENDS GENET, V27, P258, DOI 10.1016/j.tig.2011.04.001; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Chevin LM, 2008, GENETICS, V180, P1645, DOI 10.1534/genetics.108.093351; Eckert AJ, 2010, GENETICS, V185, P969, DOI 10.1534/genetics.110.115543; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Giakountis A, 2010, PLANT PHYSIOL, V152, P177, DOI 10.1104/pp.109.140772; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; Hancock AM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001375; Hernandez RD, 2011, SCIENCE, V331, P920, DOI 10.1126/science.1198878; Le Corre V, 2002, MOL BIOL EVOL, V19, P1261, DOI 10.1093/oxfordjournals.molbev.a004187; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Leinonen PH, 2011, EVOLUTION, V65, P90, DOI 10.1111/j.1558-5646.2010.01119.x; Sattath S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001302; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826	15	19	20	3	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 7	2011	334	6052					49	50		10.1126/science.1213788	http://dx.doi.org/10.1126/science.1213788			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21980101				2022-12-28	WOS:000295580300033
J	Fast, EM; Toomey, ME; Panaram, K; Desjardins, D; Kolaczyk, ED; Frydman, HM				Fast, Eva M.; Toomey, Michelle E.; Panaram, Kanchana; Desjardins, Danielle; Kolaczyk, Eric D.; Frydman, Horacio M.			Wolbachia Enhance Drosophila Stem Cell Proliferation and Target the Germline Stem Cell Niche	SCIENCE			English	Article							LIFE-SHORTENING WOLBACHIA; AEDES-AEGYPTI; RAPID SPREAD; INFECTION; INCOMPATIBILITY; MELANOGASTER; SIMULANS; BIOLOGY; FUSOME; DEATH	Wolbachia are widespread maternally transmitted intracellular bacteria that infect most insect species and are able to alter the reproduction of innumerous hosts. The cellular bases of these alterations remain largely unknown. Here, we report that Drosophila mauritiana infected with a native Wolbachia wMau strain produces about four times more eggs than the noninfected counterpart. Wolbachia infection leads to an increase in the mitotic activity of germline stem cells (GSCs), as well as a decrease in programmed cell death in the germarium. Our results suggest that up-regulation of GSC division is mediated by a tropism of Wolbachia for the GSC niche, the cellular microenvironment that supports GSCs.	[Fast, Eva M.; Toomey, Michelle E.; Panaram, Kanchana; Desjardins, Danielle; Frydman, Horacio M.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Toomey, Michelle E.; Frydman, Horacio M.] Boston Univ, Natl Emerging Infect Dis Lab, Boston, MA 02118 USA; [Kolaczyk, Eric D.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA	Boston University; Boston University; Boston University	Frydman, HM (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	hfrydman@bu.edu		Frydman, Horacio/0000-0003-0191-7948; Fast, Eva/0000-0002-4261-5244	Boston Univ.; National Institute of Allergy and Infectious Diseases [1K22AI74909-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI074909] Funding Source: NIH RePORTER	Boston Univ.; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. McCall, G. Cooper, D. Waxman, C. Bradham, and A. Boxer for valuable suggestions in the manuscript; E. Wieschaus, the McCall Lab, T. Blute, D. Gantz, and M. Bisher for help and support with PCD and EM experiments; E. Wieschaus, T. Schupbach, R. Lehmann, P. Lasko, D. Stern, V. Orgogozo, and M. Ramos for fly stocks and reagents; members of the Frydman Lab for assistance and suggestions during the realization of this work; J. Li and D. Robson for help with MatLab software; and A. Mahowald for sharing his unpublished results and encouraging us to analyze Wolbachia in the testis. Finally, we would like to thank the anonymous reviewers for their helpful comments. This work was supported by funds from Boston Univ. and National Institute of Allergy and Infectious Diseases (grant 1K22AI74909-01A1 to H. M. F.). The data described in this paper are available in the SOM.	Bazzocchi C, 2007, PARASITE IMMUNOL, V29, P73, DOI 10.1111/j.1365-3024.2006.00915.x; Bourtzis K, 2008, ADV EXP MED BIOL, V627, P104, DOI 10.1007/978-0-387-78225-6_9; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; de Cuevas M, 2011, DEVELOPMENT, V138, P2861, DOI 10.1242/dev.056242; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Fry AJ, 2004, HEREDITY, V93, P379, DOI 10.1038/sj.hdy.6800514; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; HOFFMANN AA, 1990, GENETICS, V126, P933; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; LIN HF, 1994, DEVELOPMENT, V120, P947; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Pannebakker BA, 2007, P NATL ACAD SCI USA, V104, P213, DOI 10.1073/pnas.0607845104; Pfarr KM, 2006, MINI-REV MED CHEM, V6, P203, DOI 10.2174/138955706775475984; Poinsot D, 1997, EVOLUTION, V51, P180, DOI 10.1111/j.1558-5646.1997.tb02399.x; Pritchett TL, 2009, APOPTOSIS, V14, P969, DOI 10.1007/s10495-009-0369-z; Reynolds KT, 2003, GENETICS, V164, P1027; Sacchi L, 2010, TISSUE CELL, V42, P328, DOI 10.1016/j.tice.2010.07.009; Serbus LR, 2008, ANNU REV GENET, V42, P683, DOI 10.1146/annurev.genet.41.110306.130354; TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Weiss B., 2011, TRENDS PARASITOL; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Werren JH, 2011, P NATL ACAD SCI USA, V108, P10863, DOI 10.1073/pnas.1102343108; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328	30	124	132	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 18	2011	334	6058					990	992		10.1126/science.1209609	http://dx.doi.org/10.1126/science.1209609			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CA	22021671	Green Accepted			2022-12-28	WOS:000297101800059
J	Chatterjee, A; Abeydeera, ND; Bale, S; Pai, PJ; Dorrestein, PC; Russell, DH; Ealick, SE; Begley, TP				Chatterjee, Abhishek; Abeydeera, N. Dinuka; Bale, Shridhar; Pai, Pei-Jing; Dorrestein, Pieter C.; Russell, David H.; Ealick, Steven E.; Begley, Tadhg P.			Saccharomyces cerevisiae THI4p is a suicide thiamine thiazole synthase	NATURE			English	Article							ESCHERICHIA-COLI; BIOSYNTHESIS; ENZYME; EUKARYOTES; GENE; IDENTIFICATION; PROTEIN	Thiamine pyrophosphate 1 is an essential cofactor in all living systems(1). Its biosynthesis involves the separate syntheses of the pyrimidine 2 and thiazole 3 precursors, which are then coupled(2). Two biosynthetic routes to the thiamine thiazole have been identified. In prokaryotes, five enzymes act on three substrates to produce the thiazole via a complex oxidative condensation reaction, the mechanistic details of which are now well established(2-6). In contrast, only one gene product is involved in thiazole biosynthesis in eukaryotes (THI4p in Saccharomyces cerevisiae)(7). Here we report the preparation of fully active recombinant wild-type THI4p, the identification of an iron-dependent sulphide transfer reaction from a conserved cysteine residue of the protein to a reaction intermediate and the demonstration that THI4p is a suicide enzyme undergoing only a single turnover.	[Abeydeera, N. Dinuka; Pai, Pei-Jing; Russell, David H.; Begley, Tadhg P.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Chatterjee, Abhishek; Bale, Shridhar; Ealick, Steven E.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	Texas A&M University System; Texas A&M University College Station; Cornell University; University of California System; University of California San Diego	Begley, TP (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.	see3@cornell.edu; begley@chem.tamu.edu	Russell, David H/C-3618-2015; chatterjee, abhishek/N-9443-2019; Dorrestein, Pieter/D-5012-2012; Dorrestein, Pieter/ABF-2930-2020; Begley, Tadhg/B-5801-2015	Russell, David H/0000-0003-0830-3914; chatterjee, abhishek/0000-0002-6231-5302; 	NIH [DK44083]; Robert E. Welch Foundation [A-0034, DK67081]; NSF [DBI0821700]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067081, R37DK044083, R01DK044083] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert E. Welch Foundation(The Welch Foundation); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank F. W. McLafferty for initial FTMS analysis of THI4p. This research was funded by NIH grant DK44083 (to T. P. B.), the Robert E. Welch Foundation grant A-0034 (to T. P. B.), DK67081 (to S. E. E.) and NSF grant DBI0821700 (to D. H. R.).	Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Begley TP, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P547; Begley TP, 2006, NAT PROD REP, V23, P15, DOI 10.1039/b207131m; Chatterjee A, 2008, J AM CHEM SOC, V130, P11394, DOI 10.1021/ja802140a; Chatterjee A, 2007, J AM CHEM SOC, V129, P2914, DOI 10.1021/ja067606t; Chatterjee A, 2006, J AM CHEM SOC, V128, P7158, DOI 10.1021/ja061413o; DeLano W.L, PYMOL MOL GRAPHICS S; DEMPLE B, 1985, P NATL ACAD SCI USA, V82, P2688, DOI 10.1073/pnas.82.9.2688; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faou P, 2004, J MOL BIOL, V344, P1147, DOI 10.1016/j.jmb.2004.09.097; Godoi PHC, 2006, J BIOL CHEM, V281, P30957, DOI 10.1074/jbc.M604469200; Hazra AB, 2011, J AM CHEM SOC, V133, P9311, DOI 10.1021/ja1110514; Jordan F, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P561; Jurgenson CT, 2006, BIOCHEMISTRY-US, V45, P11061, DOI 10.1021/bi061025z; Jurgenson CT, 2009, ANNU REV BIOCHEM, V78, P569, DOI 10.1146/annurev.biochem.78.072407.102340; Kriek M, 2007, J BIOL CHEM, V282, P17413, DOI 10.1074/jbc.M700782200; Machado CR, 1997, J MOL BIOL, V273, P114, DOI 10.1006/jmbi.1997.1302; Medina-Silva R, 2006, RES MICROBIOL, V157, P275, DOI 10.1016/j.resmic.2005.07.004; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; PRAEKELT UM, 1994, YEAST, V10, P481, DOI 10.1002/yea.320100407; Ruiz-Roldan C, 2008, FUNGAL GENET BIOL, V45, P6, DOI 10.1016/j.fgb.2007.09.003; SEDGWICK B, 1988, J BIOL CHEM, V263, P4430; Suter B, 2007, GENOME RES, V17, P1774, DOI 10.1101/gr.6667007; TEO I, 1986, CELL, V45, P315, DOI 10.1016/0092-8674(86)90396-X	25	110	117	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2011	478	7370					542	U146		10.1038/nature10503	http://dx.doi.org/10.1038/nature10503			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	22031445	Green Accepted			2022-12-28	WOS:000296194200049
J	Lewis, KH; Rosenthal, MB				Lewis, Kristina H.; Rosenthal, Meredith B.			Individual Responsibility or a Policy Solution - Cap and Trade for the US Diet?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							WORK		[Lewis, Kristina H.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02115 USA; [Lewis, Kristina H.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Rosenthal, Meredith B.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Harvard T.H. Chan School of Public Health	Lewis, KH (corresponding author), Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02115 USA.			Lewis, Kristina/0000-0002-4921-7230; Rosenthal, Meredith/0000-0003-3410-0184				Brownell KD, 2009, NEW ENGL J MED, V360, P1805, DOI 10.1056/NEJMp0902392; Chestnut LG, 2005, J ENVIRON MANAGE, V77, P252, DOI 10.1016/j.jenvman.2005.05.014; Forshee RA, 2008, NUTR REV, V66, P280, DOI 10.1111/j.1753-4887.2008.00033.x; Matisoff DC, 2010, ENVIRONMENT, V52, P10, DOI 10.1080/00139150903479530; Tietenberg T., 2010, Agricultural and Resource Economics Review, V39, P359	5	12	13	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2011	365	17					1561	1563		10.1056/NEJMp1105128	http://dx.doi.org/10.1056/NEJMp1105128			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	837HI	22029976				2022-12-28	WOS:000296181800013
J	Long, JCS				Long, Jane C. S.			Piecemeal cuts won't add up to radical reductions	NATURE			English	Editorial Material									Lawrence Livermore Natl Lab, Livermore, CA USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Long, JCS (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA USA.	janecslong@gmail.com							0	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 27	2011	478	7370					429	429		10.1038/478429a	http://dx.doi.org/10.1038/478429a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	22031399	Bronze			2022-12-28	WOS:000296194200004
J	Palefsky, JM; Giuliano, AR; Goldstone, S; Moreira, ED; Aranda, C; Jessen, H; Hillman, R; Ferris, D; Coutlee, F; Stoler, MH; Marshall, JB; Radley, D; Vuocolo, S; Haupt, RM; Guris, D; Garner, EIO				Palefsky, Joel M.; Giuliano, Anna R.; Goldstone, Stephen; Moreira, Edson D., Jr.; Aranda, Carlos; Jessen, Heiko; Hillman, Richard; Ferris, Daron; Coutlee, Francois; Stoler, Mark H.; Marshall, J. Brooke; Radley, David; Vuocolo, Scott; Haupt, Richard M.; Guris, Dalya; Garner, Elizabeth I. O.			HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; RISK-FACTORS; QUADRIVALENT VACCINE; CANCER PRECURSORS; PREVALENCE; WOMEN; MEN; HIV; POPULATION; EFFICACY	BACKGROUND The rate of anal cancer is increasing among both women and men, particularly men who have sex with men. Caused by infection with human papillomavirus (HPV), primarily HPV type 16 or 18, anal cancer is preceded by high-grade anal intraepithelial neoplasia (grade 2 or 3). We studied the safety and efficacy of quadrivalent HPV vaccine (qHPV) against anal intraepithelial neoplasia associated with HPV-6, 11, 16, or 18 infection in men who have sex with men. METHODS In a substudy of a larger double-blind study, we randomly assigned 602 healthy men who have sex with men, 16 to 26 years of age, to receive either qHPV or placebo. The primary efficacy objective was prevention of anal intraepithelial neoplasia or anal cancer related to infection with HPV-6, 11, 16, or 18. Efficacy analyses were performed in intention-to-treat and per-protocol efficacy populations. The rates of adverse events were documented. RESULTS Efficacy of the qHPV vaccine against anal intraepithelial neoplasia associated with HPV-6, 11, 16, or 18 was 50.3% (95% confidence interval [CI], 25.7 to 67.2) in the intention-to-treat population and 77.5% (95% CI, 39.6 to 93.3) in the per-protocol efficacy population; the corresponding efficacies against anal intraepithelial neoplasia associated with HPV of any type were 25.7% (95% CI, -1.1 to 45.6) and 54.9% (95% CI, 8.4 to 79.1), respectively. Rates of anal intraepithelial neoplasia per 100 person-years were 17.5 in the placebo group and 13.0 in the vaccine group in the intention-to-treat population and 8.9 in the placebo group and 4.0 in the vaccine group in the per-protocol efficacy population. The rate of grade 2 or 3 anal intraepithelial neoplasia related to infection with HPV-6, 11, 16, or 18 was reduced by 54.2% (95% CI, 18.0 to 75.3) in the intention-to-treat population and by 74.9% (95% CI, 8.8 to 95.4) in the per-protocol efficacy population. The corresponding risks of persistent anal infection with HPV-6, 11, 16, or 18 were reduced by 59.4% (95% CI, 43.0 to 71.4) and 94.9% (95% CI, 80.4 to 99.4), respectively. No vaccine-related serious adverse events were reported. CONCLUSIONS Use of the qHPV vaccine reduced the rates of anal intraepithelial neoplasia, including of grade 2 or 3, among men who have sex with men. The vaccine had a favorable safety profile and may help to reduce the risk of anal cancer. (Funded by Merck and the National Institutes of Health; ClinicalTrials.gov number, NCT00090285.)	[Palefsky, Joel M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Giuliano, Anna R.] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Risk Assessment Detect & Intervent Program, Tampa, FL 33612 USA; [Goldstone, Stephen] Mt Sinai Sch Med, New York, NY USA; [Moreira, Edson D., Jr.] Brazilian Minist Hlth, Assoc Obras Sociais Irma Dulce, Salvador, BA, Brazil; [Moreira, Edson D., Jr.] Brazilian Minist Hlth, Oswaldo Cruz Fdn, Salvador, BA, Brazil; [Aranda, Carlos] Natl Publ Hlth Inst, Univ Med Ctr, Cuernavaca, Morelos, Mexico; [Jessen, Heiko] J2 Private Clin Infect Dis, Berlin, Germany; [Hillman, Richard] Univ Sydney, Sexually Transmitted Infect Res Ctr, Sydney, NSW 2006, Australia; [Ferris, Daron] Med Coll Georgia, Augusta, GA 30912 USA; [Coutlee, Francois] Univ Montreal, Ctr Hosp Univ Montreal, Ctr Rech, Montreal, PQ, Canada; [Stoler, Mark H.] Univ Virginia, Charlottesville, VA USA; [Marshall, J. Brooke; Radley, David; Vuocolo, Scott; Haupt, Richard M.; Guris, Dalya; Garner, Elizabeth I. O.] Merck, N Wales, PA USA	University of California System; University of California San Francisco; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Icahn School of Medicine at Mount Sinai; Fundacao Oswaldo Cruz; University of Sydney; University System of Georgia; Augusta University; Universite de Montreal; University of Virginia	Palefsky, JM (corresponding author), Univ Calif San Francisco, Dept Med, Box 0654, San Francisco, CA 94143 USA.	joel.palefsky@ucsf.edu	Moreira, Edson D/J-1758-2012; Moreira Jr, Edson Duarte/GRF-5620-2022; Hillman, Richard/AAM-1177-2020; Hug, Balthasar L./G-1568-2010; Jessen, Heiko/P-2192-2019; Moreira, Edson/W-7437-2019; Marshall, Brooke/ABD-2070-2020	Moreira, Edson D/0000-0002-7081-8348; Moreira Jr, Edson Duarte/0000-0002-7081-8348; Hillman, Richard/0000-0002-1859-0761; Moreira, Edson/0000-0002-7081-8348; 	Merck; National Institutes of Health (NIH/NCRR) [M01-RR-00079, UL1 RR024131]; Merck Sharp Dohme; GlaxoSmithKline; Qiagen; AIDS Malignancy Consortium; National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000079, UL1RR024131] Funding Source: NIH RePORTER	Merck(Merck & Company); National Institutes of Health (NIH/NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Merck Sharp Dohme(Merck & Company); GlaxoSmithKline(GlaxoSmithKline); Qiagen; AIDS Malignancy Consortium; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funded by Merck and the National Institutes of Health; ClinicalTrials.gov number, NCT00090285.); Supported by grants from Merck and the National Institutes of Health (NIH/NCRR M01-RR-00079 and UL1 RR024131, to the University of California, San Francisco General Clinical Research Center, where some participants were studied).; Dr. Coutlee reports receiving funding through his institution from Merck Sharp & Dohme and providing expert testimony for GlaxoSmithKline and Qiagen. Dr. Ferris reports receiving funding through his institution, consulting fees and honoraria, and travel support from Merck Sharp & Dohme, serving as a board member for Merck Sharp & Dohme, and receiving consulting fees and honoraria from GlaxoSmithKline. Dr. Giuliano reports serving as a board member and consultant for and receiving grant support and honoraria from Merck Sharp & Dohme. Dr. Goldstone reports receiving grant support, consulting fees, and travel support from Merck Sharp & Dohme, serving as a consultant for and receiving grants and honoraria from Qiagen, receiving grants and travel support from the AIDS Malignancy Consortium, and receiving honoraria for the development of educational presentations and reimbursement for travel, accommodations, and meeting expenses from the American Social Health Association. Dr. Jessen reports receiving travel support from Merck Sharp & Dohme. Dr. Moreira reports receiving grant support through his institution, consulting fees, honoraria, travel support, and fees for review activities from Merck Sharp & Dohme and serving as a board member and consultant for Merck Sharp & Dohme. Dr. Palefsky reports receiving grant support through his institution, travel support, and fees for review activities through his institution from Merck Sharp & Dohme, serving as a board member and consultant and providing expert testimony for Merck Sharp & Dohme and receiving fees for these activities through his institution, serving as a member of the scientific advisory board of Pharmajet and receiving consulting fees for this activity through his institution, and serving as a member of the scientific advisory board of Aura Biosciences, for which he has received stock options. Dr. Stoler reports receiving consulting fees and honoraria through his institution from - Merck Sharp & Dohme and serving as a consultant for Roche, Gen Probe, Qiagen, MTM Laboratories, Ventana, and Becton Dickinson. Drs. Garner, Guris, Haupt, Marshall, and Vuocolo and Mr. Radley report being employees of Merck Sharp & Dohme and owning stock or stock options. No other potential conflict of interest relevant to this article was reported.	Chin-Hong PV, 2005, JNCI-J NATL CANCER I, V97, P896, DOI 10.1093/jnci/dji163; Fairley CK, 2009, SEX TRANSM INFECT, V85, P499, DOI 10.1136/sti.2009.037788; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Giuliano AR, 2011, NEW ENGL J MED, V364, P1481; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Goodman MT, 2008, J INFECT DIS, V197, P957, DOI 10.1086/529207; Hoots BE, 2009, INT J CANCER, V124, P2375, DOI 10.1002/ijc.24215; Johnson LG, 2004, CANCER-AM CANCER SOC, V101, P281, DOI 10.1002/cncr.20364; Kjaer SK, 2007, J INFECT DIS, V196, P1447, DOI 10.1086/522863; MELBYE M, 1991, LANCET, V338, P657, DOI 10.1016/0140-6736(91)91233-K; Nyitray A, 2008, J INFECT DIS, V197, P1676, DOI 10.1086/588145; Nyitray AG, 2010, J INFECT DIS, V201, P1498, DOI 10.1086/652187; OGUNBIYI OA, 1994, OBSTET GYNECOL, V83, P212; Palefsky JM, 2001, J INFECT DIS, V183, P383, DOI 10.1086/318071; Palefsky J, 2009, CURR OPIN HIV AIDS, V4, P52, DOI 10.1097/COH.0b013e32831a7246; Patel HS, 2007, INT J COLORECTAL DIS, V22, P1, DOI 10.1007/s00384-005-0023-3; Pathela P, 2006, ANN INTERN MED, V145, P936, DOI 10.7326/0003-4819-145-12-200612190-00022; Pathela P, 2006, ANN INTERN MED, V145, P416, DOI 10.7326/0003-4819-145-6-200609190-00005; Piketty C, 2003, ANN INTERN MED, V138, P453, DOI 10.7326/0003-4819-138-6-200303180-00008; Scholefield JH, 2005, BRIT J SURG, V92, P1133, DOI 10.1002/bjs.4994; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Watson AJM, 2006, ANZ J SURG, V76, P715, DOI 10.1111/j.1445-2197.2006.03837.x; Weaver BA, 2004, J INFECT DIS, V189, P677, DOI 10.1086/381395	24	592	603	1	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2011	365	17					1576	1585		10.1056/NEJMoa1010971	http://dx.doi.org/10.1056/NEJMoa1010971			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HI	22029979	Green Published			2022-12-28	WOS:000296181800002
J	Stoopler, ET; Balasubramaniam, R				Stoopler, Eric T.; Balasubramaniam, Ramesh			Human Papillomavirus Lesions of the Oral Cavity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Stoopler, Eric T.] Univ Penn, Sch Dent Med, Philadelphia, PA 19104 USA; [Balasubramaniam, Ramesh] Univ Western Australia, Sch Dent, Perth, WA 6009, Australia	University of Pennsylvania; University of Western Australia	Stoopler, ET (corresponding author), Univ Penn, Sch Dent Med, Philadelphia, PA 19104 USA.								0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2011	365	17					E37	E37		10.1056/NEJMicm1104783	http://dx.doi.org/10.1056/NEJMicm1104783			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HI	22030005	Green Published			2022-12-28	WOS:000296181800008
J	Sumithran, P; Prendergast, LA; Delbridge, E; Purcell, K; Shulkes, A; Kriketos, A; Proietto, J				Sumithran, Priya; Prendergast, Luke A.; Delbridge, Elizabeth; Purcell, Katrina; Shulkes, Arthur; Kriketos, Adamandia; Proietto, Joseph			Long-Term Persistence of Hormonal Adaptations to Weight Loss	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLUCAGON-LIKE PEPTIDE-1; GASTRIC BYPASS-SURGERY; DECREASES FOOD-INTAKE; OBESE GENE-PRODUCT; LEPTIN CONCENTRATIONS; BODY-WEIGHT; PANCREATIC-POLYPEPTIDE; ENERGY-EXPENDITURE; BARIATRIC SURGERY; LOSS MAINTENANCE	BACKGROUND After weight loss, changes in the circulating levels of several peripheral hormones involved in the homeostatic regulation of body weight occur. Whether these changes are transient or persist over time may be important for an understanding of the reasons behind the high rate of weight regain after diet-induced weight loss. METHODS We enrolled 50 overweight or obese patients without diabetes in a 10-week weight-loss program for which a very-low-energy diet was prescribed. At baseline (before weight loss), at 10 weeks (after program completion), and at 62 weeks, we examined circulating levels of leptin, ghrelin, peptide YY, gastric inhibitory polypeptide, glucagon-like peptide 1, amylin, pancreatic polypeptide, cholecystokinin, and insulin and subjective ratings of appetite. RESULTS Weight loss (mean [+/- SE], 13.5 +/- 0.5 kg) led to significant reductions in levels of leptin, peptide YY, cholecystokinin, insulin (P<0.001 for all comparisons), and amylin (P = 0.002) and to increases in levels of ghrelin (P<0.001), gastric inhibitory polypeptide (P = 0.004), and pancreatic polypeptide (P = 0.008). There was also a significant increase in subjective appetite (P<0.001). One year after the initial weight loss, there were still significant differences from baseline in the mean levels of leptin (P<0.001), peptide YY (P<0.001), cholecystokinin (P = 0.04), insulin (P = 0.01), ghrelin (P<0.001), gastric inhibitory polypeptide (P<0.001), and pancreatic polypeptide (P = 0.002), as well as hunger (P<0.001). CONCLUSIONS One year after initial weight reduction, levels of the circulating mediators of appetite that encourage weight regain after diet-induced weight loss do not revert to the levels recorded before weight loss. Long-term strategies to counteract this change may be needed to prevent obesity relapse. (Funded by the National Health and Medical Research Council and others; ClinicalTrials.gov number, NCT00870259.)	[Sumithran, Priya; Delbridge, Elizabeth; Purcell, Katrina; Kriketos, Adamandia; Proietto, Joseph] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Shulkes, Arthur] Univ Melbourne, Dept Surg, Melbourne, Vic, Australia; [Prendergast, Luke A.] La Trobe Univ, Dept Math & Stat, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne; La Trobe University	Proietto, J (corresponding author), Univ Melbourne, Dept Med, Heidelberg Repatriat Hosp, 300 Waterdale Rd, Heidelberg, Vic 3081, Australia.	j.proietto@unimelb.edu.au	Proietto, Joe/B-3780-2012; Prendergast, Luke A/G-8376-2011	Prendergast, Luke A/0000-0002-9122-5429	National Health and Medical Research Council [508920]; Endocrine Society of Australia; Royal Australasian College of Physicians; Sir Edward Dunlop Medical Research Foundation	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Endocrine Society of Australia; Royal Australasian College of Physicians(General Electric); Sir Edward Dunlop Medical Research Foundation	Supported by a project grant from the National Health and Medical Research Council (508920), a scholarship from the Endocrine Society of Australia, a Shields Research Scholarship from the Royal Australasian College of Physicians (to Dr. Sumithran), and funding from the Sir Edward Dunlop Medical Research Foundation (to Dr. Proietto).	Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Anderson JW, 2001, AM J CLIN NUTR, V74, P579; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Batterham RL, 2003, J CLIN ENDOCR METAB, V88, P3989, DOI 10.1210/jc.2003-030630; Bays H, 2010, EXPERT REV CARDIOVAS, V8, P1777, DOI 10.1586/ERC.10.125; Best D. J., 1975, Applied Statistics, V24, P377, DOI 10.2307/2347111; Chearskul S, 2008, AM J CLIN NUTR, V87, P1238; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Cummings DE, 2002, NEW ENGL J MED, V346, P1623, DOI 10.1056/NEJMoa012908; Essah PA, 2010, INT J OBESITY, V34, P1239, DOI 10.1038/ijo.2010.48; Flint A, 1998, J CLIN INVEST, V101, P515, DOI 10.1172/JCI990; Geldszus R, 1996, EUR J ENDOCRINOL, V135, P659, DOI 10.1530/eje.0.1350659; GIBBS J, 1973, J COMP PHYSIOL PSYCH, V84, P488, DOI 10.1037/h0034870; Greenway FL, 2009, J CLIN ENDOCR METAB, V94, P4898, DOI 10.1210/jc.2009-1350; Gutzwiller JP, 1999, GUT, V44, P81, DOI 10.1136/gut.44.1.81; HAUNER H, 1988, ANN NUTR METAB, V32, P282, DOI 10.1159/000177467; Havel PJ, 1996, J CLIN ENDOCR METAB, V81, P4406, DOI 10.1210/jc.81.12.4406; Keim NL, 1998, AM J CLIN NUTR, V68, P794, DOI 10.1093/ajcn/68.4.794; KNAPPER JME, 1995, J NUTR, V125, P183; le Roux CW, 2006, ANN SURG, V243, P108, DOI 10.1097/01.sla.0000183349.16877.84; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; LEIBEL RL, 1995, NEW ENGL J MED, V333, P399; LEIBEL RL, 1984, METABOLISM, V33, P164, DOI 10.1016/0026-0495(84)90130-6; MacLean PS, 2004, AM J PHYSIOL-REG I, V287, pR1306, DOI 10.1152/ajpregu.00463.2004; MORLEY JE, 1991, PEPTIDES, V12, P865, DOI 10.1016/0196-9781(91)90148-I; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; RABEN A, 1994, AM J CLIN NUTR, V60, P544, DOI 10.1093/ajcn/60.4.544; Reinehr T, 2006, INT J OBESITY, V30, P1476, DOI 10.1038/sj.ijo.0803393; REZEK M, 1976, CAN J PHYSIOL PHARM, V54, P650, DOI 10.1139/y76-091; Rosenbaum M, 1997, J CLIN ENDOCR METAB, V82, P3647, DOI 10.1210/jc.82.11.3647; Rosenbaum M, 2008, AM J CLIN NUTR, V88, P906, DOI 10.1093/ajcn/88.4.906; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Stubbs RJ, 2000, BRIT J NUTR, V84, P405, DOI 10.1017/S0007114500001719; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323; World Health Organization, 2010, OB OV; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; ZHANG YY, 1995, NATURE, V374, P479, DOI 10.1038/374479a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	40	802	814	3	84	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2011	365	17					1597	1604		10.1056/NEJMoa1105816	http://dx.doi.org/10.1056/NEJMoa1105816			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HI	22029981				2022-12-28	WOS:000296181800004
J	Patel, V; Boyce, N; Collins, PY; Saxena, S; Horton, R				Patel, Vikram; Boyce, Niall; Collins, Pamela Y.; Saxena, Shekhar; Horton, Richard			A renewed agenda for global mental health	LANCET			English	Editorial Material							DISORDERS		[Patel, Vikram] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England; [Boyce, Niall; Collins, Pamela Y.] Lancet, London, England; [Patel, Vikram] Sangath, Goa, India; [Collins, Pamela Y.] NIMH, Bethesda, MD 20892 USA; [Saxena, Shekhar] World Hlth Org, Dept Mental Hlth & Subst Abuse, Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); World Health Organization	Patel, V (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	vikram.patel@lshtm.ac.uk	Collins, Pamela Y/AAD-9334-2022	Collins, Pamela Y./0000-0003-3956-448X; Patel, Vikram/0000-0003-1066-8584	Wellcome Trust [091834] Funding Source: Medline; Department for International Development (DFID) [201446] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Department for International Development (DFID)		Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Drew N, 2011, LANCET, V378, P1664, DOI 10.1016/S0140-6736(11)61458-X; Eaton J, 2011, LANCET, V378, P1592, DOI 10.1016/S0140-6736(11)60891-X; Kakuma R, 2011, LANCET, V378, P1654, DOI 10.1016/S0140-6736(11)61093-3; Kieling C, 2011, LANCET, V378, P1515, DOI 10.1016/S0140-6736(11)60827-1; Kleinman A, 2009, LANCET, V374, P603, DOI 10.1016/S0140-6736(09)61510-5; Lancet Global Mental Health Group, 2007, Lancet, V370, P1241; Lund C, 2011, LANCET, V378, P1502, DOI 10.1016/S0140-6736(11)60754-X; Patel V, 2011, BRIT J PSYCHIAT, V198, P88, DOI 10.1192/bjp.bp.109.074518; Patel V, 2010, WORLD PSYCHIATRY, V9, P169; Tol WA, 2011, LANCET, V378, P1581, DOI 10.1016/S0140-6736(11)61094-5; World Health Organization, 2016, MHGAP INT GUID MENT	12	102	104	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2011	378	9801					1441	1442		10.1016/S0140-6736(11)61385-8	http://dx.doi.org/10.1016/S0140-6736(11)61385-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	838VC	22008422	Green Accepted			2022-12-28	WOS:000296319600004
J	Haas, JS; Zavala, B; Landisman, CE				Haas, Julie S.; Zavala, Baltazar; Landisman, Carole E.			Activity-Dependent Long-Term Depression of Electrical Synapses	SCIENCE			English	Article							THALAMIC RETICULAR NUCLEUS; INHIBITORY INTERNEURONS; GABAERGIC SYNAPSES; SPIKING NEURONS; MAMMALIAN BRAIN; ADULT-RAT; NEOCORTEX; NETWORK; MODULATION; PHOSPHORYLATION	Use-dependent forms of synaptic plasticity have been extensively characterized at chemical synapses, but a relationship between natural activity and strength at electrical synapses remains elusive. The thalamic reticular nucleus (TRN), a brain area rich in gap-junctional (electrical) synapses, regulates cortical attention to the sensory surround and participates in shifts between arousal states; plasticity of electrical synapses may be a key mechanism underlying these processes. We observed long-term depression resulting from coordinated burst firing in pairs of coupled TRN neurons. Changes in gap-junctional communication were asymmetrical, indicating that regulation of connectivity depends on the direction of use. Modification of electrical synapses resulting from activity in coupled neurons is likely to be a widespread and powerful mechanism for dynamic reorganization of electrically coupled neuronal networks.	[Haas, Julie S.; Landisman, Carole E.] Harvard Univ, Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Haas, Julie S.; Zavala, Baltazar; Landisman, Carole E.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard University	Haas, JS (corresponding author), Harvard Univ, Childrens Hosp, Dept Neurol, 300 Longwood Ave, Boston, MA 02115 USA.	julie.haas@gmail.com; carole.landisman@hms.harvard.edu		Haas, Julie/0000-0002-1571-8512	Milton Fund	Milton Fund	We thank D. Feldman and K. Bender for valuable feedback on previous version of the manuscript. This work was supported by the Milton Fund.	Alev C, 2008, P NATL ACAD SCI USA, V105, P20964, DOI 10.1073/pnas.0805408105; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; Blethyn Kate L., 2008, Thalamus & Related Systems, V4, P13, DOI 10.1017/S1472928807000325; Chow CC, 2000, NEURAL COMPUT, V12, P1643, DOI 10.1162/089976600300015295; Chu ZG, 2003, J NEUROSCI, V23, P96; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; DESCHENES M, 1984, J NEUROPHYSIOL, V51, P1196, DOI 10.1152/jn.1984.51.6.1196; Devor A, 2002, J NEUROPHYSIOL, V87, P3048, DOI 10.1152/jn.2002.87.6.3048; Froemke Robert C, 2010, Front Synaptic Neurosci, V2, P19, DOI 10.3389/fnsyn.2010.00019; Fuentealba P, 2005, PROG NEUROBIOL, V75, P125, DOI 10.1016/j.pneurobio.2005.01.002; FURSHPAN EJ, 1959, J PHYSIOL-LONDON, V145, P289, DOI 10.1113/jphysiol.1959.sp006143; Galarreta M, 2001, NAT REV NEUROSCI, V2, P425, DOI 10.1038/35077566; Gibson JR, 2005, J NEUROPHYSIOL, V93, P467, DOI 10.1152/jn.00520.2004; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Haas JS, 2006, J NEUROPHYSIOL, V96, P3305, DOI 10.1152/jn.00551.2006; HOUSER CR, 1980, BRAIN RES, V200, P341, DOI 10.1016/0006-8993(80)90925-7; INOUE M, 1993, BRAIN RES, V612, P35, DOI 10.1016/0006-8993(93)91641-5; Kothmann WW, 2007, VISUAL NEUROSCI, V24, P363, DOI 10.1017/S095252380707037X; Kothmann WW, 2009, J NEUROSCI, V29, P14903, DOI 10.1523/JNEUROSCI.3436-09.2009; Lamsa Karri P, 2010, Front Synaptic Neurosci, V2, P8, DOI 10.3389/fnsyn.2010.00008; Landisman CE, 2005, SCIENCE, V310, P1809, DOI 10.1126/science.1114655; Landisman CE, 2002, J NEUROSCI, V22, P1002, DOI 10.1523/JNEUROSCI.22-03-01002.2002; Lewis TJ, 2003, J COMPUT NEUROSCI, V14, P283, DOI 10.1023/A:1023265027714; Long MA, 2004, J NEUROSCI, V24, P341, DOI 10.1523/JNEUROSCI.3358-03.2004; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; McAlonan K, 2006, J NEUROSCI, V26, P4444, DOI 10.1523/JNEUROSCI.5602-05.2006; Mitropoulou G, 2003, J NEUROSCI RES, V72, P147, DOI 10.1002/jnr.10572; Nugent FS, 2008, J PHYSIOL-LONDON, V586, P1487, DOI 10.1113/jphysiol.2007.148098; OHARA PT, 1985, J NEUROCYTOL, V14, P365, DOI 10.1007/BF01217752; Pereda AE, 1996, J NEUROSCI, V16, P983; Pinault D, 1998, J COMP NEUROL, V391, P180, DOI 10.1002/(SICI)1096-9861(19980209)391:2<180::AID-CNE3>3.0.CO;2-Z; Rorig B, 1996, MOL NEUROBIOL, V12, P225, DOI 10.1007/BF02755590; Rowe DL, 2005, INT J NEUROSCI, V115, P1273, DOI 10.1080/00207450590934499; Steriade M, 2005, TRENDS NEUROSCI, V28, P317, DOI 10.1016/j.tins.2005.03.007; STERIADE M, 1987, J NEUROPHYSIOL, V57, P260, DOI 10.1152/jn.1987.57.1.260; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Urschel S, 2006, J BIOL CHEM, V281, P33163, DOI 10.1074/jbc.M606396200; Vervaeke K, 2010, NEURON, V67, P435, DOI 10.1016/j.neuron.2010.06.028; ZOLNIK T, 2010, SOC NEUR C SAN DIEG	44	110	111	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 21	2011	334	6054					389	393		10.1126/science.1207502	http://dx.doi.org/10.1126/science.1207502			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	22021860				2022-12-28	WOS:000296052500056
J	Beck, B; Driessens, G; Goossens, S; Youssef, KK; Kuchnio, A; Caauwe, A; Sotiropoulou, PA; Loges, S; Lapouge, G; Candi, A; Mascre, G; Drogat, B; Dekoninck, S; Haigh, JJ; Carmeliet, P; Blanpain, C				Beck, Benjamin; Driessens, Gregory; Goossens, Steven; Youssef, Khalil Kass; Kuchnio, Anna; Caauwe, Amelie; Sotiropoulou, Panagiota A.; Loges, Sonja; Lapouge, Gaelle; Candi, Aurelie; Mascre, Guilhem; Drogat, Benjamin; Dekoninck, Sophie; Haigh, Jody J.; Carmeliet, Peter; Blanpain, Cedric			A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours	NATURE			English	Article							VEGF-A; CANCER; GROWTH; CELLS; NEUROPILIN-1; CATENIN; MICE	Angiogenesis is critical during tumour initiation and malignant progression(1). Different strategies aimed at blocking vascular endothelial growth factor (VEGF) and its receptors have been developed to inhibit angiogenesis in cancer patients(2). It has become increasingly clear that in addition to its effect on angiogenesis, other mechanisms including a direct effect of VEGF on tumour cells may account for the efficiency of VEGF-blockade therapies(3). Cancer stem cells (CSCs) have been described in various cancers including squamous tumours of the skin(4,5). Here we use a mouse model of skin tumours to investigate the impact of the vascular niche and VEGF signalling on controlling the stemness (the ability to self renew and differentiate) of squamous skin tumours during the early stages of tumour progression. We show that CSCs of skin papillomas are localized in a perivascular niche, in the immediate vicinity of endothelial cells. Furthermore, blocking VEGFR2 caused tumour regression not only by decreasing the microvascular density, but also by reducing CSC pool size and impairing CSC renewal properties. Conditional deletion of Vegfa in tumour epithelial cells caused tumours to regress, whereas VEGF overexpression by tumour epithelial cells accelerated tumour growth. In addition to its well-known effect on angiogenesis, VEGF affected skin tumour growth by promoting cancer stemness and symmetric CSC division, leading to CSC expansion. Moreover, deletion of neuropilin-1 (Nrp1), a VEGF co-receptor expressed in cutaneous CSCs, blocked VEGF's ability to promote cancer stemness and renewal. Our results identify a dual role for tumour-cell-derived VEGF in promoting cancer stemness: by stimulating angiogenesis in a paracrine manner, VEGF creates a perivascular niche for CSCs, and by directly affecting CSCs through Nrp1 in an autocrine loop, VEGF stimulates cancer stemness and renewal. Finally, deletion of Nrp1 in normal epidermis prevents skin tumour initiation. These results may have important implications for the prevention and treatment of skin cancers.	[Beck, Benjamin; Driessens, Gregory; Youssef, Khalil Kass; Caauwe, Amelie; Sotiropoulou, Panagiota A.; Lapouge, Gaelle; Candi, Aurelie; Mascre, Guilhem; Drogat, Benjamin; Dekoninck, Sophie; Blanpain, Cedric] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium; [Goossens, Steven; Haigh, Jody J.] Univ Ghent VIB, Dept Mol Biomed Res, Vasc Cell Biol Unit, B-9052 Ghent, Belgium; [Goossens, Steven; Kuchnio, Anna; Haigh, Jody J.] UGent Dept Mol Biomed Res, B-9052 Ghent, Belgium; [Kuchnio, Anna; Loges, Sonja; Carmeliet, Peter] VIB, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, B-3000 Louvain, Belgium; [Loges, Sonja; Carmeliet, Peter] Katholieke Univ Leuven, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, B-3000 Louvain, Belgium	Universite Libre de Bruxelles; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); KU Leuven	Blanpain, C (corresponding author), Univ Libre Bruxelles, IRIBHM, 808 Route Lennik, B-1070 Brussels, Belgium.	cedric.blanpain@ulb.ac.be	Blanpain, Cedric/ABD-8392-2021; Carmeliet, Peter/AAQ-5140-2020; Youssef, Khalil Kass/AAB-6528-2021; Loges, Sonja/ABE-9868-2021	Carmeliet, Peter/0000-0001-7961-1821; Youssef, Khalil Kass/0000-0002-4572-3160; Loges, Sonja/0000-0002-7650-8527; Beck, Benjamin/0000-0001-8162-7566; haigh, jody/0000-0002-7319-8922; Goossens, Steven/0000-0002-5693-8570; benjamin, Drogat/0000-0002-0020-4826	Brussels Region; Deutsche Krebshilfe; Hamburger Krebsgesellschaft; Roggenbuck Stiftung; Flemish Government; FNRS; Wallonia Region; Fondation Contre le Cancer; ULB foundation; fond Gaston Ithier; European Research Council (ERC); EMBO	Brussels Region; Deutsche Krebshilfe(Deutsche Krebshilfe); Hamburger Krebsgesellschaft; Roggenbuck Stiftung; Flemish Government(European Commission); FNRS(Fonds de la Recherche Scientifique - FNRS); Wallonia Region; Fondation Contre le Cancer; ULB foundation; fond Gaston Ithier; European Research Council (ERC)(European Research Council (ERC)European Commission); EMBO(European Molecular Biology Organization (EMBO))	We thank Genetech for providing blocking anti-Nrp1 antibodies and H. Fujisawa, N. Ferrara and A. Nagy for providing the Nrp1<SUP>fl/-</SUP>, Vegf<SUP>fl/fl</SUP> and ROSA26-VEGF-164 mice, respectively. C.B. is an investigator of Welbio. C.B. and P.A.S. are chercheur qualifie and B.B. is a charge de recherche of the FRS/FNRS; Am.C. and G.M. are research fellows of the FRS/FRIA. G.D. is supported by the Brussels Region, B.D. and K.K.Y. by TELEVIE and. S.G. is a postdoctoral fellow of the Basic Science Research Foundation-Flanders (FWO). S.L. is funded by the Max-Eder group leader program of the Deutsche Krebshilfe, by the Hamburger Krebsgesellschaft and by the Roggenbuck Stiftung. P.C. is funded by Long-term structural Methusalem funding by the Flemish Government. This work was supported by the FNRS, the program d'excellence CIBLES of the Wallonia Region, a research grant from the Fondation Contre le Cancer, the ULB foundation and the fond Gaston Ithier, a starting grant of the European Research Council (ERC) and the EMBO Young Investigator Program.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Ferrara N, 2007, ANNU REV MED, V58, P491, DOI 10.1146/annurev.med.58.061705.145635; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Kemp CJ, 2005, SEMIN CANCER BIOL, V15, P460, DOI 10.1016/j.semcancer.2005.06.003; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kiel MJ, 2006, IMMUNITY, V25, P862, DOI 10.1016/j.immuni.2006.11.005; Larcher F, 1998, ONCOGENE, V17, P303, DOI 10.1038/sj.onc.1201928; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Maes C, 2010, EMBO J, V29, P424, DOI 10.1038/emboj.2009.361; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Miller DW, 2005, AM J PATHOL, V167, P1389, DOI 10.1016/S0002-9440(10)61226-6; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Perez-Losada J, 2003, NAT REV CANCER, V3, P434, DOI 10.1038/nrc1095; Poulson ND, 2010, J CELL BIOL, V191, P915, DOI 10.1083/jcb.201008001; Rossiter H, 2004, CANCER RES, V64, P3508, DOI 10.1158/0008-5472.CAN-03-2581; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Staton CA, 2007, J PATHOL, V212, P237, DOI 10.1002/path.2182; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Witte L, 1998, CANCER METAST REV, V17, P155, DOI 10.1023/A:1006094117427	29	316	336	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2011	478	7369					399	+		10.1038/nature10525	http://dx.doi.org/10.1038/nature10525			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	22012397				2022-12-28	WOS:000296021100049
J	Blaydon, DC; Biancheri, P; Di, WL; Plagnol, V; Cabral, RM; Brooke, MA; van Heel, DA; Ruschendorf, F; Toynbee, M; Walne, A; O'Toole, EA; Martin, JE; Lindley, K; Vulliamy, T; Abrams, DJ; MacDonald, TT; Harper, JI; Kelsell, DP				Blaydon, Diana C.; Biancheri, Paolo; Di, Wei-Li; Plagnol, Vincent; Cabral, Rita M.; Brooke, Matthew A.; van Heel, David A.; Ruschendorf, Franz; Toynbee, Mark; Walne, Amanda; O'Toole, Edel A.; Martin, Joanne E.; Lindley, Keith; Vulliamy, Tom; Abrams, Dominic J.; MacDonald, Thomas T.; Harper, John I.; Kelsell, David P.			Inflammatory Skin and Bowel Disease Linked to ADAM17 Deletion	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NECROSIS-FACTOR-ALPHA; MICE; GENE; DESMOGLEIN-2; CARDIOMYOPATHY; EXPRESSION; MUTATIONS; HAIR	We performed genetic and immunohistochemical studies in a sister and brother with autosomal recessive neonatal inflammatory skin and bowel lesions. The girl died suddenly at 12 years of age from parvovirus B19-associated myocarditis; her brother had mild cardiomyopathy. We identified a loss-of-function mutation in ADAM17, which encodes a disintegrin and metalloproteinase 17 (also called tumor necrosis factor alpha [TNF-alpha]-converting enzyme, or TACE), as the probable cause of this syndrome. Peripheral-blood mononuclear cells (PBMCs) obtained from the brother at 17 years of age showed high levels of lipopolysaccharide-induced production of interleukin-1 beta and interleukin-6 but impaired release of TNF-alpha. Despite repeated skin infections, this young man has led a relatively normal life. (Funded by Barts and the London Charity and the European Commission Seventh Framework Programme.)	[Kelsell, David P.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Cutaneous Res, London E1 2AT, England; [Abrams, Dominic J.] Queen Mary Univ London, St Bartholomews Hosp, Barts & London Natl Hlth Serv Trust, Cardiol Res Dept, London, England; [Di, Wei-Li; Harper, John I.] UCL, Inst Child Hlth, Dept Paediat Dermatol, London, England; [Lindley, Keith] UCL, Inst Child Hlth, Dept Gastroenterol, London, England; Great Ormond St Hosp Sick Children, London, England; [Plagnol, Vincent] UCL Genet Inst, London, England; [Ruschendorf, Franz] Max Delbruck Ctr Mol Med, Dept Funct Genet & Genom, Berlin, Germany	University of London; Queen Mary University London; Barts Health NHS Trust; University of London; Queen Mary University London; University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Kelsell, DP (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Cutaneous Res, 4 Newark St, London E1 2AT, England.	d.p.kelsell@qmul.ac.uk	Abrams, Dominic/AAD-8306-2021; Plagnol, Vincent/A-5667-2011; Biancheri, Paolo/AAC-2394-2022; Cabral, Rita M/G-5706-2013; Kelsell, David P/F-8767-2011	Biancheri, Paolo/0000-0002-8163-9062; Cabral, Rita M/0000-0003-2741-8100; Brooke, Matthew/0000-0002-6392-9584; Toynbee, Mark/0000-0003-1501-1098; Kelsell, David/0000-0002-9910-7144; Blaydon, Diana/0000-0002-9998-2563; Abrams, Dominic/0000-0001-5266-2805; van Heel, David/0000-0002-0637-2265; O'Toole, Edel/0000-0002-4084-4836; Plagnol, Vincent/0000-0002-5597-9215	Barts and the London Charity; European Commission [FP7-Health-2007-A]; Medical Research Council [G1001158] Funding Source: researchfish; MRC [G1001158] Funding Source: UKRI	Barts and the London Charity; European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by grants from Barts and the London Charity and the European Commission Seventh Framework Programme (Intestinal Proteases: Opportunity for Drug Discovery grant FP7-Health-2007-A).	Arribas J, 2009, CURR PHARM DESIGN, V15, P2319, DOI 10.2174/138161209788682398; Bech-Serra JJ, 2006, MOL CELL BIOL, V26, P5086, DOI 10.1128/MCB.02380-05; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Delmar M, 2010, CIRC RES, V107, P700, DOI 10.1161/CIRCRESAHA.110.223412; Denning MF, 1998, EXP CELL RES, V239, P50, DOI 10.1006/excr.1997.3890; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Kahrizi K, 2011, EUR J HUM GENET, V19, P115, DOI 10.1038/ejhg.2010.132; Klessner JL, 2009, MOL BIOL CELL, V20, P328, DOI 10.1091/mbc.E08-04-0356; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Posch MG, 2008, MOL GENET METAB, V95, P74, DOI 10.1016/j.ymgme.2008.06.005; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Saftig P, 2011, EUR J CELL BIOL, V90, P527, DOI 10.1016/j.ejcb.2010.11.005; Syrris P, 2007, EUR HEART J, V28, P581, DOI 10.1093/eurheartj/hl380; Volpi L, 2010, AM J HUM GENET, V87, P445, DOI 10.1016/j.ajhg.2010.08.012; Volpi L, 2010, AM J HUM GENET, V86, P72, DOI 10.1016/j.ajhg.2009.11.014; Wada H, 2001, CIRCULATION, V103, P743	22	224	233	2	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2011	365	16					1502	1508		10.1056/NEJMoa1100721	http://dx.doi.org/10.1056/NEJMoa1100721			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835BW	22010916	Green Accepted			2022-12-28	WOS:000296009500004
J	Karim, SSA; Naidoo, K; Grobler, A; Padayatchi, N; Baxter, C; Gray, AL; Gengiah, T; Gengiah, S; Naidoo, A; Jithoo, N; Nair, G; El-Sadr, WM; Friedland, G; Karim, QA				Karim, Salim S. Abdool; Naidoo, Kogieleum; Grobler, Anneke; Padayatchi, Nesri; Baxter, Cheryl; Gray, Andrew L.; Gengiah, Tanuja; Gengiah, Santhanalakshmi; Naidoo, Anushka; Jithoo, Niraksha; Nair, Gonasagrie; El-Sadr, Wafaa M.; Friedland, Gerald; Karim, Quarraisha Abdool			Integration of Antiretroviral Therapy with Tuberculosis Treatment	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOUTH-AFRICA; HIV; INITIATION; EFAVIRENZ; DRUGS; TB	Background We previously reported that integrating antiretroviral therapy (ART) with tuberculosis treatment reduces mortality. However, the timing for the initiation of ART during tuberculosis treatment remains unresolved. Methods We conducted a three-group, open-label, randomized, controlled trial in South Africa involving 642 ambulatory patients, all with tuberculosis (confirmed by a positive sputum smear for acid-fast bacilli), human immunodeficiency virus infection, and a CD4+ T-cell count of less than 500 per cubic millimeter. Findings in the earlier-ART group (ART initiated within 4 weeks after the start of tuberculosis treatment, 214 patients) and later-ART group (ART initiated during the first 4 weeks of the continuation phase of tuberculosis treatment, 215 patients) are presented here. Results At baseline, the median CD4+ T-cell count was 150 per cubic millimeter, and the median viral load was 161,000 copies per milliliter, with no significant differences between the two groups. The incidence rate of the acquired immunodeficiency syndrome (AIDS) or death was 6.9 cases per 100 person-years in the earlier-ART group (18 cases) as compared with 7.8 per 100 person-years in the later-ART group (19 cases) (incidence-rate ratio, 0.89; 95% confidence interval [CI], 0.44 to 1.79; P = 0.73). However, among patients with CD4+ T-cell counts of less than 50 per cubic millimeter, the incidence rates of AIDS or death were 8.5 and 26.3 cases per 100 person-years, respectively (incidence-rate ratio, 0.32; 95% CI, 0.07 to 1.13; P = 0.06). The incidence rates of the immune reconstitution inflammatory syndrome (IRIS) were 20.1 and 7.7 cases per 100 person-years, respectively (incidence-rate ratio, 2.62; 95% CI, 1.48 to 4.82; P<0.001). Adverse events requiring a switching of antiretroviral drugs occurred in 10 patients in the earlier-ART group and 1 patient in the later-ART group (P = 0.006). Conclusions Early initiation of ART in patients with CD4+ T-cell counts of less than 50 per cubic millimeter increased AIDS-free survival. Deferral of the initiation of ART to the first 4 weeks of the continuation phase of tuberculosis therapy in those with higher CD4+ T-cell counts reduced the risks of IRIS and other adverse events related to ART without increasing the risk of AIDS or death. (Funded by the U. S. President's Emergency Plan for AIDS Relief and others; SAPIT ClinicalTrials.gov number, NCT00398996.)	[Karim, Salim S. Abdool; Naidoo, Kogieleum; Grobler, Anneke; Padayatchi, Nesri; Baxter, Cheryl; Gengiah, Tanuja; Gengiah, Santhanalakshmi; Naidoo, Anushka; Jithoo, Niraksha; Nair, Gonasagrie; Karim, Quarraisha Abdool] CAPRISA, Durban, South Africa; [Karim, Salim S. Abdool; Padayatchi, Nesri; Gray, Andrew L.; Karim, Quarraisha Abdool] Univ KwaZulu Natal, Durban, South Africa; [Karim, Salim S. Abdool; El-Sadr, Wafaa M.; Karim, Quarraisha Abdool] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [El-Sadr, Wafaa M.] Columbia Univ, Mailman Sch Publ Hlth, Int Ctr AIDS Care & Treatment Programs, New York, NY USA; [Friedland, Gerald] Yale Univ, New Haven, CT USA	University of Kwazulu Natal; Columbia University; Columbia University; Yale University	Karim, QA (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, CAPRISA, 2nd Fl,Private Bag X7, ZA-4013 Congella Durban, South Africa.	caprisa@ukzn.ac.za	Gray, Andrew/F-2104-2013; Karim, Salim Abdool/P-3117-2019; Karim, Salim Abdool/AAE-7118-2019; Franzeck, Fabian C/B-5055-2011; Karim, Salim Safurdeen Abdool/N-5947-2013; padayatchi, nesri/Q-2780-2019; Abdool Karim, Quarraisha/GVS-1160-2022; Salim, Siti Mawarni/B-7940-2010; Gengiah, Santhana/AAH-6484-2019; Hug, Balthasar L./G-1568-2010	Gray, Andrew/0000-0001-7815-8180; Karim, Salim Abdool/0000-0002-4986-2133; Karim, Salim Safurdeen Abdool/0000-0002-4986-2133; padayatchi, nesri/0000-0003-2543-9071; Abdool Karim, Quarraisha/0000-0002-0985-477X; Salim, Siti Mawarni/0000-0001-5543-5384; Gengiah, Santhana/0000-0003-2890-7248; Grobler, Anneke/0000-0002-7809-7688; Naidoo, Kogieleum/0000-0002-8874-6661; Gengiah, Tanuja/0000-0002-3405-5128	U.S. President's Emergency Plan for AIDS Relief; Centre for the AIDS Programme of Research in South Africa (CAPRISA); Global Fund; National Institutes of Health; Prince Cyril Zulu Communicable Disease Clinic, eThekwini Municipality; Division of AIDS at the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI051794] Funding Source: NIH RePORTER	U.S. President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)); Centre for the AIDS Programme of Research in South Africa (CAPRISA); Global Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prince Cyril Zulu Communicable Disease Clinic, eThekwini Municipality; Division of AIDS at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the U.S. President's Emergency Plan for AIDS Relief; the Centre for the AIDS Programme of Research in South Africa (CAPRISA); the Global Fund to Fight AIDS, Tuberculosis, and Malaria; and the National Institutes of Health Comprehensive International Program of Research on AIDS.; We thank the patients for their participation in this study; Prof. Willem Sturm of the Nelson R. Mandela School of Medicine for confirmatory tuberculosis testing; the management and staff of the Prince Cyril Zulu Communicable Disease Clinic, eThekwini Municipality, for support of the study; Drs. Gray Handley, Ed Tramont, Rod Hoff, Sandi Lehrman, and Richard Hafner of the Division of AIDS at the National Institutes of Health for study support; Drs. Gavin Churchyard, Douglas Taylor, and Mark Weaver for serving on the data and safety monitoring committee; members of the Community Advisory Board for their advice regarding the conduct of the trial; Ms. Nomapando Barnabas of the CAPRISA Community Programme for overseeing community involvement in the trial; Ms. Natasha Samsunder and Mr. Keith Coetzee for laboratory analysis; Ms. Nonhlanhla Yende for statistical support; Ms. Irene van Middelkoop for data management; and all the other members of the SAPIT study team for their commitment to high-quality study conduct.	Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Chien JW, 1998, CHEST, V114, P933, DOI 10.1378/chest.114.3.933; Cohen K, 2009, ANTIVIR THER, V14, P687; Dean GL, 2002, AIDS, V16, P75, DOI 10.1097/00002030-200201040-00010; Fishman JE, 2000, AM J ROENTGENOL, V174, P43, DOI 10.2214/ajr.174.1.1740043; Girardi E, 2001, J ACQ IMMUN DEF SYND, V26, P326, DOI 10.1097/00126334-200104010-00006; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Lalloo UG, 2009, CLIN INFECT DIS, V48, P1760, DOI 10.1086/599115; Lawn SD, 2007, AIDS, V21, P335, DOI 10.1097/QAD.0b013e328011efac; Marks DJB, 2009, INT J STD AIDS, V20, P339, DOI 10.1258/ijsa.2008.008361; Shao HJ, 2009, AIDS RES HUM RETROV, V25, P1277, DOI 10.1089/aid.2009.0100; Sharma SK, 2010, INDIAN J MED RES, V131, P804; South African Department of Health, 2004, S AFR NAT TUB CONTR; Tansuphasawadikul Somsit, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P1053; World Health Organization, 2009, RAP ADV ANT THER HIV	16	372	377	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2011	365	16					1492	1501		10.1056/NEJMoa1014181	http://dx.doi.org/10.1056/NEJMoa1014181			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835BW	22010915	Green Published, Green Accepted			2022-12-28	WOS:000296009500003
J	Liang, TJ; Yeh, MH				Liang, Tsung-Jung; Yeh, Ming-Hsin			Jejunal Diverticular Bleeding	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Liang, Tsung-Jung; Yeh, Ming-Hsin] Kaohsiung Vet Gen Hosp, Kaohsiung, Taiwan	Kaohsiung Veterans General Hospital	Liang, TJ (corresponding author), Kaohsiung Vet Gen Hosp, Kaohsiung, Taiwan.	nugatic@yahoo.com.tw	Liang, Tsung-Jung/AAQ-4058-2021	Liang, Tsung-Jung/0000-0003-4005-7661					0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2011	365	16					E35	E35		10.1056/NEJMicm1107236	http://dx.doi.org/10.1056/NEJMicm1107236			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835BW	22010938				2022-12-28	WOS:000296009500008
J	Parak, F				Parak, Fritz			Rudolf L. Mossbauer (1929-2011) OBITUARY	NATURE			English	Biographical-Item									[Parak, Fritz] Tech Univ Munich, Dept Phys, D-85748 Garching, Germany	Technical University of Munich		fritz.parak@ph.tum.de							0	1	1	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 20	2011	478	7369					325	325		10.1038/478325a	http://dx.doi.org/10.1038/478325a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	22012384	Bronze			2022-12-28	WOS:000296021100029
J	Chang, HJ				Chang, Huan J.			Lower Abdominal Swelling and Scrotal Enlargement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ABDOMINOSCROTAL-HYDROCELE					tina.chang@jama-archives.org						Bayne A, 2008, J UROLOGY, V180, P1720, DOI 10.1016/j.juro.2008.04.086; Cozzi DA, 2008, J UROLOGY, V180, P2611, DOI 10.1016/j.juro.2008.08.054; Jindal T, 2011, ARCH SURG-CHICAGO, V146, P757, DOI 10.1001/archsurg.2011.137-a; KLIN B, 1992, J UROLOGY, V148, P384, DOI 10.1016/S0022-5347(17)36605-3; KRASNA IH, 1992, J PEDIATR SURG, V27, P1349, DOI 10.1016/0022-3468(92)90295-I; Cuervo JL, 2009, J PEDIATR SURG, V44, P1766, DOI 10.1016/j.jpedsurg.2008.12.002; Nagar H, 1998, PEDIATR SURG INT, V13, P189, DOI 10.1007/s003830050286; Rasalkar DD, 2009, J HK COLLRADIOL, V12, P76	8	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 19	2011	306	15					1709	1710		10.1001/jama.2011.1434	http://dx.doi.org/10.1001/jama.2011.1434			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834MA	22009105				2022-12-28	WOS:000295963200034
J	Hansen, LO; Young, RS; Hinami, K; Leung, A; Williams, MV				Hansen, Luke O.; Young, Robert S.; Hinami, Keiki; Leung, Alicia; Williams, Mark V.			Interventions to Reduce 30-Day Rehospitalization: A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							CARE TRANSITIONS INTERVENTION; RANDOMIZED CONTROLLED-TRIAL; FOLLOW-UP; HOSPITAL DISCHARGE; HEART-FAILURE; EARLY READMISSION; CLINICAL-TRIAL; OLDER-ADULTS; HIGH-RISK; IMPACT	Background: About 1 in 5 Medicare fee-for-service patients discharged from the hospital is rehospitalized within 30 days. Beginning in 2013, hospitals with high risk-standardized readmission rates will be subject to a Medicare reimbursement penalty. Purpose: To describe interventions evaluated in studies aimed at reducing rehospitalization within 30 days of discharge. Data Sources: MEDLINE, EMBASE, Web of Science, and the Cochrane Library were searched for reports published between January 1975 and January 2011. Study Selection: English-language randomized, controlled trials; cohort studies; or noncontrolled before-after studies of interventions to reduce rehospitalization that reported rehospitalization rates within 30 days. Data Extraction: 2 reviewers independently identified candidate articles from the results of the initial search on the basis of title and abstract. Two 2-physician reviewer teams reviewed the full text of candidate articles to identify interventions and assess study quality. Data Synthesis: 43 articles were identified, and a taxonomy was developed to categorize interventions into 3 domains that encompassed 12 distinct activities. Predischarge interventions included patient education, medication reconciliation, discharge planning, and scheduling of a follow-up appointment before discharge. Postdischarge interventions included follow-up telephone calls, patient-activated hotlines, timely communication with ambulatory providers, timely ambulatory provider follow-up, and postdischarge home visits. Bridging interventions included transition coaches, physician continuity across the inpatient and outpatient setting, and patient-centered discharge instruction. Limitations: Inadequate description of individual studies' interventions precluded meta-analysis of effects. Many studies identified in the review were single-institution assessments of quality improvement activities rather than those with experimental designs. Several common interventions have not been studied outside of multicomponent "discharge bundles." Conclusion: No single intervention implemented alone was regularly associated with reduced risk for 30-day rehospitalization.	[Hansen, Luke O.] Northwestern Univ, Feinberg Sch Med, Div Hosp Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Hansen, LO (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Hosp Med, 211 E Ontario St,07-733, Chicago, IL 60611 USA.	l-hansen@northwestern.edu	Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285; Hinami, Keiki/0000-0002-1927-2546; Williams, Mark V/0000-0001-6107-0457	Northwestern University Feinberg School of Medicine; John A. Hartford Foundation; Society of Hospital Medicine; Institute for Healthcare Studies at Northwestern University from the Agency for Healthcare Research and Quality [T-32 HS 000078]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000078] Funding Source: NIH RePORTER	Northwestern University Feinberg School of Medicine; John A. Hartford Foundation; Society of Hospital Medicine; Institute for Healthcare Studies at Northwestern University from the Agency for Healthcare Research and Quality; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Grant Support: By the Northwestern University Feinberg School of Medicine (all authors). Drs. Williams and Hansen have received financial support from the John A. Hartford Foundation and the Society of Hospital Medicine for Project BOOST (Better Outcomes for Older Adults Through Safe Transitions). Dr. Young is supported by a National Research Service Award postdoctoral fellowship grant through the Institute for Healthcare Studies at Northwestern University under institutional awards from the Agency for Healthcare Research and Quality (T-32 HS 000078).	Ahmed A, 2004, EUR J HEART FAIL, V6, P421, DOI 10.1016/j.ejheart.2003.11.011; Anderson Cheryl, 2005, Congest Heart Fail, V11, P315, DOI 10.1111/j.1527-5299.2005.04458.x; Ashton CM, 1996, SOC SCI MED, V43, P1533, DOI 10.1016/S0277-9536(96)00049-4; Azevedo A, 2002, EUR J HEART FAIL, V4, P353, DOI 10.1016/S1388-9842(02)00013-2; Balaban RB, 2008, J GEN INTERN MED, V23, P1228, DOI 10.1007/s11606-008-0618-9; Bostrom J, 1996, APPL NURS RES, V9, P47, DOI 10.1016/S0897-1897(96)80402-2; Braun E, 2009, EUR J INTERN MED, V20, P221, DOI 10.1016/j.ejim.2008.07.021; Brown A, 1997, Aust J Adv Nurs, V14, P5; Centers for Medicare & Medicaid Services, MED HOSP COMP CALC 3; Cochrane Effective Practice and Organisation of Care (EPOC), EPOC RES REV AUTH; Coleman EA, 2004, HEALTH SERV RES, V39, P1449, DOI 10.1111/j.1475-6773.2004.00298.x; Coleman EA, 2004, J AM GERIATR SOC, V52, P1817, DOI 10.1111/j.1532-5415.2004.52504.x; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Creason H, 2001, Lippincotts Case Manag, V6, P146, DOI 10.1097/00129234-200107000-00004; Dedhia P, 2009, J AM GERIATR SOC, V57, P1540, DOI 10.1111/j.1532-5415.2009.02430.x; Dudas V, 2001, AM J MED, V111, P26, DOI 10.1016/S0002-9343(01)00966-4; DUNN RB, 1994, ARCH GERONTOL GERIAT, V18, P15, DOI 10.1016/0167-4943(94)90044-2; Einstadter D, 1996, J GEN INTERN MED, V11, P684, DOI 10.1007/BF02600160; EVANS RL, 1993, MED CARE, V31, P358, DOI 10.1097/00005650-199304000-00007; Forster AJ, 2005, AM J MED, V118, P1148, DOI 10.1016/j.amjmed.2005.04.019; Gow P, 1999, J Qual Clin Pract, V19, P107, DOI 10.1046/j.1440-1762.1999.00312.x; Grafft CA, 2010, ARCH INTERN MED, V170, P955, DOI 10.1001/archinternmed.2010.105; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Harrison PL, 2011, POPUL HEALTH MANAG, V14, P27, DOI 10.1089/pop.2009.0076; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; Hess DR, 2010, CHEST, V138, P1475, DOI 10.1378/chest.09-2140; Houghton A, 1996, QUAL HEALTH CARE, V5, P89, DOI 10.1136/qshc.5.2.89; Jaarsma T, 1999, EUR HEART J, V20, P673, DOI 10.1053/euhj.1998.1341; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Jencks SF, 2010, ANN INTERN MED, V153, P757, DOI 10.7326/0003-4819-153-11-201012070-00010; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Koehler BE, 2009, J HOSP MED, V4, P211, DOI 10.1002/jhm.427; Kramer JS, 2007, AM J HEALTH-SYST PH, V64, P404, DOI 10.2146/ajhp060506; Kwok T, 2004, J AM GERIATR SOC, V52, P1240, DOI 10.1111/j.1532-5415.2004.52351.x; Lucas KS, 1998, AM J HEALTH-SYST PH, V55, pS32, DOI 10.1093/ajhp/55.suppl_4.S32; McDonald K, 2001, EUR J HEART FAIL, V3, P209, DOI 10.1016/S1388-9842(00)00134-3; MCPHEE SJ, 1983, MED CARE, V21, P755, DOI 10.1097/00005650-198308000-00001; MedPAC (Medicare Payment Advisory Commission), 2007, PAYM POL INP READM; Misky GJ, 2010, J HOSP MED, V5, P392, DOI 10.1002/jhm.666; Nasir K, 2010, MED CARE, V48, P477, DOI 10.1097/MLR.0b013e3181d5fb24; NAYLOR M, 1994, ANN INTERN MED, V120, P999, DOI 10.7326/0003-4819-120-12-199406150-00005; O'Dell KM, 2005, ANN PHARMACOTHER, V39, P1423, DOI 10.1345/aph.1E640; Parker S G, 2002, Health Technol Assess, V6, P1; Parry Carla, 2009, Home Health Care Serv Q, V28, P84, DOI 10.1080/01621420903155924; Project RED, 2007, PROJ RED REENG DISCH; Rainville EC, 1999, AM J HEALTH-SYST PH, V56, P1339, DOI 10.1093/ajhp/56.13.1339; Schneider J K, 1993, Clin Nurs Res, V2, P41, DOI 10.1177/105477389300200105; Scott IA, 2010, AUST HEALTH REV, V34, P445, DOI 10.1071/AH09777; Sharma G, 2010, ARCH INTERN MED, V170, P1664, DOI 10.1001/archinternmed.2010.345; Shekelle PG, 2011, ANN INTERN MED, V154, P693, DOI 10.7326/0003-4819-154-10-201105170-00011; SMITH CS, 1995, MED CARE, V33, P221, DOI 10.1097/00005650-199503000-00001; Sorknaes AD, 2011, CLIN RESPIR J, V5, P26, DOI 10.1111/j.1752-699X.2010.00187.x; Steeman E, 2006, INT J QUAL HEALTH C, V18, P352, DOI 10.1093/intqhc/mzl026; van Walraven C, 2004, J GEN INTERN MED, V19, P624, DOI 10.1111/j.1525-1497.2004.30082.x; Wong FKY, 2008, J ADV NURS, V62, P585, DOI 10.1111/j.1365-2648.2008.04631.x	56	826	836	1	136	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2011	155	8					520	U94		10.7326/0003-4819-155-8-201110180-00008	http://dx.doi.org/10.7326/0003-4819-155-8-201110180-00008			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	835WB	22007045				2022-12-28	WOS:000296066300017
J	Musallam, KM; Tamim, HM; Richards, T; Spahn, DR; Rosendaal, FR; Habbal, A; Khreiss, M; Dandaleh, FS; Khavandi, K; Sfeir, PM; Soweid, A; Hoballah, JJ; Taher, AT; Jamali, FR				Musallam, Khaled M.; Tamim, Hani M.; Richards, Toby; Spahn, Donat R.; Rosendaal, Frits R.; Habbal, Aida; Khreiss, Mohammad; Dandaleh, Fadi S.; Khavandi, Kaivan; Sfeir, Pierre M.; Soweid, Assaad; Hoballah, Jamal J.; Taher, Ali T.; Jamali, Faek R.			Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study	LANCET			English	Article							PATIENT BLOOD MANAGEMENT; HEMOGLOBIN LEVEL; 30-DAY MORTALITY; CARDIAC-SURGERY; OLDER PATIENTS; TRANSFUSION; PREDICTION; MORBIDITY; IMPACT	Background Preoperative anaemia is associated with adverse outcomes after cardiac surgery but outcomes after non-cardiac surgery are not well established. We aimed to assess the effect of preoperative anaemia on 30-day postoperative morbidity and mortality in patients undergoing major non-cardiac surgery. Methods We analysed data for patients undergoing major non-cardiac surgery in 2008 from The American College of Surgeons' National Surgical Quality Improvement Program database (a prospective validated outcomes registry from 211 hospitals worldwide in 2008). We obtained anonymised data for 30-day mortality and morbidity (cardiac, respiratory, CNS, urinary tract, wound, sepsis, and venous thromboembolism outcomes), demographics, and preoperative and perioperative risk factors. We used multivariate logistic regression to assess the adjusted and modified (nine predefined risk factor subgroups) effect of anaemia, which was defined as mild (haematocrit concentration >29-<39% in men and >29-<36% in women) or moderate-to-severe (<= 29% in men and women) on postoperative outcomes. Findings We obtained data for 227 425 patients, of whom 69 229 (30.44%) had preoperative anaemia. After adjustment, postoperative mortality at 30 days was higher in patients with anaemia than in those without anaemia (odds ratio [OR] 1.42, 95% CI 1.31-1.54); this difference was consistent in mild anaemia (1 41, 1.30-1.53) and moderate-to-severe anaemia (1.44, 1.29-1.60). Composite postoperative morbidity at 30 days was also higher in patients with anaemia than in those without anaemia (adjusted OR 1.35, 1.30-1.40), again consistent in patients with mild anaemia (1.31, 1.26-1.36) and moderate-to-severe anaemia (1.56, 1.47-1.66). When compared with patients without anaemia or a defined risk factor, patients with anaemia and most risk factors had a higher adjusted OR for 30-day mortality and morbidity than did patients with either anaemia or the risk factor alone. Interpretation Preoperative anaemia, even to a mild degree, is independently associated with an increased risk of 30-day morbidity and mortality in patients undergoing major non-cardiac surgery.	[Musallam, Khaled M.; Tamim, Hani M.; Soweid, Assaad; Taher, Ali T.] Amer Univ Beirut, Med Ctr, Dept Internal Med, Beirut 11072020, Lebanon; [Habbal, Aida; Khreiss, Mohammad; Dandaleh, Fadi S.; Sfeir, Pierre M.; Hoballah, Jamal J.; Jamali, Faek R.] Amer Univ Beirut, Med Ctr, Dept Surg, Beirut 11072020, Lebanon; [Musallam, Khaled M.] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Angelo Bianchi Bonomi Haemophilia & Thrombosis Ct, Milan, Italy; [Tamim, Hani M.] King Saud bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Coll Med, Riyadh, Saudi Arabia; [Richards, Toby] Univ Coll London Hosp, Div Surg & Intervent Sci, London, England; [Spahn, Donat R.] Univ Hosp, Inst Anesthesiol, Zurich, Switzerland; [Spahn, Donat R.] Univ Zurich, Zurich, Switzerland; [Rosendaal, Frits R.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Khavandi, Kaivan] Kings Coll London, British Heart Fdn Ctr, Rayne Inst, St Thomas Hosp,Kings Hlth Partners AHSC, London WC2R 2LS, England	American University of Beirut; American University of Beirut; IRCCS Ca Granda Ospedale Maggiore Policlinico; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Zurich; University Zurich Hospital; University of Zurich; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Guy's & St Thomas' NHS Foundation Trust; King's Health Partners; University of London; King's College London	Jamali, FR (corresponding author), Amer Univ Beirut, Med Ctr, Dept Surg, POB 11-0236, Beirut 11072020, Lebanon.	fj03@aub.edu.lb	Girelli, Domenico/B-1183-2008; Rosendaal, Frits/Q-3842-2017; Richards, Toby/K-6547-2013	Girelli, Domenico/0000-0001-9684-1899; Rosendaal, Frits/0000-0003-2558-7496; Musallam, Khaled/0000-0003-3935-903X; Taher, Ali/0000-0001-8515-2238	Vifor Pharma; Swiss National Science Foundation in Bern (Switzerland) [33CM30_124117, 406440-131268]; Swiss Society of Anesthesiology and Reanimation in Bern; Swiss Foundation for Anaesthesia Research in Zurich (Switzerland); Bundesprogramm Chancengleichheit in Bern; CSL Behring in Bern; Vifor SA in Villars-sur-Glane (Switzerland); Novo Nordisk in Bagsvard (Denmark); CSL Behring in Hattersheim am Main (Germany)	Vifor Pharma; Swiss National Science Foundation in Bern (Switzerland); Swiss Society of Anesthesiology and Reanimation in Bern; Swiss Foundation for Anaesthesia Research in Zurich (Switzerland); Bundesprogramm Chancengleichheit in Bern; CSL Behring in Bern; Vifor SA in Villars-sur-Glane (Switzerland); Novo Nordisk in Bagsvard (Denmark); CSL Behring in Hattersheim am Main (Germany)	TR's department receives consultancy fees and research funding from Vifor Pharma. DRS receives consultancy fees and travel support from Vifor Pharma. DRS's department receives research funding from the Swiss National Science Foundation in Bern (Switzerland; grant numbers 33CM30_124117 and 406440-131268), the Swiss Society of Anesthesiology and Reanimation in Bern, the Swiss Foundation for Anaesthesia Research in Zurich (Switzerland), the Bundesprogramm Chancengleichheit in Bern, CSL Behring in Bern, and Vifor SA in Villars-sur-Glane (Switzerland). DRS was the chairman of the ABC Faculty and is a member of the ABC Trauma Faculty, which both are massaged by Thomson Physicians World GmbH in Mannheim (Germany) and sponsored by an unrestricted educational grant from Novo Nordisk in Bagsvard (Denmark) and CSL Behring in Hattersheim am Main (Germany). In the past 5 years, DRS has received honoraria or travel support for consulting or lecturing from Abbott (Baar, Switzerland), AstraZeneca (Zug, Switzerland), Bayer (Schweiz; Zurich), Baxter (Rome, Italy), B Braun Melsungen (Melsungen, Germany), Boehringer Ingelheim (Schweiz; Basel, Switzerland), Bristol-Myers Squibb (Rueil-Malmaison Cedex, France), CSL Behring (Hattersheim am Main and Bern), Curacyte (Munich, Germany), Ethicon Biosurgery (Sommerville, NJ, USA), Fresenius (Bad Homburg vor der Hohe, Germany), Galenica (Bern), Switzerland, including Vifor SA), GlaxoSmithKline (Hamburg, Germany), Janssen-Cilag (Baar, Switzerland), Janssen-Cilag EMEA (Beerse, Belgium), Novo Nordisk (Bagsvard), Octapharma (Lachen, Switzerland), Organon (Pfaffikon, Switzerland), Oxygen Biotherapeutics (Costa Mesa, CA, USA), tem Innovations (Munich), Roche Pharma (Schweiz; Reinach, Switzerland), and Schering-Plough (Kenilworth, NJ, USA). ATT is a member of Novartis speakers' bureau. All other authors declare that they have no conflicts of interest.	[Anonymous], 1968, NUTR AN; [Anonymous], 2009, AM COLL SURG    0210; Beattie WS, 2009, ANESTHESIOLOGY, V110, P574, DOI 10.1097/ALN.0b013e31819878d3; Bernard AC, 2009, J AM COLL SURGEONS, V208, P931, DOI 10.1016/j.jamcollsurg.2008.11.019; Carson JL, 1996, LANCET, V348, P1055, DOI 10.1016/S0140-6736(96)04330-9; CARSON JL, 1988, LANCET, V1, P727; Fink AS, 2002, ANN SURG, V236, P344, DOI 10.1097/00000658-200209000-00011; Glance LG, 2011, ANESTHESIOLOGY, V114, P283, DOI 10.1097/ALN.0b013e3182054d06; Glance LG, 2010, ANESTHESIOLOGY, V113, P859, DOI 10.1097/ALN.0b013e3181eff32e; Goodnough LT, 2011, BRIT J ANAESTH, V106, P13, DOI 10.1093/bja/aeq361; Goodnough LT, 2005, ANESTH ANALG, V101, P1858, DOI 10.1213/01.ANE.0000184124.29397.EB; Hogue CW, 1998, TRANSFUSION, V38, P924, DOI 10.1046/j.1537-2995.1998.381098440856.x; Karkouti K, 2008, CIRCULATION, V117, P478, DOI 10.1161/CIRCULATIONAHA.107.718353; Khuri SF, 2007, J AM COLL SURGEONS, V204, P1089, DOI 10.1016/j.jamcollsurg.2007.03.028; Kulier A, 2007, CIRCULATION, V116, P471, DOI 10.1161/CIRCULATIONAHA.106.653501; Leichtle SW, 2011, J AM COLL SURGEONS, V212, P187, DOI 10.1016/j.jamcollsurg.2010.09.013; McCluskey SA, 2006, LIVER TRANSPLANT, V12, P1584, DOI 10.1002/lt.20868; Moskowitz DM, 2010, ANN THORAC SURG, V90, P451, DOI 10.1016/j.athoracsur.2010.04.089; NELSON AH, 1993, CRIT CARE MED, V21, P860, DOI 10.1097/00003246-199306000-00013; Ong A. H., 1997, Annals Academy of Medicine Singapore, V26, P430; Rashiq S, 2006, CAN J SURG, V49, P391; Shander A, 2004, AM J MED, V116, P58, DOI 10.1016/j.amjmed.2003.12.013; Spahn DR, 2010, ANESTHESIOLOGY, V113, P482, DOI 10.1097/ALN.0b013e3181e08e97; Spahn DR, 2008, ANESTHESIOLOGY, V109, P951, DOI 10.1097/ALN.0b013e31818e3d75; SPENCE RK, 1990, AM J SURG, V159, P320, DOI 10.1016/S0002-9610(05)81227-9; van Klei WA, 2001, BRIT J ANAESTH, V87, P250, DOI 10.1093/bja/87.2.250; van Straten AHM, 2009, CIRCULATION, V120, P118, DOI 10.1161/CIRCULATIONAHA.109.854216; Wu WC, 2007, JAMA-J AM MED ASSOC, V297, P2481, DOI 10.1001/jama.297.22.2481; Wu WC, 2010, ANN SURG, V252, P11, DOI 10.1097/SLA.0b013e3181e3e43f	29	703	729	0	44	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 15	2011	378	9800					1396	1407		10.1016/S0140-6736(11)61381-0	http://dx.doi.org/10.1016/S0140-6736(11)61381-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	838EM	21982521				2022-12-28	WOS:000296269600026
J	Lu, K; Heng, X; Garyu, L; Monti, S; Garcia, EL; Kharytonchyk, S; Dorjsuren, B; Kulandaivel, G; Jones, S; Hiremath, A; Divakaruni, SS; LaCotti, C; Barton, S; Tummillo, D; Hosic, A; Edme, K; Albrecht, S; Telesnitsky, A; Summers, MF				Lu, Kun; Heng, Xiao; Garyu, Lianko; Monti, Sarah; Garcia, Eric L.; Kharytonchyk, Siarhei; Dorjsuren, Bilguujin; Kulandaivel, Gowry; Jones, Simonne; Hiremath, Atheeth; Divakaruni, Sai Sachin; LaCotti, Courtney; Barton, Shawn; Tummillo, Daniel; Hosic, Azra; Edme, Kedy; Albrecht, Sara; Telesnitsky, Alice; Summers, Michael F.			NMR Detection of Structures in the HIV-1 5 '-Leader RNA That Regulate Genome Packaging	SCIENCE			English	Article							SECONDARY STRUCTURE; GAG GENE; REGION; SIGNAL; SITE; RETROVIRUSES; DIMERIZATION; TRANSLATION	The 5'-leader of the HIV-1 genome regulates multiple functions during viral replication via mechanisms that have yet to be established. We developed a nuclear magnetic resonance approach that enabled direct detection of structural elements within the intact leader (712-nucleotide dimer) that are critical for genome packaging. Residues spanning the gag start codon (AUG) form a hairpin in the monomeric leader and base pair with residues of the unique-5' region (U5) in the dimer. U5: AUG formation promotes dimerization by displacing and exposing a dimer-promoting hairpin and enhances binding by the nucleocapsid (NC) protein, which is the cognate domain of the viral Gag polyprotein that directs packaging. Our findings support a packaging mechanism in which translation, dimerization, NC binding, and packaging are regulated by a common RNA structural switch.	[Garcia, Eric L.; Kharytonchyk, Siarhei; Telesnitsky, Alice] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Lu, Kun; Heng, Xiao; Garyu, Lianko; Monti, Sarah; Dorjsuren, Bilguujin; Kulandaivel, Gowry; Jones, Simonne; Hiremath, Atheeth; Divakaruni, Sai Sachin; LaCotti, Courtney; Barton, Shawn; Tummillo, Daniel; Hosic, Azra; Edme, Kedy; Albrecht, Sara; Summers, Michael F.] Univ Maryland Baltimore Cty, Howard Hughes Med Inst, Baltimore, MD 21250 USA; [Lu, Kun; Heng, Xiao; Garyu, Lianko; Monti, Sarah; Dorjsuren, Bilguujin; Kulandaivel, Gowry; Jones, Simonne; Hiremath, Atheeth; Divakaruni, Sai Sachin; LaCotti, Courtney; Barton, Shawn; Tummillo, Daniel; Hosic, Azra; Edme, Kedy; Albrecht, Sara; Summers, Michael F.] Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21250 USA	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County	Telesnitsky, A (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	ateles@umich.edu; summers@hhmi.umbc.edu	Garcia, Eric/C-5065-2015; Heng, Xiao/G-4950-2012	Garcia, Eric/0000-0002-6951-8268; Kharytonchyk, Siarhei/0000-0001-7031-8135; Divakaruni, Sai Sachin/0000-0003-3478-3229; Garcia, Eric/0000-0002-7690-6998	National Institute of General Medical Sciences (NIGMS) [R01 GM42561, R25 MBRS-IMSD GM55036, MARC U*STAR 2T34 GM008663]; HHMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008663, R01GM042561, R25GM055036, T32GM007315] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a grant (R01 GM42561) from the National Institute of General Medical Sciences (NIGMS). L. G. was supported by a NIGMS grant for maximizing doctoral diversity (R25 MBRS-IMSD GM55036). B. D., K. E., S.J., G. K., and S. B. were supported by a NIGMS grant for enhancing minority access to research careers (MARC U*STAR 2T34 GM008663). B. D., G. K., and S. B. were supported by a HHMI undergraduate education grant. We thank S. R. King (Michigan) and HHMI staff (UMBC) for technical assistance.	Abbink TEM, 2003, J BIOL CHEM, V278, P11601, DOI 10.1074/jbc.M210291200; Allain FHT, 1997, J MOL BIOL, V267, P338, DOI 10.1006/jmbi.1996.0855; BAUDIN F, 1993, J MOL BIOL, V229, P382, DOI 10.1006/jmbi.1993.1041; CLEVER J, 1995, J VIROL, V69, P2101, DOI 10.1128/JVI.69.4.2101-2109.1995; Clever JL, 2002, J VIROL, V76, P12381, DOI 10.1128/JVI.76.23.12381-12387.2002; Coffin J, 1997, RETROVIRUSES; D'Souza V, 2005, NAT REV MICROBIOL, V3, P643, DOI 10.1038/nrmicro1210; Damgaard CK, 2004, J MOL BIOL, V336, P369, DOI 10.1016/j.jmb.2003.12.010; Greatorex J., 2004, RETROVIROLOGY, V1, P23; HARRISON GP, 1992, J VIROL, V66, P4144, DOI 10.1128/JVI.66.7.4144-4153.1992; Huthoff H, 2001, RNA, V7, P143, DOI 10.1017/S1355838201001881; Jouvenet N, 2009, P NATL ACAD SCI USA, V106, P19114, DOI 10.1073/pnas.0907364106; Kerwood DJ, 2001, BIOCHEMISTRY-US, V40, P14518, DOI 10.1021/bi0111909; Kutluay SB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001200; Lever AML, 2007, ADV PHARMACOL, V55, P1, DOI 10.1016/S1054-3589(07)55001-5; Lu K, 2011, J MOL BIOL, V410, P609, DOI 10.1016/j.jmb.2011.04.029; McBride MS, 1996, J VIROL, V70, P2963, DOI 10.1128/JVI.70.5.2963-2973.1996; Miele G, 1996, J VIROL, V70, P944, DOI 10.1128/JVI.70.2.944-951.1996; Moore MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000627; Nikolaitchik O, 2006, J VIROL, V80, P4691, DOI 10.1128/JVI.80.10.4691-4697.2006; Onafuwa-Nuga A, 2009, MICROBIOL MOL BIOL R, V73, P451, DOI 10.1128/MMBR.00012-09; Paillart JC, 2004, NAT REV MICROBIOL, V2, P461, DOI 10.1038/nrmicro903; Paillart JC, 2004, J BIOL CHEM, V279, P48397, DOI 10.1074/jbc.M408294200; Poole E, 2005, TRAFFIC, V6, P741, DOI 10.1111/j.1600-0854.2005.00312.x; Poon DTK, 2002, VIROLOGY, V293, P368, DOI 10.1006/viro.2001.1283; Russell Rodney S, 2004, Retrovirology, V1, P23, DOI 10.1186/1742-4690-1-23; Song R, 2008, BIOCHEMISTRY-US, V47, P3283, DOI 10.1021/bi7023173; SUMMERS MF, 1992, PROTEIN SCI, V1, P563, DOI 10.1002/pro.5560010502; Tolbert BS, 2010, J BIOMOL NMR, V47, P205, DOI 10.1007/s10858-010-9424-x; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Yu ET, 2008, P NATL ACAD SCI USA, V105, P12248, DOI 10.1073/pnas.0800509105	32	191	191	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2011	334	6053					242	245		10.1126/science.1210460	http://dx.doi.org/10.1126/science.1210460			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998393	Green Accepted			2022-12-28	WOS:000295833600051
J	Martin, WJ; Glass, RI; Balbus, JM; Collins, FS				Martin, William J., II; Glass, Roger I.; Balbus, John M.; Collins, Francis S.			A Major Environmental Cause of Death	SCIENCE			English	Editorial Material							INDOOR AIR-POLLUTION; SMOKE		[Martin, William J., II; Glass, Roger I.; Balbus, John M.; Collins, Francis S.] NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Martin, WJ (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.	wjmartin@mail.nih.gov; glassr@mail.nih.gov			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		[Anonymous], 2011, NIH WORKSH WASH DC 9; Arnold BF, 2010, P NATL ACAD SCI USA, V107, P22605, DOI 10.1073/pnas.1008944107; Bruce N, 2007, B WORLD HEALTH ORGAN, V85, P535, DOI 10.2471/BLT.06.035832; Fullerton DG, 2008, T ROY SOC TROP MED H, V102, P843, DOI 10.1016/j.trstmh.2008.05.028; Imai K, 2009, STAT SCI, V24, P29, DOI 10.1214/08-STS274; McCracken J, 2007, EPIDEMIOLOGY, V18, pS185; Nores P., 2011, SCIENCE, V334, P157; Organization WH, 2009, GLOB HLTH RISKS MORT; Patrick E, 2007, FORCED MIGRATION REV, V27, P40; Victora CG, 2011, LANCET, V377, P85, DOI 10.1016/S0140-6736(10)60810-0; World Bank, 2011, HOUS COOK STOV ENV H; World Health Organization, 2009, QUANT ENV HLTH IMP G	12	123	127	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2011	334	6053					180	181		10.1126/science.1213088	http://dx.doi.org/10.1126/science.1213088			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998373	Green Published			2022-12-28	WOS:000295833600029
J	Tay, Y; Kats, L; Salmena, L; Weiss, D; Tan, SM; Ala, U; Karreth, F; Poliseno, L; Provero, P; Di Cunto, F; Lieberman, J; Rigoutsos, I; Pandolfi, PP				Tay, Yvonne; Kats, Lev; Salmena, Leonardo; Weiss, Dror; Tan, Shen Mynn; Ala, Ugo; Karreth, Florian; Poliseno, Laura; Provero, Paolo; Di Cunto, Ferdinando; Lieberman, Judy; Rigoutsos, Isidore; Pandolfi, Pier Paolo			Coding-Independent Regulation of the Tumor Suppressor PTEN by Competing Endogenous mRNAs	CELL			English	Article							MICRORNA; IDENTIFICATION; EXPRESSION; GENE; REGIONS; TARGETS; PROTEIN; CLUSTER	Here, we demonstrate that protein-coding RNA transcripts can crosstalk by competing for common microRNAs, with microRNA response elements as the foundation of this interaction. We have termed such RNA transcripts as competing endogenous RNAs (ceRNAs). We tested this hypothesis in the context of PTEN, a key tumor suppressor whose abundance determines critical outcomes in tumorigenesis. By a combined computational and experimental approach, we identified and validated endogenous protein-coding transcripts that regulate PTEN, antagonize PI3K/AKT signaling, and possess growth-and tumor-suppressive properties. Notably, we also show that these genes display concordant expression patterns with PTEN and copy number loss in cancers. Our study presents a road map for the prediction and validation of ceRNA activity and networks and thus imparts a trans-regulatory function to protein-coding mRNAs.	[Tay, Yvonne; Kats, Lev; Salmena, Leonardo; Weiss, Dror; Ala, Ugo; Karreth, Florian; Poliseno, Laura; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Canc Genet Program,Beth Israel Deaconess Med Ctr, Div Genet,Beth Israel Deaconess Canc Ctr,Dept Med, Boston, MA 02115 USA; [Tan, Shen Mynn; Lieberman, Judy] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Tan, Shen Mynn; Lieberman, Judy] Harvard Univ, Sch Med, Program Cellular & Mol Med, Childrens Hosp Boston, Boston, MA 02115 USA; [Tan, Shen Mynn; Lieberman, Judy] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Ala, Ugo; Provero, Paolo; Di Cunto, Ferdinando] Univ Turin, Mol Biotechnol Ctr, Turin, Italy; [Ala, Ugo; Provero, Paolo; Di Cunto, Ferdinando] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Rigoutsos, Isidore] Thomas Jefferson Univ, Computat Med Ctr, Jefferson Med Coll, Philadelphia, PA 19107 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; University of Turin; University of Turin; Jefferson University	Pandolfi, PP (corresponding author), Harvard Univ, Sch Med, Canc Genet Program,Beth Israel Deaconess Med Ctr, Div Genet,Beth Israel Deaconess Canc Ctr,Dept Med, Boston, MA 02115 USA.	ppandolf@bidmc.harvard.edu	Lieberman, Judy/A-2717-2015; Rigoutsos, Isidore/C-5381-2012; Kats, Lev/AAW-3252-2021; Ala, Ugo/K-2029-2016; Provero, Paolo/AAC-1930-2019; Di Cunto, Ferdinando/K-5575-2016; Poliseno, Laura/B-5711-2012	Kats, Lev/0000-0001-8742-8138; Ala, Ugo/0000-0001-5408-6397; Pandolfi, Pier Paolo/0000-0002-5352-5295; Rigoutsos, Isidore/0000-0003-1529-8631; Salmena, Leonardo/0000-0003-4023-658X; di cunto, ferdinando/0000-0001-9367-6357; Poliseno, Laura/0000-0001-6557-955X	Harvard Catalyst; The Harvard Clinical and Translational Science Center (NIH) [UL1 RR 025758]; Human Frontier Science Program; Canadian Institutes of Health Research; Fondazione per la Ricerca Biomedica ONLUS of Torino; Department of Defense (DOD); Italian Association for Cancer Research (AIRC) [IG-9408]; Jefferson Medical College of Thomas Jefferson University; NIH [R01 CA-82328-09]; NATIONAL CANCER INSTITUTE [R01CA082328] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER	Harvard Catalyst; The Harvard Clinical and Translational Science Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fondazione per la Ricerca Biomedica ONLUS of Torino; Department of Defense (DOD)(United States Department of Defense); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Jefferson Medical College of Thomas Jefferson University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Pandolfi laboratory members for critical discussions. Real-time PCR analysis was conducted through the Harvard Catalyst Laboratory for Innovative Translational Technologies with support from Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (NIH Award #UL1 RR 025758 and financial contributions from Harvard University and its affiliated academic health care centers). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, the National Center for Research Resources, or the National Institutes of Health. We thank B. Vogelstein for DICER<SUP>Ex5</SUP> cells, M. Gorospe for the pMS2 plasmids, and I. Legnini for experimental support. Y.T. was supported by a Special Fellow Award from The Leukemia & Lymphoma Society. L. K. was supported by an NHMRC Overseas Postdoctoral Fellowship. L. S. was supported by fellowships from the Human Frontier Science Program and the Canadian Institutes of Health Research. U. A. was supported by a fellowship from the Fondazione per la Ricerca Biomedica ONLUS of Torino. S. M. T. was supported by a Department of Defense (DOD) Breast Cancer Research Program (BCRP) postdoctoral fellowship award. P. P. and U. A. gratefully acknowledge support from the Italian Association for Cancer Research (AIRC) under grant IG-9408. I. R. was supported by funding from the Jefferson Medical College of Thomas Jefferson University. This work was supported, in part, by NIH grant R01 CA-82328-09 to P.P.	Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Berger A. H., 2011, NATURE IN PRESS; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Jeyapalan Z, 2011, NUCLEIC ACIDS RES, V39, P3026, DOI 10.1093/nar/gkq1003; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kloc M, 2008, DEV BIOL, V317, P401, DOI 10.1016/j.ydbio.2008.03.003; Kurashina K, 2008, CANCER SCI, V99, P1835, DOI 10.1111/j.1349-7006.2008.00881.x; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Mercer TR, 2011, NUCLEIC ACIDS RES, V39, P2393, DOI 10.1093/nar/gkq1158; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Piro R. M., 2011, EUR J HUM GENET, DOI [10.1038/ehg.2011.96, DOI 10.1038/EHG.2011.96]; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Prosser DC, 2008, J CELL SCI, V121, P3052, DOI 10.1242/jcs.028696; Ritchie W, 2009, NAT METHODS, V6, P397, DOI 10.1038/nmeth0609-397; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Wang H, 2010, EMBO J, V29, P2566, DOI 10.1038/emboj.2010.152; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575	38	779	835	3	127	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 14	2011	147	2					344	357		10.1016/j.cell.2011.09.029	http://dx.doi.org/10.1016/j.cell.2011.09.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000013	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000296199300013
J	Klein, EA; Thompson, IM; Tangen, CM; Crowley, JJ; Lucia, MS; Goodman, PJ; Minasian, LM; Ford, LG; Parnes, HL; Gaziano, JM; Karp, DD; Lieber, MM; Walther, PJ; Klotz, L; Parsons, JK; Chin, JL; Darke, AK; Lippman, SM; Goodman, GE; Meyskens, FL; Baker, LH				Klein, Eric A.; Thompson, Ian M., Jr.; Tangen, Catherine M.; Crowley, John J.; Lucia, M. Scott; Goodman, Phyllis J.; Minasian, Lori M.; Ford, Leslie G.; Parnes, Howard L.; Gaziano, J. Michael; Karp, Daniel D.; Lieber, Michael M.; Walther, Philip J.; Klotz, Laurence; Parsons, J. Kellogg; Chin, Joseph L.; Darke, Amy K.; Lippman, Scott M.; Goodman, Gary E.; Meyskens, Frank L., Jr.; Baker, Laurence H.			Vitamin E and the Risk of Prostate Cancer The Selenium and Vitamin E Cancer Prevention Trial (SELECT)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							E SUPPLEMENTATION; CARDIOVASCULAR-DISEASE; PHYSICIANS HEALTH; TIME; MEN	Context The initial report of the Selenium and Vitamin E Cancer Prevention Trial (SELECT) found no reduction in risk of prostate cancer with either selenium or vitamin E supplements but a statistically nonsignificant increase in prostate cancer risk with vitamin E. Longer follow-up and more prostate cancer events provide further insight into the relationship of vitamin E and prostate cancer. Objective To determine the long-term effect of vitamin E and selenium on risk of prostate cancer in relatively healthy men. Design, Setting, and Participants A total of 35 533 men from 427 study sites in the United States, Canada, and Puerto Rico were randomized between August 22, 2001, and June 24, 2004. Eligibility criteria included a prostate-specific antigen (PSA) of 4.0 ng/mL or less, a digital rectal examination not suspicious for prostate cancer, and age 50 years or older for black men and 55 years or older for all others. The primary analysis included 34 887 men who were randomly assigned to 1 of 4 treatment groups: 8752 to receive selenium; 8737, vitamin E; 8702, both agents, and 8696, placebo. Analysis reflect the final data collected by the study sites on their participants through July 5, 2011. Interventions Oral selenium (200 mu g/d from L-selenomethionine) with matched vitamin E placebo, vitamin E (400 IU/d of all rac-alpha-tocopheryl acetate) with matched selenium placebo, both agents, or both matched placebos for a planned follow-up of a minimum of 7 and maximum of 12 years. Main Outcome Measures Prostate cancer incidence. Results This report includes 54 464 additional person-years of follow-up and 521 additional cases of prostate cancer since the primary report. Compared with the placebo (referent group) in which 529 men developed prostate cancer, 620 men in the vitamin E group developed prostate cancer (hazard ratio [HR], 1.17; 99% CI, 1.004-1.36, P=.008); as did 575 in the selenium group (HR, 1.09; 99% CI, 0.93-1.27; P=.18), and 555 in the selenium plus vitamin E group (HR, 1.05; 99% CI, 0.89-1.22, P=.46). Compared with placebo, the absolute increase in risk of prostate cancer per 1000 person-years was 1.6 for vitamin E, 0.8 for selenium, and 0.4 for the combination. Conclusion Dietary supplementation with vitamin E significantly increased the risk of prostate cancer among healthy men.	[Parsons, J. Kellogg] Univ Calif San Diego, Dept Surg, Moores Canc Ctr, La Jolla, CA 92093 USA; [Klotz, Laurence] Nybrook Med Ctr, N York, ON, Canada; [Chin, Joseph L.] London Hlth Sci Ctr, London, ON, Canada; [Goodman, Gary E.] Swedish Med Ctr Canc Inst, Seattle, WA USA; [Meyskens, Frank L., Jr.] Univ Calif Irvine, Dept Med, Orange, CA USA; [Baker, Laurence H.] Univ Michigan, Div Hematol Oncol, Ann Arbor, MI 48109 USA	University of California System; University of California San Diego; London Health Sciences Centre; Swedish Cancer Institute; Swedish Medical Center; University of California System; University of California Irvine; University of Michigan System; University of Michigan	Klein, EA (corresponding author), Cleveland Clin, Glickman Urol & Kidney Inst, Desk Q10-1,9500 Euclid Ave, Cleveland, OH 44195 USA.	kleine@ccf.org		Darke, Amy/0000-0002-9821-2065	National Cancer Institute; Pfizer; Abbott; GlaxoSmithKline; Janssen; Amgen; Novartis; Firmagon; National Cancer Institute, National Institutes of Health, Department of Health and Human Services [CA37429]; National Center for Complementary and Alternative Medicine (National Institutes of Health); NATIONAL CANCER INSTITUTE [U10CA037429] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pfizer(Pfizer); Abbott(Abbott Laboratories); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Amgen(Amgen); Novartis(Novartis); Firmagon; National Cancer Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary and Alternative Medicine (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Thompson reported receiving research support from the National Cancer Institute for a randomized controlled trial testing finasteride against placebo, both of which are supplied by Merck. Dr Gaziano reported receiving grant support (to his institution) from Wyeth (now Pfizer) in the form of vitamin and placebo pills and packaging. Dr Karp reported receiving grants to his institution from Pfizer. Dr Klotz reported receiving travel support for meetings from sanofi-aventis, Merck, and AstraZeneca and research support for investigator-initiated trials from Abbott and GlaxoSmithKline, and institutional grants pending. Dr Chin reported receiving consultancy fees from Janssen, Amgen, Novartis, and Firmagon; receiving payment for lectures from Firmagon; and payment for development of educational presentations from AstraZeneca, Novartis, and Firmagon. Dr Meyskens reported being a co-founder of Cancer Prevention Pharmaceuticals. Dr Baker reported board membership for Merck for which he receives no compensation. Otherwise there were no other conflicts of interest disclosed.; This work was supported in part by Public Health Service Cooperative Agreement grant CA37429 awarded by the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, and in part by the National Center for Complementary and Alternative Medicine (National Institutes of Health). Study agents and packaging were provided by Perrigo Co, Allegan, Michigan; Sabinsa Corp, Piscataway, New Jersey; Tishcon Corp, Westbury, New York; and DSM Nutritional Products Inc, Parsipanny, New Jersey.	Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; Cooperberg MR, 2010, J CLIN ONCOL, V28, P1117, DOI 10.1200/JCO.2009.26.0133; Fleshner NE, 2011, J CLIN ONCOL, V29, P2386, DOI 10.1200/JCO.2010.32.0994; Ford ES, 2005, ANN INTERN MED, V143, P116, DOI 10.7326/0003-4819-143-2-200507190-00010; Gaziano JM, 2009, JAMA-J AM MED ASSOC, V301, P52, DOI 10.1001/jama.2008.862; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O; Graat JM, 2002, JAMA-J AM MED ASSOC, V288, P715, DOI 10.1001/jama.288.6.715; Green S, 2002, J CLIN ONCOL, V20, P3424, DOI 10.1200/JCO.2002.03.003; GREENBERG ER, 1994, NEW ENGL J MED, V331, P141, DOI 10.1056/NEJM199407213310301; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Latini DM, 2007, J UROLOGY, V178, P826, DOI 10.1016/j.juro.2007.05.039; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Lippman SM, 2005, JNCI-J NATL CANCER I, V97, P94, DOI 10.1093/jnci/dji009; Marshall JR, 2011, CANCER PREV RES, V4, P1761, DOI 10.1158/1940-6207.CAPR-10-0343; McCance DR, 2010, LANCET, V376, P259, DOI 10.1016/S0140-6736(10)60630-7; McNeil JJ, 2004, OPHTHALMOLOGY, V111, P75, DOI 10.1016/j.ophtha.2003.04.009; Office of Dietary Supplements. National Institutes of Health, NAT I HLTH DIET SUPP; Omenn GS, 1996, J NATL CANCER I, V88, P1550, DOI 10.1093/jnci/88.21.1550; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704; Sesso HD, 2008, JAMA-J AM MED ASSOC, V300, P2123, DOI 10.1001/jama.2008.600; Taylor HR, 2002, BMJ-BRIT MED J, V325, P11, DOI 10.1136/bmj.325.7354.11; Theoret MR, 2011, NEW ENGL J MED, V365, P97, DOI 10.1056/NEJMp1106783; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Tosoian JJ, 2011, J CLIN ONCOL, V29, P2185, DOI 10.1200/JCO.2010.32.8112; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; Zaytoun OM, 2011, UROLOGY, V77, P1035, DOI 10.1016/j.urology.2010.12.067	31	1074	1108	1	137	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 12	2011	306	14					1549	1556		10.1001/jama.2011.1437	http://dx.doi.org/10.1001/jama.2011.1437			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831FS	21990298	Green Accepted			2022-12-28	WOS:000295714700020
J	Brookes, JD; Carey, CC				Brookes, Justin D.; Carey, Cayelan C.			Resilience to Blooms	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; CYANOBACTERIA DOMINANCE; NUTRIENT INPUTS; FRESH-WATER; LAKE; EUTROPHICATION; PHYTOPLANKTON; SHALLOW; PHOSPHORUS; NITROGEN		[Brookes, Justin D.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [Carey, Cayelan C.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA	University of Adelaide; Cornell University	Brookes, JD (corresponding author), Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia.	justin.brookes@adelaide.edu.au; ccc99@cornell.edu	Brookes, Justin/G-4270-2013; Carey, Cayelan/D-4874-2016	Carey, Cayelan/0000-0001-8835-4476; Brookes, JUSTIN/0000-0001-8408-9142				Arnott SE, 2003, ENVIRON MONIT ASSESS, V88, P365, DOI 10.1023/A:1025537628078; Carpenter S.R., 1993, TROPHIC CASCADE LAKE; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Cooke G.D., 2005, RESTORATION MANAGEME, Vthird, DOI DOI 10.1002/RRR.3450090207; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Elliott JA, 2010, GLOBAL CHANGE BIOL, V16, P864, DOI 10.1111/j.1365-2486.2009.01998.x; Hamilton DP, 2002, INT VER THEOR ANGEW, V28, P467; Ibelings BW, 2007, ECOSYSTEMS, V10, P4, DOI 10.1007/s10021-006-9009-4; Jeppesen E., 2002, ECOSYST HEALTH, V5, P3; Jeppesen E, 2009, J ENVIRON QUAL, V38, P1930, DOI 10.2134/jeq2008.0113; Johnk KD, 2008, GLOBAL CHANGE BIOL, V14, P495, DOI 10.1111/j.1365-2486.2007.01510.x; Jones I, 2005, FRESHWATER BIOL, V50, P1239, DOI 10.1111/j.1365-2427.2005.01397.x; Kohler J, 2005, FRESHWATER BIOL, V50, P1639, DOI 10.1111/j.1365-2427.2005.01430.x; Kumagai Michio, 2000, Limnology, V1, P1, DOI 10.1007/s102010070022; Markensten H, 2010, ECOL APPL, V20, P752, DOI 10.1890/08-2109.1; McKee D, 2003, LIMNOL OCEANOGR, V48, P707, DOI 10.4319/lo.2003.48.2.0707; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Moss B, 2003, J APPL ECOL, V40, P782, DOI 10.1046/j.1365-2664.2003.00839.x; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Rinke K, 2010, FRESHWATER BIOL, V55, P1674, DOI 10.1111/j.1365-2427.2010.02401.x; Smith VH, 1999, ENVIRON POLLUT, V100, P179, DOI 10.1016/S0269-7491(99)00091-3; Stich HB, 2010, GLOBAL CHANGE BIOL, V16, P877, DOI 10.1111/j.1365-2486.2009.02005.x; Wagner C, 2009, LIMNOL OCEANOGR, V54, P2460, DOI 10.4319/lo.2009.54.6_part_2.2460	23	189	219	9	230	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 7	2011	334	6052					46	47		10.1126/science.1207349	http://dx.doi.org/10.1126/science.1207349			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21980099				2022-12-28	WOS:000295580300031
J	Saiz-Jimenez, C; Cuezva, S; Jurado, V; Fernandez-Cortes, A; Porca, E; Benavente, D; Canaveras, JC; Sanchez-Moral, S				Saiz-Jimenez, Cesareo; Cuezva, Soledad; Jurado, Valme; Fernandez-Cortes, Angel; Porca, Estefania; Benavente, David; Canaveras, Juan C.; Sanchez-Moral, Sergio			Paleolithic Art in Peril: Policy and Science Collide at Altamira Cave	SCIENCE			English	Editorial Material							COMMUNITIES; FABRICS; SPAIN		[Saiz-Jimenez, Cesareo; Jurado, Valme; Porca, Estefania] Spanish Natl Res Council IRNAS CSIC, Inst Nat Resources & Agrobiol, Seville 41012, Spain; [Cuezva, Soledad; Benavente, David; Canaveras, Juan C.] Univ Alicante, E-03080 Alicante, Spain; [Fernandez-Cortes, Angel; Sanchez-Moral, Sergio] Spanish Natl Res Council MNCN CSIC, Natl Museum Nat Sci, Madrid 28006, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); Universitat d'Alacant; Consejo Superior de Investigaciones Cientificas (CSIC)	Saiz-Jimenez, C (corresponding author), Spanish Natl Res Council IRNAS CSIC, Inst Nat Resources & Agrobiol, Seville 41012, Spain.	saiz@irnase.csic.es	Cuezva, Soledad/M-4131-2015; Cañaveras, Juan C./H-6705-2015; JURADO, VALME/E-3468-2016; Fernandez-Cortes, Angel/I-5489-2012; Sanchez-Moral, Sergio/A-7333-2013; Benavente, David/H-2357-2015; SAIZ-JIMENEZ, CESAREO/I-8885-2012; Fernandez-Cortes, Angel/AGK-5192-2022	Cuezva, Soledad/0000-0002-2439-4767; Cañaveras, Juan C./0000-0003-0323-3400; JURADO, VALME/0000-0003-0972-9909; Fernandez-Cortes, Angel/0000-0002-8482-3308; Sanchez-Moral, Sergio/0000-0002-7382-3441; Benavente, David/0000-0001-7325-4042; SAIZ-JIMENEZ, CESAREO/0000-0003-0036-670X; Fernandez-Cortes, Angel/0000-0002-8482-3308				Bastian F, 2010, MICROBIOL-SGM, V156, P644, DOI 10.1099/mic.0.036160-0; Canaveras JC, 2001, GEOMICROBIOL J, V18, P223; Constenla T., 2010, PAIS            1221; Cuezva S, 2009, INT J SPELEOL, V38, P83; Holden C, 2002, SCIENCE, V297, P47; Jurado V, 2009, NATURWISSENSCHAFTEN, V96, P1027, DOI 10.1007/s00114-009-0561-6; Lasheras J. A., 2006, COALITION, V12, P7; Pitts M., 2011, GUARDIAN        0117, pG2; Porca E, 2011, ECOL INDIC, V11, P1594, DOI 10.1016/j.ecolind.2011.04.003; Sanchez-Moral S, 1999, SCI TOTAL ENVIRON, V243, P67, DOI 10.1016/S0048-9697(99)00348-4; Sanchez-Moral S., 2002, REDESCUBRIR ALTAMIRA, P245; Schabereiter-Gurtner C, 2002, FEMS MICROBIOL LETT, V211, P7, DOI 10.1111/j.1574-6968.2002.tb11195.x; Villar E., 1984, ESTUDIOS FISICO QUMI, P95	13	90	96	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 7	2011	334	6052					42	43		10.1126/science.1206788	http://dx.doi.org/10.1126/science.1206788			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	829KW	21980097	Green Submitted			2022-12-28	WOS:000295580300029
J	Lewis, SRR; Mahony, PJ; Simpson, J				Lewis, Sian R. R.; Mahony, Peter J.; Simpson, John			EASILY MISSED? Appendicitis	BRITISH MEDICAL JOURNAL			English	Editorial Material							EARLY-DIAGNOSIS; APPENDECTOMY; SCORE		[Mahony, Peter J.] Belvoir Hlth Grp, Nottingham, England; [Simpson, John] Univ Nottingham Hosp, Queens Med Ctr, Dept Gen Surg, Nottingham NG7 2UH, England	University of Nottingham		j.simpson@nottingham.ac.uk						ADDISS DG, 1990, AM J EPIDEMIOL, V132, P910, DOI 10.1093/oxfordjournals.aje.a115734; Ahmed I, 2007, SURG RADIOL ANAT, V29, P165, DOI 10.1007/s00276-007-0182-8; ALVARADO A, 1986, ANN EMERG MED, V15, P557, DOI 10.1016/S0196-0644(86)80993-3; Andersen BR, 2005, COCHRANE DB SYST REV, V3; Andersson M, 2008, WORLD J SURG, V32, P1843, DOI 10.1007/s00268-008-9649-y; Andersson REB, 2004, BRIT J SURG, V91, P28, DOI 10.1002/bjs.4464; Andersson REB, 2001, INT J EPIDEMIOL, V30, P1281, DOI 10.1093/ije/30.6.1281; Andersson RE, 2007, WORLD J SURG, V31, P86, DOI 10.1007/s00268-006-0056-y; Bickell NA, 2006, J AM COLL SURGEONS, V202, P401, DOI 10.1016/j.jamcollsurg.2005.11.016; Cappendijk VC, 2000, ARCH DIS CHILD, V83, P64, DOI 10.1136/adc.83.1.64; Hale DA, 1997, ANN SURG, V225, P252, DOI 10.1097/00000658-199703000-00003; Hospital Episode Statistics, PRIM DIAGN SUMM; Kang JY, 2003, BRIT J SURG, V90, P1586, DOI 10.1002/bjs.4363; Murphy JB, 1904, AM J MED SCI, V128, P187; PUSKAR D, 1995, UROLOGY, V45, P108, DOI 10.1016/S0090-4295(95)97134-3; Terasawa T, 2004, ANN INTERN MED, V141, P537, DOI 10.7326/0003-4819-141-7-200410050-00011; WILSON D, 1994, ULSTER MED J, V63, P3	17	5	6	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 6	2011	343								d5976	10.1136/bmj.d5976	http://dx.doi.org/10.1136/bmj.d5976			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832CT	21980077				2022-12-28	WOS:000295779600003
J	Gozalo, P; Teno, JM; Mitchell, SL; Skinner, J; Bynum, J; Tyler, D; Mor, V				Gozalo, Pedro; Teno, Joan M.; Mitchell, Susan L.; Skinner, Jon; Bynum, Julie; Tyler, Denise; Mor, Vincent			End-of-Life Transitions among Nursing Home Residents with Cognitive Issues	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADVANCED DEMENTIA; COMMON OUTCOMES; ADVERSE EVENTS; CARE; MEDICARE; HOSPITALIZATION; MDS; REHOSPITALIZATIONS; IDENTIFICATION; HISTORIES	BACKGROUND Health care transitions in the last months of life can be burdensome and potentially of limited clinical benefit for patients with advanced cognitive and functional impairment. METHODS To examine health care transitions among Medicare decedents with advanced cognitive and functional impairment who were nursing home residents 120 days before death, we linked nationwide data from the Medicare Minimum Data Set and claims files from 2000 through 2007. We defined patterns of transition as burdensome if they occurred in the last 3 days of life, if there was a lack of continuity in nursing homes after hospitalization in the last 90 days of life, or if there were multiple hospitalizations in the last 90 days of life. We also considered various factors explaining variation in these rates of burdensome transition. We examined whether there was an association between regional rates of burdensome transition and the likelihood of feeding-tube insertion, hospitalization in an intensive care unit (ICU) in the last month of life, the presence of a stage IV decubitus ulcer, and hospice enrollment in the last 3 days of life. RESULTS Among 474,829 nursing home decedents, 19.0% had at least one burdensome transition (range, 2.1% in Alaska to 37.5% in Louisiana). In adjusted analyses, blacks, Hispanics, and those without an advance directive were at increased risk. Nursing home residents in regions in the highest quintile of burdensome transitions (as compared with those in the lowest quintile) were significantly more likely to have a feeding tube (adjusted risk ratio, 3.38), have spent time in an ICU in the last month of life (adjusted risk ratio, 2.10), have a stage IV decubitus ulcer (adjusted risk ratio, 2.28), or have had a late enrollment in hospice (adjusted risk ratio, 1.17). CONCLUSIONS Burdensome transitions are common, vary according to state, and are associated with markers of poor quality in end-of-life care. (Funded by the National Institute on Aging.)	[Teno, Joan M.] Brown Univ, Warren Alpert Med Sch, Ctr Gerontol & Hlth Care Res, Program Publ Hlth,Dept Hlth Serv Policy & Practic, Providence, RI 02912 USA; [Mitchell, Susan L.] Inst Aging Res, Boston, MA USA; [Skinner, Jon; Bynum, Julie] Dartmouth Med Sch, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA	Brown University; Dartmouth College	Teno, JM (corresponding author), Brown Univ, Warren Alpert Med Sch, Ctr Gerontol & Hlth Care Res, Program Publ Hlth,Dept Hlth Serv Policy & Practic, Providence, RI 02912 USA.	joan_teno@brown.edu		Tyler, Denise/0000-0001-8555-9011	National Institute on Aging [P01AG027296, K24AG033640]; NATIONAL INSTITUTE ON AGING [K24AG033640, P01AG027296] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants (P01AG027296, to Dr. Mor, and K24AG033640, to Dr. Mitchell) from the National Institute on Aging.	Bach PB, 2004, JAMA-J AM MED ASSOC, V292, P2765, DOI 10.1001/jama.292.22.2765; Barnato AE, 2007, MED CARE, V45, P386, DOI 10.1097/01.mlr.0000255248.79308.41; Boockvar K, 2004, ARCH INTERN MED, V164, P545, DOI 10.1001/archinte.164.5.545; Carter MW, 2003, J AGING HEALTH, V15, P295, DOI 10.1177/0898264303015002001; Coleman E. A., 2002, INT J INTEGR CARE, V2, pe02; Coleman EA, 2003, J AM GERIATR SOC, V51, P549, DOI 10.1046/j.1532-5415.2003.51185.x; CORRIGAN JM, 1992, HEALTH SERV RES, V27, P81; Field TS, 2001, ARCH INTERN MED, V161, P1629, DOI 10.1001/archinte.161.13.1629; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; GILLICK MR, 1982, SOC SCI MED, V16, P1033, DOI 10.1016/0277-9536(82)90175-7; Givens JL, 2011, ARCH INTERN MED, V171, P217; Givens JL, 2010, ARCH INTERN MED, V170, P1102, DOI 10.1001/archinternmed.2010.181; Grabowski DC, 2010, HEALTH SERV RES, V45, P1963, DOI 10.1111/j.1475-6773.2010.01104.x; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Gruneir A, 2007, GERONTOLOGIST, V47, P447, DOI 10.1093/geront/47.4.447; Harrison A, 2002, HEALTH SERV RES, V37, P1031, DOI 10.1034/j.1600-0560.2002.64_2.x; Hirdes JP, 2003, J AM GERIATR SOC, V51, P96, DOI 10.1034/j.1601-5215.2002.51017.x; Intrator O, 2007, HEALTH SERV RES, V42, P1651, DOI 10.1111/j.1475-6773.2006.00670.x; Intrator O, 2011, HEALTH SERV RES, V46, P120, DOI 10.1111/j.1475-6773.2010.01194.x; Jencks SF, 2011, NEW ENGL J MED, V364, P1582; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kane RL, 2004, GERONTOLOGIST, V44, P95, DOI 10.1093/geront/44.1.95; Kane RL, 2003, J AM GERIATR SOC, V51, P1427, DOI 10.1046/j.1532-5415.2003.51461.x; Kruse RL, 2004, MED CARE, V42, P860, DOI 10.1097/01.mlr.0000135828.95415.b1; Loeb M, 2006, JAMA-J AM MED ASSOC, V295, P2503, DOI 10.1001/jama.295.21.2503; McClellan M, 2010, HEALTH AFFAIR, V29, P982, DOI 10.1377/hlthaff.2010.0194; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Mitchell SL, 2009, NEW ENGL J MED, V361, P1529, DOI 10.1056/NEJMoa0902234; Moore C, 2003, J GEN INTERN MED, V18, P646, DOI 10.1046/j.1525-1497.2003.20722.x; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Richardson SS, 2007, HEALTH SERV RES, V42, P183, DOI 10.1111/j.1475-6773.2006.00608.x; Roblin DW, 1999, MED CARE, V37, P1155, DOI 10.1097/00005650-199911000-00007; Saliba D, 2000, J AM GERIATR SOC, V48, P154, DOI 10.1111/j.1532-5415.2000.tb03906.x; Teno JM, 2011, J AM GERIATR SOC, V59, P881, DOI 10.1111/j.1532-5415.2011.03385.x; Thomas DR, 2008, J AM MED DIR ASSOC, V9, P292, DOI 10.1016/j.jamda.2008.03.006; Weissman JS, 1999, MED CARE, V37, P490, DOI 10.1097/00005650-199905000-00008; Wetle T, 2004, END LIFE NURSING HOM; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	40	311	313	1	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 29	2011	365	13					1212	1221		10.1056/NEJMsa1100347	http://dx.doi.org/10.1056/NEJMsa1100347			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	825YO	21991894	Green Accepted			2022-12-28	WOS:000295318400009
J	Liu, J; Renault, L; Veaute, X; Fabre, F; Stahlberg, H; Heyer, WD				Liu, Jie; Renault, Ludovic; Veaute, Xavier; Fabre, Francis; Stahlberg, Henning; Heyer, Wolf-Dietrich			Rad51 paralogues Rad55-Rad57 balance the antirecombinase Srs2 in Rad51 filament formation	NATURE			English	Article							DOUBLE-STRAND-BREAK; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; MITOTIC RECOMBINATION; DNA-REPAIR; PROTEIN; HELICASE; GENE; MUTATIONS; EXCHANGE	Homologous recombination is a high-fidelity DNA repair pathway. Besides a critical role in accurate chromosome segregation during meiosis, recombination functions in DNA repair and in the recovery of stalled or broken replication forks to ensure genomic stability. In contrast, inappropriate recombination contributes to genomic instability, leading to loss of heterozygosity, chromosome rearrangements and cell death. The RecA/UvsX/RadA/Rad51 family of proteins catalyses the signature reactions of recombination, homology search and DNA strand invasion(1,2). Eukaryotes also possess Rad51 paralogues, whose exact role in recombination remains to be defined(3). Here we show that the Saccharomyces cerevisiae Rad51 paralogues, the Rad55-Rad57 heterodimer, counteract the antirecombination activity of the Srs2 helicase. The Rad55-Rad57 heterodimer associates with the Rad51-single-stranded DNA filament, rendering it more stable than a nucleoprotein filament containing Rad51 alone. The Rad51-Rad55-Rad57 co-filament resists disruption by the Srs2 antirecombinase by blocking Srs2 translocation, involving a direct protein interaction between Rad55-Rad57 and Srs2. Our results demonstrate an unexpected role of the Rad51 paralogues in stabilizing the Rad51 filament against a biologically important antagonist, the Srs2 antirecombination helicase. The biological significance of this mechanism is indicated by a complete suppression of the ionizing radiation sensitivity of rad55 or rad57 mutants by concomitant deletion of SRS2, as expected for biological antagonists. We propose that the Rad51 presynaptic filament is a meta-stable reversible intermediate, whose assembly and disassembly is governed by the balance between Rad55-Rad57 and Srs2, providing a key regulatory mechanism controlling the initiation of homologous recombination. These data provide a paradigm for the potential function of the human RAD51 paralogues, which are known to be involved in cancer predisposition and human disease.	[Liu, Jie; Heyer, Wolf-Dietrich] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Renault, Ludovic; Stahlberg, Henning; Heyer, Wolf-Dietrich] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Veaute, Xavier; Fabre, Francis] CEA, CNRS, UMR217, CEA DSV Inst Radiobiol Cellulaire & Mol, F-92265 Fontenay Aux Roses, France; [Stahlberg, Henning] Univ Basel, Ctr Cellular Imaging & Nanoanalyt, CH-4056 Basel, Switzerland	University of California System; University of California Davis; University of California System; University of California Davis; CEA; Centre National de la Recherche Scientifique (CNRS); University of Basel	Heyer, WD (corresponding author), Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA.	wdheyer@ucdavis.edu	Stahlberg, Henning/H-1868-2011	Stahlberg, Henning/0000-0002-1185-4592; Renault, Ludovic/0000-0001-6464-8808; Liu, Jie/0000-0001-5817-9144	Tobacco-Related Disease Research Program [17FT-0046]; European Community [LSHG-CT-2003-503303]; Centre National de la Recherche Scientifique; Commissariat a l'Energie Atomique; SystemsX.ch; National Institutes of Health [U54GM74929, CA92267, GM58015]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058015, U54GM074929] Funding Source: NIH RePORTER	Tobacco-Related Disease Research Program(University of California System); European Community(European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Commissariat a l'Energie Atomique(French Atomic Energy Commission); SystemsX.ch; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Alexeeva for the cell culture support. We thank P. Sung, R. Kolodner and L. Symington for plasmids and yeast strains. We are grateful to S. Kowalczykowski, N. Hunter, D. Castano-Diez, P. Ringler and all members of the Heyer laboratory for discussions and comments on the manuscript. This work was supported by Postdoctoral Fellowship 17FT-0046 from the Tobacco-Related Disease Research Program (J.L.), by the European Community (LSHG-CT-2003-503303) and the Centre National de la Recherche Scientifique, the Commissariat a l'Energie Atomique (X. V., F. F.), by SystemsX.ch (H. S.), and the National Institutes of Health grants U54GM74929 (H. S.), CA92267 and GM58015 (W.-D.H.).	ABOUSSEKHRA A, 1989, NUCLEIC ACIDS RES, V17, P7211, DOI 10.1093/nar/17.18.7211; AGUILERA A, 1988, GENETICS, V119, P779; Antony E, 2009, MOL CELL, V35, P105, DOI 10.1016/j.molcel.2009.05.026; Bashkirov VI, 2006, METHOD ENZYMOL, V409, P166, DOI 10.1016/S0076-6879(05)09010-5; Beernink HTH, 1999, TRENDS BIOCHEM SCI, V24, P385, DOI 10.1016/S0968-0004(99)01451-6; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Burgess RC, 2009, J CELL BIOL, V185, P969, DOI 10.1083/jcb.200810055; Dupaigne P, 2008, MOL CELL, V29, P243, DOI 10.1016/j.molcel.2007.11.033; Fugger K, 2009, J CELL BIOL, V186, P655, DOI 10.1083/jcb.200812138; Fung CW, 2009, GENETICS, V181, P1195, DOI 10.1534/genetics.109.100842; Herzberg K, 2006, MOL CELL BIOL, V26, P8396, DOI 10.1128/MCB.01317-06; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hilario J, 2009, P NATL ACAD SCI USA, V106, P361, DOI 10.1073/pnas.0811965106; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; LOVETT ST, 1987, GENETICS, V116, P547; Mazin AV, 2003, J BIOL CHEM, V278, P14029, DOI 10.1074/jbc.M212779200; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Modesti M, 2007, STRUCTURE, V15, P599, DOI 10.1016/j.str.2007.04.003; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Saponaro M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000858; SCHIESTL RH, 1990, GENETICS, V124, P817; Schwendener S, 2010, J BIOL CHEM, V285, P15739, DOI 10.1074/jbc.M110.110478; Solinger JA, 2002, MOL CELL, V10, P1175, DOI 10.1016/S1097-2765(02)00743-8; Sommers JA, 2009, J BIOL CHEM, V284, P7505, DOI 10.1074/jbc.M809019200; Spell Rachelle Miller, 2004, Methods Mol Biol, V262, P3; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Thacker J, 2005, CANCER LETT, V219, P125, DOI 10.1016/j.canlet.2004.08.018; Van Dyck E, 1998, J MOL BIOL, V284, P1027, DOI 10.1006/jmbi.1998.2203; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9; Zhang XP, 2011, METHODS MOL BIOL, V745, P329, DOI 10.1007/978-1-61779-129-1_19	39	141	141	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 10	2011	479	7372					245	U129		10.1038/nature10522	http://dx.doi.org/10.1038/nature10522			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PD	22020281	Green Submitted, Green Accepted			2022-12-28	WOS:000298030800046
J	Boerma, T; de Zoysa, I				Boerma, Ties; de Zoysa, Isabelle			Beyond accountability: learning from large-scale evaluations	LANCET			English	Editorial Material							HIV; IMPACT		[Boerma, Ties] WHO, CH-1211 Geneva, Switzerland	World Health Organization	Boerma, T (corresponding author), WHO, Ave Appia 20, CH-1211 Geneva, Switzerland.	boermat@who.int						[Anonymous], 2010, LANCET, V375, P526, DOI 10.1016/S0140-6736(10)60056-6; Baird J, 2011, SOC SCI MED, V72, P1948, DOI 10.1016/j.socscimed.2010.04.038; Bennett S, 2006, LANCET, V367, P79, DOI 10.1016/S0140-6736(06)67928-2; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI94, DOI 10.1093/heapol/czi056; Bryce J, 2010, LANCET, V375, P572, DOI 10.1016/S0140-6736(09)62060-2; Chandrasekaran P, 2008, AIDS, V22, pS1, DOI 10.1097/01.aids.0000343760.70078.89; Dandona L, BMC PUBLIC IN PRESS; Kumar R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-549; Laga M., 2008, AIDS, V22, pS1; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Ng M, 2011, LANCET, V378, P1643, DOI 10.1016/S0140-6736(11)61390-1; Pickles M, 2010, SEX TRANSM INFECT, V86, pI33, DOI 10.1136/sti.2009.038950; Piot P, 2010, SEX TRANSM INFECT S1, V86, P1; Victora CG, 2011, LANCET, V377, P85, DOI 10.1016/S0140-6736(10)60810-0	14	10	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 5	2011	378	9803					1610	1612		10.1016/S0140-6736(11)61519-5	http://dx.doi.org/10.1016/S0140-6736(11)61519-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	844ST	21993159				2022-12-28	WOS:000296768300010
J	Takeda, Y; Costa, S; Delamarre, E; Roncal, C; de Oliveira, RL; Squadrito, ML; Finisguerra, V; Deschoemaeker, S; Bruyere, F; Wenes, M; Hamm, A; Serneels, J; Magat, J; Bhattacharyya, T; Anisimov, A; Jordan, BF; Alitalo, K; Maxwell, P; Gallez, B; Zhuang, ZW; Saito, Y; Simons, M; De Palma, M; Mazzone, M				Takeda, Yukiji; Costa, Sandra; Delamarre, Estelle; Roncal, Carmen; de Oliveira, Rodrigo Leite; Squadrito, Mario Leonardo; Finisguerra, Veronica; Deschoemaeker, Sofie; Bruyere, Francoise; Wenes, Mathias; Hamm, Alexander; Serneels, Jens; Magat, Julie; Bhattacharyya, Tapan; Anisimov, Andrey; Jordan, Benedicte F.; Alitalo, Kari; Maxwell, Patrick; Gallez, Bernard; Zhuang, Zhen W.; Saito, Yoshihiko; Simons, Michael; De Palma, Michele; Mazzone, Massimiliano			Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis	NATURE			English	Article							NF-KAPPA-B; TUMOR ANGIOGENESIS; IKK-BETA; INHIBITION; MOUSE; OXYGENATION; DEFICIENCY; INJURY; CELLS	PHD2 serves as an oxygen sensor that rescues blood supply by regulating vessel formation and shape in case of oxygen shortage(1-5). However, it is unknown whether PHD2 can influence arteriogenesis. Here we studied the role of PHD2 in collateral artery growth by using hindlimb ischaemia as a model, a process that compensates for the lack of blood flow in case of major arterial occlusion(6-8). We show that Phd2 (also known as Egln1) haplodeficient (Phd2(+/-)) mice displayed preformed collateral arteries that preserved limb perfusion and prevented tissue necrosis in ischaemia. Improved arteriogenesis in Phd2(+/-) mice was due to an expansion of tissue-resident, M2-like macrophages(9,10) and their increased release of arteriogenic factors, leading to enhanced smooth muscle cell (SMC) recruitment and growth. Both chronic and acute deletion of one Phd2 allele in macrophages was sufficient to skew their polarization towards a pro-arteriogenic phenotype. Mechanistically, collateral vessel preconditioning relied on the activation of canonical NF-kappa B pathway in Phd2(+/-) macrophages. These results unravel how PHD2 regulates arteriogenesis and artery homeostasis by controlling a specific differentiation state in macrophages and suggest new treatment options for ischaemic disorders.	[Takeda, Yukiji; Costa, Sandra; Delamarre, Estelle; Roncal, Carmen; de Oliveira, Rodrigo Leite; Finisguerra, Veronica; Deschoemaeker, Sofie; Wenes, Mathias; Hamm, Alexander; Serneels, Jens; Mazzone, Massimiliano] VIB, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, Belgium; [Takeda, Yukiji; Costa, Sandra; Delamarre, Estelle; Roncal, Carmen; de Oliveira, Rodrigo Leite; Finisguerra, Veronica; Deschoemaeker, Sofie; Wenes, Mathias; Hamm, Alexander; Serneels, Jens; Mazzone, Massimiliano] Katholieke Univ Leuven, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, Belgium; [Takeda, Yukiji; Roncal, Carmen; de Oliveira, Rodrigo Leite; Bruyere, Francoise] VIB, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, B-3000 Louvain, Belgium; [Takeda, Yukiji; Roncal, Carmen; de Oliveira, Rodrigo Leite; Bruyere, Francoise] Katholieke Univ Leuven, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, B-3000 Louvain, Belgium; [Costa, Sandra] Univ Minho, Life & Hlth Sci Res Inst, P-4710057 Braga, Portugal; [Roncal, Carmen] CIMA Univ Navarra, Atherosclerosis Res Lab, Pamplona 31008, Spain; [Squadrito, Mario Leonardo; De Palma, Michele] San Raffaele Inst, Angiogenesis & Tumor Targeting Unit, I-20132 Milan, Italy; [Squadrito, Mario Leonardo; De Palma, Michele] San Raffaele Inst, HSR TIGET, I-20132 Milan, Italy; [Squadrito, Mario Leonardo] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Magat, Julie; Jordan, Benedicte F.; Gallez, Bernard] Catholic Univ Louvain, Biomed Magnet Resonance Unit, B-1200 Brussels, Belgium; [Bhattacharyya, Tapan; Maxwell, Patrick] UCL, Rayne Inst, London WC1E 6JF, England; [Anisimov, Andrey; Alitalo, Kari] Biomedicum Helsinki, Res Programs Unit, Mol Canc Biol Lab, Helsinki 00014, Finland; [Anisimov, Andrey; Alitalo, Kari] Biomedicum Helsinki, Inst Mol Med, Helsinki 00014, Finland; [Zhuang, Zhen W.; Simons, Michael] Yale Univ, Sch Med, New Haven, CT 06510 USA; [Saito, Yoshihiko] Nara Med Univ, Dept Internal Med 1, Nara 6348522, Japan	Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); KU Leuven; Universidade do Minho; University of Navarra; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Universite Catholique Louvain; University of London; King's College London; University College London; University of Helsinki; University of Helsinki; Yale University; Nara Medical University	Mazzone, M (corresponding author), VIB, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, Belgium.	massimiliano.mazzone@vib-kuleuven.be	Costa, Sandra/B-4253-2011; Finisguerra, Veronica/AGS-6956-2022; Deschoemaeker, Sofie/AAF-8321-2020; Costa, Sandra/AAV-7175-2020; Deschoemaeker, Sofie/AAE-1359-2022; Magat, Julie/ABC-5523-2021; De Palma, Michele/L-5350-2016; Maxwell, Patrick H/C-5557-2008; Alitalo, Kari K/J-5013-2014; Squadrito, Mario Leonardo/U-2090-2019; Simons, Michael/G-8553-2014	Costa, Sandra/0000-0001-6795-4245; Deschoemaeker, Sofie/0000-0001-5449-282X; Costa, Sandra/0000-0001-6795-4245; Deschoemaeker, Sofie/0000-0001-5449-282X; De Palma, Michele/0000-0001-9128-5459; Maxwell, Patrick H/0000-0002-0338-2679; Alitalo, Kari K/0000-0002-7331-0902; Simons, Michael/0000-0003-0348-7734; Wenes, Mathias/0000-0001-8478-8592; Leite de Oliveira, Rodrigo/0000-0002-9696-2014; Roncal, Carmen/0000-0003-0616-9600; Bhattacharyya, Tapan/0000-0003-3385-2536; Mazzone, Massimiliano/0000-0001-8824-4015; Magat, Julie/0000-0002-0967-9625; Squadrito, Mario Leonardo/0000-0002-1188-0299	FWO, Belgium [G.0726.10]; VIB; ARC; FCT; FWO; DFG; COST action [TD0901]; ERC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053793] Funding Source: NIH RePORTER	FWO, Belgium(FWO); VIB; ARC(Australian Research Council); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FWO(FWO); DFG(German Research Foundation (DFG)); COST action(European Cooperation in Science and Technology (COST)); ERC(European Research Council (ERC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from FWO (G.0726.10), Belgium, and from VIB. The authors are thankful to P. Carmeliet for the Phd2 KO and cKO mice, M. Karin for the Ikbkb cKO mice, P. Ratcliffe for the PHD2<SUP>H313A</SUP> construct, A. Luttun and P. Fazzari for comments, Y. Jonsson and T. Janssens for technical assistance. VE-Cadherin:CreERT and PDGFRB:Cre transgenic mice were generated at Cancer Research UK and kindly donated by R. Adams. E. D. was funded by ARC, S. C. by FCT, R.L.O. and V. F. by FWO, A. H. by DFG. C. R. was supported by COST action TD0901. M. D. P. was supported by an ERC starting grant.	Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Fong CHY, 2008, J EXP MED, V205, P1269, DOI 10.1084/jem.20080124; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Fu J, 2010, J BIOL CHEM, V285, P8927, DOI 10.1074/jbc.M109.078600; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Helisch A, 2006, ARTERIOSCL THROM VAS, V26, P520, DOI 10.1161/01.ATV.0000202677.55012.a0; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Huang M, 2008, CIRCULATION, V118, pS226, DOI 10.1161/CIRCULATIONAHA.107.760785; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jordan BF, 2009, MAGN RESON MED, V61, P634, DOI 10.1002/mrm.21594; Karshovska E, 2008, J THROMB HAEMOST, V6, P1812, DOI 10.1111/j.1538-7836.2008.03086.x; Kumar MS, 2003, ARTERIOSCL THROM VAS, V23, P737, DOI 10.1161/01.ATV.0000065197.07635.BA; Loinard C, 2009, CIRCULATION, V120, P50, DOI 10.1161/CIRCULATIONAHA.108.813303; Lutgens E, 1999, CARDIOVASC RES, V41, P586, DOI 10.1016/S0008-6363(98)00216-8; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; MEERPOHL HG, 1976, EUR J IMMUNOL, V6, P213, DOI 10.1002/eji.1830060313; Milkiewicz M, 2004, J PHYSIOL-LONDON, V560, P21, DOI 10.1113/jphysiol.2004.069757; Nangaku M, 2007, ARTERIOSCL THROM VAS, V27, P2548, DOI 10.1161/ATVBAHA.107.148551; Nucera S, 2011, INT J DEV BIOL, V55, P495, DOI 10.1387/ijdb.103227sn; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Schaper W, 2009, BASIC RES CARDIOL, V104, P5, DOI 10.1007/s00395-008-0760-x; Simons M, 2003, NAT REV DRUG DISCOV, V2, P863, DOI 10.1038/nrd1226; Squadrito ML, 2011, MOL ASPECTS MED, V32, P123, DOI 10.1016/j.mam.2011.04.005; Wolf C, 1998, J MOL CELL CARDIOL, V30, P2291, DOI 10.1006/jmcc.1998.0790; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049	34	222	233	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2011	479	7371					122	U153		10.1038/nature10507	http://dx.doi.org/10.1038/nature10507			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840FA	21983962	Green Accepted			2022-12-28	WOS:000296422600044
J	Du, J; Say, RF; Lu, W; Fuchs, G; Einsle, O				Du, Juan; Say, Rafael F.; Lu, Wei; Fuchs, Georg; Einsle, Oliver			Active-site remodelling in the bifunctional fructose-1,6-bisphosphate aldolase/phosphatase	NATURE			English	Article							CRYSTAL-STRUCTURE; ALDOLASE; EVOLUTION; MECHANISM; MUSCLE; ARCHAEBACTERIA; EXPRESSION; ENZYMES; CLONING; GENE	Fructose-1,6-bisphosphate (FBP) aldolase/phosphatase is a bifunctional, thermostable enzyme that catalyses two subsequent steps in gluconeogenesis in most archaea and in deeply branching bacterial lineages(1-3). It mediates the aldol condensation of heat-labile dihydroxyacetone phosphate (DHAP) and glyceraldehyde-3-phosphate (GAP) to FBP4, as well as the subsequent, irreversible hydrolysis of the product to yield the stable fructose-6-phosphate (F6P) and inorganic phosphate; no reaction intermediates are released. Here we present a series of structural snapshots of the reaction that reveal a substantial remodelling of the active site through the movement of loop regions that create different catalytic functionalities at the same location. We have solved the three-dimensional structures of FBP aldolase/phosphatase from thermophilic Thermoproteus neutrophilus(5,6) in a ligand-free state as well as in complex with the substrates DHAP and FBP and the product F6P to resolutions up to 1.3 angstrom. In conjunction with mutagenesis data, this pinpoints the residues required for the two reaction steps and shows that the sequential binding of additional Mg2+ cations reversibly facilitates the reaction. FBP aldolase/phosphatase is an ancestral gluconeogenic enzyme optimized for high ambient temperatures(1,2), and our work resolves how consecutive structural rearrangements reorganize the catalytic centre of the protein to carry out two canonical reactions in a very non-canonical type of bifunctionality.	[Du, Juan; Lu, Wei; Einsle, Oliver] Univ Freiburg, Inst Organ Chem & Biochem, Lehrstuhl Biochem, D-79104 Freiburg, Germany; [Say, Rafael F.; Fuchs, Georg] Univ Freiburg, Lehrstuhl Mikrobiol, D-79104 Freiburg, Germany; [Einsle, Oliver] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Einsle, O (corresponding author), Univ Freiburg, Inst Organ Chem & Biochem, Lehrstuhl Biochem, Albertstr 21, D-79104 Freiburg, Germany.	einsle@biochemie.uni-freiburg.de		Einsle, Oliver/0000-0001-8722-2893	Deutsche Forschungsgemeinschaft [Ei520/3-2, Fu118/15-4, Fu118/15-5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (grant Ei520/3-2 to O.E., Fu118/15-4 and 15-5 to G. F.). Diffraction data were collected at beam lines X06SA and X06DA at the Swiss Light Source (Villigen, Switzerland). The authors thank the beam line staff for assistance during data collection.	ALEFOUNDER PR, 1989, BIOCHEM J, V257, P529, DOI 10.1042/bj2570529; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Berg IA, 2010, NAT REV MICROBIOL, V8, P447, DOI 10.1038/nrmicro2365; Blom NS, 1996, NAT STRUCT BIOL, V3, P856, DOI 10.1038/nsb1096-856; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Ciszak EM, 2003, J BIOL CHEM, V278, P21240, DOI 10.1074/jbc.M300339200; Cooper SJ, 1996, STRUCTURE, V4, P1303, DOI 10.1016/S0969-2126(96)00138-4; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FOTHERGILLGILMORE LA, 1993, PROG BIOPHYS MOL BIO, V59, P105, DOI 10.1016/0079-6107(93)90001-Z; GAMBLIN SJ, 1990, FEBS LETT, V262, P282, DOI 10.1016/0014-5793(90)80211-Z; GRAZI E, 1962, BIOCHEM BIOPH RES CO, V9, P38, DOI 10.1016/0006-291X(62)90083-9; HESTER G, 1991, FEBS LETT, V292, P237, DOI 10.1016/0014-5793(91)80875-4; Imanaka H, 2002, J BIOSCI BIOENG, V94, P237, DOI 10.1263/jbb.94.237; LAI CY, 1965, J BIOL CHEM, V240, P1347; LEBHERZ HG, 1969, BIOCHEMISTRY-US, V8, P109, DOI 10.1021/bi00829a016; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Lorentzen E, 2004, BIOCHEM SOC T, V32, P259, DOI 10.1042/BST0320259; Lorentzen E, 2003, J BIOL CHEM, V278, P47253, DOI 10.1074/jbc.M305922200; MESSNER P, 1986, J BACTERIOL, V166, P1046, DOI 10.1128/jb.166.3.1046-1054.1986; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishimasu H, 2004, STRUCTURE, V12, P949, DOI 10.1016/j.str.2004.03.026; PENHOET E, 1967, BIOCHEMISTRY-US, V6, P2940, DOI 10.1021/bi00861a039; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Ronimus Ron S., 2003, Archaea, V1, P199, DOI 10.1155/2003/162593; ROSE IA, 1958, J BIOL CHEM, V231, P315; RUTTER WJ, 1964, FED PROC, V23, P1248; Say RF, 2010, NATURE, V464, P1077, DOI 10.1038/nature08884; Siebers B, 2001, J BIOL CHEM, V276, P28710, DOI 10.1074/jbc.M103447200; St-Jean M, 2005, J BIOL CHEM, V280, P27262, DOI 10.1074/jbc.M502413200; St-Jean M, 2009, BIOCHEMISTRY-US, V48, P4528, DOI 10.1021/bi8021558; Stetter KO, 2006, PHILOS T R SOC B, V361, P1837, DOI 10.1098/rstb.2006.1907; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TOLAN DR, 1987, AM J HUM GENET, V41, P907; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; ZILLIG W, 1989, CAN J MICROBIOL, V35, P73, DOI 10.1139/m89-011	37	41	47	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2011	478	7370					534	U134		10.1038/nature10458	http://dx.doi.org/10.1038/nature10458			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	21983965				2022-12-28	WOS:000296194200047
J	Ellis, G; Whitehead, MA; Robinson, D; O'Neill, D; Langhorne, P				Ellis, Graham; Whitehead, Martin A.; Robinson, David; O'Neill, Desmond; Langhorne, Peter			Comprehensive geriatric assessment for older adults admitted to hospital: meta-analysis of randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONSULTATION TEAM; ACUTE-CARE; FUNCTIONAL OUTCOMES; MANAGEMENT UNIT; STROKE UNIT; SENIOR CARE; INPATIENT; INTERVENTION; HOME; SERVICES	Objective To evaluate the effectiveness of comprehensive geriatric assessment in hospital for older adults admitted as an emergency. Search strategy We searched the EPOC Register, Cochrane's Controlled Trials Register, the Database of Abstracts of Reviews of Effects (DARE), Medline, Embase, CINAHL, AARP Ageline, and handsearched high yield journals. Selection criteria Randomised controlled trials of comprehensive geriatric assessment (whether by mobile teams or in designated wards) compared with usual care. Comprehensive geriatric assessment is a multidimensional interdisciplinary diagnostic process used to determine the medical, psychological, and functional capabilities of a frail elderly person to develop a coordinated and integrated plan for treatment and long term follow-up. Data collection and analysis Three independent reviewers assessed eligibility and trial quality and extracted published data. Two additional reviewers moderated. Results Twenty two trials evaluating 10 315 participants in six countries were identified. For the primary outcome "living at home," patients who underwent comprehensive geriatric assessment were more likely to be alive and in their own homes at the end of scheduled follow-up (odds ratio 1.16 (95% confidence interval 1.05 to 1.28; P=0.003; number needed to treat 33) at a median follow-up of 12 months versus 1.25 (1.11 to 1.42; P<0.001; number needed to treat 17) at a median follow-up of six months) compared with patients who received general medical care. In addition, patients were less likely to be living in residential care (0.78, 0.69 to 0.88; P<0.001). Subgroup interaction suggested differences between the subgroups "wards" and "teams" in favour of wards. Patients were also less likely to die or experience deterioration (0.76, 0.64 to 0.90; P=0.001) and were more likely to experience improved cognition (standardised mean difference 0.08, 0.01 to 0.15; P=0.02) in the comprehensive geriatric assessment group. Conclusions Comprehensive geriatric assessment increases patients' likelihood of being alive and in their own homes after an emergency admission to hospital. This seems to be especially true for trials of wards designated for comprehensive geriatric assessment and is associated with a potential cost reduction compared with general medical care.	[Ellis, Graham] Monklands Hosp, Airdrie, N Lanarkshire, Scotland; [Whitehead, Martin A.] Wishaw Gen Hosp, Wishaw, N Lanarkshire, Scotland; [Robinson, David] St James Hosp, Mercers Inst Res Ageing, Dublin 8, Ireland; [O'Neill, Desmond] Adelaide & Meath Hosp, Dept Med Gerontol, Trinity Ctr Hlth Sci, Dublin 24, Ireland; [Langhorne, Peter] Univ Glasgow, Acad Sect Geriatr Med, Glasgow, Lanark, Scotland	Monklands Hospital; Trinity College Dublin; Trinity College Dublin; University of Glasgow	Ellis, G (corresponding author), Monklands Hosp, Airdrie, N Lanarkshire, Scotland.	Graham.ellis@lanarkshire.scot.nhs.uk						ALLEN CM, 1986, JAMA-J AM MED ASSOC, V255, P2617, DOI 10.1001/jama.255.19.2617; APPLEGATE WB, 1990, NEW ENGL J MED, V322, P1572, DOI 10.1056/NEJM199005313222205; Asplund K, 2000, J AM GERIATR SOC, V48, P1381, DOI 10.1111/j.1532-5415.2000.tb02626.x; BACHMAN SS, 1987, HOSP HEALTH SERV ADM, V32, P509; Bachmann S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1718; Baztan JJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b50; BECKER PM, 1987, JAMA-J AM MED ASSOC, V257, P2313, DOI 10.1001/jama.257.17.2313; Cameron ID, 2009, COCHRANE DB SYST REV, V4; Cohen HJ, 2002, NEW ENGL J MED, V346, P905, DOI 10.1056/NEJMsa010285; Collard A F, 1985, QRB Qual Rev Bull, V11, P180; Counsell SR, 2000, J AM GERIATR SOC, V48, P1572, DOI 10.1111/j.1532-5415.2000.tb03866.x; Covinsky K E, 1998, Jt Comm J Qual Improv, V24, P63; Covinsky KE, 1997, J AM GERIATR SOC, V45, P729, DOI 10.1111/j.1532-5415.1997.tb01478.x; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; Ellis G, 2004, BRIT MED BULL, V71, P45, DOI 10.1093/bmb/ldh033; Ellis G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006211.pub2; FRETWELL MD, 1990, J AM GERIATR SOC, V38, P1073, DOI 10.1111/j.1532-5415.1990.tb01368.x; Handoll HHG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007125.pub2; HARRIS RD, 1991, AUST NZ J MED, V21, P230, DOI 10.1111/j.1445-5994.1991.tb00448.x; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; HOGAN DB, 1987, CAN MED ASSOC J, V136, P713; Kay G, 1992, Perspectives, V16, P2; Kircher TTJ, 2007, AGE AGEING, V36, P36, DOI 10.1093/ageing/afl102; Kortebein P, 2007, JAMA-J AM MED ASSOC, V297, P1772, DOI 10.1001/jama.297.16.1772-b; LANDEFELD CS, 1995, NEW ENGL J MED, V332, P1338, DOI 10.1056/NEJM199505183322006; Langhorne P, 2005, AGE AGEING, V34, P324, DOI 10.1093/ageing/afi038; MCVEY LJ, 1989, ANN INTERN MED, V110, P79, DOI 10.7326/0003-4819-110-1-79; MILLER ST, 1994, J AM GERIATR SOC, V42, P11, DOI 10.1111/j.1532-5415.1994.tb06066.x; Mudge AM, 2010, J GERONTOL A-BIOL, V65, P863, DOI 10.1093/gerona/glq069; National Statistics (UK), 2011, POP; NAUGHTON BJ, 1994, J AM GERIATR SOC, V42, P1045, DOI 10.1111/j.1532-5415.1994.tb06207.x; Nikolaus T, 1999, AGE AGEING, V28, P543, DOI 10.1093/ageing/28.6.543; Organization for Economic Co- operation and Development (OECD), 2004, AG SOC LOOM PENS CRI; Phibbs CS, 2006, MED CARE, V44, P91, DOI 10.1097/01.mlr.0000188981.06522.e0; Pound P, 1999, AGE AGEING, V28, P433, DOI 10.1093/ageing/28.5.433; Powell C, 1990, AGE AGEING S, V19, P21; REUBEN DB, 1995, NEW ENGL J MED, V332, P1345, DOI 10.1056/NEJM199505183322007; Rockwood K, 2004, AGE AGEING, V33, P429, DOI 10.1093/ageing/afh153; RUBENSTEIN L Z, 1991, Journal of the American Geriatrics Society, V39, p8S; RUBENSTEIN LZ, 1995, AGING-CLIN EXP RES, V7, P212, DOI 10.1007/BF03324318; RUBENSTEIN LZ, 1984, NEW ENGL J MED, V311, P1664, DOI 10.1056/NEJM198412273112604; Saltvedt I, 2005, EUR J CLIN PHARMACOL, V61, P921, DOI 10.1007/s00228-005-0046-2; Saltvedt I, 2004, AGING CLIN EXP RES, V16, P300; Saltvedt I, 2002, J AM GERIATR SOC, V50, P792, DOI 10.1046/j.1532-5415.2002.50202.x; Saltvedt I, 2006, GERONTOLOGY, V52, P223, DOI 10.1159/000093654; SALTZ CC, 1988, GERONTOLOGIST, V28, P344, DOI 10.1093/geront/28.3.344; SHAMIAN J, 1984, J AM GERIATR SOC, V32, P794, DOI 10.1111/j.1532-5415.1984.tb06299.x; SILLIMAN RA, 1990, J AM GERIATR SOC, V38, P461, DOI 10.1111/j.1532-5415.1990.tb03546.x; Stoke Unit Trialists' Collaboration, 2009, COCHRANE DB SYST REV, V4; STUCK AE, 1993, LANCET, V342, P1032, DOI 10.1016/0140-6736(93)92884-V; THOMAS DR, 1993, J AM GERIATR SOC, V41, P101, DOI 10.1111/j.1532-5415.1993.tb02040.x; Van Craen K, 2010, J AM GERIATR SOC, V58, P83, DOI 10.1111/j.1532-5415.2009.02621.x; White S J, 1994, J Tenn Med Assoc, V87, P425; WINOGRAD CH, 1993, ARCH INTERN MED, V153, P2017, DOI 10.1001/archinte.153.17.2017	55	519	538	1	78	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	2011	343								d6553	10.1136/bmj.d6553	http://dx.doi.org/10.1136/bmj.d6553			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840DA	22034146	Green Submitted, hybrid, Green Accepted, Green Published			2022-12-28	WOS:000296417300003
J	Bewley, S				Bewley, Susan			BREAST CANCER SCREENING The NHS breast screening programme needs independent review	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MORTALITY; MAMMOGRAPHY		Kings Coll London, Div Womens Hlth, London, England	University of London; King's College London	Bewley, S (corresponding author), Kings Coll London, Div Womens Hlth, London, England.	susan.bewley@kcl.ac.uk		bewley, susan/0000-0001-8064-652X				Autier P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4411; Badwe RA, 1996, LANCET, V347, P325; Baum M, 2005, EUR J CANCER, V41, P508, DOI 10.1016/j.ejca.2004.09.031; Baum M, 1999, EUR J CANCER, V35, P886, DOI 10.1016/S0959-8049(99)00067-2; Baum M., 2009, TIMES           0219; Baum M, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6152; Cancer Research UK, MAMM BREAST SCREEN; Godlee F, 2010, BMJ-BRIT MED J, V341, pc4096; Gotzsche PC, 2011, J ROY SOC MED, V104, P361, DOI 10.1258/jrsm.2011.110078; Gotzsche PC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub4; Jorgensen KJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1241; Jorgensen KJ, 2010, J ROY SOC MED, V103, P14, DOI 10.1258/jrsm.2009.090342; Kalager M, 2010, NEW ENGL J MED, V363, P1203, DOI 10.1056/NEJMoa1000727; McPherson K, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3106; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; NHS Cancer Screening Programmes, NHS BREAST SCREEN; NHS Cancer Screening Programmes, PSA PROST SCREEN ANT; Nordic Cochrane Centre, SCREEN BREAST CANC M; Prinjha S, 2011, J MED SCREEN, V18, P34, DOI 10.1258/jms.2011.010143; Retsky MW, 2008, APMIS, V116, P730, DOI 10.1111/j.1600-0463.2008.00990.x; Welch HG, 2010, NEW ENGL J MED, V363, P13	21	26	26	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2011	343								d6894	10.1136/bmj.d6894	http://dx.doi.org/10.1136/bmj.d6894			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	840CW	22028484				2022-12-28	WOS:000296416900014
J	Login, FH; Balmand, S; Vallier, A; Vincent-Monegat, C; Vigneron, A; Weiss-Gayet, M; Rochat, D; Heddi, A				Login, Frederic H.; Balmand, Severine; Vallier, Agnes; Vincent-Monegat, Carole; Vigneron, Aurelien; Weiss-Gayet, Michele; Rochat, Didier; Heddi, Abdelaziz			Antimicrobial Peptides Keep Insect Endosymbionts Under Control	SCIENCE			English	Article							WEEVIL SITOPHILUS-ORYZAE; SYMBIOTIC BACTERIA; GENE-EXPRESSION; DIFFERENTIATION; EVOLUTION; APHIDS	Vertically transmitted endosymbionts persist for millions of years in invertebrates and play an important role in animal evolution. However, the functional basis underlying the maintenance of these long-term resident bacteria is unknown. We report that the weevil coleoptericin-A (ColA) antimicrobial peptide selectively targets endosymbionts within the bacteriocytes and regulates their growth through the inhibition of cell division. Silencing the colA gene with RNA interference resulted in a decrease in size of the giant filamentous endosymbionts, which escaped from the bacteriocytes and spread into insect tissues. Although this family of peptides is commonly linked with microbe clearance, this work shows that endosymbiosis benefits from ColA, suggesting that long-term host-symbiont coevolution might have shaped immune effectors for symbiont maintenance.	[Login, Frederic H.; Balmand, Severine; Vallier, Agnes; Vincent-Monegat, Carole; Vigneron, Aurelien; Heddi, Abdelaziz] INSA Lyon, INRA, UMR203 BF2I, F-69621 Villeurbanne, France; [Login, Frederic H.; Balmand, Severine; Vallier, Agnes; Vincent-Monegat, Carole; Vigneron, Aurelien; Weiss-Gayet, Michele; Heddi, Abdelaziz] Univ Lyon, F-69003 Lyon, France; [Weiss-Gayet, Michele] Univ Lyon 1, CNRS UMR5534, Ctr Genet & Physiol Mol & Cellulaire, F-69622 Villeurbanne, France; [Rochat, Didier] Univ Paris 06, INRA, Physiol Insecte Signalisat & Commun UMR1272, F-78026 Versailles, France	INRAE; Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay	Heddi, A (corresponding author), INSA Lyon, INRA, UMR203 BF2I, F-69621 Villeurbanne, France.	abdelaziz.heddi@insa-lyon.fr	Vincent-Monégat, Carole/G-7287-2011; agnes, vallier/G-7281-2011; hongbo, yi/G-9615-2011; Vigneron, Aurélien/G-7268-2011	Vigneron, Aurélien/0000-0003-4986-6465	INRA; INSA de Lyon; Region Rhone-Alpes; COST action [FA0701]; NSF [EF-0523818]; Ministerio de Educacion y Ciencia [BFU2006-06003/BMC];  [ANR-06-BLAN-0316];  [ANR-2010-BLAN-170101]	INRA; INSA de Lyon; Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); COST action(European Cooperation in Science and Technology (COST)); NSF(National Science Foundation (NSF)); Ministerio de Educacion y Ciencia(Spanish Government); ; 	This work was supported by INRA, INSA de Lyon, the French ANR-06-BLAN-0316 (EndoSymArt) and ANR-2010-BLAN-170101 (ImmunSymbArt), a grant from Region Rhone-Alpes (cluster infectiologie), and the COST action FA0701 (Arthropod Symbioses). The data reported in this paper are posted in the supporting online material (14). colA (EY122872) and colB (EY122826) sequences are published in GenBank. SPE omp sequences (GenBank JN575265, JN575266, JN575267) were provided by C. Dale and R. B. Weiss (University of Utah) from an ongoing SPE genome sequencing and annotation project supported by NSF grant EF-0523818 and the Ministerio de Educacion y Ciencia project BFU2006-06003/BMC to A. Moya and A. Latorre (University of Valencia). We thank R. Gil and K. Oakeson for omp sequence analysis; V. E. Shevchik, G. Condemine, and M. Lemaire for supplying E. coli and S. cerevisiae strains; W. J. Miller and B. Loppin for critical reading of the manuscript; and V. James for correction of English. Electron microscopy was carried out in Centre Technologique des Microstructures (UCBL). This paper is an homage to the work of Paul Nardon.	Anselme C, 2006, APPL ENVIRON MICROB, V72, P6766, DOI 10.1128/AEM.00942-06; Anselme C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-43; BULET P, 1991, J BIOL CHEM, V266, P24520; Chapman E, 2006, P NATL ACAD SCI USA, V103, P15800, DOI 10.1073/pnas.0607534103; Charles H, 2001, CR ACAD SCI III-VIE, V324, P489, DOI 10.1016/S0764-4469(01)01328-2; Charles H, 1997, INSECT BIOCHEM MOLEC, V27, P345, DOI 10.1016/S0965-1748(97)00005-2; Charles H, 1997, BIOCHEM BIOPH RES CO, V239, P769, DOI 10.1006/bbrc.1997.7552; Conord C, 2008, MOL BIOL EVOL, V25, P859, DOI 10.1093/molbev/msn027; Dale C, 2002, P NATL ACAD SCI USA, V99, P12397, DOI 10.1073/pnas.182213299; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; FOUREL D, 1990, J BACTERIOL, V172, P3675, DOI 10.1128/jb.172.7.3675-3680.1990; Heddi A, 1998, J MOL EVOL, V47, P52, DOI 10.1007/PL00006362; Heddi A, 1999, P NATL ACAD SCI USA, V96, P6814, DOI 10.1073/pnas.96.12.6814; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Mergaert P, 2006, P NATL ACAD SCI USA, V103, P5230, DOI 10.1073/pnas.0600912103; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sagisaka A, 2001, INSECT MOL BIOL, V10, P293, DOI 10.1046/j.0962-1075.2001.00261.x; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Troll JV, 2010, ENVIRON MICROBIOL, V12, P2190, DOI 10.1111/j.1462-2920.2009.02121.x; Van de Velde W, 2010, SCIENCE, V327, P1122, DOI 10.1126/science.1184057; Weiss BL, 2008, P NATL ACAD SCI USA, V105, P15088, DOI 10.1073/pnas.0805666105	23	231	241	3	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2011	334	6054					362	365		10.1126/science.1209728	http://dx.doi.org/10.1126/science.1209728			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	22021855				2022-12-28	WOS:000296052500049
J	Blanc, FX; Sok, T; Laureillard, D; Borand, L; Rekacewicz, C; Nerrienet, E; Madec, Y; Marcy, O; Chan, S; Prak, N; Kim, C; Lak, KK; Hak, C; Dim, B; Sin, CI; Sun, S; Guillard, B; Sar, B; Vong, S; Fernandez, M; Fox, L; Delfraissy, JF; Goldfeld, AE				Blanc, Francois-Xavier; Sok, Thim; Laureillard, Didier; Borand, Laurence; Rekacewicz, Claire; Nerrienet, Eric; Madec, Yoann; Marcy, Olivier; Chan, Sarin; Prak, Narom; Kim, Chindamony; Lak, Khemarin Kim; Hak, Chanroeurn; Dim, Bunnet; Sin, Chhun Im; Sun, Sath; Guillard, Bertrand; Sar, Borann; Vong, Sirenda; Fernandez, Marcelo; Fox, Lawrence; Delfraissy, Jean-Francois; Goldfeld, Anne E.		CAMELIA ANRS 1295-CIPRA KH001	Earlier versus Later Start of Antiretroviral Therapy in HIV-Infected Adults with Tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MORTALITY; OUTCOMES; PROGRAM; PREVALENCE; DIAGNOSIS; SURVIVAL; IMPACT; SAFETY; DRUGS; CARE	Background Tuberculosis remains an important cause of death among patients infected with the human immunodeficiency virus (HIV). Robust data are lacking with regard to the timing for the initiation of antiretroviral therapy (ART) in relation to the start of antituberculosis therapy. Methods We tested the hypothesis that the timing of ART initiation would significantly affect mortality among adults not previously exposed to antiretroviral drugs who had newly diagnosed tuberculosis and CD4+ T-cell counts of 200 per cubic millimeter or lower. After beginning the standard, 6-month treatment for tuberculosis, patients were randomly assigned to either earlier treatment (2 weeks after beginning tuberculosis treatment) or later treatment (8 weeks after) with stavudine, lamivudine, and efavirenz. The primary end point was survival. Results A total of 661 patients were enrolled and were followed for a median of 25 months. The median CD4+ T-cell count was 25 per cubic millimeter, and the median viral load was 5.64 log(10) copies per milliliter. The risk of death was significantly reduced in the group that received ART earlier, with 59 deaths among 332 patients (18%), as compared with 90 deaths among 329 patients (27%) in the later-ART group (hazard ratio, 0.62; 95% confidence interval [CI]; 0.44 to 0.86; P = 0.006). The risk of tuberculosis-associated immune reconstitution inflammatory syndrome was significantly increased in the earlier-ART group (hazard ratio, 2.51; 95% CI, 1.78 to 3.59; P<0.001). Irrespective of the study group, the median gain in the CD4+ T-cell count was 114 per cubic millimeter, and the viral load was undetectable at week 50 in 96.5% of the patients. Conclusions Initiating ART 2 weeks after the start of tuberculosis treatment significantly improved survival among HIV-infected adults with CD4+ T-cell counts of 200 per cubic millimeter or lower. (Funded by the French National Agency for Research on AIDS and Viral Hepatitis and the National Institutes of Health; CAMELIA ClinicalTrials.gov number, NCT01300481.)	[Blanc, Francois-Xavier; Delfraissy, Jean-Francois] Bicetre Hosp, AP HP, Dept Internal Med, Pneumol Unit, Le Kremlin Bicetre, France; [Delfraissy, Jean-Francois] Univ Paris 11, INSERM, U1012, Le Kremlin Bicetre, France; [Sok, Thim; Laureillard, Didier; Marcy, Olivier; Chan, Sarin; Lak, Khemarin Kim; Dim, Bunnet; Sun, Sath; Fernandez, Marcelo; Goldfeld, Anne E.] Khmer Soviet Friendship Hosp, Cambodian Hlth Comm, Phnom Penh, Cambodia; [Borand, Laurence; Nerrienet, Eric; Guillard, Bertrand; Sar, Borann; Vong, Sirenda] Khmer Soviet Friendship Hosp, Inst Pasteur Cambodia, Phnom Penh, Cambodia; [Prak, Narom] Khmer Soviet Friendship Hosp, Dept Infect Dis, Phnom Penh, Cambodia; [Sin, Chhun Im] Khmer Soviet Friendship Hosp, Dept Pneumol, Phnom Penh, Cambodia; [Kim, Chindamony; Dim, Bunnet] Med Sans Frontieres, Phnom Penh, Cambodia; [Hak, Chanroeurn] Calmette Hosp, Phnom Penh, Cambodia; [Kim, Chindamony] Donkeo Prov Hosp, Takeo, Cambodia; [Lak, Khemarin Kim; Sun, Sath] Svay Rieng Prov Hosp, Svay Rieng, Cambodia; [Dim, Bunnet] Siem Reap Prov Hosp, Siem Reap, Cambodia; [Laureillard, Didier] Georges Pompidou European Hosp, AP HP, Dept Clin Immunol, Paris, France; [Rekacewicz, Claire; Delfraissy, Jean-Francois] Agence Natl Rech Sida & Hepatites Virales, Paris, France; [Madec, Yoann] Inst Pasteur, Unite Epidemiol Malad Emergentes, Paris, France; [Fox, Lawrence] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA; [Goldfeld, Anne E.] Harvard Univ, Sch Med, Childrens Hosp, Immune Dis Inst, Boston, MA USA; [Goldfeld, Anne E.] Harvard Univ, Sch Med, Childrens Hosp, Program Cellular & Mol Med, Boston, MA USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Blanc, FX (corresponding author), CHU Bicetre, Unite Fonct Pneumol, 78 Rue Gen Leclerc, F-94275 Le Kremlin Bicetre, France.	xavier.blanc@bct.aphp.fr; goldfeld@idi.harvard.edu	Goldfeld, Anne/AAF-1818-2019; Nouhin, Janin/AAS-6946-2020; Blanc, François-Xavier/D-7425-2015; Marcy, Olivier/T-3299-2019	Nouhin, Janin/0000-0003-4985-8377; Blanc, François-Xavier/0000-0001-7644-2188; Marcy, Olivier/0000-0003-3350-112X; Madec, Yoann/0000-0002-6201-1261; Laureillard, Didier/0000-0002-0104-9047	French National Agency for Research on AIDS and Viral Hepatitis [ANRS 1295]; National Institutes of Health; National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS [CIPRA KH001/DAID-ES ID 10425]; Annenberg Foundation; Aeras Global TB Vaccine Foundation; scientific team of the ANRS; logistic team of the ANRS; Organisation Franco-Cambodgienne de Pneumologie; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI061736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010425] Funding Source: NIH RePORTER	French National Agency for Research on AIDS and Viral Hepatitis(ANRS); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Annenberg Foundation; Aeras Global TB Vaccine Foundation; scientific team of the ANRS; logistic team of the ANRS; Organisation Franco-Cambodgienne de Pneumologie; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funded by the French National Agency for Research on AIDS and Viral Hepatitis and the National Institutes of Health; CAMELIA ClinicalTrials.gov number, NCT01300481.; Supported by the French National Agency for Research on AIDS and Viral Hepatitis (ANRS 1295) and the National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS (CIPRA KH001/DAID-ES ID 10425).; Dr. Delfraissy reports serving on the international board for HIV treatment of GlaxoSmithKline, Merck Sharp & Dohme-Chibret, Gilead, and Bristol-Myers Squibb; and Dr. Goldfeld, receiving funds from the Annenberg Foundation to her laboratory and to the Cambodian Health Committee to conduct studies and serving as a consultant for the Aeras Global TB Vaccine Foundation, which provides funds to the Cambodian Health Committee to conduct studies. No other potential conflict of interest relevant to this article was reported.; We thank the patients for their participation in the trial; Franoise Barre-Sinoussi for her help with initiating the CIPRA project and the CAMELIA trial and for her support throughout the trial; H. E. Eng Huot for his early and continuing support; Philippe Glaziou for providing the initial design of the study; Charles Mayaud for his clinical mentorship; Jean-Louis Sarthou for ensuring high-quality laboratory and basic scientific support during the trial; H. E. Mean Chhivun and H. E. Mao Tan Eang for the support of the Cambodian National AIDS and Tuberculosis Programs, respectively; Takmao, Kossamak, and Kampong Trach Hospitals for referring patients to the study sites; Bart Janssens, Petros Isaakidis, and Tony Reid for the support from Medecins sans Frontieres Belgium to two of our study sites (Donkeo and Siem Reap Provincial Hospitals); the data and safety monitoring board, chaired by John Modlin, and the scientific advisory board, chaired by Charles Mayaud, for their significant contributions to the study; the scientific and logistic teams of the ANRS (Brigitte Bazin, Severine Blesson, Alpha Diallo, Annie Metro, Saphonn Vonthanak, Isabelle Fournier-Nicolle, and Michel Kazatchkine) and the National Institutes of Health (Jane E. Bupp, Ray Y. Chen, Margaret Matula, Rod Hoff, Sandra Nusinoff Lehrman, Karen Near, Barbara Laughon, Mike Ussery, Trinh Ly, Mary Fanning, and Ana Martinez) for their support and intellectual contributions; and Pierre L'Her, Etienne Leroy-Terquem, the Organisation Franco-Cambodgienne de Pneumologie, Pean Polidy, Sylvia Taylor, Josephine Braun, Vincent Guillemet, Adrienne Shapiro, Catherine Quillet, Jean-Paul Dousset, Anne-Marie Taburet, Wayne Wilson, and Vincent Deubel for their support.	Cain KP, 2009, EMERG INFECT DIS, V15, P258, DOI 10.3201/eid1502.080942; Dannenberg AM, 2010, CLIN MICROBIOL REV, V23, P781, DOI 10.1128/CMR.00005-10; Ferradini L, 2007, AIDS, V21, P2293, DOI 10.1097/QAD.0b013e32828cc8b7; GOLDFELD AE, 2009, INFECT BIOL SERIES, P209; Harries AD, 2006, LANCET, V367, P944, DOI 10.1016/S0140-6736(06)68387-6; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Koenig SP, 2009, CLIN INFECT DIS, V48, P829, DOI 10.1086/597098; Kyeyune R, 2010, JAIDS-J ACQ IMM DEF, V55, P446, DOI 10.1097/QAI.0b013e3181eb611a; LANG TA, 2006, REPORT STAT MED, P115; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2009, CURR OPIN HIV AIDS, V4, P325, DOI 10.1097/COH.0b013e32832c7d61; Lawn SD, 2009, AIDS, V23, P335, DOI 10.1097/QAD.0b013e328321823f; Meintjes G, 2010, AIDS, V24, P2381, DOI 10.1097/QAD.0b013e32833dfc68; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Rouet F, 2005, J CLIN MICROBIOL, V43, P2709, DOI 10.1128/JCM.43.6.2709-2717.2005; Rouet F, 2007, JAIDS-J ACQ IMM DEF, V45, P380, DOI 10.1097/QAI.0b013e3180640cf5; Slutsky AS, 2004, NEW ENGL J MED, V350, P1143, DOI 10.1056/NEJMsb033476; Spire B, 2008, ANTIVIR THER, V13, P697; TAMURA M, 2004, 15 INT AIDS C BANGK; THAI S, 2004, 15 INT AIDS C BANGK; Thim S, 2004, JAMA-J AM MED ASSOC, V292, P566, DOI 10.1001/jama.292.5.566-c; Varma JK, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-42; Velasco M, 2009, JAIDS-J ACQ IMM DEF, V50, P148, DOI 10.1097/QAI.0b013e31819367e7; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2010, ANT THER HIV INF AD; Wood R, 2008, S AFR J HIV MED, P18; World Health Organization, 2010, GLOB TUB CONTR WHO R	33	455	467	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2011	365	16					1471	1481		10.1056/NEJMoa1013911	http://dx.doi.org/10.1056/NEJMoa1013911			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835BW	22010913	Green Accepted, Green Published			2022-12-28	WOS:000296009500001
J	Langford, NK; Ramelow, S; Prevedel, R; Munro, WJ; Milburn, GJ; Zeilinger, A				Langford, N. K.; Ramelow, S.; Prevedel, R.; Munro, W. J.; Milburn, G. J.; Zeilinger, A.			Efficient quantum computing using coherent photon conversion	NATURE			English	Article							LINEAR OPTICS; COMPUTATION; SCHEME; FIBER	Single photons are excellent quantum information carriers: they were used in the earliest demonstrations of entanglement(1) and in the production of the highest-quality entanglement reported so far(2,3). However, current schemes for preparing, processing and measuring them are inefficient. For example, down-conversion provides heralded, but randomly timed, single photons(4), and linear optics gates are inherently probabilistic(5). Here we introduce a deterministic process-coherent photon conversion (CPC)-that provides a new way to generate and process complex, multiquanta states for photonic quantum information applications. The technique uses classically pumped nonlinearities to induce coherent oscillations between orthogonal states of multiple quantum excitations. One example of CPC, based on a pumped four-wave-mixing interaction, is shown to yield a single, versatile process that provides a full set of photonic quantum processing tools. This set satisfies the DiVincenzo criteria for a scalable quantum computing architecture(6), including deterministic multiqubit entanglement gates (based on a novel form of photon-photon interaction), high-quality heralded single-and multiphoton states free from higher-order imperfections, and robust, high-efficiency detection. It can also be used to produce heralded multiphoton entanglement, create optically switchable quantum circuits and implement an improved form of down-conversion with reduced higher-order effects. Such tools are valuable building blocks for many quantum-enabled technologies. Finally, using photonic crystal fibres we experimentally demonstrate quantum correlations arising from a four-colour nonlinear process suitable for CPC and use these measurements to study the feasibility of reaching the deterministic regime with current technology(4,7). Our scheme, which is based on interacting bosonic fields, is not restricted to optical systems but could also be implemented in optomechanical, electromechanical and superconducting systems(8-12) with extremely strong intrinsic nonlinearities. Furthermore, exploiting higher-order nonlinearities with multiple pump fields yields a mechanism for multiparty mediation of the complex, coherent dynamics.	[Langford, N. K.; Ramelow, S.; Prevedel, R.; Milburn, G. J.; Zeilinger, A.] Univ Vienna, Vienna Ctr Quantum Sci & Technol, Fac Phys, A-1090 Vienna, Austria; [Langford, N. K.; Ramelow, S.; Zeilinger, A.] Austrian Acad Sci, Inst Quantum Opt & Quantum Informat, A-1090 Vienna, Austria; [Langford, N. K.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Prevedel, R.] Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada; [Munro, W. J.] Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan; [Munro, W. J.] NTT Corp, NTT Basic Res Labs, Kanagawa 2430198, Japan; [Milburn, G. J.] Univ Queensland, Ctr Engn Quantum Syst, St Lucia, Qld 4072, Australia	University of Vienna; Austrian Academy of Sciences; University of Oxford; University of Waterloo; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; Nippon Telegraph & Telephone Corporation; University of Queensland	Langford, NK (corresponding author), Univ Vienna, Vienna Ctr Quantum Sci & Technol, Fac Phys, Boltzmanngasse 5, A-1090 Vienna, Austria.	nathan.langford@univie.ac.at; anton.zeilinger@univie.ac.at	Munro, William/A-8453-2011; Prevedel, Robert/L-3377-2014; Zeilinger, Anton/A-1170-2011; Prevedel, Robert/AAP-2599-2020; MIlburn, Gerard J/B-6381-2008; Langford, Nathan K/A-5699-2012; Ramelow, Sven/H-6798-2012	Munro, William/0000-0003-1835-2250; Prevedel, Robert/0000-0003-3366-4703; Prevedel, Robert/0000-0003-3366-4703; MIlburn, Gerard J/0000-0002-5404-9681; Langford, Nathan K/0000-0003-4338-3059; Ramelow, Sven/0000-0002-7801-4440	ERC [QIT4QAD]; Austrian Science Fund [F4007]; EC (QU-ESSENCE and QAP); Vienna Doctoral Program on Complex Quantum Systems; John Templeton Foundation; Japanese FIRST programme; Ontario Ministry of Research and Innovation	ERC(European Research Council (ERC)European Commission); Austrian Science Fund(Austrian Science Fund (FWF)); EC (QU-ESSENCE and QAP)(European CommissionEuropean Commission Joint Research Centre); Vienna Doctoral Program on Complex Quantum Systems; John Templeton Foundation; Japanese FIRST programme; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	The authors would like to acknowledge discussions with T. Jennewein, A. Fedrizzi, D. R. Austin, T. Paterek, B. J. Smith, W. J. Wadsworth, M. Halder, J. G. Rarity, F. Verstraete and A. G. White. This work was supported by the ERC (Advanced Grant QIT4QAD), the Austrian Science Fund (grant F4007 and an Erwin Schroedinger Fellowship), the EC (QU-ESSENCE and QAP), the Vienna Doctoral Program on Complex Quantum Systems, the John Templeton Foundation and in part by the Japanese FIRST programme and the Ontario Ministry of Research and Innovation.	Barbieri M, 2009, J MOD OPTIC, V56, P209, DOI 10.1080/09500340802337374; Barreiro JT, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.260501; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Chang DE, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/023003; CLAUSER JF, 1978, REP PROG PHYS, V41, P1881, DOI 10.1088/0034-4885/41/12/002; Cohen O, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.123603; DiVincenzo DP, 1998, SUPERLATTICE MICROST, V23, P419, DOI 10.1006/spmi.1997.0520; Eggleton BJ, 2011, NAT PHOTONICS, V5, P141, DOI [10.1038/nphoton.2011.309, 10.1038/NPHOTON.2011.309]; Fedrizzi A, 2007, OPT EXPRESS, V15, P15377, DOI 10.1364/OE.15.015377; Franson JD, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.062302; Fulconis J, 2005, OPT EXPRESS, V13, P7572, DOI 10.1364/OPEX.13.007572; Holmes CA, 2009, FORTSCHR PHYS, V57, P1052, DOI 10.1002/prop.200900074; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Kok P, 2007, REV MOD PHYS, V79, P135, DOI 10.1103/RevModPhys.79.135; Koshino K, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.013804; Leung PM, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.042307; Marquardt F, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.205416; Moon K, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.140504; Munro WJ, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.033819; Nemoto K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.250502; PANCHARATNAM S, 1956, P INDIAN ACAD SCI A, V44, P247, DOI DOI 10.1007/BF03046050; Prevedel R, 2007, NATURE, V445, P65, DOI 10.1038/nature05346; RAUCH H, 1975, PHYS LETT A, V54, P425, DOI 10.1016/0375-9601(75)90798-7; Shapiro JH, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/1/016; SHOR PW, 1995, PHYS REV A, V52, pR2493, DOI 10.1103/PhysRevA.52.R2493; Thompson JD, 2008, NATURE, V452, P72, DOI 10.1038/nature06715; VanDevender AP, 2007, OPT EXPRESS, V15, P4677, DOI 10.1364/OE.15.004677; Walther P, 2005, NATURE, V434, P169, DOI 10.1038/nature03347; Zeilinger A., 1992, NASA C PUBLICATION, V3135, P73	30	99	100	4	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 20	2011	478	7369					360	363		10.1038/nature10463	http://dx.doi.org/10.1038/nature10463			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	21993627	Green Submitted			2022-12-28	WOS:000296021100040
J	Glass, RI; Patel, M; Parashar, U				Glass, Roger I.; Patel, Manish; Parashar, Umesh			Lessons From the US Rotavirus Vaccination Program	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHILDREN		[Patel, Manish; Parashar, Umesh] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Glass, Roger I.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Patel, M (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd,MS A34, Atlanta, GA 30333 USA.	mpatel@cdc.gov						Black Carla L., 2011, Morbidity and Mortality Weekly Report, V60, P1157; Boom JA, 2010, PEDIATRICS, V125, pE199, DOI 10.1542/peds.2009-1021; Curns AT, 2010, J INFECT DIS, V201, P1617, DOI 10.1086/652403; Lopman BA, 2011, J INFECT DIS, V204, P980, DOI 10.1093/infdis/jir492; Parashar Umesh D., 2006, Morbidity and Mortality Weekly Report, V55, P1; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Patel MM, 2011, NEW ENGL J MED, V364, P2283, DOI 10.1056/NEJMoa1012952; Richardson V, 2010, NEW ENGL J MED, V362, P299, DOI 10.1056/NEJMoa0905211; Staat MA, 2011, PEDIATRICS, V128, pE267, DOI 10.1542/peds.2010-3722; Tate JE, 2011, PEDIATR INFECT DIS J, V30, pS56, DOI 10.1097/INF.0b013e3181fefdc0	10	10	10	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 19	2011	306	15					1701	1702		10.1001/jama.2011.1475	http://dx.doi.org/10.1001/jama.2011.1475			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834MA	22009102				2022-12-28	WOS:000295963200030
J	Agarwal, R				Agarwal, Rajiv			Urine dipstick readings >= 1+had limited sensitivity but high specificity for detecting albuminuria in adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							KIDNEY-DISEASE		Indiana Univ Sch Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Agarwal, R (corresponding author), Indiana Univ Sch Med, Indianapolis, IN 46202 USA.		Agarwal, Rajiv/H-3454-2019	Agarwal, Rajiv/0000-0001-8355-7100				Agarwal R, 2005, HYPERTENSION, V46, P514, DOI 10.1161/01.HYP.0000178102.85718.66; de Zeeuw D, 2004, KIDNEY INT, V65, P2309, DOI 10.1111/j.1523-1755.2004.00653.x; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Thadhani R, 2011, AM J NEPHROL, V33, P139, DOI 10.1159/000323551	4	2	2	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2011	155	8							JC4-10	10.7326/0003-4819-155-8-201110180-02010	http://dx.doi.org/10.7326/0003-4819-155-8-201110180-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835WB	22007069				2022-12-28	WOS:000296066300009
J	Bentz, CJ				Bentz, Charles J.			A personalized, cellular phone text-messaging program increased smoking cessation at 6 months	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Legacy Hlth, Tobacco Cessat & Prevent, Portland, OR 97205 USA	Legacy Health	Bentz, CJ (corresponding author), Legacy Hlth, Tobacco Cessat & Prevent, Portland, OR 97205 USA.							Fiore MC, 2008, TREATING TOBACCO USE; Smith A, 2010, MOBILE ACCESS 2010 P, P4	2	0	0	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2011	155	8							JC4-4	10.7326/0003-4819-155-8-201110180-02004	http://dx.doi.org/10.7326/0003-4819-155-8-201110180-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835WB	22007063				2022-12-28	WOS:000296066300003
J	Chapman, JR				Chapman, Jeremy R.			The consequences of successful transplantation	LANCET			English	Editorial Material							ORGAN DONATION; RECIPIENTS; CANCER; REJECTION		Univ Sydney, Westmead Hosp, Ctr Transplant & Renal Res, Millennium Inst, Westmead, NSW 2145, Australia	University of Sydney	Chapman, JR (corresponding author), Univ Sydney, Westmead Hosp, Ctr Transplant & Renal Res, Millennium Inst, Westmead, NSW 2145, Australia.	jeremy_chapman@wsahs.nsw.gov.au						[Anonymous], 2011, DAWN            0702; [Anonymous], 2011, THESUNDAILY     0921; Delmonico FL, 2011, LANCET, V378, P1414, DOI 10.1016/S0140-6736(11)61486-4; Jardine AG, 2011, LANCET, V378, P1419, DOI 10.1016/S0140-6736(11)61334-2; Manalich R, 2009, TRANSPL P, V41, P2030, DOI 10.1016/j.transproceed.2009.06.035; McDonald S, 2008, 32 ANZDATA REG; Nakorchevsky A, 2010, J AM SOC NEPHROL, V21, P362, DOI 10.1681/ASN.2009060628; Nankivell BJ, 2004, TRANSPLANTATION, V78, P557, DOI 10.1097/01.TP.0000128636.70499.6E; Nankivell BJ, 2011, LANCET, V378, P1428, DOI 10.1016/S0140-6736(11)60699-5; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Noel L, 2010, TRANSPLANTATION, V90, P234, DOI 10.1097/TP.0b013e3181ec297b; Noel L, 2010, TRANSPLANTATION, V90, P229, DOI 10.1097/TP.0b013e3181ec29f0; Rush D, 1998, J AM SOC NEPHROL, V9, P2129; SHEIL AGR, 1977, TRANSPLANT P, V9, P1133; Vajdic CM, 2006, JAMA-J AM MED ASSOC, V296, P2823, DOI 10.1001/jama.296.23.2823; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Wong G, 2009, TRANSPLANTATION, V87, P1078, DOI 10.1097/TP.0b013e31819d32eb	17	11	11	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 15	2011	378	9800					1357	1359		10.1016/S0140-6736(10)61111-7	http://dx.doi.org/10.1016/S0140-6736(10)61111-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	838EM	22000122				2022-12-28	WOS:000296269600004
J	Nankivell, BJ; Kuypers, DRJ				Nankivell, Brian J.; Kuypers, Dirk R. J.			Organ Transplantation 3 Diagnosis and prevention of chronic kidney allograft loss	LANCET			English	Article							EARLY CYCLOSPORINE WITHDRAWAL; ANTIBODY-MEDIATED REJECTION; DECEASED-DONOR KIDNEYS; CHRONIC-RENAL-FAILURE; MYCOPHENOLATE-MOFETIL; CALCINEURIN INHIBITORS; SERUM CREATININE; PREDICTIVE-VALUE; GENE-EXPRESSION; GRAFT-SURVIVAL	Kidney transplantation is the best possible treatment for many patients with end-stage renal failure, but progressive dysfunction and eventual allograft loss with return to dialysis is associated with increased mortality and morbidity. Immune injury from acute or chronic rejection and non-immune causes, such as nephrotoxicity from calcineurin inhibitors, ischaemia-reperfusion injury, recurrent glomerular disease, and allograft BK viral infection, are potential threats. Serial monitoring of renal function enables early recognition of chronic allograft dysfunction, and investigations such as therapeutic drug concentrations, urinalysis, imaging, and a diagnostic biopsy should be undertaken before irreversible nephron loss has occurred. Specific interventions targeting the pathophysiological cause of dysfunction include strengthening of immunosuppression for chronic rejection, or calcineurin inhibitor minimisation, substitution, or elimination if nephrotoxicity dominates. Recommended proactive preventive measures are control of hypertension, proteinuria, dyslipidaemia, diabetes, smoking, and other comorbidities. Strategies to maintain transplant function and improve long-term graft survival are important goals of translational research.	[Nankivell, Brian J.] Univ Sydney, Westmead Hosp, Dept Renal Med, Sydney, NSW 2145, Australia; [Kuypers, Dirk R. J.] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Nephrol & Renal Transplantat, Louvain, Belgium	University of Sydney; KU Leuven; University Hospital Leuven	Nankivell, BJ (corresponding author), Univ Sydney, Westmead Hosp, Dept Renal Med, Sydney, NSW 2145, Australia.	brian_nankivell@wsahs.nsw.gov.au	Kuypers, Dirk RJ/D-4393-2018	Kuypers, Dirk RJ/0000-0001-5546-9680	Chugai; F Hoffmann-La Roche; Astellas	Chugai; F Hoffmann-La Roche(Hoffmann-La Roche); Astellas(Astellas Pharmaceuticals)	BJN has received lecture fees and travel expenses from Chugai. DRJK has received lecture fees and travel expenses from F Hoffmann-La Roche, and Astellas.	Abramowicz D, 2005, J AM SOC NEPHROL, V16, P2234, DOI 10.1681/ASN.2004100844; Akioka Y, 2009, CLIN TRANSPLANT, V23, P2, DOI 10.1111/j.1399-0012.2009.01000.x; Anglicheau D, 2008, TRANSPLANTATION, V86, P192, DOI 10.1097/TP.0b013e31817eef7b; Ansell D, 2007, AM J TRANSPLANT, V7, P1167, DOI 10.1111/j.1600-6143.2007.01745.x; Arjona A, 2009, DRUG NEWS PERSPECT, V22, P409, DOI 10.1358/dnp.2009.22.7.1401356; Bestard O, 2008, J AM SOC NEPHROL, V19, P1419, DOI 10.1681/ASN.2007050539; Briganti EM, 2002, NEW ENGL J MED, V347, P103, DOI 10.1056/NEJMoa013036; Bunnapradist S, 2008, CLIN TRANSPLANT, V22, P815, DOI 10.1111/j.1399-0012.2008.00892.x; Butler JA, 2004, TRANSPLANTATION, V77, P769, DOI 10.1097/01.TP.0000110408.83054.88; Canaud G, 2009, AM J TRANSPLANT, V9, P1081, DOI 10.1111/j.1600-6143.2009.02580.x; Cherukuri A, 2010, TRANSPLANTATION, V89, P200, DOI 10.1097/TP.0b013e3181c352c5; Colvin RB, 2007, J AM SOC NEPHROL, V18, P1046, DOI 10.1681/ASN.2007010073; Cosio FG, 2005, AM J TRANSPLANT, V5, P2464, DOI 10.1111/j.1600-6143.2005.01050.x; Cross NB, 2009, TRANSPLANTATION, V88, P7, DOI 10.1097/TP.0b013e3181a9e960; de Vries APJ, 2006, AM J TRANSPLANT, V6, P364, DOI 10.1111/j.1600-6143.2005.01192.x; Dudley C, 2005, TRANSPLANTATION, V79, P466, DOI 10.1097/01.TP.0000151632.21551.00; Dupont PJ, 2007, TRANSPLANTATION, V84, P351, DOI 10.1097/01.tp.0000275377.09660.fa; Einecke G, 2010, J CLIN INVEST, V120, P1862, DOI 10.1172/JCI41789; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; El-Zoghby ZM, 2009, AM J TRANSPLANT, V9, P527, DOI 10.1111/j.1600-6143.2008.02519.x; Fine RN, 2009, AM J TRANSPLANT, V9, P35, DOI 10.1111/j.1600-6143.2008.02495.x; Flechner SM, 2008, CLIN TRANSPLANT, V22, P1, DOI 10.1111/j.1399-0012.2007.00739.x; Gasser M, 2000, Ann Transplant, V5, P61; Giessing M, 2009, J AM SOC NEPHROL, V20, P37, DOI 10.1681/ASN.2008040423; Gourishankar S, 2010, AM J TRANSPLANT, V10, P324, DOI 10.1111/j.1600-6143.2009.02954.x; Grebe SO, 2002, CURR DRUG METAB, V3, P189, DOI 10.2174/1389200024605109; Hall IE, 2010, J AM SOC NEPHROL, V21, P189, DOI 10.1681/ASN.2009030264; Halloran PF, 2004, NEW ENGL J MED, V351, P2715, DOI 10.1056/NEJMra033540; Hazzan M, 2005, J AM SOC NEPHROL, V16, P2509, DOI 10.1681/ASN.2005030312; He X, 2009, TRANSPLANTATION, V87, P384, DOI 10.1097/TP.0b013e31819004a1; Heinze G, 2006, J AM SOC NEPHROL, V17, P889, DOI 10.1681/ASN.2005090955; Hernandez D, 2009, TRANSPLANTATION, V88, P803, DOI 10.1097/TP.0b013e3181b4ac2f; Hu M, 2008, J IMMUNOL, V180, P6593, DOI 10.4049/jimmunol.180.10.6593; Ivanyi B, 2008, NAT CLIN PRACT NEPHR, V4, P446, DOI 10.1038/ncpneph0854; Johnston O, 2010, TRANSPLANTATION, V89, P1057, DOI 10.1097/TP.0b013e3181d0e15e; Kaplan B, 2003, AM J TRANSPLANT, V3, P1560, DOI 10.1046/j.1600-6135.2003.00275.x; Kasiske BL, 2010, KIDNEY INT, V77, P299, DOI 10.1038/ki.2009.377; Kasiske BL, 2002, AM J KIDNEY DIS, V39, P762, DOI 10.1053/ajkd.2002.31996; Kauffman HM, 2007, TRANSPLANTATION, V83, P404, DOI 10.1097/01.tp.0000251780.01031.81; King KE, 2004, CURR OPIN IMMUNOL, V16, P545, DOI 10.1016/j.coi.2004.07.004; Knight SR, 2010, TRANSPLANTATION, V89, P1, DOI 10.1097/TP.0b013e3181c518cc; Knight SR, 2009, TRANSPLANTATION, V87, P785, DOI 10.1097/TP.0b013e3181952623; Kowalski RJ, 2006, TRANSPLANTATION, V82, P663, DOI 10.1097/01.tp.0000234837.02126.70; Lee PC, 2009, TRANSPLANTATION, V88, P568, DOI 10.1097/TP.0b013e3181b11b72; Li BG, 2001, NEW ENGL J MED, V344, P947, DOI 10.1056/NEJM200103293441301; Ling XB, 2010, J AM SOC NEPHROL, V21, P646, DOI 10.1681/ASN.2009080876; Marcen R, 2009, TRANSPLANTATION, V87, P1340, DOI 10.1097/TP.0b013e3181a23837; McDonald S, 2007, AM J TRANSPLANT, V7, P1201, DOI 10.1111/j.1600-6143.2007.01759.x; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P1289, DOI 10.1111/j.1600-6143.2004.00515.x; Mengel M, 2009, AM J TRANSPLANT, V9, P1859, DOI 10.1111/j.1600-6143.2009.02727.x; Mengel M, 2010, CURR OPIN NEPHROL HY, V19, P260, DOI 10.1097/MNH.0b013e3283381ea5; Moers C, 2009, NEW ENGL J MED, V360, P7, DOI 10.1056/NEJMoa0802289; Moore J, 2009, TRANSPLANTATION, V87, P591, DOI 10.1097/TP.0b013e318195a421; Moroni G, 2010, TRANSPL INT, V23, P208, DOI 10.1111/j.1432-2277.2009.00977.x; Morrissey PE, 2007, DRUGS, V67, P1463, DOI 10.2165/00003495-200767100-00007; Mota A, 2004, AM J TRANSPLANT, V4, P953, DOI 10.1111/j.1600-6143.2004.00446.x; Muthukumar T, 2005, NEW ENGL J MED, V353, P2342, DOI 10.1056/NEJMoa051907; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Nankivell BJ, 2006, AM J TRANSPLANT, V6, P2006, DOI 10.1111/j.1600-6143.2006.01436.x; Nankivell BJ, 2006, TRANSPLANTATION, V81, P643, DOI 10.1097/01.tp.0000190423.82154.01; Nankivell BJ, 2004, TRANSPLANTATION, V78, P557, DOI 10.1097/01.TP.0000128636.70499.6E; Nankivell BJ, 2001, CLIN TRANSPLANT, V15, P11, DOI 10.1034/j.1399-0012.2001.150103.x; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Navaneethan SD, 2009, COCHRANE DB SYST REV, V2; Ojo AO, 2003, NEW ENGL J MED, V349, P931, DOI 10.1056/NEJMoa021744; Pascual J, 2008, AM J KIDNEY DIS, V52, P553, DOI 10.1053/j.ajkd.2008.06.005; Pascual J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005632.pub2; Prendergast MB, 2010, CLIN J AM SOC NEPHRO, V5, P1305, DOI 10.2215/CJN.07241009; Radermacher J, 2003, NEW ENGL J MED, V349, P115, DOI 10.1056/NEJMoa022602; Rao PS, 2007, AM J KIDNEY DIS, V49, P294, DOI 10.1053/j.ajkd.2006.11.022; Rao PS, 2009, CLIN J AM SOC NEPHRO, V4, P1827, DOI 10.2215/CJN.02270409; Rao PS, 2009, TRANSPLANTATION, V88, P231, DOI 10.1097/TP.0b013e3181ac620b; Roodnat JI, 2009, AM J TRANSPLANT, V9, P2150, DOI 10.1111/j.1600-6143.2009.02745.x; Schena FP, 2009, TRANSPLANTATION, V87, P233, DOI 10.1097/TP.0b013e3181927a41; Schroppel B, 2010, J AM SOC NEPHROL, V21, P536, DOI 10.1681/ASN.2009040390; Schwarz A, 2005, AM J TRANSPLANT, V5, P1992, DOI 10.1111/j.1600-6143.2005.00988.x; Seron D, 2008, TRANSPLANTATION, V86, P82, DOI 10.1097/TP.0b013e318174428d; Shihab FS, 2008, TRANSPLANTATION, V85, P1261, DOI 10.1097/TP.0b013e31816b4388; Sigdel TK, 2010, PROTEOM CLIN APPL, V4, P32, DOI 10.1002/prca.200900124; Sis B, 2007, AM J TRANSPLANT, V7, P1743, DOI 10.1111/j.1600-6143.2007.01836.x; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; Sis B, 2009, AM J TRANSPLANT, V9, P2312, DOI 10.1111/j.1600-6143.2009.02761.x; Solez K, 2007, AM J TRANSPLANT, V7, P518, DOI 10.1111/j.1600-6143.2006.01688.x; Stegall MD, 2010, CURR OPIN ORGAN TRAN, V15, P8, DOI 10.1097/MOT.0b013e3283342712; Tedla Fasika, 2007, J Clin Hypertens (Greenwich), V9, P538, DOI 10.1111/j.1524-6175.2007.06588.x; Webster A, 2010, COCHRANE DB SYST REV, V1; Webster AC, 2005, BMJ-BRIT MED J, V331, P810, DOI 10.1136/bmj.38569.471007.AE; Weimer R, 2006, AM J TRANSPLANT, V6, P1865, DOI 10.1111/j.1600-6143.2006.01407.x; White CA, 2008, AM J KIDNEY DIS, V51, P1005, DOI 10.1053/j.ajkd.2008.02.308; White CA, 2010, CLIN CHEM, V56, P474, DOI 10.1373/clinchem.2009.135111; Zeier M, 2002, J AM SOC NEPHROL, V13, P2570, DOI 10.1097/01.ASN.0000030078.74889.69	91	231	242	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 15	2011	378	9800					1428	1437		10.1016/S0140-6736(11)60699-5	http://dx.doi.org/10.1016/S0140-6736(11)60699-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	838EM	22000139				2022-12-28	WOS:000296269600030
J	Sadek, AR; Gray, WP				Sadek, Ahmed-Ramadan; Gray, William Peter			Chopping and changing: long-term results of epilepsy surgery	LANCET			English	Editorial Material							TEMPORAL-LOBE EPILEPSY; FOLLOW-UP; LOBECTOMY; SCLEROSIS		[Sadek, Ahmed-Ramadan; Gray, William Peter] Southampton Univ Hosp NHS Trust, Wessex Neurol Ctr, Southampton, Hants, England; [Sadek, Ahmed-Ramadan; Gray, William Peter] Univ Southampton, Div Clin Neurosci, Fac Med, Southampton SO16 6YD, Hants, England	University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton	Sadek, AR (corresponding author), Southampton Univ Hosp NHS Trust, Wessex Neurol Ctr, Southampton, Hants, England.	w.p.gray@soton.ac.uk		Gray, William/0000-0001-7595-8887	Medical Research Council [G0801418B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Cohen-Gadol AA, 2006, J NEUROSURG, V104, P513, DOI 10.3171/jns.2006.104.4.513; de Tisi J, 2011, LANCET, V378, P1388, DOI 10.1016/S0140-6736(11)60890-8; Duncan JS, 2010, NAT REV NEUROL, V6, P537, DOI 10.1038/nrneurol.2010.131; ELWES RDC, 1991, J NEUROL NEUROSUR PS, V54, P949, DOI 10.1136/jnnp.54.11.949; Engel J, 1996, NEW ENGL J MED, V334, P647, DOI 10.1056/NEJM199603073341008; Engel J., 1993, WHO SHOULD BE SURG C; Janszky J, 2005, EPILEPSY RES, V64, P35, DOI 10.1016/j.eplepsyres.2005.02.004; Lee SA, 2006, SEIZURE-EUR J EPILEP, V15, P397, DOI 10.1016/j.seizure.2006.05.003; McIntosh AM, 2004, BRAIN, V127, P2018, DOI 10.1093/brain/awh221; Salanova V, 1999, EPILEPSIA, V40, P1417, DOI 10.1111/j.1528-1157.1999.tb02014.x; Salanova V, 1996, BRAIN, V119, P989, DOI 10.1093/brain/119.3.989; Tellez-Zenteno JF, 2005, BRAIN, V128, P1188, DOI 10.1093/brain/awh449; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501	13	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 15	2011	378	9800					1360	1362		10.1016/S0140-6736(11)61593-6	http://dx.doi.org/10.1016/S0140-6736(11)61593-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	838EM	22000124				2022-12-28	WOS:000296269600006
J	Zaher, HS; Green, R				Zaher, Hani S.; Green, Rachel			A Primary Role for Release Factor 3 in Quality Control during Translation Elongation in Escherichia coli	CELL			English	Article							PEPTIDYL-TRANSFER-RNA; STOP CODON RECOGNITION; FACTOR RF3; CHAIN TERMINATION; MESSENGER-RNA; GTPASE ACTIVITY; IN-VITRO; P-SITE; RIBOSOME; DISSOCIATION	Release factor 3 (RF3) is a GTPase found in a broad range of bacteria where it is thought to play a critical "recycling" role in translation by facilitating the removal of class 1 release factors (RF1 and RF2) from the ribosome following peptide release. More recently, RF3 was shown in vitro to stimulate a retrospective editing reaction on the bacterial ribosome wherein peptides carrying mistakes are prematurely terminated during protein synthesis. Here, we examine the role of RF3 in the bacterial cell and show that the deletion of this gene sensitizes cells to other perturbations that reduce the overall fidelity of protein synthesis. We further document substantial effects on mRNA stability and protein expression using reporter systems, native mRNAs and proteins. We conclude that RF3 plays a primary role in vivo in specifying the fidelity of protein synthesis thus impacting overall protein quantity and quality.	[Zaher, Hani S.; Green, Rachel] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Green, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	ragreen@jhmi.edu			NIH [K99/R00]; HHMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059425, K99GM094210, R00GM094210] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Beth Rogers for help in preparing reagents; Allen Buskirk, Nick Guydosh, and Chris Shoemaker for comments on the manuscript; Tord Hagervall (Umea University, Sweden) for strain JK463; Phil Farabaugh (University of Maryland) for the hyperaccurate and error-prone strains; and the Keio collection (Japan) for strain JW5873. The work was supported by the NIH and HHMI (R.G.) and an NIH K99/R00 (H.S.Z.)	ADAMSKI FM, 1994, J MOL BIOL, V238, P302, DOI 10.1006/jmbi.1994.1293; ANDERSSON DI, 1982, MOL GEN GENET, V187, P467, DOI 10.1007/BF00332630; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; CAPECCHI MR, 1967, P NATL ACAD SCI USA, V58, P1144, DOI 10.1073/pnas.58.3.1144; CAPECCHI MR, 1969, COLD SPRING HARB SYM, V34, P469, DOI 10.1101/SQB.1969.034.01.053; CASKEY T, 1969, COLD SPRING HARB SYM, V34, P479, DOI 10.1101/SQB.1969.034.01.054; CRAIGEN WJ, 1986, NATURE, V322, P273, DOI 10.1038/322273a0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eyler DE, 2011, RNA, V17, P925, DOI 10.1261/rna.2623711; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Freistroffer DV, 1997, EMBO J, V16, P4126, DOI 10.1093/emboj/16.13.4126; Gao HX, 2007, CELL, V129, P929, DOI 10.1016/j.cell.2007.03.050; GRENTZMANN G, 1995, J BIOL CHEM, V270, P10595, DOI 10.1074/jbc.270.18.10595; GRENTZMANN G, 1994, P NATL ACAD SCI USA, V91, P5848, DOI 10.1073/pnas.91.13.5848; Heurgue-Hamard V, 2000, EMBO J, V19, P2701, DOI 10.1093/emboj/19.11.2701; Heurgue-Hamard V, 1998, EMBO J, V17, P808, DOI 10.1093/emboj/17.3.808; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Ito K, 1996, P NATL ACAD SCI USA, V93, P5443, DOI 10.1073/pnas.93.11.5443; Jahn CE, 2008, J MICROBIOL METH, V75, P318, DOI 10.1016/j.mimet.2008.07.004; Janssen BD, 2009, J MOL BIOL, V394, P251, DOI 10.1016/j.jmb.2009.09.020; JORGENSEN F, 1993, J MOL BIOL, V230, P41, DOI 10.1006/jmbi.1993.1124; Karimi R, 1996, EMBO J, V15, P1149, DOI 10.1002/j.1460-2075.1996.tb00453.x; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Kisselev L, 2003, EMBO J, V22, P175, DOI 10.1093/emboj/cdg017; Klaholz BP, 2004, NATURE, V427, P862, DOI 10.1038/nature02332; Kramer EB, 2010, RNA, V16, P1797, DOI 10.1261/rna.2201210; Margus T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-15; Mathews MB, 2007, TRANSLATIONAL CONTRO, V1, P1; MIKUNI O, 1994, P NATL ACAD SCI USA, V91, P5798, DOI 10.1073/pnas.91.13.5798; MILMAN G, 1969, P NATL ACAD SCI USA, V63, P183, DOI 10.1073/pnas.63.1.183; Mora L, 2003, MOL MICROBIOL, V50, P1467, DOI 10.1046/j.1365-2958.2003.03799.x; Nakamura Y, 1996, CELL, V87, P147, DOI 10.1016/S0092-8674(00)81331-8; Nogueira T, 2001, J MOL BIOL, V310, P709, DOI 10.1006/jmbi.2001.4796; Pisareva VP, 2006, J BIOL CHEM, V281, P40224, DOI 10.1074/jbc.M607461200; PRECUP J, 1987, J BIOL CHEM, V262, P11351; RON EZ, 1966, SCIENCE, V153, P1119, DOI 10.1126/science.153.3740.1119; STERNBERG N, 1983, ANNU REV GENET, V17, P123, DOI 10.1146/annurev.ge.17.120183.001011; THOMPSON RC, 1982, P NATL ACAD SCI-BIOL, V79, P4922, DOI 10.1073/pnas.79.16.4922; Watanabe Y, 2010, FEBS LETT, V584, P790, DOI 10.1016/j.febslet.2009.12.048; Youngman EM, 2007, MOL CELL, V28, P533, DOI 10.1016/j.molcel.2007.09.015; Zaher HS, 2010, RNA, V16, P1980, DOI 10.1261/rna.2241810; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582; Zaher HS, 2004, BIOCHEMISTRY-US, V43, P7873, DOI 10.1021/bi0497300; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3; Zavialov AV, 2003, CELL, V114, P113, DOI 10.1016/S0092-8674(03)00478-1; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6	47	39	40	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 14	2011	147	2					396	408		10.1016/j.cell.2011.08.045	http://dx.doi.org/10.1016/j.cell.2011.08.045			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000017	Green Accepted, Bronze			2022-12-28	WOS:000296199300017
J	Chalmers, JD; Hill, AT				Chalmers, James D.; Hill, Adam T.			RATIONAL TESTING Investigation of "non-responding" presumed lower respiratory tract infection in primary care	BRITISH MEDICAL JOURNAL			English	Editorial Material							COMMUNICATION-SKILLS; GENERAL-PRACTICE; ACUTE COUGH; MANAGEMENT		[Chalmers, James D.; Hill, Adam T.] Royal Infirm Edinburgh NHS Trust, Dept Resp Med, Edinburgh EH16 4SA, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh	Chalmers, JD (corresponding author), Royal Infirm Edinburgh NHS Trust, Dept Resp Med, Edinburgh EH16 4SA, Midlothian, Scotland.	jamesdchalmers@googlemail.com		Chalmers, James/0000-0001-5514-7868				Butler CC, 2011, EUR RESPIR J, V38, P119, DOI 10.1183/09031936.00133910; Butler CC, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2242; Cals JWL, 2007, PATIENT EDUC COUNS, V68, P270, DOI 10.1016/j.pec.2007.06.014; Cals JWL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1374; Fahey T, 1998, BRIT MED J, V316, P906, DOI 10.1136/bmj.316.7135.906; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Macfarlane J, 1997, BRIT MED J, V315, P1206, DOI 10.1136/bmj.315.7117.1206; Macfarlane J, 2000, THORAX, V55, P153, DOI 10.1136/thorax.55.2.153; Macfarlane J, 1997, BMJ-BRIT MED J, V315, P1211, DOI 10.1136/bmj.315.7117.1211; O'Brien William T Sr, 2006, J Am Coll Radiol, V3, P703, DOI 10.1016/j.jacr.2006.02.007; Pasteur MC, 2010, THORAX, V65, pI1, DOI 10.1136/thx.2010.136119; Stoller JK, 2002, NEW ENGL J MED, V346, P988, DOI 10.1056/NEJMcp012477	12	7	7	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 13	2011	343								d5840	10.1136/bmj.d5840	http://dx.doi.org/10.1136/bmj.d5840			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	835EQ	21998344				2022-12-28	WOS:000296018300001
J	McGowan, K				McGowan, Kat			MASTERCLASS The gathering brainstorm	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 13	2011	478	7368					S19	S20		10.1038/478S19a	http://dx.doi.org/10.1038/478S19a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21993822	Bronze			2022-12-28	WOS:000295782800012
J	Vais, H; Foskett, JK; Mak, DOD				Vais, Horia; Foskett, J. Kevin; Mak, Don-On Daniel			InsP(3)R channel gating altered by clustering?	NATURE			English	Letter							CA2+; INACTIVATION; RECRUITMENT; ACTIVATION; IP3		[Vais, Horia; Foskett, J. Kevin; Mak, Don-On Daniel] Univ Penn, Dept Physiol, Perleman Sch Med, Philadelphia, PA 19104 USA; [Foskett, J. Kevin] Univ Penn, Dept Cell & Dev Biol, Perleman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Vais, H (corresponding author), Univ Penn, Dept Physiol, Perleman Sch Med, Philadelphia, PA 19104 USA.	dmak@mail.med.upenn.edu	Foskett, Kevin/R-2549-2019	Foskett, J. Kevin/0000-0002-8854-0268	NIGMS NIH HHS [R01 GM074999, R01 GM065830, R01 GM074999-05S1, R01 GM065830-08] Funding Source: Medline; NIMH NIH HHS [R01 MH059937-11, R01 MH059937] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074999, R01GM065830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059937] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ionescu L, 2006, J PHYSIOL-LONDON, V573, P645, DOI 10.1113/jphysiol.2006.109504; Kenyon JL, 2000, J NEUROSCI METH, V96, P105, DOI 10.1016/S0165-0270(99)00189-2; Mak DOD, 2000, J GEN PHYSIOL, V115, P241, DOI 10.1085/jgp.115.3.241; Mak DOD, 1997, J GEN PHYSIOL, V109, P571, DOI 10.1085/jgp.109.5.571; Mak DOD, 1998, P NATL ACAD SCI USA, V95, P15821, DOI 10.1073/pnas.95.26.15821; Mak DOD, 2001, J GEN PHYSIOL, V117, P435, DOI 10.1085/jgp.117.5.435; Rahman T, 2009, CHANNELS, V3, P226, DOI 10.4161/chan.3.4.9247; TaufiqUrRahman, 2009, NATURE, V458, P655, DOI 10.1038/nature07763; Vais H, 2010, BIOPHYS J, V99, P407, DOI 10.1016/j.bpj.2010.04.034	9	7	7	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2011	478	7368					E1	E2		10.1038/nature10493	http://dx.doi.org/10.1038/nature10493			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21993761	Green Accepted			2022-12-28	WOS:000295782800001
J	Suntivich, J; May, KJ; Gasteiger, HA; Goodenough, JB; Shao-Horn, Y				Suntivich, Jin; May, Kevin J.; Gasteiger, Hubert A.; Goodenough, John B.; Shao-Horn, Yang			A Perovskite Oxide Optimized for Oxygen Evolution Catalysis from Molecular Orbital Principles	SCIENCE			English	Article							ROTATING-DISK ELECTRODE; REDUCTION ACTIVITY; ALKALINE-SOLUTIONS; FUEL-CELLS; ELECTROCATALYSIS; TEMPERATURE; BATTERIES; SURFACES; PLANET; WATER	The efficiency of many energy storage technologies, such as rechargeable metal-air batteries and hydrogen production from water splitting, is limited by the slow kinetics of the oxygen evolution reaction (OER). We found that Ba(0.5)Sr(0.5)Co(0.8)Fe(0.2)O(3-delta) (BSCF) catalyzes the OER with intrinsic activity that is at least an order of magnitude higher than that of the state-of-the-art iridium oxide catalyst in alkaline media. The high activity of BSCF was predicted from a design principle established by systematic examination of more than 10 transition metal oxides, which showed that the intrinsic OER activity exhibits a volcano-shaped dependence on the occupancy of the 3d electron with an e(g) symmetry of surface transition metal cations in an oxide. The peak OER activity was predicted to be at an e(g) occupancy close to unity, with high covalency of transition metal-oxygen bonds.	[Suntivich, Jin; Shao-Horn, Yang] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Suntivich, Jin; May, Kevin J.; Gasteiger, Hubert A.; Shao-Horn, Yang] MIT, Electrochem Energy Lab, Cambridge, MA 02139 USA; [May, Kevin J.; Gasteiger, Hubert A.; Shao-Horn, Yang] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Goodenough, John B.] Univ Texas Austin, Texas Mat Inst, Austin, TX 78712 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Texas System; University of Texas Austin	Shao-Horn, Y (corresponding author), MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.	shaohorn@mit.edu	Gasteiger, Hubert/Y-8338-2019; Biradar, Nirmala/AAY-2295-2020; May, Kevin Joseph/AAD-5896-2020	Gasteiger, Hubert/0000-0001-8199-8703; May, Kevin Joseph/0000-0002-1082-8333; /0000-0002-3427-4363; Goodenough, John Bannister/0000-0001-9350-3034	Chesonis Foundation; Natural Sciences and Engineering Research Council of Canada; Robert A. Welch Foundation; U.S. Department of Energy Hydrogen Initiative [DE-FG02-05ER15728]; MRSEC of the National Science Foundation [DMR 08-019762]; U.S. Department of Energy, Division of Material Sciences and Division of Chemical Sciences [DE-AC02-98CH10886]; Office of Naval Research	Chesonis Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Robert A. Welch Foundation(The Welch Foundation); U.S. Department of Energy Hydrogen Initiative(United States Department of Energy (DOE)); MRSEC of the National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy, Division of Material Sciences and Division of Chemical Sciences(United States Department of Energy (DOE)); Office of Naval Research(Office of Naval Research)	Supported by a Chesonis Foundation Fellowship (J.S.), a Natural Sciences and Engineering Research Council of Canada postgraduate scholarship (K.J.M.), the Robert A. Welch Foundation (J.B.G.), and the U.S. Department of Energy Hydrogen Initiative program under award DE-FG02-05ER15728. The research made use of the Shared Experimental Facilities supported by the MRSEC Program of the National Science Foundation under award DMR 08-019762. We acknowledge collaboration with H. Nakanishi (Toyota Motor Corporation). We thank Y. Lee, N. Yabuuchi, and L. Wang (oxide synthesis), D. G. Kwabi and A. N. Mansour (x-ray absorption), C. K. Brozek and M. Dinca (surface area measurements), and Exponent (thermogravimetry). The National Synchrotron Light Source is supported by the U.S. Department of Energy, Division of Material Sciences and Division of Chemical Sciences, under contract DE-AC02-98CH10886. Beamline X11 is supported by the Office of Naval Research and contributions from Participating Research Team members. A patent related to this invention has been filed.	Armand M, 2008, NATURE, V451, P652, DOI 10.1038/451652a; Ballhausen CJ, 1962, INORG CHEM, V1, P111, DOI 10.1021/ic50001a022; Betley TA, 2008, INORG CHEM, V47, P1849, DOI 10.1021/ic701972n; BOCKRIS JO, 1984, J ELECTROCHEM SOC, V131, P290, DOI 10.1149/1.2115565; DAVIDSON CR, 1982, J ELECTROANAL CHEM, V132, P129, DOI 10.1016/0022-0728(82)85012-2; Gasteiger HA, 2005, APPL CATAL B-ENVIRON, V56, P9, DOI 10.1016/j.apcatb.2004.06.021; Gasteiger HA, 2009, SCIENCE, V324, P48, DOI 10.1126/science.1172083; Gray HB, 2009, NAT CHEM, V1, P7, DOI 10.1038/nchem.141; Hammer B, 2000, ADV CATAL, V45, P71; Harvey AS, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/1/015801; Harvey AS, 2009, PHYS CHEM CHEM PHYS, V11, P3090, DOI 10.1039/b819414a; Kanan MW, 2008, SCIENCE, V321, P1072, DOI 10.1126/science.1162018; Koper MTM, 2011, J ELECTROANAL CHEM, V660, P254, DOI 10.1016/j.jelechem.2010.10.004; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Lu YC, 2010, J AM CHEM SOC, V132, P12170, DOI 10.1021/ja1036572; Man IC, 2011, CHEMCATCHEM, V3, P1159, DOI 10.1002/cctc.201000397; MATSUMOTO Y, 1980, J ELECTROCHEM SOC, V127, P811, DOI 10.1149/1.2129762; MATSUMOTO Y, 1979, J ELECTROANAL CHEM, V102, P77, DOI 10.1016/S0022-0728(79)80031-5; MATSUMOTO Y, 1979, ELECTROCHIM ACTA, V24, P421, DOI 10.1016/0013-4686(79)87030-9; Rossmeisl J, 2007, J ELECTROANAL CHEM, V607, P83, DOI 10.1016/j.jelechem.2006.11.008; Schmidt TJ, 1998, J ELECTROCHEM SOC, V145, P2354, DOI 10.1149/1.1838642; Shao ZP, 2004, NATURE, V431, P170, DOI 10.1038/nature02863; Stamenkovic VR, 2007, SCIENCE, V315, P493, DOI 10.1126/science.1135941; Suntivich J, 2011, NAT CHEM, V3, P546, DOI 10.1038/nchem.1069; Suntivich J, 2010, J ELECTROCHEM SOC, V157, pB1263, DOI 10.1149/1.3456630; TRASATTI S, 1980, J ELECTROANAL CHEM, V111, P125, DOI 10.1016/s0022-0728(80)80084-2; WATTIAUX A, 1987, J ELECTROCHEM SOC, V134, P1714, DOI 10.1149/1.2100741; Yan JQ, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.014402	28	3459	3490	184	4242	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2011	334	6061					1383	1385		10.1126/science.1212858	http://dx.doi.org/10.1126/science.1212858			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858HW	22033519				2022-12-28	WOS:000297787700047
J	Vivian, JP; Duncan, RC; Berry, R; O'Connor, GM; Reid, HH; Beddoe, T; Gras, S; Saunders, PM; Olshina, MA; Widjaja, JML; Harpur, CM; Lin, J; Maloveste, SM; Price, DA; Lafont, BAP; McVicar, DW; Clements, CS; Brooks, AG; Rossjohn, J				Vivian, Julian P.; Duncan, Renee C.; Berry, Richard; O'Connor, Geraldine M.; Reid, Hugh H.; Beddoe, Travis; Gras, Stephanie; Saunders, Philippa M.; Olshina, Maya A.; Widjaja, Jacqueline M. L.; Harpur, Christopher M.; Lin, Jie; Maloveste, Sebastien M.; Price, David A.; Lafont, Bernard A. P.; McVicar, Daniel W.; Clements, Craig S.; Brooks, Andrew G.; Rossjohn, Jamie			Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B	NATURE			English	Article							COMPLEX CLASS-I; HLA-B; CRYSTAL-STRUCTURE; POLYMORPHISMS; PROGRESSION; MOLECULES; SELECTION; SUBTYPES; HISTORY; KIR3DS1	Members of the killer cell immunoglobulin-like receptor (KIR) family, a large group of polymorphic receptors expressed on natural killer (NK) cells, recognize particular peptide-laden human leukocyte antigen (pHLA) class I molecules and have a pivotal role in innate immune responses(1). Allelic variation and extensive polymorphism within the three-domain KIR family (KIR3D, domains D0-D1-D2) affects pHLA binding specificity and is linked to the control of viral replication and the treatment outcome of certain haematological malignancies(1-3). Here we describe the structure of a human KIR3DL1 receptor bound to HLA-B*5701 complexed with a self-peptide. KIR3DL1 clamped around the carboxy-terminal end of the HLA-B*5701 antigen-binding cleft, resulting in two discontinuous footprints on the pHLA. First, the D0 domain, a distinguishing feature of the KIR3D family, extended towards beta 2-microglobulin and abutted a region of the HLA molecule with limited polymorphism, thereby acting as an 'innate HLA sensor' domain. Second, whereas the D2-HLAB*5701 interface exhibited a high degree of complementarity, the D1-pHLA-B*5701 contacts were suboptimal and accommodated a degree of sequence variation both within the peptide and the polymorphic region of the HLA molecule. Although the two-domain KIR (KIR2D) and KIR3DL1 docked similarly onto HLA-C-4,C-5 and HLA-B respectively, the corresponding D1-mediated interactions differed markedly, thereby providing insight into the specificity of KIR3DL1 for discrete HLA-A and HLA-B allotypes. Collectively, in association with extensive mutagenesis studies at the KIR3DL1-pHLA-B*5701 interface, we provide a framework for understanding the intricate interplay between peptide variability, KIR3D and HLA polymorphism in determining the specificity requirements of this essential innate interaction that is conserved across primate species.	[Saunders, Philippa M.; Widjaja, Jacqueline M. L.; Harpur, Christopher M.; Lin, Jie; Brooks, Andrew G.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Vivian, Julian P.; Duncan, Renee C.; Berry, Richard; Reid, Hugh H.; Beddoe, Travis; Gras, Stephanie; Olshina, Maya A.; Clements, Craig S.; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [O'Connor, Geraldine M.; McVicar, Daniel W.] NCI, Canc & Inflammat Program, Frederick, MD 21702 USA; [Maloveste, Sebastien M.; Lafont, Bernard A. P.] NIAID, Nonhuman Primate Immunogenet & Cellular Immunol U, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Price, David A.; Rossjohn, Jamie] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff CF14 4XN, S Glam, Wales; [Price, David A.] NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	University of Melbourne; Monash University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cardiff University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Brooks, AG (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	agbrooks@unimelb.edu.au; jamie.rossjohn@monash.edu	Rossjohn, Jamie/F-9032-2013; McVicar, Daniel/G-1970-2015; gras, stephanie/C-8307-2013; Lafont, Bernard A. P./B-7236-2014; Beddoe, Travis/F-3415-2014; Price, David A/C-7876-2013	Rossjohn, Jamie/0000-0002-2020-7522; Lafont, Bernard A. P./0000-0003-2140-6205; Beddoe, Travis/0000-0003-4550-2277; Price, David A/0000-0001-9416-2737; Widjaja, Jacqueline/0000-0002-4946-5584; gras, stephanie/0000-0001-7416-038X; Brooks, Andrew/0000-0002-4085-9683; Harpur, Chris/0000-0002-3238-9861; Vivian, Julian/0000-0002-9400-4437; O'Connor, Geraldine/0000-0002-7440-162X; McVicar, Daniel/0000-0002-1112-5111; berry, richard/0000-0001-7043-0469	National Health and Medical Research Council of Australia (NHMRC); Australian Research Council (ARC); National Cancer Institute, National Institutes of Health; National Institute of Allergy and Infectious Diseases, National Institutes of Health; National Institutes of Health; NHMRC; Medical Research Council (UK); ARC QEII; Medical Research Council [G0501963] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [ZIABC010747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001026] Funding Source: NIH RePORTER; MRC [G0501963] Funding Source: UKRI	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ARC QEII(Australian Research Council); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the staff at the MX2 beamline of the Australian synchrotron for assistance with data collection. We thank A. Radu Aricescu for the gift of the pHLsec vector. This research was supported by the National Health and Medical Research Council of Australia (NHMRC), the Australian Research Council (ARC) and the Intramural Research Programs of the National Cancer Institute and the National Institute of Allergy and Infectious Diseases, National Institutes of Health. D. W. M. and G.M.O'C. were supported by the Intramural AIDS Targeted Antiviral Program of the National Institutes of Health. J.P.V. is supported by an NHMRC Peter Doherty Research Fellowship; D. A. P. is supported by a Medical Research Council (UK) Senior Clinical Fellowship; B. A. P. L. is supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; C. S. C. is supported by an ARC QEII Fellowship; J.R. is supported by an ARC Federation Fellowship.	Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Carr WH, 2005, J IMMUNOL, V175, P5222, DOI 10.4049/jimmunol.175.8.5222; Carr WH, 2007, J IMMUNOL, V178, P647, DOI 10.4049/jimmunol.178.2.647; CELLA M, 1994, J EXP MED, V180, P1235, DOI 10.1084/jem.180.4.1235; Chessman D, 2008, IMMUNITY, V28, P822, DOI 10.1016/j.immuni.2008.04.020; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dohring C, 1996, J IMMUNOL, V156, P3098; Fadda L, 2010, P NATL ACAD SCI USA, V107, P10160, DOI 10.1073/pnas.0913745107; Fan QR, 2001, NAT IMMUNOL, V2, P452, DOI 10.1038/87766; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; GUMPERZ JE, 1995, J EXP MED, V181, P1133, DOI 10.1084/jem.181.3.1133; Hansasuta P, 2004, EUR J IMMUNOL, V34, P1673, DOI 10.1002/eji.200425089; Hulsmeyer M, 2005, J MOL BIOL, V346, P1367, DOI 10.1016/j.jmb.2004.12.047; Khakoo SI, 2002, J EXP MED, V196, P911, DOI 10.1084/jem.20020304; LITWIN V, 1994, J EXP MED, V180, P537, DOI 10.1084/jem.180.2.537; Maenaka K, 1999, J BIOL CHEM, V274, P28329, DOI 10.1074/jbc.274.40.28329; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Norman PJ, 2007, NAT GENET, V39, P1092, DOI 10.1038/ng2111; O'Connor GM, 2011, J IMMUNOL, V187, P2162, DOI 10.4049/jimmunol.1002906; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Peruzzi M, 1996, J IMMUNOL, V157, P3350; Petrie EJ, 2008, J EXP MED, V205, P725, DOI 10.1084/jem.20072525; Sanjanwala B, 2008, J IMMUNOL, V181, P6293, DOI 10.4049/jimmunol.181.9.6293; Sharma D, 2009, J IMMUNOL, V183, P4569, DOI 10.4049/jimmunol.0901734; Trowsdale J, 2001, IMMUNOL REV, V181, P20, DOI 10.1034/j.1600-065X.2001.1810102.x; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884	29	147	152	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2011	479	7373					401	U155		10.1038/nature10517	http://dx.doi.org/10.1038/nature10517			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	848OA	22020283	Green Accepted			2022-12-28	WOS:000297059700046
J	Buchholz, U; Bernard, H; Werber, D; Bohmer, MM; Remschmidt, C; Wilking, H; Delere, Y; an der Heiden, M; Adlhoch, C; Dreesman, J; Ehlers, J; Ethelberg, S; Faber, M; Frank, C; Fricke, G; Greiner, M; Hohle, M; Ivarsson, S; Jark, U; Kirchner, M; Koch, J; Krause, G; Luber, P; Rosner, B; Stark, K; Kuhne, M				Buchholz, Udo; Bernard, Helen; Werber, Dirk; Boehmer, Merle M.; Remschmidt, Cornelius; Wilking, Hendrik; Delere, Yvonne; an der Heiden, Matthias; Adlhoch, Cornelia; Dreesman, Johannes; Ehlers, Joachim; Ethelberg, Steen; Faber, Mirko; Frank, Christina; Fricke, Gerd; Greiner, Matthias; Hoehle, Michael; Ivarsson, Sofie; Jark, Uwe; Kirchner, Markus; Koch, Judith; Krause, Gerard; Luber, Petra; Rosner, Bettina; Stark, Klaus; Kuehne, Michael			German Outbreak of Escherichia coli O104:H4 Associated with Sprouts	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								BACKGROUND A large outbreak of the hemolytic-uremic syndrome caused by Shiga-toxin-producing Escherichia coli O104:H4 occurred in Germany in May 2011. The source of infection was undetermined. METHODS We conducted a matched case-control study and a recipe-based restaurant cohort study, along with environmental, trace-back, and trace-forward investigations, to determine the source of infection. RESULTS The case-control study included 26 case subjects with the hemolytic-uremic syndrome and 81 control subjects. The outbreak of illness was associated with sprout consumption in univariable analysis (matched odds ratio, 5.8; 95% confidence interval [CI], 1.2 to 29) and with sprout and cucumber consumption in multivariable analysis. Among case subjects, 25% reported having eaten sprouts, and 88% reported having eaten cucumbers. The recipe-based study among 10 groups of visitors to restaurant K included 152 persons, among whom bloody diarrhea or diarrhea confirmed to be associated with Shiga-toxin-producing E. coli developed in 31 (20%). Visitors who were served sprouts were significantly more likely to become ill (relative risk, 14.2; 95% CI, 2.6 to 8). Sprout consumption explained 100% of cases. Trace-back investigation of sprouts from the distributor that supplied restaurant K led to producer A. All 41 case clusters with known trading connections could be explained by producer A. The outbreak strain could not be identified on seeds from the implicated lot. CONCLUSIONS Our investigations identified sprouts as the most likely outbreak vehicle, underlining the need to take into account food items that may be overlooked during subjects' recall of consumption.	[Buchholz, Udo; Bernard, Helen; Werber, Dirk; Boehmer, Merle M.; Remschmidt, Cornelius; Wilking, Hendrik; Delere, Yvonne; an der Heiden, Matthias; Adlhoch, Cornelia; Faber, Mirko; Frank, Christina; Hoehle, Michael; Koch, Judith; Krause, Gerard; Rosner, Bettina; Stark, Klaus] Robert Koch Inst, Dept Infect Dis Epidemiol, D-13086 Berlin, Germany; [Wilking, Hendrik; Adlhoch, Cornelia] Robert Koch Inst, Postgrad Training Appl Epidemiol Program, D-13086 Berlin, Germany; [Fricke, Gerd; Luber, Petra] Fed Off Consumer Protect & Food Safety, Berlin, Germany; [Greiner, Matthias] Fed Inst Risk Assessment, Berlin, Germany; [Dreesman, Johannes; Kirchner, Markus] Govt Inst Publ Hlth Lower Saxony, Hannover, Germany; [Ehlers, Joachim; Jark, Uwe; Kuehne, Michael] Lower Saxony State Off Consumer Protect & Food Sa, Oldenburg, Germany; [Greiner, Matthias] Vet Univ, Hannover, Germany; [Ivarsson, Sofie] Swedish Inst Communicable Dis Control, Solna, Sweden; [Ethelberg, Steen] Statens Serum Inst, Dept Epidemiol, DK-2300 Copenhagen, Denmark	Robert Koch Institute; Robert Koch Institute; Federal Institute for Risk Assessment; University of Veterinary Medicine Hannover, Foundation; Swedish Institute for Infectious Disease Control; Statens Serum Institut	Buchholz, U (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, DGZ Ring 1, D-13086 Berlin, Germany.	buchholzu@rki.de	Adlhoch, Cornelia/AAH-5888-2021; Werber, Dirk/L-2264-2019; Faber, MIrko/O-1191-2018; Greiner, Matthias/D-2812-2013; Höhle, Michael/AFM-0575-2022	Adlhoch, Cornelia/0000-0002-8842-0469; Faber, MIrko/0000-0002-9196-570X; Greiner, Matthias/0000-0003-4974-5970; Höhle, Michael/0000-0002-0423-6702; Krause, Gerard/0000-0003-3328-8808; Ethelberg, Steen/0000-0002-9709-356X; Werber, Dirk/0000-0002-8076-788X; Wilking, Hendrik/0000-0002-8574-5831; an der Heiden, Matthias/0000-0001-5863-4549; Frank, Christina/0000-0001-6776-8450	county health departments of Bremen; Bremerhaven; Cuxhaven; Lubeck	county health departments of Bremen; Bremerhaven; Cuxhaven; Lubeck	thank the senior and junior owner and particularly the chef of restaurant K in Lubeck for their support and patience; physicians, patients, and colleagues in the hospitals in Bremen (Klinikum Bremen Mitte), Bremerhaven (Klinikum Bremerhaven), and Lubeck (Universitatsklinikum Schleswig-Holstein, Campus Lubeck), as well as county health departments of Bremen, Bremerhaven, Cuxhaven, and Lubeck for their support in conducting the case-control study; and Johan Giesecke, Stephen Palmer, Kare Molbak, Henriette de Valk, Roland Salmon, Lyle Petersen, Robert Tauxe, and Hubert Deluyker for their input into the interpretation of study and surveillance data and the management of the outbreak.	Askar M, 2011, EUROSURVEILLANCE, V16, P2; Buchholz U, 2002, JAMA-J AM MED ASSOC, V288, P604, DOI 10.1001/jama.288.5.604; Bundesinstitut fur Risikobewertung (BfR), 2011, 0232011 BFR; European Centre for Disease Prevention and Control, 2011, ECDC RAP RISK ASS OU; European Food Safety Authority, 2011, TRAC SEEDS PART FEN; Frank C, 2011, EUROSURVEILLANCE, V16, P2; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Gault G, 2011, EUROSURVEILLANCE, V16, P5; Hauri AM, 2011, EUROSURVEILLANCE, V16, P15; Michino H, 1999, AM J EPIDEMIOL, V150, P787, DOI 10.1093/oxfordjournals.aje.a010082; Mody RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016579; Robert Koch Institut, 2011, EPIDEMIOL B, V31, P295; Robert Koch-Institute, 2011, NEUE ERK EHEC AUSBR; Taormina PJ, 1999, EMERG INFECT DIS, V5, P626, DOI 10.3201/eid0505.990503; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Wadl M, 2011, EUROSURVEILLANCE, V16, P11; Wheeler C, 2005, NEW ENGL J MED, V353, P890, DOI 10.1056/NEJMoa050855; World Health Organization, INT HLTH REG EHEC OU; World Health Organization (WHO), 2008, FOODB DIS OUTBR GUID	19	501	508	0	96	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 10	2011	365	19					1763	1770		10.1056/NEJMoa1106482	http://dx.doi.org/10.1056/NEJMoa1106482			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844QQ	22029753				2022-12-28	WOS:000296762800005
J	Van Keymeulen, A; Rocha, AS; Ousset, M; Beck, B; Bouvencourt, G; Rock, J; Sharma, N; Dekoninck, S; Blanpain, C				Van Keymeulen, Alexandra; Rocha, Ana Sofia; Ousset, Marielle; Beck, Benjamin; Bouvencourt, Gaelle; Rock, Jason; Sharma, Neha; Dekoninck, Sophie; Blanpain, Cedric			Distinct stem cells contribute to mammary gland development and maintenance	NATURE			English	Article							BREAST-CANCER; IN-VITRO; MOUSE; MORPHOGENESIS; PROGENITOR; EPITHELIUM; SKIN; IDENTIFICATION; POPULATION; COMMITMENT	The mammary epithelium is composed of several cell lineages including luminal, alveolar and myoepithelial cells. Transplantation studies have suggested that the mammary epithelium is maintained by the presence of multipotent mammary stem cells. To define the cellular hierarchy of the mammary gland during physiological conditions, we performed genetic lineage-tracing experiments and clonal analysis of the mouse mammary gland during development, adulthood and pregnancy. We found that in postnatal unperturbed mammary gland, both luminal and myoepithelial lineages contain long-lived unipotent stem cells that display extensive renewing capacities, as demonstrated by their ability to clonally expand during morphogenesis and adult life as well as undergo massive expansion during several cycles of pregnancy. The demonstration that the mammary gland contains different types of long-lived stem cells has profound implications for our understanding of mammary gland physiology and will be instrumental in unravelling the cells at the origin of breast cancers.	[Van Keymeulen, Alexandra; Rocha, Ana Sofia; Ousset, Marielle; Beck, Benjamin; Bouvencourt, Gaelle; Sharma, Neha; Dekoninck, Sophie; Blanpain, Cedric] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium; [Rock, Jason] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Universite Libre de Bruxelles; Duke University	Blanpain, C (corresponding author), Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium.	Cedric.Blanpain@ulb.ac.be	Blanpain, Cedric/ABD-8392-2021	Sharma, Neha/0000-0002-8062-1661; Beck, Benjamin/0000-0001-8162-7566; OUSSET, Marielle/0000-0002-2092-2729	TELEVIE; Portuguese Science Foundation (FCT); Fondation Contre le Cancer; FNRS; CIBLES of the Wallonia Region; ULB fondation; fond Gaston Ithier; European Research Council (ERC); EMBO;  [F32HL102920]	TELEVIE; Portuguese Science Foundation (FCT)(Portuguese Foundation for Science and Technology); Fondation Contre le Cancer; FNRS(Fonds de la Recherche Scientifique - FNRS); CIBLES of the Wallonia Region; ULB fondation; fond Gaston Ithier; European Research Council (ERC)(European Research Council (ERC)); EMBO(European Molecular Biology Organization (EMBO)); 	We thank our colleagues who provided us with reagents, which are cited in the text, and B. Hogan for sharing unpublished mice. We thank our colleagues from the Blanpain laboratory and C. Govaerts for their comments on the manuscript. We thank J. Rosen for discussion and M. Van Lohuizen and K. Nacerddine for their help with the transplantation assay. We thank F. Bollet-Quivogne and J.-M. Vanderwinden for their help with confocal imaging. C. B. and A. V. K. are chercheur qualifie, B. B. is charge de recherche and M.O. is a collaborateur scientifique of the FRS/FNRS. A. S. R. is supported by TELEVIE and the Portuguese Science Foundation (FCT). N.S. is supported by the Fondation Contre le Cancer. J. R. is supported by the grant F32HL102920. C. B. is an investigator of Welbio. This work was supported by the FNRS, TELEVIE, the program d'excellence CIBLES of the Wallonia Region, a research grant from the Fondation Contre le Cancer, the ULB fondation, the fond Gaston Ithier, a starting grant of the European Research Council (ERC) and the EMBO Young Investigator Program.	Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Booth BW, 2007, J CELL PHYSIOL, V212, P729, DOI 10.1002/jcp.21071; Chepko G, 1997, TISSUE CELL, V29, P239, DOI 10.1016/S0040-8166(97)80024-9; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fernandez-Gonzalez R, 2009, INTEGR BIOL, V1, P80, DOI 10.1039/b816933k; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; Kendrick H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-591; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Naylor S, 2000, J CELL SCI, V113, P2129; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Pechoux C, 1999, DEV BIOL, V206, P88, DOI 10.1006/dbio.1998.9133; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; RUDLAND PS, 1989, J HISTOCHEM CYTOCHEM, V37, P1087, DOI 10.1177/37.7.2471725; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Smith GH, 1996, BREAST CANCER RES TR, V39, P21, DOI 10.1007/BF01806075; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Srinivasan K, 2003, DEV CELL, V4, P371, DOI 10.1016/S1534-5807(03)00054-6; Stingl J, 1998, DIFFERENTIATION, V63, P201, DOI 10.1111/j.1432-0436.1998.00201.x; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stingl J, 2009, J PATHOL, V217, P229, DOI 10.1002/path.2457; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; Tsai YC, 1996, CANCER RES, V56, P402; Van Keymeulen A, 2009, J CELL BIOL, V187, P91, DOI 10.1083/jcb.200907080; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Visvader J. E., 2011, COLD SPRING HARBOR P, V3, P1; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wagner KU, 2002, DEVELOPMENT, V129, P1377; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Welm Bryan E, 2008, Cell Stem Cell, V2, P90, DOI 10.1016/j.stem.2007.10.002	37	572	584	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 10	2011	479	7372					189	U58		10.1038/nature10573	http://dx.doi.org/10.1038/nature10573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PD	21983963				2022-12-28	WOS:000298030800033
J	de Sherbinin, A; Castro, M; Gemenne, F; Cernea, MM; Adamo, S; Fearnside, PM; Krieger, G; Lahmani, S; Oliver-Smith, A; Pankhurst, A; Scudder, T; Singer, B; Tan, Y; Wannier, G; Boncour, P; Ehrhart, C; Hugo, G; Pandey, B; Shi, G				de Sherbinin, A.; Castro, M.; Gemenne, F.; Cernea, M. M.; Adamo, S.; Fearnside, P. M.; Krieger, G.; Lahmani, S.; Oliver-Smith, A.; Pankhurst, A.; Scudder, T.; Singer, B.; Tan, Y.; Wannier, G.; Boncour, P.; Ehrhart, C.; Hugo, G.; Pandey, B.; Shi, G.			Preparing for Resettlement Associated with Climate Change	SCIENCE			English	Editorial Material							MIGRATION		[de Sherbinin, A.; Adamo, S.] Columbia Univ, Earth Inst, CIESIN, Palisades, NY 10964 USA; [Castro, M.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Gemenne, F.] Sci Po, Inst Sustainable Dev & Int Relat IDDRI, F-75007 Paris, France; [Cernea, M. M.] Brookings Inst, Washington, DC 20036 USA; [Fearnside, P. M.] Natl Inst Res Amazonia, BR-69083 Manaus, Amazonas, Brazil; [Krieger, G.] NewFields LLC, Denver, CO 80202 USA; [Lahmani, S.] Agence Francaise Dev, F-75012 Paris, France; [Oliver-Smith, A.] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Pankhurst, A.] Wageningen Univ, NL-6701 Wageningen, Netherlands; [Scudder, T.] CALTECH, Pasadena, CA 91125 USA; [Singer, B.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA; [Tan, Y.; Hugo, G.] Univ Adelaide, Discipline Geog Environm & Populat, Adelaide, SA 5000, Australia; [Wannier, G.] Columbia Law Sch, Ctr Climate Change Law, New York, NY 10027 USA; [Boncour, P.] Int Org Migrat, CH-1211 Geneva, Switzerland; [Ehrhart, C.] CARE Int, Hanoi, Vietnam; [Shi, G.] Hohai Univ, Natl Res Ctr Resettlement, Nanjing 210098, Peoples R China	Columbia University; Harvard University; Harvard T.H. Chan School of Public Health; Institut d'Etudes Politiques Paris (Sciences Po); Brookings Institution; Institute Nacional de Pesquisas da Amazonia; State University System of Florida; University of Florida; Wageningen University & Research; California Institute of Technology; State University System of Florida; University of Florida; University of Adelaide; Columbia University; International Organization for Migration; Hohai University	de Sherbinin, A (corresponding author), Columbia Univ, Earth Inst, CIESIN, Palisades, NY 10964 USA.	adesherbinin@ciesin.columbia.edu	Servamb, Inct/K-3437-2013; Krieger, Gerhard/D-5164-2012; Fearnside, Philip M/D-6559-2011; Castro, Marcia/S-2681-2019; Fearnside, Philip M/GQA-6023-2022	Krieger, Gerhard/0000-0002-4548-0285; Fearnside, Philip M/0000-0003-3672-9082; Castro, Marcia/0000-0003-4606-2795; Fearnside, Philip M/0000-0003-3672-9082; Pankhurst, Alula/0000-0002-3925-6834; Adamo, Susana Beatriz/0000-0002-9168-7172; Shi, Guoqing/0000-0003-4499-074X; de Sherbinin, Alex/0000-0002-8875-4864; Tan, Yan/0000-0002-4013-1713				[Anonymous], GUIDING PRINCIPLES I; *AS DEV BANK, CLIM IND MIGR; Black R, 2011, ENVIRON PLANN A, V43, P431, DOI 10.1068/a43154; Bronen Robin, 2008, FORCED MIGRATION REV, V31, P30; Cantero EA, 2011, PREVENTIVE RESETTLEM, P85; Cernea M. M., 2000, Risks and reconstruction: experiences of resettlers and refugees., P11; Cernea M. M., 2008, CAN COMPENSATION PRE, P15; Correa E, 2011, POPULATIONS RISK DIS; de Sherbinin A, 2011, SCI AM, V304, P64, DOI 10.1038/scientificamerican0111-64; Displacement Solutions, 2008, BOUG RES IN M REP, P4; Fearnside P. M., 2005, Mitigation and Adaptation Strategies for Global Change, V10, P675, DOI 10.1007/s11027-005-7303-7; Ferris Elizabeth, 2011, FRONT LINE CLIMATE C; Gemenne F, 2011, PHILOS T R SOC A, V369, P182, DOI 10.1098/rsta.2010.0287; Guerrier G, 2011, SCIENCE, V334, P38, DOI 10.1126/science.334.6052.38-a; Keiser J, 2005, AM J TROP MED HYG, V72, P392, DOI 10.4269/ajtmh.2005.72.392; McLeman R, 2006, CLIMATIC CHANGE, V76, P31, DOI 10.1007/s10584-005-9000-7; MERTI S, 2008, LOSING GROUND; New M, 2011, PHILOS T R SOC A, V369, P6, DOI 10.1098/rsta.2010.0303; Oliver-Smith A., 2009, ANTHR CLIMATE CHANGE, P116; Rogers S, 2006, POPUL ENVIRON, V28, P41, DOI 10.1007/s11111-007-0033-x; Scudder T., 2005, FUTURE LARGE DAMS DE; Tan Y., 2008, RESETTLEMENT 3 GORGE; *UN FRAM CONV CLIM, ENH ACT AD; NANSEN PRINCIPLES	24	159	161	3	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 28	2011	334	6055					456	457		10.1126/science.1208821	http://dx.doi.org/10.1126/science.1208821			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	837UR	22034418				2022-12-28	WOS:000296230500026
J	Bressler, NM; Beck, RW; Ferris, FL				Bressler, Neil M.; Beck, Roy W.; Ferris, Frederick L., III			Panretinal Photocoagulation for Proliferative Diabetic Retinopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IRIS NEOVASCULARIZATION; LASER PHOTOCOAGULATION; INTRAVITREAL INJECTION; RETINAL NEOVASCULARIZATION; BEVACIZUMAB AVASTIN; TRANSIENT MYOPIA; FOLLOW-UP; INHIBITION	A 55-year-old man with a 20-year history of type 2 diabetes mellitus was referred to a retina specialist after noticing a few black floaters in his left eye for the preceding week. His glycated hemoglobin level was 8.2%. He had no history of laser treatment for proliferative diabetic retinopathy in either eye. Ophthalmoscopic examination of the right eye showed venous beading, intraretinal microvascular abnormalities, and no macular edema. Ophthalmoscopic examination of the left eye showed extensive neovascularization of the disk, consisting of new vessels extending beyond the optic disk in all directions (Fig. 1A). The retina specialist diagnosed severe nonproliferative diabetic retinopathy in the right eye and high-risk proliferative diabetic retinopathy in the left eye, with no macular edema in either eye. The specialist recommended prompt initiation of panretinal photocoagulation in the left eye.	[Ferris, Frederick L., III] NEI, Div Epidemiol & Clin Applicat, NIH, Bethesda, MD 20892 USA; [Bressler, Neil M.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Beck, Roy W.] Jaeb Ctr Hlth Res, Tampa, FL USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Johns Hopkins University; JAEB Center For Health Research	Ferris, FL (corresponding author), NEI, Div Epidemiol & Clin Applicat, NIH, 10 Ctr Dr,MSC 1204, Bethesda, MD 20892 USA.	ferrisf@nei.nih.gov		Ferris, Frederick/0000-0002-4933-0639	Abbott Medical Optics; Alimera Sciences; Allergan; Bausch Lomb; ForSight Labs; Genzyme; Lumenis; Notal Vision; Novartis; QLT; Regeneron; Genentech; NATIONAL EYE INSTITUTE [ZIAEY000485] Funding Source: NIH RePORTER	Abbott Medical Optics; Alimera Sciences; Allergan(AbbVieAllergan); Bausch Lomb; ForSight Labs; Genzyme(Sanofi-AventisGenzyme Corporation); Lumenis; Notal Vision; Novartis(Novartis); QLT; Regeneron(Regeneron); Genentech(Roche HoldingGenentech); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Dr. Bressler reports that his institution has received grant support from Abbott Medical Optics, Alimera Sciences, Allergan, Bausch & Lomb, ForSight Labs, Genzyme, Lumenis, Notal Vision, Novartis, QLT, Regeneron, and Genentech. No other potential conflict of interest relevant to this article was reported.	Adamis AP, 2006, OPHTHALMOLOGY, V113, P23, DOI 10.1016/j.ophtha.2005.10.012; ADAMIS AP, 1994, AM J OPHTHALMOL, V118, P445, DOI 10.1016/S0002-9394(14)75794-0; Adamis AP, 1996, ARCH OPHTHALMOL-CHIC, V114, P66, DOI 10.1001/archopht.1996.01100130062010; Aiello LP, 2005, NEW ENGL J MED, V353, P839, DOI 10.1056/NEJMe058142; AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; *AM AC OPHTH RET P, 2009, PREF PRACT PATT DIAB; Amano S, 1998, INVEST OPHTH VIS SCI, V39, P18; [Anonymous], 1995, DIABETES, V44, P968; [Anonymous], 1976, Am J Ophthalmol, V81, P383; [Anonymous], NATL DIABETES FACT S; Avery RL, 2006, OPHTHALMOLOGY, V113, P1695, DOI 10.1016/j.ophtha.2006.05.064; BLANKENSHIP GW, 1988, OPHTHALMOLOGY, V95, P170; BLONDEAU P, 1981, ARCH OPHTHALMOL-CHIC, V99, P1239; Bressler NM, 2009, ARCH OPHTHALMOL-CHIC, V127, P1566, DOI 10.1001/archophthalmol.2009.308; Brucker AJ, 2009, ARCH OPHTHALMOL-CHIC, V127, P132, DOI 10.1001/archophthalmol.2008.565; Chew EY, 2003, OPHTHALMOLOGY, V110, P1683, DOI 10.1016/S0161-6420(03)00579-7; *DIAB RET CLIN RES, OBS STUD DEV DIAB MA; Early Treatment Diabetic Retinopathy Study Res Grp, 1991, OPHTHALMOLOGY, V98, P766; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; FERRIS FL, 1993, JAMA-J AM MED ASSOC, V269, P1290, DOI 10.1001/jama.269.10.1290; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fong DS, 2007, RETINA-J RET VIT DIS, V27, P816, DOI 10.1097/IAE.0b013e318042d32c; Googe J, 2011, RETINA-J RET VIT DIS, V31, P1009, DOI 10.1097/IAE.0b013e318217d739; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Huamonte F U, 1976, Ophthalmic Surg, V7, P88; Isaacs TW, 2006, CLIN EXP OPHTHALMOL, V34, P802, DOI 10.1111/j.1442-9071.2006.01378.x; Javitt JC, 1996, ANN INTERN MED, V124, P164, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00017; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; Krzystolik MG, 2002, ARCH OPHTHALMOL-CHIC, V120, P338; LERNER BC, 1984, AM J OPHTHALMOL, V97, P704, DOI 10.1016/0002-9394(84)90501-4; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; LIANG JC, 1984, RETINA-J RET VIT DIS, V4, P166, DOI 10.1097/00006982-198400430-00007; MALECAZE F, 1994, ARCH OPHTHALMOL-CHIC, V112, P1476, DOI 10.1001/archopht.1994.01090230090028; Mason JO, 2006, AM J OPHTHALMOL, V142, P685, DOI 10.1016/j.ajo.2006.04.058; MENSHER JH, 1977, ARCH OPHTHALMOL-CHIC, V95, P113; Mohamed Q, 2007, JAMA-J AM MED ASSOC, V298, P902, DOI 10.1001/jama.298.8.902; Oshima Y, 2006, AM J OPHTHALMOL, V142, P155, DOI 10.1016/j.ajo.2006.02.015; Schwesinger C, 2001, AM J PATHOL, V158, P1161, DOI 10.1016/S0002-9440(10)64063-1; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Spaide RF, 2006, RETINA-J RET VIT DIS, V26, P275, DOI 10.1097/00006982-200603000-00004; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; The Diabetic Retinopathy Study Research Group, 1994, INVEST OPHTHALMOL VI, V27, P239; Tolentino MJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P964, DOI 10.1001/archopht.1996.01100140172010; Yuki T, 1997, OPHTHALMOLOGY, V104, P1259, DOI 10.1016/S0161-6420(97)30149-3; Zamir E, 1996, ARCH OPHTHALMOL-CHIC, V114, P1284, DOI 10.1001/archopht.1996.01100140484028	46	79	85	2	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2011	365	16					1520	1526		10.1056/NEJMct0908432	http://dx.doi.org/10.1056/NEJMct0908432			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835BW	22010918				2022-12-28	WOS:000296009500006
J	Konhauser, KO; Lalonde, SV; Planavsky, NJ; Pecoits, E; Lyons, TW; Mojzsis, SJ; Rouxel, OJ; Barley, ME; Rosiere, C; Fralick, PW; Kump, LR; Bekker, A				Konhauser, Kurt O.; Lalonde, Stefan V.; Planavsky, Noah J.; Pecoits, Ernesto; Lyons, Timothy W.; Mojzsis, Stephen J.; Rouxel, Olivier J.; Barley, Mark E.; Rosiere, Carlos; Fralick, Phillip W.; Kump, Lee R.; Bekker, Andrey			Aerobic bacterial pyrite oxidation and acid rock drainage during the Great Oxidation Event	NATURE			English	Article							BANDED IRON-FORMATIONS; ATMOSPHERIC OXYGEN; HEXAVALENT CHROMIUM; DISSOLVED-OXYGEN; SULFUR ISOTOPES; GEOCHEMISTRY; RISE; EVOLUTION; SEDIMENTS; GENESIS	The enrichment of redox-sensitive trace metals in ancient marine sedimentary rocks has been used to determine the timing of the oxidation of the Earth's land surface(1,2). Chromium (Cr) is among the emerging proxies for tracking the effects of atmospheric oxygenation on continental weathering; this is because its supply to the oceans is dominated by terrestrial processes that can be recorded in the Cr isotope composition of Precambrian iron formations(3). However, the factors controlling past and present seawater Cr isotope composition are poorly understood. Here we provide an independent and complementary record of marine Cr supply, in the form of Cr concentrations and authigenic enrichment in iron-rich sedimentary rocks. Our data suggest that Cr was largely immobile on land until around 2.48 Gyr ago, but within the 160 Myr that followed-and synchronous with independent evidence for oxygenation associated with the Great Oxidation Event (see, for example, refs 4-6)-marked excursions in Cr content and Cr/Ti ratios indicate that Cr was solubilized at a scale unrivalled in history. As Cr isotope fractionations at that time were muted, Cr must have been mobilized predominantly in reduced, Cr(III), form. We demonstrate that only the oxidation of an abundant and previously stable crustal pyrite reservoir by aerobic-respiring, chemolithoautotrophic bacteria could have generated the degree of acidity required to solubilize Cr(III) from ultramafic source rocks and residual soils(7). This profound shift in weathering regimes beginning at 2.48 Gyr ago constitutes the earliest known geochemical evidence for acidophilic aerobes and the resulting acid rock drainage, and accounts for independent evidence of an increased supply of dissolved sulphate(8) and sulphide-hosted trace elements to the oceans around that time(1,9). Our model adds to amassing evidence that the Archaean-Palaeoproterozoic boundary was marked by a substantial shift in terrestrial geochemistry and biology.	[Konhauser, Kurt O.; Lalonde, Stefan V.; Pecoits, Ernesto] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; [Lalonde, Stefan V.; Rouxel, Olivier J.] Univ Europeene Bretagne, Inst Univ Europeen Mer, F-29280 Plouzane, France; [Planavsky, Noah J.; Lyons, Timothy W.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Mojzsis, Stephen J.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [Rouxel, Olivier J.] IFREMER, Ctr Brest, F-29280 Plouzane, France; [Barley, Mark E.] Univ Western Australia, Sch Earth & Environm, Crawley, WA 6009, Australia; [Rosiere, Carlos] Univ Fed Minas Gerais, Inst Geociencias, BR-3127091 Belo Horizonte, MG, Brazil; [Fralick, Phillip W.] Lakehead Univ, Dept Geol, Thunder Bay, ON P7B 5E1, Canada; [Kump, Lee R.] Penn State Univ, Dept Geosci, University Pk, PA 16827 USA; [Bekker, Andrey] Univ Manitoba, Dept Geol Sci, Winnipeg, MB R3T 2N2, Canada	University of Alberta; Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); University of California System; University of California Riverside; University of Colorado System; University of Colorado Boulder; Ifremer; University of Western Australia; Universidade Federal de Minas Gerais; Lakehead University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Manitoba	Konhauser, KO (corresponding author), Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada.	kurtk@ualberta.ca	Lalonde, Stefan V/I-8879-2014; Rouxel, Olivier J/F-3954-2014; Rosière, Carlos/E-3479-2013; MOJZSIS, STEPHEN/AAU-9527-2020; Kump, Lee/H-8287-2012	Lalonde, Stefan V/0000-0003-1318-2280; Rouxel, Olivier J/0000-0002-1431-222X; Rosière, Carlos/0000-0003-2364-6536; MOJZSIS, STEPHEN/0000-0003-0000-125X; Konhauser, Kurt/0000-0001-7722-7068; Bekker, Andrey/0000-0002-1154-0585	Natural Sciences and Engineering Research Council of Canada; National Science Foundation Division of Earth Sciences; National Science Foundation; Agouron Institute; NASA; NASA's Astrobiology Institute; Australian Research Council; Conselho Nacional de Desenvolvimento Cientifico e Technologico	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Science Foundation Division of Earth Sciences(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Agouron Institute(Pfizer); NASA(National Aeronautics & Space Administration (NASA)); NASA's Astrobiology Institute; Australian Research Council(Australian Research Council); Conselho Nacional de Desenvolvimento Cientifico e Technologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the Natural Sciences and Engineering Research Council of Canada (K.O.K., S.V.L., A.B., P.W.F.), the National Science Foundation Division of Earth Sciences (T.W.L., O.J.R., L.R.K.), the National Science Foundation's Graduate Research Program (N.J.P.), the Agouron Institute (E.P., T.W.L.), NASA's Exobiology Program (T.W.L., S.J.M.), NASA's Astrobiology Institute (T.W.L., L.R.K., N.J.P.), the Australian Research Council (M.E.B.), and the Conselho Nacional de Desenvolvimento Cientifico e Technologico (C.R.) We also thank V. Suckau (USIMINAS) for sample collection, G. Chen for assistance with LA-ICP-MS analyses, and J. Robbins for data compilation.	Aharon P, 2005, PRECAMBRIAN RES, V137, P207, DOI 10.1016/j.precamres.2005.03.008; Anbar AD, 2007, SCIENCE, V317, P1903, DOI 10.1126/science.1140325; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Bekker A, 2010, ECON GEOL, V105, P467, DOI 10.2113/gsecongeo.105.3.467; Berner R.A., 2012, GLOBAL ENV WATER AIR, Vsecond; Blank CE, 2004, GEOBIOLOGY, V2, P1, DOI 10.1111/j.1472-4677.2004.00020.x; Chester R., 2000, MARINE GEOCHEMISTRY; CONDIE KC, 1993, CHEM GEOL, V104, P1, DOI 10.1016/0009-2541(93)90140-E; Dorland H.C., 1999, THESIS RAND AFRIKAAN; ERIKSSON KA, 1973, J SEDIMENT PETROL, V43, P1046; FENDORF SE, 1995, GEODERMA, V67, P55, DOI 10.1016/0016-7061(94)00062-F; Frei R, 2009, NATURE, V461, P250, DOI 10.1038/nature08266; Gleisner M, 2006, CHEM GEOL, V225, P16, DOI 10.1016/j.chemgeo.2005.07.020; Guo QJ, 2009, GEOLOGY, V37, P399, DOI 10.1130/G25423A.1; Gustafsson J. P, VISUAL MINTEQ; Holland HD, 2002, GEOCHIM COSMOCHIM AC, V66, P3811, DOI 10.1016/S0016-7037(02)00950-X; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Klein C, 2005, AM MINERAL, V90, P1473, DOI 10.2138/am.2005.1871; Konhauser KO, 2009, NATURE, V458, P750, DOI 10.1038/nature07858; Lyons TW, 2009, GEOBIOLOGY, V7, P489, DOI 10.1111/j.1472-4669.2009.00222.x; Morgan JJ, 2005, GEOCHIM COSMOCHIM AC, V69, P35, DOI 10.1016/j.gca.2004.06.013; MOSES CO, 1987, GEOCHIM COSMOCHIM AC, V51, P1561, DOI 10.1016/0016-7037(87)90337-1; Nordstrom DK, 1997, REV MINERAL, V35, P361; Oze C, 2004, INT GEOL REV, V46, P97, DOI 10.2747/0020-6814.46.2.97; Oze C, 2007, P NATL ACAD SCI USA, V104, P6544, DOI 10.1073/pnas.0701085104; Papineau D, 2007, EARTH PLANET SC LETT, V255, P188, DOI 10.1016/j.epsl.2006.12.015; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; RAI D, 1989, SCI TOTAL ENVIRON, V86, P15, DOI 10.1016/0048-9697(89)90189-7; Reinhard CT, 2009, SCIENCE, V326, P713, DOI 10.1126/science.1176711; Rye R, 1998, AM J SCI, V298, P621, DOI 10.2475/ajs.298.8.621; Schauble E, 2004, CHEM GEOL, V205, P99, DOI 10.1016/j.chemgeo.2003.12.015; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Shiraki K., 1997, SHIGEN CHISHITSU, V47, P319, DOI 10.11456/shigenchishitsu1992.47.319; SINGER PC, 1970, SCIENCE, V167, P1121, DOI 10.1126/science.167.3921.1121; Spier CA, 2007, PRECAMBRIAN RES, V152, P170, DOI 10.1016/j.precamres.2006.10.003; WANG PC, 1989, APPL ENVIRON MICROB, V55, P1665, DOI 10.1128/AEM.55.7.1665-1669.1989; Wille M, 2007, GEOCHIM COSMOCHIM AC, V71, P2417, DOI 10.1016/j.gca.2007.02.019	37	233	240	8	260	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 20	2011	478	7369					369	+		10.1038/nature10511	http://dx.doi.org/10.1038/nature10511			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	22012395				2022-12-28	WOS:000296021100042
J	Henskens, LHG; Broos, N; Hautermans, K				Henskens, L. H. G.; Broos, N.; Hautermans, K.			A patient with bilateral shoulder and pelvic girdle aching	BRITISH MEDICAL JOURNAL			English	Editorial Material							GIANT-CELL ARTERITIS; ERYTHROCYTE SEDIMENTATION-RATE; POLYMYALGIA-RHEUMATICA; INFLUENZA VACCINATION; DISEASE; SEVERITY		[Henskens, L. H. G.; Hautermans, K.] Maastricht Univ, Dept Gen Practice, NL-6200 MD Maastricht, Netherlands; [Broos, N.] Netherlands Pharmacovigilance Ctr, Larebs Hertogenbosch, Netherlands	Maastricht University	Henskens, LHG (corresponding author), Maastricht Univ, Dept Gen Practice, NL-6200 MD Maastricht, Netherlands.	l.henskens@gmail.com						Black S, 2009, LANCET, V374, P2115, DOI 10.1016/S0140-6736(09)61877-8; Cantini F, 2000, SEMIN ARTHRITIS RHEU, V30, P17, DOI 10.1053/sarh.2000.8366; Dababneh A, 1998, J RHEUMATOL, V25, P2140; Dasgupta B, 2008, J RHEUMATOL, V35, P270; Dasgupta B, 2010, RHEUMATOLOGY, V49, P186, DOI 10.1093/rheumatology/kep303a; GERTH HJ, 1992, DEUT MED WOCHENSCHR, V117, P1259; Gonzalez-Gay MA, 2003, SEMIN ARTHRITIS RHEU, V33, P38, DOI 10.1053/sarh.2002.50025; Gonzalez-Gay MA, 2009, ARTHRIT CARE RES, V61, P1454, DOI 10.1002/art.24459; GonzalezGay MA, 1997, ARCH INTERN MED, V157, P317, DOI 10.1001/archinte.157.3.317; Hakvoort L, 2010, HUISART WETENSCHAP, V53, P88; Hutchings A, 2007, ARTHRIT RHEUM-ARTHR, V57, P803, DOI 10.1002/art.22777; Liozon E, 2000, J AM GERIATR SOC, V48, P1533, DOI 10.1111/jgs.2000.48.11.1533a; Marti J, 2004, J AM GERIATR SOC, V52, P1412, DOI 10.1111/j.1532-5415.2004.52379_11.x; Martinez-Taboada VM, 2000, CLIN EXP RHEUMATOL, V18, pS34; Michet CJ, 2008, BRIT MED J, V336, P765, DOI 10.1136/bmj.39514.653588.80; Perez C, 2000, MUSCLE NERVE, V23, P824, DOI 10.1002/(SICI)1097-4598(200005)23:5<824::AID-MUS24>3.0.CO;2-M; Saadoun D, 2001, REV MED INTERNE, V22, P172, DOI 10.1016/S0248-8663(00)00307-6; Salvarani C, 2002, NEW ENGL J MED, V347, P261, DOI 10.1056/NEJMra011913; Salvarani C, 1999, ANN RHEUM DIS, V58, P303, DOI 10.1136/ard.58.5.303; Smeeth L, 2006, ANN RHEUM DIS, V65, P1093, DOI 10.1136/ard.2005.046912; Toplak N, 2009, ANN NY ACAD SCI, V1173, P619, DOI 10.1111/j.1749-6632.2009.04759.x; Weyand CM, 2003, ANN INTERN MED, V139, P505, DOI 10.7326/0003-4819-139-6-200309160-00015	22	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	OCT 14	2011	343								d6233	10.1136/bmj.d6233	http://dx.doi.org/10.1136/bmj.d6233			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835ET	22001649				2022-12-28	WOS:000296018600002
J	Karreth, FA; Tay, Y; Perna, D; Ala, U; Tan, SM; Rust, AG; DeNicola, G; Webster, KA; Weiss, D; Perez-Mancera, PA; Krauthammer, M; Halaban, R; Provero, P; Adams, DJ; Tuveson, DA; Pandolfi, PP				Karreth, Florian A.; Tay, Yvonne; Perna, Daniele; Ala, Ugo; Tan, Shen Mynn; Rust, Alistair G.; DeNicola, Gina; Webster, Kaitlyn A.; Weiss, Dror; Perez-Mancera, Pedro A.; Krauthammer, Michael; Halaban, Ruth; Provero, Paolo; Adams, David J.; Tuveson, David A.; Pandolfi, Pier Paolo			In Vivo Identification of Tumor-Suppressive PTEN ceRNAs in an Oncogenic BRAF-Induced Mouse Model of Melanoma	CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MIR-200 FAMILY; REPRESSORS ZEB1; TARGETING ZEB1; MESSENGER-RNAS; MICRORNAS; CANCER; GENE; MUTATIONS	We recently proposed that competitive endogenous RNAs (ceRNAs) sequester microRNAs to regulate mRNA transcripts containing common microRNA recognition elements (MREs). However, the functional role of ceRNAs in cancer remains unknown. Loss of PTEN, a tumor suppressor regulated by ceRNA activity, frequently occurs in melanoma. Here, we report the discovery of significant enrichment of putative PTEN ceRNAs among genes whose loss accelerates tumorigenesis following Sleeping Beauty insertional mutagenesis in a mouse model of melanoma. We validated several putative PTEN ceRNAs and further characterized one, the ZEB2 transcript. We show that ZEB2 modulates PTEN protein levels in a microRNA-dependent, protein coding-independent manner. Attenuation of ZEB2 expression activates the PI3K/AKT pathway, enhances cell transformation, and commonly occurs in human melanomas and other cancers expressing low PTEN levels. Our study genetically identifies multiple putative microRNA decoys for PTEN, validates ZEB2 mRNA as a bona fide PTEN ceRNA, and demonstrates that abrogated ZEB2 expression cooperates with BRAF(V600E) to promote melanomagenesis.	[Karreth, Florian A.; Tay, Yvonne; Ala, Ugo; Webster, Kaitlyn A.; Weiss, Dror; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Canc Ctr, Beth Israel Deaconess Med Ctr, Canc Genet Program,Div Genet,Dept Med & Pathol,Me, Boston, MA 02215 USA; [DeNicola, Gina] Harvard Univ, Beth Israel Deaconess Canc Ctr, Beth Israel Deaconess Med Ctr, Div Signal Transduct,Dept Med & Pathol,Med Sch, Boston, MA 02215 USA; [Perna, Daniele; Perez-Mancera, Pedro A.; Tuveson, David A.] CRUK, Li Ka Shing Ctr, Cambridge Res Inst, Cambridge CB2 0RE, England; [Ala, Ugo; Provero, Paolo] Univ Turin, Mol Biotechnol Ctr, Turin, Italy; [Ala, Ugo; Provero, Paolo] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Tan, Shen Mynn] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02215 USA; [Tan, Shen Mynn] Harvard Univ, Sch Med, Program Cellular & Mol Med, Childrens Hosp Boston, Boston, MA 02215 USA; [Tan, Shen Mynn] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02215 USA; [Rust, Alistair G.; Adams, David J.] Wellcome Trust Sanger Inst, Hinxton CB10 1HH, England; [Krauthammer, Michael] Yale Univ, Dept Pathol, New Haven, CT 06520 USA; [Halaban, Ruth] Yale Univ, Dept Dermatol, New Haven, CT 06520 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; CRUK Cambridge Institute; University of Cambridge; University of Turin; University of Turin; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Wellcome Trust Sanger Institute; Yale University; Yale University	Pandolfi, PP (corresponding author), Harvard Univ, Beth Israel Deaconess Canc Ctr, Beth Israel Deaconess Med Ctr, Canc Genet Program,Div Genet,Dept Med & Pathol,Me, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Provero, Paolo/AAC-1930-2019; Ala, Ugo/K-2029-2016	Ala, Ugo/0000-0001-5408-6397; Pandolfi, Pier Paolo/0000-0002-5352-5295; DeNicola, Gina/0000-0001-6611-6696; Webster, Kaitlyn/0000-0001-9902-0500; Adams, David/0000-0001-9490-0306; Rust, Alistair/0000-0001-7287-192X; Krauthammer, Michael/0000-0002-4808-1845	Harvard Catalyst; The Harvard Clinical and Translational Science Center (NIH) [UL1 RR 025758]; Harvard University and its affiliated academic health care centers; University of Cambridge,; Cancer Research UK; The Li Ka Shing Foundation; Hutchison Whampoa Limited; NIHR Cambridge Biomedical Research Centre; The Wellcome Trust; The Leukemia & Lymphoma Society; Italian Association for Cancer Research (AIRC); Fundacion Ibercaja; Fondazione per la Ricerca Biomedica ONLUS of Torino; Department of Defense; AIRC [IG-9408]; Yale SPORE in Skin Cancer; National Cancer Institute [1 P50 CA121974]; NIH [R01 CA-82328-09]; NATIONAL CANCER INSTITUTE [R01CA082328, P50CA121974] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER	Harvard Catalyst; The Harvard Clinical and Translational Science Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University and its affiliated academic health care centers; University of Cambridge,(University of Cambridge); Cancer Research UK(Cancer Research UK); The Li Ka Shing Foundation; Hutchison Whampoa Limited; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); The Wellcome Trust(Wellcome Trust); The Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fundacion Ibercaja; Fondazione per la Ricerca Biomedica ONLUS of Torino; Department of Defense(United States Department of Defense); AIRC(Fondazione AIRC per la ricerca sul cancro); Yale SPORE in Skin Cancer; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Pandolfi and Tuveson laboratory members for critical discussions. qRT-PCR analysis was conducted with support from Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (NIH award #UL1 RR 025758 and financial contributions from Harvard University and its affiliated academic health care centers). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, the National Center for Research Resources, or the National Institutes of Health. We thank B. Vogelstein for DICER<SUP>-/-</SUP> cells and M. Bosenberg for TyrCreERt2 mice. We thank F. Connor and other members of the Tuveson lab for assistance and the animal care staff and histology core at CRI. Mice were maintained in compliance with the UK home office regulations. This research was supported by the University of Cambridge, Cancer Research UK, The Li Ka Shing Foundation, Hutchison Whampoa Limited, the NIHR Cambridge Biomedical Research Centre, and The Wellcome Trust. Y.T. was supported by a Special Fellow Award from The Leukemia & Lymphoma Society. D. P. received an International Fellowship in Cancer Research from the Italian Association for Cancer Research (AIRC). P.A.P.-M. was supported by the Fundacion Ibercaja. U. A. received a fellowship from the Fondazione per la Ricerca Biomedica ONLUS of Torino. S. M. T. was supported by a Department of Defense Breast Cancer Research Program fellowship. P. P. and U. A. received support from AIRC under grant IG-9408. This work was supported by the Yale SPORE in Skin Cancer funded by the National Cancer Institute grant number 1 P50 CA121974 to R. H. and by NIH grant R01 CA-82328-09 to P.P.P.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bosenberg M, 2006, GENESIS, V44, P262, DOI 10.1002/dvg.20205; Brose MS, 2002, CANCER RES, V62, P6997; Candeias MM, 2008, NAT CELL BIOL, V10, P1098, DOI 10.1038/ncb1770; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; D'Errico Ilenia, 2004, Briefings in Functional Genomics & Proteomics, V3, P157, DOI 10.1093/bfgp/3.2.157; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Elson-Schwab I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013176; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Halaban R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004563; Jenny A, 2006, DEVELOPMENT, V133, P2827, DOI 10.1242/dev.02456; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lee DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013599; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Mezzanzanica D, 2010, INT J BIOCHEM CELL B, V42, P1262, DOI 10.1016/j.biocel.2009.12.017; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Pang YX, 2010, ACTA BIOCH BIOPH SIN, V42, P363, DOI 10.1093/abbs/gmq038; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Piro RM, 2011, EUR J HUM GENET, V19, P1173, DOI 10.1038/ejhg.2011.96; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; van Helden J, 2004, BIOINFORMATICS, V20, P399, DOI 10.1093/bioinformatics/btg425; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Zhang LM, 2010, CARCINOGENESIS, V31, P559, DOI 10.1093/carcin/bgp335	36	516	550	0	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 14	2011	147	2					382	395		10.1016/j.cell.2011.09.032	http://dx.doi.org/10.1016/j.cell.2011.09.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000016	Green Accepted, Bronze			2022-12-28	WOS:000296199300016
J	Luo, DH; Ding, SC; Vela, A; Kohlway, A; Lindenbach, BD; Pyle, AM				Luo, Dahai; Ding, Steve C.; Vela, Adriana; Kohlway, Andrew; Lindenbach, Brett D.; Pyle, Anna Marie			Structural Insights into RNA Recognition by RIG-I	CELL			English	Article							DICERS HELICASE DOMAIN; CRYSTAL-STRUCTURE; PATTERN-RECOGNITION; REGULATORY DOMAIN; TERMINAL DOMAIN; NS3 HELICASE; PROTEIN; ACTIVATION; COMPLEX; TRANSLOCATION	Intracellular RIG-I-like receptors (RLRs, including RIG-I, MDA-5, and LGP2) recognize viral RNAs as pathogen-associated molecular patterns (PAMPs) and initiate an antiviral immune response. To understand the molecular basis of this process, we determined the crystal structure of RIG-I in complex with double-stranded RNA (dsRNA). The dsRNA is sheathed within a network of protein domains that include a conserved "helicase" domain (regions HEL1 and HEL2), a specialized insertion domain (HEL2i), and a C-terminal regulatory domain (CTD). A V-shaped pincer connects HEL2 and the CTD by gripping an a-helical shaft that extends from HEL1. In this way, the pincer coordinates functions of all the domains and couples RNA binding with ATP hydrolysis. RIG-I falls within the Dicer-RIG-I clade of the superfamily 2 helicases, and this structure reveals complex interplay between motor domains, accessory mechanical domains, and RNA that has implications for understanding the nanomechanical function of this protein family and other ATPases more broadly.	[Luo, Dahai; Pyle, Anna Marie] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Ding, Steve C.; Vela, Adriana; Kohlway, Andrew] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Lindenbach, Brett D.] Yale Univ, Sect Microbial Pathogenesis, New Haven, CT 06520 USA; [Pyle, Anna Marie] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Luo, Dahai; Pyle, Anna Marie] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute	Pyle, AM (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	anna.pyle@yale.edu	Luo, Dahai/J-6022-2012	Luo, Dahai/0000-0001-7637-7275	NIH [AI089826]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089826] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Marco Marcia, Dr. Kevin Keating, Dr. Vivien Nagy, Dr. Olga Fedorova, and other members of the Pyle Lab for their generous help and insightful discussions. We thank scientists (Drs. Kanagalaghatta Rajashankar, Frank Murphy, Kay Perry, Narayanasami Sukumar, and Malcolm Capel) from APS NECAT 24-ID and scientists (Drs. Marc Allaire and Lin Yang) from NSLS X9 for the beamline access and technical support. We would like to thank Kevin Smith, Ganes C. Sen, Jurg Tschopp, Wang Penghua, and Erol Fikrig for providing us with reagents. We also thank Wenxiang Cao and Enrique De la Cruz for advice on the ATPase assay. B.D.L. was supported by NIH grant AI089826. This research was funded by Howard Hughes Medical Institute. D.L. is a postdoctoral associate, and A.M.P. is an Investigator with the Howard Hughes Medical Institute. D.L. and A.M.P. designed the experiments. D.L. performed protein expression, purification, crystallization, X-ray diffraction data collection and analysis, and structure determination and refinement. D.L. carried out RNAse digestion and SEC. D.L. and S.C.D. collected SAXS data. S.C.D. performed mutagenesis and purified the mutant proteins. A.S.K. and S.C.D. performed the ATPase assays. A.V. and S.C.D. carried out the cloning and the initial expression and purification studies. D.L. and B.D.L. performed the cell-based assay. D.L. and A.M.P. wrote the manuscript with input from all authors.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Appleby TC, 2011, J MOL BIOL, V405, P1139, DOI 10.1016/j.jmb.2010.11.034; Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Binder M, 2011, J BIOL CHEM, V286, P27278, DOI 10.1074/jbc.M111.256974; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; Del Campo M, 2009, MOL CELL, V35, P598, DOI 10.1016/j.molcel.2009.07.032; DeLano W.L., 2002, PVMOL USERS MANUAL; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fujita T, 2007, BIOCHIMIE, V89, P754, DOI 10.1016/j.biochi.2007.01.013; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2010, J VIROL, V84, P3220, DOI 10.1128/JVI.02241-09; Gee P, 2008, J BIOL CHEM, V283, P9488, DOI 10.1074/jbc.M706777200; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Kubler K, 2010, CANCER RES, V70, P5293, DOI 10.1158/0008-5472.CAN-10-0825; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Lindsley JE, 2000, METH MOL B, V95, P57; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Lu C, 2011, NUCLEIC ACIDS RES, V39, P1565, DOI 10.1093/nar/gkq974; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; Marq JB, 2011, J BIOL CHEM, V286, P6108, DOI 10.1074/jbc.M110.186262; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; Matranga C, 2010, J BIOL CHEM, V285, P25363, DOI 10.1074/jbc.M110.117010; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mi ZQ, 2010, PROTEIN CELL, V1, P275, DOI 10.1007/s13238-010-0030-1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Nishino T, 2005, STRUCTURE, V13, P143, DOI 10.1016/j.str.2004.11.008; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pippig DA, 2009, NUCLEIC ACIDS RES, V37, P2014, DOI 10.1093/nar/gkp059; Poeck H, 2008, NAT MED, V14, P1256, DOI 10.1038/nm.1887; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schlee M, 2009, IMMUNOL REV, V227, P66, DOI 10.1111/j.1600-065X.2008.00724.x; Schutz P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012791; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Soifer HS, 2008, NUCLEIC ACIDS RES, V36, P6511, DOI 10.1093/nar/gkn687; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Tang ED, 2009, J VIROL, V83, P3420, DOI 10.1128/JVI.02623-08; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Wang Y, 2010, J BIOL CHEM, V285, P36836, DOI 10.1074/jbc.M110.167973; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Welker NC, 2011, MOL CELL, V41, P589, DOI 10.1016/j.molcel.2011.02.005; Welker NC, 2010, RNA, V16, P893, DOI 10.1261/rna.2122010; Yang QS, 2006, NAT STRUCT MOL BIOL, V13, P981, DOI 10.1038/nsmb1165; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zitvogel L, 2009, J CLIN INVEST, V119, P2127, DOI 10.1172/JCI39991; Zou J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-85	77	290	303	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 14	2011	147	2					409	422		10.1016/j.cell.2011.09.023	http://dx.doi.org/10.1016/j.cell.2011.09.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000018	Green Accepted, Bronze			2022-12-28	WOS:000296199300018
J	Gaillard, F; Scaillet, B; Arndt, NT				Gaillard, Fabrice; Scaillet, Bruno; Arndt, Nicholas T.			Atmospheric oxygenation caused by a change in volcanic degassing pressure	NATURE			English	Article							REDOX EVOLUTION; SILICATE MELTS; MANTLE REDOX; SULFUR; RISE; TECTONICS; FLUXES; EARTH	The Precambrian history of our planet is marked by two major events: a pulse of continental crust formation at the end of the Archaean eon and a weak oxygenation of the atmosphere (the Great Oxidation Event) that followed, at 2.45 billion years ago. This oxygenation has been linked to the emergence of oxygenic cyanobacteria(1,2) and to changes in the compositions of volcanic gases(3,4), but not to the composition of erupting lavas-geochemical constraints indicate that the oxidation state of basalts and their mantle sources has remained constant since 3.5 billion years ago(5,6). Here we propose that a decrease in the average pressure of volcanic degassing changed the oxidation state of sulphur in volcanic gases, initiating the modern biogeochemical sulphur cycle and triggering atmospheric oxygenation. Using thermodynamic calculations simulating gas-melt equilibria in erupting magmas, we suggest that mostly submarine Archaean volcanoes produced gases with SO2/H2S < 1 and low sulphur content. Emergence of the continents due to a global decrease in sea level and growth of the continental crust in the late Archaean then led to widespread subaerial volcanism, which in turn yielded gases much richer in sulphur and dominated by SO2. Dissolution of sulphur in sea water and the onset of sulphate reduction processes could then oxidize the atmosphere.	[Gaillard, Fabrice; Scaillet, Bruno] Univ Tours, Univ Orleans, CNRS INSU, Inst Sci Terre Orleans, F-45071 Orleans 2, France; [Arndt, Nicholas T.] Univ Grenoble 1, CNRS, ISTerre, F-38400 St Martin Dheres, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Orleans; Universite de Tours; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Gustave-Eiffel; Universite de Savoie	Gaillard, F (corresponding author), Univ Tours, Univ Orleans, CNRS INSU, Inst Sci Terre Orleans, 1A Rue Ferollerie, F-45071 Orleans 2, France.	gaillard@cnrs-orleans.fr	Scaillet, Bruno/A-5846-2012; Gaillard, Fabrice/H-1308-2012	Gaillard, Fabrice/0000-0001-8079-0476; Scaillet, Bruno/0000-0003-1561-0226; Gaillard, Fabrice/0000-0002-4443-8253	INSU-PNP; ANR [ANR-10-BLAN-60301, ANR-10-BLAN-62101]	INSU-PNP; ANR(French National Research Agency (ANR))	We thank T. Lyons, D. Canil and N. Sleep for comments. We acknowledge support by INSU-PNP and the ANR (grants ANR-10-BLAN-60301 and ANR-10-BLAN-62101).	Aiuppa A, 2005, GEOCHIM COSMOCHIM AC, V69, P1861, DOI 10.1016/j.gca.2004.09.018; [Anonymous], 2006, GEOBIOLOGY, DOI [DOI 10.1111/J.1472-4669.2006.00085.X, DOI 10.1111/j.1472-4669.2006.00085.x]; Arndt N, 1999, PRECAMBRIAN RES, V97, P155, DOI 10.1016/S0301-9268(99)00030-3; BICKLE MJ, 1978, EARTH PLANET SC LETT, V40, P301, DOI 10.1016/0012-821X(78)90155-3; Bounama C, 2001, HYDROL EARTH SYST SC, V5, P569, DOI 10.5194/hess-5-569-2001; Buick R, 2008, PHILOS T R SOC B, V363, P2731, DOI 10.1098/rstb.2008.0041; Burgisser A, 2007, NATURE, V445, P194, DOI 10.1038/nature05509; Butterfield DA, 1997, PHILOS T R SOC A, V355, P369, DOI 10.1098/rsta.1997.0013; Campbell IH, 2008, NAT GEOSCI, V1, P554, DOI 10.1038/ngeo259; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Canil D, 2002, EARTH PLANET SC LETT, V195, P75, DOI 10.1016/S0012-821X(01)00582-9; CARMICHAEL ISE, 1991, CONTRIB MINERAL PETR, V106, P129, DOI 10.1007/BF00306429; Claire M., 2006, GEOBIOLOGY, V4, P239, DOI [10.1111/j.1472-4669.2006.00084.x, DOI 10.1111/J.1472-4669.2006.00084.X]; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2007, NATURE, V449, P706, DOI 10.1038/nature06202; Flament N, 2008, EARTH PLANET SC LETT, V275, P326, DOI 10.1016/j.epsl.2008.08.029; Gaillard F, 2003, GEOCHIM COSMOCHIM AC, V67, P2427, DOI 10.1016/S0016-7037(02)01407-2; Gaillard F, 2009, EARTH PLANET SC LETT, V279, P34, DOI 10.1016/j.epsl.2008.12.028; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Halevy I, 2010, SCIENCE, V329, P204, DOI 10.1126/science.1190298; Holland HD, 2002, GEOCHIM COSMOCHIM AC, V66, P3811, DOI 10.1016/S0016-7037(02)00950-X; KASTING JF, 1993, J GEOL, V101, P245, DOI 10.1086/648219; KASTING JF, 1992, EARTH PLANET SC LETT, V109, P507, DOI 10.1016/0012-821X(92)90110-H; KRESS VC, 1991, CONTRIB MINERAL PETR, V108, P82, DOI 10.1007/BF00307328; Kump LR, 2007, NATURE, V448, P1033, DOI 10.1038/nature06058; Kump LR, 2005, EARTH PLANET SC LETT, V235, P654, DOI 10.1016/j.epsl.2005.04.040; Li ZXA, 2004, EARTH PLANET SC LETT, V228, P483, DOI 10.1016/j.epsl.2004.10.006; Lyons TW, 2010, ELEMENTS, V6, P93, DOI 10.2113/gselements.6.2.93; Morizet Y, 2010, CHEM GEOL, V279, P1, DOI 10.1016/j.chemgeo.2010.09.011; O'Neill HSC, 2002, J PETROL, V43, P1049, DOI 10.1093/petrology/43.6.1049; Oppenheimer C, 2011, REV MINERAL GEOCHEM, V73, P363, DOI 10.2138/rmg.2011.73.13; Pommier A, 2010, GEOCHIM COSMOCHIM AC, V74, P1653, DOI 10.1016/j.gca.2009.12.005; Sandiford M., 2006, EVOLUTION DIFFERENTI, P67; Scott CT, 2011, GEOLOGY, V39, P119, DOI 10.1130/G31571.1; SHI PF, 1992, AM MINERAL, V77, P1038; SLEEP NH, 1982, J GEOL, V90, P363, DOI 10.1086/628691; Taylor S. R., 1985, CONTINENTAL CRUST IT, DOI DOI 10.1002/GJ.3350210116	37	204	211	7	141	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 13	2011	478	7368					229	U112		10.1038/nature10460	http://dx.doi.org/10.1038/nature10460			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21993759	Green Submitted			2022-12-28	WOS:000295782800047
J	Huntington, HP				Huntington, Henry P.			The local perspective	NATURE			English	Editorial Material							KNOWLEDGE		Pew Environm Grp, Eagle River, AK 99577 USA		Huntington, HP (corresponding author), Pew Environm Grp, 23834 Clearing Dr, Eagle River, AK 99577 USA.	hhuntington@pewtrusts.org						Briggs C. L., 1986, LEARNING ASK; Gearheard S, 2010, SIKU: KNOWING OUR ICE: DOCUMENTING INUIT SEA-ICE KNOWLEDGE AND USE, P181, DOI 10.1007/978-90-481-8587-0_8; Huntington HP, 1998, ARCTIC, V51, P237, DOI 10.14430/arctic1065; Huntington HP, 1999, ARCTIC, V52, P49; Mahoney A, 2009, B AM METEOROL SOC, V90, P370, DOI 10.1175/2008BAMS2696.1; Parry M. L., 2007, CLIMATE CHANGE 2007; Riseth JA, 2011, POLAR REC, V47, P202, DOI 10.1017/S0032247410000434; Thewissen JGM, 2011, MAR MAMMAL SCI, V27, P282, DOI 10.1111/j.1748-7692.2010.00406.x; Weatherhead E, 2010, GLOBAL ENVIRON CHANG, V20, P523, DOI 10.1016/j.gloenvcha.2010.02.002	9	100	104	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 13	2011	478	7368					182	183		10.1038/478182a	http://dx.doi.org/10.1038/478182a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21993743				2022-12-28	WOS:000295782800028
J	Fournier-Level, A; Korte, A; Cooper, MD; Nordborg, M; Schmitt, J; Wilczek, AM				Fournier-Level, A.; Korte, A.; Cooper, M. D.; Nordborg, M.; Schmitt, J.; Wilczek, A. M.			A Map of Local Adaptation in Arabidopsis thaliana	SCIENCE			English	Article							RECENT POSITIVE SELECTION; GENOME-WIDE ASSOCIATION; CLIMATE-CHANGE; GENETIC-BASIS; TRADE-OFFS; STRESS; PLANTS; TREE	Local adaptation is critical for species persistence in the face of rapid environmental change, but its genetic basis is not well understood. Growing the model plant Arabidopsis thaliana in field experiments in four sites across the species' native range, we identified candidate loci for local adaptation from a genome-wide association study of lifetime fitness in geographically diverse accessions. Fitness-associated loci exhibited both geographic and climatic signatures of local adaptation. Relative to genomic controls, high-fitness alleles were generally distributed closer to the site where they increased fitness, occupying specific and distinct climate spaces. Independent loci with different molecular functions contributed most strongly to fitness variation in each site. Independent local adaptation by distinct genetic mechanisms may facilitate a flexible evolutionary response to changing environment across a species range.	[Fournier-Level, A.; Cooper, M. D.; Schmitt, J.; Wilczek, A. M.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Korte, A.; Nordborg, M.] Austrian Acad Sci, Gregor Mendel Inst, A-1030 Vienna, Austria; [Wilczek, A. M.] Deep Springs Coll, Big Pine, CA 93513 USA	Brown University; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Schmitt, J (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	johanna_schmitt@brown.edu	Korte, Arthur/H-3190-2019	Korte, Arthur/0000-0003-0831-1463; FOURNIER-LEVEL, ALEXANDRE/0000-0002-6047-7164; Nordborg, Magnus/0000-0001-7178-9748	NSF [EF-0425759]; Alexander von Humboldt Research Award	NSF(National Science Foundation (NSF)); Alexander von Humboldt Research Award(Alexander von Humboldt Foundation)	We thank M. Blazquez, C. Dean, M. Hoffmann, H. Kuittinen, and O. Savolainen for hosting the experiments; J. Anderson, D. Eaton, J. F. Egan, C. Lopez-Gallego, L. J. Martin, C. D. Muir, R. Petipas, J. Roe, and R. N. Schaeffer for managing the field experiments; Brown undergraduates for fruit counts; and J. Bergelson, A. Hancock, and J. Mossman for comments on the manuscript. Supported by NSF grant EF-0425759 and an Alexander von Humboldt Research Award. Supplemental data for the phenotypes and the associated SNPs are available at http://dx.doi.org/10.5061/dryad.37f9t. Genotype data for the SNPs used in this study are available at http://regmap.uchicago.edu.	Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Bergelson J, 2010, NAT REV GENET, V11, P867, DOI 10.1038/nrg2896; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; De Carvalho D, 2010, MOL ECOL, V19, P1638, DOI 10.1111/j.1365-294X.2010.04595.x; Eckert AJ, 2010, MOL ECOL, V19, P3789, DOI 10.1111/j.1365-294X.2010.04698.x; Ehrenreich IM, 2006, AM J BOT, V93, P953, DOI 10.3732/ajb.93.7.953; Hall MC, 2010, MOL ECOL, V19, P2739, DOI 10.1111/j.1365-294X.2010.04680.x; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Mariac C, 2011, MOL ECOL, V20, P80, DOI 10.1111/j.1365-294X.2010.04893.x; MCCORMAC AC, 1992, J PLANT PHYSIOL, V140, P707, DOI 10.1016/S0176-1617(11)81027-8; Molinier J, 2005, MUTAT RES-FUND MOL M, V571, P235, DOI 10.1016/j.mrfmmm.2004.09.016; Mowla SB, 2006, PLANT J, V48, P743, DOI 10.1111/j.1365-313X.2006.02911.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pourcel L, 2005, PLANT CELL, V17, P2966, DOI 10.1105/tpc.105.035154; Reed DH, 2001, EVOLUTION, V55, P1095, DOI 10.1111/j.0014-3820.2001.tb00629.x; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Weaver LM, 1998, PLANT MOL BIOL, V37, P455, DOI 10.1023/A:1005934428906; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826	24	478	483	4	341	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 7	2011	334	6052					86	89		10.1126/science.1209271	http://dx.doi.org/10.1126/science.1209271			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21980109				2022-12-28	WOS:000295580300045
J	Slamon, D; Eiermann, W; Robert, N; Pienkowski, T; Martin, M; Press, M; Mackey, J; Glaspy, J; Chan, A; Pawlicki, M; Tamas, P; Valero, V; Liu, MC; Sauter, G; von Minckwitz, G; Visco, F; Bee, V; Buyse, M; Bendahmane, B; Tabah-Fisch, I; Lindsay, MA; Riva, A; Crown, J				Slamon, Dennis; Eiermann, Wolfgang; Robert, Nicholas; Pienkowski, Tadeusz; Martin, Miguel; Press, Michael; Mackey, John; Glaspy, John; Chan, Arlene; Pawlicki, Marek; Tamas Pinter; Valero, Vicente; Liu, Mei-Ching; Sauter, Guido; von Minckwitz, Gunter; Visco, Frances; Bee, Valerie; Buyse, Marc; Bendahmane, Belguendouz; Tabah-Fisch, Isabelle; Lindsay, Mary-Ann; Riva, Alessandro; Crown, John		Breast Canc Int Res Grp	Adjuvant Trastuzumab in HER2-Positive Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MONOCLONAL-ANTIBODY; OVARIAN-CANCER; RANDOMIZED-TRIALS; TUMOR-CELLS; HER2 STATUS; CHEMOTHERAPY; RECEPTOR; THERAPY; DOXORUBICIN; GROWTH	BACKGROUND Trastuzumab improves survival in the adjuvant treatment of HER-positive breast cancer, although combined therapy with anthracycline-based regimens has been associated with cardiac toxicity. We wanted to evaluate the efficacy and safety of a new nonanthracycline regimen with trastuzumab. METHODS We randomly assigned 3222 women with HER2-positive early-stage breast cancer to receive doxorubicin and cyclophosphamide followed by docetaxel every 3 weeks (AC-T), the same regimen plus 52 weeks of trastuzumab (AC-T plus trastuzumab), or docetaxel and carboplatin plus 52 weeks of trastuzumab (TCH). The primary study end point was disease-free survival. Secondary end points were overall survival and safety. RESULTS At a median follow-up of 65 months, 656 events triggered this protocol-specified analysis. The estimated disease-free survival rates at 5 years were 75% among patients receiving AC-T, 84% among those receiving AC-T plus trastuzumab, and 81% among those receiving TCH. Estimated rates of overall survival were 87%, 92%, and 91%, respectively. No significant differences in efficacy (disease-free or overall survival) were found between the two trastuzumab regimens, whereas both were superior to AC-T. The rates of congestive heart failure and cardiac dysfunction were significantly higher in the group receiving AC-T plus trastuzumab than in the TCH group (P<0.001). Eight cases of acute leukemia were reported: seven in the groups receiving the anthracycline-based regimens and one in the TCH group subsequent to receiving an anthracycline outside the study. CONCLUSIONS The addition of 1 year of adjuvant trastuzumab significantly improved disease-free and overall survival among women with HER2-positive breast cancer. The risk-benefit ratio favored the nonanthracycline TCH regimen over AC-T plus trastuzumab, given its similar efficacy, fewer acute toxic effects, and lower risks of cardiotoxicity and leukemia. (Funded by Sanofi-Aventis and Genentech; BCIRG-006 ClinicalTrials.gov number, NCT00021255.)	[Slamon, Dennis; Glaspy, John] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Press, Michael] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Eiermann, Wolfgang] Frauenklin Roten Kreuz, Munich, Germany; [Sauter, Guido] Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Hamburg, Germany; [von Minckwitz, Gunter] Zentrum Frauenheilkunde, Frankfurt, Germany; [Robert, Nicholas] US Oncol Res, Houston, TX USA; [Valero, Vicente] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Pienkowski, Tadeusz] Marie Curie Sklodowska Univ, Warsaw, Poland; [Martin, Miguel] Hosp Univ San Carlos, Madrid, Spain; [Mackey, John] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Chan, Arlene] Mt Hosp, Mt Breast Grp, Perth, WA, Australia; [Press, Michael] City Oncol Dispensary, St Petersburg, Russia; [Tamas Pinter] Petz Oktato Korhaz Onkoradiol, Budapest, Hungary; [Liu, Mei-Ching] Sun Yat Sen Canc Ctr, Taipei, Taiwan; [Visco, Frances] Natl Breast Canc Coalit, Washington, DC USA; [Bee, Valerie; Lindsay, Mary-Ann; Riva, Alessandro] Breast Canc Int Res Grp, Paris, France; [Bendahmane, Belguendouz; Tabah-Fisch, Isabelle] Sanofi Aventis, Paris, France; [Buyse, Marc] Int Inst Drug Dev, Louvain, Belgium; [Crown, John] St Vincents Univ Hosp, All Ireland Cooperat Oncol Res Grp, Dublin 4, Ireland	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of Southern California; University of Hamburg; University Medical Center Hamburg-Eppendorf; US Oncology Network; University of Texas System; UTMD Anderson Cancer Center; Maria Curie-Sklodowska University; University of Alberta; Sanofi-Aventis; International Drug Development Institute; All-Ireland Cooperative Oncology Research Group; University College Dublin; Saint Vincent's University Hospital	Slamon, D (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, 10945 Le Conte Ave,Suite 3360, Los Angeles, CA 90095 USA.	dslamon@mednet.ucla.edu	Romero, Jose Luis Alonso/AAC-3782-2020; Buyse, Marc/J-4658-2013; Stanculeanu, Dana Lucia/AAB-7964-2019; Martin, Miguel/V-6589-2019; Calvo, Lourdes/M-2352-2014; Martin, Miguel/AAJ-9242-2020; Wardley, Andrew/N-8135-2015; Mieszkowska, Magdalena/O-6753-2017; Schwartsmann, Gilberto/G-4256-2016; Crown, John/AAL-3367-2020; Francis, Prudence A/J-4003-2012; Petruzelka, Lubos/A-2750-2017; Sanches, Solange/G-6255-2017; Kwong, Ava/D-8005-2013	Romero, Jose Luis Alonso/0000-0001-8746-2096; Stanculeanu, Dana Lucia/0000-0003-3930-2543; Martin, Miguel/0000-0001-9237-3231; Wardley, Andrew/0000-0002-9639-0888; Schwartsmann, Gilberto/0000-0002-7850-1644; Francis, Prudence A/0000-0002-7207-9286; Petruzelka, Lubos/0000-0002-4397-0635; VANLEMMENS, LAURENCE/0000-0001-7799-1648; Adrover, Encarna/0000-0001-8676-8560; Pienkowski, Tadeusz/0000-0002-0110-5950; Crown, John/0000-0002-3125-7613; Lemos Ferrari, Bruno/0000-0002-7728-1125; Breitbach, Georg-Peter/0000-0002-8257-917X; Buyse, Marc/0000-0002-4559-0994; , International Journal of Business and Applied Social Science/0000-0001-7850-0193; Kwong, Ava/0000-0002-6968-9489; Gligorov, Joseph/0000-0002-9900-6386	Sanofi-Aventis; Genentech; Department of Defense; Revlon/UCLA; Peter and Denise Wittich Breast Cancer Program; U.S. Army Medical Research and Development Command [DAMD-03-1-0626]; National Cancer Institute [CA 48780]; California Breast Cancer Research Program [12IB-0155, 14NB-0179]; Roche; Amgen; Eli Lilly; NATIONAL CANCER INSTITUTE [R01CA048780] Funding Source: NIH RePORTER	Sanofi-Aventis(Sanofi-Aventis); Genentech(Roche HoldingGenentech); Department of Defense(United States Department of Defense); Revlon/UCLA; Peter and Denise Wittich Breast Cancer Program; U.S. Army Medical Research and Development Command(United States Department of DefenseUnited States ArmyUnited States Army Medical Research & Development Command (USAMRDC)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); California Breast Cancer Research Program; Roche(Roche Holding); Amgen(Amgen); Eli Lilly(Eli Lilly); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Sanofi-Aventis and Genentech; a Department of Defense Breast Cancer Innovator Award and funding from the Revlon/UCLA Women's Cancer Program and the Peter and Denise Wittich Breast Cancer Program (to Dr. Slamon); and grants (to Dr. Press) from the U.S. Army Medical Research and Development Command (DAMD-03-1-0626), the National Cancer Institute (CA 48780), and the California Breast Cancer Research Program (12IB-0155 and 14NB-0179) for studies of TOP2A.; Dr. Slamon reports receiving honoraria and reimbursement for travel expenses from Genentech and Sanofi-Aventis; Dr. Eiermann, receiving honoraria, lecture fees, and reimbursement for travel expenses from Roche and Sanofi-Aventis; Dr. Robert, receiving reimbursement for travel expenses from Fairfax Northern Virginia Hematology Oncology PC and that his institution has received grant support, honoraria, and payments for the development of educational presentations from Fairfax Northern Virginia Hematology Oncology PC on his behalf; Dr. Pienkowski, serving as a board member for Sanofi-Aventis and Roche, receiving honoraria from Roche and GlaxoSmithKline, and that he and his institution have received lecture fees and reimbursement for travel expenses from Roche and Sanofi-Aventis; Dr. Press, receiving consulting fees, honoraria, lecture fees, and reimbursement for travel expenses from Genentech; Dr. Mackey, receiving honoraria from Roche; Dr. Glaspy, receiving lecture fees from Genentech, Amgen, and Eli Lilly; Dr. Chan, serving on an advisory board for and receiving consulting fees, grant support, and honoraria from Roche and -receiving reimbursement for travel expenses from Sanofi-Aventis; Dr. Pinter, receiving consulting and lecture fees from Roche; Dr. Valero, receiving honoraria and reimbursement for travel expenses from Roche; Dr. Sauter, receiving honoraria and reimbursement for travel expenses from Roche; Dr. von Minckwitz, receiving fees for expert testimony, lecture fees, and reimbursement for travel expenses from Roche and Sanofi-Aventis; Dr. Buyse, being an employee of and having an equity interest in the International Drug Development Institute; Dr. Bendahmane and Dr. Tabah-Fisch, being employees of Sanofi-Aventis; Dr. Tabah-Fisch, receiving stock options from Sanofi-Aventis; and Dr. Crown, receiving honoraria and reimbursement for travel expenses from Roche and Sanofi-Aventis and that his institution has also received grant support from Roche on his behalf. No other potential conflict of interest relevant to this article was reported. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.	Abe O, 1998, LANCET, V352, P930; Arboleda MJ, 2003, CANCER RES, V63, P196; BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; De Luca A, 2008, J CELL PHYSIOL, V214, P559, DOI 10.1002/jcp.21260; Doyle JJ, 2005, J CLIN ONCOL, V23, P8597, DOI 10.1200/JCO.2005.02.5841; Dressler LG, 2005, J CLIN ONCOL, V23, P4287, DOI 10.1200/JCO.2005.11.012; Feigin ME, 2009, EXP CELL RES, V315, P707, DOI 10.1016/j.yexcr.2008.10.034; Gennari A, 2008, JNCI-J NATL CANCER I, V100, P14, DOI 10.1093/jnci/djm252; HANCOCK MC, 1991, CANCER RES, V51, P4575; Hershman D, 2007, JNCI-J NATL CANCER I, V99, P196, DOI 10.1093/jnci/djk028; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165; Izumi Y, 2002, NATURE, V416, P279, DOI 10.1038/416279b; Joensuu H, 2006, NEW ENGL J MED, V354, P809, DOI 10.1056/NEJMoa053028; Marcotte R, 2008, J MAMMARY GLAND BIOL, V13, P323, DOI 10.1007/s10911-008-9087-3; MUSS HB, 1994, NEW ENGL J MED, V331, P211; MUSS HB, 1994, NEW ENGL J MED, V330, P1260, DOI 10.1056/NEJM199405053301802; O'Malley FP, 2009, JNCI-J NATL CANCER I, V101, P644, DOI 10.1093/jnci/djp067; Paik S, 2000, J NATL CANCER I, V92, P1991, DOI 10.1093/jnci/92.24.1991; Paik SM, 1998, JNCI-J NATL CANCER I, V90, P1361, DOI 10.1093/jnci/90.18.1361; Pegram M, 1999, ONCOGENE, V18, P2241, DOI 10.1038/sj.onc.1202526; PEGRAM M, 2007, J CLIN ONCOL S2, V25, pS964; Pegram MD, 1999, SEMIN ONCOL, V26, P89; Pegram MD, 2004, JNCI-J NATL CANCER I, V96, P759, DOI 10.1093/jnci/djh133; Pegram MD, 2004, JNCI-J NATL CANCER I, V96, P739, DOI 10.1093/jnci/djh131; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; PIETRAS RJ, 1994, ONCOGENE, V9, P1829; PIETRAS RJ, 1995, ONCOGENE, V10, P2435; Pinder MC, 2007, J CLIN ONCOL, V25, P3808, DOI 10.1200/JCO.2006.10.4976; Press MF, 2011, J CLIN ONCOL, V29, P859, DOI 10.1200/JCO.2009.27.5644; Pritchard KI, 2006, NEW ENGL J MED, V354, P2103, DOI 10.1056/NEJMoa054504; Robert N, 2006, J CLIN ONCOL, V24, P2786, DOI 10.1200/JCO.2005.04.1764; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; She QB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003065; Slamon DJ, 2009, JNCI-J NATL CANCER I, V101, P615, DOI 10.1093/jnci/djp092; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Slamon DJ, 1996, FINAL STUDY REPORT F; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Tan-Chiu E, 2005, J CLIN ONCOL, V23, P7811, DOI 10.1200/JCO.2005.02.4091; Tripathy D, 2004, J CLIN ONCOL, V22, P1063, DOI 10.1200/JCO.2004.06.557; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	44	1752	1819	5	188	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 6	2011	365	14					1273	1283		10.1056/NEJMoa0910383	http://dx.doi.org/10.1056/NEJMoa0910383			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829KL	21991949	Green Accepted			2022-12-28	WOS:000295578700004
J	Okie, S				Okie, Susan			Confronting Alzheimer's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Georgetown Univ, Sch Med, Washington, DC 20007 USA	Georgetown University	Okie, S (corresponding author), Georgetown Univ, Sch Med, Washington, DC 20007 USA.							Alzheimer's Association, NEW DIAGN CRIT GUID; Alzheimer's Association, 2010, CHANG TRAJ ALZH DIS; Alzheimer's Association, 2009, 2 ALZH ASS DARTM I H; BYNUM J, 2009, 1 ALZH ASS DARTM I H; Mittelman MS, 2006, NEUROLOGY, V67, P1592, DOI 10.1212/01.wnl.0000242727.81172.91	5	22	22	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2011	365	12					1069	1072		10.1056/NEJMp1107288	http://dx.doi.org/10.1056/NEJMp1107288			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	822WR	21992119				2022-12-28	WOS:000295081600004
J	Fricke, HC; Hencecroth, J; Hoerner, ME				Fricke, Henry C.; Hencecroth, Justin; Hoerner, Marie E.			Lowland-upland migration of sauropod dinosaurs during the Late Jurassic epoch	NATURE			English	Article							ISOTOPE COMPOSITIONS; HYDROGEN ISOTOPES; OXYGEN; ENAMEL	Sauropod dinosaurs were the largest vertebrates ever to walk the Earth, and as mega-herbivores they were important parts of terrestrial ecosystems. In the Late Jurassic-aged Morrison depositional basin of western North America, these animals occupied lowland river-floodplain settings characterized by a seasonally dry climate(1,2). Massive herbivores with high nutritional and water needs could periodically experience nutritional and water stress under these conditions, and thus the common occurrence of sauropods in this basin has remained a paradox. Energetic arguments and mammalian analogues have been used to suggest that migration allowed sauropods access to food and water resources over a wide region or during times of drought or both(3,4), but there has been no direct support for these hypotheses. Here we compare oxygen isotope ratios (delta O-18) of tooth-enamel carbonate from the sauropod Camarasaurus with those of ancient soil, lake and wetland (that is, 'authigenic') carbonates that formed in lowland settings. We demonstrate that certain populations of these animals did in fact undertake seasonal migrations of several hundred kilometres from lowland to upland environments. This ability to describe patterns of sauropod movement will help to elucidate the role that migration played in the ecology and evolution of gigantism of these and associated dinosaurs.	[Fricke, Henry C.; Hencecroth, Justin; Hoerner, Marie E.] Colorado Coll, Dept Geol, Colorado Springs, CO 80903 USA	Colorado College	Fricke, HC (corresponding author), Colorado Coll, Dept Geol, Colorado Springs, CO 80903 USA.	hfricke@coloradocollege.edu			National Science Foundation [EAR-0319041, EAR 0923831]; Colorado College	National Science Foundation(National Science Foundation (NSF)); Colorado College	We thank S. Hartman, D. Lovelace and D. Chure for providing context and fossil specimens. The research was funded in part by National Science Foundation EAR-0319041 and Colorado College. We thank G. Olack and A. Colman for the phosphate oxygen isotope analyses, supported by National Science Foundation Major Research Instrumentation award EAR 0923831.	Amiot R, 2004, EARTH PLANET SC LETT, V226, P255, DOI 10.1016/j.epsl.2004.07.015; Bowen GJ, 2010, ANNU REV EARTH PL SC, V38, P161, DOI 10.1146/annurev-earth-040809-152429; DODSON P, 1980, PALEOBIOLOGY, V6, P6, DOI 10.1017/S0094837300012446; Dunagan SP, 2004, SEDIMENT GEOL, V167, P269, DOI 10.1016/j.sedgeo.2004.01.007; Engelmann GF, 2004, SEDIMENT GEOL, V167, P297, DOI 10.1016/j.sedgeo.2004.01.008; Erickson GM, 1996, P NATL ACAD SCI USA, V93, P14623, DOI 10.1073/pnas.93.25.14623; Fallin M. J., 2005, THESIS U COLORADO BO; Fricke HC, 1996, PALAEOGEOGR PALAEOCL, V126, P91, DOI 10.1016/S0031-0182(96)00072-7; Gat JR, 1996, ANNU REV EARTH PL SC, V24, P225, DOI 10.1146/annurev.earth.24.1.225; Jennings DS, 2011, SEDIMENT GEOL, V238, P23, DOI 10.1016/j.sedgeo.2011.03.005; Kohn MJ, 2002, REV MINERAL GEOCHEM, V48, P455, DOI 10.2138/rmg.2002.48.12; Kohn MJ, 1998, CHEM GEOL, V152, P97, DOI 10.1016/S0009-2541(98)00099-0; Lovelace D, 2006, PALEONTOLOGY GEOLOGY, V36, P47; Parrish JT, 2004, SEDIMENT GEOL, V167, P137, DOI 10.1016/j.sedgeo.2004.01.004; Podlesak DW, 2008, GEOCHIM COSMOCHIM AC, V72, P19, DOI 10.1016/j.gca.2007.10.003; Rees P. M., 2003, INWARM CLIMATES EART, P297; Sellwood BW, 2008, P GEOLOGIST ASSOC, V119, P5, DOI 10.1016/S0016-7878(59)80068-7; Thomas KJS, 2004, PALAEOGEOGR PALAEOCL, V206, P257, DOI 10.1016/j.palaeo.2004.01.007; Turner CE, 2004, SEDIMENT GEOL, V167, P309, DOI 10.1016/j.sedgeo.2004.01.009	19	30	31	2	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2011	480	7378					513	515		10.1038/nature10570	http://dx.doi.org/10.1038/nature10570			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22031326				2022-12-28	WOS:000298318000058
J	Guinto, RLL; Yore, D; Habibullah, NK; de Leon, AM; Tillman, T; Elliott-Green, A; Gopinathan, U				Guinto, Ramon Lorenzo Luis; Yore, Daniel; Habibullah, Nilofer Khan; de Leon, Altagracia Mares; Tillman, Taavi; Elliott-Green, Alex; Gopinathan, Unni			Students' perspective on rooting out causes of health injustice	LANCET			English	Editorial Material									[Guinto, Ramon Lorenzo Luis; Yore, Daniel; Habibullah, Nilofer Khan; de Leon, Altagracia Mares; Tillman, Taavi; Elliott-Green, Alex; Gopinathan, Unni] World Med Assoc, IFMSA Gen Secretariat, Int Federat Med Students Assoc, F-01212 Ferney Voltaire, France		Gopinathan, U (corresponding author), World Med Assoc, IFMSA Gen Secretariat, Int Federat Med Students Assoc, F-01212 Ferney Voltaire, France.	unni.gnathan@gmail.com	Tillmann, Taavi/R-6026-2016	Tillmann, Taavi/0000-0002-8428-3719; Guinto, Ramon Lorenzo Luis/0000-0002-3181-0423				Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Daniels N, 1999, DAEDALUS, V128, P215; *INT FED MED STUD, 2011, POL STAT HLTH IN SOC; *ROOT OUT REACH OU, INT FED MED STUD ASS; United Nations Development Program, HUM DEV IND	5	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 10	2011	378	9808					E20	E21		10.1016/S0140-6736(11)61628-0	http://dx.doi.org/10.1016/S0140-6736(11)61628-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	863DY	22019146				2022-12-28	WOS:000298144200002
J	Hoffman, RM				Hoffman, Richard M.			Screening for Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPARING RADICAL PROSTATECTOMY; DIGITAL RECTAL EXAMINATION; INFORMED DECISION-MAKING; RANDOMIZED-TRIAL; UNITED-STATES; MORTALITY; MEN; MANAGEMENT; IMPACT; TIME		[Hoffman, Richard M.] Univ New Mexico, Sch Med, Dept Med, Albuquerque, NM 87131 USA; [Hoffman, Richard M.] Univ New Mexico, Sch Med, Dept Family & Community Med, Albuquerque, NM 87131 USA; [Hoffman, Richard M.] New Mexico Vet Affairs Hlth Care Syst, Med Serv, Albuquerque, NM USA	University of New Mexico; University of New Mexico	Hoffman, RM (corresponding author), 1501 San Pedro Dr SE,Mailstop 111, Albuquerque, NM 87108 USA.	rhoffman@unm.edu		Hoffman, Richard/0000-0002-4714-7726	Foundation for Informed Medical Decision Making	Foundation for Informed Medical Decision Making	Dr. Hoffman reports receiving payment for providing expert testimony regarding prostate-cancer screening and partial salary support for medical editing from the Foundation for Informed Medical Decision Making, a not-for-profit 501(c)(3) private foundation that develops content for patient-education programs (including programs on prostate-cancer screening and treatment) and having an arrangement to produce these programs with a for-profit company, Health Dialog. No other potential conflict of interest relevant to this article was reported.	Altekruse SF, 2010, SEER CANC STAT REV 1; American Urological Association, 1992, AM UR ASS 1992 POL S; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; [Anonymous], 2008, PHAS 3 RAND STUD ACT; Barry MJ, 2002, ANN INTERN MED, V136, P127, DOI 10.7326/0003-4819-136-2-200201150-00010; Bartsch G, 2008, BJU INT, V101, P809, DOI 10.1111/j.1464-410X.2008.07502.x; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Braddock CH, 1999, JAMA-J AM MED ASSOC, V282, P2313, DOI 10.1001/jama.282.24.2313; CHODAK GW, 1989, J UROLOGY, V141, P1136, DOI 10.1016/S0022-5347(17)41192-X; Coley CM, 1997, ANN INTERN MED, V126, P394, DOI 10.7326/0003-4819-126-5-199703010-00010; Collin SM, 2008, LANCET ONCOL, V9, P445, DOI 10.1016/S1470-2045(08)70104-9; Concato J, 2006, ARCH INTERN MED, V166, P38, DOI 10.1001/archinte.166.1.38; Cooperberg MR, 2010, J CLIN ONCOL, V28, P1117, DOI 10.1200/JCO.2009.26.0133; D'Amico AV, 2008, JAMA-J AM MED ASSOC, V299, P289, DOI 10.1001/jama.299.3.289; Draisma G, 2009, JNCI-J NATL CANCER I, V101, P374, DOI 10.1093/jnci/djp001; Etzioni R, 2008, CANCER CAUSE CONTROL, V19, P175, DOI 10.1007/s10552-007-9083-8; Fowler FJ, 2006, J GEN INTERN MED, V21, P715, DOI 10.1111/j.1525-1497.2006.00464.x; Gonzalgo Mark L, 2007, J Natl Compr Canc Netw, V5, P737; Greene KL, 2009, J UROLOGY, V182, P2232, DOI 10.1016/j.juro.2009.07.093; Grubb RL, 2008, BJU INT, V102, P1524, DOI 10.1111/j.1464-410X.2008.08214.x; Guerra CE, 2007, J GEN INTERN MED, V22, P901, DOI 10.1007/s11606-007-0142-3; Hoffman RM, 2009, ARCH INTERN MED, V169, P1611, DOI 10.1001/archinternmed.2009.262; Hoffman RM, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-27; Holmberg L, 2002, NEW ENGL J MED, V347, P781, DOI 10.1056/NEJMoa012794; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Jones CU, 2011, NEW ENGL J MED, V365, P107, DOI 10.1056/NEJMoa1012348; Klotz L, 2010, CURR ONCOL, V17, pS11; Loeb S, 2011, J CLIN ONCOL, V29, P464, DOI 10.1200/JCO.2010.30.6373; Lu-Yao G, 2002, BMJ-BRIT MED J, V325, P740, DOI 10.1136/bmj.325.7367.740; Lu-Yao GL, 2009, JAMA-J AM MED ASSOC, V302, P1202, DOI 10.1001/jama.2009.1348; METTLIN C, 1993, CA-CANCER J CLIN, V43, P42, DOI 10.3322/canjclin.43.1.42; Phillips C, 2011, NCI CANC B, V8; Rimer BK, 2004, CANCER-AM CANCER SOC, V101, P1214, DOI 10.1002/cncr.20512; Roobol MJ, 2009, EUR UROL, V56, P584, DOI 10.1016/j.eururo.2009.07.018; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; SEIDMAN H, 1985, CA-CANCER J CLIN, V35, P36, DOI 10.3322/canjclin.35.1.36; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sirovich BE, 2003, JAMA-J AM MED ASSOC, V289, P1414, DOI 10.1001/jama.289.11.1414; SMITH DS, 1995, UROLOGY, V45, P70, DOI 10.1016/S0090-4295(95)96812-1; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Thompson I, 2007, J UROLOGY, V177, P2106, DOI 10.1016/j.juro.2007.03.003; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Thompson IM, 2004, NEW ENGL J MED, V351, P1470; U.S. Preventive Services Task Force, SCREEN PROS IN PRESS; Volk RJ, 2007, AM J PREV MED, V33, P428, DOI 10.1016/j.amepre.2007.07.030; Widmark A, 2009, LANCET, V373, P301, DOI 10.1016/S0140-6736(08)61815-2; Wilt TJ, 2008, ANN INTERN MED, V148, P888, DOI 10.7326/0003-4819-148-11-200806030-00023; Wilt TJ, 2008, ANN INTERN MED, V148, P435, DOI 10.7326/0003-4819-148-6-200803180-00209; Wilt TJ, 2009, CONTEMP CLIN TRIALS, V30, P81, DOI 10.1016/j.cct.2008.08.002; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066; Wright Jonathan L, 2007, Rev Urol, V9, P207	51	147	151	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2011	365	21					2013	2019		10.1056/NEJMcp1103642	http://dx.doi.org/10.1056/NEJMcp1103642			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851PF	22029754				2022-12-28	WOS:000297282600011
J	Iglehart, JK				Iglehart, John K.			Medicare Payment Reform - Proposals for Paying for an SGR Repeal	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Aaron HJ, 2011, NEW ENGL J MED, V365, P1655, DOI 10.1056/NEJMp1109940; HACKBARTH GM, 2011, LETT SENATORS MAX BA; Medicare Payment Advisory Commission, 2011, REP C MED HLTH DEL S; SHANKER T, 2011, NY TIMES        1014, pA18	4	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 17	2011	365	20					1859	1861		10.1056/NEJMp1111954	http://dx.doi.org/10.1056/NEJMp1111954			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	848HG	22029757				2022-12-28	WOS:000297041900004
J	Nomura, DK; Morrison, BE; Blankman, JL; Long, JZ; Kinsey, SG; Marcondes, MCG; Ward, AM; Hahn, YK; Lichtman, AH; Conti, B; Cravatt, BF				Nomura, Daniel K.; Morrison, Bradley E.; Blankman, Jacqueline L.; Long, Jonathan Z.; Kinsey, Steven G.; Marcondes, Maria Cecilia G.; Ward, Anna M.; Hahn, Yun Kyung; Lichtman, Aron H.; Conti, Bruno; Cravatt, Benjamin F.			Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation	SCIENCE			English	Article							MOUSE MODEL; PARKINSONS-DISEASE; PHOSPHOLIPASE A(2); MICE; INHIBITION; CYCLOOXYGENASE-2; INFLAMMATION; SYSTEM; INJURY; LIPOPOLYSACCHARIDE	Phospholipase A(2)(PLA(2)) enzymes are considered the primary source of arachidonic acid for cyclooxygenase (COX)-mediated biosynthesis of prostaglandins. Here, we show that a distinct pathway exists in brain, where monoacylglycerol lipase (MAGL) hydrolyzes the endocannabinoid 2-arachidonoylglycerol to generate a major arachidonate precursor pool for neuroinflammatory prostaglandins. MAGL-disrupted animals show neuroprotection in a parkinsonian mouse model. These animals are spared the hemorrhaging caused by COX inhibitors in the gut, where prostaglandins are instead regulated by cytosolic PLA(2). These findings identify MAGL as a distinct metabolic node that couples endocannabinoid to prostaglandin signaling networks in the nervous system and suggest that inhibition of this enzyme may be a new and potentially safer way to suppress the proinflammatory cascades that underlie neurodegenerative disorders.	[Nomura, Daniel K.; Blankman, Jacqueline L.; Long, Jonathan Z.; Ward, Anna M.; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Nomura, Daniel K.; Blankman, Jacqueline L.; Long, Jonathan Z.; Ward, Anna M.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Nomura, Daniel K.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Program Metab Biol, Berkeley, CA 94720 USA; [Morrison, Bradley E.; Marcondes, Maria Cecilia G.; Conti, Bruno] Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA; [Kinsey, Steven G.] W Virginia Univ, Dept Psychol, Morgantown, WV 26506 USA; [Hahn, Yun Kyung; Lichtman, Aron H.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA	Scripps Research Institute; Scripps Research Institute; University of California System; University of California Berkeley; Scripps Research Institute; West Virginia University; Virginia Commonwealth University	Nomura, DK (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dnomura@berkeley.edu; cravatt@scripps.edu		Conti, Bruno/0000-0002-9185-5201; Long, Jonathan/0000-0003-2631-7463; Morrison, Brad/0000-0002-6356-7149	NIH [DA017259, K99DA030908, R00DA030908, 5P01DA009789, P01DA01725, AG028040, R03DA027936, DA026261, T32DA007027]; Institute for Drug and Alcohol Studies at Virginia Commonwealth University; Ellison Medical Foundation; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE ON AGING [R01AG028040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA027936, K99DA030908, P01DA017259, P01DA009789, F31DA026261, R00DA030908, T32DA007027] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Drug and Alcohol Studies at Virginia Commonwealth University; Ellison Medical Foundation(Lawrence Ellison Foundation); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the members of the Cravatt laboratory for helpful discussion and critical reading of the manuscript. This work was supported by the NIH (DA017259 (B.F.C.), K99DA030908, R00DA030908 (D.K.N.), 5P01DA009789 and P01DA01725 (A.H.L.), AG028040 (B.C. and B.E.M.), R03DA027936 (M.C.G.M.), DA026261 (J.L.B.), and T32DA007027 (S.G.K.); Institute for Drug and Alcohol Studies at Virginia Commonwealth University; the Ellison Medical Foundation; and the Skaggs Institute for Chemical Biology. A patent has been filed (U.S. Patent Application no. 12/998,642) "Methods and compositions related to targeting monoacylglycerol lipase," which relates to inhibitors of monoacylglycerol lipase and associated methods, compositions, and potential uses for treating human disorders that are associated with endocannabinoid signaling. Authors who are listed inventors are J.Z.L., D.K.N, and B.F.C. The data reported in this paper are tabulated in the main text and supporting online material. Author contributions: D.K.N. and B.F.C. wrote the paper; D.K.N., B.E.M., J.L.B., S.G.K., M.C.G.M., and A.M.W. performed experiments; J.Z.L. provided reagents; and D.K.N., B.F.C., B.C., and A.H. conceived and planned experiments.	Aid S, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-17; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Carrasco E, 2007, J NEUROSCI RES, V85, P3109, DOI 10.1002/jnr.21425; Choi SH, 2008, FASEB J, V22, P1491, DOI 10.1096/fj.07-9411com; Choi SH, 2009, AGING-US, V1, P234, DOI 10.18632/aging.100021; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Farias SE, 2008, J LIPID RES, V49, P1990, DOI 10.1194/jlr.M800200-JLR200; Garcia-Bueno B, 2009, J NEUROSCI, V29, P12970, DOI 10.1523/JNEUROSCI.2373-09.2009; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Golovko MY, 2008, J LIPID RES, V49, P893, DOI 10.1194/jlr.D700030-JLR200; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Kinsey SG, 2011, J PHARMACOL EXP THER, V338, P795, DOI 10.1124/jpet.110.175778; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Lambert DM, 2005, J MED CHEM, V48, P5059, DOI 10.1021/jm058183t; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Mckee AC, 2008, BRAIN RES, V1207, P225, DOI 10.1016/j.brainres.2008.01.095; Ng SC, 2010, CURR OPIN GASTROEN, V26, P611, DOI 10.1097/MOG.0b013e32833e91eb; Nomura DK, 2008, NAT CHEM BIOL, V4, P373, DOI 10.1038/nchembio.86; Price DA, 2009, EUR J NEUROSCI, V29, P2177, DOI 10.1111/j.1460-9568.2009.06764.x; Rosenberger TA, 2003, J LIPID RES, V44, P109, DOI 10.1194/jlr.M200298-JLR200; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Sapirstein A, 2005, AM J PHYSIOL-REG I, V288, pR1774, DOI 10.1152/ajpregu.00815.2004; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Teismann P, 2003, P NATL ACAD SCI USA, V100, P5473, DOI 10.1073/pnas.0837397100	29	489	523	1	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 11	2011	334	6057					809	813		10.1126/science.1209200	http://dx.doi.org/10.1126/science.1209200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845US	22021672	Green Accepted			2022-12-28	WOS:000296849600048
J	Eaton, J; McCay, L; Semrau, M; Chatterjee, S; Baingana, F; Araya, R; Ntulo, C; Thornicroft, G; Saxena, S				Eaton, Julian; McCay, Layla; Semrau, Maya; Chatterjee, Sudipto; Baingana, Florence; Araya, Ricardo; Ntulo, Christina; Thornicroft, Graham; Saxena, Shekhar			Global Mental Health 4 Scale up of services for mental health in low-income and middle-income countries	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIAL; RURAL DISTRICT; TREATMENT GAP; SOUTH-AFRICA; PRIMARY-CARE; SRI-LANKA; DISORDERS; INTERVENTION; POLICY; GOA	Mental disorders constitute a huge global burden of disease, and there is a large treatment gap, particularly in low-income and middle-income countries. One response to this issue has been the call to scale up mental health services. We assess progress in scaling up such services worldwide using a systematic review of literature and a survey of key national stakeholders in mental health. The large number of programmes identified suggested that successful strategies can be adopted to overcome barriers to scaling up, such as the low priority accorded to mental health, scarcity of human and financial resources, and difficulties in changing poorly organised services. However, there was a lack of well documented examples of services that had been taken to scale that could guide how to replicate successful scaling up in other settings. Recommendations are made on the basis of available evidence for how to take forward the process of scaling up services globally.	[Eaton, Julian] CBM Int, W Africa Reg Offi, Abuja 2, Garki, Nigeria; [McCay, Layla] London Sch Hyg & Trop Med, London WC1, England; [Semrau, Maya; Thornicroft, Graham] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Chatterjee, Sudipto] Sangath Soc, Goa, India; [Baingana, Florence] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Araya, Ricardo] Univ Bristol, Acad Unit Psychiat, Bristol, Avon, England; [Ntulo, Christina] BasicNeeds UK, Kampala, Uganda; [Saxena, Shekhar] WHO, Dept Mental Hlth & Subst Abuse, CH-1211 Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London; Makerere University; University of Bristol; World Health Organization	Eaton, J (corresponding author), CBM Int, W Africa Reg Offi, Abuja 2, Garki, Nigeria.	julian_eaton@cbm-westafrica.org	Thornicroft, Graham/B-4027-2010; McCay, Layla/H-4030-2017; Araya, Ricardo/S-3144-2019	Thornicroft, Graham/0000-0003-0662-0879; McCay, Layla/0000-0003-1759-5218; Araya, Ricardo/0000-0002-0420-5148; Semrau, Maya/0000-0003-0366-1093	National Institute for Health Research (NIHR); NIHR Specialist Mental Health Biomedical Research Centre at the Institute of Psychiatry, King's College London; South London and Maudsley NHS Foundation Trust; UK Medical Research Council; Wellcome Trust; Department for International Development (DFID) [201446] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Specialist Mental Health Biomedical Research Centre at the Institute of Psychiatry, King's College London; South London and Maudsley NHS Foundation Trust; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Department for International Development (DFID)	We thank the respondents to the survey (listed on webappendix pp 34 37) for sharing their knowledge of mental health services in the countries in which they work and Alex Sales (Tavistock Centre, UK) and Joel Amah (CBM, Togo) for Spanish and French translations, respectively, of the survey and associated responses. The Librarian Service at the London School of Hygiene and Tropical Medicine helped to undertake the systematic review. For the case study of West Bank and Gaza, we thank Nargiza Khodjaeva (Technical Officer on Mental Health, WHO Office in Jerusalem), Hazem Ashour (President of Mental Health Unit of the Ministry of Health in the West Bank), and Mustafa Elmasri (WHO local consultant in Gaza) for their contributions. GT is supported in relation to a National Institute for Health Research (NIHR) Applied Programme grant awarded to the South London and Maudsley NHS Foundation Trust, and in relation to the NIHR Specialist Mental Health Biomedical Research Centre at the Institute of Psychiatry, King's College London and the South London and Maudsley NHS Foundation Trust. GT holds a visiting professorship at the University of KwaZulu Natal in Durban. MS is supported by a PhD studentship grant from the UK Medical Research Council. FB is supported by a Wellcome Trust Research Fellowship Grant. The views expressed in this review are those of the authors and do not necessarily represent the decisions, policies, or views of their respective institutions.	[Anonymous], 2009, MENT HLTH SYST SEL L; Araya Mesfin, 2009, Ethiop Med J, V47, P61; Araya R, 2009, LANCET, V374, P597, DOI 10.1016/S0140-6736(09)61490-2; Assalman Iyas, 2008, Int Psychiatry, V5, P64; Barbui C, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000322; Basic Needs, 2009, COMM MENT HLTH PRACT; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Benegal V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000170; Caldas de Almeida J, 2008, INNOVATIVE MENTAL HL; Chahine L M, 2009, East Mediterr Health J, V15, P1596; Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2; Chisholm D, 2007, BRIT J PSYCHIAT, V191, P528, DOI 10.1192/bjp.bp.107.038463; Cohen A, 2011, INT J MENT HEALTH SY, V5, DOI 10.1186/1752-4458-5-3; Cronin B, 2007, ANNU REV INFORM SCI, V41, pVII, DOI 10.1002/aris.2007.1440410101; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Department for International Development, UG KEY FACTS; Dias A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002333; Eaton J, 2008, Afr J Psychiatry (Johannesbg), V11, P179; Eaton J, 2008, SOC PSYCH PSYCH EPID, V43, P552, DOI 10.1007/s00127-008-0321-5; Eaton Julian, 2009, Int Psychiatry, V6, P63; Eaton J, 2009, AFR J PSYCHIATRY, V12, P1; Flisher AJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000235; Guerra M, 2009, BRIT J PSYCHIAT, V195, P510, DOI 10.1192/bjp.bp.109.064055; Gureje O, 2009, WORLD PSYCHIATRY, V8, P115; Hanlon C, 2010, WORLD PSYCHIATRY, V9, P185; IHME, 2010, FIN GLOB HLTH 2010 D; Inter-Agency Standing Committee (IASC), 2007, IASC GUID MENT HLTH; Jacob KS, 2007, LANCET, V370, P1061, DOI 10.1016/S0140-6736(07)61241-0; Jenkins R, 2010, INT J MENT HEALTH SY, V4, DOI 10.1186/1752-4458-4-17; Kauye F, 2007, INT PSYCHIAT, V4, P9; Kauye Felix, 2008, Int Psychiatry, V5, P29; Kigozi F, 2007, S AFRICAN PSYCHIAT R, V10, P17, DOI DOI 10.4314/AJPSY.V10I1.30228; Kiima D, 2010, INT J MENT HEALTH SY, V4, DOI 10.1186/1752-4458-4-19; Killion C, 2009, ARCH PSYCHIAT NURS, V23, P157, DOI 10.1016/j.apnu.2008.05.005; Kohn R, 2004, B WORLD HEALTH ORGAN, V82, P858; Lewin S A, 2005, Cochrane Database Syst Rev, pCD004015; Maiga DD, 2011, INF PSYCHIAT, V87, P127, DOI DOI 10.3917/INPSY.8702.0127; Mangham LJ, 2010, HEALTH POLICY PLANN, V25, P85, DOI 10.1093/heapol/czp066; Mari JJ, 2010, ACTA PSYCHIAT SCAND, V121, P152, DOI 10.1111/j.1600-0447.2009.01476.x; Mari JD, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000165; Mateus Mario D, 2008, Int J Ment Health Syst, V2, P12, DOI 10.1186/1752-4458-2-12; Mbuba CK, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000162; Ministry of Health, 2010, ANN HLTH SECT PERF R; Murray CJL, 2008, LANCET, V371, P1191, DOI 10.1016/S0140-6736(08)60526-7; Mwape L, 2010, INT J MENT HEALTH SY, V4, DOI 10.1186/1752-4458-4-21; Omar MA, 2010, INT J MENT HEALTH SY, V4, DOI 10.1186/1752-4458-4-24; On'okoko Michel Okitapoy, 2010, Int Psychiatry, V7, P41; Patel V, 2009, PSYCHOL MED, V39, P1759, DOI 10.1017/S0033291709005224; Patel V, 2008, LANCET, V372, P1354, DOI 10.1016/S0140-6736(08)61556-1; Patel V, 2008, SAJP-S AFR J PSYCHI, V14, P108; Patel V, 2008, J CHILD PSYCHOL PSYC, V49, P313, DOI 10.1111/j.1469-7610.2007.01824.x; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Patel V, 2010, LANCET, V376, P2086, DOI 10.1016/S0140-6736(10)61508-5; Patel V, 2010, WORLD PSYCHIATRY, V9, P169; Patel V, 2010, JAMA-J AM MED ASSOC, V303, P1976, DOI 10.1001/jama.2010.616; Patel V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000160; Patel V, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000159; Patel V, 2009, INT J PUBLIC HEALTH, V54, P1, DOI 10.1007/s00038-009-0016-z; Patel VH, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-4; Pemjean Alfredo, 2010, Int Psychiatry, V7, P7; Petersen I, 2009, HEALTH POLICY PLANN, V24, P140, DOI 10.1093/heapol/czn049; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Prince MJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000176; Rahman A, 2009, ANN TROP MED PARASIT, V103, P95, DOI 10.1179/136485909X398186; Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2; Raja S, 2010, INT J MENT HEALTH SY, V4, DOI 10.1186/1752-4458-4-11; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Saraceno B, 2007, LANCET, V370, P1164, DOI 10.1016/S0140-6736(07)61263-X; Saraceno B, 2007, INT J PUBLIC HEALTH, V52, P140, DOI 10.1007/s00038-007-7013-x; Saxena S, 2006, BRIT J PSYCHIAT, V188, P81, DOI 10.1192/bjp.bp.105.011221; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; Shengelia B, 2005, SOC SCI MED, V61, P97, DOI 10.1016/j.socscimed.2004.11.055; Shyangwa Pramod M, 2008, Int Psychiatry, V5, P36; Silove D, 2008, ARCH GEN PSYCHIAT, V65, P1205, DOI 10.1001/archpsyc.65.10.1205; Siva N, 2010, LANCET, V375, P880, DOI 10.1016/S0140-6736(10)60370-4; Souza Renato, 2009, Int J Ment Health Syst, V3, P17, DOI 10.1186/1752-4458-3-17; Ssebunnya J, 2010, AFR J PSYCHIATRY, V13, P128; Thara Rangawsamy, 2008, Int J Ment Health Syst, V2, P11, DOI 10.1186/1752-4458-2-11; Thornicroft G, 2007, LANCET, V370, P807, DOI 10.1016/S0140-6736(07)61392-0; Thornicroft G, 2010, WORLD PSYCHIATRY, V9, P67; Trans-Cultural Psychiatry Organisation, 2010, PSYCH SUPP CHILDR AS; United Nations Economic and Social Council and WHO, 2009, KEY MESS NONC DIS IN; van Heerden MS, 2008, SAJP-S AFR J PSYCHI, V14, P4; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7; WHO, 2008, MENT HLTH GAP ACT PR; WHO, 2022, MENT DIS; WHO, 2001, WORLD HLTH REP MENT; WHO/UNESCO/ILO/IDDC, 2010, COMM BAS REH GUID SU; Wickramage KST, 2009, MENTAL HLTH SRI LANK; World Bank, 2010, DAT COUNTR LEND GROU; World Health Organization, 2016, MHGAP INT GUID MENT; World Health Organization (WHO), 2008, INT MENT HLTH PRIM C; World Network of Users and Survivors of Psychiatry, 2008, IMPL MAN UN CONV RIG; Xin Yu, 2010, Int Psychiatry, V7, P3	94	376	387	2	46	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 29	2011	378	9802					1592	1603		10.1016/S0140-6736(11)60891-X	http://dx.doi.org/10.1016/S0140-6736(11)60891-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	844SL	22008429				2022-12-28	WOS:000296767500025
J	Kang, HJ; Kawasawa, YI; Cheng, F; Zhu, Y; Xu, XM; Li, MF; Sousa, AMM; Pletikos, M; Meyer, KA; Sedmak, G; Guennel, T; Shin, Y; Johnson, MB; Krsnik, Z; Mayer, S; Fertuzinhos, S; Umlauf, S; Lisgo, SN; Vortmeyer, A; Weinberger, DR; Mane, S; Hyde, TM; Huttner, A; Reimers, M; Kleinman, JE; Sestan, N				Kang, Hyo Jung; Kawasawa, Yuka Imamura; Cheng, Feng; Zhu, Ying; Xu, Xuming; Li, Mingfeng; Sousa, Andre M. M.; Pletikos, Mihovil; Meyer, Kyle A.; Sedmak, Goran; Guennel, Tobias; Shin, Yurae; Johnson, Matthew B.; Krsnik, Zeljka; Mayer, Simone; Fertuzinhos, Sofia; Umlauf, Sheila; Lisgo, Steven N.; Vortmeyer, Alexander; Weinberger, Daniel R.; Mane, Shrikant; Hyde, Thomas M.; Huttner, Anita; Reimers, Mark; Kleinman, Joel E.; Sestan, Nenad			Spatio-temporal transcriptome of the human brain	NATURE			English	Article							GENE-EXPRESSION; PYRAMIDAL NEURONS; LIFE-SPAN; INSIGHTS; DIFFERENTIATION; TBR1; NEUROLIGINS; PROJECTIONS; MUTATIONS; EVOLUTION	Brain development and function depend on the precise regulation of gene expression. However, our understanding of the complexity and dynamics of the transcriptome of the human brain is incomplete. Here we report the generation and analysis of exon-level transcriptome and associated genotyping data, representing males and females of different ethnicities, from multiple brain regions and neocortical areas of developing and adult post-mortem human brains. We found that 86 per cent of the genes analysed were expressed, and that 90 per cent of these were differentially regulated at the whole-transcript or exon level across brain regions and/or time. The majority of these spatio-temporal differences were detected before birth, with subsequent increases in the similarity among regional transcriptomes. The transcriptome is organized into distinct co-expression networks, and shows sex-biased gene expression and exon usage. We also profiled trajectories of genes associated with neurobiological categories and diseases, and identified associations between single nucleotide polymorphisms and gene expression. This study provides a comprehensive data set on the human brain transcriptome and insights into the transcriptional foundations of human neurodevelopment.	[Kang, Hyo Jung; Kawasawa, Yuka Imamura; Cheng, Feng; Zhu, Ying; Xu, Xuming; Li, Mingfeng; Sousa, Andre M. M.; Pletikos, Mihovil; Meyer, Kyle A.; Sedmak, Goran; Shin, Yurae; Johnson, Matthew B.; Krsnik, Zeljka; Mayer, Simone; Fertuzinhos, Sofia; Sestan, Nenad] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Kang, Hyo Jung; Kawasawa, Yuka Imamura; Cheng, Feng; Zhu, Ying; Xu, Xuming; Li, Mingfeng; Sousa, Andre M. M.; Pletikos, Mihovil; Meyer, Kyle A.; Sedmak, Goran; Shin, Yurae; Johnson, Matthew B.; Krsnik, Zeljka; Mayer, Simone; Fertuzinhos, Sofia; Sestan, Nenad] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Sousa, Andre M. M.] Univ Porto, Abel Salazar Biomed Sci Inst, Grad Program Areas Basic & Appl Biol, P-4099003 Oporto, Portugal; [Pletikos, Mihovil; Sedmak, Goran] Univ Zagreb, Sch Med, Croatian Inst Brain Res, Grad Program Neurosci, Zagreb 10000, Croatia; [Guennel, Tobias; Reimers, Mark] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23298 USA; [Mayer, Simone] Int Max Planck Res Sch Mol Biol, Msc PhD Mol Biol Program, D-37077 Gottingen, Germany; [Umlauf, Sheila; Mane, Shrikant] Yale Univ, Sch Med, Yale Ctr Genome Anal, New Haven, CT 06510 USA; [Lisgo, Steven N.] Newcastle Univ, Inst Med Genet, Int Ctr Life, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Vortmeyer, Alexander; Huttner, Anita] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Weinberger, Daniel R.; Hyde, Thomas M.; Kleinman, Joel E.] NIMH, Clin Brain Disorders Branch, NIH, Bethesda, MD 20892 USA; [Hyde, Thomas M.] Johns Hopkins Univ Med Campus, Lieber Inst Brain Dev, Baltimore, MD 21205 USA	Yale University; Yale University; Universidade do Porto; University of Zagreb; Virginia Commonwealth University; Max Planck Society; Yale University; Newcastle University - UK; Yale University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Johns Hopkins University; Johns Hopkins Medicine	Sestan, N (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA.	nenad.sestan@yale.edu	Sedmak, Goran/AAK-3342-2021; Sousa, André M. M. M. M./C-1203-2015; Sedmak, Goran/AAB-3436-2019; Fertuzinhos, Sofia MS/G-8316-2011; Zhu, Ying/T-2268-2019; Cheng, Feng/A-9760-2009; Krsnik, Zeljka/AAI-2999-2020; Mayer, Simone/H-1840-2015	Sedmak, Goran/0000-0002-9049-2461; Sousa, André M. M. M. M./0000-0003-1740-5066; Sedmak, Goran/0000-0002-9049-2461; Cheng, Feng/0000-0003-3619-8090; Mayer, Simone/0000-0002-6381-2474; Lisgo, Steven/0000-0001-5186-3971; Krsnik, Zeljka/0000-0001-5238-6820; Zhu, Ying/0000-0002-6594-3734	Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD000836]; China Scholarship Council; Portuguese Foundation for Science and Technology; Samsung Scholarship Foundation; German Academic Exchange Service - DAAD; NIDA [DA026119]; US National Institutes of Health [MH081896, MH089929, NS054273]; Kavli Foundation; NARSAD; James S. McDonnell Foundation;  [G0700089];  [GR082557]; MRC [G0700089, G9900837] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD000836] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD000836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH081896, RC2MH089929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054273, U24NS051869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA026119] Funding Source: NIH RePORTER; Medical Research Council [G9900837, G0700089] Funding Source: researchfish	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); China Scholarship Council(China Scholarship Council); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Samsung Scholarship Foundation(Samsung); German Academic Exchange Service - DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kavli Foundation; NARSAD(NARSAD); James S. McDonnell Foundation; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Belanger, V. Imamovic, R. Johnson, P. Larton, S. Lindsay, B. Poulos, J. Rajan, D. Rimm and R. Zielke for assistance with tissue acquisition, D. Singh for technical assistance, I. Kostovic and Z. Petanjek for dendrite measurements, P. Levitt for suggesting the inclusion of ITC in the study, and D. Karolchik and A. Zweig for help in creating tracks for the UCSC Genome Browser. We also thank A. Beckel-Mitchener, M. Freund, M. Gerstein, D. Geschwind, T. Insel, M. Judas, J. Knowles, E. Lein, P. Levitt, N. Parikshak and members of the Sestan laboratory for discussions and criticism. Tissue was obtained from several sources including the Human Fetal Tissue Repository at the Albert Einstein College of Medicine, the NICHD Brain and Tissue Bank for Developmental Disorders at the University of Maryland, the Laboratory of Developmental Biology at the University of Washington (supported by grant HD000836 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development) and the Joint MRC/Wellcome Trust Human Developmental Biology Resource (http://hdbr.org) at the IHG, Newcastle Upon Tyne (UK funding awards G0700089 and GR082557). Support for predoctoral fellowships was provided by the China Scholarship Council (Y.Z.), the Portuguese Foundation for Science and Technology (A. M. M. S.), the Samsung Scholarship Foundation (Y.S.), a Fellowship of the German Academic Exchange Service - DAAD (S. Mayer) and NIDA grant DA026119 (T. G.). This work was supported by grants from the US National Institutes of Health (MH081896, MH089929, NS054273), the Kavli Foundation and NARSAD, and by a James S. McDonnell Foundation Scholar Award (N.S.).	Abrahams BS, 2007, P NATL ACAD SCI USA, V104, P17849, DOI 10.1073/pnas.0706128104; Ariani F, 2008, AM J HUM GENET, V83, P89, DOI 10.1016/j.ajhg.2008.05.015; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Han WQ, 2011, P NATL ACAD SCI USA, V108, P3041, DOI 10.1073/pnas.1016723108; Hansen DV, 2011, NEURON, V70, P645, DOI 10.1016/j.neuron.2011.05.006; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hill RS, 2005, NATURE, V437, P64, DOI 10.1038/nature04103; Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Ip BK, 2010, J ANAT, V217, P300, DOI 10.1111/j.1469-7580.2010.01259.x; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Kostovic I, 2006, DEV MED CHILD NEUROL, V48, P388, DOI 10.1017/S0012162206000831; Kwan KY, 2008, P NATL ACAD SCI USA, V105, P16021, DOI 10.1073/pnas.0806791105; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Liu C, 2010, MOL PSYCHIATR, V15, P779, DOI 10.1038/mp.2009.128; McKenna WL, 2011, J NEUROSCI, V31, P549, DOI 10.1523/JNEUROSCI.4131-10.2011; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Perroud N., 2010, PHARMACOGENOMICS J; Petanjek Z, 2008, CEREB CORTEX, V18, P915, DOI 10.1093/cercor/bhm124; Preuss TM, 2004, NAT REV GENET, V5, P850, DOI 10.1038/nrg1469; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Reinius B, 2009, MOL PSYCHIATR, V14, P988, DOI 10.1038/mp.2009.79; Ren CZ, 2006, GENOMICS, V88, P163, DOI 10.1016/j.ygeno.2006.03.021; Rubenstein JLR, 2011, J CHILD PSYCHOL PSYC, V52, P339, DOI 10.1111/j.1469-7610.2010.02307.x; Somel M, 2010, GENOME RES, V20, P1207, DOI 10.1101/gr.106849.110; State MW, 2010, NEURON, V68, P254, DOI 10.1016/j.neuron.2010.10.004; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sun T, 2005, SCIENCE, V308, P1794, DOI 10.1126/science.1110324; Svenningsson P, 2006, SCIENCE, V311, P77, DOI 10.1126/science.1117571; Vawter MP, 2004, NEUROPSYCHOPHARMACOL, V29, P373, DOI 10.1038/sj.npp.1300337; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Weickert CS, 2009, MOL PSYCHIATR, V14, P558, DOI 10.1038/mp.2009.5; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	49	1238	1254	8	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2011	478	7370					483	489		10.1038/nature10523	http://dx.doi.org/10.1038/nature10523			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	22031440	Green Accepted			2022-12-28	WOS:000296194200036
J	Ettinger, WH				Ettinger, Walter H.			Can Hospitalization-Associated Disability Be Prevented?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ettinger, Walter H.] Univ Massachusetts, Med Ctr, Sch Med, Div Geriatr Med,Dept Med, Worcester, MA 01655 USA; [Ettinger, Walter H.] Univ Massachusetts, Med Ctr, UMass Mem Med Ctr, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Ettinger, WH (corresponding author), 55 N Lake Ave, Worcester, MA 01655 USA.	walter.ettinger@umassmemorial.org						[Anonymous], FED REG; Baztan JJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b50; Covinsky KE, 2011, JAMA-J AM MED ASSOC, V306, P1782, DOI 10.1001/jama.2011.1556; Department of Health and Human Services Office of Inspector General, 2010, OEI060900090 DEP HLT; Dykes PC, 2010, JAMA-J AM MED ASSOC, V304, P1912, DOI 10.1001/jama.2010.1567; Fryback DG, 2010, MEASURING HLTH RELAT; Gill TM, 2010, JAMA-J AM MED ASSOC, V304, P1919, DOI 10.1001/jama.2010.1568; Massachusetts Hospital Association, 2011, SUMM TRENDS SEL NURS; Mehta KM, 2011, J AM GERIATR SOC, V59, P1206, DOI 10.1111/j.1532-5415.2011.03409.x	9	18	18	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 26	2011	306	16					1800	1801		10.1001/jama.2011.1563	http://dx.doi.org/10.1001/jama.2011.1563			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HH	22028358				2022-12-28	WOS:000296181600027
J	Spence, D				Spence, Des			FROM THE FRONTLINE The abuse of privileged children	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 26	2011	343								d6914	10.1136/bmj.d6914	http://dx.doi.org/10.1136/bmj.d6914			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	840CY	22031917				2022-12-28	WOS:000296417100019
J	Stoltzfus, T; Hall, MA				Stoltzfus, Timothy; Hall, Mark A.			Not So Fast - Jurisdictional Barriers to the ACA Litigation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Stoltzfus, Timothy] Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA; [Hall, Mark A.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; [Hall, Mark A.] Wake Forest Univ, Sch Law, Winston Salem, NC 27109 USA	Washington & Lee University; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University	Stoltzfus, T (corresponding author), Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA.			Hall, Mark A./0000-0001-6277-144X					0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2011	365	16								10.1056/NEJMp1111295	http://dx.doi.org/10.1056/NEJMp1111295			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835BW	21992496				2022-12-28	WOS:000296009500015
J	Volk, ML; Biggins, SW; Huang, MA; Argo, CK; Fontana, RJ; Anspach, RR				Volk, Michael L.; Biggins, Scott W.; Huang, Mary Ann; Argo, Curtis K.; Fontana, Robert J.; Anspach, Renee R.			Decision Making in Liver Transplant Selection Committees A Multicenter Study	ANNALS OF INTERNAL MEDICINE			English	Article							OUTCOMES	Background: To receive a liver transplant, patients must first be placed on a waiting list-a decision made at most transplant centers by a multidisciplinary committee. The function of these committees has never been studied. Objective: To describe decision making in liver transplant committees and identify opportunities for process improvement. Design: Observational multicenter study. Setting: 4 liver transplant centers in the United States. Participants: 68 members of liver transplant committees across the 4 centers. Measurements: 63 meetings were observed, and 50 committee members were interviewed. Recorded transcripts and field notes were analyzed by using standard qualitative sociologic methods. Results: Although the structure of the meetings varied by center, the process was uniform and primarily involved inductive reasoning to review possible reasons for patient exclusion. Patients were excluded if they were too well, too sick (in the setting of advanced liver disease), or too old or had nonhepatic comorbid conditions, substance abuse problems, or other psychosocial barriers. Dominant themes in the discussions included member angst over deciding who lived or died, a high correlation between psychosocial barriers to transplantation and the patient's socioeconomic status, and the influence of external forces on decision making. Unwritten center policies and confusion regarding advocacy versus stewardship roles were consistently identified as barriers to effective group decision making. Limitations: The use of qualitative methods provides broad understanding but limits specific inferences. The 4 centers may not reflect the practices of every transplant center nationwide. Conclusion: The difficult decisions made by liver transplant committees are reasonably consistent and well-intentioned, but the process might be improved by having more explicit written policies and clarifying roles. This may inform resource allocation in other areas of medicine.	[Volk, Michael L.] Univ Michigan Hlth Syst, Div Gastroenterol & Hepatol, Ann Arbor, MI 48109 USA; Univ Michigan, Ann Arbor, MI 48109 USA; Henry Ford Hlth Syst, Detroit, MI USA; Univ Colorado, Aurora, CO USA; Univ Virginia, Charlottesville, VA USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Henry Ford Health System; Henry Ford Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Virginia	Volk, ML (corresponding author), Univ Michigan Hlth Syst, Div Gastroenterol & Hepatol, 300 N Ingalls St,7C27, Ann Arbor, MI 48109 USA.	mvolk@med.umich.edu	biggins, scott/AAQ-6532-2020		Greenwall Foundation; National Institutes of Health [NIH K23DK085204]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK085204] Funding Source: NIH RePORTER	Greenwall Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	By the Greenwall Foundation (Drs. Volk and Anspach) and by grant NIH K23DK085204 from the National Institutes of Health (Dr. Volk).	Abecassis MM, 2009, AM J TRANSPLANT, V9, P1279, DOI 10.1111/j.1600-6143.2009.02606.x; BECKER HS, 1958, AM SOCIOL REV, V23, P652, DOI 10.2307/2089053; Boulware LE, 2007, AM J TRANSPLANT, V7, P1778, DOI 10.1111/j.1600-6143.2007.01848.x; Cohen DJ, 2008, ANN FAM MED, V6, P331, DOI 10.1370/afm.818; Greitemeyer T, 2006, J EXP PSYCHOL-APPL, V12, P31, DOI 10.1037/1076-898X.12.1.31; Health Resources and Services Administration, 2010, ORG PROC TRANSPL NET; Howard RJ, 2007, AM J TRANSPLANT, V7, P2443, DOI 10.1111/j.1600-6143.2007.01961.x; Institute of Medicine, 2001, CROSSING QUALITY CHA; Iserson KV, 2007, ANN EMERG MED, V49, P275, DOI 10.1016/j.annemergmed.2006.05.019; Kim WR, 2002, HEPATOLOGY, V36, P227, DOI 10.1053/jhep.2002.34734; Murray KF, 2005, HEPATOLOGY, V41, P1407, DOI 10.1002/hep.20704; Patel V, 2004, CAMBRIDGE HDB THINKI; Patton MQ., 2015, QUALITATIVE RES EVAL, V3; Rawls J., 1971, THEORY JUSTICE; Reynolds SJ, 2006, J APPL PSYCHOL, V91, P737, DOI 10.1037/0021-9010.91.4.737; Scientific Registry of Transplant Recipients, 2010, US HOSP LIV TRANSPL; United Network for Organ Sharing, 2011, BYL APP B ATT 1 CRIT; Walker D, 2006, QUAL HEALTH RES, V16, P547, DOI 10.1177/1049732305285972	18	51	51	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2011	155	8					503	U71		10.7326/0003-4819-155-8-201110180-00006	http://dx.doi.org/10.7326/0003-4819-155-8-201110180-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	835WB	22007044	Green Accepted			2022-12-28	WOS:000296066300015
J	Johansson, MEV; Hansson, GC				Johansson, Malin E. V.; Hansson, Gunnar C.			Keeping Bacteria at a Distance	SCIENCE			English	Editorial Material							MUCUS LAYERS; COLON; MUCIN; PROTECTION		[Johansson, Malin E. V.; Hansson, Gunnar C.] Univ Gothenburg, Dept Med Biochem, Gothenburg, Sweden	University of Gothenburg	Johansson, MEV (corresponding author), Univ Gothenburg, Dept Med Biochem, Gothenburg, Sweden.	gunnar.hansson@medkem.gu.se	Hansson, Gunnar C/A-1236-2009; Johansson, Malin E. V./HCH-7451-2022; Hansson, Gunnar C./AAF-7324-2019	Hansson, Gunnar C/0000-0002-1900-1869; Hansson, Gunnar C./0000-0002-1900-1869; Johansson, Malin E. V./0000-0002-4237-6677	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095473] Funding Source: NIH RePORTER; NIAID NIH HHS [U01 AI095473] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bas A, 2011, P NATL ACAD SCI USA, V108, P4376, DOI 10.1073/pnas.1010647108; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Swamy M, 2010, NAT IMMUNOL, V11, P656, DOI 10.1038/ni.1905; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020	10	73	75	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					182	183		10.1126/science.1213909	http://dx.doi.org/10.1126/science.1213909			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998374				2022-12-28	WOS:000295833600030
J	Kuss, SK; Best, GT; Etheredge, CA; Pruijssers, AJ; Frierson, JM; Hooper, LV; Dermody, TS; Pfeiffer, JK				Kuss, Sharon K.; Best, Gavin T.; Etheredge, Chris A.; Pruijssers, Andrea J.; Frierson, Johnna M.; Hooper, Lora V.; Dermody, Terence S.; Pfeiffer, Julie K.			Intestinal Microbiota Promote Enteric Virus Replication and Systemic Pathogenesis	SCIENCE			English	Article							HUMAN POLIOVIRUS RECEPTOR; TRANSGENIC MICE	Intestinal bacteria aid host health and limit bacterial pathogen colonization. However, the influence of bacteria on enteric viruses is largely unknown. We depleted the intestinal microbiota of mice with antibiotics before inoculation with poliovirus, an enteric virus. Antibiotic-treated mice were less susceptible to poliovirus disease and supported minimal viral replication in the intestine. Exposure to bacteria or their N-acetylglucosamine-containing surface polysaccharides, including lipopolysaccharide and peptidoglycan, enhanced poliovirus infectivity. We found that poliovirus binds lipopolysaccharide, and exposure of poliovirus to bacteria enhanced host cell association and infection. The pathogenesis of reovirus, an unrelated enteric virus, also was more severe in the presence of intestinal microbes. These results suggest that antibiotic-mediated microbiota depletion diminishes enteric virus infection and that enteric viruses exploit intestinal microbes for replication and transmission.	[Kuss, Sharon K.; Best, Gavin T.; Etheredge, Chris A.; Hooper, Lora V.; Pfeiffer, Julie K.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Pruijssers, Andrea J.; Dermody, Terence S.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37240 USA; [Pruijssers, Andrea J.; Frierson, Johnna M.; Dermody, Terence S.] Vanderbilt Univ, Sch Med, Elizabeth B Lamb Ctr Pediat Res, Nashville, TN 37240 USA; [Frierson, Johnna M.; Dermody, Terence S.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37240 USA; [Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Hooper, Lora V.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute	Pfeiffer, JK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.	julie.pfeiffer@utsouthwestern.edu	Pruijssers, Andrea J/S-5725-2018	Pruijssers, Andrea J/0000-0001-7910-626X	Public Health Service [T32 AI007520]; T32 AI07611; Elizabeth B. Lamb Center for Pediatric Research; Pew Scholar award;  [F32 NS071986];  [R37 AI38296];  [P30 CA68485];  [P60 DK20593];  [R01 AI74668]; NATIONAL CANCER INSTITUTE [P30CA068485, T32CA009582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074668, T32AI007611, R01AI038296, R37AI038296, T32AI007520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070855, P60DK020593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS071986] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); T32 AI07611; Elizabeth B. Lamb Center for Pediatric Research; Pew Scholar award; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. Duerkop, C. Behrendt-Boyd, J. Charles, J. Richardson, and S. Gore for assistance; B. Levine and V. Sperandio for manuscript comments; and S. Koike for PVRtg mice. This research was supported by Public Health Service awards T32 AI007520 (S. K. K.); F32 NS071986 (A. J. P.); T32 AI07611 (J. M. F.); R37 AI38296, P30 CA68485, and P60 DK20593 (T. S. D.); R01 AI74668 (J. K. P.); the Elizabeth B. Lamb Center for Pediatric Research (T. S. D.); and a Pew Scholar award (J. K. P.). The data reported in the paper are tabulated in the main manuscript and in the supporting online material. The sequence data are available in GenBank (accession no. BankIt1475845 SEq. 10 JN613288).	ABRAMS GD, 1967, P SOC EXP BIOL MED, V126, P301; [Anonymous], 2001, FIELDS VIROLOGY; Barton ES, 2003, J CLIN INVEST, V111, P1823, DOI 10.1172/JCI200316303; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Hayes KS, 2010, SCIENCE, V328, P1391, DOI 10.1126/science.1187703; Ida-Hosonuma M, 2005, J VIROL, V79, P4460, DOI 10.1128/JVI.79.7.4460-4469.2005; Ida-Hosonuma M, 2003, ARCH VIROL, V148, P29, DOI 10.1007/s00705-002-0910-7; KOIKE S, 1991, P NATL ACAD SCI USA, V88, P951, DOI 10.1073/pnas.88.3.951; Kuss SK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000082; Ohka S, 2007, J VIROL, V81, P7902, DOI 10.1128/JVI.02675-06; PODOLSKY DK, 1985, J BIOL CHEM, V260, P8262; REN R, 1990, CELL, V63, P353, DOI 10.1016/0092-8674(90)90168-E; Tyler K. L., 2001, FIELDS VIROLOGY, V1, P1729	13	396	412	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2011	334	6053					249	252		10.1126/science.1211057	http://dx.doi.org/10.1126/science.1211057			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998395	Green Accepted			2022-12-28	WOS:000295833600053
J	Coleman, RE; Marshall, H; Cameron, D; Dodwell, D; Burkinshaw, R; Keane, M; Gil, M; Houston, SJ; Grieve, RJ; Barrett-Lee, PJ; Ritchie, D; Pugh, J; Gaunt, C; Rea, U; Peterson, J; Davies, C; Hiley, V; Gregory, W; Bell, R				Coleman, Robert E.; Marshall, Helen; Cameron, David; Dodwell, David; Burkinshaw, Roger; Keane, Maccon; Gil, Miguel; Houston, Stephen J.; Grieve, Robert J.; Barrett-Lee, Peter J.; Ritchie, Diana; Pugh, Julia; Gaunt, Claire; Rea, Una; Peterson, Jennifer; Davies, Claire; Hiley, Victoria; Gregory, Walter; Bell, Richard		AZURE Investigators	Breast-Cancer Adjuvant Therapy with Zoledronic Acid	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORAL CLODRONATE; FOLLOW-UP; BONE; PAMIDRONATE; DOXORUBICIN; PREVENTION; SURVIVAL; EFFICACY; TRIALS	BACKGROUND Data suggest that the adjuvant use of bisphosphonates reduces rates of recurrence and death in patients with early-stage breast cancer. We conducted a study to determine whether treatment with zoledronic acid, in addition to standard adjuvant therapy, would improve disease outcomes in such patients. METHODS In this open-label phase 3 study, we randomly assigned 3360 patients to receive standard adjuvant systemic therapy either with or without zoledronic acid. The zoledronic acid was administered every 3 to 4 weeks for 6 doses and then every 3 to 6 months to complete 5 years of treatment. The primary end point of the study was disease-free survival. A second interim analysis revealed that a prespecified boundary for lack of benefit had been crossed. RESULTS At a median follow-up of 59 months, there was no significant between-group difference in the primary end point, with a rate of disease-free survival of 77% in each group (adjusted hazard ratio in the zoledronic acid group, 0.98; 95% confidence interval [CI], 0.85 to 1.13; P = 0.79). Disease recurrence or death occurred in 377 patients in the zoledronic acid group and 375 of those in the control group. The numbers of deaths - 243 in the zoledronic acid group and 276 in the control group - were also similar, resulting in rates of overall survival of 85.4% in the zoledronic acid group and 83.1% in the control group (adjusted hazard ratio, 0.85; 95% CI, 0.72 to 1.01; P = 0.07). In the zoledronic acid group, there were 17 confirmed cases of osteonecrosis of the jaw (cumulative incidence, 1.1%; 95% CI, 0.6 to 1.7; P < 0.001) and 9 suspected cases; there were no cases in the control group. Rates of other adverse effects were similar in the two study groups. CONCLUSIONS These findings do not support the routine use of zoledronic acid in the adjuvant management of breast cancer. (Funded by Novartis Pharmaceuticals and the National Cancer Research Network; AZURE Current Controlled Trials number, ISRCTN79831382.)	[Coleman, Robert E.; Burkinshaw, Roger] Univ Sheffield, Acad Unit Clin Oncol, Weston Pk Hosp, Sheffield S10 2SJ, S Yorkshire, England; [Marshall, Helen; Davies, Claire; Hiley, Victoria; Gregory, Walter] Univ Leeds, Clin Trials Res Unit, Leeds, W Yorkshire, England; [Dodwell, David] Univ Leeds, St James Inst Oncol, Leeds, W Yorkshire, England; [Cameron, David] Univ Edinburgh, Western Gen Hosp, Edinburgh, Midlothian, Scotland; [Houston, Stephen J.] Royal Surrey Cty Hosp, St Lukes Canc Ctr, Guildford, Surrey, England; [Grieve, Robert J.] Univ Hosp Coventry & Warwickshire Natl Hosp Serv, Coventry, W Midlands, England; [Barrett-Lee, Peter J.] Velindre Canc Ctr, Cardiff, S Glam, Wales; [Ritchie, Diana] Beatson W Scotland Canc Ctr, Glasgow, Lanark, Scotland; [Pugh, Julia] Inst Canc Res, Clin Trials Support Unit, Sutton, Surrey, England; [Gaunt, Claire] Univ Birmingham, Canc Res United Kingdom Clin Trials Unit, Birmingham, W Midlands, England; [Rea, Una] Natl Serv Scotland, Natl Hlth Serv, Canc Clin Trials Team, Edinburgh, Midlothian, Scotland; [Keane, Maccon] Univ Hosp Galway, Galway, Ireland; [Gil, Miguel] Inst Invest Biomed Bellvitge, Inst Catala Oncol, Barcelona, Spain; [Peterson, Jennifer] Canc Council Victoria, Victoria Cooperat Oncol Grp, Carlton, Vic, Australia; [Bell, Richard] Andrew Love Canc Ctr, Geelong, Vic, Australia	University of Sheffield; Weston Park Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; University of Edinburgh; Royal Surrey County Hospital; Velindre Cancer Centre; Beatson Oncology Centre; University of London; Institute of Cancer Research - UK; University of Birmingham; NHS Blood & Transplant (NHSBT); NHS National Services Scotland; Ollscoil na Gaillimhe-University of Galway; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Cancer Council Victoria	Coleman, RE (corresponding author), Univ Sheffield, Acad Unit Clin Oncol, Weston Pk Hosp, Sheffield S10 2SJ, S Yorkshire, England.	r.e.coleman@sheffield.ac.uk	; Brunet, Joan/C-5292-2018; Wardley, Andrew/N-8135-2015; Perren, Timothy/D-5387-2013; Colomer, Ramon/C-5142-2008	Marshall, Helen/0000-0003-0944-0152; McDermott, Ray/0000-0002-8952-4315; Crown, John/0000-0002-3125-7613; Ciruelos, Eva/0000-0002-2796-1042; Brunet, Joan/0000-0003-1945-3512; Wardley, Andrew/0000-0002-9639-0888; Perren, Timothy/0000-0001-8472-8856; Barrett-Lee, peter/0000-0002-6246-7357; Colomer, Ramon/0000-0002-6393-3444; Lluch, Ana/0000-0003-2766-407X; ARNEDOS, MONICA/0000-0001-5269-1251	Novartis Pharmaceuticals; National Cancer Research Network; Cancer Research UK [10588] Funding Source: researchfish	Novartis Pharmaceuticals(Novartis); National Cancer Research Network; Cancer Research UK(Cancer Research UK)	Supported by a grant from Novartis Pharmaceuticals and by the National Cancer Research Network.	Aft R, 2010, LANCET ONCOL, V11, P421, DOI 10.1016/S1470-2045(10)70054-1; Coleman R, 2011, BREAST CANCER RES TR, V127, P429, DOI 10.1007/s10549-011-1429-y; Coleman RE, 2010, BRIT J CANCER, V102, P1099, DOI 10.1038/sj.bjc.6605604; Diel IJ, 2008, ANN ONCOL, V19, P2007, DOI 10.1093/annonc/mdn429; Eidtmann H, 2010, ANN ONCOL, V21, P2188, DOI 10.1093/annonc/mdq217; *EUR ORG RES TREAT, 2004, MAN CLIN RES BREAST; Gnant M, 2009, NEW ENGL J MED, V360, P679, DOI 10.1056/NEJMoa0806285; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Kristensen B, 2008, ACTA ONCOL, V47, P740, DOI 10.1080/02841860801964988; Marx RE, 2003, J ORAL MAXIL SURG, V61, P1115, DOI 10.1016/S0278-2391(03)00720-1; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Neville-Webbe HL, 2010, EUR J CANCER, V46, P1211, DOI 10.1016/j.ejca.2010.02.041; Nicks KM, 2010, ANN NY ACAD SCI, V1192, P153, DOI 10.1111/j.1749-6632.2009.05349.x; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Ottewell PD, 2008, JNCI-J NATL CANCER I, V100, P1167, DOI 10.1093/jnci/djn240; Ottewell PD, 2008, CLIN CANCER RES, V14, P4658, DOI 10.1158/1078-0432.CCR-07-1545; Powles T, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1384; Saarto T, 2004, ACTA ONCOL, V43, P650, DOI 10.1080/02841860410032885; WHITEHEAD J, 2010, STAT METHODS ME 0927; Woodward EJ, 2010, CURR PHARM DESIGN, V16, P2998	20	354	364	0	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 13	2011	365	15					1396	1405		10.1056/NEJMoa1105195	http://dx.doi.org/10.1056/NEJMoa1105195			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832DQ	21995387	Green Published			2022-12-28	WOS:000295782500007
J	Qato, DM; Alexander, GC				Qato, Dima M.; Alexander, G. Caleb			Improving the Food and Drug Administration's Mandate to Ensure Postmarketing Drug Safety	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Alexander, G. Caleb] Univ Chicago, Ctr Hlth & Social Sci, Chicago, IL 60637 USA; [Qato, Dima M.; Alexander, G. Caleb] Univ Chicago Hosp, Gen Internal Med Sect, Dept Med, Chicago, IL 60637 USA; [Qato, Dima M.] Univ Chicago, NORC, Ctr Demog & Econ Aging, Chicago, IL 60637 USA; [Alexander, G. Caleb] Univ Chicago, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA; [Alexander, G. Caleb] Univ Illinois, Dept Pharm Practice, Chicago Sch Pharm, Chicago, IL USA	University of Chicago; University of Chicago; University of Illinois System; University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Alexander, GC (corresponding author), Univ Chicago, Ctr Hlth & Social Sci, 5841 S Maryland,MC 2007, Chicago, IL 60637 USA.	galexand@uchicago.edu		Qato, Dima/0000-0001-5411-6998	AHRQ HHS [R01 HS0189960] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Alexander GC, 2011, ANN INTERN MED, V154, P833, DOI 10.7326/0003-4819-154-12-201106210-00012; [Anonymous], 2011, TUFTS CTR STUDY DRUG, V13; [Anonymous], GUIDANCE IND FORMAT; [Anonymous], APPROVED RISK EVALUA; Dhalla IA, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5142; Institute of Medicine, FUT DRUG SAF PROM PR; Shrank WH, 2007, HEALTH AFFAIR, V26, P731, DOI 10.1377/hlthaff.26.3.731; Svarstad Bonnie L, 2003, J Am Pharm Assoc (2003), V43, P383, DOI 10.1331/154434503321831102; Willy M, 2011, 27 INT C PHARM THER	9	20	20	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 12	2011	306	14					1595	1596		10.1001/jama.2011.1457	http://dx.doi.org/10.1001/jama.2011.1457			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831FS	21990303				2022-12-28	WOS:000295714700026
J	Varoon, K; Zhang, XY; Elyassi, B; Brewer, DD; Gettel, M; Kumar, S; Lee, JA; Maheshwari, S; Mittal, A; Sung, CY; Cococcioni, M; Francis, LF; McCormick, AV; Mkhoyan, KA; Tsapatsis, M				Varoon, Kumar; Zhang, Xueyi; Elyassi, Bahman; Brewer, Damien D.; Gettel, Melissa; Kumar, Sandeep; Lee, J. Alex; Maheshwari, Sudeep; Mittal, Anudha; Sung, Chun-Yi; Cococcioni, Matteo; Francis, Lorraine F.; McCormick, Alon V.; Mkhoyan, K. Andre; Tsapatsis, Michael			Dispersible Exfoliated Zeolite Nanosheets and Their Application as a Selective Membrane	SCIENCE			English	Article							LAYERED ALUMINOPHOSPHATE; CRYSTALS; NANOPARTICLES; SEPARATION; CHEMISTRY; PRECURSOR; CATALYSTS; MCM-22; DOT; MFI	Thin zeolite films are attractive for a wide range of applications, including molecular sieve membranes, catalytic membrane reactors, permeation barriers, and low-dielectric-constant materials. Synthesis of thin zeolite films using high-aspect-ratio zeolite nanosheets is desirable because of the packing and processing advantages of the nanosheets over isotropic zeolite nanoparticles. Attempts to obtain a dispersed suspension of zeolite nanosheets via exfoliation of their lamellar precursors have been hampered because of their structure deterioration and morphological damage (fragmentation, curling, and aggregation). We demonstrated the synthesis and structure determination of highly crystalline nanosheets of zeolite frameworks MWW and MFI. The purity and morphological integrity of these nanosheets allow them to pack well on porous supports, facilitating the fabrication of molecular sieve membranes.	[Varoon, Kumar; Zhang, Xueyi; Elyassi, Bahman; Brewer, Damien D.; Gettel, Melissa; Kumar, Sandeep; Lee, J. Alex; Maheshwari, Sudeep; Mittal, Anudha; Sung, Chun-Yi; Cococcioni, Matteo; Francis, Lorraine F.; McCormick, Alon V.; Mkhoyan, K. Andre; Tsapatsis, Michael] Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Tsapatsis, M (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 151 Amundson Hall,421 Washington Ave SE, Minneapolis, MN 55455 USA.	tsapatsis@umn.edu	Zhang, Xueyi/G-2532-2011; Cococcioni, Matteo/L-5955-2013; Elyassi, Bahman/B-1497-2008; Tsapatsis, Michael/AAA-2527-2019; Kumar, Sandeep/D-7367-2011	Zhang, Xueyi/0000-0002-3790-5116; Agrawal, Kumar Varoon/0000-0002-5170-6412; Mkhoyan, Andre/0000-0003-3568-5452	U.S. Department of Energy (DOE) [DE-09FE0001322]; Petroleum Institute of Abu Dhabi; NSF [NSF-NIRT CMMI 0707610]; Industrial Partnership for Research in Interfacial and Material Engineering; Minnesota Supercomputing Institute at the University of Minnesota; Catalysis Center for Energy Innovation, an Energy Frontier Research Center; DOE's Office of Science, Office of Basic Energy Sciences [DESC0001004]	U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Petroleum Institute of Abu Dhabi; NSF(National Science Foundation (NSF)); Industrial Partnership for Research in Interfacial and Material Engineering; Minnesota Supercomputing Institute at the University of Minnesota; Catalysis Center for Energy Innovation, an Energy Frontier Research Center; DOE's Office of Science, Office of Basic Energy Sciences	We acknowledge support from the U.S. Department of Energy (DOE) (grant DE-09FE0001322), the Petroleum Institute of Abu Dhabi through the ADMIRE partnership, NSF (grant NSF-NIRT CMMI 0707610), and the Industrial Partnership for Research in Interfacial and Material Engineering and Minnesota Supercomputing Institute at the University of Minnesota. Aspects of this work (MFI nanosheet synthesis and imaging by TEM) were supported as part of the Catalysis Center for Energy Innovation, an Energy Frontier Research Center funded by DOE's Office of Science, Office of Basic Energy Sciences under Award Number DESC0001004. Portions of it were conducted at the University of Minnesota Characterization Facility, which receives partial support from NSF through the National Nanotechnology Infrastructure Network.	Caro J, 2008, MICROPOR MESOPOR MAT, V115, P215, DOI 10.1016/j.micromeso.2008.03.008; Choi J, 2009, SCIENCE, V325, P590, DOI 10.1126/science.1176095; Choi M, 2009, NATURE, V461, P246, DOI 10.1038/nature08288; Corma A, 1998, NATURE, V396, P353, DOI 10.1038/24592; COWLEY JM, 1957, ACTA CRYSTALLOGR, V10, P609, DOI 10.1107/S0365110X57002194; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Gao QM, 1997, J SOLID STATE CHEM, V129, P37, DOI 10.1006/jssc.1996.7211; Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502; Hedlund J, 2003, J MEMBRANE SCI, V222, P163, DOI 10.1016/S0376-7388(03)00285-0; Juttu GG, 2000, MICROPOR MESOPOR MAT, V40, P9, DOI 10.1016/S1387-1811(00)00233-X; KIRKLAND EJ, 1987, ULTRAMICROSCOPY, V23, P77, DOI 10.1016/0304-3991(87)90229-4; Lai ZP, 2003, SCIENCE, V300, P456, DOI 10.1126/science.1082169; Lee PS, 2011, J AM CHEM SOC, V133, P493, DOI 10.1021/ja107942n; LEONOWICZ ME, 1994, SCIENCE, V264, P1910, DOI 10.1126/science.264.5167.1910; Lew CM, 2010, ACCOUNTS CHEM RES, V43, P210, DOI 10.1021/ar900146w; Li Z, 2008, CHEM MATER, V20, P1896, DOI 10.1021/cm702880p; Liu L, 2009, INORG CHEM, V48, P4598, DOI 10.1021/ic900107p; Maheshwari S., 2009, THESIS U MINNESOTA M; Maheshwari S, 2008, J AM CHEM SOC, V130, P1507, DOI 10.1021/ja077711i; NAGAHARA LA, 1994, J VAC SCI TECHNOL B, V12, P1694, DOI 10.1116/1.587265; Narkhede VV, 2009, CHEM MATER, V21, P4339, DOI 10.1021/cm901883e; Ogino I, 2011, J AM CHEM SOC, V133, P3288, DOI 10.1021/ja111147z; Osada M, 2009, J MATER CHEM, V19, P2503, DOI 10.1039/b820160a; Roth WJ, 2011, MICROPOR MESOPOR MAT, V144, P158, DOI 10.1016/j.micromeso.2011.04.006; Rubio C, 2010, EUR J INORG CHEM, P159, DOI 10.1002/ejic.200900915; Schlenker JL, 1996, J APPL CRYSTALLOGR, V29, P178, DOI 10.1107/S0021889895014191; Snyder MA, 2007, ANGEW CHEM INT EDIT, V46, P7560, DOI 10.1002/anie.200604910; Srivastava S, 2008, ACCOUNTS CHEM RES, V41, P1831, DOI 10.1021/ar8001377; Takabashi N, 2011, CHEM MATER, V23, P266, DOI 10.1021/cm102942s; Wu P, 2004, J PHYS CHEM B, V108, P19126, DOI 10.1021/jp037459a; Yu JH, 2003, ACCOUNTS CHEM RES, V36, P481, DOI 10.1021/ar0201557; Yuan HM, 2000, J SOLID STATE CHEM, V151, P145, DOI 10.1006/jssc.2000.8637	32	472	490	21	946	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 7	2011	334	6052					72	75		10.1126/science.1208891	http://dx.doi.org/10.1126/science.1208891			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21980106				2022-12-28	WOS:000295580300041
J	Wood, TA; Lintuvuori, JS; Schofield, AB; Marenduzzo, D; Poon, WCK				Wood, T. A.; Lintuvuori, J. S.; Schofield, A. B.; Marenduzzo, D.; Poon, W. C. K.			A Self-Quenched Defect Glass in a Colloid-Nematic Liquid Crystal Composite	SCIENCE			English	Article							GELS; PARTICLES	Colloidal particles immersed in liquid crystals frustrate orientational order. This generates defect lines known as disclinations. At the core of these defects, the orientational order drops sharply. We have discovered a class of soft solids, with shear moduli up to 10(4) pascals, containing high concentrations of colloidal particles (volume fraction phi greater than or similar to 20%) directly dispersed into a nematic liquid crystal. Confocal microscopy and computer simulations show that the mechanical strength derives from a percolated network of defect lines entangled with the particles in three dimensions. Such a "self-quenched glass" of defect lines and particles can be considered a self-organized analog of the "vortex glass" state in type II superconductors.	[Poon, W. C. K.] Scottish Univ Phys Alliance, Edinburgh EH9 3JZ, Midlothian, Scotland; Univ Edinburgh, Sch Phys & Astron, Edinburgh EH9 3JZ, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Poon, WCK (corresponding author), Scottish Univ Phys Alliance, James Clerk Maxwell Bldg,Kings Bldg,Mayfield Rd, Edinburgh EH9 3JZ, Midlothian, Scotland.	w.poon@ed.ac.uk	Schofield, Andrew Bruce/AAV-4862-2020; Wood, Tiffany/B-2085-2010; Lintuvuori, Juho S/A-9190-2013; Poon, Wilson/V-3495-2019; Lintuvuori, Juho/AAF-8146-2019; Poon, Wilson C K/B-5960-2013	Schofield, Andrew Bruce/0000-0002-8741-856X; Wood, Tiffany/0000-0003-2353-4817; Poon, Wilson/0000-0003-0760-7940; Lintuvuori, Juho/0000-0003-4108-9550; Poon, Wilson C K/0000-0003-0760-7940; Marenduzzo, Davide/0000-0003-3974-4915	Engineering and Physical Sciences Research Council [EP/D071070/1, EP/E030173/1]; EPSRC [EP/D071070/1, EP/E030173/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The work was funded by Engineering and Physical Sciences Research Council grants EP/D071070/1 and EP/E030173/1. We thank R. Besseling and M. Cates for illuminating discussions.	Agarwal A, 2008, ADV MATER, V20, P4804, DOI 10.1002/adma.200800932; Anderson VJ, 2001, EUR PHYS J E, V4, P11, DOI 10.1007/PL00013680; Araki T, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.127801; Araki T, 2011, NAT MATER, V10, P303, DOI [10.1038/nmat2982, 10.1038/NMAT2982]; BENGUIGUI L, 1984, PHYS REV LETT, V53, P2028, DOI 10.1103/PhysRevLett.53.2028; Berthier L, 2011, REV MOD PHYS, V83, P587, DOI 10.1103/RevModPhys.83.587; BOWICK MJ, 1994, SCIENCE, V263, P943, DOI 10.1126/science.263.5149.943; BRANDT EH, 1995, REP PROG PHYS, V58, P1465, DOI 10.1088/0034-4885/58/11/003; BRAY AJ, 1994, ADV PHYS, V43, P357, DOI 10.1080/00018739400101505; BUNNING JD, 1981, J PHYS-PARIS, V42, P1175, DOI 10.1051/jphys:019810042080117500; CHMIELEWSKI AG, 1984, RHEOL ACTA, V23, P207, DOI 10.1007/BF01332076; Cugliandolo LF, 1996, J PHYS A-MATH GEN, V29, P1347, DOI 10.1088/0305-4470/29/7/007; De Gennes, 1995, PHYS LIQUID CRYSTALS; Guzman O, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.235507; Herzig EM, 2007, NAT MATER, V6, P966, DOI 10.1038/nmat2055; Mertelj A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021711; Musevic I, 2008, SOFT MATTER, V4, P195, DOI 10.1039/b714250a; Osterman N, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.061701; Pal SK, 2009, SMALL, V5, P2589, DOI 10.1002/smll.200900961; Poulin P, 1997, SCIENCE, V275, P1770, DOI 10.1126/science.275.5307.1770; Ravnik M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.247801; Stark H, 2001, PHYS REP, V351, P387, DOI 10.1016/S0370-1573(00)00144-7; Stratford K, 2005, SCIENCE, V309, P2198, DOI 10.1126/science.1116589; Tkalec U, 2011, SCIENCE, V333, P62, DOI 10.1126/science.1205705; Torok J, 2000, EUR PHYS J B, V18, P697, DOI 10.1007/s100510070017; WALKER LM, 1995, J RHEOL, V39, P925, DOI 10.1122/1.550624; Woltman SJ, 2007, NAT MATER, V6, P929, DOI 10.1038/nmat2010; Zapotocky M, 1999, SCIENCE, V283, P209, DOI 10.1126/science.283.5399.209	29	124	127	1	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 7	2011	334	6052					79	83		10.1126/science.1209997	http://dx.doi.org/10.1126/science.1209997			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21980107				2022-12-28	WOS:000295580300043
